PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Antonellis, A; Dennis, MY; Burzynski, G; Huynh, J; Maduro, V; Hodonsky, CJ; Khajavi, M; Szigeti, K; Mukkamala, S; Bessling, SL; Pavan, WJ; McCallion, AS; Lupski, JR; Green, ED				Antonellis, Anthony; Dennis, Megan Y.; Burzynski, Grzegorz; Huynh, Jimmy; Maduro, Valerie; Hodonsky, Chani J.; Khajavi, Mehrdad; Szigeti, Kinga; Mukkamala, Sandeep; Bessling, Seneca L.; Pavan, William J.; McCallion, Andrew S.; Lupski, James R.; Green, Eric D.		NISC Comparative Sequencing Progra	A Rare Myelin Protein Zero (MPZ) Variant Alters Enhancer Activity In Vitro and In Vivo	PLOS ONE			English	Article							GROWTH-RESPONSE 2; SCHWANN-CELLS; GENE; MUTATIONS; EGR2; SOX10; TRANSCRIPTION; EXPRESSION; ZEBRAFISH; SEQUENCES	Background: Myelin protein zero (MPZ) is a critical structural component of myelin in the peripheral nervous system. The MPZ gene is regulated, in part, by the transcription factors SOX10 and EGR2. Mutations in MPZ, SOX10, and EGR2 have been implicated in demyelinating peripheral neuropathies, suggesting that components of this transcriptional network are candidates for harboring disease-causing mutations (or otherwise functional variants) that affect MPZ expression. Methodology: We utilized a combination of multi-species sequence comparisons, transcription factor-binding site predictions, targeted human DNA re-sequencing, and in vitro and in vivo enhancer assays to study human non-coding MPZ variants. Principal Findings: Our efforts revealed a variant within the first intron of MPZ that resides within a previously described SOX10 binding site is associated with decreased enhancer activity, and alters binding of nuclear proteins. Additionally, the genomic segment harboring this variant directs tissue-relevant reporter gene expression in zebrafish. Conclusions: This is the first reported MPZ variant within a cis-acting transcriptional regulatory element. While we were unable to implicate this variant in disease onset, our data suggests that similar non-coding sequences should be screened for mutations in patients with neurological disease. Furthermore, our multi-faceted approach for examining the functional significance of non-coding variants can be readily generalized to study other loci important for myelin structure and function.	[Antonellis, Anthony; Hodonsky, Chani J.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Antonellis, Anthony] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Dennis, Megan Y.; Maduro, Valerie; Mukkamala, Sandeep; Green, Eric D.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Burzynski, Grzegorz; Huynh, Jimmy; Bessling, Seneca L.; McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Burzynski, Grzegorz; Huynh, Jimmy; Bessling, Seneca L.; McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Khajavi, Mehrdad; Szigeti, Kinga; Lupski, James R.] Dept Mol & Human Genet, Houston, TX USA; [Szigeti, Kinga] Dept Neurol, Houston, TX USA; [Green, Eric D.; NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr NISC, NIH, Bethesda, MD 20892 USA; [Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Baylor College of Medicine; Baylor College of Medicine	Antonellis, A (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	egreen@nhgri.nih.gov	Burzynski, Grzegorz M/D-2800-2009; Hodonsky, Chani/AAC-8429-2020	Hodonsky, Chani/0000-0001-8566-5877; Pavan, William/0000-0001-8281-5120	National Human Genome Research Institute (National Institutes of Health); Charcot-Marie-Tooth Association; National Institute of General Medical Sciences [R01GM071648]; National Institute of Neurological Diseases and Stroke [R01NS062972, R00NS060983]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS060983, R01NS062972] Funding Source: NIH RePORTER	National Human Genome Research Institute (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Charcot-Marie-Tooth Association; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Intramural Research Program of the National Human Genome Research Institute (National Institutes of Health), a fellowship (AA) and grant (JRL) from the Charcot-Marie-Tooth Association, grant R01GM071648 from the National Institute of General Medical Sciences (ASM), grant R01NS062972 (ASM) from the National Institute of Neurological Diseases and Stroke, and grant R00NS060983 from the National Institute of Neurological Diseases and Stroke (AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonellis A, 2006, HUM MOL GENET, V15, P259, DOI 10.1093/hmg/ddi442; Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Brown AM, 1997, J BIOL CHEM, V272, P28939, DOI 10.1074/jbc.272.46.28939; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elnitski Laura, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1002s00; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Inouye H, 1999, BIOPHYS J, V76, P423, DOI 10.1016/S0006-3495(99)77209-7; Ionasescu VV, 1996, NEUROLOGY, V47, P541, DOI 10.1212/WNL.47.2.541; Jang SW, 2009, J BIOL CHEM, V284, P20111, DOI 10.1074/jbc.M109.022426; Jones EA, 2007, NEURON GLIA BIOL, V3, P377, DOI 10.1017/S1740925X08000173; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kazakova N, 2006, DEV BIOL, V297, P1, DOI 10.1016/j.ydbio.2006.03.020; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Quarles RH, 2002, CELL MOL LIFE SCI, V59, P1851, DOI 10.1007/PL00012510; Roa BB, 1996, HUM MUTAT, V7, P36, DOI 10.1002/(SICI)1098-1004(1996)7:1<36::AID-HUMU5>3.0.CO;2-N; Schweitzer M, 2006, MOL CELL NEUROSCI, V31, P161, DOI 10.1016/j.mcn.2005.10.007; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; SU Y, 1993, P NATL ACAD SCI USA, V90, P10856, DOI 10.1073/pnas.90.22.10856; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Thompson AJ, 2002, J NEUROSCI RES, V67, P766, DOI 10.1002/jnr.10167; TODA K, 1994, J NEUROCHEM, V63, P1646; Warner LE, 1999, HUM MOL GENET, V8, P1245, DOI 10.1093/hmg/8.7.1245; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Yoshida M, 1996, NEURON, V16, P1115, DOI 10.1016/S0896-6273(00)80138-5	43	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14346	10.1371/journal.pone.0014346	http://dx.doi.org/10.1371/journal.pone.0014346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179557	Green Published, gold, Green Submitted			2022-12-27	WOS:000285381200004
J	Daunizeau, J; den Ouden, HEM; Pessiglione, M; Kiebel, SJ; Friston, KJ; Stephan, KE				Daunizeau, Jean; den Ouden, Hanneke E. M.; Pessiglione, Matthias; Kiebel, Stefan J.; Friston, Karl J.; Stephan, Klaas E.			Observing the Observer (II): Deciding When to Decide	PLOS ONE			English	Article							SPEED-ACCURACY TRADEOFF; FREE-ENERGY; BAYESIAN-INFERENCE; DECISION-MAKING; INFORMATION; MODELS; BRAIN	In a companion paper [1], we have presented a generic approach for inferring how subjects make optimal decisions under uncertainty. From a Bayesian decision theoretic perspective, uncertain representations correspond to "posterior" beliefs, which result from integrating (sensory) information with subjective "prior" beliefs. Preferences and goals are encoded through a "loss" (or "utility") function, which measures the cost incurred by making any admissible decision for any given (hidden or unknown) state of the world. By assuming that subjects make optimal decisions on the basis of updated (posterior) beliefs and utility (loss) functions, one can evaluate the likelihood of observed behaviour. In this paper, we describe a concrete implementation of this meta-Bayesian approach (i.e. a Bayesian treatment of Bayesian decision theoretic predictions) and demonstrate its utility by applying it to both simulated and empirical reaction time data from an associative learning task. Here, inter-trial variability in reaction times is modelled as reflecting the dynamics of the subjects' internal recognition process, i.e. the updating of representations (posterior densities) of hidden states over trials while subjects learn probabilistic audio-visual associations. We use this paradigm to demonstrate that our meta-Bayesian framework allows for (i) probabilistic inference on the dynamics of the subject's representation of environmental states, and for (ii) model selection to disambiguate between alternative preferences (loss functions) human subjects could employ when dealing with trade-offs, such as between speed and accuracy. Finally, we illustrate how our approach can be used to quantify subjective beliefs and preferences that underlie inter-individual differences in behaviour.	[Daunizeau, Jean; Friston, Karl J.; Stephan, Klaas E.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Pessiglione, Matthias] Hop La Pitie Salpetriere, Brain & Spine Inst, Paris, France; [Daunizeau, Jean; Stephan, Klaas E.] Univ Zurich, Inst Empir Res Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Kiebel, Stefan J.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [den Ouden, Hanneke E. M.] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Zurich; Max Planck Society; Radboud University Nijmegen	Daunizeau, J (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	j.daunizeau@fil.ion.ucl.ac.uk	Friston, Karl/D-9230-2011; Kiebel, Stefan J/B-1551-2009; Pessiglione, Mathias/E-2141-2017; Daunizeau, Jean/AAB-3996-2019; Ouden, Hanneke den/D-3019-2009; Daunizeau, Jean/F-9225-2010	Friston, Karl/0000-0001-7984-8909; Kiebel, Stefan J/0000-0002-5052-1117; Pessiglione, Mathias/0000-0002-6992-3677; Ouden, Hanneke den/0000-0001-7039-5130; Daunizeau, Jean/0000-0001-9142-1270; Stephan, Klaas Enno/0000-0002-8594-9092	Wellcome Trust; SystemsX.ch; NCCR; University of Zurich	Wellcome Trust(Wellcome Trust); SystemsX.ch; NCCR(Swiss National Science Foundation (SNSF)); University of Zurich	This work was funded by the Wellcome Trust (HDO, KJF), SystemsX.ch (JD, KES) and NCCR "Neural Plasticity" (KES). The authors also gratefully acknowledge support by the University Research Priority Program "Foundations of Human Social Behaviour" at the University of Zurich (JD, KES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAL M, 2003, THESIS ION UK; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bestmann S, 2008, CURR BIOL, V18, P775, DOI 10.1016/j.cub.2008.04.051; Bishop C. M, 2006, PATTERN RECOGNITION; Bogacz R, 2010, Q J EXP PSYCHOL, V63, P863, DOI 10.1080/17470210903091643; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; CAURAUGH JH, 1990, RES Q EXERCISE SPORT, V61, P331, DOI 10.1080/02701367.1990.10607496; DAUNIZEAU J, 2010, NEUROIMAGE IN PRESS; Daunizeau J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015554; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Durbin James, 2001, TIME SERIES ANAL STA, Vsecond; FRISTON K, 2009, NEURAL NETW IN PRESS; Friston KJ, 2007, SYNTHESE, V159, P417, DOI 10.1007/s11229-007-9237-y; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; GLIMCHER P, 2009, HDB NEUROECONOMICS; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; MacKay D. J. C., 2003, INFORM THEORY INFERE; MATTHYS C, PLOS COMP BIOL UNPUB; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Pitt MA, 2002, TRENDS COGN SCI, V6, P421, DOI 10.1016/S1364-6613(02)01964-2; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Summerfield C, 2008, NEURON, V59, P336, DOI 10.1016/j.neuron.2008.05.021; Usher M, 2002, J MATH PSYCHOL, V46, P704, DOI 10.1006/jmps.2002.1420; VANDEKERCKHOVE L, 2010, PSYCHOL MET IN PRESS	34	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15555	10.1371/journal.pone.0015555	http://dx.doi.org/10.1371/journal.pone.0015555			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	694JH	21179484	Green Published, gold			2022-12-27	WOS:000285292500026
J	Drame, PM; Poinsignon, A; Besnard, P; Cornelie, S; Le Mire, J; Toto, JC; Foumane, V; Dos-Santos, MA; Sembene, M; Fortes, F; Simondon, F; Carnevale, P; Remoue, F				Drame, Papa Makhtar; Poinsignon, Anne; Besnard, Patrick; Cornelie, Sylvie; Le Mire, Jacques; Toto, Jean-Claude; Foumane, Vincent; Dos-Santos, Maria Adelaide; Sembene, Mbacke; Fortes, Filomeno; Simondon, Francois; Carnevale, Pierre; Remoue, Franck			Human Antibody Responses to the Anopheles Salivary gSG6-P1 Peptide: A Novel Tool for Evaluating the Efficacy of ITNs in Malaria Vector Control	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; CHILD-MORTALITY; EPIDEMIOLOGIC MARKER; ARTHROPOD SALIVA; GAMBIAE COMPLEX; GLAND PROTEINS; AEDES-AEGYPTI; LYME-DISEASE; BED NETS; MORBIDITY	To optimize malaria control, WHO has prioritised the need for new indicators to evaluate the efficacy of malaria vector control strategies. The gSG6-P1 peptide from gSG6 protein of Anopheles gambiae salivary glands was previously designed as a specific salivary sequence of malaria vector species. It was shown that the quantification of human antibody (Ab) responses to Anopheles salivary proteins in general and especially to the gSG6-P1 peptide was a pertinent biomarker of human exposure to Anopheles. The present objective was to validate this indicator in the evaluation of the efficacy of Insecticide Treated Nets (ITNs). A longitudinal evaluation, including parasitological, entomological and immunological assessments, was conducted on children and adults from a malaria-endemic area before and after the introduction of ITNs. Significant decrease of anti-gSG6-P1 IgG response was observed just after the efficient ITNs use. Interestingly, specific IgG Ab level was especially pertinent to evaluate a short-time period of ITNs efficacy and at individual level. However, specific IgG rose back up within four months as correct ITN use waned. IgG responses to one salivary peptide could constitute a reliable biomarker for the evaluation of ITN efficacy, at short-and long-term use, and provide a valuable tool in malaria vector control based on a real measurement of human-vector contact.	[Drame, Papa Makhtar; Remoue, Franck] Inst Rech Dev, UR016, Cotonou, Benin; [Poinsignon, Anne; Cornelie, Sylvie; Carnevale, Pierre] Inst Rech Dev, UR016, Montpellier, France; [Besnard, Patrick; Le Mire, Jacques; Dos-Santos, Maria Adelaide] Malaria Control Program SONAMET Clin, Lobito, Angola; [Toto, Jean-Claude; Foumane, Vincent] Org Coordinat Lutte Endemies Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon; [Sembene, Mbacke] Cheikh Anta DIOP Univ, Dept Anim Biol, Dakar, Senegal; [Fortes, Filomeno] Minist Publ Hlth, Malaria Control Program, Luanda, Angola; [Simondon, Francois] Inst Rech Dev, VIH SIDA & Malad Associees, UMR145, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University Cheikh Anta Diop Dakar; University of Yaounde I	Drame, PM (corresponding author), Inst Rech Dev, UR016, Cotonou, Benin.	papa-makhtar.drame@ird.fr		cornelie, sylvie/0000-0003-3662-1450; Poinsignon, Anne/0000-0003-2921-4486; Fortes, Fabiane/0000-0001-6217-3474; Simondon, Francois/0000-0003-0395-1314	IRD (Departement Soutien et Formation); Research Ministry of France; Francois Lacoste (Fonds Inkermann); ACERGY-SONAMET Company; French Ministry of Defense (Delegation Generale pour l'Armement); IRD (Departement Expertise et Valorisation)	IRD (Departement Soutien et Formation); Research Ministry of France(European Commission); Francois Lacoste (Fonds Inkermann); ACERGY-SONAMET Company; French Ministry of Defense (Delegation Generale pour l'Armement); IRD (Departement Expertise et Valorisation)	Papa-Makhtar Drame was supported by a fellowship provided by the IRD (Departement Soutien et Formation). Anne Poinsignon was supported by fellowships provided by the Research Ministry of France then by Francois Lacoste (Fonds Inkermann). This work was supported by ACERGY-SONAMET Company (Malaria Control Program), the French Ministry of Defense (Delegation Generale pour l'Armement) and the IRD (Departement Expertise et Valorisation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade BB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-121; [Anonymous], 2004, COCHRANE DB SYST REV; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Billingsley PF, 2006, PARASITE IMMUNOL, V28, P143, DOI 10.1111/j.1365-3024.2006.00805.x; Binka FN, 1998, AM J TROP MED HYG, V59, P80, DOI 10.4269/ajtmh.1998.59.80; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Calzetta M, 2008, AM J TROP MED HYG, V78, P169, DOI 10.4269/ajtmh.2008.78.169; Chouaibou M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-77; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Cuamba N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-2; DAS MK, 1991, J AM MOSQUITO CONTR, V7, P319; Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Lane RS, 1999, AM J TROP MED HYG, V61, P850, DOI 10.4269/ajtmh.1999.61.850; Lombardo F, 2009, INSECT BIOCHEM MOLEC, V39, P457, DOI 10.1016/j.ibmb.2009.04.006; Maxwell CA, 2002, TROP MED INT HEALTH, V7, P1003, DOI 10.1046/j.1365-3156.2002.00966.x; Mussi ADH, 2007, ACTA TROP, V104, P108, DOI 10.1016/j.actatropica.2007.07.011; Nascimento RJ, 2001, AM J TROP MED HYG, V65, P219, DOI 10.4269/ajtmh.2001.65.219; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Peng ZK, 2002, J ALLERGY CLIN IMMUN, V110, P816, DOI 10.1067/mai.2002.128736; POINSIGNON A, 2010, TROP MED IN IN PRESS; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Remoue F., 2005, Update in tropical immunology, P377; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; REUNALA T, 1994, INT ARCH ALLERGY IMM, V104, P366, DOI 10.1159/000236693; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI 10.1017/S003118200400681X; SCHWARTZ BS, 1990, AM J EPIDEMIOL, V132, P58, DOI 10.1093/oxfordjournals.aje.a115643; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Takken W, 2009, TRENDS PARASITOL, V25, P101, DOI 10.1016/j.pt.2008.12.002; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; World Health Organization, 2008, WORLD MAL REP; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	47	61	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15596	10.1371/journal.pone.0015596	http://dx.doi.org/10.1371/journal.pone.0015596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179476	Green Submitted, Green Published, gold			2022-12-27	WOS:000285292500028
J	Jiang, DS; Schwarz, H				Jiang, Dongsheng; Schwarz, Herbert			Regulation of Granulocyte and Macrophage Populations of Murine Bone Marrow Cells by G-CSF and CD137 Protein	PLOS ONE			English	Article							HEMATOPOIETIC GROWTH-FACTORS; COLONY-STIMULATING FACTOR; FACTOR-RECEPTOR FAMILY; HUMAN DENDRITIC CELLS; MONOCYTE ACTIVATION; PROGENITOR CELLS; PROLIFERATION; LIGAND; 4-1BB; DIFFERENTIATION	Background: Granulocytes and monocytes/macrophages differentiate from common myeloid progenitor cells. Granulocyte colony-stimulating factor (G-CSF) and CD137 (4-1BB, TNFRSF9) are growth and differentiation factors that induce granulocyte and macrophage survival and differentiation, respectively. This study describes the influence of G-CSF and recombinant CD137-Fc protein on myelopoiesis. Methodology/Principal Findings: Both, G-CSF and CD137 protein support proliferation and survival of murine bone marrow cells. G-CSF enhances granulocyte numbers while CD137 protein enhances macrophage numbers. Both growth factors together give rise to more cells than each factor alone. Titration of G-CSF and CD137 protein dose-dependently changes the granulocyte/macrophage ratio in bone marrow cells. Both factors individually induce proliferation of hematopoietic progenitor cells (lin(-), c-kit(+)) and differentiation to granulocytes and macrophages, respectively. The combination of G-CSF and CD137 protein further increases proliferation, and results in a higher number of macrophages than CD137 protein alone, and a lower number of granulocytes than G-CSF alone demonstrating that CD137 protein-induced monocytic differentiation is dominant over G-CSF-induced granulocytic differentiation. CD137 protein induces monocytic differentiation even in early hematopoietic progenitor cells, the common myeloid progenitors and the granulocyte macrophage progenitors. Conclusions/Significance: This study confirms earlier data on the regulation of myelopoiesis by CD137 receptor - ligand interaction, and extends them by demonstrating the restriction of this growth promoting influence to the monocytic lineage.	[Jiang, Dongsheng; Schwarz, Herbert] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Jiang, Dongsheng; Schwarz, Herbert] Natl Univ Singapore, Yong Loo Lin Sch Med, Immunol Programme, Singapore 117595, Singapore; [Schwarz, Herbert] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Jiang, DS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore.	phssh@nus.edu.sg	Jiang, Dongsheng/AAG-1284-2020	Jiang, Dongsheng/0000-0003-0961-2671	Singapore Stem Cell Consortium [SSCC-06-009]	Singapore Stem Cell Consortium	This research was supported by grant (SSCC-06-009) from the Singapore Stem Cell Consortium (http://www.sscc.a-star.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COOK N, 1989, EMBO J, V8, P2967, DOI 10.1002/j.1460-2075.1989.tb08446.x; Drenkard D, 2007, FASEB J, V21, P456, DOI 10.1096/fj.05-4739com; Gyger M, 2000, BONE MARROW TRANSPL, V26, P1, DOI 10.1038/sj.bmt.1702464; Heinisch IVWM, 2000, EUR J IMMUNOL, V30, P3441, DOI 10.1002/1521-4141(2000012)30:12<3441::AID-IMMU3441>3.0.CO;2-L; Heinisch IVWM, 2001, J ALLERGY CLIN IMMUN, V108, P21, DOI 10.1067/mai.2001.116864; HOGAN PG, 1988, BLOOD REV, V2, P50, DOI 10.1016/0268-960X(88)90008-2; Jiang D, 2008, STEM CELLS, V26, P2372, DOI 10.1634/stemcells.2008-0158; Jiang DS, 2008, J IMMUNOL, V181, P3923, DOI 10.4049/jimmunol.181.6.3923; Ju SW, 2009, INT IMMUNOL, V21, P1135, DOI 10.1093/intimm/dxp077; Ju SW, 2003, HYBRIDOMA HYBRIDOM, V22, P333, DOI 10.1089/153685903322538872; Kim YJ, 2002, J HEMATOTH STEM CELL, V11, P895, DOI 10.1089/152581602321080556; Kwajah MMS, 2010, EUR J IMMUNOL, V40, P1938, DOI 10.1002/eji.200940105; Laderach D, 2003, CELL IMMUNOL, V226, P37, DOI 10.1016/j.cellimm.2003.11.003; Langstein J, 2000, BIOCHEM BIOPH RES CO, V273, P117, DOI 10.1006/bbrc.2000.2889; Langstein J, 1999, BLOOD, V94, P3161, DOI 10.1182/blood.V94.9.3161.421k31_3161_3168; Langstein J, 1999, J LEUKOCYTE BIOL, V65, P829, DOI 10.1002/jlb.65.6.829; Langstein J, 1998, J IMMUNOL, V160, P2488; Lee SW, 2008, NAT IMMUNOL, V9, P917, DOI 10.1038/ni.1632; Lippert U, 2008, EUR J IMMUNOL, V38, P1024, DOI [10.1002/eji.200737800, 10.1002/eji.200890024]; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; MOORE MAS, 1990, CANCER, V65, P836, DOI 10.1002/1097-0142(19900201)65:3+<836::AID-CNCR2820651331>3.0.CO;2-X; Pauly S, 2002, J LEUKOCYTE BIOL, V72, P35; Saito K, 2004, J BIOL CHEM, V279, P13555, DOI 10.1074/jbc.M303791200; Santangelo S, 2001, ANN SURG, V233, P97, DOI 10.1097/00000658-200101000-00015; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; Schwarz H, 2005, J LEUKOCYTE BIOL, V77, P281, DOI 10.1189/jlb.0904558; Schwarz H, 1996, BLOOD, V87, P2839, DOI 10.1182/blood.V87.7.2839.bloodjournal8772839; SHAO Z, 2010, J LEUKOC BIOL; Shoup M, 1998, ANN SURG, V228, P112, DOI 10.1097/00000658-199807000-00017; Simon HU, 2001, SWISS MED WKLY, V131, P455; Simon HU, 1997, J IMMUNOL, V158, P3902; So T, 2006, INT J HEMATOL, V83, P1, DOI 10.1532/IJH97.05120; Soellner L, 2007, CELL SIGNAL, V19, P1899, DOI 10.1016/j.cellsig.2007.04.014; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839	34	27	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15565	10.1371/journal.pone.0015565	http://dx.doi.org/10.1371/journal.pone.0015565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179444	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900047
J	Lacerda, HM; Richiardi, L; Pettersson, A; Corbin, M; Merletti, F; Akre, O				Lacerda, Hadriano M.; Richiardi, Lorenzo; Pettersson, Andreas; Corbin, Marine; Merletti, Franco; Akre, Olof			Cancer Risk in Mothers of Men Operated for Undescended Testis	PLOS ONE			English	Article							TESTICULAR CANCER; OVARIAN-CANCER; EUROPEAN COUNTRIES; LUNG-CANCER; CRYPTORCHIDISM; SMOKING; AGE; COHORT	Background: Undescended testis, or cryptorchidism, occurs in 2-5% of boys born at term, and by 12 months of age about 1% of all boys have manifest cryptorchidism. Several hormonal substances control this process and disruption of the foetal sex-hormones balance is a potential cause of undescended testis, however, to a great extent the aetiology of cryptorchidism is unclear. Methodology: To study risk factors involved in the aetiology of undescended testis, we assessed cancer risk in 15,885 mothers of men operated for undescended testis in Sweden. Women were followed-up for a median period of 23 years during which 811 first primary malignancies occurred. Their cancer incidence was compared with that in the general population estimating standardized incidence ratio (SIR) and corresponding 95% confidence interval (CI). Principal Findings: The overall cancer risk experienced by the mothers of cryptorchid men did not differ significantly from that of the general population (SIR = 0.94; 95% C.I. = 0.88-1.01). Specifically, there was a reduction in ovarian cancer risk (SIR = 0.72; 95% C.I. = 0.51-0.99), while the risk of lung (SIR = 1.38 95% C.I. 1.03-1.81) and biliary tract/liver cancer (SIR: 1.76, 95% CI: 1.03-2.82) were increased. Conclusions: Although we cannot rule out the role of chance, our data suggest a positive association between undescended testis and maternal lung cancer and a negative association with ovarian cancer, where the first may be partly attributable to smoking and the second to an altered hormonal milieu during pregnancy and thus both exposures may be risk factors for cryptorchidism.	[Lacerda, Hadriano M.; Richiardi, Lorenzo; Corbin, Marine; Merletti, Franco; Akre, Olof] Univ Turin, Canc Epidemiol Unit, CPO, I-10124 Turin, Italy; [Lacerda, Hadriano M.; Richiardi, Lorenzo; Corbin, Marine; Merletti, Franco; Akre, Olof] Univ Turin, CeRMS, I-10124 Turin, Italy; [Pettersson, Andreas; Akre, Olof] Karolinska Inst, Clin Epidemiol Unit, Stockholm, Sweden; [Corbin, Marine] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand	University of Turin; University of Turin; Karolinska Institutet; Massey University	Lacerda, HM (corresponding author), Univ Turin, Canc Epidemiol Unit, CPO, I-10124 Turin, Italy.	hadrilac@gmail.com	richiardi, lorenzo/J-3480-2018	richiardi, lorenzo/0000-0003-0316-9402	Swedish Cancer Society [4952-B04-01XAA]; Region of Piedmont; Stockholm County Council; Karolinska Institutet; Compagnia San Paolo Foundation; Italian Association for Research on Cancer	Swedish Cancer Society(Swedish Cancer Society); Region of Piedmont(Regione Piemonte); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Compagnia San Paolo Foundation(Compagnia di San Paolo); Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro)	The authors were funded by the Swedish Cancer Society (4952-B04-01XAA). The work of Hadriano M. Lacerda was supported by a grant from the Region of Piedmont, and Olof Akre is supported by a grant from the Stockholm County Council and Karolinska Institutet. Lorenzo Richiardi was supported by grants from Compagnia San Paolo Foundation and the Italian Association for Research on Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1994, LANCET, V344, P1250, DOI 10.1016/S0140-6736(94)90749-8; Akre O, 1999, EPIDEMIOLOGY, V10, P364, DOI 10.1097/00001648-199907000-00005; Bergstrom R, 1996, J NATL CANCER I, V88, P727, DOI 10.1093/jnci/88.11.727; BERKOWITZ GS, 1993, PEDIATRICS, V92, P44; BERKOWITZ GS, 1995, EPIDEMIOLOGY, V6, P127, DOI 10.1097/00001648-199503000-00007; Biggs ML, 2002, EPIDEMIOLOGY, V13, P197, DOI 10.1097/00001648-200203000-00015; Brekelmans CTM, 2003, CURR OPIN OBSTET GYN, V15, P63, DOI 10.1097/00001703-200302000-00010; Cnattingius S, 2008, CANCER EPIDEM BIOMAR, V17, P2344, DOI 10.1158/1055-9965.EPI-08-0390; FERNANADA M, 2007, E CAM, P1; GERTIG D, 2008, TXB CANC EPIDEMIOLOG; Gorlova OY, 2007, INT J CANCER, V121, P111, DOI 10.1002/ijc.22615; Hemminki K, 2006, INT J ANDROL, V29, P205, DOI 10.1111/j.1365-2605.2005.00599.x; Jensen MS, 2007, EPIDEMIOLOGY, V18, P220, DOI 10.1097/01.ede.0000254061.90686.9f; Jones ME, 1998, PAEDIATR PERINAT EP, V12, P383; Kaijser M, 2003, CANCER EPIDEM BIOMAR, V12, P643; Levy JB, 1995, J ANDROL, V16, P459; McGlynn KA, 2006, CANCER EPIDEM BIOMAR, V15, P1820, DOI 10.1158/1055-9965.EPI-06-0389; McGlynn KA, 2006, INT J EPIDEMIOL, V35, P787, DOI 10.1093/ije/dyl024; Mucci LA, 2007, CANCER EPIDEM BIOMAR, V16, P1828, DOI 10.1158/1055-9965.EPI-06-0962; MUIR C, 1991, CANC REGISTRATION PR; PETTERSSON A, 2007, NEW ENGLAND J MED; PETTERSSON A, 2007, INT J CANC; RAMANWILMS L, 1995, OBSTET GYNECOL, V85, P141, DOI 10.1016/0029-7844(94)00341-A; Richiardi L, 2004, CANCER EPIDEM BIOMAR, V13, P2157; SWEDEN S, 2007, BACKGROUND FACTS POP; Toppari J, 1999, HORM RES, V51, P261, DOI 10.1159/000023412	26	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14285	10.1371/journal.pone.0014285	http://dx.doi.org/10.1371/journal.pone.0014285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170324	Green Published, gold, Green Submitted			2022-12-27	WOS:000285181400009
J	Dong, MH; Bettencourt, R; Barrett-Connor, E; Loomba, R				Dong, Mamie H.; Bettencourt, Ricki; Barrett-Connor, Elizabeth; Loomba, Rohit			Alanine Aminotransferase Decreases with Age: The Rancho Bernardo Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; BODY-MASS INDEX; SERUM ALANINE; PLASMA ADIPONECTIN; METABOLIC SYNDROME; UNITED-STATES; HEALTHY-SUBJECTS; NATIONAL-HEALTH; VIRUS-INFECTION; HEART-DISEASE	Background: Serum alanine aminotransferase (ALT) is a marker of liver injury. The 2005 American Gastroenterology Association Future Trends Committee report states that serum ALT levels remain constant with age. This study examines the association between serum ALT and age in a community-dwelling cohort in the United States. Methods: A cross-sectional study of 2,364 (54% female) participants aged 30-93 years from the Rancho Bernardo Study cohort who attended a research clinic visit in 1984-87. Demographic, metabolic co-variates, ALT, bilirubin, gamma glutamyl transferase (GGT), albumin, and adiposity signaling biomarkers (leptin, IL-6, adiponectin, ghrelin) were measured. Participants were divided into four-groups based upon age quartile, and multivariable-adjusted least squares of means (LSM) were examined (p for trend <0.05). Results: ALT decreased with increasing age, with mean ALT levels (IU/L) of 23, 21, 20, and 17 for those between quartile ages 30-62, 63-71, 72-77, and 78-93 years (p < 0.0001). Trends of decreasing LSM ALT with age and the decreasing prevalence of categorically defined elevated serum ALT with age remained robust after adjusting for sex, alcohol use, metabolic syndrome components, and biomarkers of adiposity (p-value <0.0001), and was not materially changed after adjusting for bilirubin, GGT, and albumin. Conclusions: ALT levels decrease with age in both men and women independent of metabolic syndrome components, adiposity signaling biomarkers, and other commonly used liver function tests. Further studies are needed to understand the mechanisms responsible for a decline in ALT with age, and to establish the optimal cut-point of normal ALT in the elderly.	[Dong, Mamie H.; Loomba, Rohit] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Bettencourt, Ricki; Barrett-Connor, Elizabeth; Loomba, Rohit] Univ Calif San Diego, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dong, MH (corresponding author), Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA.	roloomba@ucsd.edu	Bettencourt, Ricki/M-3531-2019; Loomba, Rohit/AAE-7831-2019	Loomba, Rohit/0000-0002-4845-9991	American Gastroenterological Association (AGA) Foundation; T. Franklin Williams Scholarship Award; Atlantic Philanthropies, Inc; John A. Hartford Foundation; Association of Specialty Professors; American Gastroenterological Association; UCSD Digestive Diseases Research Development Center, U.S. PHS [DK080506]; National Institutes of Health [RO1AG28507, R37AG007181, RO1DK31801]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, R01DK031801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028507, R37AG007181] Funding Source: NIH RePORTER	American Gastroenterological Association (AGA) Foundation; T. Franklin Williams Scholarship Award; Atlantic Philanthropies, Inc; John A. Hartford Foundation; Association of Specialty Professors; American Gastroenterological Association; UCSD Digestive Diseases Research Development Center, U.S. PHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported in part by the American Gastroenterological Association (AGA) Foundation - Sucampo - ASP Designated Research Award in Geriatric Gastroenterology and by a T. Franklin Williams Scholarship Award; Funding was provided by Atlantic Philanthropies, Inc, the John A. Hartford Foundation, the Association of Specialty Professors, and the American Gastroenterological Association to Rohit Loomba, MD, MHSc. This research was funded in part with the support of the UCSD Digestive Diseases Research Development Center, U.S. PHS grant #DK080506. This work was supported in part by the National Institutes of Health grants RO1AG28507, R37AG007181, and RO1DK31801 to Elizabeth Barrett-Connor, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Angulo P, 1999, HEPATOLOGY, V30, p406A; Arndt V, 1998, INT ARCH OCC ENV HEA, V71, P405, DOI 10.1007/s004200050299; BARRETTCONNOR E, 1989, JAMA-J AM MED ASSOC, V261, P2095, DOI 10.1001/jama.261.14.2095; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Calvaruso V, 2009, J VIRAL HEPATITIS, V16, P529, DOI 10.1111/j.1365-2893.2009.01150.x; Carlson JJ, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-32; Chen ZW, 2008, J ZHEJIANG UNIV-SC B, V9, P616, DOI 10.1631/jzus.B0720016; Choi KM, 2004, EUR J ENDOCRINOL, V150, P715, DOI 10.1530/eje.0.1500715; Coleman PJ, 1998, J INFECT DIS, V178, P954, DOI 10.1086/515696; Davies JS, 2009, MOL ENDOCRINOL, V23, P914, DOI 10.1210/me.2008-0432; Elinav E, 2005, AM J GASTROENTEROL, V100, P2201, DOI 10.1111/j.1572-0241.2005.41822.x; Elinav E, 2006, J AM GERIATR SOC, V54, P1719, DOI 10.1111/j.1532-5415.2006.00921.x; Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677; Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0; Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P4823, DOI 10.1210/jc.2003-030214; Hall KE, 2005, GASTROENTEROLOGY, V129, P1305, DOI 10.1053/j.gastro.2005.06.013; Ioannou GN, 2006, AM J GASTROENTEROL, V101, P76, DOI 10.1111/j.1572-0241.2005.00341.x; Kamada Y, 2009, J CLIN GASTROENTEROL, V43, P995, DOI 10.1097/MCG.0b013e3181962de8; Kariv R, 2006, LIVER INT, V26, P445, DOI 10.1111/j.1478-3231.2006.01197.x; Khedmat H, 2007, WORLD J GASTROENTERO, V13, P889, DOI 10.3748/wjg.v13.i6.889; Langenberg C, 2005, AM J EPIDEMIOL, V162, P1189, DOI 10.1093/aje/kwi338; Langenberg C, 2006, DIABETES CARE, V29, P1363, DOI 10.2337/dc05-2385; Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P712, DOI 10.1093/gerona/glq082; Leclercq I, 1999, ACTA GASTRO-ENT BELG, V62, P16; Liangpunsakul S, 2005, AM J MED SCI, V329, P111, DOI 10.1097/00000441-200503000-00001; Liu CM, 2005, WORLD J GASTROENTERO, V11, P1616, DOI 10.3748/wjg.v11.i11.1616; Loomba R, 2009, ALIMENT PHARM THER, V30, P1137, DOI 10.1111/j.1365-2036.2009.04141.x; Loomba R, 2008, GASTROENTEROLOGY, V134, P953, DOI 10.1053/j.gastro.2008.01.037; Lu JY, 2007, INTERN MED J, V37, P365, DOI 10.1111/j.1445-5994.2007.01364.x; Maahs DM, 2005, CIRCULATION, V111, P747, DOI 10.1161/01.CIR.0000155251.03724.A5; McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328; Miyaaki H, 2008, LIVER INT, V28, P519, DOI 10.1111/j.1478-3231.2007.01614.x; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Mohamadnejad M, 2003, WORLD J GASTROENTERO, V9, P2322; Patt CH, 2003, DIGEST DIS SCI, V48, P797, DOI 10.1023/A:1022809430756; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Qi L, 2007, J CLIN ENDOCR METAB, V92, P3618, DOI 10.1210/jc.2007-0877; Ruhl CE, 2004, AM J CLIN NUTR, V80, P576; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004; Sakai Y, 1997, HEPATOLOGY, V25, P421; Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315; Tarantino G, 2007, CLIN INVEST MED, V30, pE192, DOI 10.25011/cim.v30i5.2895; Wakabayashi H, 2002, J SURG RES, V106, P246, DOI 10.1006/jsre.2002.6462; 1976, PREV MED, V5, P207	48	59	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14254	10.1371/journal.pone.0014254	http://dx.doi.org/10.1371/journal.pone.0014254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170382	Green Published, gold, Green Submitted			2022-12-27	WOS:000285084100008
J	Hasson, D; Gustavsson, P				Hasson, Dan; Gustavsson, Petter			Declining Sleep Quality among Nurses: A Population-Based Four-Year Longitudinal Study on the Transition from Nursing Education to Working Life	PLOS ONE			English	Article							AUSTRALIAN NURSES; STAFF NURSE; STRESS; INSOMNIA; FATIGUE; SATISFACTION; HEALTH; SAMPLE; CARE; PERFORMANCE	Background: Several studies have established impaired sleep is a common problem among nurses. Overworked, fatigued and stressed nurses are at a higher risk of making mistakes that threaten patient safety as well as their own health. The aim of the present study was to longitudinally monitor the development of sleep quality in nurses, starting from the last semester at the university, with three subsequent annual follow-ups once the nurses had entered working life. Methodology/Principal Findings: Nationwide, longitudinal questionnaire study of nursing students and newly qualified nurses in Sweden. The results imply a continuous decline in sleep quality among nurses during the three years of follow-up, starting from their last semester of nursing education and continuing for three years into their working life. The most pronounced short-term decline in sleep quality seems to occur in the transition between student life and working life. Conclusion/Significance: This finding is important since it may affect the quality of care and the health of nurses negatively.	[Hasson, Dan] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Hasson, Dan] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Gustavsson, Petter] Karolinska Inst, Dept Clin Neurosci, Psychol Sect, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet	Hasson, D (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	dan.hasson@ki.se	Hasson, Dan/T-9262-2019	Gustavsson, Petter/0000-0001-9571-9349	AFA (Arbetsmarknadens Forsakringsaktiebolag); FAS (Swedish Council for Working Life and Social Research) Centre for Research on Hearing Problems in Working Life; Tysta Skolan	AFA (Arbetsmarknadens Forsakringsaktiebolag); FAS (Swedish Council for Working Life and Social Research) Centre for Research on Hearing Problems in Working Life(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Tysta Skolan	The LANE study has been made possible by funding from the insurance company AFA (Arbetsmarknadens Forsakringsaktiebolag). DH is supported by a grant from FAS (Swedish Council for Working Life and Social Research) Centre for Research on Hearing Problems in Working Life and Tysta Skolan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L H, 2001, LDI Issue Brief, V6, P1; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P585, DOI 10.1016/S0022-3999(02)00447-6; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Akerstedt T, 2007, PHYSIOL BEHAV, V90, P209, DOI 10.1016/j.physbeh.2006.09.007; Akerstedt T, 2006, SCAND J WORK ENV HEA, V32, P493, DOI 10.5271/sjweh.1054; Akerstedt Torbjorn, 2004, Lakartidningen, V101, P1501; Ancoli-Israel S, 1999, SLEEP, V22, pS347; Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; BENNETT P, 2001, STRESS NURSES COPING, P55; Bird J, 1995, Nurs Stand, V9, P18; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cohen J, 1977, STAT POWER ANAL BEHA, p[xv, 474]; Demerouti E, 2000, J ADV NURS, V32, P454, DOI 10.1046/j.1365-2648.2000.01496.x; Edell-Gustafsson UM, 2002, SCAND J CARING SCI, V16, P179, DOI 10.1046/j.1471-6712.2002.00078.x; ESCOT C, 2001, STRESS LEVELS NURSIN, P273; GOLD DR, 1992, AM J PUBLIC HEALTH, V82, P1011, DOI 10.2105/AJPH.82.7.1011; Goldstein DS, 2002, STRESS, V5, P54, DOI 10.1080/10253890290012345; GRAYTOFT P, 1981, SOC SCI MED-MED SOC, V15, P639, DOI 10.1016/0271-7123(81)90087-0; HALLSTEN L, 2004, ARBETSLIV HALSA 2004, P151; Hasselhorn HM, 2003, WORKING CONDITIONS I; Healy CM, 2000, J ADV NURS, V31, P681, DOI 10.1046/j.1365-2648.2000.01323.x; Hughes RG, 2004, AM J NURS, V104, P36, DOI 10.1097/00000446-200403000-00017; Jean-Louis G, 2000, SLEEP, V23, P1115; Johnson C J, 2003, J Nurs Manag, V11, P336, DOI 10.1046/j.1365-2834.2003.00404.x; Josten EJC, 2003, J ADV NURS, V44, P643, DOI 10.1046/j.0309-2402.2003.02854.x; Kramer M., 1974, REALITY SHOCK WHY NU; Kronholm E, 2006, J SLEEP RES, V15, P276, DOI 10.1111/j.1365-2869.2006.00543.x; KRYGER MH, 2007, 2007 SLEEP AM POLL; Linton SJ, 2004, BRIT J HEALTH PSYCH, V9, P127, DOI 10.1348/135910704773891005; Maben J, 1998, J CLIN NURS, V7, P145, DOI 10.1046/j.1365-2702.1998.00119.x; MARSHALL GD, 2000, ENCY STRESS, P626; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McGrath A, 2003, INT J NURS STUD, V40, P555, DOI 10.1016/S0020-7489(03)00058-0; MCGRATH A, 2003, INT J NURS STUD, V26, P359; McVicar A, 2003, J ADV NURS, V44, P633, DOI 10.1046/j.0309-2402.2003.02853.x; MILLER C, 2004, LEARNING 1 3 YEARS P; Moore Charlotte, 2006, Br J Nurs, V15, P540; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Morin CM, 2003, INSOMNIA CLIN GUIDE; Muecke S, 2005, J ADV NURS, V50, P433, DOI 10.1111/j.1365-2648.2005.03409.x; Neckelmann D, 2007, SLEEP, V30, P873, DOI 10.1093/sleep/30.7.873; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Page A., 2004, KEEPING PATIENTS SAF; Piko B, 1999, J R SOC PROMO HEALTH, V119, P156, DOI 10.1177/146642409911900304; Rogers AE, 2003, SLEEP, V26, pA423; Schenck CH, 2003, JAMA-J AM MED ASSOC, V289, P2475, DOI 10.1001/jama.289.19.2475; Scott LD, 2006, J NURS ADMIN, V36, P86, DOI 10.1097/00005110-200602000-00007; Simon GE, 1997, AM J PSYCHIAT, V154, P1417; Trinkoff AM, 2003, J NURS ADMIN, V33, P153, DOI 10.1097/00005110-200303000-00006; Trinkoff AM, 2003, AM J PREV MED, V24, P270, DOI 10.1016/S0749-3797(02)00639-6; VANCAUTER E, 2000, ENCY STRESS, P447; VGONTZAS AN, 2000, ENCY STRESS, P449; WEINFURT KP, 2000, READING UNDERSTANDIN, pR13; WEST M, 1989, J OCCUP PSYCHOL, V62, P271, DOI 10.1111/j.2044-8325.1989.tb00500.x; Whitehead J, 2001, Br J Nurs, V10, P330; Whitehead J., 2001, BR J NURS, V10, P334; WILLENBERG HS, 2000, ENCY STRESS, P709; Winwood PC, 2006, J ADV NURS, V56, P679, DOI 10.1111/j.1365-2648.2006.04055.x; Winwood PC, 2006, J ADV NURS, V56, P438, DOI 10.1111/j.1365-2648.2006.04011.x	62	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14265	10.1371/journal.pone.0014265	http://dx.doi.org/10.1371/journal.pone.0014265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691MJ	21170381	Green Published, gold, Green Submitted			2022-12-27	WOS:000285084100015
J	Martin, T; Lu, SW; van Tilbeurgh, H; Ripoll, DR; Dixelius, C; Turgeon, BG; Debuchy, R				Martin, Tom; Lu, Shun-Wen; van Tilbeurgh, Herman; Ripoll, Daniel R.; Dixelius, Christina; Turgeon, B. Gillian; Debuchy, Robert			Tracing the Origin of the Fungal alpha 1 Domain Places Its Ancestor in the HMG-Box Superfamily: Implication for Fungal Mating-Type Evolution	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; TRANSCRIPTION FACTOR; NEUROSPORA-CRASSA; SACCHAROMYCES-CEREVISIAE; MOLECULAR-BASIS; SEX GENES; SEQUENCE; DNA; LOCI; IDENTIFICATION	Background: Fungal mating types in self-incompatible Pezizomycotina are specified by one of two alternate sequences occupying the same locus on corresponding chromosomes. One sequence is characterized by a gene encoding an HMG protein, while the hallmark of the other is a gene encoding a protein with an alpha 1 domain showing similarity to the M protein of Saccharomyces cerevisiae. DNA-binding HMG proteins are ubiquitous and well characterized. In contrast, alpha 1 domain proteins have limited distribution and their evolutionary origin is obscure, precluding a complete understanding of mating-type evolution in Ascomycota. Although much work has focused on the role of the S. cerevisiae Mat alpha 1p protein as a transcription factor, it has not yet been placed in any of the large families of sequence-specific DNA-binding proteins. Methodology/Principal Findings: We present sequence comparisons, phylogenetic analyses, and in silico predictions of secondary and tertiary structures, which support our hypothesis that the alpha 1 domain is related to the HMG domain. We have also characterized a new conserved motif in alpha 1 proteins of Pezizomycotina. This motif is immediately adjacent to and downstream of the alpha 1 domain and consists of a core sequence Y-[LMIF]-x(3)-G-[WL] embedded in a larger conserved motif. Conclusions/Significance: Our data suggest that extant alpha 1-box genes originated from an ancestral HMG gene, which confirms the current model of mating-type evolution within the fungal kingdom. We propose to incorporate alpha 1 proteins in a new subclass of HMG proteins termed MAT alpha_ HMG.	[Martin, Tom; Dixelius, Christina] Swedish Univ Agr Sci SLU, Dept Plant Biol & Forest Genet, Uppsala Bioctr, Uppsala, Sweden; [Lu, Shun-Wen; Ripoll, Daniel R.; Turgeon, B. Gillian] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [van Tilbeurgh, Herman] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR8619, F-91405 Orsay, France; [Debuchy, Robert] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France	Swedish University of Agricultural Sciences; Cornell University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Martin, T (corresponding author), Swedish Univ Agr Sci SLU, Dept Plant Biol & Forest Genet, Uppsala Bioctr, Uppsala, Sweden.	robert.debuchy@igmors.u-psud.fr	Debuchy, Robert/J-3040-2012	Debuchy, Robert/0000-0003-1206-0361; Turgeon, Barbara/0000-0001-7979-7662	Swedish University of Agricultural Sciences (Sveriges lantbruksuniversitet, SLU); NSF; Agence nationale de la recherche (ANR) [ANR-05-BLAN-0385];  [SWE-2005-453]	Swedish University of Agricultural Sciences (Sveriges lantbruksuniversitet, SLU); NSF(National Science Foundation (NSF)); Agence nationale de la recherche (ANR)(French National Research Agency (ANR)); 	TM is supported by Sida SWE-2005-453 (http://www.sida.se) and the Swedish University of Agricultural Sciences (Sveriges lantbruksuniversitet, SLU) (http://www.slu.se/sv/fakulteter/nl). SWL was supported by an NSF grant to BGT (http://www.nsf.gov/). CD is supported by the Swedish University of Agricultural Sciences (Sveriges lantbruksuniversitet, SLU) (http://www.slu.se/sv/fakulteter/nl). RD is supported by contract ANR-05-BLAN-0385 from the Agence nationale de la recherche (ANR) (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Casselton L, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P536; Casselton LA, 2008, BIOESSAYS, V30, P711, DOI 10.1002/bies.20782; Cerdan R, 2001, PROTEIN SCI, V10, P504, DOI 10.1110/ps.35501; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Cozijnsen AJ, 2003, CURR GENET, V43, P351, DOI 10.1007/s00294-003-0391-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; DENNY P, 1992, NUCLEIC ACIDS RES, V20, P2887, DOI 10.1093/nar/20.11.2887; Dyer PS, 2008, CURR BIOL, V18, pR207, DOI 10.1016/j.cub.2008.01.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fraser JA, 2007, EUKARYOT CELL, V6, P622, DOI 10.1128/EC.00018-07; GLASS NL, 1990, P NATL ACAD SCI USA, V87, P4912, DOI 10.1073/pnas.87.13.4912; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Grossetete S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-81; HAGEN DC, 1993, MOL CELL BIOL, V13, P6866, DOI 10.1128/MCB.13.11.6866; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KAHMANN R, 1995, CURR OPIN GENET DEV, V5, P559, DOI 10.1016/0959-437X(95)80023-9; Kanematsu S, 2007, CURR GENET, V52, P11, DOI 10.1007/s00294-007-0132-3; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee SC, 2008, CURR BIOL, V18, P1675, DOI 10.1016/j.cub.2008.09.030; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Lee SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010539; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; McGuire IC, 2001, FUNGAL GENET BIOL, V34, P131, DOI 10.1006/fgbi.2001.1295; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Nielsen O, 1996, MOL GEN GENET, V253, P387, DOI 10.1007/PL00008604; Nixon CE, 2010, GENETICS, V185, P497, DOI 10.1534/genetics.110.115907; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Pascual-Garcia A, 2010, PROTEINS, V78, P181, DOI 10.1002/prot.22616; PHILLEY ML, 1994, GENETICS, V137, P715; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; Sadreyev RI, 2009, NUCLEIC ACIDS RES, V37, pW90, DOI 10.1093/nar/gkp360; Saupe S, 1996, MOL GEN GENET, V250, P115, DOI 10.1007/BF02191831; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Soullier S, 1999, J MOL EVOL, V48, P517, DOI 10.1007/PL00006495; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Tsong Annie E., 2007, P75; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Turgeon B. Gillian, 2007, P93; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Waalwijk C, 2004, EUR J PLANT PATHOL, V110, P533, DOI 10.1023/B:EJPP.0000032393.72921.5b; Waalwijk C, 2002, FUNGAL GENET BIOL, V35, P277, DOI 10.1006/fgbi.2001.1322; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wirsel S, 1998, MOL GEN GENET, V259, P272, DOI 10.1007/s004380050813; Yokoyama E, 2003, APPL ENVIRON MICROB, V69, P5019, DOI 10.1128/AEM.69.8.5019-5022.2003; YUAN YLO, 1993, GENE DEV, V7, P1584, DOI 10.1101/gad.7.8.1584; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	76	68	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15199	10.1371/journal.pone.0015199	http://dx.doi.org/10.1371/journal.pone.0015199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170349	Green Submitted, Green Published, gold			2022-12-27	WOS:000285084100027
J	Gatton, ML; Cheng, Q				Gatton, Michelle L.; Cheng, Qin			Interrupting Malaria Transmission: Quantifying the Impact of Interventions in Regions of Low to Moderate Transmission	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM GAMETOCYTES; SUB-SAHARAN AFRICA; MODEL; INTENSITY; DYNAMICS; PATTERNS; IMMUNITY; VIETNAM; VACCINE; RATES	Malaria has been eliminated from over 40 countries with an additional 39 currently planning for, or committed to, elimination. Information on the likely impact of available interventions, and the required time, is urgently needed to help plan resource allocation. Mathematical modelling has been used to investigate the impact of various interventions; the strength of the conclusions is boosted when several models with differing formulation produce similar data. Here we predict by using an individual-based stochastic simulation model of seasonal Plasmodium falciparum transmission that transmission can be interrupted and parasite reintroductions controlled in villages of 1,000 individuals where the entomological inoculation rate is <7 infectious bites per person per year using chemotherapy and bed net strategies. Above this transmission intensity bed nets and symptomatic treatment alone were not sufficient to interrupt transmission and control the importation of malaria for at least 150 days. Our model results suggest that 1) stochastic events impact the likelihood of successfully interrupting transmission with large variability in the times required, 2) the relative reduction in morbidity caused by the interventions were age-group specific, changing over time, and 3) the post-intervention changes in morbidity were larger than the corresponding impact on transmission. These results generally agree with the conclusions from previously published models. However the model also predicted changes in parasite population structure as a result of improved treatment of symptomatic individuals; the survival probability of introduced parasites reduced leading to an increase in the prevalence of sub-patent infections in semi-immune individuals. This novel finding requires further investigation in the field because, if confirmed, such a change would have a negative impact on attempts to eliminate the disease from areas of moderate transmission.	[Gatton, Michelle L.; Cheng, Qin] Queensland Inst Med Res, Malaria Drug Resistance & Chemotherapy Lab, Brisbane, Qld 4006, Australia; [Gatton, Michelle L.] Griffith Med Res Coll, Brisbane, Qld, Australia; [Cheng, Qin] Australian Army Malaria Inst, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute	Gatton, ML (corresponding author), Queensland Inst Med Res, Malaria Drug Resistance & Chemotherapy Lab, Brisbane, Qld 4006, Australia.	michelle.gatton@qimr.edu.au	Gatton, Michelle/H-3139-2019; Cheng, Qin/AAO-2198-2020	Gatton, Michelle/0000-0003-1188-609X; Cheng, Qin/0000-0001-7776-4437	National Institutes of Health [2RO1 AI-47500]; NHMRC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by National Institutes of Health grant 2RO1 AI-47500. M. L. G. was supported in part by an NHMRC Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Albrecht L, 2010, GENE, V453, P37, DOI 10.1016/j.gene.2010.01.001; [Anonymous], MALARIA PRINCIPLES P; Boyd M. F., 1937, American Journal of Tropical Medicine, V17, P213; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; BURKOT TR, 1990, AM J TROP MED HYG, V43, P321, DOI 10.4269/ajtmh.1990.43.321; COATNEY GR, 1971, PRIMATE MALARIA; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Deressa W, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-49; Dicko A, 2007, AM J TROP MED HYG, V77, P1028, DOI 10.4269/ajtmh.2007.77.1028; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Eichner M, 2001, T ROY SOC TROP MED H, V95, P497, DOI 10.1016/S0035-9203(01)90016-1; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garnham PCC., 1966, MALARIA PARASITES OT; Gatton ML, 2006, J ANTIMICROB CHEMOTH, V58, P47, DOI 10.1093/jac/dkl158; Gatton ML, 2004, INFECT IMMUN, V72, P6538, DOI 10.1128/IAI.72.11.6538-6545.2004; Gatton ML, 2004, PARASITOLOGY, V128, P367, DOI 10.1017/S0031182003004608; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Giao PT, 2005, TROP MED INT HEALTH, V10, P919, DOI 10.1111/j.1365-3156.2005.01472.x; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu WD, 2003, T ROY SOC TROP MED H, V97, P43, DOI 10.1016/S0035-9203(03)90018-6; Gu WD, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-256; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Koella JC, 1996, PARASITOLOGY, V113, P105, DOI 10.1017/S0031182000066348; KROEGER A, 1995, AM J TROP MED HYG, V53, P313, DOI 10.4269/ajtmh.1995.53.313; KWIATKOWSKI D, 1989, J EXP MED, V169, P357, DOI 10.1084/jem.169.1.357; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; McKenzie FE, 2002, AM J TROP MED HYG, V67, P571, DOI 10.4269/ajtmh.2002.67.571; Moonen B, 2009, SHRINKING MALARIA MA, P1; Nshakira N, 2002, TROP MED INT HEALTH, V7, P309, DOI 10.1046/j.1365-3156.2002.00858.x; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Orjuela-Sanchez P, 2009, PARASITOLOGY, V136, P1097, DOI 10.1017/S0031182009990539; Paget-McNicol S, 2002, PARASITOLOGY, V124, P225, DOI 10.1017/S0031182001001160; Pichon G, 2000, PARASITOLOGY, V121, P115, DOI 10.1017/S0031182099006277; Rieckmann KH, 2006, ANN TROP MED PARASIT, V100, P647, DOI 10.1179/136485906X112185; SMALLEY ME, 1977, PARASITOLOGY, V74, P1, DOI 10.1017/S0031182000047478; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Song JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-57; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; *UN SECR DEP EC SO, 2007, WORLD POP PROSP 2004; Van Nam N, 2005, TROP MED INT HEALTH, V10, P357, DOI 10.1111/j.1365-3156.2005.01387.x; White LJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-212; WHO, 2008, GLOB MAL CONTR EL RE; *WHO, 2006, LIF TABL WHO MEMB ST; World Health Organization, 2007, MAL EL FIELD MAN LOW	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15149	10.1371/journal.pone.0015149	http://dx.doi.org/10.1371/journal.pone.0015149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152042	Green Published, Green Submitted, gold			2022-12-27	WOS:000284868000027
J	Glessner, JT; Wang, K; Sleiman, PMA; Zhang, HT; Kim, CE; Flory, JH; Bradfield, JP; Imielinski, M; Frackelton, EC; Qiu, HJ; Mentch, F; Grant, SFA; Hakonarson, H				Glessner, Joseph T.; Wang, Kai; Sleiman, Patrick M. A.; Zhang, Haitao; Kim, Cecilia E.; Flory, James H.; Bradfield, Jonathan P.; Imielinski, Marcin; Frackelton, Edward C.; Qiu, Haijun; Mentch, Frank; Grant, Struan F. A.; Hakonarson, Hakon			Duplication of the SLIT3 Locus on 5q35.1 Predisposes to Major Depressive Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION	Major depressive disorder (MDD) is a common psychiatric and behavioral disorder. To discover novel variants conferring risk to MDD, we conducted a whole-genome scan of copy number variation (CNV), including 1,693 MDD cases and 4,506 controls genotyped on the Perlegen 600K platform. The most significant locus was observed on 5q35.1, harboring the SLIT3 gene (P = 2x10(-3)). Extending the controls with 30,000 subjects typed on the Illumina 550 k array, we found the CNV to remain exclusive to MDD cases (P = 3.2x10(-9)). Duplication was observed in 5 unrelated MDD cases encompassing 646 kb with highly similar breakpoints. SLIT3 is integral to repulsive axon guidance based on binding to Roundabout receptors. Duplication of 5q35.1 is a highly penetrant variation accounting for 0.7% of the subset of 647 cases harboring large CNVs, using a threshold of a minimum of 10 SNPs and 100 kb. This study leverages a large dataset of MDD cases and controls for the analysis of CNVs with matched platform and ethnicity. SLIT3 duplication is a novel association which explains a definitive proportion of the largely unknown etiology of MDD.	[Glessner, Joseph T.; Wang, Kai; Sleiman, Patrick M. A.; Zhang, Haitao; Kim, Cecilia E.; Flory, James H.; Bradfield, Jonathan P.; Imielinski, Marcin; Frackelton, Edward C.; Qiu, Haijun; Mentch, Frank; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Genet, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Glessner, JT (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu		Glessner, Joseph/0000-0001-5131-2811	Children's Hospital of Philadelphia; Cotswold Foundation; National Center for Research Resources [U54 RR020278-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER	Children's Hospital of Philadelphia; Cotswold Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study is supported by an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia (HH) and by a Research Development Award from the Cotswold Foundation (HH & SFAG). The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278-01 (S. Gabriel, principal investigator) from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; HAKONARSON H, 2009, P 59 ANN M AM SOC HU; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Knowles JA, 2009, MOL PSYCHIAT; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; MUGLIA P, 2008, MOL PSYCHIAT; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326	16	48	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15463	10.1371/journal.pone.0015463	http://dx.doi.org/10.1371/journal.pone.0015463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152026	Green Published, gold, Green Submitted			2022-12-27	WOS:000284821300020
J	Chintagari, NR; Jin, N; Gao, L; Wang, Y; Xi, D; Liu, L				Chintagari, Narendranath Reddy; Jin, Nili; Gao, Li; Wang, Yang; Xi, Dong; Liu, Lin			Role of GABA Receptors in Fetal Lung Development in Rats	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; GAMMA-AMINOBUTYRIC-ACID; ALVEOLAR EPITHELIAL-CELLS; SMOOTH MUSCLE ACTIN; TRACHEAL OCCLUSION; CLEFT-PALATE; PULMONARY HYPOPLASIA; MICE DEFICIENT; KNOCKOUT MICE; II CELLS	Fluid accumulation is critical for lung distension and normal development. The multi-subunit c-amino butyric acid type A receptors (GABA(A)) mainly act by mediating chloride ion (Cl-) fluxes. Since fetal lung actively secretes Cl- -rich fluid, we investigated the role of GABA(A) receptors in fetal lung development. The physiological ligand, GABA, and its synthesizing enzyme, glutamic acid decarboxylase, were predominantly localized to saccular epithelium. To examine the effect of activating GABA(A) receptors in fetal lung development in vivo, timed-pregnant rats of day 18 gestation underwent an in utero surgery for the administration of GABA(A) receptor modulators into the fetuses. The fetal lungs were isolated on day 21 of gestation and analyzed for changes in fetal lung development. Fetuses injected with GABA had a significantly higher body weight and lung weight when compared to phosphate-buffered saline (control)-injected fetuses. GABA-injected fetal lungs had a higher number of saccules than the control. GABA increased the number of alveolar epithelial type II cells as indicated by surfactant protein C-positive cells. However, GABA decreased the number of alpha-smooth muscle actin-positive myofibroblasts, but did not affect the number of Clara cells or alveolar type I cells. GABA-mediated effects were blocked by the GABA(A) receptor antagonist, bicuculline. GABA also increased cell proliferation and Cl- efflux in fetal distal lung epithelial cells. In conclusion, our results indicate that GABA(A) receptors accelerate fetal lung development, likely through an enhanced cell proliferation and/or fluid secretion.	[Chintagari, Narendranath Reddy; Jin, Nili; Gao, Li; Wang, Yang; Xi, Dong; Liu, Lin] Oklahoma State Univ, Lundberg Kienlen Lung Biol & Toxicol Lab, Dept Physiol Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Liu, L (corresponding author), Oklahoma State Univ, Lundberg Kienlen Lung Biol & Toxicol Lab, Dept Physiol Sci, Stillwater, OK 74078 USA.	lin.liu@okstate.edu	Wang, Yang/G-4496-2014	Wang, Yang/0000-0002-2626-478X	NIH [HL083188, HL087884]; Center for Veterinary Health Sciences, Oklahoma State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL087884, R01HL083188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Veterinary Health Sciences, Oklahoma State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH HL083188 and NIH HL087884 (LL), and a seed grant from the Center for Veterinary Health Sciences, Oklahoma State University (NRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Barghorn A, 1998, PEDIATR PATHOL LAB M, V18, P5, DOI 10.1080/107710498174173; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Blaisdell CJ, 2004, AM J PHYSIOL-LUNG C, V286, pL420, DOI 10.1152/ajplung.00113.2003; Chen ZM, 2004, BIOCHEM BIOPH RES CO, V319, P774, DOI 10.1016/j.bbrc.2004.05.048; Chintagari NR, 2006, AM J RESP CELL MOL, V34, P677, DOI 10.1165/rcmb.2005-0418OC; Chiu P, 2008, PRENATAL DIAG, V28, P592, DOI 10.1002/pd.2007; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; CULIAT CT, 1995, NAT GENET, V11, P344, DOI 10.1038/ng1195-344; Davies LA, 2008, MOL THER, V16, P812, DOI 10.1038/mt.2008.25; De Paepe ME, 1999, AM J RESP CELL MOL, V21, P65, DOI 10.1165/ajrcmb.21.1.3511; FAUZA DO, 1994, J PEDIATR SURG, V29, P882, DOI 10.1016/0022-3468(94)90008-6; Flecknoe S, 2000, AM J PHYSIOL-LUNG C, V278, pL1180, DOI 10.1152/ajplung.2000.278.6.L1180; Geigerseder Christof, 2004, Reprod Biol Endocrinol, V2, P13, DOI 10.1186/1477-7827-2-13; Gillie DJ, 2001, AM J RESP CELL MOL, V25, P14, DOI 10.1165/ajrcmb.25.1.4500; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Harrison MR, 2003, NEW ENGL J MED, V349, P1916, DOI 10.1056/NEJMoa035005; HARRISON MR, 1994, JAMA-J AM MED ASSOC, V271, P382, DOI 10.1001/jama.271.5.382; HILL AC, 1994, ANN THORAC SURG, V57, P946, DOI 10.1016/0003-4975(94)90211-9; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; HOOPER SB, 1995, CLIN EXP PHARMACOL P, V22, P235, DOI 10.1111/j.1440-1681.1995.tb01988.x; Ingbar DH, 1996, AM J PHYSIOL-LUNG C, V270, pL619, DOI 10.1152/ajplung.1996.270.4.L619; Jin N, 2005, CELL TISSUE RES, V321, P173, DOI 10.1007/s00441-005-1130-8; Jin N, 2008, GENE EXPR PATTERNS, V8, P397, DOI 10.1016/j.gep.2008.04.008; Jin NL, 2006, J BIOL CHEM, V281, P36012, DOI 10.1074/jbc.M606895200; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kitterman JA, 2002, AM J PHYSIOL-LUNG C, V282, pL431, DOI 10.1152/ajplung.00161.2001; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V53, P1; Koivusalo AI, 2008, J PEDIATR SURG, V43, P279, DOI 10.1016/j.jpedsurg.2007.10.014; Larson JE, 2006, AM J PHYSIOL-LUNG C, V291, pL4, DOI 10.1152/ajplung.00372.2005; Maltais F, 2003, AM J PHYSIOL-LUNG C, V284, pL622, DOI 10.1152/ajplung.00079.2002; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; MOYA FR, 1995, AM J OBSTET GYNECOL, V173, P1401, DOI 10.1016/0002-9378(95)90624-X; MURRAY CB, 1995, AM J RESP CELL MOL, V12, P597, DOI 10.1165/ajrcmb.12.6.7766424; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Olver RE, 2004, ANNU REV PHYSIOL, V66, P77, DOI 10.1146/annurev.physiol.66.071702.145229; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Schwirtlich M, 2010, FASEB J, V24, P1218, DOI 10.1096/fj.09-143586; Stege G, 2003, PEDIATRICS, V112, P532, DOI 10.1542/peds.112.3.532; Sur C, 2001, J NEUROSCI, V21, P3409, DOI 10.1523/JNEUROSCI.21-10-03409.2001; TENBRINCK R, 1990, J PEDIATR SURG, V25, P426, DOI 10.1016/0022-3468(90)90386-N; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Walter EC, 2009, AM J RESP CRIT CARE, V180, P176, DOI 10.1164/rccm.200901-0046OC; Yamada M, 2005, J HISTOCHEM CYTOCHEM, V53, P735, DOI 10.1369/jhc.4A6483.2005; Zdebik AA, 2004, J BIOL CHEM, V279, P22276, DOI 10.1074/jbc.M309899200	47	10	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14171	10.1371/journal.pone.0014171	http://dx.doi.org/10.1371/journal.pone.0014171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152393	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100047
J	Cobiac, LJ; Vos, T; Veerman, JL				Cobiac, Linda J.; Vos, Theo; Veerman, J. Lennert			Cost-Effectiveness of Interventions to Promote Fruit and Vegetable Consumption	PLOS ONE			English	Article							INCREASE CONSUMPTION; DIETARY INTERVENTION; PRIMARY PREVENTION; PHYSICAL-ACTIVITY; HEALTH; RISK; TRIAL; OVERWEIGHT; DISEASE; BURDEN	Background: Fruits and vegetables are an essential part of the human diet, but many people do not consume the recommended serves to prevent cardiovascular disease and cancer. In this research, we evaluate the cost-effectiveness of interventions to promote fruit and vegetable consumption to determine which interventions are good value for money, and by how much current strategies can reduce the population disease burden. Methods/Principal Findings: In a review of published literature, we identified 23 interventions for promoting fruit and vegetable intake in the healthy adult population that have sufficient evidence for cost-effectiveness analysis. For each intervention, we model the health impacts in disability-adjusted life years (DALYs), the costs of intervention and the potential cost-savings from averting disease treatment, to determine cost-effectiveness of each intervention over the lifetime of the population, from an Australian health sector perspective. Interventions that rely on dietary counselling, telephone contact, worksite promotion or other methods to encourage change in dietary behaviour are not highly effective or cost-effective. Only five out of 23 interventions are less than an A$50,000 per disability-adjusted life year cost-effectiveness threshold, and even the most effective intervention can avert only 5% of the disease burden attributed to insufficient fruit and vegetable intake. Conclusions/Significance: We recommend more investment in evaluating interventions that address the whole population, such as changing policies influencing price or availability of fruits and vegetables, to see if these approaches can provide more effective and cost-effective incentives for improving fruit and vegetable intake.	[Cobiac, Linda J.; Vos, Theo; Veerman, J. Lennert] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	University of Queensland	Cobiac, LJ (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.	l.cobiac@uq.edu.au	Veerman, Lennert/A-9973-2011	Veerman, Lennert/0000-0002-3206-8232	Australia's National Health and Medical Research Council [351558]	Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a grant from Australia's National Health and Medical Research Council (www.nhmrc.gov.au), Project ID no. 351558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ABS, 2006, NAT HLTH SURV CONF U; ABS, 2006, CONS PRIC IND AUSTR; AIHW, 2006, HLTH EXP AUSTR; AIHW, 2001, DIS COSTS IMP STUD D; Appleby J, 2007, BRIT MED J, V335, P358, DOI 10.1136/bmj.39308.560069.BE; Ashfield-Watt PAL, 2007, PUBLIC HEALTH NUTR, V10, P671, DOI 10.1017/S1368980007382517; Australian Bureau of Statistics (ABS), 2009, NAT HLTH SURV SUMM R; Barendregt J J, 1998, Math Popul Stud, V7, P29; Barendregt JJ., 2003, POPUL HEALTH METR, V1, P4, DOI [DOI 10.1186/1478-7954-1-4, 10.1186/1478-7954-1-4]; Begg S., 2007, BURDEN DIS INJURY AU; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bemelmans W, 2008, PREV MED, V46, P127, DOI 10.1016/j.ypmed.2007.07.029; Beresford SAA, 2001, PREV MED, V32, P230, DOI 10.1006/pmed.2000.0806; Bonneux L, 1998, BRIT MED J, V316, P26, DOI 10.1136/bmj.316.7124.26; CARTER R, 2000, TRIAL PROGRAM BUDGET, P1919; CARTER R, 2008, EXPERT REV PHARMACOE, V8; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Cobiac L, 2009, ADDICTION, V104, P1646, DOI 10.1111/j.1360-0443.2009.02708.x; Cobiac LJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000110; Dalziel K, 2007, HEALTH PROMOT INT, V22, P271, DOI 10.1093/heapro/dam027; Dansinger ML, 2007, ANN INTERN MED, V147, P41, DOI 10.7326/0003-4819-147-1-200707030-00007; Dixon H, 1998, PREV MED, V27, P572, DOI 10.1006/pmed.1998.0328; Emmons KM, 1999, J OCCUP ENVIRON MED, V41, P545, DOI 10.1097/00043764-199907000-00003; Engbers LH, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-253; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Gold MR, 1996, COST EFFECTIVENESS H; Greene GW, 2008, GERONTOLOGIST, V48, P378, DOI 10.1093/geront/48.3.378; Haby MM, 2006, INT J OBESITY, V30, P1463, DOI 10.1038/sj.ijo.0803469; Havas S, 2003, PREV MED, V37, P406, DOI 10.1016/S0091-7435(03)00160-9; Hebert J R, 1993, Ann Epidemiol, V3, P629, DOI 10.1016/1047-2797(93)90086-J; Heimendinger J, 2005, J HEALTH COMMUN, V10, P65, DOI 10.1080/10810730500263646; Herman DR, 2008, AM J PUBLIC HEALTH, V98, P98, DOI 10.2105/AJPH.2005.079418; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Kristal AR, 1997, AM J HEALTH PROMOT, V11, P422, DOI 10.4278/0890-1171-11.6.422; Kristal AR, 2000, PREV MED, V31, P380, DOI 10.1006/pmed.2000.0711; Kroke A, 2004, PUBLIC HEALTH NUTR, V7, P279, DOI 10.1079/PHN2003535; Liew D, 2006, EUR J CARDIOV PREV R, V13, P515, DOI 10.1097/01.hjr.0000224488.03221.97; Lock K, 2004, COMP QUANTIFICATION; Marcus AC, 1998, PREV MED, V27, pS16, DOI 10.1006/pmed.1998.0405; Moodie M, 2008, ECON HUM BIOL, V6, P363, DOI 10.1016/j.ehb.2008.06.001; Morgenstern H, 1982, J Community Health, V7, P292, DOI 10.1007/BF01318961; National Health and Medical Research Council (NHMRC), 1999, GUID DEV IMPL EV CLI; Nitzke S, 2007, AM J HEALTH PROMOT, V22, P6, DOI 10.4278/0890-1171-22.1.6; Pomerleau J, 2005, J NUTR, V135, P2486, DOI 10.1093/jn/135.10.2486; Radakovich K, 2006, NUTR CANCER, V55, P44, DOI 10.1207/s15327914nc5501_6; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Roux L, 2008, AM J PREV MED, V35, P578, DOI 10.1016/j.amepre.2008.06.040; Roux L, 2006, OBESITY, V14, P1093, DOI 10.1038/oby.2006.125; Sacerdote C, 2006, INT J EPIDEMIOL, V35, P409, DOI 10.1093/ije/dyi170; Shiell A, 2009, HEALTH RISK SOC, V11, P71, DOI 10.1080/13698570802537029; Sorensen G, 1998, AM J PUBLIC HEALTH, V88, P1685, DOI 10.2105/AJPH.88.11.1685; Sorensen G, 1996, AM J PUBLIC HEALTH, V86, P939, DOI 10.2105/AJPH.86.7.939; Steptoe A, 2003, BRIT MED J, V326, P855, DOI 10.1136/bmj.326.7394.855; Stevens VJ, 2003, PREV MED, V36, P594, DOI 10.1016/S0091-7435(03)00019-7; Tilley BC, 1999, PREV MED, V28, P284, DOI 10.1006/pmed.1998.0439; Van Baal PHM, 2007, HEALTH ECON, V16, P421, DOI 10.1002/hec.1181; Veerman JL, 2006, EUR J PUBLIC HEALTH, V16, P31, DOI 10.1093/eurpub/cki166; Vos T, 2005, AUST NZ J PSYCHIAT, V39, P701, DOI 10.1111/j.1440-1614.2005.01654.x; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization, 2001, MACR HLTH INV HLTH E	61	48	49	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14148	10.1371/journal.pone.0014148	http://dx.doi.org/10.1371/journal.pone.0014148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	687DK	21152389	Green Published, gold			2022-12-27	WOS:000284755100027
J	Corbett, NP; Blimkie, D; Ho, KC; Cai, B; Sutherland, DP; Kallos, A; Crabtree, J; Rein-Weston, A; Lavoie, PM; Turvey, SE; Hawkins, NR; Self, SG; Wilson, CB; Hajjar, AM; Fortuno, ES; Kollmann, TR				Corbett, Nathan P.; Blimkie, Darren; Ho, Kevin C.; Cai, Bing; Sutherland, Darren P.; Kallos, Arlene; Crabtree, Juliet; Rein-Weston, Annie; Lavoie, Pascal M.; Turvey, Stuart E.; Hawkins, Natalie R.; Self, Steven G.; Wilson, Christopher B.; Hajjar, Adeline M.; Fortuno, Edgardo S., III; Kollmann, Tobias R.			Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of Human Blood Mononuclear Cells	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; FLOW-CYTOMETRY; VACCINE DEVELOPMENT; HUMAN NEWBORN; AGE; BIRTH; INFECTIONS; CHILDHOOD; MIFLOWCYT; INFANT	Newborns and young infants suffer increased infectious morbidity and mortality as compared to older children and adults. Morbidity and mortality due to infection are highest during the first weeks of life, decreasing over several years. Furthermore, most vaccines are not administered around birth, but over the first few years of life. A more complete understanding of the ontogeny of the immune system over the first years of life is thus urgently needed. Here, we applied the most comprehensive analysis focused on the innate immune response following TLR stimulation over the first 2 years of life in the largest such longitudinal cohort studied to-date (35 subjects). We found that innate TLR responses (i) known to support Th17 adaptive immune responses (IL-23, IL-6) peaked around birth and declined over the following 2 years only to increase again by adulthood; (ii) potentially supporting antiviral defense (IFN-alpha) reached adult level function by 1 year of age; (iii) known to support Th1 type immunity (IL-12p70, IFN-gamma) slowly rose from a low at birth but remained far below adult responses even at 2 years of age; (iv) inducing IL-10 production steadily declined from a high around birth to adult levels by 1 or 2 years of age, and; (v) leading to production of TNF-alpha or IL-1 beta varied by stimuli. Our data contradict the notion of a linear progression from an 'immature' neonatal to a 'mature' adult pattern, but instead indicate the existence of qualitative and quantitative age-specific changes in innate immune reactivity in response to TLR stimulation.	[Corbett, Nathan P.; Blimkie, Darren; Ho, Kevin C.; Cai, Bing; Sutherland, Darren P.; Kallos, Arlene; Lavoie, Pascal M.; Turvey, Stuart E.; Fortuno, Edgardo S., III; Kollmann, Tobias R.] Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada; [Crabtree, Juliet; Rein-Weston, Annie; Hajjar, Adeline M.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Hawkins, Natalie R.; Self, Steven G.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Wilson, Christopher B.] Bill & Melinda Gates Fdn, Seattle, WA USA	University of British Columbia; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Bill & Melinda Gates Foundation	Corbett, NP (corresponding author), Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada.	tkollm@mac.com	Turvey, Stuart/HGV-1191-2022	Crabtree, Juliet/0000-0003-4921-0087; Turvey, Stuart/0000-0003-1599-1065; Hajjar, Adeline/0000-0002-4838-8070; Fortuno, Edgardo/0000-0001-5294-1679; Corbett, Nathan/0000-0002-7114-8788; Kollmann, Tobias/0000-0003-2403-9762; Lavoie, Pascal/0000-0002-2205-0362	National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01 AI50023]; AllerGen NCE [07-A1A, 07-B2B]; Michael Smith Foundation for Health Research; National Sciences and Engineering Research Council; Burroughs Wellcome Fund; Canadian Institutes of Health Research; SickKids Foundation; Child & Family Research Institute; Women & Children's Health Research Institute (Alberta); Manitoba Institute of Child Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050023] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AllerGen NCE; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); SickKids Foundation; Child & Family Research Institute; Women & Children's Health Research Institute (Alberta); Manitoba Institute of Child Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a National Institute of Allergy and Infectious Diseases, National Institutes of Health Grant number: N01 AI50023 (http://www.nih.gov), AllerGen NCE Grant numbers: 07-A1A, 07-B2B (http://www.allergen-nce.ca), the Michael Smith Foundation for Health Research (http://www.msfhr.org), and the National Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca). TRK is supported in part by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (http://www.bwfund.org), and by a Canadian Institutes of Health Research Training Grant in the Canadian Child Health Clinician Scientist Program in partnership with SickKids Foundation, Child & Family Research Institute (BC), and Women & Children's Health Research Institute (Alberta), Manitoba Institute of Child Health (http://cchcsp.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Blimkie D, 2010, CYTOM PART A, V77A, P546, DOI 10.1002/cyto.a.20862; Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Goriely S, 2008, CURR OPIN ORGAN TRAN, V13, P4, DOI 10.1097/MOT.0b013e3282f406c4; Jansen K, 2008, J IMMUNOL METHODS, V336, P183, DOI 10.1016/j.jim.2008.04.013; Kagina BMN, 2009, VACCINE, V27, P5488, DOI 10.1016/j.vaccine.2009.06.103; Kato K, 1935, J PEDIATR-US, V7, P7, DOI 10.1016/S0022-3476(35)80143-1; Klein J.O., 2006, CURRENT CONCEPTS INF; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lewis D. B., 2006, INFECT DIS FETUS NEW, P25; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Marchini G, 2000, ACTA PAEDIATR, V89, P1082, DOI 10.1080/713794557; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Schultz C, 2002, CLIN DIAGN LAB IMMUN, V9, P295, DOI 10.1128/CDLI.9.2.295-298.2002; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Turvey SE, 2006, CLIN IMMUNOL, V120, P1, DOI 10.1016/j.clim.2006.02.003; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105	36	125	127	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15041	10.1371/journal.pone.0015041	http://dx.doi.org/10.1371/journal.pone.0015041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152080	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100053
J	Raghavan, K; Ruskin, HJ; Perrin, D; Goasmat, F; Burns, J				Raghavan, Karthika; Ruskin, Heather J.; Perrin, Dimitri; Goasmat, Francois; Burns, John			Computational Micromodel for Epigenetic Mechanisms	PLOS ONE			English	Article							HISTONE-MODIFICATION; METHYLATION; CANCER; ACETYLATION	Characterization of the epigenetic profile of humans since the initial breakthrough on the human genome project has strongly established the key role of histone modifications and DNA methylation. These dynamic elements interact to determine the normal level of expression or methylation status of the constituent genes in the genome. Recently, considerable evidence has been put forward to demonstrate that environmental stress implicitly alters epigenetic patterns causing imbalance that can lead to cancer initiation. This chain of consequences has motivated attempts to computationally model the influence of histone modification and DNA methylation in gene expression and investigate their intrinsic interdependency. In this paper, we explore the relation between DNA methylation and transcription and characterize in detail the histone modifications for specific DNA methylation levels using a stochastic approach.	[Raghavan, Karthika; Ruskin, Heather J.; Perrin, Dimitri; Goasmat, Francois] Dublin City Univ, Ctr Sci Comp & Complex Syst Modeling, Dublin 9, Ireland; [Burns, John] Inst Technol, Tallaght, Ireland	Dublin City University; Institute of Technology Tralee; Technological University Dublin	Raghavan, K (corresponding author), Dublin City Univ, Ctr Sci Comp & Complex Syst Modeling, Dublin 9, Ireland.	kaghavan@computing.dcu.ie	Perrin, Dimitri/H-8630-2013	Perrin, Dimitri/0000-0002-4007-5256; Burns, John/0000-0001-9194-4995; Burns, John/0000-0003-2701-4229	Science Foundation Ireland [07/RFP/CMSR724]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	Financial support from Science Foundation Ireland (Research Frontiers Programme 07/RFP/CMSR724) is warmly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; David Allis C., 2007, EPIGENETICS-US; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; DOERFLER W, 1990, FEBS LETT, V268, P329, DOI 10.1016/0014-5793(90)81280-2; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JUNG I, 2009, IBC, V1, P1; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Perrin D, 2008, ERCIM NEWS, P46; Riggs AD, 2004, P NATL ACAD SCI USA, V101, P4, DOI 10.1073/pnas.0307781100; Sun JM, 2007, NUCLEIC ACIDS RES, V35, P6640, DOI 10.1093/nar/gkm737; Taplick J, 1998, FEBS LETT, V436, P349, DOI 10.1016/S0014-5793(98)01164-8; Turner B., 2001, CHROMATIN GENE REGUL; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Yasuhara JC, 2005, P NATL ACAD SCI USA, V102, P10958, DOI 10.1073/pnas.0503424102; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang LW, 2007, J PROTEOME RES, V6, P81, DOI 10.1021/pr060139u	22	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14031	10.1371/journal.pone.0014031	http://dx.doi.org/10.1371/journal.pone.0014031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152421	gold, Green Submitted, Green Published			2022-12-27	WOS:000284755100004
J	Boone, N; Loriod, B; Bergon, A; Sbai, O; Formisano-Treziny, C; Gabert, J; Khrestchatisky, M; Nguyen, C; Feron, F; Axelrod, FB; Ibrahim, E				Boone, Nathalie; Loriod, Beatrice; Bergon, Aurelie; Sbai, Oualid; Formisano-Treziny, Christine; Gabert, Jean; Khrestchatisky, Michel; Nguyen, Catherine; Feron, Francois; Axelrod, Felicia B.; Ibrahim, El Cherif			Olfactory Stem Cells, a New Cellular Model for Studying Molecular Mechanisms Underlying Familial Dysautonomia	PLOS ONE			English	Article							ELONGATOR COMPLEX; RNA-POLYMERASE; EXPRESSION; GENE; PROTEIN; IKBKAP; DIFFERENTIATION; CULTURE; TRANSCRIPTION; MUTATION	Background: Familial dysautonomia (FD) is a hereditary neuropathy caused by mutations in the IKBKAP gene, the most common of which results in variable tissue-specific mRNA splicing with skipping of exon 20. Defective splicing is especially severe in nervous tissue, leading to incomplete development and progressive degeneration of sensory and autonomic neurons. The specificity of neuron loss in FD is poorly understood due to the lack of an appropriate model system. To better understand and modelize the molecular mechanisms of IKBKAP mRNA splicing, we collected human olfactory ectomesenchymal stem cells (hOE-MSC) from FD patients. hOE-MSCs have a pluripotent ability to differentiate into various cell lineages, including neurons and glial cells. Methodology/Principal Findings: We confirmed IKBKAP mRNA alternative splicing in FD hOE-MSCs and identified 2 novel spliced isoforms also present in control cells. We observed a significant lower expression of both IKBKAP transcript and IKAP/hELP1 protein in FD cells resulting from the degradation of the transcript isoform skipping exon 20. We localized IKAP/hELP1 in different cell compartments, including the nucleus, which supports multiple roles for that protein. We also investigated cellular pathways altered in FD, at the genome-wide level, and confirmed that cell migration and cytoskeleton reorganization were among the processes altered in FD. Indeed, FD hOE-MSCs exhibit impaired migration compared to control cells. Moreover, we showed that kinetin improved exon 20 inclusion and restores a normal level of IKAP/hELP1 in FD hOE-MSCs. Furthermore, we were able to modify the IKBKAP splicing ratio in FD hOE-MSCs, increasing or reducing the WT (exon 20 inclusion): MU (exon 20 skipping) ratio respectively, either by producing free-floating spheres, or by inducing cells into neural differentiation. Conclusions/Significance: hOE-MSCs isolated from FD patients represent a new approach for modeling FD to better understand genetic expression and possible therapeutic approaches. This model could also be applied to other neurological genetic diseases.	[Boone, Nathalie; Sbai, Oualid; Khrestchatisky, Michel; Feron, Francois; Ibrahim, El Cherif] Univ Mediterranee Fac Med Nord, NICN CNRS UMR 6184, IFR Jean Roche, Marseille, France; [Loriod, Beatrice; Bergon, Aurelie; Nguyen, Catherine] INSERM, TAGC, U928, F-13258 Marseille, France; [Formisano-Treziny, Christine; Gabert, Jean] Fac Med Marseille, CRO2, F-13385 Marseille, France; [Gabert, Jean] Hop Nord Marseille, AP HM, Marseille, France; [Axelrod, Felicia B.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; New York University	Boone, N (corresponding author), Univ Mediterranee Fac Med Nord, NICN CNRS UMR 6184, IFR Jean Roche, Marseille, France.	el-cherif.ibrahim@univmed.fr	Bergon, Aurélie/M-4977-2016; IBRAHIM, El Chérif/K-3899-2016; Nguyen, Catherine/M-4119-2016; loriod, beatrice bl/L-2948-2016; Feron, Francois/J-5639-2014	Bergon, Aurélie/0000-0003-1518-4562; IBRAHIM, El Chérif/0000-0003-3973-7862; Nguyen, Catherine/0000-0001-9376-6360; loriod, beatrice bl/0000-0001-5801-2264; 	Association Francaise de Recherche contre les Myopathies (AFM); Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT)	Association Francaise de Recherche contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT)	The authors thank the Association Francaise de Recherche contre les Myopathies (AFM) for supporting their work. NB was supported by a PhD fellowship from the Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; AXELROD FB, 1981, PEDIATRICS, V67, P517; Ballester B, 2006, ONCOGENE, V25, P1560, DOI 10.1038/sj.onc.1209178; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Carmel I, 2004, RNA, V10, P828, DOI 10.1261/rna.5196404; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Cornez I, 2008, BIOCHEM PHARMACOL, V75, P2122, DOI 10.1016/j.bcp.2008.03.006; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; Dong JL, 2002, AM J MED GENET, V110, P253, DOI 10.1002/ajmg.10450; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; Feron F, 1999, SCHIZOPHR RES, V40, P211, DOI 10.1016/S0920-9964(99)00055-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hims MM, 2007, GENOMICS, V90, P389, DOI 10.1016/j.ygeno.2007.05.012; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Ibrahim EC, 2007, HUM MUTAT, V28, P41, DOI 10.1002/humu.20401; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-38; McCurdy RD, 2006, SCHIZOPHR RES, V82, P163, DOI 10.1016/j.schres.2005.10.012; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; Murrell W, 2008, STEM CELLS, V26, P2183, DOI 10.1634/stemcells.2008-0074; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Othman M, 2005, BIOTECH HISTOCHEM, V80, P189, DOI 10.1080/10520290500469777; PEARSON J, 1978, J NEUROL SCI, V39, P47, DOI 10.1016/0022-510X(78)90187-9; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Pros E, 2010, EUR J HUM GENET, V18, P614, DOI 10.1038/ejhg.2009.212; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Resta N, 2006, J CELL PHYSIOL, V209, P67, DOI 10.1002/jcp.20708; Roisen FJ, 2001, BRAIN RES, V890, P11, DOI 10.1016/S0006-8993(00)03016-X; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Simson GG, 2009, PEDIATR RES, V65, P341, DOI 10.1203/PDR.0b013e318194fd52; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Talby L, 2006, LEUKEMIA RES, V30, P665, DOI 10.1016/j.leukres.2005.10.007; Tanabe S, 2008, J BIOCHEM, V144, P399, DOI 10.1093/jb/mvn082; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Valensi-Kurtz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009290; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Viktorov IV, 2007, B EXP BIOL MED+, V144, P596, DOI 10.1007/s10517-007-0385-3; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Winstead W, 2005, AM J RHINOL, V19, P83, DOI 10.1177/194589240501900115; WOLOZIN B, 1992, J MOL NEUROSCI, V3, P137, DOI 10.1007/BF02919405; Zhang XD, 2006, BRAIN RES, V1073, P109, DOI 10.1016/j.brainres.2005.12.059; Zhang XD, 2004, EXP NEUROL, V186, P112, DOI 10.1016/j.expneurol.2003.10.022	67	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15590	10.1371/journal.pone.0015590	http://dx.doi.org/10.1371/journal.pone.0015590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187979	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200045
J	Spallarossa, P; Altieri, P; Barisione, C; Passalacqua, M; Aloi, C; Fugazza, G; Frassoni, F; Podesta, M; Canepa, M; Ghigliotti, G; Brunelli, C				Spallarossa, Paolo; Altieri, Paola; Barisione, Chiara; Passalacqua, Mario; Aloi, Concetta; Fugazza, Giuseppina; Frassoni, Francesco; Podesta, Marina; Canepa, Marco; Ghigliotti, Giorgio; Brunelli, Claudio			p38 MAPK and JNK Antagonistically Control Senescence and Cytoplasmic p16INK4A Expression in Doxorubicin-Treated Endothelial Progenitor Cells	PLOS ONE			English	Article							KINASE INHIBITOR P16(INK4A); CARDIAC STEM-CELL; PREMATURE SENESCENCE; HUMAN FIBROBLASTS; APOPTOSIS; PATHWAY; CARDIOMYOCYTES; CANCER; DAMAGE; ERYTHROPOIETIN	Patients treated with low-dose anthracyclines often show late onset cardiotoxicity. Recent studies suggest that this form of cardiotoxicity is the result of a progenitor cell disease. In this study we demonstrate that Cord Blood Endothelial Progenitor Cells (EPCs) exposed to low, sub-apoptotic doses of doxorubicin show a senescence phenotype characterized by increased SA-b-gal activity, decreased TRF2 and chromosomal abnormalities, enlarged cell shape, and disarrangement of F-actin stress fibers accompanied by impaired migratory ability. P16(INK4A) localizes in the cytoplasm of doxorubicin-induced senescent EPCs and not in the nucleus as is the case in EPCs rendered senescent by different stimuli. This localization together with the presence of an arrest in G2, and not at the G1 phase boundary, which is what usually occurs in response to the cell cycle regulatory activity of p16(INK4A), suggests that doxorubicin-induced p16(INK4A) does not regulate the cell cycle, even though its increase is closely associated with senescence. The effects of doxorubicin are the result of the activation of MAPKs p38 and JNK which act antagonistically. JNK attenuates the senescence, p16(INK4A) expression and cytoskeleton remodeling that are induced by activated p38. We also found that conditioned medium from doxorubicin-induced senescent cardiomyocytes does not attract untreated EPCs, unlike conditioned medium from apoptotic cardiomyocytes which has a strong chemoattractant capacity. In conclusion, this study provides a better understanding of the senescence of doxorubicin-treated EPCs, which may be helpful in preventing and treating late onset cardiotoxicity.	[Spallarossa, Paolo; Altieri, Paola; Barisione, Chiara; Aloi, Concetta; Canepa, Marco; Ghigliotti, Giorgio; Brunelli, Claudio] Univ Genoa, Div Cardiol, Res Ctr Cardiovasc Biol, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Biochem Sect, Dept Expt Med, Ctr Excellence Biomed Res, Genoa, Italy; [Fugazza, Giuseppina] Univ Genoa, Dept Internal Med, Lab Cytogenet, I-16126 Genoa, Italy; [Frassoni, Francesco] San Martino Hosp, Stem Cell & Cell Therapy Ctr, Genoa, Italy; [Podesta, Marina] San Martino Hosp, Div 2, Dept Hematol, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Spallarossa, P (corresponding author), Univ Genoa, Div Cardiol, Res Ctr Cardiovasc Biol, Genoa, Italy.	paola.altieri@unige.it	Spallarossa, Paolo/AAC-8981-2019; Podestà, Marina/K-3875-2016; Aloi, Concetta/AAS-6518-2020; Frassoni, Francesco/K-3971-2018; Passalacqua, Mario/W-1973-2019; Canepa, Marco/K-3850-2018	Podestà, Marina/0000-0002-6755-613X; Aloi, Concetta/0000-0002-5937-0781; Frassoni, Francesco/0000-0003-1262-0648; Passalacqua, Mario/0000-0003-2779-6259; barisione, chiara/0000-0001-8831-1054; CANEPA, MARCO/0000-0001-9063-5576; Ghigliotti, Giorgio/0000-0001-8484-542X	University of Genova	University of Genova	This work was supported by University of Genova (cofinanziamento di Ateneo). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaja Elena, 2004, Angiogenesis, V7, P323, DOI 10.1007/s10456-005-0368-9; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; BROWN BS, 1997, BIOCHEM, V323, P233; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Corselli M, 2008, EXP HEMATOL, V36, P340, DOI 10.1016/j.exphem.2007.10.008; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doyle B, 2008, STEM CELLS DEV, V17, P941, DOI 10.1089/scd.2007.0214; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Evangelou K, 2004, BIOTECH HISTOCHEM, V79, P5, DOI 10.1080/10520290310001659466; Gerland LM, 2003, EXP GERONTOL, V38, P887, DOI 10.1016/S0531-5565(03)00132-3; Hamed S, 2006, EUR HEART J, V27, P1876, DOI 10.1093/eurheartj/ehl044; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hu YH, 2003, CIRCULATION, V108, P3122, DOI 10.1161/01.CIR.0000105722.96112.67; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; KENNETH R, 2006, NEW ENGL J MED, V354, P789; Liu Q, 2009, MOL MED REP, V2, P169, DOI 10.3892/mmr_00000079; Londono-Vallejo JA, 2008, BIOCHIMIE, V90, P73, DOI 10.1016/j.biochi.2007.07.009; Maejima Y, 2008, AGING CELL, V7, P125, DOI 10.1111/j.1474-9726.2007.00358.x; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Mossmann T., 1983, J IMMUNOL METHODS, V65, P55; Multani AS, 2000, NEOPLASIA, V2, P339, DOI 10.1038/sj.neo.7900105; Murasawa S, 2005, ARTERIOSCL THROM VAS, V25, P1388, DOI 10.1161/01.ATV.0000168409.69960.e9; Nelyudova A, 2007, CELL CYCLE, V6, P2171, DOI 10.4161/cc.6.17.4610; Ottonello L, 2009, BRIT J PHARMACOL, V157, P294, DOI 10.1111/j.1476-5381.2009.00162.x; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Spallarossa P, 2004, J MOL CELL CARDIOL, V37, P837, DOI 10.1016/j.yjmcc.2004.05.024; Spallarossa P, 2010, J PHARMACOL EXP THER, V332, P87, DOI 10.1124/jpet.109.159525; Spallarossa P, 2009, AM J PHYSIOL-HEART C, V297, pH2169, DOI 10.1152/ajpheart.00068.2009; Su DM, 2009, J BIOL CHEM, V284, P12153, DOI 10.1074/jbc.M807930200; Timolati F, 2006, J MOL CELL CARDIOL, V41, P845, DOI 10.1016/j.yjmcc.2006.08.002; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Vigneron A, 2005, CANCER RES, V65, P8927, DOI 10.1158/0008-5472.CAN-05-0461; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Yang DG, 2008, AGEING RES REV, V7, P137, DOI 10.1016/j.arr.2008.02.001; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296	48	60	61	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15583	10.1371/journal.pone.0015583	http://dx.doi.org/10.1371/journal.pone.0015583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187925	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200044
J	Braconi, C; Swenson, E; Kogure, T; Huang, NY; Patel, T				Braconi, Chiara; Swenson, Erica; Kogure, Takayuki; Huang, Nianyuan; Patel, Tushar			Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma	PLOS ONE			English	Article							MALIGNANT HUMAN CHOLANGIOCYTES; GENE-EXPRESSION SIGNATURES; CALCIUM-CHANNEL BLOCKERS; SERUM INTERLEUKIN-6; CANCER; GROWTH; INHIBITOR; MORTALITY; BILIARY; KINASE	Background: The need for new therapies for cholangiocarcinoma is highlighted by their poor prognosis and refractoriness to chemotherapy. Increased production of Interleukin-6 promotes cholangiocarcinoma growth and contributes to chemoresistance by activating cell survival mechanisms. We sought to identify biologically active compounds capable of ameliorating the phenotypic effects of IL-6 expression and to explore their potential therapeutic use for cholangiocarcinoma. Methodology: A genomic signature associated with Interleukin-6 expression in Mz-ChA-1 human malignant cholangiocytes was derived. Computational bioinformatics analysis was performed to identify compounds that induced inverse gene changes to the signature. The effect of these compounds on cholangiocarcinoma growth was then experimentally verified in vitro and in vivo. Interactions with other therapeutic agents were evaluated using median effects analysis. Principal Findings: A group of structurally related compounds, nitrendipine, nifedipine and felodipine was identified. All three compounds were cytotoxic to Mz-ChA-1 cells with an IC50 for felodipine of 26 mu M, nitrendipine, 44 mu M and nifedipine, 15 mu M. Similar results were observed in KMCH-1, CC-LP-1 and TFK-1 cholangiocarcinoma cell lines. At a fractional effect of 0.5, all three agents were synergistic with either camptothecin or gemcitabine in Mz-ChA-1 cells in vitro. Co-administration of felodipine and gemcitabine decreased the growth of Mz-ChA-1 cell xenografts in nude athymic mice. Conclusions: Computational bioinformatics analysis of phenotype-based genomic expression can be used to identify therapeutic agents. Using this drug discovery approach based on targeting a defined tumor associated phenotype, we identified compounds with the potential for therapeutic use in cholangiocarcinoma.	[Braconi, Chiara; Swenson, Erica; Kogure, Takayuki; Huang, Nianyuan; Patel, Tushar] Ohio State Univ, Coll Med, Dept Internal Med, Ohio State Univ Comprehens Canc Ctr, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Braconi, C (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Ohio State Univ Comprehens Canc Ctr, Columbus, OH 43210 USA.	patel.lab@gmail.com	patel, tushar/J-3976-2013; Kogure, Takayuki/AAI-3946-2021	patel, tushar/0000-0001-7021-9532; braconi, chiara/0000-0003-4835-1259	National Institutes of Health [DK 069370]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been funded by the National Institutes of Health (DK 069370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baradari V, 2007, WORLD J GASTROENTERO, V13, P4458; Braconi C, 2009, CANCER-AM CANCER SOC, V115, P3738, DOI 10.1002/cncr.24417; Cheon YK, 2007, AM J GASTROENTEROL, V102, P2164, DOI 10.1111/j.1572-0241.2007.01403.x; Chin GM, 2006, MOL CANCER THER, V5, P2580, DOI 10.1158/1535-7163.MCT-06-0201; CHIU LY, 2009, TOXICOL LETT; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coleman CI, 2008, J HYPERTENS, V26, P622, DOI 10.1097/HJH.0b013e3282f3ef5e; Debes JD, 2004, CANCER EPIDEM BIOMAR, V13, P255, DOI 10.1158/1055-9965.EPI-03-0093; Goydos JS, 1998, ANN SURG, V227, P398, DOI 10.1097/00000658-199803000-00012; Gregory J, 2009, PEDIATR BLOOD CANCER, V53, P1005, DOI 10.1002/pbc.22165; Huether A, 2007, BIOCHEM PHARMACOL, V73, P1308, DOI 10.1016/j.bcp.2006.12.031; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Khan SA, 2007, GUT, V56, P1755, DOI 10.1136/gut.2007.138859; Khan SA, 2002, J HEPATOL, V37, P806, DOI 10.1016/S0168-8278(02)00297-0; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Meng F, 2006, J HEPATOL, V44, P1055, DOI 10.1016/j.jhep.2005.10.030; Meng FM, 2005, AM J PHYSIOL-CELL PH, V289, pC971, DOI 10.1152/ajpcell.00081.2005; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Olsen JH, 1997, HYPERTENSION, V29, P1091, DOI 10.1161/01.HYP.29.5.1091; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087; Patel T, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-10; Patt YZ, 2004, CANCER, V101, P578, DOI 10.1002/cncr.20368; Philip PA, 2006, J CLIN ONCOL, V24, P3069, DOI 10.1200/JCO.2005.05.3579; Singh P, 2006, CURR OPIN GASTROEN, V22, P294, DOI 10.1097/01.mog.0000218967.60633.64; Sugawara H, 1998, HISTOPATHOLOGY, V33, P145, DOI 10.1046/j.1365-2559.1998.00445.x; Tadlock L, 2001, HEPATOLOGY, V33, P43, DOI 10.1053/jhep.2001.20676; Tangkijvanich P, 2004, HEPATO-GASTROENTEROL, V51, P15; Vijapurkar U, 2007, CANCER RES, V67, P237, DOI 10.1158/0008-5472.CAN-06-2406; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Yamagiwa Y, 2006, LIFE SCI, V78, P2494, DOI 10.1016/j.lfs.2005.10.015; Yamagiwa Y, 2003, HEPATOLOGY, V38, P158, DOI 10.1053/jhep.2003.50257	36	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15195	10.1371/journal.pone.0015195	http://dx.doi.org/10.1371/journal.pone.0015195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179572	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000285381200017
J	Turgut, D; Atilgan, AR; Atilgan, C				Turgut, Deniz; Atilgan, Ali Rana; Atilgan, Canan			Assortative Mixing in Close-Packed Spatial Networks	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; PROTEIN STRUCTURES; RESIDUES; MORPHOLOGIES; MOTIONS; ENZYME	Background: In recent years, there is aroused interest in expressing complex systems as networks of interacting nodes. Using descriptors from graph theory, it has been possible to classify many diverse systems derived from social and physical sciences alike. In particular, folded proteins as examples of self-assembled complex molecules have also been investigated intensely using these tools. However, we need to develop additional measures to classify different systems, in order to dissect the underlying hierarchy. Methodology and Principal Findings: In this study, a general analytical relation for the dependence of nearest neighbor degree correlations on degree is derived. Dependence of local clustering on degree is shown to be the sole determining factor of assortative versus disassortative mixing in networks. The characteristics of networks constructed from spatial atomic/molecular systems exemplified by self-organized residue networks built from folded protein structures and block copolymers, atomic clusters and well-compressed polymeric melts are studied. Distributions of statistical properties of the networks are presented. For these densely-packed systems, assortative mixing in the network construction is found to apply, and conditions are derived for a simple linear dependence. Conclusions: Our analyses (i) reveal patterns that are common to close-packed clusters of atoms/molecules, (ii) identify the type of surface effects prominent in different close-packed systems, and (iii) associate fingerprints that may be used to classify networks with varying types of correlations.	[Turgut, Deniz; Atilgan, Ali Rana; Atilgan, Canan] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Sabanci University	Turgut, D (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	canan@sabanciuniv.edu	Atilgan, Ali Rana/A-7805-2011; Atilgan, Canan/C-7646-2009	Atilgan, Ali Rana/0000-0003-0604-6301; Atilgan, Canan/0000-0003-0557-6044; Turgut, Deniz/0000-0003-0543-3561	Scientific and Technological Research Council of Turkey [106T522]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was funded by the Scientific and Technological Research Council of Turkey Grant Number 106T522. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Inc, 2008, MAT STUD REL 4 4; Aftabuddin M, 2007, BIOPHYS J, V93, P225, DOI 10.1529/biophysj.106.098004; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Atilgan AR, 2007, BIOPHYS J, V92, P3052, DOI [10.1529/biophysj.106.099440, 10.1529/biophysj. 106.099440]; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Atilgan C, 2010, PROTEINS, V78, P3363, DOI 10.1002/prot.22843; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bahar I, 1999, J MOL BIOL, V285, P1023, DOI 10.1006/jmbi.1998.2371; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baysal C, 2001, PROTEINS, V45, P62, DOI 10.1002/prot.1124; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bode C, 2007, FEBS LETT, V581, P2776, DOI 10.1016/j.febslet.2007.05.021; Bollabas B, 1998, MODERN GRAPH THEORY, P394; Brinda KV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-296; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Can H, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3236518; Chung Fan, 1997, SPECTRAL GRAPH THEOR, P212; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Demirel MC, 1998, PROTEIN SCI, V7, P2522, DOI 10.1002/pro.5560071205; Erdos P, 1961, B I INT STAT; Fariselli P, 1999, PROTEIN ENG, V12, P15, DOI 10.1093/protein/12.1.15; Godsil C.D., 2001, ALGEBRAIC GRAPH THEO; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Higman VA, 2006, PHYSICA A, V368, P595, DOI 10.1016/j.physa.2006.01.062; Huberman BA, 1999, NATURE, V401, P131, DOI 10.1038/43604; Ipsen M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046109; Kacar G, 2010, J PHYS CHEM C, V114, P370, DOI 10.1021/jp908324d; Kleinberg J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P163, DOI 10.1145/335305.335325; Lee CY, 2007, PHYSICA A, V386, P564, DOI 10.1016/j.physa.2007.08.030; Mohar B., 1991, GRAPH THEORY COMBINA, V2; Muppirala UK, 2006, PROTEIN ENG DES SEL, V19, P265, DOI 10.1093/protein/gzl009; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ozen AS, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2162885; Paperin G, 2008, DUAL PHASE EVOLUTION, P575; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sathyapriya R, 2007, PROTEINS, V68, P541, DOI 10.1002/prot.21401; Serrano A, 2005, PHYS REV E, V72; Tsolou G, 2006, MACROMOL THEOR SIMUL, V15, P381, DOI 10.1002/mats.200500088; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Wales D.J, CAMBRIDGE CLUSTER DA; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xiang YH, 2004, J PHYS CHEM A, V108, P3586, DOI 10.1021/jp037780t; Xiang YH, 2004, J PHYS CHEM A, V108, P9516, DOI 10.1021/jp047807o; Xulvi-Brunet R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066102	54	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15551	10.1371/journal.pone.0015551	http://dx.doi.org/10.1371/journal.pone.0015551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179578	Green Published, gold, Green Submitted			2022-12-27	WOS:000285381200029
J	Schwartz, AK; Weese, DJ; Bentzen, P; Kinnison, MT; Hendry, AP				Schwartz, Amy K.; Weese, Dylan J.; Bentzen, Paul; Kinnison, Michael T.; Hendry, Andrew P.			Both Geography and Ecology Contribute to Mating Isolation in Guppies	PLOS ONE			English	Article							MALE PREDATION RISK; POECILIA-RETICULATA; SEXUAL SELECTION; MATE-CHOICE; FEMALE PREFERENCE; NATURAL-SELECTION; TRINIDADIAN GUPPIES; PARALLEL EVOLUTION; MALE COLOR; REPRODUCTIVE SKEW	Local adaptation to different environments can promote mating isolation - either as an incidental by-product of trait divergence, or as a result of selection to avoid maladaptive mating. Numerous recent empirical examples point to the common influence of divergent natural selection on speciation based largely on evidence of strong pre-mating isolation between populations from different habitat types. Accumulating evidence for natural selection's influence on speciation is therefore no longer a challenge. The difficulty, rather, is in determining the mechanisms involved in the progress of adaptive divergence to speciation once barriers to gene flow are already present. Here, we present results of both laboratory and field experiments with Trinidadian guppies (Poecilia reticulata) from different environments, who do not show complete reproductive isolation despite adaptive divergence. We investigate patterns of mating isolation between populations that do and do not exchange migrants and show evidence for both by-product and reinforcement mechanisms depending on female ecology. Specifically, low-predation females discriminate against all high-predation males thus implying a by-product mechanism, whereas high-predation females only discriminate against low-predation males from further upstream in the same river, implying selection to avoid maladaptive mating. Our study thus confirms that mechanisms of adaptive speciation are not necessarily mutually exclusive and uncovers the complex ecology-geography interactions that underlie the evolution of mating isolation in nature.	[Schwartz, Amy K.; Hendry, Andrew P.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Schwartz, Amy K.; Hendry, Andrew P.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Weese, Dylan J.; Kinnison, Michael T.] Univ Maine, Dept Biol Sci, Orono, ME USA; [Bentzen, Paul] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	McGill University; McGill University; University of Maine System; University of Maine Orono; Dalhousie University	Schwartz, AK (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.	amy.schwartz@glasgow.ac.uk	Hendry, Andrew/C-5765-2008	Hendry, Andrew/0000-0002-4807-6667; Kinnison, Michael/0000-0003-4211-2118; Bentzen, Paul/0000-0003-4288-7730	National Science Foundation [DEB 0235605]; Natural Science and Technology Research Council of Quebec; Natural Sciences and Engineering Research Council of Canada	National Science Foundation(National Science Foundation (NSF)); Natural Science and Technology Research Council of Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by the National Science Foundation (DEB 0235605), the Natural Science and Technology Research Council of Quebec (http://www.fqrnt.gouv.qc.ca), and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HJ, 2006, EVOLUTION, V60, P2352, DOI 10.1111/j.0014-3820.2006.tb01870.x; BAERENDS G. P., 1955, BEHAVIOUR, V8, P249, DOI 10.1163/156853955X00238; Becher SA, 2004, P ROY SOC B-BIOL SCI, V271, P1009, DOI 10.1098/rspb.2004.2701; Boughman JW, 2005, EVOLUTION, V59, P361; BREDEN F, 1987, NATURE, V329, P831, DOI 10.1038/329831a0; Brooks R, 2002, GENETICA, V116, P343, DOI 10.1023/A:1021228308636; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; CARVALHO GR, 1991, BIOL J LINN SOC, V42, P389, DOI 10.1111/j.1095-8312.1991.tb00571.x; Coyne J.A., 2004, SPECIATION; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Croft DP, 2003, OECOLOGIA, V137, P62, DOI 10.1007/s00442-003-1268-6; Darden SK, 2008, BIOL LETTERS, V4, P449, DOI 10.1098/rsbl.2008.0308; DUGATKIN LA, 1992, AM NAT, V139, P1384, DOI 10.1086/285392; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Evans JP, 2003, BIOL J LINN SOC, V78, P605, DOI 10.1046/j.0024-4066.2002.00193.x; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Gamble S, 2003, ECOL LETT, V6, P463, DOI 10.1046/j.1461-0248.2003.00449.x; Gordon SP, 2009, AM NAT, V174, P34, DOI 10.1086/599300; Hall M, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-1; Haskins C. P., 1961, VERTEBRATE SPECIATIO, P320; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; HOUDE AE, 1990, SCIENCE, V248, P1405, DOI 10.1126/science.248.4961.1405; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kay KM, 2008, EVOLUTION, V62, P2628, DOI 10.1111/j.1558-5646.2008.00463.x; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; KODRICBROWN A, 1993, BEHAV ECOL SOCIOBIOL, V32, P415, DOI 10.1007/BF00168825; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; LUYTEN PH, 1991, BEHAV ECOL SOCIOBIOL, V28, P329, DOI 10.1007/BF00164382; Magellan K, 2007, J FISH BIOL, V71, P1864, DOI 10.1111/j.1095-8649.2007.01640.x; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Millar NP, 2006, OIKOS, V113, P1; Neff BD, 2008, MOL ECOL, V17, P2975, DOI 10.1111/j.1365-294X.2008.03816.x; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Nosil P, 2008, BIOL J LINN SOC, V95, P305, DOI 10.1111/j.1095-8312.2008.01048.x; Nosil P, 2008, BIOL J LINN SOC, V95, P26, DOI 10.1111/j.1095-8312.2008.01091.x; Ojanguren AF, 2007, BEHAVIOUR, V144, P503, DOI 10.1163/156853907780713055; Paterson IG, 2005, MOL ECOL NOTES, V5, P269, DOI 10.1111/j.1471-8286.2005.00895.x; Pilastro A, 2004, EVOLUTION, V58, P665, DOI 10.1111/j.0014-3820.2004.tb01690.x; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; RODD FH, 1995, ANIM BEHAV, V49, P1139, DOI 10.1006/anbe.1995.0149; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schwartz AK, 2007, EVOL ECOL RES, V9, P71; SEGHERS BH, 1974, EVOLUTION, V28, P486, DOI 10.1111/j.1558-5646.1974.tb00774.x; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SHAW PW, 1991, J FISH BIOL, V39, P203, DOI 10.1111/j.1095-8649.1991.tb05084.x; STONER G, 1988, BEHAV ECOL SOCIOBIOL, V22, P285, DOI 10.1007/BF00299844; Suk HY, 2009, HEREDITY, V102, P425, DOI 10.1038/hdy.2009.7; Watanabe T, 2003, MOL ECOL NOTES, V3, P487, DOI 10.1046/j.1471-8286.2003.00490.x; Weese DJ, 2010, EVOLUTION, V64, P1802, DOI 10.1111/j.1558-5646.2010.00945.x; Zajitschek SRK, 2008, AM NAT, V172, P843, DOI 10.1086/593001	57	17	18	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15659	10.1371/journal.pone.0015659	http://dx.doi.org/10.1371/journal.pone.0015659			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179541	Green Published, Green Submitted, gold			2022-12-27	WOS:000285340000029
J	Senter, P; Kirkland, JI; Bird, J; Bartlett, JA				Senter, Phil; Kirkland, James I.; Bird, John; Bartlett, Jeff A.			A New Troodontid Theropod Dinosaur from the Lower Cretaceous of Utah	PLOS ONE			English	Article							YIXIAN FORMATION; CHINA; ARCHAEOPTERYX	Background: The theropod dinosaur family Troodontidae is known from the Upper Jurassic, Lower Cretaceous, and Upper Cretaceous of Asia and from the Upper Jurassic and Upper Cretaceous of North America. Before now no undisputed troodontids from North America have been reported from the Early Cretaceous. Methodology/Principal Findings: Herein we describe a theropod maxilla from the Lower Cretaceous Cedar Mountain Formation of Utah and perform a phylogenetic analysis to determine its phylogenetic position. The specimen is distinctive enough to assign to a new genus and species, Geminiraptor suarezarum. Phylogenetic analysis places G. suarezarum within Troodontidae in an unresolved polytomy with Mei, Byronosaurus, Sinornithoides, Sinusonasus, and Troodon + (Saurornithoides + Zanabazar). Geminiraptor suarezarum uniquely exhibits extreme pneumatic inflation of the maxilla internal to the antorbital fossa such that the anterior maxilla has a triangular cross-section. Unlike troodontids more closely related to Troodon, G. suarezarum exhibits bony septa between the dental alveoli and a promaxillary foramen that is visible in lateral view. Conclusions/Significance: This is the first report of a North American troodontid from the Lower Cretaceous. It therefore contributes to a fuller understanding of troodontid biogeography through time. It also adds to the known dinosaurian fauna of the Cedar Mountain Formation.	[Senter, Phil] Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA; [Kirkland, James I.] Utah Geol Survey, Salt Lake City, UT USA; [Bird, John] Coll Eastern Utah Prehist Museum, Price, UT USA; [Bartlett, Jeff A.] Coll Eastern Utah, Price, UT USA	University of North Carolina; Fayetteville State University; Utah System of Higher Education; Utah State University; Utah State University College of Eastern Utah; Utah System of Higher Education; Utah State University; Utah State University College of Eastern Utah	Senter, P (corresponding author), Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA.	psenter@uncfsu.edu			Utah Geological Survey; Discovery Channel Quest	Utah Geological Survey; Discovery Channel Quest	We thank Don DeBlieux for his detailed preparation of this delicate fossil. P. S. thanks the following people for access to specimens in their care: Daniel Brinkman (Yale Peabody Museum), Carl Mehling, Mark Norell (American Museum of Natural History), Xu Xing, and Zheng Fang (Institute of Vertebrate Paleontology and Paleoanthropology). We also thank the following people for helpful reviews: Martha Hayden, Mike Lowe, Michael Hylland, Andrew Farke, Peter Makovicky, and Sunny Hwang. We also thank Andrew McDonald and David Wharton for help with Latin. The discovery of the site took place during part of a project funded by the Utah Geological Survey and a Discovery Channel Quest Grant to J.I.K.	BARSBOLD R, 1987, Acta Palaeontologica Polonica, V32, P121; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Chure Daniel J., 1994, Brigham Young University Geology Studies, V40, P11; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; Gilmore CW, 1924, B DEP GEOL U ALBERTA, V1, P1; GREENHALGH B.W., 2007, CENTRAL UTAH DIVERSE, V36, P81; Hartman S, 2005, J VERTEBR PALEONTOL, V25, p67A; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Kirkland JI, 2007, UTAH GEOLOGICAL ASS, V35, P1; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 2003, AM MUS NOVIT, P1; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Norell MA, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)446<0001:ATDFUT>2.0.CO;2; Norell MA, 2009, AM MUS NOVIT, P1; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; OSTROM JH, 1969, PEA MUS NAT HIST B, V31, P1; Owen R, 1842, 11 M BRIT ASS ADV SC, P60; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; Seeley, 1887, P R SOC LONDON, V63, P165; Senter P, 2010, J EVOLUTION BIOL, V23, P1732, DOI 10.1111/j.1420-9101.2010.02039.x; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Swofford DL., 2001, PAUP PHYLOGENETIC AN; VONHUENE F, 1914, CENTRALBLATT MINERAL, P154; WITMER LM, 1997, SOC VERTEBRATE PALEO, V3, P1; Xu X, 2004, ACTA GEOL SIN-ENGL, V78, P22; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2001, CAN J EARTH SCI, V38, P1739, DOI 10.1139/e01-082	31	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14329	10.1371/journal.pone.0014329	http://dx.doi.org/10.1371/journal.pone.0014329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179513	gold, Green Published			2022-12-27	WOS:000285340000007
J	Gill, DK; Huang, YD; Levine, GL; Sambor, A; Carter, DK; Sato, A; Kopycinski, J; Hayes, P; Hahn, B; Birungi, J; Tarragona-Fiol, T; Wan, H; Randles, M; Cooper, AR; Ssemaganda, A; Clark, L; Kaleebu, P; Self, SG; Koup, R; Wood, B; McElrath, MJ; Cox, JH; Hural, J; Gilmour, J				Gill, Dilbinder K.; Huang, Yunda; Levine, Gail L.; Sambor, Anna; Carter, Donald K.; Sato, Alicia; Kopycinski, Jakub; Hayes, Peter; Hahn, Bridget; Birungi, Josephine; Tarragona-Fiol, Tony; Wan, Hong; Randles, Mark; Cooper, Andrew Raxworthy; Ssemaganda, Aloysius; Clark, Lorna; Kaleebu, Pontiano; Self, Steven G.; Koup, Richard; Wood, Blake; McElrath, M. Juliana; Cox, Josephine H.; Hural, John; Gilmour, Jill			Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories	PLOS ONE			English	Article							VACCINE TRIALS; CELL; IMMUNITY; PROFICIENCY; RESPONSES; ENTERPRISE; CANCER; PANEL	Background: The Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC) was created to provide standardized immunogenicity monitoring services for HIV vaccine trials. The ex vivo interferon-gamma (IFN-gamma) ELISpot is used extensively as a primary immunogenicity assay to assess T cell-based vaccine candidates in trials for infectious diseases and cancer. Two independent, GCLP-accredited central laboratories of CTC-VIMC routinely use their own standard operating procedures (SOPs) for ELISpot within two major networks of HIV vaccine trials. Studies are imperatively needed to assess the comparability of ELISpot measurements across laboratories to benefit optimal advancement of vaccine candidates. Methods: We describe an equivalence study of the two independently qualified IFN-g ELISpot SOPs. The study design, data collection and subsequent analysis were managed by independent statisticians to avoid subjectivity. The equivalence of both response rates and positivity calls to a given stimulus was assessed based on pre-specified acceptance criteria derived from a separate pilot study. Findings: Detection of positive responses was found to be equivalent between both laboratories. The 95% C. I. on the difference in response rates, for CMV (-1.5%, 1.5%) and CEF (-0.4%, 7.8%) responses, were both contained in the pre-specified equivalence margin of interval [ -15%, 15%]. The lower bound of the 95% C. I. on the proportion of concordant positivity calls for CMV (97.2%) and CEF (89.5%) were both greater than the pre-specified margin of 70%. A third CTC-VIMC central laboratory already using one of the two SOPs also showed comparability when tested in a smaller sub-study. Interpretation: The described study procedure provides a prototypical example for the comparison of bioanalytical methods in HIV vaccine and other disease fields. This study also provides valuable and unprecedented information for future vaccine candidate evaluations on the comparison and pooling of ELISpot results generated by the CTC-VIMC central core laboratories.	[Gill, Dilbinder K.; Kopycinski, Jakub; Hayes, Peter; Tarragona-Fiol, Tony; Cooper, Andrew Raxworthy; Clark, Lorna] Univ London Imperial Coll Sci Technol & Med, Int AIDS Vaccine Initiat Human Immunol Lab, London, England; [Huang, Yunda; Sato, Alicia; Self, Steven G.; Wood, Blake] Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA; [Levine, Gail L.; Sambor, Anna] Fdn Natl Inst Hlth, Bethesda, MD USA; [Carter, Donald K.; Hahn, Bridget; McElrath, M. Juliana; Hural, John] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Birungi, Josephine; Ssemaganda, Aloysius; Kaleebu, Pontiano] Uganda Virus Res Inst, Entebbe, Uganda; [Wan, Hong; Randles, Mark; Cox, Josephine H.; Gilmour, Jill] Int AIDS Vaccine Initiat, New York, NY USA; [Koup, Richard] Vaccine Res Ctr, Bethesda, MD USA	Imperial College London; International AIDS Vaccine Initiative; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; Fred Hutchinson Cancer Center; Uganda Virus Research Institute; International AIDS Vaccine Initiative	Gill, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Int AIDS Vaccine Initiat Human Immunol Lab, London, England.	d.gill@imperial.ac.uk		Cox, Josephine/0000-0003-1301-7373; Huang, Yunda/0000-0003-1546-6172	Bill & Melinda Gates Foundation [38650]; MRC [MC_U950097145] Funding Source: UKRI; Medical Research Council [MC_U950097145] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, ZIAAI005073] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Collaboration for AIDS Vaccine Discovery (CAVD) Grant 38650 from the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2005, STAT MED, V24, P729, DOI 10.1002/sim.1781; Almeida CAM, 2009, J IMMUNOL METHODS, V344, P1, DOI 10.1016/j.jim.2009.02.007; Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Cox JH, 2005, AIDS RES HUM RETROV, V21, P68, DOI 10.1089/aid.2005.21.68; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Esparza J, 2005, INT MICROBIOL, V8, P93; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Herr W, 1997, J IMMUNOL METHODS, V203, P141, DOI 10.1016/S0022-1759(97)00019-7; Janetzki S, 2008, CANCER IMMUNOL IMMUN, V57, P303, DOI 10.1007/s00262-007-0380-6; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Moodie Z, 2006, J IMMUNOL METHODS, V315, P121, DOI 10.1016/j.jim.2006.07.015; Rini BI, 2006, CANCER-AM CANCER SOC, V107, P67, DOI 10.1002/cncr.21956; Russell ND, 2003, J INFECT DIS, V187, P226, DOI 10.1086/367702; Smith Jeffrey G., 2003, Journal of Medical Virology, V70, pS38, DOI 10.1002/jmv.10318; STILES T, 2003, GOOD CLIN LAB PRACTI, P1; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Todryk SM, 2009, EUR J IMMUNOL, V39, P3042, DOI 10.1002/eji.200939434	24	37	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14330	10.1371/journal.pone.0014330	http://dx.doi.org/10.1371/journal.pone.0014330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179404	Green Submitted, Green Published, gold			2022-12-27	WOS:000285292500008
J	Harley, E; Fowler, K; Cotton, S				Harley, Elisabeth; Fowler, Kevin; Cotton, Samuel			No Detectable Fertility Benefit from a Single Additional Mating in Wild Stalk-Eyed Flies	PLOS ONE			English	Article							POSTCOPULATORY INBREEDING AVOIDANCE; CHROMOSOME MEIOTIC DRIVE; ARTIFICIAL SELECTION; CORRELATED RESPONSES; SEXUAL-DIMORPHISM; MATE PREFERENCE; SPERM SELECTION; FLY; FEMALES; POLYANDRY	Background: Multiple mating by female insects is widespread, and the explanation(s) for repeated mating by females has been the subject of much discussion. Females may profit from mating multiply through direct material benefits that increase their own reproductive output, or indirect genetic benefits that increase offspring fitness. One particular direct benefit that has attracted significant attention is that of fertility assurance, as females often need to mate multiply to achieve high fertility. This hypothesis has never been tested in a wild insect population. Methodology/Principal Findings: Female Malaysian stalk-eyed flies (Teleopsis dalmanni) mate repeatedly during their lifetime, and have been shown to be sperm limited under both laboratory and field conditions. Here we ask whether receiving an additional mating alleviates sperm limitation in wild females. In our experiment one group of females received a single additional mating, while a control group received an interrupted, and therefore unsuccessful, mating. Females that received an additional mating did not lay more fertilised eggs in total, nor did they lay proportionately more fertilised eggs. Female fertility declined significantly through time, demonstrating that females were sperm limited. However, receipt of an additional mating did not significantly alter the rate of this decline. Conclusions/Significance: Our data suggest that the fertility consequences of a single additional mating were small. We discuss this effect (or lack thereof), and suggest that it is likely to be attributed to small ejaculate size, a high proportion of failed copulations, and the presence of X-linked meiotic drive in this species.	[Harley, Elisabeth; Fowler, Kevin; Cotton, Samuel] UCL, Res Dept Genet Evolut & Environm, London, England	University of London; University College London	Harley, E (corresponding author), UCL, Res Dept Genet Evolut & Environm, London, England.	s.cotton@ucl.ac.uk			UK Natural Environment Research Council [NE/E012620/1]; UK Biotechnology & Biological Sciences Research Council; NERC [NE/G00563X/1, NE/E012620/1] Funding Source: UKRI; Natural Environment Research Council [NE/E012620/1, NE/G00563X/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Biotechnology & Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a UK Natural Environment Research Council Post-doctoral Fellowship to S. C. (NE/E012620/1). E. H. is supported by a UK Biotechnology & Biological Sciences Research Council Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Baker RH, 2001, EVOLUTION, V55, P1373; Baker RH, 2001, BEHAV ECOL, V12, P732, DOI 10.1093/beheco/12.6.732; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BOGGS CL, 1979, SCIENCE, V206, P83, DOI 10.1126/science.206.4414.83; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; BURKHARDT D, 1985, NATURWISSENSCHAFTEN, V72, P204, DOI 10.1007/BF01195763; BUTLIN RK, 1987, EVOLUTION, V41, P221, DOI 10.1111/j.1558-5646.1987.tb05785.x; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Corley LS, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-53; Cotton S, 2010, EVOL ECOL, V24, P83, DOI 10.1007/s10682-009-9292-6; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Fry CL, 2004, EVOLUTION, V58, P1622, DOI 10.1111/j.0014-3820.2004.tb01743.x; Gershman SN, 2007, ETHOLOGY, V113, P1099, DOI 10.1111/j.1439-0310.2007.01418.x; Grant CA, 2005, HEREDITY, V95, P444, DOI 10.1038/sj.hdy.6800733; Hingle A, 2001, P ROY SOC B-BIOL SCI, V268, P1239, DOI 10.1098/rspb.2001.1647; Hingle A, 2001, ANIM BEHAV, V61, P589, DOI 10.1006/anbe.2000.1613; Hosken DJ, 2003, J EVOLUTION BIOL, V16, P485, DOI 10.1046/j.1420-9101.2003.00537.x; Ivy TM, 2005, EVOLUTION, V59, P152, DOI 10.1111/j.0014-3820.2005.tb00902.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johns PM, 2007, HEREDITY, V99, P56, DOI 10.1038/sj.hdy.6800963; Kotrba M, 1996, ZOOL J LINN SOC-LOND, V117, P305, DOI 10.1111/j.1096-3642.1996.tb02192.x; Lamunyon CW, 2000, ANIM BEHAV, V59, P395, DOI 10.1006/anbe.1999.1294; LORCH PD, 1993, BEHAV ECOL SOCIOBIOL, V32, P303; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Orsetti DM, 2003, ANIM BEHAV, V66, P477, DOI 10.1006/anbe.2003.2263; Presgraves DC, 1997, GENETICS, V147, P1169; Reguera P, 2004, J INSECT PHYSIOL, V50, P103, DOI 10.1016/j.jinsphys.2003.10.004; RIDLEY M, 1988, BIOL REV, V63, P509, DOI 10.1111/j.1469-185X.1988.tb00669.x; Rogers DW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-236; Rogers DW, 2006, ANIM BEHAV, V72, P1363, DOI 10.1016/j.anbehav.2006.03.027; Rogers DW, 2005, J EVOLUTION BIOL, V18, P642, DOI 10.1111/j.1420-9101.2004.00860.x; Rogers DW, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-37; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Small J, 2009, ANIM BEHAV, V78, P1213, DOI 10.1016/j.anbehav.2009.08.009; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Thornhill R., 1983, pi; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Wang Q, 2006, J INSECT BEHAV, V19, P337, DOI 10.1007/s10905-006-9027-2; Webberley KM, 2002, J PARASITOL, V88, P707, DOI 10.1645/0022-3395(2002)088[0707:TEOAOO]2.0.CO;2; Wilkinson GS, 2006, J EVOLUTION BIOL, V19, P1851, DOI 10.1111/j.1420-9101.2006.01169.x; Wilkinson GS, 2001, P ROY SOC B-BIOL SCI, V268, P2559, DOI 10.1098/rspb.2001.1831; Wilkinson GS, 2001, HEREDITY, V87, P17, DOI 10.1046/j.1365-2540.2001.00898.x; Wilkinson GS, 2003, GENETICA, V117, P37, DOI 10.1023/A:1022360531703; Wilkinson GS, 2005, INTEGR COMP BIOL, V45, P500, DOI 10.1093/icb/45.3.500; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; Wilkinson GS, 1998, BEHAV ECOL, V9, P525, DOI 10.1093/beheco/9.5.525; Wright TF, 2004, GENET RES, V84, P27, DOI 10.1017/S0016672304006986; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260	55	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14309	10.1371/journal.pone.0014309	http://dx.doi.org/10.1371/journal.pone.0014309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179210	gold, Green Published, Green Submitted			2022-12-27	WOS:000285246900015
J	Jors, S; Grimm, C; Becker, L; Heller, S				Joers, Simone; Grimm, Christian; Becker, Lars; Heller, Stefan			Genetic Inactivation of Trpml3 Does Not Lead to Hearing and Vestibular Impairment in Mice	PLOS ONE			English	Article							MUCOLIPIDOSIS TYPE-IV; VARITINT-WADDLER VA; RECEPTOR POTENTIAL CHANNEL; HAIR-CELLS; MOUSE; MUTATIONS; DEAFNESS; ABNORMALITIES; TRANSDUCTION; PHENOTYPE	TRPML3, a member of the transient receptor potential (TRP) family, is an inwardly rectifying, non-selective Ca(2+)-permeable cation channel that is regulated by extracytosolic Na(+) and H(+) and can be activated by a variety of small molecules. The severe auditory and vestibular phenotype of the TRPML3(A419P) varitint-waddler mutation made this protein particularly interesting for inner ear biology. To elucidate the physiological role of murine TRPML3, we conditionally inactivated Trpml3 in mice. Surprisingly, lack of functional TRPML3 did not lead to circling behavior, balance impairment or hearing loss.	[Joers, Simone] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Jors, S (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	hellers@stanford.edu	Grimm, Christian/ABF-9121-2020	Grimm, Christian/0000-0002-0177-5559	National Institutes of Health [DC004563, P30 DC010363]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010363, R01DC004563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants DC004563 and P30 DC010363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Cable J, 1998, HEARING RES, V123, P125, DOI 10.1016/S0378-5955(98)00107-5; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Chow LML, 2006, DEV DYNAM, V235, P2991, DOI 10.1002/dvdy.20948; Cuajungco MP, 2007, BBA-MOL BASIS DIS, V1772, P1022, DOI 10.1016/j.bbadis.2007.01.002; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Grimm C, 2009, J BIOL CHEM, V284, P13823, DOI 10.1074/jbc.M809045200; Jero J, 2001, ACTA OTO-LARYNGOL, V121, P585, DOI 10.1080/000164801316878863; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kim HJ, 2003, JARO-J ASSOC RES OTO, V4, P83, DOI 10.1007/s10162-002-3011-0; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LIBERMAN MC, 1995, HEARING RES, V90, P158, DOI 10.1016/0378-5955(95)00160-2; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Tabuchi K, 2005, NEUROSCI LETT, V382, P304, DOI 10.1016/j.neulet.2005.03.035; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	29	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14317	10.1371/journal.pone.0014317	http://dx.doi.org/10.1371/journal.pone.0014317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179200	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900022
J	Arnold, SEJ; Faruq, S; Savolainen, V; McOwan, PW; Chittka, L				Arnold, Sarah E. J.; Faruq, Samia; Savolainen, Vincent; McOwan, Peter W.; Chittka, Lars			FReD: The Floral Reflectance Database - A Web Portal for Analyses of Flower Colour	PLOS ONE			English	Article							INSECT POLLINATORS; VISUAL-SYSTEM; VISION; COMMUNITIES; ANTIRRHINUM; ULTRAVIOLET; GRASSLAND; PHENOLOGY; HONEYBEE; SIGNALS	Background: Flower colour is of great importance in various fields relating to floral biology and pollinator behaviour. However, subjective human judgements of flower colour may be inaccurate and are irrelevant to the ecology and vision of the flower's pollinators. For precise, detailed information about the colours of flowers, a full reflectance spectrum for the flower of interest should be used rather than relying on such human assessments. Methodology/Principal Findings: The Floral Reflectance Database (FReD) has been developed to make an extensive collection of such data available to researchers. It is freely available at http://www.reflectance.co.uk. The database allows users to download spectral reflectance data for flower species collected from all over the world. These could, for example, be used in modelling interactions between pollinator vision and plant signals, or analyses of flower colours in various habitats. The database contains functions for calculating flower colour loci according to widely-used models of bee colour space, reflectance graphs of the spectra and an option to search for flowers with similar colours in bee colour space. Conclusions/Significance: The Floral Reflectance Database is a valuable new tool for researchers interested in the colours of flowers and their association with pollinator colour vision, containing raw spectral reflectance data for a large number of flower species.	[Arnold, Sarah E. J.; Chittka, Lars] Queen Mary Univ London, Res Ctr Psychol, Sch Biol & Chem Sci, London, England; [Faruq, Samia; McOwan, Peter W.] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England; [Savolainen, Vincent] Imperial Coll London, Ascot, Berks, England; [Savolainen, Vincent] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England	University of London; Queen Mary University London; University of London; Queen Mary University London; Imperial College London; Royal Botanic Gardens, Kew	Arnold, SEJ (corresponding author), Univ Greenwich, Nat Resources Inst, Chatham, England.	l.chittka@qmul.ac.uk	Arnold, Sarah/H-6490-2019; Chittka, Lars/C-3110-2012	Arnold, Sarah/0000-0001-7345-0529; Chittka, Lars/0000-0001-8153-1732; Savolainen, Vincent/0000-0001-5350-9984	Biotechnology and Biological Sciences Research Council [BBS/S/L/2005/12155A]; Royal Botanic Gardens, Kew; Royal Society; Natural Environment Research Council [NE/F002769/1] Funding Source: researchfish; NERC [NE/F002769/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Botanic Gardens, Kew; Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors acknowledge the following funding sources: A studentship from the Biotechnology and Biological Sciences Research Council (BBS/S/L/2005/12155A) to SEJA with support from the Royal Botanic Gardens, Kew and The Royal Society Wolfson Award to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIKAWA K, 1987, NATURWISSENSCHAFTEN, V74, P297, DOI 10.1007/BF00366422; Arnold SEJ, 2009, ISR J PLANT SCI, V57, P211, DOI 10.1560/IJPS.57.3.211; Arnold SEJ, 2009, ARTHROPOD-PLANT INTE, V3, P27, DOI 10.1007/s11829-009-9056-9; BACKHAUS W, 1991, VISION RES, V31, P1381, DOI 10.1016/0042-6989(91)90059-E; BACKHAUS W, 1987, BIOL CYBERN, V55, P321, DOI 10.1007/BF02281978; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P115, DOI 10.1080/07929978.1997.10676678; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; Chittka L., 2005, PRACTICAL POLLINATIO, P157; DAUMER K, 1956, Z VERGL PHYSIOL, V38, P413; DAUMER K, 1958, Z VERGL PHYSIOL, V41, P49; de Ibarra NH, 2009, J COMP PHYSIOL A, V195, P319, DOI 10.1007/s00359-009-0412-0; Dyer AG, 1996, AUST J BOT, V44, P473, DOI 10.1071/BT9960473; FRANTS VI, 1991, J AM SOC INFORM SCI, V42, P16, DOI 10.1002/(SICI)1097-4571(199101)42:1<16::AID-ASI3>3.0.CO;2-I; Gumbert A, 1999, P ROY SOC B-BIOL SCI, V266, P1711, DOI 10.1098/rspb.1999.0836; Kevan P.G., 1983, P3; Kevan P. G., 1998, COLOR VISION PERSPEC, P163; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; KEVAN PG, 1972, CAN J BOTANY, V50, P2289, DOI 10.1139/b72-298; KEVAN PG, 1978, LINNEAN SOC S SERIES, V6, P51; LUNAU K, 1990, J COMP PHYSIOL A, V166, P827; LUNAU K, 1992, CAN J ZOOL, V70, P2139, DOI 10.1139/z92-288; MALONEY LT, 1986, J OPT SOC AM A, V3, pP43; MCCANN M T, 1986, Michigan Botanist, V25, P66; Menzel R., 1989, P281; MENZEL R, 1993, BIOL REV, V68, P81, DOI 10.1111/j.1469-185X.1993.tb00732.x; MENZEL R, 1983, J COMP PHYSIOL, V151, P441, DOI 10.1007/BF00605460; MENZEL R, 1990, COLOR VISION FLOWER; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; PENNY JHJ, 1983, NEW PHYTOL, V95, P707, DOI 10.1111/j.1469-8137.1983.tb03534.x; Proctor M., 1996, NATURAL HIST POLLINA; Tastard E, 2008, ARTHROPOD-PLANT INTE, V2, P237, DOI 10.1007/s11829-008-9046-3; Vorobyev M, 1997, ISRAEL J PLANT SCI, V45, P103, DOI 10.1080/07929978.1997.10676677; Warren J, 2005, GRASS FORAGE SCI, V60, P332, DOI 10.1111/j.1365-2494.2005.00482.x; Waser N.M., 1983, P241; WEEVERS T, 1952, ACTA BOT NEERL, V1, P81; Whibley AC, 2006, SCIENCE, V313, P963, DOI 10.1126/science.1129161; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117	40	77	79	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14287	10.1371/journal.pone.0014287	http://dx.doi.org/10.1371/journal.pone.0014287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170326	Green Accepted, gold, Green Published			2022-12-27	WOS:000285181400010
J	Zlobec, I; Karamitopoulou, E; Terracciano, L; Piscuoglio, S; Iezzi, G; Muraro, MG; Spagnoli, G; Baker, K; Tzankov, A; Lugli, A				Zlobec, Inti; Karamitopoulou, Eva; Terracciano, Luigi; Piscuoglio, Salvatore; Iezzi, Giandomenica; Muraro, Manuele Giuseppe; Spagnoli, Giulio; Baker, Kristi; Tzankov, Alexandar; Lugli, Alessandro			TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer	PLOS ONE			English	Article							T-CELLS; INTRAEPITHELIAL LYMPHOCYTES; MICROSATELLITE INSTABILITY; TUMOR MICROENVIRONMENT; GENE-EXPRESSION; APOPTOSIS	Background: Evidence suggests a confounding effect of mismatch repair (MMR) status on immune response in colorectal cancer. The identification of innate and adaptive immune cells, that can complement the established prognostic effect of CD8 in MMR-proficient colorectal cancers patients, representing 85% of all cases, has not been performed. Methodology/Principal Findings: Colorectal cancers from a test (n = 1197) and external validation (n = 209) cohort of MMR-proficient colorectal cancers were mounted onto single and multiple punch tissue microarrays. Immunohistochemical quantification (score 0-3) was performed for CD3, CD4, CD8, CD45RO, CD68, CD163, FoxP3, GranzymeB, iNOS, mast cell tryptase, MUM1, PD1 and TIA-1 tumor-infiltrating (TILs) reactive cells. Coexpression experiments on fresh colorectal cancer specimens using specific cell population markers were performed. In the test group, higher numbers of CD3+ (p<0.001), CD4+ (p = 0.029), CD8+ (p<0.001), CD45RO+ (p = 0.048), FoxP3+ (p<0.001), GranzymeB+ (p<0.001), iNOS+ (p = 0.035), MUM1+ (p = 0.014), PD1+ (p = 0.034) and TIA-1+ TILs (p<0.001) were linked to favourable outcome. Adjusting for age, gender, TNM stage and post-operative therapy, higher CD8+ (p<0.001; HR (95%CI): 0.66 (0.64-0.68)) and TIA-1+ (p<0.001; HR (95%CI): 0.56 (0.5-0.6)) were independent prognostic factors. Moreover, among patients with CD8+ infiltrates, TIA-1 further stratified 355 (35.6%) patients into prognostic subgroups (p<0.001; HR (95% CI): 0.89 (95% CI: 0.8-0.9)). Results were confirmed on the validation cohort (p = 0.006). TIA-1+ cells were mostly CD8+ (57%), but also stained for TCR gamma delta (22%), CD66b (13%) and only rarely for CD4+, macrophage and NK cell markers. Conclusions: TIA-1 adds prognostic information to TNM stage and adjuvant therapy in MMR-proficient colorectal cancer patients. The prognostic effect of CD8+ TILs is confounded by the presence of TIA-1+ which translates into improved risk stratification for approximately 35% of all patients with MMR-proficient colorectal cancers.	[Zlobec, Inti; Terracciano, Luigi; Tzankov, Alexandar; Lugli, Alessandro] Univ Basel, Inst Pathol, Basel, Switzerland; [Karamitopoulou, Eva] Attikon Univ Hosp, Dept Pathol 2, Athens, Greece; [Piscuoglio, Salvatore] Univ Basel, Res Grp Human Genet, Dept Biomed, Basel, Switzerland; [Iezzi, Giandomenica; Muraro, Manuele Giuseppe; Spagnoli, Giulio] Univ Basel, Inst Surg Res & Hosp Management, Basel, Switzerland; [Baker, Kristi] Brigham & Womens Hosp, Dept Gastroenterol, Boston, MA 02115 USA	University of Basel; University Hospital Attikon; University of Basel; University of Basel; Harvard University; Brigham & Women's Hospital	Zlobec, I (corresponding author), Univ Basel, Inst Pathol, Basel, Switzerland.	izlobec@uhbs.ch	Piscuoglio, Salvatore/AAB-4959-2022; Tzankov, Alexandar/H-5656-2019; Terracciano, Luigi M./AAB-5335-2022; Tzankov, Alexandar/A-9155-2008	Piscuoglio, Salvatore/0000-0003-2686-2939; Tzankov, Alexandar/0000-0002-1100-3819; Terracciano, Luigi M./0000-0002-9393-9660; Muraro, Manuele Giuseppe/0000-0002-4590-1916; Zlobec, Inti/0000-0001-6741-3000; Baker, Kristi/0000-0002-2993-3889; Karamitopoulou-Diamantis, Eva/0000-0002-4833-1373; Iezzi, Giandomenica/0000-0001-5841-495X	Institute for Pathology, University Hospital of Basel	Institute for Pathology, University Hospital of Basel	The authors were funded by the Institute for Pathology, University Hospital of Basel, Research pool account. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro T, 2006, J CLIN ONCOL, V24, P5350, DOI 10.1200/JCO.2006.06.4766; Baker K, 2009, CANCER IMMUNOL IMMUN, V58, P135, DOI 10.1007/s00262-008-0534-1; Baker K, 2007, EUR J CANCER, V43, P624, DOI 10.1016/j.ejca.2006.11.012; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; CARROLL RP, 2010, J AM SOC NEPHROL; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; Compton C, 2006, PROGNOSTIC FACTORS C; Dadabayev AR, 2004, CANCER IMMUNOL IMMUN, V53, P978, DOI 10.1007/s00262-004-0548-2; de Kruijf EM, 2010, CLIN CANCER RES, V16, P1272, DOI 10.1158/1078-0432.CCR-09-1844; Dolcetti R, 1999, AM J PATHOL, V154, P1805, DOI 10.1016/S0002-9440(10)65436-3; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Forch P, 2001, APOPTOSIS, V6, P463, DOI 10.1023/A:1012441824719; FREY DM, 2009, INT J CANC; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Goethals L, 2006, J PATHOL, V208, P607, DOI 10.1002/path.1934; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Jenkins MA, 2007, GASTROENTEROLOGY, V133, P48, DOI 10.1053/j.gastro.2007.04.044; Mallett S, 2010, BRIT J CANCER, V102, P173, DOI 10.1038/sj.bjc.6605462; Mocellin S, 2003, INT J CANCER, V107, P317, DOI 10.1002/ijc.11369; O'Malley DP, 2007, AM J CLIN PATHOL, V127, P850, DOI 10.1309/A8FHDA0VVRJ05GJP; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Rubio CA, 1999, ANTICANCER RES, V19, P3221; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Santucci M, 2003, CANCER, V97, P610, DOI 10.1002/cncr.11107; Sasaki A, 2008, EJSO-EUR J SURG ONC, V34, P173, DOI 10.1016/j.ejso.2007.08.008; Shetye J, 1998, CLIN CANCER RES, V4, P1921; STEYERBERG EW, 2008, CLIN PREDICTION MODE, pCH17; SUZUKI H, 2009, CANC IMMUNOL IMMUNOT	33	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14282	10.1371/journal.pone.0014282	http://dx.doi.org/10.1371/journal.pone.0014282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21179245	gold, Green Published, Green Submitted			2022-12-27	WOS:000285181400008
J	Borges, TJ; Porto, BN; Teixeira, CA; Rodrigues, M; Machado, FD; Ornaghi, AP; de Souza, APD; Maito, F; Pavanelli, WR; Silva, JS; Bonorino, C				Borges, Thiago J.; Porto, Barbara N.; Teixeira, Cesar A.; Rodrigues, Marcelle; Machado, Felipe D.; Ornaghi, Ana Paula; de Souza, Ana Paula D.; Maito, Fabio; Pavanelli, Wander R.; Silva, Joao S.; Bonorino, Cristina			Prolonged Survival of Allografts Induced by Mycobacterial Hsp70 Is Dependent on CD4+CD25+Regulatory T Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DENDRITIC CELLS; ADJUVANT ARTHRITIS; INTERLEUKIN-10 PRODUCTION; ORGAN-TRANSPLANTATION; LYMPH-NODES; ANTIGEN; HEAT-SHOCK-PROTEIN-70; PROLIFERATION; TUBERCULOSIS	Background: Heat shock proteins (Hsps) are stress induced proteins with immunomodulatory properties. The Hsp70 of Mycobacterium tuberculosis (TBHsp70) has been shown to have an anti-inflammatory role on rodent autoimmune arthritis models, and the protective effects were demonstrated to be dependent on interleukin-10 (IL-10). We have previously observed that TBHsp70 inhibited maturation of dendritic cells (DCs) and induced IL-10 production by these cells, as well as in synovial fluid cells. Methodology/Principal Findings: We investigated if TBHsp70 could inhibit allograft rejection in two murine allograft systems, a transplanted allogeneic melanoma and a regular skin allograft. In both systems, treatment with TBHsp70 significantly inhibited rejection of the graft, and correlated with regulatory T cells (Tregs) recruitment. This effect was not tumor mediated because injection of TBHsp70 in tumor-free mice induced an increase of Tregs in the draining lymph nodes as well as inhibition of proliferation of lymph node T cells and an increase in IL-10 production. Finally, TBHsp70 inhibited skin allograft acute rejection, and depletion of Tregs using a monoclonal antibody completely abolished this effect. Conclusions/Significance: We present the first evidence for an immunosuppressive role for this protein in a graft rejection system, using an innovative approach - immersion of the graft tissue in TBHsp70 solution instead of protein injection. Also, this is the first study that demonstrates dependence on Treg cells for the immunosuppressive role of TBHsp70. This finding is relevant for the elucidation of the immunomodulatory mechanism of TBHsp70. We propose that this protein can be used not only for chronic inflammatory diseases, but is also useful for organ transplantation management.	[Borges, Thiago J.; Porto, Barbara N.; Teixeira, Cesar A.; Rodrigues, Marcelle; Machado, Felipe D.; Ornaghi, Ana Paula; de Souza, Ana Paula D.; Maito, Fabio; Bonorino, Cristina] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Borges, Thiago J.; Porto, Barbara N.; Teixeira, Cesar A.; Rodrigues, Marcelle; Machado, Felipe D.; Ornaghi, Ana Paula; de Souza, Ana Paula D.; Maito, Fabio; Bonorino, Cristina] Pontificia Univ Catolica Rio Grande do Sul, Inst Pesquisas Biomed, Porto Alegre, RS, Brazil; [Pavanelli, Wander R.] Univ Estadual Londrina, Dept Patol Geral, Londrina, Brazil; [Silva, Joao S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Imunol, Ribeirao Preto, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Estadual de Londrina; Universidade de Sao Paulo	Borges, TJ (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.	cbonorino@pucrs.br	Duarte, Ana/S-1904-2016; Bonorino, Cristina/U-2780-2019; Borges, Thiago/Q-3711-2019; Souza, Ana/J-9534-2015; Silva, Joao/A-4484-2008; Duarte, Ana/GRT-0033-2022	Duarte, Ana/0000-0002-6021-5068; Borges, Thiago/0000-0002-6554-0169; Silva, Joao/0000-0002-3410-3927; 	Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP)	Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Financiadora de Estudos e Projetos (FINEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; BILLINGHAM RE, 1951, J EXP BIOL, V28, P385; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; de Souza AP, 2009, EXPERT REV ANTICANC, V9, P1317, DOI [10.1586/era.09.88, 10.1586/ERA.09.88]; Detanico T, 2004, CLIN EXP IMMUNOL, V135, P336, DOI 10.1111/j.1365-2249.2004.02351.x; Durrbach A, 2010, NAT REV NEPHROL, V6, P160, DOI 10.1038/nrneph.2009.233; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Guarrera JV, 2008, CURR OPIN ORGAN TRAN, V13, P148, DOI 10.1097/MOT.0b013e3282f63930; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Jo SK, 2006, J AM SOC NEPHROL, V17, P3082, DOI 10.1681/ASN.2005101077; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Khoruts A, 2004, EUR J IMMUNOL, V34, P1085, DOI 10.1002/eji.200324170; Kim JI, 2009, AM J TRANSPLANT, V9, P2736, DOI 10.1111/j.1600-6143.2009.02847.x; Kingston AE, 1996, CLIN EXP IMMUNOL, V103, P77, DOI 10.1046/j.1365-2249.1996.929628.x; Kuboki S, 2007, AM J PHYSIOL-GASTR L, V292, pG201, DOI 10.1152/ajpgi.00186.2006; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MEHLERT A, 1989, MOL MICROBIOL, V3, P125, DOI 10.1111/j.1365-2958.1989.tb01801.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motta A, 2007, IMMUNOLOGY, V121, P462, DOI 10.1111/j.1365-2567.2007.02564.x; Nabel GJ, 1999, NATURE, V397, P471, DOI 10.1038/17207; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Okada Y, 2009, GEN THORAC CARDIOVAS, V57, P635, DOI 10.1007/s11748-009-0492-3; Ouyang J, 2010, SCAND J IMMUNOL, V71, P336, DOI 10.1111/j.1365-3083.2010.02384.x; Prakken BJ, 2001, J IMMUNOL, V167, P4147, DOI 10.4049/jimmunol.167.8.4147; Qin FXF, 2009, CELL MOL IMMUNOL, V6, P3, DOI 10.1038/cmi.2009.2; RIETSCHEL ET, 1993, IMMUNOBIOLOGY, V187, P169, DOI 10.1016/S0171-2985(11)80338-4; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schonder Kristine S, 2010, Paediatr Drugs, V12, P35, DOI 10.2165/11316180-000000000-00000; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; SHARMA S K, 1986, Biotechnology and Applied Biochemistry, V8, P5; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Tanaka S, 1999, J IMMUNOL, V163, P5560; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Turnquist HR, 2010, METHODS MOL BIOL, V595, P135, DOI 10.1007/978-1-60761-421-0_8; Ulmansky R, 2002, J IMMUNOL, V168, P6463, DOI 10.4049/jimmunol.168.12.6463; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wendling U, 2000, J IMMUNOL, V164, P2711, DOI 10.4049/jimmunol.164.5.2711; Wieten L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004186; Yamagami S, 2002, CORNEA, V21, P405, DOI 10.1097/00003226-200205000-00014; Yuan XD, 2010, TRANSPL INT, V23, P561, DOI 10.1111/j.1432-2277.2009.01047.x; Zhang XS, 2008, CLIN IMMUNOL, V127, P313, DOI 10.1016/j.clim.2008.01.013	46	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14264	10.1371/journal.pone.0014264	http://dx.doi.org/10.1371/journal.pone.0014264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170379	Green Published, Green Submitted, gold			2022-12-27	WOS:000285084100014
J	Ratti, C; Sobolevsky, S; Calabrese, F; Andris, C; Reades, J; Martino, M; Claxton, R; Strogatz, SH				Ratti, Carlo; Sobolevsky, Stanislav; Calabrese, Francesco; Andris, Clio; Reades, Jonathan; Martino, Mauro; Claxton, Rob; Strogatz, Steven H.			Redrawing the Map of Great Britain from a Network of Human Interactions	PLOS ONE			English	Article							MOBILE COMMUNICATION-NETWORKS; COMMUNITY STRUCTURE; FUNCTIONAL REGIONS; IDENTIFICATION; MODULARITY; PATTERNS	Do regional boundaries defined by governments respect the more natural ways that people interact across space? This paper proposes a novel, fine-grained approach to regional delineation, based on analyzing networks of billions of individual human transactions. Given a geographical area and some measure of the strength of links between its inhabitants, we show how to partition the area into smaller, non-overlapping regions while minimizing the disruption to each person's links. We tested our method on the largest non-Internet human network, inferred from a large telecommunications database in Great Britain. Our partitioning algorithm yields geographically cohesive regions that correspond remarkably well with administrative regions, while unveiling unexpected spatial structures that had previously only been hypothesized in the literature. We also quantify the effects of partitioning, showing for instance that the effects of a possible secession of Wales from Great Britain would be twice as disruptive for the human network than that of Scotland.	[Ratti, Carlo; Sobolevsky, Stanislav; Calabrese, Francesco; Andris, Clio; Reades, Jonathan; Martino, Mauro] MIT, Senseable City Lab, Cambridge, MA 02139 USA; [Reades, Jonathan] UCL, Ctr Adv Spatial Anal, London, England; [Claxton, Rob] BT Grp, Ipswich, Suffolk, England; [Strogatz, Steven H.] Cornell Univ, Dept Math, Ithaca, NY 14853 USA	Massachusetts Institute of Technology (MIT); University of London; University College London; Cornell University	Ratti, C (corresponding author), MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fcalabre@mit.edu	Sobolevsky, Stanislav/ABH-7108-2020; Strogatz, Steven H/A-1641-2014	Sobolevsky, Stanislav/0000-0001-6281-0656; Strogatz, Steven H/0000-0003-2923-3118; Reades, Jonathan/0000-0002-1443-9263	ATT Foundation; National Science Foundation; National Defense Science and Engineering Fellowship Program; Audi Volkswagen; BT Group plc; BT Group; MIT; GE; SNCF; ENEL	ATT Foundation; National Science Foundation(National Science Foundation (NSF)); National Defense Science and Engineering Fellowship Program(United States Department of Defense); Audi Volkswagen; BT Group plc; BT Group; MIT; GE; SNCF; ENEL	The authors were partially funded by the AT&T Foundation, the National Science Foundation, the National Defense Science and Engineering Fellowship Program, and Audi Volkswagen. Rob Claxton was funded by BT Group plc, which contributed to data collection and had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the BT Group, the National Science Foundation, the AT&T Foundation, the National Defense Science and Engineering Fellowship Program, the MIT SMART program, GE, Audi Volkswagen, SNCF, ENEL and the members of the MIT Senseable City Lab Consortium for supporting the research. Janet Owers provided expert editorial guidance.	Arenas A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/176; Barkley DL, 1996, LAND ECON, V72, P336, DOI 10.2307/3147201; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; BROWN LA, 1971, J REGIONAL SCI, V11, P57, DOI 10.1111/j.1467-9787.1971.tb00240.x; Christaller W, 1933, CENTRAL PLACES SO GE; Coombes M, 2000, ENVIRON PLANN A, V32, P1499, DOI 10.1068/a29165; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fujita M., 2001, SPATIAL EC CITIES RE; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; HALL P, ALLEN UNWIN LONDON S; HEMMASI M, 1980, ECON GEOGR, V56, P223, DOI 10.2307/142714; JOHNSTON KP, 1995, SURV CURR BUS, V84, P75; Karlsson C, 2006, ANN REGIONAL SCI, V40, P1, DOI 10.1007/s00168-005-0019-5; KILLIAN MS, 1993, INEQUALITIES LABOUR; Krings G., 2009, J STAT MECH-THEORY E, V7, P1; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Losch A., 1938, SO EC J, V5, P71, DOI DOI 10.2307/3693804; MICKLANDER A, 1971, COMMUTING COMMUTING; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Nielsen TAS, 2008, J TRANSP GEOGR, V16, P90, DOI 10.1016/j.jtrangeo.2007.04.005; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; PORTER AP, 2009, NOT AM MATH SOC, V56, P1082; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Thiemann C., 2010, STRUCTURE BORDERS SM; TRUDGILL P, 1999, OXFORD DIALECTS ENGL; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; ZIPF G, 1949, EC GEOGRAPHY; Ziv E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046117	35	233	244	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14248	10.1371/journal.pone.0014248	http://dx.doi.org/10.1371/journal.pone.0014248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691MJ	21170390	Green Published, Green Submitted, gold			2022-12-27	WOS:000285084100002
J	Le Blastier, S; Hamels, A; Cabeen, M; Schille, L; Tilquin, F; Dieu, M; Raes, M; Matroule, JY				Le Blastier, Sophie; Hamels, Aurore; Cabeen, Matthew; Schille, Lionel; Tilquin, Francoise; Dieu, Marc; Raes, Martine; Matroule, Jean-Yves			Phosphate Starvation Triggers Production and Secretion of an Extracellular Lipoprotein in Caulobacter crescentus	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; II SECRETION; KLEBSIELLA-PNEUMONIAE; SORTING SIGNALS; OUTER-MEMBRANE; PATHWAY; PULLULANASE	Life in oligotrophic environments necessitates quick adaptive responses to a sudden lack of nutrients. Secretion of specific degradative enzymes into the extracellular medium is a means to mobilize the required nutrient from nearby sources. The aquatic bacterium Caulobacter crescentus must often face changes in its environment such as phosphate limitation. Evidence reported in this paper indicates that under phosphate starvation, C. crescentus produces a membrane surface-anchored lipoprotein named ElpS subsequently released into the extracellular medium. A complete set of 12 genes encoding a type II secretion system (T2SS) is located adjacent to the elpS locus in the C. crescentus genome. Deletion of this T2SS impairs release of ElpS in the environment, which surprisingly remains present at the cell surface, indicating that the T2SS is not involved in the translocation of ElpS to the outer membrane but rather in its release. Accordingly, treatment with protease inhibitors prevents release of ElpS in the extracellular medium suggesting that ElpS secretion relies on a T2SS-secreted protease. Finally, secretion of ElpS is associated with an increase in alkaline phosphatase activity in culture supernatants, suggesting a role of the secreted protein in inorganic phosphate mobilization. In conclusion, we have shown that upon phosphate starvation, C. crescentus produces an outer membrane bound lipoprotein, ElpS, which is further cleaved and released in the extracellular medium in a T2SS-dependent manner. Our data suggest that ElpS is associated with an alkaline phosphatase activity, thereby allowing the bacterium to gather inorganic phosphates from a poor environment.	[Le Blastier, Sophie; Hamels, Aurore; Schille, Lionel; Tilquin, Francoise; Matroule, Jean-Yves] Univ Namur, Unite Rech Biol Mol, Namur, Belgium; [Cabeen, Matthew] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Dieu, Marc; Raes, Martine] Univ Namur, Unite Rech Biol Cellulaire, Namur, Belgium	University of Namur; Yale University; University of Namur	Le Blastier, S (corresponding author), Univ Namur, Unite Rech Biol Mol, Namur, Belgium.	jean-yves.matroule@fundp.ac.be		Dieu, Marc/0000-0002-3902-542X	University of Namur; FRS-FNRS (Fond National pour la Recherche Scientifique, Belgium)	University of Namur; FRS-FNRS (Fond National pour la Recherche Scientifique, Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the University of Namur and by an FRS-FNRS (Fond National pour la Recherche Scientifique, Belgium) research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Brokx SJ, 2004, J BACTERIOL, V186, P3254, DOI 10.1128/JB.186.10.3254-3258.2004; Cavard D, 2002, J BACTERIOL, V184, P3723, DOI 10.1128/JB.184.13.3723-3733.2002; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Corbett M, 2005, MOL PLANT MICROBE IN, V18, P334, DOI 10.1094/MPMI-18-0334; De Groot A, 2001, J BACTERIOL, V183, P959, DOI 10.1128/JB.183.3.959-967.2001; DENFERT C, 1987, MOL MICROBIOL, V1, P107, DOI 10.1111/j.1365-2958.1987.tb00534.x; DeShazer D, 1999, J BACTERIOL, V181, P4661, DOI 10.1128/JB.181.15.4661-4664.1999; Desvaux M, 2004, TRENDS MICROBIOL, V12, P306, DOI 10.1016/j.tim.2004.05.002; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Ireland MME, 2002, MOL MICROBIOL, V45, P1029, DOI 10.1046/j.1365-2958.2002.03071.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Lewenza S, 2008, J BACTERIOL, V190, P6119, DOI 10.1128/JB.00603-08; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; Parche S, 1997, J BACTERIOL, V179, P4631, DOI 10.1128/jb.179.14.4631-4634.1997; POINDEXTER JS, 1978, J BACTERIOL, V135, P1141, DOI 10.1128/JB.135.3.1141-1145.1978; POINDEXTER JS, 1984, ARCH MICROBIOL, V138, P140, DOI 10.1007/BF00413014; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; POQUET I, 1993, MOL MICROBIOL, V9, P1061, DOI 10.1111/j.1365-2958.1993.tb01235.x; PUGSLEY AP, 1986, J BACTERIOL, V166, P1083, DOI 10.1128/jb.166.3.1083-1088.1986; PUGSLEY AP, 1991, J BIOL CHEM, V266, P13640; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Rittmann D, 2005, APPL ENVIRON MICROB, V71, P4339, DOI 10.1128/AEM.71.8.4339-4344.2005; Rossier O, 2005, INFECT IMMUN, V73, P2020, DOI 10.1128/IAI.73.4.2020-2032.2005; Roussel-Jazede V, 2010, INFECT IMMUN, V78, P3083, DOI 10.1128/IAI.01193-09; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423; SCHMIDT JM, 1969, J BACTERIOL, V98, P816, DOI 10.1128/JB.98.2.816-817.1969; STEED PM, 1993, J BACTERIOL, V175, P6797, DOI 10.1128/jb.175.21.6797-6809.1993; Swift S, 1997, J BACTERIOL, V179, P5271, DOI 10.1128/jb.179.17.5271-5281.1997; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; Tjalsma H, 1999, J BIOL CHEM, V274, P1698, DOI 10.1074/jbc.274.3.1698; Tokuda H, 2009, BIOSCI BIOTECH BIOCH, V73, P465, DOI 10.1271/bbb.80778; Viarre V, 2009, J BIOL CHEM, V284, P33815, DOI 10.1074/jbc.M109.065938; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; WILLSKY GR, 1976, J BACTERIOL, V127, P595, DOI 10.1128/JB.127.1.595-609.1976	47	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14198	10.1371/journal.pone.0014198	http://dx.doi.org/10.1371/journal.pone.0014198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152032	Green Published, gold, Green Submitted			2022-12-27	WOS:000284868000012
J	Malinowska, M; Wilkinson, FL; Langford-Smith, KJ; Langford-Smith, A; Brown, JR; Crawford, BE; Vanier, MT; Grynkiewicz, G; Wynn, RF; Wraith, JE; Wegrzyn, G; Bigger, BW				Malinowska, Marcelina; Wilkinson, Fiona L.; Langford-Smith, Kia J.; Langford-Smith, Alex; Brown, Jillian R.; Crawford, Brett E.; Vanier, Marie T.; Grynkiewicz, Grzegorz; Wynn, Rob F.; Wraith, J. Ed; Wegrzyn, Grzegorz; Bigger, Brian W.			Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease	PLOS ONE			English	Article							SUBSTRATE REDUCTION THERAPY; ENZYME REPLACEMENT THERAPY; N-BUTYLDEOXYNOJIRIMYCIN; SANFILIPPO-SYNDROME; CHRONIC SAFETY; IIIB; PROTEIN; RATS; MICE; ACTIVATION	Background: Neurodegenerative metabolic disorders such as mucopolysaccharidosis IIIB (MPSIIIB or Sanfilippo disease) accumulate undegraded substrates in the brain and are often unresponsive to enzyme replacement treatments due to the impermeability of the blood brain barrier to enzyme. MPSIIIB is characterised by behavioural difficulties, cognitive and later motor decline, with death in the second decade of life. Most of these neurodegenerative lysosomal storage diseases lack effective treatments. We recently described significant reductions of accumulated heparan sulphate substrate in liver of a mouse model of MPSIIIB using the tyrosine kinase inhibitor genistein. Methodology/Principal Findings: We report here that high doses of genistein aglycone, given continuously over a 9 month period to MPSIIIB mice, significantly reduce lysosomal storage, heparan sulphate substrate and neuroinflammation in the cerebral cortex and hippocampus, resulting in correction of the behavioural defects observed. Improvements in synaptic vesicle protein expression and secondary storage in the cerebral cortex were also observed. Conclusions/Significance: Genistein may prove useful as a substrate reduction agent to delay clinical onset of MPSIIIB and, due to its multimodal action, may provide a treatment adjunct for several other neurodegenerative metabolic diseases.	[Malinowska, Marcelina; Wilkinson, Fiona L.; Langford-Smith, Kia J.; Langford-Smith, Alex; Bigger, Brian W.] Univ Manchester, Fac Med & Human Sci, Mucopolysaccharidosis MPS Stem Cell Res Grp, Manchester, Lancs, England; [Malinowska, Marcelina; Wegrzyn, Grzegorz] Univ Gdansk, Fac Biol, Dept Mol Biol, PL-80952 Gdansk, Poland; [Brown, Jillian R.; Crawford, Brett E.] Zacharon Pharmaceut Inc, San Diego, CA USA; [Vanier, Marie T.] Lyon Univ, Unit 820, INSERM, Lyon, France; [Grynkiewicz, Grzegorz] Pharmaceut Res Inst, Warsaw, Poland; [Wynn, Rob F.; Bigger, Brian W.] Cent Manchester Univ Hosp NHS Fdn Trust, Royal Manchester Childrens Hosp, Manchester Acad Hlth Sci Ctr, Bone Marrow Transplant Unit, Manchester, Lancs, England; [Wraith, J. Ed] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; Fahrenheit Universities; University of Gdansk; BioMarin Pharmaceutical Inc.; Zacharon Pharmaceuticals Inc.; Institut National de la Sante et de la Recherche Medicale (Inserm); Pharmaceutical Research Institute - Poland; Royal Manchester Children's Hospital; University of Manchester; University of Manchester	Malinowska, M (corresponding author), Univ Manchester, Fac Med & Human Sci, Mucopolysaccharidosis MPS Stem Cell Res Grp, Manchester, Lancs, England.	Brian.Bigger@manchester.ac.uk	Wegrzyn, Grzegorz/AAL-1179-2020; Grynkiewicz, Grzegorz/E-6967-2019; Langford-Smith, Alex/K-7624-2017; Langford-Smith, Kia/H-5255-2011; Langford-Smith, Alex/H-5249-2011; Wegrzyn, Grzegorz/ABD-6699-2020; Malinowska, Marcelina/Q-9362-2018; Bigger, Brian/I-3553-2012	Langford-Smith, Alex/0000-0001-7006-0592; Langford-Smith, Alex/0000-0001-7006-0592; Wegrzyn, Grzegorz/0000-0003-4042-7466; Malinowska, Marcelina/0000-0002-5586-4354; Wilkinson, Fiona/0000-0002-0358-3489; Wynn, robert/0000-0002-6046-8428; Bigger, Brian/0000-0002-9708-1112	UK Society for Mucopolysaccharide Diseases [J4G/25/04]; Ministry of Science and Higher Education (Poland) [N302 046 32/3603]; EU [TEAM/2008-2/7]; Polish MPS Society; Manchester Biomedical Research Centre; InnoDoktorant; European Social Fund; Program of Introduction of Modern Education Elements at University of Gdansk	UK Society for Mucopolysaccharide Diseases; Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland); EU(European Commission); Polish MPS Society; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); InnoDoktorant; European Social Fund(European Social Fund (ESF)); Program of Introduction of Modern Education Elements at University of Gdansk	This work was funded by the UK Society for Mucopolysaccharide Diseases (J4G/25/04), with contributions from the Japanese Society of the Patients and Families with MPS, MPS Schweiz, Gesellschaft fur Mukopolysaccharidosen, Asociacion MPS Espana, The Irish Society for Mucopolysaccharide Diseases, the Canadian Society for Mucopolysaccharide and Related Diseases, the National MPS Society, the Swedish MPS Society, Gesellschaft fur MPS e.V., VKS, with partial support by Ministry of Science and Higher Education (Poland) (N302 046 32/3603) and Foundation for Polish Science Team Programme, co-financed by the EU European Regional Development Fund (TEAM/2008-2/7). Support from the Polish MPS Society and the Manchester Biomedical Research Centre is also acknowledged. MM was supported by the InnoDoktorant, scholarships for PhD students from the European Social Fund, and by the Program of Introduction of Modern Education Elements at University of Gdansk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also as Jillian R. Brown and Brett E. Crawford are affiliated to Zacharon Pharmaceuticals Inc, Zacharon Pharmaceuticals Inc did play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ARCHER LD, J NEUROSCI RES, V88, P233; Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Gografe SI, 2009, COMPARATIVE MED, V59, P139; Jeyakumar M, 2004, ANN NEUROL, V56, P642, DOI 10.1002/ana.20242; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Kong LY, 1997, NEUROCHEM INT, V30, P491, DOI 10.1016/S0197-0186(96)00086-1; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; Malinowska M, 2009, MOL GENET METAB, V98, P235, DOI 10.1016/j.ymgme.2009.06.013; Marini H, 2007, ANN INTERN MED, V146, P839, DOI 10.7326/0003-4819-146-12-200706190-00005; McClain RM, 2005, FOOD CHEM TOXICOL, V43, P1461, DOI 10.1016/j.fct.2005.02.017; McClain RM, 2006, FOOD CHEM TOXICOL, V44, P56, DOI 10.1016/j.fct.2005.05.021; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Netland EE, 1998, NEUROBIOL AGING, V19, P201, DOI 10.1016/S0197-4580(98)00047-5; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Paxinos F, 2004, MOUSE BRAIN STEREOTA; Piotrowska E, 2008, CURR THER RES CLIN E, V69, P166, DOI 10.1016/j.curtheres.2008.04.002; Piotrowska E, 2006, EUR J HUM GENET, V14, P846, DOI 10.1038/sj.ejhg.5201623; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111/j.1651-2227.2008.00656.x; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sfakianos J, 1997, J NUTR, V127, P1260, DOI 10.1093/jn/127.7.1260; Tsai TH, 2005, J CHROMATOGR A, V1073, P317, DOI 10.1016/j.chroma.2004.10.048; Valstar MI, 2008, J INHERIT METAB DIS; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Wang XJ, 2005, NEUROREPORT, V16, P267, DOI 10.1097/00001756-200502280-00013; Warri A, 2008, BRIT J CANCER, V98, P1485, DOI 10.1038/sj.bjc.6604321; Wraith JE, 2006, J INHERIT METAB DIS, V29, P442, DOI 10.1007/s10545-006-0239-6; Wraith J E, 2002, Semin Neonatol, V7, P75, DOI 10.1053/siny.2001.0088; Wynn RF, 2009, J PEDIATR-US, V154, P609, DOI 10.1016/j.jpeds.2008.11.005; XU X, 1995, J NUTR, V125, P2307, DOI 10.1093/jn/125.9.2307	37	106	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14192	10.1371/journal.pone.0014192	http://dx.doi.org/10.1371/journal.pone.0014192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152017	Green Published, Green Submitted, gold			2022-12-27	WOS:000284821300009
J	Ferrada, E; Wagner, A				Ferrada, Evandro; Wagner, Andreas			Evolutionary Innovations and the Organization of Protein Functions in Genotype Space	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PUNCTUATED EVOLUTION; DNA-POLYMERASES; SELECTION; DATABASE; FOLD; CLASSIFICATION; DESIGNABILITY; SUPERFAMILIES; CONSTRAINTS	The organization of protein structures in protein genotype space is well studied. The same does not hold for protein functions, whose organization is important to understand how novel protein functions can arise through blind evolutionary searches of sequence space. In systems other than proteins, two organizational features of genotype space facilitate phenotypic innovation. The first is that genotypes with the same phenotype form vast and connected genotype networks. The second is that different neighborhoods in this space contain different novel phenotypes. We here characterize the organization of enzymatic functions in protein genotype space, using a data set of more than 30,000 proteins with known structure and function. We show that different neighborhoods of genotype space contain proteins with very different functions. This property both facilitates evolutionary innovation through exploration of a genotype network, and it constrains the evolution of novel phenotypes. The phenotypic diversity of different neighborhoods is caused by the fact that some functions can be carried out by multiple structures. We show that the space of protein functions is not homogeneous, and different genotype neighborhoods tend to contain a different spectrum of functions, whose diversity increases with increasing distance of these neighborhoods in sequence space. Whether a protein with a given function can evolve specific new functions is thus determined by the protein's location in sequence space.	[Ferrada, Evandro; Wagner, Andreas] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA; [Ferrada, Evandro; Wagner, Andreas] Swiss Inst Bioinformat, Lausanne, Switzerland; [Wagner, Andreas] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of Zurich; The Santa Fe Institute; Swiss Institute of Bioinformatics; University of New Mexico	Ferrada, E (corresponding author), Univ Zurich, Dept Biochem, Zurich, Switzerland.	e.ferrada@bioc.uzh.ch		Ferrada, Evandro/0000-0003-3242-1726	Swiss National Science Foundation [315200-116814, 315200-119697, 315230-129708]; University of Zurich; UZH Forschungskredit	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; UZH Forschungskredit	AW acknowledges support through Swiss National Science Foundation grants 315200-116814, 315200-119697 and 315230-129708, as well as through the YeastX project of SystemsX.ch, and the University Priority Research Program in systems biology at the University of Zurich. EF acknowledges support through UZH Forschungskredit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; AMUNDSON R, 1994, PHILOS SCI, V61, P556, DOI 10.1086/289822; [Anonymous], 1980, CODING INFORM THEORY; ARONSON HEG, 1994, PROTEIN SCI, V3, P1706, DOI 10.1002/pro.5560031009; Axe DD, 2004, J MOL BIOL, V341, P1295, DOI 10.1016/j.jmb.2004.06.058; Babajide A, 2001, J THEOR BIOL, V212, P35, DOI 10.1006/jtbi.2001.2343; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; BornbergBauer E, 1997, BIOPHYS J, V73, P2393, DOI 10.1016/S0006-3495(97)78268-7; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; Brannigan JA, 2002, NAT REV MOL CELL BIO, V3, P964, DOI 10.1038/nrm975; Buchler NEG, 1999, PROTEINS, V34, P113; Choo Y, 2000, CURR OPIN STRUC BIOL, V10, P411, DOI 10.1016/S0959-440X(00)00107-X; CHOTHIA C, 1987, COLD SPRING HARB SYM, V52, P399, DOI 10.1101/SQB.1987.052.01.046; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802; FINKELSTEIN AV, 1995, SUBCELLULAR BIOCH, V24; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Fontana W, 1998, J THEOR BIOL, V194, P491, DOI 10.1006/jtbi.1998.0771; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Hodin J, 2000, MOD AN FORM WORKSH F; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; KLEINA LG, 1990, J MOL BIOL, V212, P295, DOI 10.1016/0022-2836(90)90126-7; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Kunin V, 2005, BIOINFORMATICS, V21, P2618, DOI 10.1093/bioinformatics/bti386; Kussell E, 2005, PROTEIN PEPTIDE LETT, V12, P111, DOI 10.2174/0929866053005881; Li H, 1996, SCIENCE, V273, P666, DOI 10.1126/science.273.5275.666; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; Mann M., 2009, P 5 WORKSH CONSTR BA; Mantaci S, 2008, INT J APPROX REASON, V47, P109, DOI 10.1016/j.ijar.2007.03.011; Martin AC, 1998, STRUCTURE, V6, P875, DOI 10.1016/S0969-2126(98)00089-6; MICHAEL SF, 1992, P NATL ACAD SCI USA, V89, P4796, DOI 10.1073/pnas.89.11.4796; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; PAWLOWSKI K, 2000, PAC S BIOCOMPUT, V8, P42; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; REIDHAAROLSON JF, 1990, PROTEINS, V7, P306, DOI 10.1002/prot.340070403; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; Rodrigues JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000613; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Sangar V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-294; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Taylor SV, 2001, P NATL ACAD SCI USA, V98, P10596, DOI 10.1073/pnas.191159298; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Xia Y, 2004, CURR OPIN STRUC BIOL, V14, P202, DOI 10.1016/j.sbi.2004.03.001	63	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14172	10.1371/journal.pone.0014172	http://dx.doi.org/10.1371/journal.pone.0014172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152394	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000284755100048
J	Khouri, R; Novais, F; Santana, G; de Oliveira, CI; dos Santos, MAV; Barral, A; Barral-Netto, M; Van Weyenbergh, J				Khouri, Ricardo; Novais, Fernanda; Santana, Giselia; de Oliveira, Camila Indiani; Vannier dos Santos, Marcos Andre; Barral, Aldina; Barral-Netto, Manoel; Van Weyenbergh, Johan			DETC Induces Leishmania Parasite Killing in Human In Vitro and Murine In Vivo Models: A Promising Therapeutic Alternative in Leishmaniasis	PLOS ONE			English	Article							DIFFUSE CUTANEOUS LEISHMANIASIS; NITRIC-OXIDE SYNTHASE; ACETYL-L-CYSTEINE; FACTOR-KAPPA-B; SUPEROXIDE-DISMUTASE; IMMUNE-RESPONSE; MAJOR INFECTION; BALB/C MICE; DIETHYLDITHIOCARBAMATE; SURVIVAL	Background: Chemotherapy remains the primary tool for treatment and control of human leishmaniasis. However, currently available drugs present serious problems regarding side-effects, variable efficacy, and cost. Affordable and less toxic drugs are urgently needed for leishmaniasis. Methodology/Principal Findings: We demonstrate, by microscopy and viability assays, that superoxide dismutase inhibitor diethyldithiocarbamate (DETC) dose-dependently induces parasite killing (p<0.001) and is able to "sterilize'' Leishmania amazonensis infection at 2 mM in human macrophages in vitro. We also show that DETC-induced superoxide production (p < 0.001) and parasite destruction (p < 0.05) were reverted by the addition of the antioxidant N-acetylcysteine, indicating that DETC-induced killing occurs through oxidative damage. Furthermore, ultrastructural analysis by electron microscopy demonstrates a rapid and highly selective destruction of amastigotes in the phagosome upon DETC treatment, without any apparent damage to the host cell, including its mitochondria. In addition, DETC significantly induced parasite killing in Leishmania promastigotes in axenic culture. In murine macrophages infected with Leishmania braziliensis, DETC significantly induced in vitro superoxide production (p = 0.0049) and parasite killing (p = 0.0043). In vivo treatment with DETC in BALB/C mice infected with Leishmania braziliensis caused a significant decrease in lesion size (p<0.0001), paralleled by a 100-fold decrease (p = 0.0087) in parasite burden. Conclusions/Significance: Due to its strong leishmanicidal effect in human macrophages in vitro, its in vivo effectiveness in a murine model, and its previously demonstrated in vivo safety profile in HIV treatment, DETC treatment might be considered as a valuable therapeutic option in human leishmaniasis, including HIV/Leishmania co-infection.	[Khouri, Ricardo; Novais, Fernanda; Santana, Giselia; de Oliveira, Camila Indiani; Vannier dos Santos, Marcos Andre; Barral, Aldina; Barral-Netto, Manoel; Van Weyenbergh, Johan] Fundacao Oswaldo Cruz FIOCRUZ, LIMI, Ctr Pesquisa Goncalo Moniz, LIP,LBP, Salvador, BA, Brazil; [Barral, Aldina; Barral-Netto, Manoel; Van Weyenbergh, Johan] INCT, Inst Invest Immunol, Sao Paulo, Brazil	Fundacao Oswaldo Cruz	Khouri, R (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, LIMI, Ctr Pesquisa Goncalo Moniz, LIP,LBP, Salvador, BA, Brazil.	johan@bahia.fiocruz.br	Vannier-Santos, Marcos A/L-3649-2013; Van Weyenbergh, Johan/B-4187-2009; Vannier-Santos, Marcos/G-5517-2012; Khouri, Ricardo/M-3184-2018; Van Weyenbergh, Johan/Q-3829-2019; Barral-Netto, Manoel/B-3904-2009; Vannier-Santos, Marcos/AAG-5053-2021; Barral, Aldina/B-4191-2009; de Oliveira, Camila I/B-4358-2009	Van Weyenbergh, Johan/0000-0003-3234-8426; Khouri, Ricardo/0000-0001-5664-4436; Van Weyenbergh, Johan/0000-0003-3234-8426; Barral-Netto, Manoel/0000-0002-5823-7903; Vannier-Santos, Marcos/0000-0001-9241-2261; Barral, Aldina/0000-0002-7177-464X; de Oliveira, Camila I/0000-0002-7868-5164	CNPq; CAPES; European Union [E06D103200BR]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); European Union(European Commission)	This work was supported by CNPq (AB and MBN are CNPq senior investigators), CAPES and Alban Program, European Union Program of High Level Scholarship for Latin America, scholarship no. E06D103200BR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato VS, 2007, AM J TROP MED HYG, V77, P266, DOI 10.4269/ajtmh.2007.77.266; BARRAL A, 1995, INT J DERMATOL, V34, P474, DOI 10.1111/j.1365-4362.1995.tb00613.x; Blos M, 2003, EUR J IMMUNOL, V33, P1224, DOI 10.1002/eji.200323825; COCCO D, 1981, J BIOL CHEM, V256, P8983; Cruz KK, 2008, PARASITE IMMUNOL, V30, P171, DOI 10.1111/j.1365-3024.2007.01014.x; Cvek B, 2007, CURR PHARM DESIGN, V13, P3155, DOI 10.2174/138161207782110390; de Moura TR, 2005, INFECT IMMUN, V73, P5827, DOI 10.1128/IAI.73.9.5827-5834.2005; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Getachew F, 2007, MOL BIOCHEM PARASIT, V154, P62, DOI 10.1016/j.molbiopara.2007.04.007; Ghosh S, 2003, BIOCHEM J, V369, P447, DOI 10.1042/BJ20021684; Hothersall JS, 1997, BIOCHEM J, V322, P477, DOI 10.1042/bj3220477; HUBNER L, 1991, INT J IMMUNOPHARMACO, V13, P1067, DOI 10.1016/0192-0561(91)90157-3; Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; Llanos-Cuentas A, 2008, CLIN INFECT DIS, V46, P223, DOI 10.1086/524042; Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993; Menezes D, 2006, PARASITOL RES, V98, P99, DOI 10.1007/s00436-005-0010-1; Mikoyan VD, 1997, BBA-GEN SUBJECTS, V1336, P225, DOI 10.1016/S0304-4165(97)00032-9; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Modabber Farrokh, 2007, Kinetoplastid Biol Dis, V6, P3, DOI 10.1186/1475-9292-6-3; Monteiro MC, 2008, PARASITOL RES, V102, P801, DOI 10.1007/s00436-007-0827-x; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Novais FO, 2009, J IMMUNOL, V183, P8088, DOI 10.4049/jimmunol.0803720; Obminska-Mrukowicz Bozena, 2005, J Vet Sci, V6, P25; REISINGER EC, 1990, LANCET, V335, P679, DOI 10.1016/0140-6736(90)90802-C; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Rocha-Vieira E, 2003, IMMUNOLOGY, V108, P401, DOI 10.1046/j.1365-2567.2003.01582.x; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Tuon FF, 2008, INT J DERMATOL, V47, P109, DOI 10.1111/j.1365-4632.2008.03417.x; Vannier-Santos MA, 2009, CURR DRUG TARGETS, V10, P246, DOI 10.2174/138945009787581168; Vannier-Santos MA, 1999, MICROBIOL-UK, V145, P3213, DOI 10.1099/00221287-145-11-3213; Vannier-Santos MA, 2008, MICROBIOL-SGM, V154, P3104, DOI 10.1099/mic.0.2007/013896-0; Vannier-Santos Marcos A., 2001, Biological Procedures Online, V3, P8, DOI 10.1251/bpo19; Zerpa O, 2007, BRIT J DERMATOL, V156, P1328, DOI 10.1111/j.1365-2133.2007.07872.x; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x	40	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14394	10.1371/journal.pone.0014394	http://dx.doi.org/10.1371/journal.pone.0014394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200432	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900009
J	Berthet, N; Deletoile, A; Passet, V; Kennedy, GC; Manuguerra, JC; Cole, ST; Brisse, S				Berthet, Nicolas; Deletoile, Alexis; Passet, Virginie; Kennedy, Giulia C.; Manuguerra, Jean-Claude; Cole, Stewart T.; Brisse, Sylvain			Reconstructed Ancestral Sequences Improve Pathogen Identification Using Resequencing DNA Microarrays	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; PROTEIN SEQUENCES; LIKELIHOOD; ENTEROBACTERIACEAE; CORONAVIRUS; VIRUSES	We describe the benefit of using reconstructed ancestral sequences (RAS) on resequencing microarrays for rapid pathogen identification, with Enterobacteriaceae rpoB sequences as a model. Our results demonstrate a sharp improvement of call rate and accuracy when using RASs as compared to extant sequences. This improvement was attributed to the lower sequence divergence of RASs, which also expanded the sequence space covered by the microarray. Extension of this novel microarray design strategy to viruses, antimicrobial resistance elements or toxins is straightforward.	[Berthet, Nicolas] Inst Pasteur, Epidemiol & Pathophysiol Oncogen Virus Unit, CNRS, URA3015, Paris, France; [Kennedy, Giulia C.] Affymetrix, Santa Clara, CA USA; [Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France; [Cole, Stewart T.] Ecole Polytech Fed Lausanne, Lab Microbial Pathogenesis, Global Hlth Inst, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Affymetrix; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Berthet, N (corresponding author), Inst Pasteur, Epidemiol & Pathophysiol Oncogen Virus Unit, CNRS, URA3015, Paris, France.	sylvain.brisse@pasteur.fr	Berthet, Nicolas/J-9373-2012; Brisse, Sylvain/M-8723-2013	Brisse, Sylvain/0000-0002-2516-2108	National Institute of Allergy and Infectious Diseases, National Institutes of Health [UCI AI062613]; Institut Pasteur [246]; Institut de Veille Sanitaire (Saint-Maurice, France); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC1AI062613] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institut Pasteur(European Commission); Institut de Veille Sanitaire (Saint-Maurice, France); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health [Grant No. UCI AI062613 to G.C.K.] and by Institut Pasteur [Grant PTR DEVA no246 to N.B.]. Platform Genotyping of Pathogens and Public Health receives financial support from Institut Pasteur and the Institut de Veille Sanitaire (Saint-Maurice, France). Affymetrix employs G.C.K. and contributed to data analysis. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthet N, 2008, MICROB BIOTECHNOL, V1, P79, DOI 10.1111/j.1751-7915.2007.00012.x; Berthet N, 2010, NAT BIOTECHNOL, V28, P25, DOI 10.1038/nbt0110-25; Blanchette Mathieu, 2008, V422, P171, DOI 10.1007/978-1-59745-581-7_11; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dacheux L, 2010, J VIROL, V84, P9557, DOI 10.1128/JVI.00771-10; Deletoile A, 2009, J CLIN MICROBIOL, V47, P300, DOI 10.1128/JCM.01916-08; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Elias I, 2007, J COMPUT BIOL, V14, P216, DOI 10.1089/cmb.2006.0101; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; Hall BG, 2006, P NATL ACAD SCI USA, V103, P5431, DOI 10.1073/pnas.0508991103; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Landraud L, 2010, INFECT DIS, P1690; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569; Lin B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000419; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Metzgar D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008995; Naum M, 2008, J MOL EVOL, V66, P630, DOI 10.1007/s00239-008-9115-3; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07; Salerno A, 2007, J BACTERIOL, V189, P7808, DOI 10.1128/JB.00796-07; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; Wang Z, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-577; Wilson WJ, 2002, MOL CELL PROBE, V16, P119, DOI 10.1006/mcpr.2001.0397; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067	36	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15243	10.1371/journal.pone.0015243	http://dx.doi.org/10.1371/journal.pone.0015243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187950	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200025
J	Ling, A; Cordaux, R				Ling, Alison; Cordaux, Richard			Insertion Sequence Inversions Mediated by Ectopic Recombination between Terminal Inverted Repeats	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; GENE CONVERSION; TRANSPOSABLE ELEMENTS; GENOME; EVOLUTION; RETROTRANSPOSONS; DIVERSITY; EVENTS	Transposable elements are widely distributed and diverse in both eukaryotes and prokaryotes, as exemplified by DNA transposons. As a result, they represent a considerable source of genomic variation, for example through ectopic (i.e. nonallelic homologous) recombination events between transposable element copies, resulting in genomic rearrangements. Ectopic recombination may also take place between homologous sequences located within transposable element sequences. DNA transposons are typically bounded by terminal inverted repeats (TIRs). Ectopic recombination between TIRs is expected to result in DNA transposon inversions. However, such inversions have barely been documented. In this study, we report natural inversions of the most common prokaryotic DNA transposons: insertion sequences (IS). We identified natural TIR-TIR recombination-mediated inversions in 9% of IS insertion loci investigated in Wolbachia bacteria, which suggests that recombination between IS TIRs may be a quite common, albeit largely overlooked, source of genomic diversity in bacteria. We suggest that inversions may impede IS survival and proliferation in the host genome by altering transpositional activity. They may also alter genomic instability by modulating the outcome of ectopic recombination events between IS copies in various orientations. This study represents the first report of TIR-TIR recombination within bacterial IS elements and it thereby uncovers a novel mechanism of structural variation for this class of prokaryotic transposable elements.	[Ling, Alison; Cordaux, Richard] Univ Poitiers, CNRS, UMR Ecol 6556, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Ling, A (corresponding author), Univ Poitiers, CNRS, UMR Ecol 6556, Poitiers, France.	richard.cordaux@univ-poitiers.fr			Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This research was funded by a Young Investigator ATIP award from the Centre National de la Recherche Scientifique (CNRS) to RC. AL was supported by a postdoctoral fellowship from the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Arends HM, 2002, J GEN VIROL, V83, P1573, DOI 10.1099/0022-1317-83-7-1573; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Belshaw R, 2007, J VIROL, V81, P9437, DOI 10.1128/JVI.02216-06; Chandler M, 2002, MOBILE DNA, V2, P305; Cordaux R, 2008, MOL BIOL EVOL, V25, P1889, DOI 10.1093/molbev/msn134; Cordaux R, 2008, GENE, V409, P20, DOI 10.1016/j.gene.2007.10.035; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cordaux R, 2009, MOL BIOL EVOL, V26, P1679, DOI 10.1093/molbev/msp093; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Filee J, 2007, MICROBIOL MOL BIOL R, V71, P121, DOI 10.1128/MMBR.00031-06; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leclercq S, 2011, MOL BIOL EVOL, V28, P685, DOI 10.1093/molbev/msq238; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Martin DW, 1997, VIROLOGY, V232, P300, DOI 10.1006/viro.1997.8573; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118; REZNIKOFF WS, 2002, MOBILE DNA, V2, P403; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; Salzberg SL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r23; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Siguier P, 2009, RES MICROBIOL, V160, P232, DOI 10.1016/j.resmic.2009.02.003; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Vitte C, 2003, MOL BIOL EVOL, V20, P528, DOI 10.1093/molbev/msg055; WEBER PC, 1988, CELL, V54, P369, DOI 10.1016/0092-8674(88)90200-0; WEBER PC, 1988, J BACTERIOL, V170, P4972, DOI 10.1128/jb.170.10.4972-4975.1988; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954	36	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15654	10.1371/journal.pone.0015654	http://dx.doi.org/10.1371/journal.pone.0015654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187977	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200058
J	Poonia, B; Kijak, GH; Pauza, CD				Poonia, Bhawna; Kijak, Gustavo H.; Pauza, C. David			High Affinity Allele for the Gene of FCGR3A Is Risk Factor for HIV Infection and Progression	PLOS ONE			English	Article							FC-GAMMA-RIIA; VARIANT GENOTYPES; KAPOSIS-SARCOMA; POLYMORPHISMS; RECEPTORS; CELLS; EXPRESSION; CORRELATE; IGG	Background: We investigated the genetics of Fc receptors, which function as activating receptors on immune cells and help to control HIV through antibody-mediated cellular cytotoxicity. Thus, Fc receptors may be important for virus immunity but might also promote immune hyperactivation that would enhance infection. Methodology/Principal Findings: We measured abundance of low and high activity alleles in two Fc receptor genes, FCGR2A and FCGR3A, for persons with HIV disease, natural virus suppressors (HIV+, without disease) and healthy controls to show whether genotypes were associated with infection and disease. Individuals homozygous for the high activity allele of FCGR3A (158VV) were predominantly found among HIV progressors and this group was also skewed toward higher allele frequencies for the V158 variant. Both of the HIV positive groups (progressors and natural virus suppressors) had significantly higher frequencies of the V158 allele compared with uninfected controls. There were no apparent associations among FCGR2A alleles and HIV status. Conclusions/Significance: Our results indicate that high activity alleles of FCGR3A may be risk factors for HIV infection or progression and we need to understand how allelic variants affect the balance between virus control and immune activation.	[Kijak, Gustavo H.] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR)		bpoonia@ihv.umaryland.edu			PHS [AI068508]; NATIONAL CANCER INSTITUTE [R01CA142458] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by PHS grant AI068508 (C.D.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Brouwer KC, 2004, AIDS, V18, P1187, DOI 10.1097/00002030-200405210-00012; Fontenot D, 2009, P NATL ACAD SCI USA, V106, P16776, DOI 10.1073/pnas.0907347106; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; HUSSAIN LA, 1992, CLIN EXP IMMUNOL, V90, P530; HUSSAIN LA, 1991, AIDS, V5, P1089, DOI 10.1097/00002030-199109000-00004; Kim DH, 2006, BLOOD, V108, P2720, DOI 10.1182/blood-2006-01-009480; Lehrnbecher T, 2000, BLOOD, V95, P2386; Lehrnbecher T, 1999, BLOOD, V94, p431A; Ozturk C, 2006, CLIN EXP MED, V6, P27, DOI 10.1007/s10238-006-0090-y; POVOLOTSKY J, 1991, J INFECT DIS, V163, P247, DOI 10.1093/infdis/163.2.247; Sajadi MM, 2007, AIDS, V21, P517; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Thabet MM, 2009, ANN RHEUM DIS, V68, P1775, DOI 10.1136/ard.2008.099309	16	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15562	10.1371/journal.pone.0015562	http://dx.doi.org/10.1371/journal.pone.0015562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187939	Green Published, Green Submitted			2022-12-27	WOS:000285575200041
J	Thomas, S; Popov, VL; Walker, DH				Thomas, Sunil; Popov, Vsevolod L.; Walker, David H.			Exit Mechanisms of the Intracellular Bacterium Ehrlichia	PLOS ONE			English	Article							HOST-CELLS; ANAPLASMA-PHAGOCYTOPHILUM; CHAFFEENSIS; INFECTION; PROTEIN; MYCOBACTERIA; REPLICATION; FILOPODIA; PARASITE; INVASION	Background: The obligately intracellular bacterium Ehrlichia chaffeensis that resides in mononuclear phagocytes is the causative agent of human monocytotropic ehrlichiosis. Ehrlichia muris and Ixodes ovatus Ehrlichia (IOE) are agents of mouse models of ehrlichiosis. The mechanism by which Ehrlichia are transported from an infected host cell to a non-infected cell has not been demonstrated. Methodology/Principal Findings: Using fluorescence microscopy and transmission and scanning electron microscopy, we demonstrated that Ehrlichia was transported through the filopodia of macrophages during early stages of infection. If host cells were not present in the vicinity of an Ehrlichia-infected cell, the leading edge of the filopodium formed a fan-shaped structure filled with the pathogen. Formation of filopodia in the host macrophages was inhibited by cytochalasin D and ehrlichial transport were prevented due to the absence of filopodia formation. At late stages of infection the host cell membrane was ruptured, and the bacteria were released. Conclusions/Significance: Ehrlichia are transported through the host cell filopodium during initial stages of infection, but are released by host cell membrane rupture during later stages of infection.	[Thomas, Sunil] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Thomas, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	dwalker@utmb.edu		Thomas, Sunil/0000-0003-4780-8851	National Institute of Allergy and Infectious Diseases [AI031431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031431, R21AI031431] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant from the National Institute of Allergy and Infectious Diseases (AI031431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blouin EF, 1998, J MED ENTOMOL, V35, P788, DOI 10.1093/jmedent/35.5.788; FINLAY BB, 1988, BIOCHIMIE, V70, P1089, DOI 10.1016/0300-9084(88)90271-4; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; HARTWIG JH, 1977, J CELL BIOL, V75, pA253; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Lasunskaia EB, 2006, J LEUKOCYTE BIOL, V80, P1480, DOI 10.1189/jlb.0106066; Li JSY, 2003, INFECT IMMUN, V71, P4229, DOI 10.1128/IAI.71.8.4229-4237.2003; MAEDA K, 1987, NEW ENGL J MED, V316, P853, DOI 10.1056/NEJM198704023161406; Maender Jennifer L, 2004, Dermatol Ther, V17, P499, DOI 10.1111/j.1396-0296.2004.04052.x; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Popov VL, 1998, J MED MICROBIOL, V47, P235, DOI 10.1099/00222615-47-3-235; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Rikihisa Y, 2010, VET PARASITOL, V167, P155, DOI 10.1016/j.vetpar.2009.09.017; Rosania GR, 1996, CELL MOTIL CYTOSKEL, V34, P230, DOI 10.1002/(SICI)1097-0169(1996)34:3<230::AID-CM6>3.0.CO;2-D; Srivastava KD, 1998, J IMMUNOL, V161, P5039; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Thomas S, 2009, PARASITE IMMUNOL, V31, P296, DOI 10.1111/j.1365-3024.2009.01099.x; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Wood W, 2002, INT J BIOCHEM CELL B, V34, P726, DOI 10.1016/S1357-2725(01)00172-8	23	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15775	10.1371/journal.pone.0015775	http://dx.doi.org/10.1371/journal.pone.0015775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187937	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200069
J	Leder, K; Holland, EC; Michor, F				Leder, Kevin; Holland, Eric C.; Michor, Franziska			The Therapeutic Implications of Plasticity of the Cancer Stem Cell Phenotype	PLOS ONE			English	Article							MYELOID-LEUKEMIA; BREAST-CANCER; IDENTIFICATION; HETEROGENEITY; MODEL	The cancer stem cell hypothesis suggests that tumors contain a small population of cancer cells that have the ability to undergo symmetric self-renewing cell division. In tumors that follow this model, cancer stem cells produce various kinds of specified precursors that divide a limited number of times before terminally differentiating or undergoing apoptosis. As cells within the tumor mature, they become progressively more restricted in the cell types to which they can give rise. However, in some tumor types, the presence of certain extra-or intracellular signals can induce committed cancer progenitors to revert to a multipotential cancer stem cell state. In this paper, we design a novel mathematical model to investigate the dynamics of tumor progression in such situations, and study the implications of a reversible cancer stem cell phenotype for therapeutic interventions. We find that higher levels of dedifferentiation substantially reduce the effectiveness of therapy directed at cancer stem cells by leading to higher rates of resistance. We conclude that plasticity of the cancer stem cell phenotype is an important determinant of the prognosis of tumors. This model represents the first mathematical investigation of this tumor trait and contributes to a quantitative understanding of cancer.	[Leder, Kevin; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Leder, Kevin; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, Canc Biol & Genet Program, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Memorial Sloan Kettering Cancer Center	Leder, K (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	michor@jimmy.harvard.edu			National Cancer Institute [U54CA143798]; NATIONAL CANCER INSTITUTE [R01CA100688, U54CA143798] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Award Number U54CA143798 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Dingli D, 2007, CELL CYCLE, V6, P461, DOI 10.4161/cc.6.4.3853; Ganguly R, 2006, CELL PROLIFERAT, V39, P3, DOI 10.1111/j.1365-2184.2006.00369.x; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Haeno H, 2009, P NATL ACAD SCI USA, V106, P16616, DOI 10.1073/pnas.0908107106; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; PIETRAS KOA, 2010, EXP CELL RES; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sharif A, 2007, ONCOGENE, V26, P2695, DOI 10.1038/sj.onc.1210071; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Turner C, 2009, CELL PROLIFERAT, V42, P529, DOI 10.1111/j.1365-2184.2009.00619.x; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang JCY, 1998, BLOOD, V91, P2406, DOI 10.1182/blood.V91.7.2406.2406_2406_2414; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999	26	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14366	10.1371/journal.pone.0014366	http://dx.doi.org/10.1371/journal.pone.0014366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179426	Green Published, Green Submitted, gold			2022-12-27	WOS:000285572900005
J	Nieves, W; Heang, J; Asakrah, S; Bentrup, KHZ; Roy, CJ; Morici, LA				Nieves, Wildaliz; Heang, Julie; Asakrah, Saja; Bentrup, Kerstin Hoener Zu; Roy, Chad J.; Morici, Lisa A.			Immunospecific Responses to Bacterial Elongation Factor Tu during Burkholderia Infection and Immunization	PLOS ONE			English	Article							IMMUNOPROTEOMIC IDENTIFICATION; CAPSULAR POLYSACCHARIDE; PSEUDOMONAS-AERUGINOSA; PSEUDOMALLEI INFECTION; MYCOPLASMA-PNEUMONIAE; VACCINE CANDIDATES; IMMUNE-RESPONSES; MURINE MODEL; PROTECTION; PROTEINS	Burkholderia pseudomallei is the etiological agent of melioidosis, a disease endemic in parts of Southeast Asia and Northern Australia. Currently there is no licensed vaccine against infection with this biological threat agent. In this study, we employed an immunoproteomic approach and identified bacterial Elongation factor-Tu (EF-Tu) as a potential vaccine antigen. EF-Tu is membrane-associated, secreted in outer membrane vesicles (OMVs), and immunogenic during Burkholderia infection in the murine model of melioidosis. Active immunization with EF-Tu induced antigen-specific antibody and cell-mediated immune responses in mice. Mucosal immunization with EF-Tu also reduced lung bacterial loads in mice challenged with aerosolized B. thailandensis. Our data support the utility of EF-Tu as a novel vaccine immunogen against bacterial infection.	[Nieves, Wildaliz; Heang, Julie; Asakrah, Saja; Bentrup, Kerstin Hoener Zu; Roy, Chad J.; Morici, Lisa A.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Roy, Chad J.] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA	Tulane University; Tulane University	Nieves, W (corresponding author), Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.	lmorici@tulane.edu	asakrah, saja/ABB-6947-2021; asakrah, saja/ABH-3939-2020	asakrah, saja/0000-0002-0037-2707; Roy, Chad/0000-0002-1710-6974	National Institute of Allergy and Infectious Diseases (NIAID)/NIH [U54 AI057156]; Louisiana Vaccine Center/South Louisiana Institute for Infectious Disease Research Cooperative Pilot; Tulane Research Enhancement Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Louisiana Vaccine Center/South Louisiana Institute for Infectious Disease Research Cooperative Pilot; Tulane Research Enhancement Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant Number U54 AI057156 from National Institute of Allergy and Infectious Diseases (NIAID)/NIH, a Louisiana Vaccine Center/South Louisiana Institute for Infectious Disease Research Cooperative Pilot Research grant to L.M., and a Tulane Research Enhancement Grant to L.M. and C.R. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the RCE Programs Office, NIAID, or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO A, MICROBES INFECT; Ariel N, 2003, INFECT IMMUN, V71, P4563, DOI 10.1128/IAI.71.8.4563-4579.2003; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Balasubramanian S, 2009, INFECT IMMUN, V77, P3533, DOI 10.1128/IAI.00081-09; Barel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-145; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; BECK BD, 1978, P NATL ACAD SCI USA, V75, P1250, DOI 10.1073/pnas.75.3.1250; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Breitbach Katrin, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS89, DOI 10.1016/S0035-9203(08)70022-1; Bunk S, 2008, J IMMUNOL, V180, P5490, DOI 10.4049/jimmunol.180.8.5490; Chen YS, 2006, INFECT IMMUN, V74, P1699, DOI 10.1128/IAI.74.3.1699-1705.2006; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; Druar C, 2008, FEMS IMMUNOL MED MIC, V52, P78, DOI 10.1111/j.1574-695X.2007.00345.x; DuBois AB, 2007, VACCINE, V25, P4747, DOI 10.1016/j.vaccine.2007.03.048; Elvin SJ, 2006, INFECT IMMUN, V74, P1706, DOI 10.1128/IAI.74.3.1706-1711.2006; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Gat O, 2006, INFECT IMMUN, V74, P3987, DOI 10.1128/IAI.00174-06; Glynn A, 2005, VACCINE, V23, P1957, DOI 10.1016/j.vaccine.2004.10.025; Gupta MK, 2009, J PROTEOME RES, V8, P2319, DOI 10.1021/pr8009462; Haque A, 2006, J INFECT DIS, V193, P370, DOI 10.1086/498983; Haque A, 2006, J INFECT DIS, V194, P1241, DOI 10.1086/508217; Hara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006496; Harding SV, 2007, VACCINE, V25, P2664, DOI 10.1016/j.vaccine.2006.12.006; Harland DN, 2007, INFECT IMMUN, V75, P4173, DOI 10.1128/IAI.00404-07; Healey GD, 2005, INFECT IMMUN, V73, P5945, DOI 10.1128/IAI.73.9.5945-5951.2005; Jonak J, 2007, J CHROMATOGR B, V849, P141, DOI 10.1016/j.jchromb.2006.11.053; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Klinman DM, 2009, ADV DRUG DELIVER REV, V61, P248, DOI 10.1016/j.addr.2008.12.012; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Leelarasamee A, 2004, CURR OPIN INFECT DIS, V17, P131, DOI 10.1097/00001432-200404000-00011; Lopez JE, 2008, J IMMUNOL METHODS, V332, P129, DOI 10.1016/j.jim.2007.12.018; Mayer F, 2003, CELL BIOL INT, V27, P429, DOI 10.1016/S1065-6995(03)00035-0; Moe GR, 2002, INFECT IMMUN, V70, P6021, DOI 10.1128/IAI.70.11.6021-6031.2002; MORICI LA, MICROB PATHOG, V48, P9; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; NEWMAN M, 1995, IMMUNOLOGICAL FORMUL, P1; Owen SJ, 2009, J INFECT DIS, V199, P1761, DOI 10.1086/599210; Peacock SJ, 2006, CURR OPIN INFECT DIS, V19, P421, DOI 10.1097/01.qco.0000244046.31135.b3; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Savitt AG, 2009, CLIN VACCINE IMMUNOL, V16, P414, DOI 10.1128/CVI.00362-08; Stevens JM, 2005, J BACTERIOL, V187, P7857, DOI 10.1128/JB.187.22.7857-7862.2005; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Watanabe M, 2003, INFECT IMMUN, V71, P733, DOI 10.1128/IAI.71.2.733-738.2003; West T Eoin, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS119, DOI 10.1016/S0035-9203(08)70028-2; Wiersinga WJ, 2008, CELL MICROBIOL, V10, P81, DOI 10.1111/j.1462-5822.2007.01016.x; Wiersinga WJ, 2009, CURR OPIN INFECT DIS, V22, P102, DOI 10.1097/QCO.0b013e328322e727; Wongratanacheewin S, 2004, INFECT IMMUN, V72, P4494, DOI 10.1128/IAI.72.8.4494-4502.2004; YOKOSAWA H, 1973, J BIOL CHEM, V248, P375	51	58	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14361	10.1371/journal.pone.0014361	http://dx.doi.org/10.1371/journal.pone.0014361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179405	Green Published, Green Submitted, gold			2022-12-27	WOS:000285572900004
J	Vogler, C; Gschwind, L; Rothlisberger, B; Huber, A; Filges, I; Miny, P; Auschra, B; Stetak, A; Demougin, P; Vukojevic, V; Kolassa, IT; Elbert, T; de Quervain, DJF; Papassotiropoulos, A				Vogler, Christian; Gschwind, Leo; Roethlisberger, Benno; Huber, Andreas; Filges, Isabel; Miny, Peter; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; Kolassa, Iris-Tatjana; Elbert, Thomas; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas			Microarray-Based Maps of Copy-Number Variant Regions in European and Sub-Saharan Populations	PLOS ONE			English	Article							HUMAN GENOME; SEGMENTAL DUPLICATIONS; EVOLUTIONARY HISTORY; STRUCTURAL VARIATION; ARRAY-CGH; DISEASE; HAPLOTYPE; GENE; SUSCEPTIBILITY	The genetic basis of phenotypic variation can be partially explained by the presence of copy-number variations (CNVs). Currently available methods for CNV assessment include high-density single-nucleotide polymorphism (SNP) microarrays that have become an indispensable tool in genome-wide association studies (GWAS). However, insufficient concordance rates between different CNV assessment methods call for cautious interpretation of results from CNV-based genetic association studies. Here we provide a cross-population, microarray-based map of copy-number variant regions (CNVRs) to enable reliable interpretation of CNV association findings. We used the Affymetrix Genome-Wide Human SNP Array 6.0 to scan the genomes of 1167 individuals from two ethnically distinct populations (Europe, N = 717; Rwanda, N = 450). Three different CNV-finding algorithms were tested and compared for sensitivity, specificity, and feasibility. Two algorithms were subsequently used to construct CNVR maps, which were also validated by processing subsamples with additional microarray platforms (Illumina 1M-Duo BeadChip, Nimblegen 385K aCGH array) and by comparing our data with publicly available information. Both algorithms detected a total of 42669 CNVs, 74% of which clustered in 385 CNVRs of a cross-population map. These CNVRs overlap with 862 annotated genes and account for approximately 3.3% of the haploid human genome. We created comprehensive cross-populational CNVR-maps. They represent an extendable framework that can leverage the detection of common CNVs and additionally assist in interpreting CNV-based association studies.	[Vogler, Christian; Gschwind, Leo; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Basel, Switzerland; [Vogler, Christian; Gschwind, Leo; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Basel, Switzerland; [Vogler, Christian; Gschwind, Leo; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas] Univ Basel, Dept Med, Basel, Switzerland; [Roethlisberger, Benno; Huber, Andreas] Cantonal Hosp, Ctr Lab Med, Aarau, Switzerland; [Filges, Isabel; Miny, Peter] Univ Childrens Hosp, Dept Biomed, Basel, Switzerland; [Kolassa, Iris-Tatjana; Elbert, Thomas] Univ Konstanz, Dept Psychol, Constance, Germany	University of Basel; University of Basel; University of Basel; University of Konstanz	Vogler, C (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	christian.vogler@unibas.ch	Kolassa, Iris Tatjana/Y-3032-2018; Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939; de Quervain, Dominique/0000-0001-7131-2464; Papassotiropoulos, Andreas/0000-0002-2210-9651; Vogler, Christian/0000-0003-3922-109X; Vukojevic, Vanja/0000-0001-5303-9492	Swiss National Science Foundation (SNSF) [PP00B-106708]; Sinergia [CRSIKO_122691]; National Centre of Competence in Research (NCCR) Swiss Etiological Study of Adjustment and Mental Health (sesam); Swiss National Science Foundation (SNF) [51A240-104890]; University of Basel; F. Hoffmann-La Roche Corp.; European Union [242257]; European Science Foundation	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Sinergia; National Centre of Competence in Research (NCCR) Swiss Etiological Study of Adjustment and Mental Health (sesam)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); University of Basel; F. Hoffmann-La Roche Corp.(Hoffmann-La Roche); European Union(European Commission); European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported in part by the Swiss National Science Foundation (SNSF) grants PP00B-106708 (D. Q.) and Sinergia CRSIKO_122691 (D. Q. and A. P.). This work is part of the National Centre of Competence in Research (NCCR) Swiss Etiological Study of Adjustment and Mental Health (sesam), The Swiss National Science Foundation (SNF) (project no. 51A240-104890); the University of Basel, the F. Hoffmann-La Roche Corp. and the Freie Akademische Gesellschaft provided core support for the NCCR sesam. This work is also part of the 7th framework programme of the European Union (ADAMS, project number 242257, FP7-HEALTH-2009) and of the European Science Foundation grant, EUROStress (D. Q. and A. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Cahan P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn110; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Filges I, 2009, AM J MED GENET A, V149A, P237, DOI 10.1002/ajmg.a.32622; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goidts V, 2006, HUM GENET, V120, P270, DOI 10.1007/s00439-006-0217-y; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; HASTINGS PJ, 2009, NAT REV GENET; *INC BOZ, GOLD HEL CNAM SOFTW; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Onyut Lamaro P, 2009, Confl Health, V3, P6, DOI 10.1186/1752-1505-3-6; *R DEV COR TEAM, 2009, COMP RFFS; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Solomon NM, 2004, J MED GENET, V41, P669, DOI 10.1136/jmg.2003.016949; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Tishkoff SA, 2003, CURR OPIN GENET DEV, V13, P569, DOI 10.1016/j.gde.2003.10.010; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006	32	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15246	10.1371/journal.pone.0015246	http://dx.doi.org/10.1371/journal.pone.0015246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179565	gold, Green Published, Green Submitted			2022-12-27	WOS:000285381200019
J	Zammar, G; Meister, H; Shah, J; Phadtare, A; Cofiel, L; Pietrobon, R				Zammar, Guilherme; Meister, Henrique; Shah, Jatin; Phadtare, Amruta; Cofiel, Luciana; Pietrobon, Ricardo			So Different, yet So Similar: Meta-Analysis and Policy Modeling of Willingness to Participate in Clinical Trials among Brazilians and Indians	PLOS ONE			English	Article							HIV VACCINE TRIALS; RHEUMATOID-ARTHRITIS PATIENTS; INJECTION-DRUG USERS; RIO-DE-JANEIRO; MONETARY INCENTIVES; SYSTEM DYNAMICS; EFFICACY TRIAL; MEN; ATTITUDES; RECRUITMENT	Background: With the global expansion of clinical trials and the expectations of the rise of the emerging economies known as BRICs (Brazil, Russia, India and China), the understanding of factors that affect the willingness to participate in clinical trials of patients from those countries assumes a central role in the future of health research. Methods: We conducted a systematic review and meta-analysis (SRMA) of willingness to participate in clinical trials among Brazilian patients and then we compared it with Indian patients (with results of another SRMA previously conducted by our group) through a system dynamics model. Results: Five studies were included in the SRMA of Brazilian patients. Our main findings are 1) the major motivation for Brazilian patients to participate in clinical trials is altruism, 2) monetary reimbursement is the least important factor motivating Brazilian patients, 3) the major barrier for Brazilian patients to not participate in clinical trials is the fear of side effects, and 4) Brazilian patients are more likely willing to participate in clinical trials than Indians. Conclusion: Our study provides important insights for investigators and sponsors for planning trials in Brazil (and India) in the future. Ignoring these results may lead to unnecessary fund/time spending. More studies are needed to validate our results and for better understanding of this poorly studied theme.	[Zammar, Guilherme; Meister, Henrique] Pontificia Univ Catolica Parana PUCPR, Curitiba, Parana, Brazil; [Zammar, Guilherme; Meister, Henrique; Shah, Jatin; Phadtare, Amruta; Cofiel, Luciana; Pietrobon, Ricardo] Duke Univ, Res Res Grp, Durham, NC USA; [Shah, Jatin; Pietrobon, Ricardo] Duke Natl Univ Singapore NUS, Grad Sch Med, Singapore, Singapore; [Phadtare, Amruta] Kalpavriksha Healthcare & Res, Thana, India; [Pietrobon, Ricardo] Duke Univ, Dept Surg, Durham, NC USA	Pontificia Universidade Catolica do Parana; Duke University; Duke University	Zammar, G (corresponding author), Pontificia Univ Catolica Parana PUCPR, Curitiba, Parana, Brazil.	rpietro@duke.edu	Shah, Jatin/B-6039-2011	Shah, Jatin/0000-0002-2457-491X; Pietrobon, Ricardo/0000-0003-2996-2193				[Anonymous], MERRIAMWEBSTERS ONLI; Bartlett C, 2005, Health Technol Assess, V9, piii; BARTLETT C, 2005, HLTH TECHNOLOGY ASSE, V9, P151; Bartlett C, 2005, HEALTH TECHNOL ASSES, V9, pix; Bentley JP, 2004, J MED ETHICS, V30, P293, DOI 10.1136/jme.2002.001594; BEVAN EG, 1993, BRIT J CLIN PHARMACO, V35, P204, DOI 10.1111/j.1365-2125.1993.tb05687.x; Brooks RA, 2007, AIDS CARE, V19, P52, DOI 10.1080/09540120600872711; Candilis PJ, 2006, SCHIZOPHRENIA BULL, V32, P159; Carneiro M, 2000, J ACQ IMMUN DEF SYND, V25, P182, DOI 10.1097/00126334-200010010-00013; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; Colfax G, 2005, JAIDS-J ACQ IMM DEF, V39, P359, DOI 10.1097/01.qai.0000152039.88422.ec; Costenbader KH, 2007, ARTHRIT RHEUM-ARTHR, V57, P49, DOI 10.1002/art.22480; de Souza CTV, 2003, AIDS CARE, V15, P539, DOI 10.1080/0954012031000134773; Dunn LB, 2009, SCHIZOPHRENIA BULL, V35, P730, DOI 10.1093/schbul/sbn003; FASTH T, 2010, PLOS CURRENTS, V2; Golub ET, 2005, AIDS BEHAV, V9, P301, DOI 10.1007/s10461-005-9004-3; Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694; Halpern SD, 2004, ARCH INTERN MED, V164, P801, DOI 10.1001/archinte.164.7.801; Halpern SD, 2003, AM HEART J, V146, P985, DOI 10.1016/S0002-8703(03)00507-6; Harro CD, 2004, JAIDS-J ACQ IMM DEF, V37, P1385, DOI 10.1097/01.qai.0000122983.87519.b5; Hays RB, 1999, J ACQ IMMUN DEF SYND, V20, P164, DOI 10.1097/00042560-199902010-00009; Hirsch G, 2010, AM J PUBLIC HEALTH, V100, P616, DOI 10.2105/AJPH.2009.159434; Hoel AW, 2009, J VASC SURG, V50, P349, DOI 10.1016/j.jvs.2009.01.012; Jenkins RA, 2000, SEX TRANSM INFECT, V76, P386, DOI 10.1136/sti.76.5.386; Lee SJ, 2005, J RHEUMATOL, V32, P2317; Madhivanan P, 2009, VACCINE, V27, P5203, DOI 10.1016/j.vaccine.2009.06.073; Martinson BC, 2000, PREV MED, V31, P706, DOI 10.1006/pmed.2000.0762; MATTSON ME, 1985, CONTROL CLIN TRIALS, V6, P156, DOI 10.1016/0197-2456(85)90121-7; McGrath JW, 2001, J ACQ IMMUN DEF SYND, V27, P381, DOI 10.1097/00126334-200108010-00009; Moreira Edson Duarte Jr, 2006, J Pediatr Adolesc Gynecol, V19, P81, DOI 10.1016/j.jpag.2006.01.003; Nguyen Tung T, 2005, J Natl Cancer Inst Monogr, P102; Nyamathi Adeline, 2004, J Interprof Care, V18, P369, DOI 10.1080/13561820400011735; Perisse AR, 2000, J ACQ IMMUN DEF SYND, V25, P459, DOI 10.1097/00126334-200012150-00012; Raisch DW, 2007, MIL MED, V172, P27, DOI 10.7205/MILMED.172.1.27; Robinson SB, 1996, J COMMUN HEALTH, V21, P77, DOI 10.1007/BF01682300; Rochon Paula A, 2004, Account Res, V11, P215, DOI 10.1080/08989620490891412; Rojavin MA, 2006, CONTEMP CLIN TRIALS, V27, P103, DOI 10.1016/j.cct.2005.11.014; Rossini M, 2006, OSTEOPOROSIS INT, V17, P914, DOI 10.1007/s00198-006-0073-6; Sahay S, 2005, VACCINE, V23, P1351, DOI 10.1016/j.vaccine.2004.09.032; Lacativa PGS, 2008, CIENC SAUDE COLETIVA, V13, P1023, DOI 10.1590/S1413-81232008000300025; Seal KH, 2003, DRUG ALCOHOL DEPEN, V71, P127, DOI 10.1016/S0376-8716(03)00074-7; SHAH JY, PLOS ONE, V5; Sleimen-Malkoun R, 2010, MEDICINA-LITHUANIA, V46, P374, DOI 10.3390/medicina46060053; STERMAN JD, 2006, BUSINESS DYNAMICS; Westhoff CL, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.015; Whitesides GM, 1999, SCIENCE, V284, P89, DOI 10.1126/science.284.5411.89; Wilson D, 2003, GOLDMAN SACHS GLOBAL, V99, P1, DOI DOI 10.4337/9781847202987.00008; Wolfe F, 2007, ARTHRITIS RHEUM-US, V56, P2135, DOI 10.1002/art.22719; Wolstenholme EF, 2003, SYST DYNAM REV, V19, P7, DOI 10.1002/sdr.259; VENSIM DSS 5 9C WIND	50	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14368	10.1371/journal.pone.0014368	http://dx.doi.org/10.1371/journal.pone.0014368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695OI	21179556	Green Published, Green Submitted, gold			2022-12-27	WOS:000285381200013
J	Boogert, NJ; Bui, C; Howarth, K; Giraldeau, LA; Lefebvre, L				Boogert, Neeltje J.; Bui, Cavina; Howarth, Krista; Giraldeau, Luc-Alain; Lefebvre, Louis			Does Foraging Behaviour Affect Female Mate Preferences and Pair Formation in Captive Zebra Finches?	PLOS ONE			English	Article							TAENIOPYGIA-GUTTATA; DARWINS FINCHES; SEXUAL SELECTION; SYMPATRIC MORPHS; PLUMAGE COLOR; ZENAIDA DOVES; CHOICE; SPECIATION; MALES; BIRDS	Background: Successful foraging is essential for survival and reproductive success. In many bird species, foraging is a learned behaviour. To cope with environmental change and survive periods in which regular foods are scarce, the ability to solve novel foraging problems by learning new foraging techniques can be crucial. Although females have been shown to prefer more efficient foragers, the effect of males' foraging techniques on female mate choice has never been studied. We tested whether females would prefer males showing the same learned foraging technique as they had been exposed to as juveniles, or whether females would prefer males that showed a complementary foraging technique. Methodology/Principal Findings: We first trained juvenile male and female zebra finches (Taeniopygia guttata) to obtain a significant proportion of their food by one of two foraging techniques. We then tested whether females showed a preference for males with the same or the alternative technique. We found that neither a male's foraging technique nor his foraging performance affected the time females spent in his proximity in the mate-choice apparatus. We then released flocks of these finches into an aviary to investigate whether assortative pairing would be facilitated by birds taught the same technique exploiting the same habitat. Zebra finches trained as juveniles in a specific foraging technique maintained their foraging specialisation in the aviary as adults. However, pair formation and nest location were random with regard to foraging technique. Conclusions/Significance: Our findings show that zebra finches can be successfully trained to be foraging specialists. However, the robust negative results of the conditions tested here suggest that learned foraging specializations do not affect mate choice or pair formation in our experimental context.	[Boogert, Neeltje J.; Bui, Cavina; Howarth, Krista; Lefebvre, Louis] McGill Univ, Montreal, PQ, Canada; [Giraldeau, Luc-Alain] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	McGill University; University of Quebec; University of Quebec Montreal	Boogert, NJ (corresponding author), McGill Univ, Montreal, PQ, Canada.	njboogert@gmail.com			Natural Sciences and Engineering Research Council of Canada; McGill University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); McGill University	This research was funded by Natural Sciences and Engineering Research Council of Canada discovery grants to LL and L-AG. NJB was financially supported by a Dr. Richard H. Tomlinson Fellowship and a Dr. Milton Leong Fellowship from McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amy M, 2008, ANIM BEHAV, V76, P971, DOI 10.1016/j.anbehav.2008.03.023; Artzy-Randrup Y, 2006, P NATL ACAD SCI USA, V103, P11619, DOI 10.1073/pnas.0602339103; Baldwin JM, 1896, AM NAT, V30, P441, DOI DOI 10.1086/276408; Bateson P., 1988, P191; BEAUCHAMP G, 1991, ANIM BEHAV, V41, P247, DOI 10.1016/S0003-3472(05)80476-2; Beauchamp G, 1997, ETHOL ECOL EVOL, V9, P105, DOI 10.1080/08927014.1997.9522890; Belovsky GE, 1996, BEHAV ECOL, V7, P438, DOI 10.1093/beheco/7.4.438; Beltman JB, 2005, P ROY SOC B-BIOL SCI, V272, P1455, DOI 10.1098/rspb.2005.3104; Birkhead TR, 1998, BEHAV ECOL SOCIOBIOL, V44, P179, DOI 10.1007/s002650050530; Bitton PP, 2008, BEHAV ECOL SOCIOBIOL, V62, P1543, DOI 10.1007/s00265-008-0583-7; Boogert NJ, 2008, ANIM BEHAV, V76, P1735, DOI 10.1016/j.anbehav.2008.08.009; Boogert NJ, 2010, BEHAV PROCESS, V85, P135, DOI 10.1016/j.beproc.2010.06.020; Bortolottia GR, 2008, BEHAV PROCESS, V78, P100, DOI 10.1016/j.beproc.2008.01.007; Burger R, 2006, EVOLUTION, V60, P2185; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; Burley NT, 2006, EVOLUTION, V60, P1076; Candolin U, 2009, AM NAT, V173, P273, DOI 10.1086/595753; Carlier P, 1996, BEHAVIOUR, V133, P1197, DOI 10.1163/156853996X00369; Cezilly F, 1997, IBIS, V139, P331, DOI 10.1111/j.1474-919X.1997.tb04632.x; Christensen R, 2007, J ORNITHOL, V148, P463, DOI 10.1007/s10336-007-0173-x; CLAYTON NS, 1990, ANIM BEHAV, V39, P474, DOI 10.1016/S0003-3472(05)80411-7; CLAYTON NS, 1990, PHILOS T R SOC B, V330, P351, DOI 10.1098/rstb.1990.0205; Deerenberg C, 1999, ANIM BEHAV, V58, P173, DOI 10.1006/anbe.1999.1123; Doebeli M, 2007, P ROY SOC B-BIOL SCI, V274, P347, DOI 10.1098/rspb.2006.3725; Drullion D, 2008, BEHAV ECOL SOCIOBIOL, V63, P269, DOI 10.1007/s00265-008-0658-5; FISHER J., 1949, BRITISH BIRDS, V42, P347; FUTUYMA DJ, 1998, EVOLUTIONARY BIOL, P751; Gajdon GK, 2006, ANIM COGN, V9, P173, DOI 10.1007/s10071-006-0018-7; Gibbons ME, 2005, ANIM BEHAV, V69, P721, DOI 10.1016/j.anbehav.2004.06.021; GIRALDEAU LA, 1984, AM NAT, V124, P72, DOI 10.1086/284252; GRANT BR, 1989, AM NAT, V133, P377, DOI 10.1086/284924; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant PR, 2008, P ROY SOC B-BIOL SCI, V275, P661, DOI 10.1098/rspb.2007.0898; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Helfenstein F, 2003, ANIM BEHAV, V65, P1027, DOI 10.1006/anbe.2003.2129; Hill GE, 2002, P ROY SOC B-BIOL SCI, V269, P1119, DOI 10.1098/rspb.2002.1980; Hinde R. A., 1951, BR BIRDS, V44, P392; Holveck MJ, 2007, ANIM BEHAV, V74, P297, DOI 10.1016/j.anbehav.2006.08.016; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Huber SK, 2007, P R SOC B, V274, P1709, DOI 10.1098/rspb.2007.0224; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; Karino K, 2005, BEHAV ECOL SOCIOBIOL, V59, P1, DOI 10.1007/s00265-005-0001-3; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; LEMON WC, 1991, NATURE, V352, P153, DOI 10.1038/352153a0; LEMON WC, 1992, ANIM BEHAV, V44, P851, DOI 10.1016/S0003-3472(05)80581-0; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Ludwig SC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1601, DOI 10.1007/s00265-008-0589-1; MacDougall AK, 2003, NATURWISSENSCHAFTEN, V90, P464, DOI 10.1007/s00114-003-0459-7; Mayr E., 1963, ANIMAL SPECIES EVOLU; MILLER AH, 1956, EVOLUTION, V10, P262, DOI 10.2307/2406011; Moravec ML, 2006, ETHOLOGY, V112, P1108, DOI 10.1111/j.1439-0310.2006.01267.x; Neubauer RL, 1999, EVOL ECOL, V13, P365, DOI 10.1023/A:1006708826432; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Podos J, 2010, PHILOS T R SOC B, V365, P1031, DOI 10.1098/rstb.2009.0289; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; R Core Team, 2018, R LANG ENV STAT COMP; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Rutstein AN, 2007, ANIM BEHAV, V74, P1277, DOI 10.1016/j.anbehav.2007.02.022; SILCOX AP, 1982, ANIM BEHAV, V30, P1237, DOI 10.1016/S0003-3472(82)80216-9; Slater P.J.B., 1988, Advances in the Study of Behavior, V18, P1; Snowberg LK, 2009, J EVOLUTION BIOL, V22, P762, DOI 10.1111/j.1420-9101.2009.01699.x; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; ten Cate C, 1999, ADV STUD BEHAV, V28, P1; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; Van Oers K, 2008, ANIM BEHAV, V76, P555, DOI 10.1016/j.anbehav.2008.03.011; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Wiersma P, 2005, J EXP BIOL, V208, P4091, DOI 10.1242/jeb.01854; Witte K, 2003, ANIM BEHAV, V65, P195, DOI 10.1006/anbe.2002.2009; Witte K, 2006, BEHAVIOUR, V143, P969, DOI 10.1163/156853906778623626; Witte K, 2006, ETHOL ECOL EVOL, V18, P195, DOI 10.1080/08927014.2006.9522707; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Zann RA., 1996, ZEBRA FINCH SYNTHESI	75	4	4	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14340	10.1371/journal.pone.0014340	http://dx.doi.org/10.1371/journal.pone.0014340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179514	Green Published, gold, Green Submitted			2022-12-27	WOS:000285340000012
J	Fraile-Ramos, A; Cepeda, V; Elstak, E; van der Sluijs, P				Fraile-Ramos, Alberto; Cepeda, Victoria; Elstak, Edo; van der Sluijs, Peter			Rab27a Is Required for Human Cytomegalovirus Assembly	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; MONOCLONAL-ANTIBODIES; ENVELOPMENT; CELLS; COMPARTMENTS; TEGUMENT; IDENTIFICATION; LOCALIZATION; GLYCOPROTEIN; REACTIVATION	Human cytomegalovirus (HCMV) completes its final envelopment on intracellular membranes before it is released from the cell. The mechanisms underlying these processes are not understood. Here we studied the role of Rab27a, a regulator of lysosome-related organelle transport, in HCMV production. HCMV infection increased Rab27a expression, and recruitment of Rab27a to membranous strutures at the assembly site. Immuno-gold labelling demonstrated association of Rab27a with viral envelopes. CMV production was reduced after knock-down of Rab27a, and in Rab27a-deficient ashen melanocytes. This study shows a requirement for Rab27a in the CMV life cycle and suggests that CMV and LRO biogenesis share common molecular mechanisms.	[Fraile-Ramos, Alberto; Cepeda, Victoria] CSIC, Dept Mol & Cell Biol, Ctr Nacl Biotecnol, Madrid, Spain; [Elstak, Edo; van der Sluijs, Peter] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Utrecht University; Utrecht University Medical Center	Fraile-Ramos, A (corresponding author), CSIC, Dept Mol & Cell Biol, Ctr Nacl Biotecnol, Madrid, Spain.	alberto.fraile@cnb.csic.es	Fraile-Ramos, Alberto/M-2072-2017	Fraile-Ramos, Alberto/0000-0002-0701-5454	Ramon y Cajal contract; Spanish Ministry of Science and Innovation [BFU2006-14379/BMC, BFU2009-07569/BMC]	Ramon y Cajal contract(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	AF-R was supported by a Ramon y Cajal contract and by Grants BFU2006-14379/BMC and BFU2009-07569/BMC from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casey TM, 2007, MOL CELL PROTEOMICS, V6, P767, DOI 10.1074/mcp.M600365-MCP200; Cekinovic D, 2008, J VIROL, V82, P12172, DOI 10.1128/JVI.01214-08; Cepeda V, 2010, CELL MICROBIOL, V12, P386, DOI 10.1111/j.1462-5822.2009.01405.x; CRANAGE MP, 1988, J VIROL, V62, P1416, DOI 10.1128/JVI.62.4.1416-1422.1988; Das S, 2007, J VIROL, V81, P11861, DOI 10.1128/JVI.01077-07; Fraile-Ramos A, 2002, TRAFFIC, V3, P218, DOI 10.1034/j.1600-0854.2002.030307.x; Fraile-Ramos A, 2007, CELL MICROBIOL, V9, P2955, DOI 10.1111/j.1462-5822.2007.01024.x; Hertel L, 2004, J VIROL, V78, P11988, DOI 10.1128/JVI.78.21.11988-12011.2004; Homman-Loudiyi M, 2003, J VIROL, V77, P3191, DOI 10.1128/JVI.77.5.3191-3203.2003; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Krzyzaniak MA, 2009, TRAFFIC, V10, P1439, DOI 10.1111/j.1600-0854.2009.00967.x; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; McSharry BP, 2001, J GEN VIROL, V82, P855, DOI 10.1099/0022-1317-82-4-855; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; MINSON AC, 1986, J GEN VIROL, V67, P1001, DOI 10.1099/0022-1317-67-6-1001; Mocarski ES, 1996, INTERVIROLOGY, V39, P320, DOI 10.1159/000150503; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moorman NJ, 2010, MOL CELL PROTEOMICS, V9, P851, DOI 10.1074/mcp.M900485-MCP200; Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; NOWAK B, 1984, VIROLOGY, V132, P325, DOI 10.1016/0042-6822(84)90039-4; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Sanchez V, 2000, J VIROL, V74, P975, DOI 10.1128/JVI.74.2.975-986.2000; Seo JY, 2006, J VIROL, V80, P5611, DOI 10.1128/JVI.02630-05; Silva MC, 2003, J VIROL, V77, P10594, DOI 10.1128/JVI.77.19.10594-10605.2003; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; TOOZE J, 1993, EUR J CELL BIOL, V60, P163; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002	37	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15318	10.1371/journal.pone.0015318	http://dx.doi.org/10.1371/journal.pone.0015318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170347	gold, Green Submitted, Green Published			2022-12-27	WOS:000285084100034
J	Taki, Y; Hashizume, H; Sassa, Y; Takeuchi, H; Asano, M; Asano, K; Kawashima, R				Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko; Takeuchi, Hikaru; Asano, Michiko; Asano, Kohei; Kawashima, Ryuta			Breakfast Staple Types Affect Brain Gray Matter Volume and Cognitive Function in Healthy Children	PLOS ONE			English	Article							GLYCEMIC INDEX; SCHOOL BREAKFAST; CORTICAL DEVELOPMENT; ADOLESCENTS; PERFORMANCE; INTELLIGENCE; ATTENTION; DIET; IQ; DENSITY	Childhood diet is important for brain development. Furthermore, the quality of breakfast is thought to affect the cognitive functioning of well-nourished children. To analyze the relationship among breakfast staple type, gray matter volume, and intelligence quotient (IQ) in 290 healthy children, we used magnetic resonance images and applied voxel-based morphometry. We divided subjects into rice, bread, and both groups according to their breakfast staple. We showed that the rice group had a significantly larger gray matter ratio (gray matter volume percentage divided by intracranial volume) and significantly larger regional gray matter volumes of several regions, including the left superior temporal gyrus. The bread group had significantly larger regional gray and white matter volumes of several regions, including the right frontoparietal region. The perceptual organization index (POI; IQ subcomponent) of the rice group was significantly higher than that of the bread group. All analyses were adjusted for age, gender, intracranial volume, socioeconomic status, average weekly frequency of having breakfast, and number of side dishes eaten for breakfast. Although several factors may have affected the results, one possible mechanism underlying the difference between the bread and the rice groups may be the difference in the glycemic index (GI) of these two substances; foods with a low GI are associated with less blood-glucose fluctuation than are those with a high GI. Our study suggests that breakfast staple type affects brain gray and white matter volumes and cognitive function in healthy children; therefore, a diet of optimal nutrition is important for brain maturation during childhood and adolescence.	[Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko; Takeuchi, Hikaru; Asano, Michiko; Asano, Kohei; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Taki, Y (corresponding author), Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	ytaki@idac.tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011	Takeuchi, Hikaru/0000-0002-8022-9694	Ministry of Education, Culture, Sports, Science and Technology [20790875]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by a Grant-in-Aid for Young Scientists (B), 20790875, from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Busch CR, 2002, PHYSIOL BEHAV, V77, P333, DOI 10.1016/S0031-9384(02)00882-X; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; CONNERS CK, 1983, J PSYCHIATR RES, V17, P193, DOI 10.1016/0022-3956(82)90022-X; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fujita K, 2006, JAPANESE WECHSLER AD; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Lozano RH, 2006, NUTR HOSP, V21, P346; Horwood LJ, 2001, ARCH DIS CHILD-FETAL, V84, pF23, DOI 10.1136/fn.84.1.F23; Hoyland A, 2009, NUTR RES REV, V22, P220, DOI 10.1017/S0954422409990175; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ingwersen J, 2007, APPETITE, V49, P240, DOI 10.1016/j.appet.2006.06.009; Isaacs EB, 2008, PEDIATR RES, V63, P308, DOI 10.1203/PDR.0b013e318163a271; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; Mahoney CR, 2005, PHYSIOL BEHAV, V85, P635, DOI 10.1016/j.physbeh.2005.06.023; MATA M, 1980, J NEUROCHEM, V34, P213, DOI 10.1111/j.1471-4159.1980.tb04643.x; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Morales IF, 2008, NUTR HOSP, V23, P383; Murphy JM, 1998, ARCH PEDIAT ADOL MED, V152, P899; Noriega JAV, 2000, ARCH LATINOAM NUTR, V50, P35; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; POLLITT E, 1981, AM J CLIN NUTR, V34, P1526, DOI 10.1093/ajcn/34.8.1526; POLLITT E, 1983, J PSYCHIATR RES, V17, P169, DOI 10.1016/0022-3956(82)90018-8; Pollitt E, 1998, AM J CLIN NUTR, V67, p747S, DOI 10.1093/ajcn/67.4.747S; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Roberts SB, 2000, NUTR REV, V58, P163, DOI 10.1111/j.1753-4887.2000.tb01855.x; Sasaki S., 2002, Journal of Community Nutrition, V4, P83; *SCI TECHN AG J, 1997, STAND TABL FOOD COMP; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shemilt I, 2004, CHILD CARE HLTH DEV, V30, P413, DOI 10.1111/j.1365-2214.2004.00453.x; Talairach J., 1988, COPLANAR STEREOTAXIC; Ueno K, 1998, WECHSLER INTELLIGENC, V3rd; Vaisman N, 1996, ARCH PEDIAT ADOL MED, V150, P1089, DOI 10.1001/archpedi.1996.02170350091016; Wesnes KA, 2003, APPETITE, V41, P329, DOI 10.1016/j.appet.2003.08.009; Wilke M, 2003, NEUROIMAGE, V20, P202, DOI 10.1016/S1053-8119(03)00199-X	44	63	64	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15213	10.1371/journal.pone.0015213	http://dx.doi.org/10.1371/journal.pone.0015213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170334	Green Submitted, Green Published, gold			2022-12-27	WOS:000285084100031
J	Bartee, E; Eyster, CA; Viswanathan, K; Mansouri, M; Donaldson, JG; Fruh, K				Bartee, Eric; Eyster, Craig A.; Viswanathan, Kasinath; Mansouri, Mandana; Donaldson, Julie G.; Frueh, Klaus			Membrane-Associated RING-CH Proteins Associate with Bap31 and Target CD81 and CD44 to Lysosomes	PLOS ONE			English	Article							MHC CLASS-II; COMPLEX CLASS-I; E3 UBIQUITIN LIGASE; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; DENDRITIC CELLS; AMINO-ACIDS; MASS-SPECTROMETRY; MARCH-II; MOLECULES	Membrane-associated RING-CH (MARCH) proteins represent a family of transmembrane ubiquitin ligases modulating intracellular trafficking and turnover of transmembrane protein targets. While homologous proteins encoded by gamma-2 herpesviruses and leporipoxviruses have been studied extensively, limited information is available regarding the physiological targets of cellular MARCH proteins. To identify host cell proteins targeted by the human MARCH-VIII ubiquitin ligase we used stable isotope labeling of amino-acids in cell culture (SILAC) to monitor MARCH-dependent changes in the membrane proteomes of human fibroblasts. Unexpectedly, we observed that MARCH-VIII reduced the surface expression of Bap31, a chaperone that predominantly resides in the endoplasmic reticulum (ER). We demonstrate that Bap31 associates with the transmembrane domains of several MARCH proteins and controls intracellular transport of MARCH proteins. In addition, we observed that MARCH-VIII reduced the surface expression of the hyaluronic acid-receptor CD44 and both MARCH-VIII and MARCH-IV sequestered the tetraspanin CD81 in endo-lysosomal vesicles. Moreover, gene knockdown of MARCH-IV increased surface levels of endogenous CD81 suggesting a constitutive involvement of this family of ubiquitin ligases in the turnover of tetraspanins. Our data thus suggest a role of MARCH-VIII and MARCH-IV in the regulated turnover of CD81 and CD44, two ubiquitously expressed, multifunctional proteins.	[Bartee, Eric] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Viswanathan, Kasinath; Mansouri, Mandana; Frueh, Klaus] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Eyster, Craig A.; Donaldson, Julie G.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Bartee, E (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	Fruehk@ohsu.edu		Bartee, Eric/0000-0003-1793-446X; Frueh, Klaus/0000-0001-8014-3877	National Institutes of Health [RO1 CA/AI 094011, R21 CA 109674]; National Center for Research Resources [RR00163]; Ruth L. Kirschstein National Research Service Awards [T32 AI007472]; Oregon Health and Science University Tartar Trust; NATIONAL CANCER INSTITUTE [R01CA094011, R21CA109674] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, K01RR000163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ruth L. Kirschstein National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health and Science University Tartar Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by National Institutes of Health (RO1 CA/AI 094011, R21 CA 109674) and the National Center for Research Resources (RR00163) to K.F. and by the Ruth L. Kirschstein National Research Service Awards T32 AI007472 and the Oregon Health and Science University Tartar Trust to E.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abache T, 2007, J CELL BIOCHEM, V102, P650, DOI 10.1002/jcb.21318; Abe F, 2009, J IMMUNOL, V182, P4776, DOI 10.4049/jimmunol.0800242; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; de la Hera A, 1989, Int Immunol, V1, P598, DOI 10.1093/intimm/1.6.598; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Ducret A, 2003, EUR J BIOCHEM, V270, P342, DOI 10.1046/j.1432-1033.2003.03395.x; Fukuda H, 2006, J BIOCHEM, V139, P137, DOI 10.1093/jb/mvj012; Gottlinger HG, 2008, NATURE, V451, P406, DOI 10.1038/nature06364; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Guerin JL, 2002, J VIROL, V76, P2912, DOI 10.1128/JVI.76.6.2912-2923.2002; Hoer S, 2007, FEBS LETT, V581, P45, DOI 10.1016/j.febslet.2006.11.075; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; ISHIDO S, MOL CELLS, V29, P229; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Mansouri M, 2003, J VIROL, V77, P1427, DOI 10.1128/JVI.77.2.1427-1440.2003; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Marhaba R, 2004, J MOL HISTOL, V35, P211; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Morokuma Y, 2007, J BIOL CHEM, V282, P24806, DOI 10.1074/jbc.M700414200; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; Nathan JA, 2009, EXP CELL RES, V315, P1593, DOI 10.1016/j.yexcr.2008.10.026; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Regan JA, 2008, J VIROL, V82, P10042, DOI 10.1128/JVI.01240-08; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stojanovic M, 2005, J BIOL CHEM, V280, P30018, DOI 10.1074/jbc.M501306200; Szczesna-Skorupa E, 2006, J BIOL CHEM, V281, P4142, DOI 10.1074/jbc.M509522200; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zen K, 2004, J BIOL CHEM, V279, P44924, DOI 10.1074/jbc.M402115200	58	55	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15132	10.1371/journal.pone.0015132	http://dx.doi.org/10.1371/journal.pone.0015132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151997	gold, Green Submitted, Green Published			2022-12-27	WOS:000284868000025
J	Xu, B; Gerin, I; Miao, HZ; Dang, VP; Johnson, CN; Xu, RC; Chen, XW; Cawthorn, WP; MacDougald, OA; Koenig, RJ				Xu, Bin; Gerin, Isabelle; Miao, Hongzhi; Dang Vu-Phan; Johnson, Craig N.; Xu, Ruichuan; Chen, Xiao-Wei; Cawthorn, William P.; MacDougald, Ormond A.; Koenig, Ronald J.			Multiple Roles for the Non-Coding RNA SRA in Regulation of Adipogenesis and Insulin Sensitivity	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; DEPENDENT KINASE INHIBITORS; BINDING PROTEIN-ALPHA; STROMAL CELL CLONE; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTORS; PPAR-GAMMA; HORMONE-RECEPTOR; ENERGY-BALANCE; C/EBP-ALPHA	Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a master transcriptional regulator of adipogenesis. Hence, the identification of PPAR gamma coactivators should help reveal mechanisms controlling gene expression in adipose tissue development and physiology. We show that the non-coding RNA, Steroid receptor RNA Activator (SRA), associates with PPAR gamma and coactivates PPAR gamma-dependent reporter gene expression. Overexpression of SRA in ST2 mesenchymal precursor cells promotes their differentiation into adipocytes. Conversely, knockdown of endogenous SRA inhibits 3T3-L1 preadipocyte differentiation. Microarray analysis reveals hundreds of SRA-responsive genes in adipocytes, including genes involved in the cell cycle, and insulin and TNF alpha signaling pathways. Some functions of SRA may involve mechanisms other than coactivation of PPAR gamma. SRA in adipocytes increases both glucose uptake and phosphorylation of Akt and FOXO1 in response to insulin. SRA promotes S-phase entry during mitotic clonal expansion, decreases expression of the cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1, and increases phosphorylation of Cdk1/Cdc2. SRA also inhibits the expression of adipocyte-related inflammatory genes and TNF alpha-induced phosphorylation of c-Jun NH(2)-terminal kinase. In conclusion, SRA enhances adipogenesis and adipocyte function through multiple pathways.	[Xu, Bin; Xu, Ruichuan; MacDougald, Ormond A.; Koenig, Ronald J.] Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Gerin, Isabelle; Cawthorn, William P.; MacDougald, Ormond A.] Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Miao, Hongzhi] Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA; [Dang Vu-Phan] Univ Michigan, Med Ctr, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; [Johnson, Craig N.] Univ Michigan, Med Ctr, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chen, Xiao-Wei] Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, B (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	bxu@umich.edu	Cawthorn, William P./Y-2115-2019; Chen, Xiaowei/F-7026-2014; Cawthorn, William/K-1945-2012	Cawthorn, William P./0000-0001-7832-5057; Cawthorn, William/0000-0001-7832-5057; MacDougald, Ormond/0000-0001-6907-7960; Johnson, Craig/0000-0003-3955-7394; Chen, Xiao-Wei/0000-0001-6466-6248	Michigan Diabetes Research and Training Center (NIH) [5P60-DK020572]; National Institutes of Health [DK51563]; Belgian Funds National de la Recherche Scientifique; University of Michigan Center for Organogenesis; Royal Commission for the Exhibition (UK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051563, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	Michigan Diabetes Research and Training Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian Funds National de la Recherche Scientifique; University of Michigan Center for Organogenesis(University of Michigan System); Royal Commission for the Exhibition (UK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a Pilot and Feasibility Grant and the Cell and Molecular Biology Core of the Michigan Diabetes Research and Training Center (NIH Grant 5P60-DK020572) (B.X., R.J.K), National Institutes of Health grant DK51563 to O.A.M., fellowships to I. G. from the Belgian Funds National de la Recherche Scientifique and the University of Michigan Center for Organogenesis, and Postdoctoral Research Fellowship to W.P.C. from the Royal Commission for the Exhibition of 1851 (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Arango NA, 2005, DEV BIOL, V288, P276, DOI 10.1016/j.ydbio.2005.09.045; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Ding J, 2003, BIOSCI BIOTECH BIOCH, V67, P314, DOI 10.1271/bbb.67.314; El-Jack AK, 1999, J BIOL CHEM, V274, P7946, DOI 10.1074/jbc.274.12.7946; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fleming I, 1998, BIOCHEM J, V333, P719, DOI 10.1042/bj3330719; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gerin I, 2009, J BIOL CHEM, V284, P10755, DOI 10.1074/jbc.M809115200; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeong JW, 2006, MOL ENDOCRINOL, V20, P1138, DOI 10.1210/me.2005-0407; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kawashima H, 2003, BIOCHEM J, V369, P163, DOI 10.1042/BJ20020743; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Larsen L, 2002, APMIS, V110, P833, DOI 10.1034/j.1600-0463.2002.1101201.x; Lebrun P, 2008, ACTA PHYSIOL, V192, P29, DOI 10.1111/j.1748-1716.2007.01782.x; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Reichert M, 1999, ONCOGENE, V18, P459, DOI 10.1038/sj.onc.1202308; Ronn SG, 2007, DIABETES, V56, P541, DOI 10.2337/db06-1068; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P3621, DOI 10.1093/nar/27.17.3621; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Wang ZY, 2006, CELL METAB, V3, P111, DOI 10.1016/j.cmet.2006.01.002; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Xu B, 2005, MOL CELL ENDOCRINOL, V245, P147, DOI 10.1016/j.mce.2005.11.010; Xu B, 2004, J BIOL CHEM, V279, P33051, DOI 10.1074/jbc.M404930200; Xu B, 2009, MOL CELL BIOL, V29, P1719, DOI 10.1128/MCB.01010-08; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhao XS, 2007, MOL ENDOCRINOL, V21, P686, DOI 10.1210/me.2006-0414; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	75	141	160	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14199	10.1371/journal.pone.0014199	http://dx.doi.org/10.1371/journal.pone.0014199			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152033	Green Published, gold, Green Submitted			2022-12-27	WOS:000284868000013
J	Saraswati, S; Alfaro, MP; Thorne, CA; Atkinson, J; Lee, E; Young, PP				Saraswati, Sarika; Alfaro, Maria P.; Thorne, Curtis A.; Atkinson, James; Lee, Ethan; Young, Pampee P.			Pyrvinium, a Potent Small Molecule Wnt Inhibitor, Promotes Wound Repair and Post-MI Cardiac Remodeling	PLOS ONE			English	Article							CATENIN DOWN-REGULATION; ISOLATED RAT HEARTS; BETA-CATENIN; SIGNALING PATHWAY; MYOCARDIAL INFARCT; PLASMA-MEMBRANE; STEM-CELLS; AXIN; TISSUE; PHOSPHORYLATION	Wnt signaling plays an important role in developmental and stem cell biology. To test the hypothesis that temporary inhibition of Wnt signaling will enhance granulation tissue and promote angiogenesis in tissue repair, we employed a recently characterized small molecule Wnt inhibitor. Pyrvinium is an FDA-approved drug that we identified as a Wnt inhibitor in a chemical screen for small molecules that stabilize beta-catenin and inhibit Axin degradation. Our subsequent characterization of pyrvinium has revealed that its critical cellular target in the Wnt pathway is Casein Kinase 1 alpha. Daily administration of pyrvinium directly into polyvinyl alcohol (PVA) sponges implanted subcutaneously in mice generated better organized and vascularized granulation tissue; this compound also increased the proliferative index of the tissue within the sponges. To evaluate its effect in myocardial repair, we induced a myocardial infarction (MI) by coronary artery ligation and administered a single intramyocardial dose of pyrvinium. Mice were evaluated by echocardiography at 7 and 30 days post-MI and treatment; post mortem hearts were evaluated by histology at 30 days. Pyrvinium reduced adverse cardiac remodeling demonstrated by decreased left ventricular internal diameter in diastole (LVIDD) as compared to a control compound. Increased Ki-67(+) cells were observed in peri-infarct and distal myocardium of pyrvinium-treated animals. These results need to be further followed-up to determine if therapeutic inhibition of canonical Wnt may avert adverse remodeling after ischemic injury and its impact on myocardial repair and regeneration.	[Saraswati, Sarika; Alfaro, Maria P.; Atkinson, James; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Thorne, Curtis A.; Lee, Ethan] Vanderbilt Univ, Dept Cell & Dev Biol, Med Ctr, Nashville, TN USA; [Atkinson, James; Young, Pampee P.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Internal Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Saraswati, S (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA.	pampee.young@vanderbilt.edu			National Institutes of Health (NIH) [R01-HL088424, HL08842402S1, RO1-GM081635]; Veterans Affairs merit award; American Cancer Society [RSG-05-126-01]; National Cancer Institute [P50 CA95103]; National Institutes of Health [1 R01 GM081635-01]; NATIONAL CANCER INSTITUTE [P50CA095103] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006528] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants R01-HL088424, HL08842402S1, RO1-GM081635 and a Veterans Affairs merit award to PPY; American Cancer Society Research Scholar Grant RSG-05-126-01, National Cancer Institute Grant GI SPORE P50 CA95103, and National Institutes of Health Grant 1 R01 GM081635-01 to EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Bak I, 2006, AM J PHYSIOL-HEART C, V291, pH1329, DOI 10.1152/ajpheart.01243.2005; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blankesteijn WM, 2001, ACTA PHYSIOL SCAND, V173, P75, DOI 10.1046/j.1365-201X.2001.00887.x; Brade T, 2006, CARDIOVASC RES, V72, P198, DOI 10.1016/j.cardiores.2006.06.025; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cooney R, 1997, J TRAUMA, V42, P415, DOI 10.1097/00005373-199703000-00008; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Eisenberg LM, 2006, DEV BIOL, V293, P305, DOI 10.1016/j.ydbio.2006.02.014; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Juhasz B, 2007, ANTIOXID REDOX SIGN, V9, P1851, DOI 10.1089/ars.2006.1535; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Kovacs P, 2001, N-S ARCH PHARMACOL, V364, P501, DOI 10.1007/s002100100483; KRUMMEL TM, 1988, J PEDIATR SURG, V23, P647, DOI 10.1016/S0022-3468(88)80638-9; LaFramboise WA, 2005, J MOL CELL CARDIOL, V38, P103, DOI 10.1016/j.yjmcc.2004.09.011; Malekar P, 2010, HYPERTENSION, V55, P939, DOI 10.1161/HYPERTENSIONAHA.109.141127; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Oerlemans MI, 2009, CIRCULATION, V120, pS847; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Prabhu SD, 2005, J MOL CELL CARDIOL, V38, P547, DOI 10.1016/j.yjmcc.2005.01.014; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Solloway MJ, 2003, CARDIOVASC RES, V58, P264, DOI 10.1016/S0008-6363(03)00286-4; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V42, P1487, DOI 10.1016/j.freeradbiomed.2007.02.011; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van de Schans VAM, 2007, HYPERTENSION, V49, P473, DOI 10.1161/01.HYP.0000255946.55091.24; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Young PP, 2002, P NATL ACAD SCI USA, V99, P11951, DOI 10.1073/pnas.182215799; Zelarayan LC, 2008, P NATL ACAD SCI USA, V105, P19762, DOI 10.1073/pnas.0808393105	52	115	118	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15521	10.1371/journal.pone.0015521	http://dx.doi.org/10.1371/journal.pone.0015521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21170416	Green Submitted, gold, Green Published			2022-12-27	WOS:000284686500045
J	Charlson, ES; Chen, J; Custers-Allen, R; Bittinger, K; Li, HZ; Sinha, R; Hwang, J; Bushman, FD; Collman, RG				Charlson, Emily S.; Chen, Jun; Custers-Allen, Rebecca; Bittinger, Kyle; Li, Hongzhe; Sinha, Rohini; Hwang, Jennifer; Bushman, Frederic D.; Collman, Ronald G.			Disordered Microbial Communities in the Upper Respiratory Tract of Cigarette Smokers	PLOS ONE			English	Article							BACTERIAL INTERFERENCE; POTENTIAL PATHOGENS; SMOKING-CESSATION; HOUSE-DUST; DIVERSITY; NASOPHARYNX; SEQUENCES; RECOVERY; STRAINS; OTITIS	Cigarette smokers have an increased risk of infectious diseases involving the respiratory tract. Some effects of smoking on specific respiratory tract bacteria have been described, but the consequences for global airway microbial community composition have not been determined. Here, we used culture-independent high-density sequencing to analyze the microbiota from the right and left nasopharynx and oropharynx of 29 smoking and 33 nonsmoking healthy asymptomatic adults to assess microbial composition and effects of cigarette smoking. Bacterial communities were profiled using 454 pyrosequencing of 16S sequence tags (803,391 total reads), aligned to 16S rRNA databases, and communities compared using the UniFrac distance metric. A Random Forest machine-learning algorithm was used to predict smoking status and identify taxa that best distinguished between smokers and nonsmokers. Community composition was primarily determined by airway site, with individuals exhibiting minimal side-of-body or temporal variation. Within airway habitats, microbiota from smokers were significantly more diverse than nonsmokers and clustered separately. The distributions of several genera were systematically altered by smoking in both the oro- and nasopharynx, and there was an enrichment of anaerobic lineages associated with periodontal disease in the oropharynx. These results indicate that distinct regions of the human upper respiratory tract contain characteristic microbial communities that exhibit disordered patterns in cigarette smokers, both in individual components and global structure, which may contribute to the prevalence of respiratory tract complications in this population.	[Charlson, Emily S.; Custers-Allen, Rebecca; Bittinger, Kyle; Sinha, Rohini; Hwang, Jennifer; Bushman, Frederic D.; Collman, Ronald G.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Chen, Jun; Li, Hongzhe] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Charlson, Emily S.; Collman, Ronald G.] Univ Penn, Sch Med, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Charlson, ES (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu; collmanr@mail.med.upenn.edu	Bittinger, Kyle/ABG-2342-2020	Bushman, Frederic/0000-0003-4740-4056; Collman, Ronald/0000-0002-0508-3701	National Institutes of Health [U01 HL98957]; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Lung Human Microbiome Project Grant U01 HL98957 from the National Institutes of Health to R.G.C. and F.D.B. The authors also acknowledge the Penn Genome Frontiers Institute and a grant with the Pennsylvania Department of Health; the Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALY R, 1974, J INFECT DIS, V129, P720, DOI 10.1093/infdis/129.6.720; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; ARONSON MD, 1982, JAMA-J AM MED ASSOC, V248, P181, DOI 10.1001/jama.248.2.181; Brook I, 2005, CHEST, V127, P2072, DOI 10.1378/chest.127.6.2072; BROOK I, 1995, ARCH OTOLARYNGOL, V121, P1405; Brook I, 2005, OTOLARYNG HEAD NECK, V133, P139, DOI 10.1016/j.otohns.2005.03.012; Brook I, 2008, ANN OTO RHINOL LARYN, V117, P727, DOI 10.1177/000348940811701003; Brook I, 2007, ARCH OTOLARYNGOL, V133, P135, DOI 10.1001/archotol.133.2.135; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; CROWE CC, 1973, J INFECT DIS, V128, P527, DOI 10.1093/infdis/128.4.527; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Downes J, 2001, J MED MICROBIOL, V50, P947, DOI 10.1099/0022-1317-50-11-947; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P27, DOI 10.1111/j.1574-695X.1999.tb01713.x; ERTEL A, 1991, CHEST, V100, P628, DOI 10.1378/chest.100.3.628; Fullmer SC, 2009, J DENT RES, V88, P524, DOI 10.1177/0022034509338676; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Kaarakainen P, 2009, SCI TOTAL ENVIRON, V407, P4673, DOI 10.1016/j.scitotenv.2009.04.046; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mikkelsen L, 2000, ORAL MICROBIOL IMMUN, V15, P263, DOI 10.1034/j.1399-302x.2000.150409.x; Pakarinen J, 2008, ENVIRON MICROBIOL, V10, P3317, DOI 10.1111/j.1462-2920.2008.01723.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rasmussen TT, 2000, APMIS, V108, P663, DOI 10.1034/j.1600-0463.2000.d01-13.x; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Senn L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-9; Shchipkova AY, 2010, J DENT RES, V89, P1247, DOI 10.1177/0022034510377203; STANLEY PJ, 1986, THORAX, V41, P519, DOI 10.1136/thx.41.7.519; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; TURKELTAUB PC, 1991, ANN ALLERGY, V67, P147; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Winkelhoff AJ, 2001, J PERIODONTOL, V72, P666, DOI 10.1902/jop.2001.72.5.666; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wos-Oxley ML, 2010, ISME J, V4, P839, DOI 10.1038/ismej.2010.15; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yang J, 2010, J DAIRY SCI, V93, P3136, DOI 10.3168/jds.2009-2898; Zambon JJ, 1996, J PERIODONTOL, V67, P1050, DOI 10.1902/jop.1996.67.10s.1050; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	52	240	250	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15216	10.1371/journal.pone.0015216	http://dx.doi.org/10.1371/journal.pone.0015216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188149	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200022
J	Crewther, DP; Crewther, SG				Crewther, David P.; Crewther, Sheila G.			Different Temporal Structure for Form versus Surface Cortical Color Systems - Evidence from Chromatic Non-Linear VEP	PLOS ONE			English	Article							VISUAL-EVOKED-POTENTIALS; PRIMATE STRIATE CORTEX; FUNCTIONAL-ORGANIZATION; OCCIPITOTEMPORAL CORTEX; MACAQUE V1; MONKEY; V2; CONTRAST; COMPONENTS; NEURONS	Physiological studies of color processing have typically measured responses to spatially varying chromatic stimuli such as gratings, while psychophysical studies of color include color naming, color and light, as well as spatial and temporal chromatic sensitivities. This raises the question of whether we have one or several cortical color processing systems. Here we show from non-linear analysis of human visual evoked potentials (VEP) the presence of distinct and independent temporal signatures for form and surface color processing. Surface color stimuli produced most power in the second order Wiener kernel, indicative of a slowly recovering neural system, while chromatic form stimulation produced most power in the first order kernel (showing rapid recovery). We find end-spectral saturation-dependent signals, easily separable from achromatic signals for surface color stimuli. However physiological responses to form color stimuli, though varying somewhat with saturation, showed similar waveform components. Lastly, the spectral dependence of surface and form color VEP was different, with the surface color responses almost vanishing with yellow-grey isoluminant stimulation whereas the form color VEP shows robust recordable signals across all hues. Thus, surface and form colored stimuli engage different neural systems within cortex, pointing to the need to establish their relative contributions under the diverse chromatic stimulus conditions used in the literature.	[Crewther, David P.] Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia; [Crewther, Sheila G.] La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia	Swinburne University of Technology; La Trobe University	Crewther, DP (corresponding author), Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia.	dcrewther@swin.edu.au	Crewther, Sheila G/A-2165-2008					BAIZER JS, 1977, J NEUROPHYSIOL, V40, P1024, DOI 10.1152/jn.1977.40.5.1024; Beauchamp MS, 1999, CEREB CORTEX, V9, P257, DOI 10.1093/cercor/9.3.257; BERNINGER TA, 1989, BRIT J OPHTHALMOL, V73, P502, DOI 10.1136/bjo.73.7.502; BRADLEY A, 1992, APPL OPTICS, V31, P3657, DOI 10.1364/AO.31.003657; Cant JS, 2008, PERCEPTION, V37, P57, DOI 10.1068/p5727; Cant JS, 2007, CEREB CORTEX, V17, P713, DOI 10.1093/cercor/bhk022; Chatterjee S, 2003, NATURE, V426, P668, DOI 10.1038/nature02163; Conway BR, 2002, CEREB CORTEX, V12, P915, DOI 10.1093/cercor/12.9.915; Crewther DP, 2002, CLIN EXP OPHTHALMOL, V30, P231, DOI 10.1046/j.1442-9071.2002.00517.x; CROGNALE MA, 1993, J OPT SOC AM A, V10, P1818, DOI 10.1364/JOSAA.10.001818; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DOW B, 1990, SCIENCE VISION; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; ESTEVEZ O, 1983, COLOUR VISION, P261; FIORENTINI A, 1991, NATO ADV SCI I A-LIF, V203, P139; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; GOURAS P, 1968, J PHYSIOL-LONDON, V199, P533, DOI 10.1113/jphysiol.1968.sp008667; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; Johnson EN, 2008, J NEUROSCI, V28, P8096, DOI 10.1523/JNEUROSCI.1404-08.2008; KAISER PK, 1996, HUMAN COLOR VISION W; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Klistorner A, 1997, VISION RES, V37, P2161, DOI 10.1016/S0042-6989(97)00003-5; Klistorner A, 1998, VISION RES, V38, P3979, DOI 10.1016/S0042-6989(97)00394-5; KULIKOWSKI J, 1989, ELECTROPHYSIOL CORRE; LENNIE P, 1990, J NEUROSCI, V10, P649; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; Lu HD, 2007, CEREB CORTEX, V17, P2675, DOI 10.1093/cercor/bhl177; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; PAULUS WM, 1984, ELECTROEN CLIN NEURO, V58, P107, DOI 10.1016/0013-4694(84)90023-3; PAULUS WM, 1986, PROC R SOC SER B-BIO, V227, P53, DOI 10.1098/rspb.1986.0009; RABIN J, 1994, VISION RES, V34, P2657, DOI 10.1016/0042-6989(94)90222-4; Roe AW, 1999, J NEUROPHYSIOL, V82, P2719, DOI 10.1152/jn.1999.82.5.2719; Roe AW, 2005, ANAT REC PART A, V287A, P1213, DOI 10.1002/ar.a.20248; ROE AW, 2006, J VIS, V6, P405; Self MW, 2005, CEREB CORTEX, V15, P1270, DOI 10.1093/cercor/bhi010; Sutter Erich, 2000, Documenta Ophthalmologica, V100, P49, DOI 10.1023/A:1002702917233; Ts'o DY, 2001, VISION RES, V41, P1333, DOI 10.1016/S0042-6989(01)00076-1; TSO DY, 1988, J NEUROSCI, V8, P1712; Usher M, 1998, NATURE, V394, P179, DOI 10.1038/28166; Wang Y, 2007, CEREB CORTEX, V17, P116, DOI 10.1093/cercor/bhj131; Xiao YP, 2007, NEUROIMAGE, V35, P771, DOI 10.1016/j.neuroimage.2006.11.059; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15266	10.1371/journal.pone.0015266	http://dx.doi.org/10.1371/journal.pone.0015266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187960	Green Published, gold			2022-12-27	WOS:000285575200028
J	Fischer, K; Dierks, A; Franke, K; Geister, TL; Liszka, M; Winter, S; Pflicke, C				Fischer, Klaus; Dierks, Anneke; Franke, Kristin; Geister, Thorin L.; Liszka, Magdalena; Winter, Sarah; Pflicke, Claudia			Environmental Effects on Temperature Stress Resistance in the Tropical Butterfly Bicyclus Anynana	PLOS ONE			English	Article							BENEFICIAL ACCLIMATION HYPOTHESIS; DROSOPHILA-MELANOGASTER; THERMAL TOLERANCE; CHILL-COMA; PHENOTYPIC PLASTICITY; HSP70 EXPRESSION; MATING SUCCESS; RECOVERY-TIME; HEAT-SHOCK; LIFE-SPAN	Background: The ability to withstand thermal stress is considered to be of crucial importance for individual fitness and species' survival. Thus, organisms need to employ effective mechanisms to ensure survival under stressful thermal conditions, among which phenotypic plasticity is considered a particularly quick and effective one. Methodology/Principal Findings: In a series of experiments we here investigate phenotypic adjustment in temperature stress resistance following environmental manipulations in the butterfly Bicyclus anynana. Cooler compared to warmer acclimation temperatures generally increased cold but decreased heat stress resistance and vice versa. In contrast, short-time hardening responses revealed more complex patterns, with, e.g., cold stress resistance being highest at intermediate hardening temperatures. Adult food stress had a negative effect on heat but not on cold stress resistance. Additionally, larval feeding treatment showed interactive effects with adult feeding for heat but not for cold stress resistance, indicating that nitrogenous larval resources may set an upper limit to performance under heat stress. In contrast to expectations, cold resistance slightly increased during the first eight days of adult life. Light cycle had marginal effects on temperature stress resistance only, with cold resistance tending to be higher during daytime and thus active periods. Conclusions/Significance: Our results highlight that temperature-induced plasticity provides an effective tool to quickly and strongly modulate temperature stress resistance, and that such responses are readily reversible. However, resistance traits are not only affected by ambient temperature, but also by, e.g., food availability and age, making their measurement challenging. The latter effects are largely underexplored and deserve more future attention. Owing to their magnitude, plastic responses in thermal tolerance should be incorporated into models trying to forecast effects of global change on extant biodiversity.	[Fischer, Klaus; Dierks, Anneke; Franke, Kristin; Winter, Sarah] Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany; [Geister, Thorin L.; Liszka, Magdalena; Pflicke, Claudia] Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Bayreuth	Fischer, K (corresponding author), Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany.	klaus.fischer@uni-greifswald.de			German Research Council (DFG) [Fi 846/1-2, 1-3, 1-4]	German Research Council (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Council (DFG grants no. Fi 846/1-2, 1-3 and 1-4 to KFi). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LH, 2010, J INSECT PHYSIOL, V56, P336, DOI 10.1016/j.jinsphys.2009.11.006; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Ayrinhac A, 2004, FUNCT ECOL, V18, P700, DOI 10.1111/j.0269-8463.2004.00904.x; Bahrndorff S, 2009, FUNCT ECOL, V23, P340, DOI 10.1111/j.1365-2435.2008.01503.x; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; Bauerfeind SS, 2009, EXP GERONTOL, V44, P805, DOI 10.1016/j.exger.2009.10.007; Bijlsma R, 2005, J EVOLUTION BIOL, V18, P744, DOI 10.1111/j.1420-9101.2005.00962.x; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1997, ENV STRESS ADAPTATIO, P105; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Castaneda LE, 2005, J INSECT PHYSIOL, V51, P1346, DOI 10.1016/j.jinsphys.2005.08.005; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; David JR, 2003, FUNCT ECOL, V17, P425, DOI 10.1046/j.1365-2435.2003.00750.x; Deere JA, 2006, J INSECT PHYSIOL, V52, P693, DOI 10.1016/j.jinsphys.2006.03.009; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diffenbaugh NS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030000; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Fischer K, 2003, ECOLOGY, V84, P3138, DOI 10.1890/02-0733; Fischer K, 2001, ANIM BEHAV, V61, P723, DOI 10.1006/anbe.2000.1662; Fischer K, 2008, P ROY SOC B-BIOL SCI, V275, P1517, DOI 10.1098/rspb.2007.1455; Geister TL, 2007, BEHAV ECOL, V18, P658, DOI 10.1093/beheco/arm024; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; HOFFMANN AA, 1991, EVOL GEN ENVIR STRES; Jensen D, 2007, J INSECT PHYSIOL, V53, P179, DOI 10.1016/j.jinsphys.2006.11.008; Karl I, 2009, J EVOLUTION BIOL, V22, P172, DOI 10.1111/j.1420-9101.2008.01630.x; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Karl I, 2007, BIOL J LINN SOC, V91, P403, DOI 10.1111/j.1095-8312.2007.00806.x; Karl I, 2010, POPUL ECOL, V52, P307, DOI 10.1007/s10144-009-0191-z; Karl I, 2009, FUNCT ECOL, V23, P1132, DOI 10.1111/j.1365-2435.2009.01607.x; KARLSSON B, 1994, OIKOS, V69, P224, DOI 10.2307/3546142; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Kellermann VM, 2006, EVOLUTION, V60, P1104, DOI 10.1554/05-710.1; Kellett M, 2005, FUNCT ECOL, V19, P853, DOI 10.1111/j.1365-2435.2005.01025.x; Lalouette L, 2010, BIOL LETTERS, V6, P346, DOI 10.1098/rsbl.2009.0873; LARSEN TB, 1991, BUTTERFLIES KENYA OX; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; Loeschcke V, 2005, J THERM BIOL, V30, P255, DOI 10.1016/j.jtherbio.2004.12.005; Loeschcke V, 2007, AM NAT, V169, P175, DOI 10.1086/510632; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Macdonald SS, 2004, J INSECT PHYSIOL, V50, P695, DOI 10.1016/j.jinsphys.2004.05.004; Marais E, 2009, J INSECT PHYSIOL, V55, P336, DOI 10.1016/j.jinsphys.2008.11.016; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; McMillan DM, 2005, FUNCT ECOL, V19, P844, DOI 10.1111/j.1365-2435.2005.01031.x; Merckx T, 2006, FUNCT ECOL, V20, P436, DOI 10.1111/j.1365-2435.2006.01124.x; Overgaard J, 2005, J INSECT PHYSIOL, V51, P1173, DOI 10.1016/j.jinsphys.2005.06.007; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Pappas C, 2007, COMP BIOCHEM PHYS A, V146, P355, DOI 10.1016/j.cbpa.2006.11.010; Pigliucci M., 2001, SYN ECO EVO; Pijpe J, 2008, AM NAT, V171, P81, DOI 10.1086/524200; Rajamohan A, 2008, J INSECT PHYSIOL, V54, P708, DOI 10.1016/j.jinsphys.2008.01.011; Rajamohan A, 2009, PHYSIOL ENTOMOL, V34, P217, DOI 10.1111/j.1365-3032.2009.00677.x; Rako L, 2006, J INSECT PHYSIOL, V52, P94, DOI 10.1016/j.jinsphys.2005.09.007; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sejerkilde M, 2003, J INSECT PHYSIOL, V49, P719, DOI 10.1016/S0022-1910(03)00095-7; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; Sinclair BJ, 2003, TRENDS ECOL EVOL, V18, P257, DOI 10.1016/S0169-5347(03)00014-4; Sorensen JG, 2002, ECOL LETT, V5, P16, DOI 10.1046/j.1461-0248.2002.00296.x; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Stjernholm F, 2006, FUNCT ECOL, V20, P442, DOI 10.1111/j.1365-2435.2006.01120.x; Terblanche JS, 2007, J INSECT PHYSIOL, V53, P455, DOI 10.1016/j.jinsphys.2007.01.006; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; van't Hof AE, 2005, MOL ECOL NOTES, V5, P169, DOI 10.1111/j.1471-8286.2004.00870.x; WILLMER P, 2000, ENV PHYSIOL ANIMAL O; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9; WINDIG JJ, 1994, ECOL ENTOMOL, V19, P285, DOI 10.1111/j.1365-2311.1994.tb00420.x; Woods HA, 2002, EVOLUTION, V56, P1863; ZEILSTRA I, 2003, PHYSIOL ENTOMOL, V30, P92	76	86	88	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15284	10.1371/journal.pone.0015284	http://dx.doi.org/10.1371/journal.pone.0015284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187968	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200031
J	Jin, JY; Zhou, L; Wang, Y; Li, Z; Zhao, JG; Zhang, QY; Gui, JF				Jin, Jun-Yan; Zhou, Li; Wang, Yang; Li, Zhi; Zhao, Jiu-Gang; Zhang, Qi-Ya; Gui, Jian-Fang			Antibacterial and Antiviral Roles of a Fish beta-Defensin Expressed Both in Pituitary and Testis	PLOS ONE			English	Article							NF-KAPPA-B; ANTIMICROBIAL PEPTIDE; DIFFERENTIAL EXPRESSION; SEX REVERSAL; HUMAN BETA-DEFENSIN-3; TRANSCRIPTION FACTOR; GENE CLUSTERS; IDENTIFICATION; DISCOVERY; INNATE	Defensins are a group of cationic peptides that exhibit broad-spectrum antimicrobial activity. In this study, we cloned and characterized a beta-defensin from pituitary cDNA library of a protogynous hermaphroditic orange- spotted grouper (Epinephelus coioides). Interestingly, the beta-defensin was shown to be dominantly expressed in pituitary and testis by RT-PCR and Western blot analysis, and its transcript level is significantly upregulated in reproduction organs from intersexual gonad to testis during the natural and artificial sex reversal. Promoter sequence and the responsible activity region analyses revealed the pituitary-specific POU1F1a transcription binding site and testis-specific SRY responsible site, and demonstrated that the pituitary-specific POU1F1a transcription binding site that locates between 2180 and 2208 bp is the major responsible region of grouper beta-defensin promoter activity. Immunofluorescence localization observed its pituicyte expression in pituitary and spermatogonic cell expression in testis. Moreover, both in vitro antibacterial activity assay of the recombinant beta-defensin and in vivo embryo microinjection of the beta-defensin mRNA were shown to be effective in killing Gram-negative bacteria. And, its antiviral role was also demonstrated in EPC cells transfected with the beta-defensin construct. Additionally, the antibacterial activity was sensitive to concentrations of Na+, K+, Ca2+ and Mg2+. The above intriguing findings strongly suggest that the fish beta-defensin might play significant roles in both innate immunity defense and reproduction endocrine regulation.	[Jin, Jun-Yan; Zhou, Li; Wang, Yang; Li, Zhi; Zhao, Jiu-Gang; Zhang, Qi-Ya; Gui, Jian-Fang] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Wuhan Ctr Dev Biol, Inst Hydrobiol,Grad Sch, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Jin, JY (corresponding author), Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Wuhan Ctr Dev Biol, Inst Hydrobiol,Grad Sch, Wuhan, Peoples R China.	jfgui@ihb.ac.cn			National Key Basic Research Program [2010CB126301]; National Natural Science Foundation of China [U0631007]; State Key Laboratory of Freshwater Ecology and Biotechnology [2008FBZ15, 085B181F01]; Institute of Hydrobiology, Chinese Academy of Sciences [075A011301, 085A011301]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); Institute of Hydrobiology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by National Key Basic Research Program (2010CB126301), National Natural Science Foundation of China (U0631007), Open Project of State Key Laboratory of Freshwater Ecology and Biotechnology (2008FBZ15, 085B181F01), and Innovation Project of Institute of Hydrobiology, Chinese Academy of Sciences (075A011301, 085A011301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Casadei E, 2009, MOL IMMUNOL, V46, P3358, DOI 10.1016/j.molimm.2009.07.018; de la Vega RCR, 2005, TRENDS GENET, V21, P330, DOI 10.1016/j.tig.2005.03.009; DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952; Dong B, 2007, BIOCHEM J, V401, P57, DOI 10.1042/BJ20060570; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Falco A, 2008, MOL IMMUNOL, V45, P757, DOI 10.1016/j.molimm.2007.06.358; Frolich O, 2001, BIOL REPROD, V64, P1072, DOI 10.1095/biolreprod64.4.1072; Froy O, 2005, IUBMB LIFE, V57, P41, DOI 10.1080/15216540500088912; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hamil KG, 2000, ENDOCRINOLOGY, V141, P1245, DOI 10.1210/en.141.3.1245; Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Howell MD, 2007, J ALLERGY CLIN IMMUN, V119, P1022, DOI 10.1016/j.jaci.2007.01.044; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; Huang YH, 2007, APOPTOSIS, V12, P1569, DOI 10.1007/s10495-007-0089-1; Ibrahim NM, 2001, BIOL REPROD, V65, P575, DOI 10.1095/biolreprod65.2.575; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Krishnakumari V, 2009, ANTIMICROB AGENTS CH, V53, P256, DOI 10.1128/AAC.00470-08; Li CJ, 2005, MOL CELL ENDOCRINOL, V233, P33, DOI 10.1016/j.mce.2005.01.010; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; MACLEOD RJ, 1991, P NATL ACAD SCI USA, V88, P552, DOI 10.1073/pnas.88.2.552; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; Nam BH, 2010, FISH SHELLFISH IMMUN, V28, P267, DOI 10.1016/j.fsi.2009.11.004; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; OSBORN RW, 1995, FEBS LETT, V368, P257, DOI 10.1016/0014-5793(95)00666-W; Palladino MA, 2003, BIOL REPROD, V68, P509, DOI 10.1095/biolreprod.102.008953; Patil AA, 2005, PHYSIOL GENOMICS, V23, P5, DOI 10.1152/physiolgenomics.00104.2005; Peng JX, 2009, J EXP ZOOL PART B, V312B, P855, DOI 10.1002/jez.b.21301; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Sang YM, 2006, MAMM GENOME, V17, P332, DOI 10.1007/s00335-005-0158-0; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Semple CA, 2006, MOL DIVERS, V10, P575, DOI 10.1007/s11030-006-9031-7; Soman SS, 2009, MOL IMMUNOL, V46, P2029, DOI 10.1016/j.molimm.2009.03.003; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; TOMINAGA T, 1990, J ENDOCRINOL, V125, P287, DOI 10.1677/joe.0.1250287; Tsutsumi-Ishii Y, 2002, J LEUKOCYTE BIOL, V71, P154; Van As P, 2000, GEN COMP ENDOCR, V120, P127, DOI 10.1006/gcen.2000.7529; Wang D, 2009, ANIM GENET, V40, P978, DOI 10.1111/j.1365-2052.2009.01941.x; Wang XL, 2005, GENE, V350, P99, DOI 10.1016/j.gene.2005.02.002; Wang Y, 2004, MOL CELL ENDOCRINOL, V220, P77, DOI 10.1016/j.mce.2004.03.007; Weinberg A, 2006, Adv Dent Res, V19, P42; Weltzien FA, 2003, COMP BIOCHEM PHYS A, V134, P315, DOI 10.1016/S1095-6433(02)00266-0; Wu N, 2009, BIOL REPROD, V81, P275, DOI 10.1095/biolreprod.108.074955; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yao B, 2007, J EXP ZOOL PART A, V307A, P207, DOI 10.1002/jez.361; Yeh SL, 2003, AQUACULTURE, V218, P729, DOI 10.1016/S0044-8486(02)00565-3; Yenugu S, 2004, ENDOCRINOLOGY, V145, P3165, DOI 10.1210/en.2003-1698; Yudin AI, 2003, BIOL REPROD, V69, P1118, DOI 10.1095/biolreprod.103.016105; Zhao JG, 2009, DEV COMP IMMUNOL, V33, P624, DOI 10.1016/j.dci.2008.11.006; Zhao Z, 2008, VIROLOGY, V372, P118, DOI 10.1016/j.virol.2007.10.028; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127; Zhou L, 2006, AQUACULTURE, V256, P129, DOI 10.1016/j.aquaculture.2006.01.022; Zhou L, 2010, FISH PHYSIOL BIOCHEM, V36, P181, DOI 10.1007/s10695-008-9219-0; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07; Zou J, 2007, MOL IMMUNOL, V44, P638, DOI 10.1016/j.molimm.2006.01.012	69	82	89	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e12883	10.1371/journal.pone.0012883	http://dx.doi.org/10.1371/journal.pone.0012883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188147	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200001
J	Ravva, SV; Sarreal, CZ; Mandrell, RE				Ravva, Subbarao V.; Sarreal, Chester Z.; Mandrell, Robert E.			Identification of Protozoa in Dairy Lagoon Wastewater that Consume Escherichia coli O157:H7 Preferentially	PLOS ONE			English	Article							ACANTHAMOEBA-POLYPHAGA; SALMONELLA-ENTERICA; BACTERIAL PATHOGENS; LEGIONELLA-PNEUMOPHILA; MYCOBACTERIUM-AVIUM; O157-H7 SURVIVAL; BEEF-CATTLE; LETTUCE; AMEBAS; GROWTH	Escherichia coli O157:H7 (EcO157), an agent of life threatening hemolytic-uremic syndrome, resides in ruminants and is released in feces at numbers as high as 10 million cells/gram. EcO157 could survive in manure for as long as 21 months, but we observed a 90% decrease in cells of an outbreak strain of EcO157 within half a day in wastewater from dairy lagoons. Although chemical, environmental and biological factors may be responsible for this decrease, we observed an 11-fold increase in native protozoa when wastewater was re-inoculated with 2X10(7) cells of EcO157/mL. These protozoa engulfed the green fluorescent protein labeled EcO157 within 2 hours after inoculation, but expelled vacuoles filled with live EcO157 cells within 3 days into surrounding wastewater, whereas other protozoa retained the EcO157-filled vacuoles for 7 days. EcO157 was not detected by confocal microscopy either inside or outside protozoa after 7 days. Mixed cultures of protozoa enriched from wastewater consumed EcO157 preferentially as compared to native aerobic bacteria, but failed to eliminate them when EcO157 cells declined to 10(4)/mL. We isolated three protozoa from mixed cultures and typed them by 18S sequencing as Vorticella microstoma, Platyophyra sp. and Colpoda aspera. While all three protozoa internalized EcO157, only Platyophyra and Colpoda acted as predators. Similar to mixed cultures, these protozoa failed to eliminate EcO157 from PBS containing no other supplemental nutrients or prey. However, spiking PBS with cereal grass medium as nutrients induced predation of EcO157 by Platyophyra sp. after 3 days or enhanced predation by Colpoda after 5 days. Therefore, attempts to enrich protozoa to decrease EcO157 from dairy lagoons, may correspond to an increase in protozoa similar to Vorticella and possibly facilitate transport of bacterial pathogens to food crops grown in proximity.				subbarao.ravva@ars.usda.gov	Mandrell, Robert E/O-9814-2018		U. S. Department of Agriculture, Agricultural Research Service [5325-32000-005, 5325-42000-044]	U. S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was funded by the U. S. Department of Agriculture, Agricultural Research Service under Current Research Information System projects 5325-32000-005 and 5325-42000-044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER M, 1981, ANNU REV MICROBIOL, V35, P113, DOI 10.1146/annurev.mi.35.100181.000553; Amaral AL, 2008, ANAL BIOANAL CHEM, V391, P1321, DOI 10.1007/s00216-008-1845-y; Artz RRE, 2002, FEMS MICROBIOL LETT, V216, P117, DOI 10.1016/S0378-1097(02)01002-9; Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1111/j.1574-6968.1999.tb13516.x; BARKER J, 1994, MICROBIOL-UK, V140, P1253, DOI 10.1099/00221287-140-6-1253; Blodgett R., 2006, BACTERIOLOGICAL ANAL; Bouyer S, 2007, ENVIRON MICROBIOL, V9, P1341, DOI 10.1111/j.1462-2920.2006.01229.x; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P5285, DOI 10.1128/AEM.01073-08; Brandl MT, 2005, APPL ENVIRON MICROB, V71, P1562, DOI 10.1128/AEM.71.3.1562-1569.2005; Burow LC, 2005, LETT APPL MICROBIOL, V40, P117, DOI 10.1111/j.1472-765X.2004.01642.x; CASIDA LE, 1989, APPL ENVIRON MICROB, V55, P1857, DOI 10.1128/AEM.55.8.1857-1859.1989; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; Cody SH, 1999, ANN INTERN MED, V130, P202, DOI 10.7326/0003-4819-130-3-199902020-00005; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; DeWaal CS, 2009, OUTBREAK ALERT 2009; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Franz E, 2005, APPL ENVIRON MICROB, V71, P6165, DOI 10.1128/AEM.71.10.6165-6174.2005; Garcia MT, 2008, J APPL MICROBIOL, V105, P837, DOI 10.1111/j.1365-2672.2008.03804.x; Gaze WH, 2003, MICROBIAL ECOL, V46, P358, DOI 10.1007/s00248-003-1001-3; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P1851; Gourabathini P, 2008, APPL ENVIRON MICROB, V74, P2518, DOI 10.1128/AEM.02709-07; Guan TY, 2003, J ENVIRON QUAL, V32, P383, DOI 10.2134/jeq2003.0383; Hancock DD, 1998, PREV VET MED, V35, P11, DOI 10.1016/S0167-5877(98)00050-6; Hristov AN, 2001, J ANIM SCI, V79, P515; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Huws SA, 2008, FEMS MICROBIOL LETT, V282, P258, DOI 10.1111/j.1574-6968.2008.01123.x; Huws SA, 2006, ENVIRON MICROBIOL, V8, P1130, DOI 10.1111/j.1462-2920.2006.00991.x; KING CH, 1988, APPL ENVIRON MICROB, V54, P3023, DOI 10.1128/AEM.54.12.3023-3033.1988; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; LeJeune JT, 2001, J DAIRY SCI, V84, P1856, DOI 10.3168/jds.S0022-0302(01)74626-7; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Mandrell R. E., 2009, MICROBIAL SAFETY FRE, P5; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; Rasmussen MA, 2005, INFECT IMMUN, V73, P4668, DOI 10.1128/IAI.73.8.4668-4675.2005; Ravva SV, 2006, J APPL MICROBIOL, V101, P891, DOI 10.1111/j.1365-2672.2006.02956.x; Ravva SV, 2007, APPL ENVIRON MICROB, V73, P2191, DOI 10.1128/AEM.02213-06; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Schlimme W, 1997, FEMS MICROBIOL ECOL, V23, P239, DOI 10.1016/S0168-6496(97)00028-7; Shin EC, 2004, J APPL MICROBIOL, V97, P378, DOI 10.1111/j.1365-2672.2004.02304.x; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; Strauch E, 2007, FUTURE MICROBIOL, V2, P63, DOI 10.2217/17460913.2.1.63; Tanji Y, 2004, APPL MICROBIOL BIOT, V64, P270, DOI 10.1007/s00253-003-1438-9; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; VANCE RD, 1972, J ANIM SCI, V35, P598; Wand H, 2007, WATER RES, V41, P159, DOI 10.1016/j.watres.2006.08.024; WATSON PJ, 1981, J GEN MICROBIOL, V122, P323; Wright ADG, 1997, J EUKARYOT MICROBIOL, V44, P61, DOI 10.1111/j.1550-7408.1997.tb05693.x	51	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15671	10.1371/journal.pone.0015671	http://dx.doi.org/10.1371/journal.pone.0015671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187934	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200060
J	Yu, KD; Huang, AJ; Shao, ZM				Yu, Ke-Da; Huang, A-Ji; Shao, Zhi-Ming			Tailoring Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A CYP2D6 Multiple-Genotype-Based Modeling Analysis and Validation	PLOS ONE			English	Article							CYTOCHROME-P450 2D6; AMERICAN-SOCIETY; TAMOXIFEN; WOMEN; GENE; POLYMORPHISMS; PHARMACOGENETICS; ASSOCIATION; METABOLISM; INHIBITORS	Purpose: Previous studies have suggested that postmenopausal women with breast cancer who present with wild-type CYP2D6 may actually have similar or superior recurrence-free survival outcomes when given tamoxifen in place of aromatase inhibitors (AIs). The present study established a CYP2D6 multiple-genotype-based model to determine the optimal endocrine therapy for patients harboring wild-type CYP2D6. Methods: We created a Markov model to determine whether tamoxifen or AIs maximized 5-year disease-free survival (DFS) for extensive metabolizer (EM) patients using annual hazard ratio (HR) data from the BIG 1-98 trial. We then replicated the model by evaluating 9-year event-free survival (EFS) using HR data from the ATAC trial. In addition, we employed two-way sensitivity analyses to explore the impact of HR of decreased-metabolizer (DM) and its frequency on survival by studying a range of estimates. Results: The 5-year DFS of tamoxifen-treated EM patients was 83.3%, which is similar to that of genotypically unselected patients who received an AI (83.7%). In the validation study, we further demonstrated that the 9-year EFS of tamoxifen-treated EM patients was 81.4%, which is higher than that of genotypically unselected patients receiving tamoxifen (78.4%) and similar to that of patients receiving an AI (83.2%). Two-way sensitivity analyses demonstrated the robustness of the results. Conclusions: Our modeling analyses indicate that, among EM patients, the DFS/EFS outcome of patients receiving tamoxifen is similar to that of patients receiving an AI. Further prospective clinical trials are needed to evaluate the value of the CYP2D6 genotype in the selection of endocrine therapy.	[Yu, Ke-Da] Fudan Univ, Dept Oncol, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China; Fudan Univ, Ctr Canc, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yu, KD (corresponding author), Fudan Univ, Dept Oncol, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			Youth Foundation of Shanghai Public Health Bureau; Youth Foundation of Shanghai Medical College; Municipal Hospitals [SHDC12010116]; National Natural Science Foundation of China [30971143, 30972936, 81001169]	Youth Foundation of Shanghai Public Health Bureau; Youth Foundation of Shanghai Medical College; Municipal Hospitals; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the 2009 Youth Foundation of Shanghai Public Health Bureau, the 2009 Youth Foundation of Shanghai Medical College, the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), and the National Natural Science Foundation of China (30971143, 30972936, 81001169). The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; BIJL MJ, 2009, BREAST CANC IN PRESS; Bonanni B, 2006, J CLIN ONCOL, V24, P3708, DOI 10.1200/JCO.2006.06.8072; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Colomer R, 2008, CLIN CANCER RES, V14, P811, DOI 10.1158/1078-0432.CCR-07-1923; Cooke AL, 2008, J CLIN ONCOL, V26, P5227, DOI 10.1200/JCO.2007.15.7123; Desta Z, 2007, J CLIN ONCOL, V25, P5147, DOI 10.1200/JCO.2007.13.4957; Gaedigk A, 2008, CLIN PHARMACOL THER, V83, P234, DOI 10.1038/sj.clpt.6100406; Gjerde J, 2008, ANN ONCOL, V19, P56, DOI 10.1093/annonc/mdm434; Goetz MP, 2008, CLIN CANCER RES, V14, P5864, DOI 10.1158/1078-0432.CCR-08-0619; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Hemeryck A, 2002, CURR DRUG METAB, V3, P13, DOI 10.2174/1389200023338017; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Lim HS, 2007, J CLIN ONCOL, V25, P3837, DOI 10.1200/JCO.2007.11.4850; Lin NU, 2008, J CLIN ONCOL, V26, P798, DOI 10.1200/JCO.2007.15.0946; Locker GY, 2007, BREAST CANCER RES TR, V106, P229, DOI 10.1007/s10549-006-9483-6; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; Punglia RS, 2008, JNCI-J NATL CANCER I, V100, P642, DOI 10.1093/jnci/djn100; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Schroth W, 2009, JAMA-J AM MED ASSOC, V302, P1429, DOI 10.1001/jama.2009.1420; Seruga B, 2009, J CLIN ONCOL, V27, P840, DOI 10.1200/JCO.2008.19.5594; Skedgel C, 2007, BREAST CANCER RES TR, V101, P325, DOI 10.1007/s10549-006-9299-4; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Wegman P, 2005, BREAST CANCER RES, V7, pR284, DOI 10.1186/bcr993; Wegman P, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1640; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15649	10.1371/journal.pone.0015649	http://dx.doi.org/10.1371/journal.pone.0015649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187922	gold, Green Submitted, Green Published			2022-12-27	WOS:000285575200055
J	Jagannathan, V; Kaur, P; Datta, S				Jagannathan, Vijayalakshmi; Kaur, Parvinder; Datta, Santanu			Polyphosphate Kinase from M. tuberculosis: An Interconnect between the Genetic and Biochemical Role	PLOS ONE			English	Article							ESCHERICHIA-COLI; INORGANIC POLYPHOSPHATE; MYCOBACTERIUM-TUBERCULOSIS; NONREPLICATING PERSISTENCE; METABOLISM; MECHANISM; SURVIVAL; PRODUCT; ASSAY	The enzyme Polyphosphate Kinase (PPK) catalyses the reversible transfer of the terminal gamma-Pi of ATP to form a long chain Polyphosphate (PolyP). Using an IPTG inducible mycobacterial vector, the vulnerability of this gene has been evaluated by antisense knockdown experiments in M. tuberculosis. Expression profiling studies point to the fact that down regulation of PPK caused cidality during the late phase in contrast to its bacteriostatic mode immediately following antisense expression. PPK thus seems to be a suitable anti-tubercular drug target. The enzyme which is a tetramer has been cloned in E. coli and purified to homogeneity. An enzyme assay suitable for High Throughput Screening was optimized by using the statistical Taguchi protocol and the kinetic parameters determined. The enzyme displayed a strong product inhibition by ADP. In order to accurately estimate the product inhibition, progress curve analysis of the enzyme reaction was monitored. The kinetic equation describing the progress curve was suitably modified by taking into account the product inhibition. The reversible nature of the enzyme indicated a possibility of a two way ATP <-> ADP switch operating in the bacteria as a response to its growth requirement.	[Jagannathan, Vijayalakshmi; Kaur, Parvinder; Datta, Santanu] AstraZeneca India Pvt Ltd, Bangalore, Karnataka, India	AstraZeneca	Jagannathan, V (corresponding author), AstraZeneca India Pvt Ltd, Bangalore, Karnataka, India.	santanu.datta@gmail.com			AstraZeneca	AstraZeneca(AstraZeneca)	The project as detailed in the article was funded in-house by AstraZeneca. The funders played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Berlett BS, 2000, ANAL BIOCHEM, V287, P329, DOI 10.1006/abio.2000.4876; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; Cornish-Bowden A, 1999, FUNDAMENTALS ENZYME; CORPER H. J., 1933, AMER REV TUBERC, V28, P856; CROOKE E, 1994, J BIOL CHEM, V269, P6290; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GRIFFIN JB, 1965, J BIOL CHEM, V240, P4427; Hu JM, 1999, J BACTERIOL, V181, P469, DOI 10.1128/JB.181.2.469-476.1999; Jonnalagadda SB, 2000, J CHEM EDUC, V77, P506, DOI 10.1021/ed077p506; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Kulaev IS, 2000, BIOCHEMISTRY-MOSCOW+, V65, P271; LEITAO JM, 1995, MAR ECOL PROG SER, V121, P279, DOI 10.3354/meps121279; Mullan A, 2002, ANAL BIOCHEM, V308, P294, DOI 10.1016/S0003-2697(02)00249-X; Nesmeyanova MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P309; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; ROBINSON NA, 1986, J BIOL CHEM, V261, P4481; Roy R. K., 2001, DESIGN EXPT USING TA; SUREKA K, 2009, MOL MICROBIOL, DOI DOI 10.1111/J.1365-2958.06925.X; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; TINOCO, 1995, PHYS CHEM PRINCIPLES; TINSLEY CR, 1993, INFECT IMMUN, V61, P3703, DOI 10.1128/IAI.61.9.3703-3710.1993; Tzeng CM, 2000, J BIOL CHEM, V275, P3977, DOI 10.1074/jbc.275.6.3977; WALLACE, 1961, AM REV RESPIR DIS, V83, P66; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139	31	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14336	10.1371/journal.pone.0014336	http://dx.doi.org/10.1371/journal.pone.0014336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179463	gold, Green Published, Green Submitted			2022-12-27	WOS:000285340000009
J	Smolders, J; Peelen, E; Thewissen, M; Tervaert, JWC; Menheere, P; Hupperts, R; Damoiseaux, J				Smolders, Joost; Peelen, Evelyn; Thewissen, Marielle; Tervaert, Jan Willem Cohen; Menheere, Paul; Hupperts, Raymond; Damoiseaux, Jan			Safety and T Cell Modulating Effects of High Dose Vitamin D-3 Supplementation in Multiple Sclerosis	PLOS ONE			English	Article							INTERFERON-BETA; FOXP3; ENCEPHALOMYELITIS; EXPRESSION; RECEPTOR; RISK	Background: A poor vitamin D status has been associated with a high disease activity of multiple sclerosis (MS). Recently, we described associations between vitamin D status and peripheral T cell characteristics in relapsing remitting MS (RRMS) patients. In the present study, we studied the effects of high dose vitamin D-3 supplementation on safety and T cell related outcome measures. Methodology/Principal Findings: Fifteen RRMS patients were supplemented with 20 000 IU/d vitamin D-3 for 12 weeks. Vitamin D and calcium metabolism were carefully monitored, and T cell characteristics were studied by flowcytometry. All patients finished the protocol without side-effects, hypercalcaemia, or hypercalciuria. The median vitamin D status increased from 50 nmol/L (31-175) at week 0 to 380 nmol/L (151-535) at week 12 (P<0.001). During the study, 1 patient experienced an exacerbation of MS and was censored from the T cell analysis. The proportions of (naive and memory) CD4(+) Tregs remained unaffected. Although Treg suppressive function improved in several subjects, this effect was not significant in the total cohort (P=0.143). An increased proportion of IL-10(+) CD4(+) T cells was found after supplementation (P=0.021). Additionally, a decrease of the ratio between IFN-gamma(+) and IL-4(+) CD4(+) T cells was observed (P=0.035). Conclusion/Significance: Twelve week supplementation of high dose vitamin D-3 in RRMS patients was well tolerated and did not induce decompensation of calcium metabolism. The skewing towards an anti-inflammatory cytokine profile supports the evidence on vitamin D as an immune-modulator, and may be used as outcome measure for upcoming randomized placebo-controlled trials.	[Smolders, Joost; Peelen, Evelyn; Tervaert, Jan Willem Cohen; Hupperts, Raymond] Maastricht Univ, Sch Mental Hlth & Neurosci, Med Ctr, Maastricht, Netherlands; [Smolders, Joost; Peelen, Evelyn; Thewissen, Marielle; Tervaert, Jan Willem Cohen; Damoiseaux, Jan] Maastricht Univ, Dept Internal Med, Med Ctr, Div Clin & Expt Immunol, Maastricht, Netherlands; [Smolders, Joost; Peelen, Evelyn; Hupperts, Raymond] Orbis Med Ctr, Acad MS Ctr Limburg, Sittard, Netherlands; [Menheere, Paul] Maastricht Univ, Dept Clin Chem, Med Ctr, Maastricht, Netherlands; [Tervaert, Jan Willem Cohen; Damoiseaux, Jan] Maastricht Univ, Clin Immunol Lab, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University; Orbis Medical Center; Maastricht University; Maastricht University	Smolders, J (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Med Ctr, Maastricht, Netherlands.	j.smolders@mumc.nl	Peelen, Evelyn/H-9955-2012; Thewissen, Marielle/G-3545-2014; Smolders, Joost/B-7658-2009; Damoiseaux, Jan/B-8993-2009; tervaert, jan willem cohen/AAB-1111-2019	Smolders, Joost/0000-0001-9766-8661; Damoiseaux, Jan/0000-0003-4007-6985; 				ABBAS AK, NATURE, V383, P787; Andreev E, 1999, J INTERN MED, V246, P247, DOI 10.1046/j.1365-2796.1999.00515.x; Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Becklund BR, 2010, P NATL ACAD SCI USA, V107, P6418, DOI 10.1073/pnas.1001119107; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Doorenbos CRC, 2009, NAT REV NEPHROL, V5, P691, DOI 10.1038/nrneph.2009.185; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Haas J, 2009, J NEUROIMMUNOL, V216, P113, DOI 10.1016/j.jneuroim.2009.06.011; Hayes CE, 1997, P SOC EXP BIOL MED, V216, P21, DOI 10.3181/00379727-216-44153A; Kimball SM, 2007, AM J CLIN NUTR, V86, P645, DOI 10.1093/ajcn/86.3.645; Korporal M, 2008, ARCH NEUROL-CHICAGO, V65, P1434, DOI 10.1001/archneur.65.11.1434; Kurtzke JF, 1983, NEUROLOGY, V33, P14; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Maalouf J, 2008, J CLIN ENDOCR METAB, V93, P2693, DOI 10.1210/jc.2007-2530; Mahon BD, 2003, J NEUROIMMUNOL, V134, P128, DOI 10.1016/S0165-5728(02)00396-X; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; PSTON A, 2008, LANCET, V372, P1502; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; Smolders J, 2010, J STEROID BIOCHEM, V121, P243, DOI 10.1016/j.jsbmb.2010.03.001; Smolders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006635; Soilu-Hanninen M, 2005, MULT SCLER J, V11, P266, DOI 10.1191/1352458505ms1157oa; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; van Etten E, 2007, J STEROID BIOCHEM, V103, P546, DOI 10.1016/j.jsbmb.2006.12.094; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	34	138	138	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15235	10.1371/journal.pone.0015235	http://dx.doi.org/10.1371/journal.pone.0015235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179201	Green Submitted, gold, Green Published			2022-12-27	WOS:000285246900034
J	Kau, JH; Sun, DS; Huang, HS; Lien, TS; Huang, HH; Lin, HC; Chang, HH				Kau, Jyh-Hwa; Sun, Der-Shan; Huang, Hsuan-Shun; Lien, Te-Sheng; Huang, Hsin-Hsien; Lin, Hung-Chi; Chang, Hsin-Hou			Sublethal Doses of Anthrax Lethal Toxin on the Suppression of Macrophage Phagocytosis	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; MAP-KINASE-KINASE; BACILLUS-ANTHRACIS; MAMMALIAN-CELLS; ESCHERICHIA-COLI; PROTEIN; PHOSPHORYLATION; BACTERIA; APOPTOSIS; ADHESION	Background: Lethal toxin (LT), the major virulence factor produced by Bacillus anthracis, has been shown to suppress the immune system, which is beneficial to the establishment of B. anthracis infections. It has been suggested that the suppression of MEK/MAPK signaling pathways of leukocytes contributes to LT-mediated immunosuppressive effects. However, the involvement of MAPK independent pathways has not been clearly elucidated; nor has the crucial role played by LT in the early stages of infection. Determining whether LT exerts any pathological effects before being enriched to an MEK inhibitory level is an important next step in the furtherance of this field. Methodology/Principal Findings: Using a cell culture model, we determined that low doses of LT inhibited phagocytosis of macrophages, without influencing MAPK pathways. Consistent low doses of LT significantly suppressed bacterial clearance and enhanced the mortality of mice with bacteremia, without suppressing the MEK1 of splenic and peripheral blood mononuclear cells. Conclusion/Significance: These results suggest that LT suppresses the phagocytes in a dose range lower than that required to suppress MEK1 in the early stages of infection.	[Kau, Jyh-Hwa; Huang, Hsin-Hsien; Lin, Hung-Chi] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Sun, Der-Shan; Huang, Hsuan-Shun; Lien, Te-Sheng; Chang, Hsin-Hou] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan	National Defense Medical Center; Tzu Chi University	Kau, JH (corresponding author), Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan.	hhchang@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council of Taiwan ROC [95-2311-B-320-006, 96-2311-B-320-005-MY3, 99-2311-B-320-003-MY3]	National Science Council of Taiwan ROC(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan ROC under grant no. 95-2311-B-320-006, 96-2311-B-320-005-MY3 and 99-2311-B-320-003-MY3. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Buck M, 2007, AM J PHYSIOL-CELL PH, V293, pC1788, DOI 10.1152/ajpcell.00141.2007; Chang HH, 2003, CELL BIOL INT, V27, P123, DOI 10.1016/S1065-6995(02)00295-0; Chang HH, 2002, J INFECT DIS, V186, P743, DOI 10.1086/342600; Chang HH, 2000, J BIOMED SCI, V7, P42, DOI 10.1159/000025428; Chang HH, 2000, J BIOTECHNOL, V78, P115, DOI 10.1016/S0168-1656(99)00227-8; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Coombes BK, 2004, CURR BIOL, V14, pR856, DOI 10.1016/j.cub.2004.09.043; Crawford MA, 2006, J IMMUNOL, V176, P7557, DOI 10.4049/jimmunol.176.12.7557; Cui XZ, 2006, J INFECT DIS, V193, P829, DOI 10.1086/500468; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; During RL, 2005, J INFECT DIS, V192, P837, DOI 10.1086/432516; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Fukao T, 2004, LANCET INFECT DIS, V4, P166, DOI 10.1016/S1473-3099(04)00940-5; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Ha SD, 2007, J BIOL CHEM, V282, P26275, DOI 10.1074/jbc.M703668200; HUANG HS, 2010, BLOOD IN PRESS; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; Kau JH, 2005, J INFECT DIS, V192, P1465, DOI 10.1086/491477; Kau JH, 2002, CURR MICROBIOL, V44, P106, DOI 10.1007/s00284-001-0059-8; Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167; LIAO GJ, 1994, BLOOD, V83, P2294; Mabry R, 2006, CLIN VACCINE IMMUNOL, V13, P671, DOI 10.1128/CVI.00023-06; MANDELL GL, 1973, J CLIN INVEST, V52, P1673, DOI 10.1172/JCI107348; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; ORTEGABARRIA E, 1991, CELL, V67, P411, DOI 10.1016/0092-8674(91)90192-2; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; PEZARD C, 1993, J GEN MICROBIOL, V139, P2459, DOI 10.1099/00221287-139-10-2459; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Scherle PA, 1998, J IMMUNOL, V161, P5681; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tournier JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/j.mam.2009.06.002; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; VAUDAUX P, 1979, ANTIMICROB AGENTS CH, V16, P743, DOI 10.1128/AAC.16.6.743; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05; Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394	51	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14289	10.1371/journal.pone.0014289	http://dx.doi.org/10.1371/journal.pone.0014289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170330	Green Published, Green Submitted, gold			2022-12-27	WOS:000285181400012
J	Fowler, CB; Chesnick, IE; Moore, CD; O'Leary, TJ; Mason, JT				Fowler, Carol B.; Chesnick, Ingrid E.; Moore, Cedric D.; O'Leary, Timothy J.; Mason, Jeffrey T.			Elevated Pressure Improves the Extraction and Identification of Proteins Recovered from Formalin-Fixed, Paraffin-Embedded Tissue Surrogates	PLOS ONE			English	Article							FORMALDEHYDE-INDUCED MODIFICATIONS; NONMETASTATIC LUNG ADENOCARCINOMA; EGG-WHITE LYSOZYME; ANTIGEN RETRIEVAL; PROTEOMIC ANALYSIS; HYDROSTATIC-PRESSURE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; SERUM-ALBUMIN; X-RAY	Background: Proteomic studies of formalin-fixed paraffin-embedded (FFPE) tissues are frustrated by the inability to extract proteins from archival tissue in a form suitable for analysis by 2-D gel electrophoresis or mass spectrometry. This inability arises from the difficulty of reversing formaldehyde-induced protein adducts and cross-links within FFPE tissues. We previously reported the use of elevated hydrostatic pressure as a method for efficient protein recovery from a hen egg-white lysozyme tissue surrogate, a model system developed to study formalin fixation and histochemical processing. Principal Findings: In this study, we demonstrate the utility of elevated hydrostatic pressure as a method for efficient protein recovery from FFPE mouse liver tissue and a complex multi-protein FFPE tissue surrogate comprised of hen egg-white lysozyme, bovine carbonic anhydrase, bovine ribonuclease A, bovine serum albumin, and equine myoglobin (55:15:15:10:5 wt%). Mass spectrometry of the FFPE tissue surrogates retrieved under elevated pressure showed that both the low and high-abundance proteins were identified with sequence coverage comparable to that of the surrogate mixture prior to formaldehyde treatment. In contrast, non-pressure-extracted tissue surrogate samples yielded few positive and many false peptide identifications. Studies with soluble formalin-treated bovine ribonuclease A demonstrated that pressure modestly inhibited the rate of reversal (hydrolysis) of formaldehyde-induced protein cross-links. Dynamic light scattering studies suggest that elevated hydrostatic pressure and heat facilitate the recovery of proteins free of formaldehyde adducts and cross-links by promoting protein unfolding and hydration with a concomitant reduction in the average size of the protein aggregates. Conclusions: These studies demonstrate that elevated hydrostatic pressure treatment is a promising approach for improving the recovery of proteins from FFPE tissues in a form suitable for proteomic analysis.	[Fowler, Carol B.; Chesnick, Ingrid E.; Moore, Cedric D.; Mason, Jeffrey T.] Armed Forces Inst Pathol, Dept Biophys, Rockville, MD USA; [Fowler, Carol B.; O'Leary, Timothy J.] Vet Hlth Adm, Biomed Lab Res & Dev Serv, Washington, DC USA	United States Department of Defense; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Fowler, CB (corresponding author), Armed Forces Inst Pathol, Dept Biophys, Rockville, MD USA.	carol.fowler1@us.army.mil	Oleary, Timothy/AAF-2829-2021; Oleary, Timothy/AAE-5219-2021	O'LEARY, TIMOTHY/0000-0002-2435-9136	National Cancer Institute, National Institutes of Health [1R21 CA134359]; NATIONAL CANCER INSTITUTE [R21CA134359] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under grants 1R21 CA134359. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; AZIMZADEH O, 2010, J PROTEOME RES; Balgley BM, 2009, J PROTEOME RES, V8, P917, DOI 10.1021/pr800503u; BERTHOU J, 1983, PROC R SOC SER B-BIO, V217, P471, DOI 10.1098/rspb.1983.0021; Bratthauer GL, 2010, METHODS MOL BIOL, V588, P93, DOI 10.1007/978-1-59745-324-0_13; Buxbaum JL, 2010, J PANCREAS, V11, P536; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Caudle WM, 2010, EXPERT REV NEUROTHER, V10, P925, DOI [10.1586/ern.10.54, 10.1586/ERN.10.54]; Fleron M, 2010, J PROTEOMICS, V73, P1986, DOI 10.1016/j.jprot.2010.06.003; Fowler CB, 2008, LAB INVEST, V88, p365A; Fowler CB, 2008, LAB INVEST, V88, P785, DOI 10.1038/labinvest.2008.43; Fowler CB, 2007, LAB INVEST, V87, P836, DOI 10.1038/labinvest.3700596; Frye KJ, 1998, PROTEIN SCI, V7, P2217, DOI 10.1002/pro.5560071020; Guo T, 2007, J HISTOCHEM CYTOCHEM, V55, P763, DOI 10.1369/jhc.7A7177.2007; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Jou YJ, 2010, ANAL CHIM ACTA, V681, P41, DOI 10.1016/j.aca.2010.09.030; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kerschgens J, 2009, TRENDS MOL MED, V15, P352, DOI 10.1016/j.molmed.2009.06.004; Kobashigawa Y, 1999, PROTEIN SCI, V8, P2765; LILJAS A, 1972, NATURE-NEW BIOL, V235, P131, DOI 10.1038/newbio235131a0; Machida K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013470; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Metz B, 2006, BIOCONJUGATE CHEM, V17, P815, DOI 10.1021/bc050340f; Moreno FJ, 2003, J AGR FOOD CHEM, V51, P394, DOI 10.1021/jf025731s; Nishimura T, 2010, J PROTEOMICS, V73, P1100, DOI 10.1016/j.jprot.2009.11.010; Ostasiewicz P, 2010, J PROTEOME RES, V9, P3688, DOI 10.1021/pr100234w; Patel V, 2008, CLIN CANCER RES, V14, P1002, DOI 10.1158/1078-0432.CCR-07-1497; POOLE S, 1984, J SCI FOOD AGR, V35, P701, DOI 10.1002/jsfa.2740350618; PRIETO DA, 2005, BIOTECHNIQUES S, V0038, P00032, DOI DOI 10.2144/05386SU06; Rait VK, 2004, LAB INVEST, V84, P300, DOI 10.1038/labinvest.3700041; Rait VK, 2004, LAB INVEST, V84, P292, DOI 10.1038/labinvest.3700045; Refaee M, 2003, J MOL BIOL, V327, P857, DOI 10.1016/S0022-2836(03)00209-2; Reymond MA, 2007, ADV CLIN CHEM, V44, P103, DOI 10.1016/S0065-2423(07)44004-5; Shi SR, 2006, J HISTOCHEM CYTOCHEM, V54, P739, DOI 10.1369/jhc.5B6851.2006; Sompuram SR, 2004, AM J CLIN PATHOL, V121, P190, DOI 10.1309/BRN7CTX1E84NWWPL; St John RJ, 1999, P NATL ACAD SCI USA, V96, P13029, DOI 10.1073/pnas.96.23.13029; Strader MB, 2006, ANAL CHEM, V78, P125, DOI 10.1021/ac051348l; Valera VA, 2010, J CANCER, V1, P184; Velic A, 2010, SEMIN NEPHROL, V30, P487, DOI 10.1016/j.semnephrol.2010.07.006; Voshol H, 2009, FEBS J, V276, P6871, DOI 10.1111/j.1742-4658.2009.07395.x; WLODAWER A, 1982, J BIOL CHEM, V257, P1325; Xu H, 2008, J PROTEOME RES, V7, P1098, DOI 10.1021/pr7006768	43	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14253	10.1371/journal.pone.0014253	http://dx.doi.org/10.1371/journal.pone.0014253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170380	Green Published, gold, Green Submitted			2022-12-27	WOS:000285084100007
J	Howe, LD; Tilling, K; Benfield, L; Logue, J; Sattar, N; Ness, AR; Smith, GD; Lawlor, DA				Howe, Laura D.; Tilling, Kate; Benfield, Li; Logue, Jennifer; Sattar, Naveed; Ness, Andy R.; Smith, George Davey; Lawlor, Debbie A.			Changes in Ponderal Index and Body Mass Index across Childhood and Their Associations with Fat Mass and Cardiovascular Risk Factors at Age 15	PLOS ONE			English	Article							INFANCY WEIGHT-GAIN; OVERWEIGHT; ADOLESCENTS; CHILDREN; OBESITY; PREVALENCE; BMI	Background: Little is known about whether associations between childhood adiposity and later adverse cardiovascular health outcomes are driven by tracking of overweight from childhood to adulthood and/or by vascular and metabolic changes from childhood overweight that persist into adulthood. Our objective is to characterise associations between trajectories of adiposity across childhood and a wide range of cardiovascular risk factors measured in adolescence, and explore the extent to which these are mediated by fat mass at age 15. Methods and Findings: Using data from the Avon Longitudinal Study of Parents and Children, we estimated individual trajectories of ponderal index (PI) from 0-2 years and BMI from 2-10 years using random-effects linear spline models (N = 4601). We explored associations between PI/BMI trajectories and DXA-determined total-body fat-mass and cardiovascular risk factors at 15 years (systolic and diastolic blood pressure, fasting LDL-and HDL-cholesterol, triglycerides, C-reactive protein, glucose, insulin) with and without adjustment for confounders. Changes in PI/BMI during all periods of infancy and childhood were associated with greater DXA-determined fat-mass at age 15. BMI changes in childhood, but not PI changes from 0-2 years, were associated with most cardiovascular risk factors in adolescence; associations tended to be strongest for BMI changes in later childhood (ages 8.5-10), and were largely mediated by fat mass at age 15. Conclusion: Changes in PI/BMI from 0-10 years were associated with greater fat-mass at age 15. Greater increases in BMI from age 8.5-10 years are most strongly associated with cardiovascular risk factors at age 15, with much of these associations mediated by fat-mass at this age. We found little evidence supporting previous reports that rapid PI changes in infancy are associated with future cardiovascular risk. This study suggests that associations between early overweight and subsequent adverse cardiovascular health are largely due to overweight children tending to remain overweight.	[Howe, Laura D.; Benfield, Li; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Howe, Laura D.; Tilling, Kate; Benfield, Li; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Logue, Jennifer; Sattar, Naveed] Univ Glasgow, Fac Med, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Ness, Andy R.] Univ Bristol, Dept Oral & Dent Sci, Bristol, Avon, England	University of Bristol; University of Bristol; University of Glasgow; University of Bristol	Howe, LD (corresponding author), Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	laura.howe@bristol.ac.uk	Tilling, Kate/AAY-1578-2021; Davey Smith, George/A-7407-2013; Ness, Andy R/M-7612-2013; Logue, Jennifer/O-5076-2019; Berryman, Katie/J-4236-2014	Davey Smith, George/0000-0002-1407-8314; Ness, Andy R/0000-0003-3548-9523; Logue, Jennifer/0000-0001-9549-2738; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Lawlor, Debbie A/0000-0002-6793-2262; Howe, Laura/0000-0003-3357-2796; Tilling, Kate/0000-0002-1010-8926	National Institutes of Health (NIH) [R01 DK077659]; UK Economic and Social Research Council [RES-060-23-0011]; UK Medical Research Council (MRC); Wellcome Trust; University of Bristol; UK MRC [G0600705]; ESRC [ES/E00234X/1] Funding Source: UKRI; MRC [G0600705] Funding Source: UKRI; Economic and Social Research Council [ES/E00234X/1] Funding Source: researchfish; Medical Research Council [G9815508, G0600705] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077659] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by grants from the National Institutes of Health (NIH) (R01 DK077659) and the UK Economic and Social Research Council (RES-060-23-0011). The latter provides the salary for LH. The UK Medical Research Council (MRC), the Wellcome Trust and the University of Bristol provide core funding support for ALSPAC. The UK MRC (G0600705) and the University of Bristol provide core funding for the MRC Centre of Causal Analyses in Translational Epidemiology. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cole T J, 2004, BMC Pediatr, V4, P6; Dubois L, 2007, INT J EPIDEMIOL, V36, P132, DOI 10.1093/ije/dyl281; FALASCHETTI E, 2010, EUROPEAN HE IN PRESS; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Gardner DSL, 2009, PEDIATRICS, V123, pE67, DOI 10.1542/peds.2008-1292; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Howe LD, 2009, ARCH DIS CHILD, V94, P950, DOI 10.1136/adc.2009.162552; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Ong KK, 2009, J CLIN ENDOCR METAB, V94, P1527, DOI 10.1210/jc.2008-2489; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Owen CG, 2009, INT J OBESITY, V33, P866, DOI 10.1038/ijo.2009.102; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Skinner AC, 2009, PEDIATRICS, V124, pE905, DOI 10.1542/peds.2009-0179; *STATACORP, 2010, STAT 11 0 VERS; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747	21	68	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15186	10.1371/journal.pone.0015186	http://dx.doi.org/10.1371/journal.pone.0015186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170348	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000285084100026
J	Ritsema, T; van Zanten, M; Leon-Reyes, A; Voesenek, LACJ; Millenaar, FF; Pieterse, CMJ; Peeters, AJM				Ritsema, Tita; van Zanten, Martijn; Leon-Reyes, Antonio; Voesenek, Laurentius A. C. J.; Millenaar, Frank F.; Pieterse, Corne M. J.; Peeters, Anton J. M.			Kinome Profiling Reveals an Interaction Between Jasmonate, Salicylate and Light Control of Hyponastic Petiole Growth in Arabidopsis thaliana	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PHYTOCHROME-A; PROTEIN-KINASES; TRANSCRIPTION FACTOR; METHYL JASMONATE; CELL-CYCLE; SIGNAL-TRANSDUCTION; NATURAL VARIATION; RESPONSIVE GENES; PLANT-RESISTANCE	Plants defend themselves against infection by biotic attackers by producing distinct phytohormones. Especially jasmonic acid (JA) and salicylic acid (SA) are well known defense-inducing hormones. Here, the effects of MeJA and SA on the Arabidopsis thaliana kinome were monitored using PepChip arrays containing kinase substrate peptides to analyze posttranslational interactions in MeJA and SA signaling pathways and to test if kinome profiling can provide leads to predict posttranslational events in plant signaling. MeJA and SA mediate differential phosphorylation of substrates for many kinase families. Also some plant specific substrates were differentially phosphorylated, including peptides derived from Phytochrome A, and Photosystem II D protein. This indicates that MeJA and SA mediate cross-talk between defense signaling and light responses. We tested the predicted effects of MeJA and SA using light-mediated upward leaf movement (differential petiole growth also called hyponastic growth). We found that MeJA, infestation by the JA-inducing insect herbivore Pieris rapae, and SA suppressed low light-induced hyponastic growth. MeJA and SA acted in a synergistic fashion via two (partially) divergent signaling routes. This work demonstrates that kinome profiling using PepChip arrays can be a valuable complementary, similar to omics tool to give directions towards predicting behavior of organisms after a given stimulus and can be used to obtain leads for physiological relevant phenomena in planta.	[Ritsema, Tita; van Zanten, Martijn; Leon-Reyes, Antonio; Voesenek, Laurentius A. C. J.; Millenaar, Frank F.; Pieterse, Corne M. J.; Peeters, Anton J. M.] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands; [Voesenek, Laurentius A. C. J.; Pieterse, Corne M. J.] Ctr BioSyst Genom, Wageningen, Netherlands	Utrecht University; Centre for BioSystems Genomics	Ritsema, T (corresponding author), Amsterdam Mol Therapeut, Amsterdam, Netherlands.		Pieterse, Corné/A-9326-2011; Peeters, Anton J.M./B-9610-2011; Voesenek, Laurentius A.C.J./B-9661-2011; van Zanten, Martijn/G-1969-2010	Pieterse, Corné/0000-0002-5473-4646; van Zanten, Martijn/0000-0002-2810-7374; Leon-Reyes, Antonio/0000-0001-9142-9694; Voesenek, Laurentius/0000-0002-3361-3837	TI Pharma [T3-103]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Dutch Organization for Scientific Research [865.04.002]	TI Pharma; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was financially supported by TI Pharma (http://www.tipharma.com) grant: T3-103 (TR) and VICI grant 865.04.002 from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (http://www.nwo.nl), which is the Dutch Organization for Scientific Research (CMJP and TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Allada R, 2005, MOL CELL BIOCHEM, V274, P141, DOI 10.1007/s11010-005-2943-1; Alvarez R, 2003, PLANT PHYSIOL, V132, P1097, DOI 10.1104/pp.103.023937; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Azad AK, 2004, PLANT CELL PHYSIOL, V45, P608, DOI 10.1093/pcp/pch069; Ballare CL, 2009, PLANT CELL ENVIRON, V32, P713, DOI 10.1111/j.1365-3040.2009.01958.x; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Benschop JJ, 2007, PLANT PHYSIOL, V143, P1013, DOI 10.1104/pp.106.092700; Booij-James IS, 2002, PLANT PHYSIOL, V130, P2069, DOI 10.1104/pp.013441; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chen IC, 2007, PLANT PHYSIOL, V143, P1189, DOI 10.1104/pp.106.094185; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Cox MCH, 2004, PLANT PHYSIOL, V136, P2948, DOI 10.1104/pp.104.049197; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Diks SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000777; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Eisenbarth DA, 2005, J EXP BOT, V56, P1831, DOI 10.1093/jxb/eri173; Faigon-Soverna A, 2006, PLANT CELL, V18, P2919, DOI 10.1105/tpc.105.038810; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Feilner Tanja, 2007, V355, P379; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Forsberg J, 2001, PHOTOSYNTH RES, V68, P71, DOI 10.1023/A:1011891017067; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Franklin KA, 2007, PLANT J, V50, P108, DOI 10.1111/j.1365-313X.2007.03036.x; Genoud T, 2002, PLANT J, V31, P87, DOI 10.1046/j.1365-313X.2002.01338.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Griebel T, 2008, PLANT PHYSIOL, V147, P790, DOI 10.1104/pp.108.119503; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Homma MK, 2005, MOL CELL BIOCHEM, V274, P47, DOI 10.1007/s11010-005-3111-3; Izaguirre MM, 2006, P NATL ACAD SCI USA, V103, P7170, DOI 10.1073/pnas.0509805103; Jensen AB, 1998, PLANT J, V13, P691, DOI 10.1046/j.1365-313X.1998.00069.x; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kok K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005145; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Kramer A, 2004, PHYTOCHEMISTRY, V65, P1777, DOI 10.1016/j.phytochem.2004.04.009; Kurashige NS, 2005, AM J BOT, V92, P21, DOI 10.3732/ajb.92.1.21; Lam WKF, 2001, J ECON ENTOMOL, V94, P1459, DOI 10.1603/0022-0493-94.6.1459; Leon-Reyes A, 2010, MOL PLANT MICROBE IN, V23, P187, DOI 10.1094/MPMI-23-2-0187; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; McGuire R, 2005, FUNCT ECOL, V19, P1025, DOI 10.1111/j.1365-2435.2005.01047.x; MCMICHAEL RW, 1990, BIOCHEMISTRY-US, V29, P3872, DOI 10.1021/bi00468a011; Millenaar FF, 2005, PLANT PHYSIOL, V137, P998, DOI 10.1104/pp.104.053967; Millenaar FF, 2009, NEW PHYTOL, V184, P141, DOI 10.1111/j.1469-8137.2009.02921.x; Moreno JE, 2009, P NATL ACAD SCI USA, V106, P4935, DOI 10.1073/pnas.0900701106; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269, DOI 10.1104/pp.102.1.269; Niki T, 1998, PLANT CELL PHYSIOL, V39, P500, DOI 10.1093/oxfordjournals.pcp.a029397; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pozo MJ, 2008, NEW PHYTOL, V180, P511, DOI 10.1111/j.1469-8137.2008.02578.x; Riemann M, 2009, PLANTA, V229, P1035, DOI 10.1007/s00425-009-0891-9; Ritsema T, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-3; Ritsema T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006605; Robson F, 2010, PLANT CELL, V22, P1143, DOI 10.1105/tpc.109.067728; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Sharrock RA, 2002, PLANT PHYSIOL, V130, P442, DOI 10.1104/pp.005389; Shimotohno A, 2006, PLANT J, V47, P701, DOI 10.1111/j.1365-313X.2006.02820.x; Smith H, 1997, PLANT PHYSIOL, V114, P637, DOI 10.1104/pp.114.2.637; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Stulemeijer IJE, 2007, PLANT PHYSIOL, V144, P1481, DOI 10.1104/pp.107.101063; Swiatek A, 2004, FEBS LETT, V572, P118, DOI 10.1016/j.febslet.2004.07.018; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thum KE, 2001, PLANT CELL, V13, P2747, DOI 10.1105/tpc.13.12.2747; Trupkin SA, 2007, PLANT MOL BIOL, V63, P669, DOI 10.1007/s11103-006-9115-x; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; van Zanten M, 2010, CRIT REV PLANT SCI, V29, P300, DOI 10.1080/07352689.2010.502086; Winz RA, 2001, PLANT PHYSIOL, V125, P2189, DOI 10.1104/pp.125.4.2189; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Zhai QZ, 2007, PLANT CELL PHYSIOL, V48, P1061, DOI 10.1093/pcp/pcm076	82	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14255	10.1371/journal.pone.0014255	http://dx.doi.org/10.1371/journal.pone.0014255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170386	Green Submitted, Green Published, gold			2022-12-27	WOS:000285084100009
J	Campana, MG; Whitten, CM; Edwards, CJ; Stock, F; Murphy, AM; Binns, MM; Barker, GWW; Bower, MA				Campana, Michael G.; Whitten, C. Mark; Edwards, Ceiridwen J.; Stock, Frauke; Murphy, Angela M.; Binns, Matthew M.; Barker, Graeme W. W.; Bower, Mim A.			Accurate Determination of Phenotypic Information from Historic Thoroughbred Horses by Single Base Extension	PLOS ONE			English	Article							ANCIENT-DNA; COAT COLOR; GENE; RELIABILITY; MUTATION; SAMPLES; HAIR; MC1R	Historic DNA data have the potential to identify phenotypic information otherwise invisible in the historical, archaeological and palaeontological record. In order to determine whether a single nucleotide polymorphism typing protocol based on single based extension (SNaPshot (TM)) could produce reliable phenotypic data from historic samples, we genotyped three coat colour markers for a sample of historic Thoroughbred horses for which both phenotypic and correct genotypic information were known from pedigree information in the General Stud Book. Experimental results were consistent with the pedigrees in all cases. Thus we demonstrate that historic DNA techniques can produce reliable phenotypic information from museum specimens.	[Campana, Michael G.] Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England; [Whitten, C. Mark; Murphy, Angela M.; Binns, Matthew M.] Univ London Royal Vet Coll, London, England; [Edwards, Ceiridwen J.; Stock, Frauke] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Barker, Graeme W. W.; Bower, Mim A.] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3DZ, England	University of Cambridge; University of London; University of London Royal Veterinary College; Trinity College Dublin; University of Cambridge	Campana, MG (corresponding author), Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England.	mgc32@cam.ac.uk	Edwards, Ceiridwen/F-8855-2010	Edwards, Ceiridwen/0000-0001-9126-1377; Campana, Michael/0000-0003-0461-6462	Horserace Betting Levy Board [VET/PRJ/722]; D M McDonald Grants Awards Fund; Leverhulme Trust [F/09 757/B]; University of Cambridge	Horserace Betting Levy Board; D M McDonald Grants Awards Fund; Leverhulme Trust(Leverhulme Trust); University of Cambridge(University of Cambridge)	This work was supported by the Horserace Betting Levy Board (grant VET/PRJ/722, http://www.hblb.org.uk/), the D M McDonald Grants & Awards Fund 2008 (www.mcdonald.cam.ac.uk) and the Leverhulme Trust (grant F/09 757/B, http://www.leverhulme.org.uk/). The Overseas Research Studentship, the Cambridge Overseas, and Peterhouse, University of Cambridge supported M. G. C. (www.cam.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouakaze C, 2007, INT J LEGAL MED, V121, P493, DOI 10.1007/s00414-007-0177-3; Bower MA, 2005, NUCLEIC ACIDS RES, V33, P2549, DOI 10.1093/nar/gki550; BOWER MA, TRUTH BONES SC UNPUB; Cooper A, 2000, SCIENCE, V289, P1139; Edwards CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009255; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Goossens B, 1998, MOL ECOL, V7, P1237, DOI 10.1046/j.1365-294x.1998.00407.x; Kalmar T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e67; Li H, 2007, HUM GENET, V122, P383, DOI 10.1007/s00439-007-0407-2; Mariat D, 2003, GENET SEL EVOL, V35, P119, DOI 10.1051/gse:2002039; Marklund L, 1996, MAMM GENOME, V7, P895, DOI 10.1007/s003359900264; Miller CR, 2002, GENETICS, V160, P357; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; Rieder S, 2009, J ANIM BREED GENET, V126, P415, DOI 10.1111/j.1439-0388.2009.00832.x; Royo LJ, 2008, J ANIM SCI, V86, P1291, DOI 10.2527/jas.2007-0498; Sanchez JJ, 2006, NAT PROTOC, V1, P1370, DOI 10.1038/nprot.2006.247; Spencer M, 2004, AM J HUM GENET, V75, P240, DOI 10.1086/422826; Svensson EM, 2007, ANIM GENET, V38, P378, DOI 10.1111/j.1365-2052.2007.01620.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189	23	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15172	10.1371/journal.pone.0015172	http://dx.doi.org/10.1371/journal.pone.0015172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152043	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000284868000029
J	Joo, Y; Ha, S; Hong, BH; Kim, JA; Chang, KA; Liew, H; Kim, S; Sun, W; Kim, JH; Chong, YH; Suh, YH; Kim, HS				Joo, Yuyoung; Ha, Sungji; Hong, Bo-Hyun; Kim, Jeong A.; Chang, Keun-A; Liew, Hyunjeong; Kim, Seonghan; Sun, Woong; Kim, Joung-Hun; Chong, Young Hae; Suh, Yoo-Hun; Kim, Hye-Sun			Amyloid Precursor Protein Binding Protein-1 Modulates Cell Cycle Progression in Fetal Neural Stem Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEDD8 CONJUGATION; TERMINAL REGION; APP-BP1; APOPTOSIS; UBIQUITIN; NEURONS; PHOSPHORYLATION; SYSTEM; FAMILY	Amyloid precursor protein binding protein-1 (APP-BP1) binds to the carboxyl terminus of the amyloid precursor protein (APP) and serves as the bipartite activation enzyme for the ubiquitin-like protein, NEDD8. In the present study, we explored the physiological role of APP-BP1 in the cell cycle progression of fetal neural stem cells. Our results show that cell cycle progression of the cells is arrested at the G1 phase by depletion of APP-BP1, which results in a marked decrease in the proliferation of the cells. This action of APP-BP1 is antagonistically regulated by the interaction with APP. Consistent with the evidence that APP-BP1 function is critical for cell cycle progression, the amount of APP-BP1 varies depending upon cell cycle phase, with culminating expression at S-phase. Furthermore, our FRET experiment revealed that phosphorylation of APP at threonine 668, known to occur during the G2/M phase, is required for the interaction between APP and APP-BP1. We also found a moderate ubiquitous level of APP-BP1 mRNA in developing embryonic and early postnatal brains; however, APP-BP1 expression is reduced by P12, and only low levels of APP-BP1 were found in the adult brain. In the cerebral cortex of E16 rats, substantial expression of both APP-BP1 and APP mRNAs was observed in the ventricular zone. Collectively, these results indicate that APP-BP1 plays an important role in the cell cycle progression of fetal neural stem cells, through the interaction with APP, which is fostered by phopshorylation of threonine 668.	[Joo, Yuyoung; Ha, Sungji; Hong, Bo-Hyun; Kim, Jeong A.; Chang, Keun-A; Liew, Hyunjeong; Kim, Seonghan; Suh, Yoo-Hun; Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Sun, Woong] Korea Univ, Sch Med, Dept Anat, Seoul, South Korea; [Kim, Joung-Hun] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Chong, Young Hae] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Bundang Hosp, Songnam, South Korea	Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Pohang University of Science & Technology (POSTECH); Ewha Womans University; Seoul National University (SNU)	Joo, Y (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea.	hyisun@snu.ac.kr	Suh, Yoo-Hun/J-2761-2012; Kim, Hye Sun/J-2752-2012	Liew, Hyunjeong/0000-0002-3910-374X; sun, woong/0000-0003-1792-4894	Brain Research Center; National Research Foundation of Korea [2008-314-E00179]; Ministry of Education, Science and Technology, Republic of Korea [ROI-2008-000-20275-0]	Brain Research Center; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Brain Research Center of the Twenty-First Century Frontier Research Program Grant and National Research Foundation of Korea Grants 2008-314-E00179 awarded to J-H. Kim and ROI-2008-000-20275-0 awarded to H-S Kim by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassermann F, 2010, CELL DEATH DIFFER, V17, P78, DOI 10.1038/cdd.2009.104; Bruni P, 2002, J BIOL CHEM, V277, P35481, DOI 10.1074/jbc.M205227200; Cardozo T, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S9; Chen YZ, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-3; Chen YZ, 2003, J CELL BIOL, V163, P27, DOI 10.1083/jcb.200304003; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; Chen YZ, 2003, J NEUROCHEM, V85, P801, DOI 10.1046/j.1471-4159.2003.01727.x; Chow NW, 1996, J BIOL CHEM, V271, P11339, DOI 10.1074/jbc.271.19.11339; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Kim HJ, 2007, CELL DEATH DIFFER, V14, P103, DOI 10.1038/sj.cdd.4401935; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kitahara R, 2006, J MOL BIOL, V363, P395, DOI 10.1016/j.jmb.2006.07.074; Marin I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-267; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Ohki Y, 2009, BIOCHEM BIOPH RES CO, V381, P443, DOI 10.1016/j.bbrc.2009.02.090; OHTA M, 1993, DEV BRAIN RES, V75, P151, DOI 10.1016/0165-3806(93)90019-7; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Sakuma M, 2009, J NEUROCHEM, V109, P465, DOI 10.1111/j.1471-4159.2009.05988.x; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Tang BL, 2007, J NEUROCHEM, V100, P314, DOI 10.1111/j.1471-4159.2006.04215.x; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456	30	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14203	10.1371/journal.pone.0014203	http://dx.doi.org/10.1371/journal.pone.0014203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151996	Green Submitted, Green Published, gold			2022-12-27	WOS:000284868000017
J	Pannekoek, Y; Dickx, V; Beeckman, DSA; Jolley, KA; Keijzers, WC; Vretou, E; Maiden, MCJ; Vanrompay, D; van der Ende, A				Pannekoek, Yvonne; Dickx, Veerle; Beeckman, Delphine S. A.; Jolley, Keith A.; Keijzers, Wendy C.; Vretou, Evangelia; Maiden, Martin C. J.; Vanrompay, Daisy; van der Ende, Arie			Multi Locus Sequence Typing of Chlamydia Reveals an Association between Chlamydia psittaci Genotypes and Host Species	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CHLAMYDOPHILA-PSITTACI; PET BIRDS; INFECTION; STRAINS; TRANSMISSION; ABORTION; PNEUMONIAE; FAMILY; IDENTIFICATION	Chlamydia comprises a group of obligate intracellular bacterial parasites responsible for a variety of diseases in humans and animals, including several zoonoses. Chlamydia trachomatis causes diseases such as trachoma, urogenital infection and lymphogranuloma venereum with severe morbidity. Chlamydia pneumoniae is a common cause of community-acquired respiratory tract infections. Chlamydia psittaci, causing zoonotic pneumonia in humans, is usually hosted by birds, while Chlamydia abortus, causing abortion and fetal death in mammals, including humans, is mainly hosted by goats and sheep. We used multi-locus sequence typing to asses the population structure of Chlamydia. In total, 132 Chlamydia isolates were analyzed, including 60 C. trachomatis, 18 C. pneumoniae, 16 C. abortus, 34 C. psittaci and one of each of C. pecorum, C. caviae, C. muridarum and C. felis. Cluster analyses utilizing the Neighbour-Joining algorithm with the maximum composite likelihood model of concatenated sequences of 7 housekeeping fragments showed that C. psittaci 84/2334 isolated from a parrot grouped together with the C. abortus isolates from goats and sheep. Cluster analyses of the individual alleles showed that in all instances C. psittaci 84/2334 formed one group with C. abortus. Moving 84/2334 from the C. psittaci group to the C. abortus group resulted in a significant increase in the number of fixed differences and elimination of the number of shared mutations between C. psittaci and C. abortus. C. psittaci M56 from a muskrat branched separately from the main group of C. psittaci isolates. C. psittaci genotypes appeared to be associated with host species. The phylogentic tree of C. psittaci did not follow that of its host bird species, suggesting host species jumps. In conclusion, we report for the first time an association between C. psittaci genotypes with host species.	[Pannekoek, Yvonne; Keijzers, Wendy C.; van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Dickx, Veerle; Beeckman, Delphine S. A.; Vanrompay, Daisy] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Jolley, Keith A.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Vretou, Evangelia] Hellenic Pasteur Inst, Dept Microbiol, Biotechnol Lab, Athens, Greece	University of Amsterdam; Academic Medical Center Amsterdam; Ghent University; University of Oxford	Pannekoek, Y (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.	a.vanderende@amc.uva.nl	Maiden, Martin/N-6805-2019; Maiden, Martin C J/C-5055-2014; Jolley, Keith/ABE-8587-2020; van der Ende, Arie/A-4346-2012	Maiden, Martin/0000-0001-6321-5138; Maiden, Martin C J/0000-0001-6321-5138; Jolley, Keith/0000-0002-0751-0287; Beeckman, Delphine/0000-0002-5239-2558; Pannekoek, Yvonne/0000-0003-1154-652X; van der Ende, Arie/0000-0003-1298-3086	Wellcome Trust; Federal Public Service of Health, Food Chain Safety and Environment [RF-6177]; European Commission [512061]; Belgian Federal Public Service of Health, Food Chain Safety and Environment [RF-6177]	Wellcome Trust(Wellcome Trust); Federal Public Service of Health, Food Chain Safety and Environment; European Commission(European CommissionEuropean Commission Joint Research Centre); Belgian Federal Public Service of Health, Food Chain Safety and Environment	The development of the Chlamydiales MLST web site has been funded by the Wellcome Trust. Veerle Dickx is funded by the Federal Public Service of Health, Food Chain Safety and Environment (convention RF-6177). This research was partly funded by the Sixth Framework Programme of the European Commission, Proposal/Contract no.: 512061 (Network of Excellence 'European Virtual Institute for Functional Genomics of Bacterial Pathogens' [http://www.noe-epg.uni-wuerzburg.de]) and partially by the Belgian Federal Public Service of Health, Food Chain Safety and Environment (convention RF-6177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeckman DSA, 2009, CLIN MICROBIOL INFEC, V15, P11, DOI 10.1111/j.1469-0691.2008.02669.x; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; BUXTON D, 1986, VET REC, V118, P510, DOI 10.1136/vr.118.18.510; Campbell Lee Ann, 2003, Semin Respir Infect, V18, P48, DOI 10.1053/srin.2003.50006; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; DENAMUR E, 1991, J GEN MICROBIOL, V137, P2525, DOI 10.1099/00221287-137-11-2525; Essig A, 1995, CLIN INFECT DIS, V21, P1495, DOI 10.1093/clinids/21.6.1495; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Francis T, 1938, J EXP MED, V68, P147, DOI 10.1084/jem.68.2.147; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hanage WP, 2006, PHILOS T R SOC B, V361, P2039, DOI 10.1098/rstb.2006.1926; Harkinezhad T, 2007, J MED MICROBIOL, V56, P1097, DOI 10.1099/jmm.0.47157-0; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heddema ER, 2006, J MED MICROBIOL, V55, P1571, DOI 10.1099/jmm.0.46692-0; Herrmann B, 2000, INT J SYST EVOL MICR, V50, P149, DOI 10.1099/00207713-50-1-149; HINTON DG, 1993, AUST VET J, V70, P174, DOI 10.1111/j.1751-0813.1993.tb06123.x; Hughes C, 1997, INFECT CONT HOSP EP, V18, P165; HUMINER D, 1988, LANCET, V2, P615; HUMINER D, 1992, ISRAEL J MED SCI, V28, P739; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kaibu H, 2006, JPN J INFECT DIS, V59, P349; Kern JM, 2009, FEMS IMMUNOL MED MIC, V55, P131, DOI 10.1111/j.1574-695X.2008.00514.x; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Laroucau K, 2008, INFECT GENET EVOL, V8, P171, DOI 10.1016/j.meegid.2007.12.002; Laroucau K, 2009, VET MICROBIOL, V137, P335, DOI 10.1016/j.vetmic.2009.01.029; Laroucau K, 2009, VET MICROBIOL, V135, P82, DOI 10.1016/j.vetmic.2008.09.048; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Meijer A, 2004, EUR J CLIN MICROBIOL, V23, P487, DOI 10.1007/s10096-004-1139-z; Mitchell CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000903; Moroney JF, 1998, CLIN INFECT DIS, V26, P1425, DOI 10.1086/516368; Morrison RP, 2003, J CLIN INVEST, V111, P1647, DOI 10.1172/JCI200318770; Myers GSA, 2009, J BACTERIOL, V191, P7225, DOI 10.1128/JB.00746-09; Pannekoek Y, 2001, INFECT IMMUN, V69, P4654, DOI 10.1128/IAI.69.7.4654-4656.2001; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Pospischil A, 2002, SCHWEIZ ARCH TIERH, V144, P463, DOI 10.1024/0036-7281.144.9.463; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Pudjiatmoko, 1997, INT J SYST BACTERIOL, V47, P425; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Saito T, 2005, J CLIN MICROBIOL, V43, P3011, DOI 10.1128/JCM.43.6.3011-3013.2005; SALINAS J, 1995, VET MICROBIOL, V43, P219, DOI 10.1016/0378-1135(94)00100-B; SaltiMontesanto V, 1997, AM J VET RES, V58, P228; SAYADA C, 1995, RES MICROBIOL, V146, P155, DOI 10.1016/0923-2508(96)80893-X; SMITH JM, 1992, J MOL EVOL, V34, P126; SOURIAU A, 1993, VET REC, V132, P217, DOI 10.1136/vr.132.9.217; Stephens RS, 2009, FEMS IMMUNOL MED MIC, V55, P115, DOI 10.1111/j.1574-695X.2008.00516.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Droogenbroeck C, 2009, VET MICROBIOL, V135, P78, DOI 10.1016/j.vetmic.2008.09.047; Van Loock M, 2003, INT J SYST EVOL MICR, V53, P761, DOI 10.1099/ijs.0.02329-0; Vanrompay D, 1997, RES MICROBIOL, V148, P327, DOI 10.1016/S0923-2508(97)81588-4; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Vanrompay D, 2007, EMERG INFECT DIS, V13, P1108, DOI 10.3201/eid1307.070074; Verminnen K, 2008, J CLIN MICROBIOL, V46, P281, DOI 10.1128/JCM.01153-07; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Vretou E, 1996, VET MICROBIOL, V51, P275, DOI 10.1016/0378-1135(96)00048-X; Walder G, 2005, OBSTET GYNECOL, V106, P1215, DOI 10.1097/01.AOG.0000161060.69470.9c; White JA, 2009, CURR OPIN INFECT DIS, V22, P57, DOI 10.1097/QCO.0b013e328320a8ae; Yatsentyuk SP, 2007, RUSS J GENET+, V43, P1215, DOI 10.1134/S1022795407110026	66	78	79	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14179	10.1371/journal.pone.0014179	http://dx.doi.org/10.1371/journal.pone.0014179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152037	Green Submitted, Green Published, gold			2022-12-27	WOS:000284868000005
J	Sokolov, MV; Neumann, RD				Sokolov, Mykyta V.; Neumann, Ronald D.			Radiation-Induced Bystander Effects in Cultured Human Stem Cells	PLOS ONE			English	Article							NORMAL HUMAN FIBROBLASTS; MEDIATED INTERCELLULAR COMMUNICATION; DOUBLE-STRAND BREAKS; IONIZING-RADIATION; ALPHA-PARTICLE; DNA-DAMAGE; MICROBEAM IRRADIATION; CELLULAR-RESPONSE; LET RADIATION; GLIOMA-CELLS	Background: The radiation-induced "bystander effect" (RIBE) was shown to occur in a number of experimental systems both in vitro and in vivo as a result of exposure to ionizing radiation (IR). RIBE manifests itself by intercellular communication from irradiated cells to non-irradiated cells which may cause DNA damage and eventual death in these bystander cells. It is known that human stem cells (hSC) are ultimately involved in numerous crucial biological processes such as embryologic development; maintenance of normal homeostasis; aging; and aging-related pathologies such as cancerogenesis and other diseases. However, very little is known about radiation-induced bystander effect in hSC. To mechanistically interrogate RIBE responses and to gain novel insights into RIBE specifically in hSC compartment, both medium transfer and cell co-culture bystander protocols were employed. Methodology/Principal Findings: Human bone-marrow mesenchymal stem cells (hMSC) and embryonic stem cells (hESC) were irradiated with doses 0.2 Gy, 2 Gy and 10 Gy of X-rays, allowed to recover either for 1 hr or 24 hr. Then conditioned medium was collected and transferred to non-irradiated hSC for time course studies. In addition, irradiated hMSC were labeled with a vital CMRA dye and co-cultured with non-irradiated bystander hMSC. The medium transfer data showed no evidence for RIBE either in hMSC and hESC by the criteria of induction of DNA damage and for apoptotic cell death compared to non-irradiated cells (p>0.05). A lack of robust RIBE was also demonstrated in hMSC co-cultured with irradiated cells (p>0.05). Conclusions/Significance: These data indicate that hSC might not be susceptible to damaging effects of RIBE signaling compared to differentiated adult human somatic cells as shown previously. This finding could have profound implications in a field of radiation biology/oncology, in evaluating radiation risk of IR exposures, and for the safety and efficacy of hSC regenerative-based therapies.	[Sokolov, Mykyta V.; Neumann, Ronald D.] NIH, Div Nucl Med, Dept Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Sokolov, MV (corresponding author), NIH, Div Nucl Med, Dept Radiol & Imaging Sci, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	sokolovm@mail.nih.gov			National Institutes of Health, Clinical Center; CLINICAL CENTER [ZIACL060001] Funding Source: NIH RePORTER	National Institutes of Health, Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This research was supported by the Intramural Research Program of the National Institutes of Health, Clinical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asur R, 2010, MUTAT RES-FUND MOL M, V686, P15, DOI 10.1016/j.mrfmmm.2009.12.007; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Bertucci A, 2009, J RADIAT RES, V50, pA49, DOI 10.1269/jrr.08132S; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Chou CH, 2007, CLIN CANCER RES, V13, P851, DOI 10.1158/1078-0432.CCR-06-2459; Cogan N, 2010, MUTAT RES-FUND MOL M, V683, P1, DOI 10.1016/j.mrfmmm.2009.09.012; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Elkind MM, 1967, RADIOBIOLOGY CULTURE, p[XVI, 615]; Ermakov A. V., 2010, Radiatsionnaya Biologiya Radioekologiya, V50, P42; Facoetti A, 2006, RADIAT PROT DOSIM, V122, P271, DOI 10.1093/rpd/ncl431; Fournier C, 2009, RADIAT RES, V171, P530, DOI 10.1667/RR1457.1; Ghandhi SA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-31; Groesser T, 2008, RADIAT RES, V170, P794, DOI 10.1667/RR1458.1; Hamada N, 2008, MUTAT RES-FUND MOL M, V639, P35, DOI 10.1016/j.mrfmmm.2007.11.001; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Han W, 2010, CARCINOGENESIS, V31, P275, DOI 10.1093/carcin/bgp301; Iyer R, 2000, CANCER RES, V60, P1290; KADHIM MA, 1994, LANCET, V344, P987, DOI 10.1016/S0140-6736(94)91643-8; Kadhim MA, 2010, MUTAT RES-FUND MOL M, V688, P91, DOI 10.1016/j.mrfmmm.2010.03.013; Kanasugi Y, 2007, INT J RADIAT BIOL, V83, P73, DOI 10.1080/09553000601121116; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kashino G, 2007, MUTAT RES-FUND MOL M, V619, P134, DOI 10.1016/j.mrfmmm.2007.02.005; Koturbash I, 2006, ONCOGENE, V25, P4267, DOI 10.1038/sj.onc.1209467; Koturbash I, 2008, INT J RADIAT ONCOL, V70, P554, DOI 10.1016/j.ijrobp.2007.09.039; Mackonis EC, 2007, PHYS MED BIOL, V52, P5469, DOI 10.1088/0031-9155/52/18/001; Matsumoto H, 2001, RADIAT RES, V155, P387, DOI 10.1667/0033-7587(2001)155[0387:IORBAN]2.0.CO;2; MAUNEY J, 2010, MATRIX BIOL; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 2001, CARCINOGENESIS, V22, P1465, DOI 10.1093/carcin/22.9.1465; Mothersill C, 2010, RADIAT RES, V174, P119, DOI 10.1667/RR2036.1; NAGASAWA H, 1992, CANCER RES, V52, P6394; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Rzeszowska-Wolny J, 2009, EUR J PHARMACOL, V625, P156, DOI 10.1016/j.ejphar.2009.07.028; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Sedelnikova OA, 2007, CANCER RES, V67, P4295, DOI 10.1158/0008-5472.CAN-06-4442; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shao CL, 2006, RADIAT RES, V166, P479, DOI 10.1667/RR3600.1; Shao CL, 2003, FASEB J, V17, P1422, DOI 10.1096/fj.02-1115com; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Sokolov MV, 2005, ONCOGENE, V24, P7257, DOI 10.1038/sj.onc.1208886; Sokolov MV, 2007, CELL CYCLE, V6, P2210, DOI 10.4161/cc.6.18.4682; Sokolov MV, 2010, GENE, V455, P8, DOI 10.1016/j.gene.2010.01.006; Sowa MB, 2010, INT J RADIAT BIOL, V86, P102, DOI 10.3109/09553000903419957; Tartier L, 2007, CANCER RES, V67, P5872, DOI 10.1158/0008-5472.CAN-07-0188; Terzoudi GI, 2010, RADIAT RES, V173, P789, DOI 10.1667/RR2023.1; VALLEPRIETO A, 2010, STEM CELLS DEV; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Zhang Y, 2009, MUTAT RES-FUND MOL M, V671, P20, DOI 10.1016/j.mrfmmm.2009.08.006	54	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14195	10.1371/journal.pone.0014195	http://dx.doi.org/10.1371/journal.pone.0014195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152027	Green Submitted, Green Published, gold			2022-12-27	WOS:000284868000011
J	Heimann, E; Jones, HA; Resjo, S; Manganiello, VC; Stenson, L; Degerman, E				Heimann, Emilia; Jones, Helena A.; Resjo, Svante; Manganiello, Vincent C.; Stenson, Lena; Degerman, Eva			Expression and Regulation of Cyclic Nucleotide Phosphodiesterases in Human and Rat Pancreatic Islets	PLOS ONE			English	Article							INSULIN-INDUCED PHOSPHORYLATION; GLUCAGON-LIKE PEPTIDE-1; PROTEIN-KINASE B; CAMP-PHOSPHODIESTERASE; ANTILIPOLYTIC ACTION; GLUCOSE-INTOLERANCE; ENERGY HOMEOSTASIS; IN-VITRO; SECRETION; ACTIVATION	As shown by transgenic mouse models and by using phosphodiesterase 3 (PDE3) inhibitors, PDE3B has an important role in the regulation of insulin secretion in pancreatic beta-cells. However, very little is known about the regulation of the enzyme. Here, we show that PDE3B is activated in response to high glucose, insulin and cAMP elevation in rat pancreatic islets and INS-1 (832/13) cells. Activation by glucose was not affected by the presence of diazoxide. PDE3B activation was coupled to an increase as well as a decrease in total phosphorylation of the enzyme. In addition to PDE3B, several other PDEs were detected in human pancreatic islets: PDE1, PDE3, PDE4C, PDE7A, PDE8A and PDE10A. We conclude that PDE3B is activated in response to agents relevant for beta-cell function and that activation is linked to increased as well as decreased phosphorylation of the enzyme. Moreover, we conclude that several PDEs are present in human pancreatic islets.	[Heimann, Emilia; Jones, Helena A.; Resjo, Svante; Stenson, Lena; Degerman, Eva] Lund Univ, Dept Expt Med Sci, Div Diabet Metab & Endocrinol, Lund, Sweden; [Manganiello, Vincent C.] NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	Lund University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Heimann, E (corresponding author), Lund Univ, Dept Expt Med Sci, Div Diabet Metab & Endocrinol, Lund, Sweden.	emilia.heimann@med.lu.se	Jones, Helena/C-8847-2013	Jones, Helena/0000-0002-3948-161X	Swedish Research Council [3362]; Swedish Diabetes Association; Swedish Society of Medicine; A. Pahlsson foundation; P. Hakansson foundation; Novo Nordisk Foundation, Denmark; Royal Physiographic Society in Lund; Lund University Diabetes Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002540] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Swedish Society of Medicine; A. Pahlsson foundation; P. Hakansson foundation; Novo Nordisk Foundation, Denmark(Novo Nordisk Foundation); Royal Physiographic Society in Lund; Lund University Diabetes Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Swedish Research Council Project 3362 (to ED); the Swedish Diabetes Association (http://www.diabetes.se/); the Swedish Society of Medicine; the A. Pahlsson and P. Hakansson foundations; Novo Nordisk Foundation, Denmark (http://www.novonordiskfonden.dk/en/index.asp); the Royal Physiographic Society in Lund (http://www.fysiografen.se/); and Lund University Diabetes Center (http://www.ludc.med.lu.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2000, J IMMUNOL, V164, P4678, DOI 10.4049/jimmunol.164.9.4678; Ahmad M, 2000, BRIT J PHARMACOL, V129, P1228, DOI 10.1038/sj.bjp.0703165; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; BEAVO JA, 2007, CYCLIC NUCL PHOSPHOD; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantin LD, 2007, BIOORG MED CHEM LETT, V17, P2869, DOI 10.1016/j.bmcl.2007.02.061; Cheung P, 2003, METABOLISM, V52, P1496, DOI 10.1016/S0026-0495(03)00271-3; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; DEGERMAN E, 1990, P NATL ACAD SCI USA, V87, P533, DOI 10.1073/pnas.87.2.533; DEGERMAN E, 2007, CYCLIC NUCLEOTIDE PH, P79; Dov A, 2008, ENDOCRINOLOGY, V149, P741, DOI 10.1210/en.2007-0968; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; ELKS ML, 1985, ENDOCRINOLOGY, V116, P2119, DOI 10.1210/endo-116-5-2119; ElMetwally M, 1997, EUR J PHARMACOL, V324, P227, DOI 10.1016/S0014-2999(97)00076-9; ERIKSSON H, 1995, BBA-MOL CELL RES, V1266, P101, DOI 10.1016/0167-4889(94)00237-9; Han P, 1999, J BIOL CHEM, V274, P22337, DOI 10.1074/jbc.274.32.22337; Harndahl L, 2004, J BIOL CHEM, V279, P15214, DOI 10.1074/jbc.M308952200; Harndahl L, 2002, J BIOL CHEM, V277, P37446, DOI 10.1074/jbc.M205401200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; KREYMANN B, 1987, LANCET, V2, P1300; Leibiger IB, 2002, FEBS LETT, V532, P1, DOI 10.1016/S0014-5793(02)03627-X; Lindh R, 2007, BBA-MOL CELL RES, V1773, P584, DOI 10.1016/j.bbamcr.2007.01.010; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; MURAD F, 1971, P NATL ACAD SCI USA, V68, P736, DOI 10.1073/pnas.68.4.736; Parker JC, 1997, BIOCHEM BIOPH RES CO, V236, P665, DOI 10.1006/bbrc.1997.7034; Parker JC, 1995, BIOCHEM BIOPH RES CO, V217, P916, DOI 10.1006/bbrc.1995.2858; Pyne NJ, 2003, DIABETOLOGIA, V46, P1179, DOI 10.1007/s00125-003-1176-7; Rahn T, 1996, J BIOL CHEM, V271, P11575, DOI 10.1074/jbc.271.19.11575; RASCON A, 1994, J BIOL CHEM, V269, P11962; Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; SHAFIEENICK R, 1995, BRIT J PHARMACOL, V115, P1486, DOI 10.1111/j.1476-5381.1995.tb16641.x; SHIBATA H, 1990, BIOCHEM BIOPH RES CO, V170, P533, DOI 10.1016/0006-291X(90)92124-I; Sjoholm A, 2002, ENDOCRINOLOGY, V143, P4592, DOI 10.1210/en.2002-220672; SJOHOLM A, 1993, BIOSCIENCE REP, V13, P349, DOI 10.1007/BF01150479; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; TAIRA M, 1993, J BIOL CHEM, V268, P18573; Vander Mierde D, 2007, ENDOCRINOLOGY, V148, P609, DOI 10.1210/en.2006-1012; Waddleton D, 2008, BIOCHEM PHARMACOL, V76, P884, DOI 10.1016/j.bcp.2008.07.025; Walz HA, 2007, CELL SIGNAL, V19, P1505, DOI 10.1016/j.cellsig.2007.01.030; Walz HA, 2006, J ENDOCRINOL, V189, P629, DOI 10.1677/joe.1.06522; Wijkander J, 1998, ENDOCRINOLOGY, V139, P219, DOI 10.1210/en.139.1.219; Willoughby D, 2010, J CELL SCI, V123, P107, DOI 10.1242/jcs.062067; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348; Zhao AZ, 1998, J CLIN INVEST, V102, P869, DOI 10.1172/JCI3920; Zhao AZ, 1997, P NATL ACAD SCI USA, V94, P3223, DOI 10.1073/pnas.94.7.3223; Zmuda-Trzebiatowska E, 2006, CELL SIGNAL, V18, P382, DOI 10.1016/j.cellsig.2005.05.007	48	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14191	10.1371/journal.pone.0014191	http://dx.doi.org/10.1371/journal.pone.0014191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152070	Green Submitted, gold, Green Published			2022-12-27	WOS:000284821300008
J	Riveros, C; Mellor, D; Gandhi, KS; McKay, FC; Cox, MB; Berretta, R; Vaezpour, SY; Inostroza-Ponta, M; Broadley, SA; Heard, RN; Vucic, S; Stewart, GJ; Williams, DW; Scott, RJ; Lechner-Scott, J; Booth, DR; Moscato, P				Riveros, Carlos; Mellor, Drew; Gandhi, Kaushal S.; McKay, Fiona C.; Cox, Mathew B.; Berretta, Regina; Vaezpour, S. Yahya; Inostroza-Ponta, Mario; Broadley, Simon A.; Heard, Robert N.; Vucic, Stephen; Stewart, Graeme J.; Williams, David W.; Scott, Rodney J.; Lechner-Scott, Jeanette; Booth, David R.; Moscato, Pablo		ANZgene Multiple Sclerosis Genetic	A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis	PLOS ONE			English	Article							NF-KAPPA-B; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN-TYROSINE-PHOSPHATASE; CARBONIC-ANHYDRASE-II; OLIGODENDROCYTE PROGENITOR DIFFERENTIATION; MONOCLONAL-ANTIBODY TREATMENT; DEPENDENT DIABETES-MELLITUS; YIN YANG 1	Background: Several lines of evidence suggest that transcription factors are involved in the pathogenesis of Multiple Sclerosis (MS) but complete mapping of the whole network has been elusive. One of the reasons is that there are several clinical subtypes of MS and transcription factors that may be involved in one subtype may not be in others. We investigate the possibility that this network could be mapped using microarray technologies and contemporary bioinformatics methods on a dataset derived from whole blood in 99 untreated MS patients (36 Relapse Remitting MS, 43 Primary Progressive MS, and 20 Secondary Progressive MS) and 45 age-matched healthy controls. Methodology/Principal Findings: We have used two different analytical methodologies: a non-standard differential expression analysis and a differential co-expression analysis, which have converged on a significant number of regulatory motifs that are statistically overrepresented in genes that are either differentially expressed (or differentially co-expressed) in cases and controls (e. g., V$KROX_Q6, p-value, <3.31E-6; V$CREBP1_Q2, p-value, < 9.93E-6, V$YY1_02, p-value, <1.65E-5). Conclusions/Significance: Our analysis uncovered a network of transcription factors that potentially dysregulate several genes in MS or one or more of its disease subtypes. The most significant transcription factor motifs were for the Early Growth Response EGR/KROX family, ATF2, YY1 (Yin and Yang 1), E2F-1/DP-1 and E2F-4/DP-2 heterodimers, SOX5, and CREB and ATF families. These transcription factors are involved in early T-lymphocyte specification and commitment as well as in oligodendrocyte dedifferentiation and development, both pathways that have significant biological plausibility in MS causation.	[Riveros, Carlos; Mellor, Drew; Cox, Mathew B.; Berretta, Regina; Vaezpour, S. Yahya; Inostroza-Ponta, Mario; Scott, Rodney J.; Lechner-Scott, Jeanette; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW 2308, Australia; [Riveros, Carlos; Mellor, Drew; Cox, Mathew B.; Berretta, Regina; Vaezpour, S. Yahya; Inostroza-Ponta, Mario; Scott, Rodney J.; Lechner-Scott, Jeanette; Moscato, Pablo] Hunter Med Res Inst, Newcastle, NSW, Australia; [Moscato, Pablo] Australian Res Council, Ctr Excellence Bioinformat, St Lucia, Qld, Australia; [Gandhi, Kaushal S.; McKay, Fiona C.; Heard, Robert N.; Vucic, Stephen; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Broadley, Simon A.] Griffith Univ, Sch Med, Brisbane, Qld 4111, Australia; [Broadley, Simon A.] Gold Coast Hosp, Dept Neurol, Southport, Qld, Australia; [Williams, David W.] Univ Newcastle, John Hunter Hosp, Newcastle, NSW 2308, Australia; [Vaezpour, S. Yahya] Amirkabir Univ Technol, Dept Comp Engn, Tehran, Iran; [Mellor, Drew] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, Australia; [Inostroza-Ponta, Mario] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Sydney; Westmead Institute for Medical Research; Griffith University; Gold Coast University Hospital; John Hunter Hospital; University of Newcastle; Amirkabir University of Technology; University of Western Australia; Universidad de Santiago de Chile	Riveros, C (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	Scott, Rodney J/B-2827-2013; Riveros, Carlos/F-3373-2012; Foote, Simon J/F-2802-2013; Inostroza-Ponta, Mario/G-7548-2012; Riveros, Carlos/A-6880-2013; MOSCATO, PABLO ALBERTO/G-7668-2013; Kermode, Allan/G-3568-2019; Browning, Brian L/A-1178-2010; Slee, Mark/J-4731-2015	Scott, Rodney J/0000-0001-7724-3404; Riveros, Carlos/0000-0002-2551-7618; Kermode, Allan/0000-0002-4476-4016; Browning, Brian L/0000-0001-6454-6633; Field, Judith/0000-0002-7089-0999; McKay, Fiona Catherine/0000-0002-9610-0668; Stankovich, Jim/0000-0001-9344-7749; Berretta, Regina/0000-0002-4420-3446; Inostroza-Ponta, Mario/0000-0003-1295-8972; Kilpatrick, Trevor/0000-0003-3999-085X; Vucic, Steve/0000-0002-8323-873X; Moscato, Pablo/0000-0003-2570-5966; Slee, Mark/0000-0003-4323-2453; Lechner-Scott, Jeannette/0000-0002-3850-447X	Australian Research Council Centre of Excellence in Bioinformatics; Australian Research Council [LP0776744, DP0559755, DP0773279]; University of Newcastle; Universidad de Santiago de Chile, Departamento de Investigaciones Cientificas y Tecnologicas [060919IP]; John Hunter Hospital Charitable Trust; Macquarie Bank; Multiple Sclerosis Research Australia	Australian Research Council Centre of Excellence in Bioinformatics(Australian Research Council); Australian Research Council(Australian Research Council); University of Newcastle; Universidad de Santiago de Chile, Departamento de Investigaciones Cientificas y Tecnologicas; John Hunter Hospital Charitable Trust; Macquarie Bank; Multiple Sclerosis Research Australia	This project had the following sources of funding: Australian Research Council Centre of Excellence in Bioinformatics (PM), Australian Research Council Linkage Project LP0776744 (ANZgene, MS Research Australia), Australian Research Council Discovery project DP0559755 (PM and RB) and DP0773279 (PM, RS and DM). The University of Newcastle via central funding to the Priority Research Centre in Bioinformatics, Biomarker Discovery and Information-based Medicine (PM, RS, RB, CR, DM, MIP). The University of Newcastle's Strategic Initiative Fund for project: Newcastle Bioinformatics Initiative, 2003-2007 (PM, RB, MIP). Universidad de Santiago de Chile, Departamento de Investigaciones Cientificas y Tecnologicas project 060919IP (MIP). Australia Research Council Biogen Idec PhD award (KG). Grant from the John Hunter Hospital Charitable Trust Fund and a special grant from Macquarie Bank (MBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank people with MS in Australia and New Zealand for supporting this research. We are grateful to Multiple Sclerosis Research Australia for supporting this project, and in particular to the expediting efforts from Mr Jeremy Wright and Ms Christine Remediakis.	Ai WD, 2000, J VIROL, V74, P5198, DOI 10.1128/JVI.74.11.5198-5205.2000; Akkad DA, 2009, J AUTOIMMUN, V32, P110, DOI 10.1016/j.jaut.2009.01.002; Akl H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-85; Ali F, 2008, MOL BIOL EVOL, V25, P2247, DOI 10.1093/molbev/msn184; Alter M, 2006, NEUROLOGY, V66, P1061, DOI 10.1212/01.wnl.0000204194.47925.0d; ANDERSEN O, 1993, J NEUROL, V240, P417, DOI 10.1007/BF00867354; Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Avasarala JR, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-2; Avossa D, 2006, NEUROSCIENCE, V138, P1179, DOI 10.1016/j.neuroscience.2005.12.009; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Awasthi A, 2008, J CLIN IMMUNOL, V28, P660, DOI 10.1007/s10875-008-9239-7; Azimi N, 2000, AIDS RES HUM RETROV, V16, P1717, DOI 10.1089/08892220050193209; Azzouz M, 1997, MUSCLE NERVE, V20, P45, DOI 10.1002/(SICI)1097-4598(199701)20:1<45::AID-MUS6>3.0.CO;2-H; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; BAN EMH, 1994, IMMUNOL RES, V13, P1, DOI 10.1007/BF02918219; BAN M, 2009, EUR J HUM GENET; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Benjamins JA, 2003, NEUROCHEM RES, V28, P143, DOI 10.1023/A:1021612615554; Berndt JA, 2001, J NEUROCHEM, V77, P935, DOI 10.1046/j.1471-4159.2001.00307.x; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bonetti B, 1999, AM J PATHOL, V155, P1433, DOI 10.1016/S0002-9440(10)65456-9; Brightt JJ, 2008, EXPERT OPIN THER TAR, V12, P1565, DOI [10.1517/14728220802515400, 10.1517/14728220802515400 ]; Brynedal B, 2009, P NATL ACAD SCI USA, V106, pE58, DOI 10.1073/pnas.0904338106; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; CAMMER W, 1995, J NEUROSCI RES, V40, P451, DOI 10.1002/jnr.490400404; Cammer W, 1998, NEUROCHEM RES, V23, P407, DOI 10.1023/A:1022421920265; Caserta S, 2007, TRENDS IMMUNOL, V28, P245, DOI 10.1016/j.it.2007.04.006; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chang X, 2006, CLIN IMMUNOL, V121, P274, DOI 10.1016/j.clim.2006.07.004; Chavanas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003408; Christophi GP, 2008, LAB INVEST, V88, P243, DOI 10.1038/labinvest.3700720; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Coles AJ, 1998, MULT SCLER, V4, P232, DOI 10.1177/135245859800400327; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Colombatti M, 2001, GLIA, V35, P224, DOI 10.1002/glia.1087; Compston Alastair., 2005, MCALPINES MULTIPLE S, V4th; Cron RQ, 2006, J IMMUNOL, V176, P811, DOI 10.4049/jimmunol.176.2.811; CROSBY SD, 1992, P NATL ACAD SCI USA, V89, P4739, DOI 10.1073/pnas.89.10.4739; Dabrowska A, 2008, J IMMUNOL, V181, P8460, DOI 10.4049/jimmunol.181.12.8460; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; de Saint Basile G, 2004, J CLIN INVEST, V114, P1512, DOI 10.1172/JCI200422588; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Dediu D, 2008, J THEOR BIOL, V254, P400, DOI 10.1016/j.jtbi.2008.05.028; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Della Chiesa M, 2008, EUR J IMMUNOL, V38, P2284, DOI 10.1002/eji.200838434; Dermitzakis ET, 2008, NAT GENET, V40, P492, DOI 10.1038/ng0508-492; Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312; Diab A, 2002, J IMMUNOL, V168, P2508, DOI 10.4049/jimmunol.168.5.2508; Dobson-Stone C, 2007, NEUROIMAGE, V37, P394, DOI 10.1016/j.neuroimage.2007.05.011; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; DURACK DT, 1981, P NATL ACAD SCI-BIOL, V78, P5165, DOI 10.1073/pnas.78.8.5165; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards S, 1998, J NEUROL NEUROSUR PS, V64, P736, DOI 10.1136/jnnp.64.6.736; EGGERT M, 2006, FRONTIERS MED CHEM, V3, P383; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Fayyad U., 1993, INT JOINT C ART INT; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Feinstein Douglas L, 2003, Diabetes Technol Ther, V5, P67, DOI 10.1089/152091503763816481; Feng X, 2002, J NEUROIMMUNOL, V129, P205, DOI 10.1016/S0165-5728(02)00182-0; Fernandez-Malave E, 2006, BLOOD, V108, P3420, DOI 10.1182/blood-2006-03-010850; FERNER RE, 1995, J NEUROL NEUROSUR PS, V58, P582, DOI 10.1136/jnnp.58.5.582; Fischer A, 2005, CURR OPIN ALLERGY CL, V5, P491, DOI 10.1097/01.all.0000191886.12645.79; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Flores N, 2003, J NEUROIMMUNOL, V135, P141, DOI 10.1016/S0165-5728(02)00440-X; Fortunato G, 2008, J INTERF CYTOK RES, V28, P141, DOI 10.1089/jir.2007.0049; FRANCIS DA, 1991, HUM IMMUNOL, V32, P119, DOI 10.1016/0198-8859(91)90108-L; Frisullo G, 2009, IMMUNOLOGY, V127, P418, DOI 10.1111/j.1365-2567.2008.02963.x; Frisullo G, 2008, J NEUROIMMUNOL, V205, P126, DOI 10.1016/j.jneuroim.2008.09.003; Frost P, 2008, MED HYPOTHESES, V70, P17, DOI 10.1016/j.mehy.2007.04.039; Fukuyama T, 2009, MOL CELL BIOL, V29, P3894, DOI 10.1128/MCB.01598-08; GANDHI KS, HUM MOL GENET; Gardner JM, 2009, NAT IMMUNOL, V10, P934, DOI 10.1038/ni0909-934; Georgescu C, 2008, P NATL ACAD SCI USA, V105, P20100, DOI 10.1073/pnas.0806501105; Gerhauser I, 2007, J NEUROIMMUNOL, V188, P86, DOI 10.1016/j.jneuroim.2007.05.019; Gerstner B, 2008, J NEUROSCI, V28, P1236, DOI 10.1523/JNEUROSCI.3213-07.2008; Gobin SJP, 2001, GLIA, V36, P68, DOI 10.1002/glia.1096; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Grekova MC, 1996, ANN NEUROL, V40, P108, DOI 10.1002/ana.410400117; Grekova MC, 2000, J NEUROIMMUNOL, V106, P214, DOI 10.1016/S0165-5728(99)00264-7; Grekova MC, 2002, LAB INVEST, V82, P1131, DOI 10.1097/01.LAB.0000029149.3881.84; Grunebaum E, 2006, IMMUNOL RES, V35, P117, DOI 10.1385/IR:35:1:117; Guennoun R, 2001, MOL BRAIN RES, V90, P75, DOI 10.1016/S0169-328X(01)00094-8; Guo J, 2001, J BIOL CHEM, V276, P48871, DOI 10.1074/jbc.M101592200; Guo J, 2008, J ALLERGY CLIN IMMUN, V122, P195, DOI 10.1016/j.jaci.2008.03.012; GUTMANN DH, 1993, J NEUROSCI RES, V36, P216, DOI 10.1002/jnr.490360212; Guy J, 2008, OPHTHAL RES, V40, P212, DOI 10.1159/000119879; Habib AA, 1998, J NEUROCHEM, V70, P1704; Habib AA, 1998, ONCOGENE, V16, P1525, DOI 10.1038/sj.onc.1201683; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hawkes CH, 2009, MULT SCLER J, V15, P661, DOI 10.1177/1352458509104592; Hayes SM, 2003, IMMUNOL REV, V191, P28, DOI 10.1034/j.1600-065X.2003.00011.x; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; He Y, 2007, NEURON GLIA BIOL, V3, P221, DOI 10.1017/S1740925X08000057; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; HILLEL SP, 1994, ANN NEUROL, V36, pS25; HILLERT J, 1992, J NEUROL NEUROSUR PS, V55, P887, DOI 10.1136/jnnp.55.10.887; Hilliard B, 1999, J IMMUNOL, V163, P2937; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Hirst CL, 2008, J NEUROL, V255, P231, DOI 10.1007/s00415-008-0696-y; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hjelmervik TOR, 2005, ARTHRITIS RHEUM, V52, P1534, DOI 10.1002/art.21006; Hong J, 2006, P NATL ACAD SCI USA, V103, P5024, DOI 10.1073/pnas.0508784103; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hourani Mou'ath, 2008, V453, P379, DOI 10.1007/978-1-60327-429-6_20; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Huang CJ, 2002, INT J DEV NEUROSCI, V20, P289, DOI 10.1016/S0736-5748(02)00022-9; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Ince PG, 1998, J NEUROPATH EXP NEUR, V57, P895, DOI 10.1097/00005072-199810000-00002; Inostroza-Ponta M, 2006, INT FED INFO PROC, V217, P179; INOSTROZAPONTA M, 2007, LECT NOTES COMPUTER; *INT MULT SCLER GE, 2008, GENES IMMUN, V10, P11; Jessen KR, 1998, MICROSC RES TECHNIQ, V41, P393, DOI 10.1002/(SICI)1097-0029(19980601)41:5<393::AID-JEMT6>3.0.CO;2-R; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Ji HB, 2002, J BIOL CHEM, V277, P47898, DOI 10.1074/jbc.M201025200; JOHNSTONE D, 2008, P 19 INT C GEN INF G; Jones EA, 2007, NEURON GLIA BIOL, V3, P377, DOI 10.1017/S1740925X08000173; Jones JL, 2008, NEURODEGENER DIS, V5, P27, DOI 10.1159/000109935; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Khalil MI, 2008, J VIROL, V82, P11723, DOI 10.1128/JVI.01322-08; Kida E, 2006, J NEUROPATH EXP NEUR, V65, P664, DOI 10.1097/01.jnen.0000225905.52002.3e; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x; Kim SM, 2009, AM J PHYSIOL-RENAL, V296, pF382, DOI 10.1152/ajprenal.90543.2008; Klotz L, 2009, NEUROSCI LETT, V449, P81, DOI 10.1016/j.neulet.2008.10.066; KNUTSON B, 2009, J GEN VIROL; KRAMER B, 1994, BBA-GENE STRUCT EXPR, V1219, P413, DOI 10.1016/0167-4781(94)90066-3; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; Kuipers HF, 2008, BLOOD, V112, P1610, DOI 10.1182/blood-2008-01-135111; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Kumar M, 2006, J NEUROIMMUNOL, V180, P178, DOI 10.1016/j.jneuroim.2006.08.003; Lan MS, 1996, P NATL ACAD SCI USA, V93, P6367, DOI 10.1073/pnas.93.13.6367; Larocque D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005867; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Lorentzen AR, 2009, ANN NEUROL, V65, P658, DOI 10.1002/ana.21695; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Lu J, 1996, P NATL ACAD SCI USA, V93, P2307, DOI 10.1073/pnas.93.6.2307; Magnaghi V, 2007, J MOL NEUROSCI, V31, P149, DOI 10.1385/JMN/31:02:149; Mai RT, 2006, ONCOGENE, V25, P448, DOI 10.1038/sj.onc.1209052; Martinez A, 2008, ARTHRITIS RHEUM-US, V58, P2598, DOI 10.1002/art.23792; Martinez-Forero I, 2008, EUR J IMMUNOL, V38, P576, DOI 10.1002/eji.200737271; Mckay FC, 2008, J AUTOIMMUN, V31, P52, DOI 10.1016/j.jaut.2008.02.003; Mendes Alexandre, 2008, V141, P131; Mercier G, 2001, MOL BRAIN RES, V97, P137, DOI 10.1016/S0169-328X(01)00311-4; Miao DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1889, DOI 10.2741/2195; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Miterski B, 2002, GENES IMMUN, V3, P211, DOI 10.1038/sj.gene.6363846; Mittelstadt PR, 1999, J BIOL CHEM, V274, P3222, DOI 10.1074/jbc.274.5.3222; MONTALVO EA, 1995, J VIROL, V69, P4158, DOI 10.1128/JVI.69.7.4158-4165.1995; Montes M, 2009, CLIN IMMUNOL, V130, P133, DOI 10.1016/j.clim.2008.08.030; MOREAU T, 1994, LANCET, V344, P298, DOI 10.1016/S0140-6736(94)91339-0; Moreau T, 1996, Mult Scler, V1, P357; Morgenthaler NG, 1997, AUTOIMMUNITY, V25, P203, DOI 10.3109/08916939708994729; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Mrak RE, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-5; Muhammad F, 2009, AM J MED GENET A, V149A, P926, DOI 10.1002/ajmg.a.32749; Mullin M, 2007, FEBS LETT, V581, P4309, DOI 10.1016/j.febslet.2007.07.077; Muraro PA, 2007, NEUROTHERAPEUTICS, V4, P676, DOI 10.1016/j.nurt.2007.07.003; Murphy P, 1996, DEVELOPMENT, V122, P2847; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Nguyen VT, 2002, J BIOL CHEM, V277, P13796, DOI 10.1074/jbc.M111906200; Nicholas AK, 2009, J MED GENET, V46, P249, DOI 10.1136/jmg.2008.062380; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; O'Keefe GM, 2002, J NEUROVIROL, V8, P496, DOI 10.1080/13550280290100941; Oh J, 2005, J VIROL, V79, P12852, DOI 10.1128/JVI.79.20.12852-12860.2005; Oh SJ, 2008, BONE MARROW TRANSPL, V41, P1047, DOI 10.1038/bmt.2008.37; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; OLERUP O, 1989, P NATL ACAD SCI USA, V86, P7113, DOI 10.1073/pnas.86.18.7113; Olsen JK, 2001, J CLIN INVEST, V108, P311; Pan QH, 2004, J BIOL CHEM, V279, P51068, DOI 10.1074/jbc.M406145200; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Panteri R, 2006, MOL CELL NEUROSCI, V32, P133, DOI 10.1016/j.mcn.2006.03.004; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; PATWARDHAN S, 1991, ONCOGENE, V6, P917; Peng SL, 2008, FRONT BIOSCI-LANDMRK, V13, P4218, DOI 10.2741/3001; Perini P, 2001, J NEUROL NEUROSUR PS, V71, P679, DOI 10.1136/jnnp.71.5.679; Perry RP, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-15; Petro TM, 2005, IMMUNOL LETT, V97, P47, DOI 10.1016/j.imlet.2004.09.013; Plumb J, 2006, MULT SCLER J, V12, P375, DOI 10.1191/135248506ms1276oa; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Pollard KS, 2009, SCI AM, V300, P44, DOI 10.1038/scientificamerican0509-44; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pugliatti M, 2008, ACTA NEUROL SCAND, V117, P34, DOI 10.1111/j.1600-0404.2008.01029.x; Qin HW, 2005, BLOOD, V106, P3114, DOI 10.1182/blood-2005-02-0759; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Ramagopalan SV, 2008, TRENDS NEUROSCI, V31, P645, DOI 10.1016/j.tins.2008.09.001; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Rodriguez M, 2006, FASEB J, V20, P343, DOI 10.1096/fj.05-4650fje; Roifman CM, 2004, CURR OPIN ALLERGY CL, V4, P479, DOI 10.1097/00130832-200412000-00002; Roifman CM, 2005, IMMUNOL REV, V203, P143, DOI 10.1111/j.0105-2896.2005.00236.x; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Rosenbaum T, 1999, ANN NY ACAD SCI, V883, P203, DOI 10.1111/j.1749-6632.1999.tb08583.x; Rosenberg HF, 2008, CURR PHARM BIOTECHNO, V9, P135, DOI 10.2174/138920108784567236; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; Rosso OA, 2009, J NEUROSCI METH, V181, P257, DOI 10.1016/j.jneumeth.2009.04.028; Roth TM, 2007, GLIA, V55, P1123, DOI 10.1002/glia.20534; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2009, IMMUNOL CELL BIOL, V87, P109, DOI 10.1038/icb.2008.100; Rothenberg EV, 2004, SEMIN IMMUNOL, V16, P227, DOI 10.1016/j.smim.2004.08.002; Rothenberg EV, 2002, SEMIN IMMUNOL, V14, P431, DOI 10.1016/S1044532302000787; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Saadi A, 2009, EUR J MED GENET, V52, P180, DOI 10.1016/j.ejmg.2009.03.013; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Salzer JL, 2008, J CELL BIOL, V181, P575, DOI 10.1083/jcb.200804136; Samten B, 2008, J IMMUNOL, V181, P2056, DOI 10.4049/jimmunol.181.3.2056; Sasaki S, 2004, ACTA NEUROPATHOL, V107, P452, DOI 10.1007/s00401-004-0838-y; Satoh J, 2008, DIS MARKERS, V25, P27, DOI 10.1155/2008/824640; Schellekens J, 2008, MOL IMMUNOL, V45, P2255, DOI 10.1016/j.molimm.2007.11.014; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; Schmidli RS, 1998, AUTOIMMUNITY, V28, P15, DOI 10.3109/08916939808993841; Schmidt S, 2004, J LEUKOCYTE BIOL, V75, P478, DOI 10.1189/jlb.0803402; SCHMITT SG, 2009, INVEST OPHTHALMOL VI; Schumacher M, 2001, BRAIN RES REV, V37, P343, DOI 10.1016/S0165-0173(01)00139-4; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Seiwa C, 2002, J NEUROSCI RES, V69, P305, DOI 10.1002/jnr.10291; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Shimada M, 2009, J RADIAT RES, V50, P295, DOI 10.1269/jrr.09039; Shimizu S, 2001, BIOCHEM BIOPH RES CO, V288, P165, DOI 10.1006/bbrc.2001.5754; SIBLEY WA, 1985, LANCET, V1, P1313; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Simpson B S, 2007, Int MS J, V14, P48; Smestad C, 2008, J NEUROL, V255, P49, DOI 10.1007/s00415-007-0659-8; Sock E, 1997, J NEUROCHEM, V68, P1911; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stenner MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003319; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Su H, 2004, IMMUNITY, V21, P133, DOI 10.1016/j.immuni.2004.07.015; Svejgaard A, 2008, IMMUNOGENETICS, V60, P275, DOI 10.1007/s00251-008-0295-1; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tajouri L, 2003, MOL BRAIN RES, V119, P170, DOI 10.1016/j.molbrainres.2003.09.008; Takada H, 2005, EUR J PEDIATR, V164, P311, DOI 10.1007/s00431-005-1639-6; Taki S, 2002, CYTOKINE GROWTH F R, V13, P379, DOI 10.1016/S1359-6101(02)00023-0; Tanaka R, 2000, GENES CELLS, V5, P277, DOI 10.1046/j.1365-2443.2000.00325.x; Thompson AJ, 2000, ANN NEUROL, V47, P831; Timpson N, 2007, SCIENCE, V317, DOI 10.1126/science.1141705; Tone Y, 2007, J IMMUNOL, V179, P1760, DOI 10.4049/jimmunol.179.3.1760; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Wakatsuki S, 2009, J BIOL CHEM, V284, P2957, DOI 10.1074/jbc.M803191200; Wang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-225; Weinstock-Guttman B, 2008, J NEUROIMMUNOL, V205, P113, DOI 10.1016/j.jneuroim.2008.09.004; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Williams AJK, 2008, DIABETOLOGIA, V51, P1444, DOI 10.1007/s00125-008-1047-3; Wu S, 2008, BIOCHEM BIOPH RES CO, V365, P75, DOI 10.1016/j.bbrc.2007.10.145; Wu Shourong, 2007, Nucleic Acids Symp Ser (Oxf), P347; Wucherpfennig KW, 1997, J CLIN INVEST, V100, P1114, DOI 10.1172/JCI119622; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773; Yui MA, 2004, J IMMUNOL, V173, P5381, DOI 10.4049/jimmunol.173.9.5381; Zaheer S, 2007, NEUROCHEM RES, V32, P2123, DOI 10.1007/s11064-007-9383-0; Zalani S, 1997, J VIROL, V71, P3268, DOI 10.1128/JVI.71.4.3268-3274.1997; Zeis T, 2008, BRAIN, V131, P288, DOI 10.1093/brain/awm291; Zheng Y, 2008, EMBO REP, V9, P50, DOI 10.1038/sj.embor.7401138; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187	285	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14176	10.1371/journal.pone.0014176	http://dx.doi.org/10.1371/journal.pone.0014176			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152067	Green Published, gold			2022-12-27	WOS:000284821300001
J	He, J; Chen, DW; Bing, Y				He Jun; Chen Daiwen; Yu Bing			Metabolic and Transcriptomic Responses of Weaned Pigs Induced by Different Dietary Amylose and Amylopectin Ratio	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; ACTIVATED-RECEPTOR-ALPHA; FATTY-ACID OXIDATION; LIPID-METABOLISM; ADIPOSE-TISSUE; AMINO-ACIDS; MICE; CARBOHYDRATE; LIVER; GLUCOSE	Starch is one of the major dietary energy sources for mammals. However, the nutritional value of starch largely depends on its amylose and amylopectin ratio. In this study, the overall metabolic and transcriptomic responses of weaned pigs fed with different dietary starches were assessed. Sixteen weaned pigs were randomly allotted to two experimental diets containing either of pure cassava starch (CS) or maize starch (MS) as the sole energy source (the amylose-amylopectin ratio were 0.25 and 0.43, respectively). Results indicated that the body weight gain was not affected by different dietary starches. However, a moderate fatty liver was observed in CS-fed group. Long-term ingestion of CS not only increased the total liver fat content, but significantly elevated the liver triglyceride and cholesterol content (P < 0.05). In addition, the serum insulin and cholesterol concentrations were both elevated in CS-fed group (P < 0.05). Microarray analysis led to the identification of 648 genes differentially expressed in liver (P < 0.05), and a lot of them were involved in lipid and carbohydrate metabolism. Additionally, pathway analysis indicated that both the insulin and PPAR signaling pathways were acutely affected by dietary amylose-amylopectin ratio. Long-term ingestion of CS activated the transcription of lipogenic genes such as hmgr and fasn, but decreased the expression of lipolytic genes such as aox1, ppara and fbp. The microarray results correlated well with the measurements of several key enzymes involved in hepatic lipid metabolism. Our results suggested that both the metabolic and transcriptomic responses of weaned pigs were tightly regulated by dietary starch composition, and a high amylose ratio starch (i.e MS) may be more healthful for mammals as the long-term energy source by down-regulation of hepatic lipogenesis and steroidogenesis.	[He Jun; Chen Daiwen; Yu Bing] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China; [He Jun; Chen Daiwen; Yu Bing] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	He, J (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China.	daiwenc@yahoo.com	He, Jun/G-5896-2010		China Ministry of Education [IRTO555-5]	China Ministry of Education(Ministry of Education, China)	This work was granted by Program for Changjiang Scholars and Innovative Research Team in University with grant No. IRTO555-5, China Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Bird A R, 2000, Curr Issues Intest Microbiol, V1, P25; Deng J, 2010, J ANIM PHYSIOL AN N, V94, P220, DOI 10.1111/j.1439-0396.2008.00902.x; Englyst HN, 1996, BRIT J NUTR, V75, P327, DOI 10.1079/BJN19960137; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FOLCH J, 1957, J BIOL CHEM, V226, P497; GhusainChoueiri AA, 1995, BRIT J NUTR, V74, P821, DOI 10.1079/BJN19950009; HELLERSTEIN MK, 1991, J CLIN INVEST, V87, P1841, DOI 10.1172/JCI115206; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; IDE T, 1987, LIPIDS, V22, P6, DOI 10.1007/BF02534867; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Kashireddy PV, 2004, HEPATOL RES, V30, P104, DOI 10.1016/j.hepres.2004.06.004; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Li TJ, 2008, ANIMAL, V2, P723, DOI 10.1017/S1751731108001614; Li TJ, 2007, LIVEST SCI, V109, P73, DOI 10.1016/j.livsci.2007.01.073; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Minehira K, 2004, INT J OBESITY, V28, P1291, DOI 10.1038/sj.ijo.0802760; Nagai Y, 2007, FEBS LETT, V581, P218, DOI 10.1016/j.febslet.2006.12.014; National Research Council, 1998, NUTR REQ SWIN, Vtenth; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Scribner KB, 2007, OBESITY, V15, P2190, DOI 10.1038/oby.2007.260; Siler SQ, 1999, AM J CLIN NUTR, V70, P928; Sondike SB, 2003, J PEDIATR-US, V142, P253, DOI 10.1067/mpd.2003.4; Stevnebo A, 2006, ANIM FEED SCI TECH, V130, P23, DOI 10.1016/j.anifeedsci.2006.01.015; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; VanderMeulen J, 1997, BRIT J NUTR, V78, P533, DOI 10.1079/BJN19970173; Wolever TMS, 2000, BRIT J NUTR, V83, pS97; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; YING YL, 2004, J ANIM FEED SCI, V13, P523; Yu L, 2010, J IND MICROBIOL BIOT, V37, P313, DOI 10.1007/s10295-009-0676-y	37	30	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15110	10.1371/journal.pone.0015110	http://dx.doi.org/10.1371/journal.pone.0015110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152049	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100075
J	Zhu, YZ; Cai, CS; Zhang, W; Guo, HX; Zhang, JP; Ji, YY; Ma, GY; Wu, JL; Li, QT; Lu, CP; Guo, XK				Zhu, Yong-Zhang; Cai, Cheng-Song; Zhang, Wei; Guo, Hong-Xiong; Zhang, Jin-Ping; Ji, Ya-Yong; Ma, Guang-Yuan; Wu, Jia-Lin; Li, Qing-Tian; Lu, Cheng-Ping; Guo, Xiao-Kui			Immunoproteomic Analysis of Human Serological Antibody Responses to Vaccination with Whole-Cell Pertussis Vaccine (WCV)	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; STREPTOCOCCUS-SUIS TYPE-2; GROUP-A STREPTOCOCCUS; BORDETELLA-PERTUSSIS; 2-DIMENSIONAL ELECTROPHORESIS; IMMUNOGENIC PROTEINS; EXTRACELLULAR PROTEINS; SYSTEMIC CANDIDIASIS; BACILLUS-ANTHRACIS; PROTEOME ANALYSIS	Background: Pertussis (whooping cough) caused by Bordetella pertussis (B.p), continues to be a serious public health threat. Vaccination is the most economical and effective strategy for preventing and controlling pertussis. However, few systematic investigations of actual human immune responses to pertussis vaccines have been performed. Therefore, we utilized a combination of two-dimensional electrophoresis (2-DE), immunoblotting, and mass spectrometry to reveal the entire antigenic proteome of whole-cell pertussis vaccine (WCV) targeted by the human immune system as a first step toward evaluating the repertoire of human humoral immune responses against WCV. Methodology/Principal Findings: Immunoproteomic profiling of total membrane enriched proteins and extracellular proteins of Chinese WCV strain 58003 identified a total of 30 immunoreactive proteins. Seven are known pertussis antigens including Pertactin, Serum resistance protein, chaperonin GroEL and two OMP porins. Sixteen have been documented to be immunogenic in other pathogens but not in B.p, and the immunogenicity of the last seven proteins was found for the first time. Furthermore, by comparison of the human and murine immunoproteomes of B.p, with the exception of four human immunoreactive proteins that were also reactive with mouse immune sera, a unique group of antigens including more than 20 novel immunoreactive proteins that uniquely reacted with human immune serum was confirmed. Conclusions/Significance: This study is the first time that the repertoire of human serum antibody responses against WCV was comprehensively investigated, and a small number of previously unidentified antigens of WCV were also found by means of the classic immunoproteomic strategy. Further research on these newly identified predominant antigens of B.p exclusively against humans will not only remarkably accelerate the development of diagnostic biomarkers and subunit vaccines but also provide detailed insight into human immunity mechanisms against WCV. In particular, this work highlights the heterogeneity of the B.p immunoreactivity patterns of the mouse model and the human host.	[Zhu, Yong-Zhang; Cai, Cheng-Song; Guo, Xiao-Kui] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China; [Zhu, Yong-Zhang; Zhang, Jin-Ping; Ji, Ya-Yong; Ma, Guang-Yuan; Wu, Jia-Lin] WuXi Ctr Dis Prevent & Control, Mol Biol Lab, Wuxi, Peoples R China; [Zhang, Wei; Lu, Cheng-Ping] Nanjing Agr Univ, Minist Agr, Key Lab Anim Dis Diagnost & Immunol, Nanjing, Peoples R China; [Guo, Hong-Xiong] Jiangsu Ctr Dis Prevent & Control, Dept STD & AIDS Prevent & Control, Nanjing, Peoples R China; [Li, Qing-Tian] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Lab Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Shanghai Jiao Tong University	Zhu, YZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China.	qingtianli@gmail.com; microbiology@sjtu.edu.cn	Guo, Hongxiong/GPS-7405-2022	Guo, Xiao-Kui/0000-0002-1595-9965	National Natural Science Foundation of China [30900051]; Natural Science Foundation of Jiangsu Province of China [BK2010158]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province)	This work was supported by The National Natural Science Foundation of China (Grant No: 30900051) and The Natural Science Foundation of Jiangsu Province of China (Grant No: BK2010158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2006, J IMMUNOL METHODS, V309, P34, DOI 10.1016/j.jim.2005.11.003; Alam SI, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-162; Altindis E, 2009, VACCINE, V27, P542, DOI 10.1016/j.vaccine.2008.11.020; Argiro L, 2000, VACCINE, V18, P2039, DOI 10.1016/S0264-410X(99)00521-6; ARMSTRONG SK, 1986, J BACTERIOL, V166, P212, DOI 10.1128/jb.166.1.212-216.1986; Ayalew S, 2010, PROTEOMICS, V10, P2151, DOI 10.1002/pmic.200900557; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Boonjakuakul JK, 2007, INFECT IMMUN, V75, P2548, DOI 10.1128/IAI.01974-06; Borisova O, 2007, CLIN VACCINE IMMUNOL, V14, P234, DOI 10.1128/CVI.00294-06; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Bouchez V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002437; Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Bumann D, 2002, INFECT IMMUN, V70, P6494, DOI 10.1128/IAI.70.11.6494-6498.2002; Caro V, 2008, J CLIN MICROBIOL, V46, P2125, DOI 10.1128/JCM.02484-07; CHARLES IG, 1991, EUR J IMMUNOL, V21, P1147, DOI 10.1002/eji.1830210509; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Cole JN, 2005, INFECT IMMUN, V73, P3137, DOI 10.1128/IAI.73.5.3137-3146.2005; COONEY BJ, 1993, INFECT IMMUN, V61, P4682, DOI 10.1128/IAI.61.11.4682-4688.1993; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; da Fonseca CA, 2001, MICROBES INFECT, V3, P535, DOI 10.1016/S1286-4579(01)01409-5; Das P, 2002, LANCET INFECT DIS, V2, P322, DOI 10.1016/S1473-3099(02)00308-0; DELGIUDICE G, 1993, J IMMUNOL, V150, P2025; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; Elahi S, 2005, INFECT IMMUN, V73, P3636, DOI 10.1128/IAI.73.6.3636-3645.2005; Elder KD, 2004, INFECT IMMUN, V72, P5919, DOI 10.1128/IAI.72.10.5919-5924.2004; Erttmann KD, 2005, BBA-MOL BASIS DIS, V1741, P85, DOI 10.1016/j.bbadis.2004.12.010; Fuchslocher B, 2003, INFECT IMMUN, V71, P3043, DOI 10.1128/IAI.71.6.3043-3052.2003; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; GRANDI G, 2004, GENOMICS PROTEOMICS; Guiso N, 2009, CLIN INFECT DIS, V49, P1565, DOI 10.1086/644733; Gupta MK, 2009, J PROTEOME RES, V8, P2319, DOI 10.1021/pr8009462; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Havlasova J, 2005, PROTEOMICS, V5, P2090, DOI 10.1002/pmic.200401123; Janovska S, 2007, IMMUNOL LETT, V108, P151, DOI 10.1016/j.imlet.2006.12.004; JOHNSON FD, 1994, J BACTERIOL, V176, P5350, DOI 10.1128/JB.176.17.5350-5356.1994; Jones AL, 2007, J IMMUNOL, V179, P3196, DOI 10.4049/jimmunol.179.5.3196; Kawai K, 2004, VACCINE, V22, P3411, DOI 10.1016/j.vaccine.2004.02.026; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Leroy B, 2007, PROTEOMICS, V7, P1164, DOI 10.1002/pmic.200600988; Li H, 2010, J PROTEOME RES, V9, P2573, DOI 10.1021/pr1000219; Liao YH, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-172; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Litt DJ, 2004, J INFECT DIS, V190, P1488, DOI 10.1086/424464; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; Lopez JE, 2009, MICROBIOL-SGM, V155, P2641, DOI 10.1099/mic.0.029918-0; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; Oliver DC, 2001, VACCINE, V20, P235, DOI 10.1016/S0264-410X(01)00269-9; Packard ER, 2004, J MED MICROBIOL, V53, P355, DOI 10.1099/jmm.0.05515-0; Peng XX, 2004, VACCINE, V22, P2750, DOI 10.1016/j.vaccine.2004.01.038; Vidakovics ML, 2007, J PROTEOME RES, V6, P2518, DOI 10.1021/pr060681i; Pitarch A, 2006, MOL CELL PROTEOMICS, V5, P79, DOI 10.1074/mcp.M500243-MCP200; Pitarch A, 2004, PROTEOMICS, V4, P3084, DOI 10.1002/pmic.200400903; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; POOLMAN J, 1990, OUTER MEMBRANE VESIC, P202; REDD SC, 1988, J CLIN MICROBIOL, V26, P1373, DOI 10.1128/JCM.26.7.1373-1377.1988; REDHEAD K, 1984, INFECT IMMUN, V44, P724, DOI 10.1128/IAI.44.3.724-729.1984; Roberts R, 2008, VACCINE, V26, P4639, DOI 10.1016/j.vaccine.2008.07.004; Salim KY, 2005, INFECT IMMUN, V73, P6026, DOI 10.1128/IAI.73.9.6026-6038.2005; Sanchez-Campillo M, 1999, ELECTROPHORESIS, V20, P2269, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D; Sellman BR, 2005, INFECT IMMUN, V73, P6591, DOI 10.1128/IAI.73.10.6591-6600.2005; Serruto D, 2004, J BIOTECHNOL, V113, P15, DOI 10.1016/j.jbiotec.2004.03.024; Shin GW, 2009, VET MICROBIOL, V139, P113, DOI 10.1016/j.vetmic.2009.05.007; Storsaeter J, 1998, VACCINE, V16, P1907, DOI 10.1016/S0264-410X(98)00227-8; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS83, DOI 10.1097/01.inf.0000160919.94330.1a; TeixeiraGomes AP, 1997, ELECTROPHORESIS, V18, P1491, DOI 10.1002/elps.1150180824; THOMAS MG, 1989, J INFECT DIS, V159, P211, DOI 10.1093/infdis/159.2.211; Twine SM, 2006, BIOCHEM BIOPH RES CO, V346, P999, DOI 10.1016/j.bbrc.2006.06.008; van den Berg BM, 1999, INFECT IMMUN, V67, P1050, DOI 10.1128/IAI.67.3.1050-1055.1999; van Loo IHM, 2002, J CLIN MICROBIOL, V40, P1994, DOI 10.1128/JCM.40.6.1994-2001.2002; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Vytvytska O, 2002, PROTEOMICS, V2, P580, DOI 10.1002/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G; *WHO, 2006, WORLD HLTH REP 2004; Williams JN, 2009, INFECT IMMUN, V77, P5080, DOI 10.1128/IAI.00701-09; WOODS DE, 1989, INFECT IMMUN, V57, P1018, DOI 10.1128/IAI.57.4.1018-1024.1989; Xia XX, 2008, PROTEOMICS, V8, P2089, DOI 10.1002/pmic.200700826; YAN F, 2009, VET J; Ying TY, 2005, PROTEOMICS, V5, P4777, DOI 10.1002/pmic.200401326; Zhang W, 2007, ZOONOSES PUBLIC HLTH, V54, P253, DOI 10.1111/j.1863-2378.2007.01056.x; Zhang W, 2007, PROTEOMICS, V7, P4468, DOI 10.1002/pmic.200700294; Zhu YZ, 2008, OMICS, V12, P161, DOI 10.1089/omi.2008.0029	87	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13915	10.1371/journal.pone.0013915	http://dx.doi.org/10.1371/journal.pone.0013915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21170113	gold, Green Published, Green Submitted			2022-12-27	WOS:000284035900020
J	Avlund, M; Krishna, S; Semsey, S; Dodd, IB; Sneppen, K				Avlund, Mikkel; Krishna, Sandeep; Semsey, Szabolcs; Dodd, Ian B.; Sneppen, Kim			Minimal Gene Regulatory Circuits for a Lysis-Lysogeny Choice in the Presence of Noise	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; PHAGE-LAMBDA; ESCHERICHIA-COLI; KINETIC-ANALYSIS; DECISION-MAKING; SINGLE-CELL; EXPRESSION; TEMPERATE; REPRESSOR; INFECTION	Gene regulatory networks (GRNs) that make reliable decisions should have design features to cope with random fluctuations in the levels or activities of biological molecules. The phage lambda GRN makes a lysis-lysogeny decision informed by the number of phages infecting the cell. To analyse the design of decision making GRNs, we generated random in silico GRNs comprised of two or three transcriptional regulators and selected those able to perform a lambda-like decision in the presence of noise. Various two-protein networks analogous to the lambda CI-Cro GRN worked in noise-less conditions but failed when noise was introduced. Adding a lambda CII-like protein significantly improved robustness to noise. CII relieves the CI-like protein of its 'decider' function, allowing CI to be optimized as a decision 'maintainer'. CII's lysogenic decider function was improved by its instability and rapid removal once the decision was taken, preventing its interference with maintenance. A more reliable decision also resulted from simulated co-transcription of the genes for CII and the Cro-like protein, which correlates fluctuations in these opposing decider functions and makes their ratio less noisy. Thus, the lambda decision network contains design features for reducing and resisting noise.	[Avlund, Mikkel; Krishna, Sandeep; Semsey, Szabolcs; Sneppen, Kim] Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen, Denmark; [Krishna, Sandeep] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Dodd, Ian B.] Univ Adelaide, Adelaide, SA, Australia	University of Copenhagen; Niels Bohr Institute; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Adelaide	Avlund, M (corresponding author), Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	sneppen@nbi.dk	Semsey, Szabolcs/L-6329-2013	krishna, sandeep/0000-0002-0581-173X; Sneppen, Kim/0000-0001-9820-3567; Dodd, Ian/0000-0003-2969-6841; Semsey, Szabolcs/0000-0002-4522-5495	Japanese Ministry of Health Labor and Welfare; Takeda Science Foundation	Japanese Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by the Japanese Ministry of Health Labor and Welfare and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Arkin A, 1998, GENETICS, V149, P1633; Aurell E, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051914; Avlund M, 2009, J MOL BIOL, V394, P681, DOI 10.1016/j.jmb.2009.09.053; Avlund M, 2009, J VIROL, V83, P11416, DOI 10.1128/JVI.01057-09; Baek K, 2003, J MOL BIOL, V334, P363, DOI 10.1016/j.jmb.2003.09.037; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; BETTER M, 1983, VIROLOGY, V126, P168, DOI 10.1016/0042-6822(83)90469-5; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Degnan PH, 2007, MOL MICROBIOL, V64, P232, DOI 10.1111/j.1365-2958.2007.05650.x; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; DODD IB, 1990, J MOL BIOL, V214, P27, DOI 10.1016/0022-2836(90)90144-B; EISEN H, 1970, P NATL ACAD SCI USA, V66, P855, DOI 10.1073/pnas.66.3.855; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; GANN A, 1992, Current Biology, V2, P282, DOI 10.1016/0960-9822(92)90861-4; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; GOTTESMAN S, 1981, CELL, V24, P225, DOI 10.1016/0092-8674(81)90518-3; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Kapfhammer D, 2002, J BACTERIOL, V184, P6592, DOI 10.1128/JB.184.23.6592-6601.2002; Karlsson JL, 2006, J BACTERIOL, V188, P3923, DOI 10.1128/JB.01953-05; Kobiler O, 2005, P NATL ACAD SCI USA, V102, P4470, DOI 10.1073/pnas.0500670102; Kobiler O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000363; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; KOURILSKY P, 1974, BIOCHIMIE, V56, P1517; Kropinski AM, 2000, J BACTERIOL, V182, P6066, DOI 10.1128/JB.182.21.6066-6074.2000; Little JW, 1999, EMBO J, V18, P4299, DOI 10.1093/emboj/18.15.4299; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedersen M, 2008, J MOL BIOL, V384, P577, DOI 10.1016/j.jmb.2008.09.071; Ptashne M, 2004, GENETIC SWITCH PHAGE; RATTRAY A, 1984, J BACTERIOL, V159, P238, DOI 10.1128/JB.159.1.238-242.1984; REICHARDT LF, 1975, J MOL BIOL, V93, P289, DOI 10.1016/0022-2836(75)90133-3; Rokney A, 2008, MOL MICROBIOL, V68, P29, DOI 10.1111/j.1365-2958.2008.06119.x; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; SHEAN CS, 1992, CELL, V70, P513, DOI 10.1016/0092-8674(92)90175-C; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Svenningsen SL, 2005, P NATL ACAD SCI USA, V102, P4465, DOI 10.1073/pnas.0409839102; Trusina A, 2005, PLOS COMPUT BIOL, V1, P599, DOI 10.1371/journal.pcbi.0010074; Von Dassow G, 2002, J EXP ZOOL, V294, P179, DOI 10.1002/jez.10144; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034	47	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15037	10.1371/journal.pone.0015037	http://dx.doi.org/10.1371/journal.pone.0015037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188148	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200013
J	Fleming, NI; Knower, KC; Lazarus, KA; Fuller, PJ; Simpson, ER; Clyne, CD				Fleming, Nicholas I.; Knower, Kevin C.; Lazarus, Kyren A.; Fuller, Peter J.; Simpson, Evan R.; Clyne, Colin D.			Aromatase Is a Direct Target of FOXL2: C134W in Granulosa Cell Tumors via a Single Highly Conserved Binding Site in the Ovarian Specific Promoter	PLOS ONE			English	Article							LIVER RECEPTOR HOMOLOG-1; TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION; GENE-TRANSCRIPTION; DNA-BINDING; MUTATIONAL ANALYSIS; PROXIMAL PROMOTER; CYP19 GENE; EXPRESSION; LINE	Background: Granulosa cell tumors (GCT) of the ovary often express aromatase and synthesize estrogen, which in turn may influence their progression. Recently a specific point mutation (C134W) in the FOXL2 protein was identified in >94% of adult-type GCT and it is likely to contribute to their development. A number of genes are known to be regulated by FOXL2, including aromatase/CYP19A1, but it is unclear which are direct targets and whether the C134W mutation alters their regulation. Recently, it has been reported that FOXL2 forms a complex with steroidogenic factor 1 (SF-1) which is a known regulator of aromatase in granulosa cells. Methodology/Principal Findings: In this work, the human GCT-derived cell lines KGN and COV434 were heterozygous and wildtype for the FOXL2: C134W mutation, respectively. KGN had abundant FOXL2 mRNA expression but it was not expressed in COV434. Expression of exogenous FOXL2: C134W in COV434 cells induced higher expression of a luciferase reporter for the ovarian specific aromatase promoter, promoter II (PII) (-516bp) than expression of wildtype FOXL2, but did not alter induction of a similar reporter for the steroidogenic acute regulatory protein (StAR) promoter (-1300bp). Coimmunoprecipitation confirmed that FOXL2 bound SF-1 and that it also bound its homologue, liver receptor homologue 1 (LRH-1), however, the C134W mutation did not alter these interactions or induce a selective binding of the proteins. A highly conserved putative binding site for FOXL2 was identified in PII. FOXL2 was demonstrated to bind the site by electrophoretic mobility shift assays (EMSA) and site-directed mutagenesis of this element blocked its differential induction by wildtype FOXL2 and FOXL2: C134W. Conclusions/Significance: These findings suggest that aromatase is a direct target of FOXL2: C134W in adult-type GCT via a single distinctive and highly conserved binding site in PII and therefore provide insight into the pathogenic mechanism of this mutation.	[Fleming, Nicholas I.; Knower, Kevin C.; Lazarus, Kyren A.; Fuller, Peter J.; Simpson, Evan R.; Clyne, Colin D.] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Fuller, Peter J.; Simpson, Evan R.; Clyne, Colin D.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Prince Henry's Institute of Medical Research; Monash University	Fleming, NI (corresponding author), Prince Henrys Inst Med Res, Clayton, Vic, Australia.	colin.clyne@princehenrys.org	Knower, Kevin/C-2869-2014	Fuller, Peter/0000-0002-0948-2072	National Health and Medical Research Council (NHMRC) of Australia; U.S. Department of Defense [W81XWH-08-BCRP-POSTDOC]; Prince Henry's Institute; Victorian Breast Cancer Research Consortium Inc.; Victorian Government; NHMRC [338516, 494802]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); U.S. Department of Defense(United States Department of Defense); Prince Henry's Institute; Victorian Breast Cancer Research Consortium Inc.; Victorian Government; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	PJF and ERS were supported by the National Health and Medical Research Council (NHMRC) (www.nhmrc.gov.au) of Australia through a Senior Principal Research Fellowships. CDC was supported by the NHMRC R.D. Wright Fellowship #338516. KCK was supported by a U.S. Department of Defense Postdoctoral Training Award (W81XWH-08-BCRP-POSTDOC). KAL was supported by a Prince Henry's Institute Vacation Scholarship (www.princehenrys.org). The work was supported by a NHMRC Program Grant #494802 and also a grant from the Victorian Breast Cancer Research Consortium Inc. (www.vbcrc.org.au). Prince Henry's Institute is also supported by the Victorian Government's Operational Infrastructure Support Program (www.vic.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VR, 1995, MOL CELL PROBE, V9, P453, DOI 10.1006/mcpr.1995.0069; Bates DL, 2008, J MOL BIOL, V381, P1292, DOI 10.1016/j.jmb.2008.06.072; Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; Bentsi-Barnes IK, 2010, FERTIL STERIL, V94, P353, DOI 10.1016/j.fertnstert.2009.09.050; Bilandzic M, 2009, MOL ENDOCRINOL, V23, P539, DOI 10.1210/me.2008-0300; Bittinger S, 2009, INT J GYNECOL CANCER, V19, P339, DOI 10.1111/IGC.0b013e3181a1cdfd; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Bratus A, 2009, CYTOGENET GENOME RES, V126, P180, DOI 10.1159/000245918; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chu S, 2004, MOL ENDOCRINOL, V18, P1919, DOI 10.1210/me.2004-0021; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; Escudero JM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-4; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jin TR, 2000, BREAST CANCER RES TR, V62, P151, DOI 10.1023/A:1006481228794; Kalfa N, 2008, J UROLOGY, V180, P1810, DOI 10.1016/j.juro.2008.03.097; Kalfa N, 2007, FERTIL STERIL, V87, P896, DOI 10.1016/j.fertnstert.2006.11.016; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim MS, 2010, J PATHOL, V221, P147, DOI 10.1002/path.2688; Kim SY, 2009, ENDOCRINOLOGY, V150, P5085, DOI 10.1210/en.2009-0313; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Loffler KA, 2003, ENDOCRINOLOGY, V144, P3237, DOI 10.1210/en.2002-0095; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; Marongiu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009477; Michael MD, 1997, MOL CELL ENDOCRINOL, V134, P147, DOI 10.1016/S0303-7207(97)00178-0; MICHAEL MD, 1995, J BIOL CHEM, V270, P13561, DOI 10.1074/jbc.270.22.13561; Moniot B, 2000, MECH DEVELOP, V91, P323, DOI 10.1016/S0925-4773(99)00267-1; Murphy MW, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-58; Murphy TC, 2004, INVEST OPHTH VIS SCI, V45, P2531, DOI 10.1167/iovs.04-0167; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Onuma H, 2006, MOL ENDOCRINOL, V20, P2831, DOI 10.1210/me.2006-0085; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Park M, 2010, MOL ENDOCRINOL, V24, P1024, DOI 10.1210/me.2009-0375; Peng N, 2003, J CLIN ENDOCR METAB, V88, P6020, DOI 10.1210/jc.2003-030880; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stevens K, 2000, J BIOL CHEM, V275, P30471, DOI 10.1074/jbc.M004891200; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Tsai KL, 2006, J BIOL CHEM, V281, P17400, DOI 10.1074/jbc.M600478200; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Uhlenhaut NH, 2006, MOL GENET METAB, V88, P225, DOI 10.1016/j.ymgme.2006.03.005; VANDENBERGBAKKER CAM, 1993, INT J CANCER, V53, P613, DOI 10.1002/ijc.2910530415; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Woods DC, 2008, CANCER LETT, V260, P20, DOI 10.1016/j.canlet.2007.10.016; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146	66	99	100	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14389	10.1371/journal.pone.0014389	http://dx.doi.org/10.1371/journal.pone.0014389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188138	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200011
J	Gonci, B; Nemeth, V; Balogh, E; Szabo, B; Denes, A; Kornyei, Z; Vicsek, T				Goenci, Balazs; Nemeth, Valeria; Balogh, Emeric; Szabo, Balint; Denes, Adam; Koernyei, Zsuzsanna; Vicsek, Tamas			Viral Epidemics in a Cell Culture: Novel High Resolution Data and Their Interpretation by a Percolation Theory Based Model	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PSEUDORABIES VIRUS; IN-VITRO; SPREAD; INFECTION; REPLICATION; SUSCEPTIBILITY; TRANSMISSION; INTERFERON; DISEASE	Because of its relevance to everyday life, the spreading of viral infections has been of central interest in a variety of scientific communities involved in fighting, preventing and theoretically interpreting epidemic processes. Recent large scale observations have resulted in major discoveries concerning the overall features of the spreading process in systems with highly mobile susceptible units, but virtually no data are available about observations of infection spreading for a very large number of immobile units. Here we present the first detailed quantitative documentation of percolation-type viral epidemics in a highly reproducible in vitro system consisting of tens of thousands of virtually motionless cells. We use a confluent astroglial monolayer in a Petri dish and induce productive infection in a limited number of cells with a genetically modified herpesvirus strain. This approach allows extreme high resolution tracking of the spatio-temporal development of the epidemic. We show that a simple model is capable of reproducing the basic features of our observations, i.e., the observed behaviour is likely to be applicable to many different kinds of systems. Statistical physics inspired approaches to our data, such as fractal dimension of the infected clusters as well as their size distribution, seem to fit into a percolation theory based interpretation. We suggest that our observations may be used to model epidemics in more complex systems, which are difficult to study in isolation.	[Goenci, Balazs; Nemeth, Valeria; Balogh, Emeric; Szabo, Balint; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Balogh, Emeric] Univ Babes Bolyai, Dept Theoret Phys, R-3400 Cluj Napoca, Romania; [Balogh, Emeric] Univ Szeged, Dept Opt & Quantum Elect, Szeged, Hungary; [Denes, Adam; Koernyei, Zsuzsanna] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Denes, Adam] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Vicsek, Tamas] Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary	Eotvos Lorand University; Babes Bolyai University from Cluj; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Manchester; Hungarian Academy of Sciences	Gonci, B (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary.	vicsek@hal.elte.hu	Balogh, Emeric/F-7629-2010	Balogh, Emeric/0000-0002-8253-7105	National Office of Research and Technology, Hungary; European Research Council [227878]	National Office of Research and Technology, Hungary(National Office for Research and Technology); European Research Council(European Research Council (ERC)European Commission)	National Office of Research and Technology, Hungary, http://www.nkth.gov.hu/english, Grant: NKTH ELTE CellCom RET http://cellkom.elte.hu/projects. html, European Research Council, http://erc.europa.eu/ Grant: EU ERC COLLMOT No: 227878 http://erc.europa.eu/index.cfm?fuseaction = page.display&topicID = 517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAINBARRAT A, 2008, DYNAM PROC COMPL NET; APPLEYARD G, 1971, J GEN VIROL, V13, P9, DOI 10.1099/0022-1317-13-1-9; Boldogkoi Z, 2002, MOL BRAIN RES, V109, P105, DOI 10.1016/S0169-328X(02)00546-6; Boldogkoi Z, 2004, PROG NEUROBIOL, V72, P417, DOI 10.1016/j.pneurobio.2004.03.010; BRAUER F, 2001, NATH MOD POP BIO EPI; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; CARD JP, 1993, J NEUROSCI, V13, P2515, DOI 10.1523/JNEUROSCI.13-06-02515.1993; Carrascosa AL, 1999, ARCH VIROL, V144, P1309, DOI 10.1007/s007050050589; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; DALEY DJ, 1999, EPIDEM MOD INTR CAMB; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; Duca KA, 2001, BIOTECHNOL PROGR, V17, P1156, DOI 10.1021/bp010115m; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fitting S, 2010, J PROTEOME RES, V9, P1795, DOI 10.1021/pr900926n; Garner JA, 2003, ADV DRUG DELIVER REV, V55, P1497, DOI 10.1016/j.addr.2003.07.006; Granzow H, 1997, J VIROL, V71, P2072, DOI 10.1128/JVI.71.3.2072-2082.1997; Haseltine EL, 2008, B MATH BIOL, V70, P1730, DOI 10.1007/s11538-008-9316-3; Heindl JE, 2010, INFECT IMMUN, V78, P193, DOI 10.1128/IAI.00252-09; HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438; Hua H, 2009, P NATL ACAD SCI USA, V106, P1318, DOI 10.1073/pnas.0811973106; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; KATSUMOTO T, 1981, J GEN VIROL, V52, P267, DOI 10.1099/0022-1317-52-2-267; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; KHELIFA R, 1982, J VIROL, V42, P402; Kornyei Z, 2005, GLIA, V49, P430, DOI 10.1002/glia.20123; LAI PC, 2009, SPAT EPID APPR DIS M; Lam V, 2005, BIOTECHNOL BIOENG, V90, P793, DOI 10.1002/bit.20467; Law M, 2002, J GEN VIROL, V83, P209, DOI 10.1099/0022-1317-83-1-209; Lee Y, 1996, NAT BIOTECHNOL, V14, P491, DOI 10.1038/nbt0496-491; Li DQ, 1999, CLIN CANCER RES, V5, P4175; MARQUIS H, 2006, CURR PROT MICROBIOL, P4; PFEIFFER DU, 2008, SPAT ANALYS EPIDEM O; PRICE RW, 1982, ARCH VIROL, V71, P127, DOI 10.1007/BF01314882; Rhodes CJ, 1998, J FRANKLIN I, V335B, P199, DOI 10.1016/S0016-0032(96)00096-8; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; STAUFFER D, 1991, INTR PERC THEORY LON; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; van der Meulen KM, 2002, VET MICROBIOL, V86, P157, DOI 10.1016/S0378-1135(01)00499-0; VICSEK T, 1992, FRACT GROWTH PHEN SI; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Way SS, 1998, INFECT IMMUN, V66, P1342, DOI 10.1128/IAI.66.4.1342-1348.1998; Zhu Y, 2007, J VIROL METHODS, V139, P100, DOI 10.1016/j.jviromet.2006.09.006	45	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15571	10.1371/journal.pone.0015571	http://dx.doi.org/10.1371/journal.pone.0015571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187920	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200043
J	Rajicic, N; Cuschieri, J; Finkelstein, DM; Miller-Graziano, CL; Hayden, D; Moldawer, LL; Moore, E; O'Keefe, G; Pelik, K; Warren, HS; Schoenfeld, DA				Rajicic, Natasa; Cuschieri, Joseph; Finkelstein, Dianne M.; Miller-Graziano, Carol L.; Hayden, Douglas; Moldawer, Lyle L.; Moore, Ernest; O'Keefe, Grant; Pelik, Kimberly; Warren, H. Shaw; Schoenfeld, David A.		Inflammation Host Response Injury	Identification and Interpretation of Longitudinal Gene Expression Changes in Trauma	PLOS ONE			English	Article							MULTIPLE; INFLAMMATION; NEUTROPHILS; PATTERNS	Rationale: The relationship between leukocyte gene expression and recovery of respiratory function after injury may provide information on the etiology of multiple organ dysfunction. Objectives: To find a list of genes for which expression after injury predicts respiratory recovery, and to identify which networks and pathways characterize these genes. Methods: Blood was sampled at 12 hours and at 1, 4, 7, 21 and 28 days from 147 patients who had been admitted to the hospital after blunt trauma. Leukocyte gene expression was measured using Affymetrix oligonucleotide arrays. A linear model, fit to each probe-set expression value, was used to impute the gene expression trajectory over the entire follow-up period. The proportional hazards model score test was used to calculate the statistical significance of each probe-set trajectory in predicting respiratory recovery. A list of genes was determined such that the expected proportion of false positive results was less than 10%. These genes were compared to the Gene Ontology for 'response to stimulus' and, using Ingenuity software, were mapped into networks and pathways. Measurements and Main Results: The median time to respiratory recovery was 6 days. There were 170 probe-sets representing 135 genes that were found to be related to respiratory recovery. These genes could be mapped to nine networks. Two known pathways that were activated were antigen processing and presentation and JAK-signaling. Conclusions: The examination of the relationship of gene expression over time with a patient's clinical course can provide information which may be useful in determining the mechanism of recovery or lack of recovery after severe injury.	[Rajicic, Natasa] Pfizer Inc, New York, NY 10017 USA; [Cuschieri, Joseph] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Finkelstein, Dianne M.; Hayden, Douglas; Pelik, Kimberly; Schoenfeld, David A.] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Miller-Graziano, Carol L.] Univ Rochester, Rochester, NY USA; [Moldawer, Lyle L.] Univ Florida, Shands Hosp, Gainesville, FL USA; [Moore, Ernest] Univ Colorado, Denver Hlth Med Ctr, Denver, CO 80202 USA; [O'Keefe, Grant] Univ Washington, Div Trauma & Gen Surg, Harborview, WA USA; [Warren, H. Shaw] Massachusetts Gen Hosp, Infect Dis Unit, Charlestown, MA USA	Pfizer; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; University of Rochester; State University System of Florida; University of Florida; Denver Health Medical Center; University of Colorado System; University of Colorado Denver; University of Washington; Harvard University; Massachusetts General Hospital	Rajicic, N (corresponding author), Pfizer Inc, New York, NY 10017 USA.	Natasa.Rajicic@pfizer.com	O'KEEFE, GRANT/GON-5797-2022	xiao, wenzhong/0000-0003-4944-6380; Moldawer, Lyle/0000-0002-9041-9838; West, Michaela A/0000-0002-6598-4114	National Institute of General Medical Sciences [U54 GM-62119-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a Large Scale Collaborative Research Grant from the National Institute of General Medical Sciences, U54 GM-62119-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BO, 1991, J APPL PHYSIOL, V71, P1862, DOI 10.1152/jappl.1991.71.5.1862; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Biffl WL, 1999, SURGERY, V126, P198, DOI 10.1067/msy.1999.98738; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; Brownstein BH, 2006, PHYSIOL GENOMICS, V24, P298, DOI 10.1152/physiolgenomics.00213.2005; Ciesla DJ, 2005, ARCH SURG-CHICAGO, V140, P432, DOI 10.1001/archsurg.140.5.432; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; ERICKSON SE, 2009, CRIT CARE MED, V37, P1798; Frank EG, 2001, EMBO J, V20, P2914, DOI 10.1093/emboj/20.11.2914; Maier M, 2008, SHOCK, V30, P344, DOI 10.1097/SHK.0b013e3181673eb4; Meldrum DR, 1997, ANN SURG, V226, P587, DOI 10.1097/00000658-199711000-00003; Moore EE, 2005, SHOCK, V24, P71, DOI 10.1097/01.shk.0000191336.01036.fe; MOORE FA, 1995, SURG CLIN N AM, V75, P257, DOI 10.1016/S0039-6109(16)46587-4; Murphy TJ, 2004, J LEUKOCYTE BIOL, V75, P400, DOI 10.1189/jlb.0503233; Rajicic N, 2006, BIOINFORMATICS, V22, P2643, DOI 10.1093/bioinformatics/btl450; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Warren HS, 2009, MOL MED, V15, P220, DOI 10.2119/molmed.2009.00027; Zallen G, 1999, J TRAUMA, V46, P42, DOI 10.1097/00005373-199901000-00007; INFLAMMATION HOST RE; 2007, GENE SET ANAL TOOLKI	23	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14380	10.1371/journal.pone.0014380	http://dx.doi.org/10.1371/journal.pone.0014380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187951	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200007
J	Tsurumi, C; Esser, N; Firat, E; Gaedicke, S; Follo, M; Behe, M; Elsasser-Beile, U; Grosu, AL; Graeser, R; Niedermann, G				Tsurumi, Chizuko; Esser, Norbert; Firat, Elke; Gaedicke, Simone; Follo, Marie; Behe, Martin; Elsaesser-Beile, Ursula; Grosu, Anca-Ligia; Graeser, Ralph; Niedermann, Gabriele			Non-Invasive In Vivo Imaging of Tumor-Associated CD133/Prominin	PLOS ONE			English	Article							CANCER STEM-CELLS; PANCREATIC-CANCER; INITIATING CELLS; DNA-DAMAGE; CD133; ANTIBODIES; IDENTIFICATION; RADIOBIOLOGY; GLIOBLASTOMA; CHALLENGES	Background: Cancer stem cells are thought to play a pivotal role in tumor maintenance, metastasis, tumor therapy resistance and relapse. Hence, the development of methods for non-invasive in vivo detection of cancer stem cells is of great importance. Methodology/Principal Findings: Here, we describe successful in vivo detection of CD133/prominin, a cancer stem cell surface marker for a variety of tumor entities. The CD133-specific monoclonal antibody AC133.1 was used for quantitative fluorescence-based optical imaging of mouse xenograft models based on isogenic pairs of CD133 positive and negative cell lines. A first set consisted of wild-type U251 glioblastoma cells, which do not express CD133, and lentivirally transduced CD133-overexpressing U251 cells. A second set made use of HCT116 colon carcinoma cells, which uniformly express CD133 at levels comparable to primary glioblastoma stem cells, and a CD133-negative HCT116 derivative. Not surprisingly, visualization and quantification of CD133 in overexpressing U251 xenografts was successful; more importantly, however, significant differences were also found in matched HCT116 xenograft pairs, despite the lower CD133 expression levels. The binding of i.v.-injected AC133.1 antibodies to CD133 positive, but not negative, tumor cells isolated from xenografts was confirmed by flow cytometry. Conclusions/Significance: Taken together, our results show that non-invasive antibody-based in vivo imaging of tumor-associated CD133 is feasible and that CD133 antibody-based tumor targeting is efficient. This should facilitate developing clinically applicable cancer stem cell imaging methods and CD133 antibody-based therapeutics.	[Tsurumi, Chizuko; Firat, Elke; Gaedicke, Simone; Grosu, Anca-Ligia; Niedermann, Gabriele] Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany; [Follo, Marie] Univ Hosp Freiburg, Dept Internal Med 1, Freiburg, Germany; [Behe, Martin] Univ Hosp Freiburg, Dept Nucl Med, Freiburg, Germany; [Elsaesser-Beile, Ursula] Univ Hosp Freiburg, Dept Urol, Freiburg, Germany; [Esser, Norbert; Graeser, Ralph] ProQinase GmbH, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; ProQinase	Tsurumi, C (corresponding author), Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany.	gabriele.niedermann@uniklinik-freiburg.de	Behe, Martin/E-2941-2013	Follo, Marie/0000-0002-3090-7442	Clotten Foundation	Clotten Foundation	This work was supported by a grant from the Clotten Foundation. ProQuinase did not sponsor this study. The costs were equally shared between the University of Freiburg and ProQuinase. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt K, 2010, PROSTATE, V70, P1413, DOI 10.1002/pros.21176; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chiou SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002090; Deonarain MP, 2009, MABS-AUSTIN, V1, P12, DOI 10.4161/mabs.1.1.7347; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Firat E, 2010, INT J RADIAT BIOL, V86, P252, DOI 10.3109/09553000903419320; Hart LS, 2008, J CLIN ONCOL, V26, P2901, DOI 10.1200/JCO.2008.16.9573; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; KOSSODO S, 2009, MOL IMAGING BIOL; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Montet X, 2005, CANCER RES, V65, P6330, DOI 10.1158/0008-5472.CAN-05-0382; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Ogawa M, 2009, CANCER RES, V69, P1268, DOI 10.1158/0008-5472.CAN-08-3116; Okamoto OK, 2008, EXPERT REV MOL DIAGN, V8, P387, DOI 10.1586/14737159.8.4.387; Olafsen T, 2010, SEMIN NUCL MED, V40, P167, DOI 10.1053/j.semnuclmed.2009.12.005; Pajonk F, 2010, STEM CELLS, V28, P639, DOI 10.1002/stem.318; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh SK, 2003, CANCER RES, V63, P5821; Smith LM, 2008, BRIT J CANCER, V99, P100, DOI 10.1038/sj.bjc.6604437; Sureban SM, 2008, GASTROENTEROLOGY, V134, pA86; Tsurumi C, 2009, BIOCHEM BIOPH RES CO, V386, P563, DOI 10.1016/j.bbrc.2009.06.068; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Woodward WA, 2008, CANCER METAST REV, V27, P459, DOI 10.1007/s10555-008-9130-2; Woodward WA, 2009, SEMIN RADIAT ONCOL, V19, P87, DOI 10.1016/j.semradonc.2008.11.003; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	40	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15605	10.1371/journal.pone.0015605	http://dx.doi.org/10.1371/journal.pone.0015605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187924	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200047
J	Dresing, P; Borkens, S; Kocur, M; Kropp, S; Scheu, S				Dresing, Philipp; Borkens, Stephanie; Kocur, Magdalena; Kropp, Sonja; Scheu, Stefanie			A Fluorescence Reporter Model Defines "Tip-DCs'' as the Cellular Source of Interferon beta in Murine Listeriosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; DENDRITIC CELLS; MONOCYTOGENES INFECTION; BACTERIAL-INFECTION; MICE LACKING; ENDOTOXIC-SHOCK; I INTERFERONS; IFN-GAMMA; MONOCYTES; MACROPHAGES	Production of type I interferons, consisting mainly of multiple IFN alpha subtypes and IFN beta, represents an essential part of the innate immune defense against invading pathogens. While in most situations, namely viral infections, this class of cytokines is indispensable for host survival they mediate a detrimental effect during infection with L. monocytogenes by rendering macrophages insensitive towards IFN gamma signalling which leads to a lethal bacterial pathology in mice. Due to a lack of suitable analytic tools the precise identity of the cell population responsible for type I IFN production remains ill-defined and so far these cells have been described to be macrophages. As in general IFN beta is the first type I interferon to be produced, we took advantage of an IFN beta fluorescence reporter-knockin mouse model in which YFP is expressed from a bicistronic mRNA linked by an IRES to the endogenous ifnb mRNA to assess the IFN beta production on a single cell level in situ. Our results showed highest frequencies and absolute numbers of IFN beta(+) cells in the spleen 24 h after infection with L. monocytogenes where they were located predominately in the white pulp within the foci of infection. Detailed FACS surface marker analyses, intracellular cytokine stainings and T cell proliferation assays revealed that the IFN beta(+) cells were a phenotypically and functionally further specialized subpopulation of TNF and iNOS producing DCs (Tip-DCs) which are known to be essential for the early containment of L. monocytogenes infection. We proved that the IFN beta(+) cells exhibited the hallmark characteristics of Tip-DCs as they produced iNOS and TNF and possessed T cell priming abilities. These results point to a yet unappreciated ambiguous role for a multi-effector, IFN beta producing subpopulation of Tip-DCs in controlling the balance between containment of L. monocytogenes infection and effects detrimental to the host driven by IFN beta.	[Dresing, Philipp] Univ Dusseldorf, Inst Med Microbiol, Dusseldorf, Germany; Univ Dusseldorf, Hosp Hyg, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Dresing, P (corresponding author), Univ Dusseldorf, Inst Med Microbiol, Dusseldorf, Germany.	stefanie.scheu@uni-duesseldorf.de	Scheu, Stefanie/H-3670-2019	Scheu, Stefanie/0000-0002-9707-8191	Deutsche Forschungsgemeinschaft [SCHE692/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHE692/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Moussawi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000722; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Freudenberg MA, 2002, J IMMUNOL, V169, P1665, DOI 10.4049/jimmunol.169.4.1665; Garifulin O, 2007, PLOS GENET, V3, P1587, DOI 10.1371/journal.pgen.0030152; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gregory SH, 1996, J IMMUNOL, V157, P2514; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HAVELL EA, 1989, J IMMUNOL, V143, P2894; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Jablonska J, 2007, INFECT IMMUN, V75, P462, DOI 10.1128/IAI.00443-06; Jia T, 2009, J IMMUNOL, V183, P1271, DOI 10.4049/jimmunol.0900460; Jin YX, 2001, INFECT IMMUN, V69, P1093, DOI 10.1128/IAI.69.2.1093-1100.2001; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kursar M, 2002, J IMMUNOL, V168, P6382, DOI 10.4049/jimmunol.168.12.6382; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Muraille E, 2005, EUR J IMMUNOL, V35, P1463, DOI 10.1002/eji.200526024; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stockinger S, 2008, IMMUNOBIOLOGY, V213, P889, DOI 10.1016/j.imbio.2008.07.020; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004	48	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15567	10.1371/journal.pone.0015567	http://dx.doi.org/10.1371/journal.pone.0015567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179567	Green Submitted, Green Published, gold			2022-12-27	WOS:000285381200031
J	Moore, TJ; Glenmullen, J; Furberg, CD				Moore, Thomas J.; Glenmullen, Joseph; Furberg, Curt D.			Prescription Drugs Associated with Reports of Violence Towards Others	PLOS ONE			English	Article							SUICIDAL ADVERSE EVENTS	Context: Violence towards others is a seldom-studied adverse drug event and an atypical one because the risk of injury extends to others. Objective: To identify the primary suspects in adverse drug event reports describing thoughts or acts of violence towards others, and assess the strength of the association. Methodology: From the Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) data, we extracted all serious adverse event reports for drugs with 200 or more cases received from 2004 through September 2009. We identified any case report indicating homicide, homicidal ideation, physical assault, physical abuse or violence related symptoms. Main Outcome Measures: Disproportionality in reporting was defined as a) 5 or more violence case reports, b) at least twice the number of reports expected given the volume of overall reports for that drug, c) a chi 2 statistic indicating the violence cases were unlikely to have occurred by chance (p < 0.01). Results: We identified 1527 cases of violence disproportionally reported for 31 drugs. Primary suspect drugs included varenicline (an aid to smoking cessation), 11 antidepressants, 6 sedative/hypnotics and 3 drugs for attention deficit hyperactivity disorder. The evidence of an association was weaker and mixed for antipsychotic drugs and absent for all but 1 anticonvulsant/mood stabilizer. Two or fewer violence cases were reported for 435/484 (84.7%) of all evaluable drugs suggesting that an association with this adverse event is unlikely for these drugs. Conclusions: Acts of violence towards others are a genuine and serious adverse drug event associated with a relatively small group of drugs. Varenicline, which increases the availability of dopamine, and antidepressants with serotonergic effects were the most strongly and consistently implicated drugs. Prospective studies to evaluate systematically this side effect are needed to establish the incidence, confirm differences among drugs and identify additional common features.	[Moore, Thomas J.] Inst Safe Medicat Practices, Alexandria, VA USA; [Glenmullen, Joseph] Harvard Univ, Sch Med, Cambridge Hosp, Dept Psychiat, Cambridge, MA 02138 USA; [Furberg, Curt D.] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA	Harvard University; Cambridge Health Alliance; Cambridge Hospital; Wake Forest University; Wake Forest Baptist Medical Center	Moore, TJ (corresponding author), Inst Safe Medicat Practices, Alexandria, VA USA.	tmoore@ismp.org		Moore, Thomas/0000-0003-0994-836X				*ASTRAZENECA PHARM, 2010, SEROQUEL QUET FUM TA; Brown J.H., 2001, GOODMAN GILMANS PHAR, V10th ed., P10; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; *GLAXOSMITHKLINE, 2009, PAXIL PAR HYDR TABL; *JAZZ PHARM, 2009, XYREM SOD OX SOL PAC; *MEDDRA MAINT SUPP, 2009, INTR GUID MEDDRA VER; *MERCK CO I, 2010, SINGULAIR MONT SOD T; MOORE T, 2008, QUARTERWATCH 2008 QU; Moore TJ, 2010, ANN PHARMACOTHER, V44, P1389, DOI 10.1345/aph.1P172; Moore TJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4964; MOORE TJ, 2010, QUARTERWATCH 2009 QU; MOORE TJ, 2008, STRONG SIGNAL SEEN N; Mosholder AD, 2006, J CHILD ADOL PSYCHOP, V16, P25, DOI 10.1089/cap.2006.16.25; Mosholder AD, 2006, J CHILD ADOL PSYCHOP, V16, P33, DOI 10.1089/cap.2006.16.33; National Library of Medicine, 2010, UN MED LANG SYST UML; *PFIZ INC, 2008, ZOLOFT SERTR HYDR TA; Pfizer Inc, 2010, CHANTIX VAR TARTR TA; *SAN ADV US, 2009, AMBIEN ZOLP TARTR TA; U. S. Food and Drug Administration, 2007, NEW WARN PROP ANT; United States Food and Drug Administration, 2010, ADV EV REP SYST AERS; 2008, PRESCRIRE INT, V17, P199	22	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15337	10.1371/journal.pone.0015337	http://dx.doi.org/10.1371/journal.pone.0015337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179515	Green Submitted, Green Published, gold			2022-12-27	WOS:000285340000021
J	Tanase, CA				Tanase, Carmen-Alexandra			Histidine Domain-Protein Tyrosine Phosphatase Interacts with Grb2 and GrpL	PLOS ONE			English	Article							HD-PTP; ADAPTER; RECEPTOR; KINASE; GADS; RAS; LAT; EXPRESSION; SUBSTRATE; MIGRATION	Background: Histidine domain-protein tyrosine phosphatase (HD-PTP) plays a key role in vesicle trafficking and biogenesis. Although it is a large protein with at least five distinct structural domains, only a few of its interactors are presently known, and the significance of these interactions is largely obscure. Methodology and Results: In this study we performed a yeast two-hybrid screening using a human colon cDNA library and found that Grb2 and GrpL are binding partners of HD-PTP. Co-immunoprecipitation, pull-down and immunocytochemistry experiments confirmed the interactions. We also discovered that the central proline-rich and histidine-rich domain of HD-PTP is responsible for these interactions. Significance: The interaction of HD-PTP with two adapters of the Grb2 family, essential for numerous signaling pathways, suggests that HD-PTP might be important for signaling through a plethora of receptors. 2	Inst Biochem, Dept Enzymol, Bucharest, Romania	Romanian Academy of Sciences; Institute of Biochemistry, Bucharest	Tanase, CA (corresponding author), Inst Biochem, Dept Enzymol, Bucharest, Romania.	ctanase@biochim.ro	Tanase, Carmen/D-2293-2009; Tanase, Carmen/ABD-7943-2020		Romanian Council for Research and Higher Education [3182]; European Commission [MIRG 022374]	Romanian Council for Research and Higher Education(Consiliul National al Cercetarii Stiintifice (CNCS)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the Romanian Council for Research and Higher Education (grant number 3182) and by a Marie Curie International Reintegration Grant (MIRG 022374) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Balagopalan L, 2009, IMMUNOL REV, V232, P84, DOI 10.1111/j.1600-065X.2009.00840.x; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Castiglioni S, 2007, BIOCHEM BIOPH RES CO, V364, P534, DOI 10.1016/j.bbrc.2007.10.022; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Geisler C, 2004, CRIT REV IMMUNOL, V24, P67; Gingras MC, 2009, INT J DEV BIOL, V53, P1069, DOI 10.1387/ijdb.082820mg; Gingras MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005105; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Harkiolaki M, 2009, STRUCTURE, V17, P809, DOI 10.1016/j.str.2009.03.017; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Ichioka F, 2007, ARCH BIOCHEM BIOPHYS, V457, P142, DOI 10.1016/j.abb.2006.11.008; Jang IK, 2009, IMMUNOL REV, V232, P150, DOI 10.1111/j.1600-065X.2009.00842.x; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Johmura S, 2003, IMMUNITY, V18, P777, DOI 10.1016/S1074-7613(03)00139-0; Joneson T, 1997, J MOL MED-JMM, V75, P587, DOI 10.1007/s001090050143; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Katoh M, 2006, INT J ONCOL, V29, P163; Mariotti M, 2009, INT J BIOCHEM CELL B, V41, P687, DOI 10.1016/j.biocel.2008.08.005; Mariotti M, 2009, CANCER LETT, V273, P155, DOI 10.1016/j.canlet.2008.08.017; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; REIF K, 1994, J BIOL CHEM, V269, P14081; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Stasyk T, 2007, MOL CELL PROTEOMICS, V6, P908, DOI 10.1074/mcp.M600463-MCP200; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Tanase Carmen-Alexandra, 2008, Romanian Journal of Biochemistry, V45, P169; Toyooka S, 2000, BIOCHEM BIOPH RES CO, V278, P671, DOI 10.1006/bbrc.2000.3870; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Yamazaki T, 2002, J CELL SCI, V115, P1791; Yankee TM, 2005, EUR J IMMUNOL, V35, P1184, DOI 10.1002/eji.200425507; Yankee TM, 2004, J IMMUNOL, V173, P1711, DOI 10.4049/jimmunol.173.3.1711; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	37	9	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14339	10.1371/journal.pone.0014339	http://dx.doi.org/10.1371/journal.pone.0014339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179510	gold, Green Published, Green Submitted			2022-12-27	WOS:000285340000011
J	Bazazi, S; Ioannou, CC; Simpson, SJ; Sword, GA; Torney, CJ; Lorch, PD; Couzin, ID				Bazazi, Sepideh; Ioannou, Christos C.; Simpson, Stephen J.; Sword, Gregory A.; Torney, Colin J.; Lorch, Patrick D.; Couzin, Iain D.			The Social Context of Cannibalism in Migratory Bands of the Mormon Cricket	PLOS ONE			English	Article							PUBLIC INFORMATION; SELF-ORGANIZATION; FACILITATION; MOVEMENT; BEHAVIOR	Cannibalism has been shown to be important to the collective motion of mass migratory bands of insects, such as locusts and Mormon crickets. These mobile groups consist of millions of individuals and are highly destructive to vegetation. Individuals move in response to attacks from approaching conspecifics and bite those ahead, resulting in further movement and encounters with others. Despite the importance of cannibalism, the way in which individuals make attack decisions and how the social context affects these cannibalistic interactions is unknown. This can be understood by examining the decisions made by individuals in response to others. We performed a field investigation which shows that adult Mormon crickets were more likely to approach and attack a stationary cricket that was side-on to the flow than either head- or abdomen-on, suggesting that individuals could reduce their risk of an attack by aligning with neighbours. We found strong social effects on cannibalistic behaviour: encounters lasted longer, were more likely to result in an attack, and attacks were more likely to be successful if other individuals were present around a stationary individual. This local aggregation appears to be driven by positive feedback whereby the presence of individuals attracts others, which can lead to further crowding. This work improves our understanding of the local social dynamics driving migratory band formation, maintenance and movement at the population level.	[Bazazi, Sepideh] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Bazazi, Sepideh; Ioannou, Christos C.; Torney, Colin J.; Couzin, Iain D.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Simpson, Stephen J.; Sword, Gregory A.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Lorch, Patrick D.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	University of Oxford; Princeton University; University of Sydney; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Bazazi, S (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	sbazazi@gmail.com	Couzin, Iain D./Q-6862-2018; Torney, Colin/C-6082-2015	Couzin, Iain D./0000-0001-8556-4558; Torney, Colin/0000-0003-1673-7835; Ioannou, Christos/0000-0002-9739-889X; Sword, Gregory/0000-0003-2094-2436; Simpson, Stephen J./0000-0003-0256-7687	Natural Environment Research Council; Princeton University; Searle Scholars Program [08-SPP-201]; National Science Foundation [PHY-0848755]; Office of Naval Research [N00014-09-1-1074]; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; Engineering and Physical Sciences Research Council; Australian Research Council Federation and Laureate Fellowships; Australian Research Council; Division Of Physics [0848755] Funding Source: National Science Foundation	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Princeton University(Princeton University); Searle Scholars Program; National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Australian Research Council Federation and Laureate Fellowships(Australian Research Council); Australian Research Council(Australian Research Council); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by Natural Environment Research Council (S.B.), Princeton University, Searle Scholars Program (08-SPP-201 to I.D.C), National Science Foundation (PHY-0848755 to I.D.C.), Office of Naval Research (N00014-09-1-1074 to I.D.C., C.C.I. and C.J.T.) a Defense Advanced Research Projects Agency Grant No. HR0011-05-1-0057 to Princeton University, the Engineering and Physical Sciences Research Council (I.D.C., S.J.S.), the Australian Research Council Federation and Laureate Fellowships (S.J.S.) and the Australian Research Council Discovery Scheme (S.J.S., G.A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; [Anonymous], 2020, ECONOMIST 0326; Baude M, 2008, ANIM BEHAV, V76, P1863, DOI 10.1016/j.anbehav.2008.08.010; BAZAZI S, 2010, P ROYAL SOC LONDON B; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; BUHL J, BEHAV ECOLO IN PRESS; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Chittka L, 2005, CURR BIOL, V15, pR869, DOI 10.1016/j.cub.2005.10.018; Collett TS, 2002, CURR BIOL, V12, pR615, DOI 10.1016/S0960-9822(02)01132-6; Collins LM, 2007, J R SOC INTERFACE, V4, P65, DOI 10.1098/rsif.2006.0157; Coolen I, 2005, CURR BIOL, V15, P1931, DOI 10.1016/j.cub.2005.09.015; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; COWAN FT, 1929, TECH B USDA, V0161, P00001; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Danchin E., 2008, BEHAV ECOLOGY; DECASTRO JM, 1990, PHYSIOL BEHAV, V47, P1129, DOI 10.1016/0031-9384(90)90363-9; Elgar M., 1992, CANNIBALISM ECOLOGY, V1st; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Gwynne DT, 2001, CORNELL S ARTHR BIOL; Heyes G., 1996, SOCIAL LEARNING ANIM; Krause J, 2002, LIVING GROUPS; KURTA A, 1982, BIOTROPICA, V14, P132, DOI 10.2307/2387742; LAIDRE M, 2009, P ROYAL SOC LONDON B, V10; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lorch PD, 2005, ECOL ENTOMOL, V30, P548, DOI 10.1111/j.0307-6946.2005.00725.x; MacVean C.M., 1987, P116; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Simpson SJ, 2006, P NATL ACAD SCI USA, V103, P4152, DOI 10.1073/pnas.0508915103; Srygley RB, 2009, ECOL ENTOMOL, V34, P663, DOI 10.1111/j.1365-2311.2009.01117.x; SWEETING MP, 1985, J ANIM SCI, V60, P369, DOI 10.2527/jas1985.602369x; Sword GA, 2005, ANIM BEHAV, V69, P437, DOI 10.1016/j.anbehav.2004.04.016; Sword GA, 2005, NATURE, V433, P703, DOI 10.1038/433703a; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; WAKELAND CLAUDE, 1959, U S DEPT AGRIC TECH BULL, V1202, P1; Webster Sandra J., 2001, Animal Cognition, V4, P69, DOI 10.1007/s100710100108	44	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15118	10.1371/journal.pone.0015118	http://dx.doi.org/10.1371/journal.pone.0015118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179402	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500014
J	Blythe, MJ; Kao, D; Malla, S; Rowsell, J; Wilson, R; Evans, D; Jowett, J; Hall, A; Lemay, V; Lam, S; Aboobaker, AA				Blythe, Martin J.; Kao, Damian; Malla, Sunir; Rowsell, Joanna; Wilson, Ray; Evans, Deborah; Jowett, Jamie; Hall, Amy; Lemay, Virginie; Lam, Sabrina; Aboobaker, A. Aziz			A Dual Platform Approach to Transcript Discovery for the Planarian Schmidtea Mediterranea to Establish RNAseq for Stem Cell and Regeneration Biology	PLOS ONE			English	Article							FUNCTIONAL GENOMICS; MESSENGER-RNA; SELF-RENEWAL; GENE; PROTEIN; EXPRESSION; POLARITY; DATABASE; SEQ; MAINTENANCE	The use of planarians as a model system is expanding and the mechanisms that control planarian regeneration are being elucidated. The planarian Schmidtea mediterranea in particular has become a species of choice. Currently the planarian research community has access to this whole genome sequencing project and over 70,000 expressed sequence tags. However, the establishment of massively parallel sequencing technologies has provided the opportunity to define genetic content, and in particular transcriptomes, in unprecedented detail. Here we apply this approach to the planarian model system. We have sequenced, mapped and assembled 581,365 long and 507,719,814 short reads from RNA of intact and mixed stages of the first 7 days of planarian regeneration. We used an iterative mapping approach to identify and define de novo splice sites with short reads and increase confidence in our transcript predictions. We more than double the number of transcripts currently defined by publicly available ESTs, resulting in a collection of 25,053 transcripts described by combining platforms. We also demonstrate the utility of this collection for an RNAseq approach to identify potential transcripts that are enriched in neoblast stem cells and their progeny by comparing transcriptome wide expression levels between irradiated and intact planarians. Our experiments have defined an extensive planarian transcriptome that can be used as a template for RNAseq and can also help to annotate the S. mediterranea genome. We anticipate that suites of other 'omic approaches will also be facilitated by building on this comprehensive data set including RNAseq across many planarian regenerative stages, scenarios, tissues and phenotypes generated by RNAi.	[Blythe, Martin J.; Malla, Sunir; Rowsell, Joanna; Wilson, Ray; Aboobaker, A. Aziz] Univ Nottingham, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2RD, England; [Kao, Damian; Evans, Deborah; Jowett, Jamie; Hall, Amy; Lemay, Virginie; Lam, Sabrina; Aboobaker, A. Aziz] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Evolutionary Dev Biol Lab, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Blythe, MJ (corresponding author), Univ Nottingham, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2RD, England.	Aziz.Aboobaker@nottingham.ac.uk		Moreton, Joanna/0000-0003-3193-1812; Aboobaker, Aziz/0000-0003-4902-5797	BBSRC; MRC; Biotechnology and Biological Sciences Research Council [BB/E01030X/1] Funding Source: researchfish; Medical Research Council [G0601133] Funding Source: researchfish; BBSRC [BB/E01030X/1] Funding Source: UKRI; MRC [G0601133] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by project grants from the BBSRC and MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000505; Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; CHANDEBOIS R, 1965, CR HEBD ACAD SCI, V260, P4834; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Felix DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000915; Fernandez-Taboada E, 2010, DEVELOPMENT, V137, P1055, DOI 10.1242/dev.042564; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Kobayashi C, 2007, DEV BIOL, V306, P714, DOI 10.1016/j.ydbio.2007.04.010; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Molina MD, 2007, DEV BIOL, V311, P79, DOI 10.1016/j.ydbio.2007.08.019; Mollet IG, 2010, NUCLEIC ACIDS RES, V38, P4740, DOI 10.1093/nar/gkq197; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Orii H, 2005, DEV GENES EVOL, V215, P143, DOI 10.1007/s00427-004-0460-y; Oviedo NJ, 2007, DEVELOPMENT, V134, P3121, DOI 10.1242/dev.006635; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rossi L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r62; Salo E, 2006, BIOESSAYS, V28, P546, DOI 10.1002/bies.20416; Salvetti A, 2000, DEV DYNAM, V218, P603, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1016>3.0.CO;2-C; Salvetti A, 2005, DEVELOPMENT, V132, P1863, DOI 10.1242/dev.01785; Scimone ML, 2010, DEVELOPMENT, V137, P1231, DOI 10.1242/dev.042051; Solana J, 2009, DEV BIOL, V328, P410, DOI 10.1016/j.ydbio.2009.01.043; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang YY, 2007, P NATL ACAD SCI USA, V104, P5901, DOI 10.1073/pnas.0609708104; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102	62	53	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15617	10.1371/journal.pone.0015617	http://dx.doi.org/10.1371/journal.pone.0015617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179477	Green Submitted, gold, Green Published			2022-12-27	WOS:000285292500030
J	Hegeman, MA; Hennus, MP; van Meurs, M; Cobelens, PM; Kavelaars, A; Jansen, NJ; Schultz, MJ; van Vught, AJ; Molema, G; Heijnen, CJ				Hegeman, Maria A.; Hennus, Marije P.; van Meurs, Matijs; Cobelens, Pieter M.; Kavelaars, Annemieke; Jansen, Nicolaas J.; Schultz, Marcus J.; van Vught, Adrianus J.; Molema, Grietje; Heijnen, Cobi J.			Angiopoietin-1 Treatment Reduces Inflammation but Does Not Prevent Ventilator-Induced Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; MECHANICAL VENTILATION; MURINE MODEL; IN-VIVO; PERMEABILITY; PULMONARY; RATS; ACTIVATION; EXPRESSION; RESPONSES	Background: Loss of integrity of the epithelial and endothelial barriers is thought to be a prominent feature of ventilator-induced lung injury (VILI). Based on its function in vascular integrity, we hypothesize that the angiopoietin (Ang)-Tie2 system plays a role in the development of VILI. The present study was designed to examine the effects of mechanical ventilation on the Ang-Tie2 system in lung tissue. Moreover, we evaluated whether treatment with Ang-1, a Tie2 receptor agonist, protects against inflammation, vascular leakage and impaired gas exchange induced by mechanical ventilation. Methods: Mice were anesthetized, tracheotomized and mechanically ventilated for 5 hours with either an inspiratory pressure of 10 cmH(2)O ('low' tidal volume similar to 7.5 ml/kg; LVT) or 18 cmH(2)O ('high' tidal volume similar to 15 ml/kg; HVT). At initiation of HVT-ventilation, recombinant human Ang-1 was intravenously administered (1 or 4 mu g per animal). Non-ventilated mice served as controls. Results: HVT-ventilation influenced the Ang-Tie2 system in lungs of healthy mice since Ang-1, Ang-2 and Tie2 mRNA were decreased. Treatment with Ang-1 increased Akt-phosphorylation indicating Tie2 signaling. Ang-1 treatment reduced infiltration of granulocytes and expression of keratinocyte-derived chemokine (KC), macrophage inflammatory protein (MIP)-2, monocyte chemotactic protein (MCP)-1 and interleukin (IL)-1 beta caused by HVT-ventilation. Importantly, Ang-1 treatment did not prevent vascular leakage and impaired gas exchange in HVT-ventilated mice despite inhibition of inflammation, vascular endothelial growth factor (VEGF) and Ang-2 expression. Conclusions: Ang-1 treatment downregulates pulmonary inflammation, VEGF and Ang-2 expression but does not protect against vascular leakage and impaired gas exchange induced by HVT-ventilation.	[Hegeman, Maria A.; Cobelens, Pieter M.; Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Hegeman, Maria A.; Hennus, Marije P.; Jansen, Nicolaas J.; van Vught, Adrianus J.] Univ Med Ctr Utrecht, Dept Pediat Intens Care, Utrecht, Netherlands; [van Meurs, Matijs] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [van Meurs, Matijs; Molema, Grietje] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, Groningen, Netherlands; [Cobelens, Pieter M.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Hegeman, MA (corresponding author), Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands.	c.heijnen@umcutrecht.nl	Hennus, Marije/D-1643-2014; Schultz, Marcus J/K-6147-2012; Schultz, Marcus/AAB-6379-2021	Schultz, Marcus/0000-0003-3969-7792; Molema, Grietje/0000-0002-4147-6676; Hennus, Marije/0000-0003-1508-0456	Catharijne Foundation, The Netherlands	Catharijne Foundation, The Netherlands(Netherlands Government)	This study was financially supported by the Catharijne Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Copland IB, 2004, AM J RESP CRIT CARE, V169, P739, DOI 10.1164/rccm.200310-1417OC; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1985, AM REV RESPIR DIS, V132, P880; EGAN EA, 1982, J APPL PHYSIOL, V53, P121, DOI 10.1152/jappl.1982.53.1.121; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Haitsma JJ, 2003, CLIN PHYSIOL FUNCT I, V23, P349, DOI 10.1046/j.1475-0961.2003.00518.x; Hamanaka K, 2007, AM J PHYSIOL-LUNG C, V293, pL923, DOI 10.1152/ajplung.00221.2007; Hegeman MA, 2009, CRIT CARE, V13, DOI 10.1186/cc8168; Huang YQ, 2008, CRIT CARE MED, V36, P262, DOI 10.1097/01.CCM.0000297955.02633.A4; Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kuebler WM, 2003, AM J RESP CRIT CARE, V168, P1391, DOI 10.1164/rccm.200304-562OC; Lee KS, 2005, MOL PHARMACOL, V68, P1281, DOI 10.1124/mol.105.016055; Lemieux C, 2005, BLOOD, V105, P1523, DOI 10.1182/blood-2004-09-3531; McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nijboer CHA, 2007, J CEREBR BLOOD F MET, V27, P282, DOI 10.1038/sj.jcbfm.9600342; Nin N, 2008, INTENS CARE MED, V34, P948, DOI 10.1007/s00134-007-0959-6; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; PARKER JC, 1993, CRIT CARE MED, V21, P131, DOI 10.1097/00003246-199301000-00024; PARKER JC, 1984, J APPL PHYSIOL, V57, P1809, DOI 10.1152/jappl.1984.57.6.1809; Pugin J, 2003, CRIT CARE MED, V31, pS200, DOI 10.1097/01.CCM.0000057844.31307.ED; Simoes DCM, 2008, AM J RESP CRIT CARE, V177, P1314, DOI 10.1164/rccm.200708-1141OC; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Uhlig U, 2004, AM J RESP CRIT CARE, V169, P201, DOI 10.1164/rccm.200303-343OC; van der Heijden M, 2009, EXPERT OPIN THER TAR, V13, P39, DOI 10.1517/14728220802626256 ; van Meurs M, 2009, CRIT CARE, V13, DOI 10.1186/cc7153; Vreugdenhil HA, 2004, EUR RESPIR J, V23, P122, DOI 10.1183/09031936.03.00035003; Weppler A, 2008, EXP LUNG RES, V34, P425, DOI 10.1080/01902140802130105; Wilson MR, 2005, AM J PHYSIOL-LUNG C, V288, pL599, DOI 10.1152/ajplung.00304.2004; Wilson MR, 2003, J APPL PHYSIOL, V95, P1385, DOI 10.1152/japplphysiol.00213.2003; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; Wolthuis EK, 2009, SHOCK, V31, P262, DOI 10.1097/SHK.0b013e31817d42dd; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688	43	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15653	10.1371/journal.pone.0015653	http://dx.doi.org/10.1371/journal.pone.0015653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179479	Green Published, Green Submitted, gold			2022-12-27	WOS:000285292500033
J	Crawford, DC; Brown-Gentry, K; Rieder, MJ				Crawford, Dana C.; Brown-Gentry, Kristin; Rieder, Mark J.			VKORC1 Common Variation and Bone Mineral Density in the Third National Health and Nutrition Examination Survey	PLOS ONE			English	Article							K EPOXIDE REDUCTASE; SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; VITAMIN-K; OSTEOPOROSIS OUTCOMES; POSTMENOPAUSAL WOMEN; GENOTYPE-PHENOTYPE; GENDER SPECIFICITY; FEMORAL-NECK; US ADULTS	Osteoporosis, defined by low bone mineral density (BMD), is common among postmenopausal women. The distribution of BMD varies across populations and is shaped by both environmental and genetic factors. Because the candidate gene vitamin K epoxide reductase complex subunit 1 (VKORC1) generates vitamin K quinone, a cofactor for the gamma-carboxylation of bone-related proteins such as osteocalcin, we hypothesized that VKORC1 genetic variants may be associated with BMD and osteoporosis in the general population. To test this hypothesis, we genotyped six VKORC1 SNPs in 7,159 individuals from the Third National Health and Nutrition Examination Survey (NHANES III). NHANES III is a nationally representative sample linked to health and lifestyle variables including BMD, which was measured using dual energy x-ray absorptiometry (DEXA) on four regions of the proximal femur. In adjusted models stratified by race/ethnicity and sex, SNPs rs9923231 and rs9934438 were associated with increased BMD (p = 0.039 and 0.024, respectively) while rs8050894 was associated with decreased BMD (p = 0.016) among non-Hispanic black males (n = 619). VKORC1 rs2884737 was associated with decreased BMD among Mexican-American males (n = 795; p = 0.004). We then tested for associations between VKORC1 SNPs and osteoporosis, but the results did not mirror the associations observed between VKORC1 and BMD, possibly due to small numbers of cases. This is the first report of VKORC1 common genetic variation associated with BMD, and one of the few reports available that investigate the genetics of BMD and osteoporosis in diverse populations.	[Crawford, Dana C.; Brown-Gentry, Kristin] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Rieder, Mark J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Vanderbilt University; Vanderbilt University; University of Washington; University of Washington Seattle	Crawford, DC (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA.	crawford@chgr.mc.vanderbilt.edu	Crawford, Dana/C-1054-2012; Crawford, Dana/O-5578-2019	Crawford, Dana/0000-0002-6437-6248	NIH [NS053646, U01 HL065962]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053646] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by NIH grants NS053646 (MJR) and U01 HL065962. The funders (NIH) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NAT GENET, V41, P1199; Arden NK, 1996, J BONE MINER RES, V11, P530; Binkley N, 2007, J BONE MINER RES, V22, P695, DOI 10.1359/JBMR.070208; Brown LB, 2004, GENET EPIDEMIOL, V27, P153, DOI 10.1002/gepi.20009; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; CDC, 2002, FED REGISTER, V67, P51585; Centers for Disease Control and Prevention, 2006, FED REG, V71, P2248; Centers for Disease Control and Prevention, 2004, PLAN OP 3 NAT HLTH N; Centers for Disease Control and Prevention, 2007, FED REG, V72, P59094; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Crawford DC, 2007, PHARMACOGENOMICS, V8, P487, DOI 10.2217/14622416.8.5.487; Crosier MD, 2009, J NUTR SCI VITAMINOL, V55, P112, DOI 10.3177/jnsv.55.112; Duncan EL, 2003, J BONE MINER RES, V18, P1531, DOI 10.1359/jbmr.2003.18.8.1531; Guo Y, 2010, J BONE MINER RES, V25, P1042, DOI 10.1359/jbmr.091040; Howie BN, 2006, HUM GENET, V120, P58, DOI 10.1007/s00439-006-0182-5; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Iwamoto J, 2009, NUTR RES, V29, P221, DOI 10.1016/j.nutres.2009.03.012; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; KRALL EA, 1993, J BONE MINER RES, V8, P1; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Limdi NA, 2008, PHARMACOGENOMICS, V9, P1445, DOI 10.2217/14622416.9.10.1445; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Lohr LS, 1999, SAMPLING DESIGN ANAL; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Looker AC, 2010, J BONE MINER RES, V25, P64, DOI 10.1359/jbmr.090706; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Ng MYM, 2006, ANN HUM GENET, V70, P428, DOI 10.1111/j.1469-1809.2005.00242.x; Nimptsch K, 2009, BRIT J NUTR, V101, P1812, DOI 10.1017/S0007114508131750; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Peacock M, 2009, BONE, V45, P218, DOI 10.1016/j.bone.2009.04.236; Pearson DA, 2007, NUTR CLIN PRACT, V22, P517, DOI 10.1177/0115426507022005517; Ralston SH, 2006, PLOS MED, V3, P515, DOI 10.1371/journal.pmed.0030090; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Robitaille J, 2008, AM J PREV MED, V35, P47, DOI 10.1016/j.amepre.2008.03.027; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Sato Y, 1997, STROKE, V28, P2390, DOI 10.1161/01.STR.28.12.2390; Sato Y, 1999, AM J PHYS MED REHAB, V78, P317, DOI 10.1097/00002060-199907000-00005; Snelling AM, 2001, J WOMEN HEALTH GEN-B, V10, P57, DOI 10.1089/152460901750067124; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Videman T, 2007, J BONE MINER RES, V22, P1455, DOI 10.1359/JBMR.070606; Wang DX, 2008, BLOOD, V112, P1013, DOI 10.1182/blood-2008-03-144899; Wang XJ, 2007, J BONE MINER RES, V22, P527, DOI 10.1359/JBMR.070106; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; 2008, FED REG, V73, P51487	54	18	19	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15088	10.1371/journal.pone.0015088	http://dx.doi.org/10.1371/journal.pone.0015088			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179439	Green Submitted, Green Published, gold			2022-12-27	WOS:000285246900028
J	Swartz, W; Sala, E; Tracey, S; Watson, R; Pauly, D				Swartz, Wilf; Sala, Enric; Tracey, Sean; Watson, Reg; Pauly, Daniel			The Spatial Expansion and Ecological Footprint of Fisheries (1950 to Present)	PLOS ONE			English	Article							GLOBAL FISHERIES	Using estimates of the primary production required (PPR) to support fisheries catches (a measure of the footprint of fishing), we analyzed the geographical expansion of the global marine fisheries from 1950 to 2005. We used multiple threshold levels of PPR as percentage of local primary production to define 'fisheries exploitation' and applied them to the global dataset of spatially-explicit marine fisheries catches. This approach enabled us to assign exploitation status across a 0.5 degrees latitude/longitude ocean grid system and trace the change in their status over the 56-year time period. This result highlights the global scale expansion in marine fisheries, from the coastal waters off North Atlantic and West Pacific to the waters in the Southern Hemisphere and into the high seas. The southward expansion of fisheries occurred at a rate of almost one degree latitude per year, with the greatest period of expansion occurring in the 1980s and early 1990s. By the mid 1990s, a third of the world's ocean, and two-thirds of continental shelves, were exploited at a level where PPR of fisheries exceed 10% of PP, leaving only unproductive waters of high seas, and relatively inaccessible waters in the Arctic and Antarctic as the last remaining 'frontiers.' The growth in marine fisheries catches for more than half a century was only made possible through exploitation of new fishing grounds. Their rapidly diminishing number indicates a global limit to growth and highlights the urgent need for a transition to sustainable fishing through reduction of PPR.	[Swartz, Wilf; Watson, Reg; Pauly, Daniel] Univ British Columbia, Sea Us Project, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Sala, Enric] Ctr Estudis Avancats Blanes CSIC, Blanes, Spain; [Sala, Enric] Natl Geog Soc, Washington, DC USA; [Tracey, Sean] Univ Tasmania, Marine Res Labs, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas, Australia	University of British Columbia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); National Geographic Society; University of Tasmania	Swartz, W (corresponding author), Univ British Columbia, Sea Us Project, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada.	d.pauly@fisheries.ubc.ca	Watson, Reg A/F-4850-2012; Pauly, Daniel Marc/AAY-2316-2021	Watson, Reg A/0000-0001-7201-8865; Pauly, Daniel/0000-0003-3756-4793	Pew Charitable Trusts; National Geographic Society; Waitt Foundation	Pew Charitable Trusts; National Geographic Society(National Geographic Society); Waitt Foundation	This research was funded by the Pew Charitable Trusts (via fundings to the Sea Around Us project), National Geographic Society and the Waitt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Bouvet M, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001126; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Conkright ME, 2003, INT J REMOTE SENS, V24, P969, DOI 10.1080/01431160110115573; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Dulvy N, 2009, IOCCG REP, P11; Froese R, 2009, MAR POLICY, V33, P180, DOI 10.1016/j.marpol.2008.03.009; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jacquet J. L., 2007, FISHERIES CTR RES RE, V15, P35; JACQUET JL, 2007, FISHERIES CTR RES RE, V15; MFA, 2009, FISHERIES AQUACULTUR; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D., 2008, UNEP LARGE MARINE EC, P23; PLATT T, 1988, SCIENCE, V241, P1613, DOI 10.1126/science.241.4873.1613; Rees W.E., 1996, OUR ECOLOGICAL FOOTP; Roberts C., 2007, UNNATURAL HIST SEA; Rosenberg AA, 2005, FRONT ECOL ENVIRON, V3, P84, DOI 10.2307/3868514; Sherman K., 2008, UNEP REGIONAL SEAS R, V182, P735; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Ward M., 2004, QUANTIFYING WORLD UN; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x; [No title captured]	31	262	267	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15143	10.1371/journal.pone.0015143	http://dx.doi.org/10.1371/journal.pone.0015143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151994	gold, Green Published			2022-12-27	WOS:000284868000026
J	Untersmayr, E; Diesner, SC; Oostingh, GJ; Selzle, K; Pfaller, T; Schultz, C; Zhang, YY; Krishnamurthy, D; Starkl, P; Knittelfelder, R; Forster-Waldl, E; Pollak, A; Scheiner, O; Poschl, U; Jensen-Jarolim, E; Duschl, A				Untersmayr, Eva; Diesner, Susanne C.; Oostingh, Gertie Janneke; Selzle, Kathrin; Pfaller, Tobias; Schultz, Cornelia; Zhang, Yingyi; Krishnamurthy, Durga; Starkl, Philipp; Knittelfelder, Regina; Foerster-Waldl, Elisabeth; Pollak, Arnold; Scheiner, Otto; Poeschl, Ulrich; Jensen-Jarolim, Erika; Duschl, Albert			Nitration of the Egg-Allergen Ovalbumin Enhances Protein Allergenicity but Reduces the Risk for Oral Sensitization in a Murine Model of Food Allergy	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; SITE-DIRECTED MUTAGENESIS; NITRIC-OXIDE SYNTHASE; CHEMICAL-MODIFICATION; AIR-POLLUTION; BIRCH POLLEN; BALB/C MICE; CELL LINES; IN-VITRO; IGE	Background: Nitration of proteins on tyrosine residues, which can occur due to polluted air under "ummer smog" conditions, has been shown to increase the allergic potential of allergens. Since nitration of tyrosine residues is also observed during inflammatory responses, this modification could directly influence protein immunogenicity and might therefore contribute to food allergy induction. In the current study we have analyzed the impact of protein nitration on sensitization via the oral route. Methodology/Principal Findings: BALB/c mice were immunized intragastrically by feeding untreated ovalbumin (OVA), sham-nitrated ovalbumin (snOVA) or nitrated ovalbumin (nOVA) with or without concomitant acid-suppression. To analyze the impact of the sensitization route, the allergens were also injected intraperitoneally. Animals being fed OVA or snOVA under acid-suppressive medication developed significantly elevated levels of IgE, and increased titers of specific IgG1 and IgG2a antibodies. Interestingly, oral immunizations of nOVA under anti-acid treatment did not result in IgG and IgE formation. In contrast, intraperitoneal immunization induced high levels of OVA specific IgE, which were significantly increased in the group that received nOVA by injection. Furthermore, nOVA triggered significantly enhanced mediator release from RBL cells passively sensitized with sera from allergic mice. Gastric digestion experiments demonstrated protein nitration to interfere with protein stability as nOVA was easily degraded, whereas OVA and snOVA remained stable up to 120 min. Additionally, HPLC-chip-MS/MS analysis showed that one tyrosine residue (Y-107) being very efficiently nitrated is part of an ovalbumin epitope recognized exclusively after oral sensitization. Conclusions/Significance: These data indicated that despite the enhanced triggering capacity in existing allergy, nitration of OVA may be associated with a reduced de novo sensitizing capability via the oral route due to enhanced protein digestibility and/or changes in antibody epitopes.	[Untersmayr, Eva; Diesner, Susanne C.; Schultz, Cornelia; Krishnamurthy, Durga; Starkl, Philipp; Knittelfelder, Regina; Scheiner, Otto; Jensen-Jarolim, Erika] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Diesner, Susanne C.; Foerster-Waldl, Elisabeth; Pollak, Arnold] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Oostingh, Gertie Janneke; Pfaller, Tobias; Duschl, Albert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Selzle, Kathrin; Zhang, Yingyi; Poeschl, Ulrich] Max Planck Inst Chem, Biogeochem Dept, D-55128 Mainz, Germany	Medical University of Vienna; Medical University of Vienna; Salzburg University; Max Planck Society	Untersmayr, E (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria.	eva.untersmayr@meduniwien.ac.at	Duschl, Albert/E-5872-2011; Zhang, Yingyi/G-8276-2012; Jensen-Jarolim, Erika/C-5120-2018; Oostingh, Gertie Janneke/HHC-1098-2022; Pöschl, Ulrich/A-6263-2010; Zhang, Yingyi/I-2312-2017; Untersmayr, Eva/GRY-4470-2022	Duschl, Albert/0000-0002-7034-9860; Jensen-Jarolim, Erika/0000-0003-4019-5765; Pöschl, Ulrich/0000-0003-1412-3557; Zhang, Yingyi/0000-0002-6919-9148; Forster-Waldl, Elisabeth/0000-0002-8484-9890; Starkl, Philipp/0000-0001-7521-129X; Untersmayr, Eva/0000-0002-1963-499X; Oostingh, Gertie Janneke/0000-0001-5083-217X; Diesner-Treiber, Susanne/0000-0001-8955-4752	Austrian Science funds FWF (Fonds zur Foerderung der wissenschaftlichen Forschung) [P21577-B11, APW01205FW]; Austrian Science Fund (FWF) [P 21577] Funding Source: researchfish	Austrian Science funds FWF (Fonds zur Foerderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by P21577-B11 and APW01205FW of the Austrian Science funds FWF (Fonds zur Foerderung der wissenschaftlichen Forschung; www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubier M, 2005, B ACAD NAT MED PARIS, V189, P1419, DOI 10.1016/S0001-4079(19)33452-1; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Birnboim HC, 2003, J IMMUNOL, V171, P528, DOI 10.4049/jimmunol.171.2.528; Bommel H, 2000, J ALLERGY CLIN IMMUN, V105, P796, DOI 10.1067/mai.2000.105124; Borchers AT, 2005, J ASTHMA, V42, P225, DOI 10.1081/JAS-200051302; BUDAGOVSKAIA VN, 1984, VOP PITANIYA, V3, P30; Corrado G, 1998, SCAND J GASTROENTERO, V33, P1135, DOI 10.1080/00365529850172467; De Lazzari F, 1994, Minerva Gastroenterol Dietol, V40, P1; DELAZZARI F, 1994, ITAL J GASTROENTEROL, V26, P7; Diesner SC, 2008, IMMUNOL LETT, V121, P45, DOI 10.1016/j.imlet.2008.08.006; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Figura N, 1999, ITAL J GASTROENTEROL, V31, P186; Franze T, 2005, ENVIRON SCI TECHNOL, V39, P1673, DOI 10.1021/es0488737; Greenacre SAB, 2001, FREE RADICAL RES, V34, P541, DOI 10.1080/10715760100300471; Gruijthuijsen YK, 2006, INT ARCH ALLERGY IMM, V141, P265, DOI 10.1159/000095296; Henmar H, 2008, CLIN EXP IMMUNOL, V153, P316, DOI 10.1111/j.1365-2249.2008.03710.x; Hoffmann A, 1999, ALLERGY, V54, P446, DOI 10.1034/j.1398-9995.1999.00917.x; Holen E, 1996, CLIN EXP ALLERGY, V26, P1080, DOI 10.1046/j.1365-2222.1996.d01-412.x; Ibarrola I, 2004, CLIN EXP ALLERGY, V34, P303, DOI 10.1111/j.1365-2222.2004.01859.x; KAHLERT H, 1992, MOL IMMUNOL, V29, P1191, DOI 10.1016/0161-5890(92)90055-3; Matysiak-Budnik T, 2004, AM J GASTROENTEROL, V99, P225, DOI 10.1111/j.1572-0241.2004.04080.x; Matysiak-Budnik T, 2002, J PEDIATR GASTR NUTR, V34, P5, DOI 10.1097/00005176-200201000-00003; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mine Y, 2007, BBA-PROTEINS PROTEOM, V1774, P200, DOI 10.1016/j.bbapap.2006.12.003; MITRA I, 1992, BIOCHEM INT, V26, P25; OKA T, 1970, FEBS LETT, V10, P222, DOI 10.1016/0014-5793(70)80633-0; Oldreive C, 2001, FREE RADICAL RES, V35, P215, DOI 10.1080/10715760100300761; Pannala AS, 2006, FREE RADICAL BIO MED, V41, P896, DOI 10.1016/j.freeradbiomed.2006.05.010; Sakaguchi AA, 1999, FREE RADICAL BIO MED, V27, P781, DOI 10.1016/S0891-5849(99)00124-0; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; Scholl L, 2005, AM J CLIN NUTR, V81, P154; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; Souza JM, 2000, ARCH BIOCHEM BIOPHYS, V380, P360, DOI 10.1006/abbi.2000.1940; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; TROUT GE, 1969, BIOCHEMISTRY-US, V8, P4183, DOI 10.1021/bi00838a041; Untersmayr E, 2005, FASEB J, V19, P656, DOI 10.1096/fj.04-3170fje; Untersmayr E, 2003, J ALLERGY CLIN IMMUN, V112, P616, DOI [10.1016/S0091-6749(03)01719-6, 10.1016/mai.2003.1681]; Untersmayr E, 2008, MECH AGEING DEV, V129, P120, DOI 10.1016/j.mad.2007.10.015; Untersmayr E, 2006, PHARMACOL THERAPEUT, V112, P787, DOI 10.1016/j.pharmthera.2006.06.004; Vieths S, 1999, EUR FOOD RES TECHNOL, V209, P379, DOI 10.1007/s002170050513; Wurtzen PA, 2007, INT ARCH ALLERGY IMM, V144, P287, DOI 10.1159/000106317; Zhang JW, 1999, BIOCHEM BIOPH RES CO, V261, P610, DOI 10.1006/bbrc.1999.1078; Zhang YY, 2011, ANAL BIOANAL CHEM, V399, P459, DOI 10.1007/s00216-010-4280-9	44	31	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14210	10.1371/journal.pone.0014210	http://dx.doi.org/10.1371/journal.pone.0014210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151984	Green Submitted, Green Published, gold			2022-12-27	WOS:000284868000020
J	de Greeff, SC; de Melker, HE; van Gageldonk, PGM; Schellekens, JFP; van der Klis, FRM; Mollema, L; Mooi, FR; Berbers, GAM				de Greeff, Sabine C.; de Melker, Hester E.; van Gageldonk, Pieter G. M.; Schellekens, Joop F. P.; van der Klis, Fiona R. M.; Mollema, Liesbeth; Mooi, Frits R.; Berbers, Guy A. M.			Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis	PLOS ONE			English	Article							DISEASE BURDEN; VACCINATION; INFECTION; POPULATION; TOXIN; EPIDEMIOLOGY; ANTIBODIES; ANTITOXIN; SEROEPIDEMIOLOGY; SENSITIVITY	Background: In many countries, the reported pertussis has increased despite high vaccination coverage. However, accurate determination of the burden of disease is hampered by reporting artifacts. The infection frequency is more reliably estimated on the basis of the prevalence of high IgG concentrations against pertussis toxin (IgG-Ptx). We determined whether the increase in reported pertussis in the last decade is associated with an increase in the number of infections. Methodology/Principal Findings: In a cross-sectional population-based serosurveillance study conducted in 2006-07, from a randomly selected age-stratified sample of 7,903 persons, serum IgG-Ptx concentrations were analyzed using a fluorescent bead-based multiplex immuno assay. In 2006-07, 9.3% (95% CI 8.5-10.1) of the population above 9 years of age had an IgG-Ptx concentration above 62.5 EU/ml (suggestive for pertussis infection in the past year), which was more than double compared to 1995-96 (4.0%; 95% CI 3.3-4.7). The reported incidence showed a similar increase as the seroprevalence between both periods. Conclusions: Although changes in the vaccination program have reduced pertussis morbidity in childhood, they have not affected the increased infection rate in adolescent and adult pertussis. Indeed, the high circulation of B. pertussis in the latter age-categories may limit the effectiveness of pediatric vaccination.	[de Greeff, Sabine C.; de Melker, Hester E.; Mollema, Liesbeth] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Gageldonk, Pieter G. M.; van der Klis, Fiona R. M.; Mooi, Frits R.; Berbers, Guy A. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Schellekens, Joop F. P.] Infect Dis Lab, Groningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	de Greeff, SC (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	sabine.de.greeff@rivm.nl		van Gageldonk, Pieter/0000-0003-2753-9674				Aguas R, 2006, LANCET INFECT DIS, V6, P112, DOI 10.1016/S1473-3099(06)70384-X; BERBERS GAM, 2008, SEROLOGISCH ONDERZOE; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2009, EPIDEMIOL INFECT, V137, P1388, DOI 10.1017/S0950268809002489; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; EDWARDS KM, 1995, PEDIATRICS, V96, P548; Forsyth Kevin, 2005, Pediatr Infect Dis J, V24, pS93, DOI 10.1097/01.inf.0000160921.74004.12; Giammanco A, 2003, VACCINE, V22, P112, DOI 10.1016/S0264-410X(03)00514-0; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; Hallander HO, 2009, APMIS, V117, P797, DOI 10.1111/j.1600-0463.2009.02530.x; Hallander HO, 2005, VACCINE, V23, P5359, DOI 10.1016/j.vaccine.2005.06.009; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Hellenbrand W, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-22; Hendrikx LH, 2009, VACCINE, V27, P6530, DOI 10.1016/j.vaccine.2009.08.052; MEADE BD, 1995, PEDIATRICS, V96, P570; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nagel J, 1985, Dev Biol Stand, V61, P325; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Quinn HE, 2010, EPIDEMIOL INFECT, V138, P426, DOI 10.1017/S0950268809990707; Quinn HE, 2007, COMMUN DIS INTELL, V31, P205; Teunis PFM, 2002, EPIDEMIOL INFECT, V129, P479, DOI 10.1017/S0950268802007896; van Boven M, 2005, P ROY SOC B-BIOL SCI, V272, P1617, DOI 10.1098/rspb.2005.3108; van der Klis FRM, 2009, NETH J MED, V67, P301; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; Versteegh FGA, 2005, EPIDEMIOL INFECT, V133, P737, DOI 10.1017/S0950268805003833	36	136	139	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14183	10.1371/journal.pone.0014183	http://dx.doi.org/10.1371/journal.pone.0014183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152071	gold, Green Published, Green Submitted			2022-12-27	WOS:000284821300004
J	Hall, LML; Moran, CN; Milne, GR; Wilson, J; MacFarlane, NG; Forouhi, NG; Hariharan, N; Salt, IP; Sattar, N; Gill, JMR				Hall, Lesley M. L.; Moran, Colin N.; Milne, Gillian R.; Wilson, John; MacFarlane, Niall G.; Forouhi, Nita G.; Hariharan, Narayanan; Salt, Ian P.; Sattar, Naveed; Gill, Jason M. R.			Fat Oxidation, Fitness and Skeletal Muscle Expression of Oxidative/Lipid Metabolism Genes in South Asians: Implications for Insulin Resistance?	PLOS ONE			English	Article							TYPE-2 DIABETIC-PATIENTS; CORONARY-HEART-DISEASE; POLYCYSTIC-OVARY-SYNDROME; MAXIMAL OXYGEN INTAKE; WEIGHT-LOSS; GLUCOSE-TRANSPORT; ADIPOSE-TISSUE; IN-VIVO; STIMULATED PHOSPHORYLATION; MITOCHONDRIAL CAPACITY	Background: South Asians are more insulin resistant than Europeans, which cannot be fully explained by differences in adiposity. We investigated whether differences in oxidative capacity and capacity for fatty acid utilisation in South Asians might contribute, using a range of whole-body and skeletal muscle measures. Methodology/Principal Findings: Twenty men of South Asian ethnic origin and 20 age and BMI-matched men of white European descent underwent exercise and metabolic testing and provided a muscle biopsy to determine expression of oxidative and lipid metabolism genes and of insulin signalling proteins. In analyses adjusted for age, BMI, fat mass and physical activity, South Asians, compared to Europeans, exhibited; reduced insulin sensitivity by 26% (p = 0.010); lower VO(2max) (40.6+/-6.6 vs 52.4+/-5.7 ml.kg(-1).min(-1), p = 0.001); and reduced fat oxidation during submaximal exercise at the same relative (3.77+/-2.02 vs 6.55+/-2.60 mg.kg(-1).min(-1) at 55% VO(2max), p = 0.013), and absolute (3.46+/-2.20 vs 6.00+/-1.93 mg.kg(-1).min(-1) at 25 ml O(2).kg(-1).min(-1), p = 0.021), exercise intensities. South Asians exhibited significantly higher skeletal muscle gene expression of CPT1A and FASN and significantly lower skeletal muscle protein expression of PI3K and PKB Ser473 phosphorylation. Fat oxidation during submaximal exercise and VO2max both correlated significantly with insulin sensitivity index and PKB Ser473 phosphorylation, with VO2max or fat oxidation during exercise explaining 10-13% of the variance in insulin sensitivity index, independent of age, body composition and physical activity. Conclusions/Significance: These data indicate that reduced oxidative capacity and capacity for fatty acid utilisation at the whole body level are key features of the insulin resistant phenotype observed in South Asians, but that this is not the consequence of reduced skeletal muscle expression of oxidative and lipid metabolism genes.	[Hall, Lesley M. L.; Moran, Colin N.; Milne, Gillian R.; Wilson, John; Salt, Ian P.; Sattar, Naveed; Gill, Jason M. R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [MacFarlane, Niall G.] Univ Glasgow, Sch Life Sci, Glasgow, Lanark, Scotland; [Forouhi, Nita G.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Hariharan, Narayanan] Pfizer Global Res & Dev, Collegeville, PA USA	University of Glasgow; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Pfizer	Hall, LML (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	jason.gill@glasgow.ac.uk	Moran, Colin Neil/F-5416-2011	Moran, Colin Neil/0000-0001-6226-8131; Forouhi, Nita/0000-0002-5041-248X; Salt, Ian/0000-0003-0055-3724	Diabetes UK [06/0003224]; Translational Medicine Research Collaboration [CVMD-GU-004]; MRC [MC_UP_A100_1003] Funding Source: UKRI; Medical Research Council [MC_UP_A100_1003] Funding Source: researchfish	Diabetes UK(Diabetes UK); Translational Medicine Research Collaboration; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a project grant from Diabetes UK (www.diabetes.org.uk) (Grant number: 06/0003224) and an award (Grant number: CVMD-GU-004) from the Translational Medicine Research Collaboration (www.tmrc.co.uk), a consortium made up of the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, the four associated NHS Health Boards (Grampian, Tayside, Lothian and Greater Glasgow and Clyde), Scottish Enterprise and Pfizer (formerly Wyeth) Pharmaceuticals. The funders had no role in study design, data collection or decision to publish.	Abate N, 2004, J CLIN ENDOCR METAB, V89, P2750, DOI 10.1210/jc.2003-031843; Adochio R, 2009, ENDOCRINOLOGY, V150, P1165, DOI 10.1210/en.2008-0437; ANDREASSON K, 1991, ACTA PHYSIOL SCAND, V142, P255, DOI 10.1111/j.1748-1716.1991.tb09154.x; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Berggren JR, 2008, AM J PHYSIOL-ENDOC M, V294, pE726, DOI 10.1152/ajpendo.00354.2007; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Bruce CR, 2004, MED SCI SPORT EXER, V36, P1196, DOI 10.1249/01.MSS.0000074670.03001.98; Bruce CR, 2003, J CLIN ENDOCR METAB, V88, P5444, DOI 10.1210/jc.2003-030791; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Chandalia M, 1999, J CLIN ENDOCR METAB, V84, P2329, DOI 10.1210/jc.84.7.2329; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cleasby ME, 2007, MOL ENDOCRINOL, V21, P215, DOI 10.1210/me.2006-0154; Colomiere M, 2009, EUR J ENDOCRINOL, V160, P567, DOI 10.1530/EJE-09-0031; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cubbon RM, 2010, ARTERIOSCL THROM VAS, V30, P878, DOI 10.1161/ATVBAHA.109.201012; Davey GJG, 2000, J EXERC PHYSL, V3, P12; FEHILY AM, 1987, HUM NUTR-APPL NUTR, V41A, P319; FLATT JP, 1985, J CLIN INVEST, V76, P1019, DOI 10.1172/JCI112054; Forouhi NG, 1999, DIABETOLOGIA, V42, P932, DOI 10.1007/s001250051250; Forouhi NG, 2003, BLOOD COAGUL FIBRIN, V14, P755, DOI 10.1097/00001721-200312000-00011; Frayn Keith N., 1997, P101; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Goodpaster B, 2003, DIABETES, V52, pA236; Goodpaster BH, 2005, EXERC SPORT SCI REV, V33, P150; Hammarstedt A, 2005, DIABETOLOGIA, V48, P96, DOI 10.1007/s00125-004-1612-3; Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7; Hardy C P, 1985, Br J Sports Med, V19, P217; Hedman A, 2000, ACTA PHYSIOL SCAND, V169, P125; Helge JW, 2006, EUR J APPL PHYSIOL, V97, P566, DOI 10.1007/s00421-006-0220-y; HENRIKSSON KG, 1979, ACTA NEUROL SCAND, V59, P317; Hepple RT, 1997, J APPL PHYSIOL, V82, P1305, DOI 10.1152/jappl.1997.82.4.1305; Hojlund K, 2008, DIABETES, V57, P357, DOI 10.2337/db07-0706; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Krook A, 1998, DIABETES, V47, pA237; Lee J, 2001, INT J EPIDEMIOL, V30, P983, DOI 10.1093/ije/30.5.983; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; LITHELL H, 1981, DIABETES, V30, P19, DOI 10.2337/diabetes.30.1.19; Marfell-Jones M, 2006, INT STANDARDS ANTHR; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Melanson EL, 2005, OBES RES, V13, P2102, DOI 10.1038/oby.2005.261; Meyer MM, 2002, DIABETOLOGIA, V45, P813, DOI 10.1007/s00125-002-0830-9; Misra A, 2004, NUTRITION, V20, P482, DOI 10.1016/j.nut.2004.01.020; Moran CN, 2011, METABOLISM, V60, P206, DOI 10.1016/j.metabol.2009.12.026; Murphy C, 2007, ARTERIOSCL THROM VAS, V27, P936, DOI 10.1161/01.ATV.0000258788.11372.d0; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Nyholm B, 2004, EUR J ENDOCRINOL, V150, P207, DOI 10.1530/eje.0.1500207; Ostergard T, 2006, AM J PHYSIOL-ENDOC M, V290, pE998, DOI 10.1152/ajpendo.00012.2005; Rajkhowa M, 2009, BIOCHEM J, V418, P665, DOI 10.1042/BJ20082176; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Riou ME, 2009, APPL PHYSIOL NUTR ME, V34, P99, DOI 10.1139/H08-144; Sahlin K, 2007, AM J PHYSIOL-ENDOC M, V292, pE223, DOI 10.1152/ajpendo.00266.2006; Saltin B, 1986, ACTA PHYSL SCAND S, V556, P21; Schenk S, 2009, J PHYSIOL-LONDON, V587, P4949, DOI 10.1113/jphysiol.2009.175489; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Standaert ML, 1999, ENDOCRINOLOGY, V140, P4470, DOI 10.1210/en.140.10.4470; Stentz Frankie B., 2007, Genomics Proteomics & Bioinformatics, V5, P216, DOI 10.1016/S1672-0229(08)60009-1; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73; Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429; Venables MC, 2005, J APPL PHYSIOL, V98, P160, DOI 10.1152/japplphysiol.00662.2003; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	75	74	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14197	10.1371/journal.pone.0014197	http://dx.doi.org/10.1371/journal.pone.0014197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152018	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000284821300012
J	Tomatis, VM; Trenchi, A; Gomez, GA; Daniotti, JL				Tomatis, Vanesa M.; Trenchi, Alejandra; Gomez, Guillermo A.; Daniotti, Jose L.			Acyl-Protein Thioesterase 2 Catalizes the Deacylation of Peripheral Membrane-Associated GAP-43	PLOS ONE			English	Article							GROWTH-ASSOCIATED PROTEIN-43; DYNAMIC FATTY ACYLATION; GTP-BINDING PROTEINS; H-RAS; NEUROMODULIN GAP-43; NEURONAL DEVELOPMENT; PRENYLATED PROTEINS; TARGETING DOMAIN; PLASMA-MEMBRANE; PALMITOYLATION	An acylation/deacylation cycle is necessary to maintain the steady-state subcellular distribution and biological activity of S-acylated peripheral proteins. Despite the progress that has been made in identifying and characterizing palmitoyl-transferases (PATs), much less is known about the thioesterases involved in protein deacylation. In this work, we investigated the deacylation of growth-associated protein-43 (GAP-43), a dually acylated protein at cysteine residues 3 and 4. Using fluorescent fusion constructs, we measured in vivo the rate of deacylation of GAP-43 and its single acylated mutants in Chinese hamster ovary (CHO)-K1 and human HeLa cells. Biochemical and live cell imaging experiments demonstrated that single acylated mutants were completely deacylated with similar kinetic in both cell types. By RT-PCR we observed that acyl-protein thioesterase 1 (APT-1), the only bona fide thioesterase shown to mediate deacylation in vivo, is expressed in HeLa cells, but not in CHO-K1 cells. However, APT-1 overexpression neither increased the deacylation rate of single acylated GAP-43 nor affected the steady-state subcellular distribution of dually acylated GAP-43 both in CHO-K1 and HeLa cells, indicating that GAP-43 deacylation is not mediated by APT-1. Accordingly, we performed a bioinformatic search to identify putative candidates with acyl-protein thioesterase activity. Among several candidates, we found that APT-2 is expressed both in CHO-K1 and HeLa cells and its overexpression increased the deacylation rate of single acylated GAP-43 and affected the steady-state localization of diacylated GAP-43 and H-Ras. Thus, the results demonstrate that APT-2 is the protein thioesterase involved in the acylation/deacylation cycle operating in GAP-43 subcellular distribution.	[Tomatis, Vanesa M.; Trenchi, Alejandra; Gomez, Guillermo A.; Daniotti, Jose L.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC, UNC CONICET,Dept Quim Biol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Tomatis, VM (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	daniotti@dqb.fcq.unc.edu.ar	Tomatis, Vanesa/D-5367-2017; Gomez, Guillermo/J-2993-2014	Tomatis, Vanesa/0000-0003-4379-8502; Gomez, Guillermo/0000-0002-0494-2404	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina; CONICET (Argentina)	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by Grants from Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC) (www.secyt.unc.edu.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (www.conicet.gov.ar), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (www.agencia.gov.ar) and Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina (www.mincyt.cba.gov.ar). V. M. T., A. T. and G. A. G. were recipients of CONICET (Argentina) Fellowship. J.L.D is a career investigator of CONICET (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Baker LP, 1997, NEUROSCI LETT, V234, P156, DOI 10.1016/S0304-3940(97)00667-8; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bhatnagar RS, 1997, TRENDS CELL BIOL, V7, P14, DOI 10.1016/S0962-8924(97)10044-7; Biewenga JE, 1996, ACTA BIOCHIM POL, V43, P327; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Cho SG, 2000, J NEUROSCI RES, V59, P32, DOI 10.1002/(SICI)1097-4547(20000101)59:1<32::AID-JNR5>3.0.CO;2-A; COGGINS PJ, 1991, J NEUROCHEM, V56, P1095, DOI 10.1111/j.1471-4159.1991.tb11398.x; De Moliner KL, 2005, J NEUROSCI RES, V79, P652, DOI 10.1002/jnr.20388; Deck P, 2005, ANGEW CHEM INT EDIT, V44, P4975, DOI 10.1002/anie.200462625; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Denny JB, 2004, EUR J BIOCHEM, V271, P2480, DOI 10.1111/j.1432-1033.2004.04179.x; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; El-Husseini AE, 2001, J BIOL CHEM, V276, P44984, DOI 10.1074/jbc.M103049200; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; Fishman MC, 1996, PERSPECT DEV NEUROBI, V4, P193; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Gomez GA, 2005, J BIOL CHEM, V280, P34997, DOI 10.1074/jbc.M506256200; Gomez GA, 2007, FEBS J, V274, P2210, DOI 10.1111/j.1742-4658.2007.05758.x; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Kanaani J, 2008, J CELL SCI, V121, P437, DOI 10.1242/jcs.011916; Liang XQ, 2002, J BIOL CHEM, V277, P33032, DOI 10.1074/jbc.M204607200; LIU YC, 1993, BIOCHEMISTRY-US, V32, P10714, DOI 10.1021/bi00091a023; LIU YC, 1994, J NEUROSCI, V14, P5807; Lu JY, 2006, J LIPID RES, V47, P1352, DOI 10.1194/jlr.R600010-JLR200; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; NEWMAN CMH, 1993, BIOCHIM BIOPHYS ACTA, V1155, P79, DOI 10.1016/0304-419X(93)90023-6; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; STOCKER KM, 1992, DEV BIOL, V149, P406, DOI 10.1016/0012-1606(92)90295-R; STRITTMATTER SM, 1994, J NEUROSCI, V14, P5503; Sugimoto H, 1996, J BIOL CHEM, V271, P7705, DOI 10.1074/jbc.271.13.7705; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Toyoda T, 1999, BBA-MOL CELL BIOL L, V1437, P182, DOI 10.1016/S1388-1981(99)00007-4; Trenchi A, 2009, BIOCHEM J, V421, P357, DOI 10.1042/BJ20090484; VANHOOFF COM, 1989, J CELL BIOL, V108, P1115, DOI 10.1083/jcb.108.3.1115; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451; ZUBER MX, 1989, NATURE, V341, P345, DOI 10.1038/341345a0	65	91	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15045	10.1371/journal.pone.0015045	http://dx.doi.org/10.1371/journal.pone.0015045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152083	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100054
J	Yu, CY; Mayba, O; Lee, JV; Tran, J; Harris, C; Speed, TP; Wang, JC				Yu, Chi-Yi; Mayba, Oleg; Lee, Joyce V.; Tran, Joanna; Harris, Charlie; Speed, Terence P.; Wang, Jen-Chywan			Genome-Wide Analysis of Glucocorticoid Receptor Binding Regions in Adipocytes Reveal Gene Network Involved in Triglyceride Homeostasis	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; INDUCED INSULIN-RESISTANCE; HUMAN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; GLUCOSE-TOLERANCE; 11-BETA-HSD1 INHIBITION; MAPK PHOSPHATASE-1; NUCLEAR FACTOR-3	Glucocorticoids play important roles in the regulation of distinct aspects of adipocyte biology. Excess glucocorticoids in adipocytes are associated with metabolic disorders, including central obesity, insulin resistance and dyslipidemia. To understand the mechanisms underlying the glucocorticoid action in adipocytes, we used chromatin immunoprecipitation sequencing to isolate genome-wide glucocorticoid receptor (GR) binding regions (GBRs) in 3T3-L1 adipocytes. Furthermore, gene expression analyses were used to identify genes that were regulated by glucocorticoids. Overall, 274 glucocorticoid-regulated genes contain or locate nearby GBR. We found that many GBRs were located in or nearby genes involved in triglyceride (TG) synthesis (Scd-1, 2, 3, GPAT3, GPAT4, Agpat2, Lpin1), lipolysis (Lipe, Mgll), lipid transport (Cd36, Lrp-1, Vldlr, Slc27a2) and storage (S3-12). Gene expression analysis showed that except for Scd-3, the other 13 genes were induced in mouse inguinal fat upon 4-day glucocorticoid treatment. Reporter gene assays showed that except Agpat2, the other 12 glucocorticoid-regulated genes contain at least one GBR that can mediate hormone response. In agreement with the fact that glucocorticoids activated genes in both TG biosynthetic and lipolytic pathways, we confirmed that 4-day glucocorticoid treatment increased TG synthesis and lipolysis concomitantly in inguinal fat. Notably, we found that 9 of these 12 genes were induced in transgenic mice that have constant elevated plasma glucocorticoid levels. These results suggested that a similar mechanism was used to regulate TG homeostasis during chronic glucocorticoid treatment. In summary, our studies have identified molecular components in a glucocorticoid-controlled gene network involved in the regulation of TG homeostasis in adipocytes. Understanding the regulation of this gene network should provide important insight for future therapeutic developments for metabolic diseases.	[Yu, Chi-Yi; Lee, Joyce V.; Tran, Joanna; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Mayba, Oleg; Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Harris, Charlie; Wang, Jen-Chywan] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94141 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yu, CY (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	walwang@berkeley.edu	Speed, Terence P/B-8085-2009; Wang, Jen-Chywan/AAX-4445-2020	Speed, Terence P/0000-0002-5403-7998; Wang, Jen-Chywan/0000-0001-6030-6886	National Institutes of Health (NIH) [DK083591, DK081680]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083591, K08DK081680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health (NIH) (DK083591 to JCW and DK081680 to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM T, 1993, J BIOL CHEM, V268, P15681; Bazuine M, 2004, MOL ENDOCRINOL, V18, P1697, DOI 10.1210/me.2003-0213; BERDANIER CD, 1989, FASEB J, V3, P2179, DOI 10.1096/fasebj.3.10.2666232; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Deblois G, 2008, MOL ENDOCRINOL, V22, P1999, DOI 10.1210/me.2007-0546; Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; DINNEEN S, 1993, J CLIN INVEST, V92, P2283, DOI 10.1172/JCI116832; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dudoit S, 2003, BIOTECHNIQUES, P45; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ensler K, 2002, BBA-MOL CELL BIOL L, V1581, P36, DOI 10.1016/S1388-1981(02)00118-X; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Gounarides JS, 2008, ENDOCRINOLOGY, V149, P758, DOI 10.1210/en.2007-1214; Gravholt CH, 2002, OBES RES, V10, P774, DOI 10.1038/oby.2002.105; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Krapivner S, 2008, J CLIN ENDOCR METAB, V93, P1995, DOI 10.1210/jc.2007-1850; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li JP, 2003, P NATL ACAD SCI USA, V100, P9476, DOI 10.1073/pnas.1133426100; Liu X, 2001, Pac Symp Biocomput, P127; Lloyd DJ, 2009, DIABETES OBES METAB, V11, P688, DOI 10.1111/j.1463-1326.2009.01034.x; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI17845; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MAYOSMITH W, 1989, RADIOLOGY, V170, P515, DOI 10.1148/radiology.170.2.2911678; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nishizuka M, 2001, J BIOL CHEM, V276, P29625, DOI 10.1074/jbc.C100272200; Nuotio-Antar AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1517, DOI 10.1152/ajpendo.00522.2007; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Ragolia L, 2008, PROSTAG OTH LIPID M, V87, P34, DOI 10.1016/j.prostaglandins.2008.06.001; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; RIZZA RA, 1982, J CLIN ENDOCR METAB, V54, P131, DOI 10.1210/jcem-54-1-131; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; ROUX J, 1995, DNA CELL BIOL, V14, P385, DOI 10.1089/dna.1995.14.385; Sakaue H, 2004, J BIOL CHEM, V279, P39951, DOI 10.1074/jbc.M407353200; Sakoda H, 2000, DIABETES, V49, P1700, DOI 10.2337/diabetes.49.10.1700; Samra JS, 1998, J CLIN ENDOCR METAB, V83, P626, DOI 10.1210/jc.83.2.626; Seckl JR, 2004, TRENDS ENDOCRIN MET, V15, P418, DOI 10.1016/j.tem.2004.09.007; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; STEGER DJ, GENES DEV, V24, P1035; STENZELPOORE MP, 1992, ENDOCRINOLOGY, V130, P3378, DOI 10.1210/en.130.6.3378; Tomlinson JW, 2007, J CLIN ENDOCR METAB, V92, P857, DOI 10.1210/jc.2006-2325; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Walker BR, 2006, DIABETIC MED, V23, P1281, DOI 10.1111/j.1464-5491.2006.01998.x; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang JC, 1996, MOL ENDOCRINOL, V10, P794, DOI 10.1210/me.10.7.794; Wang YX, 2004, J NUTR, V134, P1032; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yamada K, 1999, J BIOL CHEM, V274, P5880, DOI 10.1074/jbc.274.9.5880; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang M, 2007, NAT CELL BIOL, V9, P970, DOI 10.1038/ncb1623; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	69	121	123	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15188	10.1371/journal.pone.0015188	http://dx.doi.org/10.1371/journal.pone.0015188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187916	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200019
J	Chapin, H; Jantzen, K; Kelso, JAS; Steinberg, F; Large, E				Chapin, Heather; Jantzen, Kelly; Kelso, J. A. Scott; Steinberg, Fred; Large, Edward			Dynamic Emotional and Neural Responses to Music Depend on Performance Expression and Listener Experience	PLOS ONE			English	Article							BEAT PERCEPTION; BRAIN; MOTOR; TIME; PREMOTOR; RHYTHMS; CORTEX; SYNCHRONIZATION; VISUALIZATION; COMMUNICATION	Apart from its natural relevance to cognition, music provides a window into the intimate relationships between production, perception, experience, and emotion. Here, emotional responses and neural activity were observed as they evolved together with stimulus parameters over several minutes. Participants listened to a skilled music performance that included the natural fluctuations in timing and sound intensity that musicians use to evoke emotional responses. A mechanical performance of the same piece served as a control. Before and after fMRI scanning, participants reported real-time emotional responses on a 2-dimensional rating scale (arousal and valence) as they listened to each performance. During fMRI scanning, participants listened without reporting emotional responses. Limbic and paralimbic brain areas responded to the expressive dynamics of human music performance, and both emotion and reward related activations during music listening were dependent upon musical training. Moreover, dynamic changes in timing predicted ratings of emotional arousal, as well as real-time changes in neural activity. BOLD signal changes correlated with expressive timing fluctuations in cortical and subcortical motor areas consistent with pulse perception, and in a network consistent with the human mirror neuron system. These findings show that expressive music performance evokes emotion and reward related neural activations, and that music's affective impact on the brains of listeners is altered by musical training. Our observations are consistent with the idea that music performance evokes an emotional response through a form of empathy that is based, at least in part, on the perception of movement and on violations of pulse-based temporal expectancies.	[Chapin, Heather; Kelso, J. A. Scott; Large, Edward] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; [Jantzen, Kelly] Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA; [Kelso, J. A. Scott] Univ Ulster, Intelligent Syst Res Ctr, Derry, North Ireland; [Steinberg, Fred] Univ MRI Boca Raton, Boca Raton, FL USA	State University System of Florida; Florida Atlantic University; Western Washington University; Ulster University	Chapin, H (corresponding author), Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA.	large@ccs.fau.edu			National Science Foundation [BCS-0094229]; Fulbright visiting research chair; National Institute of Mental Health [T151063]; Pierre de Fermat Chair; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048229] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Fulbright visiting research chair; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pierre de Fermat Chair; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation career award BCS-0094229 and a Fulbright visiting research chair awarded to E. W. Large, and by National Institute of Mental Health grant T151063 and the Pierre de Fermat Chair to J.A.S. Kelso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Becker Judith, 2004, DEEP LISTENERS MUSIC; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BESSON M, 1994, NEUROSCI LETT, V168, P101, DOI 10.1016/0304-3940(94)90426-X; Bhatara AK, 2010, MUSICAL EXPRES UNPUB; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P, 1972, EMOTION HUMAN FACE G; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Fujioka T, 2009, ANN NY ACAD SCI, V1169, P89, DOI 10.1111/j.1749-6632.2009.04779.x; Gabrielsson A., 1996, PSYCHOL MUSIC, V24, P68, DOI DOI 10.1177/0305735696241007; Gaser C, 2003, J NEUROSCI, V23, P9240; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2009, ANN NY ACAD SCI, V1169, P35, DOI 10.1111/j.1749-6632.2009.04553.x; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Hurley D, 2008, NY TIMES        0603; Huron D.B., 2006, SWEET ANTICIPATION M; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; Jones MR., 1981, PSYCHOMUSICOLOGY J R, V1, P34, DOI [DOI 10.1037/H0094282, 10.1037/h0094282]; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2008, PLOS ONE; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Large E. W., 1994, Connection Science, V6, P177, DOI 10.1080/09540099408915723; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Large EW, 2007, MIDI TOOLBOX MATLAB; Large EW, 1992, JUDGMENTS SIMI UNPUB; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Levitin DJ, 2003, NEUROIMAGE, V20, P2142, DOI 10.1016/j.neuroimage.2003.08.016; Lewis Michael, 2008, HDB EMOTIONS, V3rd; London J., 2004, HEARING TIME; MADSEN CK, 1990, B COUN RES MUSIC ED, P45; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Meyer L., 1956, EMOTION MEANING MUSI; Mitterschiffthaler MT, 2007, HUMAN BRAIN MAPPING; Molnar-Szakacs I, 2006, SOC COGN AFFECT NEUR, V1, P235, DOI 10.1093/scan/nsl029; Nair D. G., 2002, P 7 INT C MUS PERC C, P627; Neale J.M., 1986, SCI BEHAV INTRO METH; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; PALMER C, 1991, J ACOUST SOC AM, V90, P60, DOI 10.1121/1.401249; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Rankin SK, 2009, MUSIC PERCEPT, V26, P401, DOI 10.1525/MP.2009.26.5.401; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Royet JP, 2000, J NEUROSCI, V20, P7752; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V38, P311; Schmithorst VJ, 2002, NEUROSCI LETT, V321, P57, DOI 10.1016/S0304-3940(02)00054-X; Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561; Schubert E, 1999, AUST J PSYCHOL, V51, P154, DOI 10.1080/00049539908255353; Schubert E, 1996, CONTINUOUS RESPONSE, P263; SCHUBERT E, 2001, MUSIC EMOTION THEORY, P393; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; Sloboda JA, 2001, MUSIC PERCEPT, V19, P87, DOI 10.1525/mp.2001.19.1.87; Sloboda JA., 2001, MUSIC EMOTION THEORY; Snyder JS, 2005, COGNITIVE BRAIN RES, V24, P117, DOI 10.1016/j.cogbrainres.2004.12.014; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; Talairach J., 1988, COPLANAR STEREOTAXIC; TODD NPM, 1992, J ACOUST SOC AM, V91, P3540, DOI 10.1121/1.402843; [No title captured]	82	93	96	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e13812	10.1371/journal.pone.0013812	http://dx.doi.org/10.1371/journal.pone.0013812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695OI	21179549	Green Submitted, gold, Green Published			2022-12-27	WOS:000285381200001
J	Cruz-Motta, JJ; Miloslavich, P; Palomo, G; Iken, K; Konar, B; Pohle, G; Trott, T; Benedetti-Cecchi, L; Herrera, C; Hernandez, A; Sardi, A; Bueno, A; Castillo, J; Klein, E; Guerra-Castro, E; Gobin, J; Gomez, DI; Riosmena-Rodriguez, R; Mead, A; Bigatti, G; Knowlton, A; Shirayama, Y				Jose Cruz-Motta, Juan; Miloslavich, Patricia; Palomo, Gabriela; Iken, Katrin; Konar, Brenda; Pohle, Gerhard; Trott, Tom; Benedetti-Cecchi, Lisandro; Herrera, Cesar; Hernandez, Alejandra; Sardi, Adriana; Bueno, Andrea; Castillo, Julio; Klein, Eduardo; Guerra-Castro, Edlin; Gobin, Judith; Isabel Gomez, Diana; Riosmena-Rodriguez, Rafael; Mead, Angela; Bigatti, Gregorio; Knowlton, Ann; Shirayama, Yoshihisa			Patterns of Spatial Variation of Assemblages Associated with Intertidal Rocky Shores: A Global Perspective	PLOS ONE			English	Article							SPECIES-DIVERSITY; LATITUDINAL GRADIENTS; MARINE BIODIVERSITY; COMMUNITY STRUCTURE; ZONATION PATTERNS; CLIMATE-CHANGE; HUMAN IMPACT; ABUNDANCE; ECOLOGY; INVERTEBRATES	Assemblages associated with intertidal rocky shores were examined for large scale distribution patterns with specific emphasis on identifying latitudinal trends of species richness and taxonomic distinctiveness. Seventy-two sites distributed around the globe were evaluated following the standardized sampling protocol of the Census of Marine Life NaGISA project (www.nagisa.coml.org). There were no clear patterns of standardized estimators of species richness along latitudinal gradients or among Large Marine Ecosystems (LMEs); however, a strong latitudinal gradient in taxonomic composition (i.e., proportion of different taxonomic groups in a given sample) was observed. Environmental variables related to natural influences were strongly related to the distribution patterns of the assemblages on the LME scale, particularly photoperiod, sea surface temperature (SST) and rainfall. In contrast, no environmental variables directly associated with human influences (with the exception of the inorganic pollution index) were related to assemblage patterns among LMEs. Correlations of the natural assemblages with either latitudinal gradients or environmental variables were equally strong suggesting that neither neutral models nor models based solely on environmental variables sufficiently explain spatial variation of these assemblages at a global scale. Despite the data shortcomings in this study (e. g., unbalanced sample distribution), we show the importance of generating biological global databases for the use in large-scale diversity comparisons of rocky intertidal assemblages to stimulate continued sampling and analyses.	[Jose Cruz-Motta, Juan; Miloslavich, Patricia; Klein, Eduardo] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Miranda, Venezuela; [Palomo, Gabriela] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Ecosistemas Costeros, Buenos Aires, DF, Argentina; [Iken, Katrin; Konar, Brenda; Knowlton, Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Pohle, Gerhard] Huntsman Marine Sci Ctr, St Andrews, NB, Canada; [Trott, Tom] Suffolk Univ, Boston, MA 02114 USA; [Benedetti-Cecchi, Lisandro] Univ Pisa, Dipartimento Biol, Pisa, Tuscany, Italy; [Jose Cruz-Motta, Juan; Miloslavich, Patricia; Herrera, Cesar; Hernandez, Alejandra; Sardi, Adriana; Bueno, Andrea; Castillo, Julio; Klein, Eduardo] Univ Simon Bolivar, Ctr Biodiversidad Marina, Caracas, Miranda, Venezuela; [Guerra-Castro, Edlin] Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Miranda, Venezuela; [Gobin, Judith] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Isabel Gomez, Diana] Inst Invest Marinas & Costeras Jose Benito Vives, Santa Marta, Magdalena, Colombia; [Riosmena-Rodriguez, Rafael] Univ Autonoma Baja California Sur, Programa Invest Bot Marina, La Paz, Mexico; [Mead, Angela] Univ Cape Town, ZA-7925 Cape Town, Western Cape, South Africa; [Bigatti, Gregorio] Ctr Estudios Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Shirayama, Yoshihisa] Kyoto Univ, Field Sci Educ & Res Ctr, Seto Marine Biol Lab, Wakayama, Japan	Simon Bolivar University; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University of Alaska System; University of Alaska Fairbanks; Suffolk University; University of Pisa; Simon Bolivar University; Venezuelan Institute Science Research; University West Indies Mona Jamaica; University West Indies Saint Augustine; Universidad Autonoma de Baja California; University of Cape Town; Kyoto University	Cruz-Motta, JJ (corresponding author), Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Miranda, Venezuela.	juancruz@usb.ve	Herrera, César/AAI-3001-2021; Trott, Thomas J/N-4660-2018; Guerra-Castro, Edlin/E-3639-2014; Benedetti-Cecchi, Lisandro/J-8225-2019	Herrera, César/0000-0003-0307-6724; Trott, Thomas J/0000-0002-1851-5243; Guerra-Castro, Edlin/0000-0003-3529-4507; Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Sardi, Adriana E./0000-0001-5323-2006; Klein, Eduardo/0000-0003-2935-7065; Bueno, Andrea/0000-0002-4205-5275; Palomo, Maria Gabriela/0000-0002-9102-1282; BIGATTI, GREGORIO/0000-0001-7053-6802; Cruz Motta, Juan Jose/0000-0001-6117-9014; Miloslavich, Patricia/0000-0001-5409-1401	Alfred P. Sloan Foundation; Chevron (Venezuela) through a LOCTI (Ley Organica de Ciencia, Tecnologia e Innovacion); Decanato de Investigaciones (Universidad Simon Bolivar, Caracas, Venezuela)	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Chevron (Venezuela) through a LOCTI (Ley Organica de Ciencia, Tecnologia e Innovacion); Decanato de Investigaciones (Universidad Simon Bolivar, Caracas, Venezuela)	Funding for this study was given by Alfred P. Sloan Foundation, Chevron (Venezuela) through a LOCTI (Ley Organica de Ciencia, Tecnologia e Innovacion) scheme and Decanato de Investigaciones (Universidad Simon Bolivar, Caracas, Venezuela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BARREIRO R, 1993, MAR ENVIRON RES, V36, P39, DOI 10.1016/0141-1136(93)90088-H; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V215, P79, DOI 10.3354/meps215079; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; Bolton JJ, 2002, S AFR J MARINE SCI, V24, P9, DOI 10.2989/025776102784528402; BOLTON JJ, 1994, BOT MAR, V37, P241, DOI 10.1515/botm.1994.37.3.241; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; BUSTAMANTE RH, 1995, OECOLOGIA, V102, P189, DOI 10.1007/BF00333251; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Castilla JC, 1996, ENVIRON MONIT ASSESS, V40, P171, DOI 10.1007/BF00414390; Castilla JC, 2000, J EXP MAR BIOL ECOL, V250, P3, DOI 10.1016/S0022-0981(00)00177-5; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; Clark R, 1997, MARINE POLLUTION, V4; CLARKE A, 1992, TRENDS ECOL EVOL, V7, P286, DOI 10.1016/0169-5347(92)90222-W; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR, 1998, OECOLOGIA, V113, P278, DOI 10.1007/s004420050379; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cruz-Motta JJ, 2007, CIENC MAR, V33, P133, DOI 10.7773/cm.v33i2.1113; Fisher JAD, 2010, GLOBAL ECOL BIOGEOGR, V19, P1, DOI 10.1111/j.1466-8238.2009.00482.x; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gaston Kevin J., 2004, BIODIVERSITY INTRO; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Genner MJ, 2010, GLOBAL CHANGE BIOL, V16, P517, DOI 10.1111/j.1365-2486.2009.02027.x; Gessner MO, 2004, OIKOS, V104, P419, DOI 10.1111/j.0030-1299.1999.13252.x; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Good TP, 2004, B MAR SCI, V74, P459; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; He F, 2005, FUNCT ECOL, V19, P187, DOI 10.1111/j.0269-8463.2005.00944.x; Heath MR, 2008, SCIENCE, V321, DOI 10.1126/science.1157390; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Hubbell Stephen P., 2001, V32, pi; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; IKEN K, 2010, PLOS ONE IN PRESS; Ingolfsson A, 2005, J BIOGEOGR, V32, P169, DOI 10.1111/j.1365-2699.2004.01150.x; KENDALL MA, 1993, J EXP MAR BIOL ECOL, V172, P157, DOI 10.1016/0022-0981(93)90095-6; Kerr Jeremy, 2001, Trends in Ecology and Evolution, V16, P424, DOI 10.1016/S0169-5347(01)02226-1; Konar B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013195; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Lindstrom SC, 1999, BOT MAR, V42, P265, DOI 10.1515/BOT.1999.030; Lopez MM, 2005, REV BIOL TROP, V53, P291; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Meeus JH., 1991, ASTRONOMICAL ALGORIT; Menconi M, 1999, J EXP MAR BIOL ECOL, V233, P1, DOI 10.1016/S0022-0981(98)00123-3; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Nisbet E, 2007, NATURE, V450, P789, DOI 10.1038/450789a; Nunez SG, 1999, CIENC MAR, V25, P629, DOI 10.7773/cm.v25i4.722; O'Connor NE, 2005, ECOLOGY, V86, P1783, DOI 10.1890/04-1172; Okuda T, 2004, POPUL ECOL, V46, P159, DOI 10.1007/s10144-004-0185-9; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Reise K, 1998, HELGOLANDER MEERESUN, V52, P219, DOI 10.1007/BF02908898; Rigby PR, 2007, SAMPLING BIODIVERSIT; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Robles C, 2002, ECOLOGY, V83, P1521, DOI 10.1890/0012-9658(2002)083[1521:HACDOA]2.0.CO;2; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Sagarin RD, 2002, J BIOGEOGR, V29, P985, DOI 10.1046/j.1365-2699.2002.00705.x; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; Santelices Bernabe, 1998, Diversity and Distributions, V4, P71, DOI 10.1046/j.1472-4642.1998.00005.x; Sherman K, 2007, NMFSNE208 NOAA US DE; Sink KJ, 2005, AFR J MAR SCI, V27, P81, DOI 10.2989/18142320509504070; SOUTHWARD AJ, 1978, J FISH RES BOARD CAN, V35, P682, DOI 10.1139/f78-120; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P51, DOI 10.1016/S0022-0981(00)00179-9; Walther GR, 2000, PHYTOCOENOLOGIA, V30, P409; Watson R.T., 2001, CLIMATE CHANGE 2001, P388; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zacharias MA, 2001, J BIOGEOGR, V28, P471, DOI 10.1046/j.1365-2699.2001.00559.x	92	28	31	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14354	10.1371/journal.pone.0014354	http://dx.doi.org/10.1371/journal.pone.0014354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179546	Green Published, gold, Green Submitted			2022-12-27	WOS:000285381200008
J	Ward, LM; MacLean, SE; Kirschner, A				Ward, Lawrence M.; MacLean, Shannon E.; Kirschner, Aaron			Stochastic Resonance Modulates Neural Synchronization within and between Cortical Sources	PLOS ONE			English	Article							STEADY-STATE RESPONSES; POSTERIOR CINGULATE; PHASE SYNCHRONIZATION; BLIND SEPARATION; GAMMA; OSCILLATIONS; DYNAMICS; COMPONENTS; MECHANISM; AROUSAL	Neural synchronization is a mechanism whereby functionally specific brain regions establish transient networks for perception, cognition, and action. Direct addition of weak noise (fast random fluctuations) to various neural systems enhances synchronization through the mechanism of stochastic resonance (SR). Moreover, SR also occurs in human perception, cognition, and action. Perception, cognition, and action are closely correlated with, and may depend upon, synchronized oscillations within specialized brain networks. We tested the hypothesis that SR-mediated neural synchronization occurs within and between functionally relevant brain areas and thus could be responsible for behavioral SR. We measured the 40-Hz transient response of the human auditory cortex to brief pure tones. This response arises when the ongoing, random-phase, 40-Hz activity of a group of tuned neurons in the auditory cortex becomes synchronized in response to the onset of an above-threshold sound at its "preferred" frequency. We presented a stream of near-threshold standard sounds in various levels of added broadband noise and measured subjects' 40-Hz response to the standards in a deviant-detection paradigm using high-density EEG. We used independent component analysis and dipole fitting to locate neural sources of the 40-Hz response in bilateral auditory cortex, left posterior cingulate cortex and left superior frontal gyrus. We found that added noise enhanced the 40-Hz response in all these areas. Moreover, added noise also increased the synchronization between these regions in alpha and gamma frequency bands both during and after the 40-Hz response. Our results demonstrate neural SR in several functionally specific brain regions, including areas not traditionally thought to contribute to the auditory 40-Hz transient response. In addition, we demonstrated SR in the synchronization between these brain regions. Thus, both intra-and inter-regional synchronization of neural activity are facilitated by the addition of moderate amounts of random noise. Because the noise levels in the brain fluctuate with arousal system activity, particularly across sleep-wake cycles, optimal neural noise levels, and thus SR, could be involved in optimizing the formation of task-relevant brain networks at several scales under normal conditions.	[Ward, Lawrence M.; MacLean, Shannon E.; Kirschner, Aaron] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Ward, Lawrence M.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Ward, LM (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	lward@psych.ubc.ca		Ward, Lawrence/0000-0003-4431-5015	Natural Sciences and Engineering Research Council of Canada [A9958]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a Discovery Grant (A9958) from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) to LMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Bohorquez J, 2008, CLIN NEUROPHYSIOL, V119, P2598, DOI 10.1016/j.clinph.2008.08.002; CRICK F, 1990, COLD SH Q B, V55, P953; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Doesburg SM, 2009, BRAIN RES, V1303, P97, DOI 10.1016/j.brainres.2009.09.069; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GALAMBOS R, 1992, J ACOUST SOC AM, V92, P2683, DOI 10.1121/1.404383; GALAMBOS R, 1992, J ACOUST SOC AM, V92, P2691, DOI 10.1121/1.404384; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; GELDARD FA, 1972, HUMAN SENSES; GINGL Z, 1995, EUROPHYS LETT, V29, P191, DOI 10.1209/0295-5075/29/3/001; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Greenwood PE, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051110; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; JUNG P, 1995, PHYS REV LETT, V74, P2130, DOI 10.1103/PhysRevLett.74.2130; KILENY P, 1986, J SPEECH HEAR RES, V29, P20, DOI 10.1044/jshr.2901.20; Kitajo K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.218103; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lugo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002860; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Manjarrez E, 2002, NEUROSCI LETT, V324, P213, DOI 10.1016/S0304-3940(02)00212-4; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Meinecke FC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.084102; Mori T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.218101; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; NICOLIS C, 1981, SOL PHYS, V74, P473, DOI 10.1007/BF00154530; Nielsen FA, 2005, NEUROIMAGE, V27, P520, DOI 10.1016/j.neuroimage.2005.04.034; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shalgi S, 2007, NEUROPSYCHOLOGIA, V45, P1878, DOI 10.1016/j.neuropsychologia.2006.11.023; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Srebro R, 1999, PHYS REV E, V59, P2566, DOI 10.1103/PhysRevE.59.2566; STAPELLS DR, 1984, EAR HEARING, V5, P105, DOI 10.1097/00003446-198403000-00009; STAPELLS DR, 1987, ELECTROEN CLIN NEURO, V67, P260, DOI 10.1016/0013-4694(87)90024-1; Stapells DR, 2005, SOUND FDN EARLY AMPL, P43; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Stone J.V., 2004, INDEPENDENT COMPONEN; Stufflebeam SM, 2000, NEUROREPORT, V11, P4081, DOI 10.1097/00001756-200012180-00034; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Tanaka K, 2008, CLIN NEUROPHYSIOL, V119, P2104, DOI 10.1016/j.clinph.2008.05.007; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Ward LM, 2009, CONTEMP PHYS, V50, P563, DOI 10.1080/00107510902879246; Ward LM, 2005, AIP CONF PROC, V800, P245, DOI 10.1063/1.2138621; Ward LM, 2004, FLUCT NOISE LETT, V4, pL11, DOI 10.1142/S0219477504001616; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Zaks MA, 1999, PHYS REV LETT, V82, P4228, DOI 10.1103/PhysRevLett.82.4228	69	69	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14371	10.1371/journal.pone.0014371	http://dx.doi.org/10.1371/journal.pone.0014371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179552	gold, Green Submitted, Green Published			2022-12-27	WOS:000285381200014
J	Coenen, MJH; Enevold, C; Barrera, P; Schijvenaars, MMVAP; Toonen, EJM; Scheffer, H; Padyukov, L; Kastbom, A; Klareskog, L; Barton, A; Kievit, W; Rood, MJ; Jansen, TL; Swinkels, D; van Riel, PLCM; Franke, B; Bendtzen, K; Radstake, TRDJ				Coenen, Marieke J. H.; Enevold, Christian; Barrera, Pilar; Schijvenaars, Mascha M. V. A. P.; Toonen, Erik J. M.; Scheffer, Hans; Padyukov, Leonid; Kastbom, Alf; Klareskog, Lars; Barton, Anne; Kievit, Wietske; Rood, Maarten J.; Jansen, Tim L.; Swinkels, Dorine; van Riel, Piet L. C. M.; Franke, Barbara; Bendtzen, Klaus; Radstake, Timothy R. D. J.			Genetic Variants in Toll-Like Receptors Are Not Associated with Rheumatoid Arthritis Susceptibility or Anti-Tumour Necrosis Factor Treatment Outcome	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; GENOME-WIDE ASSOCIATION; DISEASE SEVERITY; TOLL-LIKE-RECEPTOR-4; POPULATION; EXPRESSION; RISK	Background: Several studies point to a role of Toll-like receptors (TLRs) in the development of rheumatoid arthritis (RA). We investigated if genetic variants in TLR genes are associated with RA and response to tumour necrosis factor blocking (anti-TNF) medication. Methodology and Principal Findings: 22 single nucleotide polymorphisms (SNPs) in seven TLR genes were genotyped in a Dutch cohort consisting of 378 RA patients and 294 controls. Significantly associated variants were investigated in replication cohorts from The Netherlands, United Kingdom and Sweden (2877 RA patients and 2025 controls). 182 of the Dutch patients were treated with anti-TNF medication. Using these patients and a replication cohort (269 Swedish patients) we analysed if genetic variants in TLR genes were associated with anti-TNF outcome. In the discovery phase of the study we found a significant association of SNPs rs2072493 in TLR5 and rs3853839 in TLR7 with RA disease susceptibility. Meta-analysis of discovery and replication cohorts did not confirm these findings. SNP rs2072493 in TLR5 was associated with anti-TNF outcome in the Dutch but not in the Swedish population. Conclusion: We conclude that genetic variants in TLRs do not play a major role in susceptibility for developing RA nor in anti-TNF treatment outcome in a Caucasian population.	[Coenen, Marieke J. H.; Schijvenaars, Mascha M. V. A. P.; Toonen, Erik J. M.; Scheffer, Hans; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, IGMD, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Enevold, Christian; Bendtzen, Klaus] Univ Copenhagen Hosp, Rigshosp, Inst Inflammat Res, Dept Rheumatol, DK-2100 Copenhagen, Denmark; [Barrera, Pilar; van Riel, Piet L. C. M.; Radstake, Timothy R. D. J.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Padyukov, Leonid; Klareskog, Lars] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Kastbom, Alf] Linkoping Univ, Dept Clin & Expt Med, Div Rheumatol, Linkoping, Sweden; [Barton, Anne] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester, Lancs, England; [Rood, Maarten J.] Ziekenhuis Gelderse Vallei, Dept Rheumatol, Ede, Netherlands; [Jansen, Tim L.] Med Ctr Leeuwarden, Dept Rheumatol, Leeuwarden, Netherlands; [Swinkels, Dorine] Radboud Univ Nijmegen, Clin Chem Lab, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Rigshospitalet; University of Copenhagen; Radboud University Nijmegen; Karolinska Institutet; Karolinska University Hospital; Linkoping University; University of Manchester; Gelderse Vallei Hospital; Medical Center Leeuwarden; Radboud University Nijmegen	Coenen, MJH (corresponding author), Radboud Univ Nijmegen, Med Ctr, IGMD, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	m.coenen@antrg.umcn.nl	Kastbom, Alf/F-6137-2011; Toonen, Erik/G-7337-2015; Kievit, Wietske/A-5666-2015; Jansen, T.L.Th.A./L-4407-2015; Scheffer, Hans/E-4644-2012; Swinkels, Dorine W./H-8098-2014; Coenen, Marieke/A-2159-2010; van Riel, P.L.C.M./H-8082-2014; Franke, Barbara/D-4836-2009; Schijvenaars, Mascha/P-8712-2015; Barton, Anne/N-2053-2014; Padyukov, Leonid/A-4890-2009	Kastbom, Alf/0000-0001-7187-1477; Scheffer, Hans/0000-0002-2986-0915; Swinkels, Dorine W./0000-0002-1040-9446; Coenen, Marieke/0000-0001-8796-2031; Franke, Barbara/0000-0003-4375-6572; Barton, Anne/0000-0003-3316-2527; Enevold, Christian/0000-0002-2748-1997; Padyukov, Leonid/0000-0003-2950-5670; Jansen, Tim L/0000-0003-3026-3154; Klareskog, Lars/0000-0001-9601-6186; Toonen, Erik/0000-0001-9039-635X	Danish Biotechnology program; Lundbeck Foundation; Netherlands Organisation for Scientific Research [916.76.020]	Danish Biotechnology program; Lundbeck Foundation(Lundbeckfonden); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Danish Biotechnology program (C. Enevold) and The Lundbeck Foundation (C. Enevold) and a personal grant to M. Coenen from the Netherlands Organisation for Scientific Research (grant 916.76.020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coenen MJH, 2009, GENES IMMUN, V10, P101, DOI 10.1038/gene.2008.77; De Rycke L, 2005, ARTHRITIS RHEUM-US, V52, P2146, DOI 10.1002/art.21155; Enevold C, 2010, J RHEUMATOL, V37, P905, DOI 10.3899/jrheum.090775; Etem EO, 2011, RHEUMATOL INT, V31, P1369, DOI 10.1007/s00296-010-1472-8; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Jaen O, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2589; Kang ES, 2007, RHEUMATOL INT, V27, P887, DOI 10.1007/s00296-007-0311-z; Kastbom A, 2007, ARTHRITIS RHEUM, V56, P448, DOI 10.1002/art.22390; Kilding R, 2003, CLIN EXP RHEUMATOL, V21, P340; Kuuliala K, 2006, ANN RHEUM DIS, V65, P1241, DOI 10.1136/ard.2006.055137; Lee EY, 2006, INT J IMMUNOGENET, V33, P211, DOI 10.1111/j.1744-313X.2006.00599.x; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radstake TRDJ, 2004, ARTHRITIS RHEUM, V50, P999, DOI 10.1002/art.20114; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Sanchez E, 2004, TISSUE ANTIGENS, V63, P54, DOI 10.1111/j.1399-0039.2004.00162.x; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P1328, DOI 10.1136/ard.2007.083337; Taylor JD, 2001, BIOTECHNIQUES, V30, P661, DOI 10.2144/01303dd04; Toonen EJM, 2008, ANN RHEUM DIS, V67, P1174, DOI 10.1136/ard.2008.088138; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; Welsing PMJ, 2004, J RHEUMATOL, V31, P14; Ye F, 2001, HUM MUTAT, V17, P305, DOI 10.1002/humu.28	27	22	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14326	10.1371/journal.pone.0014326	http://dx.doi.org/10.1371/journal.pone.0014326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179534	Green Published, gold, Green Submitted			2022-12-27	WOS:000285340000005
J	Junaid, M; Lapins, M; Eklund, M; Spjuth, O; Wikberg, JES				Junaid, Muhammad; Lapins, Maris; Eklund, Martin; Spjuth, Ola; Wikberg, Jarl E. S.			Proteochemometric Modeling of the Susceptibility of Mutated Variants of the HIV-1 Virus to Reverse Transcriptase Inhibitors	PLOS ONE			English	Article							ORGANIC-COMPOUNDS; DESIGN; THERAPIES; SET	Background: Reverse transcriptase is a major drug target in highly active antiretroviral therapy (HAART) against HIV, which typically comprises two nucleoside/nucleotide analog reverse transcriptase (RT) inhibitors (NRTIs) in combination with a non-nucleoside RT inhibitor or a protease inhibitor. Unfortunately, HIV is capable of escaping the therapy by mutating into drug-resistant variants. Computational models that correlate HIV drug susceptibilities to the virus genotype and to drug molecular properties might facilitate selection of improved combination treatment regimens. Methodology/Principal Findings: We applied our earlier developed proteochemometric modeling technology to analyze HIV mutant susceptibility to the eight clinically approved NRTIs. The data set used covered 728 virus variants genotyped for 240 sequence residues of the DNA polymerase domain of the RT; 165 of these residues contained mutations; totally the data-set covered susceptibility data for 4,495 inhibitor-RT combinations. Inhibitors and RT sequences were represented numerically by 3D-structural and physicochemical property descriptors, respectively. The two sets of descriptors and their derived cross-terms were correlated to the susceptibility data by partial least-squares projections to latent structures. The model identified more than ten frequently occurring mutations, each conferring more than two-fold loss of susceptibility for one or several NRTIs. The most deleterious mutations were K65R, Q151M, M184V/I, and T215Y/F, each of them decreasing susceptibility to most of the NRTIs. The predictive ability of the model was estimated by cross-validation and by external predictions for new HIV variants; both procedures showed very high correlation between the predicted and actual susceptibility values (Q(2) = 0.89 and Q(ext)(2) = 0.86). The model is available at www.hivdrc.org as a free web service for the prediction of the susceptibility to any of the clinically used NRTIs for any HIV-1 mutant variant. Conclusions/Significance: Our results give directions how to develop approaches for selection of genome-based optimum combination therapy for patients harboring mutated HIV variants.	[Junaid, Muhammad; Lapins, Maris; Eklund, Martin; Spjuth, Ola; Wikberg, Jarl E. S.] Uppsala Univ, Dept Pharmaceut Pharmacol, Uppsala, Sweden	Uppsala University	Junaid, M (corresponding author), Uppsala Univ, Dept Pharmaceut Pharmacol, Uppsala, Sweden.	Jarl.Wikberg@farmbio.uu.se	Spjuth, Ola/Q-2638-2019	Spjuth, Ola/0000-0002-8083-2864; Lapins, Maris/0000-0002-0122-6680	Uppsala University [KoF 07]; Stiftelsen Lakare mot AIDS Forskningsfond; Wiberg's foundation	Uppsala University; Stiftelsen Lakare mot AIDS Forskningsfond; Wiberg's foundation	Support was received from Uppsala University (KoF 07), Stiftelsen Lakare mot AIDS Forskningsfond and Wiberg's foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2009, J INFECT DIS, V199, P999, DOI 10.1086/597305; [Anonymous], [No title captured]; Beerenwinkel N, 2005, BIOINFORMATICS, V21, P3943, DOI 10.1093/bioinformatics/bti654; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cozzi-Lepri A, 2005, ANTIVIR THER, V10, P791; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; Eriksson L, 1996, CHEMOMETR INTELL LAB, V34, P1, DOI 10.1016/0169-7439(96)00023-8; Eriksson L., 2001, MULTI MEGAVARIATE DA; Gao F, 2004, J VIROL, V78, P2426, DOI 10.1128/JVI.78.5.2426-2433.2004; GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; GOODY RS, 1991, FEBS LETT, V291, P1, DOI 10.1016/0014-5793(91)81089-Q; JINGSHAN R, 2005, TRENDS PHARMACOL SCI, V26, P4; Kjer J, 2008, HIV MED, V9, P642, DOI 10.1111/j.1468-1293.2008.00612.x; KONTIJEVSKIS A, 2007, PLOS COMPUT BIOL; Lapins M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-181; Lapinsh M, 2001, BBA-GEN SUBJECTS, V1525, P180, DOI 10.1016/S0304-4165(00)00187-2; Lapinsh M, 2005, BIOINFORMATICS, V21, P4289, DOI 10.1093/bioinformatics/bti703; Lapinsh M, 2005, MOL PHARMACOL, V67, P50, DOI 10.1124/mol.104.002857; Lapinsh M, 2003, J MED CHEM, V46, P2572, DOI 10.1021/jm020945m; Lapinsh M, 2002, MOL PHARMACOL, V61, P1465, DOI 10.1124/mol.61.6.1465; Mandrika I, 2007, PROTEIN ENG DES SEL, V20, P301, DOI 10.1093/protein/gzm022; Parniak M A, 2000, Adv Pharmacol, V49, P67; Prusis P, 2001, BBA-PROTEIN STRUCT M, V1544, P350, DOI 10.1016/S0167-4838(00)00249-1; Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rosen-Zvi M, 2008, BIOINFORMATICS, V24, pI399, DOI 10.1093/bioinformatics/btn141; Saigo H, 2007, BIOINFORMATICS, V23, P2455, DOI 10.1093/bioinformatics/btm353; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Strombergsson H, 2006, PROTEINS, V63, P24, DOI 10.1002/prot.20777; Todeschini R., 2008, HDB MOL DESCRIPTORS; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; *UNAIDS, AIDS EP UPD 2009; Wagener J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-279; Wang K, 2004, ANTIVIR THER, V9, P703; Wikberg J. E. S., 2004, CHEMOGENOMICS DRUG D, P289, DOI DOI 10.1002/3527603948.CH10; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; RELEASE NOTES HIVDB	40	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14353	10.1371/journal.pone.0014353	http://dx.doi.org/10.1371/journal.pone.0014353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179544	Green Published, gold, Green Submitted			2022-12-27	WOS:000285340000015
J	Lee, K; Brownstein, JS; Mills, RG; Kohane, IS				Lee, Kyungjoon; Brownstein, John S.; Mills, Richard G.; Kohane, Isaac S.			Does Collocation Inform the Impact of Collaboration?	PLOS ONE			English	Article							OPEN ACCESS; TEAMS	Background: It has been shown that large interdisciplinary teams working across geography are more likely to be impactful. We asked whether the physical proximity of collaborators remained a strong predictor of the scientific impact of their research as measured by citations of the resulting publications. Methodology/Principal Findings: Articles published by Harvard investigators from 1993 to 2003 with at least two authors were identified in the domain of biomedical science. Each collaboration was geocoded to the precise three-dimensional location of its authors. Physical distances between any two coauthors were calculated and associated with corresponding citations. Relationship between distance of coauthors and citations for four author relationships (first-last, first-middle, last-middle, and middle-middle) were investigated at different spatial scales. At all sizes of collaborations (from two authors to dozens of authors), geographical proximity between first and last author is highly informative of impact at the microscale (i.e. within building) and beyond. The mean citation for first-last author relationship decreased as the distance between them increased in less than one km range as well as in the three categorized ranges (in the same building, same city, or different city). Such a trend was not seen in other three author relationships. Conclusions/Significance: Despite the positive impact of emerging communication technologies on scientific research, our results provide striking evidence for the role of physical proximity as a predictor of the impact of collaborations.	[Lee, Kyungjoon; Kohane, Isaac S.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Brownstein, John S.; Kohane, Isaac S.] Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Lee, K (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	isaac_kohane@harvard.edu	Kohane, Isaac Kohane/K-3716-2012; Brownstein, John S/A-1438-2011	Kohane, Isaac Kohane/0000-0003-2192-5160; Lee, Kyungjoon/0000-0002-4026-476X	Kauffman Foundation; Office of the Provost at Harvard University	Kauffman Foundation; Office of the Provost at Harvard University	This research was supported by the Kauffman Foundation and the Office of the Provost at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordons M, 1996, SCIENTOMETRICS, V37, P279, DOI 10.1007/BF02093625; Calver MC, 2010, CONSERV BIOL, V24, P872, DOI 10.1111/j.1523-1739.2010.01509.x; Craig ID, 2007, J INFORMETR, V1, P239, DOI 10.1016/j.joi.2007.04.001; Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	7	72	72	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14279	10.1371/journal.pone.0014279	http://dx.doi.org/10.1371/journal.pone.0014279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179507	Green Submitted, gold, Green Published			2022-12-27	WOS:000285340000002
J	Saminathan, R; Bai, J; Sadrolodabaee, L; Karthik, GM; Singh, O; Subramaniyan, K; Ching, CB; Chen, WN; Chowbay, B				Saminathan, Ramasamy; Bai, Jing; Sadrolodabaee, Laleh; Karthik, Govindasamy Muralidharan; Singh, Onkar; Subramaniyan, Koilan; Ching, Chi Bun; Chen, Wei Ning; Chowbay, Balram			VKORC1 Pharmacogenetics and Pharmacoproteomics in Patients on Warfarin Anticoagulant Therapy: Transthyretin Precursor as a Potential Biomarker	PLOS ONE			English	Article							LC-MS/MS ANALYSIS; CYTOCHROME P4502C9; DOSE REQUIREMENTS; PROTEIN PROFILE; ASIAN PATIENTS; S-ENANTIOMERS; R-ENANTIOMERS; POLYMORPHISMS; CYP2C9; CELLS	Background: Recognizing specific protein changes in response to drug administration in humans has the potential for the development of personalized medicine. Such changes can be identified by pharmacoproteomics approach based on proteomic technologies. It can also be helpful in matching a particular target-based therapy to a particular marker in a subgroup of patients, in addition to the profile of genetic polymorphism. Warfarin is a commonly prescribed oral anticoagulant in patients with prosthetic valve disease, venous thromboembolism and stroke. Methods and Finding: We used a combined pharmacogenetics and iTRAQ-coupled LC-MS/MS pharmacoproteomics approach to analyze plasma protein profiles of 53 patients, and identified significantly upregulated level of transthyretin precursor in patients receiving low dose of warfarin but not in those on high dose of warfarin. In addition, real-time RT-PCR, western blotting, human IL-6 ELISA assay were done for the results validation. Conclusion: This combined pharmacogenomics and pharmacoproteomics approach may be applied for other target-based therapies, in matching a particular marker in a subgroup of patients, in addition to the profile of genetic polymorphism.	[Saminathan, Ramasamy; Karthik, Govindasamy Muralidharan; Singh, Onkar; Subramaniyan, Koilan; Chowbay, Balram] Natl Canc Ctr, Div Med Sci, Humphrey Oei Inst Canc Res, Lab Clin Pharmacol, Singapore, Singapore; [Bai, Jing; Sadrolodabaee, Laleh; Ching, Chi Bun; Chen, Wei Ning] Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Saminathan, R (corresponding author), Natl Canc Ctr, Div Med Sci, Humphrey Oei Inst Canc Res, Lab Clin Pharmacol, Singapore, Singapore.	WNChen@ntu.edu.sg; ctebal@nccs.com.sg	bai, jing/R-1506-2016	, Yang/0000-0002-6620-8897	National Medical Research Council [NMRC/EDG/0033/2008 and NMRCB1011]; SGH Research Fund [96/03]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SGH Research Fund	This work was supported by the National Medical Research Council grants (NMRC/EDG/0033/2008 and NMRCB1011) and the SGH Research Fund 96/03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher RK, 2002, ANN PHARMACOTHER, V36, P1512, DOI 10.1345/aph.1C025; Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Anand SS, 1999, JAMA-J AM MED ASSOC, V282, P2058, DOI 10.1001/jama.282.21.2058; BARTALENA L, 1992, MOL ENDOCRINOL, V6, P935, DOI 10.1210/me.6.6.935; Beyth Rebecca J, 2002, Curr Hematol Rep, V1, P41; BRECKENRIDGE A, 1974, CLIN PHARMACOL THER, V15, P424; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Citarella F, 1997, BLOOD, V90, P1501, DOI 10.1182/blood.V90.4.1501.1501_1501_1507; FELDTRASMUSSEN U, 2007, THYROID HORMONE TRAN; Gan GG, 2003, INT J HEMATOL, V78, P84, DOI 10.1007/BF02983247; Kamali F, 2004, CLIN PHARMACOL THER, V75, P204, DOI 10.1016/j.clpt.2003.10.001; KAMALI F, ANN REV MED, P63; Kater AP, 2002, CLIN DIAGN LAB IMMUN, V9, P1396, DOI 10.1128/CDLI.9.6.1396-1397.2002; KUROHARA M, 2008, KOBE J MED SCI, V51, pE1; Lal S, 2008, BRIT J CLIN PHARMACO, V65, P260, DOI 10.1111/j.1365-2125.2007.03053.x; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Limdi NA, 2008, PHARMACOTHERAPY, V28, P1084, DOI 10.1592/phco.28.9.1084; Liu LY, 2007, CANCER SCI, V98, P1617, DOI 10.1111/j.1349-7006.2007.00576.x; Maclean PS, 2003, J THROMB HAEMOST, V1, P1838, DOI 10.1046/j.1538-7836.2003.t01-1-00372.x; Palha JA, 2002, CLIN CHEM LAB MED, V40, P1292, DOI 10.1515/CCLM.2002.223; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Sandanaraj E, 2009, DRUG METAB PHARMACOK, V24, P365, DOI 10.2133/dmpk.24.365; Scordo MG, 2002, CLIN PHARMACOL THER, V72, P702, DOI 10.1067/mcp.2002.129321; Scordo MG, 2001, BRIT J CLIN PHARMACO, V52, P447, DOI 10.1046/j.0306-5251.2001.01460.x; SMITH P, 1990, NEW ENGL J MED, V323, P147, DOI 10.1056/NEJM199007193230302; Sui JJ, 2008, MOL CELL PROTEOMICS, V7, P1007, DOI 10.1074/mcp.M700485-MCP200; Sui JJ, 2007, J PROTEOME RES, V6, P1643, DOI 10.1021/pr0605926; Takahashi H, 2001, CLIN PHARMACOKINET, V40, P587, DOI 10.2165/00003088-200140080-00003; Taube J, 2000, BLOOD, V96, P1816, DOI 10.1182/blood.V96.5.1816.h8001816_1816_1819; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; Yoon YR, 2001, BRIT J CLIN PHARMACO, V51, P277, DOI 10.1046/j.1365-2125.2001.00340.x; Zhang JH, 2008, PROTEOMICS, V8, P1595, DOI 10.1002/pmic.200700556; Zhao F, 2004, CLIN PHARMACOL THER, V76, P210, DOI 10.1016/j.clpt.2004.05.005	36	19	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15064	10.1371/journal.pone.0015064	http://dx.doi.org/10.1371/journal.pone.0015064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179214	Green Submitted, gold, Green Published			2022-12-27	WOS:000285246900027
J	Schauwecker, PE				Schauwecker, P. Elyse			Galanin Receptor 1 Deletion Exacerbates Hippocampal Neuronal Loss after Systemic Kainate Administration in Mice	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; TEMPORAL-LOBE EPILEPSY; KAINIC ACID; CELL-DEATH; NEURODEGENERATIVE DISEASE; KINDLING EPILEPTOGENESIS; GENETIC DISSECTION; STATUS EPILEPTICUS; TYPE-2 RECEPTORS; SEIZURE ACTIVITY	Background: Galanin is a neuropeptide with a wide distribution in the central and peripheral nervous systems and whose physiological effects are mediated through three G protein-coupled receptor subtypes, GalR1, GalR2, and GalR3. Several lines of evidence indicate that galanin, as well as activation of the GalR1 receptor, is a potent and effective modulator of neuronal excitability in the hippocampus. Methodology/Principal Findings: In order to test more formally the potential influence of GalR1 on seizure-induced excitotoxic cell death, we conducted functional complementation tests in which transgenic mice that exhibit decreased expression of the GalR1 candidate mRNA underwent kainate-induced status epilepticus to determine if the quantitative trait of susceptibility to seizure-induced cell death is determined by the activity of GalR1. In the present study, we report that reduction of GalR1 mRNA via null mutation or injection of the GalR1 antagonist, galantide, prior to kainate-induced status epilepticus induces hippocampal damage in a mouse strain known to be highly resistant to kainate-induced neuronal injury. Wild-type and GalR1 knockout mice were subjected to systemic kainate administration. Seven days later, Nissl and NeuN immune-staining demonstrated that hippocampal cell death was significantly increased in GalR1 knockout strains and in animals injected with the GalR1 antagonist. Compared to GalR1-expressing mice, GalR1-deficient mice had significantly larger hippocampal lesions after status epilepticus. Conclusions/Significance: Our results suggest that a reduction of GalR1 expression in the C57BL/6J mouse strain renders them susceptible to excitotoxic injury following systemic kainate administration. From these results, GalR1 protein emerges as a new molecular target that may have a potential therapeutic value in modulating seizure-induced cell death.	Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Southern California	Schauwecker, PE (corresponding author), Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA.	schauwec@usc.edu			National Institutes of Health [NS38696]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS38696 to Paula Elyse Schauwecker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli T, 2002, J NEUROSCI RES, V70, P766, DOI 10.1002/jnr.10415; Babb T L, 1986, Adv Neurol, V44, P949; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1990, EUR J NEUROSCI, V2, P62, DOI 10.1111/j.1460-9568.1990.tb00381.x; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; BENARI Y, 1984, DEV BRAIN RES, V14, P284, DOI 10.1016/0165-3806(84)90314-6; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Blumcke I, 2000, EPILEPSIA, V41, pS174, DOI 10.1111/j.1528-1157.2000.tb01577.x; Branchek TA, 2000, TRENDS PHARMACOL SCI, V21, P109, DOI 10.1016/S0165-6147(00)01446-2; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; COYLE JT, 1983, J NEUROCHEM, V41, P1; Crawley JN, 1996, LIFE SCI, V58, P2185, DOI 10.1016/0024-3205(96)00093-8; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Elliott-Hunt CR, 2007, J NEUROCHEM, V100, P780, DOI 10.1111/j.1471-4159.2006.04239.x; Elliott-Hunt CR, 2004, P NATL ACAD SCI USA, V101, P5105, DOI 10.1073/pnas.0304823101; Engel J Jr, 1989, Acta Neurochir Suppl (Wien), V46, P3; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Haberman RP, 2003, NAT MED, V9, P1076, DOI 10.1038/nm901; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Hwang IK, 2004, BRAIN RES, V1023, P193, DOI 10.1016/j.brainres.2004.07.023; Iismaa T P, 1999, Results Probl Cell Differ, V26, P257; Jacoby AS, 2002, MOL BRAIN RES, V107, P195, DOI 10.1016/S0169-328X(02)00451-5; Jayakar SS, 2004, INT J NEUROSCI, V114, P695, DOI 10.1080/00207450490430453; Jungnickel SRF, 2005, NEUROSCIENCE, V131, P407, DOI 10.1016/j.neuroscience.2004.11.023; Kalra SP, 1998, ANN NY ACAD SCI, V863, P236, DOI 10.1111/j.1749-6632.1998.tb10698.x; Kokaia M, 2001, P NATL ACAD SCI USA, V98, P14006, DOI 10.1073/pnas.231496298; Kong S, 2008, GENES BRAIN BEHAV, V7, P587, DOI 10.1111/j.1601-183X.2008.00395.x; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Leibowitz SF, 2005, NEUROPEPTIDES, V39, P327, DOI 10.1016/j.npep.2004.12.022; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu HX, 2002, TRENDS PHARMACOL SCI, V23, P468, DOI 10.1016/S0165-6147(02)02074-6; Lorenzana A, 2007, EUR J NEUROSCI, V25, P1998, DOI 10.1111/j.1460-9568.2007.05443.x; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Lu Xiaoying, 2007, CNS & Neurological Disorders-Drug Targets, V6, P183, DOI 10.2174/187152707780619335; Mahoney SA, 2003, J NEUROSCI, V23, P416, DOI 10.1523/JNEUROSCI.23-02-00416.2003; Mattson MP, 1996, ADV NEUROL, V71, P1; Mazarati A, 2005, NEUROPEPTIDES, V39, P277, DOI 10.1016/j.npep.2004.12.003; Mazarati A, 2004, NEUROSCIENCE, V128, P431, DOI 10.1016/j.neuroscience.2004.06.052; Mazarati AM, 2000, J NEUROSCI, V20, P6276, DOI 10.1523/JNEUROSCI.20-16-06276.2000; Mazarati A, 2006, J PHARMACOL EXP THER, V318, P700, DOI 10.1124/jpet.106.104703; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; NADLER JV, 1980, BRAIN RES, V195, P47; NADLER JV, 1980, J COMP NEUROL, V192, P333, DOI 10.1002/cne.901920209; O'Meara G, 2000, P NATL ACAD SCI USA, V97, P11569, DOI 10.1073/pnas.210254597; Ogren SO, 2006, CNS DRUGS, V20, P633; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; Pirondi S, 2005, J NEUROCHEM, V95, P821, DOI 10.1111/j.1471-4159.2005.03437.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Rozen S, 2000, Methods Mol Biol, V132, P365; Santos JB, 2003, EPILEPSIA, V44, P995, DOI 10.1046/j.1528-1157.2003.66302.x; Schauwecker PE, 2000, EXP NEUROL, V161, P139, DOI 10.1006/exnr.1999.7251; Schauwecker PE, 2004, J COMP NEUROL, V477, P96, DOI 10.1002/cne.20245; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Sidman Richard L., 1971, ATLAS MOUSE BRAIN SP; Silva AP, 2003, NEUROPHARMACOLOGY, V44, P282, DOI 10.1016/S0028-3908(02)00382-9; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Tan NCK, 2006, CURR OPIN NEUROL, V19, P157, DOI 10.1097/01.wco.0000218232.66054.46; Upton N, 2003, CURR OPIN PHARMACOL, V3, P19, DOI 10.1016/S1471-4892(02)00010-3; Wiesenfeld-Hallin Z, 2001, EUR J PHARMACOL, V429, P49, DOI 10.1016/S0014-2999(01)01305-X; WOLF HK, 1993, J NEUROPATH EXP NEUR, V52, P499, DOI 10.1097/00005072-199309000-00008	69	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15657	10.1371/journal.pone.0015657	http://dx.doi.org/10.1371/journal.pone.0015657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179451	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900051
J	Schultz, O; Oberhauser, F; Saech, J; Rubbert-Roth, A; Hahn, M; Krone, W; Laudes, M				Schultz, Olaf; Oberhauser, Frank; Saech, Jasemine; Rubbert-Roth, Andrea; Hahn, Moritz; Krone, Wilhelm; Laudes, Matthias			Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; ARTHRITIS; RECEPTOR; TOCILIZUMAB; EXPRESSION; RESISTANCE; IL-6; APOLIPOPROTEIN(A); METAANALYSIS	Background: Interleukin-6 (IL-6) is a pro-inflammatory cytokine that has been found to be increased in type 2 diabetic subjects. However, it still remains unclear if these elevated IL-6 levels are co-incidental or if this cytokine is causally related to the development of insulin resistance and type 2 diabetes in humans. Therefore, in the present study we examined insulin sensitivity, serum adipokine levels and lipid parameters in human subjects before and after treatment with the IL-6 receptor antibody Tocilizumab. Methodology/Principal Findings: 11 non-diabetic patients with rheumatoid disease were included in the study. HOMA-IR was calculated and serum levels for leptin, adiponectin, triglycerides, LDL-cholesterol, HDL-cholesterol and lipoprotein (a) (Lp (a)) were measured before as well as one and three months after Tocilizumab treatment. The HOMA index for insulin resistance decreased significantly. While leptin concentrations were not altered by inhibition of IL-6 signalling, adiponectin concentrations significantly increased. Thus the leptin to adiponectin ratio, a novel marker for insulin resistance, exhibited a significant decrease. Serum triglycerides, LDL-cholesterol and HDL-cholesterol tended to be increased whereas Lp (a) levels significantly decreased. Conclusions/Significance: Inhibition of IL-6 signalling improves insulin sensitivity in humans with immunological disease suggesting that elevated IL-6 levels in type 2 diabetic subjects might be causally involved in the pathogenesis of insulin resistance. Furthermore, our data indicate that inhibition of IL-6 signalling decreases Lp (a) serum levels, which might reduce the cardiovascular risk of human subjects.	[Schultz, Olaf; Oberhauser, Frank; Krone, Wilhelm; Laudes, Matthias] Univ Cologne, Dept Internal Med 2, Cologne, Germany; [Schultz, Olaf; Oberhauser, Frank; Krone, Wilhelm; Laudes, Matthias] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Saech, Jasemine; Rubbert-Roth, Andrea] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Hahn, Moritz] Univ Cologne, Inst Med Stat Informat & Epidemiol, Cologne, Germany; [Krone, Wilhelm] Univ Cologne, CECAD Cluster Excellence Cellular Stress Response, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Schultz, O (corresponding author), Univ Cologne, Dept Internal Med 2, Cologne, Germany.	matthias.laudes@uk-koeln.de	Laudes, Matthias/C-8885-2011		Chugai/Roche Pharmaceuticals	Chugai/Roche Pharmaceuticals(Roche Holding)	This study was supported by a grant from Chugai/Roche Pharmaceuticals to Matthias Laudes. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Dangas G, 1998, J AM COLL CARDIOL, V32, P2035, DOI 10.1016/S0735-1097(98)00469-0; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Glund S, 2008, ACTA PHYSIOL, V192, P37, DOI 10.1111/j.1748-1716.2007.01779.x; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Hamid YH, 2005, DIABETOLOGIA, V48, P251, DOI 10.1007/s00125-004-1623-0; Huth C, 2006, DIABETES, V55, P2915, DOI 10.2337/db06-0600; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.107.151621; Kawashiri SY, 2009, RHEUMATOL INT; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lawn RM, 1996, CLIN GENET, V49, P167; Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; OGATA A, 2010, ANN RHEUM DIS; Oldfield V, 2009, BIODRUGS, V23, P125, DOI 10.2165/00063030-200923020-00005; Patel AM, 2010, EXPERT REV CLIN IMMU, V6, P855, DOI 10.1586/ECI.10.69; Rieusset J, 2004, DIABETES, V53, P2232, DOI 10.2337/diabetes.53.9.2232; Rosenvinge A, 2007, SCAND J RHEUMATOL, V36, P91, DOI 10.1080/03009740601179605; SANGRAR W, 1995, BIOCHEMISTRY-US, V34, P5151, DOI 10.1021/bi00015a028; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; Siddiqui MAA, 2005, DRUGS, V65, P2179, DOI 10.2165/00003495-200565150-00014; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Takahashi M, 1996, HORM METAB RES, V28, P751, DOI 10.1055/s-2007-979893; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Voulgari PV, 2006, EXPERT OPIN BIOL TH, V6, P1349, DOI 10.1517/14712598.6.12.1349; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wiens A, 2009, SCAND J IMMUNOL, V70, P337, DOI 10.1111/j.1365-3083.2009.02296.x; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yamagishi S, 2006, MINI-REV MED CHEM, V6, P313, DOI 10.2174/138955706776073501; Yun KA, 2004, SCAND J CLIN LAB INV, V64, P223, DOI 10.1080/00365510410005749	44	155	167	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14328	10.1371/journal.pone.0014328	http://dx.doi.org/10.1371/journal.pone.0014328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179199	Green Submitted, Green Published, gold			2022-12-27	WOS:000285246900024
J	Zhang, L; Pei, YF; Li, JA; Papasian, CJ; Deng, HW				Zhang, Lei; Pei, Yu-Fang; Li, Jian; Papasian, Christopher J.; Deng, Hong-Wen			Efficient Utilization of Rare Variants for Detection of Disease-Related Genomic Regions	PLOS ONE			English	Article							POPULATION STRATIFICATION; GENETIC ASSOCIATION; WIDE ASSOCIATION; COMMON DISEASES; SEQUENCE; ALLELES; SPECTRUM; HDL	When testing association between rare variants and diseases, an efficient analytical approach involves considering a set of variants in a genomic region as the unit of analysis. One factor complicating this approach is that the vast majority of rare variants in practical applications are believed to represent background neutral variation. As a result, analyzing a single set with all variants may not represent a powerful approach. Here, we propose two alternative strategies. In the first, we analyze the subsets of rare variants exhaustively. In the second, we categorize variants selectively into two subsets: one in which variants are overrepresented in cases, and the other in which variants are overrepresented in controls. When the proportion of neutral variants is moderate to large we show, by simulations, that the both proposed strategies improve the statistical power over methods analyzing a single set with total variants. When applied to a real sequencing association study, the proposed methods consistently produce smaller p-values than their competitors. When applied to another real sequencing dataset to study the difference of rare allele distributions between ethnic populations, the proposed methods detect the overrepresentation of variants between the CHB (Chinese Han in Beijing) and YRI (Yoruba people of Ibadan) populations with small p-values. Additional analyses suggest that there is no difference between the CHB and CHD (Chinese Han in Denver) datasets, as expected. Finally, when applied to the CHB and JPT (Japanese people in Tokyo) populations, existing methods fail to detect any difference, while it is detected by the proposed methods in several regions.	[Zhang, Lei; Pei, Yu-Fang; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Li, Jian; Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Beijing Jiao Tong Univ, Coll Life Sci & Engn, Beijing, Peoples R China	University of Shanghai for Science & Technology; University of Missouri System; University of Missouri Kansas City; Beijing Jiaotong University	Zhang, L (corresponding author), Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China.	dengh@umkc.edu	Zhang, Lei/L-1016-2016; Li, Jian/G-4445-2015	Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	National Science Foundation of China; National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; Huo Ying Dong Education Foundation, Hunan Province; Ministry of Education of China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR057049, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huo Ying Dong Education Foundation, Hunan Province; Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The investigators of this work benefited from the support of grants from the National Science Foundation of China, National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081 and R21 AA015973), Huo Ying Dong Education Foundation, Hunan Province, and the Ministry of Education of China. Computing support was partially provided by the High Performance Computing Cluster Center at Xi'an Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hindorff LA, 2009, CATALOG PUBLISHED GE; Jannot AS, 2003, GENET EPIDEMIOL, V25, P158, DOI 10.1002/gepi.10256; Keen-Kim D, 2006, HUM MOL GENET, V15, P3324, DOI 10.1093/hmg/ddl408; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	36	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14288	10.1371/journal.pone.0014288	http://dx.doi.org/10.1371/journal.pone.0014288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170328	Green Submitted, Green Published, gold			2022-12-27	WOS:000285181400011
J	Gupta, R; Dandu, M; Packel, L; Rutherford, G; Leiter, K; Phaladze, N; Korte, FPD; Iacopino, V; Weiser, SD				Gupta, Reshma; Dandu, Madhavi; Packel, Laura; Rutherford, George; Leiter, Karen; Phaladze, Nthabiseng; Korte, Fiona Percy-de; Iacopino, Vincent; Weiser, Sheri D.			Depression and HIV in Botswana: A Population-Based Study on Gender-Specific Socioeconomic and Behavioral Correlates	PLOS ONE			English	Article							PSYCHOSOCIAL RISK-FACTORS; MENTAL-DISORDERS; SOUTH-AFRICA; PSYCHIATRIC-DISORDERS; DISEASE PROGRESSION; PERCEIVED STRESS; WOMEN; SYMPTOMS; HEALTH; PREVALENCE	Background: Depression is a leading contributor to the burden of disease worldwide, a critical barrier to HIV prevention and a common serious HIV co-morbidity. However, depression screening and treatment are limited in sub-Saharan Africa, and there are few population-level studies examining the prevalence and gender-specific factors associated with depression. Methods: We conducted a cross-sectional population-based study of 18-49 year-old adults from five districts in Botswana with the highest prevalence of HIV-infection. We examined the prevalence of depressive symptoms, using a Hopkins Symptom Checklist for Depression (HSCL-D) score of >= 1.75 to define depression, and correlates of depression using multivariate logistic regression stratified by sex. Results: Of 1,268 participants surveyed, 25.3% of women and 31.4% of men had depression. Among women, lower education (adjusted odds ratio [AOR] 2.07, 95% confidence interval [1.30-3.32]), higher income (1.77 [1.09-2.86]), and lack of control in sexual decision-making (2.35 [1.46-3.81]) were positively associated with depression. Among men, being single (1.95 [1.02-3.74]), living in a rural area (1.63 [1.02-2.65]), having frequent visits to a health provider (3.29 [1.88-5.74]), anticipated HIV stigma (fearing discrimination if HIV status was revealed) (2.04 [1.27-3.29]), and intergenerational sex (2.28 [1.17-4.41]) were independently associated with depression. Discussion: Depression is highly prevalent in Botswana, and its correlates are gender-specific. Our findings suggest multiple targets for screening and prevention of depression and highlight the need to integrate mental health counseling and treatment into primary health care to decrease morbidity and improve HIV management efforts.	[Gupta, Reshma; Dandu, Madhavi] Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA 94143 USA; [Dandu, Madhavi; Packel, Laura; Rutherford, George] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Rutherford, George] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Phaladze, Nthabiseng] Univ Botswana, Sch Nursing, Gaborone, Botswana; [Iacopino, Vincent] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Weiser, Sheri D.] Univ Calif San Francisco, Dept Med, Div HIV AIDS, San Francisco, CA USA; [Weiser, Sheri D.] Univ Calif San Francisco, Dept Med, Posit Hlth Program, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Botswana; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gupta, R (corresponding author), Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA 94143 USA.	r44gupta@yahoo.com			Physicians for Human Rights; Tides Foundation; NIH/NCRR/ODUCSF-CTSI [TL1 RR024129]; NIMH [K23 MH079713-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH079713] Funding Source: NIH RePORTER	Physicians for Human Rights; Tides Foundation; NIH/NCRR/ODUCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by Physicians for Human Rights and the Tides Foundation. Reshma Gupta acknowledges support by NIH/NCRR/ODUCSF-CTSI Grant Number TL1 RR024129. Dr. Weiser acknowledges funding through NIMH K23 MH079713-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas MA, 1997, PSYCHOL MED, V27, P59, DOI 10.1017/S0033291796004163; Alaimo K, 2002, J NUTR, V132, P719, DOI 10.1093/jn/132.4.719; [Anonymous], 2008, EP FACT SHEET HIV AI; Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318; BANKOLE A, 2004, AFRICAN POPULATI OCT, P21; Boarts JM, 2009, J EVID-INFORM SOC WO, V6, P4, DOI 10.1080/15433710802633247; Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Boris NW, 2008, ARCH PEDIAT ADOL MED, V162, P836, DOI 10.1001/archpedi.162.9.836; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; BURACK JH, 1993, JAMA-J AM MED ASSOC, V270, P2568, DOI 10.1001/jama.270.21.2568; Chipimo PJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-298; Cooper PJ, 1999, BRIT J PSYCHIAT, V175, P554, DOI 10.1192/bjp.175.6.554; COSTELLO EJ, 1991, PSYCHIATRY, V54, P292; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Deyessa N, 2008, SCAND J PUBLIC HEALT, V36, P589, DOI 10.1177/1403494808086976; Evans DL, 1997, AM J PSYCHIAT, V154, P630, DOI 10.1176/ajp.154.5.630; Farinpour R, 2003, J CLIN EXP NEUROPSYC, V25, P654, DOI 10.1076/jcen.25.5.654.14577; Fleischer NL, 2007, EPIDEMIOLOGY, V18, P678, DOI 10.1097/EDE.0b013e3181567fc5; GARCIAALVAREZ R, 1986, PSYCHOPATHOLOGY, V19, P22, DOI 10.1159/000285128; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gureje O, 2007, LANCET, V370, P957, DOI 10.1016/S0140-6736(07)61446-9; Hallman, 2004, SOCIOECONOMIC DISADV; Hamad R, 2008, J EPIDEMIOL COMMUN H, V62, P538, DOI 10.1136/jech.2007.066191; Hand GA, 2006, AIDS CARE, V18, P1011, DOI 10.1080/09540120600568376; Holzemer WL, 2007, J ADV NURS, V58, P541, DOI 10.1111/j.1365-2648.2007.04244.x; Holzemer WL, 1999, AIDS PATIENT CARE ST, V13, P185, DOI 10.1089/apc.1999.13.185; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hughes J, 2004, DISABIL REHABIL, V26, P371, DOI 10.1080/09638280410001662932; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Longfield K, 2004, STUD FAMILY PLANN, V35, P125, DOI 10.1111/j.1728-4465.2004.00014.x; Meade CS, 2005, CLIN PSYCHOL REV, V25, P433, DOI 10.1016/j.cpr.2005.02.001; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; MYER L, 2008, SOC SCI MED, V66, P147; *NAT ARLV PROJ TEA, 2006, MAS ANT THER PROGR B; Olley BO, 2006, J PSYCHOSOM RES, V61, P479, DOI 10.1016/j.jpsychores.2006.03.010; Patel V, 1997, BRIT J PSYCHIAT, V171, P60, DOI 10.1192/bjp.171.1.60; Rogers G, 2003, HIV Med, V4, P271, DOI 10.1046/j.1468-1293.2003.00155.x; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rowan PJ, 2002, PSYCHOL MED, V32, P903, DOI 10.1017/S0033291702005767; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; SMART T, 2005, HIV AIDS TREATMENT P; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Sorrell JBJ, 2005, CULT HEALTH SEX, V7, P585, DOI [10.1080/136910500250198, 10.1080/13691050500250198]; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; Thavichachart Nuntika, 2001, Journal of the Medical Association of Thailand, V84, pS118; Uwakwe R, 2000, INT J GERIATR PSYCH, V15, P355, DOI 10.1002/(SICI)1099-1166(200004)15:4<355::AID-GPS126>3.0.CO;2-8; Weiser SD, 2006, PLOS MED, V3, P1940, DOI 10.1371/journal.pmed.0030392; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; Wolfe WR, 2008, AM J PUBLIC HEALTH, V98, P1865, DOI 10.2105/AJPH.2007.122044	54	59	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14252	10.1371/journal.pone.0014252	http://dx.doi.org/10.1371/journal.pone.0014252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691MJ	21170384	Green Published, gold			2022-12-27	WOS:000285084100006
J	Lu, SQ; Zhang, Y; Long, MA				Lue, Shouqin; Zhang, Yan; Long, Mian			Visualization of Allostery in P-Selectin Lectin Domain Using MD Simulations	PLOS ONE			English	Article							FORMS CATCH BONDS; MOLECULAR-DYNAMICS; CELL-ADHESION; LIGAND RECOGNITION; LEUKOCYTE ADHESION; BINDING; SHEAR; FORCE; DISSOCIATION; INTEGRIN	Allostery of P-selectin lectin (Lec) domain followed by an epithelial growth factor (EGF)-like domain is essential for its biological functionality, but the underlying pathways have not been well understood. Here the molecular dynamics simulations were performed on the crystallized structures to visualize the dynamic conformational change for state 1 (S1) or state 2 (S2) Lec domain with respective bent (B) or extended (E) EGF orientation. Simulations illustrated that both S1 and S2 conformations were unable to switch from one to another directly. Instead, a novel S1' conformation was observed from S1 when crystallized B-S1 or reconstructed "E-S1" structure was employed, which was superposed well with that of equilibrated S1 Lec domain alone. It was also indicated that the corresponding allosteric pathway from S1 to S1' conformation started with the separation between residues Q30 and K67 and terminated with the release of residue N87 from residue C109. These results provided an insight into understanding the structural transition and the structure-function relationship of P-selectin allostery.	[Lue, Shouqin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100080, Peoples R China; [Lue, Shouqin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Natl Micrograv Lab, Beijing 100080, Peoples R China; [Lue, Shouqin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS	Lu, SQ (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100080, Peoples R China.	mlong@imech.ac.cn			National Natural Science Foundation of China [10702075, 30670172, 30730032, 10332060]; National Key Basic Research Foundation of China [2006CB910303]; CAS [KSCX2-YW-N-011, KJCX2-YW-L08]; National High Technology Research and Development Program of China [2007AA02Z306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); CAS(Chinese Academy of Sciences); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China grants 10702075, 30670172, 30730032, and 10332060 (http://www.nsfc.gov.cn/Portal0/default106.htm), National Key Basic Research Foundation of China grant 2006CB910303 (http://www.most.gov.cn/eng/index.htm), Knowledge Innovation Program of CAS grants KSCX2-YW-N-011 and KJCX2-YW-L08 (http://english.cas.cn/), and National High Technology Research and Development Program of China grant 2007AA02Z306 (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; Croce K, 1998, BIOCHEMISTRY-US, V37, P16472, DOI 10.1021/bi981341g; Dwir O, 2000, J BIOL CHEM, V275, P18682, DOI 10.1074/jbc.M001103200; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; GIBSON RM, 1995, BLOOD, V85, P151, DOI 10.1182/blood.V85.1.151.bloodjournal851151; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KANSAS GS, 1994, J CELL BIOL, V124, P609, DOI 10.1083/jcb.124.4.609; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Lue Shouqin, 2005, Molecular & Cellular Biomechanics, V2, P161; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Thomas WE, 2009, CURR OPIN STRUC BIOL, V19, P50, DOI 10.1016/j.sbi.2008.12.006; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Waldron TT, 2009, P NATL ACAD SCI USA, V106, P85, DOI 10.1073/pnas.0810620105; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	29	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15417	10.1371/journal.pone.0015417	http://dx.doi.org/10.1371/journal.pone.0015417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170343	gold, Green Published, Green Submitted			2022-12-27	WOS:000285084100036
J	Fukui, Y; Ihara, S				Fukui, Yasuhisa; Ihara, Sayoko			A Mutant of SWAP-70, a Phosphatidylinositoltrisphosphate Binding Protein, Transforms Mouse Embryo Fibroblasts, Which Is Inhibited by Sanguinarine	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; APOPTOSIS; ACTIN; CELLS	SWAP-70, a phosphatidylinositol trisphosphate (PtdIns(3,4,5)P-3) binding protein, has been suggested to be involved in transformation of mouse embryo fibroblasts (MEFs) as well as membrane ruffling after growth factor stimulation of the cells. A mutant, SWAP-70-374, was found to be able to bind to F-actin in vitro, whereas wild-type SWAP-70 failed to do so. This mutant was present at the plasma membrane without any stimulation while the wild-type protein was present only in the cytosol unless cells were stimulated with EGF. Expression of this mutant in MEFs resulted in morphologic transformation, fast growth, and loss of contact inhibition, suggesting that SWAP-70 with this mutation can transform the cells. ERK1/2 was activated in SWAP-70-374-transformed cells. Use of MEK inhibitors revealed that the ERK1/2 pathway does not affect the cell growth of MEFs but is responsible for loss of contact inhibition. To investigate the function of SWAP-70 further, drugs that can inhibit SWAP-70-dependent cell responses were screened. Among various drugs, sanguinarine was found to inhibit transformation of MEFs by SWAP-70-374. This drug was able to inhibit SWAP-70-mediated membrane ruffling as well, suggesting that its effect was closely related to the SWAP-70 signaling pathway. These results suggest that SWAP-70-374 can activate some signaling pathways, including the ERK1/2 pathway, to transform MEFs.	[Fukui, Yasuhisa] Hoshi Univ, Lab Signal Transduct, Tokyo 142, Japan; [Fukui, Yasuhisa] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ihara, Sayoko] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	Hoshi University; National Health Research Institutes - Taiwan; University of Tokyo	Fukui, Y (corresponding author), Hoshi Univ, Lab Signal Transduct, Tokyo 142, Japan.	990412@nhri.org.tw	Fukui, Yasuhisa/E-8806-2010		Ministry of Education, Science, Sports, and Culture of Japan [20013044, 20580096]; Takeda Science Foundation; National Institute of Biomedical Innovation, Japan; National Health Research Institutes, Taiwan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	Grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan, #20013044 and #20580096 (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm) to Y.F. and S.I., a grant from Takeda Science Foundation (http://www.takeda-sci.or.jp/) to S.I., a grant from the National Institute of Biomedical Innovation, Japan (http://www.nibio.go.jp/) to Y.F., and a grant from National Health Research Institutes, Taiwan (http://www.nhri.org.tw) to Y.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan H, 2007, PHOTOCHEM PHOTOBIOL, V83, P986, DOI 10.1111/j.1751-1097.2007.00156.x; Ahsan H, 2007, CANCER LETT, V249, P198, DOI 10.1016/j.canlet.2006.08.018; B RS, 2009, CHEM BIOL, V16, P203, DOI 10.1016/j.chembiol.2008.12.006; De Stefano I, 2009, BIOCHEM PHARMACOL, V78, P1374, DOI 10.1016/j.bcp.2009.07.011; Fukui Y, 2007, BIOCHEM BIOPH RES CO, V356, P512, DOI 10.1016/j.bbrc.2007.03.011; Heerema AE, 2004, APPL IMMUNOHISTO M M, V12, P21; Hilpela P, 2003, MOL BIOL CELL, V14, P3242, DOI 10.1091/mbc.e03-01-0043; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Jang BC, 2009, TOXICOL IN VITRO, V23, P281, DOI 10.1016/j.tiv.2008.12.013; Larsson DE, 2010, ANTICANCER RES, V30, P149; Matkar SS, 2008, CHEM-BIOL INTERACT, V172, P63, DOI 10.1016/j.cbi.2007.12.006; Murugan AK, 2008, IUBMB LIFE, V60, P236, DOI 10.1002/iub.33; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Seol HJ, 2009, TRANSL ONCOL, V2, P300, DOI 10.1593/tlo.09172; Serafim TL, 2008, BIOCHEM PHARMACOL, V76, P1459, DOI 10.1016/j.bcp.2008.07.013; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1	19	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14180	10.1371/journal.pone.0014180	http://dx.doi.org/10.1371/journal.pone.0014180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152038	Green Published, gold, Green Submitted			2022-12-27	WOS:000284868000006
J	Demenescu, LR; Kortekaas, R; den Boer, JA; Aleman, A				Demenescu, Liliana R.; Kortekaas, Rudie; den Boer, Johan A.; Aleman, Andre			Impaired Attribution of Emotion to Facial Expressions in Anxiety and Major Depression	PLOS ONE			English	Article							SOCIAL ANXIETY; ATTENTIONAL BIAS; RECOGNITION; CHILDREN; DEFICITS; FACE; IDENTIFICATION; PERCEPTION; DISORDER; MOOD	Background: Recognition of others' emotions is an important aspect of interpersonal communication. In major depression, a significant emotion recognition impairment has been reported. It remains unclear whether the ability to recognize emotion from facial expressions is also impaired in anxiety disorders. There is a need to review and integrate the published literature on emotional expression recognition in anxiety disorders and major depression. Methodology/Principal Findings: A detailed literature search was used to identify studies on explicit emotion recognition in patients with anxiety disorders and major depression compared to healthy participants. Eighteen studies provided sufficient information to be included. The differences on emotion recognition impairment between patients and controls (Cohen's d) with corresponding confidence intervals were computed for each study. Over all studies, adults with anxiety disorders had a significant impairment in emotion recognition (d = -0.35). In children with anxiety disorders no significant impairment of emotion recognition was found (d = -0.03). Major depression was associated with an even larger impairment in recognition of facial expressions of emotion (d = -0.58). Conclusions/Significance: Results from the current analysis support the hypothesis that adults with anxiety disorders or major depression both have a deficit in recognizing facial expression of emotions, and that this deficit is more pronounced in major depression than in anxiety.	[Demenescu, Liliana R.; Kortekaas, Rudie; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, Groningen, Netherlands; [Demenescu, Liliana R.] Rhein Westfal TH Aachen, Dept Psychiat & Psychotherapy, Aachen, Germany; [den Boer, Johan A.] Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands	University of Groningen; RWTH Aachen University; University of Groningen	Demenescu, LR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, Groningen, Netherlands.	ldemenescu@ukaachen.de	Aleman, Andre/E-1341-2012; Demenescu, Liliana Ramona/C-4884-2014	Demenescu, Liliana Ramona/0000-0002-8770-0725	University of Groningen, The Netherlands	University of Groningen, The Netherlands(Netherlands Government)	The present study was funded by University of Groningen, The Netherlands. The founders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Allen JL, 2006, BEHAV CHANGE, V23, P239, DOI 10.1375/bech.23.4.239; ARCHER J, 1992, BRIT J CLIN PSYCHOL, V31, P45, DOI 10.1111/j.2044-8260.1992.tb00967.x; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; Beauregard M, 1998, NEUROREPORT, V9, P3253, DOI 10.1097/00001756-199810050-00022; Bennett MR, 2005, PROG NEUROBIOL, V75, P29, DOI 10.1016/j.pneurobio.2004.11.002; Bouhuys AL, 1997, J AFFECT DISORDERS, V43, P213, DOI 10.1016/S0165-0327(97)01432-8; Bourke C, 2010, AUST NZ J PSYCHIAT, V44, P681, DOI 10.3109/00048674.2010.496359; Bradley BP, 1999, BRIT J CLIN PSYCHOL, V38, P267, DOI 10.1348/014466599162845; Campbell DW, 2009, DEPRESS ANXIETY, V26, P419, DOI 10.1002/da.20474; Clark DM, 2002, BIOL PSYCHIAT, V51, P92, DOI 10.1016/S0006-3223(01)01296-3; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooper RM, 2008, J ANXIETY DISORD, V22, P1120, DOI 10.1016/j.janxdis.2007.11.010; Corcoran KM, 2008, J ANXIETY DISORD, V22, P56, DOI 10.1016/j.janxdis.2007.01.003; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Easter J, 2005, J CHILD ADOL PSYCHOP, V15, P563, DOI 10.1089/cap.2005.15.563; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Ellis C. R., 1997, J CHILD FAM STUD, V6, P453, DOI DOI 10.1023/A:1025097429527; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FEINBERG TE, 1986, ARCH GEN PSYCHIAT, V43, P276; Gilboa-Schechtman E, 1999, COGNITION EMOTION, V13, P305, DOI 10.1080/026999399379294; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; GUR RC, 1992, PSYCHIAT RES, V42, P241, DOI 10.1016/0165-1781(92)90116-K; Guyer AE, 2007, J CHILD PSYCHOL PSYC, V48, P863, DOI 10.1111/j.1469-7610.2007.01758.x; Hale WW, 1998, PSYCHIAT RES, V80, P265, DOI 10.1016/S0165-1781(98)00070-5; Harmer CJ, 2003, NEUROPSYCHOPHARMACOL, V28, P148, DOI 10.1038/sj.npp.1300004; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirsch CR, 2004, CLIN PSYCHOL REV, V24, P799, DOI 10.1016/j.cpr.2004.07.005; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Kan Y, 2004, J NEUROL NEUROSUR PS, V75, P1667, DOI 10.1136/jnnp.2004.036079; Keightley ML, 2003, NEUROPSYCHOLOGIA, V41, P585, DOI 10.1016/S0028-3932(02)00199-9; Keltner D, 1998, REV GEN PSYCHOL, V2, P320, DOI [10.1037/1089-2680.2.3.320, DOI 10.1037/1089-2680.2.3.320]; Kessler H, 2007, DEPRESS ANXIETY, V24, P223, DOI 10.1002/da.20223; Lang AJ, 2004, DEPRESS ANXIETY, V20, P190, DOI 10.1002/da.20030; LeMoult J, 2009, J ABNORM PSYCHOL, V118, P828, DOI 10.1037/a0016944; Lenti C, 2000, PERCEPT MOTOR SKILL, V91, P227, DOI 10.2466/PMS.91.5.227-236; Leppanen JM, 2004, PSYCHIAT RES, V128, P123, DOI 10.1016/j.psychres.2004.05.020; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Manassis K, 2000, DEPRESS ANXIETY, V12, P209, DOI 10.1002/1520-6394(2000)12:4<209::AID-DA4>3.0.CO;2-A; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; McClure EB, 2003, AM J PSYCHIAT, V160, P1172, DOI 10.1176/appi.ajp.160.6.1172; Melfsen S, 2002, J NONVERBAL BEHAV, V26, P109, DOI 10.1023/A:1015665521371; Mendlewicz L, 2005, J AFFECT DISORDERS, V89, P195, DOI 10.1016/j.jad.2005.07.010; Mennin DS, 2005, BEHAV RES THER, V43, P1281, DOI 10.1016/j.brat.2004.08.008; Mikhailova ES, 1996, BIOL PSYCHIAT, V40, P697, DOI 10.1016/0006-3223(96)00032-7; Mohlman J, 2007, BEHAV RES THER, V45, P591, DOI 10.1016/j.brat.2006.03.007; Mullins DT, 2004, J NONVERBAL BEHAV, V28, P3; PERSAD SM, 1993, J ABNORM PSYCHOL, V102, P358, DOI 10.1037/0021-843X.102.3.358; RUBINOW DR, 1992, BIOL PSYCHIAT, V31, P947, DOI 10.1016/0006-3223(92)90120-O; Simonian SJ, 2001, CHILD PSYCHIAT HUM D, V32, P137, DOI 10.1023/A:1012298707253; Surcinelli P, 2006, J ANXIETY DISORD, V20, P110, DOI 10.1016/j.janxdis.2004.11.010; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Tse WS, 2004, J NERV MENT DIS, V192, P260, DOI 10.1097/01.nmd.0000120884.60002.2b; Venn HR, 2006, INT J NEUROPSYCHOPH, V9, P229, DOI 10.1017/S1461145705006012; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; WINTON EC, 1995, BEHAV RES THER, V33, P193, DOI 10.1016/0005-7967(94)E0019-F; ZUROFF DC, 1986, J CLIN PSYCHOL, V42, P411, DOI 10.1002/1097-4679(198605)42:3<411::AID-JCLP2270420302>3.0.CO;2-T	62	165	166	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15058	10.1371/journal.pone.0015058	http://dx.doi.org/10.1371/journal.pone.0015058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	688AU	21152015	Green Published, gold, Green Submitted			2022-12-27	WOS:000284821300015
J	Baker, JG				Baker, Jillian G.			A Full Pharmacological Analysis of the Three Turkey beta-Adrenoceptors and Comparison with the Human beta-Adrenoceptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(1)-ADRENERGIC RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; HUMAN BETA-1-ADRENOCEPTOR; ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; PROVIDE EVIDENCE; AGONIST ACTIONS; KNOCKOUT MICE; GUINEA-PIG	Background: There are three turkey beta-adrenoceptors: the original turkey beta-adrenoceptor from erythrocytes (t beta trunc, for which the X-ray crystal structure has recently been determined), t beta 3C and t beta 4C-receptors. This study examined the similarities and differences between these avian receptors and mammalian receptors with regards to binding characteristics and functional high and low affinity agonist conformations. Methodology/Principal Findings: Stable cell lines were constructed with each of the turkey beta-adrenoceptors and (3)H-CGP12177 whole cell binding, CRE-SPAP production and (3)H-cAMP accumulation assays performed. It was confirmed that the three turkey beta-adrenoceptors are distinct from each other in terms of amino acid sequence and binding characteristics. The greatest similarity of any of the turkey beta-adrenoceptors to human beta-adrenoceptors is between the turkey beta 3C-receptor and the human beta 2-adrenoceptor. There are pharmacologically distinct differences between the binding of ligands for the t beta trunc and t beta 4C and the human beta-adrenoceptors (e. g. with CGP20712A and ICI118551). The tbtrunc and t beta 4C-adrenoceptors appear to exist in at least two different agonist conformations in a similar manner to that seen at both the human and rat beta 1-adrenoceptor and human beta 3-adrenoceptors. The t beta b3C-receptor, similar to the human beta 2-adrenoceptor, does not, at least so far, appear to exist in more than one agonist conformation. Conclusions/Significance: There are several similarities, but also several important differences, between the recently crystallised turkey beta-adrenoceptor and the human beta-adrenoceptors. These findings are important for those the field of drug discovery using the recently structural information from crystallised receptors to aid drug design. Furthermore, comparison of the amino-acid sequence for the turkey and human adrenoceptors may therefore shed more light on the residues involved in the existence of the secondary beta-adrenoceptor conformation.	Univ Nottingham, Inst Cell Signalling, Nottingham NG7 2RD, England	University of Nottingham	Baker, JG (corresponding author), Univ Nottingham, Inst Cell Signalling, Nottingham NG7 2RD, England.	jillian.baker@nottingham.ac.uk		baker, jillian/0000-0003-2371-8202	Wellcome Trust [073377/Z/03/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Clinician Scientist Fellowship awarded to JGB (grant number 073377/Z/03/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch JRS, 2004, BRIT J PHARMACOL, V143, P517, DOI 10.1038/sj.bjp.0705991; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Baker JG, 2002, BRIT J PHARMACOL, V137, P400, DOI 10.1038/sj.bjp.0704855; Baker JG, 2003, MOL PHARMACOL, V63, P1312, DOI 10.1124/mol.63.6.1312; Baker JG, 2003, MOL PHARMACOL, V64, P679, DOI 10.1124/mol.64.3.679; Baker JG, 2005, J PHARMACOL EXP THER, V313, P1163, DOI 10.1124/jpet.104.082875; Baker JG, 2005, MOL PHARMACOL, V68, P1645, DOI 10.1124/mol.105.015461; Baker JG, 2008, MOL PHARMACOL, V74, P1246, DOI 10.1124/mol.108.048371; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; BILEZIKIAN J P, 1973, Journal of Biological Chemistry, V248, P5577; BILEZIKIAN JP, 1973, J BIOL CHEM, V248, P5584; CHEN XH, 1994, J BIOL CHEM, V269, P24810; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cohen ML, 2000, RECEPTOR CHANNEL, V7, P17; DONALDSON J, 1988, BIOCHEM PHARMACOL, V37, P715, DOI 10.1016/0006-2952(88)90146-3; Goepel M, 1997, UROL RES, V25, P199, DOI 10.1007/BF00941983; Granneman JG, 2001, AM J PHYSIOL-ENDOC M, V280, pE199, DOI 10.1152/ajpendo.2001.280.2.E199; Hutchinson DS, 2005, J PHARMACOL EXP THER, V312, P1064, DOI 10.1124/jpet.104.076901; Joseph SS, 2004, N-S ARCH PHARMACOL, V369, P525, DOI 10.1007/s00210-004-0884-y; Kaumann AJ, 1997, N-S ARCH PHARMACOL, V355, P667, DOI 10.1007/PL00004999; Kaumann AJ, 2001, N-S ARCH PHARMACOL, V363, P87, DOI 10.1007/s002100000336; Kaumann AJ, 2008, PHARMACOL THERAPEUT, V118, P303, DOI 10.1016/j.pharmthera.2008.03.009; KENAKIN TP, 1992, PHARMACOL REV, V44, P351; Konkar AA, 2000, MOL PHARMACOL, V57, P252; Konkar AA, 2000, J PHARMACOL EXP THER, V294, P923; Kozlowska H, 2003, BRIT J PHARMACOL, V140, P3, DOI 10.1038/sj.bjp.0705421; Lewis CJ, 2004, BRIT J PHARMACOL, V141, P813, DOI 10.1038/sj.bjp.0705668; Liang W, 2001, J ANIM SCI, V79, P877; Lowe MD, 2002, BRIT J PHARMACOL, V135, P451, DOI 10.1038/sj.bjp.0704450; Molenaar P, 2003, BRIT J PHARMACOL, V140, P1, DOI 10.1038/sj.bjp.0705420; NISHIMURA J, 1987, CIRC RES, V60, P837, DOI 10.1161/01.RES.60.6.837; Oye I., 1996, BIOCHIM BIOPHYS ACTA, V127, P347; Pak MD, 1996, J RECEPT SIGNAL TR R, V16, P1, DOI 10.3109/10799899609039938; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sarsero D, 2003, N-S ARCH PHARMACOL, V367, P10, DOI 10.1007/s00210-002-0652-9; SCHRAMM M, 1972, P NATL ACAD SCI USA, V69, P523, DOI 10.1073/pnas.69.2.523; STEPHENSON RP, 1956, BRIT J PHARMACOL, V11, P5109; WALTER M, 1984, N-S ARCH PHARMACOL, V327, P159, DOI 10.1007/BF00500912; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	43	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15487	10.1371/journal.pone.0015487	http://dx.doi.org/10.1371/journal.pone.0015487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152092	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100087
J	Fry, AM; Chittaganpitch, M; Baggett, HC; Peret, TCT; Dare, RK; Sawatwong, P; Thamthitiwat, S; Areerat, P; Sanasuttipun, W; Fischer, J; Maloney, SA; Erdman, DD; Olsen, SJ				Fry, Alicia M.; Chittaganpitch, Malinee; Baggett, Henry C.; Peret, Teresa C. T.; Dare, Ryan K.; Sawatwong, Pongpun; Thamthitiwat, Somsak; Areerat, Peera; Sanasuttipun, Wichai; Fischer, Julie; Maloney, Susan A.; Erdman, Dean D.; Olsen, Sonja J.			The Burden of Hospitalized Lower Respiratory Tract Infection due to Respiratory Syncytial Virus in Rural Thailand	PLOS ONE			English	Article							PNEUMONIA; SURVEILLANCE; INFLUENZA; SEVERITY; OUTBREAK; CHILDREN; DISEASE	Background: We describe the epidemiology of hospitalized RSV infections for all age groups from population-based surveillance in two rural provinces in Thailand. Methods: From September 1, 2003 through December 31, 2007, we enrolled hospitalized patients with acute lower respiratory tract illness, who had a chest radiograph ordered by the physician, from all hospitals in SaKaeo and Nakhom Phanom Provinces. We tested nasopharyngeal specimens for RSV with reverse transcriptase polymerase chain reaction (RTPCR) assays and paired-sera from a subset of patients with IgG enzyme immunoassay. Rates were adjusted for enrollment. Results: Among 11,097 enrolled patients, 987 (8.9%) had RSV infection. Rates of hospitalized RSV infection overall (and radiographically-confirmed pneumonia) were highest among children aged <1 year: 1,067/100,000 (534/100,000 radiographically-confirmed pneumonia) and 1-4 year: 403/100,000 (222/100,000), but low among enrolled adults aged >= 65 years: 42/100,000. Age <1 year (adjusted odds ratio [aOR] = 13.2, 95% confidence interval [CI] 7.7, 22.5) and 1-4 year (aOR = 8.3, 95% CI 5.0, 13.9) were independent predictors of hospitalized RSV infection. Conclusions: The incidence of hospitalized RSV lower respiratory tract illness among children <5 years was high in rural Thailand. Efforts to prevent RSV infection could substantially reduce the pneumonia burden in children aged <5 years.	[Fry, Alicia M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Chittaganpitch, Malinee] Thailand Minist Publ Hlth, Natl Inst Hlth, Nonthaburi, Thailand; [Peret, Teresa C. T.; Dare, Ryan K.; Erdman, Dean D.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Baggett, Henry C.; Sawatwong, Pongpun; Thamthitiwat, Somsak; Areerat, Peera; Sanasuttipun, Wichai; Fischer, Julie; Maloney, Susan A.] Thai MOPH USCDC Collaborat, Int Emerging Infect Program, Nonthaburi, Thailand; [Olsen, Sonja J.] Ctr Dis Control & Prevent, Div Emerging Infect & Surveillance Serv, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Fry, AM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	agf1@cdc.gov		Dare, Ryan/0000-0001-9540-2683				Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CHANOCK RM, 1961, JAMA-J AM MED ASSOC, V176, P647; DENNY FW, 1986, J PEDIATR-US, V108, P635, DOI 10.1016/S0022-3476(86)81034-4; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Erdman DD, 2003, J CLIN MICROBIOL, V41, P4298, DOI 10.1128/JCM.41.9.4298-4303.2003; Falsey AR, 1996, VACCINE, V14, P1214, DOI 10.1016/S0264-410X(96)00030-8; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Gilca R, 2006, J INFECT DIS, V193, P54, DOI 10.1086/498526; GLEZEN WP, 1973, NEW ENGL J MED, V288, P498, DOI 10.1056/NEJM197303082881005; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Javadi M, 2006, INT J INFECT DIS, V10, P129, DOI 10.1016/j.ijid.2005.01.007; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Martinello RA, 2002, J INFECT DIS, V186, P839, DOI 10.1086/342414; Mazzulli T, 1999, J INFECT DIS, V180, P1686, DOI 10.1086/315085; MURPHY TF, 1981, AM J EPIDEMIOL, V113, P12, DOI 10.1093/oxfordjournals.aje.a113061; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Olsen SJ, 2010, EPIDEMIOL INFECT, V138, P1811, DOI 10.1017/S0950268810000646; Olsen SJ, 2006, INT J INFECT DIS, V10, P439, DOI 10.1016/j.ijid.2006.06.004; *PED AAP, 2009, POL STAT MOD REC US; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Suwanjutha Subharee, 2002, Journal of the Medical Association of Thailand, V85, pS1111; Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; World Health Organization and UNICEF, 2009, GLOB ACT PLAN PREV C	28	109	110	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15098	10.1371/journal.pone.0015098	http://dx.doi.org/10.1371/journal.pone.0015098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152047	gold, Green Published			2022-12-27	WOS:000284755100070
J	Ronconi, RA; Ryan, PG; Ropert-Coudert, Y				Ronconi, Robert A.; Ryan, Peter G.; Ropert-Coudert, Yan			Diving of Great Shearwaters (Puffinus gravis) in Cold and Warm Water Regions of the South Atlantic Ocean	PLOS ONE			English	Article							FORAGING ECOLOGY; DIVE DEPTH; TASMANIA; FISHERY; DIET	Background: Among the most widespread seabirds in the world, shearwaters of the genus Puffinus are also some of the deepest diving members of the Procellariiformes. Maximum diving depths are known for several Puffinus species, but dive depths or diving behaviour have never been recorded for great shearwaters (P. gravis), the largest member of this genus. This study reports the first high sampling rate (2 s) of depth and diving behaviour for Puffinus shearwaters. Methodology/Principal Findings: Time-depth recorders (TDRs) were deployed on two female great shearwaters nesting on Inaccessible Island in the South Atlantic Ocean, recording 10 consecutive days of diving activity. Remote sensing imagery and movement patterns of 8 males tracked by satellite telemetry over the same period were used to identify probable foraging areas used by TDR-equipped females. The deepest and longest dive was to 18.9 m and lasted 40 s, but most (>50%) dives were <2 m deep. Diving was most frequent near dawn and dusk, with <0.5% of dives occurring at night. The two individuals foraged in contrasting oceanographic conditions, one in cold (8 to 10 degrees C) water of the Sub-Antarctic Front, likely 1000 km south of the breeding colony, and the other in warmer (10 to 16 degrees C) water of the Sub-tropical Frontal Zone, at the same latitude as the colony, possibly on the Patagonian Shelf, 4000 km away. The cold water bird spent fewer days commuting, conducted four times as many dives as the warm water bird, dived deeper on average, and had a greater proportion of bottom time during dives. Conclusions/Significance: General patterns of diving activity were consistent with those of other shearwaters foraging in cold and warm water habitats. Great shearwaters are likely adapted to forage in a wide range of oceanographic conditions, foraging mostly with shallow dives but capable of deep diving.	[Ronconi, Robert A.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Ryan, Peter G.] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Ropert-Coudert, Yan] Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, Strasbourg, France	Dalhousie University; National Research Foundation - South Africa; University of Cape Town	Ronconi, RA (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	rronconi@dal.ca		Ryan, Peter/0000-0002-3356-2056	European Commission; BirdLife International; United States Fish and Wildlife Service; University of Cape Town; Killam Trust; Dalhousie University	European Commission(European CommissionEuropean Commission Joint Research Centre); BirdLife International; United States Fish and Wildlife Service(US Fish & Wildlife Service); University of Cape Town; Killam Trust; Dalhousie University	Financial support was provided by South African National Antarctic Programme, the European Commission's EDF-9 through the South Atlantic Invasive Species project, BirdLife International, the United States Fish and Wildlife Service, and the University of Cape Town. R. A. R. was supported by the Killam Trust, Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JS, 2003, SCI MAR, V67, P129, DOI 10.3989/scimar.2003.67s2129; [Anonymous], 1993, HDB AUSTR NZ ANTARCT; Belkin IM, 1996, J GEOPHYS RES-OCEANS, V101, P3675, DOI 10.1029/95JC02750; BROWN RGB, 1978, CONDOR, V80, P123, DOI 10.2307/1367911; Bugoni Leandro, 2008, Endangered Species Research, V5, P137, DOI 10.3354/esr00115; Bull Leigh S., 2005, Marine Ornithology, V33, P27; Burger AE, 2001, AUK, V118, P755, DOI 10.1642/0004-8038(2001)118[0755:DDOS]2.0.CO;2; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Cuthbert RJ, 2005, EMU, V105, P305, DOI 10.1071/MU05036; Elliott H. F. I., 1957, Ibis, V99, P545, DOI 10.1111/j.1474-919X.1957.tb03049.x; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; HAGAN Y, 1952, BIRDS TRISTAN CUNHA; Kato A, 2006, MAR ECOL PROG SER, V308, P293, DOI 10.3354/meps308293; Keitt BS, 2000, AUK, V117, P507, DOI 10.1642/0004-8038(2000)117[0507:DDADOT]2.0.CO;2; Kuroda N., 1954, CLASSIFICATION PHYLO; Mougin JL, 1998, REV ECOL-TERRE VIE, V53, P69; Peck DR, 2006, J AVIAN BIOL, V37, P245, DOI 10.1111/j.2006.0908-8857.03558.x; Petry MV, 2008, MAR BIOL, V154, P613, DOI 10.1007/s00227-008-0954-7; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Rayner MJ, 2008, MAR ECOL PROG SER, V370, P271, DOI 10.3354/meps07660; REES EIS, 1961, SEA SWALLOW, V14, P54; Rowan M. K., 1952, Ibis, V94, P97, DOI 10.1111/j.1474-919X.1952.tb01791.x; RYAN P.G., 2007, FIELD GUIDE ANIMALS; RYAN PG, TRISTAN THR IN PRESS; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; Shealer David A., 2002, P137; WARHAM J, 1977, NEW ZEAL J ZOOL, V4, P73, DOI 10.1080/03014223.1977.9517938; WARHAM J, 1990, PETRELS THEIR ECOLOG; Weimerskirch H, 1996, IBIS, V138, P786, DOI 10.1111/j.1474-919X.1996.tb08837.x; Weimerskirch H, 1998, MAR ECOL PROG SER, V167, P261, DOI 10.3354/meps167261; WILLIAMS TD, 1992, AUK, V109, P223, DOI 10.2307/4088190; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409; WILSON RP, 1995, POLAR BIOL, V15, P575	36	45	46	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15508	10.1371/journal.pone.0015508	http://dx.doi.org/10.1371/journal.pone.0015508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152089	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100088
J	Chopra, P; Lee, J; Kang, J; Lee, S				Chopra, Pankaj; Lee, Jinseung; Kang, Jaewoo; Lee, Sunwon			Improving Cancer Classification Accuracy Using Gene Pairs	PLOS ONE			English	Article							MICROARRAY DATA; EXPRESSION; TUMOR; PREDICTION; DIAGNOSIS; SELECTION; PATTERNS	Recent studies suggest that the deregulation of pathways, rather than individual genes, may be critical in triggering carcinogenesis. The pathway deregulation is often caused by the simultaneous deregulation of more than one gene in the pathway. This suggests that robust gene pair combinations may exploit the underlying bio-molecular reactions that are relevant to the pathway deregulation and thus they could provide better biomarkers for cancer, as compared to individual genes. In order to validate this hypothesis, in this paper, we used gene pair combinations, called doublets, as input to the cancer classification algorithms, instead of the original expression values, and we showed that the classification accuracy was consistently improved across different datasets and classification algorithms. We validated the proposed approach using nine cancer datasets and five classification algorithms including Prediction Analysis for Microarrays (PAM), C4.5 Decision Trees (DT), Naive Bayesian (NB), Support Vector Machine (SVM), and k-Nearest Neighbor (k-NN).	[Chopra, Pankaj] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Lee, Jinseung; Kang, Jaewoo; Lee, Sunwon] Korea Univ, Coll Informat & Commun, Dept Comp Sci & Engn, Seoul, South Korea; [Kang, Jaewoo] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea	Emory University; Korea University; Korea University; Korea University Medicine (KU Medicine)	Chopra, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	kangj@korea.ac.kr			Korean government (MEST) [2010-0015713, 2009-0086140, R01-2008-000-20564-0]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Second Brain Korea 21 Project Grant, a Microsoft Research Asia Grant, a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2010-0015713, 2009-0086140), and a Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (MEST) (R01-2008-000-20564-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Chopra P, 2009, WASH DC US P IEEE IN; Chopra P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-92; Dettling M, 2003, BIOINFORMATICS, V19, P1061, DOI 10.1093/bioinformatics/btf867; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Geman D., 2004, STAT APPL GENET MOL, V3, P1, DOI [10.2202/1544-6115.1071, DOI 10.2202/1544-6115.1071]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hall M, 2009, SIGKDD EXPLORATIONS, P2; Kang JW, 2005, LECT NOTES COMPUT SC, V3615, P105; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lin KM, 2009, INT J DATA MIN BIOIN, V3, P3, DOI 10.1504/IJDMB.2009.023881; Liu J, 2008, BIOINFORMATICS, V24, pI86, DOI 10.1093/bioinformatics/btn145; Mramor M, 2007, BIOINFORMATICS, V23, P2147, DOI 10.1093/bioinformatics/btm312; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Quinlan J. R., 1993, C4 5 PROGRAM MACHINE; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ripley B. D., 1996, PATTERN RECOGNITION; Rogers MF, 2009, BIOINFORMATICS, V25, P1173, DOI 10.1093/bioinformatics/btp122; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vapnik V., 2013, NATURE STAT LAERNING; Welsh JB, 2001, CANCER RES, V61, P5974; Yoon S, 2010, SOFT COMPUT, V14, P151, DOI 10.1007/s00500-009-0437-x; Zhou XHJ, 2005, NAT BIOTECHNOL, V23, P238, DOI 10.1038/nbt1058	31	66	66	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14305	10.1371/journal.pone.0014305	http://dx.doi.org/10.1371/journal.pone.0014305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200431	gold, Green Published, Green Submitted			2022-12-27	WOS:000285576900002
J	Galpaz, N; Reymond, M				Galpaz, Navot; Reymond, Matthieu			Natural Variation in Arabidopsis thaliana Revealed a Genetic Network Controlling Germination Under Salt Stress	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SEED-GERMINATION; CROSS-TALK; TOLERANCE; POPULATIONS; ADAPTATION; DROUGHT; SHAPE; COLD; QTLS	Plant responses to environmental stresses are polygenic and complex traits. In this study quantitative genetics using natural variation in Arabidopsis thaliana was used to investigate the genetic architecture of plant responses to salt stress. Eighty seven A. thaliana accessions were screened and showed a large variation for root development and seed germination under 125 and 200 mM NaCl, respectively. Twenty two quantitative trait loci for these traits have been detected by phenotyping two recombinants inbred line populations, Sha x Col and Sha x Ler. Four QTLs controlling germination under salt were detected in the Sha x Col population. Interestingly, only one allelic combination at these four QTLs inhibits germination under salt stress, implying strong epistatic interactions between them. In this interacting context, we confirmed the effect of one QTL by phenotyping selected heterozygous inbred families. We also showed that this QTL is involved in the control of germination under other stress conditions such as KCl, mannitol, cold, glucose and ABA. Our data highlights the presence of a genetic network which consists of four interacting QTLs and controls germination under limiting environmental conditions.	[Galpaz, Navot; Reymond, Matthieu] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Reymond, Matthieu] INRA Ctr Versailles Grignon, INRA AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, Versailles, France	Max Planck Society; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Galpaz, N (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany.	matthieu.reymond@versailles.inra.fr			ARABRAS [ERAPG-003-03]; Max Planck Society; Minerva Fellowship Program; Alexander Von Humboldt Research Fellowship	ARABRAS; Max Planck Society(Max Planck SocietyFoundation CELLEX); Minerva Fellowship Program; Alexander Von Humboldt Research Fellowship(Alexander von Humboldt Foundation)	Funding was provided by the ARABRAS program (ERAPG-003-03) and by the Max Planck Society. N.G. acknowledges support from the Minerva Fellowship Program and Alexander Von Humboldt Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Clerkx EJM, 2004, PLANT PHYSIOL, V135, P432, DOI 10.1104/pp.103.036814; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Foolad Majid R, 2007, Int J Plant Genomics, V2007, P97386, DOI [10.1155/2007/64358, 10.1155/2007/97386]; Foolad MR, 1999, PLANT BREEDING, V118, P167, DOI 10.1046/j.1439-0523.1999.118002167.x; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Jang JY, 2008, J INTEGR PLANT BIOL, V50, P593, DOI 10.1111/j.1744-7909.2008.00650.x; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; JOHNSON DW, 1992, THEOR APPL GENET, V83, P833, DOI 10.1007/BF00226705; Joosen RVL, 2010, PLANT J, V62, P148, DOI 10.1111/j.1365-313X.2009.04116.x; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; LEE BH, 2010, COLD SPRING HARB PRO; Lefebvre V, 2009, INT J MOL SCI, V10, P3547, DOI 10.3390/ijms10083547; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Quesada V, 2002, PLANT PHYSIOL, V130, P951, DOI 10.1104/pp.006536; Ren ZH, 2010, P NATL ACAD SCI USA, V107, P5669, DOI 10.1073/pnas.0910798107; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Rowe HC, 2008, GENETICS, V180, P2237, DOI 10.1534/genetics.108.091439; Rus A, 2001, P NATL ACAD SCI USA, V98, P14150, DOI 10.1073/pnas.241501798; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	41	35	35	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15198	10.1371/journal.pone.0015198	http://dx.doi.org/10.1371/journal.pone.0015198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188145	Green Published, gold			2022-12-27	WOS:000285575200021
J	Han, HE; Sellamuthu, S; Shin, BH; Lee, YJ; Song, S; Seo, JS; Baek, IS; Bae, J; Kim, H; Yoo, YJ; Jung, YK; Song, WK; Han, PL; Park, WJ				Han, Hye-Eun; Sellamuthu, Saravanan; Shin, Bae Hyun; Lee, Yong Jae; Song, Sungmin; Seo, Ji-Seon; Baek, In-Sun; Bae, Jeomil; Kim, Hannah; Yoo, Yung Joon; Jung, Yong-Keun; Song, Woo Keun; Han, Pyung-Lim; Park, Woo Jin			The Nuclear Inclusion a (NIa) Protease of Turnip Mosaic Virus (TuMV) Cleaves Amyloid-beta	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; PLAQUE-FORMATION; IN-VITRO; COGNITIVE DEFICITS; PRECURSOR PROTEIN; DOWN-SYNDROME; ACCUMULATION; NEPRILYSIN	Background: The nuclear inclusion a (NIa) protease of turnip mosaic virus (TuMV) is responsible for the processing of the viral polyprotein into functional proteins. NIa was previously shown to possess a relatively strict substrate specificity with a preference for Val-Xaa-His-Gln down arrow, with the scissile bond located after Gln. The presence of the same consensus sequence, Val(12)-His-His-Gln(15), near the presumptive alpha-secretase cleavage site of the amyloid-beta (A beta) peptide led us to hypothesize that NIa could possess activity against A beta. Methodology/Principal Findings: Western blotting results showed that oligomeric as well as monomeric forms of A beta can be degraded by NIa in vitro. The specific cleavage of A beta was further confirmed by mass spectrometry analysis. NIa was shown to exist predominantly in the cytoplasm as observed by immunofluorescence microscopy. The overexpression of NIa in B103 neuroblastoma cells resulted in a significant reduction in cell death caused by both intracellularly generated and exogenously added A beta. Moreover, lentiviral-mediated expression of NIa in APP(sw)/PS1 transgenic mice significantly reduced the levels of A beta and plaques in the brain. Conclusions/Significance: These results indicate that the degradation of A beta in the cytoplasm could be a novel strategy to control the levels of A beta, plaque formation, and the associated cell death.	[Han, Hye-Eun; Sellamuthu, Saravanan; Shin, Bae Hyun; Lee, Yong Jae; Bae, Jeomil; Yoo, Yung Joon; Song, Woo Keun; Park, Woo Jin] GIST, Dept Life Sci, Kwangju, South Korea; [Song, Sungmin; Jung, Yong-Keun] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Seo, Ji-Seon; Baek, In-Sun; Kim, Hannah; Han, Pyung-Lim] Ewha Womans Univ, Div Nano Sci, Seoul, South Korea; [Seo, Ji-Seon; Baek, In-Sun; Kim, Hannah; Han, Pyung-Lim] Ewha Womans Univ, Brain Dis Res Inst, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU); Ewha Womans University; Ewha Womans University	Han, HE (corresponding author), GIST, Dept Life Sci, Kwangju, South Korea.	wjpark@gist.ac.kr	Seo, Ji-Seon/AAM-5949-2020	Han, Pyung-Lim/0000-0002-1735-6746; Jung, Yong-Keun/0000-0002-9686-3120; Bae, Jeomil/0000-0001-9374-6802	National Research Foundation of Korea [2009-0085747]; Korean government (MEST) [M6-0605-00-0001]; Gwangju Institute of Science and Technology (GIST)	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Gwangju Institute of Science and Technology (GIST)	This work was supported by a grant from the National Research Foundation of Korea (No. 2009-0085747), a grant from the Global Research Laboratory Program (M6-0605-00-0001) funded by the Korean government (MEST), and a grant from the "Systems biology infrastructure establishment grant'' provided by Gwangju Institute of Science and Technology (GIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Burns MP, 2009, HUM MOL GENET, V18, P3206, DOI 10.1093/hmg/ddp258; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Grant Susan M., 2000, Journal of Alzheimer's Disease, V2, P207; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kang H, 2001, J GEN VIROL, V82, P3115, DOI 10.1099/0022-1317-82-12-3115; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; KIM DH, 1995, VIROLOGY, V213, P517, DOI 10.1006/viro.1995.0024; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee EK, 2006, BIOCHEM BIOPH RES CO, V344, P471, DOI 10.1016/j.bbrc.2006.03.166; Lee KW, 2009, J NEUROCHEM, V108, P165, DOI 10.1111/j.1471-4159.2008.05769.x; LEHEL C, 1994, J BIOL CHEM, V269, P4761; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Marr RA, 2003, J NEUROSCI, V23, P1992; MARTIN BL, 1995, J BIOL CHEM, V270, P26727, DOI 10.1074/jbc.270.45.26727; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; Mouri A, 2006, BEHAV BRAIN RES, V168, P83, DOI 10.1016/j.bbr.2005.10.014; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Rodriguez-Navarro JA, 2008, HUM MOL GENET, V17, P3128, DOI 10.1093/hmg/ddn210; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Song SM, 2004, TRENDS MOL MED, V10, P565, DOI 10.1016/j.molmed.2004.09.005; Song SM, 2008, J CELL BIOL, V182, P675, DOI 10.1083/jcb.200711066; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XL, 2007, FREE RADICAL BIO MED, V43, P1569, DOI 10.1016/j.freeradbiomed.2007.09.007; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	46	11	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15645	10.1371/journal.pone.0015645	http://dx.doi.org/10.1371/journal.pone.0015645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187975	Green Submitted, gold, Green Published			2022-12-27	WOS:000285575200054
J	Li, DJ; Yue, YP; Duan, DS				Li, Dejia; Yue, Yongping; Duan, Dongsheng			Marginal Level Dystrophin Expression Improves Clinical Outcome in a Strain of Dystrophin/Utrophin Double Knockout Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; TRANSGENIC MDX MICE; GLYCOPROTEIN COMPLEX; FULL-LENGTH; DEFICIENT MICE; MUSCLE-FIBERS; LIFE-SPAN; UTROPHIN; SKELETAL; MODEL	Inactivation of all utrophin isoforms in dystrophin-deficient mdx mice results in a strain of utrophin knockout mdx (uko/mdx) mice. Uko/mdx mice display severe clinical symptoms and die prematurely as in Duchenne muscular dystrophy (DMD) patients. Here we tested the hypothesis that marginal level dystrophin expression may improve the clinical outcome of uko/mdx mice. It is well established that mdx3cv (3cv) mice express a near-full length dystrophin protein at similar to 5% of the normal level. We crossed utrophin-null mutation to the 3cv background. The resulting uko/3cv mice expressed the same level of dystrophin as 3cv mice but utrophin expression was completely eliminated. Surprisingly, uko/3cv mice showed a much milder phenotype. Compared to uko/mdx mice, uko/3cv mice had significantly higher body weight and stronger specific muscle force. Most importantly, uko/3cv outlived uko/mdx mice by several folds. Our results suggest that a threshold level dystrophin expression may provide vital clinical support in a severely affected DMD mouse model. This finding may hold clinical implications in developing novel DMD therapies.	[Li, Dejia; Yue, Yongping; Duan, Dongsheng] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Li, DJ (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA.	duand@missouri.edu		Duan, Dongsheng/0000-0003-4109-1132	National Institutes of Health [AR-49419]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (AR-49419, DD) and the Muscular Dystrophy Association (DD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake DJ, 1996, BRAIN PATHOL, V6, P37, DOI 10.1111/j.1750-3639.1996.tb00781.x; Bostick B, 2010, MUSCLE NERVE, V42, P600, DOI 10.1002/mus.21763; BRAMBATI B, 1980, LANCET, V2, P969; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; COX GA, 1993, NAT GENET, V4, P87, DOI 10.1038/ng0593-87; COX GA, 1994, NAT GENET, V8, P333, DOI 10.1038/ng1294-333; Cozzi F, 2001, ACTA NEUROPATHOL, V101, P469; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Dinopoulos A, 2010, NEUROMUSCULAR DISORD, V20, P61, DOI 10.1016/j.nmd.2009.08.008; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; GREENBERG DS, 1994, NAT GENET, V8, P340, DOI 10.1038/ng1294-340; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Hernandez-Gonzalez EO, 2005, J CELL SCI, V118, P137, DOI 10.1242/jcs.01584; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; HOFFMAN EP, 1992, NEUROLOGY, V42, P967, DOI 10.1212/WNL.42.5.967; Judge LM, 2006, J CELL SCI, V119, P1537, DOI 10.1242/jcs.02857; Kunkel LM, 2005, AM J HUM GENET, V76, P205, DOI 10.1086/428143; Lai Y, 2005, NAT BIOTECHNOL, V23, P1435, DOI 10.1038/nbt1153; Li DJ, 2008, AM J PATHOL, V172, P1332, DOI 10.2353/ajpath.2008.071042; Li DJ, 2009, HUM MOL GENET, V18, P1209, DOI 10.1093/hmg/ddp015; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Merrick D, 2009, DIS MODEL MECH, V2, P374, DOI 10.1242/dmm.001008; Mitrpant Chalermchai, 2009, Curr Mol Pharmacol, V2, P110; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Rafael JA, 2000, MAMM GENOME, V11, P725, DOI 10.1007/s003350010149; Rafael JA, 1999, MUSCLE NERVE, V22, P517, DOI 10.1002/(SICI)1097-4598(199904)22:4<517::AID-MUS14>3.0.CO;2-6; Rafael JA, 1996, J CELL BIOL, V134, P93, DOI 10.1083/jcb.134.1.93; SHIN JH, 2010, FENOTYP MDX MDX3CV M; THANH LT, 1995, AM J HUM GENET, V56, P725; Verma M, 2010, HUM MOL GENET, V19, P4145, DOI 10.1093/hmg/ddq334; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; WELLS DJ, 1995, HUM MOL GENET, V4, P1245, DOI 10.1093/hmg/4.8.1245; Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007	36	31	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15286	10.1371/journal.pone.0015286	http://dx.doi.org/10.1371/journal.pone.0015286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187970	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200032
J	Prager, EM; Brielmaier, J; Bergstrom, HC; McGuire, J; Johnson, LR				Prager, Eric M.; Brielmaier, Jennifer; Bergstrom, Hadley C.; McGuire, Jennifer; Johnson, Luke R.			Localization of Mineralocorticoid Receptors at Mammalian Synapses	PLOS ONE			English	Article							LONG-TERM-MEMORY; GLUCOCORTICOID-RECEPTOR; CHRONIC STRESS; AMYGDALOID COMPLEX; RAT HIPPOCAMPUS; FEAR; CORTICOSTERONE; MODULATION; BRAIN; ACTIVATION	In the brain, membrane associated nongenomic steroid receptors can induce fast-acting responses to ion conductance and second messenger systems of neurons. Emerging data suggest that membrane associated glucocorticoid and mineralocorticoid receptors may directly regulate synaptic excitability during times of stress when adrenal hormones are elevated. As the key neuron signaling interface, the synapse is involved in learning and memory, including traumatic memories during times of stress. The lateral amygdala is a key site for synaptic plasticity underlying conditioned fear, which can both trigger and be coincident with the stress response. A large body of electrophysiological data shows rapid regulation of neuronal excitability by steroid hormone receptors. Despite the importance of these receptors, to date, only the glucocorticoid receptor has been anatomically localized to the membrane. We investigated the subcellular sites of mineralocorticoid receptors in the lateral amygdala of the Sprague-Dawley rat. Immunoblot analysis revealed the presence of mineralocorticoid receptors in the amygdala. Using electron microscopy, we found mineralocorticoid receptors expressed at both nuclear including: glutamatergic and GABAergic neurons and extra nuclear sites including: presynaptic terminals, neuronal dendrites, and dendritic spines. Importantly we also observed mineralocorticoid receptors at postsynaptic membrane densities of excitatory synapses. These data provide direct anatomical evidence supporting the concept that, at some synapses, synaptic transmission is regulated by mineralocorticoid receptors. Thus part of the stress signaling response in the brain is a direct modulation of the synapse itself by adrenal steroids.	[Prager, Eric M.; Johnson, Luke R.] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA; [Brielmaier, Jennifer; Bergstrom, Hadley C.; McGuire, Jennifer; Johnson, Luke R.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Johnson, Luke R.] Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Prager, EM (corresponding author), Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA.	Luke.Johnson@usuhs.mil	Prager, Eric/O-1567-2015; Bergstrom, Hadley/S-1178-2019	Prager, Eric/0000-0002-3810-0985; Johnson PhD, Luke R/0000-0002-5088-1788; McGuire, Jennifer/0000-0003-3058-5241; Bergstrom, Hadley/0000-0003-3677-1619	Uniformed Services University [208867]	Uniformed Services University	This work was supported by Uniformed Services University grant 208867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIZA JL, 1988, NEURON, V1, P887, DOI 10.1016/0896-6273(88)90136-5; BARSEGYAN A, 2010, P NATL ACAD SCI US; Basu J, 2004, CURR SCI INDIA, V87, P212; Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Brunner R, 2006, ANN NY ACAD SCI, V1071, P434, DOI 10.1196/annals.1364.037; Conboy L, 2010, NEUROPSYCHOPHARMACOL, V35, P674, DOI 10.1038/npp.2009.172; Conrad CD, 2004, NEUROBIOL LEARN MEM, V81, P185, DOI 10.1016/j.nlm.2004.01.002; Cordero MI, 2002, STRESS, V5, P71, DOI 10.1080/102538902900124404; Cordero MI, 2003, BRAIN RES, V970, P242, DOI 10.1016/S0006-8993(03)02352-7; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; de Kloet ER, 2000, KIDNEY INT, V57, P1329, DOI 10.1046/j.1523-1755.2000.00971.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Donley MP, 2005, BEHAV BRAIN RES, V164, P197, DOI 10.1016/j.bbr.2005.06.020; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Farb CR, 1997, SYNAPSE, V27, P106, DOI 10.1002/(SICI)1098-2396(199710)27:2<106::AID-SYN2>3.3.CO;2-F; Ferguson D, 2008, HIPPOCAMPUS, V18, P1103, DOI 10.1002/hipo.20467; FFRENCHMULLEN JMH, 1995, J NEUROSCI, V15, P903; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; GRAY EG, 1959, J ANAT, V93, P420; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Hlavacova N, 2008, HORM BEHAV, V54, P90, DOI 10.1016/j.yhbeh.2008.02.004; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Johnson LR, 2005, NEUROSCIENCE, V136, P289, DOI 10.1016/j.neuroscience.2005.06.050; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levin ER, 2008, AM J PHYSIOL-REG I, V295, pR1425, DOI 10.1152/ajpregu.90605.2008; LIPOSITS Z, 1993, J NEUROSCI RES, V35, P14, DOI 10.1002/jnr.490350103; Liu L, 2007, NEUROSCI LETT, V420, P245, DOI 10.1016/j.neulet.2007.05.003; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Lou SJ, 1998, BIOCHEM BIOPH RES CO, V244, P403, DOI 10.1006/bbrc.1998.8280; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 1999, BEHAV NEUROSCI, V113, P420, DOI 10.1037/0735-7044.113.3.420; Marino M, 2006, IUBMB LIFE, V58, P716, DOI 10.1080/15216540601019485; Maroun M, 2008, NEUROPSYCHOPHARMACOL, V33, P394, DOI 10.1038/sj.npp.1301401; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mitra R, 2009, BEHAV BRAIN RES, V205, P535, DOI 10.1016/j.bbr.2009.08.014; Mitra R, 2009, BIOL PSYCHIAT, V66, P686, DOI 10.1016/j.biopsych.2009.04.016; Morsink MC, 2006, J NEUROCHEM, V99, P1282, DOI 10.1111/j.1471-4159.2006.04187.x; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Nishimura T, 2000, CELL STRUCT FUNCT, V25, P161, DOI 10.1247/csf.25.161; Olijslagers JE, 2008, EUR J NEUROSCI, V27, P2542, DOI 10.1111/j.1460-9568.2008.06220.x; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pare D, 1998, TRENDS NEUROSCI, V21, P240, DOI 10.1016/S0166-2236(98)01240-5; PARE D, 1993, NEUROSCIENCE, V57, P1061, DOI 10.1016/0306-4522(93)90049-L; Patel PD, 2000, J PSYCHIATR RES, V34, P383, DOI 10.1016/S0022-3956(00)00035-2; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Peters A., 1991, FINE STRUCTURE NERVO; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; Prager EM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286re5; Pugh CR, 1997, BEHAV NEUROSCI, V111, P503, DOI 10.1037/0735-7044.111.3.503; Rashidy-Pour A, 2004, BEHAV BRAIN RES, V154, P193, DOI 10.1016/j.bbr.2004.02.007; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Rodrigues SM, 2009, BIOL PSYCHIAT, V65, P441, DOI 10.1016/j.biopsych.2008.09.003; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sheng ZJ, 2003, NEUROSCI RES, V46, P205, DOI 10.1016/S0168-0102(03)00056-7; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; Smith Y, 1998, J COMP NEUROL, V391, P164, DOI 10.1002/(SICI)1096-9861(19980209)391:2<164::AID-CNE2>3.0.CO;2-0; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; Tasker JG, 2006, OBESITY, V14, P259; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; VISCARDI RM, 1993, STEROIDS, V58, P357, DOI 10.1016/0039-128X(93)90038-O; Vyas A, 2006, NEUROSCIENCE, V143, P387, DOI 10.1016/j.neuroscience.2006.08.003; Vyas A, 2004, BEHAV NEUROSCI, V118, P1450, DOI 10.1037/0735-7044.118.6.1450; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	84	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14344	10.1371/journal.pone.0014344	http://dx.doi.org/10.1371/journal.pone.0014344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179518	Green Submitted, Green Published, gold			2022-12-27	WOS:000285340000013
J	Puri, IK; Li, LW				Puri, Ishwar K.; Li, Liwu			Mathematical Modeling for the Pathogenesis of Alzheimer's Disease	PLOS ONE			English	Article							SENILE PLAQUES; MICROGLIA; INFLAMMATION; DEPOSITION	Despite extensive research, the pathogenesis of neurodegenerative Alzheimer's disease ( AD) still eludes our comprehension. This is largely due to complex and dynamic cross-talks that occur among multiple cell types throughout the aging process. We present a mathematical model that helps define critical components of AD pathogenesis based on differential rate equations that represent the known cross-talks involving microglia, astroglia, neurons, and amyloid-beta (A beta). We demonstrate that the inflammatory activation of microglia serves as a key node for progressive neurodegeneration. Our analysis reveals that targeting microglia may hold potential promise in the prevention and treatment of AD.	[Puri, Ishwar K.] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA; [Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Puri, IK (corresponding author), Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA.	ikpuri@vt.edu; lwli@vt.edu	Puri, Ishwar/B-8734-2008	Puri, Ishwar/0000-0002-8713-4188; Li, Liwu/0000-0001-8870-5299; Puri, Ishwar/0000-0002-6638-5762	Virginia Tech	Virginia Tech	Internal funding from Virginia Tech supported this work. Virginia Tech had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Cuello AC, 2010, NEURODEGENER DIS, V7, P96, DOI 10.1159/000285514; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; Edelstein-Keshet L, 2002, J THEOR BIOL, V216, P301, DOI 10.1006/jtbi.2002.2540; Edelstein-Keshet L., 2005, MATH MODELS BIOL SOC; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Ganguly R, 2006, CELL PROLIFERAT, V39, P3, DOI 10.1111/j.1365-2184.2006.00369.x; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Luca M, 2003, B MATH BIOL, V65, P693, DOI 10.1016/S0092-8240(03)00030-2; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Pang Y, 2010, NEUROSCIENCE, V166, P464, DOI 10.1016/j.neuroscience.2009.12.040; Park Keun W, 2008, Curr Aging Sci, V1, P192; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630	23	34	34	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15176	10.1371/journal.pone.0015176	http://dx.doi.org/10.1371/journal.pone.0015176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179474	Green Submitted, Green Published, gold			2022-12-27	WOS:000285292500015
J	Zhang, RN; Mehla, R; Chauhan, A				Zhang, Ruonan; Mehla, Rajeev; Chauhan, Ashok			Perturbation of Host Nuclear Membrane Component RanBP2 Impairs the Nuclear Import of Human Immunodeficiency Virus-1 Preintegration Complex (DNA)	PLOS ONE			English	Article							HIV-1 MATRIX PROTEIN; PORE COMPLEX; LOCALIZATION SIGNAL; NONDIVIDING CELLS; MESSENGER-RNA; NUCLEOCYTOPLASMIC TRANSPORT; TYPE-1; INFECTION; INTEGRASE; EXPORT	HIV-1 is a RNA virus that requires an intermediate DNA phase via reverse transcription (RT) step in order to establish productive infection in the host cell. The nascent viral DNA synthesized via RT step and the preformed viral proteins are assembled into pre-integration complex (PIC) in the cell cytoplasm. To integrate the viral DNA into the host genome, the PIC must cross cell nuclear membrane through the nuclear pore complex (NPC). RanBP2, also known as Nup358, is a major component of the cytoplasmic filaments that emanates from the nuclear pore complex and has been implicated in various nucleo-cytoplasmic transport pathways including those for HIV Rev-protein. We sought to investigate the role of RanBP2 in HIV-1 replication. In our investigations, we found that RanBP2 depletion via RNAi resulted in profound inhibition of HIV-1 infection and played a pivotal role in the nuclear entry of HIV DNA. More precisely, there was a profound decline in 2-LTR DNA copies (marker for nuclear entry of HIV DNA) and an unchanged level of viral reverse transcription in RanBP2-ablated HIV-infected cells compared to RanBP3-depleted or non-specific siRNA controls. We further demonstrated that the function of Rev was unaffected in RanBP2-depleted latently HIV infected cells (reactivated). We also serendipitously found that RanBP2 depletion inhibited the global ectopic gene expression. In conclusion, RanBP2 is a host factor that is involved in the nuclear import of HIV-1 PIC (DNA), but is not critical to the nuclear export of the viral mRNAs or nucleo-cytoplasmic shuttling of Rev. RanBP2 could be a potential target for efficient inhibition of HIV.	[Zhang, Ruonan; Mehla, Rajeev; Chauhan, Ashok] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Zhang, RN (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Ashok.Chauhan@uscmed.sc.edu			National Institute of Neurological Disorders (NINDS), National Institutes of Health [RO1 NS 050064]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050064] Funding Source: NIH RePORTER	National Institute of Neurological Disorders (NINDS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported with federal funds from National Institute of Neurological Disorders (NINDS), National Institutes of Health grant RO1 NS 050064 (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Agostini I, 2000, EXP CELL RES, V259, P398, DOI 10.1006/excr.2000.4992; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Armon-Omer A, 2004, J MOL BIOL, V336, P1117, DOI 10.1016/j.jmb.2003.11.057; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Chauhan A, 2003, J BIOL CHEM, V278, P13512, DOI 10.1074/jbc.M209381200; Chauhan A, 2007, FASEB J, V21, P777, DOI 10.1096/fj.06-7054com; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Clarke PR, 2008, DEV CELL, V14, P316, DOI 10.1016/j.devcel.2008.02.005; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; Depienne C, 2000, EXP CELL RES, V260, P387, DOI 10.1006/excr.2000.5016; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Ebina H, 2004, MICROBES INFECT, V6, P715, DOI 10.1016/j.micinf.2004.04.002; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; Fouchier RAM, 1999, ADV VIRUS RES, V52, P275, DOI 10.1016/S0065-3527(08)60302-4; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gallay P, 1996, J VIROL, V70, P1027, DOI 10.1128/JVI.70.2.1027-1032.1996; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; HU C, 2010, J VIROL         0915; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011; Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kootstra NA, 1999, VIROLOGY, V253, P170, DOI 10.1006/viro.1998.9482; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Luban J, 2008, CURR BIOL, V18, pR710, DOI 10.1016/j.cub.2008.07.037; Maco Bohumil, 2006, V322, P273; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Mannioui A, 2005, VIROLOGY, V339, P21, DOI 10.1016/j.virol.2005.05.023; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Meyer BE, 1996, J VIROL, V70, P2350, DOI 10.1128/JVI.70.4.2350-2359.1996; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Riviere L, 2010, J VIROL, V84, P729, DOI 10.1128/JVI.01952-09; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; Stevenson M, 2000, NAT MED, V6, P626, DOI 10.1038/76191; Strebel Klaus, 2003, AIDS, V17 Suppl 4, pS25, DOI 10.1097/00002030-200317004-00003; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Truant R, 1999, MOL CELL BIOL, V19, P1210; Vijaykumar TS, 2008, VIROLOGY, V381, P1, DOI 10.1016/j.virol.2008.07.039; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yamashita M, 2005, PLOS PATHOG, V1, P170, DOI 10.1371/journal.ppat.0010018; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	69	68	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15620	10.1371/journal.pone.0015620	http://dx.doi.org/10.1371/journal.pone.0015620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179483	Green Submitted, Green Published, gold			2022-12-27	WOS:000285292500032
J	Narayanaswamy, BE; Renaud, PE; Duineveld, GCA; Berge, J; Lavaleye, MSS; Reiss, H; Brattegard, T				Narayanaswamy, Bhavani E.; Renaud, Paul E.; Duineveld, Gerard C. A.; Berge, Jorgen; Lavaleye, Marc S. S.; Reiss, Henning; Brattegard, Torleiv			Biodiversity Trends along the Western European Margin	PLOS ONE			English	Review							CORAL LOPHELIA-PERTUSA; FAROE-SHETLAND CHANNEL; SEA BENTHIC COMMUNITY; SPECIES-DIVERSITY; NORTH-SEA; TAXONOMIC DISTINCTNESS; CONTINENTAL-MARGIN; MACROFAUNA COMMUNITIES; LATITUDINAL GRADIENTS; POLYCHAETE DIVERSITY	The seas along the western European margin encompass a vast geographical area comprising numerous different habitats, and are home to more than 10,000 metazoan species. Although research in this extensive region has been undertaken since the early 1800s, many new species are being described and distributional patterns identified. Recent studies incorporating the most extensive data series ever used in such European studies have failed to find any relationship between latitude and infaunal shelf biodiversity. Along the European shelf, species richness generally increases to a depth of 200 m and then decreases from 300-500 m. In the deep Northeast Atlantic, a unimodal curve illustrates how macrofaunal species diversity changes with depth whilst the megafauna appear to have a bimodal distribution. Regional studies are equivocal in that poleward increases in species diversity have been observed in some studies or taxa, but not in others. In the North Sea, arguably the best studied system in European waters, there appears to be a distinct increase in diversity with increasing latitude. Since this trend is confounded by similar latitudinal gradients in depth and trawling intensity, there is no clear explanation for the biodiversity pattern. Climatic shifts in diversity patterns and species ranges have recently been observed. Here we report previously unpublished data on changes in species richness that have been observed along the Norwegian coast over the past two decades, with the most northerly region seeing more than a 15% increase in the number of species being discovered there. This review synthesizes published and new biodiversity data across multiple spatial and temporal scales, and from the coast to the deep-sea, to provide an overview of what is known along the western European margin. Threats to the biodiversity of the region are highlighted, as well as identifying where there are still gaps in our knowledge.	[Narayanaswamy, Bhavani E.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Renaud, Paul E.] Inst Akvaplan Niva AS, Polar Environm Ctr, Tromso, Norway; [Duineveld, Gerard C. A.; Lavaleye, Marc S. S.] Netherlands Org Sci Res, Texel, Netherlands; [Renaud, Paul E.; Berge, Jorgen] Univ Ctr Svalbard, Longyearbyen, Norway; [Reiss, Henning] Senckenberg Inst, Dept Marine Res, Wilhelmshaven, Germany; [Brattegard, Torleiv] Univ Bergen, Dept Biol, Bergen, Norway	UHI Millennium Institute; Akvaplan-niva; University Centre Svalbard (UNIS); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Bergen	Narayanaswamy, BE (corresponding author), Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	Bhavani.Narayanaswamy@sams.ac.uk	Renaud, Paul E/C-7191-2008; Berge, Jørgen/B-8749-2008; Berge, Jørgen/E-7544-2015	Berge, Jørgen/0000-0003-0900-5679; Berge, Jørgen/0000-0003-0900-5679; Narayanaswamy, Bhavani/0000-0002-5810-9127; Reiss, Henning/0000-0003-1393-0269	European Census of Marine Life; Census of Marine Life; Stavros Niarchos Foundation; Argyll and Islands Enterprise; Akvaplan-niva; EU; Foundation TOTAL; Alfred P. Sloan Foundation [B2009-01]; Natural Environment Research Council [dml010004] Funding Source: researchfish; NERC [dml010004] Funding Source: UKRI	European Census of Marine Life; Census of Marine Life; Stavros Niarchos Foundation; Argyll and Islands Enterprise; Akvaplan-niva(Akvaplan-niva); EU(European Commission); Foundation TOTAL; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors gratefully acknowledge the support given by the European Census of Marine Life, the Census of Marine Life, the Stavros Niarchos Foundation, Argyll and Islands Enterprise, and Akvaplan-niva. The authors would like to thank C Griffiths and M DuRand for their comments, which improved the manuscript. The authors are also indebted to all those who have undertaken the research through the various Census of Marine Life projects, EU-funded MarBEF and HERMES programs, as well as those that have been nationally funded.; This work was supported by Foundation TOTAL (grant number: The European Census of Marine Life: Biodiversity 2009-2010) and the Alfred P. Sloan Foundation (grant number B2009-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose WG, 2009, ZOOSYMPOSIA, V2, P457; Anisimova N.A., 1989, P281; Arvanitidis C, 2009, MAR ECOL PROG SER, V382, P265, DOI 10.3354/meps07955; BARNETT PRO, 1984, OCEANOL ACTA, V7, P399; Bekkby T, 2009, ICES J MAR SCI, V66, P2106, DOI 10.1093/icesjms/fsp195; Berge J, 2005, MAR ECOL PROG SER, V303, P167, DOI 10.3354/meps303167; Bergman MJN, 2000, ICES J MAR SCI, V57, P1321, DOI 10.1006/jmsc.2000.0917; Bett BJ, 2001, CONT SHELF RES, V21, P917, DOI 10.1016/S0278-4343(00)00119-9; BETT BJ, 2000, BENTHIC ECOLOGY FAER; Beuchel F, 2006, J MARINE SYST, V63, P35, DOI 10.1016/j.jmarsys.2006.05.002; Biles CL, 2002, HYDROL EARTH SYST SC, V6, P999, DOI 10.5194/hess-6-999-2002; Blacker R. W., 1957, Fish Invest Ministr Agr London (2), V20, P1; Blake JA, 2004, DEEP-SEA RES PT II, V51, P1797, DOI 10.1016/j.dsr2.2004.07.014; Bonsdorff E, 2006, J EXP MAR BIOL ECOL, V330, P383, DOI 10.1016/j.jembe.2005.12.041; BRANDT A, 1996, MEDD GROE BIOSCIENCE, V44, P1; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; BRATTEGARD T, 1995, 19971 DN DIR NAT MAN; Brattegard T, 1997, 19971 DN; Brown J. H., 1985, MACROECOLOGY; BRUDE OW, 1998, 98 INSROP; Callaway R, 2002, ICES J MAR SCI, V59, P1199, DOI 10.1006/jmsc.2002.1288; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Claussen U, 2009, HYDROBIOLOGIA, V629, P49, DOI 10.1007/s10750-009-9763-3; Cochrane SKJ, 2009, J SEA RES, V61, P222, DOI 10.1016/j.seares.2009.01.003; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Corliss BH, 2009, DEEP-SEA RES PT I, V56, P835, DOI 10.1016/j.dsr.2008.12.009; CRAEYMEERSCH JA, 2008, C07008 IMARES; CREUTZBERG F, 1987, J CONSEIL, V43, P159; Culver SJ, 2000, DEEP-SEA RES PT I, V47, P259, DOI 10.1016/S0967-0637(99)00055-2; Cushing D.H., 1982, CLIMATE FISHERIES; DAAN R, 2006, 20063 NIOZ, P93; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Danovaro R, 2009, OCEANOGRAPHY, V22, P16, DOI 10.5670/oceanog.2009.02; Dauvin J.-C., 1994, Biodiversity Letters, V2, P171, DOI 10.2307/2999658; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; DAYTON PK, 1994, AM ZOOL, V34, P90; DAYTON PK, 1990, CHEM BIOL GEOLOGY, P631; Degraer S, 2008, CONT SHELF RES, V28, P369, DOI 10.1016/j.csr.2007.09.001; Degraer S, 2007, HELGOLAND MAR RES, V61, P143, DOI 10.1007/s10152-007-0062-y; DEUBEL H, 2000, BER POLARFORSCH, V370, P1; DIPPNER J. W., 1997, DTSCH HYDROGR Z, V49, P277; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; DUINEVELD GCA, 1990, NETH J SEA RES, V26, P125, DOI 10.1016/0077-7579(90)90062-L; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; DYER MF, 1982, J MAR BIOL ASSOC UK, V62, P297, DOI 10.1017/S0025315400057295; Eleftheriou A., 2005, METHODS STUDY MARINE, V3rd ed, DOI DOI 10.1111/maec.12189; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Escaravage V, 2009, MAR ECOL PROG SER, V382, P253, DOI 10.3354/meps08008; Flach E, 1999, J SEA RES, V42, P303, DOI 10.1016/S1385-1101(99)00034-9; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Frauenheim K., 1989, Senckenbergiana Maritima, V20, P101; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Frid CLJ, 2009, J MAR BIOL ASSOC UK, V89, P1, DOI 10.1017/S0025315408002956; Gage JD, 2005, AM FISH S S, V41, P503; Gage JD, 2004, MAR ECOL PROG SER, V277, P181, DOI 10.3354/meps277181; Gage JD, 2000, HYDROBIOLOGIA, V440, P261, DOI 10.1023/A:1004143816391; Gage JD, 2001, CONT SHELF RES, V21, P957, DOI 10.1016/S0278-4343(00)00120-5; GAGE JD, 1986, P ROY SOC EDINB B, V88, P159, DOI 10.1017/S026972700000453X; Gage JD, 2002, MAR ECOL PROG SER, V225, P97, DOI 10.3354/meps225097; Galkin Yuri I., 1998, Berichte zur Polarforschung, V287, P100; Gass SE, 2006, MAR POLLUT BULL, V52, P549, DOI 10.1016/j.marpolbul.2005.10.002; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gauthier O, 2010, MAR ECOL PROG SER, V402, P285, DOI 10.3354/meps08395; Gering JC, 2002, ECOL LETT, V5, P433, DOI 10.1046/j.1461-0248.2002.00335.x; Glemarec M., 1973, OCEANOGR MAR BIOL AN, V11, P263; Golikov A.N., 1989, P325; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Grebmeier J.M., 1991, Journal of Marine Systems, V2, P495, DOI 10.1016/0924-7963(91)90049-Z; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Groger J, 2006, J SEA RES, V55, P266, DOI 10.1016/j.seares.2005.11.005; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hagberg J, 2000, ESTUAR COAST SHELF S, V50, P373, DOI 10.1006/ecss.1999.0578; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Hansen B, 2000, PROG OCEANOGR, V45, P109, DOI 10.1016/S0079-6611(99)00052-X; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; HEIP C, 1992, ICES J MAR SCI, V49, P13, DOI 10.1093/icesjms/49.1.13; HEIP C, 1995, HELGOLANDER MEERESUN, V49, P313, DOI 10.1007/BF02368359; HERMAN Y, 1989, ARCTIC SEAS CLIMATOL; Hernandez-Stefanoni JL, 2006, BIODIVERS CONSERV, V15, P1441, DOI 10.1007/s10531-005-0598-6; HESSLER RR, 1967, DEEP-SEA RES, V14, P65; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Holte B, 2004, SARSIA, V89, P91, DOI 10.1080/00364820410003496; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Husebo A, 2002, HYDROBIOLOGIA, V471, P91, DOI 10.1023/A:1016549203368; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; *ICES, 2008, REP ICES ADV COMM 20, V1; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; Jennings S, 1999, J MAR BIOL ASSOC UK, V79, P385, DOI 10.1017/S0025315498000502; JENSEN A, 1992, SARSIA, V77, P53, DOI 10.1080/00364827.1992.10413492; Jones DOB, 2007, MAR BIOL, V151, P1731, DOI 10.1007/s00227-007-0606-3; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Kaiser MJ, 2000, J ANIM ECOL, V69, P494, DOI 10.1046/j.1365-2656.2000.00412.x; Kirby RR, 2008, LIMNOL OCEANOGR, V53, P1805, DOI 10.4319/lo.2008.53.5.1805; Knox G.A., 1977, COMP BENTHOS SO OCEA, P423; Kroncke I, 1998, POLAR BIOL, V19, P383, DOI 10.1007/s003000050263; KRONCKE I, 1994, POLAR BIOL, V14, P519, DOI 10.1007/BF00238221; KRONCKE I, 1992, HELGOLANDER MEERESUN, V46, P137, DOI 10.1007/BF02366052; Kroncke I, 1998, MAR ECOL PROG SER, V167, P25, DOI 10.3354/meps167025; Kroncke I, 2003, MAR ECOL-P S Z N I, V24, P193, DOI 10.1046/j.0173-9565.2003.00825.x; Kuklinski P, 2009, POLAR RES, V28, P222, DOI 10.1111/j.1751-8369.2009.00105.x; KUNITZER A, 1992, ICES J MAR SCI, V49, P127, DOI 10.1093/icesjms/49.2.127; Lambshead PJD, 2000, MAR ECOL PROG SER, V194, P159, DOI 10.3354/meps194159; Lambshead PJD, 2002, MAR ECOL PROG SER, V236, P129, DOI 10.3354/meps236129; Leichter J. J., 2009, MARINE MACRECOLOGY, P205; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Levinton J., 1995, MARINE BIOL FUNCTION; Lindeboom H.J., 2008, ECOLOGISCHE ATLAS NO; LINDEBOOM HJ, 1994, 19981 NIOZ RIVODLO; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; MACIOLEK N, 1987, STUDY BIOL PROCESSES; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MarBEF, 2004, EUR NOD OC BIOG INF; MICHAELSEN W, 1897, NEUE FOLGE, V1, P5; Middelboe AL, 1998, J PHYCOL, V34, P457, DOI 10.1046/j.1529-8817.1998.340457.x; Mokievsky V, 2002, MAR ECOL PROG SER, V238, P101, DOI 10.3354/meps238101; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Narayanaswamy BE, 2005, MAR BIOL RES, V1, P20, DOI 10.1080/17451000510018971; Narayanaswamy BE, 2010, MAR ECOL-EVOL PERSP, V31, P237, DOI 10.1111/j.1439-0485.2010.00360.x; NESIS KN, 1960, SOVIET FISHERIES INV; Neumann H, 2008, CLIM RES, V37, P241, DOI 10.3354/cr00769; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Olabarria C, 2005, DEEP-SEA RES PT I, V52, P15, DOI 10.1016/j.dsr.2004.09.005; Olabarria C, 2006, BIODIVERS CONSERV, V15, P3685, DOI 10.1007/s10531-005-1344-9; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; PATERSON GLJ, 1995, DEEP-SEA RES PT I, V42, P1199, DOI 10.1016/0967-0637(95)00041-4; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Polyakov IV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023740; Price ARG, 1999, BIOL J LINN SOC, V66, P187, DOI 10.1111/j.1095-8312.1999.tb01883.x; Raffaelli D, 2003, J SEA RES, V49, P133, DOI 10.1016/S1385-1101(02)00200-9; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; REES H. L., 2007, ICES COOPERATIVE RES, V288, P1; Rees HL, 2006, J MAR BIOL ASSOC UK, V86, P1, DOI 10.1017/S002531540601280X; Reid PC, 2003, FISH OCEANOGR, V12, P260, DOI 10.1046/j.1365-2419.2003.00252.x; Reid PC, 2001, SENCK MARIT, V31, P107, DOI 10.1007/BF03043021; Reiss H, 2006, HELGOLAND MAR RES, V60, P224, DOI 10.1007/s10152-006-0038-3; Reiss H, 2010, ICES J MAR SCI, V67, P278, DOI 10.1093/icesjms/fsp253; Renaud PE, 2009, MAR ECOL PROG SER, V382, P239, DOI 10.3354/meps07963; Renaud PE, 2006, J EXP MAR BIOL ECOL, V330, P297, DOI 10.1016/j.jembe.2005.12.035; RENAUD PE, 2007, IMPACTS WARMING POLA; Rex M.A., 1983, DEEP SEA BIOL SEA, V8, P453; Rex MA, 1997, MARINE BIODIVERSITY-BOOK, P94, DOI 10.1017/CBO9780511752360.006; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Rex MA, 2000, P NATL ACAD SCI USA, V97, P4082, DOI 10.1073/pnas.050589497; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; ROBERTS DG, 1979, DEEP-SEA RES, V26, P417, DOI 10.1016/0198-0149(79)90055-4; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2000, HYDROBIOLOGIA, V441, P173, DOI 10.1023/A:1017550612340; Ruesink JL, 2006, MAR ECOL PROG SER, V311, P203, DOI 10.3354/meps311203; Sarnthein M, 2003, BOREAS, V32, P447, DOI 10.1080/03009480310003351; Schroeder Alexander, 2005, Berichte zur Polar- und Meeresforschung, V494, P1; Sherwin TJ, 2008, DEEP-SEA RES PT I, V55, P396, DOI 10.1016/j.dsr.2007.12.006; SIBUET M, 1977, DEEP-SEA RES, V24, P549, DOI 10.1016/0146-6291(77)90527-6; SIRENKO BI, 2001, EXPLORATIONS FAUNA S, V51, P1; SMITH KL, 1972, LIMNOL OCEANOGR, V17, P142, DOI 10.4319/lo.1972.17.1.0142; Solan M, 2006, MAR ECOL PROG SER, V311, P175, DOI 10.3354/meps311175; Solan M, 2008, AQUAT BIOL, V2, P289, DOI 10.3354/ab00058; Somerfield PJ, 2009, MAR ECOL PROG SER, V382, P279, DOI 10.3354/meps07934; Steffens M, 2006, POLAR BIOL, V29, P837, DOI 10.1007/s00300-006-0122-9; Stein Ulrike, 1990, Mitteilungen aus dem Zoologischen Museum der Christian-Albrechts-Universitaet zu Kiel Supplement, V3, P1; Stuart CT, 2003, ECOSY WORLD, V28, P295; SVAVARSSON J, 1990, PROG OCEANOGR, V24, P297, DOI 10.1016/0079-6611(90)90039-5; Thomas E, 1996, GEOLOGY, V24, P355, DOI 10.1130/0091-7613(1996)024<0355:CDSBFT>2.3.CO;2; Thompson RC, 1996, J EXP MAR BIOL ECOL, V202, P73, DOI 10.1016/0022-0981(96)00032-9; THOMSON JW, 1873, DEPTHS SEA; Thrush SF, 2006, ECOL APPL, V16, P1636, DOI 10.1890/1051-0761(2006)016[1636:PTEOHH]2.0.CO;2; TURRELL JW, 1995, SCIENCE, V269, P676; TYLER PA, 1986, P ROY SOC EDINB B, V88, P175, DOI 10.1017/S0269727000004541; Vanden Berghe E, 2009, MAR ECOL PROG SER, V382, P225, DOI 10.3354/meps07826; Vassilenko S.V., 1989, P431; Verfaillie E, 2006, CONT SHELF RES, V26, P2454, DOI 10.1016/j.csr.2006.07.028; Walker MK, 2010, MAR FRESHWATER RES, V61, P1015, DOI 10.1071/MF09244; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Warwick RM, 2002, MAR ECOL PROG SER, V234, P1, DOI 10.3354/meps234001; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207; Webb TJ, 2009, MAR ECOL PROG SER, V382, P287, DOI 10.3354/meps07754; Weslawski J.M., 2009, POLARFORSCHUNG, V78, P105; Weslawski Jan Marcin, 2003, Polish Polar Research, V24, P73; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Widdicombe S, 2004, MAR ECOL PROG SER, V275, P1, DOI 10.3354/meps275001; Willems W, 2007, ICES COOPERATIVE RES, V288, P69; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wlodarska-Kowalczuk M, 2004, DEEP-SEA RES PT I, V51, P1903, DOI 10.1016/j.dsr.2004.07.013; Wollenburg JE, 2000, MAR MICROPALEONTOL, V40, P189, DOI 10.1016/S0377-8398(00)00039-6; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zuhlke R, 2001, SENCK MARIT, V31, P269, DOI 10.1007/BF03043036; 2009, MANAGEMENT NATURA 20	197	35	36	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14295	10.1371/journal.pone.0014295	http://dx.doi.org/10.1371/journal.pone.0014295			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179189	Green Submitted, gold, Green Published			2022-12-27	WOS:000285246900008
J	Schaefer, M; Heinze, HJ; Galazky, I				Schaefer, Michael; Heinze, Hans-Jochen; Galazky, Imke			Alien Hand Syndrome: Neural Correlates of Movements without Conscious Will	PLOS ONE			English	Article							MOTOR; INHIBITION; CORTEX	Background: The alien hand syndrome is a striking phenomenon characterized by purposeful and autonomous movements that are not voluntarily initiated. This study aimed to examine neural correlates of this rare neurological disorder in a patient with corticobasal degeneration and alien hand syndrome of the left hand. Methodology/Principal Findings: We employed functional magnetic resonance imaging to investigate brain responses associated with unwanted movements in a case study. Results revealed that alien hand movements involved a network of brain activations including the primary motor cortex, premotor cortex, precuneus, and right inferior frontal gyrus. Conscious and voluntary movements of the alien hand elicited a similar network of brain responses but lacked an activation of the inferior frontal gyrus. The results demonstrate that alien and unwanted movements may engage similar brain networks than voluntary movements, but also imply different functional contributions of prefrontal areas. Since the inferior frontal gyrus was uniquely activated during alien movements, the results provide further support for a specific role of this brain region in inhibitory control over involuntary motor responses. Conclusions/Significance: We discuss the outcome of this study as providing evidence for a distributed neural network associated with unwanted movements in alien hand syndrome, including brain regions known to be related to movement execution and planning as well as areas that have been linked to inhibition control (inferior frontal gyrus) and experience of agency (precuneus).	[Schaefer, Michael; Heinze, Hans-Jochen; Galazky, Imke] Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany	Otto von Guericke University	Schaefer, M (corresponding author), Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany.	mischa@neuro2.med.uni-magdeburg.de			Deutsche Forschungsgemeinschaft [Scha105/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MS was supported by the Deutsche Forschungsgemeinschaft (Scha105/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assal F, 2007, ANN NEUROL, V62, P301, DOI 10.1002/ana.21173; Biran I, 2004, ARCH NEUROL-CHICAGO, V61, P292, DOI 10.1001/archneur.61.2.292; Brainin M, 2008, J NEUROL NEUROSUR PS, V79, P246, DOI 10.1136/jnnp.2007.116046; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; FitzGerald DB, 2007, MOVEMENT DISORD, V22, P581, DOI 10.1002/mds.21337; Goldstein K, 1908, J PSYCHOL NEUROL, V11, P169; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Marey-Lopez J, 2002, J NEUROL NEUROSUR PS, V73, P447, DOI 10.1136/jnnp.73.4.447; Marti-Fabregas J, 2000, CEREBROVASC DIS, V10, P70, DOI 10.1159/000016028; Porro CA, 1996, J NEUROSCI, V16, P7688; Scepkowski Lisa A, 2003, Behav Cogn Neurosci Rev, V2, P261, DOI 10.1177/1534582303260119	12	29	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15010	10.1371/journal.pone.0015010	http://dx.doi.org/10.1371/journal.pone.0015010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179436	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900025
J	van Rooijen, BD; Claessens, MMAE; Subramaniam, V				van Rooijen, Bart D.; Claessens, Mireille M. A. E.; Subramaniam, Vinod			Membrane Permeabilization by Oligomeric alpha-Synuclein: In Search of the Mechanism	PLOS ONE			English	Article							SOLUBLE AMYLOID OLIGOMERS; PARKINSONS-DISEASE; VESICLE PERMEABILIZATION; BILAYER-MEMBRANES; LIPID-BILAYERS; ION CHANNELS; MUTATION; PATHOGENESIS; AGGREGATION; INSERTION	Background: The question of how the aggregation of the neuronal protein alpha-synuclein contributes to neuronal toxicity in Parkinson's disease has been the subject of intensive research over the past decade. Recently, attention has shifted from the amyloid fibrils to soluble oligomeric intermediates in the alpha-synuclein aggregation process. These oligomers are hypothesized to be cytotoxic and to permeabilize cellular membranes, possibly by forming pore-like complexes in the bilayer. Although the subject of alpha-synuclein oligomer-membrane interactions has attracted much attention, there is only limited evidence that supports the pore formation by alpha-synuclein oligomers. In addition the existing data are contradictory. Methodology/Principal Findings: Here we have studied the mechanism of lipid bilayer disruption by a well-characterized alpha-synuclein oligomer species in detail using a number of in vitro bilayer systems and assays. Dye efflux from vesicles induced by oligomeric alpha-synuclein was found to be a fast all-or-none process. Individual vesicles swiftly lose their contents but overall vesicle morphology remains unaltered. A newly developed assay based on a dextran-coupled dye showed that non-equilibrium processes dominate the disruption of the vesicles. The membrane is highly permeable to solute influx directly after oligomer addition, after which membrane integrity is partly restored. The permeabilization of the membrane is possibly related to the intrinsic instability of the bilayer. Vesicles composed of negatively charged lipids, which are generally used for measuring alpha-synuclein-lipid interactions, were unstable to protein adsorption in general. Conclusions/Significance: The dye efflux from negatively charged vesicles upon addition of alpha-synuclein has been hypothesized to occur through the formation of oligomeric membrane pores. However, our results show that the dye efflux characteristics are consistent with bilayer defects caused by membrane instability. These data shed new insights into potential mechanisms of toxicity of oligomeric alpha-synuclein species.	[van Rooijen, Bart D.; Claessens, Mireille M. A. E.; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Subramaniam, Vinod] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	University of Twente; University of Twente	van Rooijen, BD (corresponding author), Univ Twente, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.	v.subramaniam@utwente.nl	Subramaniam, Vinod/B-4197-2010	Subramaniam, Vinod/0000-0001-6712-7266	Nanotechnology network in the Netherlands (NanoNed) [7921]; Faculty of Science and Technology at the University of Twente	Nanotechnology network in the Netherlands (NanoNed); Faculty of Science and Technology at the University of Twente	This work was part of the Nanotechnology network in the Netherlands (NanoNed), project number 7921 within the NanoNed program BioNanoSystems. Funding from the Faculty of Science and Technology at the University of Twente is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; HAUSER H, 1984, BIOCHEMISTRY-US, V23, P34, DOI 10.1021/bi00296a006; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KIM HY, 2009, J AM CHEM SOC; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Ladokhin AS, 1995, BIOPHYS J, V69, P1964, DOI 10.1016/S0006-3495(95)80066-4; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Melikov KC, 2001, BIOPHYS J, V80, P1829, DOI 10.1016/S0006-3495(01)76153-X; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; RUBAS W, 1995, J DRUG TARGET, V3, P15, DOI 10.3109/10611869509015928; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shoemaker SD, 2002, BIOPHYS J, V83, P2007, DOI 10.1016/S0006-3495(02)73962-3; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tamamizu-Kato S, 2006, BIOCHEMISTRY-US, V45, P10947, DOI 10.1021/bi060939i; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Valincius G, 2008, BIOPHYS J, V95, P4845, DOI 10.1529/biophysj.108.130997; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; van Rooijen BD, 2008, FEBS LETT, V582, P3788, DOI 10.1016/j.febslet.2008.10.009; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	37	103	109	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14292	10.1371/journal.pone.0014292	http://dx.doi.org/10.1371/journal.pone.0014292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179192	Green Published, gold			2022-12-27	WOS:000285246900006
J	Garcia, O; Torres, M; Helguera, P; Coskun, P; Busciglio, J				Garcia, Octavio; Torres, Maria; Helguera, Pablo; Coskun, Pinar; Busciglio, Jorge			A Role for Thrombospondin-1 Deficits in Astrocyte-Mediated Spine and Synaptic Pathology in Down's Syndrome	PLOS ONE			English	Article							TRISOMY 16 MOUSE; HUMAN CORTICAL-NEURONS; HUMAN-CHROMOSOME 21; DENDRITIC SPINES; CEREBRAL-CORTEX; GLIAL-CELLS; ALZHEIMER-DISEASE; IN-VITRO; MITOCHONDRIAL DYSFUNCTION; STRUCTURAL ABNORMALITIES	Background: Down's syndrome (DS) is the most common genetic cause of mental retardation. Reduced number and aberrant architecture of dendritic spines are common features of DS neuropathology. However, the mechanisms involved in DS spine alterations are not known. In addition to a relevant role in synapse formation and maintenance, astrocytes can regulate spine dynamics by releasing soluble factors or by physical contact with neurons. We have previously shown impaired mitochondrial function in DS astrocytes leading to metabolic alterations in protein processing and secretion. In this study, we investigated whether deficits in astrocyte function contribute to DS spine pathology. Methodology/Principal Findings: Using a human astrocyte/rat hippocampal neuron coculture, we found that DS astrocytes are directly involved in the development of spine malformations and reduced synaptic density. We also show that thrombospondin 1 (TSP-1), an astrocyte-secreted protein, possesses a potent modulatory effect on spine number and morphology, and that both DS brains and DS astrocytes exhibit marked deficits in TSP-1 protein expression. Depletion of TSP-1 from normal astrocytes resulted in dramatic changes in spine morphology, while restoration of TSP-1 levels prevented DS astrocyte-mediated spine and synaptic alterations. Astrocyte cultures derived from TSP-1 KO mice exhibited similar deficits to support spine formation and structure than DS astrocytes. Conclusions/Significance: These results indicate that human astrocytes promote spine and synapse formation, identify astrocyte dysfunction as a significant factor of spine and synaptic pathology in the DS brain, and provide a mechanistic rationale for the exploration of TSP-1-based therapies to treat spine and synaptic pathology in DS and other neurological conditions.	[Garcia, Octavio; Torres, Maria; Helguera, Pablo; Coskun, Pinar; Busciglio, Jorge] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Inst Memory Impairments & Neurol Disorders, Dept Neurobiol & Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine	Garcia, O (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Inst Memory Impairments & Neurol Disorders, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	jbuscigl@uci.edu	Garcia, Octavio/AAF-2127-2020	Garcia, Octavio/0000-0002-5792-0209; Coskun, E. Pinar/0000-0002-8010-8403	Larry L. Hillblom Foundation; National Institutes of Health [HD38466]; Alzheimers Disease Research Center [AG16573]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016573] Funding Source: NIH RePORTER	Larry L. Hillblom Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimers Disease Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from The Larry L. Hillblom Foundation and the National Institutes of Health (grant no. HD38466, and Alzheimers Disease Research Center grant no. AG16573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, DEV DYNAM, V218, P280; ASCH AS, 1986, P NATL ACAD SCI USA, V83, P2904, DOI 10.1073/pnas.83.9.2904; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Bambrick LL, 1997, GLIA, V19, P352, DOI 10.1002/(SICI)1098-1136(199704)19:4<352::AID-GLIA8>3.0.CO;2-Z; Bambrick LL, 2003, J NEUROSCI RES, V73, P89, DOI 10.1002/jnr.10630; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Benavides-Piccione R, 2004, PROG NEUROBIOL, V74, P111, DOI 10.1016/j.pneurobio.2004.08.001; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Booth GE, 2000, DEVELOPMENT, V127, P237; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Busciglio J, 1998, ANN NY ACAD SCI, V851, P429, DOI 10.1111/j.1749-6632.1998.tb09021.x; Caceres M, 2007, CEREB CORTEX, V17, P2312, DOI 10.1093/cercor/bhl140; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; DEFREITAS MF, 1995, NEURON, V15, P333, DOI 10.1016/0896-6273(95)90038-1; Deshpande A, 2008, FASEB J, V22, P2357, DOI 10.1096/fj.07-096909; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dowell JA, 2009, J PROTEOME RES, V8, P4135, DOI 10.1021/pr900248y; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fiala JC, 1998, J NEUROSCI, V18, P8900; Franciotta D, 2006, NEUROSCI LETT, V395, P67, DOI 10.1016/j.neulet.2005.10.048; Giehl K, 2008, AM J PHYSIOL-RENAL, V294, pF407, DOI 10.1152/ajprenal.00093.2007; Greenwood JA, 1998, J BIOL CHEM, V273, P1755, DOI 10.1074/jbc.273.3.1755; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Guazzarotti L, 2009, AJIDD-AM J INTELLECT, V114, P100, DOI 10.1352/2009.114.100-109; Guizzetti M, 2008, J BIOL CHEM, V283, P31884, DOI 10.1074/jbc.M801316200; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hallam DM, 2000, J NEUROIMMUNOL, V110, P66, DOI 10.1016/S0165-5728(00)00289-7; Hallam DM, 1998, NEUROSCI LETT, V252, P17, DOI 10.1016/S0304-3940(98)00541-2; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hayashi K, 1996, J NEUROSCI, V16, P7161; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Helguera P, 2005, J NEUROSCI, V25, P2295, DOI 10.1523/JNEUROSCI.5107-04.2005; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Iwamoto T, 2009, ARCH ORAL BIOL, V54, P963, DOI 10.1016/j.archoralbio.2009.07.009; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; JORGENSEN OS, 1990, J NEUROL SCI, V98, P63; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Keene SD, 2009, PROTEOMICS, V9, P768, DOI 10.1002/pmic.200800385; Kobayashi C, 2007, J COMP NEUROL, V503, P618, DOI 10.1002/cne.21408; Kurt MA, 2004, BRAIN RES, V1022, P101, DOI 10.1016/j.brainres.2004.06.075; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Lu ZJ, 2010, FASEB J, V24, P1925, DOI 10.1096/fj.09-150573; Lymn JS, 1999, ARTERIOSCL THROM VAS, V19, P2133, DOI 10.1161/01.ATV.19.9.2133; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; MAHESHWARI RK, 1980, NATURE, V287, P454, DOI 10.1038/287454a0; MARINPAD.M, 1972, BRAIN RES, V44, P625, DOI 10.1016/0006-8993(72)90324-1; MARINPADILLA M, 1976, J COMP NEUROL, V167, P63, DOI 10.1002/cne.901670105; Maroun LE, 1996, J THEOR BIOL, V181, P41, DOI 10.1006/jtbi.1996.0113; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Moore NH, 2009, J NEUROCHEM, V108, P891, DOI 10.1111/j.1471-4159.2008.05836.x; Mori T, 2005, CURR TOP DEV BIOL, V69, P67, DOI 10.1016/S0070-2153(05)69004-7; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; MURPHY M, 1992, J IMMUNOL, V149, P2506; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nelson PG, 1997, P NATL ACAD SCI USA, V94, P12644, DOI 10.1073/pnas.94.23.12644; NICKOLOFF BJ, 1988, J INVEST DERMATOL, V91, P213, DOI 10.1111/1523-1747.ep12465005; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Nishiwaki T, 2006, J BONE MINER RES, V21, P596, DOI 10.1359/JBMR.051216; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSHEA KS, 1991, NEURON, V7, P231, DOI 10.1016/0896-6273(91)90261-W; OSTERHOUT DJ, 1992, DEV BIOL, V150, P256, DOI 10.1016/0012-1606(92)90240-H; PAPA M, 1995, J NEUROSCI, V15, P1; Pelsman A, 2003, INT J DEV NEUROSCI, V21, P117, DOI 10.1016/S0736-5748(03)00031-5; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Roberts DD, 2007, CLIN CANCER RES, V13, P795, DOI 10.1158/1078-0432.CCR-06-1758; Sebastia J, 2004, EUR J NEUROSCI, V20, P2355, DOI 10.1111/j.1460-9568.2004.03686.x; Shukkur EA, 2006, HUM MOL GENET, V15, P2752, DOI 10.1093/hmg/ddl211; SUETSUGU M, 1980, ACTA NEUROPATHOL, V50, P207, DOI 10.1007/BF00688755; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; TAKASHIMA S, 1994, J INTELL DISABIL RES, V38, P265; TAN YH, 1976, NATURE, V260, P141, DOI 10.1038/260141a0; TAN YH, 1974, SCIENCE, V186, P61, DOI 10.1126/science.186.4158.61; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yu KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002470; ZIHNI L, 1994, LEUKEMIA RES, V18, P1, DOI 10.1016/0145-2126(94)90002-7; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	114	75	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14200	10.1371/journal.pone.0014200	http://dx.doi.org/10.1371/journal.pone.0014200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152035	gold, Green Published			2022-12-27	WOS:000284868000014
J	Gibson, EM; Wang, C; Tjho, S; Khattar, N; Kriegsfeld, LJ				Gibson, Erin M.; Wang, Connie; Tjho, Stephanie; Khattar, Neera; Kriegsfeld, Lance J.			Experimental 'Jet Lag' Inhibits Adult Neurogenesis and Produces Long-Term Cognitive Deficits in Female Hamsters	PLOS ONE			English	Article							LIGHT-DARK CYCLE; MALE SIBERIAN HAMSTERS; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; SHIFT-WORK; CELL-PROLIFERATION; CIRCADIAN-RHYTHMS; LUTEINIZING-HORMONE; SLEEP-DEPRIVATION; PROMOTES SURVIVAL	Background: Circadian disruptions through frequent transmeridian travel, rotating shift work, and poor sleep hygiene are associated with an array of physical and mental health maladies, including marked deficits in human cognitive function. Despite anecdotal and correlational reports suggesting a negative impact of circadian disruptions on brain function, this possibility has not been experimentally examined. Methodology/Principal Findings: In the present study, we investigated whether experimental 'jet lag' (i.e., phase advances of the light: dark cycle) negatively impacts learning and memory and whether any deficits observed are associated with reductions in hippocampal cell proliferation and neurogenesis. Because insults to circadian timing alter circulating glucocorticoid and sex steroid concentrations, both of which influence neurogenesis and learning/memory, we assessed the contribution of these endocrine factors to any observed alterations. Circadian disruption resulted in pronounced deficits in learning and memory paralleled by marked reductions in hippocampal cell proliferation and neurogenesis. Significantly, deficits in hippocampal-dependent learning and memory were not only seen during the period of the circadian disruption, but also persisted well after the cessation of jet lag, suggesting long-lasting negative consequences on brain function. Conclusions/Significance: Together, these findings support the view that circadian disruptions suppress hippocampal neurogenesis via a glucocorticoid-independent mechanism, imposing pronounced and persistent impairments on learning and memory.	[Gibson, Erin M.; Wang, Connie; Tjho, Stephanie; Khattar, Neera; Kriegsfeld, Lance J.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Kriegsfeld, Lance J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gibson, EM (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	Kriegsfeld@berkeley.edu		Gibson, Erin/0000-0001-9749-3814	University of California, Berkeley; National Institutes of Health [HD-050470]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050470] Funding Source: NIH RePORTER	University of California, Berkeley(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by The Hellman Award (University of California, Berkeley) and National Institutes of Health Grant HD-050470 (L.J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborg G, 1996, INT J EPIDEMIOL, V25, P783, DOI 10.1093/ije/25.4.783; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Anand S, 2004, BIOL REPROD, V70, P1033, DOI 10.1095/biolreprod.103.019380; Anand S, 2002, ENDOCRINOLOGY, V143, P2178, DOI 10.1210/en.143.6.2178; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; Barha CK, 2009, J NEUROENDOCRINOL, V21, P155, DOI 10.1111/j.1365-2826.2008.01809.x; Barker JM, 2008, NEUROSCIENCE, V152, P888, DOI 10.1016/j.neuroscience.2007.10.071; Bildt C, 2002, INT ARCH OCC ENV HEA, V75, P252, DOI 10.1007/s00420-001-0299-8; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Borgs L, 2009, CELL CYCLE, V8, P832, DOI 10.4161/cc.8.6.7869; Cain SW, 2004, PHYSIOL BEHAV, V82, P339, DOI 10.1016/j.physbeh.2004.04.004; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Cho K, 2000, J NEUROSCI, V20, part. no.; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; Daniel JM, 1997, HORM BEHAV, V32, P217, DOI 10.1006/hbeh.1997.1433; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Ferbinteanu J, 2001, HIPPOCAMPUS, V11, P187, DOI 10.1002/hipo.1036; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Frick KM, 2001, BEHAV NEUROSCI, V115, P229, DOI 10.1037//0735-7044.115.1.229; Frielingsdorf H, 2007, NEUROBIOL DIS, V26, P47, DOI 10.1016/j.nbd.2006.11.015; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Galea LAM, 2008, CAN J EXP PSYCHOL, V62, P247, DOI 10.1037/a0014501; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; GOLOMBEK DA, 1993, CHRONOBIOL INT, V10, P435, DOI 10.3109/07420529309059719; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; Hansen J, 2006, CANCER CAUSE CONTROL, V17, P531, DOI 10.1007/s10552-005-9006-5; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Jasnow AM, 2001, HORM BEHAV, V40, P428, DOI 10.1006/hbeh.2001.1708; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P204, DOI 10.5271/sjweh.1000; Lee KJ, 2006, EXP MOL MED, V38, P44, DOI 10.1038/emm.2006.6; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Loh DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012546; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; Maywood ES, 2007, COLD SPRING HARB SYM, V72, P85, DOI 10.1101/sqb.2007.72.005; Maywood ES, 2006, PROG BRAIN RES, V153, P253, DOI 10.1016/S0079-6123(06)53015-8; Meyer-Bernstein EL, 1999, ENDOCRINOLOGY, V140, P207, DOI 10.1210/en.140.1.207; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mirescu C, 2006, P NATL ACAD SCI USA, V103, P19170, DOI 10.1073/pnas.0608644103; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Mueller AD, 2008, AM J PHYSIOL-REG I, V294, pR1693, DOI 10.1152/ajpregu.00858.2007; ORSINI M, 1961, P ANIMAL CARE PANEL, V14, P193; OTTENWELLER JE, 1985, LIFE SCI, V37, P1551, DOI 10.1016/0024-3205(85)90188-2; Pizzio GA, 2005, EUR J NEUROSCI, V22, P665, DOI 10.1111/j.1460-9568.2005.04247.x; POOLE CJM, 1992, BRIT J IND MED, V49, P513; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Ralph MR, 2002, BEHAV BRAIN RES, V136, P179, DOI 10.1016/S0166-4328(02)00131-6; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Sei H, 2003, LIFE SCI, V73, P53, DOI 10.1016/S0024-3205(03)00251-0; Shors TJ, 2006, ANNU REV PSYCHOL, V57, P55, DOI 10.1146/annurev.psych.57.102904.190205; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SKIPPER JK, 1990, J ADV NURS, V15, P835, DOI 10.1111/j.1365-2648.1990.tb01915.x; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; STEPHAN FK, 1972, PHYSIOL BEHAV, V8, P315, DOI 10.1016/0031-9384(72)90379-4; TAKAMURE M, 1991, PHYSIOL BEHAV, V50, P443, DOI 10.1016/0031-9384(91)90092-3; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Van der Borght K, 2005, BEHAV BRAIN RES, V157, P23, DOI 10.1016/j.bbr.2004.06.004; Van Gelder RN, 2003, SCIENCE, V300, P1534, DOI 10.1126/science.1085446; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Wallsser JA, 2006, DEV CELL, V10, P539, DOI 10.1016/j.devcel.2006.04.014; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhu JL, 2004, AM J OBSTET GYNECOL, V191, P285, DOI 10.1016/j.ajog.2003.12.002	81	126	127	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15267	10.1371/journal.pone.0015267	http://dx.doi.org/10.1371/journal.pone.0015267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152025	gold, Green Published, Green Submitted			2022-12-27	WOS:000284821300019
J	Rastegar, F; Gao, JL; Shenaq, D; Luo, Q; Shi, QO; Kim, SH; Jiang, W; Wagner, ER; Huang, EY; Gao, YH; Shen, JK; Yang, K; He, BC; Chen, LA; Zuo, GW; Luo, JY; Luo, XJ; Bi, Y; Liu, X; Li, M; Hu, N; Wang, LY; Luther, G; Luu, HH; Haydon, RC; He, TC				Rastegar, Farbod; Gao, Jian-Li; Shenaq, Deana; Luo, Qing; Shi, Qiong; Kim, Stephanie H.; Jiang, Wei; Wagner, Eric R.; Huang, Enyi; Gao, Yanhong; Shen, Jikun; Yang, Ke; He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Luo, Jinyong; Luo, Xiaoji; Bi, Yang; Liu, Xing; Li, Mi; Hu, Ning; Wang, Linyuan; Luther, Gaurav; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan			Lysophosphatidic Acid Acyltransferase beta (LPAAT beta) Promotes the Tumor Growth of Human Osteosarcoma	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; EXTREMITY OSTEOSARCOMA; MOLECULAR-MECHANISMS; PULMONARY METASTASES; EXPRESSION; GENE; TARGET; INHIBITION	Background: Osteosarcoma is the most common primary malignancy of bone with poorly characterized molecular pathways important in its pathogenesis. Increasing evidence indicates that elevated lipid biosynthesis is a characteristic feature of cancer. We sought to investigate the role of lysophosphatidic acid acyltransferase beta (LPAAT beta, aka, AGPAT2) in regulating the proliferation and growth of human osteosarcoma cells. LPAAT beta can generate phosphatidic acid, which plays a key role in lipid biosynthesis as well as in cell proliferation and survival. Although elevated expression of LPAAT beta has been reported in several types of human tumors, the role of LPAAT beta in osteosarcoma progression has yet to be elucidated. Methodology/Principal Findings: Endogenous expression of LPAAT beta in osteosarcoma cell lines is analyzed by using semi-quantitative PCR and immunohistochemical staining. Adenovirus-mediated overexpression of LPAAT beta and silencing LPAAT beta expression is employed to determine the effect of LPAAT beta on osteosarcoma cell proliferation and migration in vitro and osteosarcoma tumor growth in vivo. We have found that expression of LPAAT beta is readily detected in 8 of the 10 analyzed human osteosarcoma lines. Exogenous expression of LPAAT beta promotes osteosarcoma cell proliferation and migration, while silencing LPAAT beta expression inhibits these cellular characteristics. We further demonstrate that exogenous expression of LPAAT beta effectively promotes tumor growth, while knockdown of LPAAT beta expression inhibits tumor growth in an orthotopic xenograft model of human osteosarcoma. Conclusions/Significance: Our results strongly suggest that LPAAT beta expression may be associated with the aggressive phenotypes of human osteosarcoma and that LPAAT beta may play an important role in regulating osteosarcoma cell proliferation and tumor growth. Thus, targeting LPAAT beta may be exploited as a novel therapeutic strategy for the clinical management of osteosarcoma. This is especially attractive given the availability of selective pharmacological inhibitors.	[Rastegar, Farbod; Gao, Jian-Li; Shenaq, Deana; Luo, Qing; Shi, Qiong; Kim, Stephanie H.; Jiang, Wei; Wagner, Eric R.; Huang, Enyi; Gao, Yanhong; Shen, Jikun; Yang, Ke; He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Luo, Jinyong; Luo, Xiaoji; Bi, Yang; Liu, Xing; Li, Mi; Hu, Ning; Wang, Linyuan; Luther, Gaurav; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Gao, Jian-Li; He, Tong-Chuan] Zhejiang Univ, Sch Pharm, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Qing; Bi, Yang; Liu, Xing; Li, Mi; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Stem Cell Biol & Therapy Lab, Chongqing, Peoples R China; [Shi, Qiong; He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Luo, Jinyong; Luo, Xiaoji; Hu, Ning] Chongqing Med Univ, Diagnost Med Designated Chinese Minist Educ, Key Lab, Chongqing, Peoples R China; [Shi, Qiong; He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Luo, Jinyong; Luo, Xiaoji; Hu, Ning] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Huang, Enyi] Chongqing Univ, Sch Bioengn, Chongqing, Peoples R China; [Gao, Yanhong] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Geriatr, Shanghai 200030, Peoples R China; [Yang, Ke] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China	University of Chicago; University of Chicago Medical Center; Zhejiang University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing University; Shanghai Jiao Tong University; Army Medical University	Rastegar, F (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA.	tche@surgery.bsd.uchicago.edu	; GAO, JianLi/J-4997-2017	Wagner, Eric/0000-0001-9241-5702; GAO, JianLi/0000-0002-5977-0021	Brinson Foundation; National Institutes of Health; University of Chicago Comprehensive Cancer Center	Brinson Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center	The reported work was supported in part by research grants from the Brinson Foundation (TCH), National Institutes of Health (TCH and HHL) and the Animal Imaging Pilot Grant from The University of Chicago Comprehensive Cancer Center (to RCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bonham L, 2003, EXPERT OPIN THER TAR, V7, P643; Burton A, 2006, LANCET ONCOL, V7, P893, DOI 10.1016/S1470-2045(06)70926-3; CHEN L, 2010, J BONE MINER RES; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Chou AJ, 2006, EXPERT REV ANTICANC, V6, P1075, DOI 10.1586/14737140.6.7.1075; Coon M, 2003, MOL CANCER THER, V2, P1067; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Diefenbach CSM, 2006, CANCER-AM CANCER SOC, V107, P1511, DOI 10.1002/cncr.22184; Douvas MG, 2006, LEUKEMIA RES, V30, P1027, DOI 10.1016/j.leukres.2005.11.018; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Feugeas O, 1996, J CLIN ONCOL, V14, P467, DOI 10.1200/JCO.1996.14.2.467; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Gazitt Y, 2009, INT J ONCOL, V34, P551, DOI 10.3892/ijo_00000181; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GIENI RS, 1995, J IMMUNOL METHODS, V187, P85, DOI 10.1016/0022-1759(95)00170-F; Gordon N, 2009, CANCER TREAT RES, V152, P497, DOI 10.1007/978-1-4419-0284-9_29; Gorlick R, 2003, CLIN CANCER RES, V9, P5442; Gorlick R, 2009, CANC TREAT, V152, P467, DOI 10.1007/978-1-4419-0284-9_27; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; Haydon RC, 2007, CLIN ORTHOP RELAT R, P237, DOI 10.1097/BLO.0b013e31802b683c; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hideshima T, 2003, CANCER RES, V63, P8428; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kaste SC, 1999, CANCER-AM CANCER SOC, V86, P1602, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1602::AID-CNCR31>3.0.CO;2-R; La Rosee P, 2006, CLIN CANCER RES, V12, P6540, DOI 10.1158/1078-0432.CCR-06-0140; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luo XJ, 2008, CLIN ORTHOP RELAT R, V466, P2060, DOI 10.1007/s11999-008-0361-x; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luu HH, 2005, CANCER LETT, V229, P135, DOI 10.1016/j.canlet.2005.02.015; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Menendez JA, 2010, BBA-MOL CELL BIOL L, V1801, P381, DOI 10.1016/j.bbalip.2009.09.005; Meyers PA, 1997, PEDIATR CLIN N AM, V44, P973, DOI 10.1016/S0031-3955(05)70540-X; Mintz MB, 2005, CANCER RES, V65, P1748, DOI 10.1158/0008-5472.CAN-04-2463; Murphey MD, 1997, RADIOGRAPHICS, V17, P1205, DOI 10.1148/radiographics.17.5.9308111; Niesporek S, 2005, BRIT J CANCER, V92, P1729, DOI 10.1038/sj.bjc.6602528; Pagel JM, 2005, CLIN CANCER RES, V11, P4857, DOI 10.1158/1078-0432.CCR-04-2352; Pakos EE, 2004, CLIN CANCER RES, V10, P6208, DOI 10.1158/1078-0432.CCR-04-0246; Sandberg AA, 2003, CANCER GENET CYTOGEN, V145, P1, DOI 10.1016/S0165-4608(03)00105-5; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Springett GM, 2005, CANCER RES, V65, P9415, DOI 10.1158/0008-5472.CAN-05-0516; Stamps AC, 1997, BIOCHEM J, V326, P455, DOI 10.1042/bj3260455; Su YX, 2009, CLIN EXP METASTAS, V26, P599, DOI 10.1007/s10585-009-9259-6; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WARD WG, 1994, J CLIN ONCOL, V12, P1849, DOI 10.1200/JCO.1994.12.9.1849; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; Whelan JS, 1997, EUR J CANCER, V33, P1611, DOI 10.1016/S0959-8049(97)00251-7; Yokoyama R, 1998, PATHOL RES PRACT, V194, P615, DOI 10.1016/S0344-0338(98)80096-4; Yonemoto T, 1998, CLIN ORTHOP RELAT R, P194; ZHOU Q, 2009, MED ONCOL	68	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14182	10.1371/journal.pone.0014182	http://dx.doi.org/10.1371/journal.pone.0014182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152068	Green Published, Green Submitted, gold			2022-12-27	WOS:000284821300003
J	Gandelman, OA; Church, VL; Moore, CA; Kiddle, G; Carne, CA; Parmar, S; Jalal, H; Tisi, LC; Murray, JAH				Gandelman, Olga A.; Church, Vicki L.; Moore, Cathy A.; Kiddle, Guy; Carne, Christopher A.; Parmar, Surendra; Jalal, Hamid; Tisi, Laurence C.; Murray, James A. H.			Novel Bioluminescent Quantitative Detection of Nucleic Acid Amplification in Real-Time	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; FIREFLY LUCIFERASE; CHLAMYDIA-TRACHOMATIS; ENZYMATIC METHOD; DNA; PYROPHOSPHATE; PCR; QUANTIFICATION; THERMOSTABILITY; MICROBIOLOGY	Background: The real-time monitoring of polynucleotide amplification is at the core of most molecular assays. This conventionally relies on fluorescent detection of the amplicon produced, requiring complex and costly hardware, often restricting it to specialised laboratories. Principal Findings: Here we report the first real-time, closed-tube luminescent reporter system for nucleic acid amplification technologies (NAATs) enabling the progress of amplification to be continuously monitored using simple light measuring equipment. The Bioluminescent Assay in Real-Time (BART) continuously reports through bioluminescent output the exponential increase of inorganic pyrophosphate (PPi) produced during the isothermal amplification of a specific nucleic acid target. BART relies on the coupled conversion of inorganic pyrophosphate (PPi) produced stoichiometrically during nucleic acid synthesis to ATP by the enzyme ATP sulfurylase, and can therefore be coupled to a wide range of isothermal NAATs. During nucleic acid amplification, enzymatic conversion of PPi released during DNA synthesis into ATP is continuously monitored through the bioluminescence generated by thermostable firefly luciferase. The assay shows a unique kinetic signature for nucleic acid amplifications with a readily identifiable light output peak, whose timing is proportional to the concentration of original target nucleic acid. This allows qualitative and quantitative analysis of specific targets, and readily differentiates between negative and positive samples. Since quantitation in BART is based on determination of time-to-peak rather than absolute intensity of light emission, complex or highly sensitive light detectors are not required. Conclusions: The combined chemistries of the BART reporter and amplification require only a constant temperature maintained by a heating block and are shown to be robust in the analysis of clinical samples. Since monitoring the BART reaction requires only a simple light detector, the iNAAT-BART combination is ideal for molecular diagnostic assays in both laboratory and low resource settings.	[Gandelman, Olga A.; Church, Vicki L.; Moore, Cathy A.; Kiddle, Guy; Tisi, Laurence C.] Lumora Ltd, Ely, England; [Gandelman, Olga A.; Church, Vicki L.; Moore, Cathy A.; Murray, James A. H.] Univ Cambridge, Inst Biotechnol, Cambridge, England; [Carne, Christopher A.] Addenbrookes Hosp, Clin 1A, Cambridge, England; [Parmar, Surendra; Jalal, Hamid] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Cambridge, England; [Murray, James A. H.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cardiff University	Gandelman, OA (corresponding author), Lumora Ltd, Ely, England.	o.gandelman@lumora.co.uk	Murray, James AH/D-3399-2009	Murray, James AH/0000-0002-2282-3839	Department of Trade and Industry (DTI), UK [4644 (SEC/120/40)]	Department of Trade and Industry (DTI), UK	This research was funded by the Department of Trade and Industry (DTI), UK: grant for research and development: Molecular Diagnostics (project reference: 4644 (SEC/120/40)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi Y, 2006, J BIOTECHNOL, V125, P484, DOI 10.1016/j.jbiotec.2006.04.007; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Brenan Colin, 2005, Drug Discov Today Technol, V2, P247, DOI 10.1016/j.ddtec.2005.08.017; Brovko L. Yu., 1994, Biokhimiya, V59, P273; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Cai T, 2008, J CLIN VIROL, V41, P270, DOI 10.1016/j.jcv.2007.11.025; Cali JJ, 2008, EXPERT OPIN DRUG MET, V4, P103, DOI [10.1517/17425255.4.1.103, 10.1517/17425255.4.1.103 ]; Eriksson J, 2004, NUCLEOS NUCLEOT NUCL, V23, P1583, DOI 10.1081/NCN-200031402; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Fontes R, 2008, FEBS J, V275, P1500, DOI 10.1111/j.1742-4658.2008.06309.x; GANDELMAN O, 1994, J BIOLUM CHEMILUM, V9, P363, DOI 10.1002/bio.1170090603; Gill P, 2008, NUCLEOS NUCLEOT NUCL, V27, P224, DOI 10.1080/15257770701845204; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; HANNAH R, 2000, BIOLUMINESCENCE CHEM, P289; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Jalal H, 2006, J CLIN MICROBIOL, V44, P206, DOI 10.1128/JCM.44.1.206-213.2006; Jannes Geert, 2006, V345, P1; Karamohamed S, 1998, BIOTECHNIQUES, V24, P302, DOI 10.2144/98242rr02; Law GHE, 2006, BIOCHEM J, V397, P305, DOI 10.1042/BJ20051847; MIELZYNSKA I, 2004, USING MOL DIAGNOSTIC; MILLER B, 2009, IVD TECHNOLOGY, V15, P35; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; MOYER JD, 1983, ANAL BIOCHEM, V131, P187, DOI 10.1016/0003-2697(83)90152-5; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; NYREN P, 1987, ANAL BIOCHEM, V167, P235, DOI 10.1016/0003-2697(87)90158-8; NYREN P, 1985, ANAL BIOCHEM, V151, P504, DOI 10.1016/0003-2697(85)90211-8; Nyren P, 1997, ANAL BIOCHEM, V244, P367, DOI 10.1006/abio.1996.9913; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Steghens JP, 1998, BIOCHEM J, V336, P109, DOI 10.1042/bj3360109; TABARY T, 1992, J IMMUNOL METHODS, V156, P55, DOI 10.1016/0022-1759(92)90010-Q; Toye B, 1998, J CLIN MICROBIOL, V36, P2356, DOI 10.1128/JCM.36.8.2356-2358.1998; White PJ, 1996, BIOCHEM J, V319, P343, DOI 10.1042/bj3190343	33	58	72	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14155	10.1371/journal.pone.0014155	http://dx.doi.org/10.1371/journal.pone.0014155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152399	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000284755100033
J	Gong, C; Yao, HR; Liu, QA; Chen, JQ; Shi, JW; Su, FX; Song, EW				Gong, Chang; Yao, Herui; Liu, Qiang; Chen, Jingqi; Shi, Junwei; Su, Fengxi; Song, Erwei			Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; SIDE POPULATION; RESISTANCE; THERAPEUTICS; CULTURE; NOTCH	Purpose: Evidence is lacking whether the number of breast tumor-initiating cells (BT-ICs) directly correlates with the sensitivity of breast tumors to chemotherapy. Here, we evaluated the association between proportion of BT-ICs and chemoresistance of the tumors. Methods: Immunohistochemical staining(IHC) was used to examine the expression of aldehyde dehydrogenase 1 (ALDH1) and proliferating cell nuclear antigen, and TUNEL was used to detect the apoptosis index. The significance of various variables in patient survival was analyzed using a Cox proportional hazards model. The percentage of BT-ICs in breast cancer cell lines and primary breast tumors was determined by ALDH1 enzymatic assay, CD44(+)/CD24(-) phenotype and mammosphere formation assay. Results: ALDH1 expression determined by IHC in primary breast cancers was associated with poor clinical response to neoadjuvant chemotherapy and reduced survival in breast cancer patients. Breast tumors that contained higher proportion of BT-ICs with CD44(+)/CD24(-) phenotype, ALDH1 enzymatic activity and sphere forming capacity were more resistant to neoadjuvant chemotherapy. Chemoresistant cell lines AdrR/MCF-7 and SK-3rd, had increased number of cells with sphere forming capacity, CD44(+)/CD24(-) phenotype and side-population. Regardless the proportion of T-ICs, FACS-sorted CD44(+)/CD24(-) cells that derived from primary tumors or breast cancer lines were about 10-60 fold more resistant to chemotherapy relative to the non-CD44(+)/CD24(-) cells and their parental cells. Furthermore, our data demonstrated that MDR1 (multidrug resistance 1) and ABCG2 (ATP-binding cassette sub-family G member 2) were upregulated in CD44(+)/CD24(-) cells. Treatment with lapatinib or salinomycin reduced the proportion of BT-ICs by nearly 50 fold, and thus enhanced the sensitivity of breast cancer cells to chemotherapy by around 30 fold. Conclusions: These data suggest that the proportion of BT-ICs is associated with chemotherapeutic resistance of breast cancer. It highlights the importance of targeting T-ICs, rather than eliminating the bulk of rapidly dividing and terminally differentiated cells, in novel anti-cancer strategies.	[Gong, Chang; Yao, Herui; Liu, Qiang; Chen, Jingqi; Shi, Junwei; Su, Fengxi; Song, Erwei] Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Qiang] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Song, Erwei] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Harvard University; Dana-Farber Cancer Institute; Sun Yat Sen University	Gong, C (corresponding author), Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	songerwei02@yahoo.com.cn	Liu, Qiang/HHZ-3181-2022	Liu, Qiang/0000-0002-5451-4862	National Natural Science Foundation of China [30772550, 30801376, 30830110, 30831160515, 30921140312, 30973505]; Research Fund for the Doctoral Program of Higher Education (RFDP) [20070558248]; Sun Yat-Sen Excellent Medicine Youth Project [F002008010]; Ministry of Science and Technology of China [2010CB912800, 2009CB521706, 2005CB724605]; Science Foundation of Guangdong Province [8251008901000011, 2009B030801005]; foundation of Guangzhou Science and Technology Bureau [2009Y-C011-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Sun Yat-Sen Excellent Medicine Youth Project; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); foundation of Guangzhou Science and Technology Bureau	This work was supported by grants from the National Natural Science Foundation of China (30772550, 30801376, 30830110, 30831160515, 30921140312, 30973505), The Research Fund for the Doctoral Program of Higher Education (RFDP) (20070558248), Sun Yat-Sen Excellent Medicine Youth Project (F002008010), 973 (2010CB912800, 2009CB521706, 2005CB724605) Projects from Ministry of Science and Technology of China, Science Foundation of Guangdong Province (8251008901000011, 2009B030801005) and foundation of Guangzhou Science and Technology Bureau (2009Y-C011-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McClelland RA, 2001, ENDOCRINOLOGY, V142, P2776, DOI 10.1210/en.142.7.2776; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Senderowicz AM, 2003, CANCER CHEMOTH PHARM, V52, pS61, DOI 10.1007/s00280-003-0624-x; Shi W, 2006, J MAMMARY GLAND BIOL, V11, P41, DOI 10.1007/s10911-006-9011-7; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Xiao Z, 2005, ONCOGENE, V24, P1403, DOI 10.1038/sj.onc.1208309; Yin LQ, 2008, CANCER RES, V68, P800, DOI 10.1158/0008-5472.CAN-07-2545; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	28	51	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15630	10.1371/journal.pone.0015630	http://dx.doi.org/10.1371/journal.pone.0015630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187973	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200051
J	Ma, LS; Bradu, A; Podoleanu, AG; Bloor, JW				Ma, Lisha; Bradu, Adrian; Podoleanu, Adrian Gh.; Bloor, James W.			Arrhythmia Caused by a Drosophila Tropomyosin Mutation Is Revealed Using a Novel Optical Coherence Tomography Instrument	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; HEART DEVELOPMENT; MELANOGASTER HEART; POTASSIUM CHANNEL; TARGETED ABLATION; LARVAL HEART; GENES; FAILURE; DEVELOP; TINMAN	Background: Dilated cardiomyopathy (DCM) is a severe cardiac condition that causes high mortality. Many genes have been confirmed to be involved in this disease. An ideal system with which to uncover disease mechanisms would be one that can measure the changes in a wide range of cardiac activities associated with mutations in specific, diversely functional cardiac genes. Such a system needs a genetically manipulable model organism that allows in vivo measurement of cardiac phenotypes and a detecting instrument capable of recording multiple phenotype parameters. Methodology and Principal Findings: With a simple heart, a transparent body surface at larval stages and available genetic tools we chose Drosophila melanogaster as our model organism and developed for it a dual en-face/Doppler optical coherence tomography (OCT) instrument capable of recording multiple aspects of heart activity, including heart contraction cycle dynamics, ostia dynamics, heartbeat rate and rhythm, speed of heart wall movement and light reflectivity of cardiomyocytes in situ. We applied this OCT instrument to a model of Tropomyosin-associated DCM established in adult Drosophila. We show that DCM pre-exists in the larval stage and is accompanied by an arrhythmia previously unidentified in this model. We also detect reduced mobility and light reflectivity of cardiomyocytes in mutants. Conclusion: These results demonstrate the capability of our OCT instrument to characterize in detail cardiac activity in genetic models for heart disease in Drosophila.	[Ma, Lisha; Bloor, James W.] Univ Kent, Sch Biosci, Cell & Dev Biol Grp, Canterbury, Kent, England; [Bradu, Adrian; Podoleanu, Adrian Gh.] Univ Kent, Sch Phys Sci, Appl Opt Grp, Canterbury, Kent, England	University of Kent; University of Kent	Ma, LS (corresponding author), Bournemouth Univ, Sch Appl Sci, Talbot Campus, Poole BH12 5BB, Dorset, England.	lma@bournemouth.ac.uk	Podoleanu, Adrian/F-7094-2012; Bradu, Adrian/D-2312-2011	Podoleanu, Adrian/0000-0002-4899-9656; Bradu, Adrian/0000-0002-6890-1599	United Kingdom Biotechnology and Biological Sciences Research Council [BBSRC-BB/E002870/1]; European Research Council [249889]; BBSRC [BB/E002870/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E002870/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been supported by United Kingdom Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/science/initiatives/tdri.html) grant BBSRC-BB/E002870/1. Adrian Bradu and Adrian Podoleanu have also been supported by the European Research Council ( http://erc.europa.eu/) grant 249889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; BODMER R, 1993, DEVELOPMENT, V118, P719; Bradu A, 2009, J BIOPHOTONICS, V2, P380, DOI 10.1002/jbio.200910021; Choma MA, 2006, CIRCULATION, V114, pE35, DOI 10.1161/CIRCULATIONAHA.105.593541; Cooper AS, 2009, J VIS EXP, V32; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Dasari S, 2006, J COMP PHYSIOL B, V176, P349, DOI 10.1007/s00360-005-0058-3; Davis AM, 2008, J OPT SOC AM A, V25, P3134, DOI 10.1364/JOSAA.25.003134; Desai-Shah M., 2010, OPEN PHYSL J, V3, P16; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hedman A, 2004, J MOL CELL CARDIOL, V36, P607, DOI 10.1016/j.yjmcc.2004.01.012; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Izatt SD, 2005, P SOC PHOTO-OPT INS, V5701, P122, DOI 10.1117/12.596122; Jenkins MW, 2006, OPT EXPRESS, V14, P736, DOI 10.1364/OPEX.14.000736; Lalevee N, 2006, CURR BIOL, V16, P1502, DOI 10.1016/j.cub.2006.05.064; Liang XQ, 2009, CIRCULATION, V120, P568, DOI 10.1161/CIRCULATIONAHA.109.864686; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Monier B, 2005, DEVELOPMENT, V132, P5283, DOI 10.1242/dev.02091; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; PIRCHER M, 2007, P SOC PHOTO-OPT INS, pT4290; Podoleanu AG, 2005, BRIT J RADIOL, V78, P976, DOI 10.1259/bjr/55735832; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Rizki T.M., 1978, P397; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Slama L, 2005, J INSECT PHYSIOL, V51, P489, DOI 10.1016/j.jinsphys.2004.11.016; Vogler Georg, 2009, J Vis Exp, DOI 10.3791/1425; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Wu MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004045	36	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14348	10.1371/journal.pone.0014348	http://dx.doi.org/10.1371/journal.pone.0014348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179409	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000285572900001
J	Bagdure, D; Curtis, DJ; Dobyns, E; Glode, MP; Dominguez, SR				Bagdure, Dayanand; Curtis, Donna J.; Dobyns, Emily; Glode, Mary P.; Dominguez, Samuel R.			Hospitalized Children with 2009 Pandemic Influenza A (H1N1): Comparison to Seasonal Influenza and Risk Factors for Admission to the ICU	PLOS ONE			English	Article								Background: Limited data are available describing the clinical presentation and risk factors for admission to the intensive care unit for children with 2009 H1N1 infection. Methods: We conducted a retrospective chart review of all hospitalized children with 2009 influenza A (H1N1) and 2008-09 seasonal influenza at The Children's Hospital, Denver, Colorado. Results: Of the 307 children identified with 2009 H1N1 infections, the median age was 6 years, 61% were male, and 66% had underlying medical conditions. Eighty children (26%) were admitted to the ICU. Thirty-two (40%) of the ICU patients required intubation and 17 (53%) of the intubated patients developed acute respiratory distress syndrome (ARDS). Four patients required extracorporeal membrane oxygenation. Eight (3%) of the hospitalized children died. Admission to the ICU was significantly associated with older age and underlying neurological condition. Compared to the 90 children admitted during the 2008-09 season, children admitted with 2009 H1N1 influenza were significantly older, had a shorter length of hospitalization, more use of antivirals, and a higher incidence of ARDS. Conclusions: Compared to the 2008-09 season, hospitalized children with 2009 H1N1 influenza were much older and had more severe respiratory disease. Among children hospitalized with 2009 H1N1 influenza, risk factors for admission to the ICU included older age and having an underlying neurological condition. Children under the age of 2 hospitalized with 2009 H1N1 influenza were significantly less likely to require ICU care compared to older hospitalized children.	[Bagdure, Dayanand; Dobyns, Emily] Univ Colorado Sch Med, Childrens Hosp, Dept Pediat Crit Care, Aurora, CO USA; [Curtis, Donna J.; Glode, Mary P.; Dominguez, Samuel R.] Univ Colorado Sch Med, Childrens Hosp, Dept Pediat Infect Dis, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bagdure, D (corresponding author), Univ Colorado Sch Med, Childrens Hosp, Dept Pediat Crit Care, Aurora, CO USA.	samuel.dominguez@ucdenver.edu		CURTIS, DONNA/0000-0003-4657-4299	NIH/NCRR (National Center for Research Resources) Colorado CTSI (Clinical and Translational Science Institute) [1UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	NIH/NCRR (National Center for Research Resources) Colorado CTSI (Clinical and Translational Science Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by NIH/NCRR (National Center for Research Resources) Colorado CTSI (Clinical and Translational Science Institute) Grant Number 1UL1 RR025780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; COSTELLO BE, 2010, ANN EMERG MED; *ENV CDOHA, 2008, COL CHILD HLTH SURV; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Lister P, 2009, LANCET, V374, P605, DOI [10.1016/S0140-6736(09)61512-9, 10.1016/S0140-6736(09)61513-0]; Lockman JL, 2010, PEDIATR CRIT CARE ME, V11, P173, DOI 10.1097/PCC.0b013e3181ccedae; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Silva LFF, 2009, AM J RESP CRIT CARE, V179	12	58	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15173	10.1371/journal.pone.0015173	http://dx.doi.org/10.1371/journal.pone.0015173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179517	gold, Green Published, Green Submitted			2022-12-27	WOS:000285340000018
J	Muller, D; Jagla, T; Bodart, LM; Jahrling, N; Dodt, HU; Jagla, K; Frasch, M				Mueller, Dominik; Jagla, Teresa; Bodart, Ludivine Mihaila; Jaehrling, Nina; Dodt, Hans-Ulrich; Jagla, Krzysztof; Frasch, Manfred			Regulation and Functions of the lms Homeobox Gene during Development of Embryonic Lateral Transverse Muscles and Direct Flight Muscles in Drosophila	PLOS ONE			English	Article							CELL FATES; PATTERN DIVERSIFICATION; THORACIC MUSCLES; HOMEOTIC GENES; KEY ROLE; EXPRESSION; DIFFERENTIATION; SPECIFICATION; MYOGENESIS; LADYBIRD	Background: Patterning and differentiation of developing musculatures require elaborate networks of transcriptional regulation. In Drosophila, significant progress has been made into identifying the regulators of muscle development and defining their interactive networks. One major family of transcription factors involved in these processes consists of homeodomain proteins. In flies, several members of this family serve as muscle identity genes to specify the fates of individual muscles, or groups thereof, during embryonic and/or adult muscle development. Herein, we report on the expression and function of a new Drosophila homeobox gene during both embryonic and adult muscle development. Methodology/Principal Findings: The newly described homeobox gene, termed lateral muscles scarcer (lms), which has yet uncharacterized orthologs in other invertebrates and primitive chordates but not in vertebrates, is expressed exclusively in subsets of developing muscle tissues. In embryos, lms is expressed specifically in the four lateral transverse (LT) muscles and their founder cells in each hemisegment, whereas in larval wing imaginal discs, it is expressed in myoblasts that develop into direct flight muscles (DFMs), which are important for proper wing positioning. We have analyzed the regulatory inputs of various other muscle identity genes with overlapping or complementary expression patterns towards the cell type specific regulation of lms expression. Further we demonstrate that lms null mutants exhibit reduced numbers of embryonic LT muscles, and null mutant adults feature held-out-wing phenotypes. We provide a detailed description of the pattern and morphology of the direct flight muscles in the wild type and lms mutant flies by using the recently-developed ultramicroscopy and show that, in the mutants, all DFMs are present and present normal morphologies. Conclusions/Significance: We have identified the homeobox gene lms as a new muscle identity gene and show that it interacts with various previously-characterized muscle identity genes to regulate normal formation of embryonic lateral transverse muscles. In addition, the direct flight muscles in the adults require lms for reliably exerting their functions in controlling wing postures.	[Mueller, Dominik; Frasch, Manfred] Univ Erlangen Nurnberg, Dept Biol, Div Dev Biol, Erlangen, Germany; [Mueller, Dominik; Bodart, Ludivine Mihaila; Frasch, Manfred] Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY USA; [Jagla, Teresa; Jagla, Krzysztof] Clermont Univ, CNRS, UMR6247, INSERM,U931, Clermont Ferrand, France; [Jaehrling, Nina; Dodt, Hans-Ulrich] Vienna Univ Technol, Dept Bioelect, Inst Solid State Elect FKE, A-1040 Vienna, Austria; [Jaehrling, Nina; Dodt, Hans-Ulrich] Med Univ Vienna, Sect Bioelect, Ctr Brain Res, Vienna, Austria; [Jaehrling, Nina] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany	University of Erlangen Nuremberg; Icahn School of Medicine at Mount Sinai; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Technische Universitat Wien; Medical University of Vienna; Carl von Ossietzky Universitat Oldenburg	Muller, D (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Div Dev Biol, Erlangen, Germany.	mfrasch@biologie.uni-erlangen.de	Frasch, Manfred/H-7002-2013; Jagla, Krzysztof/E-4144-2016	Frasch, Manfred/0000-0003-1373-9798; Jagla, Krzysztof/0000-0003-4965-8818; Teresa, Jagla/0000-0002-9277-6089	National Institutes of Health [HD30832]; Hertie-Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hertie-Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Institutes of Health (HD30832) to MF (http://www.nichd.nih.gov), Hertie-Foundation to HUD (http://www.ghst.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Balagopalan L, 2001, DEV BIOL, V231, P374, DOI 10.1006/dbio.2001.0162; BATE M, 1991, DEVELOPMENT, V113, P79; BATE M, 1993, DEV DROSOPHILA MELAN, P1023; Becker K, 2008, J BIOPHOTONICS, V1, P36, DOI 10.1002/jbio.200710011; Beckett K, 2006, INT REV NEUROBIOL, V75, P55, DOI 10.1016/S0074-7742(06)75003-6; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Bernard F, 2006, DEV BIOL, V295, P164, DOI 10.1016/j.ydbio.2006.03.022; Bernard F, 2003, DEV BIOL, V260, P391, DOI 10.1016/S0012-1606(03)00255-0; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; BRAND AH, 1993, DEVELOPMENT, V118, P401; Capovilla M, 2001, DEVELOPMENT, V128, P1221; Crozatier M, 1999, DEVELOPMENT, V126, P1495; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; DOHRMANN C, 1990, GENE DEV, V4, P2098, DOI 10.1101/gad.4.12a.2098; Duan H, 2007, DEVELOPMENT, V134, P3985, DOI 10.1242/dev.008821; DUTTA D, 2005, DROSOPHILA MUSCLE DE; Enriquez J, 2010, DEVELOPMENT, V137, P457, DOI 10.1242/dev.045286; FERNANDES J, 1991, DEVELOPMENT, V113, P67; FERNANDES J, 1994, CURR BIOL, V4, P957, DOI 10.1016/S0960-9822(00)00219-0; Fujioka M, 2005, CIRC RES, V97, P1108, DOI 10.1161/01.RES.0000191546.08532.B2; Ghazi A, 2000, DEVELOPMENT, V127, P5309; Hartmann C, 1997, EMBO J, V16, P5299, DOI 10.1093/emboj/16.17.5299; HOOPER JE, 1986, EMBO J, V5, P2321, DOI 10.1002/j.1460-2075.1986.tb04500.x; Isshiki T, 1997, DEVELOPMENT, V124, P3099; Jahrling N, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/neuro.06.001.2010; Jagla K, 1997, DEVELOPMENT, V124, P3471; Jagla T, 1998, DEVELOPMENT, V125, P3699; Junion G, 2007, GENE DEV, V21, P3163, DOI 10.1101/gad.437307; Kehl BT, 1998, DEVELOPMENT, V125, P1217; KING DG, 1983, J EXP BIOL, V105, P231; Knirr S, 1999, DEVELOPMENT, V126, P4525; Kozopas KM, 2002, DEV BIOL, V243, P312, DOI 10.1006/dbio.2002.0572; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LAWRENCE PA, 1982, CELL, V29, P493, DOI 10.1016/0092-8674(82)90166-0; Liotta D, 2007, CURR BIOL, V17, P1409, DOI 10.1016/j.cub.2007.07.039; Maqbool T, 2007, J MUSCLE RES CELL M, V28, P397, DOI 10.1007/s10974-008-9133-1; Maqbool T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000122; MICHELSON AM, 1994, DEVELOPMENT, V120, P755; Miller A., 1950, BIOL DROSOPHILA, P420; MIYAN JA, 1985, PHILOS T ROY SOC B, V311, P271, DOI 10.1098/rstb.1985.0154; Muller D, 2005, GENETICS, V171, P1137, DOI 10.1534/genetics.105.044453; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Nose A, 1998, DEVELOPMENT, V125, P215; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Rivlin PK, 2001, DEV GENES EVOL, V211, P55, DOI 10.1007/s004270000126; Roy S, 1999, BIOESSAYS, V21, P486, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;486::AID-BIES5&gt;3.0.CO;2-M; Roy S, 1997, DEVELOPMENT, V124, P3333; Roy S, 1998, J CELL BIOL, V141, P1135, DOI 10.1083/jcb.141.5.1135; ROY S, 2005, DROSOPHILA MUSCLE DE; RuizGomez M, 1997, DEVELOPMENT, V124, P3407; Russell S, 2000, MOL GEN GENET, V263, P690, DOI 10.1007/s004380051218; Satou Y, 2008, DEV GENES EVOL, V218, P715, DOI 10.1007/s00427-008-0219-y; Smith ST, 1996, DEVELOPMENT, V122, P3141; Soler C, 2004, DEVELOPMENT, V131, P6041, DOI 10.1242/dev.01527; Sudarsan V, 2001, DEV CELL, V1, P829, DOI 10.1016/S1534-5807(01)00089-2; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Zhong YF, 2008, EVOL DEV, V10, P516, DOI 10.1111/j.1525-142X.2008.00266.x; Zikova M, 2003, P NATL ACAD SCI USA, V100, P12189, DOI 10.1073/pnas.2133156100	60	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14323	10.1371/journal.pone.0014323	http://dx.doi.org/10.1371/journal.pone.0014323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179520	Green Published, Green Submitted, gold			2022-12-27	WOS:000285340000003
J	Hertting, O; Holm, A; Luthje, P; Brauner, H; Dyrdak, R; Jonasson, AF; Wiklund, P; Chromek, M; Brauner, A				Hertting, Olof; Holm, Asa; Luthje, Petra; Brauner, Hanna; Dyrdak, Robert; Jonasson, Aino Fianu; Wiklund, Peter; Chromek, Milan; Brauner, Annelie			Vitamin D Induction of the Human Antimicrobial Peptide Cathelicidin in the Urinary Bladder	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; D DEFICIENCY; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; EPITHELIAL-CELLS; EXPRESSION; TUBERCULOSIS; POPULATION; RESPONSES; IMMUNITY; HEALTH	The urinary tract is frequently being exposed to potential pathogens and rapid defence mechanisms are therefore needed. Cathelicidin, a human antimicrobial peptide is expressed and secreted by bladder epithelial cells and protects the urinary tract from infection. Here we show that vitamin D can induce cathelicidin in the urinary bladder. We analyzed bladder tissue from postmenopausal women for expression of cathelicidin, before and after a three-month period of supplementation with 25-hydroxyvitamin D(3) (25D(3)). Cell culture experiments were performed to elucidate the mechanisms for cathelicidin induction. We observed that, vitamin D per se did not up-regulate cathelicidin in serum or in bladder tissue of the women in this study. However, when the bladder biopsies were infected with uropathogenic E. coli (UPEC), a significant increase in cathelicidin expression was observed after 25D(3) supplementation. This observation was confirmed in human bladder cell lines, even though here, cathelicidin induction occurred irrespectively of infection. Vitamin D treated bladder cells exerted an increased antibacterial effect against UPEC and colocalization to cathelicidin indicated the relevance of this peptide. In the light of the rapidly growing problem of resistance to common urinary tract antibiotics, we suggest that vitamin D may be a potential complement in the prevention of UTI.	[Hertting, Olof; Holm, Asa; Luthje, Petra; Dyrdak, Robert; Chromek, Milan; Brauner, Annelie] Karolinska Inst, Div Clin Microbiol, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hertting, Olof; Chromek, Milan] Karolinska Univ Hosp, Astrid Lindgrens Childrens Hosp, Stockholm, Sweden; [Jonasson, Aino Fianu] Karolinska Inst, Dept Clin Sci, Unit Obstet & Gynecol, Stockholm, Sweden; [Wiklund, Peter] Karolinska Inst, Dept Urol, Div Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Hertting, O (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Annelie.Brauner@ki.se	Chromek, Milan/AAD-9116-2022; Chromek, Milan/ABE-7455-2020; Dyrdak, Robert/AAI-2718-2020; Hertting, Olof/ABB-9574-2020	Chromek, Milan/0000-0002-8941-057X; Dyrdak, Robert/0000-0001-8456-4898; Hertting, Olof/0000-0002-0813-7998; Wiklund, Peter/0000-0001-6497-4697	Swedish Research Council [56X-20356]; ALF Project; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF Project; Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Swedish Research Council (no. 56X-20356), ALF Project Funding, and the Karolinska Institutet. O.H. has a Karolinska Institutet funded postgraduate position. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Bergman P, 2005, CELL MICROBIOL, V7, P1009, DOI 10.1111/j.1462-5822.2005.00530.x; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chromek M, 2008, J MOL MED, V86, P37, DOI 10.1007/s00109-007-0256-4; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Crescioli C, 2005, J CLIN ENDOCR METAB, V90, P962, DOI 10.1210/jc.2004-1496; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; EBELING PR, 1992, J CLIN ENDOCR METAB, V75, P176, DOI 10.1210/jc.75.1.176; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gombart AF, 2007, J STEROID BIOCHEM, V103, P552, DOI 10.1016/j.jsbmb.2006.12.095; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kimball SM, 2007, AM J CLIN NUTR, V86, P645, DOI 10.1093/ajcn/86.3.645; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Macdonald HM, 2010, BRIT J DERMATOL, V163, P434, DOI 10.1111/j.1365-2133.2010.09901.x; Mansson LE, 2007, CELL MICROBIOL, V9, P413, DOI 10.1111/j.1462-5822.2006.00799.x; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; McNally JD, 2009, PEDIATR PULM, V44, P981, DOI 10.1002/ppul.21089; Peric M, 2009, MOL IMMUNOL, V46, P3183, DOI 10.1016/j.molimm.2009.08.010; Roth DE, 2008, J INFECT DIS, V197, P676, DOI 10.1086/527488; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weber G, 2005, J INVEST DERMATOL, V124, P1080, DOI 10.1111/j.0022-202X.2005.23687.x; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Williams B, 2008, PEDIATR INFECT DIS J, V27, P941, DOI 10.1097/INF.0b013e31817525df; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR; Yates AA, 1998, J AM DIET ASSOC, V98, P699, DOI 10.1016/S0002-8223(98)00160-6; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888	36	95	107	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15580	10.1371/journal.pone.0015580	http://dx.doi.org/10.1371/journal.pone.0015580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179490	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500027
J	Mirza, A; Mustafa, M; Talevich, E; Kannan, N				Mirza, Amar; Mustafa, Morad; Talevich, Eric; Kannan, Natarajan			Co-Conserved Features Associated with cis Regulation of ErbB Tyrosine Kinases	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; DEPENDENT PROTEIN-KINASE; FACTOR-RECEPTOR; CRYSTAL-STRUCTURE; TERMINAL TAIL; EGF RECEPTOR; STRUCTURAL BASIS; SELF-PHOSPHORYLATION; CATALYTIC SUBUNIT; DOMAIN	Background: The epidermal growth factor receptor kinases, or ErbB kinases, belong to a large sub-group of receptor tyrosine kinases (RTKs), which share a conserved catalytic core. The catalytic core of ErbB kinases have functionally diverged from other RTKs in that they are activated by a unique allosteric mechanism that involves specific interactions between the kinase core and the flanking Juxtamembrane (JM) and COOH-terminal tail (C-terminal tail). Although extensive studies on ErbB and related tyrosine kinases have provided important insights into the structural basis for ErbB kinase functional divergence, the sequence features that contribute to the unique regulation of ErbB kinases have not been systematically explored. Methodology/Principal Findings: In this study, we use a Bayesian approach to identify the selective sequence constraints that most distinguish ErbB kinases from other receptor tyrosine kinases. We find that strong ErbB kinase-specific constraints are imposed on residues that tether the JM and C-terminal tail to key functional regions of the kinase core. A conserved RIxKExE motif in the JM-kinase linker region and a glutamine in the inter-lobe linker are identified as two of the most distinguishing features of the ErbB family. While the RIxKExE motif tethers the C-terminal tail to the N-lobe of the kinase domain, the glutamine tethers the C-terminal tail to hinge regions critical for inter-lobe movement. Comparison of the active and inactive crystal structures of ErbB kinases indicates that the identified residues are conformationally malleable and can potentially contribute to the cis regulation of the kinase core by the JM and C-terminal tail. ErbB3, and EGFR orthologs in sponges and parasitic worms, diverge from some of the canonical ErbB features, providing insights into subfamily and lineage-specific functional specialization. Conclusion/Significance: Our analysis pinpoints key residues for mutational analysis, and provides new clues to cancer mutations that alter the canonical modes of ErbB kinase regulation.	[Mirza, Amar; Mustafa, Morad; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Talevich, Eric; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Mirza, A (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	kannan@bmb.uga.edu		Talevich, Eric/0000-0002-8106-0720; Mustafa, Morad/0000-0001-9442-9665	American Cancer Society [RSG-10-188-01-TBE]; Georgia Cancer Coalition (GCC); University of Georgia	American Cancer Society(American Cancer Society); Georgia Cancer Coalition (GCC); University of Georgia	This study was supported by funds to NK from the American Cancer Society (RSG-10-188-01-TBE), Georgia Cancer Coalition (GCC) and University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; Chen YR, 2006, ONCOGENE, V25, P1205, DOI 10.1038/sj.onc.1209159; Cheng HC, 2010, CLIN EXP PHARMACOL P, V37, P93, DOI 10.1111/j.1440-1681.2009.05237.x; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Feinmesser RL, 1999, J BIOL CHEM, V274, P16168, DOI 10.1074/jbc.274.23.16168; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lamers MBAC, 1999, J MOL BIOL, V285, P713, DOI 10.1006/jmbi.1998.2369; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Landau M, 2008, BBA-REV CANCER, V1785, P12, DOI 10.1016/j.bbcan.2007.08.001; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Neuwald AF, 2003, GENOME RES, V13, P673, DOI 10.1101/gr.862303; Neuwald AF, 2007, TRENDS BIOCHEM SCI, V32, P487, DOI 10.1016/j.tibs.2007.08.009; Neuwald AF, 2009, BIOINFORMATICS, V25, P1869, DOI 10.1093/bioinformatics/btp342; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Papakyriakou A, 2009, PROTEINS, V76, P375, DOI 10.1002/prot.22353; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Romano RA, 2009, PROTEIN SCI, V18, P1486, DOI 10.1002/pro.146; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schaefer G, 1999, J BIOL CHEM, V274, P859, DOI 10.1074/jbc.274.2.859; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Walker F, 1998, GROWTH FACTORS, V16, P53, DOI 10.3109/08977199809017491; WALTON GM, 1990, J BIOL CHEM, V265, P1750; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Wu J, 2005, PROTEIN SCI, V14, P2871, DOI 10.1110/ps.051715205; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xia L, 2002, J BIOL CHEM, V277, P30716, DOI 10.1074/jbc.M202823200; Xu GZ, 2008, BIOORG MED CHEM LETT, V18, P4615, DOI 10.1016/j.bmcl.2008.07.020; Xu GZ, 2008, BIOORG MED CHEM LETT, V18, P3495, DOI 10.1016/j.bmcl.2008.05.024; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; Yang KS, 2010, J BIOL CHEM, V285, P24014, DOI 10.1074/jbc.M110.103317; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	67	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14310	10.1371/journal.pone.0014310	http://dx.doi.org/10.1371/journal.pone.0014310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179209	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900016
J	Blanco-Toribio, A; Muyldermans, S; Frankel, G; Fernandez, LA				Blanco-Toribio, Ana; Muyldermans, Serge; Frankel, Gad; Angel Fernandez, Luis			Direct Injection of Functional Single-Domain Antibodies from E. coli into Human Cells	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; III SECRETION SYSTEM; ATTENUATED SALMONELLA; CHAIN ANTIBODIES; MAMMALIAN-CELLS; GENOME SEQUENCE; PROTEINS; DELIVERY; THERAPY; CANCER	Intracellular proteins have a great potential as targets for therapeutic antibodies (Abs) but the plasma membrane prevents-access to these antigens. Ab fragments and IgGs are selected and engineered in E. coli and this microorganism may be also an ideal vector for their intracellular delivery. In this work we demonstrate that single-domain Ab (sdAbs) can be engineered to be injected into human cells by E. coli bacteria carrying molecular syringes assembled by a type III protein secretion system (T3SS). The injected sdAbs accumulate in the cytoplasm of HeLa cells at levels ca. 10(5) -10(6) molecules per cell and their functionality is shown by the isolation of sdAb-antigen complexes. Injection of sdAbs does not require bacterial invasion or the transfer of genetic material. These results are proof-of-principle for the capacity of E. coli bacteria to directly deliver intracellular sdAbs (intrabodies) into human cells for analytical and therapeutic purposes.	[Blanco-Toribio, Ana; Angel Fernandez, Luis] CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Madrid, Spain; [Muyldermans, Serge] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Muyldermans, Serge] Vrije Univ Brussel, Dept Mol & Cellular Interact, Brussels, Belgium; [Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Div Cell & Mol Biol, London, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Imperial College London	Blanco-Toribio, A (corresponding author), CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Campus Cantoblanco Univ Autonoma Madrid, Madrid, Spain.	lafdez@cnb.csic.es	Muyldermans, Serge/AAC-7374-2019; Muyldermans, Serge V/C-6418-2016; Fernández-Herrero, Luis Ángel/AAA-2583-2021; Fernández, Luis Ángel/D-2713-2009	Muyldermans, Serge/0000-0002-3678-3575; Muyldermans, Serge V/0000-0002-3678-3575; Fernández-Herrero, Luis Ángel/0000-0001-5920-0638; Fernández, Luis Ángel/0000-0001-5920-0638	Spanish Ministry of Science and Innovation (MICINN) [BIO2008-05201]; European Union [FP6-LSHB-CT-2005-512061]; Wellcome Trust; Royal Society-CSIC [2004GB0017]; Autonomous Community of Madrid [S-BIO-236-2006]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Wellcome Trust(Wellcome Trust); Royal Society-CSIC; Autonomous Community of Madrid	This work was supported by grants to LAF from the Spanish Ministry of Science and Innovation (MICINN) (BIO2008-05201). ABT is a holder of a PhD fellowship from the FPI Program of the Spanish MICINN (http://www.micinn.es/portal/site/MICINN/), Autonomous Community of Madrid (S-BIO-236-2006) (http://www.madrimasd.org/), and the VI Framework Program from the European Union (FP6-LSHB-CT-2005-512061 NoE "EuroPathogenomics") (http://www.noe-epg.uni-wuerzburg.de/). GF is supported by the Wellcome Trust (http://www.wellcome.ac.uk/). This work was partially supported by a Royal Society-CSIC joint grant to GF and LAF (2004GB0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; ANDERSSON P, 1991, INFECT IMMUN, V59, P2915, DOI 10.1128/IAI.59.9.2915-2921.1991; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Brinkley C, 2006, INFECT IMMUN, V74, P5408, DOI 10.1128/IAI.01840-05; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cheng CM, 2008, CANCER GENE THER, V15, P393, DOI 10.1038/cgt.2008.10; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Critchley R, 2004, GENE THER, V11, P1224, DOI 10.1038/sj.gt.3302281; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Daniell SJ, 2003, MOL MICROBIOL, V49, P301, DOI 10.1046/j.1365-2958.2003.03555.x; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1412, DOI 10.1172/JCI116717; Fernandez LA, 2004, CURR OPIN BIOTECH, V15, P364, DOI 10.1016/j.copbio.2004.06.004; Fontana J, 2007, CELL MICROBIOL, V9, P875, DOI 10.1111/j.1462-5822.2006.00837.x; FORBES NS, 2010, ENG PERFECT BACTERIA; Fraile S, 2004, MOL MICROBIOL, V53, P1109, DOI 10.1111/j.1365-2958.2004.04205.x; Friedlos F, 2008, CLIN CANCER RES, V14, P4259, DOI 10.1158/1078-0432.CCR-07-4800; Fu W, 2008, CANCER SCI, V99, P1172, DOI 10.1111/j.1349-7006.2008.00808.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Henker J, 2008, Z GASTROENTEROL, V46, P874, DOI 10.1055/s-2008-1027463; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Jurado P, 2002, J MOL BIOL, V320, P1, DOI 10.1016/S0022-2836(02)00405-9; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; KNUTTON S, 1987, INFECT IMMUN, V55, P69, DOI 10.1128/IAI.55.1.69-77.1987; Kontermann RE, 2004, METHODS, V34, P163, DOI 10.1016/j.ymeth.2004.04.002; Kruger C, 2002, NAT BIOTECHNOL, V20, P702, DOI 10.1038/nbt0702-702; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lewis GK, 2007, EXPERT REV VACCINES, V6, P431, DOI 10.1586/14760584.6.3.431; Lo A. S. -Y., 2008, V181, P343; Marches O, 2008, CELL MICROBIOL, V10, P1104, DOI 10.1111/j.1462-5822.2007.01112.x; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; McGonigal K, 2009, APPL BIOCHEM BIOTECH, V157, P226, DOI 10.1007/s12010-008-8266-4; Munera D, 2010, J BACTERIOL, V192, P3534, DOI 10.1128/JB.00046-10; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nishikawa H, 2006, J CLIN INVEST, V116, P1946, DOI 10.1172/JCI28045; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Russmann H, 2003, INFECT IMMUN, V71, P3463, DOI 10.1128/IAI.71.6.3463-3472.2003; Russmann H, 1998, SCIENCE, V281, P565, DOI 10.1126/science.281.5376.565; SCHEELE JS, 1995, P NATL ACAD SCI USA, V92, P1097, DOI 10.1073/pnas.92.4.1097; Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Singh R, 2006, EXPERT REV VACCINES, V5, P541, DOI 10.1586/14760584.5.4.541; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stein M, 1996, J BACTERIOL, V178, P6546, DOI 10.1128/jb.178.22.6546-6554.1996; Stritzker J, 2007, INT J MED MICROBIOL, V297, P151, DOI 10.1016/j.ijmm.2007.01.008; Stritzker J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-94; Sunden F, 2006, INT J ANTIMICROB AG, V28, pS26, DOI 10.1016/j.ijantimicag.2006.05.007; Sunden F, 2010, J UROLOGY, V184, P179, DOI 10.1016/j.juro.2010.03.024; Svingen PA, 2004, CLIN CANCER RES, V10, P6807, DOI 10.1158/1078-0432.CCR-0778-02; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Van den Abbeele A, 2010, CELL MOL LIFE SCI, V67, P1519, DOI 10.1007/s00018-010-0266-1; Vercruysse T, 2010, J BIOL CHEM, V285, P21768, DOI 10.1074/jbc.M110.112490; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Whale AD, 2007, MICROBIOL-SGM, V153, P1743, DOI 10.1099/mic.0.2006/004325-0; Wu Y, 2004, INFECT IMMUN, V72, P6764, DOI 10.1128/IAI.72.12.6764-6772.2004; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196; ZHU X, 2010, CANC SCI	77	40	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15227	10.1371/journal.pone.0015227	http://dx.doi.org/10.1371/journal.pone.0015227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170340	Green Published, Green Submitted, gold			2022-12-27	WOS:000285084100032
J	Flaounas, I; Turchi, M; Ali, O; Fyson, N; De Bie, T; Mosdell, N; Lewis, J; Cristianini, N				Flaounas, Ilias; Turchi, Marco; Ali, Omar; Fyson, Nick; De Bie, Tijl; Mosdell, Nick; Lewis, Justin; Cristianini, Nello			The Structure of the EU Mediasphere	PLOS ONE			English	Article							NETWORKS; NEWS	Background: A trend towards automation of scientific research has recently resulted in what has been termed "data-driven inquiry" in various disciplines, including physics and biology. The automation of many tasks has been identified as a possible future also for the humanities and the social sciences, particularly in those disciplines concerned with the analysis of text, due to the recent availability of millions of books and news articles in digital format. In the social sciences, the analysis of news media is done largely by hand and in a hypothesis-driven fashion: the scholar needs to formulate a very specific assumption about the patterns that might be in the data, and then set out to verify if they are present or not. Methodology/Principal Findings: In this study, we report what we think is the first large scale content-analysis of cross-linguistic text in the social sciences, by using various artificial intelligence techniques. We analyse 1.3 M news articles in 22 languages detecting a clear structure in the choice of stories covered by the various outlets. This is significantly affected by objective national, geographic, economic and cultural relations among outlets and countries, e. g., outlets from countries sharing strong economic ties are more likely to cover the same stories. We also show that the deviation from average content is significantly correlated with membership to the eurozone, as well as with the year of accession to the EU. Conclusions/Significance: While independently making a multitude of small editorial decisions, the leading media of the 27 EU countries, over a period of six months, shaped the contents of the EU mediasphere in a way that reflects its deep geographic, economic and cultural relations. Detecting these subtle signals in a statistically rigorous way would be out of the reach of traditional methods. This analysis demonstrates the power of the available methods for significant automation of media content analysis.	[Flaounas, Ilias; Ali, Omar; Fyson, Nick; De Bie, Tijl; Cristianini, Nello] Univ Bristol, Intelligent Syst Lab, Bristol, Avon, England; [Turchi, Marco] European Commiss, Joint Res Ctr, IPSC, Ispra, Italy; [Fyson, Nick] Univ Bristol, Bristol Ctr Complex Sci, Bristol, Avon, England; [Mosdell, Nick; Lewis, Justin] Cardiff Univ, Sch Journalism Media & Cultural Studies, Cardiff, S Glam, Wales	University of Bristol; European Commission Joint Research Centre; EC JRC ISPRA Site; University of Bristol; Cardiff University	Flaounas, I (corresponding author), Univ Bristol, Intelligent Syst Lab, Bristol, Avon, England.	nello.cristianini@bristol.ac.uk	De Bie, Tijl/B-2920-2013; Turchi, Marco/AFN-0053-2022	De Bie, Tijl/0000-0002-2692-7504; Turchi, Marco/0000-0002-5899-4496	Alexander S. Onassis Public Benefit Foundation; Engineering and Physical Sciences Research Council (EPSRC); Bristol Centre for Complexity Sciences; Royal Society; Engineering and Physical Sciences Research Council [EP/G056447/1] Funding Source: researchfish; EPSRC [EP/G056447/1] Funding Source: UKRI	Alexander S. Onassis Public Benefit Foundation; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Bristol Centre for Complexity Sciences; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors would like to thank Pascal2 Network of Excellence, which supported the group activities. I. F. is supported by Alexander S. Onassis Public Benefit Foundation; O.A. is supported by a Doctoral Training Account (DTA) grant by Engineering and Physical Sciences Research Council (EPSRC); N.F. is supported by the Bristol Centre for Complexity Sciences; N.C. is supported by a Royal Society Wolfson Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday S, 2010, J COMMUN, V60, P144, DOI 10.1111/j.1460-2466.2009.01472.x; [Anonymous], 2009, NAT METHODS, V6, P237, DOI 10.1038/nmeth0409-237; Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Brown P. F., 1993, Computational Linguistics, V19, P263; CARLSON WL, 1997, APPL STAT METHODS BU; Coyle K, 2006, J ACAD LIBR, V32, P641, DOI 10.1016/j.acalib.2006.08.002; Crane Gregory, 2006, D LIB MAGAZINE, V12; Gonzalez MC, 2007, NAT PHYS, V3, P224, DOI 10.1038/nphys581; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; KOEHN P, 2005, MACHINE TRANSLATION, V10, P79; Koehn P, 2003, P 2003 C N AM CHAPT, V1, P48, DOI DOI 10.3115/1073445.1073462; KOEHN P, 2007, ACL 07; Lewis J, 2001, CONSTRUCTING PUBLIC; Liu B., 2007, WEB DATA MINING; Lloyd L, 2005, LECT NOTES COMPUT SC, V3772, P161; Machill M, 2006, EUR J COMMUN, V21, P57, DOI 10.1177/0267323106060989; Mehler A, 2006, IEEE T VIS COMPUT GR, V12, P765, DOI 10.1109/TVCG.2006.179; Meyers O, 2009, J COMMUN, V59, P456, DOI 10.1111/j.1460-2466.2009.01424.x; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Potthast T, 2009, EMBO REP, V10, pS42, DOI 10.1038/embor.2009.130; Rade D., 2001, PRIRUCNIK VJEZBE KEM, V1st ed., P1; Savoy J, 2009, COMMUN ACM, V52, P139, DOI 10.1145/1562764.1562799; STEINBERGER R, 2009, INF ACC MULT WORLD P, P1; Steinberger R., 2006, P 5 INT C LANG RES E, P24; [No title captured]	27	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14243	10.1371/journal.pone.0014243	http://dx.doi.org/10.1371/journal.pone.0014243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691MJ	21170383	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000285084100001
J	Achoui, M; Appleton, D; Abdulla, MA; Awang, K; Mohd, MA; Mustafa, MR				Achoui, Mouna; Appleton, David; Abdulla, Mahmood Ameen; Awang, Khalijah; Mohd, Mustafa Ali; Mustafa, Mohd Rais			In Vitro and In Vivo Anti-Inflammatory Activity of 17-O-Acetylacuminolide through the Inhibition of Cytokines, NF-kappa B Translocation and IKK beta Activity	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; COLONY-STIMULATING ACTIVITY; RAW 264.7 MACROPHAGES; BEAD ARRAY ASSAYS; NITRIC-OXIDE; NATURAL-PRODUCTS; FACTOR-ALPHA; INFLAMMATORY RESPONSE; SIGNAL-TRANSDUCTION; GENE-EXPRESSION	Background and Purpose: 17-O-acetylacuminolide (AA), a diterpenoid labdane, was isolated for the first time from the plant species Neouvaria foetida. The anti-inflammatory effects of this compound were studied both in vitro and in vivo. Experimental Approach: Plant extracts were initially tested against LPS-stimulated release of tumor necrosis factor alpha (TNF-alpha) from murine macrophages (RAW264.7 cells). Based on bioassay-guided fractionation, the active compound was identified as AA. AA was tested for its ability to reduce nitric oxide (NO) production, and the inducible nitric oxide synthase (iNOS) expression. The inhibition of a panel of inflammatory cytokines (TNF, IL-1 beta, IL-6, KC, and GM-CSF) by AA was assessed at the expression and the mRNA levels. Moreover, the effect of AA on the translocation of the transcription factor nuclear factor kappa B (NF-kappa B) was evaluated in LPS-stimulated RAW264.7 cells and in TNF-stimulated L929 cells. Subsequently, AA was tested in the inhibitor of NF-kappa B kinase beta (IKK beta) activity assay. Lastly, the anti-inflammatory activity of AA in vivo was evaluated by testing TNF production in LPS-stimulated Balb/c mice. Key Results: AA effectively inhibited TNF-alpha release with an IC(50) of 2.7 mu g/mL. Moreover, AA significantly inhibited both NO production and iNOS expression. It significantly and dose-dependently inhibited TNF and IL-1 beta proteins and mRNA expression; as well as IL-6 and KC proteins. Additionally, AA prevented the translocation of NF-kappa B in both cell lines; suggesting that it is acting at a post receptor level. This was confirmed by AA's ability to inhibit IKKb activity, a kinase responsible for activating NF-kappa B, hence providing an insight on AA's mechanism of action. Finally, AA significantly reduced TNF production in vivo. Conclusions and Implications: This study presents the potential utilization of this compound, as a lead for the development of an anti-inflammatory drug.	[Achoui, Mouna; Appleton, David; Mohd, Mustafa Ali; Mustafa, Mohd Rais] Univ Malaya, Dept Pharmacol, Kuala Lumpur, Malaysia; [Abdulla, Mahmood Ameen] Univ Malaya, Dept Mol Med, Kuala Lumpur, Malaysia; [Awang, Khalijah] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Achoui, M (corresponding author), Univ Malaya, Dept Pharmacol, Kuala Lumpur, Malaysia.	rais@um.edu.my	Mustafa, Mohamed R/B-1647-2009; AWANG, KHALIJAH/B-8781-2010; Mohd, Mustafa b Ali/B-9184-2010	Mustafa, Mohamed R/0000-0002-7864-5189; AWANG, KHALIJAH/0000-0001-5971-6570; Mohd, Mustafa b Ali/0000-0002-4220-5384	IPPP [PS094/2009A]; Research University, University of Malaya [RG010/09BIO]	IPPP; Research University, University of Malaya(Universiti Malaya)	This work was supported in part by IPPP grant number (PS094/2009A), and Research University grant number (RG010/09BIO), University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aggarwal Bharat B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P327, DOI 10.2174/1568010023344571; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BERGMANN S, 1994, J IMMUNOL, V153, P1736; Cheon MS, 2009, J ETHNOPHARMACOL, V122, P473, DOI 10.1016/j.jep.2009.01.034; Cho JY, 1998, PLANTA MED, V64, P594, DOI 10.1055/s-2006-957528; Davis JN, 1999, NUTR CANCER, V35, P167, DOI 10.1207/S15327914NC352_11; de las Heras B, 2003, CURR TOP MED CHEM, V3, P171; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Dinkova-Kostova AT, 2007, MED CHEM, V3, P261, DOI 10.2174/157340607780620680; Dirsch VM, 1998, PLANTA MED, V64, P423, DOI 10.1055/s-2006-957473; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Flagella M, 2006, ANAL BIOCHEM, V352, P50, DOI 10.1016/j.ab.2006.02.013; Folmer F, 2008, BIOCHEM PHARMACOL, V75, P603, DOI 10.1016/j.bcp.2007.07.044; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Fukuzawa M, 1997, IMMUNOPHARMACOLOGY, V36, P49, DOI 10.1016/S0162-3109(96)00160-9; GODAMBE SA, 1993, CYTOKINE, V5, P327, DOI 10.1016/1043-4666(93)90064-C; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Hol J, 2010, J LEUKOCYTE BIOL, V87, P501, DOI 10.1189/jlb.0809532; Hume D A, 2001, BMC Immunol, V2, P11, DOI 10.1186/1471-2172-2-11; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; James CD, 2009, BIOMED MICRODEVICES, V11, P693, DOI 10.1007/s10544-008-9281-5; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; LEE IS, 1995, TETRAHEDRON, V51, P21; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murakami A, 2005, BIOCHEM PHARMACOL, V70, P1330, DOI 10.1016/j.bcp.2005.07.032; Nardini E, 2005, J CELL PHYSIOL, V204, P889, DOI 10.1002/jcp.20360; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; OHMORI Y, 1995, J IMMUNOL, V155, P3593; Palozza P, 2003, NUTR CANCER, V47, P76, DOI 10.1207/s15327914nc4701_10; RALPH P, 1977, J EXP MED, V146, P611, DOI 10.1084/jem.146.2.611; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Schett G, 2006, WIEN MED WOCHENSCHR, V156, P34, DOI 10.1007/s10354-005-0244-7; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; SETHI G, 2003, TRENDS PHARMACOL SCI, V30, P313; Syahida A, 2006, PHARM BIOL, V44, P50, DOI 10.1080/13880200500530765; VANARSDALE TL, 1994, J IMMUNOL, V153, P3043; WARREN MK, 1986, J IMMUNOL, V137, P2281; Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010; XIE QW, 1994, J LEUKOCYTE BIOL, V56, P576, DOI 10.1002/jlb.56.5.576	48	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15105	10.1371/journal.pone.0015105	http://dx.doi.org/10.1371/journal.pone.0015105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152019	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000284821300017
J	Gvritishvili, AG; Leung, KW; Tombran-Tink, J				Gvritishvili, Anzor G.; Leung, Kar Wah; Tombran-Tink, Joyce			Codon Preference Optimization Increases Heterologous PEDF Expression	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; HIGH-LEVEL EXPRESSION; ORTHOTOPIC OSTEOSARCOMA GROWTH; ESCHERICHIA-COLI; TRANSFER-RNA; ANTITUMOR-ACTIVITY; IN-VIVO; GENE; PROTEINS; PURIFICATION	Pigment epithelium-derived factor (PEDF) is widely known for its neurotrophic and antiangiogenic functions. Efficacy studies of PEDF in animal models are limited because of poor heterologous protein yields. Here, we redesigned the human PEDF gene to preferentially match codon frequencies of E coli without altering the amino acid sequence. Following de novo synthesis, codon optimized PEDF (coPEDF) and the wtPEDF genes were cloned into pET32a containing a 5' thioredoxin sequence (Trx) and the recombinant Trx-coPEDF or Trx-wtPEDF fusion constructs expressed in native and two tRNA augmented E coli hosts - BL21-CodonPlus(DE3)-RIL and BL21-CodonPlus(DE3)-RP, carrying extra copies of tRNA(arg,ile,leu) and tRNA(arg,pro) genes, respectively. Trx-PEDF fusion proteins were isolated using Ni-NTA metal affinity chromatography and PEDF purified after cleavage with factor X alpha. Protein purity and identity were confirmed by western blot, MALDI-TOF, and UV/CD spectral analyses. Expression of the synthetic gene was similar to 3.4 fold greater (212.7 mg/g; 62.1 mg/g wet cells) and purified yields similar to 4 fold greater (41.1 mg/g; 11.3 mg/g wet cell) than wtPEDF in the native host. A small increase in expression of both genes was observed in hosts supplemented with rare tRNA genes compared to the native host but expression of coPEDF was similar to 3 fold greater than wtPEDF in both native and codon-bias-adjusted E coli strains. Delta Gs at -3 to +50 of the Trx site of both fusion genes were -3.9 kcal/mol. Functionally, coPEDF was equally as effective as wtPEDF in reducing oxidative stress, promoting neurite outgrowth, and blocking endothelial tube formation. These findings suggest that while rare tRNA augmentation and mRNA folding energies can significantly contribute to increased protein expression, preferred codon usage, in this case, is advantageous to translational efficiency of biologically active PEDF in E coli. This strategy will undoubtedly fast forward studies to validate therapeutic utility of PEDF in vivo.	[Gvritishvili, Anzor G.; Leung, Kar Wah; Tombran-Tink, Joyce] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Tombran-Tink, Joyce] Penn State Univ, Coll Med, Dept Ophthalmol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gvritishvili, AG (corresponding author), Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA.	jttink@aol.com	Leung, Kar Wah/I-3844-2012		Ben Franklin award; David Woods Kemper Foundation; Juvenile Diabetes Research Foundation	Ben Franklin award; David Woods Kemper Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This study was supported by the Ben Franklin award, the David Woods Kemper Foundation, and the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; BAZZI MD, 1985, BIOPHYS J, V48, P957, DOI 10.1016/S0006-3495(85)83859-5; BECERRA SP, 1993, J BIOL CHEM, V268, P23148; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Bilak MM, 2002, J NEUROSCI, V22, P9378; BONEKAMP F, 1985, NUCLEIC ACIDS RES, V13, P4113, DOI 10.1093/nar/13.11.4113; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Cai J, 2006, CLIN CANCER RES, V12, P3510, DOI 10.1158/1078-0432.CCR-06-0094; Cai Y., 2010, J BIOINFORMATICS SEQ, V2, P25; Carstens Carsten-Peter, 2003, Methods Mol Biol, V205, P225; Chang SI, 2007, CANCER EPIDEM BIOMAR, V16, P228, DOI 10.1158/1055-9965.EPI-06-0567; Cinquin O, 2001, MOL BIOCHEM PARASIT, V117, P245, DOI 10.1016/S0166-6851(01)00354-1; Crawford SE, 2001, J CELL SCI, V114, P4421; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Deana A, 1998, NUCLEIC ACIDS RES, V26, P4778, DOI 10.1093/nar/26.20.4778; Deng TL, 1997, FEBS LETT, V409, P269, DOI 10.1016/S0014-5793(97)00522-X; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Duh EJ, 2002, INVEST OPHTH VIS SCI, V43, P821; Ek ETH, 2007, CANCER GENE THER, V14, P616, DOI 10.1038/sj.cgt.7701044; Ek ETH, 2007, J ORTHOP RES, V25, P1671, DOI 10.1002/jor.20434; Ek ETH, 2007, CLIN EXP METASTAS, V24, P93, DOI 10.1007/s10585-007-9062-1; Ek ETH, 2006, MOL CANCER THER, V5, P1641, DOI 10.1158/1535-7163.MCT-06-0107; Feng L, 2000, BIOCHEMISTRY-US, V39, P15399, DOI 10.1021/bi001076a; Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467; Garcia-Contreras R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002394; Gluck JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010081; GOLIATH R, 1995, AM J HUM GENET, V57, P962; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Guo Y, 2009, PROTEIN EXPRES PURIF, V65, P230, DOI 10.1016/j.pep.2008.12.013; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Halin S, 2004, CANCER RES, V64, P5664, DOI 10.1158/0008-5472.CAN-04-0835; Hu XY, 1996, PROTEIN EXPRES PURIF, V7, P289, DOI 10.1006/prep.1996.0041; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; KINK JA, 1991, J PROTOZOOL, V38, P441, DOI 10.1111/j.1550-7408.1991.tb04814.x; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; LI JN, 1995, J BACTERIOL, V177, P6593, DOI 10.1128/jb.177.22.6593-6600.1995; Mahtabifard A, 2003, J THORAC CARDIOV SUR, V126, P28, DOI 10.1016/S0022-5223(02)73616-7; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; NAMBIAR KP, 1984, SCIENCE, V223, P1299, DOI 10.1126/science.6322300; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Ogata N, 2005, AM J OPHTHALMOL, V140, P937, DOI 10.1016/j.ajo.2005.05.037; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Rosano GL, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-41; Sanchez-Sanchez F, 2008, J BIOTECHNOL, V134, P193, DOI 10.1016/j.jbiotec.2008.01.005; SANDHU KS, 2008, SILICO BIOL, V8; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; Smith DWE, 1996, BIOTECHNOL PROGR, V12, P417, DOI 10.1021/bp950056a; Spranger J, 2001, DIABETES, V50, P2641, DOI 10.2337/diabetes.50.12.2641; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; TINK JT, 2003, TRENDS MOL MED, V9, P244; TINK JT, 2003, NAT REV NEUROSCI, V4, P628; Tombran-Tink J, 1996, Mol Vis, V2, P11; TOMBRANTINK J, 1994, GENOMICS, V19, P266, DOI 10.1006/geno.1994.1057; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Volpert Katja N, 2009, J Ocul Biol Dis Infor, V2, P1, DOI 10.1007/s12177-009-9014-x; WAHAB SZ, 1993, MOL MICROBIOL, V7, P253, DOI 10.1111/j.1365-2958.1993.tb01116.x; Wang QS, 2006, PREP BIOCHEM BIOTECH, V36, P127, DOI 10.1080/10826060500533927; Widmann M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-207; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Zhang T, 2005, BIOTECHNOL LETT, V27, P403, DOI 10.1007/s10529-005-1549-8; Zhou ZY, 2004, PROTEIN EXPRES PURIF, V34, P87, DOI 10.1016/j.pep.2003.11.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	41	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15056	10.1371/journal.pone.0015056	http://dx.doi.org/10.1371/journal.pone.0015056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152082	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100056
J	Masataka, N; Hayakawa, S; Kawai, N				Masataka, Nobuo; Hayakawa, Sachiko; Kawai, Nobuyuki			Human Young Children as well as Adults Demonstrate 'Superior' Rapid Snake Detection When Typical Striking Posture Is Displayed by the Snake	PLOS ONE			English	Article							RELEVANT STIMULI; FEAR; ATTENTION; PHOBIAS; COLOR	Humans as well as some nonhuman primates have an evolved predisposition to associate snakes with fear by detecting their presence as fear-relevant stimuli more rapidly than fear-irrelevant ones. In the present experiment, a total of 74 of 3- to 4-year-old children and adults were asked to find a single target black-and-white photo of a snake among an array of eight black-and-white photos of flowers as distracters. As target stimuli, we prepared two groups of snake photos, one in which a typical striking posture was displayed by a snake and the other in which a resting snake was shown. When reaction time to find the snake photo was compared between these two types of the stimuli, its mean value was found to be significantly smaller for the photos of snakes displaying striking posture than for the photos of resting snakes in both the adults and children. These findings suggest the possibility that the human perceptual bias for snakes per se could be differentiated according to the difference of the degree to which their presence acts as a fear-relevant stimulus.	[Masataka, Nobuo; Hayakawa, Sachiko] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Kawai, Nobuyuki] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan	Kyoto University; Nagoya University	Masataka, N (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	masataka@pri.kyoto-u.ac.jp	Kawai, Nobuyuki/M-4902-2014	Kawai, Nobuyuki/0000-0003-0372-1703	Wellcome Trust [053335]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Programme Grant 053335. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SJ, 1984, ANIM BEHAV, V32, P1108, DOI 10.1016/S0003-3472(84)80227-4; BURGHARDT GM, 1983, Z TIERPSYCHOL, V62, P329; Coss RG, 2003, EVOLUTIONARY AESTHETICS, P69; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; Greene H.W., 1988, Biology of Reptilia, V16, P1; Isbell L. A., 2009, FRUIT TREE SERPENT W; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; LoBue V, 2010, DEVELOPMENTAL SCI, V13, P221, DOI 10.1111/j.1467-7687.2009.00872.x; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Masataka N., 2003, ONSET LANGUAGE; Masataka N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004768; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; OShea M., 2005, VENOMOUS SNAKES WORL; SELIGMAN ME, 1971, BEHAV THER, V2, P307, DOI 10.1016/S0005-7894(71)80064-3; Shibasaki M, 2009, J COMP PSYCHOL, V123, P131, DOI 10.1037/a0015095; Tanaka J, 2001, TRENDS COGN SCI, V5, P211, DOI 10.1016/S1364-6613(00)01626-0; Xu YD, 2002, J EXP PSYCHOL HUMAN, V28, P458, DOI 10.1037//0096-1523.28.2.458; Zebrowitz L.A., 1990, SOCIAL PERCEPTION	20	49	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15122	10.1371/journal.pone.0015122	http://dx.doi.org/10.1371/journal.pone.0015122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	687DK	21152050	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100081
J	Petravic, J; Davenport, MP				Petravic, Janka; Davenport, Miles P.			Vaccination-Induced Noncytolytic Effects in the Acute Phase of SHIV Infection	PLOS ONE			English	Article							T-CELL DEPLETION; VIRAL LOAD; VIRUS; VIREMIA; HIV-1; LYMPHOCYTES; DYNAMICS	Many studies have shown that vaccines inducing CD8+ T cell responses can reduce viral loads and preserve CD4+ T cell numbers in monkey models of HIV infection. The mechanism of viral control by the vaccine-induced CD8+ T cells is usually assumed to be cytolysis of infected cells. However, in addition to cytolysis of infected cells, CD8+ T cells secrete a range of soluble factors that suppress viral replication. We have studied the dynamics of virus and CD4+ T cells in a successful vaccination-challenge model of SHIV infection. We find that better viral control in the acute phase of infection is associated with slower decay of peak viral load. Comparing viral and CD4+ T cell dynamics in acute infection, we find that a cytolytic mode of viral control with direct killing of infected cells is inconsistent with the observed trends. On the other hand, comparison of the predicted effects of noncytolytic CD8+ effector function with the experimental data shows that noncytolytic control provides a better explanation of the experimental results. Our analysis suggests that vaccine-induced CD8+ T cells control SHIV infection by non-cytolytic means.	[Petravic, Janka; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Sydney, NSW, Australia	University of New South Wales Sydney	Petravic, J (corresponding author), Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Sydney, NSW, Australia.	m.davenport@unsw.edu.au	Petravic, Janka/AAD-9192-2020	Petravic, Janka/0000-0002-2263-2776; Davenport, Miles/0000-0002-4751-1831	National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work is funded by the National Health and Medical Research Council and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurali M, 2010, J IMMUNOL, V185, P5093, DOI 10.4049/jimmunol.1002204; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Castelli JC, 2002, BLOOD, V99, P4225, DOI 10.1182/blood-2001-11-0078; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Davenport MP, 2006, JAIDS-J ACQ IMM DEF, V41, P259, DOI 10.1097/01.qai.0000199232.31340.d3; Dioszeghy V, 2006, J VIROL, V80, P236, DOI 10.1128/JVI.80.1.236-245.2006; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; Geiben-Lynn R, 2001, J VIROL, V75, P8306, DOI 10.1128/JVI.75.17.8306-8316.2001; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lay MDH, 2009, J VIROL, V83, P7517, DOI 10.1128/JVI.00552-09; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P847, DOI 10.1098/rspb.2000.1572; Nowak MA., 2000, VIRUS DYNAMICS MATH; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Petravic J, 2008, J VIROL, V82, P11589, DOI 10.1128/JVI.01596-08; Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Tomaras GD, 2000, P NATL ACAD SCI USA, V97, P3503, DOI 10.1073/pnas.070521097; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15083	10.1371/journal.pone.0015083	http://dx.doi.org/10.1371/journal.pone.0015083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152101	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100065
J	Whitehead, NP; Yeung, EW; Froehner, SC; Allen, DG				Whitehead, Nicholas P.; Yeung, Ella W.; Froehner, Stanley C.; Allen, David G.			Skeletal Muscle NADPH Oxidase Is Increased and Triggers Stretch-Induced Damage in the mdx Mouse	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; NAD(P)H OXIDASE; KAPPA-B; MICE; CELLS; PATHOPHYSIOLOGY; CAVEOLIN-3; EXPRESSION; SYSTEM	Recent studies have shown that oxidative stress contributes to the pathogenesis of muscle damage in dystrophic (mdx) mice. In this study we have investigated the role of NADPH oxidase as a source of the oxidative stress in these mice. The NADPH oxidase subunits gp91(phox), p67(phox) and rac 1 were increased 2-3 fold in tibilais anterior muscles from mdx mice compared to wild type. Importantly, this increase occurred in 19 day old mice, before the onset of muscle necrosis and inflammation, suggesting that NADPH oxidase is an important source of oxidative stress in mdx muscle. In muscles from 9 week old mdx mice, gp91(phox) and p67(phox) were increased 3-4 fold and NADPH oxidase superoxide production was 2 times greater than wild type. In single fibers from mdx muscle NADPH oxidase subunits were all located on or near the sarcolemma, except for p67(phox), which was expressed in the cytosol. Pharmacological inhibition of NADPH oxidase significantly reduced the intracellular Ca(2+) rise following stretched contractions in mdx single fibers, and also attenuated the loss of muscle force. These results suggest that NADPH oxidase is a major source of reactive oxygen species in dystrophic muscle and its enhanced activity has a stimulatory effect on stretch-induced Ca(2+) entry, a key mechanism for muscle damage and functional impairment.	[Whitehead, Nicholas P.; Allen, David G.] Univ Sydney, Discipline Physiol, Bosch Inst, Sydney, NSW 2006, Australia; [Whitehead, Nicholas P.; Froehner, Stanley C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Yeung, Ella W.] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China	University of Sydney; University of Washington; University of Washington Seattle; Hong Kong Polytechnic University	Whitehead, NP (corresponding author), Univ Sydney, Discipline Physiol, Bosch Inst, Sydney, NSW 2006, Australia.	npwhite@u.washington.edu	Yeung, Ella/D-6672-2011	Allen, David/0000-0001-8605-1586; Yeung, Ella/0000-0002-6396-1146	National Health and Medical Research Council, Australia; National Institutes of Health (NIH); Parent Project Muscular Dystrophy (PPMD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033145] Funding Source: NIH RePORTER	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parent Project Muscular Dystrophy (PPMD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the National Health and Medical Research Council, Australia, and National Institutes of Health (NIH). NPW is the recipient of a Fellowship from Parent Project Muscular Dystrophy (PPMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Disatnik MH, 1998, J NEUROL SCI, V161, P77, DOI 10.1016/S0022-510X(98)00258-5; Dorchies OM, 2006, AM J PHYSIOL-CELL PH, V290, pC616, DOI 10.1152/ajpcell.00425.2005; Dudley RWR, 2006, AM J PHYSIOL-REG I, V291, pR704, DOI 10.1152/ajpregu.00031.2006; Evans NP, 2009, AM J PHYS MED REHAB, V88, P502, DOI 10.1097/PHM.0b013e3181a5a24f; Gauss KA, 2007, J LEUKOCYTE BIOL, V82, P729, DOI 10.1189/jlb.1206735; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Han WX, 2008, HYPERTENSION, V51, P481, DOI 10.1161/HYPERTENSIONAHA.107.103275; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Hnia K, 2007, AM J PATHOL, V170, P633, DOI 10.2353/ajpath.2007.060344; Huang J, 1995, BIOCHEMISTRY-US, V34, P16753, DOI 10.1021/bi00051a024; Javesghani D, 2002, AM J RESP CRIT CARE, V165, P412, DOI 10.1164/ajrccm.165.3.2103028; Jung C, 2008, CARDIOVASC RES, V77, P766, DOI 10.1093/cvr/cvm089; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Menazza S, 2010, HUM MOL GENET, V19, P4207, DOI 10.1093/hmg/ddq339; Messina S, 2006, AM J PATHOL, V168, P918, DOI 10.2353/ajpath.2006.050673; Mofarrahi M, 2008, ANTIOXID REDOX SIGN, V10, P559, DOI 10.1089/ars.2007.1792; Nguyen HX, 2003, J PHYSIOL-LONDON, V553, P833, DOI 10.1113/jphysiol.2003.051912; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PimoradyEsfahani A, 1997, MUSCLE NERVE, V20, P158, DOI 10.1002/(SICI)1097-4598(199702)20:2<158::AID-MUS4>3.0.CO;2-B; Rando TA, 2002, AM J PHYS MED REHAB, V81, pS175, DOI 10.1097/00002060-200211001-00018; Ravenscroft G, 2007, CELL MOTIL CYTOSKEL, V64, P727, DOI 10.1002/cm.20223; Shkryl VM, 2009, PFLUG ARCH EUR J PHY, V458, P915, DOI 10.1007/s00424-009-0670-2; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, pA5; Tseng BS, 2002, J APPL PHYSIOL, V93, P537, DOI 10.1152/japplphysiol.00202.2002; Vaghy PL, 1998, FEBS LETT, V431, P125, DOI 10.1016/S0014-5793(98)00738-8; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Venema VJ, 1997, J BIOL CHEM, V272, P28187, DOI 10.1074/jbc.272.45.28187; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Whitehead N, 2006, NEUROMUSCULAR DISORD, V16, pS159; Whitehead NP, 2008, J PHYSIOL-LONDON, V586, P2003, DOI 10.1113/jphysiol.2007.148338; Williams IA, 2007, AM J PHYSIOL-HEART C, V293, pH1969, DOI 10.1152/ajpheart.00489.2007; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Zanou N, 2009, FEBS LETT, V583, P3600, DOI 10.1016/j.febslet.2009.10.033	39	128	131	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15354	10.1371/journal.pone.0015354	http://dx.doi.org/10.1371/journal.pone.0015354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187957	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200039
J	Chadwick, W; Zhou, Y; Park, SS; Wang, LY; Mitchell, N; Stone, MD; Becker, KG; Martin, B; Maudsley, S				Chadwick, Wayne; Zhou, Yu; Park, Sung-Soo; Wang, Liyun; Mitchell, Nicholas; Stone, Matthew D.; Becker, Kevin G.; Martin, Bronwen; Maudsley, Stuart			Minimal Peroxide Exposure of Neuronal Cells Induces Multifaceted Adaptive Responses	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CHROMATIN PROTEIN HMGB2; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; PREMATURE SENESCENCE; NEUROTROPHIC FACTOR; PROTHYMOSIN-ALPHA; MESSENGER-RNA; LIFE-SPAN; MITOCHONDRIAL RESPIRATION	Oxidative exposure of cells occurs naturally and may be associated with cellular damage and dysfunction. Protracted low level oxidative exposure can induce accumulated cell disruption, affecting multiple cellular functions. Accumulated oxidative exposure has also been proposed as one of the potential hallmarks of the physiological/pathophysiological aging process. We investigated the multifactorial effects of long-term minimal peroxide exposure upon SH-SY5Y neural cells to understand how they respond to the continued presence of oxidative stressors. We show that minimal protracted oxidative stresses induce complex molecular and physiological alterations in cell functionality. Upon chronic exposure to minimal doses of hydrogen peroxide, SH-SY5Y cells displayed a multifactorial response to the stressor. To fully appreciate the peroxide-mediated cellular effects, we assessed these adaptive effects at the genomic, proteomic and cellular signal processing level. Combined analyses of these multiple levels of investigation revealed a complex cellular adaptive response to the protracted peroxide exposure. This adaptive response involved changes in cytoskeletal structure, energy metabolic shifts towards glycolysis and selective alterations in transmembrane receptor activity. Our analyses of the global responses to chronic stressor exposure, at multiple biological levels, revealed a viable neural phenotype in-part reminiscent of aged or damaged neural tissue. Our paradigm indicates how cellular physiology can subtly change in different contexts and potentially aid the appreciation of stress response adaptations.	[Chadwick, Wayne; Zhou, Yu; Park, Sung-Soo; Wang, Liyun; Stone, Matthew D.; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Mitchell, Nicholas] St Bonaventure Univ, Dept Biol, St Bonaventure, NY 14778 USA; [Becker, Kevin G.] NIA, Gene Express & Genom Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Martin, Bronwen] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chadwick, W (corresponding author), NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA.	maudsleyst@mail.nih.gov	Mitchell, Nicholas/A-7066-2018; Zhou, Yu/M-7975-2014; Maudsley, Stuart/Q-4782-2019; Maudsley, Stuart/AAV-9929-2021	Mitchell, Nicholas/0000-0003-2088-5419; Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925; Becker, Kevin/0000-0002-6794-6656	National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000325, ZICAG000616, ZIAAG000318, ZIAAG000319] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging. The funding authority had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian GS, 1996, J GERONTOL A-BIOL, V51, pB66, DOI 10.1093/gerona/51A.1.B66; Apprey V, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S119; Atamna H, 2007, MITOCHONDRION, V7, P297, DOI 10.1016/j.mito.2007.06.001; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; BOHR VA, 1995, MUTAT RES-DNAGING G, V338, P25, DOI 10.1016/0921-8734(95)00008-T; Borras C, 2009, FEBS LETT, V583, P2287, DOI 10.1016/j.febslet.2009.06.019; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Brewer GJ, 2010, EXP GERONTOL, V45, P173, DOI 10.1016/j.exger.2009.11.007; Brooks PJ, 2008, DNA REPAIR, V7, P834, DOI 10.1016/j.dnarep.2008.01.017; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chen GH, 2004, PHYSIOL BEHAV, V82, P883, DOI 10.1016/j.physbeh.2004.07.008; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chiba T, 2007, MAMM GENOME, V18, P105, DOI 10.1007/s00335-006-0119-2; Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080; Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cummings Jeffrey L., 2000, Int J Neuropsychopharmacol, V3, P21, DOI 10.1017/S1461145700001917; Davidson L, 2004, J BIOL CHEM, V279, P11906, DOI 10.1074/jbc.M310784200; Davidson L, 2004, J BIOL CHEM, V279, P1980, DOI 10.1074/jbc.M309827200; De Santi S, 2001, NEUROBIOL AGING, V22, P529, DOI 10.1016/S0197-4580(01)00230-5; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Diener T, 2010, EXP GERONTOL, V45, P638, DOI 10.1016/j.exger.2010.03.002; DOSIL M, 1990, FEBS LETT, V269, P373, DOI 10.1016/0014-5793(90)81196-U; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Erickson RR, 2006, J GERONTOL A-BIOL, V61, P435, DOI 10.1093/gerona/61.5.435; Fatokun AA, 2008, FRONT BIOSCI-LANDMRK, V13, P3288, DOI 10.2741/2926; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; FRILLINGOS S, 1992, EXPERIENTIA, V48, P236, DOI 10.1007/BF01930463; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; FUJIWARA M, 1993, PHYTOTHER RES, V7, pS60, DOI 10.1002/ptr.2650070718; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Gannon J, 2008, INT J MOL MED, V22, P33; Gilca M, 2007, J POSTGRAD MED, V53, P207, DOI 10.4103/0022-3859.33869; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Gooney M, 2004, NEUROBIOL AGING, V25, P1323, DOI 10.1016/j.neurobiolaging.2004.01.003; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Honda K, 2004, ANN NY ACAD SCI, V1012, P179, DOI 10.1196/annals.1306.015; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Inumaru J, 2009, GENES CELLS, V14, P703, DOI 10.1111/j.1365-2443.2009.01303.x; Ip FCF, 2000, NEUROREPORT, V11, P457, DOI 10.1097/00001756-200002280-00006; Ishitani R, 1996, J PHARMACOL EXP THER, V278, P447; JAGUST WJ, 1991, J CEREBR BLOOD F MET, V11, P323, DOI 10.1038/jcbfm.1991.65; Jee HJ, 2009, BIOCHEM BIOPH RES CO, V383, P358, DOI 10.1016/j.bbrc.2009.04.017; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; JOHANSSON S, 1994, ACTA PHYSIOL SCAND, V151, P331, DOI 10.1111/j.1748-1716.1994.tb09752.x; Kamimura J, 2004, J HUM GENET, V49, P360, DOI 10.1007/s10038-004-0158-z; Kilts JD, 2002, J BIOL CHEM, V277, P31257, DOI 10.1074/jbc.M203640200; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7; Kim JM, 2010, FREE RADICAL RES, V44, P454, DOI 10.3109/10715761003610737; Kim SY, 2010, BIOCHEM BIOPH RES CO, V391, P28, DOI 10.1016/j.bbrc.2009.10.154; Kojima N, 2007, NEUROSCI RES, V58, P1, DOI 10.1016/j.neures.2007.02.003; Lam PY, 2009, FREE RADICAL RES, V43, P431, DOI 10.1080/10715760902849813; LANDFIELD PW, 1987, NEUROBIOL AGING, V8, P346, DOI 10.1016/0197-4580(87)90074-1; LEVINE AS, 1986, J GERONTOL, V41, P20, DOI 10.1093/geronj/41.1.20; Li BJ, 2005, CELL CYCLE, V4, P246; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Li MY, 2003, J CELL PHYSIOL, V197, P418, DOI 10.1002/jcp.10384; Li SC, 2010, J COGNITIVE NEUROSCI, V22, P2164, DOI 10.1162/jocn.2009.21374; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Linnane AW, 2007, BIOGERONTOLOGY, V8, P445, DOI 10.1007/s10522-007-9096-4; Liochev SI, 2003, FREE RADICAL BIO MED, V34, P1383, DOI 10.1016/S0891-5849(03)00153-9; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lopes GS, 2006, EXP GERONTOL, V41, P55, DOI 10.1016/j.exger.2005.10.004; MAJUMDAR APN, 1994, J GERONTOL, V49, pB110, DOI 10.1093/geronj/49.3.B110; MARIC D, 1991, ANN NY ACAD SCI, V621, P148; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin Bronwen, 2007, IBS J Sci, V2, P35; MATOCHA MF, 1990, EXP GERONTOL, V25, P47, DOI 10.1016/0531-5565(90)90008-P; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Meltzer CC, 1998, NEUROPSYCHOPHARMACOL, V18, P407; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Mukaetova-Ladinska EB, 2008, DEMENT GERIATR COGN, V26, P32, DOI 10.1159/000141039; Murer MG, 1999, NEUROSCIENCE, V88, P1015, DOI 10.1016/S0306-4522(98)00219-X; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Nomura Y, 1999, NEUROBIOL AGING, V20, P111, DOI 10.1016/S0197-4580(99)00006-8; North KE, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S98; Ogunshola OO, 2009, CELL MOL LIFE SCI, V66, P3555, DOI 10.1007/s00018-009-0141-0; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Park SC, 2002, ANN NY ACAD SCI, V959, P45, DOI 10.1111/j.1749-6632.2002.tb02081.x; Petit-Taboue MC, 1998, NEUROIMAGE, V7, P176, DOI 10.1006/nimg.1997.0318; PICARD B, 1995, REPROD NUTR DEV, V35, P71, DOI 10.1051/rnd:19950105; Puzianowska-Kuznicka M, 2009, AGEING RES REV, V8, P160, DOI 10.1016/j.arr.2009.05.002; Quartu M, 1999, BRAIN RES BULL, V48, P375, DOI 10.1016/S0361-9230(99)00009-X; Rodriguez Sofia, 2010, Curr Aging Sci, V3, P81; Rollo CD, 2009, NEUROCHEM RES, V34, P601, DOI 10.1007/s11064-008-9858-7; Romanczyk TB, 2002, EUR J NEUROSCI, V15, P269, DOI 10.1046/j.0953-816x.2001.01858.x; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Sarraj MA, 2007, REPRODUCTION, V133, P753, DOI 10.1530/rep.1.01184; Sato Y, 2005, NEUROSCI LETT, V382, P22, DOI 10.1016/j.neulet.2005.02.053; Schaaf MJM, 2001, BRAIN RES, V915, P227, DOI 10.1016/S0006-8993(01)02855-4; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; SESHADRI T, 1993, J BIOL CHEM, V268, P18474; Sharov VS, 2006, BIOCHEM J, V394, P605, DOI 10.1042/BJ20051214; Sheehan JP, 1997, J NEUROSCI, V17, P4612; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Silhol M, 2008, REJUV RES, V11, P1031, DOI 10.1089/rej.2008.0791; Smaili SS, 2008, METHOD ENZYMOL, V442, P27, DOI 10.1016/S0076-6879(08)01402-X; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stockl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005; Stranahan AM, 2009, CURR MED CHEM, V16, P4668, DOI 10.2174/092986709789878292; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P16817, DOI 10.1073/pnas.0904414106; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P1181, DOI 10.1073/pnas.0806062106; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Terao A, 2004, NEUROSCI LETT, V355, P81, DOI 10.1016/j.neulet.2003.10.061; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Toussaint O, 2002, INT J BIOCHEM CELL B, V34, P1415, DOI 10.1016/S1357-2725(02)00034-1; Uejima H, 1998, MOL CARCINOGEN, V22, P34, DOI 10.1002/(SICI)1098-2744(199805)22:1<34::AID-MC5>3.0.CO;2-L; UEJIMA H, 1995, GENE CHROMOSOME CANC, V14, P120, DOI 10.1002/gcc.2870140206; Valdez SR, 2007, SYNAPSE, V61, P124, DOI 10.1002/syn.20353; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; VanGuilder HD, 2010, J NEUROCHEM, V113, P1577, DOI 10.1111/j.1471-4159.2010.06719.x; VERKHRATSKY A, 1994, ANN NY ACAD SCI, V747, P365; Viner RI, 1999, BIOCHEMISTRY-US, V38, P12408, DOI 10.1021/bi9909445; Wang DT, 2010, J IMMUNOL, V184, P582, DOI 10.4049/jimmunol.0902352; Wang XL, 2008, BBA-MOL CELL RES, V1783, P1876, DOI 10.1016/j.bbamcr.2008.05.015; WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9; Weinmann A, 2005, INT J MOL MED, V16, P905; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Wu D, 2010, HORM BEHAV, V58, P306, DOI 10.1016/j.yhbeh.2010.03.001; Xu K, 2010, ADV EXP MED BIOL, V662, P71, DOI 10.1007/978-1-4419-1241-1_9; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yamashita S, 2005, CANCER RES, V65, P2610, DOI 10.1158/0008-5472.CAN-04-2932; Yan LJ, 2008, MECH AGEING DEV, V129, P282, DOI 10.1016/j.mad.2008.01.006; Yang S, 2008, NEUROSCIENCE, V154, P1107, DOI 10.1016/j.neuroscience.2008.04.012; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015; Yue Z, 2008, NEUROSCI LETT, V439, P119, DOI 10.1016/j.neulet.2008.04.009; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x; ZHU W, 1994, MAMM GENOME, V5, P234, DOI 10.1007/BF00360552; Ziegenhorn AA, 2007, NEUROBIOL AGING, V28, P1436, DOI 10.1016/j.neurobiolaging.2006.06.011	156	51	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14352	10.1371/journal.pone.0014352	http://dx.doi.org/10.1371/journal.pone.0014352			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179406	gold, Green Submitted, Green Published			2022-12-27	WOS:000285572900002
J	Gonzalez-Voyer, A; Kolm, N				Gonzalez-Voyer, Alejandro; Kolm, Niclas			Sex, Ecology and the Brain: Evolutionary Correlates of Brain Structure Volumes in Tanganyikan Cichlids	PLOS ONE			English	Article							SIZE DIMORPHIC BRAINS; SPATIAL COGNITION; SPERM COMPETITION; SONG REPERTOIRE; PARENTAL CARE; PATTERNS; SELECTION; COMPLEXITY; MORPHOLOGY; BIRDS	Analyses of the macroevolutionary correlates of brain structure volumes allow pinpointing of selective pressures influencing specific structures. Here we use a multiple regression framework, including phylogenetic information, to analyze brain structure evolution in 43 Tanganyikan cichlid species. We analyzed the effect of ecological and sexually selected traits for species averages, the effect of ecological traits for each sex separately and the influence of sexual selection on structure dimorphism. Our results indicate that both ecological and sexually selected traits have influenced brain structure evolution. The patterns observed in males and females generally followed those observed at the species level. Interestingly, our results suggest that strong sexual selection is associated with reduced structure volumes, since all correlations between sexually selected traits and structure volumes were negative and the only statistically significant association between sexual selection and structure dimorphism was also negative. Finally, we previously found that monoparental female care was associated with increased brain size. However, here cerebellum and hypothalamus volumes, after controlling for brain size, associated negatively with female-only care. Thus, in accord with the mosaic model of brain evolution, brain structure volumes may not respond proportionately to changes in brain size. Indeed selection favoring larger brains can simultaneously lead to a reduction in relative structure volumes.	[Gonzalez-Voyer, Alejandro] CSIC, Estn Biol Donana, Dept Integrat Ecol, E-41080 Seville, Spain; [Gonzalez-Voyer, Alejandro; Kolm, Niclas] Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Uppsala University	Gonzalez-Voyer, A (corresponding author), CSIC, Estn Biol Donana, Dept Integrat Ecol, E-41080 Seville, Spain.	alejandro.gonzalez@ebd.csic.es	Gonzalez-Voyer, Alejandro/B-7322-2011	Kolm, Niclas/0000-0001-5791-336X	Wenner-Gren Foundations; Swedish Research Council [005-4920, 2009-5157]; Ministerio de Ciencia y Educacion, Spain	Wenner-Gren Foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministerio de Ciencia y Educacion, Spain	This work was funded through grants from the Wenner-Gren Foundations and the Swedish Research Council (005-4920 and 2009-5157) to N.K. A.G.-V. was supported by a Wenner-Gren Foundations postdoctoral stipend and a Juan de la Cierva post-doctoral fellowship from the Ministerio de Ciencia y Educacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Andersson Malte, 1994; Barton RA, 2007, J EVOLUTION BIOL, V20, P1504, DOI 10.1111/j.1420-9101.2007.01330.x; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Broglio C, 2003, FISH FISH, V4, P247, DOI 10.1046/j.1467-2979.2003.00128.x; Butler A.B., 2005, COMP VERTEBRATE NEUR, DOI DOI 10.1017/CBO9780511525636.010; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; de Winter W, 2001, NATURE, V409, P710, DOI 10.1038/35055547; Dechmann DKN, 2009, BIOL REV, V84, P161, DOI 10.1111/j.1469-185X.2008.00067.x; DEVOOGD TJ, 1993, P ROY SOC B-BIOL SCI, V254, P75, DOI 10.1098/rspb.1993.0129; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; Dunbar RIM, 1998, ETHOLOGY, V104, P695, DOI 10.1111/j.1439-0310.1998.tb00103.x; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FAIRBAIRN DJ, 2007, GENDER ROLES EVOLUTI, P1; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garamszegi LZ, 2005, BEHAV ECOL, V16, P335, DOI 10.1093/beheco/arh167; Garamszegi LZ, 2005, P ROY SOC B-BIOL SCI, V272, P159, DOI 10.1098/rspb.2004.2940; GASHAGAZA M M, 1991, Physiology and Ecology Japan, V28, P29; GITTLEMAN JL, 1994, P NATL ACAD SCI USA, V91, P5495, DOI 10.1073/pnas.91.12.5495; Gonzalez-Lagos C, 2010, J EVOLUTION BIOL, V23, P1064, DOI 10.1111/j.1420-9101.2010.01976.x; Gonzalez-Voyer A, 2008, EVOLUTION, V62, P2015, DOI 10.1111/j.1558-5646.2008.00426.x; Gonzalez-Voyer A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-238; Gonzalez-Voyer A, 2009, P ROY SOC B-BIOL SCI, V276, P161, DOI 10.1098/rspb.2008.0979; Guay PJ, 2008, AUST J ZOOL, V56, P311, DOI 10.1071/ZO08082; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Healy SD, 2005, TRENDS ECOL EVOL, V20, P17, DOI 10.1016/j.tree.2004.10.006; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; HUBER R, 1992, ENVIRON BIOL FISH, V33, P153, DOI 10.1007/BF00002561; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P167, DOI 10.1159/000113330; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; Ito H, 2007, BRAIN BEHAV EVOLUT, V69, P76, DOI 10.1159/000095196; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2003, CAN J ZOOL, V81, P1913, DOI 10.1139/Z03-190; Jacobs LF, 1996, TRENDS ECOL EVOL, V11, pA82; JACOBS LF, 1990, P NATL ACAD SCI USA, V87, P6349, DOI 10.1073/pnas.87.16.6349; Kolm N, 2009, J EVOLUTION BIOL, V22, P2524, DOI 10.1111/j.1420-9101.2009.01875.x; Konings A., 2005, BACK NATURE GUIDE TA, V2nd; Kornfield I, 2000, ANNU REV ECOL SYST, V31, P163, DOI 10.1146/annurev.ecolsys.31.1.163; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; KOTRSCHAL K, 1988, J HIRNFORSCH, V29, P341; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lefebvre L, 2002, BEHAVIOUR, V139, P939, DOI 10.1163/156853902320387918; Lemaitre JF, 2009, J EVOLUTION BIOL, V22, P2215, DOI 10.1111/j.1420-9101.2009.01837.x; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pitnick S, 2006, P ROY SOC B-BIOL SCI, V273, P719, DOI 10.1098/rspb.2005.3367; Pollen AA, 2007, BRAIN BEHAV EVOLUT, V70, P21, DOI 10.1159/000101067; Portavella M, 2005, EUR J NEUROSCI, V21, P2800, DOI 10.1111/j.1460-9568.2005.04114.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; REVELL LJ, 2010, METHODS ECOLOGY EVOL; Rodriguez F, 2002, J NEUROSCI, V22, P2894, DOI 10.1523/JNEUROSCI.22-07-02894.2002; RODRIGUEZ F, 2004, COGNITIVE EMOTIONAL, P365; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Safi K, 2005, P ROY SOC B-BIOL SCI, V272, P179, DOI 10.1098/rspb.2004.2924; Salas C, 2003, BRAIN BEHAV EVOLUT, V62, P72, DOI 10.1159/000072438; SALZBURGER W, 2005, BMC EVOLUTIONARY BIO; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Shohet AJ, 2009, J FISH BIOL, V75, P1323, DOI 10.1111/j.1095-8649.2009.02366.x; Sokal RR, 1995, BIOMETRY; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol D, 2007, P ROY SOC B-BIOL SCI, V274, P763, DOI 10.1098/rspb.2006.3765; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Szekely T, 1996, P ROY SOC B-BIOL SCI, V263, P607, DOI 10.1098/rspb.1996.0091; Team R. D. C., 2009, R LANGUAGE ENV STAT; Timmermans S, 2000, BRAIN BEHAV EVOLUT, V56, P196, DOI 10.1159/000047204; VANSTAADEN MJ, 1995, ZOOLOGY, V98, P165; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA	73	67	68	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14355	10.1371/journal.pone.0014355	http://dx.doi.org/10.1371/journal.pone.0014355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179407	Green Published, gold, Green Submitted			2022-12-27	WOS:000285572900003
J	Stafford, R; Hart, AG; Collins, L; Kirkhope, CL; Williams, RL; Rees, SG; Lloyd, JR; Goodenough, AE				Stafford, Richard; Hart, Adam G.; Collins, Laura; Kirkhope, Claire L.; Williams, Rachel L.; Rees, Samuel G.; Lloyd, Jane R.; Goodenough, Anne E.			Eu-Social Science: The Role of Internet Social Networks in the Collection of Bee Biodiversity Data	PLOS ONE			English	Article							PRESENCE-ONLY DATA; CITIZEN SCIENCE; TOOL; KNOWLEDGE	Background: Monitoring change in species diversity, community composition and phenology is vital to assess the impacts of anthropogenic activity and natural change. However, monitoring by trained scientists is time consuming and expensive. Methodology/Principal Findings: Using social networks, we assess whether it is possible to obtain accurate data on bee distribution across the UK from photographic records submitted by untrained members of the public, and if these data are in sufficient quantity for ecological studies. We used Flickr and Facebook as social networks and Flickr for the storage of photographs and associated data on date, time and location linked to them. Within six weeks, the number of pictures uploaded to the Flickr BeeID group exceeded 200. Geographic coverage was excellent; the distribution of photographs covered most of the British Isles, from the south coast of England to the Highlands of Scotland. However, only 59% of photographs were properly uploaded according to instructions, with vital information such as 'tags' or location information missing from the remainder. Nevertheless, this incorporation of information on location of photographs was much higher than general usage on Flickr (similar to 13%), indicating the need for dedicated projects to collect spatial ecological data. Furthermore, we found identification of bees is not possible from all photographs, especially those excluding lower abdomen detail. This suggests that giving details regarding specific anatomical features to include on photographs would be useful to maximise success. Conclusions/Significance: The study demonstrates the power of social network sites to generate public interest in a project and details the advantages of using a group within an existing popular social network site over a traditional (specifically-designed) web-based or paper-based submission process. Some advantages include the ability to network with other individuals or groups with similar interests, and thus increasing the size of the dataset and participation in the project.	[Stafford, Richard; Hart, Adam G.; Collins, Laura; Kirkhope, Claire L.; Williams, Rachel L.; Rees, Samuel G.; Lloyd, Jane R.; Goodenough, Anne E.] Univ Gloucestershire, Dept Nat & Social Sci, Cheltenham, Glos, England	University of Gloucestershire	Stafford, R (corresponding author), Univ Gloucestershire, Dept Nat & Social Sci, Cheltenham, Glos, England.	rstafford@glos.ac.uk	Goodenough, Anne/C-5220-2011; Stafford, Rick/B-1059-2013	Stafford, Rick/0000-0002-1964-5787; Goodenough, Anne/0000-0002-7662-6670				Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; BLOOMFIELD A, 2006, MARINE CONSERVATION; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Brooks SP, 2003, PHILOS T ROY SOC A, V361, P2681, DOI 10.1098/rsta.2003.1263; Brossard D, 2005, INT J SCI EDUC, V27, P1099, DOI 10.1080/09500690500069483; Cooper CB, 2007, ECOL SOC, V12; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Franklin J, 2009, MAPPING SPECIES DIST; *GOCC, 2009, GLOUC BIRD REP 2008; KIRKHOPE CL, 2010, P ISOCIETY 2010, P637; Kirkpatrick David, 2010, FACEBOOK EFFECT INSI; Kitchen-Wheeler AM, 2010, MAR BIOL RES, V6, P351, DOI 10.1080/17451000903233763; LLOYD JR, 2010, 30 ANN S SEA TURTL B; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Robinson ME, 2003, PAIN, V104, P259, DOI 10.1016/S0304-3959(03)00014-9; Rosenthal R., 1966, EXPT EFFECTS BEHAV R; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Staab S, 2005, IEEE INTELL SYST, V20, P80, DOI 10.1109/MIS.2005.16; Sutherland WJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P1, DOI 10.2277/ 0521606365; TWISSELL C, 2009, GLOUCESTERSHIRE NAT, V20, P26; Underwood, 1996, EXPT ECOLOGY THEIR L; WARD G, 2007, THESIS STANFORD U PA; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0; Zheng Pei, 2006, SMART PHONE NEXT GEN	25	45	48	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14381	10.1371/journal.pone.0014381	http://dx.doi.org/10.1371/journal.pone.0014381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179423	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000285572900012
J	Micewicz, ED; Cole, AL; Jung, CL; Luong, H; Phillips, ML; Pratikhya, P; Sharma, S; Waring, AJ; Cole, AM; Ruchala, P				Micewicz, Ewa D.; Cole, Amy L.; Jung, Chun-Ling; Luong, Hai; Phillips, Martin L.; Pratikhya, Pratikhya; Sharma, Shantanu; Waring, Alan J.; Cole, Alexander M.; Ruchala, Piotr			Grifonin-1: A Small HIV-1 Entry Inhibitor Derived from the Algal Lectin, Griffithsin	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIVIRAL PROTEIN GRIFFITHSIN; INACTIVATING PROTEIN; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; CARBOHYDRATE-BINDING; VIRAL PERSISTENCE; THETA-DEFENSIN; CYANOVIRIN-N; AMINO-ACIDS	Background: Griffithsin, a 121-residue protein isolated from a red algal Griffithsia sp., binds high mannose N-linked glycans of virus surface glycoproteins with extremely high affinity, a property that allows it to prevent the entry of primary isolates and laboratory strains of T-and M-tropic HIV-1. We used the sequence of a portion of griffithsin's sequence as a design template to create smaller peptides with antiviral and carbohydrate-binding properties. Methodology/Results: The new peptides derived from a trio of homologous beta-sheet repeats that comprise the motifs responsible for its biological activity. Our most active antiviral peptide, grifonin-1 (GRFN-1), had an EC50 of 190.8 +/- 11.0 nM in in vitro TZM-bl assays and an EC50 of 546.6 +/- 66.1 nM in p24(gag) antigen release assays. GRFN-1 showed considerable structural plasticity, assuming different conformations in solvents that differed in polarity and hydrophobicity. Higher concentrations of GRFN-1 formed oligomers, based on intermolecular beta-sheet interactions. Like its parent protein, GRFN-1 bound viral glycoproteins gp41 and gp120 via the N-linked glycans on their surface. Conclusion: Its substantial antiviral activity and low toxicity in vitro suggest that GRFN-1 and/or its derivatives may have therapeutic potential as topical and/or systemic agents directed against HIV-1.	[Micewicz, Ewa D.; Jung, Chun-Ling; Luong, Hai; Pratikhya, Pratikhya; Waring, Alan J.; Ruchala, Piotr] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Micewicz, Ewa D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA; [Cole, Amy L.; Cole, Alexander M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Phillips, Martin L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Sharma, Shantanu] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University System of Florida; University of Central Florida; University of California System; University of California Los Angeles; California Institute of Technology	Micewicz, ED (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	pruchala@mednet.ucla.edu		RUCHALA, PIOTR/0000-0002-5574-2779	Office of the David Geffen School of Medicine at University of California at Los Angeles; National Institutes of Health [AI-052017, AI082623]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052017, U19AI082623, R56AI052017] Funding Source: NIH RePORTER	Office of the David Geffen School of Medicine at University of California at Los Angeles; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported, in part, by funds from the Adams and Burnham endowments provided by the Dean's Office of the David Geffen School of Medicine at University of California at Los Angeles (PR) and by National Institutes of Health grants #AI-052017 and #AI082623 (to AMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Bokesch HR, 2004, FEBS LETT, V567, P287, DOI 10.1016/j.febslet.2004.04.085; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; BRUCH MD, 1991, PROTEINS, V10, P130, DOI 10.1002/prot.340100206; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AL, 2007, IMMUNOLOGY, V121, P140, DOI 10.1111/j.1365-2567.2006.02553.x; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Efimov AV, 2003, FEBS LETT, V554, P389, DOI 10.1016/S0014-5793(03)01189-X; Emau P, 2007, J MED PRIMATOL, V36, P244, DOI 10.1111/j.1600-0684.2007.00242.x; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Giomarelli B, 2006, PROTEIN EXPRES PURIF, V47, P194, DOI 10.1016/j.pep.2005.10.014; Haggerty CM, 2006, CURR OPIN HIV AIDS, V1, P62, DOI 10.1097/01.COH.0000191897.78309.70; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kiser JJ, 2008, CURR OPIN HIV AIDS, V3, P330, DOI 10.1097/COH.0b013e3282fbaa6b; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; LIU CC, 1988, J IMMUNOL METHODS, V114, P33; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Makinson A, 2009, CURR OPIN HIV AIDS, V4, P150, DOI 10.1097/COH.0b013e32832498d8; McCurdy S N, 1989, Pept Res, V2, P147; Miles AJ, 2003, SPECTROSC-INT J, V17, P653, DOI 10.1155/2003/379137; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mori T, 2001, ANTIMICROB AGENTS CH, V45, P664, DOI 10.1128/AAC.45.3.664-672.2001; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Owen SM, 2004, J PEPT RES, V63, P469, DOI 10.1111/j.1399-3011.2004.00155.x; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; TEMIN HM, 1993, NATURE, V362, P292, DOI 10.1038/362292a0; Vandekerckhove L, 2008, J ANTIMICROB CHEMOTH, V61, P1187, DOI 10.1093/jac/dkn130; Vandekerckhove L, 2009, J ANTIMICROB CHEMOTH, V63, P1087, DOI 10.1093/jac/dkp113; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Zeitlin L, 2009, P NATL ACAD SCI USA, V106, P6029, DOI 10.1073/pnas.0902239106; Ziolkowska NE, 2007, PROTEIN SCI, V16, P1485, DOI 10.1110/ps.072889407; Ziolkowska NE, 2007, PROTEINS, V67, P661, DOI 10.1002/prot.21336; Ziolkowska NE, 2006, ACTA BIOCHIM POL, V53, P617; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	52	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14360	10.1371/journal.pone.0014360	http://dx.doi.org/10.1371/journal.pone.0014360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179548	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000285381200010
J	Mendez, M; Rosenbaum, HC; Wells, RS; Stamper, A; Bordino, P				Mendez, Martin; Rosenbaum, Howard C.; Wells, Randall S.; Stamper, Andrew; Bordino, Pablo			Genetic Evidence Highlights Potential Impacts of By-Catch to Cetaceans	PLOS ONE			English	Article							PAIRWISE RELATEDNESS; CONSERVATION GENETICS; FRANCISCANA DOLPHINS; POPULATION-STRUCTURE; DIVERGENT SELECTION; MOLECULAR MARKERS; MARINE MAMMALS; PATTERNS; WHALES; FISHERIES	Incidental entanglement in fishing gear is arguably the most serious threat to many populations of small cetaceans, judging by the alarming number of captured animals. However, other aspects of this threat, such as the potential capture of mother-offspring pairs or reproductive pairs, could be equally or even more significant but have rarely been evaluated. Using a combination of demographic and genetic data we provide evidence that i) Franciscana dolphin pairs that are potentially reproductive and mother-offspring pairs form temporal bonds, and ii) are entangled simultaneously. Our results highlight potential demographic and genetic impacts of by-catch to cetacean populations: the joint entanglement of mother-offspring or reproductive pairs, compared to random individuals, might exacerbate the demographic consequences of by-catch, and the loss of groups of relatives means that significant components of genetic diversity could be lost together. Given the social nature of many odontocetes (toothed cetaceans), we suggest that these potential impacts could be rather general to the group and therefore by-catch could be more detrimental than previously considered.	[Mendez, Martin] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Mendez, Martin; Rosenbaum, Howard C.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Mendez, Martin; Bordino, Pablo] Fdn AquaMarina, Buenos Aires, DF, Argentina; [Rosenbaum, Howard C.] Wildlife Conservat Soc, Ocean Giants Program, Bronx, NY USA; [Bordino, Pablo] Wildlife Trust Alliance, New York, NY USA; [Wells, Randall S.; Bordino, Pablo] Mote Marine Lab, Chicago Zool Soc, Sarasota, FL 34236 USA; [Stamper, Andrew] Walt Disney World Resorts, Lake Buena Vista, FL USA	Columbia University; American Museum of Natural History (AMNH); Wildlife Conservation Society; Mote Marine Laboratory & Aquarium; Walt Disney Company	Mendez, M (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	mm1772@columbia.edu			Disney Worldwide Conservation Fund; Disney's Animal Programs and Environmental Initiatives; Chicago Zoological Society; Fundacion Vida Silvestre Argentina; World Wildlife Fund; Walt Disney World Resorts organization	Disney Worldwide Conservation Fund; Disney's Animal Programs and Environmental Initiatives; Chicago Zoological Society; Fundacion Vida Silvestre Argentina; World Wildlife Fund; Walt Disney World Resorts organization	This material is based upon work supported by Disney Worldwide Conservation Fund, Disney's Animal Programs and Environmental Initiatives, Chicago Zoological Society, Fundacion Vida Silvestre Argentina and the World Wildlife Fund. Walt Disney World Resorts organization only provided funding and support to Andrew Stamper. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors designed the study and the data collection strategy, collected all data and analyzed them. The authors prepared the manuscript, decided to publish it, and chose this outlet.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; Begon M., 1996, ECOLOGY; Bordino P, 2002, MAR MAMMAL SCI, V18, P833, DOI 10.1111/j.1748-7692.2002.tb01076.x; BORDINO P, 2004, 56 IWC M SORR IT; BORDINO P, 2008, SC53IA32 IWC; Crespo EA, 2010, MAR MAMMAL SCI, V26, P17, DOI 10.1111/j.1748-7692.2009.00313.x; DEMASTER DP, 1988, MAR MAMMAL SCI, V4, P297, DOI 10.1111/j.1748-7692.1988.tb00539.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Gerber LR, 2004, BIOL CONSERV, V120, P121, DOI 10.1016/j.biocon.2004.01.029; Gotelli NJ, 2001, PRIMER ECOLOGY; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; HOELZEL AR, 1994, ANNU REV ECOL SYST, V25, P377; IUCN, 2014, IUCN RED LIST THREAT; Jaureguizar AJ, 2004, FISH RES, V66, P195, DOI 10.1016/S0165-7836(03)00200-5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Krutzen M, 2003, P ROY SOC B-BIOL SCI, V270, P497, DOI 10.1098/rspb.2002.2229; Lewison RL, 2009, ECOL APPL, V19, P920, DOI 10.1890/08-0623.1; Lynch M, 1999, GENETICS, V152, P1753; Mendez M, 2008, CONSERV GENET, V9, P419, DOI 10.1007/s10592-007-9354-7; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Moore JE, 2008, ECOL APPL, V18, P1914, DOI 10.1890/07-0862.1; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosas Fernando C. Weber, 2002, Latin American Journal of Aquatic Mammals, V1, P161; Rosenbaum HC, 2002, J HERED, V93, P389, DOI 10.1093/jhered/93.6.389; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Secchi Eduardo R., 2001, Journal of Cetacean Research and Management, V3, P95; SLOOTEN E, 1991, CAN J ZOOL, V69, P1701, DOI 10.1139/z91-235; Valsecchi E., 2003, Journal of Cetacean Research and Management, V5, P69; Van de Casteele T, 2001, MOL ECOL, V10, P1539, DOI 10.1046/j.1365-294X.2001.01288.x; Wang JL, 2002, GENETICS, V160, P1203; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960	47	15	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15550	10.1371/journal.pone.0015550	http://dx.doi.org/10.1371/journal.pone.0015550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179542	gold, Green Published, Green Submitted			2022-12-27	WOS:000285340000026
J	Bishop, MA; Reynolds, BF; Powers, SP				Bishop, Mary Anne; Reynolds, Brad F.; Powers, Sean P.			An In Situ, Individual-Based Approach to Quantify Connectivity of Marine Fish: Ontogenetic Movements and Residency of Lingcod	PLOS ONE			English	Article							OPHIODON-ELONGATUS; TAGGED LINGCOD; CONSERVATION; MORTALITY; ISLAND	As modern fishery assessments change in an effort to be more accurate and encompass the range of potential ecosystem interactions, critical information on the ecology of species including life history, intra and inter-specific competitive interactions and habitat requirements must be added to the standard fishery-dependent and independent data sets. One species whose movements and habitat associations greatly affects exploitation patterns is lingcod, Ophiodon elongatus, which support an economically important fishery along the coastal waters of the Pacific Coast of North America. High site fidelity and limited movements within nearshore areas are hypothesized to have resulted in high catchability, a major factor that has contributed to overfished stocks. Thus, assessing the level of movement and connectivity among lingcod subpopulations inhabiting nearshore habitats is a prerequisite to determining the condition of lingcod stocks. We used the Pacific Ocean Shelf Tracking (POST) Project acoustic receiver array in Alaska's Prince William Sound to monitor movements and residency of 21 acoustic-tagged lingcod for up to 16 months. Eight of sixteen lingcod (50%) initially aged at 2.5- to 3.5-years-old dispersed from their tag site. Dispersal was highly seasonal, occurring in two, five-week periods from mid-December through January and from mid-April through May. Dispersal in winter may be related to sexually immature lingcod or newly-mature male lingcod being displaced by territorial males. Spring dispersal may be indicative of the onset of migratory behavior where lingcod move out into Prince William Sound and possibly the offshore waters of the Gulf of Alaska. Our results reveal a pattern of ontogenetic dispersal as lingcod approach 4-years-old and exceed 50 cm total length. The large proportion of tagged fish migrating out of Port Gravina, their tagging site, reflects a high level of connectivity among Prince William Sound subpopulations. Our results also support the hypotheses that these subpopulations may be highly susceptible to overfishing because most fish show long residence times.	[Bishop, Mary Anne; Reynolds, Brad F.] Prince William Sound Sci Ctr, Cordova, AK USA; [Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Powers, Sean P.] Ctr Ecosyst Based Fisheries Management, Dauphin Isl, AL USA	Dauphin Island Sea Lab; University of South Alabama	Bishop, MA (corresponding author), Prince William Sound Sci Ctr, Cordova, AK USA.	mbishop@pwssc.org		Powers, Sean/0000-0002-4770-9944	Pacific Ocean Shelf Tracking (POST) Project; Prince William Sound Oil Spill Recovery Institute; Rasmuson Foundation	Pacific Ocean Shelf Tracking (POST) Project; Prince William Sound Oil Spill Recovery Institute; Rasmuson Foundation	Funding for this study was provided by Pacific Ocean Shelf Tracking (POST) Project (www.postcoml.org), Prince William Sound Oil Spill Recovery Institute (www.pws-osri.org) and the Rasmuson Foundation (www.rasmuson.org). The POST Project advised the authors on the Post Gravina acoustic receiver array design and POST maintains ownership of the array. Otherwise, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Brown Evelyn D., 2002, Alaska Fishery Research Bulletin, V9, P75; Brown H, 2010, MAR ECOL PROG SER, V403, P205, DOI 10.3354/meps08465; Cass AJ, 1990, CAN SPEC PUBL FISH A, V109, P40; Gordon David A., 1994, Alaska Fishery Research Bulletin, V1, P140; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; JAGIELO TH, 1990, FISH B-NOAA, V88, P815; JAGIELO TH, 1995, T AM FISH SOC, V124, P170, DOI 10.1577/1548-8659(1995)124<0170:AASOLA>2.3.CO;2; JAGIELO TH, 2005, ASSESSMENT LINGCOD O; King JR, 2005, MOL ECOL, V14, P653, DOI 10.1111/j.1365-294X.2005.02438.x; Logan G., 2005, MANAGEMENT FRAMEWORK; Lowe CG, 2009, MAR COAST FISH, V1, P71, DOI 10.1577/C08-047.1; Martell SJD, 2000, B MAR SCI, V66, P729; MATHEWS SB, 1987, FISH B-NOAA, V85, P153; MATTHEWS KR, 1992, FISH B-NOAA, V90, P784; Reynolds BF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012130; RICHARDS LJ, 1990, CAN J FISH AQUAT SCI, V47, P948, DOI 10.1139/f90-109; SMITH BD, 1990, T AM FISH SOC, V119, P813, DOI 10.1577/1548-8659(1990)119<0813:MAMOTM>2.3.CO;2; Starr RM, 2005, MAR TECHNOL SOC J, V39, P19, DOI 10.4031/002533205787521677; Starr RM, 2004, CAN J FISH AQUAT SCI, V61, P1083, DOI 10.1139/F04-054; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Thorson JT, 2010, FISH RES, V101, P38, DOI 10.1016/j.fishres.2009.09.005; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9	24	4	4	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14267	10.1371/journal.pone.0014267	http://dx.doi.org/10.1371/journal.pone.0014267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179191	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900003
J	Pillai, MM; Yang, XD; Balakrishnan, I; Bemis, L; Torok-Storb, B				Pillai, Manoj M.; Yang, Xiaodong; Balakrishnan, Ilango; Bemis, Lynne; Torok-Storb, Beverly			MiR-886-3p Down Regulates CXCL12 (SDF1) Expression in Human Marrow Stromal Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; MYELODYSPLASTIC SYNDROMES; MICRORNA TARGETS; SMALL RNAS; FACTOR-I; IDENTIFICATION; PATHWAYS; NICHE; MICROENVIRONMENT	Stromal Derived Factor 1 (SDF1 or CXCL12), is a chemokine known to be critical for the migration of cells in several tissue systems including the homing of the hematopoietic stem cell (HSC) to its niche in the bone marrow. A comparative analysis of miRNA expression profiles of two stromal cell lines, distinguishable by function and by CXCL12 expression (CXCL12(+) and CXCL12(-)), revealed that the CXCL12(-) cells expressed >40 fold more miR-886-3p than the CXCL12(+) cells. Screening studies showed that when miR-886-3p was transfected into the CXCL12(+) stromal cells, the expression of CXCL12 was down-regulated by as much as 85% when compared to appropriate controls, and results in the loss of CXCL12-directed chemotaxis. Similar reductions in CXCL12 were obtained with the transfection of miR-886-3p into primary stromal cell cultures. Additional studies showed that miR-886-3p specifically targeted the 3' untranslated region (UTR) of CXCL12 mRNA. These data suggest a role for miRNA in modulating the expression of CXCL12, a gene product with a critical role in hematopoietic regulation.	[Pillai, Manoj M.; Yang, Xiaodong; Balakrishnan, Ilango; Bemis, Lynne] Univ Colorado Denver, Dept Med, Div Med Oncol, Aurora, CO USA; [Torok-Storb, Beverly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Fred Hutchinson Cancer Center	Pillai, MM (corresponding author), Univ Colorado Denver, Dept Med, Div Med Oncol, Aurora, CO USA.	Manoj.Pillai@UCDenver.edu	Yang, Xiaodong/B-9444-2014	Bemis, Lynne/0000-0001-9986-7154	National Institutes of Health [K08 DK073701, R01HL62923, P30DK56465]; University of Colorado Cancer Center [P30 CA046934]; Colorado Center for AIDS [P30 AI054907]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465, K08DK073701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Cancer Center; Colorado Center for AIDS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (grant K08 DK073701 to M. M. P. and grants R01HL62923 and P30DK56465 to B.T.-S.). The core facilities used in this manuscript were supported in part by the University of Colorado Cancer Center grant (P30 CA046934) and the Colorado Center for AIDS Research Grant (P30 AI054907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cherla RP, 2001, J IMMUNOL, V166, P3067, DOI 10.4049/jimmunol.166.5.3067; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Dexter T M, 1984, Kroc Found Ser, V18, P57; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Fedyk ER, 2001, J IMMUNOL, V166, P5749, DOI 10.4049/jimmunol.166.9.5749; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Flores-Figueroa E, 2008, LEUKEMIA RES, V32, P1407, DOI 10.1016/j.leukres.2008.02.013; Garcia-Moruja C, 2005, J MOL BIOL, V348, P43, DOI 10.1016/j.jmb.2005.02.016; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakayama T, 2007, J NATL CANCER I, V99, P223, DOI 10.1093/jnci/djk031; Nakayama T, 2007, BLOOD, V109, P1363, DOI 10.1182/blood-2006-06-028217; Nandy C, 2009, J MOL BIOL, V388, P776, DOI 10.1016/j.jmb.2009.03.031; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Persson H, 2009, NAT CELL BIOL, V11, P1268, DOI 10.1038/ncb1972; Pillai MM, 2006, BLOOD, V107, P3520, DOI 10.1182/blood-2005-10-4285; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; SIMMONS PJ, 1991, BLOOD, V78, P55; Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tauro S, 2001, HAEMATOLOGICA, V86, P1038; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yue JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-8; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	48	50	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14304	10.1371/journal.pone.0014304	http://dx.doi.org/10.1371/journal.pone.0014304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179442	gold, Green Published, Green Submitted			2022-12-27	WOS:000285246900014
J	Koh, AY; Mikkelsen, PJ; Smith, RS; Coggshall, KT; Kamei, A; Givskov, M; Lory, S; Pier, GB				Koh, Andrew Y.; Mikkelsen, Per J.; Smith, Roger S.; Coggshall, Kathleen T.; Kamei, Akinobu; Givskov, Michael; Lory, Stephen; Pier, Gerald B.			Utility of In Vivo Transcription Profiling for Identifying Pseudomonas aeruginosa Genes Needed for Gastrointestinal Colonization and Dissemination	PLOS ONE			English	Article							III PROTEIN SECRETION; MURINE MODEL; BACTERIAL VIRULENCE; BIOFILM DEVELOPMENT; TWITCHING MOTILITY; SYSTEMIC SPREAD; CYSTIC-FIBROSIS; EXPRESSION; INFECTIONS; STRAIN	Microarray analysis of Pseudomonas aeruginosa mRNA transcripts expressed in vivo during animal infection has not been previously used to investigate potential virulence factors needed in this setting. We compared mRNA expression in bacterial cells recovered from the gastrointestinal (GI) tracts of P. aeruginosa-colonized mice to that of P. aeruginosa in the drinking water used to colonize the mice. Genes associated with biofilm formation and type III secretion (T3SS) had markedly increased expression in the GI tract. A non-redundant transposon library in P. aeruginosa strain PA14 was used to test mutants in genes identified as having increased transcription during in vivo colonization. All of the Tn-library mutants in biofilm-associated genes had an attenuated ability to form biofilms in vitro, but there were no significant differences in GI colonization and dissemination between these mutants and WT P. aeruginosa PA14. To evaluate T3SS factors, we tested GI colonization and neutropenia-induced dissemination of both deletional (PAO1 and PAK) and insertional (PA14) mutants in four genes in the P. aeruginosa T3SS, exoS or exoU, exoT, and popB. There were no significant differences in GI colonization among these mutant strains and their WT counterparts, whereas rates of survival following dissemination were significantly decreased in mice infected by the T3SS mutant strains. However, there was a variable, strain-dependent effect on overall survival between parental and T3SS mutants. Thus, increased transcription of genes during in vivo murine GI colonization is not predictive of an essential role for the gene product in either colonization or overall survival following induction of neutropenia.	[Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Hematol Oncol, Dallas, TX 75390 USA; [Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Infect Dis, Dallas, TX 75390 USA; [Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Mikkelsen, Per J.; Givskov, Michael] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Smith, Roger S.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Coggshall, Kathleen T.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Kamei, Akinobu; Pier, Gerald B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Lory, Stephen] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Copenhagen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Koh, AY (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	Andrew.Koh@UTSouthwestern.edu	Koh, Andrew/R-6837-2019; Pier, Gerald/AAO-2692-2021	Koh, Andrew/0000-0003-2172-5126; Pier, Gerald/0000-0002-9112-2331; Givskov, Michael/0000-0001-5004-8609	National Institutes of Health [AI62983, AI22535, AI21451]; Lundbeck Fonden; Oticon Fonden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021451, R37AI021451, K08AI062983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Fonden(Lundbeckfonden); Oticon Fonden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the National Institutes of Health grants AI62983 (AYK), AI22535 (GPB) and AI21451 (SL) and the Lundbeck Fonden and Oticon Fonden (PJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DWK, 2004, BEST PRACT RES CL GA, V18, P387, DOI 10.1016/j.bpg.2003.11.002; Alexander RJ, 1998, DIGEST DIS SCI, V43, P2652, DOI 10.1023/A:1026699126899; Aliaga L, 2002, J MED MICROBIOL, V51, P615, DOI 10.1099/0022-1317-51-7-615; Allewelt M, 2000, INFECT IMMUN, V68, P3998, DOI 10.1128/IAI.68.7.3998-4004.2000; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Bertrand X, 2003, ANN FR ANESTH, V22, P505, DOI 10.1016/S0750-7658(03)00136-9; Bertrand X, 2001, INTENS CARE MED, V27, P1263, DOI 10.1007/s001340100979; BODEY GP, 1983, REV INFECT DIS, V5, P279; BRIGHT BD, 1995, PEDIATR PULM, V12, P244; Caiazza NC, 2004, J BACTERIOL, V186, P4476, DOI 10.1128/JB.186.14.4476-4485.2004; COHEN PS, 1985, INFECT IMMUN, V48, P139, DOI 10.1128/IAI.48.1.139-145.1985; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; CUTTELOD M, CLIN MICROBIOL INFEC; Czuprynski CJ, 2002, APPL ENVIRON MICROB, V68, P2893, DOI 10.1128/AEM.68.6.2893-2900.2002; Dean CR, 2002, FEMS MICROBIOL LETT, V210, P277, DOI 10.1016/S0378-1097(02)00641-9; Fitzsimons NA, 2003, J MICROBIOL METH, V55, P133, DOI 10.1016/S0167-7012(03)00121-0; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hentzer M., 2005, BIOFILMS, V2, P37, DOI DOI 10.1017/S1479050505001699; Heydorn A, 2002, APPL ENVIRON MICROB, V68, P2008, DOI 10.1128/AEM.68.4.2008-2017.2002; Koh AY, 2005, INFECT IMMUN, V73, P2262, DOI 10.1128/IAI.73.4.2262-2272.2005; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Macfarlane S, 2004, CLIN INFECT DIS, V38, P1690, DOI 10.1086/420823; Macfarlane S, 1997, Adv Dent Res, V11, P59; MARSHALL JC, 1993, ANN SURG, V218, P111, DOI 10.1097/00000658-199308000-00001; Mecsas J, 2001, INFECT IMMUN, V69, P2779, DOI 10.1128/IAI.67.5.2779-2787.2001; Moller AK, 2003, INFECT IMMUN, V71, P2142, DOI 10.1128/IAI.71.4.2142-2152.2003; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; PIER GB, 1992, INFECT IMMUN, V60, P4768, DOI 10.1128/IAI.60.11.4768-4776.1992; Pizzo P.A., 2002, PRINCIPLES PRACTICE, V4th; PLATT MD, 2008, J BACTERIOL; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reuter S, 2002, CRIT CARE MED, V30, P2222, DOI 10.1097/00003246-200210000-00008; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; SHERIDAN WG, 1990, AM J SURG, V159, P314, DOI 10.1016/S0002-9610(05)81226-7; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Whitchurch CB, 2002, J BACTERIOL, V184, P4544, DOI 10.1128/JB.184.16.4544-4554.2002; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wilson M., 2005, MICROBIAL INHABITANT; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; 2000, MMWR MORB MORTAL WKL, V49, P1087	50	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15131	10.1371/journal.pone.0015131	http://dx.doi.org/10.1371/journal.pone.0015131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170272	Green Published, gold, Green Submitted			2022-12-27	WOS:000285181400017
J	Caudal, D; Godsil, BP; Mailliet, F; Bergerot, D; Jay, TM				Caudal, Dorian; Godsil, Bill P.; Mailliet, Francois; Bergerot, Damien; Jay, Therese M.			Acute Stress Induces Contrasting Changes in AMPA Receptor Subunit Phosphorylation within the Prefrontal Cortex, Amygdala and Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GATED ION CHANNELS; SYNAPTIC PLASTICITY; WORKING-MEMORY; IN-VIVO; DEPRESSION; TRAFFICKING; TRANSMISSION; MODEL; RATS	Exposure to stress causes differential neural modifications in various limbic regions, namely the prefrontal cortex, hippocampus and amygdala. We investigated whether alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) phosphorylation is involved with these stress effects. Using an acute inescapable stress protocol with rats, we found opposite effects on AMPA receptor phosphorylation in the medial prefrontal cortex (mPFC) and dorsal hippocampus (DH) compared to the amygdala and ventral hippocampus (VH). After stress, the phosphorylation of Ser831-GluA1 was markedly decreased in the mPFC and DH, whereas the phosphorylation of Ser845-GluA1 was increased in the amygdala and VH. Stress also modulated the GluA2 subunit with a decrease in the phosphorylation of both Tyr876-GluA2 and Ser880-GluA2 residues in the amygdala, and an increase in the phosphorylation of Ser880-GluA2 in the mPFC. These results demonstrate that exposure to acute stress causes subunit-specific and region-specific changes in glutamatergic transmission, which likely lead to the reduced synaptic efficacy in the mPFC and DH and augmented activity in the amygdala and VH. In addition, these findings suggest that modifications of glutamate receptor phosphorylation could mediate the disruptive effects of stress on cognition. They also provide a means to reconcile the contrasting effects that stress has on synaptic plasticity in these regions. Taken together, the results provide support for a brain region-oriented approach to therapeutics.	[Caudal, Dorian; Godsil, Bill P.; Mailliet, Francois; Bergerot, Damien; Jay, Therese M.] Ctr Psychiat & Neurosci, INSERM U894, Paris, France; [Caudal, Dorian; Godsil, Bill P.; Mailliet, Francois; Bergerot, Damien; Jay, Therese M.] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Caudal, D (corresponding author), Ctr Psychiat & Neurosci, INSERM U894, Paris, France.	therese.jay@inserm.fr	Caudal, Dorian/D-3644-2015; Jay, Therese M/G-2297-2015	Jay, Therese M/0000-0002-2468-1141; Godsil, Bill/0000-0001-7248-4292; Jay, Therese/0000-0003-3553-9236; Caudal, Dorian/0000-0003-4288-3801	INSERM (Institut de la Sante et de la Recherche Medicale); Universite Paris Descartes; French Ministere de l'Education Nationale; INSERM	INSERM (Institut de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Descartes; French Ministere de l'Education Nationale; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from INSERM (Institut de la Sante et de la Recherche Medicale) and Universite Paris Descartes. DC was supported by a fellowship from the French Ministere de l'Education Nationale. BG was supported by a fellowship from INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bassani S, 2009, NEUROSCIENCE, V158, P55, DOI 10.1016/j.neuroscience.2008.10.007; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Chung HJ, 2000, J NEUROSCI, V20, P7258; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Delgado JY, 2005, NEUROPHARMACOLOGY, V48, P936, DOI 10.1016/j.neuropharm.2005.01.008; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DIAMOND D, 1994, STRESS IMPAIRS LTP H, P411; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FOY MR, 1987, BEHAV NEURAL BIOL, V48, P138, DOI 10.1016/S0163-1047(87)90664-9; FUMAGALLI F, 2010, HIPPOCAMPUS IN PRESS; Fumagalli F, 2009, J NEUROCHEM, V109, P1733, DOI 10.1111/j.1471-4159.2009.06088.x; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; HOLMES A, 2009, NEUROSCIENCE BIOBEHA, V33; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; LI GH, 2010, INT J PHYSL PATHOPHY, V2, P47; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Liu WH, 2010, J BIOL CHEM, V285, P6101, DOI 10.1074/jbc.M109.050229; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Maggio N, 2009, J NEUROSCI, V29, P8633, DOI 10.1523/JNEUROSCI.1901-09.2009; Mailliet F, 2008, EXP NEUROL, V211, P593, DOI 10.1016/j.expneurol.2008.02.030; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Maroun M, 2003, J NEUROSCI, V23, P4406; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Qi HS, 2009, NEUROPHARMACOLOGY, V56, P37, DOI 10.1016/j.neuropharm.2008.06.068; Reznikov LR, 2007, EUR J NEUROSCI, V25, P3109, DOI 10.1111/j.1460-9568.2007.05560.x; Robertson DAF, 2005, EUR J NEUROSCI, V21, P1511, DOI 10.1111/j.1460-9568.2005.03990.x; Rocher C, 2004, CEREB CORTEX, V14, P224, DOI 10.1093/cercor/bhg122; Sanderson DJ, 2008, PROG BRAIN RES, V169, P159, DOI 10.1016/S0079-6123(07)00009-X; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Shakesby AC, 2002, J NEUROSCI, V22, P3638; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Svenningsson P, 2007, EUR J NEUROSCI, V26, P3509, DOI 10.1111/j.1460-9568.2007.05952.x; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Taylor JR, 1999, J NEUROSCI, V19; Vouimba RM, 2004, EUR J NEUROSCI, V19, P1887, DOI 10.1111/j.1460-9568.2004.03294.x; Vouimba RM, 2007, NEUROPHARMACOLOGY, V52, P244, DOI 10.1016/j.neuropharm.2006.07.007; Wang JQ, 2005, MOL NEUROBIOL, V32, P237, DOI 10.1385/MN:32:3:237; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0	51	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15282	10.1371/journal.pone.0015282	http://dx.doi.org/10.1371/journal.pone.0015282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170339	Green Published, Green Submitted, gold			2022-12-27	WOS:000285084100033
J	Cettomai, D; Kwasa, J; Kendi, C; Birbeck, GL; Price, RW; Bukusi, EA; Cohen, CR; Meyer, AC				Cettomai, Deanna; Kwasa, Judith; Kendi, Caroline; Birbeck, Gretchen L.; Price, Richard W.; Bukusi, Elizabeth A.; Cohen, Craig R.; Meyer, Ana-Claire			Utility of Quantitative Sensory Testing and Screening Tools in Identifying HIV-Associated Peripheral Neuropathy in Western Kenya: Pilot Testing	PLOS ONE			English	Article							GRADUATED TUNING FORK; RELIABILITY; FOOT; POLYNEUROPATHY; ULCERATION; THRESHOLD	Background/Aim: Neuropathy is the most common neurologic complication of HIV but is widely under-diagnosed in resource-constrained settings. We aimed to identify tools that accurately distinguish individuals with moderate/severe peripheral neuropathy and can be administered by non-physician healthcare workers (HCW) in resource-constrained settings. Methods: We enrolled a convenience sample of 30 HIV-infected outpatients from a Kenyan HIV-care clinic. A HCW administered the Neuropathy Severity Score (NSS), Single Question Neuropathy Screen (Single-QNS), Subjective Peripheral Neuropathy Screen (Subjective-PNS), and Brief Peripheral Neuropathy Screen (Brief-PNS). Monofilament, graduated tuning fork, and two-point discrimination examinations were performed. Tools were validated against a neurologist's clinical assessment of moderate/severe neuropathy. Results: The sample was 57% male, mean age 38.6 years, and mean CD4 count 324 cells/mu L. Neurologist's assessment identified 20% (6/30) with moderate/severe neuropathy. Diagnostic utilities for moderate/severe neuropathy were: Single-QNS - 83% sensitivity, 71% specificity; Subjective-PNS-total - 83% sensitivity, 83% specificity; Subjective-PNS-max and NSS - 67% sensitivity, 92% specificity; Brief-PNS - 0% sensitivity, 92% specificity; monofilament - 100% sensitivity, 88% specificity; graduated tuning fork - 83% sensitivity, 88% specificity; two-point discrimination - 75% sensitivity, 58% specificity. Conclusions: Pilot testing suggests Single-QNS, Subjective-PNS, and monofilament examination accurately identify HIV-infected patients with moderate/severe neuropathy and may be useful diagnostic tools in resource-constrained settings.	[Cettomai, Deanna; Kwasa, Judith; Kendi, Caroline; Bukusi, Elizabeth A.; Meyer, Ana-Claire] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Cettomai, Deanna; Price, Richard W.; Meyer, Ana-Claire] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Birbeck, Gretchen L.] Michigan State Univ, Int Neurol & Psychiat Epidemiol Program, E Lansing, MI 48824 USA; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	Kenya Medical Research Institute; University of California System; University of California San Francisco; Michigan State University; University of California System; University of California San Francisco	Cettomai, D (corresponding author), Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya.	meyerac@sfgh.ucsf.edu		Saylor, Deanna/0000-0002-9297-0244; Meyer, Ana-Claire/0000-0002-4906-3059	Fulbright African Regional Research Program; American Academy of Neurology; Doris Duke International; Fogarty International, National Institutes of Health [5 R24 TW00798, 3 R24 TW00798-02S1]; Fogarty International Center through Vanderbilt University; National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); Office of the Director, National Institutes of Health; National Institute of Mental Health (NIMH)	Fulbright African Regional Research Program; American Academy of Neurology; Doris Duke International; Fogarty International, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fogarty International Center through Vanderbilt University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Fulbright African Regional Research Program, American Academy of Neurology Practice Research Training Fellowship, and Doris Duke International Clinical Research Fellowship. In addition, this study was supported by the Fogarty International Clinical Research Fellowship (5 R24 TW00798; 3 R24 TW00798-02S1) from the National Institutes of Health, Fogarty International Center through Vanderbilt University, the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), Office of the Director, National Institutes of Health and the National Institute of Mental Health (NIMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arseculeratne Y M, 2003, J Wound Care, V12, P215; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; DIAMOND JE, 1989, PHYS THER, V69, P797, DOI 10.1093/ptj/69.10.797; Ellis RJ, ARCH NEUROL, V67, P552; KANDIAH P, J NEUROL NE IN PRESS; Kastenbauer T, 2004, DIABETIC MED, V21, P563, DOI 10.1111/j.1464-5491.2004.01205.x; Martina ISJ, 1998, J NEUROL NEUROSUR PS, V65, P743, DOI 10.1136/jnnp.65.5.743; Marx RG, 1998, J HAND SURG-BRIT EUR, V23B, P499, DOI 10.1016/S0266-7681(98)80132-0; Mayfield JA, 2000, J FAM PRACTICE, V49, P499; McArthur JC, 1998, ARCH NEUROL-CHICAGO, V55, P1513, DOI 10.1001/archneur.55.12.1513; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; Merkies ISJ, 2000, J NEUROL NEUROSUR PS, V68, P669, DOI 10.1136/jnnp.68.5.669; Mitchell PD, 2001, LEPROSY REV, V72, P143; Periyasamy R, 2008, J BRACHIAL PLEX PERI, V3, DOI 10.1186/1749-7221-3-3; THIVOLET C, 1990, DIABETES CARE, V13, P1077, DOI 10.2337/diacare.13.10.1077; Venkataramana AB, 2005, AIDS READ, V15, P348; Venkataramana AB, 2005, AIDS READ, V15, P354; Venkataramana Anita B, 2005, AIDS Read, V15, P341; World Health Organization, 2006, WORLD HLTH REP WORK	19	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14256	10.1371/journal.pone.0014256	http://dx.doi.org/10.1371/journal.pone.0014256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170387	gold, Green Published			2022-12-27	WOS:000285084100010
J	Baggott, MJ; Siegrist, JD; Galloway, GP; Robertson, LC; Coyle, JR; Mendelson, JE				Baggott, Matthew J.; Siegrist, Jennifer D.; Galloway, Gantt P.; Robertson, Lynn C.; Coyle, Jeremy R.; Mendelson, John E.			Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans	PLOS ONE			English	Article							LYSERGIC-ACID DIETHYLAMIDE; COMPLEX VISUAL HALLUCINATIONS; PARKINSONS-DISEASE PATIENTS; MYSTICAL-TYPE EXPERIENCES; TOP-DOWN FACILITATION; OBJECT RECOGNITION; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; METHYLENEDIOXYAMPHETAMINE MDA; PERCEPTUAL ORGANIZATION; SPIRITUAL SIGNIFICANCE	Background: The mechanisms of drug-induced visions are poorly understood. Very few serotonergic hallucinogens have been studied in humans in decades, despite widespread use of these drugs and potential relevance of their mechanisms to hallucinations occurring in psychiatric and neurological disorders. Methodology/Principal Findings: We investigated the mechanisms of hallucinogen-induced visions by measuring the visual and perceptual effects of the hallucinogenic serotonin 5-HT2AR receptor agonist and monoamine releaser, 3,4-methylenedioxyamphetamine (MDA), in a double-blind placebo-controlled study. We found that MDA increased self-report measures of mystical-type experience and other hallucinogen-like effects, including reported visual alterations. MDA produced a significant increase in closed-eye visions (CEVs), with considerable individual variation. Magnitude of CEVs after MDA was associated with lower performance on measures of contour integration and object recognition. Conclusions/Significance: Drug-induced visions may have greater intensity in people with poor sensory or perceptual processing, suggesting common mechanisms with other hallucinatory syndromes. MDA is a potential tool to investigate mystical experiences and visual perception. Trial Registration:	[Robertson, Lynn C.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Robertson, Lynn C.] Vet Adm, Martinez, CA USA	University of California System; University of California Berkeley		matthew@baggott.net		Baggott, Matthew/0000-0003-1000-194X; Coyle, Jeremy/0000-0002-9874-6649	National Institutes of Health (NIH) [DA016776, EY016975]; NIH/National Center for Research Resources UCSF-CTSI [UL1 RR024131]; Beckley Foundation; Veterans Administration; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016776] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Beckley Foundation; Veterans Administration(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by National Institutes of Health (NIH) DA016776 and NIH/National Center for Research Resources UCSF-CTSI UL1 RR024131. Baggott was supported by the Beckley Foundation. Robertson is supported by NIH EY016975 and a Merit grant from the Veterans Administration. None of those organizations had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian GK, 2009, PSYCHOPHARMACOLOGY, V206, P575, DOI 10.1007/s00213-009-1484-9; Alles G. A., 1959, NEUROPHARMACOLOGY, P181; Anderson G M 3rd, 1978, NIDA Res Monogr, P8; [Anonymous], 1967, MESCAL MECH HALLUCIN; ASAAD G, 1986, AM J PSYCHIAT, V143, P1088; Baggott M, 2000, JAMA-J AM MED ASSOC, V284, P2190, DOI 10.1001/jama.284.17.2190; Baker LE, 1997, PHARMACOL BIOCHEM BE, V57, P737, DOI 10.1016/S0091-3057(96)00334-6; Baker TI, 2009, J PHYSIOL-PARIS, V103, P52, DOI 10.1016/j.jphysparis.2009.05.011; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Barnes J, 2003, NEUROPSYCHOLOGIA, V41, P565, DOI 10.1016/S0028-3932(02)00182-3; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Behrendt RP, 2004, BEHAV BRAIN SCI, V27, P771, DOI 10.1017/S0140525X04000184; Bennett PJ, 1999, J OPT SOC AM A, V16, P654, DOI 10.1364/JOSAA.16.000654; BERCEL NA, 1956, ARCH NEURO PSYCHIATR, V75, P588, DOI 10.1001/archneurpsyc.1956.02330240026003; Bexis S, 2006, BRIT J PHARMACOL, V147, P926, DOI 10.1038/sj.bjp.0706688; Billock VA, 2007, P NATL ACAD SCI USA, V104, P8490, DOI 10.1073/pnas.0610813104; Biousse V, 2004, NEUROLOGY, V62, P177, DOI 10.1212/01.WNL.0000103444.45882.D8; BRAUN U, 1980, J PHARM SCI, V69, P192, DOI 10.1002/jps.2600690220; Bressloff PC, 2002, NEURAL COMPUT, V14, P473, DOI 10.1162/089976602317250861; Bressloff PC, 2002, NEURAL COMPUT, V14, P493, DOI 10.1162/089976602317250870; Brown J, 2007, PSYCHOPHARMACOLOGY, V193, P437, DOI 10.1007/s00213-007-0785-0; Buttner T, 1996, J NEURAL TRANSM, V103, P1195, DOI 10.1007/BF01271204; CALVERT JE, 1988, VISION RES, V28, P1051, DOI 10.1016/0042-6989(88)90082-X; Camilleri AM, 2005, FORENSIC SCI INT, V151, P53, DOI 10.1016/j.forsciint.2004.07.004; CARPENTER RH, 1973, EXP BRAIN RES, V18, P287; Carter OL, 2004, NEUROREPORT, V15, P1947, DOI 10.1097/00001756-200408260-00023; Chandna A, 2001, INVEST OPHTH VIS SCI, V42, P875; COHEN S, 1971, PROGR DRUG RES, P68; Collerton D, 2005, BEHAV BRAIN SCI, V28, P737; Collerton D, 2003, DEMENT GERIATR COGN, V16, P229, DOI 10.1159/000072807; CORLETT PR, 2009, PSYCHOPHARMACOLOGY B; Cowan RL, 2006, PHARMACOL BIOCHEM BE, V84, P219, DOI 10.1016/j.pbb.2006.04.024; CREIGHTON FJ, 1991, BRIT J PSYCHIAT, V159, P713, DOI 10.1192/bjp.159.5.713; Dickson C, 2009, NEUROPSYCHOBIOLOGY, V60, P204, DOI 10.1159/000253556; Diederich NJ, 1998, CLIN NEUROPHARMACOL, V21, P289; Dittrich A, 1998, PHARMACOPSYCHIATRY, V31, P80, DOI 10.1055/s-2007-979351; DITTRICH A, 1994, 50 YEARS OF LSD, P101; Elliott B, 2009, EPILEPSY RES, V85, P172, DOI 10.1016/j.eplepsyres.2009.03.017; Elliott B, 2009, EPILEPSY RES, V85, P162, DOI 10.1016/j.eplepsyres.2009.03.018; ERMENTROUT GB, 1979, BIOL CYBERN, V34, P137, DOI 10.1007/BF00336965; Ffytche DH, 2008, CORTEX, V44, P1067, DOI 10.1016/j.cortex.2008.04.005; Ffytche DH, 2009, CURR OPIN NEUROL, V22, P28, DOI 10.1097/WCO.0b013e32831f1b3f; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Gabrovska VS, 2003, SCHIZOPHR RES, V59, P277, DOI 10.1016/S0920-9964(02)00168-8; Geyer M.A., 2008, TRENDS PHARM SCI; Gonzalez-Maeso J, 2009, CURR MED CHEM, V16, P1017, DOI 10.2174/092986709787581851; Griffiths RR, 2008, J PSYCHOPHARMACOL, V22, P621, DOI 10.1177/0269881108094300; Griffiths RR, 2006, PSYCHOPHARMACOLOGY, V187, P268, DOI 10.1007/s00213-006-0457-5; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HARTMAN AM, 1963, PSYCHOPHARMACOLOGIA, V4, P441, DOI 10.1007/BF00403349; Hayes RD, 2007, CEREB CORTEX, V17, P1117, DOI 10.1093/cercor/bhl021; HIRSHMAN E, 1990, J EXP PSYCHOL LEARN, V16, P634; HOFFER A, 1965, CLIN PHARMACOL THER, V6, P183; HOLLISTER LE, 1962, COMPR PSYCHIAT, V3, P235, DOI 10.1016/S0010-440X(62)80024-8; HOLLISTER LE, 1964, COMPR PSYCHIAT, V5, P170, DOI 10.1016/S0010-440X(64)80030-4; Hollister LE, 1968, CHEM PSYCHOSES LSD R; HOOD RW, 1975, J SCI STUD RELIG, V14, P29, DOI 10.2307/1384454; Hood RW, 2001, J SCI STUD RELIG, V40, P691; JAFFE J H, 1990, P522; Jin DZ, 2005, J NEUROPHYSIOL, V94, P4038, DOI 10.1152/jn.00571.2004; KEELER MH, 1965, PSYCHOPHARMACOLOGIA, V8, P131, DOI 10.1007/BF00404173; Keri Szabolcs, 2009, Cogn Neuropsychiatry, V14, P77, DOI 10.1080/13546800902757936; KERSTEN D, 1988, CLIN VISION SCI, V2, P143; Kiorpes L, 2003, VISUAL NEUROSCI, V20, P567, DOI 10.1017/S0952523803205101; KNAUER A, 1913, J NERV MENT DIS, V40, P425; KNOBLAUCH K, 2008, PSYPHY FUNCTIONS ANA; Koethe D, 2006, SCHIZOPHR RES, V88, P142, DOI 10.1016/j.schres.2006.07.023; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Lauritzen M, 2001, CEPHALALGIA, V21, P757, DOI 10.1046/j.1468-2982.2001.00244.x; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEBOVITS BZ, 1960, ARCH GEN PSYCHIAT, V2, P390; LEVINE DN, 1982, NEUROLOGY, V32, P267, DOI 10.1212/WNL.32.3.267; LYON RA, 1986, PSYCHOPHARMACOLOGY, V88, P525; Manford M, 1998, BRAIN, V121, P1819, DOI 10.1093/brain/121.10.1819; Mayer-Gross W, 1926, Z GESAMTE NEUROL PSY, V101, P354, DOI 10.1007/BF02878343; MCGUIRE P, 1992, BRIT J PSYCHIAT, V160, P276, DOI 10.1192/bjp.160.2.276a; Naranjo, 1973, HEALING JOURNEY NEW; NARANJO C, 1967, MED PHARMACOL EXP, V17, P359; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; NICHOLS DE, 1986, J PSYCHOACTIVE DRUGS, V18, P305, DOI 10.1080/02791072.1986.10472362; NODA S, 1993, J NEUROL NEUROSUR PS, V56, P1224, DOI 10.1136/jnnp.56.11.1224; OHEARN E, 1988, J NEUROSCI, V8, P2788; Oliveri M, 2003, J NEUROL NEUROSUR PS, V74, P1136, DOI 10.1136/jnnp.74.8.1136; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; PATON DM, 1975, P W PHARMACOL SOC, V18, P229; Pelli DG, 1999, J OPT SOC AM A, V16, P647, DOI 10.1364/JOSAA.16.000647; PENFIELD W, 1963, BRAIN, V86, P595, DOI 10.1093/brain/86.4.595; Pentney AR, 2001, J PSYCHOACTIVE DRUGS, V33, P213, DOI 10.1080/02791072.2001.10400568; Pieri V, 2000, J NEUROL SCI, V172, P7, DOI 10.1016/S0022-510X(99)00204-X; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; R Development Core Team, 2007, R LANG ENV STAT COMP; Ramirez-Ruiz B, 2007, DEMENT GERIATR COGN, V23, P281, DOI 10.1159/000100850; Ramirez-Ruiz B, 2006, MOVEMENT DISORD, V21, P1483, DOI 10.1002/mds.20965; REINERT DF, 1993, J SCI STUD RELIG, V32, P383, DOI 10.2307/1387178; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Sadr J, 2004, COGNITIVE SCI, V28, P259, DOI 10.1016/j.cogsci.2004.09.003; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; Schwartz O, 2009, J VISION, V9, DOI 10.1167/9.4.19; SCHWARZ B, 1955, REVERSIBILITY INDUCE; Shanon Benny, 2002, ANTIPODES MIND CHART; Shulgin A., 1997, TIHKAL CONTINUATION; Shulgin AT, 1991, PIHKAL CHEM LOVE STO; Silverstein S, 2006, SCHIZOPHR RES, V83, P41, DOI 10.1016/j.schres.2006.01.003; Silverstein Steven M, 2006, Cogn Neuropsychiatry, V11, P112, DOI 10.1080/13546800444000209; Silverstein SM, 2009, J INTEGR NEUROSCI, V8, P175, DOI 10.1142/S0219635209002113; SNODGRASS JG, 1990, J EXP PSYCHOL GEN, V119, P276, DOI 10.1037/0096-3445.119.3.276; Stace W. T., 1960, MYSTICISM PHILOS; Teich AF, 2003, J NEUROPHYSIOL, V89, P2086, DOI 10.1152/jn.00970.2002; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; TUREK IS, 1974, J PSYCHEDEL DRUG, V6, P7, DOI 10.1080/02791072.1974.10471499; Uhlhaas PJ, 2007, J PSYCHOPHARMACOL, V21, P347, DOI 10.1177/0269881107077739; Uhlhaas PJ, 2006, PSYCHIAT RES, V145, P105, DOI 10.1016/j.psychres.2005.10.016; WEIL AT, 1976, J PSYCHEDEL DRUG, V8, P335, DOI 10.1080/02791072.1976.10471861; WENDEROTH P, 1988, VISION RES, V28, P301, DOI 10.1016/0042-6989(88)90158-7; West LJ, 1962, HALLUCINATIONS; Winter JC, 2009, PSYCHOPHARMACOLOGY, V203, P251, DOI 10.1007/s00213-008-1356-8; YANG CPI, 2003, NEW ANGLE TILT ILLUS; YENSEN R, 1976, J NERV MENT DIS, V163, P233, DOI 10.1097/00005053-197610000-00002; Young R, 1996, J PHARMACOL EXP THER, V276, P594	122	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14074	10.1371/journal.pone.0014074	http://dx.doi.org/10.1371/journal.pone.0014074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	688QY	21152030	Green Published, gold, Green Submitted			2022-12-27	WOS:000284868000002
J	Roque, H; Ward, JJ; Murrells, L; Brunner, D; Antony, C				Roque, Helio; Ward, Jonathan J.; Murrells, Lindsay; Brunner, Damian; Antony, Claude			The Fission Yeast XMAP215 Homolog Dis1p Is Involved in Microtubule Bundle Organization	PLOS ONE			English	Article							INTERPHASE MICROTUBULES; ELECTRON TOMOGRAPHY; MITOTIC SPINDLES; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; CELL POLARITY; PROTEINS; KINETOCHORE; DYNAMICS	Microtubules are essential for a variety of fundamental cellular processes such as organelle positioning and control of cell shape. Schizosaccharomyces pombe is an ideal organism for studying the function and organization of microtubules into bundles in interphase cells. Using light microscopy and electron tomography we analyzed the bundle organization of interphase microtubules in S. pombe. We show that cells lacking ase1p and klp2p still contain microtubule bundles. In addition, we show that ase1p is the major determinant of inter-microtubule spacing in interphase bundles since ase1 deleted cells have an inter-microtubule spacing that differs from that observed in wild-type cells. We then identified dis1p, a XMAP215 homologue, as factor that promotes the stabilization of microtubule bundles. In wild-type cells dis1p partially co-localized with ase1p at regions of microtubule overlap. In cells deleted for ase1 and klp2, dis1p accumulated at the overlap regions of interphase microtubule bundles. In cells lacking all three proteins, both microtubule bundling and inter-microtubule spacing were further reduced, suggesting that Dis1p contributes to interphase microtubule bundling.	[Roque, Helio; Ward, Jonathan J.; Murrells, Lindsay; Brunner, Damian; Antony, Claude] European Mol Biol Lab, Cell Biol & Biophys Program, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Roque, H (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Program, Heidelberg, Germany.	brunner@embl.de; antony@embl.de	Ward, Jonathan/F-8493-2011; antony, claude/K-5342-2013; Brunner, Damian/F-2024-2011	Brunner, Damian/0000-0001-5250-492X; Roque, Helio/0000-0002-5930-1989	European Molecular Biology Laboratory; Volkswagenstiftung	European Molecular Biology Laboratory; Volkswagenstiftung(Volkswagen)	HR and LM were funded by the European Molecular Biology Laboratory International PhD Programme. JJW was funded by the Volkswagenstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Aoki K, 2006, CURR BIOL, V16, P1627, DOI 10.1016/j.cub.2006.06.065; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; BRAUN M, 2009, NAT CELL BIOL; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Chan J, 1999, P NATL ACAD SCI USA, V96, P14931, DOI 10.1073/pnas.96.26.14931; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Foethke D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.76; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Garcia MA, 2002, EMBO J, V21, P6015, DOI 10.1093/emboj/cdf611; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; GILBERT PFC, 1972, PROC R SOC SER B-BIO, V182, P89, DOI 10.1098/rspb.1972.0068; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Hagan IM, 1998, J CELL SCI, V111, P1603; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; HITT AL, 1990, J BIOL CHEM, V265, P1639; Hoog JL, 2007, METHOD CELL BIOL, V79, P145, DOI 10.1016/S0091-679X(06)79006-9; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Karsenti E, 2006, NAT CELL BIOL, V8, P1204, DOI 10.1038/ncb1498; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Marsh BJ, 2001, BIOCHEM SOC T, V29, P461, DOI 10.1042/BST0290461; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MCDONALD KL, 1992, J CELL BIOL, V118, P369, DOI 10.1083/jcb.118.2.369; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Nakaseko Y, 1996, GENES CELLS, V1, P633, DOI 10.1046/j.1365-2443.1996.00253.x; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; OToole ET, 1997, MOL BIOL CELL, V8, P1, DOI 10.1091/mbc.8.1.1; Reinsch S, 1998, J CELL SCI, V111, P2283; Samejima I, 2005, MOL BIOL CELL, V16, P3040, DOI 10.1091/mbc.e04-11-1003; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; Sawin KE, 2004, J CELL SCI, V117, P689, DOI 10.1242/jcs.00925; Segbert C, 2003, MOL BIOL CELL, V14, P4458, DOI 10.1091/mbc.E03-05-0283; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Thadani R, 2009, CURR BIOL, V19, P1861, DOI 10.1016/j.cub.2009.09.063; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tran PT, 1999, BIOL BULL, V197, P262, DOI 10.2307/1542640; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Unsworth A, 2008, MOL BIOL CELL, V19, P5104, DOI 10.1091/mbc.E08-02-0224; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; Venkatram S, 2005, MOL BIOL CELL, V16, P3052, DOI 10.1091/mbc.E04-12-1043; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859	61	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14201	10.1371/journal.pone.0014201	http://dx.doi.org/10.1371/journal.pone.0014201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151990	gold, Green Published			2022-12-27	WOS:000284868000015
J	Krueger, C; Hoffmann, FM				Krueger, Chateen; Hoffmann, F. Michael			Identification of Retinoic Acid in a High Content Screen for Agents that Overcome the Anti-Myogenic Effect of TGF-Beta-1	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; SMP-534 ANTIFIBROTIC AGENT; ACTIVATED PROTEIN-KINASE; INJURED SKELETAL-MUSCLE; VITAMIN-D DERIVATIVES; TGF-BETA; MDX MICE; DIABETIC-NEPHROPATHY; ANDROGEN RECEPTOR; EPITHELIAL-CELLS	Background: Transforming growth factor beta 1 (TGF-beta 1) is an inhibitor of muscle cell differentiation that is associated with fibrosis, poor regeneration and poor function in some diseases of muscle. When neutralizing antibodies to TGF-beta 1 or the angiotensin II inhibitor losartan were used to reduce TGF-beta 1 signaling, muscle morphology and function were restored in mouse models of Marfan Syndrome and muscular dystrophy. The goal of our studies was to identify additional agents that overcome the anti-myogenic effect of TGF-beta 1. Methodology/Principal Findings: A high-content cell-based assay was developed in a 96-well plate format that detects the expression of myosin heavy chain (MHC) in C2C12 cells. The assay was used to quantify the dose-dependent responses of C2C12 cell differentiation to TGF-beta 1 and to the TGF-beta 1 Type 1 receptor kinase inhibitor, SB431542. Thirteen agents previously described as promoting C2C12 differentiation in the absence of TGF-beta 1 were screened in the presence of TGF-beta 1. Only all-trans retinoic acid and 9-cis retinoic acid allowed a maximal level of C2C12 cell differentiation in the presence of TGF-beta 1; the angiotensin-converting enzyme inhibitor captopril and 10 nM estrogen provided partial rescue. Vitamin D was a potent inhibitor of retinoic acid-induced myogenesis in the presence of TGF-beta 1. TGF-beta 1 inhibits myoblast differentiation through activation of Smad3; however, retinoic acid did not inhibit TGF-beta 1-induced activation of a Smad3-dependent reporter gene in C2C12 cells. Conclusions/Significance: Retinoic acid alleviated the anti-myogenic effect of TGF-beta 1 by a Smad3-independent mechanism. With regard to the goal of improving muscle regeneration and function in individuals with muscle disease, the identification of retinoic acid is intriguing in that some retinoids are already approved for human therapy. However, retinoids also have well-described adverse effects. The quantitative, high-content assay will be useful to screen for less-toxic retinoids or combinations of agents that promote myoblast differentiation in the presence of TGF-beta 1.	[Krueger, Chateen] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Dept Oncol, Madison, WI 53706 USA; Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Dept Med Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Krueger, C (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Dept Oncol, 1400 Univ Ave, Madison, WI 53706 USA.	Hoffmann@oncology.wisc.edu		Hoffmann, F. Michael/0000-0002-2770-9656	Muscular Dystrophy Association [MDA69637]; National Cancer Institute [P30 CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by funding from the Muscular Dystrophy Association (www.mda.org) (Grant # MDA69637) and funding for core facilities from the National Cancer Institute (www.cancer.gov) funds to the Paul Carbone Comprehensive Cancer Center (www.cancer.wisc.edu) P30 CA014520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Amthor H, 2002, DEV BIOL, V251, P241, DOI 10.1006/dbio.2002.0812; ARNOLD HH, 1992, J CELL BIOL, V118, P877, DOI 10.1083/jcb.118.4.877; Bastie JN, 2004, MOL ENDOCRINOL, V18, P2685, DOI 10.1210/me.2003-0412; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; Blutt SE, 1997, ENDOCRINOLOGY, V138, P1491, DOI 10.1210/en.138.4.1491; Borger DR, 2000, VIROLOGY, V270, P397, DOI 10.1006/viro.2000.0282; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P3822, DOI 10.1073/pnas.88.9.3822; Brisdelli F, 2009, CURR DRUG METAB, V10, P530, DOI 10.2174/138920009789375423; Brown D, 2009, J ENDOCRINOL, V201, P129, DOI 10.1677/JOE-08-0476; Cao ZH, 2003, BLOOD, V101, P498, DOI 10.1182/blood-2002-05-1549; CARNAC G, 1993, ENDOCRINOLOGY, V133, P2171, DOI 10.1210/en.133.5.2171; Chakrabarti R, 2009, ANTI-CANCER DRUG, V20, P334, DOI 10.1097/CAD.0b013e328327994e; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Chroni E, 2010, DRUG SAFETY, V33, P25, DOI 10.2165/11319020-000000000-00000; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Danielpour D, 1996, J CELL PHYSIOL, V166, P231, DOI 10.1002/(SICI)1097-4652(199601)166:1<231::AID-JCP24>3.0.CO;2-G; De Albuquerque DA, 2004, KIDNEY INT, V65, P846, DOI 10.1111/j.1523-1755.2004.00462.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Enns DL, 2010, SPORTS MED, V40, P41, DOI 10.2165/11319760-000000000-00000; Garber K, 2009, J NATL CANCER I, V101, P1664, DOI 10.1093/jnci/djp462; GLICK AB, 1989, CELL REGUL, V1, P87, DOI 10.1091/mbc.1.1.87; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hemdan DII, 2009, J MED INVESTIG, V56, P26, DOI 10.2152/jmi.56.26; Imai S, 1997, FEBS LETT, V411, P102, DOI 10.1016/S0014-5793(97)00673-X; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iwata Y, 2005, BIOCHEM PHARMACOL, V70, P740, DOI 10.1016/j.bcp.2005.05.034; Izumi K, 2009, PROSTATE, V69, P1222, DOI 10.1002/pros.20975; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kahlert S, 1997, BIOCHEM BIOPH RES CO, V232, P373, DOI 10.1006/bbrc.1997.6223; Kempf W, 2003, HEMATOL ONCOL CLIN N, V17, P1405, DOI 10.1016/S0889-8588(03)00107-2; KOJIMA S, 1993, J CELL PHYSIOL, V155, P323, DOI 10.1002/jcp.1041550213; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; La P, 2003, ONCOGENE, V22, P198, DOI 10.1038/sj.onc.1206100; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Lee HJ, 2007, ONCOGENE, V26, P173, DOI 10.1038/sj.onc.1209774; Lengfelder E, 2005, CRIT REV ONCOL HEMAT, V56, P261, DOI 10.1016/j.critrevonc.2004.08.009; Lens M, 2008, EXPERT OPIN PHARMACO, V9, P1363, DOI 10.1517/14656566.9.8.1363 ; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; Matsuda T, 2001, J BIOL CHEM, V276, P42908, DOI 10.1074/jbc.M105316200; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Messina S, 2009, EXP NEUROL, V220, P349, DOI 10.1016/j.expneurol.2009.09.015; Miller VA, 1997, J CLIN ONCOL, V15, P790, DOI 10.1200/JCO.1997.15.2.790; Mori S, 2007, BIOCHEM BIOPH RES CO, V363, P597, DOI 10.1016/j.bbrc.2007.09.006; Mori S, 2007, BIOCHEM BIOPH RES CO, V353, P369, DOI 10.1016/j.bbrc.2006.12.056; Mucida D, 2007, CELL ADHES MIGR, V1, P142, DOI 10.4161/cam.1.3.5062; Nakae Y, 2008, HISTOCHEM CELL BIOL, V129, P489, DOI 10.1007/s00418-008-0390-2; Naylor AJD, 2009, LIFE SCI, V84, P637, DOI [10.1016/j.lfs.2009.02.011, 10.1016/j.lfs.2009.02.01]; Negishi S, 2005, AM J SPORT MED, V33, P1816, DOI 10.1177/0363546505278701; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nunes I, 1996, CANCER RES, V56, P495; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pedraza-Alva G, 2009, BIOCHEM BIOPH RES CO, V389, P360, DOI 10.1016/j.bbrc.2009.08.153; Pendaries V, 2003, ONCOGENE, V22, P8212, DOI 10.1038/sj.onc.1206913; Portier GL, 1999, IN VITRO CELL DEV-AN, V35, P219, DOI 10.1007/s11626-999-0030-8; REDLICH CA, 1995, AM J RESP CELL MOL, V12, P287, DOI 10.1165/ajrcmb.12.3.7873195; Reimann J, 2000, NEUROMUSCULAR DISORD, V10, P276, DOI 10.1016/S0960-8966(99)00118-2; ROBERTS AB, 1992, CANCER SURV, V14, P205; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Samuel CS, 2005, CLIN MED RES, V3, P241, DOI 10.3121/cmr.3.4.241; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; SPORN MB, 1990, CELL REGUL, V1, P875, DOI 10.1091/mbc.1.12.875; Stio M, 2002, IUBMB LIFE, V53, P175, DOI 10.1080/15216540212334; Stio M, 2001, J STEROID BIOCHEM, V77, P213, DOI 10.1016/S0960-0760(01)00059-0; Sugaru E, 2006, AM J NEPHROL, V26, P50, DOI 10.1159/000091786; Sugaru E, 2007, NEPHRON EXP NEPHROL, V105, pE45, DOI 10.1159/000097603; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Thielitz A, 2006, DERMATOL THER, V19, P272, DOI 10.1111/j.1529-8019.2006.00084.x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vlahopoulos S, 2005, J BIOL CHEM, V280, P7786, DOI 10.1074/JBC.m413992200; WATT KI, 2010, MUSCLE NERVE; Wengrower D, 2004, INFLAMM BOWEL DIS, V10, P536, DOI 10.1097/00054725-200409000-00007; Wrightont KH, 2008, P NATL ACAD SCI USA, V105, P9244, DOI 10.1073/pnas.0800163105; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; XIAO YH, 1995, J CELL BIOL, V129, P1345, DOI 10.1083/jcb.129.5.1345; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yu L, 2004, KIDNEY INT, V66, P1774, DOI 10.1111/j.1523-1755.2004.00901.x; Yu ZL, 2006, BIOCHEM BIOPH RES CO, V340, P929, DOI 10.1016/j.bbrc.2005.12.100; Yun BG, 2005, CELL SIGNAL, V17, P1477, DOI 10.1016/j.cellsig.2005.03.006; Yun CH, 2010, ARCH BIOCHEM BIOPHYS, V495, P8, DOI 10.1016/j.abb.2009.12.003; Zhang Chunlei, 2003, Dermatol Ther, V16, P322, DOI 10.1111/j.1396-0296.2003.01644.x; Zhang H, 2009, CELL PHYSIOL BIOCHEM, V23, P157, DOI 10.1159/000204104; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	97	15	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15511	10.1371/journal.pone.0015511	http://dx.doi.org/10.1371/journal.pone.0015511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152098	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100089
J	Lee, MC; Ting, KK; Adams, S; Brew, BJ; Chung, R; Guillemin, GJ				Lee, Ming-Chak; Ting, Ka Ka; Adams, Seray; Brew, Bruce J.; Chung, Roger; Guillemin, Gilles J.			Characterisation of the Expression of NMDA Receptors in Human Astrocytes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; AIDS DEMENTIA COMPLEX; QUINOLINIC ACID; CORTICAL ASTROCYTES; KYNURENINE PATHWAY; ALZHEIMERS-DISEASE; NR2A/B SUBUNITS; HUMAN NEURONS; MICROGLIA; OLIGODENDROCYTES	Astrocytes have long been perceived only as structural and supporting cells within the central nervous system (CNS). However, the discovery that these glial cells may potentially express receptors capable of responding to endogenous neurotransmitters has resulted in the need to reassess astrocytic physiology. The aim of the current study was to characterise the expression of NMDA receptors (NMDARs) in primary human astrocytes, and investigate their response to physiological and excitotoxic concentrations of the known endogenous NMDAR agonists, glutamate and quinolinic acid (QUIN). Primary cultures of human astrocytes were used to examine expression of these receptors at the mRNA level using RT-PCR and qPCR, and at the protein level using immunocytochemistry. The functionality role of the receptors was assessed using intracellular calcium influx experiments and measuring extracellular lactate dehydrogenase (LDH) activity in primary cultures of human astrocytes treated with glutamate and QUIN. We found that all seven currently known NMDAR subunits (NR1, NR2A, NR2B, NR2C, NR2D, NR3A and NR3B) are expressed in astrocytes, but at different levels. Calcium influx studies revealed that both glutamate and QUIN could activate astrocytic NMDARs, which stimulates Ca2+ influx into the cell and can result in dysfunction and death of astrocytes. Our data also show that the NMDAR ion channel blockers, MK801, and memantine can attenuate glutamate and QUIN mediated cell excitotoxicity. This suggests that the mechanism of glutamate and QUIN gliotoxicity is at least partially mediated by excessive stimulation of NMDARs. The present study is the first to provide definitive evidence for the existence of functional NMDAR expression in human primary astrocytes. This discovery has significant implications for redefining the cellular interaction between glia and neurons in both physiological processes and pathological conditions.	[Lee, Ming-Chak; Ting, Ka Ka; Adams, Seray; Guillemin, Gilles J.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Lee, Ming-Chak; Ting, Ka Ka; Adams, Seray; Brew, Bruce J.; Guillemin, Gilles J.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept HIV Med, Sydney, NSW 2010, Australia; [Chung, Roger] Univ Tasmania, Menzies Res Inst, Neurorepair Grp, Hobart, Tas, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of Tasmania; Menzies Institute for Medical Research	Lee, MC (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia.	g.guillemin@unsw.edu.au	Guillemin, Gilles J/C-3878-2015; Brew, Bruce/J-6513-2012; McLean, Emma/F-4616-2012; Chung, Roger/ABF-8395-2020	Guillemin, Gilles J/0000-0001-8105-4470; Chung, Roger/0000-0002-9286-947X; brew, bruce/0000-0003-0622-1392; Adams, Seray/0000-0002-3700-094X	University of New South Wales; Rebecca L. Cooper Medical Research Foundation; Deb Bailey Foundation	University of New South Wales; Rebecca L. Cooper Medical Research Foundation; Deb Bailey Foundation	This work was supported by the University of New South Wales and the Rebecca L. Cooper Medical Research Foundation and the Deb Bailey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z; Brand-Schieber E, 2003, GLIA, V42, P12, DOI 10.1002/glia.10136; CHEN Y, 2009, NEUROTOX RES; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Conti F, 1996, GLIA, V17, P254, DOI 10.1002/(SICI)1098-1136(199607)17:3<254::AID-GLIA7>3.0.CO;2-0; Conti F, 1999, CEREB CORTEX, V9, P110, DOI 10.1093/cercor/9.2.110; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; Espinosa L, 1999, J PHYSIOL-LONDON, V518, P47, DOI 10.1111/j.1469-7793.1999.0047r.x; Guillemin G, 1996, GLIA, V16, P71, DOI 10.1002/(SICI)1098-1136(199601)16:1<71::AID-GLIA8>3.0.CO;2-E; Guillemin G, 1997, J NEUROSCI RES, V49, P576, DOI 10.1002/(SICI)1097-4547(19970901)49:5<576::AID-JNR8>3.0.CO;2-8; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-16; Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x; Guillemin GJ, 2005, NEUROTOX RES, V7, P103, DOI 10.1007/BF03033781; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Guillemin GJ, 2003, NEUROREPORT, V14, P2311, DOI 10.1097/00001756-200312190-00005; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Heyes MP, 1997, BIOCHEM J, V326, P351, DOI 10.1042/bj3260351; Kalariti N, 2004, ANTICANCER RES, V24, P3923; Kerr SJ, 1998, AIDS, V12, P355, DOI 10.1097/00002030-199804000-00003; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Magistretti P.J., 2002, NEUROPSYCHOPHARMACOL; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PERKINS MN, 1983, J PHARMACOL EXP THER, V226, P551; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; Schipke CG, 2001, FASEB J, V15, P1270, DOI 10.1096/fj.00-0439fje; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Tavares RG, 2002, NEUROCHEM INT, V40, P621, DOI 10.1016/S0197-0186(01)00133-4; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Ting KK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-36; Walton HS, 2007, NEUROCHEM INT, V50, P1052, DOI 10.1016/j.neuint.2006.10.007; WALTON HS, 2006, NEUROCHEM INT; Wong R, 2006, BIOESSAYS, V28, P460, DOI 10.1002/bies.20402; YAMANAKA K, 2008, NAT NEUROSCI; Zhang Qi, 2003, J Huazhong Univ Sci Technolog Med Sci, V23, P254	40	121	126	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14123	10.1371/journal.pone.0014123	http://dx.doi.org/10.1371/journal.pone.0014123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152063	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100007
J	Medendorp, K; Vreede, L; van Groningen, JJM; Hetterschijt, L; Brugmans, L; Jansen, PAM; van den Hurk, WH; de Bruijn, DRH; van Kessel, AG				Medendorp, Klaas; Vreede, Lilian; van Groningen, Jan J. M.; Hetterschijt, Lisette; Brugmans, Linda; Jansen, Patrick A. M.; van den Hurk, Wilhelmina H.; de Bruijn, Diederik R. H.; van Kessel, Ad Geurts			The Mitotic Arrest Deficient Protein MAD2B Interacts with the Clathrin Light Chain A during Mitosis	PLOS ONE			English	Article							RENAL-CELL CARCINOMAS; SPINDLE; COMPLEX; FUSION; GENE; PRCC; TRANSLOCATION; KINETOCHORES; MEMBRANE; CANCER	Background: Although the mitotic arrest deficient protein MAD2B (MAD2L2) is thought to inhibit the anaphase promoting complex (APC) by binding to CDC20 and/or CDH1 (FZR1), its exact role in cell cycle control still remains to be established. Methodology/Principal Findings: Using a yeast two-hybrid interaction trap we identified the human clathrin light chain A (CLTA) as a novel MAD2B binding protein. A direct interaction was established in mammalian cells via GST pull-down and endogenous co-immunoprecipitation during the G2/M phase of the cell cycle. Through subsequent confocal laser scanning microscopy we found that MAD2B and CLTA co-localize at the mitotic spindle. Clathrin forms a trimeric structure, i.e., the clathrin triskelion, consisting of three heavy chains (CLTC), each with an associated light chain. This clathrin structure has previously been shown to be required for the function of the mitotic spindle through stabilization of kinetochore fibers. Upon siRNA-mediated MAD2B depletion, we found that CLTA was no longer concentrated at the mitotic spindle but, instead, diffusely distributed throughout the cell. In addition, we found a marked increase in the percentage of misaligned chromosomes. Conclusions/Significance: Previously, we identified MAD2B as an interactor of the renal cell carcinoma (RCC)-associated protein PRCC. In addition, we found that fusion of PRCC with the transcription factor TFE3 in t(X;1)(p11;q21)-positive RCCs results in an impairment of this interaction and a concomitant failure to shuttle MAD2B to the nucleus. Our current data show that MAD2B interacts with CLTA during the G2/M phase of the cell cycle and that depletion of MAD2B leads to a marked increase in the percentage of misaligned chromosomes and a redistribution of CLTA during mitosis.	[Medendorp, Klaas; Vreede, Lilian; van Groningen, Jan J. M.; Hetterschijt, Lisette; Brugmans, Linda; van den Hurk, Wilhelmina H.; de Bruijn, Diederik R. H.; van Kessel, Ad Geurts] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Jansen, Patrick A. M.] Radboud Univ Nijmegen, Dept Dermatol, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Medendorp, K (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	a.geurtsvankessel@antrg.umcn.nl	Jansen, Patrick AM/P-5602-2015; de Bruijn, D.R.H./L-4233-2015; van Kessel, Ad Geurts/A-2810-2010; Vreede, Lilian/E-2557-2018		Dutch Cancer Society	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Argani P, 2003, ONCOGENE, V22, P5374, DOI 10.1038/sj.onc.1206686; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BRONS PPT, 1990, CYTOMETRY, V11, P837, DOI 10.1002/cyto.990110710; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Cheung HW, 2006, CANCER RES, V66, P4357, DOI 10.1158/0008-5472.CAN-05-3602; de Bruijn DRH, 2008, ONCOGENE, V27, P653, DOI 10.1038/sj.onc.1210688; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kantardzhieva A, 2005, INVEST OPHTH VIS SCI, V46, P2192, DOI 10.1167/iovs.04-1417; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lenart P, 2006, CURR BIOL, V16, pR412, DOI 10.1016/j.cub.2006.05.008; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Medendorp K, 2007, CYTOGENET GENOME RES, V118, P157, DOI 10.1159/000108296; Medendorp K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007020; Medendorp K, 2009, EXP CELL RES, V315, P2399, DOI 10.1016/j.yexcr.2009.04.022; Moore DD, 1995, GLOB MOB SURV; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; van den Hurk WH, 2004, CYTOGENET GENOME RES, V106, P68, DOI 10.1159/000078562; WARREN G, 1993, NATURE, V362, P297, DOI 10.1038/362297a0; Weterman MAJ, 1996, P NATL ACAD SCI USA, V93, P15294, DOI 10.1073/pnas.93.26.15294; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; Yamauchi T, 2008, EMBO J, V27, P1852, DOI 10.1038/emboj.2008.118	34	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15128	10.1371/journal.pone.0015128	http://dx.doi.org/10.1371/journal.pone.0015128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152103	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100083
J	Rhainds, M; Fagan, WF				Rhainds, Marc; Fagan, William F.			Broad-Scale Latitudinal Variation in Female Reproductive Success Contributes to the Maintenance of a Geographic Range Boundary in Bagworms (Lepidoptera: Psychidae)	PLOS ONE			English	Article							MATING SUCCESS; SPECIES RANGE; MOTH; INSECT; LIMITS; POPULATIONS; TIME; EXPANSION; ABUNDANCE; SIZE	Background: Geographic range limits and the factors structuring them are of great interest to biologists, in part because of concerns about how global change may shift range boundaries. However, scientists lack strong mechanistic understanding of the factors that set geographic range limits in empirical systems, especially in animals. Methodology/Principal Findings: Across dozens of populations spread over six degrees of latitude in the American Midwest, female mating success of the evergreen bagworm Thyridopteryx ephemeraeformis (Lepidoptera: Psychidae) declines from similar to 100% to similar to 0% near the edge of the species range. When coupled with additional latitudinal declines in fecundity and in egg and pupal survivorship, a spatial gradient of bagworm reproductive success emerges. This gradient is associated with a progressive decline in local abundance and an increased risk of local population extinction, up to a latitudinal threshold where extremely low female fitness meshes spatially with the species' geographic range boundary. Conclusions/Significance: The reduction in fitness of female bagworms near the geographic range limit, which concords with the abundant centre hypothesis from biogeography, provides a concrete, empirical example of how an Allee effect (increased pre-reproductive mortality of females in sparsely populated areas) may interact with other demographic factors to induce a geographic range limit.	[Rhainds, Marc] Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Fredericton, NB, Canada; [Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Natural Resources Canada; Canadian Forest Service; University System of Maryland; University of Maryland College Park	Rhainds, M (corresponding author), Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Fredericton, NB, Canada.	mrhainds@nrcan.gc.ca						Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Bird JM, 2005, ECOL ENTOMOL, V30, P510, DOI 10.1111/j.0307-6946.2005.00719.x; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Chown SL, 2003, ECOGRAPHY, V26, P445, DOI 10.1034/j.1600-0587.2003.03479.x; Contarini M, 2009, ENTOMOL EXP APPL, V133, P307, DOI 10.1111/j.1570-7458.2009.00930.x; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; DEMPSTER JP, 1983, BIOL REV, V58, P461, DOI 10.1111/j.1469-185X.1983.tb00396.x; Gascoigne J, 2009, POPUL ECOL, V51, P355, DOI 10.1007/s10144-009-0146-4; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Holt RD, 2000, ECOL LETT, V3, P41, DOI 10.1046/j.1461-0248.2000.00116.x; KAUFMANN T, 1968, ANN ENTOMOL SOC AM, V61, P38, DOI 10.1093/aesa/61.1.38; Keitt TH, 2001, AM NAT, V157, P203, DOI 10.1086/318633; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; LEONHARDT BA, 1983, SCIENCE, V219, P314, DOI 10.1126/science.219.4582.314; MORDEN R D, 1971, Entomological News, V82, P151; Rhainds M, 2009, ANNU REV ENTOMOL, V54, P209, DOI 10.1146/annurev.ento.54.110807.090448; Rhainds M, 2008, ECOL ENTOMOL, V33, P663, DOI 10.1111/j.1365-2311.2008.01027.x; Rhainds M, 2010, ENTOMOL EXP APPL, V136, P211, DOI 10.1111/j.1570-7458.2010.01032.x; Robinet C, 2008, J ANIM ECOL, V77, P966, DOI 10.1111/j.1365-2656.2008.01417.x; Rooney TP, 1996, AM MIDL NAT, V136, P84, DOI 10.2307/2426633; Rosenheim JA, 2008, AM NAT, V172, P486, DOI 10.1086/591677; SADOF C, DID BAGWORMS SURVIVE; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Samis KE, 2007, ECOLOGY, V88, P1747, DOI 10.1890/06-1153.1; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; SHAROV AA, 1995, ENVIRON ENTOMOL, V24, P1239, DOI 10.1093/ee/24.5.1239; Sheppard R.F., 1975, Bulletin Ent Soc Amer, V21, P153; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; STILING P, 1988, J ANIM ECOL, V57, P581, DOI 10.2307/4926; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038	33	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14166	10.1371/journal.pone.0014166	http://dx.doi.org/10.1371/journal.pone.0014166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152445	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100043
J	Douard, G; Praud, K; Cloeckaert, A; Doublet, B				Douard, Gregory; Praud, Karine; Cloeckaert, Axel; Doublet, Benoit			The Salmonella Genomic Island 1 Is Specifically Mobilized In Trans by the IncA/C Multidrug Resistance Plasmid Family	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL PLASMIDS; TYPHIMURIUM DT104; CLINICAL ISOLATE; VARIANT SGI1-O; INCI1 PLASMID; ENTERICA; POULTRY; HUMANS; FRANCE	Background: The Salmonella genomic island 1 (SGI1) is a Salmonella enterica-derived integrative mobilizable element (IME) containing various complex multiple resistance integrons identified in several S. enterica serovars and in Proteus mirabilis. Previous studies have shown that SGI1 transfers horizontally by in trans mobilization in the presence of the IncA/C conjugative helper plasmid pR55. Methodology/Principal Findings: Here, we report the ability of different prevalent multidrug resistance (MDR) plasmids including extended-spectrum beta-lactamase (ESBL) gene-carrying plasmids to mobilize the multidrug resistance genomic island SGI1. Through conjugation experiments, none of the 24 conjugative plasmids tested of the IncFI, FII, HI2, I1, L/M, N, P incompatibility groups were able to mobilize SGI1 at a detectable level (transfer frequency <10(-9)). In our collection, ESBL gene-carrying plasmids were mainly from the IncHI2 and I1 groups and thus were unable to mobilize SGI1. However, the horizontal transfer of SGI1 was shown to be specifically mediated by conjugative helper plasmids of the broad-host-range IncA/C incompatibility group. Several conjugative IncA/C MDR plasmids as well as the sequenced IncA/C reference plasmid pRA1 of 143,963 bp were shown to mobilize in trans SGI1 from a S. enterica donor to the Escherichia coli recipient strain. Depending on the IncA/C plasmid used, the conjugative transfer of SGI1 occurred at frequencies ranging from 10(-3) to 10(-6) transconjugants per donor. Of particular concern, some large IncA/C MDR plasmids carrying the extended-spectrum cephalosporinase bla(CMY-2) gene were shown to mobilize in trans SGI1. Conclusions/Significance: The ability of the IncA/C MDR plasmid family to mobilize SGI1 could contribute to its spread by horizontal transfer among enteric pathogens. Moreover, the increasing prevalence of IncA/C plasmids in MDR S. enterica isolates worldwide has potential implications for the epidemic success of the antibiotic resistance genomic island SGI1 and its close derivatives.	[Douard, Gregory; Praud, Karine; Cloeckaert, Axel; Doublet, Benoit] INRA, UR1282, F-37380 Nouzilly, France	INRAE	Douard, G (corresponding author), INRA, UR1282, F-37380 Nouzilly, France.	Benoit.Doublet@tours.inra.fr		Doublet, Benoit/0000-0003-0531-0967	French National Institute of Agronomic Research; Ministere de l'Education Nationale et de la Recherche, France	French National Institute of Agronomic Research; Ministere de l'Education Nationale et de la Recherche, France	This research was supported by public funds from the French National Institute of Agronomic Research. GD was supported by a doctoral fellowship from the Ministere de l'Education Nationale et de la Recherche, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2007, J ANTIMICROB CHEMOTH, V59, P184, DOI 10.1093/jac/dkl471; AMABILECUEVAS CF, 1992, CELL, V70, P189, DOI 10.1016/0092-8674(92)90095-T; AOKI T, 1971, J GEN MICROBIOL, V65, P343, DOI 10.1099/00221287-65-3-343; Boyd D, 2002, ANTIMICROB AGENTS CH, V46, P1714, DOI 10.1128/AAC.46.6.1714-1722.2002; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P340, DOI 10.1128/AAC.00902-07; Call DR, 2010, ANTIMICROB AGENTS CH, V54, P590, DOI 10.1128/AAC.00055-09; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carret G, 2003, INT J ANTIMICROB AG, V21, P364, DOI 10.1016/S0924-8579(03)00021-9; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; CHABBERT YA, 1972, J BACTERIOL, V112, P666, DOI 10.1128/JB.112.2.666-675.1972; Cloeckaert A, 2007, ANTIMICROB AGENTS CH, V51, P1872, DOI 10.1128/AAC.01514-06; Cloeckaert A, 2010, ANTIMICROB AGENTS CH, V54, P4484, DOI 10.1128/AAC.00460-10; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; DATTA N, 1971, J BACTERIOL, V108, P1244, DOI 10.1128/JB.108.3.1244-1249.1971; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Doublet B, 2003, EMERG INFECT DIS, V9, P585, DOI 10.3201/eid0905.020609; Doublet B, 2010, J ANTIMICROB CHEMOTH, V65, P2260, DOI 10.1093/jac/dkq283; Doublet B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002060; Fernandez AG, 2007, ANTIMICROB AGENTS CH, V51, P4177, DOI 10.1128/AAC.00603-07; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Lindsey RL, 2009, APPL ENVIRON MICROB, V75, P1908, DOI 10.1128/AEM.02228-08; Marcade G, 2009, J ANTIMICROB CHEMOTH, V63, P67, DOI 10.1093/jac/dkn428; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Meunier D, 2010, J MED MICROBIOL, V59, P467, DOI 10.1099/jmm.0.016162-0; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Poole TL, 2009, FOODBORNE PATHOG DIS, V6, P1185, DOI 10.1089/fpd.2009.0316; ROUSSEL AF, 1978, J GEN MICROBIOL, V104, P269, DOI 10.1099/00221287-104-2-269; Su LH, 2008, FEMS IMMUNOL MED MIC, V52, P155, DOI 10.1111/j.1574-695X.2007.00360.x; Weill FX, 2004, J CLIN MICROBIOL, V42, P5767, DOI 10.1128/JCM.42.12.5767-5773.2004; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welch TJ, 2009, ANTIMICROB AGENTS CH, V53, P845, DOI 10.1128/AAC.01312-08; WITCHITZ JL, 1971, ANN I PASTEUR PARIS, V121, P733	35	87	88	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15302	10.1371/journal.pone.0015302	http://dx.doi.org/10.1371/journal.pone.0015302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187963	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200035
J	Wang, CY; Wang, T; Zheng, W; Zhao, BL; Danscher, G; Chen, YH; Wang, ZY				Wang, Chun-Yan; Wang, Tao; Zheng, Wei; Zhao, Bao-Lu; Danscher, Gorm; Chen, Yu-Hua; Wang, Zhan-You			Zinc Overload Enhances APP Cleavage and A beta Deposition in the Alzheimer Mouse Brain	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; HISTOCHEMICALLY-REACTIVE ZINC; MILD COGNITIVE IMPAIRMENT; TRANSGENIC MICE; IN-VIVO; METAL HOMEOSTASIS; PLAQUE-FORMATION; DISEASE; COPPER; TOXICITY	Background: Abnormal zinc homeostasis is involved in beta-amyloid (A beta) plaque formation and, therefore, the zinc load is a contributing factor in Alzheimer's disease (AD). However, the involvement of zinc in amyloid precursor protein (APP) processing and Ab deposition has not been well established in AD animal models in vivo. Methodology/Principal Findings: In the present study, APP and presenilin 1 (PS1) double transgenic mice were treated with a high dose of zinc (20 mg/ml ZnSO4 in drinking water). This zinc treatment increased APP expression, enhanced amyloidogenic APP cleavage and A beta deposition, and impaired spatial learning and memory in the transgenic mice. We further examined the effects of zinc overload on APP processing in SHSY-5Y cells overexpressing human APPsw. The zinc enhancement of APP expression and cleavage was further confirmed in vitro. Conclusions/Significance: The present data indicate that excess zinc exposure could be a risk factor for AD pathological processes, and alteration of zinc homeostasis is a potential strategy for the prevention and treatment of AD.	[Wang, Chun-Yan; Wang, Tao; Zheng, Wei; Chen, Yu-Hua; Wang, Zhan-You] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Shenyang, Peoples R China; [Wang, Chun-Yan; Wang, Tao; Zheng, Wei; Chen, Yu-Hua; Wang, Zhan-You] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Zhao, Bao-Lu] Acad Sinica, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Danscher, Gorm] Univ Aarhus, Dept Anat & Neurobiol, Aarhus, Denmark	China Medical University; China Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Aarhus University	Wang, CY (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Shenyang, Peoples R China.	yhchen@mail.cmu.edu.cn; zhanyouw@hotmail.com		Wang, Zhan-You/0000-0003-0807-9916	Natural Science Foundation of China [30770680]; Program for New Century Excellent Talents in University [NCET-04-0288]; Universities of the Department of Education of Liaoning Province [20060948]; National Basic Research Program of China (973 Program) [2009CB930300]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Universities of the Department of Education of Liaoning Province; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The study was supported by the Natural Science Foundation of China (30770680), the Program for New Century Excellent Talents in University (NCET-04-0288), the Research Project for Universities of the Department of Education of Liaoning Province (20060948), and the National Basic Research Program of China (973 Program 2009CB930300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Atwood CS, 1999, MET IONS BIOL SYST, V36, P309; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Boom A, 2009, BBA-MOL CELL RES, V1793, P1058, DOI 10.1016/j.bbamcr.2008.11.011; Borchardt T, 2000, CELL MOL BIOL, V46, P785; BUSH AI, 1994, J BIOL CHEM, V269, P12152; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Bush AI, 2002, NEUROBIOL AGING, V23, P1031, DOI 10.1016/S0197-4580(02)00120-3; Cardoso SM, 2005, NEUROTOX RES, V7, P273, DOI 10.1007/BF03033885; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Cuajungco MP, 2003, BRAIN RES REV, V41, P44, DOI 10.1016/S0165-0173(02)00219-9; Cuajungco MP, 1996, NEUROREPORT, V7, P1301, DOI 10.1097/00001756-199605170-00017; Cuajungco MP, 1998, BRAIN RES, V799, P97, DOI 10.1016/S0006-8993(98)00482-X; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Friedlich AL, 2004, J NEUROSCI, V24, P3453, DOI 10.1523/JNEUROSCI.0297-04.2004; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; Jenagaratnam L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005380.pub2; Kozin SA, 2001, BIOCHEM BIOPH RES CO, V285, P959, DOI 10.1006/bbrc.2001.5284; Lee JY, 1999, J NEUROSCI, V19, DOI 10.1523/jneurosci.19-11-j0002.1999; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lee JY, 2004, NEUROBIOL AGING, V25, P1315, DOI 10.1016/j.neurobiolaging.2004.01.005; Lovell MA, 2005, NEUROTOX RES, V7, P265, DOI 10.1007/BF03033884; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lovell MA, 1999, BRAIN RES, V823, P88, DOI 10.1016/S0006-8993(99)01114-2; Lovell MA, 2006, J NEUROPATH EXP NEUR, V65, P489, DOI 10.1097/01.jnen.0000229237.98124.91; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Maynard CJ, 2009, CELL MOL NEUROBIOL, V29, P757, DOI 10.1007/s10571-009-9401-7; Maynard CJ, 2005, INT J EXP PATHOL, V86, P147, DOI 10.1111/j.0959-9673.2005.00434.x; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Plonka PM, 2006, BRIT J DERMATOL, V155, P39, DOI 10.1111/j.1365-2133.2006.07376.x; Plonka PM, 2005, EXP DERMATOL, V14, P844, DOI 10.1111/j.1600-0625.2005.00365.x; Price Katherine A, 2007, Recent Pat CNS Drug Discov, V2, P180, DOI 10.2174/157488907782411774; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Smedman M, 1997, MOL CHEM NEUROPATHOL, V31, P13, DOI 10.1007/BF02815157; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; Stoltenberg M, 2005, HISTOCHEM CELL BIOL, V123, P605, DOI 10.1007/s00418-005-0787-0; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Zhang J, 2006, NEUROSCIENCE, V143, P63, DOI 10.1016/j.neuroscience.2006.07.023; Zhang J, 2006, FASEB J, V20, P1212, DOI 10.1096/fj.05-5214fje; Zhang LH, 2008, BRAIN RES BULL, V77, P55, DOI 10.1016/j.brainresbull.2008.03.014; Zhang LH, 2010, NEUROBIOL AGING, V31, P74, DOI 10.1016/j.neurobiolaging.2008.02.018; Zheng W, 2010, J ALZHEIMERS DIS, V20, P323, DOI 10.3233/JAD-2010-1363; Zheng W, 2009, FASEB J, V23, P4207, DOI 10.1096/fj.09-135749	59	48	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15349	10.1371/journal.pone.0015349	http://dx.doi.org/10.1371/journal.pone.0015349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179415	Green Submitted, Green Published, gold			2022-12-27	WOS:000285572900018
J	George, I; Alcaix, S; Henry, L; Richard, JP; Cousillas, H; Hausberger, M				George, Isabelle; Alcaix, Sandrine; Henry, Laurence; Richard, Jean-Pierre; Cousillas, Hugo; Hausberger, Martine			Neural Correlates of Experience-Induced Deficits in Learned Vocal Communication	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; ZEBRA FINCH; EUROPEAN STARLINGS; AUDITORY FOREBRAIN; SONG DEVELOPMENT; GENE-EXPRESSION; SOCIAL-INTERACTION; CONSPECIFIC SONG; HUMAN SPEECH; ORGANIZATION	Songbirds are one of the few vertebrate groups (including humans) that evolved the ability to learn vocalizations. During song learning, social interactions with adult models are crucial and young songbirds raised without direct contacts with adults typically produce abnormal songs showing phonological and syntactical deficits. This raises the question of what functional representation of their vocalizations such deprived animals develop. Here we show that young starlings that we raised without any direct contact with adults not only failed to differentiate starlings' typical song classes in their vocalizations but also failed to develop differential neural responses to these songs. These deficits appear to be linked to a failure to acquire songs' functions and may provide a model for abnormal development of communicative skills, including speech.	[George, Isabelle; Alcaix, Sandrine; Henry, Laurence; Richard, Jean-Pierre; Cousillas, Hugo; Hausberger, Martine] Univ Rennes 1, CNRS, Ethol Anim & Humaine UMR6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	George, I (corresponding author), Univ Rennes 1, CNRS, Ethol Anim & Humaine UMR6552, Rennes, France.	Isabelle.George@univ-rennes1.fr	George, Isabelle/A-7770-2008	George, Isabelle/0000-0002-4842-4959	French CNRS (Centre national de la recherche scientifique); University of Rennes 1	French CNRS (Centre national de la recherche scientifique)(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1	This study has been funded by the French CNRS (Centre national de la recherche scientifique) and the University of Rennes 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRET-HAUSBERGER M, 1989, Bioacoustics, V2, P137; ADRETHAUSBERGER M, 1984, Z TIERPSYCHOL, V66, P309; ADRETHAUSBERGER M, 1982, BEHAV ECOL SOCIOBIOL, V11, P241, DOI 10.1007/BF00299300; ADRETHAUSBERGER M, 1984, IBIS, V126, P372, DOI 10.1111/j.1474-919X.1984.tb00258.x; ADRETHAUSBERGER M, 1990, ETHOLOGY, V84, P265; ADRETHAUSBERGER M, 1988, BEHAVIOUR, V107, P138, DOI 10.1163/156853988X00322; Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; BAPTISTA LF, 1986, ANIM BEHAV, V34, P1359, DOI 10.1016/S0003-3472(86)80207-X; Bertin A, 2007, DEV PSYCHOBIOL, V49, P362, DOI 10.1002/dev.20223; Bertin A, 2009, J COMP PSYCHOL, V123, P195, DOI 10.1037/a0014050; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; BUCKINGHAM HW, 1979, J COMMUN DISORD, V12, P197, DOI 10.1016/0021-9924(79)90041-8; CARAMAZZA A, 1983, BRAIN LANG, V18, P128, DOI 10.1016/0093-934X(83)90011-1; CHAIKEN M, 1993, ANIM BEHAV, V46, P1079, DOI 10.1006/anbe.1993.1298; Chaiken M, 1997, J COMP PSYCHOL, V111, P379, DOI 10.1037/0735-7036.111.4.379; Chaiken M, 2007, CONDOR, V109, P968, DOI 10.1650/0010-5422(2007)109[968:SLAIIT]2.0.CO;2; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EENS M, 1991, BELG J ZOOL, V121, P257; EENS M, 1989, ARDEA, V77, P75; EENS M, 1991, BEHAVIOUR, V116, P210, DOI 10.1163/156853991X00049; EENS M, 1990, BIRD STUDY, V37, P48, DOI 10.1080/00063659009477038; Gentner TQ, 2004, ANN NY ACAD SCI, V1016, P282, DOI 10.1196/annals.1298.008; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; George I, 2005, NEUROSCIENCE, V136, P1, DOI 10.1016/j.neuroscience.2005.08.001; George I, 2003, J NEUROSCI METH, V125, P65, DOI 10.1016/S0165-0270(03)00025-6; George I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002203; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hattiangadi N, 2005, BRAIN LANG, V92, P12, DOI 10.1016/j.bandl.2004.05.003; Hausberger M, 2000, BEHAV BRAIN RES, V114, P89, DOI 10.1016/S0166-4328(00)00191-1; HAUSBERGER M, 1995, ETHOLOGY, V99, P193; HAUSBERGER M, 1991, BIRD BEHAV, V9, P81, DOI 10.3727/015613890791749127; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; HAUSBERGER M, 1981, BIOL BEHAV, V6, P79; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; Henry L., 1994, Bioacoustics, V5, P261; Henry L, 1998, REV ECOL-TERRE VIE, V53, P347; King AP, 2005, ETHOLOGY, V111, P101, DOI 10.1111/j.1439-0310.2004.01039.x; MELLO C, 1995, J NEUROSCI, V15, P6919; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Park KHJ, 2002, BEHAV BRAIN RES, V136, P185, DOI 10.1016/S0166-4328(02)00129-8; Poirier C, 2004, J COMP PSYCHOL, V118, P179, DOI 10.1037/0735-7036.118.2.179; Richard J-P, 1991, BIOACOUSTICS, V3, P45, DOI DOI 10.1080/09524622.1991.9753156; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Thompson JV, 2010, J NEUROPHYSIOL, V103, P1785, DOI 10.1152/jn.00885.2009; Vicario DS, 2004, ANN NY ACAD SCI, V1016, P246, DOI 10.1196/annals.1298.040; WILLIAMS H, 1990, ANIM BEHAV, V39, P745, DOI 10.1016/S0003-3472(05)80386-0	56	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14347	10.1371/journal.pone.0014347	http://dx.doi.org/10.1371/journal.pone.0014347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695OI	21179492	Green Published, Green Submitted, gold			2022-12-27	WOS:000285381200005
J	Petersen, L; Sorensen, TIA; Mortensen, EL; Andersen, PK				Petersen, Liselotte; Sorensen, Thorkild I. A.; Mortensen, Erik Lykke; Andersen, Per Kragh			Excess Mortality Rate During Adulthood Among Danish Adoptees	PLOS ONE			English	Article							ENVIRONMENTAL-INFLUENCES; PREMATURE DEATH; SOCIAL-CLASS; ADOPTION; BEHAVIOR; COHORT	Background and objective: Adoption studies have been used to disentangle the influence of genes from shared familial environment on various traits and disease risks. However, both the factors leading to adoption and living as an adoptee may bias the studies with regard to the relative influence of genes and environment compared to the general population. The aim was to investigate whether the cohort of domestic adoptees used for these studies in Denmark is similar to the general population with respect to all-cause mortality and cause-specific mortality rates. Methods: 13,111 adoptees born in Denmark in 1917, or later, and adopted in 1924 to 1947 were compared to all Danes from the same birth cohorts using standardized mortality ratios (SMR). The 12,729 adoptees alive in 1970 were similarly compared to all Danes using SMR as well as cause-specific SMR. Results: The excess in all-cause mortality before age 65 years in adoptees was estimated to be 1.30 (95% CI 1.26-1.35). Significant excess mortality before age 65 years was also observed for infections, vascular deaths, cancer, alcohol-related deaths and suicide. Analyses including deaths after age 65 generally showed slightly less excess in mortality, but the excess was significant for all-cause mortality, cancer, alcohol-related deaths and suicides. Conclusion: Adoptees have an increased all-cause mortality compared to the general population. All major specific causes of death contributed, and the highest excess is seen for alcohol-related deaths.	[Petersen, Liselotte; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Petersen, Liselotte] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Healthy Aging, Copenhagen, Denmark; [Andersen, Per Kragh] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	University of Copenhagen; Aarhus University; University of Copenhagen; University of Copenhagen; University of Copenhagen	Petersen, L (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	LLP@ncrr.dk		Petersen, Liselotte Vogdrup/0000-0002-0479-5379; Mortensen, Erik Lykke/0000-0002-6985-451X	Danish National Research Foundation; Lundbeck Foundation; Velux Fonden	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Velux Fonden(Velux Fonden)	The Danish National Research Foundation supported the adoption study. This work was also supported by grants from The Lundbeck Foundation and from Velux Fonden. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PK, 1985, BIOMETRICS, V41, P921, DOI 10.2307/2530964; BOHMAN M, 1980, ACTA PSYCHIAT SCAND, V61, P339, DOI 10.1111/j.1600-0447.1980.tb00586.x; BRODZINSKY DM, 1987, CLIN PSYCHOL REV, V7, P25, DOI 10.1016/0272-7358(87)90003-1; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; ELDRED CA, 1976, AM J ORTHOPSYCHIAT, V46, P279, DOI 10.1111/j.1939-0025.1976.tb00928.x; Folstein Marshal F., J PSYCHIATR RES, V12, P189, DOI [10.1016/0022-3956(75)90026-6, DOI 10.1016/0022-3956(75)90026-6, DOI 10.1016/0022-3956(68)90026-5]; Fraley RC., 2008, HDB PERSONALITY THEO, P518; GOODWIN DW, 1973, ARCH GEN PSYCHIAT, V28, P238; Juffer F, 2005, JAMA-J AM MED ASSOC, V293, P2501, DOI 10.1001/jama.293.20.2501; Osler M, 2006, INT J EPIDEMIOL, V35, P1272, DOI 10.1093/ije/dyl045; Pedersen CB, 2006, DAN MED BULL, V53, P441; Petersen L, 2005, GENET EPIDEMIOL, V28, P376, DOI 10.1002/gepi.20071; Petersen L, 2008, EPIDEMIOLOGY, V19, P472, DOI 10.1097/EDE.0b013e3181692769; Schulsinger F., 1979, ORIGIN PREVENTION TR, P277; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; TEASDALE TW, 1984, J BIOSOC SCI, V16, P521, DOI 10.1017/S0021932000015340; von Borczyskowski A, 2006, SOC PSYCH PSYCH EPID, V41, P95, DOI 10.1007/s00127-005-0974-2	18	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14365	10.1371/journal.pone.0014365	http://dx.doi.org/10.1371/journal.pone.0014365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695OI	21179553	Green Submitted, gold, Green Published			2022-12-27	WOS:000285381200012
J	Agarwal, R; Khan, A; Gupta, D; Aggarwal, AN; Saxena, AK; Chakrabarti, A				Agarwal, Ritesh; Khan, Ajmal; Gupta, Dheeraj; Aggarwal, Ashutosh N.; Saxena, Akshay K.; Chakrabarti, Arunaloke			An Alternate Method of Classifying Allergic Bronchopulmonary Aspergillosis Based on High-Attenuation Mucus	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; CYSTIC-FIBROSIS; CT FINDINGS; CLINICAL-SIGNIFICANCE; FUNGAL SINUSITIS; PROGNOSTIC VALUE; NORTH-INDIA; SERUM IGE; DIAGNOSIS; HYPERSENSITIVITY	Background and Aim: Allergic bronchopulmonary aspergillosis (ABPA) is classified radiologically based on the findings of central bronchiectasis (CB) and other radiologic features (ORF). However, the long-term clinical significance of these classifications remains unknown. We hypothesized that the immunological activity and outcomes of ABPA could be predicted on HRCT chest finding of high-attenuation mucus (HAM), a marker of inflammatory activity. In this study, we evaluate the severity and clinical outcomes of ABPA with different radiological classifications. Methods: Patients were classified based on CT chest findings as: (a) serologic ABPA (ABPA-S) and ABPA-CB; (b) ABPA-S, ABPA-CB, and ABPA-CB-ORF; and, (c) ABPA-S, ABPA-CB and ABPA-CB-HAM. The clinical, spirometric and serological (total and A fumigatus specific IgE levels, eosinophil count) severity of the disease and clinical outcomes in various classifications were analyzed. Results: Of the 234 (123 males, 111 females; mean age, 34.1 years) patients, 55 (23.5%) had normal HRCT, 179 (76.5%) had CB, 49 (20.9%) had HAM, and 27 (11.5%) had ORF. All immunological markers were consistently higher in the HAM classification, while in other classifications these findings were inconsistent. On multivariate analysis, the factors predicting frequent relapses were presence of HAM (OR 7.38; 95% CI, 3.21-17.0) and CB (OR 3.93; 95% CI, 1.63-9.48) after adjusting for ORF. Conclusions: The classification scheme based on HAM most consistently predicts immunological severity in ABPA. Central bronchiectasis and HAM are independent predictors of recurrent relapses in ABPA. Hence, HAM should be employed in the radiological classification of ABPA.	[Agarwal, Ritesh; Khan, Ajmal; Gupta, Dheeraj; Aggarwal, Ashutosh N.] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India; [Saxena, Akshay K.] Postgrad Inst Med Educ & Res, Dept Radiodiag, Chandigarh 160012, India; [Chakrabarti, Arunaloke] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Agarwal, R (corresponding author), Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India.	riteshpgi@gmail.com	Agarwal, Ritesh/A-3063-2009; KHAN, AJMAL/W-9962-2019	Agarwal, Ritesh/0000-0003-2547-7668; KHAN, AJMAL/0000-0002-4727-3554				Agarwal R, 2006, AM J ROENTGENOL, V186, P904, DOI 10.2214/AJR.05.0125; Agarwal R, 2009, INT J TUBERC LUNG D, V13, P936; AGARWAL R, 2010, INT J RESP IN PRESS; Agarwal R, 2006, CHEST, V130, P442, DOI 10.1378/chest.130.2.442; Agarwal R, 2007, CHEST, V132, P1183, DOI 10.1378/chest.07-0808; Agarwal R, 2011, MED MYCOL, V49, pS150, DOI 10.3109/13693786.2010.504752; Agarwal R, 2010, WORLD J RADIOL, V2, P41, DOI 10.4329/wjr.v2.i1.41; Agarwal R, 2010, MED MYCOL, V48, P988, DOI 10.3109/13693781003743148; Agarwal R, 2010, MYCOSES, V53, P138, DOI 10.1111/j.1439-0507.2008.01680.x; Agarwal R, 2010, RESP MED, V104, P204, DOI 10.1016/j.rmed.2009.09.005; Agarwal R, 2009, CHEST, V135, P805, DOI 10.1378/chest.08-2586; BULCKE JA, 1979, NEURORADIOLOGY, V17, P127; CAMPBELL MJ, 1964, AM REV RESPIR DIS, V89, P186; DILLON WP, 1990, RADIOLOGY, V174, P73, DOI 10.1148/radiology.174.1.2294574; Ghaye B, 2006, RADIOGRAPHICS, V26, P23, DOI 10.1148/rg.261055062; GOYAL R, 1992, J COMPUT ASSIST TOMO, V16, P649; GREENBERGER PA, 1984, J ALLERGY CLIN IMMUN, V74, P645, DOI 10.1016/0091-6749(84)90223-9; GREENBERGER PA, 1993, ANN ALLERGY, V70, P333; Hanak V, 2008, CHEST, V134, P133, DOI 10.1378/chest.07-3005; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; HANSELL DM, 1989, BRIT J RADIOL, V62, P1; HINSON KFW, 1952, THORAX, V7, P317, DOI 10.1136/thx.7.4.317; HOEHNE J, 1971, J LAB CLIN MED, V78, P1007; HOEHNE JH, 1973, CHEST, V63, P177, DOI 10.1378/chest.63.2.177; Karunaratne Nishantha, 2003, Australas Radiol, V47, P336, DOI 10.1046/j.1440-1673.2003.01192.x; KOPP W, 1985, RADIOLOGY, V156, P715, DOI 10.1148/radiology.156.3.4023231; Kumar R, 2003, CHEST, V124, P890, DOI 10.1378/chest.124.3.890; Logan PM, 1996, CAN ASSOC RADIOL J, V47, P374; Logan PM, 1996, IRISH J MED SCI, V165, P27, DOI 10.1007/BF02942797; LONGBOTTOM JL, 1964, J PATHOL BACTERIOL, V88, P141, DOI 10.1002/path.1700880119; MALO JL, 1979, CLIN ALLERGY, V9, P377, DOI 10.1111/j.1365-2222.1979.tb02496.x; Manning SC, 1997, LARYNGOSCOPE, V107, P170, DOI 10.1097/00005537-199702000-00007; McCarthy D S, 1971, Clin Allergy, V1, P415, DOI 10.1111/j.1365-2222.1971.tb00793.x; McCarthy DS, 1971, CLIN ALLERGY, V1, P261, DOI DOI 10.1111/J.1365-2222.1971.TB; Molinari M, 2004, Monaldi Arch Chest Dis, V61, P62; Morozov A, 2007, PEDIATR RADIOL, V37, P592, DOI 10.1007/s00247-007-0471-8; Mukherji SK, 1998, RADIOLOGY, V207, P417, DOI 10.1148/radiology.207.2.9577490; PATTERSON R, 1986, ARCH INTERN MED, V146, P916, DOI 10.1001/archinte.146.5.916; PATTERSON R, 1968, University of Michigan Medical Center Journal, V34, P8; Rajkumar DC, 2002, J ASTHMA, V39, P473, DOI 10.1081/JAS-120004905; REIFF DB, 1995, AM J ROENTGENOL, V165, P261, DOI 10.2214/ajr.165.2.7618537; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405; Screaton NJ, 2005, CLIN RADIOL, V60, P96, DOI 10.1016/j.crad.2004.06.029; Shah A, 2003, FRONT BIOSCI, V8, pE138, DOI 10.2741/944; Shah A, 2008, ANN ALLERG ASTHMA IM, V101, P363, DOI 10.1016/S1081-1206(10)60311-0; SLAVIN RG, 1988, J ALLERGY CLIN IMMUN, V81, P718, DOI 10.1016/0091-6749(88)91044-5; SLAVIN RG, 1969, AM J MED, V47, P306, DOI 10.1016/0002-9343(69)90156-9; Tillie-Leblond I, 2005, ALLERGY, V60, P1004, DOI 10.1111/j.1398-9995.2005.00887.x; Vlahakis NE, 2001, MAYO CLIN PROC, V76, P930; WANG JLF, 1978, AM REV RESPIR DIS, V117, P917	50	73	77	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15346	10.1371/journal.pone.0015346	http://dx.doi.org/10.1371/journal.pone.0015346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179536	Green Submitted, Green Published, gold			2022-12-27	WOS:000285340000023
J	Derry, JMJ; Zhong, H; Molony, C; MacNeil, D; Guhathakurta, D; Zhang, B; Mudgett, J; Small, K; El Fertak, L; Guimond, A; Selloum, M; Zhao, WQ; Champy, MF; Monassier, L; Vogt, T; Cully, D; Kasarskis, A; Schadt, EE				Derry, Jonathan M. J.; Zhong, Hua; Molony, Cliona; MacNeil, Doug; Guhathakurta, Debraj; Zhang, Bin; Mudgett, John; Small, Kersten; El Fertak, Lahcen; Guimond, Alain; Selloum, Mohammed; Zhao, Wenqing; Champy, Marie France; Monassier, Laurent; Vogt, Tom; Cully, Doris; Kasarskis, Andrew; Schadt, Eric E.			Identification of Genes and Networks Driving Cardiovascular and Metabolic Phenotypes in a Mouse F2 Intercross	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BLOOD-PRESSURE LOCI; BODY-WEIGHT; FTO GENE; NERVOUS-SYSTEM; EXPRESSION; SUSCEPTIBILITY; MICE; QTL; REGULATOR	To identify the genes and pathways that underlie cardiovascular and metabolic phenotypes we performed an integrated analysis of a mouse C57BL/6J x A/J F-2 (B6AF2) cross by relating genome-wide gene expression data from adipose, kidney, and liver tissues to physiological endpoints measured in the population. We have identified a large number of trait QTLs including loci driving variation in cardiac function on chromosomes 2 and 6 and a hotspot for adiposity, energy metabolism, and glucose traits on chromosome 8. Integration of adipose gene expression data identified a core set of genes that drive the chromosome 8 adiposity QTL. This chromosome 8 trans eQTL signature contains genes associated with mitochondrial function and oxidative phosphorylation and maps to a subnetwork with conserved function in humans that was previously implicated in human obesity. In addition, human eSNPs corresponding to orthologous genes from the signature show enrichment for association to type II diabetes in the DIAGRAM cohort, supporting the idea that the chromosome 8 locus perturbs a molecular network that in humans senses variations in DNA and in turn affects metabolic disease risk. We functionally validate predictions from this approach by demonstrating metabolic phenotypes in knockout mice for three genes from the trans eQTL signature, Akr1b8, Emr1, and Rgs2. In addition we show that the transcriptional signatures for knockout of two of these genes, Akr1b8 and Rgs2, map to the F2 network modules associated with the chromosome 8 trans eQTL signature and that these modules are in turn very significantly correlated with adiposity in the F2 population. Overall this study demonstrates how integrating gene expression data with QTL analysis in a network-based framework can aid in the elucidation of the molecular drivers of disease that can be translated from mice to humans.	[Derry, Jonathan M. J.; Zhong, Hua; Molony, Cliona; Guhathakurta, Debraj; Zhang, Bin; Kasarskis, Andrew; Schadt, Eric E.] Rosetta Inpharmat LLC, Seattle, WA USA; [MacNeil, Doug; Mudgett, John; Small, Kersten; Zhao, Wenqing; Vogt, Tom; Cully, Doris] Merck & Co Inc, Basic Res, Rahway, NJ 07065 USA; [El Fertak, Lahcen; Guimond, Alain; Selloum, Mohammed; Champy, Marie France; Monassier, Laurent] Inst Clin Souris, Illkirch Graffenstaden, France	Merck & Company; Merck & Company	Derry, JMJ (corresponding author), Sage Bionetworks, Seattle, WA USA.	derry@sagebase.org	zhong, Judy/ABE-8314-2020	Zhong, Judy/0000-0002-2163-8447	Merck Co.	Merck Co.(Merck & Company)	These studies were all planned and funded by Merck & Co. Study design, data collection and analysis, and the preparation of the manuscript were conducted by current or former Merck employees as well as scientists from the Clinique de la Souris, Illkirch, France.	Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; DiPetrillo K, 2004, PHYSIOL GENOMICS, V17, P215, DOI 10.1152/physiolgenomics.00212.2003; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hamann J, 2007, EUR J IMMUNOL, V37, P2797, DOI 10.1002/eji.200737553; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; HEXIMER SP, 2007, SCI STKE, pPE2; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Hunter KW, 2008, ANNU REV GENET, V42, P131, DOI 10.1146/annurev.genet.42.110807.091659; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; KRUGLYAK L, 1995, GENETICS, V139, P1421; Kwakkenbos MJ, 2004, IMMUNOGENETICS, V55, P655, DOI 10.1007/s00251-003-0625-2; LEGRY V, 2009, METABOLISM; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Nishizuka M, 2001, J BIOL CHEM, V276, P29625, DOI 10.1074/jbc.C100272200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Petrash JM, 2004, CELL MOL LIFE SCI, V61, P737, DOI 10.1007/s00018-003-3402-3; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Riddle EL, 2006, HYPERTENSION, V47, P415, DOI 10.1161/01.HYP.0000200714.81990.61; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Sartori M, 2008, METABOLISM, V57, P421, DOI 10.1016/j.metabol.2007.10.021; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Smith SC, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2007.01.002; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Stylianou IM, 2006, GENETICS, V174, P999, DOI 10.1534/genetics.106.059717; Sugiyama F, 2002, PHYSIOL GENOMICS, V10, P5, DOI 10.1152/physiolgenomics.00002.2002; Sugiyama F, 2001, GENOMICS, V71, P70, DOI 10.1006/geno.2000.6401; Suzuki M, 2002, CIRCULATION, V105, P1824, DOI 10.1161/01.CIR.0000014926.32463.89; Takeshita S, 2006, MAMM GENOME, V17, P927, DOI 10.1007/s00335-005-0130-z; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang XS, 2005, AM J HUM GENET, V77, P1, DOI 10.1086/431656; Woo DDL, 2003, PHYSIOL GENOMICS, V15, P236, DOI 10.1152/physiolgenomics.00027.2003; Wright FA, 1999, HYPERTENSION, V34, P625, DOI 10.1161/01.HYP.34.4.625; Wuschke S, 2007, INT J OBESITY, V31, P829, DOI 10.1038/sj.ijo.0803473; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang SM, 2003, OBES RES, V11, P828, DOI 10.1038/oby.2003.114; Zhu J, 2008, ADV GENET, V60, P603, DOI 10.1016/S0065-2660(07)00421-X; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	66	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14319	10.1371/journal.pone.0014319	http://dx.doi.org/10.1371/journal.pone.0014319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179467	Green Submitted, Green Published, gold			2022-12-27	WOS:000285292500004
J	Bresciani, E; Confalonieri, S; Cermenati, S; Cimbro, S; Foglia, E; Beltrame, M; Di Fiore, PP; Cotelli, F				Bresciani, Erica; Confalonieri, Stefano; Cermenati, Solei; Cimbro, Simona; Foglia, Efrem; Beltrame, Monica; Di Fiore, Pier Paolo; Cotelli, Franco			Zebrafish Numb and Numblike Are Involved in Primitive Erythrocyte Differentiation	PLOS ONE			English	Article							MOUSE CORTICAL NEUROGENESIS; MAMMALIAN NUMB; CELL FATE; IN-VIVO; ASYMMETRIC LOCALIZATION; VASCULAR DEVELOPMENT; NOTCH; EXPRESSION; GENE; EMBRYOS	Background: Notch signaling is an evolutionarily conserved regulatory circuitry implicated in cell fate determination in various developmental processes including hematopoietic stem cell self-renewal and differentiation of blood lineages. Known endogenous inhibitors of Notch activity are Numb-Nb and Numblike-Nbl, which play partially redundant functions in specifying and maintaining neuronal differentiation. Nb and Nbl are expressed in most tissues including embryonic and adult hematopoietic tissues in mice and humans, suggesting possible roles for these proteins in hematopoiesis. Methodology and Principal Findings: We employed zebrafish to investigate the possible functional role of Numb and Numblike during hematopoiesis, as this system allows a detailed analysis even in embryos with severe defects that would be lethal in other organisms. Here we describe that nb/nbl knockdown results in severe reduction or absence of embryonic erythrocytes in zebrafish. Interestingly, nb/nbl knocked-down embryos present severe downregulation of the erythroid transcription factor gata1. This results in erythroblasts which fail to mature and undergo apoptosis. Our results indicate that Notch activity is increased in embryos injected with nb/nbl morpholino, and we show that inhibition of Notch activation can partially rescue the hematopoietic phenotype. Conclusions and Significance: Our results provide the first in vivo evidence of an involvement of Numb and Numblike in zebrafish erythroid differentiation during primitive hematopoiesis. Furthermore, we found that, at least in part, the nb/nbl morphant phenotype is due to enhanced Notch activation within hematopoietic districts, which in turn results in primitive erythroid differentiation defects.	[Bresciani, Erica; Cimbro, Simona; Foglia, Efrem; Cotelli, Franco] Univ Milan, Dipartimento Biol, Milan, Italy; [Confalonieri, Stefano; Di Fiore, Pier Paolo] FIRC Inst Mol Oncol Fdn IFOM, Milan, Italy; [Cermenati, Solei; Beltrame, Monica] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy; [Di Fiore, Pier Paolo] European Inst Oncol IEO, Milan, Italy; [Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy	University of Milan; IFOM - FIRC Institute of Molecular Oncology; University of Milan; IRCCS European Institute of Oncology (IEO); University of Milan	Bresciani, E (corresponding author), Univ Milan, Dipartimento Biol, Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; franco.cotelli@unimi.it	Foglia, Efrem Alessandro/AGW-8220-2022; Confalonieri, Stefano/AAQ-6786-2020; Foglia, Efrem Alessandro/AAF-1840-2020; Di Fiore, Pier Paolo/K-2130-2012; Beltrame, Monica/D-8093-2017	Confalonieri, Stefano/0000-0001-6886-9851; Foglia, Efrem Alessandro/0000-0002-7446-8365; Di Fiore, Pier Paolo/0000-0002-2252-0950; Beltrame, Monica/0000-0001-5094-3494	Fondazione Cariplo [2006.0807]; Progetto Cariplo N.O.B.E.L.; Associazione Italiana per la Ricerca sul Cancro, MIUR; European Community; European Research Commission; Ferrari Foundation; Monzino Foundation	Fondazione Cariplo(Fondazione Cariplo); Progetto Cariplo N.O.B.E.L.; Associazione Italiana per la Ricerca sul Cancro, MIUR(Fondazione AIRC per la ricerca sul cancroMinistry of Education, Universities and Research (MIUR)); European Community(European Commission); European Research Commission(European CommissionEuropean Commission Joint Research Centre); Ferrari Foundation; Monzino Foundation	This study was supported by grants from Fondazione Cariplo (grant number 2006.0807) to M. B. and Progetto Cariplo N.O.B.E.L. (Biological and molecular characterization of cancer stem cells) to F. C. and P. P. D. F, and by grants from the Associazione Italiana per la Ricerca sul Cancro, MIUR, the European Community (FP6 and FP7), the European Research Commission, the Ferrari Foundation and the Monzino Foundation to PPDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2005, J IMMUNOL, V174, P890, DOI 10.4049/jimmunol.174.2.890; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Durbin L, 2000, DEVELOPMENT, V127, P1703; French MB, 2002, J IMMUNOL, V168, P3173, DOI 10.4049/jimmunol.168.7.3173; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hill AJ, 2004, TOXICOL SCI, V78, P78, DOI 10.1093/toxsci/kfh056; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kobayashi M, 2001, DEVELOPMENT, V128, P2341; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Niikura Y, 2006, MECH DEVELOP, V123, P407, DOI 10.1016/j.mod.2006.03.008; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Pasini A, 2001, MECH DEVELOP, V100, P317, DOI 10.1016/S0925-4773(00)00538-4; Patterson LJ, 2005, BLOOD, V105, P3502, DOI 10.1182/blood-2004-09-3547; Reugels AM, 2006, DEV DYNAM, V235, P934, DOI 10.1002/dvdy.20699; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; THISSE C, 1993, DEVELOPMENT, V119, P1203; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Willett CE, 2001, DEV DYNAM, V222, P694, DOI 10.1002/dvdy.1223; Wilson A, 2007, J IMMUNOL, V178, P6746, DOI 10.4049/jimmunol.178.11.6746; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	39	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14296	10.1371/journal.pone.0014296	http://dx.doi.org/10.1371/journal.pone.0014296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179188	Green Submitted, Green Published, gold			2022-12-27	WOS:000285246900009
J	Hervera, A; Negrete, R; Leanez, S; Martin-Campos, JM; Pol, O				Hervera, Arnau; Negrete, Roger; Leanez, Sergi; Martin-Campos, Jesus M.; Pol, Olga			The Spinal Cord Expression of Neuronal and Inducible Nitric Oxide Synthases and Their Contribution in the Maintenance of Neuropathic Pain in Mice	PLOS ONE			English	Article							THERMAL HYPERALGESIA; SCIATIC-NERVE; RAT; INJURY; MODEL; INOS; ANTAGONIST; INHIBITOR	Background: Nitric oxide generated by neuronal (NOS1), inducible (NOS2) or endothelial (NOS3) nitric oxide synthases contributes to pain processing, but the exact role of NOS1 and NOS2 in the maintenance of chronic peripheral neuropathic pain as well as the possible compensatory changes in their expression in the spinal cord of wild type (WT) and NOS knockout (KO) mice at 21 days after total sciatic nerve ligation remains unknown. Methodology/Principal Findings: The mechanical and thermal allodynia as well as thermal hyperalgesia induced by sciatic nerve injury was evaluated in WT, NOS1-KO and NOS2-KO mice from 1 to 21 days after surgery. The mRNA and protein levels of NOS1, NOS2 and NOS3 in the spinal cord of WT and KO mice, at 21 days after surgery, were also assessed. Sciatic nerve injury led to a neuropathic syndrome in WT mice, in contrast to the abolished mechanical allodynia and thermal hyperalgesia as well as the decreased or suppressed thermal allodynia observed in NOS1-KO and NOS2-KO animals, respectively. Sciatic nerve injury also increases the spinal cord expression of NOS1 and NOS2 isoforms, but not of NOS3, in WT and NOS1-KO mice respectively. Moreover, the presence of NOS2 is required to increase the spinal cord expression of NOS1 whereas an increased NOS1 expression might avoid the up-regulation of NOS2 in the spinal cord of nerve injured WT mice. Conclusions/Significance: These data suggest that the increased spinal cord expression of NOS1, regulated by NOS2, might be responsible for the maintenance of chronic peripheral neuropathic pain in mice and propose these enzymes as interesting therapeutic targets for their treatment.	[Hervera, Arnau; Negrete, Roger; Leanez, Sergi; Pol, Olga] Hosp Sta Creu & St Pau, Inst Recerca, Grp Neurofarmacol Mol, Barcelona, Spain; [Hervera, Arnau; Negrete, Roger; Leanez, Sergi; Pol, Olga] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Martin-Campos, Jesus M.] Hosp Sta Creu & St Pau, Inst Recerca, Grp Bioquim, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Hervera, A (corresponding author), Hosp Sta Creu & St Pau, Inst Recerca, Grp Neurofarmacol Mol, Barcelona, Spain.	opol@santpau.es	Martín-Campos, Jesús M./AAQ-5478-2021; Hervera, Arnau/C-9710-2011; Martín-Campos, Jesús Maria/AGJ-2586-2022; Leánez, Sergi/C-9709-2011; abad, Arnau Hervera/V-5435-2017; Pol, Olga/O-2146-2019; Pol, Olga/C-9194-2011	Martín-Campos, Jesús Maria/0000-0003-0414-037X; abad, Arnau Hervera/0000-0001-8362-369X; Pol, Olga/0000-0002-4621-8457; 	Fondo de Investigacian Sanitaria, Madrid [PS0900968]; Fundacio La Marato de TV3 Barcelona, Spain [070810]	Fondo de Investigacian Sanitaria, Madrid; Fundacio La Marato de TV3 Barcelona, Spain	This work was supported by Fondo de Investigacian Sanitaria, Madrid (http://www.isciii.es/htdocs/investigacion/Fondo_lineas.jsp) [Grant: PS0900968] and the Fundacio La Marato de TV3 Barcelona (http://www.fundaciomaratotv3.cat/) [Grant: 070810], Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boettger MK, 2007, EUR J PAIN, V11, P810, DOI 10.1016/j.ejpain.2006.12.008; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chu YC, 2005, PAIN, V119, P113, DOI 10.1016/j.pain.2005.09.024; Costa B, 2005, PAIN, V116, P52, DOI 10.1016/j.pain.2005.03.043; De Alba J, 2006, PAIN, V120, P170, DOI 10.1016/j.pain.2005.10.028; Guan Y, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-29; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; LaBuda CJ, 2006, EUR J PAIN, V10, P505, DOI 10.1016/j.ejpain.2005.07.004; Leanez S, 2009, EUR J PHARMACOL, V602, P41, DOI 10.1016/j.ejphar.2008.11.019; Levy D, 2000, EUR J NEUROSCI, V12, P2323, DOI 10.1046/j.1460-9568.2000.00129.x; Levy D, 1999, NEUROSCI LETT, V260, P207, DOI 10.1016/S0304-3940(98)00982-3; Levy D, 1998, EUR J NEUROSCI, V10, P1846, DOI 10.1046/j.1460-9568.1998.00186.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017; MELLER ST, 1992, NEUROSCIENCE, V50, P7, DOI 10.1016/0306-4522(92)90377-E; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Pol O, 2007, CURR MED CHEM, V14, P1945; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Tanabe M, 2009, NEUROPHARMACOLOGY, V56, P702, DOI 10.1016/j.neuropharm.2008.12.003; Tao F, 2004, NEUROSCIENCE, V128, P421, DOI 10.1016/j.neuroscience.2004.06.038; Tao F, 2003, NEUROSCIENCE, V120, P847, DOI 10.1016/S0306-4522(03)00362-2; Valsecchi AE, 2008, J NEUROCHEM, V107, P230, DOI 10.1111/j.1471-4159.2008.05614.x	23	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14321	10.1371/journal.pone.0014321	http://dx.doi.org/10.1371/journal.pone.0014321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179208	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900023
J	Nardinocchi, L; Pantisano, V; Puca, R; Porru, M; Aiello, A; Grasselli, A; Leonetti, C; Safran, M; Rechavi, G; Givol, D; Farsetti, A; D'Orazi, G				Nardinocchi, Lavinia; Pantisano, Valentina; Puca, Rosa; Porru, Manuela; Aiello, Aurora; Grasselli, Annalisa; Leonetti, Carlo; Safran, Michal; Rechavi, Gideon; Givol, David; Farsetti, Antonella; D'Orazi, Gabriella			Zinc Downregulates HIF-1 alpha and Inhibits Its Activity in Tumor Cells In Vitro and In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-I; HIF-ALPHA; HYPOXIA; ANGIOGENESIS; GENE; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; HIPK2; ERYTHROPOIETIN; TRANSFORMATION	Background: Hypoxia inducible factor-1 alpha (HIF-1 alpha) is responsible for the majority of HIF-1-induced gene expression changes under hypoxia and for the "angiogenic switch'' during tumor progression. HIF-1 alpha is often upregulated in tumors leading to more aggressive tumor growth and chemoresistance, therefore representing an important target for antitumor intervention. We previously reported that zinc downregulated HIF-1 alpha levels. Here, we evaluated the molecular mechanisms of zinc-induced HIF-1 alpha downregulation and whether zinc affected HIF-1 alpha also in vivo. Methodology/Principal Findings: Here we report that zinc downregulated HIF-1 alpha protein levels in human prostate cancer and glioblastoma cells under hypoxia, whether induced or constitutive. Investigations into the molecular mechanisms showed that zinc induced HIF-1 alpha proteasomal degradation that was prevented by treatment with proteasomal inhibitor MG132. HIF-1 alpha downregulation induced by zinc was ineffective in human RCC4 VHL-null renal carcinoma cell line; likewise, the HIF-1 alpha P402/P564A mutant was resistant to zinc treatment. Similarly to HIF-1 alpha, zinc downregulated also hypoxia-induced HIF-2 alpha whereas the HIF-1 beta subunit remained unchanged. Zinc inhibited HIF-1 alpha recruitment onto VEGF promoter and the zinc-induced suppression of HIF-1-dependent activation of VEGF correlated with reduction of glioblastoma and prostate cancer cell invasiveness in vitro. Finally, zinc administration downregulated HIF-1 alpha levels in vivo, by bioluminescence imaging, and suppressed intratumoral VEGF expression. Conclusions/Significance: These findings, by demonstrating that zinc induces HIF-1 alpha proteasomal degradation, indicate that zinc could be useful as an inhibitor of HIF-1 alpha in human tumors to repress important pathways involved in tumor progression, such as those induced by VEGF, MDR1, and Bcl2 target genes, and hopefully potentiate the anticancer therapies.	[Nardinocchi, Lavinia; Pantisano, Valentina; Puca, Rosa; Aiello, Aurora; Grasselli, Annalisa; Farsetti, Antonella; D'Orazi, Gabriella] Natl Canc Inst Regina Elena, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy; [Pantisano, Valentina] Catholic Univ, Chair Endocrinol, Rome, Italy; [Aiello, Aurora; Grasselli, Annalisa; Farsetti, Antonella] Inst Neurobiol & Mol Med, Natl Res Council, Rome, Italy; [Safran, Michal; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Safran, Michal; Rechavi, Gideon] Tel Aviv Univ, Sachler Sch Med, IL-69978 Tel Aviv, Israel; [Givol, David] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Puca, Rosa; D'Orazi, Gabriella] Univ G DAnnunzio, Sch Med, Dept Oncol & Expt Med, Chieti, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Chaim Sheba Medical Center; Tel Aviv University; Weizmann Institute of Science; G d'Annunzio University of Chieti-Pescara	Nardinocchi, L (corresponding author), Natl Canc Inst Regina Elena, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy.	gdorazi@unich.it	D'Orazi, Gabriella/T-2792-2019; Farsetti, Antonella/I-8710-2018; PORRU, MANUELA/K-4809-2018; Porru, Manuela/AAA-5510-2021; Leonetti, Carlo/B-2860-2018	D'Orazi, Gabriella/0000-0001-6876-9105; Farsetti, Antonella/0000-0002-8603-7925; PORRU, MANUELA/0000-0002-6614-9110; Porru, Manuela/0000-0002-6614-9110; Leonetti, Carlo/0000-0002-3526-7827; Aiello, Aurora/0000-0002-8303-1528	Italian Association for Cancer Research (AIRC); L'Oreal-Italia-UNESCO for Women in Science; Italian Foundation for Cancer Research (FIRC)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); L'Oreal-Italia-UNESCO for Women in Science; Italian Foundation for Cancer Research (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Italian Association for Cancer Research (AIRC) to GD, AF, and CL; LN is a recipient of a Fellowship from L'Oreal-Italia-UNESCO for Women in Science; RP is a recipient of a Fellowship from the Italian Foundation for Cancer Research (FIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyriou AA, 2009, ONCOLOGY-BASEL, V77, P1, DOI 10.1159/000218165; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Choi SM, 2006, J BIOL CHEM, V281, P34056, DOI 10.1074/jbc.M603913200; Di Stefana V, 2005, FEBS LETT, V579, P5473, DOI 10.1016/j.febslet.2005.09.008; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Grasselli A, 2008, CIRC RES, V103, P34, DOI 10.1161/CIRCRESAHA.107.169037; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KONDO K, 2002, CANCER CELL, V1, P337; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Li LM, 2005, CANCER RES, V65, P7249, DOI 10.1158/0008-5472.CAN-04-4426; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mazure NM, 1996, CANCER RES, V56, P3436; McCarty MF, 2010, MED HYPOTHESES, V74, P789, DOI 10.1016/j.mehy.2009.12.022; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Nanni S, 2002, J CLIN INVEST, V110, P219, DOI 10.1172/JCI200215552; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Nardinocchi L, 2010, CELL CYCLE, V9, P1270, DOI 10.4161/cc.9.7.11125; Nardinocchi L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006819; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Nardinocchi L, 2009, BBA-MOL CELL RES, V1793, P368, DOI 10.1016/j.bbamcr.2008.10.013; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Puca R, 2008, CANCER RES, V68, P3707, DOI 10.1158/0008-5472.CAN-07-6776; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sun X, 2001, GENE THER, V8, P638, DOI 10.1038/sj.gt.3301388; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhong XS, 2007, BIOCHEM BIOPH RES CO, V358, P92, DOI 10.1016/j.bbrc.2007.04.083	43	62	67	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15048	10.1371/journal.pone.0015048	http://dx.doi.org/10.1371/journal.pone.0015048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179202	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900026
J	Jin, L; Lenz, LL; Cambier, JC				Jin, Lei; Lenz, Laurel L.; Cambier, John C.			Cellular Reactive Oxygen Species Inhibit MPYS Induction of IFN beta	PLOS ONE			English	Article							NF-KAPPA-B; HYDROGEN-PEROXIDE; CLASS-II; PROTEIN; ADAPTER; INACTIVATION; ACTIVATION; RECEPTOR; DOMAIN; NLRX1	Many inflammatory diseases, as well as infections, are accompanied by elevation in cellular levels of Reactive Oxygen Species (ROS). Here we report that MPYS, a.k.a. STING, which was recently shown to mediate activation of IFN beta expression during infection, is a ROS sensor. ROS induce intermolecular disulfide bonds formation in MPYS homodimer and inhibit MPYS IFN beta stimulatory activity. Cys-64, -148, -292, -309 and the potential C(88)xxC(91) redox motif in MPYS are indispensable for IFN beta stimulation and IRF3 activation. Thus, our results identify a novel mechanism for ROS regulation of IFN beta stimulation.	[Jin, Lei; Lenz, Laurel L.; Cambier, John C.] Univ Colorado, Denver Sch Med & Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80202 USA	University of Colorado System; University of Colorado Denver	Jin, L (corresponding author), Univ Colorado, Denver Sch Med & Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80202 USA.	cambierj@njhealth.org		jin, lei/0000-0001-6836-1142; Lenz, Laurel/0000-0002-4933-8913; Cambier, John/0000-0002-7803-242X	NIH [3R01AI062739-05S209, 5R01AI062739-05, 5R01AI065638-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062739, R01AI065638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH 3R01AI062739-05S209 (J.C.C), 5R01AI062739-05 (J.C.C), 5R01AI065638-04 (L.L.L). J.C.C is Ida and Cecil Green Professor of Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin LH, 2003, J BIOL CHEM, V278, P24526, DOI 10.1074/jbc.M303451200; Borutaite V, 2001, FEBS LETT, V500, P114, DOI 10.1016/S0014-5793(01)02593-5; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; CSORDAS G, 2009, BIOCH BIOPHYS ACTA; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; ISHIKAWA H, 2009, NATURE; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2008, IMMUNOL LETT, V116, P184, DOI 10.1016/j.imlet.2007.11.023; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; Maccarrone M, 2003, CELL DEATH DIFFER, V10, P946, DOI 10.1038/sj.cdd.4401284; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Prinarakis E, 2008, EMBO J, V27, P865, DOI 10.1038/emboj.2008.28; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Santos CXC, 2009, ANTIOXID REDOX SIGNA; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	30	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15142	10.1371/journal.pone.0015142	http://dx.doi.org/10.1371/journal.pone.0015142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170271	Green Published, Green Submitted, gold			2022-12-27	WOS:000285181400018
J	Billings, T; Sargent, EE; Szatkiewicz, JP; Leahy, N; Kwak, IY; Bektassova, N; Walker, M; Hassold, T; Graber, JH; Broman, KW; Petkov, PM				Billings, Timothy; Sargent, Evelyn E.; Szatkiewicz, Jin P.; Leahy, Nicole; Kwak, Il-Youp; Bektassova, Nazira; Walker, Michael; Hassold, Terry; Graber, Joel H.; Broman, Karl W.; Petkov, Petko M.			Patterns of Recombination Activity on Mouse Chromosome 11 Revealed by High Resolution Mapping	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; MEIOTIC RECOMBINATION; CROSSOVER INTERFERENCE; GENETIC-CONTROL; SEX-DIFFERENCES; HOT-SPOTS; MAP; INITIATION; HOTSPOT; PRDM9	The success of high resolution genetic mapping of disease predisposition and quantitative trait loci in humans and experimental animals depends on the positions of key crossover events around the gene of interest. In mammals, the majority of recombination occurs at highly delimited 1-2 kb long sites known as recombination hotspots, whose locations and activities are distributed unevenly along the chromosomes and are tightly regulated in a sex specific manner. The factors determining the location of hotspots started to emerge with the finding of PRDM9 as a major hotspot regulator in mammals, however, additional factors modulating hotspot activity and sex specificity are yet to be defined. To address this limitation, we have collected and mapped the locations of 4829 crossover events occurring on mouse chromosome 11 in 5858 meioses of male and female reciprocal F1 hybrids of C57BL/6J and CAST/EiJ mice. This chromosome was chosen for its medium size and high gene density and provided a comparison with our previous analysis of recombination on the longest mouse chromosome 1. Crossovers were mapped to an average resolution of 127 kb, and thirteen hotspots were mapped to,8 kb. Most crossovers occurred in a small number of the most active hotspots. Females had higher recombination rate than males as a consequence of differences in crossover interference and regional variation of sex specific rates along the chromosome. Comparison with chromosome 1 showed that recombination events tend to be positioned in similar fashion along the centromere-telomere axis but independently of the local gene density. It appears that mammalian recombination is regulated on at least three levels, chromosome-wide, regional, and at individual hotspots, and these regulation levels are influenced by sex and genetic background but not by gene content.	[Billings, Timothy; Sargent, Evelyn E.; Szatkiewicz, Jin P.; Leahy, Nicole; Bektassova, Nazira; Walker, Michael; Graber, Joel H.; Petkov, Petko M.] Jackson Lab, Ctr Genome Dynam, Bar Harbor, ME 04609 USA; [Kwak, Il-Youp] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Hassold, Terry] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Broman, Karl W.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	Jackson Laboratory; University of Wisconsin System; University of Wisconsin Madison; Washington State University; University of Wisconsin System; University of Wisconsin Madison	Billings, T (corresponding author), Jackson Lab, Ctr Genome Dynam, 600 Main St, Bar Harbor, ME 04609 USA.	Petko.Petkov@jax.org	KWAK, IL YOUP/J-3354-2015	KWAK, IL YOUP/0000-0002-7117-7669; Broman, Karl/0000-0002-4914-6671; Graber, Joel/0000-0001-5137-4553; Petkov, Petko/0000-0002-6694-9150	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health [R01 GM078452, HD21341, P50 GM076468]; National Cancer Institute (NCI) [CA34196]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007065, R37HD021341] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078452, P50GM076468] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by R01 grants GM078452 to P.M.P. and HD21341 to T.H. and a P50 grant GM076468 to Gary Churchill from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health and by a Cancer Center core grant from the National Cancer Institute (NCI) CA34196 to the Jackson Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Anderson LK, 1999, GENETICS, V151, P1569; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2007, PLOS GENET, V3, P1029, DOI 10.1371/journal.pgen.0030100; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 2002, GENETICS, V160, P1123; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Fledel-Alon A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000658; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kelmenson PM, 2005, GENETICS, V169, P833, DOI 10.1534/genetics.104.035063; Koehler KE, 2002, GENETICS, V162, P297; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Korhonen J, 2009, BIOINFORMATICS, V25, P3181, DOI 10.1093/bioinformatics/btp554; Lorch PD, 2005, GENETICA, V123, P39, DOI 10.1007/s10709-003-2706-4; Lynn A, 2005, AM J HUM GENET, V77, P670, DOI 10.1086/491718; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Merkera JD, 2008, DNA REPAIR, V7, P1298, DOI 10.1016/j.dnarep.2008.04.009; Mieczkowski PA, 2006, MOL CELL BIOL, V26, P1014, DOI 10.1128/MCB.26.3.1014-1027.2006; Moens PB, 2007, J CELL SCI, V120, P1017, DOI 10.1242/jcs.03394; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Ng SH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-43; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; Persikov AV, 2009, BIOINFORMATICS, V25, P22, DOI 10.1093/bioinformatics/btn580; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; WHITE MA, 1993, P NATL ACAD SCI USA, V90, P6621, DOI 10.1073/pnas.90.14.6621	57	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15340	10.1371/journal.pone.0015340	http://dx.doi.org/10.1371/journal.pone.0015340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170346	Green Submitted, Green Published, gold			2022-12-27	WOS:000285084100035
J	Meuwese, MC; Broekhuizen, LN; Kuikhoven, M; Heeneman, S; Lutgens, E; Gijbels, MJJ; Nieuwdorp, M; Peutz, CJ; Stroes, ESG; Vink, H; van den Berg, BM				Meuwese, Marijn C.; Broekhuizen, Lysette N.; Kuikhoven, Mayella; Heeneman, Sylvia; Lutgens, Esther; Gijbels, Marion J. J.; Nieuwdorp, Max; Peutz, Carine J.; Stroes, Erik S. G.; Vink, Hans; van den Berg, Bernard M.			Endothelial Surface Layer Degradation by Chronic Hyaluronidase Infusion Induces Proteinuria in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							GLYCOCALYX BARRIER PROPERTIES; CAROTID-ARTERY BIFURCATION; GLOMERULAR BARRIER; DEGRADING ENZYMES; CELL GLYCOCALYX; ATHEROSCLEROSIS; PERMEABILITY; ACCUMULATION; PROTEOGLYCANS; VASODILATION	Objective: Functional studies show that disruption of endothelial surface layer (ESL) is accompanied by enhanced sensitivity of the vasculature towards atherogenic stimuli. However, relevance of ESL disruption as causal mechanism for vascular dysfunction remains to be demonstrated. We examined if loss of ESL through enzymatic degradation would affect vascular barrier properties in an atherogenic model. Methods: Eight week old male apolipoprotein E deficient mice on Western-type diet for 10 weeks received continuous active or heat-inactivated hyaluronidase (10 U/hr, i.v.) through an osmotic minipump during 4 weeks. Blood chemistry and anatomic changes in both macrovasculature and kidneys were examined. Results: Infusion with active hyaluronidase resulted in decreased ESL (0.32+/-0.22 mL) and plasma volume (1.03+/-0.18 mL) compared to inactivated hyaluronidase (0.52+/-0.29 mL and 1.28+/-0.08 mL, p<0.05 respectively). Active hyaluronidase increased proteinuria compared to inactive hyaluronidase (0.27+/-0.02 vs. 0.15+/-0.01 mu g/mu g protein/creatinin, p<0.05) without changes in glomerular morphology or development of tubulo-interstitial inflammation. Atherosclerotic lesions in the aortic branches showed increased matrix production (collagen, 32+/-5 vs. 18+/-3%; glycosaminoglycans, 11+/-5 vs. 0.1+/-0.01%, active vs. inactive hyaluronidase, p<0.05). Conclusion: ESL degradation in apoE deficient mice contributes to reduced increased urinary protein excretion without significant changes in renal morphology. Second, the induction of compositional changes in atherogenic plaques by hyaluronidase point towards increased plaque vulnerability. These findings support further efforts to evaluate whether ESL restoration is a valuable target to prevent (micro) vascular disease progression.	[Meuwese, Marijn C.; Broekhuizen, Lysette N.; Nieuwdorp, Max; Stroes, Erik S. G.; Vink, Hans] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kuikhoven, Mayella; Vink, Hans; van den Berg, Bernard M.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands; [Heeneman, Sylvia; Lutgens, Esther; Gijbels, Marion J. J.; Peutz, Carine J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [Gijbels, Marion J. J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Mol Genet, Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University; Maastricht University	Meuwese, MC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.vink@fys.unimaas.nl	Lutgens, Esther/E-2919-2010; van den berg, bernard m/D-8444-2014	Lutgens, Esther/0000-0002-2609-5744; van den Berg, Bernard/0000-0002-5726-5777	Dutch Heart Foundation [2006B088]	Dutch Heart Foundation(Netherlands Heart Foundation)	This work was partly funded by the Dutch Heart Foundation (grant number 2006B088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2005, PHARM RES-DORDR, V22, P1854, DOI 10.1007/s11095-005-6137-z; Broekhuizen LN, 2009, CURR OPIN LIPIDOL, V20, P57, DOI 10.1097/MOL.0b013e328321b587; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; Deen WM, 2004, J CLIN INVEST, V114, P1412, DOI 10.1172/JCI200423577; Grundmann S, 2009, J CELL MOL MED, V13, P3463, DOI 10.1111/j.1582-4934.2009.00735.x; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Ikegami-Kawai M, 2004, GLYCOBIOLOGY, V14, P65, DOI 10.1093/glycob/cwh011; Jeansson M, 2006, DIABETOLOGIA, V49, P2200, DOI 10.1007/s00125-006-0319-z; Jeansson M, 2006, AM J PHYSIOL-RENAL, V290, pF111, DOI 10.1152/ajprenal.00173.2005; Jeansson M, 2003, J AM SOC NEPHROL, V14, P1756, DOI 10.1097/01.ASN.0000072742.02714.6E; Kolodgie FD, 2004, CURR OPIN LIPIDOL, V15, P575, DOI 10.1097/00041433-200410000-00012; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P68, DOI 10.1097/01.ASN.0000103229.25389.40; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Meuwese MC, 2009, J LIPID RES, V50, P148, DOI 10.1194/jlr.P800025-JLR200; MIURA RO, 1995, ANAL BIOCHEM, V225, P333, DOI 10.1006/abio.1995.1163; Mochizuki S, 2003, AM J PHYSIOL-HEART C, V285, pH722, DOI 10.1152/ajpheart.00691.2002; Nieuwdorp M, 2007, DIABETOLOGIA, V50, P1288, DOI 10.1007/s00125-007-0666-4; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Pappenheimer JR, 2003, J PHYSIOL-LONDON, V553, P561, DOI 10.1113/jphysiol.2003.043257; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; van den Berg BM, 2009, PFLUG ARCH EUR J PHY, V457, P1199, DOI 10.1007/s00424-008-0590-6; van den Berg BM, 2006, AM J PHYSIOL-HEART C, V290, pH915, DOI 10.1152/ajpheart.00051.2005; van den Hoven MJ, 2008, KIDNEY INT, V73, P278, DOI 10.1038/sj.ki.5002706; van Haaren PMA, 2005, AM J PHYSIOL-HEART C, V289, pH2503, DOI 10.1152/ajpheart.00587.2005; VanTeeffelen JWGE, 2007, HYPERTENSION, V50, P261, DOI 10.1161/HYPERTENSIONAHA.107.089250; VanTeeffelen JWGE, 2005, AM J PHYSIOL-HEART C, V289, pH447, DOI 10.1152/ajpheart.01298.2004; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Vink H, 2000, CIRCULATION, V101, P1500, DOI 10.1161/01.CIR.101.13.1500; Wen M, 2002, LAB INVEST, V82, P999, DOI 10.1097/01.LAB.0000022222.03120.D4; Westerterp M, 2007, CIRCULATION, V116, P2173, DOI 10.1161/CIRCULATIONAHA.107.693382; Zuurbier CJ, 2005, J APPL PHYSIOL, V99, P1471, DOI 10.1152/japplphysiol.00436.2005	38	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14262	10.1371/journal.pone.0014262	http://dx.doi.org/10.1371/journal.pone.0014262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170388	Green Published, gold, Green Submitted			2022-12-27	WOS:000285084100013
J	Scaria, J; Ponnala, L; Janvilisri, T; Yan, WW; Mueller, LA; Chang, YF				Scaria, Joy; Ponnala, Lalit; Janvilisri, Tavan; Yan, Weiwei; Mueller, Lukas A.; Chang, Yung-Fu			Analysis of Ultra Low Genome Conservation in Clostridium difficile	PLOS ONE			English	Article							COMPARATIVE PHYLOGENOMICS; METABOLIC PATHWAYS; PCR RIBOTYPES; PAN-GENOME; RESISTANCE; PATHOGEN; DIARRHEA; DISEASE; STRAIN; IDENTIFICATION	Microarray-based comparative genome hybridisations (CGH) and genome sequencing of Clostridium difficile isolates have shown that the genomes of this species are highly variable. To further characterize their genome variation, we employed integration of data from CGH, genome sequencing and putative cellular pathways. Transcontinental strain comparison using CGH data confirmed the emergence of a human-specific hypervirulent cluster. However, there was no correlation between total toxin production and hypervirulent phenotype, indicating the possibility of involvement of additional factors towards hypervirulence. Calculation of C. difficile core and pan genome size using CGH and sequence data estimated that the core genome is composed of 947 to 1,033 genes and a pan genome comprised of 9,640 genes. The reconstruction, annotation and analysis of cellular pathways revealed highly conserved pathways despite large genome variation. However, few pathways such as tetrahydrofolate biosynthesis were found to be variable and could be contributing to adaptation towards virulence such as antibiotic resistance.	[Scaria, Joy; Janvilisri, Tavan; Yan, Weiwei; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Ponnala, Lalit] Cornell Univ, Ctr Adv Comp, Ithaca, NY USA; [Janvilisri, Tavan] Mahidol Univ, Fac Sci, Dept Biol, Bangkok 10400, Thailand; [Mueller, Lukas A.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Cornell University; Mahidol University; Cornell University; Boyce Thompson Institute for Plant Research	Scaria, J (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu	Janvilisri, Tavan/O-6679-2019; Mueller, Lukas A/E-8840-2011; Janvilisri, Tavan/C-8391-2015; Scaria, Joy/E-1828-2011	Janvilisri, Tavan/0000-0002-6376-5575; Janvilisri, Tavan/0000-0002-6376-5575; Scaria, Joy/0000-0002-5299-8074	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [N01-AI-30054, ZC005-06, ZC008-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030054] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract, N01-AI-30054, Project No. ZC005-06 and ZC008-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2006, J CLIN MICROBIOL, V44, P353, DOI 10.1128/JCM.44.2.353-358.2006; Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Arroyo LG, 2005, J MED MICROBIOL, V54, P163, DOI 10.1099/jmm.0.45805-0; Bentley S, 2009, NAT REV MICROBIOL, V7, P258, DOI 10.1038/nrmicro2123; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Debast SB, 2009, CLIN MICROBIOL INFEC, V15, P427, DOI 10.1111/j.1469-0691.2009.02713.x; Doyle MA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-57; Drlica K, 2009, CURR TOP MED CHEM, V9, P981, DOI 10.2174/156802609789630947; Emerson JE, 2008, J MED MICROBIOL, V57, P757, DOI 10.1099/jmm.0.47657-0; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; HE M, 2010, P NATL ACAD SCI US; HENDERSON GB, 1986, METHOD ENZYMOL, V122, P260; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Janvilisri T, 2009, J BACTERIOL, V191, P3881, DOI 10.1128/JB.00222-09; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Karjalainen T, 2002, J CLIN MICROBIOL, V40, P2452, DOI 10.1128/JCM.40.7.2452-2458.2002; Keel K, 2007, J CLIN MICROBIOL, V45, P1963, DOI 10.1128/JCM.00224-07; Kim CC, 2002, GENOME BIOL, V3; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Lemee L, 2005, MICROBIOL-SGM, V151, P3171, DOI 10.1099/mic.0.28155-0; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Ni Eidhin D, 2006, J MED MICROBIOL, V55, P69, DOI 10.1099/jmm.0.46204-0; Paley SM, 2002, BIOINFORMATICS, V18, P715, DOI 10.1093/bioinformatics/18.5.715; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pinney JW, 2007, TRENDS PARASITOL, V23, P548, DOI 10.1016/j.pt.2007.08.013; Pituch H, 2008, POL J MICROBIOL, V57, P267; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Shi J, 2006, NUCLEIC ACIDS RES, V34, P2438, DOI 10.1093/nar/gkl310; Songer JG, 2006, ANAEROBE, V12, P1, DOI 10.1016/j.anaerobe.2005.09.001; Spigaglia P, 2008, J MED MICROBIOL, V57, P784, DOI 10.1099/jmm.0.47738-0; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179; Zhao XL, 1997, P NATL ACAD SCI USA, V94, P13991, DOI 10.1073/pnas.94.25.13991	49	42	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15147	10.1371/journal.pone.0015147	http://dx.doi.org/10.1371/journal.pone.0015147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170335	Green Submitted, Green Published, gold			2022-12-27	WOS:000285084100022
J	Schoneich, S; Hedwig, B				Schoeneich, Stefan; Hedwig, Berthold			Hyperacute Directional Hearing and Phonotactic Steering in the Cricket (Gryllus bimaculatus deGeer)	PLOS ONE			English	Article							SOUND-LOCALIZATION; TELEOGRYLLUS-OCEANICUS; ACOUSTIC ORIENTATION; AUDITORY-BEHAVIOR; CAMPESTRIS L; DISCRIMINATION; ACUITY; LATERALIZATION; COMMUNICATION; INFORMATION	Background: Auditory mate or prey localisation is central to the lifestyle of many animals and requires precise directional hearing. However, when the incident angle of sound approaches 0 degrees azimuth, interaural time and intensity differences gradually vanish. This poses a demanding challenge to animals especially when interaural distances are small. To cope with these limitations imposed by the laws of acoustics, crickets employ a frequency tuned peripheral hearing system. Although this enhances auditory directionality the actual precision of directional hearing and phonotactic steering has never been studied in the behaviourally important frontal range. Principal Findings: Here we analysed the directionality of phonotaxis in female crickets (Gryllus bimaculatus) walking on an open-loop trackball system by measuring their steering accuracy towards male calling song presented at frontal angles of incidence. Within the range of +/-30 degrees, females reliably discriminated the side of acoustic stimulation, even when the sound source deviated by only 1 degrees from the animal's length axis. Moreover, for angles of sound incidence between 1 degrees and 6 degrees the females precisely walked towards the sound source. Measuring the tympanic membrane oscillations of the front leg ears with a laser vibrometer revealed between 0 degrees and 30 degrees a linear increasing function of interaural amplitude differences with a slope of 0.4 dB/degrees. Auditory nerve recordings closely reflected these bilateral differences in afferent response latency and intensity that provide the physiological basis for precise auditory steering. Conclusions: Our experiments demonstrate that an insect hearing system based on a frequency-tuned pressure difference receiver achieves directional hyperacuity which easily rivals best directional hearing in mammals and birds. Moreover, this directional accuracy of the cricket's hearing system is reflected in the animal's phonotactic motor response.	[Schoeneich, Stefan; Hedwig, Berthold] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Schoneich, S (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	ss817@cam.ac.uk; bh202@cam.ac.uk		Schoneich, Stefan/0000-0003-4503-5111	Royal Society [2005/R2]	Royal Society(Royal Society of London)	This work was supported by The Royal Society: Equipment Grant 2005/R2 to BH, http://royalsociety.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTRUM H, 1940, J COMP PHYSIOL A, V28, P326; BAILEY WJ, 1984, ANIM BEHAV, V32, P816, DOI 10.1016/S0003-3472(84)80158-X; BAILEY WJ, 1977, J EXP BIOL, V67, P61; BOYD P, 1983, J COMP PHYSIOL, V153, P523, DOI 10.1007/BF00612606; Bradbury Jack W., 1998, pi; Carr CE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000405; Faulkes Z, 2000, J NEUROPHYSIOL, V84, P1247, DOI 10.1152/jn.2000.84.3.1247; Hedwig B, 2005, J EXP BIOL, V208, P915, DOI 10.1242/jeb.01452; Hedwig B, 2004, NATURE, V430, P781, DOI 10.1038/nature02787; HEDWIG B, 1989, J COMP PHYSIOL A, V164, P409, DOI 10.1007/BF00612999; Heffner RS, 2007, HEARING RES, V234, P1, DOI 10.1016/j.heares.2007.06.001; HEFFNER RS, 1982, J COMP PHYSIOL PSYCH, V96, P926, DOI 10.1037/0735-7036.96.6.926; Hennig RM, 2004, MICROSC RES TECHNIQ, V63, P351, DOI 10.1002/jemt.20052; HORSEMAN G, 1994, J COMP PHYSIOL A, V175, P389, DOI 10.1007/BF00199247; HOY R, 1989, J EXP BIOL, V146, P287; HOY RR, 1978, FED PROC, V37, P2316; Hoy RR, 1996, ANNU REV ENTOMOL, V41, P433, DOI 10.1146/annurev.en.41.010196.002245; Huber F., 1989, CRICKET BEHAV NEUROB; Knepper M, 1997, COMPUT METH PROG BIO, V52, P75, DOI 10.1016/S0169-2607(96)01781-6; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Kostarakos K, 2010, J COMP PHYSIOL A, V196, P669, DOI 10.1007/s00359-010-0557-x; Kostarakos K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-22; Larsen O.N., 1989, P364; LARSEN ON, 1978, J COMP PHYSIOL, V123, P217, DOI 10.1007/BF00656874; LARSEN ON, 1984, NATURWISSENSCHAFTEN, V71, P538, DOI 10.1007/BF00455648; Mason AC, 2004, MICROSC RES TECHNIQ, V63, P338, DOI 10.1002/jemt.20050; Mason AC, 2001, NATURE, V410, P686, DOI 10.1038/35070564; Michelsen A, 1998, NEWS PHYSIOL SCI, V13, P32; MICHELSEN A, 1994, J COMP PHYSIOL A, V175, P153, DOI 10.1007/BF00215111; MICHELSEN A, 1995, NATURE, V375, P639, DOI 10.1038/375639a0; MICHELSEN A, 1992, EVOLUTIONARY BIOL HE, P67; Michelsen A, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/011001; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; MORCHEN A, 1978, NATURWISSENSCHAFTEN, V65, P656, DOI 10.1007/BF00401914; NOCKE H, 1972, J COMP PHYSIOL, V80, P141, DOI 10.1007/BF00696487; OLDFIELD BP, 1980, J COMP PHYSIOL, V141, P93, DOI 10.1007/BF00611882; POLLACK GS, 1982, J COMP PHYSIOL, V146, P207, DOI 10.1007/BF00610239; Pollack GS, 2003, J COMP PHYSIOL A, V189, P143, DOI 10.1007/s00359-003-0388-0; RENAUD DL, 1975, J EXP BIOL, V63, P569; RHEINLAENDER J, 1982, PHYSIOL ENTOMOL, V7, P209, DOI 10.1111/j.1365-3032.1982.tb00291.x; Rheinlaender J, 2006, J COMP PHYSIOL A, V192, P389, DOI 10.1007/s00359-005-0078-1; ROBERT D, 1992, SCIENCE, V258, P1135, DOI 10.1126/science.1439820; Robert D, 2001, BIOL BULL, V200, P190, DOI 10.2307/1543314; SCHILDBERGER K, 1994, FORTS ZOOL, V39, P209; SCHMITZ B, 1982, J COMP PHYSIOL, V148, P431, DOI 10.1007/BF00619782; Shen JX, 2008, NATURE, V453, P914, DOI 10.1038/nature06719; SIMMONS JA, 1983, J COMP PHYSIOL, V153, P321, DOI 10.1007/BF00612586; Stumpner A, 2001, NATURWISSENSCHAFTEN, V88, P159, DOI 10.1007/s001140100223; THORSON J, 1982, J COMP PHYSIOL, V146, P361, DOI 10.1007/BF00612706; von Helversen D, 1997, EXS, V84, P301; Warren R. M., 1999, AUDITORY PERCEPTION; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668; Weber T., 1989, P310; WENDLER G, 1980, NATURWISSENSCHAFTEN, V67, P99, DOI 10.1007/BF01054701; WIESE K, 1985, ZOOL JAHRB ALLG ZOOL, V89, P181; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	56	39	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15141	10.1371/journal.pone.0015141	http://dx.doi.org/10.1371/journal.pone.0015141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170344	Green Published, gold, Green Submitted			2022-12-27	WOS:000285084100021
J	Lu, L; Zhang, ZK; Zhou, T				Lue, Linyuan; Zhang, Zi-Ke; Zhou, Tao			Zipf's Law Leads to Heaps' Law: Analyzing Their Relation in Finite-Size Systems	PLOS ONE			English	Article							POWER-LAWS; COMPLEX NETWORKS; DISTRIBUTIONS; DYNAMICS; INCOME; WEB	Background: Zipf's law and Heaps' law are observed in disparate complex systems. Of particular interests, these two laws often appear together. Many theoretical models and analyses are performed to understand their co-occurrence in real systems, but it still lacks a clear picture about their relation. Methodology/Principal Findings: We show that the Heaps' law can be considered as a derivative phenomenon if the system obeys the Zipf's law. Furthermore, we refine the known approximate solution of the Heaps' exponent provided the Zipf's exponent. We show that the approximate solution is indeed an asymptotic solution for infinite systems, while in the finite-size system the Heaps' exponent is sensitive to the system size. Extensive empirical analysis on tens of disparate systems demonstrates that our refined results can better capture the relation between the Zipf's and Heaps' exponents. Conclusions/Significance: The present analysis provides a clear picture about the relation between the Zipf's law and Heaps' law without the help of any specific stochastic model, namely the Heaps' law is indeed a derivative phenomenon from the Zipf's law. The presented numerical method gives considerably better estimation of the Heaps' exponent given the Zipf's exponent and the system size. Our analysis provides some insights and implications of real complex systems. For example, one can naturally obtained a better explanation of the accelerated growth of scale-free networks.	[Lue, Linyuan; Zhou, Tao] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Lue, Linyuan; Zhang, Zi-Ke; Zhou, Tao] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Zhou, Tao] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China	University of Electronic Science & Technology of China; University of Fribourg; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Lu, L (corresponding author), Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China.	zhutou@ustc.edu	Zhou, Tao/D-5849-2012; zhou, tao/GQA-3572-2022; Zhang, Zi-Ke/G-6896-2011		Swiss National Science Foundation [200020-121848]; National Natural Science Foundation of China [10635040]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Swiss National Science Foundation (200020-121848) and the National Natural Science Foundation of China (10635040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhari A, 2010, MULTIMED TOOLS APPL, V46, P91, DOI 10.1007/s11042-009-0309-5; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Altmann EG, 2009, PLOS ONE, V4, pA31, DOI 10.1371/journal.pone.0007678; Serrano MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005372; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Baek SK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046113; BaezaYates R, 2000, J AM SOC INFORM SCI, V51, P69, DOI 10.1002/(SICI)1097-4571(2000)51:1<69::AID-ASI10>3.0.CO;2-C; BAI WJ, 2006, P 4 INT C COMM CIRC; Bak P., 1996, NATURE WORKS SCI SEL; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benz RW, 2008, J CHEM INF MODEL, V48, P1138, DOI 10.1021/ci700353m; Blasius B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.218701; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Caldarelli G., 2007, SCALE FREE NETWORKS; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Carlson JM, 1999, PHYS REV E, V60, P1412, DOI 10.1103/PhysRevE.60.1412; Carpena P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.035102; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Cattuto C, 2009, P NATL ACAD SCI USA, V106, P10511, DOI 10.1073/pnas.0901136106; Chen Q, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38001; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cordoba JC, 2008, J URBAN ECON, V63, P177, DOI 10.1016/j.jue.2007.01.005; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Dorogovtsev SN, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.025101; Dragulescu A, 2001, PHYSICA A, V299, P213, DOI 10.1016/S0378-4371(01)00298-9; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.035103; EBELING W, 1994, EUROPHYS LETT, V26, P241, DOI 10.1209/0295-5075/26/4/001; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Gelbukh A, 2001, LECT NOTES COMPUT SC, V2004, P332; Goldstein ML, 2004, EUR PHYS J B, V41, P255, DOI 10.1140/epjb/e2004-00316-5; Han XP, 2009, ARXIV09121390; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; KANTER I, 1995, PHYS REV LETT, V74, P4559, DOI 10.1103/PhysRevLett.74.4559; Kleinberg J, 2003, DATA MIN KNOWL DISC, V7, P373, DOI 10.1023/A:1024940629314; Lansey JC, 2009, J QUANT LINGUIST, V16, P40, DOI 10.1080/09296170802514153; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Iribarren JL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038702; MANDELBROT B, 1960, INT ECON REV, V1, P79, DOI 10.2307/2525289; Marsili M, 1998, PHYS REV LETT, V80, P2741, DOI 10.1103/PhysRevLett.80.2741; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Montemurro M.A., 2002, GLOTTOMETRICS, V87, P99; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026118; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; SIMON HA, 1955, BIOMETRIKA, V42, P425; Smith DMD, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/181; van Leijenhorst DC, 2005, INFORM SCIENCES, V170, P263, DOI 10.1016/j.ins.2004.03.006; Vazquez A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158702; ZANETTE DH, 2005, J QUANT LINGUIST, V12, P29, DOI DOI 10.1080/09296170500055293; Zhang GQ, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/123027; Zhang HY, 2009, INFORM PROCESS MANAG, V45, P477, DOI 10.1016/j.ipm.2009.02.001; Zhang ZK, 2008, EUR PHYS J B, V66, P557, DOI 10.1140/epjb/e2008-00453-9; Zhou T, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28002; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	56	76	80	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14139	10.1371/journal.pone.0014139	http://dx.doi.org/10.1371/journal.pone.0014139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	688QY	21152034	Green Submitted, Green Published, gold			2022-12-27	WOS:000284868000003
J	Andersson, EA; Pilgaard, K; Pisinger, C; Harder, MN; Grarup, N; Faerch, K; Sandholt, C; Poulsen, P; Witte, DR; Jorgensen, T; Vaag, A; Pedersen, O; Hansen, T				Andersson, Ehm A.; Pilgaard, Kasper; Pisinger, Charlotta; Harder, Marie N.; Grarup, Niels; Faerch, Kristine; Sandholt, Camilla; Poulsen, Pernille; Witte, Daniel R.; Jorgensen, Torben; Vaag, Allan; Pedersen, Oluf; Hansen, Torben			Do Gene Variants Influencing Adult Adiposity Affect Birth Weight? A Population-Based Study of 24 Loci in 4,744 Danish Individuals	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FAT MASS; FTO GENE; OBESITY; RISK; MC4R; CHILDHOOD	Background: Several obesity risk alleles affecting adult adiposity have been identified by the recent wave of genome wide association studies. We aimed to examine the potential effect of these variants on fetal body composition by investigating the variants in relation to birth weight and ponderal index of the newborn. Methodology/Principal Findings: Midwife records from the Danish State Archives provided information on mother's age, parity, as well as birth weight, birth length and prematurity of the newborn in 4,744 individuals of the population-based Inter99 study. Twenty-four risk alleles showing genome-wide associations with adult BMI and/or waist circumference were genotyped. None of the 24 risk variants tested showed an association with birth weight or ponderal index after correction for multiple testing. Birth weight was divided into three categories low (<= 10(th) percentile), normal (10(th) -90(th) percentile) and high birth weight (>= 90th percentile) to allow for non-linear associations. There was no difference in the number of risk alleles between the groups (p = 0.57). No interactions between each risk allele and birth weight in the prediction of adult BMI were observed. An obesity risk score was created by summing up risk alleles. The risk score did not associate with fetal body composition. Moreover there was no interaction between the risk score and birth weight/ponderal index in the prediction of adult BMI. Conclusion: 24 common variants associated with adult adiposity did not affect or interact with birth weight among Danes suggesting that the effects of these variants predominantly arise in the post-natal life.	[Andersson, Ehm A.; Harder, Marie N.; Grarup, Niels; Sandholt, Camilla; Pedersen, Oluf; Hansen, Torben] Hagedorn Res Inst, Gentofte, Denmark; [Pilgaard, Kasper; Faerch, Kristine; Poulsen, Pernille; Witte, Daniel R.; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pisinger, Charlotta; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben; Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; University of Copenhagen; University of Copenhagen; University of Southern Denmark	Andersson, EA (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	mngh@hagedorn.dk	Witte, Daniel/AAF-9535-2019; Pedersen, Oluf/AAG-8015-2020; Jørgensen, Torben/Z-1335-2018; Witte, Daniel R/C-1722-2008; Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019	Witte, Daniel/0000-0002-0769-2922; Witte, Daniel R/0000-0002-0769-2922; Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Faerch, Kristine/0000-0002-6127-0448; Pilgaard, Kasper Ascanius/0000-0003-2079-5229; Jorgensen, Torben/0000-0001-9453-2830; Vaag, Allan Arthur/0000-0002-3690-2191; Pisinger, Charlotta/0000-0002-7970-3168	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Danish Health Research Council; European Union [LSHM-CT-2004-005272]; Danish Diabetes Association; Danish Council for Independent Research (Medical Sciences)	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Danish Health Research Council; European Union(European Commission); Danish Diabetes Association; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF))	The study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP), the Danish Health Research Council, the European Union (EXGENESIS, grant no. LSHM-CT-2004-005272), the Danish Diabetes Association and the Danish Council for Independent Research (Medical Sciences). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEN MS, 1918, BMC MED GENET, V11, P58; ANDERSSON EA, DIABETOLOGIA; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bouret SG, 2009, J PEDIATR GASTR NUTR, V48, pS31, DOI 10.1097/MPG.0b013e3181977375; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; ELKS CE, PLOS MED, V7; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; Freathy RM, NAT GENET; HARDY R, HUM MOL GENET, V19, P545; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Leong NM, 2003, INT J CANCER, V103, P789, DOI 10.1002/ijc.10886; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lopez-Bermejo A, 2008, J CLIN ENDOCR METAB, V93, P1501, DOI 10.1210/jc.2007-2343; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Parsons TJ, 1999, INT J OBESITY, V23, pS1; PETRY CJ, HORM RES PEDIAT, V73, P275; PILGAARD K, 1944, J DEV ORIGINS HLTH D, P1; Ranadive SA, 2008, ENDOCRIN METAB CLIN, V37, P733, DOI 10.1016/j.ecl.2008.07.003; RZEHAK P, OBES FACTS, V3, P173; SANDHOLT CH, DIABETES; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; van Vliet-Ostaptchouk JV, 2009, OBES REV, V10, P593, DOI 10.1111/j.1467-789X.2009.00597.x; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	30	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14190	10.1371/journal.pone.0014190	http://dx.doi.org/10.1371/journal.pone.0014190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152014	Green Published, gold, Green Submitted			2022-12-27	WOS:000284821300007
J	Bishop, DVM				Bishop, Dorothy V. M.			Which Neurodevelopmental Disorders Get Researched and Why?	PLOS ONE			English	Article							RARE	Aim: There are substantial differences in the amount of research concerned with different disorders. This paper considers why. Methods: Bibliographic searches were conducted to identify publications (1985-2009) concerned with 35 neurodevelopmental disorders: Developmental dyslexia, Developmental dyscalculia, Developmental coordination disorder, Speech sound disorder, Specific language impairment, Attention deficit hyperactivity disorder, Autistic spectrum disorder, Tourette syndrome, Intellectual disability, Angelman syndrome, Cerebral palsy, Cornelia de Lange syndrome, Cri du chat syndrome, Down syndrome, Duchenne muscular dystrophy, Fetal alcohol syndrome, Fragile X syndrome, Galactosaemia, Klinefelter syndrome, Lesch-Nyhan syndrome, Lowe syndrome, Marfan syndrome, Neurofibromatosis type 1, Noonan syndrome, Phenylketonuria, Prader-Willi syndrome, Rett syndrome, Rubinstein-Taybi syndrome, Trisomy 18, Tuberous sclerosis, Turner syndrome, Velocardiofacial syndrome, Williams syndrome, XXX and XYY. A publication index reflecting N publications relative to prevalence was derived. Results: The publication index was higher for rare than common conditions. However, this was partly explained by the tendency for rare disorders to be more severe. Interpretation: Although research activity is predictable from severity and prevalence, there are exceptions. Low rates of research, and relatively low levels of NIH funding, characterise conditions that are the domain of a single discipline with limited research resources. Growth in research is not explained by severity, and was exceptionally steep for autism and ADHD.	Univ Oxford, Oxford, England	University of Oxford	Bishop, DVM (corresponding author), Univ Oxford, Oxford, England.	dorothy.bishop@psy.ox.ac.uk		Bishop, Dorothy/0000-0002-2448-4033	Wellcome Trust [053335]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Programme Grant 053335. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahi R, 2001, BRIT MED J, V323, P1461, DOI 10.1136/bmj.323.7327.1461; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ayme S, 2007, BUNDESGESUNDHEITSBLA, V50, P1477, DOI 10.1007/s00103-007-0381-9; Bishop D, 2008, RUTTERS CHILD ADOLES, P32, DOI DOI 10.1002/9781444300895.CH3; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Harris J., 2008, RUTTERS CHILD ADOLES, P459; Leggett V, 2010, DEV MED CHILD NEUROL, V52, P119, DOI 10.1111/j.1469-8749.2009.03545.x; *OFF NAT STAT, 2008, MID 2008 EST HOUS PO; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; Udwin O., 1995, BEHAV PHENOTYPES CLI, P90; Van Engeland H., 2008, RUTTERS CHILD ADOLES, P759; WHO, 2012, ICD 10 CLASS MENT BE	12	142	145	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15112	10.1371/journal.pone.0015112	http://dx.doi.org/10.1371/journal.pone.0015112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152085	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100076
J	Heuberger, S; Ellers-Kirk, C; Tabashnik, BE; Carriere, Y				Heuberger, Shannon; Ellers-Kirk, Christa; Tabashnik, Bruce E.; Carriere, Yves			Pollen- and Seed-Mediated Transgene Flow in Commercial Cotton Seed Production Fields	PLOS ONE			English	Article							GENE FLOW; BRASSICA-NAPUS; CONTAMINATION; RESISTANCE; MAIZE; POLLINATION; DISPERSAL; REFUGES	Background: Characterizing the spatial patterns of gene flow from transgenic crops is challenging, making it difficult to design containment strategies for markets that regulate the adventitious presence of transgenes. Insecticidal Bacillus thuringiensis (Bt) cotton is planted on millions of hectares annually and is a potential source of transgene flow. Methodology/Principal Findings: Here we monitored 15 non-Bt cotton (Gossypium hirsutum, L.) seed production fields (some transgenic for herbicide resistance, some not) for gene flow of the Bt cotton cry1Ac transgene. We investigated seed-mediated gene flow, which yields adventitious Bt cotton plants, and pollen-mediated gene flow, which generates outcrossed seeds. A spatially-explicit statistical analysis was used to quantify the effects of nearby Bt and non-Bt cotton fields at various spatial scales, along with the effects of pollinator abundance and adventitious Bt plants in fields, on pollen-mediated gene flow. Adventitious Bt cotton plants, resulting from seed bags and planting error, comprised over 15% of plants sampled from the edges of three seed production fields. In contrast, pollen-mediated gene flow affected less than 1% of the seed sampled from field edges. Variation in outcrossing was better explained by the area of Bt cotton fields within 750 m of the seed production fields than by the area of Bt cotton within larger or smaller spatial scales. Variation in outcrossing was also positively associated with the abundance of honey bees. Conclusions/Significance: A comparison of statistical methods showed that our spatially-explicit analysis was more powerful for understanding the effects of surrounding fields than customary models based on distance. Given the low rates of pollen-mediated gene flow observed in this study, we conclude that careful planting and screening of seeds could be more important than field spacing for limiting gene flow.	[Heuberger, Shannon; Ellers-Kirk, Christa; Tabashnik, Bruce E.; Carriere, Yves] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University of Arizona	Heuberger, S (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	heubergs@ag.arizona.edu			Western Region Sustainable Agriculture Research and Education (WSARE) [GW07-004]; Environmental Protection Agency (EPA) [FP 916819]; Cotton Foundation; Cotton Inc.; National Cotton Council; Monsanto; Dow AgroSciences	Western Region Sustainable Agriculture Research and Education (WSARE); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Cotton Foundation; Cotton Inc.; National Cotton Council; Monsanto; Dow AgroSciences	This work was supported by Western Region Sustainable Agriculture Research and Education (WSARE) Graduate Student Fellow's Grant in Sustainable Agriculture, grant number GW07-004 (http://wsare.usu.edu/) and Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Fellowship, number FP 916819 (http://www.epa.gov/ncer/fellow/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EPA and WSARE have not officially endorsed this publication, and the views expressed may not reflect the views of the EPA or WSARE.; B.E. Tabashnik has received support for research that is not related to this publication from the following sources: Cotton Foundation, Cotton Inc., National Cotton Council, Monsanto, and Dow AgroSciences. He is also a coauthor of a patent application on engineering modified Bt toxins to counter pest resistance, which is related to research described by Soberon et al. (2007, Science 318: 1640-1642). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	[Anonymous], 2008, JMP 8 0; Bannert M, 2007, EUR J AGRON, V27, P44, DOI 10.1016/j.eja.2007.01.002; Beckie HJ, 2003, ECOL APPL, V13, P1276, DOI 10.1890/02-5231; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Carriere Y, 2004, ECOL APPL, V14, P1615, DOI 10.1890/03-5268; Carriere Y, 2009, BASIC APPL ECOL, V10, P597, DOI 10.1016/j.baae.2008.10.010; Ceddia MG, 2009, AGR ECOSYST ENVIRON, V129, P65, DOI 10.1016/j.agee.2008.07.004; Chilcutt CF, 2004, P NATL ACAD SCI USA, V101, P7526, DOI 10.1073/pnas.0400546101; Colbach N, 2010, ECOL MODEL, V221, P225, DOI 10.1016/j.ecolmodel.2009.10.011; Colbach N, 2009, ENVIRON SCI POLLUT R, V16, P348, DOI 10.1007/s11356-008-0080-6; *COMM BIOL CONF GE, 2004, BIOL CONF GEN ENG OR; Committee on the Impact of Biotechnology on Farm-Level Economics and Sustainability and The National Research Council T, 2010, IMP GEN ENG CROPS FA; Eckert JE, 1933, J AGRIC RES, V47, P0257; ESRI, 1998, ARCVIEW GIS VERS 3 1; Free J.B., 1970, INSECT POLLINATION C; Friesen LF, 2003, AGRON J, V95, P1342, DOI 10.2134/agronj2003.1342; Goggi AS, 2006, FIELD CROP RES, V99, P147, DOI 10.1016/j.fcr.2006.04.005; Hayter KE, 2006, J APPL ECOL, V43, P1196, DOI 10.1111/j.1365-2664.2006.01219.x; Heuberger Shannon, 2008, Environmental Biosafety Research, V7, P87, DOI 10.1051/ebr:2008005; Heuberger S, 2008, J ECON ENTOMOL, V101, P504, DOI 10.1603/0022-0493(2008)101[504:EORCBT]2.0.CO;2; Llewellyn D, 1996, MOL BREEDING, V2, P157, DOI 10.1007/BF00441430; Llewellyn D, 2007, AGR ECOSYST ENVIRON, V121, P419, DOI 10.1016/j.agee.2006.11.019; Ma BL, 2004, CROP SCI, V44, P1273, DOI 10.2135/cropsci2004.1273; Mallory-Smith C, 2008, PEST MANAG SCI, V64, P428, DOI 10.1002/ps.1517; MCGREGOR SE, 1959, SCIENCE, V129, P97, DOI 10.1126/science.129.3341.97; MELLON M, 2004, GONE SEED TRANSGENIC; Showalter AM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.2201; Smyth S, 2002, NAT BIOTECHNOL, V20, P537, DOI 10.1038/nbt0602-537; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; UMBECK PF, 1991, J ECON ENTOMOL, V84, P1943, DOI 10.1093/jee/84.6.1943; Van Deynze AE, 2005, CROP SCI, V45, P1565, DOI 10.2135/cropsci2004.0463; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; Zhang BH, 2005, MOL BIOTECHNOL, V31, P11, DOI 10.1385/MB:31:1:011; Zhang BH, 2000, J GENET, V79, P71, DOI 10.1007/BF02728948	35	44	51	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14128	10.1371/journal.pone.0014128	http://dx.doi.org/10.1371/journal.pone.0014128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152426	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100009
J	Hsieh, YH; Hogan, MT; Barnes, M; Jett-Goheen, M; Huppert, J; Rompalo, AM; Gaydos, CA				Hsieh, Yu-Hsiang; Hogan, M. Terry; Barnes, Mathilda; Jett-Goheen, Mary; Huppert, Jill; Rompalo, Anne M.; Gaydos, Charlotte A.			Perceptions of an Ideal Point-of-Care Test for Sexually Transmitted Infections - A Qualitative Study of Focus Group Discussions with Medical Providers	PLOS ONE			English	Article							STIGMA; ISSUES; STIS	Background: A point-of-care test (POCT) for sexually transmitted infections (STIs), which offers immediate diagnosis resulting in patients receiving diagnosis and treatment in a single visit, has the ability to address some of the STI control needs. However, needs assessment from STI experts and end users about currently available STI POCTs and their future new development has not been evaluated since World Health Organization Sexually Transmitted Diseases Diagnostics Initiative was formed over 15 years ago. Therefore, our objective was to explore the perceptions of the ideal types of STI POCT for use in health care settings. Methodology/Principal Findings: A qualitative study, encompassing eight focus groups, was conducted from March 2008 through April 2009. Participants included 6 STD clinic directors, 63 clinicians, and 7 public health/laboratory/epidemiology professionals in the STI field. Discussion topics included currently available POCT, perceived barriers to using POCT in clinics, priority STI for the development of new POCT, and characteristics of the ideal POCT. All discussions were recorded and transcribed verbatim. Themes raised as barriers for current POCT included complexity, long time frames of the so-called "rapid" test, multiple time-driven steps, requiring laboratory technician, difficulty in reading result, interruption of workflow, unreliability, and invasiveness. Chlamydia trachomatis was identified as the priority organism for development of a new STI POCT. Themes indicated for the ideal POCT included rapid turnaround (up to 20 minutes), ease of use, non-invasive, accurate (preferred sensitivity and specificity in the range of high 90s), Clinical Laboratory Improvement Amendments (CLIA)-waived, user-friendly (for both patients and staff), compact, durable, and sturdy. Conclusions/Significance: Focus group discussions with STI experts and professionals highlighted chlamydia as the top priority pathogen for POCT development, and identified the qualities of new POCT for STIs. Participants endorsed ease of use, rapid turnaround and high accuracy as essential characteristics of an ideal POCT.	[Hsieh, Yu-Hsiang] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA; [Hogan, M. Terry; Barnes, Mathilda; Jett-Goheen, Mary; Rompalo, Anne M.; Gaydos, Charlotte A.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD USA; [Huppert, Jill] Cincinnati Childrens Hosp Med Ctr, Div Adolescent Med, Cincinnati, OH USA; [Huppert, Jill] Univ Cincinnati, Coll Med, Div Adolescent Med, Cincinnati, OH USA	Johns Hopkins University; Johns Hopkins University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hsieh, YH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA.	yhsieh1@jhmi.edu	Gaydos, Charlotte A./E-9937-2010		NIH [U54-EB007958, AI068613-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB007958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grant U54-EB007958 and AI068613-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, 2009, SEX TRANSM DIS US 20; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; Cole LA, 2004, AM J OBSTET GYNECOL, V190, P100, DOI 10.1016/j.ajog.2003.08.043; Cunningham SD, 2002, SEX TRANSM INFECT, V78, P334, DOI 10.1136/sti.78.5.334; Greer L, 2008, INFECT DIS CLIN N AM, V22, P601, DOI 10.1016/j.idc.2008.05.010; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Institute of Medicine, 1997, HIDD EP CONFR SEX TR; Kane B, 1999, ANN INTERN MED, V130, P870, DOI 10.7326/0003-4819-130-10-199905180-00102; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lichtenstein B, 2003, SOC SCI MED, V57, P2435, DOI 10.1016/j.socscimed.2003.08.002; Mabey D, 2001, SEX TRANSM INFECT, V77, P397, DOI 10.1136/sti.77.6.397; Morgan D.L., 1998, PLANNING FOCUS GROUP; Parrish DD, 2008, SEX TRANSM DIS, V35, pS19, DOI 10.1097/OLQ.0b013e31818f2ae1; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Powell RA, 1996, INT J QUAL HEALTH C, V8, P499, DOI 10.1093/intqhc/8.5.499; Rusch M, 2008, SEX TRANSM DIS, V35, P553, DOI 10.1097/OLQ.0b013e3181685855; Sabido M, 2009, J CLIN MICROBIOL, V47, P475, DOI 10.1128/JCM.01975-08; Schwebke JR, 1997, SEX TRANSM DIS, V24, P181, DOI 10.1097/00007435-199704000-00001; Swain Geoffrey R, 2004, Clin Med Res, V2, P29; *US FDA, 2009, CLIA WAIV; Ward P, 2006, SEX TRANSM INFECT, V82, P506, DOI 10.1136/sti.2005.017962; WHO/OMS, 2001, WHO SEX TRANSM DIS D	22	42	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14144	10.1371/journal.pone.0014144	http://dx.doi.org/10.1371/journal.pone.0014144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	687DK	21152386	Green Published, gold			2022-12-27	WOS:000284755100024
J	Osen, W; Soltek, S; Song, MX; Leuchs, B; Steitz, J; Tuting, T; Eichmuller, SB; Nguyen, XD; Schadendorf, D; Paschen, A				Osen, Wolfram; Soltek, Sabine; Song, Mingxia; Leuchs, Barbara; Steitz, Julia; Tueting, Thomas; Eichmueller, Stefan B.; Nguyen, Xuan-Duc; Schadendorf, Dirk; Paschen, Annette			Screening of Human Tumor Antigens for CD4(+) T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries	PLOS ONE			English	Article							TYROSINASE-RELATED PROTEIN-2; LARGE ESTABLISHED MELANOMA; METASTATIC MELANOMA; CANCER REGRESSION; INFILTRATING LYMPHOCYTES; ANTITUMOR LYMPHOCYTES; GENETIC IMMUNIZATION; DENDRITIC CELL; PHASE-I; IDENTIFICATION	Background: As tumor antigen-specific CD4(+) T cells can mediate strong therapeutic anti-tumor responses in melanoma patients we set out to establish a comprehensive screening strategy for the identification of tumor-specific CD4(+) T cell epitopes suitable for detection, isolation and expansion of tumor-reactive T cells from patients. Methods and Findings: To scan the human melanoma differentiation antigens TRP-1 and TRP-2 for HLA-DRB1*0301-restricted CD4(+) T cell epitopes we applied the following methodology: Splenocytes of HLA-DRB1*0301-transgenic mice immunized with recombinant adenovirus encoding TRP-1 (Ad5.TRP-1) or TRP-2 (Ad5.TRP-2) were tested for their T cell reactivity against combinatorial TRP-1- and TRP-2-specific peptide libraries. CD4(+) T cell epitopes thus identified were validated in the human system by stimulation of peripheral blood mononuclear cells (PBMC) from healthy donors and melanoma patients. Using this strategy we observed that recombinant Ad5 induced strong CD4(+) T cell responses against the heterologous tumor antigens. In Ad5. TRP-2-immunized mice CD4(+) T cell reactivity was detected against the known HLA-DRB1*0301-restricted TRP-2(60-74) epitope and against the new epitope TRP-2(149-163). Importantly, human T cells specifically recognizing target cells loaded with the TRP-2(149-163)-containing library peptide or infected with Ad5. TRP-2 were obtained from healthy individuals, and short term in vitro stimulation of PBMC revealed the presence of epitope-reactive CD4(+) T cells in melanoma patients. Similarly, immunization of mice with Ad5. TRP-1 induced CD4(+) T cell responses against TRP-1-derived peptides that turned out to be recognized also by human T cells, resulting in the identification of TRP-1(284-298) as a new HLA-DRB1*0301-restricted CD4(+) T cell epitope. Conclusions: Our screening approach identified new HLA-DRB1*0301-restricted CD4(+) T cell epitopes derived from melanoma antigens. This strategy is generally applicable to target antigens of other tumor entities and to different HLA class II molecules even without prior characterization of their peptide binding motives.	[Osen, Wolfram; Soltek, Sabine; Eichmueller, Stefan B.] German Canc Res Ctr, Clin Cooperat Unit Dermatooncol, D-6900 Heidelberg, Germany; [Leuchs, Barbara] German Canc Res Ctr, Infect & Canc Program, D-6900 Heidelberg, Germany; [Song, Mingxia; Schadendorf, Dirk; Paschen, Annette] Univ Hosp Essen, Dept Dermatol, Essen, Germany; [Steitz, Julia] Rhein Westfal TH Aachen, Inst Lab Anim Sci & Expt Surg, Aachen, Germany; [Tueting, Thomas] Univ Bonn, Dept Dermatol, D-5300 Bonn, Germany; [Nguyen, Xuan-Duc] Inst Immunol & Transfus Med, Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; RWTH Aachen University; University of Bonn	Osen, W (corresponding author), German Canc Res Ctr, Clin Cooperat Unit Dermatooncol, D-6900 Heidelberg, Germany.	annette.paschen@uk-essen.de	Tüting, Thomas/AAJ-3610-2021; Eichmüller, Stefan B/A-5053-2008; Schadendorf, Dirk/AAE-8206-2019	Tüting, Thomas/0000-0001-7146-0934; Eichmüller, Stefan B/0000-0002-3497-6904; 	EU [518234]	EU(European Commission)	This study was supported by the EU 6th framework "Cancer Immunotherapy" (518234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anichini A, 2006, CANCER RES, V66, P6405, DOI 10.1158/0008-5472.CAN-06-0854; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FERRADINI L, 1993, J CLIN INVEST, V91, P1183, DOI 10.1172/JCI116278; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Giuntoli RL, 2002, CLIN CANCER RES, V8, P922; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kong YCM, 1996, J EXP MED, V184, P1167, DOI 10.1084/jem.184.3.1167; Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100; Mitchell MS, 2002, J CLIN ONCOL, V20, P1075, DOI 10.1200/JCO.20.4.1075; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Naito Y, 1998, CANCER RES, V58, P3491; Nishikawa H, 2005, BLOOD, V106, P1008, DOI 10.1182/blood-2005-02-0607; Parkhurst MR, 1998, CANCER RES, V58, P4895; Paschen A, 2005, INT J CANCER, V116, P944, DOI 10.1002/ijc.21132; Paschen A, 2005, CLIN CANCER RES, V11, P5241, DOI 10.1158/1078-0432.CCR-05-0170; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rojas JM, 2005, CANCER IMMUNOL IMMUN, V54, P243, DOI 10.1007/s00262-004-0596-7; Rosenberg SA, 2004, P NATL ACAD SCI USA, V101, P14639, DOI 10.1073/pnas.0405730101; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shen L, 2004, CANCER IMMUNOL IMMUN, V53, P391, DOI 10.1007/s00262-003-0455-y; Steitz J, 2000, INT J CANCER, V86, P89, DOI 10.1002/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I; Tobery Timothy W, 2004, Methods Mol Med, V94, P121; Tuting T, 1999, J GENE MED, V1, P400, DOI 10.1002/(SICI)1521-2254(199911/12)1:6<400::AID-JGM68>3.0.CO;2-D; WANG RF, 1995, J EXP MED, V181, P799, DOI 10.1084/jem.181.2.799; Wang RF, 1996, J EXP MED, V184, P2207, DOI 10.1084/jem.184.6.2207; WANG RF, 1995, J EXP MED, V181, P1261; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	40	10	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14137	10.1371/journal.pone.0014137	http://dx.doi.org/10.1371/journal.pone.0014137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152437	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100018
J	Roato, I; Porta, F; Mussa, A; D'Amico, L; Fiore, L; Garelli, D; Spada, M; Ferracini, R				Roato, Ilaria; Porta, Francesco; Mussa, Alessandro; D'Amico, Lucia; Fiore, Ludovica; Garelli, Davide; Spada, Marco; Ferracini, Riccardo			Bone Impairment in Phenylketonuria Is Characterized by Circulating Osteoclast Precursors and Activated T Cell Increase	PLOS ONE			English	Article							PHALANGEAL QUANTITATIVE ULTRASOUND; MINERAL STATUS; RECEPTOR ACTIVATOR; IN-VITRO; CHILDREN; LIGAND; GROWTH; OSTEOPOROSIS; DENSITOMETRY; DEFICIENCY	Background: Phenylketonuria (PKU) is a rare inborn error of metabolism often complicated by a progressive bone impairment of uncertain etiology, as documented by both ionizing and non-ionizing techniques. Methodology: Peripheral blood mononuclear cell (PBMC) cultures were performed to study osteoclastogenesis, in the presence or absence of recombinant human monocyte-colony stimulating factor (M-CSF) and receptor activator of NFkB ligand (RANKL). Flow cytometry was utilized to analyze osteoclast precursors (OCPs) and T cell phenotype. Tumour necrosis factor alpha (TNF-alpha), RANKL and osteoprotegerin (OPG) were quantified in cell culture supernatants by ELISA. The effects of RANKFc and anti-TNF-alpha antibodies were also investigated to determine their ability to inhibit osteoclastogenesis. In addition, bone conditions and phenylalanine levels in PKU patients were clinically evaluated. Principal Findings: Several in vitro studies in PKU patients' cells identified a potential mechanism of bone formation inhibition commonly associated with this disorder. First, PKU patients disclosed an increased osteoclastogenesis compared to healthy controls, both in unstimulated and M-CSF/RANKL stimulated PBMC cultures. OCPs and the measured RANKL/OPG ratio were higher in PKU patients compared to healthy controls. The addition of specific antagonist RANKFc caused osteoclastogenesis inhibition, whereas anti-TNF-a failed to have this effect. Among PBMCs isolated from PKU patients, activated T cells, expressing CD69, CD25 and RANKL were identified. Confirmatory in vivo studies support this proposed model. These in vivo studies included the analysis of osteoclastogenesis in PKU patients, which demonstrated an inverse relation to bone condition assessed by phalangeal Quantitative Ultrasound (QUS). This was also directly related to noncompliance to therapeutic diet reflected by hyperphenylalaninemia. Conclusions: Our results indicate that PKU spontaneous osteoclastogenesis depends on the circulating OCP increase and the activation of T cells. Osteoclastogenesis correlates with clinical parameters, suggesting its value as a diagnostic tool for an early assessment of an increased bone resorption in PKU patients.	[Roato, Ilaria; D'Amico, Lucia; Ferracini, Riccardo] AOU San Giovanni Battista, Ctr Expt Res & Med Studies, Turin, Italy; [Porta, Francesco; Mussa, Alessandro; Fiore, Ludovica; Garelli, Davide; Spada, Marco; Ferracini, Riccardo] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Ferracini, Riccardo] AOU San Giovanni Battista, Dept Orthopaed, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Roato, I (corresponding author), AOU San Giovanni Battista, Ctr Expt Res & Med Studies, Turin, Italy.	roato78@libero.it	Mussa, Alessandro/H-1162-2013; Mussa, Alessandro/AAC-6235-2022; Ferracini, Riccardo/AAL-4622-2020; Porta, Francesco/G-9764-2012	Mussa, Alessandro/0000-0003-2795-6013; Mussa, Alessandro/0000-0003-2795-6013; Spada, Marco/0000-0002-8894-350X; Porta, Francesco/0000-0003-3899-4867; Roato, Ilaria/0000-0003-3029-4743	Compagnia di San Paolo and Regione Piemonte (Ricerca Sanitaria Finalizzata)	Compagnia di San Paolo and Regione Piemonte (Ricerca Sanitaria Finalizzata)(Compagnia di San Paolo)	Compagnia di San Paolo and Regione Piemonte (Ricerca Sanitaria Finalizzata) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qadreh A, 1998, ACTA PAEDIATR, V87, P1162; ALLEN JR, 1994, AM J CLIN NUTR, V59, P419, DOI 10.1093/ajcn/59.2.419; Baroncelli GI, 2006, BONE, V39, P159, DOI 10.1016/j.bone.2005.12.010; Baroncelli GI, 2008, PEDIATR RES, V63, P220, DOI 10.1203/PDR.0b013e318163a286; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; BICKEL H, 1953, LANCET, V265, P812; Brianza SZM, 2008, J IMAGING SCI TECHN, V52, DOI 10.2352/J.ImagingSci.Technol.(2008)52:3(030508); Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Cheng S, 1999, CALCIFIED TISSUE INT, V64, P470, DOI 10.1007/s002239900635; Chiu YG, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2915; Colucci S, 2004, BLOOD, V104, P3722, DOI 10.1182/blood-2004-02-0474; D'Amelio P, 2004, FASEB J, V18, P410, DOI 10.1096/fj.04-2214fje; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; De Terlizzi F, 2000, J BONE MINER RES, V15, P2458, DOI 10.1359/jbmr.2000.15.12.2458; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Faienza MF, 2009, J CLIN ENDOCR METAB, V94, P2269, DOI 10.1210/jc.2008-2446; Fewtrell MS, 2003, ARCH DIS CHILD, V88, P795, DOI 10.1136/adc.88.9.795; FROST HM, 1990, ANAT RECORD, V226, P433, DOI 10.1002/ar.1092260405; Giuliani N, 2002, BLOOD, V100, P4615, DOI 10.1182/blood-2002-04-1121; Grundt A, 2009, BIOCHEM BIOPH RES CO, V389, P550, DOI 10.1016/j.bbrc.2009.09.026; Hillman L, 1996, EUR J PEDIATR, V155, pS148, DOI 10.1007/PL00014234; Hoeks MPA, 2009, NETH J MED, V67, P2; Kim JH, 2009, J IMMUNOL, V183, P1862, DOI 10.4049/jimmunol.0803007; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; MacDonald A, 2006, ARCH DIS CHILD, V91, P588, DOI 10.1136/adc.2005.084285; MCMURRY MP, 1992, AM J CLIN NUTR, V55, P997, DOI 10.1093/ajcn/55.5.997; Mehta SS, 1998, J BONE MINER RES, V13, P114, DOI 10.1359/jbmr.1998.13.1.114; Millet P, 2005, CLIN BIOCHEM, V38, P1127, DOI 10.1016/j.clinbiochem.2005.09.002; Mussa A, 2010, BONE, V46, P1016, DOI 10.1016/j.bone.2009.12.019; Njeh CF, 1997, OSTEOPOROSIS INT, V7, P7, DOI 10.1007/BF01623454; Pluskiewicz W, 2002, OSTEOPOROSIS INT, V13, P353, DOI 10.1007/s001980200039; Porta F., 2008, J INHERIT METAB DIS; Porta F, 2008, ULTRASOUND MED BIOL, V34, P1049, DOI 10.1016/j.ultrasmedbio.2007.12.013; Prentice A, 2006, P NUTR SOC, V65, P348, DOI 10.1079/PNS2006519; Roato I, 2008, LUNG CANCER, V61, P109, DOI 10.1016/j.lungcan.2007.10.016; Roato I, 2004, FASEB J, V18, P228, DOI 10.1096/fj.04-1823fje; Roato I, 2007, ANN NY ACAD SCI, V1117, P377, DOI 10.1196/annals.1402.002; Roato I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003627; Sakata S, 2004, J BONE MINER RES, V19, P924, DOI 10.1359/JBMR.040131; SCRIVER CR, 2001, METABOLIC MOL BASES, V2, P1667; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Yago T, 2009, J CELL BIOCHEM, V108, P947, DOI 10.1002/jcb.22326; Yannicelli S, 2002, J INHERIT METAB DIS, V25, P347, DOI 10.1023/A:1020191515173; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204; Yi S., 2008, COCHRANE DB SYST REV, V4; Yoshimatsu M, 2009, BONE, V45, P1010, DOI 10.1016/j.bone.2009.07.079	47	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14167	10.1371/journal.pone.0014167	http://dx.doi.org/10.1371/journal.pone.0014167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152388	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100044
J	Choi, YK; Nash, K; Byrne, BJ; Muzyczka, N; Song, SH				Choi, Young-Kook; Nash, Kevin; Byrne, Barry J.; Muzyczka, Nicholas; Song, Sihong			The Effect of DNA-Dependent Protein Kinase on Adeno-Associated Virus Replication	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; DOUBLE-STRAND BREAK; ADENO-ASSOCIATED VIRUS; SITE-SPECIFIC ENDONUCLEASE; DAMAGE-INDUCED APOPTOSIS; IN-VITRO REPLICATION; CATALYTIC SUBUNIT; REP PROTEIN; MUTATIONAL ANALYSIS; TERMINAL REPEATS	Background: DNA-dependent protein kinase (DNA-PK) is a DNA repair enzyme and plays an important role in determining the molecular fate of the rAAV genome. However, the effect this cellular enzyme on rAAV DNA replication remains elusive. Methodology/Principal Findings: In the present study, we characterized the roles of DNA-PK on recombinant adeno-associated virus DNA replication. Inhibition of DNA-PK by a DNA-PK inhibitor or siRNA targeting DNA-PKcs significantly decreased replication of AAV in MO59K and 293 cells. Southern blot analysis showed that replicated rAAV DNA formed head-to-head or tail-to-tail junctions. The head-to-tail junction was low or undetectable suggesting AAV-ITR self-priming is the major mechanism for rAAV DNA replication. In an in vitro replication assay, anti-Ku80 antibody strongly inhibited rAAV replication, while anti-Ku70 antibody moderately decreased rAAV replication. Similarly, when Ku heterodimer (Ku70/80) was depleted, less replicated rAAV DNA were detected. Finally, we showed that AAV-ITRs directly interacted with Ku proteins. Conclusion/Significance: Collectively, our results showed that that DNA-PK enhances rAAV replication through the interaction of Ku proteins and AAV-ITRs.	[Choi, Young-Kook; Song, Sihong] Univ Florida, Dept Pharmaceut, Gainesville, FL 32610 USA; [Nash, Kevin; Muzyczka, Nicholas] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Byrne, Barry J.] Univ Florida, Dept Pediat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Choi, YK (corresponding author), Univ Florida, Dept Pharmaceut, Gainesville, FL 32610 USA.	shsong@ufl.edu	Nash, Kevin R/B-4567-2009	Nash, Kevin R/0000-0002-8607-1832; Byrne, Barry J./0000-0002-7302-1756	National Institutes of Health [P01-DK58327, PO1 HL59412, PO1 HL51811]; Juvenile Diabetes Research Foundation (JDRF); Alpha One Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051811, P01HL059412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Alpha One Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants (P01-DK58327, PO1 HL59412, PO1 HL51811) to S.S., N.M. and B.B., and grants from Juvenile Diabetes Research Foundation (JDRF) and Alpha One Foundation to S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazard-Dany N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000340; Balague C, 1997, J VIROL, V71, P3299; BEATON A, 1989, J VIROL, V63, P4450, DOI 10.1128/JVI.63.10.4450-4454.1989; Berns KI, 1996, FIELDS VIROLOGY, P2173; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; BLIER PR, 1993, J BIOL CHEM, V268, P7594; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Boulton S, 1996, CARCINOGENESIS, V17, P2285, DOI 10.1093/carcin/17.11.2285; Brister JR, 2000, J VIROL, V74, P7762, DOI 10.1128/JVI.74.17.7762-7771.2000; Brister JR, 1999, J VIROL, V73, P9325, DOI 10.1128/JVI.73.11.9325-9336.1999; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; CHANG C-T, 1989, Taiwan yixuehui zazhi, V88, P707; Chang Y N, 1990, Chin J Physiol, V33, P31; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Choi VW, 2006, J VIROL, V80, P10346, DOI 10.1128/JVI.00841-06; Conway JE, 1997, J VIROL, V71, P8780, DOI 10.1128/JVI.71.11.8780-8789.1997; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Davis MD, 2000, J VIROL, V74, P2936, DOI 10.1128/JVI.74.6.2936-2942.2000; Davis MD, 1999, J VIROL, V73, P2084, DOI 10.1128/JVI.73.3.2084-2093.1999; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Drouet J, 2005, J BIOL CHEM, V280, P7060, DOI 10.1074/jbc.M410746200; Duan DS, 2003, J VIROL, V77, P4751, DOI 10.1128/JVI.77.8.4751-4759.2003; Dubielzig R, 1999, J VIROL, V73, P8989, DOI 10.1128/JVI.73.11.8989-8998.1999; GRIFFITH AJ, 1992, J BIOL CHEM, V267, P331; Gullo C, 2006, BBA-REV CANCER, V1765, P223, DOI 10.1016/j.bbcan.2006.01.001; HERMONAT PL, 1984, J VIROL, V51, P329, DOI 10.1128/JVI.51.2.329-339.1984; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; Inagaki K, 2007, J VIROL, V81, P11304, DOI 10.1128/JVI.01225-07; Izzard RA, 1999, CANCER RES, V59, P2581; Jurvansuu J, 2005, J VIROL, V79, P569, DOI 10.1128/JVI.79.1.569-580.2005; Jurvansuu J, 2007, J MOL BIOL, V372, P397, DOI 10.1016/j.jmb.2007.06.077; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; LABOW MA, 1986, J VIROL, V60, P251, DOI 10.1128/JVI.60.1.251-258.1986; LAUGHLIN CA, 1986, J VIROL, V60, P515, DOI 10.1128/JVI.60.2.515-524.1986; LAUGHLIN CA, 1982, J VIROL, V41, P868, DOI 10.1128/JVI.41.3.868-876.1982; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MCCARTY DM, 1991, J VIROL, V65, P2936, DOI 10.1128/JVI.65.6.2936-2945.1991; MCCARTY DM, 1994, J VIROL, V68, P4988, DOI 10.1128/JVI.68.8.4988-4997.1994; MCLAUGHLIN SK, 1988, J VIROL, V62, P1963, DOI 10.1128/JVI.62.6.1963-1973.1988; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Nash K, 2008, J VIROL, V82, P1458, DOI 10.1128/JVI.01968-07; Nash K, 2007, J VIROL, V81, P5777, DOI 10.1128/JVI.02651-06; Nash K, 2009, J VIROL, V83, P454, DOI 10.1128/JVI.01939-08; Ni TH, 1998, J VIROL, V72, P2777, DOI 10.1128/JVI.72.4.2777-2787.1998; NI TH, 1994, J VIROL, V68, P1128, DOI 10.1128/JVI.68.2.1128-1138.1994; Parkinson J, 1999, J VIROL, V73, P650, DOI 10.1128/JVI.73.1.650-657.1999; Peng YL, 2002, CANCER RES, V62, P6400; Pereira DJ, 1997, J VIROL, V71, P1747, DOI 10.1128/JVI.71.3.1747-1756.1997; Pereira DJ, 1997, J VIROL, V71, P1079, DOI 10.1128/JVI.71.2.1079-1088.1997; Pereira DJ, 1997, J VIROL, V71, P4300, DOI 10.1128/JVI.71.6.4300-4309.1997; Philpott NJ, 2002, P NATL ACAD SCI USA, V99, P12381, DOI 10.1073/pnas.182430299; Price BD, 1996, CANCER RES, V56, P246; Ryan JH, 1996, J VIROL, V70, P1542, DOI 10.1128/JVI.70.3.1542-1553.1996; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; Schwartz RA, 2007, J VIROL, V81, P12936, DOI 10.1128/JVI.01523-07; Schwartz RA, 2009, J VIROL, V83, P6269, DOI 10.1128/JVI.00318-09; Shinohara ET, 2005, CANCER RES, V65, P4987, DOI 10.1158/0008-5472.CAN-04-4250; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Slanina H, 2006, J VIROL, V80, P5241, DOI 10.1128/JVI.02718-05; Song S, 1998, P NATL ACAD SCI USA, V95, P14384, DOI 10.1073/pnas.95.24.14384; Song SH, 2004, P NATL ACAD SCI USA, V101, P2112, DOI 10.1073/pnas.0307833100; Song SH, 2001, P NATL ACAD SCI USA, V98, P4084, DOI 10.1073/pnas.061014598; Stracker TH, 2004, J VIROL, V78, P441, DOI 10.1128/JVI.78.1.441-453.2004; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Toublanc E, 2004, J GENE MED, V6, P555, DOI 10.1002/jgm.542; TUTEJA N, 1994, EMBO J, V13, P4991, DOI 10.1002/j.1460-2075.1994.tb06826.x; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Walker SL, 1997, J VIROL, V71, P6996, DOI 10.1128/JVI.71.9.6996-7004.1997; Walker SL, 1997, J VIROL, V71, P2722, DOI 10.1128/JVI.71.4.2722-2730.1997; WARD P, 1994, J VIROL, V68, P6029, DOI 10.1128/JVI.68.9.6029-6037.1994; Ward P, 2001, J VIROL, V75, P10250, DOI 10.1128/JVI.75.21.10250-10258.2001; Ward P, 1996, J VIROL, V70, P4495, DOI 10.1128/JVI.70.7.4495-4501.1996; Ward P, 1998, J VIROL, V72, P420, DOI 10.1128/JVI.72.1.420-427.1998; Weger S, 1997, J VIROL, V71, P8437, DOI 10.1128/JVI.71.11.8437-8447.1997; WEINDLER FW, 1991, J VIROL, V65, P2476, DOI 10.1128/JVI.65.5.2476-2483.1991; WEITZMAN MD, 1994, P NATL ACAD SCI USA, V91, P5808, DOI 10.1073/pnas.91.13.5808; Woo RA, 2002, EMBO J, V21, P3000, DOI 10.1093/emboj/cdf307; Wu JW, 1999, J VIROL, V73, P8235, DOI 10.1128/JVI.73.10.8235-8244.1999; YALKINOGLU AO, 1988, CANCER RES, V48, P3123; Yamaguchi S, 2005, LEUKEMIA RES, V29, P307, DOI 10.1016/j.leukres.2004.07.003; Zentilin L, 2001, J VIROL, V75, P12279, DOI 10.1128/JVI.75.24.12279-12287.2001; Zhou XH, 1999, J VIROL, V73, P1580, DOI 10.1128/JVI.73.2.1580-1590.1999; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	87	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15073	10.1371/journal.pone.0015073	http://dx.doi.org/10.1371/journal.pone.0015073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188139	Green Published, gold			2022-12-27	WOS:000285575200014
J	Kenett, DY; Tumminello, M; Madi, A; Gur-Gershgoren, G; Mantegna, RN; Ben-Jacob, E				Kenett, Dror Y.; Tumminello, Michele; Madi, Asaf; Gur-Gershgoren, Gitit; Mantegna, Rosario N.; Ben-Jacob, Eshel			Dominating Clasp of the Financial Sector Revealed by Partial Correlation Analysis of the Stock Market	PLOS ONE			English	Article							NETWORKS; INFORMATION	What are the dominant stocks which drive the correlations present among stocks traded in a stock market? Can a correlation analysis provide an answer to this question? In the past, correlation based networks have been proposed as a tool to uncover the underlying backbone of the market. Correlation based networks represent the stocks and their relationships, which are then investigated using different network theory methodologies. Here we introduce a new concept to tackle the above question-the partial correlation network. Partial correlation is a measure of how the correlation between two variables, e. g., stock returns, is affected by a third variable. By using it we define a proxy of stock influence, which is then used to construct partial correlation networks. The empirical part of this study is performed on a specific financial system, namely the set of 300 highly capitalized stocks traded at the New York Stock Exchange, in the time period 2001-2003. By constructing the partial correlation network, unlike the case of standard correlation based networks, we find that stocks belonging to the financial sector and, in particular, to the investment services sub-sector, are the most influential stocks affecting the correlation profile of the system. Using a moving window analysis, we find that the strong influence of the financial stocks is conserved across time for the investigated trading period. Our findings shed a new light on the underlying mechanisms and driving forces controlling the correlation profile observed in a financial market.	[Kenett, Dror Y.; Ben-Jacob, Eshel] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Tumminello, Michele] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Tumminello, Michele; Mantegna, Rosario N.] Univ Palermo, Dipartimento Fis & Tecnol Relat, Palermo, Italy; [Madi, Asaf] Tel Aviv Univ, Fac Med, IL-69978 Tel Aviv, Israel; [Gur-Gershgoren, Gitit] Israel Secur Author, Jerusalem, Israel; [Gur-Gershgoren, Gitit] Ben Gurion Univ Negev, Sch Business & Management, IL-84105 Beer Sheva, Israel	Tel Aviv University; Carnegie Mellon University; University of Palermo; Tel Aviv University; Ben Gurion University	Kenett, DY (corresponding author), Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	rn.mantegna@gmail.com; eshelbj@gmail.com	Kenett, Dror Y/B-6133-2011; Mantegna, Rosario N/H-3652-2014; Tumminello, Michele/G-4492-2011	Kenett, Dror Y/0000-0002-3826-3469; Mantegna, Rosario N/0000-0003-4177-171X; Tumminello, Michele/0000-0001-6045-6761	French National Institute of Agronomic Research; Ministere de l'Education Nationale et de la Recherche, France	French National Institute of Agronomic Research; Ministere de l'Education Nationale et de la Recherche, France	This research was supported by public funds from the French National Institute of Agronomic Research. GD was supported by a doctoral fellowship from the Ministere de l'Education Nationale et de la Recherche, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba K, 2004, AUST NZ J STAT, V46, P657, DOI 10.1111/j.1467-842X.2004.00360.x; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Campbell J., 1997, ECONOMETRICS FINANCI; Chen L, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r3; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Di Matteo T, 2010, EUR PHYS J B, V73, P3, DOI 10.1140/epjb/e2009-00286-0; Elton E. J., 1995, MODERN PORTFOLIO THE; Gopikrishnan P, 2000, PHYSICA A, V287, P362, DOI 10.1016/S0378-4371(00)00375-7; Kenett DY, 2009, J PROBAB STAT, V2009, DOI 10.1155/2009/249370; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; MANTEGNA RN, 2000, INTRO ECONOPHYSICS C; Markowitz H. M., 1959, PORTFOLIO SELECTION; Metha M. L., 1990, RANDOM MATRICES; Noh JD, 2000, PHYS REV E, V61, P5981, DOI 10.1103/PhysRevE.61.5981; Pafka S, 2004, PHYSICA A, V343, P623, DOI 10.1016/j.physa.2004.05.079; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Plerou V, 1999, PHYS REV LETT, V83, P1471, DOI 10.1103/PhysRevLett.83.1471; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Rosenow B, 2002, EUROPHYS LETT, V59, P500, DOI 10.1209/epl/i2002-00135-4; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Shapira Y, 2009, EUR PHYS J B, V72, P657, DOI 10.1140/epjb/e2009-00384-y; SHIPLEY W, 2000, CAUSE CORRELATION BI; Spirtes P., 1993, CAUSATION PREDICTION; Tumminello M, 2007, EUR PHYS J B, V55, P209, DOI 10.1140/epjb/e2006-00414-4; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Tumminello M, 2007, INT J BIFURCAT CHAOS, V17, P2319, DOI 10.1142/S0218127407018415; Utsugi A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.026110	29	229	232	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15032	10.1371/journal.pone.0015032	http://dx.doi.org/10.1371/journal.pone.0015032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188140	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200012
J	Pennisi, A; Ling, W; Li, X; Khan, S; Wang, YP; Barlogie, B; Shaughnessy, JD; Yaccoby, S				Pennisi, Angela; Ling, Wen; Li, Xin; Khan, Sharmin; Wang, Yuping; Barlogie, Bart; Shaughnessy, John D., Jr.; Yaccoby, Shmuel			Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone	PLOS ONE			English	Article							MULTIPLE-MYELOMA; OXIDATIVE STRESS; BREAST-CANCER; MARROW MICROENVIRONMENT; OSTEOLYTIC LESIONS; BETA-CATENIN; PLASMA-CELLS; OSTEOBLAST; EXPRESSION; PROTEIN	Background: Induction of osteolytic bone lesions in multiple myeloma is caused by an uncoupling of osteoclastic bone resorption and osteoblastic bone formation. Current management of myeloma bone disease is limited to the use of antiresorptive agents such as bisphosphonates. Methodology/Principal Findings: We tested the effects of daily administered parathyroid hormone (PTH) on bone disease and myeloma growth, and we investigated molecular mechanisms by analyzing gene expression profiles of unique myeloma cell lines and primary myeloma cells engrafted in SCID-rab and SCID-hu mouse models. PTH resulted in increased bone mineral density of myelomatous bones and reduced tumor burden, which reflected the dependence of primary myeloma cells on the bone marrow microenvironment. Treatment with PTH also increased bone mineral density of uninvolved murine bones in myelomatous hosts and bone mineral density of implanted human bones in nonmyelomatous hosts. In myelomatous bone, PTH markedly increased the number of osteoblasts and bone-formation parameters, and the number of osteoclasts was unaffected or moderately reduced. Pretreatment with PTH before injecting myeloma cells increased bone mineral density of the implanted bone and delayed tumor progression. Human global gene expression profiling of myelomatous bones from SCID-hu mice treated with PTH or saline revealed activation of multiple distinct pathways involved in bone formation and coupling; involvement of Wnt signaling was prominent. Treatment with PTH also downregulated markers typically expressed by osteoclasts and myeloma cells, and altered expression of genes that control oxidative stress and inflammation. PTH receptors were not expressed by myeloma cells, and PTH had no effect on myeloma cell growth in vitro. Conclusions/Significance: We conclude that PTH-induced bone formation in myelomatous bones is mediated by activation of multiple signaling pathways involved in osteoblastogenesis and attenuated bone resorption and myeloma growth; mechanisms involve increased osteoblast production of anti-myeloma factors and minimized myeloma induction of inflammatory conditions.	[Pennisi, Angela; Ling, Wen; Li, Xin; Khan, Sharmin; Wang, Yuping; Barlogie, Bart; Shaughnessy, John D., Jr.; Yaccoby, Shmuel] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Pennisi, A (corresponding author), Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA.	yaccobyshmuel@uams.edu		Li, Xin/0000-0002-7414-5734	National Cancer Institute [CA-093897, CA-55819]; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA093897, P01CA055819] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA-093897 (SY) and CA-55819 (SY, BB, JS) from the National Cancer Institute, Senior and Translational Research Awards from the Multiple Myeloma Research Foundation (SY), and the authors' institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Abe M, 2004, BLOOD, V104, P2484, DOI 10.1182/blood-2003-11-3839; ALLAN EH, 2008, J BONE MINER RES; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/blood-2006-05-022962; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; BATAILLE R, 1991, J CLIN INVEST, V88, P62, DOI 10.1172/JCI115305; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bendre MS, 2002, CANCER RES, V62, P5571; Bilezikian JP, 2009, J BONE MINER RES, V24, P373, DOI [10.1359/JBMR.090105, 10.1359/jbmr.090105]; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Coleman RE, 2005, J CLIN ONCOL, V23, P4925, DOI 10.1200/JCO.2005.06.091; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; Edwards CM, 2008, BONE, V42, P1007, DOI 10.1016/j.bone.2008.01.027; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Giuliani N, 2006, BLOOD, V108, P3992, DOI 10.1182/blood-2006-05-026112; Graham S, 2009, EXPERT OPIN INV DRUG, V18, P1633, DOI 10.1517/13543780903241607; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Jeong BC, 2010, BONE, V46, P479, DOI 10.1016/j.bone.2009.09.019; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kulkarni NH, 2005, J CELL BIOCHEM, V95, P1178, DOI 10.1002/jcb.20506; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li X, 2008, BLOOD, V112, P159, DOI 10.1182/blood-2007-11-124164; Li X, 2007, BRIT J HAEMATOL, V138, P802, DOI 10.1111/j.1365-2141.2007.06742.x; Lindsay R, 2006, J BONE MINER RES, V21, P366, DOI 10.1359/JBMR.051109; Liu S, 2008, CANCER SCI, V99, P952, DOI 10.1111/j.1349-7006.2008.00787.x; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; Otsuki T, 2001, LEUKEMIA LYMPHOMA, V41, P397, DOI 10.3109/10428190109057995; Ozawa S, 2009, BIOMED RES-TOKYO, V30, P315, DOI 10.2220/biomedres.30.315; Park H, 2010, FEBS LETT, V584, P173, DOI 10.1016/j.febslet.2009.11.043; Pennisi A, 2009, BLOOD, V114, P1803, DOI 10.1182/blood-2009-01-201954; Pennisi A, 2009, AM J HEMATOL, V84, P6, DOI 10.1002/ajh.21310; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Qiang YW, 2008, BLOOD, V112, P374, DOI 10.1182/blood-2007-10-120253; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Roodman GD, 2004, BLOOD CELL MOL DIS, V32, P290, DOI 10.1016/j.bcmd.2004.01.001; Rosen LS, 2001, CANCER J, V7, P377; Sabbieti MG, 2009, J CELL PHYSIOL, V219, P143, DOI 10.1002/jcp.21661; Serra R, 1999, J CELL BIOL, V145, P783, DOI 10.1083/jcb.145.4.783; Sims NA, 2010, J BONE MINER RES, V25, P175, DOI 10.1002/jbmr.53; Stewart JP, 2006, J CELL BIOCHEM, V98, P1, DOI 10.1002/jcb.20774; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Weinstein RS, 2010, ENDOCRINOLOGY, V151, P2641, DOI 10.1210/en.2009-1488; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x; Yaccoby S, 1999, BLOOD, V94, P3576, DOI 10.1182/blood.V94.10.3576.422k01_3576_3582; Yaccoby S, 2006, HAEMATOL-HEMATOL J, V91, P192; Yaccoby S, 2005, CLIN CANCER RES, V11, P7599, DOI 10.1158/1078-0432.CCR-05-0523; Yaccoby S, 2004, CANCER RES, V64, P2016, DOI 10.1158/0008-5472.CAN-03-1131; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yaccoby S, 2010, BRIT J HAEMATOL, V149, P311, DOI 10.1111/j.1365-2141.2010.08141.x; Yaccoby S, 2010, LEUKEMIA LYMPHOMA, V51, P213, DOI 10.3109/10428190903503438; Yamamoto T, 2007, BONE, V40, P354, DOI 10.1016/j.bone.2006.09.002; YAO GQ, 2010, J BONE MINER METAB; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zangari M, 2005, BRIT J HAEMATOL, V131, P71, DOI 10.1111/j.1365-2141.2005.05733.x; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	74	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15233	10.1371/journal.pone.0015233	http://dx.doi.org/10.1371/journal.pone.0015233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188144	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200024
J	Bricard, G; Venkataswamy, MM; Yu, KOA; Im, JS; Ndonye, RM; Howell, AR; Veerapen, N; Illarionov, PA; Besra, GS; Li, QA; Chang, YT; Porcelli, SA				Bricard, Gabriel; Venkataswamy, Manjunatha M.; Yu, Karl O. A.; Im, Jin S.; Ndonye, Rachel M.; Howell, Amy R.; Veerapen, Natacha; Illarionov, Petr A.; Besra, Gurdyal S.; Li, Qian; Chang, Young-Tae; Porcelli, Steven A.			alpha-Galactosylceramide Analogs with Weak Agonist Activity for Human iNKT Cells Define New Candidate Anti-Inflammatory Agents	PLOS ONE			English	Article							KILLER T-CELLS; INVARIANT NKT CELLS; CD1D MOLECULES; TUMOR IMMUNOSURVEILLANCE; ANTITUMOR CYTOTOXICITY; CUTTING EDGE; NOD MICE; ACTIVATION; RECOGNITION; ANTIGENS	CD1d-restricted natural killer T cells with invariant T cell receptor alpha chains (iNKT cells) are a unique lymphocyte subset that responds to recognition of specific lipid and glycolipid antigens. They are conserved between mice and humans and exert various immunoregulatory functions through their rapid secretion of a variety of cytokines and secondary activation of dendritic cells, B cells and NK cells. In the current study, we analyzed the range of functional activation states of human iNKT cells using a library of novel analogs of alpha-galactosylceramide (alpha GalCer), the prototypical iNKT cell antigen. Measurement of cytokines secreted by human iNKT cell clones over a wide range of glycolipid concentrations revealed that iNKT cell ligands could be classified into functional groups, correlating with weak versus strong agonistic activity. The findings established a hierarchy for induction of different cytokines, with thresholds for secretion being consistently lowest for IL-13, higher for interferon-gamma (IFN gamma), and even higher for IL-4. These findings suggested that human iNKT cells can be intrinsically polarized to selective production of IL-13 by maintaining a low level of activation using weak agonists, whereas selective polarization to IL-4 production cannot be achieved through modulating the strength of the activating ligand. In addition, using a newly designed in vitro system to assess the ability of human iNKT cells to transactivate NK cells, we found that robust secondary induction of interferon-gamma secretion by NK cells was associated with strong but not weak agonist ligands of iNKT cells. These results indicate that polarization of human iNKT cell responses to Th2-like or anti-inflammatory effects may best be achieved through selective induction of IL-13 and suggest potential discrepancies with findings from mouse models that may be important in designing iNKT cell-based therapies in humans.	[Bricard, Gabriel; Venkataswamy, Manjunatha M.; Yu, Karl O. A.; Im, Jin S.; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Ndonye, Rachel M.; Howell, Amy R.] Univ Connecticut, Dept Chem, Storrs, CT USA; [Veerapen, Natacha; Illarionov, Petr A.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Edgbaston, England; [Li, Qian; Chang, Young-Tae] Natl Univ Singapore, Dept Chem, Singapore Bioimaging Consortium, A STAR, Singapore 117548, Singapore	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Connecticut; University of Birmingham; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore	Bricard, G (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	steven.porcelli@einstein.yu.edu	Chang, Young-Tae/B-2780-2010; Yu, Karl/ABC-4547-2020	Chang, Young-Tae/0000-0002-1927-3688; Besra, Gurdyal/0000-0002-5605-0395; Howell, Amy/0000-0003-1958-6411	NIH/NIAID [AI45889]; National Institute of General Medical Sciences (NIGMS) [GM087136]; Einstein Center for AIDS Research [AI 051519]; Einstein Cancer Center [CA 13330]; Personal Research Chair; Royal Society; Lister Institute-Jenner Research Fellowship; Medical Research Council; Wellcome Trust [084923/B/08/Z]; MRC [G0400421] Funding Source: UKRI; Medical Research Council [G0400421] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889, P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087136] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Einstein Center for AIDS Research; Einstein Cancer Center; Personal Research Chair; Royal Society(Royal Society of London); Lister Institute-Jenner Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant Support: This work was supported by NIH/NIAID grant AI45889 (to SAP) and National Institute of General Medical Sciences (NIGMS) grant GM087136 (to ARH). Core resources that facilitated flow cytometry were supported by the Einstein Center for AIDS Research (AI 051519) and the Einstein Cancer Center (CA 13330). GSB acknowledges support from a Personal Research Chair from Mr. James Bardrick, a Royal Society Wolfson Research Merit Award, a former Lister Institute-Jenner Research Fellowship, the Medical Research Council and The Wellcome Trust (084923/B/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; Bricard G, 2007, CELL MOL LIFE SCI, V64, P1824, DOI 10.1007/s00018-007-7007-0; Bricard G, 2009, J IMMUNOL, V182, P5140, DOI 10.4049/jimmunol.0711086; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brossay L, 1999, IMMUNOGENETICS, V50, P146, DOI 10.1007/s002510050590; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cernadas M, 2003, J IMMUNOL, V171, P4149, DOI 10.4049/jimmunol.171.8.4149; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Couedel C, 1998, EUR J IMMUNOL, V28, P4391, DOI 10.1002/(SICI)1521-4141(199812)28:12<4391::AID-IMMU4391>3.0.CO;2-2; de Lalla C, 2004, J IMMUNOL, V173, P1417, DOI 10.4049/jimmunol.173.2.1417; Forestier C, 2007, J IMMUNOL, V178, P1415, DOI 10.4049/jimmunol.178.3.1415; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Hegde S, 2009, J LEUKOCYTE BIOL, V86, P757, DOI 10.1189/jlb.0209059; Im JS, 2006, J IMMUNOL, V177, P5226, DOI 10.4049/jimmunol.177.8.5226; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Im JS, 2004, J BIOL CHEM, V279, P299, DOI 10.1074/jbc.M308803200; Ishihara S, 2000, J IMMUNOL, V165, P1659, DOI 10.4049/jimmunol.165.3.1659; Karni A, 2002, J NEUROIMMUNOL, V125, P134, DOI 10.1016/S0165-5728(02)00018-8; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Li Q, 2007, J COMB CHEM, V9, P1084, DOI 10.1021/cc070057i; Li XM, 2009, J IMMUNOL, V183, P4415, DOI 10.4049/jimmunol.0901021; Lind SM, 2009, EUR J IMMUNOL, V39, P2293, DOI 10.1002/eji.200839195; Lu X, 2006, CHEMBIOCHEM, V7, P1750, DOI 10.1002/cbic.200600197; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Metelitsa LS, 2001, J IMMUNOL, V167, P3114, DOI 10.4049/jimmunol.167.6.3114; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Mizuno M, 2004, J AUTOIMMUN, V23, P293, DOI 10.1016/j.jaut.2004.09.008; Moreno M, 2008, CLIN IMMUNOL, V129, P145, DOI 10.1016/j.clim.2008.07.004; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Motsinger A, 2003, J VIROL, V77, P8153, DOI 10.1128/JVI.77.14.8153-8158.2003; Ndonye RM, 2005, J ORG CHEM, V70, P10260, DOI 10.1021/jo051147h; Oki S, 2005, INT IMMUNOL, V17, P1619, DOI 10.1093/intimm/dxh342; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Osada T, 2005, INT IMMUNOL, V17, P1143, DOI 10.1093/intimm/dxh292; Pyz E, 2006, J IMMUNOL, V176, P7447, DOI 10.4049/jimmunol.176.12.7447; Roy KC, 2008, J IMMUNOL, V180, P2942, DOI 10.4049/jimmunol.180.5.2942; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Schmieg J, 2005, P NATL ACAD SCI USA, V102, P1127, DOI 10.1073/pnas.0408288102; Silk JD, 2008, J IMMUNOL, V180, P6452, DOI 10.4049/jimmunol.180.10.6452; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Swann JB, 2007, CURR TOP MICROBIOL, V314, P293; Terabe M, 2003, J EXP MED, V198, P1741, DOI 10.1084/jem.20022227; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Ueno Y, 2005, INFLAMM BOWEL DIS, V11, P35, DOI 10.1097/00054725-200501000-00005; Velazquez P, 2008, J IMMUNOL, V180, P2024, DOI 10.4049/jimmunol.180.4.2024; Venkataswamy MM, 2010, SEMIN IMMUNOL, V22, P68, DOI 10.1016/j.smim.2009.10.003; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Wang XH, 2008, BLOOD, V112, P4128, DOI 10.1182/blood-2008-05-157529; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2009, IMMUNOL REV, V230, P188, DOI 10.1111/j.1600-065X.2009.00802.x; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	58	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14374	10.1371/journal.pone.0014374	http://dx.doi.org/10.1371/journal.pone.0014374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179412	Green Published, Green Submitted, gold			2022-12-27	WOS:000285572900008
J	Hessol, NA; Napolitano, LA; Smith, D; Lie, Y; Levine, A; Young, M; Cohen, M; Minkoff, H; Anastos, K; D'Souza, G; Greenblatt, RM; Goedert, JJ				Hessol, Nancy A.; Napolitano, Laura A.; Smith, Dawn; Lie, Yolanda; Levine, Alexandra; Young, Mary; Cohen, Mardge; Minkoff, Howard; Anastos, Kathryn; D'Souza, Gypsyamber; Greenblatt, Ruth M.; Goedert, James J.			HIV Tropism and Decreased Risk of Breast Cancer	PLOS ONE			English	Article							WOMENS INTERAGENCY HIV; IN-VITRO; CXCR4; CHEMOKINE; RECEPTOR; CELLS; INFECTION; AIDS; INHIBITION; PATHWAY	Background: During the first two decades of the U. S. AIDS epidemic, and unlike some malignancies, breast cancer risk was significantly lower for women with human immunodeficiency virus (HIV) infection compared to the general population. This deficit in HIV-associated breast cancer could not be attributed to differences in survival, immune deficiency, childbearing or other breast cancer risk factors. HIV infects mononuclear immune cells by binding to the CD4 molecule and to CCR5 or CXCR4 chemokine coreceptors. Neoplastic breast cells commonly express CXCR4 but not CCR5. In vitro, binding HIV envelope protein to CXCR4 has been shown to induce apoptosis of neoplastic breast cells. Based on these observations, we hypothesized that breast cancer risk would be lower among women with CXCR4-tropic HIV infection. Methods and Findings: We conducted a breast cancer nested case-control study among women who participated in the WIHS and HERS HIV cohort studies with longitudinally collected risk factor data and plasma. Cases were HIV-infected women (mean age 46 years) who had stored plasma collected within 24 months of breast cancer diagnosis and an HIV viral load >= 500 copies/mL. Three HIV-infected control women, without breast cancer, were matched to each case based on age and plasma collection date. CXCR4-tropism was determined by a phenotypic tropism assay. Odds ratios (OR) and 95% confidence intervals (CI) for breast cancer were estimated by exact conditional logistic regression. Two (9%) of 23 breast cancer cases had CXCR4-tropic HIV, compared to 19 (28%) of 69 matched controls. Breast cancer risk was significantly and independently reduced with CXCR4 tropism (adjusted odds ratio, 0.10, 95% CI 0.002-0.84) and with menopause (adjusted odds ratio, 0.08, 95% CI 0.001-0.83). Adjustment for CD4(+) cell count, HIV viral load, and use of antiretroviral therapy did not attenuate the association between infection with CXCR4-tropic HIV and breast cancer. Conclusions: Low breast cancer risk with HIV is specifically linked to CXCR4-using variants of HIV. These variants are thought to exclusively bind to and signal through a receptor that is commonly expressed on hyperplastic and neoplastic breast duct cells. Additional studies are needed to confirm these observations and to understand how CXCR4 might reduce breast cancer risk.	[Hessol, Nancy A.; Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Napolitano, Laura A.; Lie, Yolanda] Monogram Biosci, San Francisco, CA USA; [Napolitano, Laura A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Smith, Dawn] Ctr Dis Control & Prevent, Atlanta, GA USA; [Levine, Alexandra] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Young, Mary] Georgetown Univ, Sch Med, Washington, DC USA; [Cohen, Mardge] Rush Univ, Dept Med, Chicago, IL 60612 USA; [Cohen, Mardge] Rush Univ, Stroger Hosp, Chicago, IL 60612 USA; [Minkoff, Howard] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA; [Minkoff, Howard] Maimonides Hosp, Brooklyn, NY 11219 USA; [Anastos, Kathryn] Montefiore Med Ctr, Bronx, NY 10467 USA; [D'Souza, Gypsyamber] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; [Goedert, James J.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Levine, Alexandra] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; City of Hope; Georgetown University; Rush University; John H Stroger Junior Hospital Cook County; Rush University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Maimonides Medical Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California	Hessol, NA (corresponding author), Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA.	goedertj@mail.nih.gov			National Institutes of Health; Centers for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI) [UL1 RR024131]; Centers for Disease Control and Prevention [U64/CCU106795, U64/CCU206798, U64/CCU306802, U64/CCU506831]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010214] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034994, U01AI035004, U01AI034993, U01AI034989, U01AI042590, U01AI031834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded in part by the Intramural Research Program of the National Cancer Institute (JJG), by other components of the National Institutes of Health, and by the Centers for Disease Control and Prevention. The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The WIHS is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). The HIV Epidemiology Research Study (HERS) was funded through Centers for Disease Control and Prevention cooperative agreements U64/CCU106795, U64/CCU206798, U64/CCU306802, and U64/CCU506831. Monogram Biosciences supported tropism testing and all assays were performed by the Monogram Clinical Reference Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr Barbara, 2004, Retrovirology, V1, P12, DOI 10.1186/1742-4690-1-12; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Chaturvedi AK, 2008, ANN EPIDEMIOL, V18, P230, DOI 10.1016/j.annepidem.2007.10.005; Colditz GA, 2000, AM J EPIDEMIOL, V152, P950, DOI 10.1093/aje/152.10.950; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Endo M, 2008, CURR HIV RES, V6, P34; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Goedert JJ, 2006, BRIT J CANCER, V95, P642, DOI 10.1038/sj.bjc.6603282; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Iwasaki Y, 2009, CANCER SCI, V100, P778, DOI 10.1111/j.1349-7006.2009.01104.x; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; Moyle G, 2009, CLIN INFECT DIS, V48, P798, DOI 10.1086/597097; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Preston-Martin S, 2002, PREV MED, V34, P386, DOI 10.1006/pmed.2001.1003; Robinson SC, 2003, CANCER RES, V63, P8360; SAS Institute Inc, 2008, STAT AN SYST SAS STA; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Schmid BC, 2004, BREAST CANCER RES TR, V84, P247, DOI 10.1023/B:BREA.0000019962.18922.87; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; Smith JR, 2007, AM J CLIN PATHOL, V127, P633, DOI 10.1309/NUQHJ79BHWYD9TAF; Thoma G, 2008, J MED CHEM, V51, P7915, DOI 10.1021/jm801065q; TONIOLO A, 1995, AIDS, V9, P859, DOI 10.1097/00002030-199508000-00005; Uccini S, 2003, AM J DERMATOPATH, V25, P377, DOI 10.1097/00000372-200310000-00003; Weber J, 2006, AIDS REV, V8, P60	29	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14349	10.1371/journal.pone.0014349	http://dx.doi.org/10.1371/journal.pone.0014349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179547	Green Published, Green Submitted, gold			2022-12-27	WOS:000285381200006
J	Du, WG; Ye, H; Zhao, B; Warner, DA; Shine, R				Du, Wei-Guo; Ye, Hua; Zhao, Bo; Warner, Daniel A.; Shine, Richard			Thermal Acclimation of Heart Rates in Reptilian Embryos	PLOS ONE			English	Article							NEST-SITE SELECTION; SNAPPING TURTLES; LIZARD EMBRYOS; OFFSPRING PHENOTYPES; CHELYDRA-SERPENTINA; ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; TEMPERATURE; INCUBATION; CONSUMPTION	In many reptiles, the thermal regimes experienced by eggs in natural nests vary as a function of ambient weather and location, and this variation has important impacts on patterns of embryonic development. Recent advances in non-invasive measurement of embryonic heart rates allow us to answer a long-standing puzzle in reptilian developmental biology: Do the metabolic and developmental rates of embryos acclimate to local incubation regimes, as occurs for metabolic acclimation by post-hatching reptiles? Based on a strong correlation between embryonic heart rate and oxygen consumption, we used heart rates as a measure of metabolic rate. We demonstrate acclimation of heart rates relative to temperature in embryos of one turtle, one snake and one lizard species that oviposit in relatively deep nests, but found no acclimation in another lizard species that uses shallow (and hence, highly thermally variable) nests. Embryonic thermal acclimation thus is widespread, but not ubiquitous, within reptiles.	[Du, Wei-Guo; Ye, Hua; Zhao, Bo] Hangzhou Normal Univ, Hangzhou Key Lab Anim Sci & Technol, Hangzhou, Peoples R China; [Du, Wei-Guo; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Warner, Daniel A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Du, Wei-Guo] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	Hangzhou Normal University; University of Sydney; Iowa State University; Chinese Academy of Sciences; Institute of Zoology, CAS	Du, WG (corresponding author), Hangzhou Normal Univ, Hangzhou Key Lab Anim Sci & Technol, Hangzhou, Peoples R China.	dwghz@126.com	Du, Wei-Guo/K-1071-2014	Warner, Daniel/0000-0001-7231-7785	Zhejiang Provincial Natural Science Foundation of China [G5080004]; University of Sydney; Australian Research Council	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); University of Sydney(University of Sydney); Australian Research Council(Australian Research Council)	This work was supported by grants from Zhejiang Provincial Natural Science Foundation of China (http://www.zjnsf.net/) (G5080004) and the University of Sydney to W.-G. Du and the Australian Research Council (http://www.arc.gov.au/) to R. Shine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Ralph A., 2008, P135; Aho E, 2001, J COMP PHYSIOL B, V171, P173, DOI 10.1007/s003600000171; Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P573, DOI 10.1086/501062; Angilletta MJ, 2000, ECOLOGY, V81, P2957, DOI 10.1890/0012-9658(2000)081[2957:TEOTEO]2.0.CO;2; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Ar A, 1999, COMP BIOCHEM PHYS A, V124, P491, DOI 10.1016/S1095-6433(99)00142-7; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Birchard GF, 1996, J COMP PHYSIOL B, V166, P461, DOI 10.1007/s003600050033; BIRCHARD GF, 1995, PHYSIOL ZOOL, V68, P799, DOI 10.1086/physzool.68.5.30163932; Blouin-Demers G, 2004, CAN J ZOOL, V82, P449, DOI 10.1139/Z04-014; BOBYN ML, 1994, CAN J ZOOL, V72, P28, DOI 10.1139/z94-005; CONGDON JD, 1987, HERPETOLOGICA, V43, P39; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; Du WG, 2008, COMP BIOCHEM PHYS A, V151, P102, DOI 10.1016/j.cbpa.2008.06.005; Du WG, 2009, J EXP BIOL, V212, P1302, DOI 10.1242/jeb.027425; Huey R.B., 1982, Biology of Reptilia, V12, P25; Huey R. B., 1996, ANIMALS TEMPERATURE, P205; KLINKHARDT MB, 1987, AQUACULTURE, V64, P219, DOI 10.1016/0044-8486(87)90327-9; Mirkovic T, 1998, PHYSIOL ZOOL, V71, P191, DOI 10.1086/515896; Nechaeva MV, 2007, COMP BIOCHEM PHYS A, V148, P599, DOI 10.1016/j.cbpa.2007.08.005; Olsson M, 1997, J EVOLUTION BIOL, V10, P369, DOI 10.1046/j.1420-9101.1997.10030369.x; Pearson JT, 1999, J COMP PHYSIOL B, V169, P256, DOI 10.1007/s003600050219; Radder R, 2006, BIOL LETTERS, V2, P415, DOI 10.1098/rsbl.2006.0495; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Shine R, 2003, BIOL J LINN SOC, V78, P325, DOI 10.1046/j.1095-8312.2003.00140.x; Shine R, 1996, ECOLOGY, V77, P1808, DOI 10.2307/2265785; Steyermark A., 2008, BIOL SNAPPING TURTLE; Tazawa H, 2005, AVIAN POULT BIOL REV, V16, P123, DOI 10.3184/147020605783437977; Thompson MB, 1998, COPEIA, P1016, DOI 10.2307/1447350; TSUJI JS, 1988, PHYSIOL ZOOL, V61, P241, DOI 10.1086/physzool.61.3.30161237; VLECK D, 1987, J APPL PHYSIOL, V62, P2103, DOI 10.1152/jappl.1987.62.5.2103; Wapstra E, 2010, J EVOLUTION BIOL, V23, P651, DOI 10.1111/j.1420-9101.2009.01924.x; Warner DA, 2002, HERPETOLOGICA, V58, P399, DOI 10.1655/0018-0831(2002)058[0399:NSIRTT]2.0.CO;2; Warner DA, 2007, OECOLOGIA, V154, P65, DOI 10.1007/s00442-007-0809-9; Whitehead P.J., 1987, P473; Zhao E, 1993, HERPETOLOGY CHINA, V10	36	40	41	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15308	10.1371/journal.pone.0015308	http://dx.doi.org/10.1371/journal.pone.0015308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179473	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500019
J	Michaud, V; Frappier, M; Dumas, MC; Turgeon, J				Michaud, Veronique; Frappier, Martin; Dumas, Marie-Christine; Turgeon, Jacques			Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism	PLOS ONE			English	Article							ARACHIDONIC-ACID METABOLISM; MOLECULAR-CLONING; GENE-EXPRESSION; CYTOCHROME-P450 ENZYMES; HEART-FAILURE; VERAPAMIL; INHIBITION; PATHWAY; CYP2J2; IDENTIFICATION	Background: Tissue-specific expression of CYP450s can regulate the intracellular concentration of drugs and explain inter-subject variability in drug action. The overall objective of our study was to determine in a large cohort of samples, mRNA levels and CYP450 activity expressed in the human heart. Methodology: CYP450 mRNA levels were determined by RTPCR in left ventricular samples (n = 68) of explanted hearts from patients with end-stage heart failure. Samples were obtained from ischemic and non-ischemic hearts. In some instances (n = 7), samples were available from both the left and right ventricles. A technique for the preparation of microsomes from human heart tissue was developed and CYP450-dependent activity was determined using verapamil enantiomers as probe-drug substrates. Principal Findings: Our results show that CYP2J2 mRNA was the most abundant isoform in all human heart left ventricular samples tested. Other CYP450 mRNAs of importance were CYP4A11, CYP2E1, CYP1A1 and CYP2C8 mRNAs while CYP2B6 and CYP2C9 mRNAs were present at low levels in only some of the hearts analyzed. CYP450 mRNAs did not differ between ischemic and non-ischemic hearts and appeared to be present at similar levels in the left and right ventricles. Incubation of verapamil with heart microsomes led to the formation of nine CYP450-dependent metabolites: a major finding was the observation that stereoselectivity was reversed compared to human liver microsomes, in which the R-enantiomer is metabolized to a greater extent. Conclusions: This study determined cardiac mRNA levels of various CYP450 isozymes involved in drug metabolism and demonstrated the prevalent expression of CYP2J2 mRNA. It revealed that cardiomyocytes can efficiently metabolize drugs and that cardiac CYP450s are highly relevant with regard to clearance of drugs in the heart. Our results support the claim that drug metabolism in the vicinity of a drug effector site can modulate drug effects.	[Michaud, Veronique] Univ Montreal, Ctr Hosp Univ Montreal, Univ Montreal Hosp Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada; Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Michaud, V (corresponding author), Univ Montreal, Ctr Hosp Univ Montreal, Univ Montreal Hosp Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada.	jacques.turgeon@umontreal.ca			Canadian Institutes of Health Research; Heart and Stroke Foundation of Quebec; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	Veronique Michaud is the recipient of a studentship from the Canadian Institutes of Health Research. Dr. Jacques Turgeon's laboratory is funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Quebec and the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboutabl ME, 2009, BRIT J PHARMACOL, V158, P1808, DOI 10.1111/j.1476-5381.2009.00461.x; ABRAHAM NG, 1987, J MOL CELL CARDIOL, V19, P73, DOI 10.1016/S0022-2828(87)80546-1; Busse D, 1995, N-S ARCH PHARMACOL, V353, P116; DeLozier TC, 2007, DRUG METAB DISPOS, V35, P682, DOI 10.1124/dmd.106.012823; Diczfalusy U, 2008, PHARMACOGENET GENOM, V18, P201, DOI 10.1097/FPC.0b013e3282f50ee9; Dubey RK, 2005, J CLIN ENDOCR METAB, V90, P247, DOI 10.1210/jc.2003-032154; Earley S, 2003, AM J PHYSIOL-HEART C, V285, pH127, DOI 10.1152/ajpheart.01052.2002; Elbekai RH, 2006, PHARMACOL THERAPEUT, V112, P564, DOI 10.1016/j.pharmthera.2005.05.011; Fischer D, 2007, EUR J HEART FAIL, V9, P770, DOI 10.1016/j.ejheart.2007.05.005; Fleming I, 2001, CIRC RES, V89, P753, DOI 10.1161/hh2101.099268; Granville DJ, 2004, P NATL ACAD SCI USA, V101, P1321, DOI 10.1073/pnas.0308185100; HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G; Hunter AL, 2005, VASC PHARMACOL, V43, P213, DOI 10.1016/j.vph.2005.07.005; KROEMER HK, 1993, N-S ARCH PHARMACOL, V348, P332; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Messina A, 2008, XENOBIOTICA, V38, P1453, DOI 10.1080/00498250802474437; Messina A, 2010, XENOBIOTICA, V40, P109, DOI 10.3109/00498250903410590; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; RASCHACK M, 1976, N-S ARCH PHARMACOL, V294, P285, DOI 10.1007/BF00508397; Rendic S, 2002, DRUG METAB REV, V34, pIX; Satoh M, 2007, CIRCULATION, V115, P3197, DOI 10.1161/CIRCULATIONAHA.106.657981; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Shen LX, 2004, DRUG METAB DISPOS, V32, P186, DOI 10.1124/dmd.32.2.186; Sidorik L, 2005, CELL BIOL INT, V29, P51, DOI 10.1016/j.cellbi.2004.11.011; STEGEMAN JJ, 1982, MOL PHARMACOL, V21, P517; Theken KN, 2007, PHARMACOGENOMICS, V8, P1369, DOI 10.2217/14622416.8.10.1369; Thum T, 2000, BRIT J PHARMACOL, V130, P1745, DOI 10.1038/sj.bjp.0703465; Thum T, 2000, LANCET, V355, P979, DOI 10.1016/S0140-6736(00)99016-0; Thum T, 2002, FASEB J, V16, P1537, DOI 10.1096/fj.02-0138com; Tracy TS, 1999, BRIT J CLIN PHARMACO, V47, P545, DOI 10.1046/j.1365-2125.1999.00923.x; VOGELGESANG B, 1984, BRIT J CLIN PHARMACO, V18, P733, DOI 10.1111/j.1365-2125.1984.tb02536.x; Walles M, 2002, J CHROMATOGR A, V970, P117, DOI 10.1016/S0021-9673(02)00641-6; Wang YH, 2004, DRUG METAB DISPOS, V32, P259, DOI 10.1124/dmd.32.2.259; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; Wu S, 1996, J BIOL CHEM, V271, P3460; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; Zordoky Beshay N. M., 2007, Journal of Pharmacological and Toxicological Methods, V56, P317, DOI 10.1016/j.vascn.2007.06.001	40	55	56	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15666	10.1371/journal.pone.0015666	http://dx.doi.org/10.1371/journal.pone.0015666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179487	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500034
J	Muinonen-Martin, AJ; Veltman, DM; Kalna, G; Insall, RH				Muinonen-Martin, Andrew J.; Veltman, Douwe M.; Kalna, Gabriela; Insall, Robert H.			An Improved Chamber for Direct Visualisation of Chemotaxis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL MOTILITY; FIBROBLAST MIGRATION; METASTASIS; GRADIENTS; ADHESION; INVASION; MV3	There has been a growing appreciation over the last decade that chemotaxis plays an important role in cancer migration, invasion and metastasis. Research into the field of cancer cell chemotaxis is still in its infancy and traditional investigative tools have been developed with other cell types and purposes in mind. Direct visualisation chambers are considered the gold standard for investigating the behaviour of cells migrating in a chemotactic gradient. We therefore drew up a list of key attributes that a chemotaxis chamber should have for investigating cancer cell chemotaxis. These include (1) compatibility with thin cover slips for optimal optical properties and to allow use of high numerical aperture (NA) oil immersion objectives; (2) gradients that are relatively stable for at least 24 hours due to the slow migration of cancer cells; (3) gradients of different steepnesses in a single experiment, with defined, consistent directions to avoid the need for complicated analysis; and (4) simple handling and disposability for use with medical samples. Here we describe and characterise the Insall chamber, a novel direct visualisation chamber. We use it to show GFP-lifeact transfected MV3 melanoma cells chemotaxing using a 60x high NA oil immersion objective, which cannot usually be done with other chemotaxis chambers. Linear gradients gave very efficient chemotaxis, contradicting earlier results suggesting that only polynomial gradients were effective. In conclusion, the chamber satisfies our design criteria, most importantly allowing high NA oil immersion microscopy to track chemotaxing cancer cells in detail over 24 hours.	[Muinonen-Martin, Andrew J.; Veltman, Douwe M.; Kalna, Gabriela; Insall, Robert H.] CRUK Beatson Inst Canc Res, Glasgow, Lanark, Scotland	Beatson Institute	Muinonen-Martin, AJ (corresponding author), CRUK Beatson Inst Canc Res, Glasgow, Lanark, Scotland.	a.muinonen-martin@beatson.gla.ac.uk	Veltman, Douwe M/D-6227-2011; Insall, Robert/G-5611-2011	Insall, Robert/0000-0003-4898-040X; Gilbey, Thomas/0000-0001-5677-3318	Cancer Research UK; DTI/Technology Strategy Board; OneNE Regional Development Agency	Cancer Research UK(Cancer Research UK); DTI/Technology Strategy Board; OneNE Regional Development Agency	Cancer Research UK Core Grant funded the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Epigem Limited and Phil Summersgill for the fabrication of the microfluidic devices. The fabrication work was carried out in the Fluence Microfluidics Application Centre supported by the DTI/Technology Strategy Board and the OneNE Regional Development Agency as part of the UK's MNT (Nanocentres) Network. We are very grateful to Margaret O'Prey and Tom Gilbey, Beatson Advanced Imaging Resource, for advice with technical aspects of imaging, and to Michael Carnell for assistance with Blender 3D rendering.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Breckenridge MT, 2010, BIOMED MICRODEVICES, V12, P543, DOI 10.1007/s10544-010-9411-8; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Friedl P, 1997, CANCER RES, V57, P2061; GERISCH G, 1981, J CELL SCI, V52, P1; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D; Maheshwari G, 1999, BIOPHYS J, V76, P2814, DOI 10.1016/S0006-3495(99)77435-7; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; RHODES JM, 1982, J IMMUNOL METHODS, V49, P235, DOI 10.1016/0022-1759(82)90280-0; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; Stathopoulos GT, 2008, MOL CANCER RES, V6, P364, DOI 10.1158/1541-7786.MCR-07-0309; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; VANMUIJEN GNP, 1991, INT J CANCER, V48, P85; Wang WG, 2002, CANCER RES, V62, P6278; Ware MF, 1998, J CELL SCI, V111, P2423; Wells A, 2000, ADV CANCER RES, V78, P31; Zicha D, 1997, Methods Mol Biol, V75, P449; ZICHA D, 1991, J CELL SCI, V99, P769; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	26	76	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15309	10.1371/journal.pone.0015309	http://dx.doi.org/10.1371/journal.pone.0015309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179457	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000285292500020
J	Tham, M; Ramasamy, S; Gan, HT; Ramachandran, A; Poonepalli, A; Yu, YH; Ahmed, S				Tham, Muly; Ramasamy, Srinivas; Gan, Hui Theng; Ramachandran, Ashray; Poonepalli, Anuradha; Yu, Yuan Hong; Ahmed, Sohail			CSPG Is a Secreted Factor that Stimulates Neural Stem Cell Survival Possibly by Enhanced EGFR Signaling	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; HIPPOCAMPAL PROGENITOR; CAENORHABDITIS-ELEGANS; NEURITE OUTGROWTH; PROTEIN-KINASE; RADIAL GLIA; DIFFERENTIATION	Understanding how autocrine/paracrine factors regulate neural stem cell (NSC) survival and growth is fundamental to the utilization of these cells for therapeutic applications and as cellular models for the brain. In vitro, NSCs can be propagated along with neural progenitors (NPs) as neurospheres (nsphs). The nsph conditioned medium (nsph-CM) contains cell-secreted factors that can regulate NSC behavior. However, the identity and exact function of these factors within the nsph-CM has remained elusive. We analyzed the nsph-CM by mass spectrometry and identified DSD-1-proteoglycan, a chondroitin sulfate proteoglycan (CSPG), apolipoprotein E (ApoE) and cystatin C as components of the nsph-CM. Using clonal assays we show that CSPG and ApoE are responsible for the ability of the nsph-CM to stimulate nsph formation whereas cystatin C is not involved. Clonal nsphs generated in the presence of CSPG show more than four-fold increase in NSCs. Thus CSPG specifically enhances the survival of NSCs. CSPG also stimulates the survival of embryonic stem cell (ESC)-derived NSCs, and thus may be involved in the developmental transition of ESCs to NSCs. In addition to its role in NSC survival, CSPG maintains the three dimensional structure of nsphs. Lastly, CSPG's effects on NSC survival may be mediated by enhanced signaling via EGFR, JAK/STAT3 and PI3K/Akt pathways.	[Tham, Muly; Ramasamy, Srinivas; Gan, Hui Theng; Ramachandran, Ashray; Poonepalli, Anuradha; Yu, Yuan Hong; Ahmed, Sohail] Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Tham, M (corresponding author), Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Tham, Anh Vu Muly/0000-0001-5138-6503	Agency for Science, Technology and Research, Singapore	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by Agency for Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama E, 2005, IMMUNOL LETT, V99, P80, DOI 10.1016/j.imlet.2005.01.005; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bauer S, 2009, ANN NY ACAD SCI, V1153, P48, DOI 10.1111/j.1749-6632.2009.03986.x; Bernhardt RR, 2000, DEV BIOL, V221, P206, DOI 10.1006/dbio.2000.9673; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Chang MY, 2003, NEUROREPORT, V14, P1191, DOI 10.1097/00001756-200307010-00001; Chung KY, 2000, DEVELOPMENT, V127, P2673; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gu WL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-128; Hayashi K, 2001, GLYCOCONJUGATE J, V18, P401, DOI 10.1023/A:1014864131288; Hayes AJ, 2008, J HISTOCHEM CYTOCHEM, V56, P125, DOI 10.1369/jhc.7A7320.2007; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Ichijo H, 2001, J NEUROSCI, V21, P9304, DOI 10.1523/JNEUROSCI.21-23-09304.2001; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Kabos P, 2004, BIOCHEM BIOPH RES CO, V318, P955, DOI 10.1016/j.bbrc.2004.04.114; Kaneko M, 2007, NEUROSCI LETT, V423, P62, DOI 10.1016/j.neulet.2007.06.038; Kato T, 2006, P NATL ACAD SCI USA, V103, P6019, DOI 10.1073/pnas.0509789103; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Kubota Y, 1999, DEV DYNAM, V214, P55, DOI 10.1002/(SICI)1097-0177(199901)214:1<55::AID-DVDY6>3.0.CO;2-E; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Masuda T, 2004, MOL CELL NEUROSCI, V25, P217, DOI 10.1016/j.mcn.2003.10.005; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nakanishi K, 2006, J BIOL CHEM, V281, P24970, DOI 10.1074/jbc.M601498200; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Perissinotto D, 2000, DEVELOPMENT, V127, P2823; Properzi F, 2003, BIOCHEM SOC T, V31, P335, DOI 10.1042/BST0310335; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; SAJDERA S, 1969, J BIOL CHEM, V244, P77; SALTER J, 2007, USING SAS PERFORM ST; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; SIRKO S, 2010, STEM CELLS; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; von Holst A, 2006, J NEUROSCI, V26, P4082, DOI 10.1523/JNEUROSCI.0422-06.2006; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zhang JQ, 2006, NEUROREPORT, V17, P981, DOI 10.1097/01.wnr.0000227977.60271.ca; Zhou JH, 2010, J NEUROIMMUNOL, V223, P55, DOI 10.1016/j.jneuroim.2010.04.002	52	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15341	10.1371/journal.pone.0015341	http://dx.doi.org/10.1371/journal.pone.0015341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179491	Green Published, Green Submitted, gold			2022-12-27	WOS:000285292500023
J	Beer, C; Flicker, L; Horner, B; Bretland, N; Scherer, S; Lautenschlager, NT; Schaper, F; Almeida, OP				Beer, Christopher; Flicker, Leon; Horner, Barbara; Bretland, Nick; Scherer, Samuel; Lautenschlager, Nicola T.; Schaper, Frank; Almeida, Osvaldo P.			Factors Associated with Self and Informant Ratings of the Quality of Life of People with Dementia Living in Care Facilities: A Cross Sectional Study	PLOS ONE			English	Article							RESIDENTIAL CARE; QOL-AD	Background: There is no consensus regarding the optimal approach to assessment of the quality of life of people with dementia. We undertook the present study to describe and determine the factors associated with ratings of the quality of life of a cohort of people with dementia living in a residential care facility. Methodology/Principal Findings: 351 people with dementia living in residential care facilities, and their staff and family informants participated in this cross sectional observational study. Quality of life was measured using self (Quality of Life in Alzheimer's Disease [QoL-AD] scale), and informant (QoL-AD and Alzheimer's Disease Related QoL Scale) reports. 226 people (64%) with dementia (median MMSE 17; 12-21) were able to self rate the QoL-AD scale and these subjects' ratings were compared to ratings by staff and family. Both staff and family informant ratings of the QoL-AD underestimated self ratings (mean difference -7.8, 95% CI -8.8, -6.7 for staff rated QoL-AD; and mean difference -7.2, 95% CI -8.5, -6.0 for family rated QoL-AD). Self ratings of QoL were lower among people who were restrained, had fallen or had pain. Informant ratings of the QoL of the participants with dementia were consistently and significantly lower for people with severe cognitive impairment, who had fallen, had presence of neuropsychiatric symptoms, or where care giver distress was present. Documented restraint, reported pain and neuropsychiatric symptoms were independently associated with lower self rating of the QoL-AD in multivariate models. Cognitive impairment, case conferencing, hospitalizations and neuropsychiatric symptoms were found to be independently associated with staff rated ADRQL. Conclusions: The majority of people with dementia living in residential care facilities can rate their own QoL. Informant ratings underestimate self ratings of QoL of people with dementia, and appear to be associated with factors which are not associated with self ratings.	[Beer, Christopher; Flicker, Leon; Lautenschlager, Nicola T.; Almeida, Osvaldo P.] Med Res Ctr, WA Ctr Hlth & Ageing, Perth, WA, Australia; [Beer, Christopher; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Horner, Barbara] Curtin Univ Technol, Ctr Res Ageing, Perth, WA, Australia; [Bretland, Nick; Almeida, Osvaldo P.] Rowethorpe Med Ctr, Bentley, WA, Australia; [Scherer, Samuel] Royal Freemasons Homes Victoria, Prahran, Vic, Australia; [Lautenschlager, Nicola T.] Univ Melbourne, Dept Psychiat, Acad Unit Psychiat Old Age, St Vincents Hlth, Parkville, Vic 3052, Australia; [Schaper, Frank] Alzheimers Australia WA Ltd, Perth, WA, Australia; [Lautenschlager, Nicola T.] Univ Western Australia, Sch Psychiat & Neurosci, Crawley, WA, Australia	University of Western Australia; Curtin University; University of Melbourne; University of Western Australia	Beer, C (corresponding author), Med Res Ctr, WA Ctr Hlth & Ageing, Perth, WA, Australia.	Christopher.beer@uwa.edu.au	Almeida, Osvaldo P./A-4925-2008; Flicker, Leon/A-9039-2008; Flicker, Leon/AAE-1530-2022; Etherton-Beer, Christopher/B-2714-2014	Almeida, Osvaldo P./0000-0002-8689-6199; Flicker, Leon/0000-0002-3650-0475; Etherton-Beer, Christopher/0000-0001-5148-0188; Schaper, Frank/0000-0002-7687-1510; Lautenschlager, Nicola/0000-0003-4850-7794	National Institute of Allergy and Infectious Diseases [1R21 AI070033 (RCM), 5T32 AI065380-05 (JDS)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070033, T32AI065380] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Institutes of Health (NIH) Grant 1R21 AI070033 (RCM) and by NIH Grant 5T32 AI065380-05 (JDS) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer C, 2009, AGE AGEING, V38, P343, DOI 10.1093/ageing/afp018; Beer CD, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-63; Clare L, 2008, SOC SCI MED, V66, P2366, DOI 10.1016/j.socscimed.2008.01.045; Clare L, 2008, GERONTOLOGIST, V48, P711, DOI 10.1093/geront/48.6.711; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Edelman P, 2005, GERONTOLOGIST, V45, P27, DOI 10.1093/geront/45.suppl_1.27; GIBSON S, 2004, PRELIMINARY FIELD TE; Hoe J, 2006, BRIT J PSYCHIAT, V188, P460, DOI 10.1192/bjp.bp.104.007658; Hoe J, 2005, AGE AGEING, V34, P130, DOI 10.1093/ageing/afi030; KITWOOD T, 1993, INT J GERIATR PSYCH, V8, P541, DOI 10.1002/gps.930080702; Logsdon R.G., 1999, J MENTAL HLTH AGING, V5, P21, DOI DOI 10.1037/T03352-000; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Molloy DW, 1997, INT PSYCHOGERIATR S, V9, P143; Rabins PV, 2000, INT PSYCHOGERIATR, V12, P47, DOI 10.1017/S104161020000675X; Rabins PV., 1999, J MENTAL HLTH AGING, V5, P33; Sloane PD, 2005, GERONTOLOGIST, V45, P37, DOI 10.1093/geront/45.suppl_1.37; Thorgrimsen L, 2003, ALZ DIS ASSOC DIS, V17, P201, DOI 10.1097/00002093-200310000-00002; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; Winzelberg GS, 2005, GERONTOLOGIST, V45, P106, DOI 10.1093/geront/45.suppl_1.106; Woods B, 1999, INT J GERIATR PSYCH, V14, P97, DOI 10.1002/(SICI)1099-1166(199902)14:2<97::AID-GPS941>3.0.CO;2-X	21	85	85	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15621	10.1371/journal.pone.0015621	http://dx.doi.org/10.1371/journal.pone.0015621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	693SY	21179448	gold, Green Published			2022-12-27	WOS:000285246900048
J	Choi, YH; Park, CH; Kim, W; Ling, H; Kang, A; Chang, MW; Im, SK; Jeong, HW; Kong, YY; Kim, KT				Choi, Yoon Ha; Park, Choon-Ho; Kim, Wanil; Ling, Hua; Kang, Aram; Chang, Matthew Wook; Im, Sun-Kyoung; Jeong, Hyun-Woo; Kong, Young-Yun; Kim, Kyong-Tai			Vaccinia-Related Kinase 1 Is Required for the Maintenance of Undifferentiated Spermatogonia in Mouse Male Germ Cells	PLOS ONE			English	Article							HUMAN VACCINIA-RELATED-KINASE-1 VRK1; STEM-CELLS; SELF-RENEWAL; BINDING-SITE; PROLIFERATION; SPERMATOGENESIS; PHOSPHORYLATION; EXPRESSION; PROTEIN; DIFFERENTIATION	Vaccinia-related kinase 1 (VRK1) is a crucial protein kinase for mitotic regulation. VRK1 is known to play a role in germ cell development, and its deficiency results in sterility. Here we describe that VRK1 is essential for the maintenance of spermatogonial stem cells. To determine whether VRK1 plays a role in these cells, we assessed the population size of undifferentiated spermatogonia. Flow cytometry analyses showed that the number of undifferentiated spermatogonia was markedly reduced in VRK1-deficient testes. VRK1 was highly expressed in spermatogonial populations, and approximately 66% of undifferentiated spermatogonia that were sorted as an Ep-CAM(+)/c-kit(-)/alpha-6-integrin(+) population showed a positive signal for VRK1. Undifferentiated stem cells expressing Plzf and Oct4 but not c-kit also expressed VRK1, suggesting that VRK1 is an intrinsic factor for the maintenance of spermatogonial stem cells. Microarray analyses of the global testicular transcriptome and quantitative RT-PCR of VRK1-deficient testes revealed significantly reduced expression levels of undifferentiated spermatogonial marker genes in early postnatal mice. Together, these results suggest that VRK1 is required for the proliferation and differentiation of undifferentiated spermatogonia, which are essential for spermatogenic cell maintenance.	[Choi, Yoon Ha; Park, Choon-Ho; Kim, Wanil; Im, Sun-Kyoung; Jeong, Hyun-Woo; Kim, Kyong-Tai] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea; [Kim, Kyong-Tai] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Ling, Hua; Kang, Aram; Chang, Matthew Wook] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore; [Kong, Young-Yun] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Seoul National University (SNU)	Choi, YH (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea.	ktk@postech.ac.kr	Chang, Matthew Wook/G-6220-2010	Chang, Matthew Wook/0000-0001-6448-6319; Jeong, Hyun-Woo/0000-0002-6976-6739; KIM, KYONG-TAI/0000-0001-7292-2627; Ling, Hua/0000-0002-0680-6422	Anti-Aging and Well-Being Research Center; Ministry of Education, Science and Technology; National Research Foundation of Korea (NRF) [2010-0019706, 20100000755, 20100002146, R31-2008-000-10105-0]	Anti-Aging and Well-Being Research Center; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was supported by grants from the Core Research Program/Anti-Aging and Well-Being Research Center, the Brain Korea 21 program of the Ministry of Education, Science and Technology. This work was also supported by the grants (2010-0019706, 20100000755, and 20100002146) and WCU program (R31-2008-000-10105-0) funded by National Research Foundation of Korea (NRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Cullen CF, 2005, J CELL BIOL, V171, P593, DOI 10.1083/jcb.200508127; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; De Rooij DG, 2000, J ANDROL, V21, P776; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Ivanovska I, 2005, GENE DEV, V19, P2571, DOI 10.1101/gad.1348905; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Klerkx EPF, 2009, DEV BIOL, V335, P12, DOI 10.1016/j.ydbio.2009.08.007; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Ohta H, 2000, DEV GROWTH DIFFER, V42, P105; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Wiebe MS, 2010, BIOL REPROD, V82, P182, DOI 10.1095/biolreprod.109.079095; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Zhao GQ, 1996, GENE DEV, V10, P1657, DOI 10.1101/gad.10.13.1657; Zhao GQ, 1998, DEVELOPMENT, V125, P1103; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	37	23	25	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15254	10.1371/journal.pone.0015254	http://dx.doi.org/10.1371/journal.pone.0015254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179456	gold, Green Submitted, Green Published			2022-12-27	WOS:000285246900039
J	Chowdhury, F; Li, YZ; Poh, YC; Yokohama-Tamaki, T; Wang, N; Tanaka, TS				Chowdhury, Farhan; Li, Yanzhen; Poh, Yeh-Chuin; Yokohama-Tamaki, Tamaki; Wang, Ning; Tanaka, Tetsuya S.			Soft Substrates Promote Homogeneous Self-Renewal of Embryonic Stem Cells via Downregulating Cell-Matrix Tractions	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; DIFFERENTIATION; STIFFNESS; NANOG; MECHANOTRANSDUCTION; HETEROGENEITY; PLURIPOTENCY; EQUILIBRIUM; PROTEINS; SURVIVAL	Maintaining undifferentiated mouse embryonic stem cell (mESC) culture has been a major challenge as mESCs cultured in Leukemia Inhibitory Factor (LIF) conditions exhibit spontaneous differentiation, fluctuating expression of pluripotency genes, and genes of specialized cells. Here we show that, in sharp contrast to the mESCs seeded on the conventional rigid substrates, the mESCs cultured on the soft substrates that match the intrinsic stiffness of the mESCs and in the absence of exogenous LIF for 5 days, surprisingly still generated homogeneous undifferentiated colonies, maintained high levels of Oct3/4, Nanog, and Alkaline Phosphatase (AP) activities, and formed embryoid bodies and teratomas efficiently. A different line of mESCs, cultured on the soft substrates without exogenous LIF, maintained the capacity of generating homogeneous undifferentiated colonies with relatively high levels of Oct3/4 and AP activities, up to at least 15 passages, suggesting that this soft substrate approach applies to long term culture of different mESC lines. mESC colonies on these soft substrates without LIF generated low cell-matrix tractions and low stiffness. Both tractions and stiffness of the colonies increased with substrate stiffness, accompanied by downregulation of Oct3/4 expression. Our findings demonstrate that mESC self-renewal and pluripotency can be maintained homogeneously on soft substrates via the biophysical mechanism of facilitating generation of low cell-matrix tractions.	[Chowdhury, Farhan; Poh, Yeh-Chuin; Wang, Ning] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Li, Yanzhen; Yokohama-Tamaki, Tamaki; Tanaka, Tetsuya S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Tanaka, Tetsuya S.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chowdhury, F (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.	nwangrw@illinois.edu; ttanaka@illinois.edu	Wang, Ning/B-6966-2008; Chowdhury, Farhan/D-1496-2009	Chowdhury, Farhan/0000-0003-1527-2677; Tanaka, Tetsuya/0000-0002-0406-0217	NIH [GM072744]; United States Department of Agriculture Cooperative State Research, Education and Extension Service [ILLU-538-323]; University of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072744] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); University of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM072744 (to N.W.), the United States Department of Agriculture Cooperative State Research, Education and Extension Service, Hatch project ILLU-538-323 (to T.S.T.), and by University of Illinois (to N.W. and T.S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AEX, 2009, CURR BIOL, V19, pR781, DOI 10.1016/j.cub.2009.06.054; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Chowdhury F, 2008, BIOPHYS J, V95, P5719, DOI 10.1529/biophysj.108.139832; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Duval D, 2000, FASEB J, V14, P1577, DOI 10.1096/fj.14.11.1577; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Evans ND, 2009, EUR CELLS MATER, V18, P1; FEINBERG AW, 2002, ORL FL 25 ANN M ADH; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Furusawa T, 2006, BIOL REPROD, V75, P555, DOI 10.1095/biolreprod.105.049502; GILBERT PM, 2010, SCIENCE         0715, DOI DOI 10.1126/SCIENCE.1191035; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kawahara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006343; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Li D, 2010, J CELL BIOL, V191, P631, DOI 10.1083/jcb.201006094; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Nagaoka M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-60; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Poh YC, 2010, BIOPHYS J, V99, pL19, DOI 10.1016/j.bpj.2010.04.057; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tanaka TS, 2008, GENESIS, V46, P347, DOI 10.1002/dvg.20404; Tanaka TS, 2009, REPROD FERT DEVELOP, V21, P67, DOI 10.1071/RD08219; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6	61	236	243	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15655	10.1371/journal.pone.0015655	http://dx.doi.org/10.1371/journal.pone.0015655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179449	Green Submitted, Green Published, gold			2022-12-27	WOS:000285246900050
J	Chow, CK; Lock, K; Madhavan, M; Corsi, DJ; Gilmore, AB; Subramanian, SV; Li, W; Swaminathan, S; Lopez-Jaramillo, P; Avezum, A; Lear, SA; Dagenais, G; Teo, K; McKee, M; Yusuf, S				Chow, Clara K.; Lock, Karen; Madhavan, Manisha; Corsi, Daniel J.; Gilmore, Anna B.; Subramanian, S. V.; Li, Wei; Swaminathan, Sumathi; Lopez-Jaramillo, Patricio; Avezum, Alvaro; Lear, Scott A.; Dagenais, Gilles; Teo, Koon; McKee, Martin; Yusuf, Salim			Environmental Profile of a Community's Health (EPOCH): An Instrument to Measure Environmental Determinants of Cardiovascular Health in Five Countries	PLOS ONE			English	Article							IRVINE-MINNESOTA INVENTORY; MEASURE BUILT ENVIRONMENTS; PHYSICAL-ACTIVITY; SOCIETAL INFLUENCES; RELIABILITY; CONSUMPTION; SETTINGS; VALIDITY; SCIENCE; SCALE	Background: The environment in which people live is known to be important in influencing diet, physical activity, smoking, psychosocial and other risk factors for cardiovascular (CV) disease. However no instrument exists that evaluates communities for these multiple environmental factors and is suitable for use across different communities, regions and countries. This report describes the design and reliability of an instrument to measure environmental determinants of CV risk factors. Method/Principal Findings: The Environmental Profile of Community Health (EPOCH) instrument comprises two parts: (I) an assessment of the physical environment, and (II) an interviewer-administered questionnaire to collect residents' perceptions of their community. We examined the inter-rater reliability amongst 3 observers from each region of the direct observation component of the instrument (EPOCH I) in 93 rural and urban communities in 5 countries (Canada, Colombia, Brazil, China and India). Data collection using the EPOCH instrument was feasible in all communities. Reliability of the instrument was excellent (Intraclass Correlation Coefficient -ICC>0.75) for 24 of 38 items and fair to good (ICC 0.4-0.75) for 14 of 38 items. Conclusion: This report shows data collection with the EPOCH instrument is feasible and direct observation of community measures reliable. The EPOCH instrument will enable further research on environmental determinants of health for population studies from a broad range of settings.	[Chow, Clara K.; Madhavan, Manisha; Corsi, Daniel J.; Teo, Koon; Yusuf, Salim] Hamilton Hlth Sci & McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Chow, Clara K.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Chow, Clara K.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Lock, Karen; Gilmore, Anna B.; McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Li, Wei] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China; [Li, Wei] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Peoples R China; [Swaminathan, Sumathi] St Johns Res Inst, Bangalore, Karnataka, India; [Lopez-Jaramillo, Patricio] Univ Santander, Res Direct, Fdn Oftalmol Santander Clin Carlos Arila Lulle, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander, Sch Med, Bucaramanga, Colombia; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Gilmore, Anna B.] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Dagenais, Gilles] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	McMaster University; Population Health Research Institute; George Institute for Global Health; University of Sydney; University of Sydney; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; St. John's National Academy of Health Sciences; St. John's Research Institute; Universidad Industrial de Santander; Universidad Industrial de Santander; Instituto Dante Pazzanese de Cardiologia; Simon Fraser University; University of Bath; Laval University	Chow, CK (corresponding author), Hamilton Hlth Sci & McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	clara@phri.ca	gilmore, anna B/I-7130-2012; Avezum, Alvaro/AAP-7687-2020; Corsi, Daniel J/S-4689-2018; Swaminathan, Sumathi/AGI-7678-2022; Avezum, Alvaro AA/K-6137-2016; McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	gilmore, anna B/0000-0003-0281-1248; Corsi, Daniel J/0000-0001-7063-3354; Avezum, Alvaro AA/0000-0002-3073-6890; McKee, Marc D/0000-0001-8349-965X; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Yusuf, Salim/0000-0003-4776-5601; Teo, Koon/0000-0002-3731-0956; McKee, Martin/0000-0002-0121-9683	Hamilton Health Sciences [08158]; Heart and Stroke Foundation of Ontario [PLP6567]; Colombian Institute for Science and Technology [6566-04-18062]; Royal Australasian College of Physicians; Public Health (Sidney Sax) Overseas Fellowship; National Health and Medical Research Council; National Heart Foundation of Australia; Heart and Stroke Foundation of Ontario; Health Foundation; National Institutes of Health [NHLBI K25 HL081275]; RWJ Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER; National Institute for Health Research [PDF/01/2008/031] Funding Source: researchfish	Hamilton Health Sciences; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Colombian Institute for Science and Technology; Royal Australasian College of Physicians(General Electric); Public Health (Sidney Sax) Overseas Fellowship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Health Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RWJ Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Hamilton Health Sciences New Investigator Grant [# 08158 to CC, SY] and a Heart and Stroke Foundation of Ontario Pilot Project Grant [# PLP6567]. Data collection in Colombia was partly supported by the Colombian Institute for Science and Technology [# 6566-04-18062 to PLJ]. CK Chow was supported by a Cottrell fellowship from the Royal Australasian College of Physicians and currently is supported by a Public Health (Sidney Sax) Overseas Fellowship co-funded by the National Health and Medical Research Council and National Heart Foundation of Australia. S Yusuf is supported by an endowed chair from the Heart and Stroke Foundation of Ontario. S Lear is a Canadian Institutes of Health Research New Investigator and the Pfizer/Heart and Stroke Foundation Chair in Cardiovascular Prevention Research at St. Paul' Hospital. A Gilmore is supported by a Health Foundation Clinician Scientist Fellowship. SV Subramanian is supported by the National Institutes of Health Career Development Award (NHLBI K25 HL081275) and the RWJ Investigator Award in Health Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamar B, 2006, AM J PUBLIC HEALTH, V96, P1359, DOI 10.2105/AJPH.2005.069617; Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339; Boarnet MG, 2006, AM J PREV MED, V30, P153, DOI 10.1016/j.amepre.2005.09.018; Brownson RC, 2004, AM J PUBLIC HEALTH, V94, P473, DOI 10.2105/AJPH.94.3.473; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Day K, 2006, AM J PREV MED, V30, P144, DOI 10.1016/j.amepre.2005.09.017; Fisher BD, 2008, AM J HEALTH PROMOT, V22, P208, DOI 10.4278/ajhp.22.3.208; FLEISS JL, 1978, PSYCHOMETRIKA, V43, P259, DOI 10.1007/BF02293867; Glanz K, 2007, AM J PREV MED, V32, P282, DOI 10.1016/j.amepre.2006.12.019; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; LEVY DT, 2008, ROLE TOBACCO CONTROL, P53; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Merchant AT, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-2; Pikora TJ, 2006, MED SCI SPORT EXER, V38, P708, DOI 10.1249/01.mss.0000210189.64458.f3; Pikora TJ, 2002, AM J PREV MED, V23, P187, DOI 10.1016/S0749-3797(02)00498-1; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Saelens BE, 2007, AM J PREV MED, V32, P273, DOI 10.1016/j.amepre.2006.12.022; Sallis JF, 2009, AM J PREV MED, V36, P484, DOI 10.1016/j.amepre.2009.01.031; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Thompson VJ, 2007, J NUTR EDUC BEHAV, V39, P2, DOI 10.1016/j.jneb.2006.06.006; Weich S, 2001, HEALTH PLACE, V7, P283, DOI 10.1016/S1353-8292(01)00019-3; White E, 2008, PRINCIPLES EXPOSURE	24	57	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14294	10.1371/journal.pone.0014294	http://dx.doi.org/10.1371/journal.pone.0014294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692UU	21170320	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000285181400013
J	Posadas, I; Santos, P; Blanco, A; Munoz-Fernandez, M; Cena, V				Posadas, Inmaculada; Santos, Pablo; Blanco, Almudena; Munoz-Fernandez, Mariangeles; Cena, Valentin			Acetaminophen Induces Apoptosis in Rat Cortical Neurons	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; MITOCHONDRIAL PERMEABILITY TRANSITION; OXIDATIVE STRESS; INDUCED HEPATOTOXICITY; GLUTATHIONE-REDUCTASE; INDUCED TOXICITY; CREATINE-KINASE; OXIDANT STRESS; UNITED-STATES; BRAIN	Background: Acetaminophen (AAP) is widely prescribed for treatment of mild pain and fever in western countries. It is generally considered a safe drug and the most frequently reported adverse effect associated with acetaminophen is hepatotoxicity, which generally occurs after acute overdose. During AAP overdose, encephalopathy might develop and contribute to morbidity and mortality. Our hypothesis is that AAP causes direct neuronal toxicity contributing to the general AAP toxicity syndrome. Methodology/Principal Findings: We report that AAP causes direct toxicity on rat cortical neurons both in vitro and in vivo as measured by LDH release. We have found that AAP causes concentration-dependent neuronal death in vitro at concentrations (1 and 2 mM) that are reached in human plasma during AAP overdose, and that are also reached in the cerebrospinal fluid of rats for 3 hours following i.p injection of AAP doses (250 and 500 mg/Kg) that are below those required to induce acute hepatic failure in rats. AAP also increases both neuronal cytochrome P450 isoform CYP2E1 enzymatic activity and protein levels as determined by Western blot, leading to neuronal death through mitochondrial-mediated mechanisms that involve cytochrome c release and caspase 3 activation. In addition, in vivo experiments show that i.p. AAP (250 and 500 mg/Kg) injection induces neuronal death in the rat cortex as measured by TUNEL, validating the in vitro data. Conclusions/Significance: The data presented here establish, for the first time, a direct neurotoxic action by AAP both in vivo and in vitro in rats at doses below those required to produce hepatotoxicity and suggest that this neurotoxicity might be involved in the general toxic syndrome observed during patient APP overdose and, possibly, also when AAP doses in the upper dosing schedule are used, especially if other risk factors (moderate drinking, fasting, nutritional impairment) are present.	[Posadas, Inmaculada; Santos, Pablo; Cena, Valentin] Univ Castilla La Mancha, Unidad Asociada Neurodeath, Dept Ciencias Med, CSIC, Albacete, Spain; [Blanco, Almudena; Munoz-Fernandez, Mariangeles] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain; [Posadas, Inmaculada; Santos, Pablo; Cena, Valentin] Inst Salud Carlos III, CIBER Enfermedades Neurodegenerativas, Madrid, Spain; [Posadas, Inmaculada; Blanco, Almudena; Munoz-Fernandez, Mariangeles; Cena, Valentin] Inst Salud Carlos III, CIBER Bioingn Biomat & Nanomed, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; General University Gregorio Maranon Hospital; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Instituto de Salud Carlos III	Posadas, I (corresponding author), Univ Castilla La Mancha, Unidad Asociada Neurodeath, Dept Ciencias Med, CSIC, Albacete, Spain.	valentin.cena@uclm.es	Cena, Valentin/L-1751-2017; Posadas, Inmaculada/M-1124-2014	Cena, Valentin/0000-0001-8928-3681; Posadas, Inmaculada/0000-0003-1854-3372; Munoz-Fernandez/0000-0002-0813-4500	Fondo de Investigaciones Sanitarias Ministerio de Sanidad y Consumo [PI52112, PI09/02029, PI081434]; Junta de Comunidades de Castilla-La Mancha [PAI07-0063-7844, PII1I09-0163-4002, POII10-0274-3182]; Red Tematica de Investigacion Cooperativa Sanitaria ISCIII [RD06/0006/0035]; Fundacion para la Investigacion del Sida en Espana [FIPSE 240800/09]; Comunidad de Madrid [S-SAL-0159-2006]; Consejeria de Educacion	Fondo de Investigaciones Sanitarias Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Red Tematica de Investigacion Cooperativa Sanitaria ISCIII; Fundacion para la Investigacion del Sida en Espana; Comunidad de Madrid(Comunidad de Madrid); Consejeria de Educacion	This work has been supported by grants from Fondo de Investigaciones Sanitarias Ministerio de Sanidad y Consumo [PI52112] and Junta de Comunidades de Castilla-La Mancha [PAI07-0063-7844] to I.P.; from Fondo de Investigaciones Sanitarias Ministerio de Sanidad y Consumo [PI09/02029], Red Tematica de Investigacion Cooperativa Sanitaria ISCIII [RD06/0006/0035], Fundacion para la Investigacion del Sida en Espana [FIPSE 240800/09] and Comunidad de Madrid [S-SAL-0159-2006] to M.A.M-F. and from Fondo de Investigaciones Sanitarias Ministerio de Sanidad y Consumo [PI081434], from Consejeria de Educacion; Junta de Comunidades de Castilla-La Mancha [PII1I09-0163-4002 and POII10-0274-3182] to V.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Amar PJ, 2007, EXPERT OPIN DRUG SAF, V6, P341, DOI 10.1517/14740338.6.4.341; Bajt ML, 2004, TOXICOL SCI, V80, P343, DOI 10.1093/toxsci/kfh151; Bisaglia M, 2002, NEUROCHEM INT, V41, P43, DOI 10.1016/S0197-0186(01)00136-X; Blantz RC, 1996, AM J KIDNEY DIS, V28, pS3, DOI 10.1016/S0272-6386(96)90561-2; Bolesta S, 2002, ANN PHARMACOTHER, V36, P331; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bosque A, 2005, J LEUKOCYTE BIOL, V77, P568, DOI 10.1189/jlb.0904514; Bossy-Wetzel E, 1999, MUTAT RES-DNA REPAIR, V434, P243, DOI 10.1016/S0921-8777(99)00032-4; Botting RM, 2000, CLIN INFECT DIS, V31, pS202, DOI 10.1086/317520; Buzanska L, 2009, STEM CELLS, V27, P2591, DOI 10.1002/stem.179; Casper D, 2000, NEUROSCI LETT, V289, P201, DOI 10.1016/S0304-3940(00)01294-5; Cigremis Y, 2009, MOL CELL BIOCHEM, V323, P31, DOI 10.1007/s11010-008-9961-8; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; David S, 1998, MOL BRAIN RES, V54, P276, DOI 10.1016/S0169-328X(97)00343-4; Dendorfer A, 2005, FREE RADICAL BIO MED, V38, P117, DOI 10.1016/j.freeradbiomed.2004.10.015; Du YS, 1997, J NEUROCHEM, V69, P1382; Eguia L, 1997, PHARMACOTHERAPY, V17, P363; Fernandez M, 2007, J NEUROCHEM, V103, P190, DOI 10.1111/j.1471-4159.2007.04767.x; FISCHER LJ, 1981, J PHARMACOL EXP THER, V219, P281; Fontana RJ, 2008, MED CLIN N AM, V92, P761, DOI 10.1016/j.mcna.2008.03.005; Fukuda M, 2005, J PHARMACOL SCI, V97, P525, DOI 10.1254/jphs.FP0040752; Gaetani P, 1998, J NEUROSURG, V89, P748, DOI 10.3171/jns.1998.89.5.0748; Galindo MF, 2003, J NEUROCHEM, V84, P1066, DOI 10.1046/j.1471-4159.2003.01592.x; Gervasini G, 2004, CLIN PHARMACOKINET, V43, P693, DOI 10.2165/00003088-200443110-00001; Gonzalez FJ, 2007, DRUG METAB DISPOS, V35, P1, DOI 10.1124/dmd.106.012492; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; HART SGE, 1994, TOXICOL APPL PHARM, V126, P267, DOI 10.1006/taap.1994.1116; Headley J, 2007, EUR J CLIN PHARMACOL, V63, P189, DOI 10.1007/s00228-006-0231-y; HENDERSON PJ, 1970, J BIOL CHEM, V245, P1319; Jaeschke H, 2003, TOXICOL LETT, V144, P279, DOI 10.1016/S0378-4274(03)00239-X; Jalan R, 2005, NEUROCHEM INT, V47, P78, DOI 10.1016/j.neuint.2005.04.010; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; James LP, 2003, FREE RADICAL RES, V37, P1289, DOI 10.1080/10715760310001617776; Jamshidzadeh A, 2008, FOOD CHEM TOXICOL, V46, P3612, DOI 10.1016/j.fct.2008.09.006; JONES AF, 1993, J CLIN PHARM THER, V18, P5, DOI 10.1111/j.1365-2710.1993.tb00560.x; Jordan J, 2000, BRIT J PHARMACOL, V130, P1496, DOI 10.1038/sj.bjp.0703451; Jordan J, 2004, J NEUROCHEM, V89, P124, DOI 10.1046/j.1471-4159.2003.02299.x; Jordan J, 2003, NEUROSCIENCE, V122, P707, DOI 10.1016/j.neuroscience.2003.08.030; Jordan J, 2002, BRIT J PHARMACOL, V137, P993, DOI 10.1038/sj.bjp.0704953; Joshi M, 2006, DRUG METAB DISPOS, V34, P647, DOI 10.1124/dmd.105.008029; Kim YC, 1998, TOXICOLOGY, V128, P53, DOI 10.1016/S0300-483X(98)00046-8; Kon K, 2004, HEPATOLOGY, V40, p647A; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kurtovic J, 2003, J INTERN MED, V253, P240, DOI 10.1046/j.1365-2796.2003.01097.x; LARSEN FS, 1995, J HEPATOL, V23, P212, DOI 10.1016/0168-8278(95)80338-6; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Locke CJ, 2008, NEUROSCI LETT, V439, P129, DOI 10.1016/j.neulet.2008.05.003; Maharaj H, 2006, METAB BRAIN DIS, V21, P189, DOI 10.1007/s11011-006-9012-7; Manyike PT, 2000, CLIN PHARMACOL THER, V67, P275, DOI 10.1067/mcp.2000.104736; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; MITCHELL JR, 1973, DRUG METAB DISPOS, V1, P418; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; Moffit JS, 2007, TOXICOLOGY, V230, P197, DOI 10.1016/j.tox.2006.11.052; NAGENDRA SN, 1991, LIFE SCI, V49, P23, DOI 10.1016/0024-3205(91)90575-V; Naziroglu M, 2009, J MEMBRANE BIOL, V231, P57, DOI 10.1007/s00232-009-9203-3; Niquet J, 2006, BIOCHEM SOC T, V34, P1347, DOI 10.1042/BST0341347; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Pacheco GS, 2009, METAB BRAIN DIS, V24, P383, DOI 10.1007/s11011-009-9143-8; Posadas I, 2007, BRIT J PHARMACOL, V150, P577, DOI 10.1038/sj.bjp.0706993; Posadas I, 2009, PHARM RES-DORDR, V26, P1181, DOI 10.1007/s11095-009-9839-9; PUNCHARD NA, 1996, FREE RADICALS PRACTI, P1; REINKE LA, 1985, DRUG METAB DISPOS, V13, P548; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; Smith SW, 2008, ANN PHARMACOTHER, V42, P1333, DOI 10.1345/aph.1K680; Taylor RM, 2006, HEPATOLOGY, V44, P1589, DOI 10.1002/hep.21439; Tindberg N, 1996, J NEUROCHEM, V67, P2066, DOI 10.1046/j.1471-4159.1996.67052066.x; Tran A, 2001, TOXICOL APPL PHARM, V170, P145, DOI 10.1006/taap.2000.9091; Tripathy D, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-10; Upadhya SC, 2000, ARCH BIOCHEM BIOPHYS, V373, P23, DOI 10.1006/abbi.1999.1477; Walubo A, 2004, HUM EXP TOXICOL, V23, P49, DOI 10.1191/0960327104ht415oa; Wilcox CM, 2005, J RHEUMATOL, V32, P2218	72	56	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15360	10.1371/journal.pone.0015360	http://dx.doi.org/10.1371/journal.pone.0015360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170329	Green Published, gold, Green Submitted			2022-12-27	WOS:000285181400023
J	Yang, Y; Huang, JH; Toth, I; Lichterfeld, M; Yu, XG				Yang, Yue; Huang, Jinghe; Toth, Ildiko; Lichterfeld, Mathias; Yu, Xu G.			Mutational Escape in HIV-1 CTL Epitopes Leads to Increased Binding to Inhibitory Myelomonocytic MHC Class I Receptors	PLOS ONE			English	Article							T-LYMPHOCYTE ESCAPE; DENDRITIC CELLS; INFECTION; RESPONSES	Escape mutations in HIV-1 cytotoxic T cell (CTL) epitopes can abrogate recognition by the TCR of HIV-1-specific CD8+ T cells, but may also change interactions with alternative MHC class I receptors. Here, we show that mutational escape in three HLA-A11-, B8- and B7- restricted immunodominant HIV-1 CTL epitopes consistently enhances binding of the respective peptide/MHC class I complex to Immunoglobulin-like transcript 4 (ILT4), an inhibitory myelomonocytic MHC class I receptor expressed on monocytes and dendritic cells. In contrast, mutational escape in an alternative immunodominant HLA-B57-restricted CTL epitope did not affect ILT4-mediated recognition by myelomonocytic cells. This suggests that in addition to abrogating recognition by HIV-1-specific CD8 T cells, mutational escape in some, but not all CTL epitopes may mediate important immunoregulatory effects by increasing binding properties to ILT4, and augmenting ILT4-mediated inhibitory effects of professional antigen-presenting cells.	[Yang, Yue; Huang, Jinghe; Toth, Ildiko; Yu, Xu G.] Harvard & MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Lichterfeld, Mathias] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital	Yang, Y (corresponding author), Harvard & MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA.	xyu@partners.org	Huang, Jinghe/O-1986-2015; Lichterfeld, Mathias/B-2042-2008	Lichterfeld, Mathias/0000-0001-9865-8350; Yu, Xu/0000-0002-8295-884X; Huang, Jinghe/0000-0002-1968-871X	National Institutes of Health [R01 AI078799, P01 AI074415]; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074415, R01AI078799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (R01 AI078799 and P01 AI074415 to XGY) and the Doris Duke Charitable Foundation (Clinical Scientist Development Award to XGY and ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan DSJ, 1999, J EXP MED, V189, P1149, DOI 10.1084/jem.189.7.1149; Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Bailey J, 2004, CURR OPIN IMMUNOL, V16, P470, DOI 10.1016/j.coi.2004.05.005; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Fantuzzi L, 2004, J VIROL, V78, P9763, DOI 10.1128/JVI.78.18.9763-9772.2004; Huang JH, 2009, J EXP MED, V206, P2959, DOI 10.1084/jem.20091386; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li DM, 2009, J IMMUNOL, V182, P1033, DOI 10.4049/jimmunol.182.2.1033; Lichterfeld M, 2007, J EXP MED, V204, P2813, DOI 10.1084/jem.20061865; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108	14	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15084	10.1371/journal.pone.0015084	http://dx.doi.org/10.1371/journal.pone.0015084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170342	Green Published, gold			2022-12-27	WOS:000285084100018
J	Vilas-Boas, F; Henrique, D				Vilas-Boas, Filipe; Henrique, Domingos			HES6-1 and HES6-2 Function through Different Mechanisms during Neuronal Differentiation	PLOS ONE			English	Article							NEURAL STEM-CELL; CHICK-EMBRYO; GLIAL DIFFERENTIATION; PROMOTES NEUROGENESIS; TRANSCRIPTION FACTORS; GONADAL DEVELOPMENT; PRONEURAL GENES; NERVOUS-SYSTEM; NOTCH; SPECIFICATION	Background: Notch signalling plays a central role in the mechanisms regulating neuronal differentiation in the vertebrate nervous system. The transcriptional repressors encoded by Hes genes are the main effectors of this pathway, acting in neural progenitors during the lateral inhibition process to repress proneural genes and inhibit differentiation. However, Hes6 genes seem to behave differently: they are expressed in differentiating neurons and facilitate the activity of proneural genes in promoting neurogenesis. Still, the molecular mechanisms underlying this unique function of Hes6 genes are not yet understood. Methodology/Principal Findings: Here, we identify two subgroups of Hes6 genes that seem conserved in most vertebrate species and characterize a novel Hes6 gene in chicken: cHes6-1. The embryonic expression pattern of cHes6-1 suggests roles for this gene in the formation of the pancreas, nervous system and in the generation of body asymmetry. We show that cHes6-1 is negatively regulated by Notch signalling in the developing embryonic spinal cord and in pancreatic progenitors, but requires Notch for the observed asymmetric expression at the lateral mesoderm. Functional studies by ectopic expression in the chick embryonic neural tube revealed that cHES6-1 up-regulates the expression of cDelta1 and cHes5 genes, in contrast with overexpression of cHES6-2, which represses the same genes. We show that this activity of cHES6-2 is dependent on its capacity to bind DNA and repress transcription, while cHES6-1 seems to function by sequestering other HES proteins and inhibit their activity as transcriptional repressors. Conclusions/Significance: Our results indicate that the two chick HES6 proteins act at different phases of neuronal differentiation, contributing to the progression of neurogenesis by different mechanisms: while cHES6-2 represses the transcription of Hes genes, cHES6-1 acts later, sequestering HES proteins. Together, the two cHES6 proteins progressively shut down the Notch-mediated progenitor program and ensure that neuronal differentiation can proceed.	[Vilas-Boas, Filipe; Henrique, Domingos] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal	Universidade de Lisboa	Vilas-Boas, F (corresponding author), Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal.	henrique@fm.ul.pt	Vilas-Boas, Filipe/B-1669-2012; Vilas-Boas, Filipe/H-5261-2019; Henrique, Domingos M/E-5460-2010	Vilas-Boas, Filipe/0000-0002-8060-5370; Vilas-Boas, Filipe/0000-0002-8060-5370; Henrique, Domingos M/0000-0001-8869-1894	Fundacao Ciencia e Tecnologia [PTDC/SAU-OBD/75106/2006]; FCT	Fundacao Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by Fundacao Ciencia e Tecnologia (www.fct.mctes.pt), project PTDC/SAU-OBD/75106/2006. Filipe Vilas-Boas is supported a FCT fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnfelt-Ronne J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-63; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bae SK, 2000, DEVELOPMENT, V127, P2933; Ball AJ, 2007, BIOCHEM BIOPH RES CO, V355, P331, DOI 10.1016/j.bbrc.2007.01.153; BELANGERJASMIN S, 2007, J NEUROCHEM; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Cossins J, 2002, DEVELOPMENT, V129, P2195; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Farah MH, 2000, DEVELOPMENT, V127, P693; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fujita S, 2003, CELL STRUCT FUNCT, V28, P205, DOI 10.1247/csf.28.205; Gibert JM, 2003, INT J DEV BIOL, V47, P643; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hu Y, 2004, P NATL ACAD SCI USA, V101, P5559, DOI 10.1073/pnas.0306988101; Ishii A, 2008, BIOCHEM BIOPH RES CO, V372, P142, DOI 10.1016/j.bbrc.2008.05.015; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Jennings BH, 1999, MOL CELL BIOL, V19, P4600; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kimura W, 2007, DEV GROWTH DIFFER, V49, P365, DOI [10.1111/j.1440-169x.2007.00933.x, 10.1111/j.1440-169X.2007.00933.x]; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lutolf S, 2002, DEVELOPMENT, V129, P373; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Matsushita S, 1996, ROUX ARCH DEV BIOL, V205, P225, DOI 10.1007/BF00365800; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mittwoch U, 1998, J EXP ZOOL, V281, P466, DOI 10.1002/(SICI)1097-010X(19980801)281:5&lt;466::AID-JEZ11&gt;3.0.CO;2-7; MURAI K, 2007, DEV BIOL; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Pedersen JK, 2005, DEV BIOL, V288, P487, DOI 10.1016/j.ydbio.2005.10.001; Poitras L, 2007, DEVELOPMENT, V134, P1755, DOI 10.1242/dev.02845; Rawdon BB, 2001, DEV DYNAM, V222, P153, DOI 10.1002/dvdy.1177; Raya A, 2004, MECH DEVELOP, V121, P1043, DOI 10.1016/j.mod.2004.05.005; RODEMER ES, 1986, J EMBRYOL EXP MORPH, V98, P269; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SECHRIST J, 1991, NEURON, V7, P947, DOI 10.1016/0896-6273(91)90340-6; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434	56	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15459	10.1371/journal.pone.0015459	http://dx.doi.org/10.1371/journal.pone.0015459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151987	gold, Green Submitted, Green Published			2022-12-27	WOS:000284868000033
J	Barel, M; Meibom, K; Charbit, A				Barel, Monique; Meibom, Karin; Charbit, Alain			Nucleolin, a Shuttle Protein Promoting Infection of Human Monocytes by Francisella tularensis	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; MURINE MACROPHAGES; EXPRESSION; ESCAPE; CELLS; COLOCALIZATION; RECEPTOR; REPLICATION; BIOGENESIS; MICROSCOPY	Background: Francisella tularensis is a highly virulent facultative intracellular bacterium, disseminating in vivo mainly within host mononuclear phagocytes. After entry into macrophages, F. tularensis initially resides in a phagosomal compartment, whose maturation is then arrested. Bacteria escape rapidly into the cytoplasm, where they replicate freely. We recently demonstrated that nucleolin, an eukaryotic protein able to traffic from the nucleus to the cell surface, acted as a surface receptor for F. tularensis LVS on human monocyte-like THP-1 cells. Methodology/Principal Findings: Here, we followed the fate of nucleolin once F. tularensis has been endocytosed. We first confirmed by siRNA silencing experiments that expression of nucleolin protein was essential for binding of LVS on human macrophage-type THP-1 cells. We then showed that nucleolin co-localized with intracellular bacteria in the phagosomal compartment. Strikingly, in that compartment, nucleolin also co-localized with LAMP-1, a late endosomal marker. Co-immunoprecipation assays further demonstrated an interaction of nucleolin with LAMP-1. Co-localization of nucleolin with LVS was no longer detectable at 24 h when bacteria were multiplying in the cytoplasm. In contrast, with an iglC mutant of LVS, which remains trapped into the phagosomal compartment, or with inert particles, nucleolin/bacteria co-localization remained almost constant. Conclusions/Significance: We herein confirm the importance of nucleolin expression for LVS binding and its specificity as nucleolin is not involved in binding of another intracellular pathogen as L. monocytogenes or an inert particle. Association of nucleolin with F. tularensis during infection continues intracellularly after endocytosis of the bacteria. The present work therefore unravels for the first time the presence of nucleolin in the phagosomal compartment of macrophages.	[Barel, Monique; Meibom, Karin; Charbit, Alain] Univ Paris 05, Fac Med Necker Enfants Malades, Paris, France; [Barel, Monique; Meibom, Karin; Charbit, Alain] INSERM, U1002, Unit Pathogenesis Syst Infect, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Barel, M (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malades, Paris, France.	monique.barel@inserm.fr	BAREL, Monique/K-3772-2017	Meibom, Karin/0000-0002-2612-6424; charbit, alain/0000-0001-5243-4861; BAREL, Monique/0000-0001-8171-7027	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University Rene Descartes Paris V	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Rene Descartes Paris V	These studies were supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS) and University Rene Descartes Paris V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2008, J MICROSC-OXFORD, V230, P121, DOI 10.1111/j.1365-2818.2008.01967.x; Akimana C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011025; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Barel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-145; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Deng JS, 1996, MOL BIOL REP, V23, P191, DOI 10.1007/BF00351168; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Derby MC, 2007, INT REV CYTOL, V261, P47, DOI 10.1016/S0074-7696(07)61002-X; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Gahan CGM, 2001, INFECT IMMUN, V69, P3924, DOI 10.1128/IAI.69.6.3924-3932.2001; Glaser P, 2001, SCIENCE, V294, P849; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; Hirata D, 2000, CLIN IMMUNOL, V97, P50, DOI 10.1006/clim.2000.4916; Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024; KHARRAT A, 1991, BIOCHEMISTRY-US, V30, P10329, DOI 10.1021/bi00106a034; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; MANDERS EMM, 1992, J CELL SCI, V103, P857; Pierini LM, 2006, CELL MICROBIOL, V8, P1361, DOI 10.1111/j.1462-5822.2006.00719.x; Rajaram MVS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007919; ROY L, BIOCH BIOPH IN PRESS; SANCHEZCORRAL P, 1989, J IMMUNOL METHODS, V122, P105, DOI 10.1016/0022-1759(89)90340-2; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2010, MICROBES INFECT, V12, P126, DOI 10.1016/j.micinf.2009.11.003; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Sjostedt A, 2003, CURR OPIN MICROBIOL, V6, P66, DOI 10.1016/S1369-5274(03)00002-X; SJOSTEDT A, 1994, INFECT IMMUN, V62, P2779; THOMAS H, 2007, CELL MICROBIOL, V9, P2543; Tooker BC, 2004, IMMUNOL LETT, V93, P137, DOI 10.1016/j.imlet.2004.03.005; vanSteensel B, 1996, J CELL SCI, V109, P787	39	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14193	10.1371/journal.pone.0014193	http://dx.doi.org/10.1371/journal.pone.0014193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152024	Green Published, gold, Green Submitted			2022-12-27	WOS:000284821300010
J	Fallani, FD; Nicosia, V; Sinatra, R; Astolfi, L; Cincotti, F; Mattia, D; Wilke, C; Doud, A; Latora, V; He, B; Babiloni, F				Fallani, Fabrizio De Vico; Nicosia, Vincenzo; Sinatra, Roberta; Astolfi, Laura; Cincotti, Febo; Mattia, Donatella; Wilke, Christopher; Doud, Alex; Latora, Vito; He, Bin; Babiloni, Fabio			Defecting or Not Defecting: How to "Read'' Human Behavior during Cooperative Games by EEG Measurements	PLOS ONE			English	Article							HIGH-RESOLUTION EEG; FUNCTIONAL MAGNETIC-RESONANCE; ANTERIOR CINGULATE CORTEX; CORTICAL RESPONSES; NETWORKS; INTEGRATION; COHERENCE; BRAIN; FLOW	Understanding the neural mechanisms responsible for human social interactions is difficult, since the brain activities of two or more individuals have to be examined simultaneously and correlated with the observed social patterns. We introduce the concept of hyper-brain network, a connectivity pattern representing at once the information flow among the cortical regions of a single brain as well as the relations among the areas of two distinct brains. Graph analysis of hyper-brain networks constructed from the EEG scanning of 26 couples of individuals playing the Iterated Prisoner's Dilemma reveals the possibility to predict non-cooperative interactions during the decision-making phase. The hyper-brain networks of two-defector couples have significantly less inter-brain links and overall higher modularity-i.e., the tendency to form two separate subgraphs-than couples playing cooperative or tit-for-tat strategies. The decision to defect can be "read'' in advance by evaluating the changes of connectivity pattern in the hyper-brain network.	[Fallani, Fabrizio De Vico; Astolfi, Laura; Cincotti, Febo; Mattia, Donatella; Babiloni, Fabio] Sci Inst Res Hospitalizat & Hlth Care IRCCS Fdn S, NEILab, Rome, Italy; [Fallani, Fabrizio De Vico; Babiloni, Fabio] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Nicosia, Vincenzo; Sinatra, Roberta; Latora, Vito] Univ Catania, Complex Syst Lab, Scuola Super Catania, Catania, Italy; [Sinatra, Roberta; Latora, Vito] Univ Catania, Dept Phys & Astron, Catania, Italy; [Sinatra, Roberta; Latora, Vito] Ist Nazl Fis Nucl, I-95129 Catania, Italy; [Astolfi, Laura] Univ Roma La Sapienza, Dept Comp Syst & Informat, Rome, Italy; [Wilke, Christopher; Doud, Alex; He, Bin] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55417 USA; [Wilke, Christopher; Doud, Alex; He, Bin] Univ Minnesota, Ctr Neuroengn, Minneapolis, MN 55417 USA	Sapienza University Rome; University of Catania; University of Catania; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Fallani, FD (corresponding author), Sci Inst Res Hospitalizat & Hlth Care IRCCS Fdn S, NEILab, Rome, Italy.	fabio.babiloni@uniroma1.it	Mattia, Donatella/D-7569-2012; Sinatra, Roberta/G-9836-2012; De Vico Fallani, Fabrizio/A-2157-2010; Nicosia, Vincenzo/C-7890-2013; Cincotti, Febo/C-3664-2008; Babiloni, Fabio/E-5169-2015; Astolfi, Laura/J-9235-2016	Mattia, Donatella/0000-0002-3092-2511; Sinatra, Roberta/0000-0002-7558-1028; Nicosia, Vincenzo/0000-0003-0636-3278; Cincotti, Febo/0000-0003-1898-6480; Babiloni, Fabio/0000-0002-4962-176X; Wilke, Christopher/0000-0003-4147-6040; Astolfi, Laura/0000-0002-1025-7526; Latora, Vito/0000-0002-0984-8038	National Institutes of Health [RO1EB006433, RO1EB007920]; National Science Foundation CBET [0933067]; COST Action NeuroMath [BM0601]; Compagnia San Paolo; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006433, R01EB007920] Funding Source: NIH RePORTER; Directorate For Engineering [0933067] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CBET(National Science Foundation (NSF)); COST Action NeuroMath(European Cooperation in Science and Technology (COST)); Compagnia San Paolo(Compagnia di San Paolo); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by the National Institutes of Health RO1EB006433, RO1EB007920, the National Science Foundation CBET 0933067 and the COST Action NeuroMath (BM0601). This work was also supported by the Compagnia San Paolo within the Project "Social and Emotive Hyperbrain". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres FG, 1999, J CLIN NEUROPHYSIOL, V16, P520, DOI 10.1097/00004691-199911000-00004; Arenas A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/176; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Babiloni C, 2004, CLIN NEUROPHYSIOL, V115, P161, DOI 10.1016/S1388-2457(03)00286-4; Babiloni C, 2003, EUR J NEUROSCI, V18, P1692, DOI 10.1046/j.1460-9568.2003.02851.x; Babiloni F, 2000, METHOD INFORM MED, V39, P179; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Fallani FD, 2007, BRAIN TOPOGR, V19, P125, DOI 10.1007/s10548-007-0019-0; DYLANHAYNES J, 2007, CURR BIOL, V17, P323; DYLANHAYNES J, 2006, NAT NEUROSCI, P523; Forstmann BU, 2006, J COGNITIVE NEUROSCI, V18, P388, DOI 10.1162/089892906775990589; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kaminski M, 2005, PHILOS T R SOC B, V360, P947, DOI 10.1098/rstb.2005.1636; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knobe J, 2005, TRENDS COGN SCI, V9, P357, DOI 10.1016/j.tics.2005.06.011; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman M. E. J., 2004, PHYS REV, V69; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Osborne MJ, 1999, COURSE GAME THEORY; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Sinatra R, 2009, INT J BIFURCAT CHAOS, V19, P665, DOI 10.1142/S0218127409023020; Urbano A, 1997, NEUROREPORT, V8, P3239, DOI 10.1097/00001756-199710200-00011; Walton ME, 2002, J NEUROSCI, V22, P10996	38	130	132	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14187	10.1371/journal.pone.0014187	http://dx.doi.org/10.1371/journal.pone.0014187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152069	gold, Green Published, Green Submitted			2022-12-27	WOS:000284821300005
J	Rathcke, CN; Kjoller, E; Fogh-Andersen, N; Zerahn, B; Vestergaard, H				Rathcke, Camilla Noelle; Kjoller, Erik; Fogh-Andersen, Niels; Zerahn, Bo; Vestergaard, Henrik			NT-proBNP and Circulating Inflammation Markers in Prediction of a Normal Myocardial Scintigraphy in Patients with Symptoms of Coronary Artery Disease	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; ISCHEMIC-HEART-DISEASE; PROGNOSTIC VALUE; CARDIOVASCULAR-DISEASE; NUCLEAR CARDIOLOGY; INFARCTION; YKL-40; RISK; MORTALITY; EXERCISE	Background: Myocardial perfusion imaging (MPI) can detect myocardial perfusion abnormalities but many examinations are without pathological findings. This study examines whether circulating biomarkers can be used as screening modality prior to MPI. Methodology/Principal Findings: 243 patients with an intermediate risk of CAD or with known CAD with renewed suspicion of ischemia were referred to MPI. Blood samples were analyzed for N-terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP), YKL-40, IL-6, matrix metalloproteinase 9 (MMP-9) and high sensitive C-reactive protein (hsCRP). Patients with myocardial perfusion defects had elevated levels of NT-proBNP (p<0.0001), YKL-40 (p = 0.03) and IL-6 (p = 0.03) but not of hsCRP (p = 0.58) nor of MMP-9 (p = 0.14). The NT-proBNP increase was observed in both genders (p < 0.0001), whereas YKL-40 (p = 0.005) and IL-6 (p = 0.02) were elevated only in men. A NT-proBNP cut off-concentration at 25 ng/l predicted a normal MPI with a negative predictive value >95% regardless of existing CAD. Conclusions: 20-25% of patients suspected of CAD could have been spared a MPI by using a NT-proBNP cut-off concentration at 25 ng/l with a negative predictive value >95%. NT-proBNP has the potential use of being a screening marker of CAD before referral of the patient to MPI.	[Rathcke, Camilla Noelle; Vestergaard, Henrik] Univ Copenhagen, Herlev Hosp, Ctr Endocrinol & Metab, Dept Internal Med, DK-2730 Herlev, Denmark; [Kjoller, Erik] Univ Copenhagen, Herlev Hosp, Dept Cardiol, DK-2730 Herlev, Denmark; [Fogh-Andersen, Niels] Univ Copenhagen, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Zerahn, Bo] Univ Copenhagen, Herlev Hosp, Dept Clin Physiol & Nucl Med, DK-2730 Herlev, Denmark; [Vestergaard, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Rathcke, CN (corresponding author), Univ Copenhagen, Herlev Hosp, Ctr Endocrinol & Metab, Dept Internal Med, DK-2730 Herlev, Denmark.	cnr@dadlnet.dk		Zerahn, Bo/0000-0002-3457-6249; Vestergaard, Henrik/0000-0003-3090-269X	Aase and Ejnar Danielsens Foundation; National Research Foundation of Health and Disease	Aase and Ejnar Danielsens Foundation; National Research Foundation of Health and Disease	The study was supported by grants from Aase and Ejnar Danielsens Foundation and The National Research Foundation of Health and Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERMAN DS, 1995, J AM COLL CARDIOL, V26, P639, DOI 10.1016/0735-1097(95)00218-S; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Clark AN, 2005, Q J NUCL MED MOL IM, V49, P43; D'Souza SP, 2003, HEART, V89, P707, DOI 10.1136/heart.89.7.707; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; DE NR, 2006, ARTERIOSCLER THROMB, V26, P340; Elhendy A, 2004, J NUCL CARDIOL, V11, P704, DOI 10.1016/j.nuclcard.2004.08.006; Ferroni P, 2003, J INVEST MED, V51, P295, DOI 10.1136/jim-51-05-17; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje; Heeschen C, 2004, CIRCULATION, V110, P3206, DOI 10.1161/01.CIR.0000147611.92021.2B; Hlatky MA, 2007, AM HEART J, V154, P1043, DOI 10.1016/j.ahj.2007.06.042; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Johansen JS, 2006, DAN MED BULL, V53, P172; Kastrup J, 2009, EUR HEART J, V30, P1066, DOI 10.1093/eurheartj/ehp049; Kaushik M, 2010, INT J CARDIOL, V142, P8, DOI 10.1016/j.ijcard.2009.10.033; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Kroll D, 2001, AM J CARDIOL, V87, P381, DOI 10.1016/S0002-9149(00)01387-4; Kucur M, 2007, CORONARY ARTERY DIS, V18, P391, DOI 10.1097/MCA.0b013e328241d991; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Majstorov Venjamin, 2008, Prilozi, V29, P67; Mercaldo ND, 2007, STAT MED, V26, P2170, DOI 10.1002/sim.2677; Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, piii; Nojgaard C, 2008, CORONARY ARTERY DIS, V19, P257, DOI 10.1097/MCA.0b013e3282f40dd5; Peer A, 2009, HEART, V95, P297, DOI 10.1136/hrt.2008.145425; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Rathcke CN, 2010, INT J CARDIOL, V143, P35, DOI 10.1016/j.ijcard.2009.01.043; Rathcke CN, 2009, DIABETES CARE, V32, P323, DOI 10.2337/dc08-1144; Shark T, 2006, J NUCL CARDIOL, V13, P495, DOI 10.1016/j.nuclcard.2006.03.019; STRATMANN HG, 1994, AM J CARDIOL, V73, P647, DOI 10.1016/0002-9149(94)90927-X; Sukhija R, 2007, AM J CARDIOL, V99, P879, DOI 10.1016/j.amjcard.2006.11.032; Underwood SR, 2004, EUR J NUCL MED MOL I, V31, P261, DOI 10.1007/s00259-003-1344-5; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wang YZ, 2008, SCAND CARDIOVASC J, V42, P295, DOI 10.1080/14017430802220567; Weber Michael, 2006, Exp Clin Cardiol, V11, P99; WINGARD DL, 1983, AM J EPIDEMIOL, V117, P165, DOI 10.1093/oxfordjournals.aje.a113527; Zeng B, 2005, INTERN MED J, V35, P331, DOI 10.1111/j.1445-5994.2005.00822.x; Zerahn B, 2000, J NUCL CARDIOL, V7, P616, DOI 10.1067/mnc.2000.109028; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	42	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14196	10.1371/journal.pone.0014196	http://dx.doi.org/10.1371/journal.pone.0014196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152016	Green Published, Green Submitted, gold			2022-12-27	WOS:000284821300011
J	Arioli, S; Ragg, E; Scaglioni, L; Fessas, D; Signorelli, M; Karp, M; Daffonchio, D; De Noni, I; Mulas, L; Oggioni, M; Guglielmetti, S; Mora, D				Arioli, Stefania; Ragg, Enzio; Scaglioni, Leonardo; Fessas, Dimitrios; Signorelli, Marco; Karp, Matti; Daffonchio, Daniele; De Noni, Ivano; Mulas, Laura; Oggioni, Marco; Guglielmetti, Simone; Mora, Diego			Alkalizing Reactions Streamline Cellular Metabolism in Acidogenic Microorganisms	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; STREPTOCOCCUS-THERMOPHILUS; LACTOCOCCUS-LACTIS; BETA-GALACTOSIDASE; LACTOSE HYDROLYSIS; INTRACELLULAR PH; UREASE; GENOME; MILK; BIOSYNTHESIS	An understanding of the integrated relationships among the principal cellular functions that govern the bioenergetic reactions of an organism is necessary to determine how cells remain viable and optimise their fitness in the environment. Urease is a complex enzyme that catalyzes the hydrolysis of urea to ammonia and carbonic acid. While the induction of urease activity by several microorganisms has been predominantly considered a stress-response that is initiated to generate a nitrogen source in response to a low environmental pH, here we demonstrate a new role of urease in the optimisation of cellular bioenergetics. We show that urea hydrolysis increases the catabolic efficiency of Streptococcus thermophilus, a lactic acid bacterium that is widely used in the industrial manufacture of dairy products. By modulating the intracellular pH and thereby increasing the activity of beta-galactosidase, glycolytic enzymes and lactate dehydrogenase, urease increases the overall change in enthalpy generated by the bioenergetic reactions. A cooperative altruistic behaviour of urease-positive microorganisms on the urease-negative microorganisms within the same environment was also observed. The physiological role of a single enzymatic activity demonstrates a novel and unexpected view of the non-transcriptional regulatory mechanisms that govern the bioenergetics of a bacterial cell, highlighting a new role for cytosol-alkalizing biochemical pathways in acidogenic microorganisms.	[Arioli, Stefania; Fessas, Dimitrios; Signorelli, Marco; Daffonchio, Daniele; De Noni, Ivano; Guglielmetti, Simone; Mora, Diego] Univ Milan, Dipartimento Sci & Tecnol Alimentari & Microbiol, Milan, Italy; [Ragg, Enzio; Scaglioni, Leonardo] Univ Milan, Dipartimento Sci Mol Agroalimentari, Milan, Italy; [Karp, Matti] Tampere Univ Technol, Dept Chem & Bioengn, FIN-33101 Tampere, Finland; [Mulas, Laura; Oggioni, Marco] Univ Siena, Dipartimento Biol Mol, Lab Microbiol Mol & Biotecnol, I-53100 Siena, Italy	University of Milan; University of Milan; Tampere University; University of Siena	Arioli, S (corresponding author), Univ Milan, Dipartimento Sci & Tecnol Alimentari & Microbiol, Milan, Italy.	diego.mora@unimi.it	De Noni, Ivano/B-7250-2015; Guglielmetti, Simone/K-2507-2018; Oggioni, Marco Rinaldo/K-3839-2016; Karp, Matti/G-4227-2014; Daffonchio, Daniele/AAF-4922-2019	Guglielmetti, Simone/0000-0002-8673-8190; Oggioni, Marco Rinaldo/0000-0003-4117-793X; Karp, Matti/0000-0001-6686-4416; Daffonchio, Daniele/0000-0003-0947-925X; DE NONI, IVANO/0000-0003-1281-7053; Scaglioni, Leonardo/0000-0002-9971-100X; Mora, Diego/0000-0002-6692-9301; RAGG, ENZIO MARIA/0000-0002-2757-8369; arioli, stefania/0000-0002-5406-8268	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Sacco S.r.L.	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Sacco S.r.L.	The work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (PRIN 2006) and by Sacco S.r.L.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioli S, 2007, APPL ENVIRON MICROB, V73, P5789, DOI 10.1128/AEM.00533-07; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Broadbent JR, 2010, J BACTERIOL, V192, P2445, DOI 10.1128/JB.01618-09; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Cook AR, 2007, INT J SYST EVOL MICR, V57, P2940, DOI 10.1099/ijs.0.64819-0; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Gaspar P, 2007, FEBS J, V274, P5924, DOI 10.1111/j.1742-4658.2007.06115.x; Geertsma ER, 2005, BIOCHEMISTRY-US, V44, P15889, DOI 10.1021/bi051638w; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Jahns T, 1996, J BACTERIOL, V178, P403, DOI 10.1128/jb.178.2.403-409.1996; Krishnan S, 2000, PROCESS BIOCHEM, V35, P1191, DOI 10.1016/S0032-9592(00)00162-X; Liu H, 2001, BIOCHEMISTRY-US, V40, P5542, DOI 10.1021/bi002426w; Loimaranta V, 1998, ANTIMICROB AGENTS CH, V42, P1906, DOI 10.1128/AAC.42.8.1906; Magni C, 1999, J BACTERIOL, V181, P1451, DOI 10.1128/JB.181.5.1451-1457.1999; MeyerRosberg K, 1996, GASTROENTEROLOGY, V111, P886, DOI 10.1016/S0016-5085(96)70056-2; Monnet C, 2005, APPL ENVIRON MICROB, V71, P3376, DOI 10.1128/AEM.71.6.3376-3378.2005; Monnet C, 2004, J DAIRY SCI, V87, P1634, DOI 10.3168/jds.S0022-0302(04)73318-4; Mora D, 2005, MICROBIOL-SGM, V151, P3814, DOI 10.1099/mic.0.28513-0; Mora D, 2005, RES MICROBIOL, V156, P897, DOI 10.1016/j.resmic.2005.04.005; Mora D, 2004, J APPL MICROBIOL, V96, P209, DOI 10.1046/j.1365-2672.2003.02148.x; NANNEN NL, 1991, J DAIRY SCI, V74, P741, DOI 10.3168/jds.S0022-0302(91)78219-2; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Pastink MI, 2009, APPL ENVIRON MICROB, V75, P3627, DOI 10.1128/AEM.00138-09; Rasmussen TB, 2008, APPL ENVIRON MICROB, V74, P4703, DOI 10.1128/AEM.00132-08; Sawatari Y, 2007, APPL ENVIRON MICROB, V73, P3909, DOI 10.1128/AEM.02834-06; SMART JB, 1985, NEW ZEAL J DAIRY SCI, V20, P43; SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993; Voit E, 2006, P NATL ACAD SCI USA, V103, P9452, DOI 10.1073/pnas.0603337103; YANG Z, 1993, AGR SCI FINLAND, V2, P395, DOI 10.23986/afsci.72665	32	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15520	10.1371/journal.pone.0015520	http://dx.doi.org/10.1371/journal.pone.0015520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152088	Green Published, gold			2022-12-27	WOS:000284755100091
J	Souza, TML; Salluh, JIF; Bozza, FA; Mesquita, M; Soares, M; Motta, FC; Pitrowsky, MT; Oliveira, MD; Mishin, VP; Gubareva, LV; Whitney, A; Rocco, SA; Goncalves, VMC; Marques, VP; Velasco, E; Siqueira, MM				Souza, Thiago Moreno L.; Salluh, Jorge I. F.; Bozza, Fernando A.; Mesquita, Milene; soares, Marcio; Motta, Fernando C.; Pitrowsky, Melissa Tassano; Oliveira, Maria de Lourdes; Mishin, Vasiliy P.; Gubareva, Larissa V.; Whitney, Anne; Rocco, Sandra Amaral; Goncalves, Vania Maria C.; Marques, Venceslaine Prado; Velasco, Eduardo; Siqueira, Marilda M.			H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; A H1N1; OSELTAMIVIR TREATMENT; VIRUS-INFECTION; A(H1N1); MANAGEMENT; PNEUMONIA; MORTALITY; LOAD	Background: The novel influenza A pandemic virus (H1N1pdm) caused considerable morbidity and mortality worldwide in 2009. The aim of the present study was to evaluate the clinical course, duration of viral shedding, H1N1pdm evolution and emergence of antiviral resistance in hospitalized cancer patients with severe H1N1pdm infections during the winter of 2009 in Brazil. Methods: We performed a prospective single-center cohort study in a cancer center in Rio de Janeiro, Brazil. Hospitalized patients with cancer and a confirmed diagnosis of influenza A H1N1pdm were evaluated. The main outcome measures in this study were in-hospital mortality, duration of viral shedding, viral persistence and both functional and molecular analyses of H1N1pdm susceptibility to oseltamivir. Results: A total of 44 hospitalized patients with suspected influenza-like illness were screened. A total of 24 had diagnosed H1N1pdm infections. The overall hospital mortality in our cohort was 21%. Thirteen (54%) patients required intensive care. The median age of the studied cohort was 14.5 years (3-69 years). Eighteen (75%) patients had received chemotherapy in the previous month, and 14 were neutropenic at the onset of influenza. A total of 10 patients were evaluated for their duration of viral shedding, and 5 (50%) displayed prolonged viral shedding (median 23, range = 11-63 days); however, this was not associated with the emergence of a resistant H1N1pdm virus. Viral evolution was observed in sequentially collected samples. Conclusions: Prolonged influenza A H1N1pdm shedding was observed in cancer patients. However, oseltamivir resistance was not detected. Taken together, our data suggest that severely ill cancer patients may constitute a pandemic virus reservoir with major implications for viral propagation.	[Souza, Thiago Moreno L.; Motta, Fernando C.; Oliveira, Maria de Lourdes; Siqueira, Marilda M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, BR-21045900 Rio De Janeiro, Brazil; [Salluh, Jorge I. F.; soares, Marcio; Pitrowsky, Melissa Tassano] Hosp Canc I INCA, Intens Care Unit, Rio De Janeiro, Brazil; [Bozza, Fernando A.] Fiocruz MS, Inst Pesquisas Evandro Chagas, Intens Care Unit, BR-21045900 Rio De Janeiro, Brazil; [Rocco, Sandra Amaral] Hosp Canc I INCA, Pediat Intens Care Unit, Rio De Janeiro, Brazil; [Goncalves, Vania Maria C.; Marques, Venceslaine Prado; Velasco, Eduardo] Hosp Canc I INCA, Infect Control Comm, Rio De Janeiro, Brazil; [Goncalves, Vania Maria C.; Marques, Venceslaine Prado; Velasco, Eduardo] Hosp Canc I INCA, Dept Infect Dis, Rio De Janeiro, Brazil; [Mishin, Vasiliy P.; Gubareva, Larissa V.; Whitney, Anne] Ctr Dis Control, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Centers for Disease Control & Prevention - USA	Souza, TML (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, BR-21045900 Rio De Janeiro, Brazil.	tmoreno@ioc.fiocruz.br; mmsiq@ioc.fiocruz.br	Soares, Marcio/B-3083-2013; Salluh, Jorge/AAF-2682-2021; Miranda, Milene/ABD-8472-2021; Salluh, Jorge IF/F-6779-2012; dantas, vicente c souza/L-2648-2013; Motta, Fernando/AAJ-2647-2021; Bozza, Fernando A/A-2618-2013; Souza, Thiago Moreno L./G-2900-2012; DE LOURDES A OLIVEIRA, MARIA/H-2474-2018	Soares, Marcio/0000-0003-2503-6088; Salluh, Jorge/0000-0002-8164-1453; Miranda, Milene/0000-0003-0037-059X; Bozza, Fernando A/0000-0003-4878-0256; Souza, Thiago Moreno L./0000-0003-2212-3899; 	Instituto Nacional de Cancer; Instituto Oswaldo Cruz/Fiocruz; Brazilian Ministry of Health/Decit; CNPq; FAPERJ; FAPERJ/SESDEC/CNPq [E-26/110.778/2010]; IOC/Fiocruz; Fiocruz	Instituto Nacional de Cancer; Instituto Oswaldo Cruz/Fiocruz; Brazilian Ministry of Health/Decit; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ/SESDEC/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); IOC/Fiocruz; Fiocruz	The work was supported by Instituto Nacional de Cancer (www.inca.gov.br), Instituto Oswaldo Cruz/Fiocruz (www.ioc.fiocruz.br) and Brazilian Ministry of Health/Decit (http://dtr2001.saude.gov.br/sctie/decit/index.htm). Dr. Soares, Dr. Bozza and Dr. Siqueira were supported in part by individual research grants from CNPq (www.cnpq.br). Dr. Souza used, in part, individual research grants from FAPERJ (www.faperj.br). FAPERJ/SESDEC/CNPq provided the grant #E-26/110.778/2010 (PPSUS-DECIT/SCTIE/MS). Thanks are also due to IOC/Fiocruz for providing MM a PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to the Instituto Nacional de Cancer, Fiocruz, FAPERJ and CNPq for their support. The authors thank Marc-Alain Widdowson (CDC/CCID/NCIRD) for critical review of the manuscript. Alicia Fry (CDC Atlanta epidemiology intelligence officer) was also extremely helpful in discussions on virus shedding.	Azoulay E, 2004, MEDICINE, V83, P360, DOI 10.1097/01.md.0000145370.63676.fb; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Casper C, 2010, BLOOD, V115, P1331, DOI 10.1182/blood-2009-11-255455; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cunha BA, 2010, J HOSP INFECT, V74, P278, DOI 10.1016/j.jhin.2009.08.024; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; Deyde VM, 2010, ANTIMICROB AGENTS CH, V54, P1102, DOI 10.1128/AAC.01417-09; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Fleury H, 2009, EUROSURVEILLANCE, V14, P14; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hajjar LA, 2010, ANN ONCOL, V21, P2333, DOI 10.1093/annonc/mdq254; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hien Tran Tinh, 2010, PLoS Med, V7, pe1000277, DOI 10.1371/journal.pmed.1000277; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Kidd IM, 2009, LANCET, V374, P1036, DOI 10.1016/S0140-6736(09)61528-2; Kobayashi Shinichi, 2008, Journal of Infection and Chemotherapy, V14, P308, DOI 10.1007/s10156-008-0615-2; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lapinsky SE, 2010, CRIT CARE MED, V38, pE52, DOI 10.1097/CCM.0b013e3181c85d5f; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; McMinn P, 1999, CLIN INFECT DIS, V29, P456, DOI 10.1086/520243; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; *MIN SAUD, 2009, PROT MAN CLIN VIG EP; *MIN SAUD, 2009, DIR ENFR PAND INF H1; *MIN SAUD INF EP, INFL PAND H1N1 2009; Mora M, 2010, EMERG INFECT DIS, V16, P1175, DOI 10.3201/eid1607.091339; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nichols WG, 2004, CLIN INFECT DIS, V39, P1300, DOI 10.1086/425004; Redelman-Sidi G, 2010, J INFECTION, V60, P257, DOI 10.1016/j.jinf.2010.01.009; Rouphael NG, 2007, LANCET INFECT DIS, V7, P814, DOI 10.1016/S1473-3099(07)70290-6; Seiter K, 2010, J CLIN ONCOL, V28, pE27, DOI 10.1200/JCO.2009.25.8889; Seville MTA, 2010, TRANSPLANTATION, V90, P571, DOI 10.1097/TP.0b013e3181e86af0; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Takiyama A, 2010, JPN J INFECT DIS, V63, P72; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; *WHO, 2009, PROT VIR SEQ; *WHO, 2009, WEEKLY EPIDEM RECORD; Witkop CT, 2010, AM J PREV MED, V38, P121, DOI 10.1016/j.amepre.2009.10.005; World Health Organization, 2009, HUM INF PAND H1N1 20; World Health Organization, 2009, CDC PROT REALT RTPCR	46	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14158	10.1371/journal.pone.0014158	http://dx.doi.org/10.1371/journal.pone.0014158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152402	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100036
J	Costea, I; Mack, DR; Israel, D; Morgan, K; Krupoves, A; Seidman, E; Deslandres, C; Lambrette, P; Grimard, G; Levy, E; Amre, DK				Costea, Irina; Mack, David R.; Israel, David; Morgan, Kenneth; Krupoves, Alfreda; Seidman, Ernest; Deslandres, Colette; Lambrette, Philippe; Grimard, Guy; Levy, Emile; Amre, Devendra K.			Genes Involved in the Metabolism of Poly-Unsaturated Fatty-Acids (PUFA) and Risk for Crohn's Disease in Children & Young Adults	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; COLONIC-MUCOSA; EXPRESSION; LEUKOTRIENE-B4; VARIANTS; EPIDEMIOLOGY; EICOSANOIDS	Background and Objectives: Epidemiological evidence for the role of polyunsaturated fatty-acids (PUFA) in Crohn's disease (CD) is unclear, although the key metabolite leucotriene B4 (LTB4) is closely linked to the inflammatory process. We hypothesized that inherited variation in key PUFA metabolic enzymes may modify susceptibility for CD. Methods and Principal Results: A case-control design was implemented at three pediatric gastroenterology clinics in Canada. Children <= 20 yrs diagnosed with CD and controls were recruited. 19 single nucleotide polymorphisms (SNPs) across the ALOX5 (4) CYP4F3 (5) and CYP4F2 (10) genes, were genotyped. Associations between SNPs/haplotypes and CD were examined. A total of 431 cases and 507 controls were studied. The mean (+/-SD) age of the cases was 12.4 (+/-3.3) years. Most cases were male (56.4%), had ileo-colonic disease (L3+/-L4, 52.7%) and inflammatory behavior (B1+/-p, 87%) at diagnosis. One genotyped CYP4F3 SNP (rs2683037) not in Hardy-Weinberg Equilibrium was excluded. No associations with the remaining 4 CYP4F3 SNPs with CD were evident. However haplotype analysis revealed associations with a two-marker haplotype (TG) (rs3794987 & rs1290617) (p = 0.02; permuted p = 0.08). CYP4F2 SNPs, rs3093158 (OR (recessive) = 0.56, 95% CI = 0.35-0.89; p = 0.01), rs2074902 (OR (trend) = 1.26, 95% CI = 1.00-1.60; p = 0.05), and rs2108622 (OR (recessive) = 1.6, 95% CI = 1.00-2.57; p = 0.05) were significantly associated whereas rs1272 (OR (recessive) = 0.58, 95% CI = 0.30-1.13; p = 0.10) showed suggestions for associations with CD. A haplotype comprising these 4 SNPs was significantly associated (p = 0.007, permuted p = 0.02) with CD. Associations with SNP rs3780901 in the ALOX5 gene were borderline non-significant (OR (dominant) = 1.29, 95% CI = 0.99-1.67; p = 0.056). A haplotype comprising the 4 ALOX5 SNPs (TCAA, p = 0.036) was associated with CD, but did not withstand corrections for multiple comparisons (permuted p = 0.14). Conclusions: Inherited variation in enzymes involved in the synthesis/metabolism of LTB4 may be associated with CD. These findings implicate PUFA metabolism as a important pathway in the CD pathogenesis.	[Costea, Irina] Publ Hlth Agcy Canada, Montreal, PQ, Canada; [Costea, Irina; Krupoves, Alfreda; Deslandres, Colette; Lambrette, Philippe; Grimard, Guy; Levy, Emile; Amre, Devendra K.] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Mack, David R.] Childrens Hosp Eastern Ontario, Div Gastroenterol Hepatol & Nutr, Ottawa, ON K1H 8L1, Canada; [Israel, David] British Columbia Childrens Hosp, Dept Gastroenterol Hepatol & Nutr, Vancouver, BC, Canada; [Morgan, Kenneth] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Morgan, Kenneth; Seidman, Ernest] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Krupoves, Alfreda] Univ Montreal, Dept Prevent & Social Med, Montreal, PQ, Canada; [Seidman, Ernest] McGill Univ, Dept Med, Montreal, PQ, Canada; [Grimard, Guy] Univ Montreal, Dept Pediat, Div Orthoped, Montreal, PQ H3C 3J7, Canada; [Levy, Emile] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada	Public Health Agency of Canada; Universite de Montreal; University of Ottawa; Children's Hospital of Eastern Ontario; BC Childrens Hospital; University of British Columbia; McGill University; McGill University; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal	Costea, I (corresponding author), Publ Hlth Agcy Canada, Montreal, PQ, Canada.	devendraamre@hotmail.com	AMRE, DEVENDRA K/D-4988-2015; Deslandres, Colette/AAO-5814-2021		Canadian Institutes of Health Research [MOP200603]; Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec; FRSQ; Sainte-Justine Hospital Foundation, Montreal; University of Montreal, Montreal	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec); Sainte-Justine Hospital Foundation, Montreal; University of Montreal, Montreal	The study was funded by the Canadian Institutes of Health Research (MOP200603). Dr. Amre is supported by a research salary award from the Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec. Dr. Costea was supported by a doctoral award from the FRSQ. Dr. Krupoves is supported by a scholarship from the Sainte-Justine Hospital Foundation, Montreal and by a scholarship from the PhD Program of the University of Montreal, Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2010, ALIMENT PHARM THER, V31, P1186, DOI 10.1111/j.1365-2036.2010.04294.x; Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x; Amre DK, 2008, AM J GASTROENTEROL, V103, P615, DOI 10.1111/j.1572-0241.2007.01661.x; Amre DK, 2007, AM J GASTROENTEROL, V102, P2016, DOI 10.1111/j.1572-0241.2007.01411.x; Amre DK, 2010, HUM GENET, V128, P131, DOI 10.1007/s00439-010-0835-2; Amre DK, 2009, AM J GASTROENTEROL, V104, P2824, DOI 10.1038/ajg.2009.430; Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Amre DK, 2003, MED HYPOTHESES, V60, P344, DOI 10.1016/S0306-9877(02)00401-2; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Belluzzi A, 2000, AM J CLIN NUTR, V71, p339S, DOI 10.1093/ajcn/71.1.339s; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Curley CR, 2006, EUR J HUM GENET, V14, P1215, DOI 10.1038/sj.ejhg.5201687; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hashizume T, 2001, BIOCHEM BIOPH RES CO, V280, P1135, DOI 10.1006/bbrc.2000.4238; HAWTHORNE AB, 1992, GUT, V33, P513, DOI 10.1136/gut.33.4.513; Hendel J, 2002, INFLAMM RES, V51, P423, DOI 10.1007/PL00000324; IKEHATA A, 1993, PROSTAG LEUKOTR ESS, V49, P489, DOI 10.1016/0952-3278(93)90036-V; IKEHATA A, 1995, SCAND J GASTROENTERO, V30, P44, DOI 10.3109/00365529509093234; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jupp J, 2007, INFLAMM BOWEL DIS, V13, P537, DOI 10.1002/ibd.20094; Kikuta Y, 2002, PROSTAG OTH LIPID M, V68-9, P345, DOI 10.1016/S0090-6980(02)00039-4; Kim SG, 2004, GASTROENTEROLOGY, V126, pA260; KINSELLA JE, 1990, NUTRITION, V6, P24; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; LAURITSEN K, 1986, GASTROENTEROLOGY, V91, P837, DOI 10.1016/0016-5085(86)90684-0; LAURITSEN K, 1988, GASTROENTEROLOGY, V95, P11, DOI 10.1016/0016-5085(88)90284-3; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; LOBOS EA, 1987, DIGEST DIS SCI, V32, P1380, DOI 10.1007/BF01296664; Low JH, 2004, INFLAMM BOWEL DIS, V10, P173, DOI 10.1097/00054725-200405000-00001; Lowe AM, 2009, INFLAMM BOWEL DIS, V15, P429, DOI 10.1002/ibd.20756; MacLean CH, 2005, AM J CLIN NUTR, V82, P611, DOI 10.1093/ajcn/82.3.611; Mamula P, 2003, GASTROENTEROL CLIN N, V32, P967, DOI 10.1016/S0889-8553(03)00046-3; Massey D, 2007, GUT, V56, P1489, DOI 10.1136/gut.2007.127928; Murakami M, 2002, BIOCHEM BIOPH RES CO, V292, P689, DOI 10.1006/bbrc.2002.6716; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Sands BE, 2004, GASTROENTEROLOGY, V126, P1518, DOI 10.1053/j.gastro.2004.02.072; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Tello-Ruiz MK, 2006, EUR J HUM GENET, V14, P780, DOI 10.1038/sj.ejhg.5201612; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081	45	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15672	10.1371/journal.pone.0015672	http://dx.doi.org/10.1371/journal.pone.0015672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187935	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200061
J	Fang, KM; Chen, JK; Hung, SC; Chen, MC; Wu, YT; Wu, TJ; Lin, HI; Chen, CH; Cheng, H; Yang, CS; Tzeng, SF				Fang, Kuan-Min; Chen, Jen-Kun; Hung, Shih-Chieh; Chen, Mei-Chun; Wu, Yi-Ting; Wu, Tsung-Jung; Lin, Hsin-I; Chen, Chia-Hua; Cheng, Henrich; Yang, Chung-Shi; Tzeng, Shun-Fen			Effects of Combinatorial Treatment with Pituitary Adenylate Cyclase Activating Peptide and Human Mesenchymal Stem Cells on Spinal Cord Tissue Repair	PLOS ONE			English	Article							MARROW STROMAL CELLS; LIPOPOLYSACCHARIDE-INDUCED NEUROTOXICITY; FUNCTIONAL RECOVERY; NERVOUS-SYSTEM; GLUTAMATE UPTAKE; AXONAL REGENERATION; REACTIVE ASTROCYTES; NEUROTROPHIC FACTOR; MICROGLIAL CELLS; GROWTH-FACTOR	The aim of this study is to understand if human mesenchymal stem cells (hMSCs) and neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) have synergistic protective effect that promotes functional recovery in rats with severe spinal cord injury (SCI). To evaluate the effect of delayed combinatorial therapy of PACAP and hMSCs on spinal cord tissue repair, we used the immortalized hMSCs that retain their potential of neuronal differentiation under the stimulation of neurogenic factors and possess the properties for the production of several growth factors beneficial for neural cell survival. The results indicated that delayed treatment with PACAP and hMSCs at day 7 post SCI increased the remaining neuronal fibers in the injured spinal cord, leading to better locomotor functional recovery in SCI rats when compared to treatment only with PACAP or hMSCs. Western blotting also showed that the levels of antioxidant enzymes, Mn-superoxide dismutase (MnSOD) and peroxiredoxin-1/6 (Prx-1 and Prx-6), were increased at the lesion center 1 week after the delayed treatment with the combinatorial therapy when compared to that observed in the vehicle-treated control. Furthermore, in vitro studies showed that co-culture with hMSCs in the presence of PACAP not only increased a subpopulation of microglia expressing galectin-3, but also enhanced the ability of astrocytes to uptake extracellular glutamate. In summary, our in vivo and in vitro studies reveal that delayed transplantation of hMSCs combined with PACAP provides trophic molecules to promote neuronal cell survival, which also foster beneficial microenvironment for endogenous glia to increase their neuroprotective effect on the repair of injured spinal cord tissue.	[Fang, Kuan-Min; Chen, Mei-Chun; Wu, Tsung-Jung; Lin, Hsin-I; Tzeng, Shun-Fen] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Chen, Jen-Kun; Wu, Yi-Ting; Chen, Chia-Hua; Yang, Chung-Shi] Natl Hlth Res Inst, Ctr Nanomed Res, Zhunan, Taiwan; [Cheng, Henrich] Taipei Vet Gen Hosp, Neural Regenerat Ctr, Taipei, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Dept Surg, Sch Med, Taipei 112, Taiwan; [Cheng, Henrich] Natl Yang Ming Univ, Dept Pharmacol, Sch Med, Taipei 112, Taiwan; [Yang, Chung-Shi] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Puli, Taiwan	National Cheng Kung University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Chi Nan University	Fang, KM (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan.	cyang@nhri.org.tw; stzeng@mail.ncku.edu.tw	Chen, Jen-Kun/C-6225-2011; Yang, Chung-Shi/E-3999-2010		Volkswagen Foundation within its Evolutionary Biology initiative [I/84 196]	Volkswagen Foundation within its Evolutionary Biology initiative	NC was supported by the Volkswagen Foundation within its Evolutionary Biology initiative, grant I/84 196. OK holds a Heisenberg Professorship of the German Science Foundation (DFG) (KR 2089/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bergles DE, 1998, J NEUROSCI, V18, P7709; Beschorner R, 2007, HISTOPATHOLOGY, V50, P897, DOI 10.1111/j.1365-2559.2007.02703.x; Bouhy D, 2006, FASEB J, V20, P1239, DOI 10.1096/fj.05-4382fje; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Chen WH, 2005, NEUROSCI LETT, V384, P117, DOI 10.1016/j.neulet.2005.04.070; Cheng H, 2002, J NEUROSCI RES, V69, P397, DOI 10.1002/jnr.10303; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Dezawa M, 2005, CURR MOL MED, V5, P723, DOI 10.2174/156652405774641070; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Grill R, 1997, J NEUROSCI, V17, P5560; Ha Yoon, 2005, Clin Neurosurg, V52, P341; Hattori Fumiyuki, 2007, V44, P357; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Horner PJ, 2000, J NEUROSCI, V20, P2218; Hsiao HY, 2007, GLIA, V55, P214, DOI 10.1002/glia.20453; Huang X, 2009, J NEUROL SCI, V277, P87, DOI 10.1016/j.jns.2008.10.022; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Kong LY, 1999, NEUROSCIENCE, V91, P493, DOI 10.1016/S0306-4522(98)00606-X; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Liu YP, 2008, J NEUROCHEM, V105, P137, DOI 10.1111/j.1471-4159.2007.05118.x; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mukaino M, 2010, EXP NEUROL, V224, P403, DOI 10.1016/j.expneurol.2010.04.020; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ono K, 2003, J NEUROSCI RES, V72, P503, DOI 10.1002/jnr.10588; PARK DH, 2010, STEM CELL REV; Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992; Phinney DG, 2005, CURR PHARM DESIGN, V11, P1255, DOI 10.2174/1381612053507495; REICHERT F, 1994, J NEUROSCI, V14, P3231; Reichert F, 1996, J NEUROIMMUNOL, V70, P153, DOI 10.1016/S0165-5728(96)00112-9; Reichert F, 1999, EXP NEUROL, V160, P508, DOI 10.1006/exnr.1999.7229; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Rossi SL, 2009, CURR OPIN BIOTECH, V20, P552, DOI 10.1016/j.copbio.2009.09.008; Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713; Rotshenker S, 2009, J MOL NEUROSCI, V39, P99, DOI 10.1007/s12031-009-9186-7; Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175; Schultz SS, 2005, CURR DRUG TARGETS, V6, P63, DOI 10.2174/1389450053345046; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64; Tzeng SF, 2004, NEUROSCI LETT, V367, P23, DOI 10.1016/j.neulet.2004.05.117; Vaudry D, 2000, PHARMACOL REV, V52, P269; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Walther M, 2000, J NEUROSCI RES, V61, P430, DOI 10.1002/1097-4547(20000815)61:4<430::AID-JNR9>3.0.CO;2-3; Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Waschek JA, 1998, P NATL ACAD SCI USA, V95, P9602, DOI 10.1073/pnas.95.16.9602; Watanabe J, 2007, PEPTIDES, V28, P1713, DOI 10.1016/j.peptides.2007.06.029; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yan YP, 2009, BRAIN RES, V1288, P116, DOI 10.1016/j.brainres.2009.06.073; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	68	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15299	10.1371/journal.pone.0015299	http://dx.doi.org/10.1371/journal.pone.0015299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187959	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200034
J	Kim, MJ; Hwang, SH; Lim, JA; Froehner, SC; Adams, ME; Kim, HS				Kim, Min Jeong; Hwang, Sung Ho; Lim, Jeong A.; Froehner, Stanley C.; Adams, Marvin E.; Kim, Hye Sun			alpha-Syntrophin Modulates Myogenin Expression in Differentiating Myoblasts	PLOS ONE			English	Article							DYSTROPHIN-ASSOCIATED PROTEINS; DIACYLGLYCEROL KINASE-ZETA; NITRIC-OXIDE SYNTHASE; SKELETAL-MUSCLE; PDZ DOMAIN; NEUROMUSCULAR-JUNCTION; NUCLEAR-LOCALIZATION; GENE; CELLS; ALPHA-1-SYNTROPHIN	Background: alpha-syntrophin is a scaffolding protein linking signaling proteins to the sarcolemmal dystrophin complex in mature muscle. However, alpha-syntrophin is also expressed in differentiating myoblasts during the early stages of muscle differentiation. In this study, we examined the relationship between the expression of alpha-syntrophin and myogenin, a key muscle regulatory factor. Methods and Findings: The absence of alpha-syntrophin leads to reduced and delayed myogenin expression. This conclusion is based on experiments using muscle cells isolated from alpha-syntrophin null mice, muscle regeneration studies in alpha-syntrophin null mice, experiments in Sol8 cells (a cell line that expresses only low levels of alpha-syntrophin) and siRNA studies in differentiating C2 cells. In primary cultured myocytes isolated from alpha-syntrophin null mice, the level of myogenin was less than 50% that from wild type myocytes (p<0.005) 40 h after differentiation induction. In regenerating muscle, the expression of myogenin in the alpha-syntrophin null muscle was reduced to approximately 25% that of wild type muscle (p<0.005). Conversely, myogenin expression is enhanced in primary cultures of myoblasts isolated from a transgenic mouse over-expressing alpha-syntrophin and in Sol8 cells transfected with a vector to over-express alpha-syntrophin. Moreover, we find that myogenin mRNA is reduced in the absence of alpha-syntrophin and increased by alpha-syntrophin over-expression. Immunofluorescence microscopy shows that alpha-syntrophin is localized to the nuclei of differentiating myoblasts. Finally, immunoprecipitation experiments demonstrate that alpha-syntrophin associates with Mixed-Lineage Leukemia 5, a regulator of myogenin expression. Conclusions: We conclude that alpha-syntrophin plays an important role in regulating myogenesis by modulating myogenin expression.	[Kim, Min Jeong; Hwang, Sung Ho; Lim, Jeong A.; Kim, Hye Sun] Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea; [Froehner, Stanley C.; Adams, Marvin E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Ajou University; University of Washington; University of Washington Seattle	Kim, MJ (corresponding author), Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea.	marva@uw.edu; hsunkim@ajou.ac.kr			Korean Government (MOEHRD) [KRF-2008-531-E00004]; National Institutes of Health (NIH) [NS33145]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033145] Funding Source: NIH RePORTER	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (KRF-2008-531-E00004) to HSK and by National Institutes of Health (NIH) grant NS33145 to SCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovici H, 2003, MOL BIOL CELL, V14, P4499, DOI 10.1091/mbc.E03-03-0190; Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Adams ME, 2004, J NEUROSCI, V24, P10302, DOI 10.1523/JNEUROSCI.3408-04.2004; ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; Arnold HH, 1996, INT J DEV BIOL, V40, P345; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Chen ZJ, 2006, J BIOL CHEM, V281, P12414, DOI 10.1074/jbc.M508651200; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; DAUBAS P, 1988, NUCLEIC ACIDS RES, V16, P1251, DOI 10.1093/nar/16.4.1251; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FLORINI JR, 1991, MOL ENDOCRINOL, V5, P718, DOI 10.1210/mend-5-5-718; Gee SH, 1998, J NEUROSCI, V18, P128; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; Hasegawa M, 1999, J BIOL CHEM, V274, P12626, DOI 10.1074/jbc.274.18.12626; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hogan A, 2001, J BIOL CHEM, V276, P26526, DOI 10.1074/jbc.M104156200; Hosaka Y, 2002, J CELL BIOL, V158, P1097, DOI 10.1083/jcb.200204076; Kameya S, 1999, J BIOL CHEM, V274, P2193, DOI 10.1074/jbc.274.4.2193; Koo JH, 2007, BIOCHEM BIOPH RES CO, V363, P405, DOI 10.1016/j.bbrc.2007.08.186; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Luo S, 2005, J CELL BIOL, V169, P813, DOI 10.1083/jcb.200412008; Marchand E, 2001, CELL CALCIUM, V29, P85, DOI 10.1054/ceca.2000.0159; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; RICHLER C, 1970, DEV BIOL, V23, P1, DOI 10.1016/S0012-1606(70)80004-5; Roy K, 2002, J BIOL CHEM, V277, P33818, DOI 10.1074/jbc.M205159200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	44	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15355	10.1371/journal.pone.0015355	http://dx.doi.org/10.1371/journal.pone.0015355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179410	Green Published, Green Submitted, gold			2022-12-27	WOS:000285572900020
J	Passerini, D; Beltramo, C; Coddeville, M; Quentin, Y; Ritzenthaler, P; Daveran-Mingot, ML; Le Bourgeois, P				Passerini, Delphine; Beltramo, Charlotte; Coddeville, Michele; Quentin, Yves; Ritzenthaler, Paul; Daveran-Mingot, Marie-Line; Le Bourgeois, Pascal			Genes but Not Genomes Reveal Bacterial Domestication of Lactococcus Lactis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; SUBSP LACTIS; SEQUENCE; DNA; CREMORIS; STRAINS; IDENTIFICATION; RESTRICTION; POPULATIONS; CHROMOSOME	Background: The population structure and diversity of Lactococcus lactis subsp. lactis, a major industrial bacterium involved in milk fermentation, was determined at both gene and genome level. Seventy-six lactococcal isolates of various origins were studied by different genotyping methods and thirty-six strains displaying unique macrorestriction fingerprints were analyzed by a new multilocus sequence typing (MLST) scheme. This gene-based analysis was compared to genomic characteristics determined by pulsed-field gel electrophoresis (PFGE). Methodology/Principal Findings: The MLST analysis revealed that L. lactis subsp. lactis is essentially clonal with infrequent intra-and intergenic recombination; also, despite its taxonomical classification as a subspecies, it displays a genetic diversity as substantial as that within several other bacterial species. Genome-based analysis revealed a genome size variability of 20%, a value typical of bacteria inhabiting different ecological niches, and that suggests a large pan-genome for this subspecies. However, the genomic characteristics (macrorestriction pattern, genome or chromosome size, plasmid content) did not correlate to the MLST-based phylogeny, with strains from the same sequence type (ST) differing by up to 230 kb in genome size. Conclusion/Significance: The gene-based phylogeny was not fully consistent with the traditional classification into dairy and non-dairy strains but supported a new classification based on ecological separation between "environmental" strains, the main contributors to the genetic diversity within the subspecies, and "domesticated" strains, subject to recent genetic bottlenecks. Comparison between gene-and genome-based analyses revealed little relationship between core and dispensable genome phylogenies, indicating that clonal diversification and phenotypic variability of the "domesticated" strains essentially arose through substantial genomic flux within the dispensable genome.	[Passerini, Delphine; Coddeville, Michele; Quentin, Yves; Ritzenthaler, Paul; Daveran-Mingot, Marie-Line; Le Bourgeois, Pascal] Univ Toulouse 3, Univ Toulouse, F-31062 Toulouse, France; [Passerini, Delphine; Coddeville, Michele; Quentin, Yves; Ritzenthaler, Paul; Daveran-Mingot, Marie-Line; Le Bourgeois, Pascal] CNRS, Lab Microbiol & Genet Mol, Toulouse, France; [Beltramo, Charlotte] SOREDAB SAS, La Tremblaye, La Boissiere Ec, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Passerini, D (corresponding author), Univ Toulouse 3, Univ Toulouse, F-31062 Toulouse, France.	marie-line.mingot@biotoul.fr; pascal.lebourgeois@biotoul.fr	Le Bourgeois, Pascal/G-6358-2010; Daveran-Mingot, Marie-Line/ABC-5525-2020	Le Bourgeois, Pascal/0000-0003-2039-1953; Daveran-Mingot, Marie-Line/0000-0001-6884-1840; Passerini, Delphine/0000-0002-5429-6260; Quentin, Yves/0000-0001-8248-0586	ANR-Agence Nationale de la Recherche - The French National Research Agency [ANR-05-PNRA-20]; Ministere de l'Enseignement Superieur et de la Recherche	ANR-Agence Nationale de la Recherche - The French National Research Agency(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was carried out with the financial support of the "ANR-Agence Nationale de la Recherche - The French National Research Agency" under the "Programme National de Recherche en Alimentation et nutrition humaine", project "ANR-05-PNRA-20, Genoferment". D. Passerini was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bergthorsson U, 1998, MOL BIOL EVOL, V15, P6, DOI 10.1093/oxfordjournals.molbev.a025847; Bilhere E, 2009, APPL ENVIRON MICROB, V75, P1291, DOI 10.1128/AEM.02563-08; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Cai H, 2007, MICROBIOL-SGM, V153, P2655, DOI 10.1099/mic.0.2007/006452-0; Chaillou S, 2009, APPL ENVIRON MICROB, V75, P970, DOI 10.1128/AEM.01721-08; CHOPIN A, 1984, PLASMID, V11, P260, DOI 10.1016/0147-619X(84)90033-7; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/106351501750435077; Cooper JE, 2006, MICROBIOL-SGM, V152, P1297, DOI 10.1099/mic.0.28620-0; Corroler D, 1998, APPL ENVIRON MICROB, V64, P4729; de las Rivas B, 2006, MICROBIOL-SGM, V152, P85, DOI 10.1099/mic.0.28482-0; Delorme C, 2010, APPL ENVIRON MICROB, V76, P451, DOI 10.1128/AEM.01018-09; DEVOS WM, 1990, J BIOL CHEM, V265, P22554; Diancourt L, 2007, APPL ENVIRON MICROB, V73, P6601, DOI 10.1128/AEM.01095-07; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dohm JC, 2006, J MOL EVOL, V63, P437, DOI 10.1007/s00239-005-0094-3; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; EFSTATHIOU JD, 1976, APPL ENVIRON MICROB, V32, P38, DOI 10.1128/AEM.32.1.38-44.1976; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FU YX, 1993, GENETICS, V133, P693; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; GODON JJ, 1992, APPL ENVIRON MICROB, V58, P4045, DOI 10.1128/AEM.58.12.4045-4047.1992; Guo H, 2005, APPL ENVIRON MICROB, V71, P7130, DOI 10.1128/AEM.71.11.7130-7138.2005; HAMMER BW, 1921, J DAIRY SCI, V4, P277; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Head NE, 2004, INFECT IMMUN, V72, P133, DOI 10.1128/IAI.72.1.133-144.2004; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Kelly W, 2002, MICROBIOL-SGM, V148, P3332, DOI 10.1099/00221287-148-11-3332; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLIJN N, 1995, APPL ENVIRON MICROB, V61, P788, DOI 10.1128/AEM.61.2.788-792.1995; KOK J, 1991, BIOCHEM SOC T, V19, P670, DOI 10.1042/bst0190670; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; Lan RT, 2000, TRENDS MICROBIOL, V8, P396, DOI 10.1016/S0966-842X(00)01791-1; Le Bourgeois P, 2000, J BACTERIOL, V182, P2481, DOI 10.1128/JB.182.9.2481-2491.2000; LEBOURGEOIS P, 1992, J BACTERIOL, V174, P6752, DOI 10.1128/JB.174.21.6752-6762.1992; LEBOURGEOIS P, 1989, FEMS MICROBIOL LETT, V59, P65, DOI 10.1016/0378-1097(89)90460-6; LEBOURGEOIS P, 1995, J BACTERIOL, V177, P2840, DOI 10.1128/jb.177.10.2840-2850.1995; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; NEI M, 1990, GENETICS, V125, P873; NELSON RJ, 1994, APPL ENVIRON MICROB, V60, P3275, DOI 10.1128/AEM.60.9.3275-3283.1994; Nicolas P, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-141; Nomura M, 2006, J APPL MICROBIOL, V101, P396, DOI 10.1111/j.1365-2672.2006.02949.x; Rademaker JLW, 2007, APPL ENVIRON MICROB, V73, P7128, DOI 10.1128/AEM.01017-07; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Raynaud S, 2005, APPL ENVIRON MICROB, V71, P8016, DOI 10.1128/AEM.71.12.8016-8023.2005; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALAMA M, 1991, APPL ENVIRON MICROB, V57, P1313, DOI 10.1128/AEM.57.5.1313-1318.1991; SALAMA MS, 1993, APPL ENVIRON MICROB, V59, P3941, DOI 10.1128/AEM.59.11.3941-3945.1993; Schonhuber W, 2001, BMC Microbiol, V1, P20, DOI 10.1186/1471-2180-1-20; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Siezen RJ, 2010, J BACTERIOL, V192, P2649, DOI 10.1128/JB.00276-10; SINHA RP, 1991, CAN J MICROBIOL, V37, P488, DOI 10.1139/m91-082; Steidler L, 2006, ANN NY ACAD SCI, V1072, P176, DOI 10.1196/annals.1326.031; Tailliez P, 1998, SYST APPL MICROBIOL, V21, P530, DOI 10.1016/S0723-2020(98)80065-9; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANSKANEN EI, 1990, APPL ENVIRON MICROB, V56, P3105, DOI 10.1128/AEM.56.10.3105-3111.1990; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Teuber M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P205, DOI 10.1007/0-387-30744-3_7; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turner KME, 2007, INT J ANTIMICROB AG, V29, P129, DOI 10.1016/j.ijantimicag.2006.11.002; Urbach E, 1997, APPL ENVIRON MICROB, V63, P694, DOI 10.1128/AEM.63.2.694-702.1997; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Ward LJH, 2004, J APPL MICROBIOL, V96, P144, DOI 10.1046/j.1365-2672.2003.02134.x; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0	86	81	82	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15306	10.1371/journal.pone.0015306	http://dx.doi.org/10.1371/journal.pone.0015306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179431	Green Submitted, Green Published, gold			2022-12-27	WOS:000285572900017
J	Mazzola, V; Latorre, V; Petito, A; Gentili, N; Fazio, L; Popolizio, T; Blasi, G; Arciero, G; Bondolfi, G				Mazzola, Viridiana; Latorre, Valeria; Petito, Annamaria; Gentili, Nicoletta; Fazio, Leonardo; Popolizio, Teresa; Blasi, Giuseppe; Arciero, Giampiero; Bondolfi, Guido			Affective Response to a Loved One's Pain: Insula Activity as a Function of Individual Differences	PLOS ONE			English	Article							EMPATHIC NEURAL RESPONSES; MEDIAL PREFRONTAL CORTEX; OTHERS PAIN; INTEROCEPTIVE AWARENESS; PHYSIOLOGICAL CONDITION; THREATENING STIMULI; SOCIAL COGNITION; PARIETAL CORTEX; I FEEL; PERCEPTION	Individual variability in emotion processing may be associated with genetic variation as well as with psychological predispositions such as dispositional affect styles. Our previous fMRI study demonstrated that amygdala reactivity was independently predicted by affective-cognitive styles (phobic prone or eating disorders prone) and genotype of the serotonin transporter in a discrimination task of fearful facial expressions. Since the insula is associated with the subjective evaluation of bodily states and is involved in human feelings, we explored whether its activity could also vary in function of individual differences. In the present fMRI study, the association between dispositional affects and insula reactivity has been examined in two groups of healthy participants categorized according to affective-cognitive styles (phobic prone or eating disorders prone). Images of the faces of partners and strangers, in both painful and neutral situations, were used as visual stimuli. Interaction analyses indicate significantly different activations in the two groups in reaction to a loved one's pain: the phobic prone group exhibited greater activation in the left posterior insula. These results demonstrate that affective-cognitive style is associated with insula activity in pain empathy processing, suggesting a greater involvement of the insula in feelings for a certain cohort of people. In the mapping of individual differences, these results shed new light on variability in neural networks of emotion.	[Mazzola, Viridiana; Latorre, Valeria; Gentili, Nicoletta; Arciero, Giampiero] Ist Psicol Postrazionalista IPRA Rome, Rome, Italy; [Latorre, Valeria] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy; [Petito, Annamaria] Univ Foggia, Dept Med Sci, Inst Psychiat & Clin Psychol, Foggia, Italy; [Gentili, Nicoletta] SW London & St Georges NHS Trust, Natl Child & Deaf Family Serv, London, England; [Fazio, Leonardo; Blasi, Giuseppe] Univ Bari, Dept Neurol & Psychiat Sci, Sect Mental Disorders, Psychiat Neurosci Grp, Bari, Italy; [Popolizio, Teresa] IRCCSS Casa Sollievo della Sofferenza, Dept Neuroradiol, San Giovanni Rotondo, Italy; [Bondolfi, Guido] Hop Univ Geneve, Dept Psychiat, Geneva, Switzerland	Universita degli Studi di Bari Aldo Moro; University of Foggia; Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; University of Geneva	Mazzola, V (corresponding author), Ist Psicol Postrazionalista IPRA Rome, Rome, Italy.	neurolab@ipra.it	Blasi, Giuseppe/HHS-5404-2022; Fazio, Leonardo/J-4570-2012	Fazio, Leonardo/0000-0003-4000-974X; Blasi, Giuseppe/0000-0003-0878-1131				Ainsworth M., 1978, PATTERNS ATTACHMENT; Akitsuki Y, 2009, NEUROIMAGE, V47, P722, DOI 10.1016/j.neuroimage.2009.04.091; ARCIERO G, 1989, EPISTEMOLOGY ONTOLOG; Arciero G, 2004, COGNITION PSYCHOTERA, P261; Arciero G., 2000, CONSTRUCTIONS DISORD, P91, DOI [10.1037/10368-005, DOI 10.1037/10368-005]; Arciero G., 2009, SELFHOOD IDENTITY PE; Ashton-James C, 2007, SOC COGNITION, V25, P518, DOI 10.1521/soco.2007.25.4.518; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bertolino A, 2005, BIOL PSYCHIAT, V57, P1517, DOI 10.1016/j.biopsych.2005.02.031; Blasi G, 2009, BIOL PSYCHIAT, V66, P847, DOI 10.1016/j.biopsych.2009.06.017; BOWLBY J, 1973, ATTACHMENT LOSS LOSS; Bowlby J, 1973, ATTACHMENT LOSS SEPA; Bowlby J, 1982, ATTACHMENT LOSS ATTA, V1; Bretherton I, 1995, MONOGR SOC RES CHILD, V60, P310, DOI 10.2307/1166187; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Cameron OG, 2002, PSYCHOSOM MED, V64, P851, DOI 10.1097/01.PSY.0000038939.33335.32; Caprara GV, 1993, BIG 5 QUESTIONNAIRE; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chartrand TL, 2007, J EXP SOC PSYCHOL, V43, P719, DOI 10.1016/j.jesp.2006.08.003; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; COSTA PT, 1992, PERSONALITY INVENTOR; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Critchley HD, 2002, NEUROIMAGE, V16, P909, DOI 10.1006/nimg.2002.1147; Danziger N, 2006, BRAIN, V129, P2494, DOI 10.1093/brain/awl155; Davis M., 1996, EMPATHY SOCIAL PSYCH; Deichert NT, 2005, COGNITION EMOTION, V19, P941, DOI 10.1080/02699930541000075; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Draghi-Lorenz R, 2001, DEV REV, V21, P263, DOI 10.1006/drev.2000.0524; Ekman P., 2003, EMOTIONS REVEALED, V2; Ekman P., 1976, PICTURES FACIAL AFFE; Eysenck H.J, 1968, EYSENCK PERSONALITY; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Gu XS, 2010, J NEUROSCI, V30, P3739, DOI 10.1523/JNEUROSCI.4844-09.2010; Guidano V. F., 1987, COMPLEXITY SELF; Guidano V.F., 1991, SELF PROCESS POSTRAT; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Han SH, 2009, HUM BRAIN MAPP, V30, P3227, DOI 10.1002/hbm.20742; Hariri AR, 2009, ANNU REV NEUROSCI, V32, P225, DOI 10.1146/annurev.neuro.051508.135335; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Izard C. E., 1991, PSYCHOL EMOTIONS; Izard C. E., 1977, HUMAN EMOTIONS; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Katkin ES, 2001, PSYCHOL SCI, V12, P366, DOI 10.1111/1467-9280.00368; Levy R., 1973, TAHITIANS; Lewis Michael, 2008, HDB EMOTIONS, V3rd; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Lundstrom BN, 2003, NEUROIMAGE, V20, P1934, DOI 10.1016/j.neuroimage.2003.07.017; Magai C., 1996, HDB EMOTION ADULT DE; MAGAI C, 1995, ROLE EMOTION SOCIAL; Mayer AR, 2006, NEUROIMAGE, V30, P938, DOI 10.1016/j.neuroimage.2005.10.050; Merleau-Ponty M., 1962, PHENOMENOLOGY PERCEP; Minio-Paluello I, 2009, BIOL PSYCHIAT, V65, P55, DOI 10.1016/j.biopsych.2008.08.006; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Picardi A, 2003, PSYCHOTHER PSYCHOSOM, V72, P363, DOI 10.1159/000073037; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos O, 2007, HUM BRAIN MAPP, V28, P9, DOI 10.1002/hbm.20258; Porges, 1993, BODY PERCEPTION QUES; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Rainville P, 2006, INT J PSYCHOPHYSIOL, V61, P5, DOI 10.1016/j.ijpsycho.2005.10.024; ROSEN BC, 1976, J MARRIAGE FAM, V38, P605, DOI 10.2307/350681; ROSEN BC, 2001, MASKS MIRRORS GENERA; Rubino V, 2007, BRAIN RES BULL, V74, P250, DOI 10.1016/j.brainresbull.2007.06.019; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stapel DA, 2001, J PERS SOC PSYCHOL, V80, P766, DOI 10.1037//0022-3514.80.5.766; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; van Baaren RB, 2003, J PERS SOC PSYCHOL, V84, P1093, DOI 10.1037/0022-3514.84.5.1093; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905; WITKIN HA, 1977, PSYCHOL BULL, V84, P661, DOI 10.1037/0033-2909.84.4.661; Wong Y, 2007, SELF CONSCIOUS EMOTI, P223; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009; [No title captured]	104	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15268	10.1371/journal.pone.0015268	http://dx.doi.org/10.1371/journal.pone.0015268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695OI	21179564	Green Published, Green Submitted, gold			2022-12-27	WOS:000285381200022
J	Westercamp, M; Bailey, RC; Bukusi, EA; Montandon, M; Kwena, Z; Cohen, CR				Westercamp, Matthew; Bailey, Robert C.; Bukusi, Elizabeth A.; Montandon, Michele; Kwena, Zachary; Cohen, Craig R.			Male Circumcision in the General Population of Kisumu, Kenya: Beliefs about Protection, Risk Behaviors, HIV, and STIs	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; NYANZA PROVINCE; PREVENTION; MEN; ACCEPTABILITY; INFECTIONS	Using a population-based survey we examined the behaviors, beliefs, and HIV/HSV-2 serostatus of men and women in the traditionally non-circumcising community of Kisumu, Kenya prior to establishment of voluntary medical male circumcision services. A total of 749 men and 906 women participated. Circumcision status was not associated with HIV/HSV-2 infection nor increased high risk sexual behaviors. In males, preference for being or becoming circumcised was associated with inconsistent condom use and increased lifetime number of sexual partners. Preference for circumcision was increased with understanding that circumcised men are less likely to become infected with HIV.	[Westercamp, Matthew; Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA; [Montandon, Michele; Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Bukusi, Elizabeth A.; Kwena, Zachary] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco; Kenya Medical Research Institute	Westercamp, M (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA.	westrcmp@uic.edu			Doris Duke Charitable Foundation; Family AIDS Care and Educational Services (Kisumu); University of California (San Francisco); Kimberly Bale	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Family AIDS Care and Educational Services (Kisumu); University of California (San Francisco)(University of California System); Kimberly Bale	This study was supported by a Doris Duke Charitable Foundation Operations Research on AIDS Care and Treatment in Africa (ORACTA) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to acknowledge the support of Director, Kenya Medical Research Institute (Nairobi); Director, Center for Microbiology Research (Nairobi); staff of the ARTIS Project and the Family AIDS Care and Educational Services (Kisumu); and the University of California (San Francisco) - particularly Kimberly Bale.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Central Bureau of Statistics [Kenya]. Ministry of Finance and Planning, 2002, KENY 1999 POP HOUS C; Cohen CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004573; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; WHO/UNAIDS Technical Consultation, 2007, MAL CIRC HIV PREV RE	14	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15552	10.1371/journal.pone.0015552	http://dx.doi.org/10.1371/journal.pone.0015552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179493	Green Published, gold			2022-12-27	WOS:000285381200030
J	Ben Amara, A; Ghigo, E; Le Priol, Y; Lepolard, C; Salcedo, SP; Lemichez, E; Bretelle, F; Capo, C; Mege, JL				Ben Amara, Amira; Ghigo, Eric; Le Priol, Yannick; Lepolard, Catherine; Salcedo, Suzana P.; Lemichez, Emmanuel; Bretelle, Florence; Capo, Christian; Mege, Jean-Louis			Coxiella burnetii, the Agent of Q Fever, Replicates within Trophoblasts and Induces a Unique Transcriptional Response	PLOS ONE			English	Article							EXPRESSION; ACTIVATION; MONOCYTES; INFECTION; PREGNANCY; PLACENTA; BRUCELLA; RECEPTOR; CELLS; DIFFERENTIATION	Q fever is a zoonosis caused by Coxiella burnetii, an obligate intracellular bacterium typically found in myeloid cells. The infection is a source of severe obstetrical complications in humans and cattle and can undergo chronic evolution in a minority of pregnant women. Because C. burnetii is found in the placentas of aborted fetuses, we investigated the possibility that it could infect trophoblasts. Here, we show that C. burnetii infected and replicated in BeWo trophoblasts within phagolysosomes. Using pangenomic microarrays, we found that C. burnetii induced a specific transcriptomic program. This program was associated with the modulation of inflammatory responses that were shared with inflammatory agonists, such as TNF, and more specific responses involving genes related to pregnancy development, including EGR-1 and NDGR1. In addition, C. burnetii stimulated gene networks organized around the IL-6 and IL-13 pathways, which both modulate STAT3. Taken together, these results revealed that trophoblasts represent a protective niche for C. burnetii. The activation program induced by C. burnetii in trophoblasts may allow bacterial replication but seems unable to interfere with the development of normal pregnancy. Such pathophysiologocal processes should require the activation of immune placental cells associated with trophoblasts.	[Ben Amara, Amira; Ghigo, Eric; Lepolard, Catherine; Bretelle, Florence; Capo, Christian; Mege, Jean-Louis] Univ Mediterranee, CNRS, IRD UMR 6236, Unite Rech Malad Infect Trop & Emergentes,IFR 48, Marseille, France; [Le Priol, Yannick] IMTSSA, Marseille, France; [Salcedo, Suzana P.] Univ Mediterranee, Ctr Immunol Marseille Luminy, UMR 6546, Marseille, France; [Lemichez, Emmanuel] Fac Med Nice, INSERM, Unite 895, Equipe 6,C3M, F-06034 Nice, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Ben Amara, A (corresponding author), Univ Mediterranee, CNRS, IRD UMR 6236, Unite Rech Malad Infect Trop & Emergentes,IFR 48, Marseille, France.	Jean-Louis.Mege@univmed.fr	salcedo, suzana/P-9830-2019; MEGE, JEAN-LOUIS/O-6063-2016; Salcedo, Suzana P/C-2853-2014; Lemichez, Emmanuel/G-3559-2013; catherine, lepolard/P-5653-2016; Eric, Ghigo/N-9427-2016	salcedo, suzana/0000-0001-5149-7756; Salcedo, Suzana P/0000-0001-5149-7756; Lemichez, Emmanuel/0000-0001-9080-7761; Bretelle, Florence/0000-0002-0909-3202; Le Priol, Yannick/0000-0002-5176-0857	Programme Hospitalier de Recherche Clinique	Programme Hospitalier de Recherche Clinique	The work was supported by the Programme Hospitalier de Recherche Clinique 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutagawa O, 2007, PLACENTA, V28, P920, DOI 10.1016/j.placenta.2007.03.005; Andrews AL, 2006, J ALLERGY CLIN IMMUN, V118, P858, DOI 10.1016/j.jaci.2006.06.041; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bastonero S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005357; Benoit M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000066; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Benoit M, 2008, EUR J IMMUNOL, V38, P1065, DOI 10.1002/eji.200738067; BENTAL T, 1995, CLIN INFECT DIS, V21, P1318, DOI 10.1093/clinids/21.5.1318; Capo C, 1999, J IMMUNOL, V163, P6078; Carcopino X, 2007, CLIN INFECT DIS, V45, P548, DOI 10.1086/520661; Caron PL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-80; Catalano RD, 2005, P NATL ACAD SCI USA, V102, P8585, DOI 10.1073/pnas.0502343102; Chen CP, 2006, BJOG-INT J OBSTET GY, V113, P152, DOI 10.1111/j.1471-0528.2005.00843.x; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Daines MO, 2006, J IMMUNOL, V176, P7495, DOI 10.4049/jimmunol.176.12.7495; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; de la Torre E, 2009, J IMMUNOL, V182, P3735, DOI 10.4049/jimmunol.0800764; Dellacasagrande J, 2002, J IMMUNOL, V169, P6309, DOI 10.4049/jimmunol.169.11.6309; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; Fitzgerald JS, 2008, HUM REPROD UPDATE, V14, P335, DOI 10.1093/humupd/dmn010; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Ghigo E, 2001, INFECT IMMUN, V69, P2345, DOI 10.1128/IAI.69.4.2345-2352.2001; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Gorvel JP, 2008, MICROBES INFECT, V10, P1010, DOI 10.1016/j.micinf.2008.07.007; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; Jensen TK, 2007, APMIS, V115, P347, DOI 10.1111/j.1600-0463.2007.apm_591.x; Jiang K, 2007, PLACENTA, V28, P538, DOI 10.1016/j.placenta.2006.06.013; Jiang SJ, 2008, INFECT IMMUN, V76, P1558, DOI 10.1128/IAI.01331-07; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Kenzel S, 2009, INFECT IMMUN, V77, P2474, DOI 10.1128/IAI.01343-08; King A, 2000, PLACENTA, V21, pS113, DOI 10.1053/plac.1999.0526; LANG G, 1991, CAN J VET RES, V55, P139; LANGLEY JM, 1990, Q FEVER, V1, P201; Lee BN, 1997, J VIROL, V71, P3628, DOI 10.1128/JVI.71.5.3628-3635.1997; Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06; McArthur SJ, 2008, PRENATAL DIAG, V28, P434, DOI 10.1002/pd.1924; Meconi S, 2001, INFECT IMMUN, V69, P2520, DOI 10.1128/IAI.69.4.2520-2526.2001; Meghari S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040023; Meghari S, 2007, EUR J IMMUNOL, V37, P24, DOI 10.1002/eji.200636054; Miwa N, 2005, MOL HUM REPROD, V11, P865, DOI 10.1093/molehr/gah246; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Naroeni A, 2001, INFECT IMMUN, V69, P486, DOI 10.1128/IAI.69.1.486-493.2001; Neta AVC, 2008, INFECT IMMUN, V76, P1897, DOI 10.1128/IAI.01554-07; Parisi A, 2006, VET MICROBIOL, V118, P101, DOI 10.1016/j.vetmic.2006.06.023; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Pospechova K, 2009, MOL CELL ENDOCRINOL, V299, P178, DOI 10.1016/j.mce.2008.12.003; Rahaman SO, 2005, CANCER RES, V65, P2956, DOI 10.1158/0008-5472.CAN-04-3592; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Renaud SJ, 2009, PLACENTA, V30, P313, DOI 10.1016/j.placenta.2009.01.001; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; Stein A, 2000, J INFECT DIS, V181, P188, DOI 10.1086/315166; Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; VANMOLL P, 1993, J COMP PATHOL, V109, P295, DOI 10.1016/S0021-9975(08)80254-X; Ferro EAV, 2008, AM J PATHOL, V172, P50, DOI 10.2353/ajpath.2008.070432; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Xu B, 1999, BIOL REPROD, V61, P681, DOI 10.1095/biolreprod61.3.681	59	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15315	10.1371/journal.pone.0015315	http://dx.doi.org/10.1371/journal.pone.0015315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179488	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500022
J	Nijland, R; Hall, MJ; Burgess, JG				Nijland, Reindert; Hall, Michael J.; Burgess, J. Grant			Dispersal of Biofilms by Secreted, Matrix Degrading, Bacterial DNase	PLOS ONE			English	Article							BACILLUS-SUBTILIS; EXTRACELLULAR DNA; EXPRESSION; INHIBITOR; ACID	Microbial biofilms are composed of a hydrated matrix of biopolymers including polypeptides, polysaccharides and nucleic acids and act as a protective barrier and microenvironment for the inhabiting microbes. While studying marine biofilms, we observed that supernatant produced by a marine isolate of Bacillus licheniformis was capable of dispersing bacterial biofilms. We investigated the source of this activity and identified the active compound as an extracellular DNase (NucB). We have shown that this enzyme rapidly breaks up the biofilms of both Gram-positive and Gram-negative bacteria. We demonstrate that bacteria can use secreted nucleases as an elegant strategy to disperse established biofilms and to prevent de novo formation of biofilms of competitors. DNA therefore plays an important dynamic role as a reversible structural adhesin within the biofilm.	[Nijland, Reindert; Burgess, J. Grant] Newcastle Univ, Sch Marine Sci & Technol, Dove Marine Lab, N Shields, England; [Hall, Michael J.] Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Nijland, R (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	grant.burgess@ncl.ac.uk	Hall, Michael/N-2458-2019; Nijland, Reindert/B-8206-2008; Hall, Michael J/A-4126-2012	Hall, Michael/0000-0001-6475-9161; Nijland, Reindert/0000-0003-0049-3768; Hall, Michael J/0000-0001-6475-9161	European Community [PIEF-GA-2008-219592]; NERC [NE/G011206/1]	European Community(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a fellowship from the European Community's Seventh Framework Programme, under grant agreement PIEF-GA-2008-219592 to RN, and a NERC follow-on fund Pathfinder grant to RN, MJH and JGB (NE/G011206/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci M, 2006, J BACTERIOL, V188, P2325, DOI 10.1128/JB.188.7.2325-2335.2006; Ando T, 2006, J BIOCHEM, V139, P805, DOI 10.1093/jb/mvj091; Bongers RS, 2005, APPL ENVIRON MICROB, V71, P8818, DOI 10.1128/AEM.71.12.8818-8824.2005; Burgess JG, 1999, J BIOTECHNOL, V70, P27, DOI 10.1016/S0168-1656(99)00054-1; CATLIN BW, 1956, SCIENCE, V124, P441, DOI 10.1126/science.124.3219.441; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, J IND MICROBIOL, V15, P137, DOI 10.1007/BF01569816; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fletcher Madilyn, 1994, Current Opinion in Biotechnology, V5, P302, DOI 10.1016/0958-1669(94)90033-7; HARTLEY RW, 1988, J MOL BIOL, V202, P913, DOI 10.1016/0022-2836(88)90568-2; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; LANDINI P, 2010, APPL MICROBIOL BIOTE; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lau PCY, 2009, BIOPHYS J, V96, P2935, DOI 10.1016/j.bpj.2008.12.3943; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Moorthy S, 2005, MOL MICROBIOL, V57, P1623, DOI 10.1111/j.1365-2958.2005.04797.x; MULCAHY H, ENV MICROBIOL, V12, P1621; Nagarajan V, 2009, FEMS MICROBIOL LETT, V295, P204, DOI 10.1111/j.1574-6968.2009.01595.x; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Sambrook J., 2002, MOL CLONING LAB MANU; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Suri R, 2005, BIODRUGS, V19, P135, DOI 10.2165/00063030-200519030-00001; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; UHLENHOPP EL, 1975, BIOPHYS J, V15, P233, DOI 10.1016/S0006-3495(75)85814-0; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P213; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yan LM, 2003, APPL ENVIRON MICROB, V69, P3719, DOI 10.1128/AEM.69.7.3719-3727.2003	30	110	121	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15668	10.1371/journal.pone.0015668	http://dx.doi.org/10.1371/journal.pone.0015668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179489	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500035
J	Correa-Costa, M; Semedo, P; Monteiro, APFS; Silva, RC; Pereira, RL; Goncalves, GM; Marques, GDM; Cenedeze, MA; Faleiros, ACG; Keller, AC; Shimizu, MHM; Seguro, AC; Reis, MA; Pacheco-Silva, A; Camara, NOS				Correa-Costa, Matheus; Semedo, Patricia; Monteiro, Ana Paula F. S.; Silva, Reinaldo C.; Pereira, Rafael L.; Goncalves, Giselle M.; Marcusso Marques, Georgia Daniela; Cenedeze, Marcos A.; Faleiros, Ana C. G.; Keller, Alexandre C.; Shimizu, Maria H. M.; Seguro, Antonio C.; Reis, Marlene A.; Pacheco-Silva, Alvaro; Camara, Niels O. S.			Induction of Heme Oxygenase-1 Can Halt and Even Reverse Renal Tubule-Interstitial Fibrosis	PLOS ONE			English	Article							RAT OBSTRUCTIVE NEPHROPATHY; URETERAL OBSTRUCTION; OXIDATIVE STRESS; TUBULOINTERSTITIAL FIBROSIS; MESENCHYMAL TRANSITION; CARBON-MONOXIDE; KIDNEY; INFLAMMATION; PROGRESSION; FIBROBLASTS	Background: The tubule-interstitial fibrosis is the hallmark of progressive renal disease and is strongly associated with inflammation of this compartment. Heme-oxygenase-1 (HO-1) is a cytoprotective molecule that has been shown to be beneficial in various models of renal injury. However, the role of HO-1 in reversing an established renal scar has not yet been addressed. Aim: We explored the ability of HO-1 to halt and reverse the establishment of fibrosis in an experimental model of chronic renal disease. Methods: Sprague-Dawley male rats were subjected to unilateral ureteral obstruction (UUO) and divided into two groups: non-treated and Hemin-treated. To study the prevention of fibrosis, animals were pre-treated with Hemin at days -2 and -1 prior to UUO. To investigate whether HO-1 could reverse established fibrosis, Hemin therapy was given at days 6 and 7 post-surgery. After 7 and/or 14 days, animals were sacrificed and blood, urine and kidney tissue samples were collected for analyses. Renal function was determined by assessing the serum creatinine, inulin clearance, proteinuria/creatininuria ratio and extent of albuminuria. Arterial blood pressure was measured and fibrosis was quantified by Picrosirius staining. Gene and protein expression of pro-inflammatory and pro-fibrotic molecules, as well as HO-1 were performed. Results: Pre-treatment with Hemin upregulated HO-1 expression and significantly reduced proteinuria, albuminuria, inflammation and pro-fibrotic protein and gene expressions in animals subjected to UUO. Interestingly, the delayed treatment with Hemin was also able to reduce renal dysfunction and to decrease the expression of pro-inflammatory molecules, all in association with significantly reduced levels of fibrosis-related molecules and collagen deposition. Finally, TGF-beta protein production was significantly lower in Hemin-treated animals. Conclusion: Treatment with Hemin was able both to prevent the progression of fibrosis and to reverse an established renal scar. Modulation of inflammation appears to be the major mechanism behind HO-1 cytoprotection.	[Correa-Costa, Matheus; Semedo, Patricia; Monteiro, Ana Paula F. S.; Silva, Reinaldo C.; Pereira, Rafael L.; Marcusso Marques, Georgia Daniela; Cenedeze, Marcos A.; Keller, Alexandre C.; Pacheco-Silva, Alvaro; Camara, Niels O. S.] Univ Fed Sao Paulo, Div Nephrol, Lab Clin & Expt Immunol, Sao Paulo, Brazil; [Correa-Costa, Matheus; Goncalves, Giselle M.; Camara, Niels O. S.] Univ Sao Paulo, Inst Biomed Sci 4, Dept Immunol, Lab Transplantat Immunobiol, Sao Paulo, Brazil; [Faleiros, Ana C. G.; Reis, Marlene A.] Univ Fed Triangulo Mineiro, Div Pathol, Uberaba, Brazil; [Shimizu, Maria H. M.; Seguro, Antonio C.] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro; Universidade de Sao Paulo	Correa-Costa, M (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Lab Clin & Expt Immunol, Sao Paulo, Brazil.	niels@icb.usp.br	Shimizu, Maria/B-7887-2013; Silva, Reinaldo/C-6285-2013; Correa-Costa, Matheus/B-2006-2014; Keller, Alexandre C/E-4621-2012; Pacheco-Silva, Alvaro/K-3583-2013; Semedo-Kuriki, Patricia/D-2429-2010; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011	Keller, Alexandre C/0000-0002-7827-0292; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248; Semedo-Kuriki, Patricia/0000-0002-2136-3308	Fundacao de Amparo Pesquisa do Estado de Sao Paulo-FAPESP [07/07139-3]; Coordenaco de Aperfeioamento de Pessoal de Nivel Superior-CAPES; Instituto Nacional de Ciencia e Tecnologia de Complexos Fluidos; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq	Fundacao de Amparo Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenaco de Aperfeioamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia de Complexos Fluidos; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo Pesquisa do Estado de Sao Paulo-FAPESP (07/07139-3), Coordenaco de Aperfeioamento de Pessoal de Nivel Superior-CAPES, Instituto Nacional de Ciencia e Tecnologia de Complexos Fluidos and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2009, AM J PHYSIOL-RENAL, V297, pF1137, DOI 10.1152/ajprenal.90449.2008; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BLANCOU P, METHODS MOL BIOL, V677, P247; BOMBARA MP, 1993, J LEUKOCYTE BIOL, V54, P399, DOI 10.1002/jlb.54.5.399; Burger D, 1998, ARTHRITIS RHEUM, V41, P1748, DOI 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.3.CO;2-V; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Desbuards N, 2009, NEPHRON EXP NEPHROL, V113, pE35, DOI 10.1159/000228081; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; EyssenHernandez R, 1996, FEBS LETT, V382, P229, DOI 10.1016/0014-5793(96)00127-5; Fioretto P, 1998, CURR OPIN NEPHROL HY, V7, P489, DOI 10.1097/00041552-199809000-00001; GAUDIO KM, 1980, AM J PHYSIOL, V238, pF205, DOI 10.1152/ajprenal.1980.238.3.F205; Giannico G, 2009, CLIN J AM SOC NEPHRO, V4, P1747, DOI 10.2215/CJN.01510209; Goncalves GM, 2006, KIDNEY INT, V70, P1742, DOI 10.1038/sj.ki.5001893; Goodman AI, 2007, KIDNEY INT, V72, P945, DOI 10.1038/sj.ki.5002447; Grimm PC, 2003, J AM SOC NEPHROL, V14, P1662, DOI 10.1097/01.ASN.0000066143.02832.5E; Hill-Kapturczak N, 2002, DNA CELL BIOL, V21, P307, DOI 10.1089/104454902753759726; Hwang M, 2006, EXP MOL PATHOL, V81, P48, DOI 10.1016/j.yexmp.2005.11.005; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Iwai T, 2008, UROLOGY, V72, P432, DOI 10.1016/j.urology.2007.11.123; Jarmi T, 2009, CURR HYPERTENS REP, V11, P56, DOI 10.1007/s11906-009-0011-z; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kie JH, 2008, J AM SOC NEPHROL, V19, P1681, DOI 10.1681/ASN.2007101099; Kim JH, 2006, J AM SOC NEPHROL, V17, P1373, DOI 10.1681/ASN.2005091001; Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; LENNON GM, 1993, BRIT J UROL, V72, P702, DOI 10.1111/j.1464-410X.1993.tb16251.x; Ma LJ, 2005, J AM SOC NEPHROL, V16, P966, DOI 10.1681/ASN.2004060492; Magnasco A, 2008, CELL TRANSPLANT, V17, P1157, DOI 10.3727/096368908787236567; Matsumoto H, 2006, MOL CELL BIOCHEM, V291, P21, DOI 10.1007/s11010-006-9190-y; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Meldrum KK, 2007, AM J PHYSIOL-REG I, V292, pR1456, DOI 10.1152/ajpregu.00620.2005; Miyajima A, 2003, J UROLOGY, V169, P1559, DOI 10.1097/01.ju.0000045686.21766.c1; Moriyama T, 2001, KIDNEY INT, V59, P2095, DOI 10.1046/j.1523-1755.2001.0590062095.x; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Noris M, 2003, KIDNEY INT, V64, P2253, DOI 10.1046/j.1523-1755.2003.00318.x; OPANASHUK LA, 1995, J NEUROSCI RES, V42, P623, DOI 10.1002/jnr.490420504; Rezzani R, 2005, J HISTOCHEM CYTOCHEM, V53, P105, DOI 10.1369/jhc.4A6456.2004; Ruggenenti P, 2001, LANCET, V357, P1601, DOI 10.1016/S0140-6736(00)04728-0; SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889; SHIN DH, FREE RADIC BIOL MED, V48, P1051; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; Tashiro K, 2003, INT J MOL MED, V12, P587; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; VOGT BA, 1995, LAB INVEST, V72, P474; Wang L, 2008, AM J PHYSIOL-RENAL, V294, pF508, DOI 10.1152/ajprenal.00306.2007; Wang PHM, 2009, INT IMMUNOPHARMACOL, V9, P653, DOI 10.1016/j.intimp.2008.10.018; Xu YF, 2009, J NEPHROL, V22, P403; Yan JD, 2009, ACTA PHARMACOL SIN, V30, P994, DOI 10.1038/aps.2009.56	54	59	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14298	10.1371/journal.pone.0014298	http://dx.doi.org/10.1371/journal.pone.0014298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179206	gold, Green Published, Green Submitted			2022-12-27	WOS:000285246900011
J	Dunn, BD; Makarova, D; Evans, D; Clark, L				Dunn, Barnaby D.; Makarova, Dasha; Evans, David; Clark, Luke			"I'm Worth More than That": Trait Positivity Predicts Increased Rejection of Unfair Financial Offers	PLOS ONE			English	Article							ECONOMIC DECISION-MAKING; VENTROMEDIAL PREFRONTAL DAMAGE; GLOBAL SELF-ESTEEM; ULTIMATUM GAME; NEGATIVE AFFECT; DEPRESSION; JUDGMENT; MODELS; PANAS; ANGER	Humans react strongly to unfairness, sometimes rejecting inequitable proposals even if this sacrifices personal financial gain. Here we explored whether emotional dispositions - trait tendencies to experience positive or negative feelings - shape the rejection of unfair financial offers. Participants played an Ultimatum Game, where the division of a sum of money is proposed and the player can accept or reject this offer. Individuals high in trait positivity and low in trait negativity rejected more unfair offers. These relationships could not be explained by existing accounts which argue that rejection behaviour results from a failure to regulate negative emotions, or serves to arbitrate social relationships and identity. Instead, the relationship between dispositional affect and rejection behaviour may be underpinned by perceived self worth, with those of a positive disposition believing that they are "worth more than that" and those of a negative disposition resigning themselves to "taking the crumbs from under the table".	[Dunn, Barnaby D.; Evans, David] UK Med Res Council, Cognit & Brain Sci Unit, Cambridge, England; [Makarova, Dasha; Clark, Luke] Univ Cambridge, Dept Expt Psychol, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England	University of Cambridge; University of Cambridge	Dunn, BD (corresponding author), UK Med Res Council, Cognit & Brain Sci Unit, Cambridge, England.	barney.dunn@mrc-cbu.cam.ac.uk		Clark, Luke/0000-0003-1103-2422; Evans, Davy/0000-0002-3018-9962	UK Medical Research Council [U1055.02.002.00001.01]	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Barney Dunn and Davy Evans involvement in the study was supported by the UK Medical Research Council (U1055.02.002.00001.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Brown JD, 2001, PERS SOC PSYCHOL B, V27, P575, DOI 10.1177/0146167201275006; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Dunn BD, 2009, BEHAV RES THER, V47, P374, DOI 10.1016/j.brat.2009.01.016; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Harle KM, 2010, J ABNORM PSYCHOL, V119, P440, DOI 10.1037/a0018612; Howell DC., 2013, STAT METHODS PSYCHOL, V8; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Moretti L, 2009, J COGNITIVE NEUROSCI, V21, P128, DOI 10.1162/jocn.2009.21011; Nelson HE., 1982, NATL ADULT READING T; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; PELHAM BW, 1989, J PERS SOC PSYCHOL, V57, P672, DOI 10.1037/0022-3514.57.4.672; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Plott Charles R., 2008, HDB EXPT EC RESULTS, V1, P509, DOI DOI 10.1016/S1574-0722(07)00057-1; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Spielberger CD, 1983, STAIT TRAIT ANXIETY; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; Watson D, 2002, J PERS SOC PSYCHOL, V83, P185, DOI 10.1037//0022-3514.83.1.185; Zak PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008330	29	19	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15095	10.1371/journal.pone.0015095	http://dx.doi.org/10.1371/journal.pone.0015095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691MJ	21170341	Green Published, Green Submitted, gold			2022-12-27	WOS:000285084100019
J	Kuang, H; Lin, LN; Tsien, JZ				Kuang, Hui; Lin, Longnian; Tsien, Joe Z.			Temporal Dynamics of Distinct CA1 Cell Populations during Unconscious State Induced by Ketamine	PLOS ONE			English	Article							NMDA RECEPTOR-CHANNEL; OSCILLATIONS IN-VIVO; MEMORY CONSOLIDATION; HEALTHY-VOLUNTEERS; THETA RHYTHM; HIPPOCAMPUS; RAT; INTERNEURONS; PHENCYCLIDINE; CONSCIOUSNESS	Ketamine is a widely used dissociative anesthetic which can induce some psychotic-like symptoms and memory deficits in some patients during the post-operative period. To understand its effects on neural population dynamics in the brain, we employed large-scale in vivo ensemble recording techniques to monitor the activity patterns of simultaneously recorded hippocampal CA1 pyramidal cells and various interneurons during several conscious and unconscious states such as awake rest, running, slow wave sleep, and ketamine-induced anesthesia. Our analyses reveal that ketamine induces distinct oscillatory dynamics not only in pyramidal cells but also in at least seven different types of CA1 interneurons including putative basket cells, chandelier cells, bistratified cells, and O-LM cells. These emergent unique oscillatory dynamics may very well reflect the intrinsic temporal relationships within the CA1 circuit. It is conceivable that systematic characterization of network dynamics may eventually lead to better understanding of how ketamine induces unconsciousness and consequently alters the conscious mind.	[Kuang, Hui; Lin, Longnian] E China Normal Univ, Key Lab MOE, Shanghai Inst Brain Funct Genom, Shanghai 200062, Peoples R China; [Kuang, Hui; Lin, Longnian] E China Normal Univ, Key Lab STCSM, Shanghai Inst Brain Funct Genom, Shanghai 200062, Peoples R China; [Kuang, Hui; Tsien, Joe Z.] Med Coll Georgia, Sch Med, Brain & Behav Discovery Inst, Augusta, GA 30912 USA	East China Normal University; East China Normal University; University System of Georgia; Augusta University	Kuang, H (corresponding author), E China Normal Univ, Key Lab MOE, Shanghai Inst Brain Funct Genom, Shanghai 200062, Peoples R China.	jtsien@mcg.edu	Kuang, Hui/I-1006-2013	Kuang, Hui/0000-0002-7806-2864	National Institutes of Health: National Institute of Mental Health (NIMH) [MH060236]; National Institute on Aging (NIA) [AG024022, AG034663, AG025918]; Amry Research Laboratory [USAMRA00002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034663, R01AG025918, R01AG024022] Funding Source: NIH RePORTER	National Institutes of Health: National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Amry Research Laboratory; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from National Institutes of Health: National Institute of Mental Health (NIMH) (MH060236), National Institute on Aging (NIA) (AG024022, AG034663 & AG025918), and from Amry Research Laboratory: USAMRA00002 (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; ALONSO A, 1987, EXP BRAIN RES, V67, P493, DOI 10.1007/BF00247282; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1985, ELECTROEN CLIN NEURO, V61, P77, DOI 10.1016/0013-4694(85)91075-2; BUZSAKI G, 1983, BRAIN RES, V266, P334, DOI 10.1016/0006-8993(83)90665-0; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; CORSSEN G, 1966, ANESTH ANAL CURR RES, V45, P29; Craven R, 2007, ANAESTHESIA, V62, P48, DOI 10.1111/j.1365-2044.2007.05298.x; DOMINO EF, 1965, CLIN PHARMACOL THER, V6, P279; DURIEUX ME, 1995, ANESTH ANALG, V81, P57, DOI 10.1097/00000539-199507000-00012; ELLISON G, 1995, BRAIN RES REV, V20, P250, DOI 10.1016/0165-0173(94)00014-G; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; FOX SE, 1981, EXP BRAIN RES, V41, P399; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Greene R, 2001, HIPPOCAMPUS, V11, P569, DOI 10.1002/hipo.1072.abs; Grunwald T, 1999, P NATL ACAD SCI USA, V96, P12085, DOI 10.1073/pnas.96.21.12085; Hakami T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006755; Harborne GC, 1996, J PSYCHOPHARMACOL, V10, P134, DOI 10.1177/026988119601000208; Honey GD, 2005, CEREB CORTEX, V15, P749, DOI 10.1093/cercor/bhh176; HUNT MJ, J PSYCHOPHARMACOL; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAZAREWICZ MT, 2009, J COGN NEUROSCI; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morgan CJA, 2004, NEUROPSYCHOPHARMACOL, V29, P208, DOI 10.1038/sj.npp.1300342; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; Newcomer JW, 2001, HIPPOCAMPUS, V11, P529, DOI 10.1002/hipo.1069.abs; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Sara SJ, 2006, LEARN MEMORY, V13, P515, DOI 10.1101/lm.338406; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SIK A, 1995, J NEUROSCI, V15, P6651; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Squire L. R., 1987, MEMORY BRAIN; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Tulving E, 2000, OXFORD HDB MEMORY; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027	50	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15209	10.1371/journal.pone.0015209	http://dx.doi.org/10.1371/journal.pone.0015209			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21165147	Green Published, gold, Green Submitted			2022-12-27	WOS:000285084100029
J	Jonsson, IM; Juuti, JT; Francois, P; AlMajidi, R; Pietiainen, M; Girard, M; Lindholm, C; Saller, MJ; Driessen, AJM; Kuusela, P; Bokarewa, M; Schrenzel, J; Kontinen, VP				Jonsson, Ing-Marie; Juuti, Jarmo T.; Francois, Patrice; AlMajidi, Rana; Pietiainen, Milla; Girard, Myriam; Lindholm, Catharina; Saller, Manfred J.; Driessen, Arnold J. M.; Kuusela, Pentti; Bokarewa, Maria; Schrenzel, Jacques; Kontinen, Vesa P.			Inactivation of the Ecs ABC Transporter of Staphylococcus aureus Attenuates Virulence by Altering Composition and Function of Bacterial Wall	PLOS ONE			English	Article							BACILLUS-SUBTILIS; PROTEIN-A; INTRAMEMBRANE PROTEOLYSIS; HUMAN DEFENSINS; IRON TRANSPORT; MUTANTS; RESISTANCE; HEME; IDENTIFICATION; REPLACEMENT	Background: Ecs is an ATP-binding cassette (ABC) transporter present in aerobic and facultative anaerobic Gram-positive Firmicutes. Inactivation of Bacillus subtilis Ecs causes pleiotropic changes in the bacterial phenotype including inhibition of intramembrane proteolysis. The molecule(s) transported by Ecs is (are) still unknown. Methodology/Principal Findings: In this study we mutated the ecsAB operon in two Staphylococcus aureus strains, Newman and LS-1. Phenotypic and functional characterization of these Ecs deficient mutants revealed a defect in growth, increased autolysis and lysostaphin sensitivity, altered composition of cell wall proteins including the precursor form of staphylokinase and an altered bacterial surface texture. DNA microarray analysis indicated that the Ecs deficiency changed expression of the virulence factor regulator protein Rot accompanied by differential expression of membrane transport proteins, particularly ABC transporters and phosphate-specific transport systems, protein A, adhesins and capsular polysaccharide biosynthesis proteins. Virulence of the ecs mutants was studied in a mouse model of hematogenous S. aureus infection. Mice inoculated with the ecs mutant strains developed markedly milder infections than those inoculated with the wild-type strains and had consequently lower mortality, less weight loss, milder arthritis and decreased persistence of staphylococci in the kidneys. The ecs mutants had higher susceptibility to ribosomal antibiotics and plant alkaloids chelerythrine and sanguinarine. Conclusions/Significance: Our results show that Ecs is essential for staphylococcal virulence and antimicrobial resistance probably since the transport function of Ecs is essential for the normal structure and function of the cell wall. Thus targeting Ecs may be a new approach in combating staphylococcal infection.	[Jonsson, Ing-Marie; Lindholm, Catharina; Bokarewa, Maria] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Juuti, Jarmo T.; AlMajidi, Rana; Pietiainen, Milla; Kontinen, Vesa P.] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Antimicrobial Resistance Unit, Helsinki, Finland; [Francois, Patrice; Girard, Myriam; Schrenzel, Jacques] Univ Geneva, Univ Hosp Geneva, Infect Dis Serv, Genom Res Lab, Geneva, Switzerland; [Saller, Manfred J.; Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Kluyver Ctr Genom Ind Fermentat, Haren, Netherlands; [Saller, Manfred J.; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Haren, Netherlands; [Kuusela, Pentti; Kontinen, Vesa P.] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Kuusela, Pentti] Helsinki Univ Cent Hosp Lab, Div Clin Microbiol, Helsinki, Finland	University of Gothenburg; Finland National Institute for Health & Welfare; University of Geneva; University of Groningen; University of Groningen; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Jonsson, IM (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	vesa.p.kontinen@helsinki.fi	Institute, Zernike/W-7033-2019; Kontinen, Vesa P/A-2260-2012; Driessen, Arnold J.M./D-1876-2012; Bokarewa, Maria I/A-8114-2019; Schrenzel, Jacques/P-8525-2017; Schrenzel, Jacques/AAC-5685-2021; francois, patrice/AAL-5583-2020	Bokarewa, Maria I/0000-0001-9424-5145; Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X; Driessen, Arnold J.M./0000-0001-9258-9104	European Science Foundation; European Commission [ERAS-CT-2003-980409]; Academy of Finland [107438, 113846, 123318]; Helsinki University Central Hospital; Swiss National Science Foundation [3100A0-112370/1, 3100A0-116075]; Swedish Medicial Research Council; Goteborg Medical Society; Swedish Association against Rheumatism; Swedish Foundation for Strategic Research; Goteborg Rheumatism Association	European Science Foundation(European Science Foundation (ESF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland(Academy of Finland); Helsinki University Central Hospital; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish Medicial Research Council; Goteborg Medical Society; Swedish Association against Rheumatism; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Goteborg Rheumatism Association	This work, as part of the European Science Foundation (www.esf.org) EUROCORES Programme EuroSCOPE, is supported by funds from the European Commission's Sixth Framework Programme under contract ERAS-CT-2003-980409. This work was also supported by research grants 107438, 113846 and 123318 from the Academy of Finland (www.aka.fi), by the Subsidy of the Helsinki University Central Hospital (www.hus.fi), and by grants 3100A0-112370/1 (awarded to J.S) and 3100A0-116075 (awarded to P. F.) from the Swiss National Science Foundation (www.snf.ch). Furthermore, the work was supported by the Swedish Medicial Research Council (www.vr.se), LUA/ALF Grants, Goteborg Medical Society, Swedish Association against Rheumatism (www.reumatikerforbundet.org), Swedish Foundation for Strategic Research (www.stratresearch.se), and Goteborg Rheumatism Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bramkamp M, 2006, MOL MICROBIOL, V62, P580, DOI 10.1111/j.1365-2958.2006.05402.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Braun V, 2009, BIOMETALS, V22, P3, DOI 10.1007/s10534-008-9199-7; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Churchill GA, 2004, BIOTECHNIQUES, V37, P173, DOI 10.2144/04372TE01; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEJONGE BLM, 1991, J BACTERIOL, V173, P1105, DOI 10.1128/jb.173.3.1105-1110.1991; Falcone M, 2009, EUR J INTERN MED, V20, P343, DOI 10.1016/j.ejim.2008.08.016; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Gao JX, 2004, J BACTERIOL, V186, P3738, DOI 10.1128/JB.186.12.3738-3748.2004; Grundling A, 2006, J BACTERIOL, V188, P6286, DOI 10.1128/JB.00457-06; Gustafsson E, 2009, INT J MED MICROBIOL, V299, P65, DOI 10.1016/j.ijmm.2008.05.011; Heinrich J, 2008, MICROBIOL-SGM, V154, P1989, DOI 10.1099/mic.0.2008/018648-0; HELLE M, 1988, EUR J IMMUNOL, V18, P1535, DOI 10.1002/eji.1830181010; HENDERSON DP, 1994, INFECT IMMUN, V62, P5120, DOI 10.1128/IAI.62.11.5120-5125.1994; JELSBAK L, 2009, INT J MED MICROBIOL, DOI DOI 10.1016/J.IJMM.2009.1007.1003; Jung KY, 2001, J MED MICROBIOL, V50, P35, DOI 10.1099/0022-1317-50-1-35; KONTINEN VP, 1988, J GEN MICROBIOL, V134, P2333; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Leskela S, 1996, MICROBIOL-SGM, V142, P71, DOI 10.1099/13500872-142-1-71; Leskela S, 1999, MOL MICROBIOL, V31, P533, DOI 10.1046/j.1365-2958.1999.01194.x; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; MILLER M, PLOS ONE, V5, pE9057; Ohlsen K, 2008, PHARMACOGENOMICS, V9, P1711, DOI 10.2217/14622416.9.11.1711; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; Pietiainen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-429; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Pummi T, 2002, J BACTERIOL, V184, P1010, DOI 10.1128/jb.184.4.1010-1018.2002; Schiott T, 1997, J BACTERIOL, V179, P4523, DOI 10.1128/jb.179.14.4523-4529.1997; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; von Eiff C, 2006, J BACTERIOL, V188, P687, DOI 10.1128/JB.188.2.687-693.2006; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902	40	16	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14209	10.1371/journal.pone.0014209	http://dx.doi.org/10.1371/journal.pone.0014209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151985	Green Published, Green Submitted, gold			2022-12-27	WOS:000284868000019
J	Ozer, A; Arikan, DC; Kirecci, E; Ekerbicer, HC				Ozer, Ali; Arikan, Deniz Cemgil; Kirecci, Ekrem; Ekerbicer, Hasan Cetin			Status of Pandemic Influenza Vaccination and Factors Affecting It in Pregnant Women in Kahramanmaras, an Eastern Mediterranean City of Turkey	PLOS ONE			English	Article							IMPACT	Background: Pregnant women are a target group for receipt of influenza vaccine because there appears to be an elevated mortality and morbidity rate associated with influenza virus infection in pregnant women. The goal of this study is to determine the factors affecting the decisions of pregnant women in Turkey to be vaccinated or not for 2009 H1N1 influenza. Methodology: We enrolled 314 of 522 (60.2%) pregnant women who attended to the antenatal clinics of the Medical Faculty of Kahramanmaras Sutcuimam University's Department of Gynecology and Obstetrics between December 23, 2009, and February 1, 2010. We developed a 48-question survey which was completed in a face-to-face interview at the clinic with each pregnant woman. Principal Findings: Of the 314 pregnant women, 27.4% were in the first trimester, 33.8% were in the second trimester, and 38.8% were in the third trimester. Twenty-eight pregnant women (8.9%) got vaccinated. Of all the women interviewed, 68.5% stated that they were comfortable with their decisions about the vaccine, 7.3% stated they were not comfortable, and 24.2% stated that they were hesitant about their decisions. The probability of receiving the 2009 H1N1 vaccine was 3.46 times higher among working women than housewives, 1.85 times higher among women who have a child than those who do not, and 1.29 times higher among women with a high-school education or higher than those with only a secondary-school education and below. Correct knowledge about the minimal risks associated with receipt of influenza vaccine were associated with a significant increase in the probability of receiving the 2009 H1N1 vaccine. Conclusions/Significance: The number of pregnant women in the study group who received the 2009 H1N1 vaccine was very low (8.9%) and two-thirds of them stated that they were comfortable with their decisions concerning the vaccine. Our results may have implications for public health measures to increase the currently low vaccination rate among pregnant women. Further studies are required to confirm whether our findings generalize to other influenza seasons and other settings.	[Ozer, Ali; Ekerbicer, Hasan Cetin] Kahramanmaras Sutcuimam Univ, Fac Med, Dept Publ Hlth, Kahramanmaras, Turkey; [Arikan, Deniz Cemgil] Kahramanmaras Sutcuimam Univ, Fac Med, Dept Obstet & Gynecol, Kahramanmaras, Turkey; [Kirecci, Ekrem] Kahramanmaras Sutcuimam Univ, Sch Hlth, Kahramanmaras, Turkey	Kahramanmaras Sutcu Imam University; Kahramanmaras Sutcu Imam University; Kahramanmaras Sutcu Imam University	Ozer, A (corresponding author), Kahramanmaras Sutcuimam Univ, Fac Med, Dept Publ Hlth, Kahramanmaras, Turkey.	aliozer91@hotmail.com	Ekerbiçer, Hasan Çetin/HHT-0237-2022; özer, ali/ABI-2209-2020	özer, ali/0000-0002-7144-4915				*CDC GOV, 2010, SWIN FLU; *DEP HLTH HUM SERV, 2008, GUID ALL TARG PAND I; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; *EUR CTR DIS PREV, 2009, INFL A H1N1 RISK ASS; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; KURUGOL Z, 2009, TURKIYE KLIN J PEDIA, V18, P358; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nuzum J W, 1976, IMJ Ill Med J, V150, P612; Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; *STRAT ADV GROUP E, 2009, WKLY EPIDEMIOL REC, V84, P301; Tuyishime Jean-de-Dieu, 2003, J Obstet Gynaecol Can, V25, P1020; World Health Organization, 2009, PAND H1N1 2009; Yudin MH, 2009, J OBSTET GYNAECOL CA, V31, P120, DOI 10.1016/S1701-2163(16)34095-6; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2425; 2010, INTERIM RESULTS INFL; 2010, EMEDSCAPE MEDSCAPE	26	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14177	10.1371/journal.pone.0014177	http://dx.doi.org/10.1371/journal.pone.0014177			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152073	Green Published, Green Submitted			2022-12-27	WOS:000284821300002
J	Flisikowski, K; Venhoranta, H; Nowacka-Woszuk, J; McKay, SD; Flyckt, A; Taponen, J; Schnabel, R; Schwarzenbacher, H; Szczerbal, I; Lohi, H; Fries, R; Taylor, JF; Switonski, M; Andersson, M				Flisikowski, Krzysztof; Venhoranta, Heli; Nowacka-Woszuk, Joanna; McKay, Stephanie D.; Flyckt, Antti; Taponen, Juhani; Schnabel, Robert; Schwarzenbacher, Hermann; Szczerbal, Izabela; Lohi, Hannes; Fries, Ruedi; Taylor, Jeremy F.; Switonski, Marek; Andersson, Magnus			A Novel Mutation in the Maternally Imprinted PEG3 Domain Results in a Loss of MIMT1 Expression and Causes Abortions and Stillbirths in Cattle (Bos taurus)	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; GENE; METHYLATION	Congenital malformations resulting in late abortions and stillbirths affect the economic wellbeing of producers and the welfare of cattle in breeding programs. An extremely high incidence of stillbirths of "half-sized" calves of normal karyotype and uninflated lungs was diagnosed in the progeny of the Finnish Ayrshire (Bos taurus) bull - YN51. No other visible anatomical abnormalities were apparent in the stillborn calves. We herein describe the positional identification of a 110 kb microdeletion in the maternally imprinted PEG3 domain that results in a loss of paternal MIMT1 expression and causes late term abortion and stillbirth in cattle. Using the BovineSNP50 BeadChip we performed a genome-wide half-sib linkage analysis that identified a 13.3 Mb associated region on BTA18 containing the maternally imprinted PEG3 domain. Within this cluster we found a 110 kb microdeletion that removes a part of the non-protein coding MER1 repeat containing imprinted transcript 1 gene (MIMT1). To confirm the elimination of gene expression in calves inheriting this deletion, we examined the mRNA levels of the three maternally imprinted genes within the PEG3 domain, in brain and cotyledon tissue collected from eight fetuses sired by the proband. None of the fetuses that inherited the microdeletion expressed MIMT1 in either tissue. The mutation, when inherited from the sire, is semi-lethal for his progeny with an observed mortality rate of 85%. The survival of 15% is presumably due to the incomplete silencing of maternally inherited MIMT1 alleles. We designed a PCR-based assay to confirm the existence of the microdeletion in the MIMT1 region that can be used to assist cattle breeders in preventing the stillbirths.	[Flisikowski, Krzysztof; Schwarzenbacher, Hermann; Fries, Ruedi] Tech Univ Munich, Lehrstuhl Tierzucht, D-8050 Freising Weihenstephan, Germany; [Venhoranta, Heli; Flyckt, Antti; Taponen, Juhani; Andersson, Magnus] Univ Helsinki, Dept Prod Anim Med, Saarentaus, Finland; [Nowacka-Woszuk, Joanna; Szczerbal, Izabela; Switonski, Marek] Univ Life Sci, Dept Genet & Anim Breeding, Poznan, Poland; [McKay, Stephanie D.; Schnabel, Robert; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Schwarzenbacher, Hermann] EDV Dienstleistungen GmbH, ZuchtData, Vienna, Austria; [Lohi, Hannes] Univ Helsinki, Dept Med Genet, Biomedicum Helsinki, Folkhalsan Inst Genet,Program Mol Med, Helsinki, Finland	Technical University of Munich; University of Helsinki; Poznan University of Life Sciences; University of Missouri System; University of Missouri Columbia; University of Helsinki	Flisikowski, K (corresponding author), Tech Univ Munich, Lehrstuhl Biotechnol Nutztiere, D-8050 Freising Weihenstephan, Germany.	flisikowski@wzw.tum.de	Lohi, Hannes/F-4596-2011; Szczerbal, Izabela/AFM-9268-2022	Lohi, Hannes/0000-0003-1087-5532; Nowacka-Woszuk, Joanna/0000-0002-1041-3576; Fries, Ruedi/0000-0002-4657-1787; McKay, Stephanie/0000-0003-1434-3111; Switonski, Marek/0000-0003-2539-9508; Schnabel, Robert/0000-0001-5018-7641; Szczerbal, Izabela/0000-0002-4238-0414	Finnish Academy; Mercedes-Zachariksen foundation; Finnish Animal Breeding Association (FABA Service)	Finnish Academy(Academy of Finland); Mercedes-Zachariksen foundation; Finnish Animal Breeding Association (FABA Service)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding from the Finnish Academy, Mercedes-Zachariksen foundation and Finnish Animal Breeding Association (FABA Service) is highly appreciated.	Arnaud P, 2006, HUM MOL GENET, V15, P589, DOI 10.1093/hmg/ddi475; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Biliya S, 2010, EXP BIOL MED, V235, P139, DOI 10.1258/ebm.2009.009251; Bittel Douglas C., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009531; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Couldrey C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-27; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Grabowski M, 2003, EUR J HUM GENET, V11, P138, DOI 10.1038/sj.ejhg.5200938; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Kim J, 2007, GENOMICS, V90, P85, DOI 10.1016/j.ygeno.2007.03.012; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Locke MM, 2002, ANIM GENET, V33, P329, DOI 10.1046/j.1365-2052.2002.00885.x; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Mariat D, 2001, CYTOGENET CELL GENET, V92, P144, DOI 10.1159/000056886; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Nicholas FW, 2005, PHILOS T R SOC B, V360, P1529, DOI 10.1098/rstb.2005.1674; SEATON A, 2006, P 8 WORLD C GEN APPL; SWITONSKI M, 1987, CYTOGENET CELL GENET, V44, P103, DOI 10.1159/000132353; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yang CK, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-12; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	27	49	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15116	10.1371/journal.pone.0015116	http://dx.doi.org/10.1371/journal.pone.0015116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152099	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100078
J	Johnson, AB; Winker, K				Johnson, Andrew B.; Winker, Kevin			Short-Term Hurricane Impacts on a Neotropical Community of Marked Birds and Implications for Early-Stage Community Resilience	PLOS ONE			English	Article							TROPICAL FOREST; POPULATIONS; HUGO; DYNAMICS; GILBERT; SHIFTS; FAT	Populations in fragmented ecosystems risk extirpation through natural disasters, which must be endured rather than avoided. Managing communities for resilience is thus critical, but details are sketchy about the capacity for resilience and its associated properties in vertebrate communities. We studied short-term resilience in a community of individually marked birds, following this community through the catastrophic destruction of its forest habitat by Hurricane Iris in Belize, Central America. We sampled for 58 d immediately before the storm, 28 d beginning 11 d after Hurricane Iris, and for 69 d approximately one year later. Our data showed that the initial capacity for resilience was strong. Many banded individuals remained after the storm, although lower post-hurricane recapture rates revealed increased turnover among individuals. Changes occurred in community dynamics and in abundances among species and guilds. Survivors and immigrants both were critical components of resilience, but in a heterogeneous, species-specific manner. Delayed effects, including higher fat storage and increased species losses, were evident one year later.	[Johnson, Andrew B.; Winker, Kevin] Univ Alaska Museum, Fairbanks, AK USA; [Johnson, Andrew B.] Univ New Mexico, Museum SW Biol, Albuquerque, NM 87131 USA	University of Alaska System; University of Alaska Fairbanks; University of New Mexico	Johnson, AB (corresponding author), Univ Alaska Museum, Fairbanks, AK USA.	kevin.winker@alaska.edu	Winker, Kevin/M-2042-2014	Winker, Kevin/0000-0002-8985-8104	University of Alaska Museum; U.S. Department of Agriculture [SCA 58-6612-8-022]	University of Alaska Museum; U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was funded by the University of Alaska Museum, an anonymous donor, and the U.S. Department of Agriculture (SCA 58-6612-8-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Ornithologists Union, 1998, CHECK LIST N AM BIRD, V7th; Anisman H, 2001, AM J PSYCHIAT, V158, P1509, DOI 10.1176/appi.ajp.158.9.1509; [Anonymous], 2001, PANARCHY UNDERSTANDI; ASKINS RA, 1991, BIOTROPICA, V23, P481, DOI 10.2307/2388270; Baker E.J., 1991, INT J MASS EMERGENCI, V9, P287; Beck RJ, 1996, J REHABIL, V62, P28; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Diamond J., 1986, COMMUNITY ECOL, P3; Dobbs RC, 2009, WETLANDS, V29, P123, DOI 10.1672/08-78.1; EDWARDS DK, 1981, STUD AVIAN BIOL, V6, P170; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; HAILMAN JP, 1965, BIRD BANDING, V36, P14, DOI 10.2307/4511130; Heinisch O., 1963, PREIS S BIOM J, V1965, P203, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; JONES HL, 2001, ANNOTATED CHECKLIST; Katti M, 1999, J ANIM ECOL, V68, P815, DOI 10.1046/j.1365-2656.1999.00331.x; Klinger R, 2006, J ANIM ECOL, V75, P1227, DOI 10.1111/j.1365-2656.2006.01158.x; LEVEY DJ, 1988, ECOLOGY, V69, P1076, DOI 10.2307/1941263; Lugo AE, 2008, AUSTRAL ECOL, V33, P368, DOI 10.1111/j.1442-9993.2008.01894.x; LYNCH JF, 1991, BIOTROPICA, V23, P488, DOI 10.2307/2388271; Mallin MA, 2002, BIOSCIENCE, V52, P999, DOI 10.1641/0006-3568(2002)052[0999:IARFMH]2.0.CO;2; Mileti D., 1999, DISASTERS DESIGN REA; Paerl HW, 2001, P NATL ACAD SCI USA, V98, P5655, DOI 10.1073/pnas.101097398; PERILLA A, 2002, J SOC CLIN PSYCHOL, V21, P40; Pravosudov VV, 1997, CURR ORNITHOL, V14, P189; REAGAN DP, 1991, BIOTROPICA, V23, P468, DOI 10.2307/2388268; Remsen JV, 1996, AUK, V113, P381, DOI 10.2307/4088905; Rittenhouse CD, 2010, GLOBAL CHANGE BIOL, V16, P905, DOI 10.1111/j.1365-2486.2009.02101.x; ROGERS CM, 1991, J FIELD ORNITHOL, V62, P349; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schoener TW, 2004, P NATL ACAD SCI USA, V101, P177, DOI 10.1073/pnas.0306887101; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stiles F.G., 1989, GUIDE BIRDS COSTA RI; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; WAIDE RB, 1991, BIOTROPICA, V23, P475, DOI 10.2307/2388269; WAUER RH, 1992, WILSON BULL, V104, P656; Whitman AA, 1998, BIOTROPICA, V30, P449, DOI 10.1111/j.1744-7429.1998.tb00079.x; Wiley James W., 1993, Bird Conservation International, V3, P319; WILL T, 1991, BIOTROPICA, V23, P497, DOI 10.2307/2388272; WINKER K, 1990, CONDOR, V92, P444, DOI 10.2307/1368241; WOOLBRIGHT LL, 1991, BIOTROPICA, V23, P462, DOI 10.2307/2388267; WUNDERLE JM, 1995, CONDOR, V97, P879, DOI 10.2307/1369528; WUNDERLE JM, 1992, AUK, V109, P148, DOI 10.2307/4088275; Wunderle Joseph M. Jr, 1996, Conservation Biology Series, V6, P253; Zar J.R., 1999, BIOSTAT ANAL	49	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15109	10.1371/journal.pone.0015109	http://dx.doi.org/10.1371/journal.pone.0015109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152062	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100074
J	Saithong, T; Painter, KJ; Millar, AJ				Saithong, Treenut; Painter, Kevin J.; Millar, Andrew J.			The Contributions of Interlocking Loops and Extensive Nonlinearity to the Properties of Circadian Clock Models	PLOS ONE			English	Article							FEEDBACK LOOPS; ARABIDOPSIS-THALIANA; MOLECULAR-BASES; ROBUSTNESS; DROSOPHILA; RHYTHMS; ENTRAINMENT; SENSITIVITY; OSCILLATOR; COMPONENTS	Background: Sensitivity and robustness are essential properties of circadian clock systems, enabling them to respond to the environment but resist noisy variations. These properties should be recapitulated in computational models of the circadian clock. Highly nonlinear kinetics and multiple loops are often incorporated into models to match experimental time-series data, but these also impact on model properties for clock models. Methodology/Principal Findings: Here, we study the consequences of complicated structure and nonlinearity using simple Goodwin-type oscillators and the complex Arabidopsis circadian clock models. Sensitivity analysis of the simple oscillators implies that an interlocked multi-loop structure reinforces sensitivity/robustness properties, enhancing the response to external and internal variations. Furthermore, we found that reducing the degree of nonlinearity could sometimes enhance the robustness of models, implying that ad hoc incorporation of nonlinearity could be detrimental to a model's perceived credibility. Conclusion: The correct multi-loop structure and degree of nonlinearity are therefore critical in contributing to the desired properties of a model as well as its capacity to match experimental data.	[Saithong, Treenut; Millar, Andrew J.] Univ Edinburgh, Inst Mol Plant Sci, Dept Biol Sci, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.] Heriot Watt Univ, Sch Math & Comp Sci, Dept Math, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.] Heriot Watt Univ, Sch Math & Comp Sci, Maxwell Inst Math Sci, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.; Millar, Andrew J.] Ctr Syst Biol Edinburgh, Edinburgh, Midlothian, Scotland	University of Edinburgh; Heriot Watt University; Heriot Watt University; University of Edinburgh	Saithong, T (corresponding author), King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand.	andrew.millar@ed.ac.uk	Painter, Kevin J/D-1055-2010; Millar, Andrew J/G-2423-2012; Saithong, Treenut/L-1395-2019	Painter, Kevin J/0000-0003-3273-6031; Millar, Andrew J/0000-0003-1756-3654; Saithong, Treenut/0000-0003-2888-6854	Higher Educational Strategic Scholarships for Frontier Research (SFR), Royal Thai Government; Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC) [BB/D019621]; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish; BBSRC [BB/D019621/1] Funding Source: UKRI	Higher Educational Strategic Scholarships for Frontier Research (SFR), Royal Thai Government; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	TS was supported by the postgraduate studentship from Higher Educational Strategic Scholarships for Frontier Research (SFR), Royal Thai Government. The Centre for Systems Biology at Edinburgh is a Centre for Integrative Systems Biology supported by Biotechnology and Biological Sciences Research Council (BBSRC) and Engineering and Physical Sciences Research Council (EPSRC) through award BB/D019621. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Boothroyd CE, 2008, ANN NY ACAD SCI, V1129, P350, DOI 10.1196/annals.1417.006; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brunner M, 2008, MOL MICROBIOL, V68, P255, DOI 10.1111/j.1365-2958.2008.06148.x; Buceta J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000602; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Doyle FJ, 2006, COMPUT CHEM ENG, V30, P1700, DOI 10.1016/j.compchemeng.2006.05.029; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Eckardt NA, 2005, PLANT CELL, V17, P645, DOI 10.1105/tpc.104.031336; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Ferreira JS, 2006, LECT NOTES CONTR INF, V341, P279; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Johnson CH, 1999, ANNU REV MICROBIOL, V53, P389, DOI 10.1146/annurev.micro.53.1.389; KIM J, 2007, BIOPHYSICAL J BIOPHY, pL1; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondo T, 2007, COLD SPRING HARB SYM, V72, P47, DOI 10.1101/sqb.2007.72.029; Kurata H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001103; Kurosawa G, 2002, J THEOR BIOL, V216, P193, DOI 10.1006/jtbi.2002.2546; Kurosawa G, 2002, J BIOL RHYTHM, V17, P568, DOI 10.1177/0748730402238239; Kwon YK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-430; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Leloup JC, 2008, BIOESSAYS, V30, P590, DOI 10.1002/bies.20762; Lindenschmidt KE, 2006, ECOL MODEL, V190, P72, DOI 10.1016/j.ecolmodel.2005.04.016; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; Masuda N, 2008, J COMPUT NEUROSCI, V24, P137, DOI 10.1007/s10827-007-0045-7; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Miyoshi F, 2007, J BIOL RHYTHM, V22, P69, DOI 10.1177/0748730406295749; Mizuno T, 2005, PLANT CELL PHYSIOL, V46, P677, DOI 10.1093/pcp/pci087; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Murray JD.., 2003, MATH BIOL, DOI DOI 10.1007/B98869; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, pS135; Paladugu SR, 2006, IEE P SYST BIOL, V153, P223, DOI 10.1049/ip-syb:20050096; Rand DA, 2004, J ROY SOC INTERFACE, V1, P119, DOI 10.1098/rsif.2004.0014; SAITHONG T, 2010, CONSISTENT ROB UNPUB; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Wolf J, 2005, SYSTEMS BIOL, V2, P35, DOI 10.1049/sb:20045035; Zak DE, 2005, COMPUT CHEM ENG, V29, P663, DOI 10.1016/j.compchemeng.2004.08.021; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	57	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e13867	10.1371/journal.pone.0013867	http://dx.doi.org/10.1371/journal.pone.0013867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152419	gold, Green Submitted, Green Published			2022-12-27	WOS:000284755100001
J	Tobe, SS; Kitchener, AC; Linacre, AMT				Tobe, Shanan S.; Kitchener, Andrew C.; Linacre, Adrian M. T.			Reconstructing Mammalian Phylogenies: A Detailed Comparison of the Cytochrome b and Cytochrome Oxidase Subunit I Mitochondrial Genes	PLOS ONE			English	Article							MOLECULAR EVIDENCE; NUCLEOTIDE SUBSTITUTION; DNA EVOLUTION; SEQUENCE; BALEEN; VARIABILITY; NUCLEAR; RATES; IDENTIFICATION; AMPLIFICATION	The phylogeny and taxonomy of mammalian species were originally based upon shared or derived morphological characteristics. However, genetic analyses have more recently played an increasingly important role in confirming existing or establishing often radically different mammalian groupings and phylogenies. The two most commonly used genetic loci in species identification are the cytochrome oxidase I gene (COI) and the cytochrome b gene (cyt b). For the first time this study provides a detailed comparison of the effectiveness of these two loci in reconstructing the phylogeny of mammals at different levels of the taxonomic hierarchy in order to provide a basis for standardizing methodologies in the future. Interspecific and intraspecific variation is assessed and for the first time, to our knowledge, statistical confidence is applied to sequence comparisons. Comparison of the DNA sequences of 217 mammalian species reveals that cyt b more accurately reconstructs their phylogeny and known relationships between species based on other molecular and morphological analyses at Super Order, Order, Family and generic levels. Cyt b correctly assigned 95.85% of mammal species to Super Order, 94.31% to Order and 98.16% to Family compared to 78.34%, 93.36% and 96.93% respectively for COI. Cyt b also gives better resolution when separating species based on sequence data. Using a Kimura 2-parameter p-distance (x100) threshold of 1.5-2.5, cyt b gives a better resolution for separating species with a lower false positive rate and higher positive predictive value than those of COI.	[Tobe, Shanan S.] Univ Strathclyde, Dept Pure & Appl Chem, Ctr Forens Sci, WestCHEM, Glasgow, Lanark, Scotland; [Kitchener, Andrew C.] Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Kitchener, Andrew C.] Univ Edinburgh, Inst Geog, Sch Geosci, Edinburgh, Midlothian, Scotland; [Linacre, Adrian M. T.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	University of Strathclyde; University of Edinburgh; Flinders University South Australia	Tobe, SS (corresponding author), Univ Strathclyde, Dept Pure & Appl Chem, Ctr Forens Sci, WestCHEM, Glasgow, Lanark, Scotland.	shanan.s.tobe@strath.ac.uk	Tobe, Shanan/AAL-9771-2021; Linacre, Adrian/I-5377-2015; Tobe, Shanan/U-1859-2019	Linacre, Adrian/0000-0001-5890-5548; Tobe, Shanan/0000-0002-4854-6278; Kitchener, Andrew/0000-0003-2594-0827	Leverhulme Trust [A20080076]	Leverhulme Trust(Leverhulme Trust)	This project was funded by the Leverhulme Trust (Grant number A20080076) awarded to AMTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiadh A, 2010, MOL PHYLOGENET EVOL, V56, P513, DOI 10.1016/j.ympev.2010.04.018; Abramov AV, 2006, ZOOL ZH, V85, P641; Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; Aitken C., 2004, STAT EVALUATION EVID; Alessandrini F, 2008, FORENS SCI INT-GEN S, V1, P584, DOI 10.1016/j.fsigss.2007.10.128; Alter SE, 2009, J MOL EVOL, V68, P97, DOI 10.1007/s00239-008-9193-2; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Ascunce MS, 2003, FOLIA PRIMATOL, V74, P165, DOI 10.1159/000070651; Asher RJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-108; Balitzki-Korte B, 2005, INT J LEGAL MED, V119, P291, DOI 10.1007/s00414-005-0537-9; BERTA A, 2006, MARINE MAMMALS EVOLU; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Buckley-Beason VA, 2006, CURR BIOL, V16, P2371, DOI 10.1016/j.cub.2006.08.066; Cardillo M, 2004, J ZOOL, V264, P11, DOI 10.1017/S0952836904005539; Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Desmyter S, 2009, FORENSIC SCI INT-GEN, V3, P89, DOI 10.1016/j.fsigen.2008.11.002; Driscoll Carlos A., 2010, Journal of Biology (London), V9, P10, DOI 10.1186/jbiol226; Dubey B, 2009, CONSERV GENET, V10, P1861, DOI 10.1007/s10592-009-9835-y; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; GEYER CJ, 1991, COMP SCI STAT, V23, P156, DOI DOI 10.1080/01621459.1995.10476590; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Groves C.P., 2001, PRIMATE TAXONOMY; Hatch LT, 2006, MOL PHYLOGENET EVOL, V41, P12, DOI 10.1016/j.ympev.2006.05.023; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HONEYCUTT RL, 1995, J MOL EVOL, V40, P260, DOI 10.1007/BF00163231; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; *INT COMM ZOOL NOM, 2003, B ZOOLOGICAL NOMENCL, V60, P81; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Kartavtsev YP, 2006, RUSS J GENET+, V42, P341, DOI 10.1134/S1022795406040016; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitchener A. C., 2010, International Zoo Yearbook, V44, P33, DOI 10.1111/j.1748-1090.2009.00087.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu FGR, 2001, SCIENCE, V291, P1786, DOI 10.1126/science.1056346; Marcot Jonathan D., 2007, P4; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Melton T, 2007, J FORENSIC SCI, V52, P1305, DOI 10.1111/j.1556-4029.2007.00553.x; Mitani Tomoaki, 2009, Leg Med (Tokyo), V11 Suppl 1, pS449, DOI 10.1016/j.legalmed.2009.02.002; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Nei M, 2000, MOL EVOLUTION PHYLOG; Nikaido M, 2006, MOL BIOL EVOL, V23, P866, DOI 10.1093/molbev/msj071; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Osterholz M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-58; Peng R, 2007, GENE, V397, P76, DOI 10.1016/j.gene.2007.04.009; Phillips MJ, 2006, SYST BIOL, V55, P122, DOI 10.1080/10635150500481614; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Price SA, 2005, BIOL REV, V80, P445, DOI 10.1017/S1464793105006743; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Rakotoarisoa JE, 2010, MOL PHYLOGENET EVOL, V57, P11, DOI 10.1016/j.ympev.2010.05.022; Reyes A, 2004, MOL BIOL EVOL, V21, P397, DOI 10.1093/molbev/msh033; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; ROSE KD, 2006, BEGINNING AGE MAMMAL; Santamaria M, 2007, BIOL CHEM, V388, P943, DOI 10.1515/BC.2007.121; Sasaki T, 2005, SYST BIOL, V54, P77, DOI 10.1080/10635150590905939; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shoshani J, 1998, MOL PHYLOGENET EVOL, V9, P572, DOI 10.1006/mpev.1998.0520; SILBERMAYR K, 2009, ANIM GENET IN PRESS; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; STEWART A, 2002, BASIC STAT EPIDEMIOL; Su B, 1999, MOL PHYLOGENET EVOL, V12, P241, DOI 10.1006/mpev.1999.0616; Tabuce R, 2008, MAMMALIA, V72, P2, DOI 10.1515/MAMM.2008.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ting N, 2008, MOL PHYLOGENET EVOL, V46, P466, DOI 10.1016/j.ympev.2007.11.008; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Zhang GY, 2009, SCIENCE, V323, P1672, DOI 10.1126/science.323.5922.1672	90	113	116	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14156	10.1371/journal.pone.0014156	http://dx.doi.org/10.1371/journal.pone.0014156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152400	gold, Green Accepted, Green Published			2022-12-27	WOS:000284755100034
J	Vishnoi, A; Roy, R; Prasad, HK; Bhattacharya, A				Vishnoi, Anchal; Roy, Rahul; Prasad, Hanumanthappa K.; Bhattacharya, Alok			Anchor-Based Whole Genome Phylogeny (ABWGP): A Tool for Inferring Evolutionary Relationship among Closely Related Microorganims	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SEQUENCE ALIGNMENT; GENE ORDER; TREE; REGIONS; IDENTIFICATION; CHROMOSOME; ORGANISMS; STRAINS; LEPROSY	Phenotypic behavior of a group of organisms can be studied using a range of molecular evolutionary tools that help to determine evolutionary relationships. Traditionally a gene or a set of gene sequences was used for generating phylogenetic trees. Incomplete evolutionary information in few selected genes causes problems in phylogenetic tree construction. Whole genomes are used as remedy. Now, the task is to identify the suitable parameters to extract the hidden information from whole genome sequences that truly represent evolutionary information. In this study we explored a random anchor (a stretch of 100 nucleotides) based approach (ABWGP) for finding distance between any two genomes, and used the distance estimates to compute evolutionary trees. A number of strains and species of Mycobacteria were used for this study. Anchor-derived parameters, such as cumulative normalized score, anchor order and indels were computed in a pair-wise manner, and the scores were used to compute distance/phylogenetic trees. The strength of branching was determined by bootstrap analysis. The terminal branches are clearly discernable using the distance estimates described here. In general, different measures gave similar trees except the trees based on indels. Overall the tree topology reflected the known biology of the organisms. This was also true for different strains of Escherichia coli. A new whole genome-based approach has been described here for studying evolutionary relationships among bacterial strains and species.	[Vishnoi, Anchal; Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Informat Technol, Ctr Computat Biol & Bioinformat, New Delhi 110067, India; [Roy, Rahul] Indian Stat Inst, New Delhi 110016, India; [Prasad, Hanumanthappa K.] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Indian Statistical Institute; Indian Statistical Institute Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Jawaharlal Nehru University, New Delhi	Vishnoi, A (corresponding author), Jawaharlal Nehru Univ, Sch Informat Technol, Ctr Computat Biol & Bioinformat, New Delhi 110067, India.	alok.bhattacharya@jnu.ac.in	vishnoi, anchal/B-8372-2011		Department of BioTechnology, India; Department of Science and Technology	Department of BioTechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology(Department of Science & Technology (India))	This work was supported by the Department of BioTechnology, India. RR was supported by a grant from the Department of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brosch R, 1999, INFECT IMMUN, V67, P5768, DOI 10.1128/IAI.67.11.5768-5774.1999; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Chen Q, 2006, MICROBIOL-SGM, V152, P1041, DOI 10.1099/mic.0.28648-0; CHIN DP, 1994, J INFECT DIS, V169, P289, DOI 10.1093/infdis/169.2.289; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Ding GH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003357; Eisen JA, 2000, CURR OPIN MICROBIOL, V3, P475, DOI 10.1016/S1369-5274(00)00125-9; Eisen JA, 1995, J MOL EVOL, V41, P1105; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fitz-Gibbon ST, 1999, NUCLEIC ACIDS RES, V27, P4218, DOI 10.1093/nar/27.21.4218; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Fukami-Kobayashi K, 2007, MOL BIOL EVOL, V24, P1181, DOI 10.1093/molbev/msm034; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Grishin NV, 2000, GENOME RES, V10, P991, DOI 10.1101/gr.10.7.991; Gu X, 2004, MOL BIOL EVOL, V21, P1401, DOI 10.1093/molbev/msh138; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; House CH, 2002, J MOL EVOL, V54, P539, DOI 10.1007/s00239-001-0054-5; Huynen MA, 2001, TRENDS GENET, V17, P304, DOI 10.1016/S0168-9525(01)02302-2; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; Kato-Maeda M, 2001, GENOME RES, V11, P547, DOI 10.1101/gr.166401; Lawrence JG, 1997, TRENDS MICROBIOL, V5, P355, DOI 10.1016/S0966-842X(97)01110-4; Lienau EK, 2010, CLADISTICS, V26, P195, DOI 10.1111/j.1096-0031.2009.00288.x; Lienau EK, 2006, SYST BIOL, V55, P441, DOI 10.1080/10635150600697416; Lunter G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-83; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANKOFF D, 1992, P NATL ACAD SCI USA, V89, P6575, DOI 10.1073/pnas.89.14.6575; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; *SWOFFORDOLSEN WAD, 1996, PHYL INF MOL SYST, pCH11; Tamames J, 2001, GENOME BIOL, V2; Tekaia F, 1999, GENOME RES, V9, P550; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Vishnoi A, 2007, NUCLEIC ACIDS RES, V35, P3654, DOI 10.1093/nar/gkm209; Vissa V. D., 2001, Genome Biology, V2, P1023, DOI 10.1186/gb-2001-2-8-reviews1023; Warren RM, 2000, MOL MICROBIOL, V37, P1405, DOI 10.1046/j.1365-2958.2000.02090.x; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385	56	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14159	10.1371/journal.pone.0014159	http://dx.doi.org/10.1371/journal.pone.0014159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152403	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100037
J	D'Castro, L; Wenborn, A; Gros, N; Joiner, S; Cronier, S; Collinge, J; Wadsworth, JDF				D'Castro, Laura; Wenborn, Adam; Gros, Nathalie; Joiner, Susan; Cronier, Sabrina; Collinge, John; Wadsworth, Jonathan D. F.			Isolation of Proteinase K-Sensitive Prions Using Pronase E and Phosphotungstic Acid	PLOS ONE			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; SPONGIFORM ENCEPHALOPATHY; STRAIN VARIATION; TRANSGENIC MICE; MOLECULAR-BASIS; DISEASE; PROTEASE; SCRAPIE; PRPSC; THERMOLYSIN	Disease-related prion protein, PrP(Sc), is classically distinguished from its normal cellular precursor, PrP(C), by its detergent insolubility and partial resistance to proteolysis. Molecular diagnosis of prion disease typically relies upon detection of protease-resistant fragments of PrP(Sc) using proteinase K, however it is now apparent that the majority of disease-related PrP and indeed prion infectivity may be destroyed by this treatment. Here we report that digestion of RML prion-infected mouse brain with pronase E, followed by precipitation with sodium phosphotungstic acid, eliminates the large majority of brain proteins, including PrP(C), while preserving >70% of infectious prion titre. This procedure now allows characterization of proteinase K-sensitive prions and investigation of their clinical relevance in human and animal prion disease without being confounded by contaminating PrP	[D'Castro, Laura] Natl Hosp Neurol & Neurosurg, MRC Prion Unit, London WC1N 3BG, England; Natl Hosp Neurol & Neurosurg, Dept Neurodegenerat Dis, UCL Inst Neurol, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	D'Castro, L (corresponding author), Natl Hosp Neurol & Neurosurg, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	j.d.wadsworth@prion.ucl.ac.uk		Wadsworth, Jonathan/0000-0002-4797-2259	UK Medical Research Council; Medical Research Council [MC_U123160655] Funding Source: researchfish; MRC [MC_U123160655] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the UK Medical Research Council (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CHANDLER RL, 1961, LANCET, V1, P1378; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hill AF, 2006, BRAIN, V129, P676, DOI 10.1093/brain/awl013; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kuczius T, 2007, EUR J NEUROSCI, V25, P2649, DOI 10.1111/j.1460-9568.2007.05518.x; Kuczius T, 2009, MOL CELL NEUROSCI, V42, P226, DOI 10.1016/j.mcn.2009.07.004; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; Owen JP, 2007, MOL BIOTECHNOL, V35, P161, DOI 10.1007/BF02686111; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, J VIROL, V79, P10796, DOI 10.1128/JVI.79.16.10796-10806.2005; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wadsworth JDF, 2007, BBA-MOL BASIS DIS, V1772, P598, DOI 10.1016/j.bbadis.2007.02.010; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200	44	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15679	10.1371/journal.pone.0015679	http://dx.doi.org/10.1371/journal.pone.0015679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187933	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200063
J	Feinberg, DA; Moeller, S; Smith, SM; Auerbach, E; Ramanna, S; Glasser, MF; Miller, KL; Ugurbil, K; Yacoub, E				Feinberg, David A.; Moeller, Steen; Smith, Stephen M.; Auerbach, Edward; Ramanna, Sudhir; Glasser, Matt F.; Miller, Karla L.; Ugurbil, Kamil; Yacoub, Essa			Multiplexed Echo Planar Imaging for Sub-Second Whole Brain FMRI and Fast Diffusion Imaging	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; TO-NOISE RATIO; FUNCTIONAL MRI; 7 TESLA; SENSORY STIMULATION; SIGNAL CHANGES; HEAD COIL; EPI; HUMANS; CONNECTIVITY	Echo planar imaging (EPI) is an MRI technique of particular value to neuroscience, with its use for virtually all functional MRI (fMRI) and diffusion imaging of fiber connections in the human brain. EPI generates a single 2D image in a fraction of a second; however, it requires 2-3 seconds to acquire multi-slice whole brain coverage for fMRI and even longer for diffusion imaging. Here we report on a large reduction in EPI whole brain scan time at 3 and 7 Tesla, without significantly sacrificing spatial resolution, and while gaining functional sensitivity. The multiplexed-EPI (M-EPI) pulse sequence combines two forms of multiplexing: temporal multiplexing (m) utilizing simultaneous echo refocused (SIR) EPI and spatial multiplexing (n) with multibanded RF pulses (MB) to achieve mxn images in an EPI echo train instead of the normal single image. This resulted in an unprecedented reduction in EPI scan time for whole brain fMRI performed at 3 Tesla, permitting TRs of 400 ms and 800 ms compared to a more conventional 2.5 sec TR, and 2-4 times reductions in scan time for HARDI imaging of neuronal fibertracks. The simultaneous SE refocusing of SIR imaging at 7 Tesla advantageously reduced SAR by using fewer RF refocusing pulses and by shifting fat signal out of the image plane so that fat suppression pulses were not required. In preliminary studies of resting state functional networks identified through independent component analysis, the 6-fold higher sampling rate increased the peak functional sensitivity by 60%. The novel M-EPI pulse sequence resulted in a significantly increased temporal resolution for whole brain fMRI, and as such, this new methodology can be used for studying non-stationarity in networks and generally for expanding and enriching the functional information.	[Feinberg, David A.] Univ Calif Berkeley, Helen Wills Inst Neurosci, Berkeley, CA 94720 USA; [Feinberg, David A.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Moeller, Steen; Auerbach, Edward; Ugurbil, Kamil; Yacoub, Essa] Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Smith, Stephen M.; Miller, Karla L.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Oxford OX3 9DU, England; [Glasser, Matt F.] Washington Univ, Sch Med, St Louis, MO USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of Oxford; Washington University (WUSTL)		david.feinberg@advancedmri.com	Yacoub, Essa/AAS-7757-2021; Auerbach, Edward John/D-9980-2015; Glasser, Matthew Frederick/AAE-7291-2019; Ugurbil, Kamil/AAD-6058-2022	Auerbach, Edward John/0000-0003-4553-1545; Miller, Karla/0000-0002-2511-3189; Smith, Stephen/0000-0001-8166-069X	16 National Institutes of Health Institutes and Centers [1U54MH091657-01]; NIH [1R44NS063537, 1R44NS073417, R01 EB000331, P30 NS057091, P41 RR08079, S10 RR1395]; National Science Foundation [DBI-9907842]; W. M. Keck Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079, P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R44NS073417, R44NS063537, P30NS057091] Funding Source: NIH RePORTER	16 National Institutes of Health Institutes and Centers; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Human Connectome Project (1U54MH091657-01) from the 16 National Institutes of Health Institutes and Centers that support the NIH Blueprint for Neuroscience Research, and NIH grants, 1R44NS063537, 1R44NS073417, R01 EB000331, P30 NS057091, and P41 RR08079. The 7 T magnet purchase was funded in part by National Science Foundation DBI-9907842 and NIH S10 RR1395 and the W. M. Keck Foundation. Authors of this work were also supported and employed by Advanced MRI Technologies. As such, one of the funders of this work (Advanced MRI Technologies) played a role in experimental design, the decision to publish, and preparation of the manuscript.	Adriany G, 2005, MAGN RESON MED, V53, P434, DOI 10.1002/mrm.20321; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Delalande C, 1999, MAGNET RESON MED, V41, P1000, DOI 10.1002/(SICI)1522-2594(199905)41:5<1000::AID-MRM20>3.0.CO;2-G; FEINBERG DA, 1986, RADIOLOGY, V161, P527, DOI 10.1148/radiology.161.2.3763926; Feinberg DA, 2002, MAGN RESON MED, V48, P1, DOI 10.1002/mrm.10227; FEINBERG DA, 1990, MAGN RESON MED, V16, P280, DOI 10.1002/mrm.1910160209; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Golay X, 2000, MAGNET RESON MED, V43, P779, DOI 10.1002/1522-2594(200006)43:6<779::AID-MRM1>3.0.CO;2-4; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Hesselmann V, 2004, J MAGN RESON IMAGING, V20, P321, DOI 10.1002/jmri.20101; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Hyde JS, 2001, MAGN RESON MED, V46, P114, DOI 10.1002/mrm.1166; Ivanov D, 2010, MAGN RESON MED, V64, P319, DOI 10.1002/mrm.22518; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; KIM SG, 1994, NMR BIOMED, V7, P69, DOI 10.1002/nbm.1940070111; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Larkman DJ, 2001, J MAGN RESON IMAGING, V13, P313, DOI 10.1002/1522-2586(200102)13:2<313::AID-JMRI1045>3.0.CO;2-W; Lee GR, 2010, NEUROIMAGE, V52, P1428, DOI 10.1016/j.neuroimage.2010.05.004; Liang ZP, 2003, IEEE T MED IMAGING, V22, P1026, DOI 10.1109/TMI.2003.815896; LIU GY, 1993, MAGNET RESON MED, V30, P764, DOI 10.1002/mrm.1910300617; Madore B, 1999, MAGNET RESON MED, V42, P813, DOI 10.1002/(SICI)1522-2594(199911)42:5<813::AID-MRM1>3.0.CO;2-S; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; MANSFIELD P, 1994, MAGN RESON MATER PHY, V2, P291, DOI 10.1007/BF01705255; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Mori S, 1999, ANAT REC, V257, P102; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Nagy Z, 2008, MAGN RESON MED, V60, P1256, DOI 10.1002/mrm.21746; Neggers SFW, 2008, NMR BIOMED, V21, P663, DOI 10.1002/nbm.1235; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Ohliger MA, 2003, MAGNET RESON MED, V50, P1018, DOI 10.1002/mrm.10597; Poser BA, 2010, NEUROIMAGE, V51, P261, DOI 10.1016/j.neuroimage.2010.01.108; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Reese TG, 2009, J MAGN RESON IMAGING, V29, P517, DOI 10.1002/jmri.21497; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sodickson DK, 1999, MAGN RESON IMAGING C, pvii; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Ugurbil K, 2003, MAGN RESON IMAGING, V21, P1263, DOI 10.1016/j.mri.2003.08.027; WANG R, 2007, DIFFUSION TOOLKIT TR; Wang Z, 2005, MAGN RESON MED, V54, P738, DOI 10.1002/mrm.20601; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; WIELOPOLSKI PA, 1995, JMRI-J MAGN RESON IM, V5, P403, DOI 10.1002/jmri.1880050406; Wiesinger F, 2004, MAGN RESON MED, V52, P953, DOI 10.1002/mrm.20281; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yacoub E, 2005, NEUROIMAGE, V24, P738, DOI 10.1016/j.neuroimage.2004.09.002; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105	57	866	881	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15710	10.1371/journal.pone.0015710	http://dx.doi.org/10.1371/journal.pone.0015710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187930	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200067
J	Hauser, PM; Burdet, FX; Cisse, OH; Keller, L; Taffe, P; Sanglard, D; Pagni, M				Hauser, Philippe M.; Burdet, Frederic X.; Cisse, Ousmane H.; Keller, Laurent; Taffe, Patrick; Sanglard, Dominique; Pagni, Marco			Comparative Genomics Suggests that the Fungal Pathogen Pneumocystis Is an Obligate Parasite Scavenging Amino Acids from Its Host's Lungs	PLOS ONE			English	Article							GENE PREDICTION; CARINII; METABOLISM; INSIGHTS; COEVOLUTION; SPECIFICITY; GENERATION; PNEUMONIA; PATHWAYS; PROTEASE	Pneumocystis jirovecii is a fungus causing severe pneumonia in immuno-compromised patients. Progress in understanding its pathogenicity and epidemiology has been hampered by the lack of a long-term in vitro culture method. Obligate parasitism of this pathogen has been suggested on the basis of various features but remains controversial. We analysed the 7.0 Mb draft genome sequence of the closely related species Pneumocystis carinii infecting rats, which is a well established experimental model of the disease. We predicted 8'085 (redundant) peptides and 14.9% of them were mapped onto the KEGG biochemical pathways. The proteome of the closely related yeast Schizosaccharomyces pombe was used as a control for the annotation procedure (4'974 genes, 14.1% mapped). About two thirds of the mapped peptides of each organism (65.7% and 73.2%, respectively) corresponded to crucial enzymes for the basal metabolism and standard cellular processes. However, the proportion of P. carinii genes relative to those of S. pombe was significantly smaller for the "amino acid metabolism'' category of pathways than for all other categories taken together (40 versus 114 against 278 versus 427, P<0.002). Importantly, we identified in P. carinii only 2 enzymes specifically dedicated to the synthesis of the 20 standard amino acids. By contrast all the 54 enzymes dedicated to this synthesis reported in the KEGG atlas for S. pombe were detected upon reannotation of S. pombe proteome (2 versus 54 against 278 versus 427, P<0.0001). This finding strongly suggests that species of the genus Pneumocystis are scavenging amino acids from their host's lung environment. Consequently, they would have no form able to live independently from another organism, and these parasites would be obligate in addition to being opportunistic. These findings have implications for the management of patients susceptible to P. jirovecii infection given that the only source of infection would be other humans.	[Hauser, Philippe M.; Burdet, Frederic X.; Cisse, Ousmane H.; Sanglard, Dominique] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Burdet, Frederic X.; Pagni, Marco] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland; [Taffe, Patrick] CHU Vaudois, Ctr Data, Swiss HIV Cohort Study, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hauser, PM (corresponding author), CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland.	Philippe.Hauser@chuv.ch	keller, laurent/AAI-7175-2020; Cisse, Ousmane/X-6408-2019; Cissé, Ousmane/N-8780-2018; Taffé, Patrick/AAW-2701-2020; Sanglard, Dominique/K-6032-2017	Cisse, Ousmane/0000-0002-2990-2185; Cissé, Ousmane/0000-0002-2990-2185; Sanglard, Dominique/0000-0002-5244-4178; Hauser, Philippe/0000-0003-2834-7922; Pagni, Marco/0000-0001-9292-9463; keller, laurent/0000-0002-5046-9953; Taffe, Patrick/0000-0002-2049-6651	Swiss National Science Foundation (snf.ch) [310030-124998]	Swiss National Science Foundation (snf.ch)(Swiss National Science Foundation (SNSF))	This study was supported by Swiss National Science Foundation (snf.ch) grant 310030-124998. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambrose HE, 2004, MICROBIOL-SGM, V150, P293, DOI 10.1099/mic.0.26539-0; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Atzori C, 2000, J INFECT DIS, V181, P1629, DOI 10.1086/315437; Basselin M, 2001, ARCH BIOCHEM BIOPHYS, V391, P90, DOI 10.1006/abbi.2001.2389; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Choi Min-Ho, 2000, Korean Journal of Parasitology, V38, P159, DOI 10.3347/kjp.2000.38.3.159; Corradi N, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1082; Cushion MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000423; Cushion MT, 2004, J EUKARYOT MICROBIOL, V51, P30, DOI 10.1111/j.1550-7408.2004.tb00158.x; Davis JL, 2008, CURR OPIN INFECT DIS, V21, P184, DOI 10.1097/QCO.0b013e3282f54fff; Demanche C, 2001, J CLIN MICROBIOL, V39, P2126, DOI 10.1128/JCM.39.6.2126-2133.2001; Ewann F, 2006, APPL ENVIRON MICROB, V72, P3993, DOI 10.1128/AEM.00684-06; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GIGLIOTTI F, 1993, INFECT IMMUN, V61, P2886, DOI 10.1128/IAI.61.7.2886-2890.1993; Hau J, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-2; JOFFRION TM, 2010, FEMS MICROB IN PRESS; Kaneshiro ES, 2004, LIPIDS, V39, P753, DOI 10.1007/s11745-004-1292-5; Keeling PJ, 2005, FOLIA PARASIT, V52, P8, DOI 10.14411/fp.2005.002; Keely SP, 2005, GENETICS, V170, P1589, DOI 10.1534/genetics.105.040733; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kutty G, 2008, J INFECT DIS, V198, P741, DOI 10.1086/590433; Nahimana A, 2000, J EUKARYOT MICROBIOL, V47, P368, DOI 10.1111/j.1550-7408.2000.tb00062.x; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Payne SH, 2006, EUKARYOT CELL, V5, P272, DOI 10.1128/EC.5.2.272-276.2006; Reichard U, 2008, MYCOSES, V51, P30, DOI 10.1111/j.1439-0507.2008.01584.x; Rodrigues MG, 2003, INT J SYST EVOL MICR, V53, P607, DOI 10.1099/ijs.0.02437-0; Sakharkar KR, 2004, INT J SYST EVOL MICR, V54, P1937, DOI 10.1099/ijs.0.63090-0; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stringer JR, 1998, FEMS IMMUNOL MED MIC, V22, P15, DOI 10.1111/j.1574-695X.1998.tb01183.x; Sugiyama Junta, 1998, Mycoscience, V39, P487, DOI 10.1007/BF02460912; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; WAKEFIELD AE, 1995, BAILLIERE CLIN INF D, V2, P431; Wakefield AE, 1998, MED MYCOL, V36, P183	42	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15152	10.1371/journal.pone.0015152	http://dx.doi.org/10.1371/journal.pone.0015152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188143	Green Published, gold			2022-12-27	WOS:000285575200016
J	Mitea, C; Salentijn, EMJ; van Veelen, P; Goryunova, SV; van der Meer, IM; van den Broeck, HC; Mujico, JR; Monserrat, V; Gilissen, LJWJ; Drijfhout, JW; Dekking, L; Koning, F; Smulders, MJM				Mitea, Cristina; Salentijn, Elma M. J.; van Veelen, Peter; Goryunova, Svetlana V.; van der Meer, Ingrid M.; van den Broeck, Hetty C.; Mujico, Jorge R.; Monserrat, Veronica; Gilissen, Luud J. W. J.; Drijfhout, Jan Wouter; Dekking, Liesbeth; Koning, Frits; Smulders, Marinus J. M.			A Universal Approach to Eliminate Antigenic Properties of Alpha-Gliadin Peptides in Celiac Disease	PLOS ONE			English	Article							CEREAL TOXICITY; WHEAT; EPITOPES; MUTAGENESIS; PREVALENCE; VARIETIES; EXPLAINS; BINDING; CELLS; DNA	Celiac disease is caused by an uncontrolled immune response to gluten, a heterogeneous mixture of wheat storage proteins, including the alpha-gliadins. It has been shown that alpha-gliadins harbor several major epitopes involved in the disease pathogenesis. A major step towards elimination of gluten toxicity for celiac disease patients would thus be the elimination of such epitopes from alpha-gliadins. We have analyzed over 3,000 expressed alpha-gliadin sequences from 11 bread wheat cultivars to determine whether they encode for peptides potentially involved in celiac disease. All identified epitope variants were synthesized as peptides and tested for binding to the disease-associated HLA-DQ2 and HLA-DQ8 molecules and for recognition by patient-derived alpha-gliadin specific T cell clones. Several specific naturally occurring amino acid substitutions were identified for each of the alpha-gliadin derived peptides involved in celiac disease that eliminate the antigenic properties of the epitope variants. Finally, we provide proof of principle at the peptide level that through the systematic introduction of such naturally occurring variations alpha-gliadins genes can be generated that no longer encode antigenic peptides. This forms a crucial step in the development of strategies to modify gluten genes in wheat so that it becomes safe for celiac disease patients. It also provides the information to design and introduce safe gluten genes in other cereals, which would exhibit improved quality while remaining safe for consumption by celiac disease patients.	[Mitea, Cristina; van Veelen, Peter; Mujico, Jorge R.; Monserrat, Veronica; Drijfhout, Jan Wouter; Dekking, Liesbeth; Koning, Frits] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Salentijn, Elma M. J.; Goryunova, Svetlana V.; van der Meer, Ingrid M.; van den Broeck, Hetty C.; Gilissen, Luud J. W. J.; Smulders, Marinus J. M.] Wageningen UR, Wageningen, Netherlands; [Gilissen, Luud J. W. J.; Smulders, Marinus J. M.] Allergy Ctr Wageningen, Wageningen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mitea, C (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	f.koning@lumc.nl; rene.smulders@wur.nl	Goryunova, Svetlana/AAE-2743-2019; Drijfhout, Jan Wouter/ABA-6318-2021; gilisen, luud/F-5496-2017; Smulders, M.J.M./B-3654-2009	Drijfhout, Jan Wouter/0000-0003-4808-5296; Smulders, M.J.M./0000-0002-8549-6046; Mujico Fernandez, Jorge Raul/0000-0002-1235-9120; van Veelen, Peter/0000-0002-7898-9408; Koning, Frits/0000-0002-4007-5715	Celiac Disease Consortium; Dutch Government [BSIK03009]; Center for Medical Systems Biology (CMSB); The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO); The Netherlands Ministry of Agriculture, Nature, and Food Safety [KB-05-001-019]	Celiac Disease Consortium; Dutch Government; Center for Medical Systems Biology (CMSB); The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); The Netherlands Ministry of Agriculture, Nature, and Food Safety	This study was supported by the Celiac Disease Consortium, an Innovative Cluster approved by The Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK03009), by the Center for Medical Systems Biology (CMSB), a center of excellence approved by The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO), and by The Netherlands Ministry of Agriculture, Nature, and Food Safety (project KB-05-001-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OD, 1997, THEOR APPL GENET, V95, P50, DOI 10.1007/s001220050531; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; de Pater S, 2009, PLANT BIOTECHNOL J, V7, P821, DOI 10.1111/j.1467-7652.2009.00446.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kawaura K, 2005, PLANT PHYSIOL, V139, P1870, DOI 10.1104/pp.105.070722; Koning F, 2005, GASTROENTEROLOGY, V129, P1294, DOI 10.1053/j.gastro.2005.07.030; Li J, 2007, CURR OPIN PLANT BIOL, V10, P131, DOI 10.1016/j.pbi.2007.01.007; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; OKITA TW, 1985, J BIOL CHEM, V260, P8203; Qiao SW, 2005, J IMMUNOL, V175, P254, DOI 10.4049/jimmunol.175.1.254; Rewers M, 2005, GASTROENTEROLOGY, V128, pS47, DOI 10.1053/j.gastro.2005.02.030; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Stepniak D, 2008, J IMMUNOL, V180, P3268, DOI 10.4049/jimmunol.180.5.3268; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Vader LW, 2003, GASTROENTEROLOGY, V125, P1105, DOI 10.1016/S0016-5085(03)01204-6; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; van de Wal Y, 1999, EUR J IMMUNOL, V29, P3133, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3133::AID-IMMU3133&gt;3.0.CO;2-G; van den Broeck H, 2010, MOL BIOSYST, V6, P2206, DOI 10.1039/c0mb00046a; van den Broeck HC, 2010, THEOR APPL GENET, V121, P1527, DOI 10.1007/s00122-010-1408-4; van Herpen TWJM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-1	31	57	69	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15637	10.1371/journal.pone.0015637	http://dx.doi.org/10.1371/journal.pone.0015637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179575	Green Published, gold			2022-12-27	WOS:000285381200034
J	Riederer, I; Sievert, W; Eissner, G; Molls, M; Multhoff, G				Riederer, Isabelle; Sievert, Wolfgang; Eissner, Guenther; Molls, Michael; Multhoff, Gabriele			Irradiation-Induced Up-Regulation of HLA-E on Macrovascular Endothelial Cells Confers Protection against Killing by Activated Natural Killer Cells	PLOS ONE			English	Article							TRANSENDOTHELIAL MIGRATION; CYTOLYTIC ACTIVITY; NK CELLS; E BINDS; ADHESION; NKG2D; CYTOTOXICITY; EXPRESSION; PEPTIDE; HSP70	Background: Apart from the platelet/endothelial cell adhesion molecule 1 (PECAM-1, CD31), endoglin (CD105) and a positive factor VIII-related antigen staining, human primary and immortalized macro-and microvascular endothelial cells (ECs) differ in their cell surface expression of activating and inhibitory ligands for natural killer (NK) cells. Here we comparatively study the effects of irradiation on the phenotype of ECs and their interaction with resting and activated NK cells. Methodology/Principal Findings: Primary macrovascular human umbilical vein endothelial cells (HUVECs) only express UL16 binding protein 2 (ULBP2) and the major histocompatibility complex (MHC) class I chain-related protein MIC-A (MIC-A) as activating signals for NK cells, whereas the corresponding immortalized EA. hy926 EC cell line additionally present ULBP3, membrane heat shock protein 70 (Hsp70), intercellular adhesion molecule ICAM-1 (CD54) and HLA-E. Apart from MIC-B, the immortalized human microvascular endothelial cell line HMEC, resembles the phenotype of EA. hy926. Surprisingly, primary HUVECs are more sensitive to Hsp70 peptide (TKD) plus IL-2 (TKD/IL-2)-activated NK cells than their immortalized EC counterpatrs. This finding is most likely due to the absence of the inhibitory ligand HLA-E, since the activating ligands are shared among the ECs. The co-culture of HUVECs with activated NK cells induces ICAM-1 (CD54) and HLA-E expression on the former which drops to the initial low levels (below 5%) when NK cells are removed. Sublethal irradiation of HUVECs induces similar but less pronounced effects on HUVECs. Along with these findings, irradiation also induces HLA-E expression on macrovascular ECs and this correlates with an increased resistance to killing by activated NK cells. Irradiation had no effect on HLA-E expression on microvascular ECs and the sensitivity of these cells to NK cells remained unaffected. Conclusion/Significance: These data emphasize that an irradiation-induced, transient up-regulation of HLA-E on macrovascular ECs might confer protection against NK cell-mediated vascular injury.	[Riederer, Isabelle; Sievert, Wolfgang; Molls, Michael; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany; [Riederer, Isabelle; Sievert, Wolfgang; Molls, Michael; Multhoff, Gabriele] Helmholtz Zentrum Munchen, CCG Innate Immun Tumor Biol, Munich, Germany; [Eissner, Guenther] Klinikum Univ Munchen, Dept Cardiac Surg, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Riederer, I (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de	Multhoff, Gabriele/AAW-9796-2021	Multhoff, Gabriele/0000-0002-2616-3137; Riederer, Isabelle/0000-0002-7856-8283	EU [FP7-211403]; DFG [SFB824/1]; BMBDF [01EZ0826]; BMBF Kompetenzverbund Strahlenforschung [03NUK007E]; multimmune GmbH	EU(European Commission); DFG(German Research Foundation (DFG)); BMBDF; BMBF Kompetenzverbund Strahlenforschung; multimmune GmbH	The funders are EU-CARDIORISK (FP7-211403), DFG (SFB824/1), BMBDF-MOBITUM (01EZ0826), BMBF Kompetenzverbund Strahlenforschung (03NUK007E) and multimmune GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external sources for this study.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Allavena P, 1996, NAT IMMUN, V15, P107; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Biassoni R, 2003, J CELL MOL MED, V7, P376, DOI 10.1111/j.1582-4934.2003.tb00240.x; Bielawska-Pohl A, 2005, J IMMUNOL, V174, P5573, DOI 10.4049/jimmunol.174.9.5573; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; CARLOS TM, 1994, BLOOD, V84, P2068; Chen WS, 2002, FASEB J, V16, pA214; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cordes N, 2007, INT J RADIAT BIOL, V83, P753, DOI 10.1080/09553000701639694; Ebert EC, 2008, IMMUNOLOGY, V124, P33, DOI 10.1111/j.1365-2567.2007.02656.x; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Gastpar R, 2004, J IMMUNOL, V172, P972, DOI 10.4049/jimmunol.172.2.972; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gifford SM, 2004, J ENDOCRINOL, V182, P485, DOI 10.1677/joe.0.1820485; Giron-Michel J, 2003, J EXP MED, V197, P763, DOI 10.1084/jem.20020150; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Gross C, 2003, CELL STRESS CHAPERON, V8, P348, DOI 10.1379/1466-1268(2003)008<0348:HSPRIA>2.0.CO;2; Gross C, 2003, J BIOL CHEM, V278, P41173, DOI 10.1074/jbc.M302644200; Gross C, 2003, BIOL CHEM, V384, P267, DOI 10.1515/BC.2003.030; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; King AG, 2000, J IMMUNOL, V164, P3774, DOI 10.4049/jimmunol.164.7.3774; Krause SW, 2004, CLIN CANCER RES, V10, P3699, DOI 10.1158/1078-0432.CCR-03-0683; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lilienfeld BG, 2008, XENOTRANSPLANTATION, V15, P136, DOI 10.1111/j.1399-3089.2008.00453.x; Marin R, 2003, IMMUNOGENETICS, V54, P767, DOI 10.1007/s00251-002-0526-9; Multhoff G, 1997, J IMMUNOL, V158, P4341; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Parham P, 2004, IMMUNOL LETT, V92, P11, DOI 10.1016/j.imlet.2003.11.016; Pende D, 2002, CANCER RES, V62, P6178; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; ROBERTSON MJ, 1990, BLOOD, V76, P2421; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stangl S, 2008, CELL STRESS CHAPERON, V13, P221, DOI 10.1007/s12192-007-0008-y; Stangl S, 2006, J IMMUNOL, V176, P6270, DOI 10.4049/jimmunol.176.10.6270; Strasly M, 2001, J IMMUNOL, V166, P3890, DOI 10.4049/jimmunol.166.6.3890; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; ULBRECHT M, 1992, J IMMUNOL, V149, P2945; Videm V, 2008, SCAND J IMMUNOL, V67, P523, DOI 10.1111/j.1365-3083.2008.02029.x; Wallin RPA, 2003, EUR J IMMUNOL, V33, P2727, DOI 10.1002/eji.200324070; Weiss EH, 2009, TRANSPLANTATION, V87, P35, DOI 10.1097/TP.0b013e318191c784; Westgaard IH, 2003, J EXP MED, V197, P1551, DOI 10.1084/jem.20021253	56	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15339	10.1371/journal.pone.0015339	http://dx.doi.org/10.1371/journal.pone.0015339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179573	Green Published, gold, Green Submitted			2022-12-27	WOS:000285381200026
J	Wu, XS; Tschumper, RC; Gutierrez, A; Mihalcik, SA; Nowakowski, GS; Jelinek, DF				Wu, Xiaosheng; Tschumper, Renee C.; Gutierrez, Albert, Jr.; Mihalcik, Stephen A.; Nowakowski, Grzegorz S.; Jelinek, Diane F.			Selective Induction of DNA Repair Pathways in Human B Cells Activated by CD4(+) T Cells	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; SOMATIC HYPERMUTATION; EXPRESSION; LYMPHOMAS; CHROMATIN; CANCER; MICE; BCL6; AID; ATR	Greater than 75% of all hematologic malignancies derive from germinal center (GC) or post-GC B cells, suggesting that the GC reaction predisposes B cells to tumorigenesis. Because GC B cells acquire expression of the highly mutagenic enzyme activation-induced cytidine deaminase (AID), GC B cells may require additional DNA repair capacity. The goal of this study was to investigate whether normal human B cells acquire enhanced expression of DNA repair factors upon AID induction. We first demonstrated that several DNA mismatch repair, homologous recombination, base excision repair, and ATR signaling genes were overexpressed in GC B cells relative to naive and memory B cells, reflecting activation of a process we have termed somatic hyperrepair (SHR). Using an in vitro system, we next characterized activation signals required to induce AID expression and SHR. Although AID expression was induced by a variety of polyclonal activators, SHR induction strictly required signals provided by contact with activated CD4(+) T cells, and B cells activated in this manner displayed reduced levels of DNA damage-induced apoptosis. We further show the induction of SHR is independent of AID expression, as GC B cells from AID -/- mice retained heightened expression of SHR proteins. In consideration of the critical role that CD4(+) T cells play in inducing the SHR process, our data suggest a novel role for CD4(+) T cells in the tumor suppression of GC/post-GC B cells.	[Wu, Xiaosheng; Tschumper, Renee C.; Gutierrez, Albert, Jr.; Mihalcik, Stephen A.; Jelinek, Diane F.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Nowakowski, Grzegorz S.] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Wu, XS (corresponding author), Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA.	jelinek.diane@mayo.edu		Mihalcik, Stephen/0000-0003-2145-467X	National Institutes of Health [R01CA136591, P01CA062242]; NATIONAL CANCER INSTITUTE [P01CA062242, R01CA136591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health (R01CA136591 and P01CA062242 awarded to DFJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang DK, 2000, J BIOL CHEM, V275, P18424, DOI 10.1074/jbc.M001140200; Darce JR, 2007, J IMMUNOL, V179, P7276, DOI 10.4049/jimmunol.179.11.7276; de Yebenes VG, 2006, TRENDS MOL MED, V12, P432, DOI 10.1016/j.molmed.2006.07.001; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Duval A, 2004, P NATL ACAD SCI USA, V101, P5002, DOI 10.1073/pnas.0400945101; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Horner M, SEER CANC STAT REV 1; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klemm L, 2009, CANCER CELL, V16, P232, DOI 10.1016/j.ccr.2009.07.030; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Longo NS, 2009, BLOOD, V113, P3706, DOI 10.1182/blood-2008-10-183632; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Park K, 1998, J IMMUNOL, V161, P6128; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Perez-Duran P, 2007, CARCINOGENESIS, V28, P2427, DOI 10.1093/carcin/bgm201; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ranuncolo SA, 2008, BLOOD CELL MOL DIS, V41, P95, DOI 10.1016/j.bcmd.2008.02.003; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Schroering AG, 2008, DNA REPAIR, V7, P951, DOI 10.1016/j.dnarep.2008.03.023; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Wei K, 2002, TRENDS MOL MED, V8, P346, DOI 10.1016/S1471-4914(02)02359-6; Wu XS, 2005, NAT IMMUNOL, V6, P964, DOI 10.1038/ni1005-964; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15549	10.1371/journal.pone.0015549	http://dx.doi.org/10.1371/journal.pone.0015549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179576	Green Submitted, Green Published, gold			2022-12-27	WOS:000285381200028
J	Leibbrandt, A; Meier, C; Konig-Schuster, M; Weinmullner, R; Kalthoff, D; Pflugfelder, B; Graf, P; Frank-Gehrke, B; Beer, M; Fazekas, T; Unger, H; Prieschl-Grassauer, E; Grassauer, A				Leibbrandt, Andreas; Meier, Christiane; Koenig-Schuster, Marielle; Weinmuellner, Regina; Kalthoff, Donata; Pflugfelder, Bettina; Graf, Philipp; Frank-Gehrke, Britta; Beer, Martin; Fazekas, Tamas; Unger, Hermann; Prieschl-Grassauer, Eva; Grassauer, Andreas			Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SULFATED POLYSACCHARIDES; ANTIVIRAL ACTIVITY; DOUBLE-BLIND; H1N1 VIRUS; IN-VITRO; OSELTAMIVIR; NEURAMINIDASE; RESISTANCE; EFFICACY	The 2009 flu pandemic and the appearance of oseltamivir-resistant H1N1 influenza strains highlight the need for treatment alternatives. One such option is the creation of a protective physical barrier in the nasal cavity. In vitro tests demonstrated that iota-carrageenan is a potent inhibitor of influenza A virus infection, most importantly also of pandemic H1N1/2009 in vitro. Consequently, we tested a commercially available nasal spray containing iota-carrageenan in an influenza A mouse infection model. Treatment of mice infected with a lethal dose of influenza A PR8/34 H1N1 virus with iota-carrageenan starting up to 48 hours post infection resulted in a strong protection of mice similar to mice treated with oseltamivir. Since alternative treatment options for influenza are rare, we conclude that the nasal spray containing iota-carrageenan is an alternative to neuraminidase inhibitors and should be tested for prevention and treatment of influenza A in clinical trials in humans.	[Leibbrandt, Andreas; Meier, Christiane; Koenig-Schuster, Marielle; Weinmuellner, Regina; Pflugfelder, Bettina; Graf, Philipp; Frank-Gehrke, Britta; Prieschl-Grassauer, Eva; Grassauer, Andreas] Marinomed Biotechnol GmbH, Vienna, Austria; [Kalthoff, Donata; Beer, Martin] Bundesforsch Inst Tiergesundheit, Inst Diagnost Virol, Friedrich Loeffler Inst, Greifswald, Germany; [Fazekas, Tamas] St Anna Childrens Hosp, A-1090 Vienna, Austria; [Unger, Hermann] Vet Univ Vienna, Lab Trop Vet Med, A-1030 Vienna, Austria	Friedrich Loeffler Institute; Saint Anna Children's Hospital; University of Veterinary Medicine Vienna	Leibbrandt, A (corresponding author), Marinomed Biotechnol GmbH, Vienna, Austria.	andreas.leibbrandt@marinomed.com		Hoffmann, Donata/0000-0003-4552-031X	Austrian Research Promotion Agency (FFG) [813886, 818252, 824211]; Marinomed	Austrian Research Promotion Agency (FFG); Marinomed	This work was supported in part by the Austrian Research Promotion Agency (FFG) grant numbers 813886, 818252, and 824211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Marinomed Biotechnologie GmbH had a role in study design, data collection and analysis, decision to publish, preparation of the manuscript and is financing the processing charge of the manuscript.; The authors AL, AG, CM, MK, RW, BP, BF, PG, and EP are employed by Marinomed. Authors HU, EP and AG are co-founders of Marinomed. AG and EP are inventors of patent #WO2009027057 held by Marinomed Biotechnologie GmbH that relates to the content of the manuscript. Marinomed Biotechnologie GmbH is financing the processing charge of this manuscript. TF has previously served as principal investigator for a clinical investigator-initiated study that was co-financed by Marinomed. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Authors MB and DK declare no competing interests.	BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; Bantia S, 2001, ANTIMICROB AGENTS CH, V45, P1162, DOI 10.1128/AAC.45.4.1162-1167.2001; Barnard D, 2009, ANTIVIR RES, V82, pA32, DOI 10.1016/j.antiviral.2009.02.059; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Benford D., 2008, WHO FOOD ADDITIVES S, V59, P65; Buck Christopher B., 2006, PLoS Pathogens, V2, DOI 10.1372/journal.ppat.0020069; Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9; Carlucci MJ, 2004, ANTIVIR RES, V64, P137, DOI 10.1016/j.antiviral.2004.07.001; Carlucci MJ, 1999, ANTIVIR RES, V43, P93, DOI 10.1016/S0166-3542(99)00038-8; Cohen SM, 2002, CRIT REV TOXICOL, V32, P413, DOI 10.1080/20024091064282; Damonte EB, 2004, CURR MED CHEM, V11, P2399, DOI 10.2174/0929867043364504; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; Eccles R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-108; Ghosh T, 2009, GLYCOBIOLOGY, V19, P2, DOI 10.1093/glycob/cwn092; GIROND S, 1991, RES VIROLOGY, V142, P261, DOI 10.1016/0923-2516(91)90011-Q; GONZALEZ ME, 1987, ANTIMICROB AGENTS CH, V31, P1388, DOI 10.1128/AAC.31.9.1388; Gooskens J, 2009, JAMA-J AM MED ASSOC, V301, P1042, DOI 10.1001/jama.2009.297; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; HAMASUNA R, 1994, J GEN VIROL, V75, P111, DOI 10.1099/0022-1317-75-1-111; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Hayden FG, 2006, J INFECT DIS, V194, pS119, DOI 10.1086/507552; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Hersh AL, 2009, AM J PUBLIC HEALTH, V99, pS362, DOI 10.2105/AJPH.2009.171462; Huang SJ, 2004, ELECTROPHORESIS, V25, P779, DOI 10.1002/elps.200305723; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jefferson T, 2006, Cochrane Database Syst Rev, pCD001169, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kalthoff D, 2010, EMERG INFECT DIS, V16, P703, DOI 10.3201/eid1604.091491; Khazeni N, 2009, ANN INTERN MED, V151, P464, DOI 10.7326/0003-4819-151-7-200910060-00143; Kilmarx PH, 2008, SEX TRANSM DIS, V35, P226, DOI 10.1097/OLQ.0b013e31815d6e0d; Matheson NJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002744.pub2; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nelson MI, 2009, VIROLOGY, V388, P270, DOI 10.1016/j.virol.2009.03.026; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Perez-Andino J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005847; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Pujol CA, 2006, PLANTA MED, V72, P121, DOI 10.1055/s-2005-373168; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; Sidwell RW, 1998, ANTIVIR RES, V37, P107, DOI 10.1016/S0166-3542(97)00065-X; Sidwell RW, 2000, ANTIVIR RES, V48, P1, DOI 10.1016/S0166-3542(00)00125-X; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; van de Velde F, 2002, TRENDS FOOD SCI TECH, V13, P73, DOI 10.1016/S0924-2244(02)00066-3; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; Witvrouw M, 1997, GEN PHARMACOL-VASC S, V29, P497, DOI 10.1016/S0306-3623(96)00563-0	61	104	113	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14320	10.1371/journal.pone.0014320	http://dx.doi.org/10.1371/journal.pone.0014320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179403	Green Published, Green Submitted, gold			2022-12-27	WOS:000285292500005
J	Sfreddo, C; Fuchs, SC; Merlo, AR; Fuchs, FD				Sfreddo, Carla; Fuchs, Sandra Costa; Merlo, Alvaro Roberto; Fuchs, Flavio Danni			Shift Work Is Not Associated with High Blood Pressure or Prevalence of Hypertension	PLOS ONE			English	Article							RECOVERY; WOMEN	Background: Working mostly at night has been suggested to be associated with upset of chronobiological rhythms and high blood pressure, but the evidence from epidemiological studies is weak. Methods: In a cross-sectional survey, we evaluated the association between shift work and blood pressure, pre-hypertension and hypertension. In total, 493 nurses, nurse technicians and assistants, were selected at random in a large general hospital setting. Hypertension was diagnosed by the mean of four automatic blood pressure readings >= 140/90 mmHg or use of blood pressure lowering agents, and pre-hypertension by systolic blood pressure >= 120-139 or diastolic blood pressure >= 80-89 mmHg. Risk factors for hypertension were evaluated by a standardized questionnaire and anthropometric measurements. The association between the shift of work and blood pressure, pre-hypertension and hypertension was explored using univariate and multivariate analyses that controlled for risk factors for hypertension by covariance analysis and modified Poisson regression. Results: The mean age of the participants was 34.3 +/- 69.4 years and 88.2% were women. Night shift workers were older, more frequently married or divorced, and less educated. The prevalence of hypertension in the whole sample was 16%, and 28% had pre-hypertension. Blood pressure (after adjustment for confounding) was not different in day and night shift workers. The prevalence of hypertension and pre-hypertension by shift work was not different in the univariate analysis and after adjustment for confounding (all risk ratios = 1.0). Conclusion: Night shift work did not increase blood pressure and was not associated with hypertension or pre-hypertension in nursing personnel working in a large general hospital.	[Sfreddo, Carla] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Porto Alegre, RS, Brazil; [Sfreddo, Carla] Univ Passo Fundo, Hosp Sao Vicente de Paulo, Passo Fundo, RS, Brazil; [Fuchs, Sandra Costa; Fuchs, Flavio Danni] Univ Fed Rio Grande do Sul, Postgrad Program Cardiol, Porto Alegre, RS, Brazil; [Merlo, Alvaro Roberto] Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Porto Alegre, RS, Brazil; [Fuchs, Flavio Danni] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Passo Fundo; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Sfreddo, C (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Porto Alegre, RS, Brazil.	ffuchs@hcpa.ufrgs.br	Fuchs, Sandra C/T-2670-2019; Iats, Inct/K-2300-2013; Fuchs, Flávio D/L-5078-2016	fuchs, flavio/0000-0002-1191-0523	National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil; Fundo de Incentivo a Pesquisa (FIPE-HCPA), Brazil	National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa (FIPE-HCPA), Brazil	This study was supported by the National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil and Fundo de Incentivo a Pesquisa (FIPE-HCPA), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barger LK, 2009, CURR NEUROL NEUROSCI, V9, P155, DOI 10.1007/s11910-009-0024-7; Hublin C, 2010, EUR J EPIDEMIOL, V25, P315, DOI 10.1007/s10654-010-9439-3; Lo SH, 2008, AM J HYPERTENS, V21, P759, DOI 10.1038/ajh.2008.186; Pickering Thomas G, 2006, J Clin Hypertens (Greenwich), V8, P819, DOI 10.1111/j.1524-6175.2006.05126.x; Stranges S, 2010, J HYPERTENS, V28, P896, DOI 10.1097/HJH.0b013e328335d076; Su TC, 2008, J OCCUP HEALTH, V50, P380, DOI 10.1539/joh.L7056; Suwazono Y, 2008, HYPERTENSION, V52, P581, DOI 10.1161/HYPERTENSIONAHA.108.114553; Yamasaki F, 1998, HYPERTENSION, V32, P417, DOI 10.1161/01.HYP.32.3.417	8	34	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15250	10.1371/journal.pone.0015250	http://dx.doi.org/10.1371/journal.pone.0015250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179460	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500017
J	Buermans, HPJ; van Wijk, B; Hulsker, MA; Smit, NCH; den Dunnen, JT; van Ommen, GB; Moorman, AF; van den Hoff, MJ; 't Hoen, PAC				Buermans, Henk P. J.; van Wijk, Bram; Hulsker, Margriet A.; Smit, Niels C. H.; den Dunnen, Johan T.; van Ommen, Gertjan B.; Moorman, Antoon F.; van den Hoff, Maurice J.; 't Hoen, Peter A. C.			Comprehensive Gene-Expression Survey Identifies Wif1 as a Modulator of Cardiomyocyte Differentiation	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; EMBRYONIC STEM-CELLS; EPICARDIAL PROGENITORS; SIGNALING PATHWAYS; CHICK-EMBRYO; HEART; TRANSCRIPTION; MYOCARDIUM; PATTERNS; LINEAGE	During chicken cardiac development the proepicardium (PE) forms the epicardium (Epi), which contributes to several non-myocardial lineages within the heart. In contrast to Epi-explant cultures, PE explants can differentiate into a cardiomyocyte phenotype. By temporal microarray expression profiles of PE-explant cultures and maturing Epi cells, we identified genes specifically associated with differentiation towards either of these lineages and genes that are associated with the Epi-lineage restriction. We found a central role for Wnt signaling in the determination of the different cell lineages. Immunofluorescent staining after recombinant-protein incubation in PE-explant cultures indicated that the early upregulated Wnt inhibitory factor-1 (Wif1), stimulates cardiomyocyte differentiation in a similar manner as Wnt stimulation. Concordingly, in the mouse pluripotent embryogenic carcinoma cell line p19cl6, early and late Wif1 exposure enhances and attenuates differentiation, respectively. In ovo exposure of the HH12 chicken embryonic heart to Wif1 increases the Tbx18-positive cardiac progenitor pool. These data indicate that Wif1 enhances cardiomyogenesis.	[Buermans, Henk P. J.; Hulsker, Margriet A.; Smit, Niels C. H.; den Dunnen, Johan T.; van Ommen, Gertjan B.; 't Hoen, Peter A. C.] Leiden Univ, Med Ctr, Leiden, Netherlands; [van Wijk, Bram; Moorman, Antoon F.; van den Hoff, Maurice J.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Buermans, HPJ (corresponding author), Leiden Univ, Med Ctr, Leiden, Netherlands.	h.buermans@lumc.nl	't Hoen, Peter/A-4857-2012; Hoen, Peter A 't/D-3950-2018; Smit, Cornelis/P-6036-2015; dunnen, johan den/ABH-4228-2020	Hoen, Peter A 't/0000-0003-4450-3112; dunnen, johan den/0000-0002-6304-1710; van den Hoff, Maurice/0000-0002-3837-8055	European Union [LSHM-CT-2205-018630]; Netherlands Heart Foundation [1996M002]	European Union(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation)	This work is financially supported by the European Union FP6 program HeartRepair LSHM-CT-2205-018630 and the Netherlands Heart Foundation grant 1996M002 (B.v.W., M.J.v.d.H. and A.F.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afouda BA, 2008, DEVELOPMENT, V135, P3185, DOI 10.1242/dev.026443; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell GW, 2004, DEV DYNAM, V229, P677, DOI 10.1002/dvdy.10503; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrman LA, 1999, DEV BIOL, V207, P163, DOI 10.1006/dbio.1998.9167; Etzion S, 2002, CIRCULATION, V106, pI125, DOI 10.1161/01.cir.0000032888.55215.b8; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Jelier R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-291; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Kwon C, 2008, CELL CYCLE, V7, P3815, DOI 10.4161/cc.7.24.7189; LANGFORD JK, 1990, ANN NY ACAD SCI, V588, P404, DOI 10.1111/j.1749-6632.1990.tb13246.x; Limana F, 2007, CIRC RES, V101, pE57; Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552; Manner J, 1999, ANAT RECORD, V255, P212; Moore JC, 2004, INT J DEV BIOL, V48, P47, DOI 10.1387/ijdb.15005574; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Peng CF, 2002, PHYSIOL GENOMICS, V9, P145, DOI 10.1152/physiolgenomics.00027.2002; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robb L, 1998, DEV DYNAM, V213, P105, DOI 10.1002/(SICI)1097-0177(199809)213:1<105::AID-AJA10>3.0.CO;2-1; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Schlueter J, 2006, DEV BIOL, V295, P546, DOI 10.1016/j.ydbio.2006.03.036; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Somi S, 2006, J HISTOCHEM CYTOCHEM, V54, P649, DOI 10.1369/jhc.5A6846.2006; Soufan AT, 2003, PHYSIOL GENOMICS, V13, P187, DOI 10.1152/physiolgenomics.00182.2002; Soukas A, 2000, GENE DEV, V14, P963; 't Hoen PAC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng020; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van den Hoff MJB, 2001, DEV BIOL, V240, P61, DOI 10.1006/dbio.2001.0449; van Wijk B, 2007, CARDIOVASC RES, V74, P244, DOI 10.1016/j.cardiores.2006.11.022; van Wijk B, 2009, CIRC RES, V105, P431, DOI 10.1161/CIRCRESAHA.109.203083; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vinciotti V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-183; Vinciotti V, 2005, BIOINFORMATICS, V21, P492, DOI 10.1093/bioinformatics/bti022; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	52	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15504	10.1371/journal.pone.0015504	http://dx.doi.org/10.1371/journal.pone.0015504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179454	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900045
J	Hallerdei, J; Scheibe, RJ; Parkkila, S; Waheed, A; Sly, WS; Gros, G; Wetzel, P; Endeward, V				Hallerdei, Janine; Scheibe, Renate J.; Parkkila, Seppo; Waheed, Abdul; Sly, William S.; Gros, Gerolf; Wetzel, Petra; Endeward, Volker			T Tubules and Surface Membranes Provide Equally Effective Pathways of Carbonic Anhydrase-Facilitated Lactic Acid Transport in Skeletal Muscle	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; KNOCKOUT MICE; XIV; IV; DIFFUSION; MOUSE; IX; EXPRESSION; HEART; CO2	We have studied lactic acid transport in the fast mouse extensor digitorum longus muscles (EDL) by intracellular and cell surface pH microelectrodes. The role of membrane-bound carbonic anhydrases (CA) of EDL in lactic acid transport was investigated by measuring lactate flux in muscles from wildtype, CAIV-, CAIX- and CAXIV-single ko, CAIV-CAXIV double ko and CAIV-CAIX-CAXIV-triple ko mice. This was complemented by immunocytochemical studies of the subcellular localization of CAIV, CAIX and CAXIV in mouse EDL. We find that CAXIV and CAIX single ko EDL exhibit markedly but not maximally reduced lactate fluxes, whereas triple ko and double ko EDL show maximal or near-maximal inhibition of CA-dependent lactate flux. Interpretation of the flux measurements in the light of the immunocytochemical results leads to the following conclusions. CAXIV, which is homogeneously distributed across the surface membrane of EDL fibers, facilitates lactic acid transport across this membrane. CAIX, which is associated only with T tubular membranes, facilitates lactic acid transport across the T tubule membrane. The removal of lactic acid from the lumen of T tubuli towards the interstitial space involves a CO(2)-HCO(3)(-) diffusional shuttle that is maintained cooperatively by CAIX within the T tubule and, besides CAXIV, by the CAIV, which is strategically located at the opening of the T tubules. The data suggest that about half the CA-dependent muscular lactate flux occurs across the surface membrane, while the other half occurs across the membranes of the T tubuli.	[Hallerdei, Janine; Scheibe, Renate J.] Hannover Med Sch, Abt Physiol Chem, D-30623 Hannover, Germany; [Parkkila, Seppo] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Waheed, Abdul; Sly, William S.] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63103 USA	Hannover Medical School; Tampere University; Saint Louis University	Hallerdei, J (corresponding author), Hannover Med Sch, Abt Physiol Chem, D-30623 Hannover, Germany.	Gros.Gerolf@MH-Hannover.de; Endeward.Volker@MH-Hannover.de	Wahhed, Abdul/AAA-3099-2020; Gros, Gerolf/K-8421-2012	Parkkila, Seppo/0000-0001-7323-8536	Deutsche Forschungsgemeinschaft [WE 1962/4-1, WE 1962/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft WE 1962/4-1,2 (website: www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMERS M, 1972, J PHYSL, V225, P57; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Bonen A, 2000, AM J PHYSIOL-ENDOC M, V278, pE1067, DOI 10.1152/ajpendo.2000.278.6.E1067; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; Eisenberg BE, 1983, SKELETAL MUSCLE, P73; Endeward V, 2009, J PHYSIOL-LONDON, V587, P1153, DOI 10.1113/jphysiol.2008.165027; GROS G, 1974, J GEN PHYSIOL, V64, P356, DOI 10.1085/jgp.64.3.356; GROS G, 1976, J GEN PHYSIOL, V67, P773, DOI 10.1085/jgp.67.6.773; Gut MO, 2002, GASTROENTEROLOGY, V123, P1889, DOI 10.1053/gast.2002.37052; HALLERDEI J, 2009, THESIS U HANNOVER GE; Innocenti A, 2005, BIOORG MED CHEM LETT, V15, P573, DOI 10.1016/j.bmcl.2004.11.057; Innocenti A, 2009, BIOORG MED CHEM LETT, V19, P5825, DOI 10.1016/j.bmcl.2009.08.088; Juel C, 1997, PHYSIOL REV, V77, P321, DOI 10.1152/physrev.1997.77.2.321; JUNGE W, 1987, BIOCHIM BIOPHYS ACTA, V890, P1, DOI 10.1016/0005-2728(87)90061-2; Kaunisto K, 2002, KIDNEY INT, V61, P2111, DOI 10.1046/j.1523-1755.2002.00371.x; Papadopoulos S, 2001, P NATL ACAD SCI USA, V98, P5904, DOI 10.1073/pnas.101109798; Parkkila S, 2001, P NATL ACAD SCI USA, V98, P1918, DOI 10.1073/pnas.98.4.1918; PEACHEY LD, 1978, BIOPHYS J, V22, P145, DOI 10.1016/S0006-3495(78)85480-0; SAHLIN K, 1976, PFLUG ARCH EUR J PHY, V367, P143, DOI 10.1007/BF00585150; Scheibe RJ, 2008, AM J PHYSIOL-CELL PH, V294, pC402, DOI 10.1152/ajpcell.00228.2007; Scheibe RJ, 2006, J HISTOCHEM CYTOCHEM, V54, P1379, DOI 10.1369/jhc.6A7003.2006; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; Trastour C, 2007, INT J CANCER, V120, P1451, DOI 10.1002/ijc.22436; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; WAHEED A, 1992, ARCH BIOCHEM BIOPHYS, V294, P550, DOI 10.1016/0003-9861(92)90724-B; Wetzel P, 2001, J PHYSIOL-LONDON, V531, P743, DOI 10.1111/j.1469-7793.2001.0743h.x; Wetzel P, 2007, AM J PHYSIOL-CELL PH, V293, pC358, DOI 10.1152/ajpcell.00057.2007	29	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15137	10.1371/journal.pone.0015137	http://dx.doi.org/10.1371/journal.pone.0015137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179203	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900030
J	Sulbaran, MZ; Di Lello, FA; Sulbaran, Y; Cosson, C; Loureiro, CL; Rangel, HR; Cantaloube, JF; Campos, RH; Moratorio, G; Cristina, J; Pujol, FH				Sulbaran, Maria Z.; Di Lello, Federico A.; Sulbaran, Yoneira; Cosson, Clarisa; Loureiro, Carmen L.; Rangel, Hector R.; Cantaloube, Jean F.; Campos, Rodolfo H.; Moratorio, Gonzalo; Cristina, Juan; Pujol, Flor H.			Genetic History of Hepatitis C Virus in Venezuela: High Diversity and Long Time of Evolution of HCV Genotype 2	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; UNITED-STATES; BLOOD-DONORS; POPULATION; PREVALENCE; INFECTION; RECOMBINATION; TRANSMISSION; SEQUENCES	Background: The subtype diversity of the hepatitis C virus (HCV) genotypes is unknown in Venezuela. Methodology/Principal Findings: Partial sequencing of the NS5B region was performed in 310 isolates circulating in patients from 1995 to 2007. In the samples collected between 2005 and 2007, HCV genotype 1 (G1) was the most common genotype (63%), composed as expected of mainly G1a and G1b. G2 was the second most common genotype (33%), being G2a almost absent and G2j the most frequent subtype. Sequence analysis of the core region confirmed the subtype assignment performed within the NS5b region in 63 isolates. The complete genome sequence of G2j was obtained. G2j has been described in France, Canada and Burkina Fasso, but it was not found in Martinique, where several subtypes of G2 circulate in the general population. Bayesian coalescence analysis indicated a most recent common ancestor (MRCA) of G2j around 1785, before the introduction of G1b (1869) and G1a (1922). While HCV G1a and G1b experienced a growth reduction since 1990, coincident with the time when blood testing was implemented in Venezuela, HCV G2j did not seem to reach growth equilibrium during this period. Conclusions/Significance: Assuming the introduction of G2j from Africa during the slave trade, the high frequency of G2j found in Venezuela could suggest: 1- the introduction of African ethnic groups different from the ones introduced to Martinique or 2- the occurrence of a founder effect. This study represents an in-depth analysis of the subtype diversity of HCV in Venezuela, which is still unexplored in the Americas and deserves further studies.	[Sulbaran, Maria Z.; Sulbaran, Yoneira; Cosson, Clarisa; Loureiro, Carmen L.; Rangel, Hector R.; Pujol, Flor H.] IVIC, CMBC, Lab Virol Mol, Caracas, Venezuela; [Di Lello, Federico A.; Campos, Rodolfo H.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina; [Cantaloube, Jean F.] Etab Francais Sang Alpes Mediterranee, Unite Emergence & Coevolut Virale, Marseille, France; [Moratorio, Gonzalo; Cristina, Juan] Univ Republica, Ctr Invest Nucl, Fac Ciencias, Dept Tecn Nucl Aplicadas, Montevideo, Uruguay; [Moratorio, Gonzalo] Inst Pasteur Montevideo, Unidad Biofis Prot, Montevideo, Uruguay	Venezuelan Institute Science Research; University of Buenos Aires; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Sulbaran, MZ (corresponding author), IVIC, CMBC, Lab Virol Mol, Caracas, Venezuela.	fhpujol@gmail.com	Rangel, Hector R/E-5575-2010; Pujol, Flor H/E-5687-2010	Rangel, Hector R/0000-0001-5937-9690; Di Lello, Federico Alejandro/0000-0001-9771-9705; Loureiro Marino, Carmen Luisa/0000-0003-3665-1107; Pujol, Flor H/0000-0001-6086-6883	Fondo Nacional de Ciencia y Tecnologia (FONACIT) [G-2005000394]; Ley Organica de Ciencia y Tecnologia (LOCTI), Venezuela; International Centre of Genetic Engineering and Biotechnology/Panamerican Health Organization/Red Latinoamericana de Ciencias Biologicas (ICGEB/PAHO/RELAB) [CRRLA/URU03-032]	Fondo Nacional de Ciencia y Tecnologia (FONACIT); Ley Organica de Ciencia y Tecnologia (LOCTI), Venezuela; International Centre of Genetic Engineering and Biotechnology/Panamerican Health Organization/Red Latinoamericana de Ciencias Biologicas (ICGEB/PAHO/RELAB)	This work was supported by Grant G-2005000394 from Fondo Nacional de Ciencia y Tecnologia (FONACIT), Ley Organica de Ciencia y Tecnologia (LOCTI) Fund 650, Venezuela, and from International Centre of Genetic Engineering and Biotechnology/Panamerican Health Organization/Red Latinoamericana de Ciencias Biologicas (ICGEB/PAHO/RELAB) through Project CRRLA/URU03-032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MS, 2001, ANN TROP MED PARASIT, V95, P187, DOI 10.1080/00034980120042944; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Alvarez-Valin F, 2000, GENETICS, V155, P1683; Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007; Cantaloube JF, 2008, J MED VIROL, V80, P1732, DOI 10.1002/jmv.21285; Cantaloube JF, 2010, J MED VIROL, V82, P562, DOI 10.1002/jmv.21724; Cantaloube JF, 2005, J CLIN MICROBIOL, V43, P3624, DOI 10.1128/JCM.43.8.3624-3629.2005; Cavalheiro Norma de Paula, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P271, DOI 10.1590/S0036-46652007000500001; Chamberlain RW, 1997, J GEN VIROL, V78, P1341, DOI 10.1099/0022-1317-78-6-1341; CHAN SW, 1992, J GEN VIROL, V73, P1131, DOI 10.1099/0022-1317-73-5-1131; Chung YL, 2003, INT J CANCER, V107, P65, DOI 10.1002/ijc.11303; Comeron JM, 1995, J MOL EVOL, V41, P1152, DOI 10.1007/BF00173196; Cristina Juan, 2005, J Clin Virol, V34 Suppl 2, pS1; Fonseca José Carlos Ferraz da, 2004, Rev. Soc. Bras. Med. Trop., V37, P1, DOI 10.1590/S0037-86822004000700001; de Bruijne J, 2009, J CLIN MICROBIOL, V47, P3832, DOI 10.1128/JCM.01146-09; Dehesa-Violante Margarita, 2007, Rev Gastroenterol Mex, V72, P344; Di Lello F, 2008, J MED VIROL, V80, P619, DOI 10.1002/jmv.21112; Di Lello FA, 2009, J MED VIROL, V81, P1887, DOI 10.1002/jmv.21607; da Silva CM, 2007, MEM I OSWALDO CRUZ, V102, P867, DOI 10.1590/S0074-02762007005000122; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Echevarría José M., 2003, Cad. Saúde Pública, V19, P1583, DOI 10.1590/S0102-311X2003000600003; Eltis David, 2000, RISE SLAVERY AM; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Frederick T, 2009, AIDS PATIENT CARE ST, V23, P915, DOI 10.1089/apc.2009.0111; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Handler Jerome S., 2002, SLAVERY ABOLIT, V23, P25, DOI DOI 10.1080/714005224; Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;92::AID-JMV2&gt;3.0.CO;2-I; Jukes TH, 1969, EVOLUTION PROTEIN MO; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Garcia-Montalvo BM, 2008, ANN HEPATOL, V7, P345; Markov PV, 2009, J GEN VIROL, V90, P2086, DOI 10.1099/vir.0.011569-0; Martial J, 2004, J CLIN MICROBIOL, V42, P784, DOI 10.1128/JCM.42.2.784-791.2004; Moratorio G, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-79; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Norder H, 1998, J CLIN MICROBIOL, V36, P3066, DOI 10.1128/JCM.36.10.3066-3069.1998; Plamondon M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000372; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pujol FH, 2007, J CLIN GASTROENTEROL, V41, P518, DOI 10.1097/01.mcg.0000248010.55149.ce; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Quarleri JF, 2000, J CLIN MICROBIOL, V38, P4560, DOI 10.1128/JCM.38.12.4560-4568.2000; Radkowski M, 2001, TRANSPLANTATION, V72, P833, DOI 10.1097/00007890-200109150-00016; Re V, 2003, MEDICINA-BUENOS AIRE, V63, P205; SALMINEN M, 1995, AIDS RES HUM RETROV, V11, pS119; Santos-Lopez G, 2008, J INFECTION, V56, P281, DOI 10.1016/j.jinf.2008.02.001; Silva Luciana, 1995, Arquivos de Gastroenterologia, V32, P168; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Talarmin A, 1997, J MED VIROL, V52, P430, DOI 10.1002/(SICI)1096-9071(199708)52:4&lt;430::AID-JMV15&gt;3.0.CO;2-K; Tebit DM, 2007, AIDS REV, V9, P75; Thomas F, 2007, J MED VIROL, V79, P26, DOI 10.1002/jmv.20765; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000	63	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14315	10.1371/journal.pone.0014315	http://dx.doi.org/10.1371/journal.pone.0014315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179440	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900020
J	Beaulieu, AM; Rath, P; Imhof, M; Siddall, ME; Roberts, J; Schnappinger, D; Nathan, CF				Beaulieu, Aimee M.; Rath, Poonam; Imhof, Marianne; Siddall, Mark E.; Roberts, Julia; Schnappinger, Dirk; Nathan, Carl F.			Genome-Wide Screen for Mycobacterium tuberculosis Genes That Regulate Host Immunity	PLOS ONE			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; NECROSIS-FACTOR-ALPHA; T-CELL RESPONSES; CORD FACTOR; EXOGENOUS REINFECTION; NITRIC-OXIDE; GUINEA-PIGS; MCE1 OPERON; INFECTION; MICE	In spite of its highly immunogenic properties, Mycobacterium tuberculosis (Mtb) establishes persistent infection in otherwise healthy individuals, making it one of the most widespread and deadly human pathogens. Mtb's prolonged survival may reflect production of microbial factors that prevent even more vigorous immunity (quantitative effect) or that divert the immune response to a non-sterilizing mode (qualitative effect). Disruption of Mtb genes has produced a list of several dozen candidate immunomodulatory factors. Here we used robotic fluorescence microscopy to screen 10,100 loss-of-function transposon mutants of Mtb for their impact on the expression of promoter-reporter constructs for 12 host immune response genes in a mouse macrophage cell line. The screen identified 364 candidate immunoregulatory genes. To illustrate the utility of the candidate list, we confirmed the impact of 35 Mtb mutant strains on expression of endogenous immune response genes in primary macrophages. Detailed analysis focused on a strain of Mtb in which a transposon disrupts Rv0431, a gene encoding a conserved protein of unknown function. This mutant elicited much more macrophage TNF alpha, IL-12p40 and IL-6 in vitro than wild type Mtb, and was attenuated in the mouse. The mutant list provides a platform for exploring the immunobiology of tuberculosis, for example, by combining immunoregulatory mutations in a candidate vaccine strain.	[Beaulieu, Aimee M.; Rath, Poonam; Imhof, Marianne; Roberts, Julia; Schnappinger, Dirk; Nathan, Carl F.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Siddall, Mark E.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	Cornell University; American Museum of Natural History (AMNH)	Beaulieu, AM (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA.	cnathan@med.cornell.edu			Ellison Medical Foundation; NIH [T32 AI07621]; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007621] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Senior Scholarship in Global Infectious Diseases Research from the Ellison Medical Foundation (CFN) and a T32 predoctoral NIH training, award T32 AI07621 (AMB). The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CS, 2009, J IMMUNOL, V182, P424, DOI 10.4049/jimmunol.182.1.424; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Bandera A, 2001, J CLIN MICROBIOL, V39, P2213, DOI 10.1128/JCM.39.6.2213-2218.2001; Barker LF, 2009, CURR OPIN IMMUNOL, V21, P331, DOI 10.1016/j.coi.2009.05.017; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; BEAULIEU AM, 2009, THESIS CORNELL U NEW; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Chen ZW, 2005, CLIN IMMUNOL, V116, P202, DOI 10.1016/j.clim.2005.04.005; Cheruvu M, 2007, TUBERCULOSIS, V87, P12, DOI 10.1016/j.tube.2006.01.021; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; D'Orazio M, 2001, BIOCHEM J, V359, P17, DOI 10.1042/0264-6021:3590017; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Dannenberg AM, 2001, TUBERCULOSIS, V81, P229, DOI 10.1054/tube.2001.0287; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gonzalez-Juarrero M, 2009, AM J RESP CELL MOL, V40, P398, DOI 10.1165/rcmb.2008-0248OC; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Guidry TV, 2007, MICROBIOL-SGM, V153, P3360, DOI 10.1099/mic.0.2007/010850-0; Guillemard E, 1998, J BIOL REG HOMEOS AG, V12, P106; Hisert KB, 2004, INFECT IMMUN, V72, P5315, DOI 10.1128/IAI.72.9.5315-5321.2004; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; KUMAR D, CELL, V140, P731; LAZAREVIC V, 1992, J GEN MICROBIOL, V138, P1949, DOI 10.1099/00221287-138-9-1949; Malen H, 2008, SCAND J IMMUNOL, V67, P245, DOI 10.1111/j.1365-3083.2007.02064.x; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Rao A, 2004, MOL GENET GENOMICS, V272, P571, DOI 10.1007/s00438-004-1088-3; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reiley WW, 2008, P NATL ACAD SCI USA, V105, P10961, DOI 10.1073/pnas.0801496105; Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1046/j.1462-5822.2004.00368.x; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; TOBIN DM, CELL, V140, P717; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; Uchida Y, 2007, CELL MICROBIOL, V9, P1275, DOI 10.1111/j.1462-5822.2006.00870.x; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Waddell SJ, 2005, LETT APPL MICROBIOL, V40, P201, DOI 10.1111/j.1472-765X.2005.01659.x; Welsh KJ, 2008, MICROBIOL-SGM, V154, P1813, DOI 10.1099/mic.0.2008/016923-0; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; World Health Organization, 2007, TUB; Yamagami H, 2001, INFECT IMMUN, V69, P810, DOI 10.1128/IAI.69.2.810-815.2001	74	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15120	10.1371/journal.pone.0015120	http://dx.doi.org/10.1371/journal.pone.0015120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170273	Green Published, gold, Green Submitted			2022-12-27	WOS:000285181400016
J	Som, A; Harder, C; Greber, B; Siatkowski, M; Paudel, Y; Warsow, G; Cap, C; Scholer, H; Fuellen, G				Som, Anup; Harder, Clemens; Greber, Boris; Siatkowski, Marcin; Paudel, Yogesh; Warsow, Gregor; Cap, Clemens; Schoeler, Hans; Fuellen, Georg			The PluriNetWork: An Electronic Representation of the Network Underlying Pluripotency in Mouse, and Its Applications	PLOS ONE			English	Article							STEM-CELLS; SELF-RENEWAL; REGULATORY NETWORKS; SYSTEMS BIOLOGY; GENE ONTOLOGY; DATABASE; DIFFERENTIATION; ANNOTATION; CIRCUITRY; UNIPROT	Background: Analysis of the mechanisms underlying pluripotency and reprogramming would benefit substantially from easy access to an electronic network of genes, proteins and mechanisms. Moreover, interpreting gene expression data needs to move beyond just the identification of the up-/downregulation of key genes and of overrepresented processes and pathways, towards clarifying the essential effects of the experiment in molecular terms. Methodology/Principal Findings: We have assembled a network of 574 molecular interactions, stimulations and inhibitions, based on a collection of research data from 177 publications until June 2010, involving 274 mouse genes/proteins, all in a standard electronic format, enabling analyses by readily available software such as Cytoscape and its plugins. The network includes the core circuit of Oct4 (Pou5f1), Sox2 and Nanog, its periphery (such as Stat3, Klf4, Esrrb, and c-Myc), connections to upstream signaling pathways (such as Activin, WNT, FGF, BMP, Insulin, Notch and LIF), and epigenetic regulators as well as some other relevant genes/proteins, such as proteins involved in nuclear import/export. We describe the general properties of the network, as well as a Gene Ontology analysis of the genes included. We use several expression data sets to condense the network to a set of network links that are affected in the course of an experiment, yielding hypotheses about the underlying mechanisms. Conclusions/Significance: We have initiated an electronic data repository that will be useful to understand pluripotency and to facilitate the interpretation of high-throughput data. To keep up with the growth of knowledge on the fundamental processes of pluripotency and reprogramming, we suggest to combine Wiki and social networking software towards a community curation system that is easy to use and flexible, and tailored to provide a benefit for the scientist, and to improve communication and exchange of research results. A PluriNetWork tutorial is available at http://www.ibima.med. uni-rostock. de/IBIMA/PluriNetWork/.	[Som, Anup; Harder, Clemens; Siatkowski, Marcin; Paudel, Yogesh; Warsow, Gregor; Fuellen, Georg] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Greber, Boris; Schoeler, Hans] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany; [Siatkowski, Marcin] German Ctr Neurodegenerat Dis, DZNE, Rostock, Germany; [Warsow, Gregor] Ernst Moritz Arndt Univ Greifswald, Inst Anat & Cell Biol, Greifswald, Germany; [Warsow, Gregor] Ernst Moritz Arndt Univ Greifswald, Dept Math & Informat, Greifswald, Germany; [Cap, Clemens] Univ Rostock, Dept Comp Sci, Rostock, Germany; [Schoeler, Hans] Univ Munster, Fac Med, Munster, Germany	University of Rostock; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Rostock; University of Munster	Som, A (corresponding author), Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany.	fuellen@uni-rostock.de	Cap, Clemens Heinrich/J-6418-2016; , HS/AAB-4434-2019	Cap, Clemens Heinrich/0000-0003-3958-6136; , HS/0000-0003-2643-5136; Greber, Boris/0000-0002-9404-7293	DFG (Deutsche Forschungsgemeinschaft) [Schwerpunktprogramm 1356]; Pluripotency and Cellular Reprogramming [FU583/2-1]; BMBF (Bundesministerium fur Bildung und Forschung) [01GN0901, 01GN0805]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Pluripotency and Cellular Reprogramming; BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	Funding by the DFG (Deutsche Forschungsgemeinschaft) Schwerpunktprogramm 1356, Pluripotency and Cellular Reprogramming (FU583/2-1), and by the BMBF (Bundesministerium fur Bildung und Forschung) (01GN0901 & 01GN0805, Generation of pluri- and multipotent stem cells) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Bult CJ, 2010, NUCLEIC ACIDS RES, V38, pD586, DOI 10.1093/nar/gkp880; Bureeva S, 2009, METHODS MOL BIOL, V563, P75, DOI 10.1007/978-1-60761-175-2_5; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chakrabarty K, 2008, BIOL CHEM, V389, P791, DOI 10.1515/BC.2008.104; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen LG, 2010, STEM CELLS, V28, P57, DOI 10.1002/stem.251; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Do JT, 2009, TRENDS PHARMACOL SCI, V30, P296, DOI 10.1016/j.tips.2009.03.003; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Krupa Y, 2009, LECT NOTES ARTIF INT, V5881, P148, DOI 10.1007/978-3-642-10203-5_13; Kwan M, 2009, HUM-COMPUT INT-SPRIN, P287, DOI 10.1007/978-1-84800-356-9_11; Le Novere N, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S11; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Leinonen R, 2004, BIOINFORMATICS, V20, P3236, DOI 10.1093/bioinformatics/bth191; Lensch MW, 2006, STEM CELL REV, V2, P185, DOI 10.1007/s12015-006-0047-2; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; MACKALL M, 2006, OTT CAN LIN S, P83; Mazumdar J, 2009, J CELL MOL MED, V13, P4319, DOI 10.1111/j.1582-4934.2009.00963.x; MCGUINNESS D, 2006, MTW06 15 INT WWW C; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Mullen EM, 2007, PPAR RES, V2007, DOI 10.1155/2007/61563; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; ROTH U, 2006, ED SCOTL 15 INT WWW; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; SUN X, 2010, AGEING RES REV; Sun Y, 2006, CRIT REV EUKAR GENE, V16, P211, DOI 10.1615/CritRevEukarGeneExpr.v16.i3.20; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; VICTOR P, 2006, ED SCOTL 15 INT WWW; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; WARSOW G, 2010, BMC SYST BI IN PRESS; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Xu H, 2010, WILEY INTERDISCIPLIN	64	47	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15165	10.1371/journal.pone.0015165	http://dx.doi.org/10.1371/journal.pone.0015165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21179244	Green Published, Green Submitted, gold			2022-12-27	WOS:000285181400019
J	Casutt-Meyer, S; Renzi, F; Schmaler, M; Jann, NJ; Amstutz, M; Cornelis, GR				Casutt-Meyer, Salome; Renzi, Francesco; Schmaler, Mathias; Jann, Naja J.; Amstutz, Marlise; Cornelis, Guy R.			Oligomeric Coiled-Coil Adhesin YadA Is a Double-Edged Sword	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; NEUTROPHIL EXTRACELLULAR TRAPS; MEDIATES SPECIFIC BINDING; YERSINIA-ENTEROCOLITICA; COLLAGEN-BINDING; ENTEROPATHOGENIC YERSINIAE; TRANSCRIPTIONAL ACTIVATOR; HUMAN-GRANULOCYTES; ESCHERICHIA-COLI; INVASIN PROTEIN	Yersinia adhesin A (YadA) is an essential virulence factor for the food-borne pathogens Yersinia enterocolitica and Yersinia pseudotuberculosis. Suprisingly, it is a pseudogene in Yersinia pestis. Even more intriguing, the introduction of a functional yadA gene in Y. pestis EV76 was shown to correlate with a decrease in virulence in a mouse model. Here, we report that wild type (wt) Y. enterocolitica E40, as well as YadA-deprived E40 induced the synthesis of neutrophil extracellular traps (NETs) upon contact with neutrophils, but only YadA-expressing Y. enterocolitica adhered to NETs and were killed. As binding seemed to be a prerequisite for killing, we searched for YadA-binding substrates and detected the presence of collagen within NETs. E40 bacteria expressing V98D,N99A mutant YadA with a severely reduced ability to bind collagen were found to be more resistant to killing, suggesting that collagen binding contributes significantly to sensitivity to NETs. Wt Y. pestis EV76 were resistant to killing by NETs, while recombinant EV76 expressing YadA from either Y. pseudotuberculosis or Y. enterocolitica were sensitive to killing by NETs, outlining the importance of YadA for susceptibility to NET-dependent killing. Recombinant EV76 endowed with YadA from Y. enterocolitica were also less virulent for the mouse than wt EV76, as shown before. In addition, EV76 carrying wt YadA were less virulent for the mouse than EV76 expressing YadA(V98D,N99A). The observation that YadA makes Yersinia sensitive to NETs provides an explanation as for why evolution selected for the inactivation of yadA in the flea-borne Y. pestis and clarifies an old enigma. Since YadA imposes the same cost to the food-borne Yersinia but was nevertheless conserved by evolution, this observation also illustrates the duality of some virulence functions.	[Casutt-Meyer, Salome; Renzi, Francesco; Amstutz, Marlise; Cornelis, Guy R.] Univ Basel, Biozentrum, Basel, Switzerland; [Schmaler, Mathias; Jann, Naja J.] Univ Basel, Dept Biomed, Basel, Switzerland	University of Basel; University of Basel	Casutt-Meyer, S (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	guy.cornelis@unibas.ch		Renzi, Francesco/0000-0001-6940-1177	Swiss National Science Foundation [3100A0-128659/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (www.snf.ch)(grant 3100A0-128659/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; BALLIGAND G, 1985, INFECT IMMUN, V48, P782, DOI 10.1128/IAI.48.3.782-786.1985; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; BLISKA JB, 1993, INFECT IMMUN, V61, P3914, DOI 10.1128/IAI.61.9.3914-3921.1993; BOLIN I, 1984, INFECT IMMUN, V43, P72; Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHINA B, 1993, INFECT IMMUN, V61, P3129, DOI 10.1128/IAI.61.8.3129-3136.1993; CHINA B, 1994, INFECT IMMUN, V62, P1275, DOI 10.1128/IAI.62.4.1275-1281.1994; CORNELIS G, 1975, J GEN MICROBIOL, V87, P285, DOI 10.1099/00221287-87-2-285; CORNELIS G, 1989, J BACTERIOL, V171, P254, DOI 10.1128/jb.171.1.254-262.1989; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; DEROUVROIT CL, 1992, MOL MICROBIOL, V6, P395, DOI 10.1111/j.1365-2958.1992.tb01483.x; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; El Tahir Y, 2000, MOL MICROBIOL, V37, P192, DOI 10.1046/j.1365-2958.2000.01992.x; EMODY L, 1989, J BACTERIOL, V171, P6674; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Han YW, 1997, INFECT IMMUN, V65, P327, DOI 10.1128/IAI.65.1.327-330.1997; Heesemann J, 1987, Contrib Microbiol Immunol, V9, P312; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; ISBERG RR, 1988, P NATL ACAD SCI USA, V85, P6682, DOI 10.1073/pnas.85.18.6682; JEPSEN LV, 1982, SCAND J CLIN LAB INV, V42, P235; KAPPERUD G, 1987, INFECT IMMUN, V55, P2247, DOI 10.1128/IAI.55.9.2247-2254.1987; Koretke KK, 2006, J STRUCT BIOL, V155, P154, DOI 10.1016/j.jsb.2006.03.012; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mayer-Scholl A, 2004, CURR OPIN MICROBIOL, V7, P62, DOI 10.1016/j.mib.2003.12.004; Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; PEPE JC, 1990, J BACTERIOL, V172, P3780, DOI 10.1128/jb.172.7.3780-3789.1990; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; ROSQVIST R, 1988, NATURE, V334, P522, DOI 10.1038/334522a0; SCHULZEKOOPS H, 1992, INFECT IMMUN, V60, P2153, DOI 10.1128/IAI.60.6.2153-2159.1992; SCHULZEKOOPS H, 1993, INFECT IMMUN, V61, P2513, DOI 10.1128/IAI.61.6.2513-2519.1993; SKURNIK M, 1989, MOL MICROBIOL, V3, P517, DOI 10.1111/j.1365-2958.1989.tb00198.x; SKURNIK M, 1992, J BACTERIOL, V174, P2047, DOI 10.1128/jb.174.6.2047-2051.1992; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; TAMM A, 1993, MOL MICROBIOL, V10, P995, DOI 10.1111/j.1365-2958.1993.tb00971.x; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Visser LG, 1996, INFECT IMMUN, V64, P1653, DOI 10.1128/IAI.64.5.1653-1658.1996; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Wong KW, 2005, CURR OPIN MICROBIOL, V8, P4, DOI 10.1016/j.mib.2004.12.009; YANG YX, 1993, INFECT IMMUN, V61, P3907, DOI 10.1128/IAI.61.9.3907-3913.1993; YOUNG VB, 1990, MOL MICROBIOL, V4, P1119, DOI 10.1111/j.1365-2958.1990.tb00686.x	56	25	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15159	10.1371/journal.pone.0015159	http://dx.doi.org/10.1371/journal.pone.0015159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170337	Green Submitted, Green Published, gold			2022-12-27	WOS:000285084100024
J	Herzberg-Schafer, SA; Staiger, H; Heni, M; Ketterer, C; Guthoff, M; Kantartzis, K; Machicao, F; Stefan, N; Haring, HU; Fritsche, A				Herzberg-Schaefer, Silke A.; Staiger, Harald; Heni, Martin; Ketterer, Caroline; Guthoff, Martina; Kantartzis, Konstantinos; Machicao, Fausto; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas			Evaluation of Fasting State-/Oral Glucose Tolerance Test-Derived Measures of Insulin Release for the Detection of Genetically Impaired beta-Cell Function	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SECRETION; POLYMORPHISMS; SENSITIVITY; VARIANTS; RISK; RESISTANCE; GLYCEMIA; CDKAL1; GENES	Background: To date, fasting state-and different oral glucose tolerance test (OGTT)-derived measures are used to estimate insulin release with reasonable effort in large human cohorts required, e.g., for genetic studies. Here, we evaluated twelve common (or recently introduced) fasting state-/OGTT-derived indices for their suitability to detect genetically determined beta-cell dysfunction. Methodology/Principal Findings: A cohort of 1364 White European individuals at increased risk for type 2 diabetes was characterized by OGTT with glucose, insulin, and C-peptide measurements and genotyped for single nucleotide polymorphisms (SNPs) known to affect glucose-and incretin-stimulated insulin secretion. One fasting state-and eleven OGTT-derived indices were calculated and statistically evaluated. After adjustment for confounding variables, all tested SNPs were significantly associated with at least two insulin secretion measures (p <= 0.05). The indices were ranked according to their associations' statistical power, and the ranks an index obtained for its associations with all the tested SNPs (or a subset) were summed up resulting in a final ranking. This approach revealed area under the curve (AUC)(Insulin(0-30))/AUC(Glucose(0-30)) as the best-ranked index to detect SNP-dependent differences in insulin release. Moreover, AUC(Insulin(0-30))/AUC(Glucose(0-30)), corrected insulin response (CIR), AUC(C-Peptide(0-30))/AUC(Glucose(0-30)), AUC(C-Peptide(0-120))/AUC(Glucose(0-120)), two different formulas for the incremental insulin response from 0-30 min, i.e., the insulinogenic indices (IGI)(2) and IGI(1), and insulin 30 min were significantly higher-ranked than homeostasis model assessment of beta-cell function (HOMA-B; p<0.05). AUC(C-Peptide(0-120))/AUC(Glucose(0-120)) was best-ranked for the detection of SNPs involved in incretin-stimulated insulin secretion. In all analyses, HOMA-beta displayed the highest rank sums and, thus, scored last. Conclusions/Significance: With AUC(Insulin(0-30))/AUC(Glucose(0-30)), CIR, AUC(C-Peptide(0-30))/AUC(Glucose(0-30)), AUCC-(Peptide(0-120))/AUC(Glucose(0-120)), IGI(2), IGI(1), and insulin 30 min, dynamic measures of insulin secretion based on early insulin and C-peptide responses to oral glucose represent measures which are more appropriate to assess genetically determined beta-cell dysfunction than fasting measures, i.e., HOMA-B. Genes predominantly influencing the incretin axis may possibly be best detected by AUC(C-Peptide(0-120))/AUC(Glucose(0-120)).	[Herzberg-Schaefer, Silke A.; Staiger, Harald; Heni, Martin; Ketterer, Caroline; Guthoff, Martina; Kantartzis, Konstantinos; Machicao, Fausto; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany; [Herzberg-Schaefer, Silke A.; Staiger, Harald; Heni, Martin; Ketterer, Caroline; Guthoff, Martina; Kantartzis, Konstantinos; Machicao, Fausto; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas] Univ Tubingen, Tubingen, Germany; [Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Nutr & Prevent Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Herzberg-Schafer, SA (corresponding author), Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014; Guthoff, Martina/D-3960-2018; Kantartzis, Konstantinos/AAC-3999-2019	Guthoff, Martina/0000-0002-4294-980X; Staiger, Harald/0000-0002-9507-5333; Heni, Martin/0000-0002-8462-3832; Kantartzis, Konstantinos/0000-0002-0584-1138; Stefan, Norbert/0000-0002-2186-9595	German Research Foundation [Fr 1561/5-1, STE 1096/1-1]; Merck Sharp Dohme; German Federal Ministry of Education and Research (BMBF)	German Research Foundation(German Research Foundation (DFG)); Merck Sharp Dohme(Merck & Company); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported in part by grants from the German Research Foundation (Fr 1561/5-1 and Heisenberg-Grant STE 1096/1-1) and Merck Sharp & Dohme, as well as by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mussig K, 2009, DIABETES, V58, P1715, DOI 10.2337/db08-1589; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Schafer SA, 2009, DIABETOLOGIA, V52, P1075, DOI 10.1007/s00125-009-1344-5; SLUITER WJ, 1976, DIABETES, V25, P241, DOI 10.2337/diabetes.25.4.241; Sparso T, 2009, DIABETES, V58, P1450, DOI 10.2337/db08-1660; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Wareham N J, 1995, Diabet Med, V12, P931	23	54	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14194	10.1371/journal.pone.0014194	http://dx.doi.org/10.1371/journal.pone.0014194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152029	Green Submitted, Green Published, gold			2022-12-27	WOS:000284868000010
J	Qiu, N; Cao, L; David, V; Quarles, LD; Xiao, ZS				Qiu, Ni; Cao, Li; David, Valentin; Quarles, L. Darryl; Xiao, Zhousheng			Kif3a Deficiency Reverses the Skeletal Abnormalities in Pkd1 Deficient Mice by Restoring the Balance Between Osteogenesis and Adipogenesis	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; INTRAFLAGELLAR TRANSPORT PROTEINS; PLURIPOTENT MESENCHYMAL CELLS; KINESIN SUPERFAMILY PROTEIN; CATION CHANNEL FUNCTION; MARROW STROMAL CELLS; PRIMARY CILIA; ADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; MICROTUBULAR STRUCTURES	Pkd1 localizes to primary cilia in osteoblasts and osteocytes. Targeted deletion of Pkd1 in osteoblasts results in osteopenia and abnormalities in Runx2-mediated osteoblast development. Kif3a, an intraflagellar transport protein required for cilia function, is also expressed in osteoblasts. To assess the relationship between Pkd1 and primary cilia function on bone development, we crossed heterozygous Pkd1- and Kif3a-deficient mice to create compound Pkd1 and Kif3a-deficient mice. Pkd1 haploinsufficiency (Pkd1(+/Delta)) resulted in osteopenia, characterized by decreased bone mineral density, trabecular bone volume, and cortical thickness. In addition, deficiency of Pkd1 resulted in impaired osteoblastic differentiation and enhanced adipogenesis in both primary osteoblasts and/or bone marrow stromal cell cultures. These changes were associated with decreased Runx2 expression, increased PPAR gamma expression, and impaired hedgehog signaling as evidenced by decreased Gli2 expression in bone and osteoblast cultures. In contrast, heterozygous Kif3a(+/Delta) mice display no abnormalities in skeletal development or osteoblast function, but exhibited decreased adipogenic markers in bone and impaired adipogenesis in vitro in association with decreased PPAR gamma expression and upregulation of Gli2. Superimposed Kif3a deficiency onto Pkd1(+/Delta) mice paradoxically corrected the effects of Pkd1 deficiency on bone mass, osteoblastic differentiation, and adipogenesis. In addition, Runx2, PPAR gamma and Gli2 expression in bone and osteoblasts were normalized in compound double Pkd1(+/Delta) and Kif3a(+/Delta) heterozygous mice. The administration of sonic hedgehog, overexpression of Gli2, and the PC1 C-tail construct all increased Gli2 and Runx2-II expression, but decreased PPAR gamma 2 gene expression in C3H10T1/2 cells. Our findings suggest a role for Pkd1 and Kif3a to counterbalance the regulation of osteogenesis and adipogenesis through differential regulation of Runx2 and PPAR gamma by Gli2.	[Qiu, Ni] Cent S Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China; [Qiu, Ni; Cao, Li; David, Valentin; Quarles, L. Darryl; Xiao, Zhousheng] Univ Tennessee, Ctr Hlth Sci, Dept Med, Div Nephrol, Memphis, TN 38163 USA	Central South University; University of Tennessee System; University of Tennessee Health Science Center	Qiu, N (corresponding author), Cent S Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China.	dquarles@uthsc.edu; zxiao2@uthsc.edu		xiao, zhousheng/0000-0002-3363-5673; Quarles, L. Darryl/0000-0002-5082-7896	National Institutes of Health, NIAMS [R21-AR056794]; National Institutes of Health, NIDDK [P50-DK057301, RO1-DK083303]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083303, P50DK057301] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the grant R21-AR056794 (NIAMS), P50-DK057301 (NIDDK), and RO1-DK083303 (NIDDK) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Delmas P, 2004, BIOCHEM BIOPH RES CO, V322, P1374, DOI 10.1016/j.bbrc.2004.08.044; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Goetz SC, 2009, METHOD CELL BIOL, V94, P199, DOI 10.1016/S0091-679X(08)94010-3; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hasegawa T, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-71; Hassane S, 2007, ARTERIOSCL THROM VAS, V27, P2177, DOI 10.1161/ATVBAHA.107.149252; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Housset C, 2005, GASTROEN CLIN BIOL, V29, P861, DOI 10.1016/S0399-8320(05)86361-4; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hunter AW, 2000, J CELL SCI, V113, P4379; JAMES AW, 2010, TISSUE ENG A; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Kesper DA, 2010, DEV DYNAM, V239, P1818, DOI 10.1002/dvdy.22301; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kolpakova-Hart E, 2008, MATRIX BIOL, V27, P505, DOI 10.1016/j.matbio.2008.05.002; Kolpakova-Hart E, 2007, DEV BIOL, V309, P273, DOI 10.1016/j.ydbio.2007.07.018; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kudo M, 2004, ENDOCRINOLOGY, V145, P4948, DOI 10.1210/en.2004-0180; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Liao GJ, 1999, FASEB J, V13, pS257, DOI 10.1096/fasebj.13.9002.S257; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mie M, 2000, TISSUE ENG, V6, P9, DOI 10.1089/107632700320847; Montalbetti N, 2007, J PHYSIOL-LONDON, V579, P717, DOI 10.1113/jphysiol.2006.125583; Mundy GR, 2008, DEV CELL, V14, P637, DOI 10.1016/j.devcel.2008.04.010; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Ocbina PJR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006839; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Okitsu Y, 2007, BIOCHEM BIOPH RES CO, V364, P383, DOI 10.1016/j.bbrc.2007.10.031; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Serra R, 2008, ANAT REC, V291, P1049, DOI 10.1002/ar.20634; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Steenhuis P, 2009, CELLS TISSUES ORGANS, V190, P150, DOI 10.1159/000187633; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Takada I, 2009, EXPERT OPIN THER TAR, V13, P593, DOI [10.1517/14728220902915310 , 10.1517/14728220902915310]; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tu QS, 2003, J CLIN INVEST, V111, P1029, DOI 10.1172/JCI200317054; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Whitfield JF, 2008, CELL SIGNAL, V20, P1019, DOI 10.1016/j.cellsig.2007.12.001; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; XIAO Z, J BIOL CHEM, V285, P1177; Xiao ZS, 2010, ANN NY ACAD SCI, V1192, P410, DOI 10.1111/j.1749-6632.2009.05239.x; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zhao M, 2009, MOL CELL BIOL, V29, P1291, DOI 10.1128/MCB.01566-08; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	79	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15240	10.1371/journal.pone.0015240	http://dx.doi.org/10.1371/journal.pone.0015240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151991	Green Submitted, Green Published, gold			2022-12-27	WOS:000284868000032
J	Saxer, G; Doebeli, M; Travisano, M				Saxer, Gerda; Doebeli, Michael; Travisano, Michael			The Repeatability of Adaptive Radiation During Long-Term Experimental Evolution of Escherichia coli in a Multiple Nutrient Environment	PLOS ONE			English	Article							SYMPATRIC SPECIATION; BACTERIAL MICROCOSMS; ADAPTATION; SELECTION; DIVERSIFICATION; POPULATIONS; DIVERGENCE; DIVERSITY; CONTINGENCY; GENERATIONS	Adaptive radiations occur when a species diversifies into different ecological specialists due to competition for resources and trade-offs associated with the specialization. The evolutionary outcome of an instance of adaptive radiation cannot generally be predicted because chance (stochastic events) and necessity (deterministic events) contribute to the evolution of diversity. With increasing contributions of chance, the degree of parallelism among different instances of adaptive radiations and the predictability of an outcome will decrease. To assess the relative contributions of chance and necessity during adaptive radiation, we performed a selection experiment by evolving twelve independent microcosms of Escherichia coli for 1000 generations in an environment that contained two distinct resources. Specialization to either of these resources involves strong trade-offs in the ability to use the other resource. After selection, we measured three phenotypic traits: 1) fitness, 2) mean colony size, and 3) colony size diversity. We used fitness relative to the ancestor as a measure of adaptation to the selective environment; changes in colony size as a measure of the evolution of new resource specialists because colony size has been shown to correlate with resource specialization; and colony size diversity as a measure of the evolved ecological diversity. Resource competition led to the rapid evolution of phenotypic diversity within microcosms. Measurements of fitness, colony size, and colony size diversity within and among microcosms showed that the repeatability of adaptive radiation was high, despite the evolution of genetic variation within microcosms. Consistent with the observation of parallel evolution, we show that the relative contributions of chance are far smaller and less important than effects due to adaptation for the traits investigated. The two-resource environment imposed similar selection pressures in independent populations and promoted parallel phenotypic adaptive radiations in all independently evolved microcosms.	[Saxer, Gerda; Travisano, Michael] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Saxer, Gerda; Doebeli, Michael] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Saxer, Gerda] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA; [Doebeli, Michael] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Travisano, Michael] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Houston System; University of Houston; University of British Columbia; Rice University; University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities	Saxer, G (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	gsaxer@rice.edu	Doebeli, Michael/D-5391-2012; Travisano, Michael/AAI-4809-2020	Travisano, Michael/0000-0001-8168-0842	Swiss National Science Foundation (SNSF); National Science Foundation (NSF); University of British Columbia	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Science Foundation (NSF)(National Science Foundation (NSF)); University of British Columbia	The authors were funded by the Swiss National Science Foundation (SNSF), National Science Foundation (NSF), and University of British Columbia through a Graduate Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender CJ, 2003, P NATL ACAD SCI USA, V100, P14074, DOI 10.1073/pnas.2332665100; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Burch CL, 1999, GENETICS, V151, P921; Chan KMA, 2002, SYST BIOL, V51, P855, DOI 10.1080/10635150290155836; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; DYKHUIZEN DE, 1983, MICROBIOL REV, V47, P150, DOI 10.1128/MMBR.47.2.150-168.1983; Friesen ML, 2004, EVOLUTION, V58, P245, DOI 10.1111/j.0014-3820.2004.tb01642.x; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HALDANE JBS, 1949, EVOLUTION, V3, P51, DOI 10.2307/2405451; HARTL DL, 1985, GENETICS, V111, P655; HELLING RB, 1987, GENETICS, V116, P349; Hendry AP, 2002, EVOLUTION, V56, P1199; JOHNSON PA, 1995, P ROY SOC B-BIOL SCI, V259, P125, DOI 10.1098/rspb.1995.0019; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; MacLean RC, 2003, P ROY SOC B-BIOL SCI, V270, P1645, DOI 10.1098/rspb.2003.2408; MacLean RC, 2002, AM NAT, V160, P569, DOI 10.1086/342816; McDonald MJ, 2009, GENETICS, V183, P1041, DOI 10.1534/genetics.109.107110; Monod J., 1971, CHANCE NECESSITY; Orr HA, 2001, EVOLUTION, V55, P1085; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Saxer G, 2009, P R SOC B, V276, P2065, DOI 10.1098/rspb.2008.1827; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Schluter D, 1996, AM NAT, V148, pS40, DOI 10.1086/285901; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sokal RR, 1995, BIOMETRY; Spencer CC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030015; Spencer CC, 2007, EVOL ECOL RES, V9, P775; Szafraniec K, 2001, P NATL ACAD SCI USA, V98, P1107, DOI 10.1073/pnas.021390798; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Travisano M, 1997, GENETICS, V146, P471; TRAVISANO M, 1995, EVOLUTION, V49, P189, DOI 10.2307/2410304; Travisano M, 1996, GENETICS, V143, P15; Travisano M., 2009, EXPT EVOLUTION CONCE; Tyerman J, 2005, P ROY SOC B-BIOL SCI, V272, P1393, DOI 10.1098/rspb.2005.3068; Tyerman JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-34; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Wahl LM, 2000, GENETICS, V156, P1437; WRIGHT S, 1988, AM NAT, V131, P115, DOI 10.1086/284777	53	28	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14184	10.1371/journal.pone.0014184	http://dx.doi.org/10.1371/journal.pone.0014184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152028	Green Published, Green Submitted, gold			2022-12-27	WOS:000284868000008
J	Li, QY; Eklund, AC; Juul, N; Haibe-Kains, B; Workman, CT; Richardson, AL; Szallasi, Z; Swanton, C				Li, Qiyuan; Eklund, Aron C.; Juul, Nicolai; Haibe-Kains, Benjamin; Workman, Christopher T.; Richardson, Andrea L.; Szallasi, Zoltan; Swanton, Charles			Minimising Immunohistochemical False Negative ER Classification Using a Complementary 23 Gene Expression Signature of ER Status	PLOS ONE			English	Article							PRIMARY BREAST-CANCER; ESTROGEN-RECEPTOR STATUS; HISTOLOGIC GRADE; RECURRENCE; PREDICT; CHEMOTHERAPY; RESISTANCE; PATTERNS; SUBTYPES; THERAPY	Background: Expression of the oestrogen receptor (ER) in breast cancer predicts benefit from endocrine therapy. Minimising the frequency of false negative ER status classification is essential to identify all patients with ER positive breast cancers who should be offered endocrine therapies in order to improve clinical outcome. In routine oncological practice ER status is determined by semi-quantitative methods such as immunohistochemistry (IHC) or other immunoassays in which the ER expression level is compared to an empirical threshold[1,2]. The clinical relevance of gene expression-based ER subtypes as compared to IHC-based determination has not been systematically evaluated. Here we attempt to reduce the frequency of false negative ER status classification using two gene expression approaches and compare these methods to IHC based ER status in terms of predictive and prognostic concordance with clinical outcome. Methodology/Principal Findings: Firstly, ER status was discriminated by fitting the bimodal expression of ESR1 to a mixed Gaussian model. The discriminative power of ESR1 suggested bimodal expression as an efficient way to stratify breast cancer; therefore we identified a set of genes whose expression was both strongly bimodal, mimicking ESR expression status, and highly expressed in breast epithelial cell lines, to derive a 23-gene ER expression signature-based classifier. We assessed our classifiers in seven published breast cancer cohorts by comparing the gene expression-based ER status to IHC-based ER status as a predictor of clinical outcome in both untreated and tamoxifen treated cohorts. In untreated breast cancer cohorts, the 23 gene signature-based ER status provided significantly improved prognostic power compared to IHCbased ER status (P = 0.006). In tamoxifen-treated cohorts, the 23 gene ER expression signature predicted clinical outcome (HR = 2.20, P = 0.00035). These complementary ER signature-based strategies estimated that between 15.1% and 21.8% patients of IHC-based negative ER status would be classified with ER positive breast cancer. Conclusion/Significance: Expression-based ER status classification may complement IHC to minimise false negative ER status classification and optimise patient stratification for endocrine therapies.	[Li, Qiyuan; Eklund, Aron C.; Juul, Nicolai; Workman, Christopher T.; Szallasi, Zoltan] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Haibe-Kains, Benjamin] Harvard Univ, Ctr Canc Computat Biol, Dana Farber Canc Inst, Computat Biol & Funct Genom Lab,Sch Publ Hlth, Boston, MA 02115 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Szallasi, Zoltan] Harvard Univ, Childrens Hosp, Harvard MIT Div Hlth Sci & Technol CHIP HST, Informat Program,Sch Med, Boston, MA 02115 USA; [Swanton, Charles] Canc Res UK London Res Inst, Translat Canc Therapeut Lab, London, England; [Swanton, Charles] Royal Marsden Hosp, Breast Unit, Sutton, Surrey, England; [Swanton, Charles] Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England	Technical University of Denmark; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Cancer Research UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Li, QY (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	zszallasi@chip.org; Charles.swanton@cancer.org.uk	Workman, Christopher T/K-1066-2015; Haibe-Kains, Benjamin/D-3702-2011	Workman, Christopher T/0000-0002-2210-3743; Haibe-Kains, Benjamin/0000-0002-7684-0079; Birkbak, Nicolai/0000-0003-1613-9587; Szallasi, Zoltan/0000-0001-5395-7509; Eklund, Aron Charles/0000-0003-0861-1001; Swanton, Charles/0000-0002-4299-3018	Cancer Research UK; Medical Research Council; Inflammatory Breast Cancer UK; Danish Council for Independent Research, Medical Sciences (FSS); National Institute of Health [NCI SPORE P50 CA 89393, R21LM008823-01A1, 1R03LM009979-01]; Breast Cancer Research Foundation (BCRF); BioSim (NoE) [LSHB-CT-2004-005137]; MRC [G0701935] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM008823, R03LM009979] Funding Source: NIH RePORTER; Medical Research Council [G0701935] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Inflammatory Breast Cancer UK; Danish Council for Independent Research, Medical Sciences (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation (BCRF); BioSim (NoE); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CS is a senior Medical Research Council clinical research fellow and is funded by Cancer Research UK, the Medical Research Council and Inflammatory Breast Cancer UK. ZS and ACE are funded by the Danish Council for Independent Research, Medical Sciences (FSS), the National Institute of Health (grants NCI SPORE P50 CA 89393, R21LM008823-01A1, 1R03LM009979-01) and by the Breast Cancer Research Foundation (BCRF). QL is funded by BioSim (NoE), FP6, LSHB-CT-2004-005137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Allred DC, 2008, ONCOLOGIST, V13, P1134, DOI 10.1634/theoncologist.2008-0184; Arpino G, 2005, JNCI-J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Badve S, 2009, J CLIN PATHOL, V62, P6, DOI 10.1136/jcp.2008.059899; BARNES DMM, 1998, EUROPEAN J CANC, V34; Bessarabova M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S8; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Eklund AC, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1116; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; Gruvberger S, 2001, CANCER RES, V61, P5979; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hilsenbeck SG, 1998, BREAST CANCER RES TR, V52, P227, DOI 10.1023/A:1006133418245; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PODHAJCER OL, 1986, CANCER, V58, P720, DOI 10.1002/1097-0142(19860801)58:3<720::AID-CNCR2820580320>3.0.CO;2-S; POPOVICI V, 2009, NATURE BIOTECHNOL; Roepman P, 2009, CLIN CANCER RES, V15, P7003, DOI 10.1158/1078-0432.CCR-09-0449; Ross JS, 2007, CLIN CANCER RES, V13, P2831, DOI 10.1158/1078-0432.CCR-06-2522; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Teschendorff AE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2138; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Wang J, 2009, CANCER INFORM, V7, P199; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WEIGELT B, LANCET ONCOL; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102; 2001, COCHRANE DATABASE SY	38	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15031	10.1371/journal.pone.0015031	http://dx.doi.org/10.1371/journal.pone.0015031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152022	Green Published, gold, Green Submitted			2022-12-27	WOS:000284821300013
J	Bonde, MM; Hansen, JT; Sanni, SJ; Haunso, S; Gammeltoft, S; Lyngso, C; Hansen, JL				Bonde, Marie Mi; Hansen, Jonas Tind; Sanni, Samra Joke; Haunso, Stig; Gammeltoft, Steen; Lyngso, Christina; Hansen, Jakob Lerche			Biased Signaling of the Angiotensin II Type 1 Receptor Can Be Mediated through Distinct Mechanisms	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; 7TH TRANSMEMBRANE DOMAIN; BETA-ARRESTIN; STRUCTURAL DETERMINANTS; MOLECULAR DETERMINANTS; FUNCTIONAL SELECTIVITY; REGULATED KINASE-1; ACTIVATION SWITCH; CRYSTAL-STRUCTURE; AT(1A) RECEPTOR	Background: Seven transmembrane receptors (7TMRs) can adopt different active conformations facilitating a selective activation of either G protein or beta-arrestin-dependent signaling pathways. This represents an opportunity for development of novel therapeutics targeting selective biological effects of a given receptor. Several studies on pathway separation have been performed, many of these on the Angiotensin II type 1 receptor (AT1R). It has been shown that certain ligands or mutations facilitate internalization and/or recruitment of beta-arrestins without activation of G proteins. However, the underlying molecular mechanisms remain largely unresolved. For instance, it is unclear whether such selective G protein-uncoupling is caused by a lack of ability to interact with G proteins or rather by an increased ability of the receptor to recruit beta-arrestins. Since uncoupling of G proteins by increased ability to recruit beta-arrestins could lead to different cellular or in vivo outcomes than lack of ability to interact with G proteins, it is essential to distinguish between these two mechanisms. Methodology/Principal Findings: We studied five AT1R mutants previously published to display pathway separation: D74N, DRY/AAY, Y292F, N298A, and Y302F (Ballesteros-Weinstein numbering: 2.50, 3.49-3.51, 7.43, 7.49, and 7.53). We find that D74N, DRY/AAY, and N298A mutants are more prone to beta-arrestin recruitment than WT. In contrast, receptor mutants Y292F and Y302F showed impaired ability to recruit beta-arrestin in response to Sar(1)-Ile(4)-Ile(8) (SII) Ang II, a ligand solely activating the beta-arrestin pathway. Conclusions/Significance: Our analysis reveals that the underlying conformations induced by these AT1R mutants most likely represent principally different mechanisms of uncoupling the G protein, which for some mutants may be due to their increased ability to recruit beta-arrestin2. Hereby, these findings have important implications for drug discovery and 7TMR biology and illustrate the necessity of uncovering the exact molecular determinants for G protein-coupling and beta-arrestin recruitment, respectively.	[Bonde, Marie Mi; Haunso, Stig; Hansen, Jakob Lerche] Copenhagen Univ Hosp, Rigshosp, Ctr Heart,Lab Mol Cardiol, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [Bonde, Marie Mi; Hansen, Jonas Tind; Lyngso, Christina; Hansen, Jakob Lerche] Univ Copenhagen, Fac Hlth Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Dept Biomed Sci, Copenhagen, Denmark; [Hansen, Jonas Tind; Sanni, Samra Joke; Gammeltoft, Steen; Lyngso, Christina] Glostrup Cty Hosp, Dept Clin Biochem, Glostrup, Denmark	Danmarks Grundforskningsfond; Rigshospitalet; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen	Bonde, MM (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Heart,Lab Mol Cardiol, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark.	JLHH@novonordisk.com		Sanni, Samra/0000-0002-9708-5674	Danish Heart Foundation; Danish National Research Foundation; Faculty of Health Sciences, University of Copenhagen; Aase og Ejnar Danielsens Foundation; Novo Nordisk Foundation; Augustinus Foundation	Danish Heart Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond); Faculty of Health Sciences, University of Copenhagen; Aase og Ejnar Danielsens Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Augustinus Foundation	This work was supported by The Danish Heart Foundation: www.hjerteforeningen.dk/forskning; The Danish National Research Foundation: www.dg.dk; The Koebmand i Odense Johan og Hanne Weimann f. Seedorffs legat: applied for through the Faculty of Health Sciences, University of Copenhagen, www.sund.ku.dk; Aase og Ejnar Danielsens Foundation: http://www.danielsensfond.dk/home; The Novo Nordisk Foundation: www.novonordiskfonden.dk; and The Augustinus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P296, DOI 10.1111/j.1742-7843.2007.00064.x; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P289, DOI 10.1111/j.1742-7843.2007.00063.x; Aplin M, 2008, TRENDS CARDIOVAS MED, V18, P305, DOI 10.1016/j.tcm.2009.01.003; Aplin M, 2009, J MOL CELL CARDIOL, V46, P15, DOI 10.1016/j.yjmcc.2008.09.123; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Benned-Jensen T, 2008, MOL PHARMACOL, V74, P1008, DOI 10.1124/mol.108.049676; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; Bonde MM, 2010, BIOCHEM PHARMACOL, V80, P86, DOI 10.1016/j.bcp.2010.03.006; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Conchon S, 1998, AM J PHYSIOL-ENDOC M, V274, pE336, DOI 10.1152/ajpendo.1998.274.2.E336; Feng YH, 2005, HYPERTENSION, V46, P419, DOI 10.1161/01.HYP.0000172621.68061.22; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Gripentrog JM, 2000, BIOCHEM J, V352, P399, DOI 10.1042/0264-6021:3520399; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Hansen JL, 2008, EUR J PHARMACOL, V590, P255, DOI 10.1016/j.ejphar.2008.05.010; Hansen JL, 2004, MOL PHARMACOL, V65, P770, DOI 10.1124/mol.65.3.770; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hines J, 2003, BIOCHEM PHARMACOL, V66, P251, DOI 10.1016/S0006-2952(03)00257-0; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; HUNYADY L, 1995, J BIOL CHEM, V270, P16602, DOI 10.1074/jbc.270.28.16602; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kendall RT, 2009, CELL MOL LIFE SCI, V66, P2953, DOI 10.1007/s00018-009-0088-1; Kule CE, 2004, REGUL PEPTIDES, V120, P141, DOI 10.1016/j.regpep.2004.03.001; Laporte SA, 1996, MOL PHARMACOL, V49, P89; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; MARIE J, 1994, J BIOL CHEM, V269, P20815; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nikiforovich GV, 2006, CHEM BIOL DRUG DES, V68, P239, DOI 10.1111/j.1747-0285.2006.00444.x; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ohyama K, 2002, BIOCHEM BIOPH RES CO, V292, P362, DOI 10.1006/bbrc.2002.6670; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sanni SJ, 2010, BRIT J PHARMACOL, V161, P150, DOI 10.1111/j.1476-5381.2010.00875.x; SANNI SJ, BR J PHARM, V161, P150; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Shibata T, 1996, BIOCHEM BIOPH RES CO, V218, P383, DOI 10.1006/bbrc.1996.0067; Smith RD, 1998, MOL PHARMACOL, V54, P935, DOI 10.1124/mol.54.6.935; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; URBAN JD, 2006, J PHARM EXP THER; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Weir MR, 2007, CLIN THER, V29, P1803, DOI 10.1016/j.clinthera.2007.09.019; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yee DK, 2006, MOL ENDOCRINOL, V20, P1924, DOI 10.1210/me.2006-0018; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; ZHOU W, 1994, MOL PHARMACOL, V45, P165	61	25	26	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14135	10.1371/journal.pone.0014135	http://dx.doi.org/10.1371/journal.pone.0014135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152433	Green Submitted, gold, Green Published			2022-12-27	WOS:000284755100016
J	Krosby, M; Rohwer, S				Krosby, Meade; Rohwer, Sievert			Ongoing Movement of the Hermit Warbler X Townsend's Warbler Hybrid Zone	PLOS ONE			English	Article							ASYMMETRIES; CLIMATE	Background: Movements of hybrid zones - areas of overlap and interbreeding between species - are difficult to document empirically. This is true because moving hybrid zones are expected to be rare, and because movement may proceed too slowly to be measured directly. Townsend's warblers (Dendroica townsendi) hybridize with hermit warblers (D. occidentalis) where their ranges overlap in Washington and Oregon. Previous morphological, behavioral, and genetic studies of this hybrid zone suggest that it has been steadily moving into the geographical range of hermit warblers, with the more aggressive Townsend's warblers replacing hermit warblers along,2000 km of the Pacific coast of Canada and Alaska. Ongoing movement of the zone, however, has yet to be empirically demonstrated. Methodology/Principal Findings: We compared recently sampled hybrid zone specimens to those collected 10-20 years earlier, to test directly the long-standing hypothesis of hybrid zone movement between these species. Newly sampled specimens were more Townsend's-like than historical specimens, consistent with ongoing movement of the zone into the geographical range of hermit warblers. Conclusions/Significance: While movement of a hybrid zone may be explained by several possible mechanisms, in this case a wealth of existing evidence suggests that movement is being driven by the competitive displacement of hermit warblers by Townsend's warblers. That no ecological differences have been found between these species, and that replacement of hermit warblers by Townsend's warblers is proceeding downward in latitude and elevation - opposite the directions of range shifts predicted by recent climate change - further support that this movement is not being driven by alternative environmental factors. If the mechanism of competitive displacement is correct, whether this process will ultimately lead to the extinction of hermit warblers will depend on the continued maintenance of the dramatic competitive asymmetry observed between the species.	[Krosby, Meade] Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Washington, Burke Museum, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Krosby, M (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	mkrosby@u.washington.edu		Krosby, Meade/0000-0001-6235-7839	National Science Foundation; Achievement Rewards for College Scientists Foundation; Burke Museum Eddy Fellowship; Kathryn Hahn Writing Fellowship; Burke Museum's Endowment for Ornithology	National Science Foundation(National Science Foundation (NSF)); Achievement Rewards for College Scientists Foundation(General Electric); Burke Museum Eddy Fellowship; Kathryn Hahn Writing Fellowship; Burke Museum's Endowment for Ornithology	M.K. was supported by a National Science Foundation Graduate Research Fellowship (http://www.nsf.gove/grfp), an Achievement Rewards for College Scientists Foundation Fellowship (http://www.arcsfoundation.org/Seattle), a Burke Museum Eddy Fellowship, and a Kathryn Hahn Writing Fellowship (http://www.biology.washington.edu/Graduate/Scholarships). Specimen collection was funded by the late Garrett Eddy and by the Burke Museum's Endowment for Ornithology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Harrison RG, 1993, HYBRID ZONES EVOLUTI; Krosby M, 2009, P ROY SOC B-BIOL SCI, V276, P615, DOI 10.1098/rspb.2008.1310; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Owen-Ashley NT, 2004, P ROY SOC B-BIOL SCI, V271, pS498, DOI 10.1098/rsbl.2004.0230; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson SF, 2000, BEHAV ECOL, V11, P93, DOI 10.1093/beheco/11.1.93; Pearson SF, 2000, AUK, V117, P175, DOI 10.1642/0004-8038(2000)117[0175:IONOAT]2.0.CO;2; Pearson SF, 2000, BEHAV ECOL, V11, P84, DOI 10.1093/beheco/11.1.84; Rohwer S, 1998, AUK, V115, P284, DOI 10.2307/4089188; Rohwer S, 2001, EVOLUTION, V55, P405; Rohwer S, 2007, AUK, V124, P1347, DOI 10.1642/0004-8038(2007)124[1347:TSCAGF]2.0.CO;2; Walls SC, 2009, GLOBAL CHANGE BIOL, V15, P1903, DOI 10.1111/j.1365-2486.2009.01867.x	14	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14164	10.1371/journal.pone.0014164	http://dx.doi.org/10.1371/journal.pone.0014164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152406	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100041
J	van Schaijk, BCL; Vos, MW; Janse, CJ; Sauerwein, RW; Khan, SM				van Schaijk, Ben C. L.; Vos, Martijn W.; Janse, Chris J.; Sauerwein, Robert W.; Khan, Shahid M.			Removal of Heterologous Sequences from Plasmodium falciparum Mutants Using FLPe-Recombinase	PLOS ONE			English	Article							TARGETED GENE DELETION; CONDITIONAL MUTAGENESIS; NEGATIVE SELECTION; MALARIA PARASITES; GENOME SEQUENCE; TRANSFORMATION; GAMETOCYTES; RESISTANCE; YEAST	Genetically-modified mutants are now indispensable Plasmodium gene-function reagents, which are also being pursued as genetically attenuated parasite vaccines. Currently, the generation of transgenic malaria-parasites requires the use of drug-resistance markers. Here we present the development of an FRT/FLP-recombinase system that enables the generation of transgenic parasites free of resistance genes. We demonstrate in the human malaria parasite, P. falciparum, the complete and efficient removal of the introduced resistance gene. We targeted two neighbouring genes, p52 and p36, using a construct that has a selectable marker cassette flanked by FRT-sequences. This permitted the subsequent removal of the selectable marker cassette by transient transfection of a plasmid that expressed a 37 degrees C thermostable and enhanced FLP-recombinase. This method of removing heterologous DNA sequences from the genome opens up new possibilities in Plasmodium research to sequentially target multiple genes and for using genetically-modified parasites as live, attenuated malaria vaccines.	[van Schaijk, Ben C. L.; Vos, Martijn W.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Janse, Chris J.; Khan, Shahid M.] Leiden Univ, Leiden Malaria Res Grp, Dept Parasitol, Ctr Infect Dis,Med Ctr, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Schaijk, BCL (corresponding author), Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	B.VanSchaijk@mmb.umcn.nl; s.m.khan@lumc.nl	Sauerwein, Robert/C-8519-2013	Khan, Shahid/0000-0002-0533-4670; Janse, Chris J/0000-0002-6410-6205	Top Institute Pharma (Netherlands) [T4-102]; European Community [242095]	Top Institute Pharma (Netherlands)(Netherlands Government); European Community(European Commission)	This study was performed within the framework of Top Institute Pharma (Netherlands) project: T4-102. Chris J. Janse received financial support from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement N<SUP>o</SUP> 242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2010, CELL MICROBIOL, V12, P930, DOI 10.1111/j.1462-5822.2010.01441.x; ANDREWS BJ, 1985, CELL, V40, P795, DOI 10.1016/0092-8674(85)90339-3; Balu B, 2007, INT J PARASITOL, V37, P1, DOI 10.1016/j.ijpara.2006.10.001; Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Carvalho TG, 2005, CURR ISSUES MOL BIOL, V7, P39, DOI 10.21775/cimb.007.039; Carvalho TG, 2004, P NATL ACAD SCI USA, V101, P14931, DOI 10.1073/pnas.0404416101; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Combe A, 2009, CELL HOST MICROBE, V5, P386, DOI 10.1016/j.chom.2009.03.008; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frey J, 2007, VACCINE, V25, P5598, DOI 10.1016/j.vaccine.2006.11.058; Gardiner DL, 2005, MOL BIOCHEM PARASIT, V140, P153, DOI 10.1016/j.molbiopara.2004.12.010; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; O'Neill MT, 2010, INT J PARASITOL; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X; Sambrook J., 2001, MOL CLONING LAB MANU; Spaccapelo R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/ajpath.2010.090504; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; THAITHONG S, 1981, T ROY SOC TROP MED H, V75, P271, DOI 10.1016/0035-9203(81)90333-3; Thaithong S., 1985, APPL GENETIC ENG RES, P379; Thompson J, 2001, MOL BIOCHEM PARASIT, V118, P147, DOI 10.1016/S0166-6851(01)00377-2; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	37	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15121	10.1371/journal.pone.0015121	http://dx.doi.org/10.1371/journal.pone.0015121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152048	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100080
J	Eran, A; Erdmann, E; Er, F				Eran, Aslihan; Erdmann, Erland; Er, Fikret			Informed Consent Prior to Coronary Angiography in a Real World Scenario: What Do Patients Remember?	PLOS ONE			English	Article							STABLE ANGINA; ILL PATIENTS; COMPETENCE; CAPACITY; SCHIZOPHRENIA; PARTICIPANTS; GUIDELINES; MANAGEMENT; QUALITY; RISK	Background: Patients' informed consent is legally essential before elective invasive cardiac angiography (CA) and successive intervention can be done. It is unknown to what extent patients can remember previous detailed information given by a specially trained doctor in an optimal scenario as compared to standard care. Methodology/Principal Findings: In this prospective cohort study 150 consecutive in-patients and 50 out-patients were included before elective CA was initiated. The informed consent was provided and documented in in-patients by trained and instructed physicians the day before CA. In contrast, out-patients received standard information by different not trained physicians, who did not know about this investigation. All patients had to sign a form stating that enough information had been given and all questions had been answered sufficiently. One hour before CA an assessment of the patients' knowledge about CA was performed using a standard point-by-point questionnaire by another independent physician. The supplied information was composed of 12 potential complications, 3 general, 4 periprocedural and 4 procedural aspects. 95% of the patients felt that they had been well and sufficiently informed. Less than half of the potential complications could be remembered by the patients and more patients could remember less serious than life-threatening complications (27.9 +/- 8.8% vs. 47.1 +/- 11.0%; p<0.001). Even obvious complications like local bleeding could not be remembered by 35% of in-patients and 36% of out-patients (p = 0.87). Surprisingly, there were only a few knowledge differences between in-and out-patients. Conclusions: The knowledge about CA of patients is vague when they give their informed consent. Even structured information given by a specially trained physician did not increase this knowledge.	[Eran, Aslihan; Erdmann, Erland; Er, Fikret] Univ Cologne, Dept Internal Med 3, Cologne, Germany	University of Cologne	Eran, A (corresponding author), Univ Cologne, Dept Internal Med 3, Cologne, Germany.	Fikret.Er@uk-koeln.de						Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; Appelbaum PS, 1999, AM J PSYCHIAT, V156, P1380; Appelbaum PS, 1997, PSYCHOSOMATICS, V38, P119, DOI 10.1016/S0033-3182(97)71480-4; Barrett R, 2005, ONCOL NURS FORUM, V32, P751, DOI 10.1188/05.ONF.751-755; Beauchamp TL, 1997, MED ETHICS; Casarett DJ, 2003, J PAIN SYMPTOM MANAG, V26, P615, DOI 10.1016/S0885-3924(03)00221-5; Dresden GM, 2001, ACAD EMERG MED, V8, P246, DOI 10.1111/j.1553-2712.2001.tb01300.x; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P127, DOI 10.1007/BF01499322; Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1; Kim SYH, 2002, AM J GERIAT PSYCHIAT, V10, P151, DOI 10.1176/appi.ajgp.10.2.151; Lipkus I M, 1999, J Natl Cancer Inst Monogr, P149; Moser DJ, 2002, AM J PSYCHIAT, V159, P1201, DOI 10.1176/appi.ajp.159.7.1201; Palmer BW, 2007, J CLIN PSYCHIAT, V68, P689, DOI 10.4088/JCP.v68n0505; Palmer BW, 2005, ARCH GEN PSYCHIAT, V62, P726, DOI 10.1001/archpsyc.62.7.726; Schapira MM, 2001, MED DECIS MAKING, V21, P459, DOI 10.1177/02729890122062811; Song Ji Hyun, 2010, Korean Journal of Internal Medicine, V25, P36, DOI 10.3904/kjim.2010.25.1.36; Stryker JE, 2006, PATIENT EDUC COUNS, V63, P104, DOI 10.1016/j.pec.2005.09.006; Tait AR, 2005, ARCH PEDIAT ADOL MED, V159, P347, DOI 10.1001/archpedi.159.4.347; Vallance JH, 2004, J CATARACT REFR SURG, V30, P1479, DOI 10.1016/j.jcrs.2003.11.050; Vollmann J, 2003, PSYCHOL MED, V33, P1463, DOI 10.1017/S0033291703008389	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15164	10.1371/journal.pone.0015164	http://dx.doi.org/10.1371/journal.pone.0015164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698EM	21188151	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200018
J	Longmate, JA; Larson, GP; Krontiris, TG; Sommer, SS				Longmate, Jeffrey A.; Larson, Garrett P.; Krontiris, Theodore G.; Sommer, Steve S.			Three Ways of Combining Genotyping and Resequencing in Case-Control Association Studies	PLOS ONE			English	Article							RARE VARIANTS; DOVAM-S; SUSCEPTIBILITY; MUTATIONS; POWER; STRATEGIES; DISEASES; CANCER; RISK	We describe three statistical results that we have found to be useful in case-control genetic association testing. All three involve combining the discovery of novel genetic variants, usually by sequencing, with genotyping methods that recognize previously discovered variants. We first consider expanding the list of known variants by concentrating variant-discovery in cases. Although the naive inclusion of cases-only sequencing data would create a bias, we show that some sequencing data may be retained, even if controls are not sequenced. Furthermore, for alleles of intermediate frequency, cases-only sequencing with bias-correction entails little if any loss of power, compared to dividing the same sequencing effort among cases and controls. Secondly, we investigate more strongly focused variant discovery to obtain a greater enrichment for disease-related variants. We show how case status, family history, and marker sharing enrich the discovery set by increments that are multiplicative with penetrance, enabling the preferential discovery of high-penetrance variants. A third result applies when sequencing is the primary means of counting alleles in both cases and controls, but a supplementary pooled genotyping sample is used to identify the variants that are very rare. We show that this raises no validity issues, and we evaluate a less expensive and more adaptive approach to judging rarity, based on group-specific variants. We demonstrate the important and unusual caveat that this method requires equal sample sizes for validity. These three results can be used to more efficiently detect the association of rare genetic variants with disease.	[Larson, Garrett P.; Krontiris, Theodore G.] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA USA; [Sommer, Steve S.] Medomics LLC, Azusa, CA USA	City of Hope		jlongmate@coh.org		Longmate, Jeffrey/0000-0002-0869-7928	National Cancer Institute [CA33572-26]; Beckman Research Institute at City of Hope; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Beckman Research Institute at City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Parts of this work were undertaken as Biostatistics Shared Resource support for multiple projects, funded by a Cancer Center Support Grant (CA33572-26) from the National Cancer Institute. The remainder was funded by the Beckman Research Institute at City of Hope. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Buzin CH, 2000, BIOTECHNIQUES, V28, P746, DOI 10.2144/00284rr04; Chen ZB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007220; Curtin K, 2009, ANN HUM GENET, V73, P54, DOI 10.1111/j.1469-1809.2008.00483.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; Larson GP, 1997, GENET TEST, V1, P165, DOI 10.1089/gte.1997.1.165; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Liu Q, 1999, BIOTECHNIQUES, V26, P932, DOI 10.2144/99265rr03; Longmate JA, 2001, AM J HUM GENET, V68, P1229, DOI 10.1086/320106; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy MI, 2009, GENOME MED, V1, DOI 10.1186/gm66; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; PATIL GP, 1988, ENCY STATISTICAL SCI, V9, P565; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; Sommer SS, 2003, CANCER GENET CYTOGEN, V145, P115, DOI 10.1016/S0165-4608(03)00119-5; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; TORNQVIST L, 1985, AM STAT, V39, P43, DOI 10.2307/2683905; Zeggini E, 2005, NAT GENET, V37, P1320, DOI 10.1038/ng1670; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14318	10.1371/journal.pone.0014318	http://dx.doi.org/10.1371/journal.pone.0014318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187953	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200005
J	Sebbane, F; Jarrett, C; Gardner, D; Long, D; Hinnebusch, BJ				Sebbane, Florent; Jarrett, Clayton; Gardner, Donald; Long, Daniel; Hinnebusch, B. Joseph			Role of the Yersinia pestis Yersiniabactin Iron Acquisition System in the Incidence of Flea-Borne Plague	PLOS ONE			English	Article							PASTEURELLA PESTIS; PIGMENTATION; TRANSMISSION; DELETION	Plague is a flea-borne zoonosis caused by the bacterium Yersinia pestis. Y. pestis mutants lacking the yersiniabactin (Ybt) siderophore-based iron transport system are avirulent when inoculated intradermally but fully virulent when inoculated intravenously in mice. Presumably, Ybt is required to provide sufficient iron at the peripheral injection site, suggesting that Ybt would be an essential virulence factor for flea-borne plague. Here, using a flea-to-mouse transmission model, we show that a Y. pestis strain lacking the Ybt system causes fatal plague at low incidence when transmitted by fleas. Bacteriology and histology analyses revealed that a Ybt-negative strain caused only primary septicemic plague and atypical bubonic plague instead of the typical bubonic form of disease. The results provide new evidence that primary septicemic plague is a distinct clinical entity and suggest that unusual forms of plague may be caused by atypical Y. pestis strains.	[Sebbane, Florent] Inst Pasteur, Ctr Infect & Immun Lille, Equipe Peste & Yersinia Pestis, F-59019 Lille, France; [Sebbane, Florent] INSERM, U1019, F-59045 Lille, France; [Sebbane, Florent] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Sebbane, Florent] Univ Lille Nord France, Lille, France; [Sebbane, Florent] Ctr Infect & Immun Lille, UDSL, Lille, France; [Jarrett, Clayton; Hinnebusch, B. Joseph] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MT USA; [Jarrett, Clayton; Gardner, Donald; Long, Daniel; Hinnebusch, B. Joseph] NIAID, Vet Pathol Sect, Rocky Mt Labs, NIH, Hamilton, MT USA	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sebbane, F (corresponding author), Inst Pasteur, Ctr Infect & Immun Lille, Equipe Peste & Yersinia Pestis, F-59019 Lille, France.	florent.sebbane@inserm.fr	Sebbane, Florent/D-4213-2009; Sebbane, Florent/ABA-2213-2020	Sebbane, Florent/0000-0003-3811-9691	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Institut National de la Sante et de la Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000919] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; and Institut National de la Sante et de la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearden SW, 1999, MOL MICROBIOL, V32, P403, DOI 10.1046/j.1365-2958.1999.01360.x; BRUBAKER RR, 1969, J BACTERIOL, V98, P1404, DOI 10.1128/JB.98.3.1404-1406.1969; Buchrieser C, 1998, J BACTERIOL, V180, P2321, DOI 10.1128/JB.180.9.2321-2329.1998; CHEN TH, 1961, J IMMUNOL, V87, P64; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Fetherston JD, 2010, INFECT IMMUN, V78, P2045, DOI 10.1128/IAI.01236-09; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; FONQUERNIE J., 1931, Bulletin de la Societe de Pathologie Exotique, V24, P446; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; ITEMAN I, 1993, INFECT IMMUN, V61, P2717, DOI 10.1128/IAI.61.6.2717-2722.1993; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; PERRY RD, 2004, YERSINIA MOL CELLULA, P257; Pollitzer R., 1954, PLAGUE; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Sebbane F, 2009, INFECT IMMUN, V77, P1222, DOI 10.1128/IAI.00950-08; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; WILLIAMS JE, 1978, AM J PUBLIC HEALTH, V68, P262, DOI 10.2105/AJPH.68.3.262	19	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14379	10.1371/journal.pone.0014379	http://dx.doi.org/10.1371/journal.pone.0014379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179420	Green Published, Green Submitted, gold			2022-12-27	WOS:000285572900011
J	Nakashima, T; Jinnin, M; Etoh, T; Fukushima, S; Masuguchi, S; Maruo, K; Inoue, Y; Ishihara, T; Ihn, H				Nakashima, Taiji; Jinnin, Masatoshi; Etoh, Tomomi; Fukushima, Satoshi; Masuguchi, Shinichi; Maruo, Keishi; Inoue, Yuji; Ishihara, Tsuyoshi; Ihn, Hironobu			Down-Regulation of mir-424 Contributes to the Abnormal Angiogenesis via MEK1 and Cyclin E1 in Senile Hemangioma: Its Implications to Therapy	PLOS ONE			English	Article							NONREPLICATING ENDOTHELIAL-CELLS; INTENSE PULSED-LIGHT; VASCULAR-LESIONS; EXPRESSION; MICRORNAS; KINASE; LASER; PROLIFERATION; MALFORMATIONS; CHILDREN	Background: Senile hemangioma, so-called cherry angioma, is known as the most common vascular anomalies specifically seen in the aged skin. The pathogenesis of its abnormal angiogenesis is still unclear. Methodology/Principal Findings: In this study, we found that senile hemangioma consisted of clusters of proliferated small vascular channels in upper dermis, indicating that this tumor is categorized as a vascular tumor. We then investigated the mechanism of endothelial proliferation in senile hemangioma, focusing on microRNA ( miRNA). miRNA PCR array analysis revealed the mir-424 level in senile hemangioma was lower than in other vascular anomalies. Protein expression of MEK1 and cyclin E1, the predicted target genes of mir-424, was increased in senile hemangioma compared to normal skin or other anomalies, but their mRNA levels were not. The inhibition of mir-424 in normal human dermal microvascular ECs (HDMECs) using specific inhibitor in vitro resulted in the increase of protein expression of MEK1 or cyclin E1, while mRNA levels were not affected by the inhibitor. Specific inhibitor of mir-424 also induced the cell proliferation of HDMECs significantly, while the cell number was decreased by the transfection of siRNA for MEK1 or cyclin E1. Conclusions/Significance: Taken together, decreased mir-424 expression and increased levels of MEK1 or cyclin E1 in senile hemangioma may cause abnormal cell proliferation in the tumor. Senile hemangioma may be the good model for cutaneous angiogenesis. Investigation of senile hemangioma and the regulatory mechanisms of angiogenesis by miRNA in the aged skin may lead to new treatments using miRNA by the transfection into senile hemangioma.	[Nakashima, Taiji; Jinnin, Masatoshi; Etoh, Tomomi; Fukushima, Satoshi; Masuguchi, Shinichi; Maruo, Keishi; Inoue, Yuji; Ishihara, Tsuyoshi; Ihn, Hironobu] Kumamoto Univ, Dept Dermatol & Plast Surg, Fac Life Sci, Kumamoto, Japan	Kumamoto University	Nakashima, T (corresponding author), Kumamoto Univ, Dept Dermatol & Plast Surg, Fac Life Sci, Kumamoto, Japan.	mjin@kumamoto-u.ac.jp		Fukushima, Satoshi/0000-0002-0622-7682	Rohto Award; JSID; Mitsubishi Pharma Research Foundation	Rohto Award; JSID; Mitsubishi Pharma Research Foundation	This study was supported in part by grants from Rohto Award, from JSID's Fellowship Shiseido Award, and from Mitsubishi Pharma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by grants from a commercial source (Rohto, Shiseido and Mitsubishi Pharma). The funders do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bernstein EF, 2009, GIORN ITAL DERMAT V, V144, P557; Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432; BRAVERMAN IM, 1983, J INVEST DERMATOL, V81, P489, DOI 10.1111/1523-1747.ep12522736; Brown LF, 1996, AM J PATHOL, V148, P1065; Bu Jingqiu, 2002, Zhonghua Kou Qiang Yi Xue Za Zhi, V37, P33; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chung JH, 2007, J DERMATOL, V34, P593, DOI 10.1111/j.1346-8138.2007.00341.x; Davidson-Moncada J, 2010, ANN NY ACAD SCI, V1183, P183, DOI 10.1111/j.1749-6632.2009.05121.x; DONSKY HJ, 1968, CAN MED ASSOC J, V99, P993; Val-Bernal JF, 2007, APMIS, V115, P1234, DOI 10.1111/j.1600-0643.2007.00756.x; Fodor L, 2006, ANN PLAS SURG, V56, P164, DOI 10.1097/01.sap.0000196579.14954.d6; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; FURER V, 2010, CLIN IMMUNO IN PRESS; Greulich H, 1998, J BIOL CHEM, V273, P13280, DOI 10.1074/jbc.273.21.13280; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; Jay H, 1998, LANCET, V351, P112, DOI 10.1016/S0140-6736(05)78149-6; Jinnin M, 2006, J CELL PHYSIOL, V206, P718, DOI 10.1002/jcp.20527; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Keenan SM, 2001, J BIOL CHEM, V276, P22404, DOI 10.1074/jbc.M100409200; KELLY RI, 1995, J AM ACAD DERMATOL, V33, P749, DOI 10.1016/0190-9622(95)91812-4; Kleinman ME, 2007, ARTERIOSCL THROM VAS, V27, P2664, DOI 10.1161/ATVBAHA.107.150284; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LISTON A, 2010, J CLIN IMMU IN PRESS; MAKINO T, 2010, BR J DERMAT IN PRESS; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Mazumder S, 2004, CURR CANCER DRUG TAR, V4, P65, DOI 10.2174/1568009043481669; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; MULLIKEN JB, VASCULAR ANOMALIES, P517; NEUMANN RA, 1990, CLIN EXP DERMATOL, V15, P115, DOI 10.1111/j.1365-2230.1990.tb02045.x; Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008; Paller AS, 2000, J INVEST DERM SYMP P, V5, P83, DOI 10.1046/j.1087-0024.2000.00011.x; Requena L, 1997, J AM ACAD DERMATOL, V37, P523, DOI 10.1016/S0190-9622(97)70169-5; Sheth S, 2008, SEMIN DIAGN PATHOL, V25, P1, DOI 10.1053/j.semdp.2007.10.001; TUDER RM, 1987, J INVEST DERMATOL, V89, P594, DOI 10.1111/1523-1747.ep12461306; Ugland H, 2008, MOL BIOL CELL, V19, P5082, DOI 10.1091/mbc.E08-01-0094; Webster G F, 2001, Clin Cornerstone, V4, P39, DOI 10.1016/S1098-3597(01)90006-7; Wolf IH, 2002, CLIN DERMATOL, V20, P273, DOI 10.1016/S0738-081X(02)00222-5; ZHENG CF, 1994, J BIOL CHEM, V269, P19947	40	92	94	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14334	10.1371/journal.pone.0014334	http://dx.doi.org/10.1371/journal.pone.0014334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179471	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500011
J	Bao, L; Xia, XF; Cui, Y				Bao, Lei; Xia, Xuefeng; Cui, Yan			Expression QTL Modules as Functional Components Underlying Higher-Order Phenotypes	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR NETWORKS; SYSTEMS GENETICS; PROTEIN; MOUSE; TRAIT; LOCI; ADIPOGENESIS; GENOMICS; MODEL	Systems genetics studies often involve the mapping of numerous regulatory relations between genetic loci and expression traits. These regulatory relations form a bipartite network consisting of genetic loci and expression phenotypes. Modular network organizations may arise from the pleiotropic and polygenic regulation of gene expression. Here we analyzed the expression QTL (eQTL) networks derived from expression genetic data of yeast and mouse liver and found 65 and 98 modules respectively. Computer simulation result showed that such modules rarely occurred in randomized networks with the same number of nodes and edges and same degree distribution. We also found significant within-module functional coherence. The analysis of genetic overlaps and the evidences from biomedical literature have linked some eQTL modules to physiological phenotypes. Functional coherence within the eQTL modules and genetic overlaps between the modules and physiological phenotypes suggests that eQTL modules may act as functional units underlying the higher-order phenotypes.	[Bao, Lei; Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN USA; [Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA; [Xia, Xuefeng] Tsinghua Univ, Inst Bioinformat, Beijing 100084, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Tsinghua University	Bao, L (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.	lebao@ucsd.edu; ycui2@uthsc.edu		Cui, Yan/0000-0002-7577-6845	NIH [NR009270, AI081050]; Department of Defense [W81XHW-05-01-0227]; American Heart Association [0830134N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR009270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported in part by NIH grants NR009270, AI081050, a Department of Defense grant W81XHW-05-01-0227 and an American Heart Association grant 0830134N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bao L, 2007, HUM MOL GENET, V16, P1381, DOI 10.1093/hmg/ddm089; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Greaves KA, 2003, METABOLISM, V52, P282, DOI 10.1053/meta.2003.50045; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Kudo T, 2009, XENOBIOTICA, V39, P889, DOI 10.3109/00498250903242592; Laudes M, 2008, J MOL MED, V86, P597, DOI 10.1007/s00109-008-0326-2; Li HQ, 2006, HUM MOL GENET, V15, P481, DOI 10.1093/hmg/ddi462; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Merezhinskaya N, 2009, HISTOL HISTOPATHOL, V24, P243, DOI 10.14670/HH-24.243; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mezey JG, 2000, GENETICS, V156, P305; Nogami S, 2007, PLOS GENET, V3, P305, DOI 10.1371/journal.pgen.0030031; Quigley D, 2009, NAT REV GENET, V10, P651, DOI 10.1038/nrg2617; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Robinson PN, 2004, BIOINFORMATICS, V20, P979, DOI 10.1093/bioinformatics/bth040; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; van Tits L, 2005, ARTERIOSCL THROM VAS, V25, P717, DOI 10.1161/01.ATV.0000157979.51673.2c; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Westfall Peter H, 2002, Methods Mol Biol, V184, P143; Zhang W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000642	36	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14313	10.1371/journal.pone.0014313	http://dx.doi.org/10.1371/journal.pone.0014313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179437	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900018
J	Vermeij, MJA; van Moorselaar, I; Engelhard, S; Hornlein, C; Vonk, SM; Visser, PM				Vermeij, Mark J. A.; van Moorselaar, Imke; Engelhard, Sarah; Hornlein, Christine; Vonk, Sophie M.; Visser, Petra M.			The Effects of Nutrient Enrichment and Herbivore Abundance on the Ability of Turf Algae to Overgrow Coral in the Caribbean	PLOS ONE			English	Article							PHASE-SHIFTS; SCLERACTINIAN CORALS; COMMUNITY STRUCTURE; REEFS; COMPETITION; MACROALGAE; SEDIMENT; STRESS; GROWTH; FLUOROMETRY	Turf algae are multispecies communities of small marine macrophytes that are becoming a dominant component of coral reef communities around the world. To assess the impact of turf algae on corals, we investigated the effects of increased nutrients (eutrophication) on the interaction between the Caribbean coral Montastraea annularis and turf algae at their growth boundary. We also assessed whether herbivores are capable of reducing the abundance of turf algae at coral-algae boundaries. We found that turf algae cause visible (overgrowth) and invisible negative effects (reduced fitness) on neighbouring corals. Corals can overgrow neighbouring turf algae very slowly (at a rate of 0.12 mm 3 wk(-1)) at ambient nutrient concentrations, but turf algae overgrew corals (at a rate of 0.34 mm 3 wk(-1)) when nutrients were experimentally increased. Exclusion of herbivores had no measurable effect on the rate turf algae overgrew corals. We also used PAM fluorometry (a common approach for measuring of a colony's "fitness") to detect the effects of turf algae on the photophysiology of neighboring corals. Turf algae always reduced the effective photochemical efficiency of neighbouring corals, regardless of nutrient and/or herbivore conditions. The findings that herbivores are not capable of controlling the abundance of turf algae and that nutrient enrichment gives turf algae an overall competitive advantage over corals together have serious implications for the health of Caribbean coral reef systems. At ambient nutrient levels, traditional conservation measures aimed at reversing coral-to-algae phase shifts by reducing algal abundance (i.e., increasing herbivore populations by establishing Marine Protected Areas or tightening fishing regulations) will not necessarily reduce the negative impact of turf algae on local coral communities. Because turf algae have become the most abundant benthic group on Curacao (and likely elsewhere in the Caribbean), new conservation strategies are required to mitigate their negative impact on coral communities.	[Vermeij, Mark J. A.; Visser, Petra M.] Carmabi Fdn, Willemstad, Curacao, Neth Antilles; [Vermeij, Mark J. A.; van Moorselaar, Imke; Engelhard, Sarah; Hornlein, Christine; Vonk, Sophie M.; Visser, Petra M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Amsterdam	Vermeij, MJA (corresponding author), Carmabi Fdn, Willemstad, Curacao, Neth Antilles.	m.vermeij@carmabi.org	Vermeij, Mark/AAR-6757-2020; Vermeij, Mark/B-2752-2013	Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527; Visser, Petra/0000-0003-3294-1908	University of Amsterdam; Government of the Netherlands Antilles; European Union [244161]	University of Amsterdam; Government of the Netherlands Antilles; European Union(European Commission)	Partial funding for this project was obtained from the University of Amsterdam's STUNT-Fund, the Government of the Netherlands Antilles and the European Union under the seventh framework program (Grant# 244161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Beer S, 1998, MAR BIOL, V131, P607, DOI 10.1007/s002270050352; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V112, P51, DOI 10.3354/meps112051; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2009, MAR ECOL PROG SER, V389, P71, DOI 10.3354/meps08142; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; Carricart-Ganivet JP, 2001, B MAR SCI, V68, P133; Chartrand KM, 2009, MAR BIOL, V156, P1691, DOI 10.1007/s00227-009-1204-3; Cheroske AG, 2000, J EXP MAR BIOL ECOL, V248, P1, DOI 10.1016/S0022-0981(00)00153-2; Costa OS, 2000, HYDROBIOLOGIA, V440, P307, DOI 10.1023/A:1004104118208; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; Fai PB, 2007, ENVIRON TOXICOL CHEM, V26, P1520, DOI 10.1897/06-394R1.1; Frade PR, 2008, CORAL REEFS, V27, P913, DOI 10.1007/s00338-008-0406-3; GLADFELTER EH, 1978, B MAR SCI, V28, P728; Gorgula SK, 2004, MAR BIOL, V145, P613, DOI 10.1007/s00227-004-1335-5; Haas A, 2010, CORAL REEFS, V29, P93, DOI 10.1007/s00338-009-0556-y; HATCHER BG, 1983, J EXP MAR BIOL ECOL, V69, P61, DOI 10.1016/0022-0981(83)90172-7; HAY ME, 1981, ECOLOGY, V62, P739, DOI 10.2307/1937742; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOKIEL PL, 1993, MAR ECOL PROG SER, V93, P175, DOI 10.3354/meps093175; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Jones RJ, 1999, MAR POLLUT BULL, V38, P864, DOI 10.1016/S0025-326X(98)90160-6; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Larned ST, 1998, MAR BIOL, V132, P409, DOI 10.1007/s002270050407; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; Littler MM, 2006, HARMFUL ALGAE, V5, P565, DOI 10.1016/j.hal.2005.11.003; Littler MM, 1997, CORAL REEFS, V16, P168; McClanahan TR, 2007, MAR POLLUT BULL, V54, P1947, DOI 10.1016/j.marpolbul.2007.09.023; McCook LJ, 2001, CORAL REEFS, V19, P419, DOI 10.1007/s003380000119; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Quan-Young LI, 2006, LIMNOL OCEANOGR, V51, P1159, DOI 10.4319/lo.2006.51.2.1159; ROGERS CS, 1997, P 8 INT COR REEF S P, V1, P555; Roy RE, 2004, REV BIOL TROP, V52, P869; Sandin SA, 2008, CARIBB J SCI, V44, P137; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; TILMAN D, 1997, SPATIAL ECOLOGY ROLE, P3; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; TITLYANOV EA, 2006, P 10 INT COR REEF S, P1931; Underwood A.J., 1986, P240; Van Veghel MLJ, 1994, THESIS U AMSTERDAM A; VANSTEVENINCK EDD, 1986, MAR ECOL PROG SER, V34, P87; Vermeij MJA, 2007, MAR ECOL PROG SER, V351, P91, DOI 10.3354/meps07085; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; VERMEIJ MJA, 2010, MAR ECOL, P1; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121	59	125	129	5	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14312	10.1371/journal.pone.0014312	http://dx.doi.org/10.1371/journal.pone.0014312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179215	Green Submitted, Green Published, gold			2022-12-27	WOS:000285246900017
J	Baum, P; Schmid, R; Ittrich, C; Rust, W; Fundel-Clemens, K; Siewert, S; Baur, M; Mara, L; Gruenbaum, L; Heckel, A; Eils, R; Kontermann, RE; Roth, GJ; Gantner, F; Schnapp, A; Park, JE; Weith, A; Quast, K; Mennerich, D				Baum, Patrick; Schmid, Ramona; Ittrich, Carina; Rust, Werner; Fundel-Clemens, Katrin; Siewert, Susanne; Baur, Martin; Mara, Lisa; Gruenbaum, Lore; Heckel, Armin; Eils, Roland; Kontermann, Roland E.; Roth, Gerald J.; Gantner, Florian; Schnapp, Andreas; Park, John E.; Weith, Andreas; Quast, Karsten; Mennerich, Detlev			Phenocopy - A Strategy to Qualify Chemical Compounds during Hit-to-Lead and/or Lead Optimization	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; GENE-EXPRESSION; PROTEIN-KINASES; IN-VITRO; INHIBITORS; DISCOVERY; CANCER; CELLS	A phenocopy is defined as an environmentally induced phenotype of one individual which is identical to the genotype-determined phenotype of another individual. The phenocopy phenomenon has been translated to the drug discovery process as phenotypes produced by the treatment of biological systems with new chemical entities (NCE) may resemble environmentally induced phenotypic modifications. Various new chemical entities exerting inhibition of the kinase activity of Transforming Growth Factor beta Receptor I (TGF-beta R1) were qualified by high-throughput RNA expression profiling. This chemical genomics approach resulted in a precise time-dependent insight to the TGF-beta biology and allowed furthermore a comprehensive analysis of each NCE's off-target effects. The evaluation of off-target effects by the phenocopy approach allows a more accurate and integrated view on optimized compounds, supplementing classical biological evaluation parameters such as potency and selectivity. It has therefore the potential to become a novel method for ranking compounds during various drug discovery phases.	[Baum, Patrick; Schmid, Ramona; Ittrich, Carina; Rust, Werner; Fundel-Clemens, Katrin; Siewert, Susanne; Baur, Martin; Heckel, Armin; Roth, Gerald J.; Gantner, Florian; Schnapp, Andreas; Park, John E.; Weith, Andreas; Quast, Karsten; Mennerich, Detlev] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach An Der Riss, Germany; [Kontermann, Roland E.] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany; [Mara, Lisa; Gruenbaum, Lore; Mennerich, Detlev] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol BIOQUANT, Heidelberg, Germany	Boehringer Ingelheim; University of Stuttgart; Boehringer Ingelheim; Ruprecht Karls University Heidelberg	Baum, P (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Biberach An Der Riss, Germany.	detlev.mennerich@boehringer-ingelheim.com	Eils, Roland/B-6121-2009; Kontermann, Roland E./F-9263-2014	Eils, Roland/0000-0002-0034-4036; 	Boehringer Ingelheim Pharma GmbH Co. KG.	Boehringer Ingelheim Pharma GmbH Co. KG.(Boehringer Ingelheim)	This study was funded by Boehringer Ingelheim Pharma GmbH & Co. KG. The funder was involved in study design (compound selection) and decision to publish the data and results (and to make them publicly available). The funder had no role in data collection and analysis or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chico LK, 2009, NAT REV DRUG DISCOV, V8, P892, DOI 10.1038/nrd2999; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Dawes LJ, 2007, MOL VIS, V13, P1181; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerhold D, 2001, PHYSIOL GENOMICS, V5, P161, DOI 10.1152/physiolgenomics.2001.5.4.161; Hamadeh HK, 2002, TOXICOL SCI, V67, P232, DOI 10.1093/toxsci/67.2.232; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KANEHISA M, 2009, NUCL ACIDS RES; Klutchko SR, 1998, J MED CHEM, V41, P3276, DOI 10.1021/jm9802259; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Lahn M, 2005, EXPERT OPIN INV DRUG, V14, P629, DOI 10.1517/13543784.14.6.629; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Lin D, 2007, STAT APPL GENET MOL, V6; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mencher S.K., 2005, BMC CLIN PHARM, V5, P3, DOI DOI 10.1186/1472-6904-5-3; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; R Core Team, 2018, R LANG ENV STAT COMP; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Rodrigues AD, 2002, CURR DRUG METAB, V3, P289, DOI 10.2174/1389200023337522; Rosendahl A, 2001, AM J RESP CELL MOL, V25, P60, DOI 10.1165/ajrcmb.25.1.4396; Roth GJ, 2010, J MED CHEM, V53, P7287, DOI 10.1021/jm100812a; Sawin PB, 1932, J HERED, V23, P39, DOI 10.1093/oxfordjournals.jhered.a103512; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; SCHMIDT DM, 1995, ANAL BIOCHEM, V232, P144, DOI 10.1006/abio.1995.0025; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Thomas RS, 2001, MOL PHARMACOL, V60, P1189, DOI 10.1124/mol.60.6.1189; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Wilkins-Port CE, 2007, CELLS TISSUES ORGANS, V185, P116, DOI 10.1159/000101312; Wu XP, 2006, MICROVASC RES, V71, P12, DOI 10.1016/j.mvr.2005.11.004; Yu L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000284; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zou J, 2002, GENOME BIOL, V3	51	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14272	10.1371/journal.pone.0014272	http://dx.doi.org/10.1371/journal.pone.0014272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170314	gold, Green Published, Green Submitted			2022-12-27	WOS:000285181400004
J	Fiehn, O; Garvey, WT; Newman, JW; Lok, KH; Hoppel, CL; Adams, SH				Fiehn, Oliver; Garvey, W. Timothy; Newman, John W.; Lok, Kerry H.; Hoppel, Charles L.; Adams, Sean H.			Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; DIET-INDUCED OBESITY; MUSCLE LIPID-CONTENT; INSULIN-RESISTANCE; SKELETAL-MUSCLE; PROTEIN-METABOLISM; WHOLE-BODY; LEUCINE METABOLISM; OXIDATION; RAT	Insulin resistance progressing to type 2 diabetes mellitus (T2DM) is marked by a broad perturbation of macronutrient intermediary metabolism. Understanding the biochemical networks that underlie metabolic homeostasis and how they associate with insulin action will help unravel diabetes etiology and should foster discovery of new biomarkers of disease risk and severity. We examined differences in plasma concentrations of >350 metabolites in fasted obese T2DM vs. obese non-diabetic African-American women, and utilized principal components analysis to identify 158 metabolite components that strongly correlated with fasting HbA1c over a broad range of the latter (r = -0.631; p<0.0001). In addition to many unidentified small molecules, specific metabolites that were increased significantly in T2DM subjects included certain amino acids and their derivatives (i.e., leucine, 2-ketoisocaproate, valine, cystine, histidine), 2-hydroxybutanoate, long-chain fatty acids, and carbohydrate derivatives. Leucine and valine concentrations rose with increasing HbA1c, and significantly correlated with plasma acetylcarnitine concentrations. It is hypothesized that this reflects a close link between abnormalities in glucose homeostasis, amino acid catabolism, and efficiency of fuel combustion in the tricarboxylic acid (TCA) cycle. It is speculated that a mechanism for potential TCA cycle inefficiency concurrent with insulin resistance is "anaplerotic stress" emanating from reduced amino acid-derived carbon flux to TCA cycle intermediates, which if coupled to perturbation in cataplerosis would lead to net reduction in TCA cycle capacity relative to fuel delivery.	[Fiehn, Oliver] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Garvey, W. Timothy; Lok, Kerry H.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Garvey, W. Timothy; Lok, Kerry H.] Birmingham VA Med Ctr, Birmingham, AL USA; [Newman, John W.; Adams, Sean H.] Univ Calif Davis, Obes & Metab Res Unit, USDA, Agr Res Serv,Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Newman, John W.; Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; Case Western Reserve University	Fiehn, O (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	sean.h.adams@ars.usda.gov	ADAMS, SEAN/N-9262-2018	ADAMS, SEAN/0000-0002-9515-2319; Newman, John/0000-0001-9632-6571	USDA-ARS [5306-51530-016-00D]; NIH-NIDDK [R01DK078328-01]; NIH [DK-038764, DK-083562, P01 HL-055782]; Department of Veterans Affairs; UAB Center for Clinical and Translational Science [UL1 RR025777]; UAB Nutrition and Obesity Research Center [P30-DK56336]; UAB Diabetes Research and Training Center [P60 DK079626]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, R01DK083562, R01DK078328, P60DK079626] Funding Source: NIH RePORTER	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); UAB Center for Clinical and Translational Science; UAB Nutrition and Obesity Research Center; UAB Diabetes Research and Training Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work was funded in part by the following: intramural USDA-ARS Project 5306-51530-016-00D and NIH-NIDDK R01DK078328-01 (to S.H.A.); NIH grants DK-038764, DK-083562, and P01 HL-055782 and the Merit Review program of the Department of Veterans Affairs (W.T.G.). The authors also acknowledge support from the research core facilities of the UAB Center for Clinical and Translational Science (UL1 RR025777), the UAB Nutrition and Obesity Research Center (P30-DK56336), and the UAB Diabetes Research and Training Center (P60 DK079626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; Baez-Saldana A, 2004, AM J CLIN NUTR, V79, P238; Bajotto G, 2009, METABOLISM, V58, P1489, DOI 10.1016/j.metabol.2009.04.029; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Devkota S, 2010, CURR OPIN CLIN NUTR, V13, P403, DOI 10.1097/MCO.0b013e32833a7737; Divers J, 2010, J LIPID RES, V51, P586, DOI 10.1194/jlr.M001842; Dobbins RL, 2001, DIABETES, V50, P123, DOI 10.2337/diabetes.50.1.123; Doisaki M, 2010, BIOCHEM BIOPH RES CO, V393, P303, DOI 10.1016/j.bbrc.2010.02.004; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn Oliver, 2007, V358, P3, DOI 10.1007/978-1-59745-244-1_1; FOIS A, 1986, J INHERIT METAB DIS, V9, P284, DOI 10.1007/BF01799663; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Goodpaster BH, 2005, EXERC SPORT SCI REV, V33, P150; GOUGEON R, 1994, DIABETES, V43, P318, DOI 10.2337/diabetes.43.2.318; Gougeon R, 2008, DIABETES CARE, V31, P128, DOI 10.2337/dc07-1268; Guillet C, 2009, J CLIN ENDOCR METAB, V94, P3044, DOI 10.1210/jc.2008-2216; Halvatsiotis P, 2002, DIABETES, V51, P2395, DOI 10.2337/diabetes.51.8.2395; Halvatsiotis PG, 2002, DIABETES NUTR METAB, V15, P136; He J, 2004, OBES RES, V12, P761, DOI 10.1038/oby.2004.92; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Hoffer LJ, 1998, METABOLISM, V47, P1145, DOI 10.1016/S0026-0495(98)90291-8; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kawasaki T, 2002, DIABETES CARE, V25, P353, DOI 10.2337/diacare.25.2.353; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kendall DM, 2009, AM J MED, V122, P37, DOI 10.1016/j.amjmed.2009.03.015; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; Kuzuya T, 2008, BIOCHEM BIOPH RES CO, V373, P94, DOI 10.1016/j.bbrc.2008.05.167; Lara-Castro C, 2008, METABOLISM, V57, P1, DOI 10.1016/j.metabol.2007.05.008; Layman DK, 2008, AM J CLIN NUTR, V87, p1571S, DOI 10.1093/ajcn/87.5.1571S; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; MARCHESINI G, 1991, CLIN NUTR, V10, P105, DOI 10.1016/0261-5614(91)90096-U; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; McLean DC, 2005, AM J PHYS ANTHROPOL, V127, P427, DOI 10.1002/ajpa.20047; Mingrone G, 2003, ATHEROSCLEROSIS, V170, P155, DOI 10.1016/S0021-9150(03)00254-5; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nairizi A, 2009, J NUTR, V139, P715, DOI 10.3945/jn.108.100081; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Pereira S, 2008, DIABETES, V57, P56, DOI 10.2337/db07-0887; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; RANDLE PJ, 1963, LANCET, V1, P785; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Sale MM, 2009, DIABETES, V58, P260, DOI 10.2337/db08-0198; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Scholz M, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P169; Seifert EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009834; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; Shulman GI, 2004, PHYSIOLOGY, V19, P183, DOI 10.1152/physiol.00007.2004; STATEN MA, 1986, DIABETES, V35, P1249, DOI 10.2337/diabetes.35.11.1249; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; UMPLEBY AM, 1990, DIABETES RES CLIN PR, V9, P89, DOI 10.1016/0168-8227(90)90014-K; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Zemel MB, 2005, J AM COLL NUTR, V24, p537S, DOI 10.1080/07315724.2005.10719502; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1; Zoppi CC, 2010, BRIT J NUTR, V103, P1237, DOI 10.1017/S0007114509993060	72	293	295	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15234	10.1371/journal.pone.0015234	http://dx.doi.org/10.1371/journal.pone.0015234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170321	Green Published, Green Submitted, gold			2022-12-27	WOS:000285181400022
J	Vogt, N; Gibaud, A; Almeida, A; Ourliac-Garnier, I; Debatisse, M; Malfoy, B				Vogt, Nicolas; Gibaud, Anne; Almeida, Anna; Ourliac-Garnier, Isabelle; Debatisse, Michelle; Malfoy, Bernard			Relationships Linking Amplification Level to Gene Over-Expression in Gliomas	PLOS ONE			English	Article							FACTOR RECEPTOR GENE; TELOMERASE ACTIVITY; CANCER; HTERT; AMPLICON; GROWTH; ONCOGENES; REVEALS; NUMBER; GENOME	Background: Gene amplification is thought to promote over-expression of genes favouring tumour development. Because amplified regions are usually megabase-long, amplification often concerns numerous syntenic or non-syntenic genes, among which only a subset is over-expressed. The rationale for these differences remains poorly understood. Methodology/Principal Finding: To address this question, we used quantitative RT-PCR to determine the expression level of a series of co-amplified genes in five xenografted and one fresh human gliomas. These gliomas were chosen because we have previously characterised in detail the genetic content of their amplicons. In all the cases, the amplified sequences lie on extra-chromosomal DNA molecules, as commonly observed in gliomas. We show here that genes transcribed in non-amplified gliomas are over-expressed when amplified, roughly in proportion to their copy number, while non-expressed genes remain inactive. When specific antibodies were available, we also compared protein expression in amplified and non-amplified tumours. We found that protein accumulation barely correlates with the level of mRNA expression in some of these tumours. Conclusions/Significance: Here we show that the tissue-specific pattern of gene expression is maintained upon amplification in gliomas. Our study relies on a single type of tumour and a limited number of cases. However, it strongly suggests that, even when amplified, genes that are normally silent in a given cell type play no role in tumour progression. The loose relationships between mRNA level and protein accumulation and/or activity indicate that translational or post-translational events play a key role in fine-tuning the final outcome of amplification in gliomas.	[Vogt, Nicolas; Gibaud, Anne; Almeida, Anna; Ourliac-Garnier, Isabelle; Debatisse, Michelle; Malfoy, Bernard] Inst Curie, Ctr Rech, Paris, France; [Vogt, Nicolas; Gibaud, Anne; Almeida, Anna; Ourliac-Garnier, Isabelle; Debatisse, Michelle; Malfoy, Bernard] CNRS, UMR3244, Paris, France; [Vogt, Nicolas; Gibaud, Anne; Almeida, Anna; Ourliac-Garnier, Isabelle; Debatisse, Michelle; Malfoy, Bernard] UPMC, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite	Vogt, N (corresponding author), Inst Curie, Ctr Rech, Paris, France.	bernard.malfoy@curie.fr	Ourliac-Garnier, Isabelle/ABH-4491-2020; Ourliac-Garnier, Isabelle/ABE-3478-2021	Ourliac-Garnier, Isabelle/0000-0002-8159-0959	Association pour la Recherche contre le Cancer [3808]	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was partially supported by the Association pour la Recherche contre le Cancer, contract 3808 (http://www.arc-cancer.net/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Boldrini L, 2006, INT J ONCOL, V28, P1555; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Debatisse M, 2005, ADV EXP MED BIOL, V570, P343, DOI 10.1007/1-4020-3764-3_12; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Garcia MJ, 2005, ONCOGENE, V24, P5235, DOI 10.1038/sj.onc.1208741; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Gibaud A, 2010, HUM MOL GENET, V19, P1276, DOI 10.1093/hmg/ddq004; Gonin-Laurent N, 2007, ONCOGENE, V26, P6106, DOI 10.1038/sj.onc.1210404; Greider CW, 2006, COLD SPRING HARB SYM, V71, P225, DOI 10.1101/sqb.2006.71.063; HALEY JD, 1989, ONCOGENE, V4, P273; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Kuuselo R, 2007, CANCER RES, V67, P1943, DOI 10.1158/0008-5472.CAN-06-3387; Lu ZM, 2009, CANCER RES, V69, P9105, DOI 10.1158/0008-5472.CAN-09-2775; MULERIS M, 1994, ONCOGENE, V9, P2717; Myllykangas S, 2007, SEMIN CANCER BIOL, V17, P42, DOI 10.1016/j.semcancer.2006.10.005; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Nowak T, 2006, ONCOL REP, V16, P301; Parssinen J, 2007, BRIT J CANCER, V96, P1258, DOI 10.1038/sj.bjc.6603692; Pelosi G, 2007, CLIN CANCER RES, V13, P1995, DOI 10.1158/1078-0432.CCR-06-2483; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Tchirkov A, 2003, BRIT J CANCER, V88, P516, DOI 10.1038/sj.bjc.6600754; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogt N, 2004, P NATL ACAD SCI USA, V101, P11368, DOI 10.1073/pnas.0402979101; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Wu YL, 2006, J CELL SCI, V119, P2797, DOI 10.1242/jcs.03001; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao P, 2007, INT J ONCOL, V31, P361; Zhdanova NS, 2007, CHROMOSOME RES, V15, P881, DOI 10.1007/s10577-007-1170-x	37	11	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14249	10.1371/journal.pone.0014249	http://dx.doi.org/10.1371/journal.pone.0014249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170331	Green Published, Green Submitted, gold			2022-12-27	WOS:000285084100003
J	Manevich, Y; Townsend, DM; Hutchens, S; Tew, KD				Manevich, Yefim; Townsend, Danyelle M.; Hutchens, Steven; Tew, Kenneth D.			Diazeniumdiolate Mediated Nitrosative Stress Alters Nitric Oxide Homeostasis through Intracellular Calcium and S-Glutathionylation of Nitric Oxide Synthetase	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; NADPH OXIDASE; SYNTHASE; ACTIVATION; NITROSYLATION; GLUTATHIOLATION; THAPSIGARGIN; REGULATOR; PRODRUG; ROLES	Background: PABA/NO is a diazeniumdiolate that acts as a direct nitrogen monoxide (NO) donor and is in development as an anticancer drug. Its mechanism of action and effect on cells is not yet fully understood. Methodology/Principal Findings: We used HPLC and mass spectrometry to identify a primary nitroaromatic glutathione metabolite of PABA/NO and used fluorescent assays to characterize drug effects on calcium and NO homeostasis, relating these to endothelial nitric oxide synthase (eNOS) activity. Unexpectedly, the glutathione conjugate was found to be a competitive inhibitor of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) presumably at the same site as thapsigargin, increasing intracellular Ca2+ release and causing auto-regulation of eNOS through S-glutathionylation. Conclusions/Significance: The initial direct release of NO after PABA/NO was followed by an eNOS-mediated generation of NO as a consequence of drug-induced increase in Ca2+ flux and calmodulin (CaM) activation. PABA/NO has a unique dual mechanism of action with direct intracellular NO generation combined with metabolite driven regulation of eNOS activation.	[Manevich, Yefim; Hutchens, Steven; Tew, Kenneth D.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Townsend, Danyelle M.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Manevich, Y (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA.	tewk@musc.edu			National Institutes of Health [CA08660, CA117259]; South Carolina Centers of Excellence program; National Center for Research Resources [C06 RR015455]; NATIONAL CANCER INSTITUTE [R41CA117259] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Centers of Excellence program; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (CA08660 and CA117259) and support from the South Carolina Centers of Excellence program. This work was conducted in a facility constructed with the support from the National Institutes of Health, Grant Number C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Aracena P, 2003, J BIOL CHEM, V278, P42927, DOI 10.1074/jbc.M306969200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Cohen RA, 2006, TRENDS CARDIOVAS MED, V16, P109, DOI 10.1016/j.tcm.2006.02.001; Denmeade SR, 2003, J NATL CANCER I, V95, P990, DOI 10.1093/jnci/95.13.990; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Findlay VJ, 2004, MOL PHARMACOL, V65, P1070, DOI 10.1124/mol.65.5.1070; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; GARVEY EP, 1994, ARCH BIOCHEM BIOPHYS, V311, P235, DOI 10.1006/abbi.1994.1232; Topal JLG, 2006, J PHARMACOL EXP THER, V318, P1368, DOI 10.1124/jpet.106.103747; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Jiang BH, 2004, BIOCHEM BIOPH RES CO, V317, P192, DOI 10.1016/j.bbrc.2004.03.036; Kakui K, 2004, MOL HUM REPROD, V10, P115, DOI 10.1093/molehr/gah023; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Lei K, 2008, ONCOGENE, V27, P4877, DOI 10.1038/onc.2008.132; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Manevich Y, 2001, AM J PHYSIOL-HEART C, V280, pH2126, DOI 10.1152/ajpheart.2001.280.5.H2126; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; MERRITT JE, 1990, BIOCHEM J, V269, P513, DOI 10.1042/bj2690513; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Patel JM, 1996, AM J RESP CELL MOL, V15, P410, DOI 10.1165/ajrcmb.15.3.8810647; Paula S, 2004, PROTEINS, V56, P595, DOI 10.1002/prot.20105; PISTOIA V, 1980, EXPERIENTIA, V36, P873, DOI 10.1007/BF01978623; Procida K, 1998, FEBS LETT, V439, P127, DOI 10.1016/S0014-5793(98)01352-0; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Richard L, 1998, EXP CELL RES, V240, P1, DOI 10.1006/excr.1998.3936; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; Saavedra JE, 2006, J MED CHEM, V49, P1157, DOI 10.1021/jm050700k; Saavedra JE, 2001, J ORG CHEM, V66, P3090, DOI 10.1021/jo0016529; SAHIN FKY, 2006, HAEMA, V9, P560; Sanchez G, 2005, J MOL CELL CARDIOL, V39, P982, DOI 10.1016/j.yjmcc.2005.08.010; Scott KD, 2003, CELL IMMUNOL, V222, P58, DOI 10.1016/S0008-8749(03)00077-7; SEIFERT R, 1987, BIOCHEM BIOPH RES CO, V146, P1296, DOI 10.1016/0006-291X(87)90790-X; Tew KD, 2007, BIOCHEM PHARMACOL, V73, P1257, DOI 10.1016/j.bcp.2006.09.027; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Townsend DM, 2006, MOL PHARMACOL, V69, P501, DOI 10.1124/mol.105.018523; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; XINHUA J, 2008, DRUG DESIGN DEV THER, V2, P123; Zhang JL, 1998, AM J PHYSIOL-LUNG C, V275, pL288, DOI 10.1152/ajplung.1998.275.2.L288	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14151	10.1371/journal.pone.0014151	http://dx.doi.org/10.1371/journal.pone.0014151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152397	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100030
J	Haque, U; Hashizume, M; Glass, GE; Dewan, AM; Overgaard, HJ; Yamamoto, T				Haque, Ubydul; Hashizume, Masahiro; Glass, Gregory E.; Dewan, Ashraf M.; Overgaard, Hans J.; Yamamoto, Taro			The Role of Climate Variability in the Spread of Malaria in Bangladeshi Highlands	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; EL-NINO; REGRESSION-MODELS; RAINFALL; EPIDEMICS; ERITREA; DIPOLE	Background: Malaria is a major public health problem in Bangladesh, frequently occurring as epidemics since the 1990s. Many factors affect increases in malaria cases, including changes in land use, drug resistance, malaria control programs, socioeconomic issues, and climatic factors. No study has examined the relationship between malaria epidemics and climatic factors in Bangladesh. Here, we investigate the relationship between climatic parameters [rainfall, temperature, humidity, sea surface temperature (SST), El Nino-Southern Oscillation (ENSO), the normalized difference vegetation index (NDVI)], and malaria cases over the last 20 years in the malaria endemic district of Chittagong Hill Tracts (CHT). Methods and Principal Findings: Monthly malaria case data from January 1989 to December 2008, monthly rainfall, temperature, humidity sea surface temperature in the Bay of Bengal and ENSO index at the Nino Region 3 (NINO3) were used. A generalized linear negative binomial regression model was developed using the number of monthly malaria cases and each of the climatic parameters. After adjusting for potential mutual confounding between climatic factors there was no evidence for any association between the number of malaria cases and temperature, rainfall and humidity. Only a low NDVI was associated with an increase in the number of malaria cases. There was no evidence of an association between malaria cases and SST in the Bay of Bengal and NINO3. Conclusion and Significance: It seems counterintuitive that a low NDVI, an indicator of low vegetation greenness, is associated with increases in malaria cases, since the primary vectors in Bangladesh, such as An. dirus, are associated with forests. This relationship can be explained by the drying up of rivers and streams creating suitable breeding sites for the vector fauna. Bangladesh has very high vector species diversity and vectors suited to these habitats may be responsible for the observed results.	[Haque, Ubydul; Hashizume, Masahiro; Yamamoto, Taro] Nagasaki Univ, NEKKEN, Inst Trop Med, Dept Int Hlth, Nagasaki 852, Japan; [Haque, Ubydul; Hashizume, Masahiro; Yamamoto, Taro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Glass, Gregory E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Dewan, Ashraf M.] Univ Dhaka, Dept Geog & Environm, Dhaka 1000, Bangladesh; [Dewan, Ashraf M.] Curtin Univ Technol, Dept Spatial Sci, Perth, WA, Australia; [Overgaard, Hans J.] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway	Nagasaki University; Nagasaki University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Dhaka; Curtin University; Norwegian University of Life Sciences	Hashizume, M (corresponding author), Nagasaki Univ, NEKKEN, Inst Trop Med, Dept Int Hlth, Nagasaki 852, Japan.	hashizum@nagasaki-u.ac.jp	Dewan, Ashraf/O-2191-2015; Overgaard, Hans/AAE-9972-2020	Dewan, Ashraf/0000-0001-5594-5464; Hashizume, Masahiro/0000-0003-4720-1750	Global Center of Excellence program, Institute of Tropical Medicine, Nagasaki University, Japan; Johns Hopkins Malaria Research Institute	Global Center of Excellence program, Institute of Tropical Medicine, Nagasaki University, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Johns Hopkins Malaria Research Institute	The study was supported by the Global Center of Excellence program, Institute of Tropical Medicine, Nagasaki University, Japan. GG was supported by the Johns Hopkins Malaria Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2007, EMERG INFECT DIS, V13, P681, DOI 10.3201/eid1305.061333; Ahmed ASMS., 1996, MAUSAM, V47, P157, DOI DOI 10.54302/MAUSAM.V47I2.3713; Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; Alam M, 2009, MALARIA J, V9, P15; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P265; [Anonymous], WORLD MAL REP 2008; Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Bhattacharya S, 2006, CURR SCI INDIA, V90, P369; Bi P, 2005, VECTOR-BORNE ZOONOT, V5, P95, DOI 10.1089/vbz.2005.5.95; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-77; Bruce MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002775; Brumback BA, 2000, J AM STAT ASSOC, V95, P16; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Elias M., 1982, J PREV SOCIAL MED, V1, P20; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Gaudart J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-61; Gleiser RM, 1997, ANN TROP MED PARASIT, V91, P917, DOI 10.1080/00034989760301; Graves PM, 2008, TROP MED INT HEALTH, V13, P218, DOI 10.1111/j.1365-3156.2007.01993.x; Gupta R, 1996, J Assoc Physicians India, V44, P385; Haque U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006737; Hashizume M, 2009, P NATL ACAD SCI USA, V106, P1857, DOI 10.1073/pnas.0806544106; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; Kusumawathie PHD, 2006, ACTA TROP, V99, P30, DOI 10.1016/j.actatropica.2006.06.007; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; M&PDC, 2009, MOSQ VECT BANGL SURV; M&PDC, 2010, MAL COUNTR REP BANGL; Mantilla G, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-6; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Menno J, 1996, TROP MED INT HEALTH, V1, P86; Michel T, 2006, ENCY INFECT DIS MODE; Muirhead T, 1940, J MALAR I INDIA, V3, P265; Nihei N, 2002, JPN J INFECT DIS, V55, P160; Nkurunziza H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-114; Noedl H, 2003, AM J TROP MED HYG, V68, P140, DOI 10.4269/ajtmh.2003.68.140; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Rahman A, 2006, AM J TROP MED HYG, V74, P17, DOI 10.4269/ajtmh.2006.74.17; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P192, DOI 10.4269/ajtmh.1982.31.192; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Salahuddin A, 2006, GLOBAL PLANET CHANGE, V53, P188, DOI 10.1016/j.gloplacha.2006.06.001; Singh N, 2002, ANN TROP MED PARASIT, V96, P349, DOI 10.1179/000349802125001113; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214; Tian LW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-110; Wiwanitkit V, 2006, J INFECTION, V52, P227, DOI 10.1016/j.jinf.2005.02.023; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100; Zhou GF, 2005, TRENDS PARASITOL, V21, P54, DOI 10.1016/j.pt.2004.11.002	55	47	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14341	10.1371/journal.pone.0014341	http://dx.doi.org/10.1371/journal.pone.0014341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179555	gold, Green Published			2022-12-27	WOS:000285381200002
J	Sheppard, SK; Dallas, JF; Wilson, DJ; Strachan, NJC; McCarthy, ND; Jolley, KA; Colles, FM; Rotariu, O; Ogden, ID; Forbes, KJ; Maiden, MCJ				Sheppard, Samuel K.; Dallas, John F.; Wilson, Daniel J.; Strachan, Norval J. C.; McCarthy, Noel D.; Jolley, Keith A.; Colles, Frances M.; Rotariu, Ovidiu; Ogden, Iain D.; Forbes, Ken J.; Maiden, Martin C. J.			Evolution of an Agriculture-Associated Disease Causing Campylobacter coli Clade: Evidence from National Surveillance Data in Scotland	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; ESCHERICHIA-COLI; RECOMBINATION; JEJUNI; DIVERSITY; INFECTION; GENOTYPES; MUTATION; STRAINS; POULTRY	The common zoonotic pathogen Campylobacter coli is an important cause of bacterial gastroenteritis worldwide but its evolution is incompletely understood. Using multilocus sequence type (MLST) data of 7 housekeeping genes from a national survey of Campylobacter in Scotland (2005/6), and a combined population genetic-phylogenetics approach, we investigated the evolutionary history of C. coli. Genealogical reconstruction of isolates from clinical infection, farm animals and the environment, revealed a three-clade genetic structure. The majority of farm animal, and all disease causing genotypes belonged to a single clade (clade 1) which had comparatively low synonymous sequence diversity, little deep branching genetic structure, and a higher number of shared alleles providing evidence of recent clonal decent. Calibration of the rate of molecular evolution, based on within-species genetic variation, estimated a more rapid rate of evolution than in traditional estimates. This placed the divergence of the clades at less than 2500 years ago, consistent with the introduction of an agricultural niche having had an effect upon the evolution of the C. coli clades. Attribution of clinical isolate genotypes to source, using an asymmetric island model, confirmed that strains from chicken and ruminants, and not pigs or turkeys, are the principal source of human C. coli infection. Taken together these analyses are consistent with an evolutionary scenario describing the emergence of agriculture-associated C. coli lineage that is an important human pathogen.	[Sheppard, Samuel K.; McCarthy, Noel D.; Jolley, Keith A.; Colles, Frances M.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Dallas, John F.; Ogden, Iain D.; Forbes, Ken J.] Univ Aberdeen, Dept Med Microbiol, Aberdeen, Scotland; [Strachan, Norval J. C.; Rotariu, Ovidiu] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Wilson, Daniel J.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 3PS, England	University of Oxford; University of Aberdeen; University of Aberdeen; University of Oxford	Sheppard, SK (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	samuel.sheppard@zoo.ox.ac.uk	Jolley, Keith/ABE-8587-2020; Strachan, Norval J/D-4744-2009; Wilson, Daniel J/AAE-8975-2019; Maiden, Martin/N-6805-2019; Maiden, Martin C J/C-5055-2014; McCarthy, Noel D/K-3314-2012	Jolley, Keith/0000-0002-0751-0287; Wilson, Daniel J/0000-0002-0940-3311; Maiden, Martin/0000-0001-6321-5138; Maiden, Martin C J/0000-0001-6321-5138; Sheppard, Samuel/0000-0001-6901-3203; Colles, Frances/0000-0002-3322-2991; McCarthy, Noel/0000-0003-1113-1017	Food Standards Agency of Scotland; DEFRA; Wellcome Trust	Food Standards Agency of Scotland; DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was funded by the Food Standards Agency of Scotland and DEFRA. SKS and MCJM are funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Buzby J C, 1997, World Health Stat Q, V50, P57; Coffey TJ, 2006, APPL ENVIRON MICROB, V72, P1420, DOI 10.1128/AEM.72.2.1420-1428.2006; Debruyne L, 2008, CAMPYLOBACTER, 3RD EDITION, P3; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Drummond AJ, 2002, GENETICS, V161, P1307; Duim B, 1999, APPL ENVIRON MICROB, V65, P2369; DYKHUIZEN DE, 1993, P NATL ACAD SCI USA, V90, P10163, DOI 10.1073/pnas.90.21.10163; Eggleston AK, 1997, CURR BIOL, V7, pR745, DOI 10.1016/S0960-9822(06)00394-0; EMBLEY TM, 1991, LETT APPL MICROBIOL, V13, P171, DOI 10.1111/j.1472-765X.1991.tb00600.x; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fearnhead P, 2008, STAT COMPUT, V18, P151, DOI 10.1007/s11222-007-9045-8; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Friedman C.R., 2000, CAMPYLOBACTER, P121; Friedman CR, 2004, CLIN INFECT DIS, V38, pS285, DOI 10.1086/381598; Gillespie IA, 2002, EMERG INFECT DIS, V8, P937, DOI 10.3201/eid0809.010817; Gormley FJ, 2008, APPL ENVIRON MICROB, V74, P383, DOI 10.1128/AEM.01455-07; Holmes EC, 1999, MOL BIOL EVOL, V16, P741, DOI 10.1093/oxfordjournals.molbev.a026159; Humphrey TJ, 2005, ANTIMICROB AGENTS CH, V49, P690, DOI 10.1128/AAC.49.2.690-698.2005; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Kessel A S, 2001, Commun Dis Public Health, V4, P171; Khanna MR, 2006, LETT APPL MICROBIOL, V43, P84, DOI 10.1111/j.1472-765X.2006.01904.x; Kinana AD, 2007, RES MICROBIOL, V158, P138, DOI 10.1016/j.resmic.2006.11.009; Konkel ME, 2007, APPL ENVIRON MICROB, V73, P2297, DOI 10.1128/AEM.02193-06; Lenski RE, 2003, J MOL EVOL, V56, P498, DOI 10.1007/s00239-002-2423-0; Litrup E, 2007, J APPL MICROBIOL, V103, P210, DOI 10.1111/j.1365-2672.2006.03214.x; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; MCCORRISTON J, 1991, AM ANTHROPOL, V93, P46, DOI 10.1525/aa.1991.93.1.02a00030; McVean G, 2002, GENETICS, V160, P1231; Miller WG, 2006, MICROBIOL-SGM, V152, P245, DOI 10.1099/mic.0.28348-0; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; Nielsen R, 1998, GENETICS, V148, P929; Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Olson CK, 2008, CAMPYLOBACTER, 3RD EDITION, P163; Pebody R G, 1997, Commun Dis Rep CDR Rev, V7, pR33; Perez-Losada M, 2007, INFECT GENET EVOL, V7, P271, DOI 10.1016/j.meegid.2006.11.003; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Rotariu O, 2009, APPL ENVIRON MICROB, V75, P6275, DOI 10.1128/AEM.00499-09; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; SOPWITH W, 2009, APPL ENV MICROBIOLOG; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tam CC, 2003, J INFECTION, V47, P28, DOI 10.1016/S0163-4453(03)00042-2; Thakur S, 2005, J CLIN MICROBIOL, V43, P5705, DOI 10.1128/JCM.43.11.5705-5714.2005; van Bergen MAP, 2005, J CLIN MICROBIOL, V43, P5888, DOI 10.1128/JCM.43.12.5888-5898.2005; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098; ZVELEBIL M, 1991, J WORLD PREHIST, V5, P233, DOI 10.1007/BF00974991	71	61	61	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15708	10.1371/journal.pone.0015708	http://dx.doi.org/10.1371/journal.pone.0015708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179537	Green Published, gold, Green Submitted			2022-12-27	WOS:000285340000030
J	Achame, EM; Baarends, WM; Gribnau, J; Grootegoed, JA				Achame, Eskeatnaf Mulugeta; Baarends, Willy M.; Gribnau, Joost; Grootegoed, J. Anton			Evaluating the Relationship between Spermatogenic Silencing of the X Chromosome and Evolution of the Y Chromosome in Chimpanzee and Human	PLOS ONE			English	Article							DOSAGE COMPENSATION; SPERM COMPETITION; SEX-CHROMOSOMES; UP-REGULATION; CHICKEN Z; MOUSE; GENE; INACTIVATION; EXPRESSION; MEIOSIS	Chimpanzees and humans are genetically very similar, with the striking exception of their Y chromosomes, which have diverged tremendously. The male-specific region (MSY), representing the greater part of the Y chromosome, is inherited from father to son in a clonal fashion, with natural selection acting on the MSY as a unit. Positive selection might involve the performance of the MSY in spermatogenesis. Chimpanzees have a highly polygamous mating behavior, so that sperm competition is thought to provide a strong selective force acting on the Y chromosome in the chimpanzee lineage. In consequence of evolution of the heterologous sex chromosomes in mammals, meiotic sex chromosome inactivation (MSCI) results in a transcriptionally silenced XY body in male meiotic prophase, and subsequently also in postmeiotic repression of the sex chromosomes in haploid spermatids. This has evolved to a situation where MSCI has become a prerequisite for spermatogenesis. Here, by analysis of microarray testicular expression data representing a small number of male chimpanzees and men, we obtained information indicating that meiotic and postmeiotic X chromosome silencing might be more effective in chimpanzee than in human spermatogenesis. From this, we suggest that the remarkable reorganization of the chimpanzee Y chromosome, compared to the human Y chromosome, might have an impact on its meiotic interactions with the X chromosome and thereby on X chromosome silencing in spermatogenesis. Further studies will be required to address comparative functional aspects of MSCI in chimpanzee, human, and other placental mammals.	[Achame, Eskeatnaf Mulugeta; Baarends, Willy M.; Gribnau, Joost; Grootegoed, J. Anton] Erasmus MC Univ Med Ctr, Dept Reprod & Dev, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Achame, EM (corresponding author), Erasmus MC Univ Med Ctr, Dept Reprod & Dev, Rotterdam, Netherlands.	j.a.grootegoed@erasmusmc.nl	Mulugeta, Eskeatnaf/AAZ-7471-2020; Mulugeta, Eskeatnaf/H-2640-2016	Mulugeta, Eskeatnaf/0000-0003-4045-4835; Mulugeta, Eskeatnaf/0000-0003-4045-4835	Netherlands Organization for Scientific Research (NWO); Erasmus University Rotterdam	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Erasmus University Rotterdam	The work was supported by The Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/nwohome.nsf/pages/SPPD_5R2QE7_Eng), in the form of career-development funding (Vidi and Vici) to WMB and JG. As candidate for the NWO Mosaic grant, EMA received a grant from Erasmus University Rotterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2007, AM J PHYS ANTHROPOL, V134, P274, DOI 10.1002/ajpa.20674; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; Barakat TS, 2010, EXP CELL RES, V316, P679, DOI 10.1016/j.yexcr.2010.01.015; Bellott DW, 2009, COLD SH Q B, V74, P345, DOI 10.1101/sqb.2009.74.048; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; CHANDLEY AC, 1984, CYTOGENET CELL GENET, V38, P241, DOI 10.1159/000132070; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; Ellis PJI, 2005, HUM MOL GENET, V14, P2705, DOI 10.1093/hmg/ddi304; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Goto H, 2009, J MOL EVOL, V68, P134, DOI 10.1007/s00239-008-9189-y; Grootegoed JA, 2000, BEST PRACT RES CL EN, V14, P331, DOI 10.1053/beem.2000.0083; HALE DW, 1994, CYTOGENET CELL GENET, V65, P278, DOI 10.1159/000133648; HANDEL MA, 1992, BIOESSAYS, V14, P817, DOI 10.1002/bies.950141205; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Itoh Y., 2007, J BIOL, V6; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Krausz C, 2006, HUM MOL GENET, V15, P2673, DOI 10.1093/hmg/ddl198; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Lu J, 2005, P NATL ACAD SCI USA, V102, P4063, DOI 10.1073/pnas.0500436102; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Malcom CM, 2003, MOL BIOL EVOL, V20, P1633, DOI 10.1093/molbev/msg178; Mank JE, 2009, HEREDITY, V102, P312, DOI 10.1038/hdy.2008.116; McCarrey JR, 2002, GENESIS, V34, P257, DOI 10.1002/gene.10163; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P1013, DOI 10.1210/jc.2009-1925; Metzler-Guillemain C, 2000, CHROMOSOME RES, V8, P571, DOI 10.1023/A:1009277722579; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Namekawa SH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000493; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nascimento JM, 2008, J R SOC INTERFACE, V5, P297, DOI 10.1098/rsif.2007.1118; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; OHNO, 1967, SEX CHROMOSOMES SEX; PALMER S, 1995, NAT GENET, V10, P472, DOI 10.1038/ng0895-472; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Perry GH, 2007, MOL BIOL EVOL, V24, P853, DOI 10.1093/molbev/msm002; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Presgraves DC, 2009, TRENDS ECOL EVOL, V24, P533, DOI 10.1016/j.tree.2009.04.007; Rozen S, 2009, AM J HUM GENET, V85, P923, DOI 10.1016/j.ajhg.2009.11.011; Schimenti J, 2005, NAT GENET, V37, P11, DOI 10.1038/ng0105-11; Schoenmakers S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000466; Shiao MS, 2007, MOL BIOL EVOL, V24, P2242, DOI 10.1093/molbev/msm153; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; SPEED RM, 1990, HUM GENET, V84, P547; SPEED RM, 1986, CHROMOSOMA, V94, P115, DOI 10.1007/BF00286989; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; TRES LL, 1977, J CELL SCI, V25, P1; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Turner JMA, 2002, J CELL SCI, V115, P4097, DOI 10.1242/jcs.00111; Tyler-Smith C, 2009, NEW ENGL J MED, V360, P925, DOI 10.1056/NEJMe0900301; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Vogt PH, 2008, INT J ANDROL, V31, P383, DOI 10.1111/j.1365-2605.2008.00890.x; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Weinbauer GF, 2001, BIOL REPROD, V64, P120, DOI 10.1095/biolreprod64.1.120; Wistuba J, 2003, BIOL REPROD, V69, P582, DOI 10.1095/biolreprod.103.015925; Yang ZW, 1998, J CLIN ENDOCR METAB, V83, P1284; Yogev L, 2004, J ANDROL, V25, P110; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	74	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15598	10.1371/journal.pone.0015598	http://dx.doi.org/10.1371/journal.pone.0015598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179482	gold, Green Published, Green Submitted			2022-12-27	WOS:000285292500029
J	Mewborn, SK; Puckelwartz, MJ; Abuisneineh, F; Fahrenbach, JP; Zhang, YA; MacLeod, H; Dellefave, L; Pytel, P; Selig, S; Labno, CM; Reddy, K; Singh, H; McNally, E				Mewborn, Stephanie K.; Puckelwartz, Megan J.; Abuisneineh, Fida; Fahrenbach, John P.; Zhang, Yuan; MacLeod, Heather; Dellefave, Lisa; Pytel, Peter; Selig, Sara; Labno, Christine M.; Reddy, Karen; Singh, Harinder; McNally, Elizabeth			Altered Chromosomal Positioning, Compaction, and Gene Expression with a Lamin A/C Gene Mutation	PLOS ONE			English	Article							FAMILIAL DILATED CARDIOMYOPATHY; DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR LAMINA; CHROMATIN ORGANIZATION; TRANSCRIPTIONAL REGULATION; LMNA MUTATIONS; IN-VITRO; ENVELOPE; GENOME; EMERIN	Background: Lamins A and C, encoded by the LMNA gene, are filamentous proteins that form the core scaffold of the nuclear lamina. Dominant LMNA gene mutations cause multiple human diseases including cardiac and skeletal myopathies. The nuclear lamina is thought to regulate gene expression by its direct interaction with chromatin. LMNA gene mutations may mediate disease by disrupting normal gene expression. Methods/Findings: To investigate the hypothesis that mutant lamin A/C changes the lamina's ability to interact with chromatin, we studied gene misexpression resulting from the cardiomyopathic LMNA E161K mutation and correlated this with changes in chromosome positioning. We identified clusters of misexpressed genes and examined the nuclear positioning of two such genomic clusters, each harboring genes relevant to striated muscle disease including LMO7 and MBNL2. Both gene clusters were found to be more centrally positioned in LMNA-mutant nuclei. Additionally, these loci were less compacted. In LMNA mutant heart and fibroblasts, we found that chromosome 13 had a disproportionately high fraction of misexpressed genes. Using three-dimensional fluorescence in situ hybridization we found that the entire territory of chromosome 13 was displaced towards the center of the nucleus in LMNA mutant fibroblasts. Additional cardiomyopathic LMNA gene mutations were also shown to have abnormal positioning of chromosome 13, although in the opposite direction. Conclusions: These data support a model in which LMNA mutations perturb the intranuclear positioning and compaction of chromosomal domains and provide a mechanism by which gene expression may be altered.	[Mewborn, Stephanie K.; Puckelwartz, Megan J.; Abuisneineh, Fida; Fahrenbach, John P.; Zhang, Yuan; MacLeod, Heather; Dellefave, Lisa; Labno, Christine M.; McNally, Elizabeth] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Puckelwartz, Megan J.; McNally, Elizabeth] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Pytel, Peter] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Selig, Sara] Technion Israel Inst Technol, Mol Med Lab, Haifa, Israel; [Selig, Sara] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Reddy, Karen; Singh, Harinder] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Reddy, Karen; Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Selig, Sara] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel	University of Chicago; University of Chicago; University of Chicago; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Howard Hughes Medical Institute; University of Chicago; University of Chicago; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Mewborn, SK (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	emcnally@uchicago.edu	McNally, Elizabeth/W-4909-2019	Reddy, Karen/0000-0003-4548-5999; fahrenbach, john/0000-0001-6785-9707; McNally, Elizabeth/0000-0002-1221-719X; Zhang, Yuan/0000-0003-0022-1201	Doris Duke Charitable Foundation; National Institutes of Health (NIH) [HL092443]; Howard Hughes Medical Institute (HHMI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092443] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Doris Duke Charitable Foundation, National Institutes of Health (NIH) HL092443 and Howard Hughes Medical Institute (HHMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Baker EA, 2005, MECH AGEING DEV, V126, P664, DOI 10.1016/j.mad.2004.12.002; Bisognin A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-68; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Charniot JC, 2006, EUR J HEART FAIL, V8, P249, DOI 10.1016/j.ejheart.2005.08.007; Correa Margarita, 2007, P R Health Sci J, V26, P229; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dillon N, 2008, DEV CELL, V15, P182, DOI 10.1016/j.devcel.2008.07.013; Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fields A P, 1995, Prog Cell Cycle Res, V1, P271; Filesi I, 2005, PHYSIOL GENOMICS, V23, P150, DOI 10.1152/physiolgenomics.00060.2005; Garg A, 2002, AM J MED, V112, P549, DOI 10.1016/S0002-9343(02)01070-7; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hao MQ, 2008, DEV DYNAM, V237, P403, DOI 10.1002/dvdy.21428; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Hegele RA, 2000, NAT MED, V6, P136, DOI 10.1038/72221; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; Kalverda B, 2008, FEBS LETT, V582, P2017, DOI 10.1016/j.febslet.2008.04.015; Kandert S, 2009, EUR J CELL BIOL, V88, P593, DOI 10.1016/j.ejcb.2009.06.002; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kurshakova MM, 2007, EMBO J, V26, P4956, DOI 10.1038/sj.emboj.7601901; MacLeod Heather M, 2003, BMC Med Genet, V4, P4, DOI 10.1186/1471-2350-4-4; Meaburn KJ, 2007, AGING CELL, V6, P139, DOI 10.1111/j.1474-9726.2007.00270.x; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Mislow JMK, 2002, J CELL SCI, V115, P61; Moir RD, 2000, J STRUCT BIOL, V129, P324, DOI 10.1006/jsbi.2000.4251; Otomo J, 2005, J CARDIOVASC ELECTR, V16, P137, DOI 10.1046/j.1540-8167.2004.40096.x; Parnaik VK, 2008, INT REV CEL MOL BIO, V266, P157, DOI 10.1016/S1937-6448(07)66004-3; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Perrot A, 2009, BASIC RES CARDIOL, V104, P90, DOI 10.1007/s00395-008-0748-6; Pethig K, 2005, CARDIOLOGY, V103, P57, DOI 10.1159/000082048; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Puckelwartz MJ, 2010, J MOL CELL CARDIOL, V48, P600, DOI 10.1016/j.yjmcc.2009.11.006; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Reddy KL, 2008, METHODS, V45, P242, DOI 10.1016/j.ymeth.2008.06.013; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Sebillon P, 2003, J MED GENET, V40, P560, DOI 10.1136/jmg.40.8.560; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Taimen P, 2009, P NATL ACAD SCI US; 2002, GENECHIP EXPRESSION	54	81	90	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14342	10.1371/journal.pone.0014342	http://dx.doi.org/10.1371/journal.pone.0014342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179469	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500013
J	Jawad, MU; Garamszegi, N; Garamszegi, SP; Correa-Medina, M; Diez, JA; Wen, R; Scully, SP				Jawad, Muhammad Umar; Garamszegi, Nandor; Garamszegi, Susanna P.; Correa-Medina, Mayrin; Diez, Juan A.; Wen, Rong; Scully, Sean P.			Matrix Metalloproteinase 1: Role in Sarcoma Biology	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN CHONDROSARCOMA; GENE-EXPRESSION; TUMOR PROGRESSION; GROWTH-FACTOR; METALLOELASTASE MMP-12; LUNG METASTASIS; BREAST-CANCER; IN-VITRO; RT-PCR	In carcinomas stromal cells participate in cancer progression by producing proteases such as MMPs. The expression MMP1 is a prognostic factor in human chondrosarcoma, however the role in tumor progression is unknown. Laser capture microdissection and In Situ hybridization were used to determine cellular origin of MMP1 in human sarcomas. A xenogenic model of tumor progression was then used and mice were divided in two groups: each harboring either the control or a stably MMP1 silenced cell line. Animals were sacrificed; the neovascularization, primary tumor volumes, and metastatic burden were assessed. LCM and RNA-ISH analysis revealed MMP1 expression was predominantly localized to the tumor cells in all samples of sarcoma (p = 0.05). The percentage lung metastatic volume at 5 weeks (p = 0.08) and number of spontaneous deaths secondary to systemic tumor burden were lower in MMP1 silenced cell bearing mice. Interestingly, this group also demonstrated a larger primary tumor size (p < 0.04) and increased angiogenesis (p < 0.01). These findings were found to be consistent when experiment was repeated using a second independent MMP1 silencing sequence. Prior clinical trials employing MMP1 inhibitors failed because of a poor understanding of the role of MMPs in tumor progression. The current findings indicating tumor cell production of MMP1 by sarcoma cells is novel and highlights the fundamental differences in MMP biology between carcinomas and sarcomas. The results also emphasize the complex roles of MMP in tumor progression of sarcomas. Not only does metastasis seem to be affected by MMP1 silencing, but also local tumor growth and angiogenesis are affected inversely.	[Jawad, Muhammad Umar; Garamszegi, Nandor; Garamszegi, Susanna P.; Scully, Sean P.] Univ Miami, Miller Sch Med, Univ Miami Hosp, Dept Orthoped, Miami, FL 33136 USA; [Wen, Rong] Univ Miami, Miller Sch Med, McKnight Vis Ctr, Bascom Palmer Eyes Inst,Dept Ophthalmol, Miami, FL 33136 USA; [Correa-Medina, Mayrin; Diez, Juan A.] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA	University of Miami; Bascom Palmer Eye Institute; University of Miami; University of Miami	Jawad, MU (corresponding author), Univ Miami, Miller Sch Med, Univ Miami Hosp, Dept Orthoped, Miami, FL 33136 USA.	sscully@med.miami.edu	Diez Juan, Antonio/D-3695-2018; Jawad, Muhammad Umar/A-2672-2017	Jawad, Muhammad Umar/0000-0002-0667-5063	NCI [CA096796]; NATIONAL CANCER INSTITUTE [R01CA096796] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The senior author received funding from NCI (CA096796) for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Basset P, 1997, MATRIX BIOL, V15, P535, DOI 10.1016/S0945-053X(97)90028-7; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Berend KR, 1998, J BONE JOINT SURG AM, V80A, P11, DOI 10.2106/00004623-199801000-00004; Bhuvarahamurthy V, 2006, ONCOL REP, V15, P1379; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Drummond AH, 1999, ANN NY ACAD SCI, V878, P228, DOI 10.1111/j.1749-6632.1999.tb07688.x; ECK SM, 2008, BREAST CANC RES TREA; Erickson HS, 2007, LAB INVEST, V87, P951, DOI 10.1038/labinvest.3700659; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Fong YC, 2004, CLIN CANCER RES, V10, P7329, DOI 10.1158/1078-0432.CCR-04-0900; GARAMSZEGI N, 2008, EXP CELL RE IN PRESS; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Haupt LM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-18; Healey JH, 2008, CLIN ORTHOP RELAT R, V466, P2029, DOI 10.1007/s11999-008-0353-x; Jiang XL, 2003, J ORTHOP RES, V21, P1063, DOI 10.1016/S0736-0266(03)00079-2; Kerkela E, 2002, J PATHOL, V198, P258, DOI 10.1002/path.1198; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; MacDougall JR, 1995, CANCER METAST REV, V14, P351, DOI 10.1007/BF00690603; Makino Hiroshi, 2008, BMC Cancer, V8, P210, DOI 10.1186/1471-2407-8-210; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Merchan JR, 2006, JNCI-J NATL CANCER I, V98, P756, DOI 10.1093/jnci/djj208; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Noel A, 2008, SEMIN CELL DEV BIOL, V19, P52, DOI 10.1016/j.semcdb.2007.05.011; POLYAK K, 2008, TRENDS GENET; Rio MC, 2005, BIOCHIMIE, V87, P299, DOI 10.1016/j.biochi.2004.11.016; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Salmela MT, 2001, BRIT J CANCER, V85, P383, DOI 10.1054/bjoc.2001.1929; Sauter W, 2008, CANCER EPIDEM BIOMAR, V17, P1127, DOI 10.1158/1055-9965.EPI-07-2840; Scully SP, 2000, CLIN ORTHOP RELAT R, pS55; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; SOORIAKUMARAN P, 2008, INT J SURG PATHOL; Thrall DE, 1997, RADIOTHER ONCOL, V44, P171, DOI 10.1016/S0167-8140(97)01931-2; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; WITTY JP, 1995, CANCER RES, V55, P1401; Witz IP, 2008, ADV CANCER RES, V100, P203, DOI 10.1016/S0065-230X(08)00007-9; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Yuan J, 2005, J ORTHOP RES, V23, P1467, DOI 10.1016/j.orthres.2005.04.004; Zheng MH, 2000, HUM PATHOL, V31, P804, DOI 10.1053/hupa.2000.8441	48	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14250	10.1371/journal.pone.0014250	http://dx.doi.org/10.1371/journal.pone.0014250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170377	Green Published, gold, Green Submitted			2022-12-27	WOS:000285084100004
J	Forsman, ZH; Concepcion, GT; Haverkort, RD; Shaw, RW; Maragos, JE; Toonen, RJ				Forsman, Zac H.; Concepcion, Gregory T.; Haverkort, Roxanne D.; Shaw, Ross W.; Maragos, James E.; Toonen, Robert J.			Ecomorph or Endangered Coral? DNA and Microstructure Reveal Hawaiian Species Complexes: Montipora dilatata/flabellata/turgescens & M. patula/verrilli	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENUS ACROPORA; EVOLUTION; MITOCHONDRIAL; HYBRIDIZATION; PLASTICITY; PATTERNS	M. dilatata, M. flabellata, and M. patula and 80 other scleractinian corals were petitioned to be listed under the US Endangered Species Act (ESA), which would have major conservation implications. One of the difficulties with this evaluation is that reproductive boundaries between morphologically defined coral species are often permeable, and morphology can be wildly variable. We examined genetic and morphological variation in Hawaiian Montipora with a suite of molecular markers (mitochondrial: COI, CR, Cyt-B, 16S, ATP6; nuclear: ATPs beta, ITS) and microscopic skeletal measurements. Mitochondrial markers and the ITS region revealed four distinct clades: I) M. patula/M. verrilli, II) M. cf. incrassata, III) M. capitata, IV) M. dilatata/M. flabellata/M. cf. turgescens. These clades are likely to occur outside of Hawai'i according to mitochondrial control region haplotypes from previous studies. The ATPs beta intron data showed a pattern often interpreted as resulting from hybridization and introgression; however, incomplete lineage sorting may be more likely since the multicopy nuclear ITS region was consistent with the mitochondrial data. Furthermore, principal components analysis (PCA) of skeletal microstructure was concordant with the mitochondrial clades, while nominal taxa overlapped. The size and shape of verrucae or papillae contributed most to identifying groups, while colony-level morphology was highly variable. It is not yet clear if these species complexes represent population-level variation or incipient speciation (CA<1MYA), two alternatives that have very different conservation implications. This study highlights the difficulty in understanding the scale of genetic and morphological variation that corresponds to species as opposed to population-level variation, information that is essential for conservation and for understanding coral biodiversity.	[Forsman, Zac H.; Haverkort, Roxanne D.; Toonen, Robert J.] Univ Hawaii, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA; [Concepcion, Gregory T.] Univ Maryland, College Pk, MD 20742 USA; [Shaw, Ross W.] Grant MacEwan Univ, Dept Biol, Edmonton, AB, Canada; [Maragos, James E.] US Fish & Wildlife Serv, Honolulu, HI USA	University of Hawaii System; University System of Maryland; University of Maryland College Park; United States Department of the Interior; US Fish & Wildlife Service	Forsman, ZH (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA.	zac@hawaii.edu	Toonen, Rob/K-2891-2012; Shaw, Ross/AAC-5404-2022; Toonen, Rob/V-6230-2019; Forsman, Zac/F-1266-2015	Toonen, Rob/0000-0001-6339-4340; Toonen, Rob/0000-0001-6339-4340; Forsman, Zac/0000-0002-5837-3614	National Oceanic and Atmospheric Administration (NOAA), National Marine Fisheries Service, Pacific Islands Regional Office [NMFS-PRPO-2010-2001945]; NOAA National Marine Sanctuaries Partnership [2005-008/66882]; MacEwan University Research Office and Divisional Arts and Science	National Oceanic and Atmospheric Administration (NOAA), National Marine Fisheries Service, Pacific Islands Regional Office(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA National Marine Sanctuaries Partnership; MacEwan University Research Office and Divisional Arts and Science	The work was made possible by funding from a grant from the National Oceanic and Atmospheric Administration (NOAA), National Marine Fisheries Service, Pacific Islands Regional Office; NMFS-PRPO-2010-2001945. ZHF was supported by a fellowship from NOAA National Marine Sanctuaries Partnership MOA#2005-008/66882. RWS was supported by funding from Grant MacEwan University Research Office and Divisional Arts and Science grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard HM, 1897, GENUS MONTIPORA GENU; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; Budd AF, 2010, SCIENCE, V328, P1558, DOI 10.1126/science.1188947; Concepcion GT, 2006, MOL ECOL NOTES, V6, P1208, DOI 10.1111/j.1471-8286.2006.01493.x; CONCEPCION GT, 2009, CONSERVATION GENET R, P1; DRUMMOND AJ, 2009, GENEIOUS V4 8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fenner D, 2005, CORALS HAWAII; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; GRAHAM K, 2007, NOAA NATL MARINE FIS; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maragos J. E., 1977, REEF SHORE FAUNA HAW, P158; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; Miller DJ, 2003, MOL ECOL, V12, P805, DOI 10.1046/j.1365-294X.2003.01808.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rozen S, 2000, Methods Mol Biol, V132, P365; SAKASHITA M, 2009, PETITION LIST 83 COR; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; van Oppen MJH, 1999, P ROY SOC B-BIOL SCI, V266, P179, DOI 10.1098/rspb.1999.0619; van Oppen MJH, 2004, MAR BIOL, V144, P9, DOI 10.1007/s00227-003-1188-3; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Veron J.E.N., 2000, CORALS WORLD, V1-3; VERON JEN, 1995, CORALS SPACE TIME BI; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; WALLACE CC, 1994, ANNU REV ECOL SYST, V25, P237, DOI 10.1146/annurev.es.25.110194.001321; Wells J.W., 1956, TREATISE INVERTEBR F, P328; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6	39	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15021	10.1371/journal.pone.0015021	http://dx.doi.org/10.1371/journal.pone.0015021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151995	gold, Green Published			2022-12-27	WOS:000284868000023
J	Sarkamo, T; Tervaniemi, M; Soinila, S; Autti, T; Silvennoinen, HM; Laine, M; Hietanen, M; Pihko, E				Sarkamo, Teppo; Tervaniemi, Mari; Soinila, Seppo; Autti, Taina; Silvennoinen, Heli M.; Laine, Matti; Hietanen, Marja; Pihko, Elina			Auditory and Cognitive Deficits Associated with Acquired Amusia after Stroke: A Magnetoencephalography and Neuropsychological Follow-Up Study	PLOS ONE			English	Article							MUSIC PERCEPTION DEFICITS; MISMATCH NEGATIVITY MMN; CONGENITAL AMUSIA; SPEECH INTONATION; BRAIN RESPONSES; NEURAL-NETWORKS; PITCH; CORTEX; MEMORY; DISCRIMINATION	Acquired amusia is a common disorder after damage to the middle cerebral artery (MCA) territory. However, its neurocognitive mechanisms, especially the relative contribution of perceptual and cognitive factors, are still unclear. We studied cognitive and auditory processing in the amusic brain by performing neuropsychological testing as well as magnetoencephalography (MEG) measurements of frequency and duration discrimination using magnetic mismatch negativity (MMNm) recordings. Fifty-three patients with a left (n = 24) or right (n = 29) hemisphere MCA stroke (MRI verified) were investigated 1 week, 3 months, and 6 months after the stroke. Amusia was evaluated using the Montreal Battery of Evaluation of Amusia (MBEA). We found that amusia caused by right hemisphere damage (RHD), especially to temporal and frontal areas, was more severe than amusia caused by left hemisphere damage (LHD). Furthermore, the severity of amusia was found to correlate with weaker frequency MMNm responses only in amusic RHD patients. Additionally, within the RHD subgroup, the amusic patients who had damage to the auditory cortex (AC) showed worse recovery on the MBEA as well as weaker MMNm responses throughout the 6-month follow-up than the non-amusic patients or the amusic patients without AC damage. Furthermore, the amusic patients both with and without AC damage performed worse than the non-amusic patients on tests of working memory, attention, and cognitive flexibility. These findings suggest domain-general cognitive deficits to be the primary mechanism underlying amusia without AC damage whereas amusia with AC damage is associated with both auditory and cognitive deficits.	[Sarkamo, Teppo; Tervaniemi, Mari] Univ Helsinki, Cognit Brain Res Unit, Inst Behav Sci, Helsinki, Finland; [Sarkamo, Teppo; Tervaniemi, Mari] Univ Jyvaskyla, Finnish Ctr Excellence Interdisciplinary Mus Res, Jyvaskyla, Finland; [Tervaniemi, Mari] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland; [Soinila, Seppo; Hietanen, Marja] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Autti, Taina; Silvennoinen, Heli M.] Univ Helsinki, Cent Hosp, Dept Radiol, Helsinki, Finland; [Laine, Matti] Abo Akad Univ, Dept Psychol, Turku, Finland; [Pihko, Elina] Univ Helsinki, Cent Hosp, BioMag Lab, Hosp Dist Helsinki & Uusimaa,HUSLAB, Helsinki, Finland; [Pihko, Elina] Aalto Univ, Sch Sci & Technol, Brain Res Unit, Low Temp Lab, Espoo, Finland	University of Helsinki; University of Jyvaskyla; University of Jyvaskyla; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Abo Akademi University; University of Helsinki; Helsinki University Central Hospital; Aalto University	Sarkamo, T (corresponding author), Univ Helsinki, Cognit Brain Res Unit, Inst Behav Sci, Helsinki, Finland.	teppo.sarkamo@helsinki.fi	Pihko, Elina/J-6026-2012	Sarkamo, Teppo/0000-0002-1470-4530; Tervaniemi, Mari/0000-0002-9651-2929	Academy of Finland [77322]; Jenny and Antti Wihuri Foundation, Helsinki, Finland; National Graduate School of Psychology, Finland; Finnish Brain Foundation, Finland	Academy of Finland(Academy of Finland); Jenny and Antti Wihuri Foundation, Helsinki, Finland; National Graduate School of Psychology, Finland; Finnish Brain Foundation, Finland	This work has been funded by the Academy of Finland (project no. 77322) (http://www.aka.fi/fi/A/); the Jenny and Antti Wihuri Foundation, Helsinki, Finland (http://www.wihurinrahasto.fi/); the National Graduate School of Psychology, Finland (http://www.gspsy.fi/index.php?id = 64); and the Finnish Brain Foundation, Finland (http://www.aivosaatio.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLFORS S, 1989, P 7 INT C BIOM, P693; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Alossa N, 2009, EUR NEUROL, V61, P269, DOI 10.1159/000206851; Ayotte J, 2000, BRAIN, V123, P1926, DOI 10.1093/brain/123.9.1926; Benton A.L., 1974, REVISED VISUAL RETEN; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Braun A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002349; Brown S, 2007, BRAIN COGNITION, V63, P59, DOI 10.1016/j.bandc.2006.08.006; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Douglas KM, 2007, NAT NEUROSCI, V10, P915, DOI 10.1038/nn1925; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Edgeworth J. A., 1998, BALLOONS TEST; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Goodglass H., 2001, BOSTON DIAGNOSTIC AP, VThird; Gosselin N, 2009, ANN NY ACAD SCI, V1169, P270, DOI 10.1111/j.1749-6632.2009.04762.x; Griffiths TD, 1999, NEUROREPORT, V10, P3825, DOI 10.1097/00001756-199912160-00019; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; HYDE KL, CEREB CORTE IN PRESS; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Ilvonen TM, 2003, STROKE, V34, P1746, DOI 10.1161/01.STR.0000078836.26328.3B; Jamison HL, 2006, CEREB CORTEX, V16, P1266, DOI 10.1093/cercor/bhj068; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Jiang CM, 2010, NEUROPSYCHOLOGIA, V48, P2630, DOI 10.1016/j.neuropsychologia.2010.05.009; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Jones JL, 2009, J COMMUN DISORD, V42, P226, DOI 10.1016/j.jcomdis.2009.01.001; Jones JL, 2009, EAR HEARING, V30, P63, DOI 10.1097/AUD.0b013e31818ff95e; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Kohlmetz C, 2001, NEUROPSYCHOLOGIA, V39, P1121, DOI 10.1016/S0028-3932(01)00079-3; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Levanen S, 1996, CEREB CORTEX, V6, P288, DOI 10.1093/cercor/6.2.288; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Mandell J, 2007, RESTOR NEUROL NEUROS, V25, P323; Mendez MF, 2001, CORTEX, V37, P139, DOI 10.1016/S0010-9452(08)70563-X; MILNER B, 1962, INTERHEMISPHER RELAT, P177; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Moreau P, 2009, ANN NY ACAD SCI, V1169, P191, DOI 10.1111/j.1749-6632.2009.04775.x; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Munte TF, 1998, NEUROSCI LETT, V256, P85, DOI 10.1016/S0304-3940(98)00760-5; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Patel AD, 2005, BRAIN COGNITION, V59, P310, DOI 10.1016/j.bandc.2004.10.003; Patel AD, 2008, MUSIC PERCEPT, V25, P357, DOI 10.1525/MP.2008.25.4.357; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Peretz I, 2005, ANN NEUROL, V58, P478, DOI 10.1002/ana.20606; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; PERETZ I, 1990, BRAIN, V113, P1185, DOI 10.1093/brain/113.4.1185; Peretz I, 2009, BRAIN, V132, P1277, DOI 10.1093/brain/awp055; Platel H, 2003, NEUROIMAGE, V20, P244, DOI 10.1016/S1053-8119(03)00287-8; Revonsuo A., 1995, COGNISPEED COMPUTER; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Sarkamo T, 2010, J COGNITIVE NEUROSCI, V22, P2716, DOI 10.1162/jocn.2009.21376; Sarkamo T, 2009, NEUROPSYCHOLOGIA, V47, P2642, DOI 10.1016/j.neuropsychologia.2009.05.015; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; Schuppert M, 2000, BRAIN, V123, P546, DOI 10.1093/brain/123.3.546; Stewart L, 2006, BRAIN, V129, P2533, DOI 10.1093/brain/awl171; Terao Y, 2006, NEUROPSYCHOLOGIA, V44, P479, DOI 10.1016/j.neuropsychologia.2005.05.013; Tervaniemi M, 2005, CLIN NEUROPHYSIOL, V116, P1897, DOI 10.1016/j.clinph.2005.03.025; Tervaniemi M, 1999, CLIN NEUROPHYSIOL, V110, P1388, DOI 10.1016/S1388-2457(99)00108-X; THOMPSON WF, 2007, P INT C MUS COMM SCI, P159; Tillmann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010173; Tillmann B, 2009, BRAIN COGNITION, V71, P259, DOI 10.1016/j.bandc.2009.08.003; Uutela K, 1999, NEUROIMAGE, V10, P173, DOI 10.1006/nimg.1999.0454; Wechsler D, 1987, WMS R WECHSLER MEMOR; Weill-Chounlamountry A., 2008, Annales de Readaptation et de Medecine Physique, V51, P332, DOI 10.1016/j.annrmp.2008.03.005; Williamson VJ, 2010, ADV COGN PSYCHOL, V6, P15, DOI 10.2478/v10053-008-0073-5; Wilson B, 1985, RIVERMEAD BEHAVIOURA; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	79	29	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15157	10.1371/journal.pone.0015157	http://dx.doi.org/10.1371/journal.pone.0015157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152040	Green Published, gold, Green Submitted			2022-12-27	WOS:000284868000028
J	Saludes, V; Bracho, MA; Valero, O; Ardevol, M; Planas, R; Gonzalez-Candelas, F; Ausina, V; Martro, E				Saludes, Veronica; Alma Bracho, Maria; Valero, Oliver; Ardevol, Merce; Planas, Ramon; Gonzalez-Candelas, Fernando; Ausina, Vicente; Martro, Elisa			Baseline Prediction of Combination Therapy Outcome in Hepatitis C Virus 1b Infected Patients by Discriminant Analysis Using Viral and Host Factors	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ANTIVIRAL THERAPY; PEGYLATED-INTERFERON; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2B; CORE PROTEIN; GENOTYPE 1B; ASSOCIATION; VARIABILITY; NONRESPONSE	Background: Current treatment of chronic hepatitis C virus (HCV) infection has limited efficacy -especially among genotype 1 infected patients-, is costly, and involves severe side effects. Thus, predicting non-response is of major interest for both patient wellbeing and health care expense. At present, treatment cannot be individualized on the basis of any baseline predictor of response. We aimed to identify pre-treatment clinical and virological parameters associated with treatment failure, as well as to assess whether therapy outcome could be predicted at baseline. Methodology: Forty-three HCV subtype 1b (HCV-1b) chronically infected patients treated with pegylated-interferon alpha plus ribavirin were retrospectively studied (21 responders and 22 non-responders). Host (gender, age, weight, transaminase levels, fibrosis stage, and source of infection) and viral-related factors (viral load, and genetic variability in the E1-E2 and Core regions) were assessed. Logistic regression and discriminant analyses were used to develop predictive models. A "leave-one-out" cross-validation method was used to assess the reliability of the discriminant models. Principal Findings: Lower alanine transaminase levels (ALT, p = 0.009), a higher number of quasispecies variants in the E1-E2 region (number of haplotypes, nHap_E1-E2) (p = 0.003), and the absence of both amino acid arginine at position 70 and leucine at position 91 in the Core region (p = 0.039) were significantly associated with treatment failure. Therapy outcome was most accurately predicted by discriminant analysis (90.5% sensitivity and 95.5% specificity, 85.7% sensitivity and 81.8% specificity after cross-validation); the most significant variables included in the predictive model were the Core amino acid pattern, the nHap_E1-E2, and gamma-glutamyl transferase and ALT levels. Conclusions and Significance: Discriminant analysis has been shown as a useful tool to predict treatment outcome using baseline HCV genetic variability and host characteristics. The discriminant models obtained in this study led to accurate predictions in our population of Spanish HCV-1b treatment naive patients.	[Saludes, Veronica; Ausina, Vicente; Martro, Elisa] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio Inst Invest Ciencies Salut Germans Trias, Microbiol Serv, Badalona, Spain; [Saludes, Veronica; Alma Bracho, Maria; Gonzalez-Candelas, Fernando; Martro, Elisa] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Alma Bracho, Maria; Gonzalez-Candelas, Fernando] Univ Valencia CSISP UV, Inst Cavanilles, Ctr Super Invest Salud Publ, Unidad Mixta Genom & Salud, Valencia, Spain; [Valero, Oliver] Univ Autonoma Barcelona, Stat Serv, Cerdanyola Del Valles, Spain; [Ardevol, Merce] Hosp Badalona Germans Trias & Pujol, Hosp Pharm, Badalona, Spain; [Planas, Ramon] Hosp Badalona Germans Trias & Pujol, Liver Unit, Badalona, Spain; [Planas, Ramon] CIBER Enfermedades Hepat & Digestivas CIBEREHD, Barcelona, Spain; [Ausina, Vicente] CIBER Enfermedades Resp CIBERES, Bunyola, Spain	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Valencia; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Saludes, V (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio Inst Invest Ciencies Salut Germans Trias, Microbiol Serv, Badalona, Spain.	emartro.igtp.germanstrias@gencat.cat	Martró, Elisa/K-9688-2015; Bracho, Maria/K-6018-2014; Candelas, Fernando Gonzalez/G-5681-2010; Saludes, Veronica/L-2059-2015	Martró, Elisa/0000-0002-2867-6649; Bracho, Maria/0000-0002-9204-5526; Candelas, Fernando Gonzalez/0000-0002-0879-5798; Saludes, Veronica/0000-0003-2139-3360; AUSINA, VICENTE/0000-0002-1798-9869; Valero, Oliver/0000-0003-0014-9916	"Instituto de Salud Carlos III - Fondo de Investigaciones Sanitarias" (ISCIII-FIS) [PI05/1131, CP09/00044]; "Ministerio de Ciencia e Innovacion" (MICINN) [CP09/00044, CD05/00258, CP07/00078, BFU2008-03000]; "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya i del Fons Social Europeu"; "Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica", Spain	"Instituto de Salud Carlos III - Fondo de Investigaciones Sanitarias" (ISCIII-FIS)(Instituto de Salud Carlos III); "Ministerio de Ciencia e Innovacion" (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya i del Fons Social Europeu"; "Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica", Spain	This study was funded by "Instituto de Salud Carlos III - Fondo de Investigaciones Sanitarias" (ISCIII-FIS) projects PI05/1131 (EM, RP, VA) and CP09/00044 (EM, MA, RP, VA, VS), grant numbers CD05/00258 ("Contratos Postdoctorales de Perfeccionamiento") and CP09/00044 ("Miguel Servet") from "Ministerio de Ciencia e Innovacion" (MICINN), within the "Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion Tecnologica (I+D+I)" (EM); and with support from "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya i del Fons Social Europeu" and "Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica", Spain (VS). This work was also partially supported by ISCIII-FIS projects CP07/00078 (MAB) and BFU2008-03000 (FG-C, MAB) from MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2004, J HEPATOL, V40, P831, DOI 10.1016/j.jhep.2004.01.019; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Bracho MA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-13; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Berg T, 2003, HEPATOLOGY, V37, P600, DOI 10.1053/jhep.2003.50106; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; CUEVAS JM, 2008, J VIRAL HEP IN PRESS; de Lucas S, 2005, J INFECT DIS, V191, P93, DOI 10.1086/426509; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HENZE N, 1990, COMMUN STAT THEORY, V19, P3595, DOI 10.1080/03610929008830400; Hofmann WP, 2003, J INFECT DIS, V187, P982, DOI 10.1086/368221; Hoofnagle JH, 2009, J INFECT DIS, V199, P1112, DOI 10.1086/597384; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Jimenez-Hernandez N, 2007, J GEN VIROL, V88, P123, DOI 10.1099/vir.0.82277-0; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kronenberger B, 2004, HEPATOLOGY, V40, P1442, DOI 10.1002/hep.20487; Lange CM, 2010, ALIMENT PHARM THER, V32, P14, DOI 10.1111/j.1365-2036.2010.04317.x; Le Guillou-Guillemette H, 2007, WORLD J GASTROENTERO, V13, P2416, DOI 10.3748/wjg.v13.i17.2416; Lopez-Labrador FX, 2006, J VIRAL HEPATITIS, V13, P104, DOI 10.1111/j.1365-2893.2005.00670.x; Lukasiewicz E, 2010, J VIRAL HEPATITIS, V17, P345, DOI 10.1111/j.1365-2893.2009.01183.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martinez-Bauer E, 2006, HEPATOLOGY, V43, P72, DOI 10.1002/hep.21002; Martro E, 2008, J CLIN MICROBIOL, V46, P192, DOI 10.1128/JCM.01623-07; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; MCLACHAN GJ, 1992, DISCRIMINANT ANAL ST; Morishima C, 2006, J INFECT DIS, V193, P931, DOI 10.1086/500952; Morrison D. F., 1967, MULTIVARIATE STAT ME; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raimondi S, 2009, J HEPATOL, V50, P1142, DOI 10.1016/j.jhep.2009.01.019; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Staden R, 2000, Methods Mol Biol, V132, P115; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Su XW, 2008, J HEPATOL, V49, P184, DOI 10.1016/j.jhep.2008.04.011; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Torres-Puente M, 2008, J VIRAL HEPATITIS, V15, P188, DOI 10.1111/j.1365-2893.2007.00929.x; Tsukada H, 2009, GASTROENTEROLOGY, V136, P1796, DOI 10.1053/j.gastro.2009.01.061; Ueda E, 2004, HEPATOL RES, V29, P89, DOI [10.1016/j.jhepres.2004.02.014, 10.1016/j.hepres.2004.02.014]; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674; *WHO, 2010, VIR CANC HEP G VIR; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; Yeh BI, 2002, J MED VIROL, V66, P481, DOI 10.1002/jmv.2169	57	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14132	10.1371/journal.pone.0014132	http://dx.doi.org/10.1371/journal.pone.0014132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152430	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100013
J	Alves, MMM; Osinga, J; Verheij, JBGM; Metzger, M; Eggen, BJL; Hofstra, RMW				Alves, Maria M. M.; Osinga, Jan; Verheij, Joke B. G. M.; Metzger, Marco; Eggen, Bart J. L.; Hofstra, Robert M. W.			Mutations in SCG10 Are Not Involved in Hirschsprung Disease	PLOS ONE			English	Article							RET; GENE; DYNAMICS; STATHMIN; GROWTH; CELL	Hirschsprung disease (HSCR) is a congenital malformation characterized by the absence of enteric neurons in the distal part of the colon. Several genes have been implicated in the development of this disease that together account for 20% of all cases, implying that other genes are involved. Since HSCR is frequently associated with other congenital malformations, the functional characterization of the proteins encoded by the genes involved in these syndromes can provide insights into the protein-network involved in HSCR development. Recently, we found that KBP, encoded by the gene involved in a HSCR-associated syndrome called Goldberg-Shprintzen syndrome, interacts with SCG10, a stathmin-like protein. To determine if SCG10 is involved in the etiology of HSCR, we determined SCG10 expression levels during development and screened 85 HSCR patients for SCG10 mutations. We showed that SCG10 expression increases during development but no germline mutation was found in any of these patients. In conclusion, this study shows that SCG10 is not directly implicated in HSCR development. However, an indirect involvement of SCG10 cannot be ruled out as this can be due to a secondary effect caused by its direct interactors.	[Alves, Maria M. M.; Osinga, Jan; Verheij, Joke B. G. M.; Hofstra, Robert M. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Metzger, Marco] Univ Leipzig, Translat Ctr Regenerat Med, Leipzig, Germany; [Eggen, Bart J. L.] Univ Groningen, Dept Neurosci, Sect Med Physiol, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; Leipzig University; University of Groningen	Alves, MMM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	r.m.w.hofstra@medgen.umcg.nl	Metzger, Marco/F-9706-2019; Alves, Maria/AAB-2054-2019	Hofstra, Robert/0000-0001-7498-3829	Graduate School of Medical Sciences (GUIDE); Jan Kornelis de Cock Stichting grant	Graduate School of Medical Sciences (GUIDE); Jan Kornelis de Cock Stichting grant	This work was supported by the Graduate School of Medical Sciences (GUIDE) and the Jan Kornelis de Cock Stichting grant to M.M.A.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MM, 2010, HUM MOL GENET, V19, P3642, DOI 10.1093/hmg/ddq280; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; BADNER JA, 1990, AM J HUM GENET, V46, P568; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hofstra RMW, 1999, AM J HUM GENET, V64, P304, DOI 10.1086/302184; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Manna T, 2007, BIOCHEMISTRY-US, V46, P3543, DOI 10.1021/bi061819d; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Sancandi M, 2000, J PEDIATR SURG, V35, P139, DOI 10.1016/S0022-3468(00)80094-9	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15144	10.1371/journal.pone.0015144	http://dx.doi.org/10.1371/journal.pone.0015144			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187955	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200015
J	Cieslak, M; Pruvost, M; Benecke, N; Hofreiter, M; Morales, A; Reissmann, M; Ludwig, A				Cieslak, Michael; Pruvost, Melanie; Benecke, Norbert; Hofreiter, Michael; Morales, Arturo; Reissmann, Monika; Ludwig, Arne			Origin and History of Mitochondrial DNA Lineages in Domestic Horses	PLOS ONE			English	Article							ANCIENT DNA; MULTIPLEX AMPLIFICATION; EXTRACTION; SEQUENCES	Domestic horses represent a genetic paradox: although they have the greatest number of maternal lineages (mtDNA) of all domestic species, their paternal lineages are extremely homogeneous on the Y-chromosome. In order to address their huge mtDNA variation and the origin and history of maternal lineages in domestic horses, we analyzed 1961 partial d-loop sequences from 207 ancient remains and 1754 modern horses. The sample set ranged from Alaska and North East Siberia to the Iberian Peninsula and from the Late Pleistocene to modern times. We found a panmictic Late Pleistocene horse population ranging from Alaska to the Pyrenees. Later, during the Early Holocene and the Copper Age, more or less separated sub-populations are indicated for the Eurasian steppe region and Iberia. Our data suggest multiple domestications and introgressions of females especially during the Iron Age. Although all Eurasian regions contributed to the genetic pedigree of modern breeds, most haplotypes had their roots in Eastern Europe and Siberia. We found 87 ancient haplotypes (Pleistocene to Mediaeval Times); 56 of these haplotypes were also observed in domestic horses, although thus far only 39 haplotypes have been confirmed to survive in modern breeds. Thus, at least seventeen haplotypes of early domestic horses have become extinct during the last 5,500 years. It is concluded that the large diversity of mtDNA lineages is not a product of animal breeding but, in fact, represents ancestral variability.	[Cieslak, Michael; Pruvost, Melanie; Ludwig, Arne] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Pruvost, Melanie; Benecke, Norbert] German Archaeol Inst, Berlin, Germany; [Hofreiter, Michael] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Hofreiter, Michael] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Morales, Arturo] Univ Autonoma Madrid, Lab Archaeozool, Madrid, Spain; [Reissmann, Monika] Humboldt Univ, Dept Breeding Biol & Mol Genet, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Max Planck Society; University of York - UK; Autonomous University of Madrid; Humboldt University of Berlin	Cieslak, M (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	melpruvost@googlemail.com; ludwig@izw-berlin.de	Muñiz, Arturo Morales/ABG-7980-2020; Hofreiter, Michael/A-3996-2017	Muñiz, Arturo Morales/0000-0002-9933-6836; Pruvost, Melanie/0000-0001-7824-2155; Hofreiter, Michael/0000-0003-0441-4705; Cieslak, Michael/0000-0002-6111-658X	Deutsche Forschungsgemeinschaft [LU852-7/2-3]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was funded by grants provided by the Deutsche Forschungsgemeinschaft (LU852-7/2-3) and by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; ANTHONY DW, 1986, CURR ANTHROPOL, V27, P291, DOI 10.1086/203441; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Giuffra E, 2000, GENETICS, V154, P1785; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lau AN, 2009, MOL BIOL EVOL, V26, P199, DOI 10.1093/molbev/msn239; LEI CZ, 2009, ANIMAL GENETICS, P933; Levine M., 1999, LATE PREHISTORIC EXP, P5; Levine MA, 2005, Domestic Horse: The Origins, Development and Management of Its Behaviour, P5; Ling YH, 2010, J HERED, V101, P639, DOI 10.1093/jhered/esq047; Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; MASHKOUR M, 2006, EQUIDS TIME SPACE OX; McGahern A, 2006, ANIM GENET, V37, P494, DOI 10.1111/j.1365-2052.2006.01495.x; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Pruvost M, 2008, PALAEOGEOGR PALAEOCL, V266, P211, DOI 10.1016/j.palaeo.2008.03.041; Rompler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Sambraus H H, 1986, Tierarztl Prax, V14, P297; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Wallner B, 2004, J HERED, V95, P158, DOI 10.1093/jhered/esh020; WARING GH, 2002, HORSE BEHABIOUR BEHA; XU X, 1994, GENE, V148, P657	29	109	119	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15311	10.1371/journal.pone.0015311	http://dx.doi.org/10.1371/journal.pone.0015311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187961	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200036
J	Knapp, GS; Hu, JC				Knapp, Gwendowlyn S.; Hu, James C.			Specificity of the E-coli LysR-Type Transcriptional Regulators	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FAMILY; PROTEINS; ACTIVATOR; DOMAINS; OXYR; DNA; OLIGOMERIZATION; DEGRADATION	Background: Families of paralogous oligomeric proteins are common in biology. How the specificity of assembly evolves is a fundamental question of biology. The LysR-Type Transcriptional Regulators (LTTR) form perhaps the largest family of transcriptional regulators in bacteria. Because genomes often encode many LTTR family members, it is assumed that many distinct homooligomers are formed simultaneously in the same cell without interfering with each other's activities, suggesting specificity in the interactions. However, this assumption has not been systematically tested. Methodology/ Principal Findings: A negative-dominant assay with lambda cI repressor fusions was used to evaluate the assembly of the LTTRs in E. coli K-12. Thioredoxin (Trx)-LTTR fusions were used to challenge the homooligomeric interactions of lambda cI-LTTR fusions. Eight cI-LTTR fusions were challenged with twenty-eight Trx fusions. LTTRs could be divided into three classes based on their interactions with other LTTRs. Conclusions/Significance: Multimerization of LTTRs in E. coli K-12 is mostly specific. However, under the conditions of the assay, many LTTRs interact with more than one noncognate partner. The physiological significance and physical basis for these interactions are not known.	[Knapp, Gwendowlyn S.; Hu, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station		jimhu@tamu.edu	Knapp, Gwendowlyn/ABG-5852-2020	Hu, James/0000-0001-9016-2684	NIH [R01 GM63652]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063652] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH award R01 GM63652 to J.C.H., which ended in 2005. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Clark T, 2004, ACTA CRYSTALLOGR D, V60, P105, DOI 10.1107/S0907444903021589; Collier LS, 1998, J BACTERIOL, V180, P2493, DOI 10.1128/JB.180.9.2493-2501.1998; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; HENIKOFF S, 1988, P NATL ACAD SCI USA, V85, P6602, DOI 10.1073/pnas.85.18.6602; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Knapp GS, 2009, PROTEIN SCI, V18, P2307, DOI 10.1002/pro.241; Knapp GS, 2009, PROTEIN SCI, V18, P101, DOI 10.1002/pro.5; Kovacikova G, 1999, J BACTERIOL, V181, P4250, DOI 10.1128/JB.181.14.4250-4256.1999; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Marino-Ramirez L, 2004, J BACTERIOL, V186, P1311, DOI 10.1128/JB.186.5.1311-1319.2004; Marino-Ramirez Leonardo, 2003, Methods Mol Biol, V205, P235; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; ROMEROARROYO CE, 1995, J BACTERIOL, V177, P5891, DOI 10.1128/jb.177.20.5891-5898.1995; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Smirnova IA, 2004, J MOL BIOL, V340, P405, DOI 10.1016/j.jmb.2004.04.071; Stec E, 2006, J MOL BIOL, V364, P309, DOI 10.1016/j.jmb.2006.06.033; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tyrrell R, 1997, STRUCTURE, V5, P1017, DOI 10.1016/S0969-2126(97)00254-2; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Xiao GP, 2006, MICROBIOL-SGM, V152, P1679, DOI 10.1099/mic.0.28605-0; ZAGURSKY RJ, 1984, GENE, V27, P183, DOI 10.1016/0378-1119(84)90139-2; Zeng X, 1997, P NATL ACAD SCI USA, V94, P3673, DOI 10.1073/pnas.94.8.3673	28	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15189	10.1371/journal.pone.0015189	http://dx.doi.org/10.1371/journal.pone.0015189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187915	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200020
J	Blackiston, D; Shomrat, T; Nicolas, CL; Granata, C; Levin, M				Blackiston, Douglas; Shomrat, Tal; Nicolas, Cindy L.; Granata, Christopher; Levin, Michael			A Second-Generation Device for Automated Training and Quantitative Behavior Analyses of Molecularly-Tractable Model Organisms	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; XENOPUS-LAEVIS TADPOLES; ABSTINENCE-INDUCED WITHDRAWAL; LEAD INHIBITS ACQUISITION; CENTRAL-NERVOUS-SYSTEM; LEFT-RIGHT ASYMMETRY; LARVAL ZEBRAFISH; CAENORHABDITIS-ELEGANS; NEURAL-NETWORK; C-ELEGANS	A deep understanding of cognitive processes requires functional, quantitative analyses of the steps leading from genetics and the development of nervous system structure to behavior. Molecularly-tractable model systems such as Xenopus laevis and planaria offer an unprecedented opportunity to dissect the mechanisms determining the complex structure of the brain and CNS. A standardized platform that facilitated quantitative analysis of behavior would make a significant impact on evolutionary ethology, neuropharmacology, and cognitive science. While some animal tracking systems exist, the available systems do not allow automated training (feedback to individual subjects in real time, which is necessary for operant conditioning assays). The lack of standardization in the field, and the numerous technical challenges that face the development of a versatile system with the necessary capabilities, comprise a significant barrier keeping molecular developmental biology labs from integrating behavior analysis endpoints into their pharmacological and genetic perturbations. Here we report the development of a second-generation system that is a highly flexible, powerful machine vision and environmental control platform. In order to enable multidisciplinary studies aimed at understanding the roles of genes in brain function and behavior, and aid other laboratories that do not have the facilities to undergo complex engineering development, we describe the device and the problems that it overcomes. We also present sample data using frog tadpoles and flatworms to illustrate its use. Having solved significant engineering challenges in its construction, the resulting design is a relatively inexpensive instrument of wide relevance for several fields, and will accelerate interdisciplinary discovery in pharmacology, neurobiology, regenerative medicine, and cognitive science.	[Blackiston, Douglas; Shomrat, Tal; Nicolas, Cindy L.; Levin, Michael] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Blackiston, Douglas; Shomrat, Tal; Nicolas, Cindy L.; Levin, Michael] Tufts Univ, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA; [Blackiston, Douglas] Forsyth Inst, Dept Regenerat & Dev Biol, Boston, MA USA; [Granata, Christopher] Boston Engn Corp, Waltham, MA USA	Tufts University; Tufts University; Harvard University; Forsyth Institute	Blackiston, D (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	michael.levin@tufts.edu	Levin, Michael/A-5918-2011	Levin, Michael/0000-0001-7292-8084; Blackiston, Douglas/0000-0001-7231-0196	National Institutes of Health [T32-DE-007327]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	D.B. was supported by National Institutes of Health T32-DE-007327; M.L. and T.S. were supported by the G. Harold and Leila Y. Mathers Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Imari L, 2008, BEHAV BRAIN RES, V189, P216, DOI 10.1016/j.bbr.2007.12.007; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; ARBIB MA, 1985, FED PROC, V44, P2956; ARBIB MA, 1967, J THEOR BIOL, V14, P131, DOI 10.1016/0022-5193(67)90110-5; Arbib Michael, 1985, SEARCH PERSON PHILOS; Baier H, 2000, CURR OPIN NEUROBIOL, V10, P451, DOI 10.1016/S0959-4388(00)00116-1; Bang PI, 2002, J NEUROSCI METH, V118, P177, DOI 10.1016/S0165-0270(02)00118-8; Barnett MW, 2001, MECH DEVELOP, V102, P157, DOI 10.1016/S0925-4773(01)00304-5; Bass SLS, 2008, BEHAV BRAIN RES, V186, P107, DOI 10.1016/j.bbr.2007.07.037; Bensing BA, 2001, INFECT IMMUN, V69, P1373, DOI 10.1128/IAI.69.3.1373-1380.2001; Berghmans S, 2007, EPILEPSY RES, V75, P18, DOI 10.1016/j.eplepsyres.2007.03.015; Bert B, 2008, BEHAV BRAIN RES, V195, P78, DOI 10.1016/j.bbr.2008.02.028; BEST J, 1963, PROTOPSYCHOLOGY; BEST JB, 1962, J COMP PHYSIOL PSYCH, V55, P560, DOI 10.1037/h0044394; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; BLOCK RA, 1967, NATURE, V215, P1465, DOI 10.1038/2151465a0; Boisvert MJ, 2000, PHYSIOL BEHAV, V71, P147, DOI 10.1016/S0031-9384(00)00317-6; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Bretaud S, 2007, NEUROSCIENCE, V146, P1109, DOI 10.1016/j.neuroscience.2006.12.073; Brightwell JJ, 2008, NEUROBIOL LEARN MEM, V89, P27, DOI 10.1016/j.nlm.2007.09.004; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; BROWN HM, 1968, J GEN PHYSIOL, V51, P255, DOI 10.1085/jgp.51.2.255; Cahill GM, 1998, NEUROREPORT, V9, P3445, DOI 10.1097/00001756-199810260-00020; Cahill Gregory M, 2007, Methods Mol Biol, V362, P83; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; CAVEMAN A, 2000, J CELL SCI, V113, P3543; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Chen ZL, 2003, GENE, V306, P127, DOI 10.1016/S0378-1119(03)00431-1; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Colaiacovo MP, 2002, GENETICS, V162, P113; COPP NH, 1984, J EXP ZOOL, V230, P219, DOI 10.1002/jez.1402300207; Corning W. C., 1970, MOL APPROACHES LEARN, P107; CORNING WC, 1968, NATURE, V219, P1227, DOI 10.1038/2191227a0; CORNING WC, 1964, J PSYCHOL, V58, P131, DOI 10.1080/00223980.1964.9916729; CORNING WC, 1961, SCIENCE, V134, P1363, DOI 10.1126/science.134.3487.1363; CORNWELL P, 1961, WORM RUNNERS DIGEST, V3, P91; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; CRAM EJ, 2003, J CELL SCI; Creton R, 2009, BEHAV BRAIN RES, V203, P127, DOI 10.1016/j.bbr.2009.04.030; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; Darland T, 2001, P NATL ACAD SCI USA, V98, P11691, DOI 10.1073/pnas.191380698; de la Cruz CC, 1999, DEV BIOL, V216, P595, DOI 10.1006/dbio.1999.9528; Delcourt J, 2006, BEHAV RES METHODS, V38, P704, DOI 10.3758/BF03193904; den Hertog J, 2005, BIOSCIENCE REP, V25, P289, DOI 10.1007/s10540-005-2891-8; Eisenstein EM, 1997, BEHAV BRAIN RES, V82, P121, DOI 10.1016/S0166-4328(97)80982-5; ELEPFANDT A, 1985, NATURWISSENSCHAFTEN, V72, P492, DOI 10.1007/BF00441080; Elepfandt A, 2000, J EXP BIOL, V203, P3621; ELEPFANDT A, 1986, J COMP PHYSIOL A, V158, P235, DOI 10.1007/BF01338566; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Ermakova GV, 1999, DEVELOPMENT, V126, P4513; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fernandes Y, 2009, ALCOHOL CLIN EXP RES, V33, P601, DOI 10.1111/j.1530-0277.2008.00874.x; Fernandez de Miguel F., 1989, Boletin de Estudios Medicos y Biologicos Universidad Nacional Autonoma de Mexico, V37, P71; Fetcho JR, 1998, ANN NY ACAD SCI, V860, P333, DOI 10.1111/j.1749-6632.1998.tb09060.x; Fukumoto T, 2005, CURR BIOL, V15, P794, DOI 10.1016/j.cub.2005.03.044; Fusaoka E, 2006, GENES CELLS, V11, P541, DOI 10.1111/j.1365-2443.2006.00962.x; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Giacomini NJ, 2006, NEUROTOXICOL TERATOL, V28, P245, DOI 10.1016/j.ntt.2006.01.013; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; Goldsmith P, 2001, NEUROREPORT, V12, pA73, DOI 10.1097/00001756-200109170-00001; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gonzalo A, 2007, ANIM BEHAV, V74, P447, DOI 10.1016/j.anbehav.2006.11.032; Goodnow RA, 2001, J CELL BIOCHEM, V84, P13, DOI 10.1002/jcb.10061; Granato M, 1996, DEVELOPMENT, V123, P399; HARTRY AL, 1964, SCIENCE, V146, P274, DOI 10.1126/science.146.3641.274; Hicks C, 2006, J NEUROBIOL, V66, P977, DOI 10.1002/neu.20290; HOFF K V, 1988, Society for Neuroscience Abstracts, V14, P692; HOFF KV, 1989, AM ZOOL, V29, pA43; HULSEY MG, 1991, PHYSIOL BEHAV, V50, P403, DOI 10.1016/0031-9384(91)90086-4; Humphries B., 1961, WORM RUNNERS DIGEST, V3; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; Jacobson A. L. A. M, 1962, CAROLINA TIPS, VXXV, P25; JACOBSON AL, 1967, J COMP PHYSIOL PSYCH, V64, P73, DOI 10.1037/h0024808; JACOBSON AL, 1966, NATURE, V209, P599, DOI 10.1038/209599a0; Jamieson D, 2000, J EXP BIOL, V203, P1857; JONES SM, 1994, J NEUROSCI, V14, P2789; Katayama T, 2001, BBA-GEN SUBJECTS, V1526, P183, DOI 10.1016/S0304-4165(01)00125-8; KATZ LC, 1981, ANIM BEHAV, V29, P20, DOI 10.1016/S0003-3472(81)80148-0; Key Brian, 2003, Methods in Cell Science, V25, P1; Koide K, 2001, J AM CHEM SOC, V123, P398, DOI 10.1021/ja0023377; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Koob GF, 2006, ADDICTION, V101, P23, DOI 10.1111/j.1360-0443.2006.01586.x; Kuriyama S, 2003, J EXP ZOOL PART A, V296A, P108, DOI 10.1002/jez.a.10247; Laurent MN, 1997, DEVELOPMENT, V124, P4905; LEE RM, 1963, SCIENCE, V139, P1048, DOI 10.1126/science.139.3559.1048; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; LUM AM, 1982, PHARMACOL BIOCHEM BE, V17, P363, DOI 10.1016/0091-3057(82)90093-4; MacNeil IA, 2001, J MOL MICROB BIOTECH, V3, P301; MacRae CA, 2002, COLD SPRING HARB SYM, V67, P301, DOI 10.1101/sqb.2002.67.301; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; MADRID JA, 1995, PHYSIOL BEHAV, V57, P129, DOI 10.1016/0031-9384(94)00214-P; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; Masse K, 2007, NATURE, V449, P1058, DOI 10.1038/nature06189; Mathis A, 2008, P ROY SOC B-BIOL SCI, V275, P2603, DOI 10.1098/rspb.2008.0754; MCCONNELL JV, 1960, AM J PSYCHOL, V73, P618, DOI 10.2307/1419955; MCCONNELL JV, 1965, WORM RUNNERS DIGEST; McElligott MB, 2005, BRAIN BEHAV EVOLUT, V66, P177, DOI 10.1159/000087158; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Miklosi A, 2001, BEHAV BRAIN RES, V122, P57, DOI 10.1016/S0166-4328(01)00167-X; Miklosi A, 1999, BEHAV BRAIN RES, V105, P199, DOI 10.1016/S0166-4328(99)00071-6; Miller G, 2006, SCIENCE, V314, P1674, DOI 10.1126/science.314.5806.1674; MILLER RR, 1977, J EXP PSYCHOL ANIM B, V3, P343, DOI 10.1037/0097-7403.3.4.343; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Moriya T, 1996, J EXP ZOOL, V276, P335, DOI 10.1002/(SICI)1097-010X(19961201)276:5<335::AID-JEZ4>3.0.CO;2-P; MURPHY J, 1963, WORM RUNNERS DIGEST, V5, P37; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Nascone N, 1997, DEV BIOL, V189, P68, DOI 10.1006/dbio.1997.8635; NEUMANN EK, 1992, BIOL CYBERN, V66, P485, DOI 10.1007/BF00204113; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nichols CD, 2006, PHARMACOL THERAPEUT, V112, P677, DOI 10.1016/j.pharmthera.2006.05.012; Nielsen DM, 2002, J NEUROSCI METH, V115, P199, DOI 10.1016/S0165-0270(02)00020-1; Ninkovic J, 2006, METHODS, V39, P262, DOI 10.1016/j.ymeth.2005.12.007; Nishimura K, 2007, DEV NEUROBIOL, V67, P1059, DOI 10.1002/dneu.20377; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Nuttall ME, 2001, CELLS TISSUES ORGANS, V169, P265, DOI 10.1159/000047890; Orii H, 2003, DEV GENES EVOL, V213, P138, DOI 10.1007/s00427-003-0310-3; Orii H, 1999, DEV BIOL, V210, P456, DOI 10.1006/dbio.1999.9275; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; Oviedo NJ, 2009, SEMIN CELL DEV BIOL, V20, P557, DOI 10.1016/j.semcdb.2009.04.005; Pagan OR, 2009, EUR J PHARMACOL, V615, P118, DOI 10.1016/j.ejphar.2009.05.022; PAN Y, BEHAV BRAIN RES; Parng C, 2005, CURR OPIN DRUG DISC, V8, P100; PARNG C, 2006, J PHARM TOXICOL METH; PARNG C, 2006, NEUROTOXICOL TERATOL; Patino MAL, 2008, PHYSIOL BEHAV, V95, P36, DOI 10.1016/j.physbeh.2008.03.021; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Prentice SD, 2001, J ELECTROMYOGR KINES, V11, P19, DOI 10.1016/S1050-6411(00)00038-9; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Pronych SP, 1996, J EXP BIOL, V199, P2689; Pulak Rock, 2006, V351, P275; PUNZO F, 1991, J HERPETOL, V25, P214, DOI 10.2307/1564653; PUNZO F, 1976, Journal of the Bombay Natural History Society, V73, P270; Rawashdeh O, 2007, SCIENCE, V318, P1144, DOI 10.1126/science.1148564; Rawls SA, 2008, EUR J PHARMACOL, V584, P278, DOI 10.1016/j.ejphar.2008.02.018; Rawls SM, 2008, SYNAPSE, V62, P927, DOI 10.1002/syn.20571; Rawls SM, 2008, NEUROPEPTIDES, V42, P229, DOI 10.1016/j.npep.2008.03.005; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Renier C, 2007, PHARMACOGENET GENOM, V17, P237, DOI 10.1097/FPC.0b013e3280119d62; Rick JM, 2000, CURR BIOL, V10, P595, DOI 10.1016/S0960-9822(00)00495-4; Rilling M, 1996, AM PSYCHOL, V51, P589, DOI 10.1037/0003-066X.51.6.589; ROBERTS A, 1978, NATURE, V273, P774, DOI 10.1038/273774a0; Roe K., 1963, WORM RUNNERS DIGEST, V5, P16; Rosenthal, 1976, EXPT EFFECTS BEHAV R; Rowlands AL, 2008, EUR J PHARMACOL, V583, P170, DOI 10.1016/j.ejphar.2008.01.012; Russo A, 2005, PHYTOMEDICINE, V12, P305, DOI 10.1016/j.phymed.2003.12.008; Sacavage S, 2008, NEUROSCI LETT, V439, P84, DOI 10.1016/j.neulet.2008.04.086; SADAUSKAS KK, 1982, ZH VYSSH NERV DEYAT+, V32, P1176; SANBERG PR, 1985, NEUROBEH TOXICOL TER, V7, P87; Sarnat H. B., 1985, CANADIAN J NEUROLOGI; SCHAEFFER DJ, 1993, ECOTOX ENVIRON SAFE, V25, P1, DOI 10.1006/eesa.1993.1001; Sison M, 2006, LAB ANIMAL, V35, P33, DOI 10.1038/laban0506-33; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Spence R, 2007, ETHOLOGY, V113, P62, DOI 10.1111/j.1439-0310.2006.01295.x; Stephen AG, 2002, BIOCHEM BIOPH RES CO, V296, P1228, DOI 10.1016/S0006-291X(02)02063-6; Stephen W. S., 1963, WORM RUNNERS DIGEST, V5, P40; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; STRICKLERSHAW S, 1991, NEUROTOXICOL TERATOL, V13, P167, DOI 10.1016/0892-0362(91)90007-J; STRICKLERSHAW S, 1990, ENVIRON TOXICOL CHEM, V9, P47, DOI 10.1002/etc.5620090107; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; THOMPSON R, 1955, J COMP PHYSIOL PSYCH, V48, P65, DOI 10.1037/h0041147; TIRAS KP, 1981, ZH VYSSH NERV DEYAT+, V31, P874; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; TORELLO MW, 1983, PHARMACOL BIOCHEM BE, V19, P13, DOI 10.1016/0091-3057(83)90303-9; Tosh CR, 2006, AM NAT, V168, pE38, DOI 10.1086/505769; Tseng ASK, 2002, GENETICS, V162, P229; Turnell ER, 2003, BIOL BULL-US, V205, P225, DOI 10.2307/1543265; UNGAR G, 1974, LIFE SCI, V14, P595, DOI 10.1016/0024-3205(74)90394-4; Uretsky ME, 1996, PSYCHOL REP, V79, P763, DOI 10.2466/pr0.1996.79.3.763; Valentinuzzi VS, 1998, LEARN MEMORY, V5, P391; van Swinderen B, 2010, J NEUROSCI, V30, P1003, DOI 10.1523/JNEUROSCI.4516-09.2010; Vandenberg LN, 2010, DEVELOPMENT, V137, P1095, DOI 10.1242/dev.041798; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Viczian AS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000174; WASSERSUG R, 1971, ANIM BEHAV, V19, P386, DOI 10.1016/S0003-3472(71)80021-0; WELLS PATRICK H., 1967, P251; WELLS PH, 1963, WORM RUNNERS DIGEST, V5, P58; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1; Zhu LQ, 2007, PHYSIOL BEHAV, V91, P106, DOI 10.1016/j.physbeh.2007.01.023; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	187	32	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14370	10.1371/journal.pone.0014370	http://dx.doi.org/10.1371/journal.pone.0014370			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179424	Green Submitted, Green Published, gold			2022-12-27	WOS:000285572900007
J	Saithong, T; Painter, KJ; Millar, AJ				Saithong, Treenut; Painter, Kevin J.; Millar, Andrew J.			Consistent Robustness Analysis (CRA) Identifies Biologically Relevant Properties of Regulatory Network Models	PLOS ONE			English	Article							CIRCADIAN CLOCK; POSTTRANSCRIPTIONAL REGULATION; ARABIDOPSIS-THALIANA; SENSITIVITY-ANALYSIS; MOLECULAR-BASES; RHYTHMS; TOC1; CYANOBACTERIA; TRANSCRIPTION; CYCLE	Background: A number of studies have previously demonstrated that "goodness of fit'' is insufficient in reliably classifying the credibility of a biological model. Robustness and/or sensitivity analysis is commonly employed as a secondary method for evaluating the suitability of a particular model. The results of such analyses invariably depend on the particular parameter set tested, yet many parameter values for biological models are uncertain. Results: Here, we propose a novel robustness analysis that aims to determine the "common robustness'' of the model with multiple, biologically plausible parameter sets, rather than the local robustness for a particular parameter set. Our method is applied to two published models of the Arabidopsis circadian clock (the one-loop [1] and two-loop [2] models). The results reinforce current findings suggesting the greater reliability of the two-loop model and pinpoint the crucial role of TOC1 in the circadian network. Conclusions: Consistent Robustness Analysis can indicate both the relative plausibility of different models and also the critical components and processes controlling each model.	[Saithong, Treenut; Millar, Andrew J.] Univ Edinburgh, Inst Mol Plant Sci, Dept Biol Sci, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.] Heriot Watt Univ, Dept Math, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.] Heriot Watt Univ, Sch Math & Comp Sci, Maxwell Inst Math Sci, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.; Millar, Andrew J.] Univ Edinburgh, Ctr Syst Biol Edinburgh, Edinburgh, Midlothian, Scotland; [Saithong, Treenut] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bangkok, Thailand	University of Edinburgh; Heriot Watt University; Heriot Watt University; University of Edinburgh; University of Edinburgh; King Mongkuts University of Technology Thonburi	Saithong, T (corresponding author), Univ Edinburgh, Inst Mol Plant Sci, Dept Biol Sci, Edinburgh, Midlothian, Scotland.	andrew.millar@ed.ac.uk	Millar, Andrew J/G-2423-2012; Painter, Kevin J/D-1055-2010; Saithong, Treenut/L-1395-2019	Millar, Andrew J/0000-0003-1756-3654; Painter, Kevin J/0000-0003-3273-6031; Saithong, Treenut/0000-0003-2888-6854	BBSRC [BB/D019621]; EPSRC [BB/D019621]; Royal Thai Government; BBSRC [BB/D019621/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Thai Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Centre for Systems Biology at Edinburgh is a Centre for Integrative Systems Biology supported by BBSRC and EPSRC through award BB/D019621. TS was supported by the postgraduate studentship from Higher Educational Strategic Scholarships for Frontier Research from the Royal Thai Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Bagheri N, 2007, BIOINFORMATICS, V23, P358, DOI 10.1093/bioinformatics/btl627; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BEERS KJ, 2006, NUMERICAL METHODS CH; Bell-Pedersen D, 2001, PHILOS T ROY SOC B, V356, P1697, DOI 10.1098/rstb.2001.0968; BORISUK MT, 1997, BIFURCATION ANAL MOD; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; BURNS JA, 1985, TRENDS BIOCHEM SCI, V10, P16, DOI 10.1016/0968-0004(85)90008-8; BURNS K, 1973, S SOC EXP BIOL, V27, P65; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Ding ZJ, 2007, GENETICS, V176, P1501, DOI 10.1534/genetics.107.072769; Doyle FJ, 2006, COMPUT CHEM ENG, V30, P1700, DOI 10.1016/j.compchemeng.2006.05.029; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Ferreira JS, 2006, LECT NOTES CONTR INF, V341, P279; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; Johnson CH, 1999, ANNU REV MICROBIOL, V53, P389, DOI 10.1146/annurev.micro.53.1.389; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kurata H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001103; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Lu J, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-11; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Millar AJ, 2004, J EXP BOT, V55, P277, DOI 10.1093/jxb/erh034; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Olivier BG, 2004, BIOINFORMATICS, V20, P2143, DOI 10.1093/bioinformatics/bth200; Poolman MG, 2000, J EXP BOT, V51, P319, DOI 10.1093/jexbot/51.suppl_1.319; Rand DA, 2004, J ROY SOC INTERFACE, V1, P119, DOI 10.1098/rsif.2004.0014; Roden LC, 2001, SEMIN CELL DEV BIOL, V12, P305, DOI 10.1006/scdb.2001.0258; SAITHONG T, 2004, THAI J BIOTECHNOLOGY, V5, P32; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Somers DE, 1998, DEVELOPMENT, V125, P485; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; TRANE C, 2008, ROBUSTNESS ANAL INTE; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Tyson JJ, 2007, NATURE, V445, P823, DOI 10.1038/445823a; Ueda HR, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100105; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226; Wolf J, 2005, SYSTEMS BIOL, V2, P35, DOI 10.1049/sb:20045035; Zak DE, 2005, COMPUT CHEM ENG, V29, P663, DOI 10.1016/j.compchemeng.2004.08.021; ZEILINGER NM, 2006, MOL SYST BIOL, P1	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15589	10.1371/journal.pone.0015589	http://dx.doi.org/10.1371/journal.pone.0015589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179566	Green Published, gold, Green Submitted			2022-12-27	WOS:000285381200033
J	Kolyada, A; Lee, CJ; De Biasio, A; Beglova, N				Kolyada, Alexey; Lee, Chang-Jin; De Biasio, Alfredo; Beglova, Natalia			A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome	PLOS ONE			English	Article							HUMAN BETA(2)-GLYCOPROTEIN I; PHOSPHOLIPID-BINDING; 5TH DOMAIN; LIPOPROTEIN RECEPTORS; LIGAND RECOGNITION; LOW-AFFINITY; ANTIBODIES; BETA-2-GLYCOPROTEIN-I; PLATELETS; AUTOANTIBODIES	Background: beta 2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an autoimmune disease characterized by thrombosis and recurrent pregnancy loss. Only the dimeric form of beta 2GPI generated by anti-beta 2GPI antibodies is pathologically important, in contrast to monomeric beta 2GPI which is abundant in plasma. Principal Findings: We created a dimeric inhibitor, A1-A1, to selectively target beta 2GPI in beta 2GPI/ antibody complexes. To make this inhibitor, we isolated the first ligand-binding module from ApoER2 (A1) and connected two A1 modules with a flexible linker. A1-A1 interferes with two pathologically important interactions in APS, the binding of beta 2GPI/ antibody complexes with anionic phospholipids and ApoER2. We compared the efficiency of A1-A1 to monomeric A1 for inhibition of the binding of beta 2GPI/ antibody complexes to anionic phospholipids. We tested the inhibition of beta 2GPI present in human serum, beta 2GPI purified from human plasma and the individual domain V of beta 2GPI. We demonstrated that when beta 2GPI/ antibody complexes are formed, A1-A1 is much more effective than A1 in inhibition of the binding of beta 2GPI to cardiolipin, regardless of the source of beta 2GPI. Similarly, A1-A1 strongly inhibits the binding of dimerized domain V of beta 2GPI to cardiolipin compared to the monomeric A1 inhibitor. In the absence of anti-beta 2GPI antibodies, both A1-A1 and A1 only weakly inhibit the binding of pathologically inactive monomeric beta 2GPI to cardiolipin. Conclusions: Our results suggest that the approach of using a dimeric inhibitor to block beta 2GPI in the pathological multivalent beta 2GPI/ antibody complexes holds significant promise. The novel inhibitor A1-A1 may be a starting point in the development of an effective therapeutic for antiphospholipid syndrome.	[Kolyada, Alexey] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kolyada, A (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	nbeglova@bidmc.harvard.edu		De Biasio, Alfredo/0000-0003-2139-2958	American Heart Association [0535027N]; American Society of Hematology; Offices of Biological and Environmental Research; Basic Energy Sciences of the US Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Society of Hematology; Offices of Biological and Environmental Research; Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was funded by the American Heart Association grant 0535027N and the American Society of Hematology Junior Faculty Scholar award to NB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Crystallographic data for this study were measured at beamline X29 of the National Synchrotron Light Source, which is supported principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources of the National Institutes of Health. Coordinates and structure factors have been deposited to the Protein Data Bank with accession number 3OP8.	Abdul-Aziz D, 2005, BIOCHEMISTRY-US, V44, P5075, DOI 10.1021/bi047575j; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Atsumi T, 2005, AUTOIMMUNITY, V38, P377, DOI 10.1080/08916930500124312; BANCSI LFJMM, 1992, THROMB HAEMOSTASIS, V67, P649; Beglov D, 2009, PROTEINS, V77, P940, DOI 10.1002/prot.22519; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; Cockrell E, 2008, LUPUS, V17, P943, DOI 10.1177/0961203308095329; Cugno M, 2010, J AUTOIMMUN, V34, P105, DOI 10.1016/j.jaut.2009.07.004; de Laat HB, 2004, BLOOD, V104, P3598, DOI 10.1182/blood-2004-03-1107; De Lano WL., 2002, THEPYMOL MOL GRAPHIC; DELAAT B, 2009, J THROMB HAEMOST; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J; George D, 2009, PROG CARDIOVASC DIS, V52, P115, DOI 10.1016/j.pcad.2009.06.005; Giannakopoulos B, 2009, BLOOD, V113, P985, DOI 10.1182/blood-2007-12-129627; Giles IP, 2003, ARTHRITIS RHEUM-US, V48, P2111, DOI 10.1002/art.11101; Guerin J, 1999, AUTOIMMUNITY, V31, P109, DOI 10.3109/08916939908994054; Hammel M, 2002, J MOL BIOL, V321, P85, DOI 10.1016/S0022-2836(02)00621-6; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; HUNT J, 1994, J IMMUNOL, V152, P653; Ioannou Y, 2009, J THROMB HAEMOST, V7, P833, DOI 10.1111/j.1538-7836.2009.03316.x; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Koike T, 2007, J AUTOIMMUN, V28, P129, DOI 10.1016/j.jaut.2007.02.009; Lee CJ, 2010, STRUCTURE, V18, P366, DOI 10.1016/j.str.2009.12.013; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lim W, 2006, JAMA-J AM MED ASSOC, V295, P1050, DOI 10.1001/jama.295.9.1050; Lin F, 2006, LUPUS, V15, P87, DOI 10.1191/0961203306lu2270oa; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Lutters BCH, 2003, J BIOL CHEM, V278, P33831, DOI 10.1074/jbc.M212655200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNall-Knapp Rene Y, 2008, Curr Rheumatol Rep, V10, P62, DOI 10.1007/s11926-008-0011-z; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120; Mehdi H, 2000, EUR J BIOCHEM, V267, P1770, DOI 10.1046/j.1432-1327.2000.01174.x; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Pennings MTT, 2007, J THROMB HAEMOST, V5, P1538, DOI 10.1111/j.1538-7836.2007.02605.x; Pennings MTT, 2007, J THROMB HAEMOST, V5, P369, DOI 10.1111/j.1538-7836.2007.02310.x; Pennings MTT, 2006, J THROMB HAEMOST, V4, P1680, DOI 10.1111/j.1538-7836.2006.02036.x; Pierangeli SS, 2007, ANN RHEUM DIS, V66, P1327, DOI 10.1136/ard.2006.065037; Pierangeli SS, 2004, THROMB RES, V114, P467, DOI 10.1016/j.thromres.2004.06.031; Rand JH, 2010, LUPUS, V19, P460, DOI 10.1177/0961203310361485; Raschi E, 2008, LUPUS, V17, P937, DOI 10.1177/0961203308095140; Romay-Penabad Z, 2009, BLOOD, V114, P3074, DOI 10.1182/blood-2008-11-188698; ROUBEY RAS, 1995, J IMMUNOL, V154, P954; Sanghera DK, 1997, HUM MOL GENET, V6, P311, DOI 10.1093/hmg/6.2.311; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Sheng YH, 1996, J IMMUNOL, V157, P3744; Sheng YH, 1998, J IMMUNOL, V161, P2038; Shi T, 2006, ARTHRITIS RHEUM-US, V54, P2558, DOI 10.1002/art.21968; Takeuchi R, 2000, BLOOD, V96, P1594, DOI 10.1182/blood.V96.4.1594.h8001594_1594_1595; Tincani A, 1996, J IMMUNOL, V157, P5732; Urbanus RT, 2008, BLOOD REV, V22, P93, DOI 10.1016/j.blre.2007.09.001; URBANUS RT, 2008, J THROMB HAEMOST; van Lummel M, 2005, J BIOL CHEM, V280, P36729, DOI 10.1074/jbc.M504172200; van Os GMA, 2010, HAMOSTASEOLOGIE, V30, P139, DOI 10.1055/s-0037-1619044; Willems GM, 1996, BIOCHEMISTRY-US, V35, P13833, DOI 10.1021/bi960657q; Yasuda S, 2000, ATHEROSCLEROSIS, V152, P337, DOI 10.1016/S0021-9150(99)00496-7	61	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15345	10.1371/journal.pone.0015345	http://dx.doi.org/10.1371/journal.pone.0015345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179511	Green Submitted, Green Published, gold			2022-12-27	WOS:000285340000022
J	Banjo, OC; Nadler, R; Reiner, PB				Banjo, Opeyemi C.; Nadler, Roland; Reiner, Peter B.			Physician Attitudes towards Pharmacological Cognitive Enhancement: Safety Concerns Are Paramount	PLOS ONE			English	Article								The ethical dimensions of pharmacological cognitive enhancement have been widely discussed in academic circles and the popular media, but missing from the conversation have been the perspectives of physicians - key decision makers in the adoption of new technologies into medical practice. We queried primary care physicians in major urban centers in Canada and the United States with the aim of understanding their attitudes towards cognitive enhancement. Our primary hypothesis was that physicians would be more comfortable prescribing cognitive enhancers to older patients than to young adults. Physicians were presented with a hypothetical pharmaceutical cognitive enhancer that had been approved by the regulatory authorities for use in healthy adults, and was characterized as being safe, effective, and without significant adverse side effects. Respondents overwhelmingly reported increasing comfort with prescribing cognitive enhancers as the patient age increased from 25 to 65. When asked about their comfort with prescribing extant drugs that might be considered enhancements (sildenafil, modafinil, and methylphenidate) or our hypothetical cognitive enhancer to a normal, healthy 40 year old, physicians were more comfortable prescribing sildenafil than any of the other three agents. When queried as to the reasons they answered as they did, the most prominent concerns physicians expressed were issues of safety that were not offset by the benefit afforded the individual, even in the face of explicit safety claims. Moreover, many physicians indicated that they viewed safety claims with considerable skepticism. It has become routine for safety to be raised and summarily dismissed as an issue in the debate over pharmacological cognitive enhancement; the observation that physicians were so skeptical in the face of explicit safety claims suggests that such a conclusion may be premature. Thus, physician attitudes suggest that greater weight be placed upon the balance between safety and benefit in consideration of pharmacological cognitive enhancement.	[Banjo, Opeyemi C.; Nadler, Roland; Reiner, Peter B.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Banjo, OC (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	peter.reiner@ubc.ca		Nadler, Roland/0000-0002-9504-7527	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) (http://www.cihr.ca/e/193.html). (F08-04061: Normality, normalization and enhancement in the neurosciences: ethical, sociocultural and neuropsychiatric aspects of cognitive enhancement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom LS, 2008, SCAND J PUBLIC HEALT, V36, P532, DOI 10.1177/1403494807087558; Bostrom N, 2005, BIOETHICS, V19, P202, DOI 10.1111/j.1467-8519.2005.00437.x; BOSTROM N, ENHANCING H IN PRESS; *BRIT MED ASS, 2007, BOOST YOUR BRAINP ET; BROOKS D, 2008, NY TIMES        0502; BUSCH C, 2010, CONTENT ANAL; Bush SS, 2006, APPL NEUROPSYCHOL, V13, P125, DOI 10.1207/s15324826an1302_7; Cakic V, 2009, J MED ETHICS, V35, P611, DOI 10.1136/jme.2009.030882; Caplan A, 2004, PLOS MED, V1, P172, DOI 10.1371/journal.pmed.0010052; CASCIO J, 2009, ATLANTIC, V304, P94; Chatterjee A, 2004, NEUROLOGY, V63, P968, DOI 10.1212/01.WNL.0000138438.88589.7C; CHATTERJEE A, 2007, CAMB Q HEALTHC ETHIC, V2, P129; Crook T, 1986, DEV NEUROPSYCHOL, V2, P261, DOI 10.1080/87565648609540348; Daniels N, 2000, CAMB Q HEALTHC ETHIC, V9, P309, DOI 10.1017/S0963180100903037; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Flower R, 2004, TRENDS PHARMACOL SCI, V25, P182, DOI 10.1016/j.tips.2004.02.006; FREELON D, 2010, RECAL SOFTWARE; Fukuyama Francis, 2002, OUR POSTHUMAN FUTURE; GARREAU J, 2006, WASHINGTON POST 0611; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hughes JJ, 2007, FUTURES, V39, P942, DOI 10.1016/j.futures.2007.03.002; HUNT E, 1995, AM SCI, V83, P356; HYMAN SE, 2006, BIOSOCIETIES, V1, P103; KOIVISTO K, 1995, NEUROLOGY, V45, P741, DOI 10.1212/WNL.45.4.741; Larrabee G J, 1994, Int Psychogeriatr, V6, P95, DOI 10.1017/S1041610294001663; Larriviere D, 2009, NEUROLOGY, V73, P1406, DOI 10.1212/WNL.0b013e3181beecfe; Metzl JM, 2007, LANCET, V369, P697, DOI 10.1016/S0140-6736(07)60317-1; PERSSON I, 2008, J APPL PHILOS, V3, P162; Pieters T, 2009, NEUROETHICS-NETH, V2, P63, DOI 10.1007/s12152-009-9033-0; POITRAS G, 2008, J BUS ETHICS, V3, P313; Racine E, 2009, J MED ETHICS, V35, P469, DOI 10.1136/jme.2009.030460; Ravelingien A, 2009, NEUROETHICS-NETH, V2, P151, DOI 10.1007/s12152-009-9042-z; Reiner Peter B, 2010, Virtual Mentor, V12, P885, DOI 10.1001/virtualmentor.2010.12.11.msoc1-1011; Rose SPR, 2002, NAT REV NEUROSCI, V3, P975, DOI 10.1038/nrn984; Sarewitz D., 2006, POLICY IMPLICATIONS; Savulescu J, 2006, ANN NY ACAD SCI, V1093, P321, DOI 10.1196/annals.1382.021; SCHNEIDER S, 2008, PENN CTR GUIDE BIOET, P95; Schulz K, 2006, NATION, V282, P11; Scripko PD, 2010, J MED ETHICS, V36, P293, DOI 10.1136/jme.2009.032383; Synofzik M, 2009, NEUROETHICS-NETH, V2, P89, DOI 10.1007/s12152-008-9029-1; The President's Council on Bioethics, 2003, THER BIOT PURS HAPP; Turner D.C., 2006, BIOSOCIETIES, V1, P113, DOI DOI 10.1017/S1745855205040044; Whitehouse PJ, 1997, HASTINGS CENT REP, V27, P14, DOI 10.2307/3528662; Wiesing U, 2008, INT LIBR ETH LAW TEC, V2, P9; YOUNG M, 2008, N 1, V7, P209	46	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14322	10.1371/journal.pone.0014322	http://dx.doi.org/10.1371/journal.pone.0014322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	694JH	21179461	Green Submitted, Green Published, gold			2022-12-27	WOS:000285292500006
J	Mroz, P; Szokalska, A; Wu, MX; Hamblin, MR				Mroz, Pawel; Szokalska, Angelika; Wu, Mei X.; Hamblin, Michael R.			Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response	PLOS ONE			English	Article							CYTOLYTIC T-LYMPHOCYTES; COMPLEMENT ACTIVATION; ANTITUMOR IMMUNITY; COLON-TUMOR; IFN-GAMMA; GENE; RECOMBINANT; CELLS; INDUCTION; MICE	Background: The mechanism by which the immune system can effectively recognize and destroy tumors is dependent on recognition of tumor antigens. The molecular identity of a number of these antigens has recently been identified and several immunotherapies have explored them as targets. Photodynamic therapy (PDT) is an anti-cancer modality that uses a non-toxic photosensitizer and visible light to produce cytotoxic reactive oxygen species that destroy tumors. PDT has been shown to lead to local destruction of tumors as well as to induction of anti-tumor immune response. Methodology/Principal Findings: We used a pair of equally lethal BALB/c colon adenocarcinomas, CT26 wild-type (CT26WT) and CT26.CL25 that expressed a tumor antigen, beta-galactosidase (beta-gal), and we treated them with vascular PDT. All mice bearing antigen-positive, but not antigen-negative tumors were cured and resistant to rechallenge. T lymphocytes isolated from cured mice were able to specifically lyse antigen positive cells and recognize the epitope derived from beta-galactosidase antigen. PDT was capable of destroying distant, untreated, established, antigen-expressing tumors in 70% of the mice. The remaining 30% escaped destruction due to loss of expression of tumor antigen. The PDT anti-tumor effects were completely abrogated in the absence of the adaptive immune response. Conclusion: Understanding the role of antigen-expression in PDT immune response may allow application of PDT in metastatic as well as localized disease. To the best of our knowledge, this is the first time that PDT has been shown to lead to systemic, antigen-specific anti-tumor immunity.	[Mroz, Pawel; Szokalska, Angelika; Wu, Mei X.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Mroz, Pawel; Wu, Mei X.; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Szokalska, Angelika] Med Univ Warsaw, Dept Immunol, Warsaw, Poland; [Wu, Mei X.; Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Medical University of Warsaw; Harvard University; Massachusetts Institute of Technology (MIT)	Mroz, P (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	hamblin@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022; Mroz, Pawel/P-1258-2019; Muchowicz, Angelika/J-7494-2012	Hamblin, Michael R/0000-0001-6431-4605; Muchowicz, Angelika/0000-0003-4707-1722; Mroz, Pawel/0000-0003-3838-4743	US NIH National Cancer Institute [RO1CA/AI838801, R01AI050875]; Genzyme-Partners Translational Research Grant; Foundation for Polish Science, International Union Against Cancer and European Structural Fund; NATIONAL CANCER INSTITUTE [R01CA083882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER	US NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genzyme-Partners Translational Research Grant; Foundation for Polish Science, International Union Against Cancer and European Structural Fund(Foundation for Polish Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by US NIH National Cancer Institute (grants RO1CA/AI838801 and R01AI050875 to MRH). P.M. was partly supported by Genzyme-Partners Translational Research Grant. A.S. was supported by the Foundation for Polish Science, International Union Against Cancer and European Structural Fund: "Mazowieckie Stypendium Doktoranckie." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER ABH, 1994, J EXP MED, V179, P1005, DOI 10.1084/jem.179.3.1005; Beatty GL, 2000, J IMMUNOL, V165, P5502, DOI 10.4049/jimmunol.165.10.5502; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Carroll MW, 1997, VACCINE, V15, P387, DOI 10.1016/S0264-410X(96)00195-8; Castano AP, 2008, P NATL ACAD SCI USA, V105, P5495, DOI 10.1073/pnas.0709256105; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Cecic I, 2006, PHOTOCHEM PHOTOBIOL, V82, P558, DOI 10.1562/2005-09-09-RA-681; Cecic I, 2006, J ENVIRON PATHOL TOX, V25, P189; Cecic I, 2005, CANCER LETT, V225, P215, DOI 10.1016/j.canlet.2004.11.059; Cecic I, 2002, CANCER LETT, V183, P43, DOI 10.1016/S0304-3835(02)00092-7; Cecic I, 2001, PHOTOCHEM PHOTOBIOL, V74, P712, DOI 10.1562/0031-8655(2001)074<0712:IOSNRI>2.0.CO;2; Cecic I, 2006, INT IMMUNOPHARMACOL, V6, P1259, DOI 10.1016/j.intimp.2006.03.008; Chen PW, 1996, J IMMUNOL, V156, P224; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; Disis ML, 2002, J CLIN ONCOL, V20, P2624, DOI 10.1200/JCO.2002.06.171; Donohue KB, 2006, IMMUNOLOGY, V119, P63, DOI 10.1111/j.1365-2567.2006.02406.x; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Dougherty TJ, 2002, J CLIN LASER MED SUR, V20, P3, DOI 10.1089/104454702753474931; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; GARRIDO F, CANC IMMUNOL IMMUNOT, V59, P1601; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Golgher D, 2002, EUR J IMMUNOL, V32, P3267, DOI 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1; Gollnick SO, 2006, LASER SURG MED, V38, P509, DOI 10.1002/lsm.20362; Gollnick SO, 2003, BRIT J CANCER, V88, P1772, DOI 10.1038/sj.bjc.6600864; Hance KW, 2009, CLIN CANCER RES, V15, P2387, DOI 10.1158/1078-0432.CCR-08-1752; Hirohashi Y, 2009, CANCER SCI, V100, P798, DOI 10.1111/j.1349-7006.2009.01137.x; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Huang Z, 2005, TECHNOL CANCER RES T, V4, P283, DOI 10.1177/153303460500400308; Irvine KR, 1996, J IMMUNOL, V156, P238; Jalili A, 2004, CLIN CANCER RES, V10, P4498, DOI 10.1158/1078-0432.CCR-04-0367; Kabingu E, 2009, CLIN CANCER RES, V15, P4460, DOI 10.1158/1078-0432.CCR-09-0400; Korbelik M, 2005, CANCER RES, V65, P1018; Korbelik M, 2007, BRIT J CANCER, V96, P67, DOI 10.1038/sj.bjc.6603508; Korbelik M, 1996, J Clin Laser Med Surg, V14, P329; Korbelik M, 2008, J PHOTOCH PHOTOBIO B, V93, P53, DOI 10.1016/j.jphotobiol.2008.04.005; Korbelik M, 2008, INT J CANCER, V122, P1411, DOI 10.1002/ijc.23248; Korbelik M, 2006, LASER SURG MED, V38, P500, DOI 10.1002/lsm.20337; KROSL G, 1995, BRIT J CANCER, V71, P549, DOI 10.1038/bjc.1995.108; Laheru D, 2005, NAT REV CANCER, V5, P459, DOI 10.1038/nrc1630; LETHE B, 1992, EUR J IMMUNOL, V22, P2283, DOI 10.1002/eji.1830220916; MANDELBOIM O, 1994, NATURE, V369, P67, DOI 10.1038/369067a0; Marshall JL, 2005, J CLIN ONCOL, V23, P720, DOI 10.1200/JCO.2005.10.206; McWilliams JA, 2008, VACCINE, V26, P1863, DOI 10.1016/j.vaccine.2008.01.052; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; Mroz P, 2007, PHOTOCH PHOTOBIO SCI, V6, P1139, DOI 10.1039/b711141j; MULE JJ, 1992, J IMMUNOL, V148, P2622; NASTALA CL, 1994, J IMMUNOL, V153, P1697; Paglia P, 1996, J EXP MED, V183, P317, DOI 10.1084/jem.183.1.317; Parkinson-Lawrence EJ, 2005, CELL IMMUNOL, V236, P161, DOI 10.1016/j.cellimm.2005.08.024; Quesnel B, 2008, APMIS, V116, P685, DOI 10.1111/j.1600-0463.2008.01163.x; Restifo NP, 2002, SEMIN CANCER BIOL, V12, P81, DOI 10.1006/scbi.2001.0399; Robbins PF, 1996, J EXP MED, V183, P1185, DOI 10.1084/jem.183.3.1185; Stewart TJ, 2008, ONCOGENE, V27, P5894, DOI 10.1038/onc.2008.268; Stott B, 2007, CANCER IMMUNOL IMMUN, V56, P649, DOI 10.1007/s00262-006-0221-z; Takeda J, 2000, CELL IMMUNOL, V204, P11, DOI 10.1006/cimm.2000.1691; TRAVERSARI C, 1992, J EXP MED, V176, P1453, DOI 10.1084/jem.176.5.1453; van der Bruggen P, 2006, CURR OPIN IMMUNOL, V18, P98, DOI 10.1016/j.coi.2005.11.013; VANDENEYNDE B, 1991, J EXP MED, V173, P1373, DOI 10.1084/jem.173.6.1373; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Wang M, 1995, J IMMUNOTHER, V18, P139, DOI 10.1097/00002371-199510000-00001	65	98	103	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15194	10.1371/journal.pone.0015194	http://dx.doi.org/10.1371/journal.pone.0015194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179470	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500016
J	Piazza, P; McMurtrey, CP; Lelic, A; Cook, RL; Hess, R; Yablonsky, E; Borowski, L; Loeb, MB; Bramson, JL; Hildebrand, WH; Rinaldo, CR				Piazza, Paolo; McMurtrey, Curtis P.; Lelic, Alina; Cook, Robert L.; Hess, Rachel; Yablonsky, Eric; Borowski, Luann; Loeb, Mark B.; Bramson, Jonathan L.; Hildebrand, William H.; Rinaldo, Charles R.			Surface Phenotype and Functionality of WNV Specific T Cells Differ with Age and Disease Severity	PLOS ONE			English	Article							WEST-NILE-VIRUS; INFECTION; RESPONSES; IDENTIFICATION; EPITOPES; HUMANS	West Nile virus (WNV) infection can result in severe neuroinvasive disease, particularly in persons with advanced age. As rodent models demonstrate that T cells play an important role in limiting WNV infection, and strong T cell responses to WNV have been observed in humans, we postulated that inadequate antiviral T cell immunity was involved in neurologic sequelae and the more severe outcomes associated with age. We previously reported the discovery of six HLA-A*0201 restricted WNV peptide epitopes, with the dominant T cell targets in naturally infected individuals being SVG9 (Env) and SLF9 (NS4b). Here, memory phenotype and polyfunctional CD8(+) T cell responses to these dominant epitopes were assessed in 40 WNV seropositive patients displaying diverse clinical symptoms. The patients' PBMC were stained with HLA-I multimers loaded with the SVG9 and SLF9 epitopes and analyzed by multicolor flow cytometry. WNV-specific CD8(+) T cells were found in peripheral blood several months post infection. The number of WNV-specific T cells in older individuals was the same, if not greater, than in younger members of the cohort. WNV-specific T cells were predominantly monofunctional for CD107a, MIP-1 beta, TNF alpha, IL-2, or IFN gamma. When CD8(+) T cell responses were stratified by disease severity, an increased number of terminally differentiated, memory phenotype (CD45RA(+) CD27(-) CCR7(-) CD57(+)) T cells were detected in patients suffering from viral neuroinvasion. In conclusion, T cells of a terminally differentiated/cytolytic profile are associated with neuroinvasion and, regardless of age, monofunctional T cells persist following infection. These data provide the first indication that particular CD8(+) T cell phenotypes are associated with disease outcome following WNV infection.	[Piazza, Paolo; Yablonsky, Eric; Borowski, Luann; Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [McMurtrey, Curtis P.; Hildebrand, William H.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Lelic, Alina; Loeb, Mark B.; Bramson, Jonathan L.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Cook, Robert L.] Univ Florida, Hlth Sci Ctr, Dept Epidemiol & Biostat, Gainesville, FL USA; [Hess, Rachel] Ctr Res Hlth Care, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; State University System of Florida; University of Florida	Piazza, P (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	William-hildebrand@ouhsc.edu		Bramson, Jonathan/0000-0003-2874-6886; Piazza, Paolo/0000-0002-2173-1342	National Institutes of Health [HHSN266200400027C, 1U01AI082057-01, N01-AI-40066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082057, N01AI040066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (www.nih.gov) Contract HHSN266200400027C (to W.H.H.), National Institutes of Health grant 1U01AI082057-01 (to W.H.H.) and in part by National Institutes of Health Contract N01-AI-40066 (to J.L.B. and M.B.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; APPLER KK, PLOS ONE, V5; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Deng YP, 2004, J IMMUNOL, V172, P3437, DOI 10.4049/jimmunol.172.6.3437; Hoffmann TK, 2000, CYTOMETRY, V41, P321, DOI 10.1002/1097-0320(20001201)41:4<321::AID-CYTO11>3.0.CO;2-9; Khan N, 2004, J IMMUNOL, V173, P7481, DOI 10.4049/jimmunol.173.12.7481; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Lecuroux C, 2009, BLOOD, V113, P3209, DOI 10.1182/blood-2008-07-167601; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Parsons R, 2008, J IMMUNOL, V181, P1563, DOI 10.4049/jimmunol.181.2.1563; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Sejvar JJ, 2007, CLIN INFECT DIS, V44, P1617, DOI 10.1086/518281; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Wang Y, 2006, J GEN VIROL, V87, P3599, DOI 10.1099/vir.0.81306-0	19	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15343	10.1371/journal.pone.0015343	http://dx.doi.org/10.1371/journal.pone.0015343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179445	Green Accepted, gold, Green Published			2022-12-27	WOS:000285246900044
J	Fabrini, R; Bocedi, A; Pallottini, V; Canuti, L; De Canio, M; Urbani, A; Marzano, V; Cornetta, T; Stano, P; Giovanetti, A; Stella, L; Canini, A; Federici, G; Ricci, G				Fabrini, Raffaele; Bocedi, Alessio; Pallottini, Valentina; Canuti, Lorena; De Canio, Michele; Urbani, Andrea; Marzano, Valeria; Cornetta, Tommaso; Stano, Pasquale; Giovanetti, Anna; Stella, Lorenzo; Canini, Antonella; Federici, Giorgio; Ricci, Giorgio			Nuclear Shield: A Multi-Enzyme Task-Force for Nucleus Protection	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; SUBCELLULAR-LOCALIZATION; PEROXIDASE ACTIVITY; OXIDATIVE STRESS; ENVELOPE; PROTEIN; EXPRESSION; ISOENZYMES; PRECURSOR; COMPLEX	Background: In eukaryotic cells the nuclear envelope isolates and protects DNA from molecules that could damage its structure or interfere with its processing. Moreover, selected protection enzymes and vitamins act as efficient guardians against toxic compounds both in the nucleoplasm and in the cytosol. The observation that a cytosolic detoxifying and antioxidant enzyme i.e. glutathione transferase is accumulated in the perinuclear region of the rat hepatocytes suggests that other unrecognized modalities of nuclear protection may exist. Here we show evidence for the existence of a safeguard enzyme machinery formed by an hyper-crowding of cationic enzymes and proteins encompassing the nuclear membrane and promoted by electrostatic interactions. Methodology/Principal Findings: Electron spectroscopic imaging, zeta potential measurements, isoelectrofocusing, comet assay and mass spectrometry have been used to characterize this surprising structure that is present in the cells of all rat tissues examined (liver, kidney, heart, lung and brain), and that behaves as a "nuclear shield''. In hepatocytes, this hyper-crowding structure is about 300 nm thick, it is mainly formed by cationic enzymes and the local concentration of key protection enzymes, such as glutathione transferase, catalase and glutathione peroxidase is up to seven times higher than in the cytosol. The catalytic activity of these enzymes, when packed in the shield, is not modified and their relative concentrations vary remarkably in different tissues. Removal of this protective shield renders chromosomes more sensitive to damage by oxidative stress. Specific nuclear proteins anchored to the outer nuclear envelope are likely involved in the shield formation and stabilization. Conclusions/Significance: The characterization of this previously unrecognized nuclear shield in different tissues opens a new interesting scenario for physiological and protection processes in eukaryotic cells. Selection and accumulation of protection enzymes near sensitive targets represents a new safeguard modality which deeply differs from the adaptive response which is based on expression of specific enzymes.	[Fabrini, Raffaele; Stella, Lorenzo; Ricci, Giorgio] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy; [Bocedi, Alessio; De Canio, Michele; Urbani, Andrea; Marzano, Valeria; Federici, Giorgio] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Pallottini, Valentina; Cornetta, Tommaso; Stano, Pasquale] Univ Roma Tre, Dept Biol, Rome, Italy; [Canuti, Lorena; Canini, Antonella] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Urbani, Andrea; Marzano, Valeria] S Lucia Res Inst IRCCS, Rome, Italy; [Giovanetti, Anna] ENEA CR, Inst Radiat Protect, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; Roma Tre University; University of Rome Tor Vergata; IRCCS Santa Lucia; Italian National Agency New Technical Energy & Sustainable Economics Development	Fabrini, R (corresponding author), Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy.	riccig@uniroma2.it	Stano, Pasquale/ABH-1195-2020; Stano, Pasquale/AGG-8333-2022; Pallottini, Valentina/AAA-3218-2021; Stella, Lorenzo/A-7996-2010; Urbani, Andrea/AAD-1675-2022; De Canio, Michele/AAY-2283-2021; Urbani, Andrea/B-2953-2012; Marzano, Valeria/K-5770-2016	Stano, Pasquale/0000-0002-2228-2825; Pallottini, Valentina/0000-0003-2511-6168; Stella, Lorenzo/0000-0002-5489-7381; De Canio, Michele/0000-0003-2552-7178; Marzano, Valeria/0000-0001-6364-2121; Canini, Antonella/0000-0003-1132-8899; Ricci, Giorgio/0000-0002-7108-2846	Italian Ministry of Education, University and Research	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This study has been supported by a grant from the Italian Ministry of Education, University and Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEI M, 1989, BIOCHIM BIOPHYS ACTA, V995, P279, DOI 10.1016/0167-4838(89)90047-2; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Basuroy S, 2006, AM J PHYSIOL-CELL PH, V291, pC897, DOI 10.1152/ajpcell.00032.2006; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bickmore WA, 2002, EMBO J, V21, P1248, DOI 10.1093/emboj/21.6.1248; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bulitta C, 1996, BBA-PROTEIN STRUCT M, V1293, P55, DOI 10.1016/0167-4838(95)00241-3; CANINI A, 1993, BOT ACTA, V106, P146, DOI 10.1111/j.1438-8677.1993.tb00351.x; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2; Cao C, 2003, J BIOL CHEM, V278, P29667, DOI 10.1074/jbc.M301292200; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; Delgado AV, 2005, PURE APPL CHEM, V77, P1753, DOI 10.1351/pac200577101753; Desaint S, 2004, J BIOL CHEM, V279, P31157, DOI 10.1074/jbc.M401888200; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; DICE JF, 1975, P NATL ACAD SCI USA, V72, P3893, DOI 10.1073/pnas.72.10.3893; Eggler AL, 2008, MOL NUTR FOOD RES, V52, pS84, DOI 10.1002/mnfr.200700249; FARRANTS AKO, 1987, BIOCHEM J, V245, P423, DOI 10.1042/bj2450423; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANKE WW, 1981, J CELL BIOL, V91, pS39, DOI 10.1083/jcb.91.3.39s; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; Horowitz GL, 2005, J AUTOM METHOD MANAG, P8, DOI 10.1155/JAMMC.2005.8; Hunter R.J., 1981, ZETA POTENTIAL COLLO; Hurst R, 1998, BIOCHEM J, V332, P97, DOI 10.1042/bj3320097; ISHIKAWA T, 1984, FEBS LETT, V169, P156, DOI 10.1016/0014-5793(84)80309-9; JOHNSON JA, 1993, J NEUROSCI, V13, P2013; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Lee SM, 2009, CELL DEATH DIFFER, V16, P738, DOI 10.1038/cdd.2009.5; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu WS, 2008, BBA-MOL CELL RES, V1783, P2415, DOI 10.1016/j.bbamcr.2008.09.001; Ma N, 2004, J NEUROCYTOL, V33, P407, DOI 10.1007/s11068-004-4206-6; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; PETERS R, 1984, EMBO J, V3, P1831, DOI 10.1002/j.1460-2075.1984.tb02055.x; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; REIMER L, 1975, ULTRAMICROSCOPY, V1, P1, DOI 10.1016/S0304-3991(75)80003-9; ROBERTSON IGC, 1985, BIOCHEM BIOPH RES CO, V127, P80, DOI 10.1016/S0006-291X(85)80128-5; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SOBOLL S, 1995, BIOCHEM J, V311, P889, DOI 10.1042/bj3110889; Stella L, 2007, J BIOL CHEM, V282, P6372, DOI 10.1074/jbc.M609906200; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Wendel A, 1981, Methods Enzymol, V77, P325; YEH HI, 1995, BIOCHEM J, V308, P69, DOI 10.1042/bj3080069; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	51	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14125	10.1371/journal.pone.0014125	http://dx.doi.org/10.1371/journal.pone.0014125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170318	Green Published, gold, Green Submitted			2022-12-27	WOS:000285181400001
J	Frietze, S; O'Geen, H; Blahnik, KR; Jin, VX; Farnham, PJ				Frietze, Seth; O'Geen, Henriette; Blahnik, Kimberly R.; Jin, Victor X.; Farnham, Peggy J.			ZNF274 Recruits the Histone Methyltransferase SETDB1 to the 3 ' Ends of ZNF Genes	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; TRANSCRIPTION FACTORS; DEVELOPMENTAL REGULATORS; METHYLATION STATES; DNA METHYLATION; H3; GENOME; IDENTIFICATION; REPRESSION; HETEROCHROMATIN	Only a small percentage of human transcription factors (e. g. those associated with a specific differentiation program) are expressed in a given cell type. Thus, cell fate is mainly determined by cell type-specific silencing of transcription factors that drive different cellular lineages. Several histone modifications have been associated with gene silencing, including H3K27me3 and H3K9me3. We have previously shown that genes for the two largest classes of mammalian transcription factors are marked by distinct histone modifications; homeobox genes are marked by H3K27me3 and zinc finger genes are marked by H3K9me3. Several histone methyltransferases (e. g. G9a and SETDB1) may be involved in mediating the H3K9me3 silencing mark. We have used ChIP-chip and ChIP-seq to demonstrate that SETDB1, but not G9a, is associated with regions of the genome enriched for H3K9me3. One current model is that SETDB1 is recruited to specific genomic locations via interaction with the corepressor TRIM28 (KAP1), which is in turn recruited to the genome via interaction with zinc finger transcription factors that contain a Kruppel-associated box (KRAB) domain. However, specific KRAB-ZNFs that recruit TRIM28 (KAP1) and SETDB1 to the genome have not been identified. We now show that ZNF274 (a KRAB-ZNF that contains 5 C2H2 zinc finger domains), can interact with KAP1 both in vivo and in vitro and, using ChIP-seq, we show that ZNF274 binding sites co-localize with SETDB1, KAP1, and H3K9me3 at the 3' ends of zinc finger genes. Knockdown of ZNF274 with siRNAs reduced the levels of KAP1 and SETDB1 recruitment to the binding sites. These studies provide the first identification of a KRAB domain-containing ZNF that is involved in recruitment of the KAP1 and SETDB1 to specific regions of the human genome.	[Frietze, Seth; O'Geen, Henriette; Blahnik, Kimberly R.; Farnham, Peggy J.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Frietze, Seth; O'Geen, Henriette; Blahnik, Kimberly R.; Farnham, Peggy J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University of California System; University of California Davis; University of California System; University of California Davis; University System of Ohio; Ohio State University	Frietze, S (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	pjfarnham@ucdavis.edu		Farnham, Peggy/0000-0003-4469-7914	Public Health Service [CA45250, 1U54HG004558]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded in part by Public Health Service grants CA45250 and 1U54HG004558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Engelkamp D, 1996, CURR OPIN GENET DEV, V6, P334, DOI 10.1016/S0959-437X(96)80011-6; Esteve PO, 2005, NUCLEIC ACIDS RES, V33, P3211, DOI 10.1093/nar/gki635; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frietze S, 2010, J BIOL CHEM, V285, P1393, DOI 10.1074/jbc.M109.063032; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hamilton AT, 2006, GENOME RES, V16, P584, DOI 10.1101/gr.4843906; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Jin VX, 2007, GENOME RES, V17, P807, DOI 10.1101/gr.6006107; Jin VX, 2009, BIOINFORMATICS, V25, P3191, DOI 10.1093/bioinformatics/btp570; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Komashko VM, 2008, GENOME RES, V18, P521, DOI 10.1101/gr.074609.107; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Oh HJ, 2006, MOL CELL ENDOCRINOL, V247, P47, DOI 10.1016/j.mce.2005.12.011; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WIENCKE JK, 2007, DIFFERENTIALLY EXPRE; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; Yano K, 2000, GENOMICS, V65, P75, DOI 10.1006/geno.2000.6140; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	59	107	113	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15082	10.1371/journal.pone.0015082	http://dx.doi.org/10.1371/journal.pone.0015082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170338	Green Submitted, gold, Green Published			2022-12-27	WOS:000285084100017
J	Jarvinen, TM; Hellquist, A; Koskenmies, S; Einarsdottir, E; Panelius, J; Hasan, T; Julkunen, H; Padyukov, L; Kvarnstrom, M; Wahren-Herlenius, M; Nyberg, F; D'Amato, M; Kere, J; Saarialho-Kere, U				Jarvinen, Tiina M.; Hellquist, Anna; Koskenmies, Sari; Einarsdottir, Elisabet; Panelius, Jaana; Hasan, Taina; Julkunen, Heikki; Padyukov, Leonid; Kvarnstrom, Marika; Wahren-Herlenius, Marie; Nyberg, Filippa; D'Amato, Mauro; Kere, Juha; Saarialho-Kere, Ulpu			Polymorphisms of the ITGAM Gene Confer Higher Risk of Discoid Cutaneous Than of Systemic Lupus Erythematosus	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FUNCTIONAL VARIANT; UP-REGULATION; ANTI-RO/SSA; HUMAN SKIN; INTEGRIN; DISEASE; CLASSIFICATION; SUSCEPTIBILITY; ASSOCIATION	Background: Lupus erythematosus (LE) is a heterogeneous disease ranging from mainly skin-restricted manifestations (discoid LE [DLE] and subacute cutaneous LE) to a progressive multisystem disease (systemic LE [SLE]). Genetic association studies have recently identified several strong susceptibility genes for SLE, including integrin alpha M (ITGAM), also known as CD11b, whereas the genetic background of DLE is less clear. Principal Findings: To specifically investigate whether ITGAM is a susceptibility gene not only for SLE, but also for cutaneous DLE, we genotyped 177 patients with DLE, 85 patients with sporadic SLE, 190 index cases from SLE families and 395 population control individuals from Finland for nine genetic markers at the ITGAM locus. SLE patients were further subdivided by the presence or absence of discoid rash and renal involvement. In addition, 235 Finnish and Swedish patients positive for Ro/SSA-autoantibodies were included in a subphenotype analysis. Analysis of the ITGAM coding variant rs1143679 showed highly significant association to DLE in patients without signs of systemic disease (P-value = 4.73x10(-11), OR = 3.20, 95% CI = 2.23-4.57). Significant association was also detected to SLE patients (P-value = 8.29x10(-6), OR = 2.14, 95% CI = 1.52-3.00), and even stronger association was found when stratifying SLE patients by presence of discoid rash (P-value = 3.59x10(-8), OR = 3.76, 95% CI = 2.29-6.18). Significance: We propose ITGAM as a novel susceptibility gene for cutaneous DLE. The risk effect is independent of systemic involvement and has an even stronger genetic influence on the risk of DLE than of SLE.	[Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana; Saarialho-Kere, Ulpu] Univ Helsinki, Inst Clin Med, Dept Dermatol, Helsinki, Finland; [Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana; Saarialho-Kere, Ulpu] Univ Helsinki, Inst Clin Med, Dept Allergol, Helsinki, Finland; [Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana; Saarialho-Kere, Ulpu] Univ Helsinki, Inst Clin Med, Dept Venereol, Helsinki, Finland; [Einarsdottir, Elisabet] Univ Helsinki, Biomedicum Helsinki, Res Programme Mol Med, Helsinki, Finland; [Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana; Saarialho-Kere, Ulpu] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Jarvinen, Tiina M.; Koskenmies, Sari; Einarsdottir, Elisabet; Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Jarvinen, Tiina M.; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Jarvinen, Tiina M.; Hellquist, Anna; D'Amato, Mauro; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Hasan, Taina] Univ Tampere, Dept Dermatol, FIN-33101 Tampere, Finland; [Hasan, Taina] Tampere Univ Hosp, Tampere, Finland; [Julkunen, Heikki] Univ Helsinki, Cent Hosp, Peijas Hosp, Vantaa, Finland; [Padyukov, Leonid; Kvarnstrom, Marika; Wahren-Herlenius, Marie] Karolinska Inst, Rheumatol Unit, Dept Med, Solna, Sweden; [Nyberg, Filippa] Uppsala Univ, Akad Univ Hosp, Dept Dermatol, Uppsala, Sweden; [Nyberg, Filippa] Danderyd Hosp, Karolinska Inst, Inst Clin Sci, Stockholm, Sweden; [Saarialho-Kere, Ulpu] Stockholm Soder Hosp, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Saarialho-Kere, Ulpu] Stockholm Soder Hosp, Karolinska Inst, Dermatol Sect, Stockholm, Sweden	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Karolinska Institutet; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Jarvinen, TM (corresponding author), Univ Helsinki, Inst Clin Med, Dept Dermatol, Helsinki, Finland.	juha.kere@ki.se	D'Amato, Mauro/B-5050-2019; Kere, Juha/AAX-9117-2021; D'Amato, Mauro/F-2450-2010; Einarsdottir, Elisabet/B-4912-2013; Wahren-Herlenius, Marie/AAN-6942-2021; Kere, Juha/A-9179-2008; Padyukov, Leonid/A-4890-2009	D'Amato, Mauro/0000-0003-2743-5197; Kere, Juha/0000-0003-1974-0271; D'Amato, Mauro/0000-0003-2743-5197; Wahren-Herlenius, Marie/0000-0002-0915-7245; Kere, Juha/0000-0003-1974-0271; Einarsdottir, Elisabet/0000-0003-3101-2285; Padyukov, Leonid/0000-0003-2950-5670; Kvarnstrom, Marika/0000-0002-4948-8380	Finska Lakaresallskapet; Academy of Finland; Sigrid Juselius Foundation; Helsinki University Central Hospital [TYH 2008248]; Helsinki Biomedical Graduate School LERU PhD Program in Biomedicine; Maire Lisko Foundation; Biomedicum Helsinki Foundation; Helsinki University; Tampere University Hospital, Finland; Edvard Welander Foundation; Finsen Foundation; Swedish Rheumatism Association; Swedish Foundation for Strategic Research; Stockholm County Council; Goran Gustafsson Foundation; Torsten and Ragnar Soderberg Foundation; Heart-Lung Foundation; King Gustaf V Foundation; Swedish Research Council	Finska Lakaresallskapet; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Central Hospital; Helsinki Biomedical Graduate School LERU PhD Program in Biomedicine; Maire Lisko Foundation; Biomedicum Helsinki Foundation; Helsinki University; Tampere University Hospital, Finland; Edvard Welander Foundation; Finsen Foundation; Swedish Rheumatism Association; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Stockholm County Council(Stockholm County Council); Goran Gustafsson Foundation; Torsten and Ragnar Soderberg Foundation; Heart-Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf V Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Finska Lakaresallskapet, Academy of Finland, Sigrid Juselius Foundation and Helsinki University Central Hospital Research Fund (project TYH 2008248), Helsinki Biomedical Graduate School LERU PhD Program in Biomedicine (TMJ), Maire Lisko Foundation (TMJ), Biomedicum Helsinki Foundation (TMJ), Helsinki University Funds (TMJ), Medical Research Fund of Tampere University Hospital (TH), Finland, Edvard Welander Foundation, Finsen Foundation, the Swedish Rheumatism Association (FN), the Swedish Foundation for Strategic Research, the Stockholm County Council, Goran Gustafsson Foundation, Torsten and Ragnar Soderberg Foundation, Heart-Lung Foundation, King Gustaf V Foundation, the Swedish Rheumatism Association (MWH), and the Swedish Research Council (MWH, USK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; GILLIAM JN, 1981, J AM ACAD DERMATOL, V4, P471, DOI 10.1016/S0190-9622(81)80261-7; Hammerberg C, 1998, J EXP MED, V187, P1133, DOI 10.1084/jem.187.7.1133; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jarvinen TM, 2010, EXP DERMATOL, V19, P123, DOI 10.1111/j.1600-0625.2009.00982.x; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kang KF, 1998, J INVEST DERMATOL, V111, P31, DOI 10.1046/j.1523-1747.1998.00121.x; Kim-Howard X, 2010, ANN RHEUM DIS, V69, P1329, DOI 10.1136/ard.2009.120543; Kolgen W, 1999, J INVEST DERMATOL, V113, P4, DOI 10.1046/j.1523-1747.1999.00625.x; Koskenmies S, 2008, LUPUS, V17, P337, DOI 10.1177/0961203307087403; Koskenmies S, 2001, J RHEUMATOL, V28, P758; Kuhn A, 2002, BRIT J DERMATOL, V146, P801, DOI 10.1046/j.1365-2133.2002.04693.x; Kuhn Annegret, 2005, Autoimmun Rev, V4, P66, DOI 10.1016/j.autrev.2004.09.005; Kuhn Annegret, 2008, V10, P119, DOI 10.1159/000131451; Lee HJ, 2006, AUTOIMMUNITY, V39, P433, DOI 10.1080/08916930600886851; Lin JH, 2007, CLIN REV ALLERG IMMU, V33, P85, DOI 10.1007/s12016-007-0031-x; Millard TP, 2001, BRIT J DERMATOL, V145, P229, DOI 10.1046/j.1365-2133.2001.04339.x; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Mosca M, 1999, CLIN EXP RHEUMATOL, V17, P615; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Oke V, 2009, J INVEST DERMATOL, V129, P2000, DOI 10.1038/jid.2008.453; Popovic K, 2007, LUPUS, V16, P10, DOI 10.1177/0961203306073135; Popovic K, 2008, ACTA DERM-VENEREOL, V88, P370, DOI 10.2340/00015555-0473; Popovic K, 2007, ARTHRITIS RHEUM, V56, P255, DOI 10.1002/art.22286; Rhodes B, 2008, RHEUMATOLOGY, V47, P1603, DOI 10.1093/rheumatology/ken247; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Suarez A, 2005, ANN RHEUM DIS, V64, P1605, DOI 10.1136/ard.2004.035048; Takahara M, 2003, J INVEST DERMATOL, V120, P802, DOI 10.1046/j.1523-1747.2003.12136.x; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tengner P, 1998, ARTHRITIS RHEUM-US, V41, P2238, DOI 10.1002/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V; Vera-Recabarren MA, 2010, CLIN EXP DERMATOL, V35, P729, DOI 10.1111/j.1365-2230.2009.03764.x; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Werth VP, 2007, BULL HOSP JT DIS, V65, P200; Werth VP, 2000, J INVEST DERMATOL, V115, P726, DOI 10.1046/j.1523-1747.2000.00118.x; Yang WL, 2009, HUM MOL GENET, V18, P2063, DOI 10.1093/hmg/ddp118; Yell JA, 1996, BRIT J DERMATOL, V135, P355, DOI 10.1046/j.1365-2133.1996.d01-1004.x	40	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14212	10.1371/journal.pone.0014212	http://dx.doi.org/10.1371/journal.pone.0014212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151989	Green Submitted, Green Published, gold			2022-12-27	WOS:000284868000021
J	Montgomery, CP; Boyle-Vavra, S; Daum, RS				Montgomery, Christopher P.; Boyle-Vavra, Susan; Daum, Robert S.			Importance of the Global Regulators Agr and SaeRS in the Pathogenesis of CA-MRSA USA300 Infection	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; INFLAMMATORY RESPONSES; GENE-EXPRESSION; IN-VITRO; VIRULENCE; SYSTEM; TRANSCRIPTION; SARA; SIGNAL	CA-MRSA infection, driven by the emergence of the USA300 genetic background, has become epidemic in the United States. USA300 isolates are hypervirulent, compared with other CA- and HA-MRSA strains, in experimental models of necrotizing pneumonia and skin infection. Interestingly, USA300 isolates also have increased expression of core genomic global regulatory and virulence factor genes, including agr and saeRS. To test the hypothesis that agr and saeRS promote the observed hypervirulent phenotype of USA300, isogenic deletion mutants of each were constructed in USA300. The effects of gene deletion on expression and protein abundance of selected downstream virulence genes were assessed by semiquantitative real-time reverse-transcriptase PCR (qRT-PCR) and western blot, respectively. The effects of gene deletion were also assessed in mouse models of necrotizing pneumonia and skin infection. Deletion of saeRS, and, to a lesser extent, agr, resulted in attenuated expression of the genes encoding a-hemolysin (hla) and the Panton-Valentine leukocidin (lukSF-PV). Despite the differences in hla transcription, the toxin was undetectable in culture supernatants of either of the deletion mutants. Deletion of agr, but not saeRS, markedly increased the expression of the gene encoding protein A (spa), which correlated with increased protein abundance. Each deletion mutant demonstrated significant attenuation of virulence, compared with wild-type USA300, in mouse models of necrotizing pneumonia and skin infection. We conclude that agr and saeRS each independently contribute to the remarkable virulence of USA300, likely by means of their effects on expression of secreted toxins.	[Montgomery, Christopher P.] Univ Chicago, Dept Pediat, Sect Crit Care, Chicago, IL 60637 USA; [Boyle-Vavra, Susan; Daum, Robert S.] Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Montgomery, CP (corresponding author), Univ Chicago, Dept Pediat, Sect Crit Care, Chicago, IL 60637 USA.	cmontgomery@bsd.uchicago.edu		Montgomery, Christopher/0000-0001-7247-0683	Pediatric Critical Care; National Institutes of Health (NIH) [AI076596-01A1, AI040481-08A1]; Grant Healthcare Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040481, R01AI040481, K08AI076596] Funding Source: NIH RePORTER	Pediatric Critical Care; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Healthcare Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Pediatric Critical Care Scientist Development Program and the National Institutes of Health (NIH) Grant AI076596-01A1 to C. P. M., and the Grant Healthcare Foundation and NIH Grant AI040481-08A1 to R. S. D. and S.B-V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; BALABAN N, 1995, FEMS MICROBIOL LETT, V133, P155, DOI 10.1016/0378-1097(95)00356-A; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Boyle-Vavra S, 2006, FEMS MICROBIOL LETT, V262, P163, DOI 10.1111/j.1574-6968.2006.00384.x; Bronner S, 2000, APPL ENVIRON MICROB, V66, P3931, DOI 10.1128/AEM.66.9.3931-3938.2000; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; FURTADO N, 2006, TOR 44 M INF DIS SOC; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Heyer G, 2002, INFECT IMMUN, V70, P127, DOI 10.1128/IAI.70.1.127-133.2002; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kornblum J., 1990, MOL BIOL STAPHYLOCOC; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lee MH, 2010, J INFECT DIS, V201, P508, DOI 10.1086/650204; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; MONTGOMERY CP, 2009, INFECT IMMUN; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Said-Salim B, 2005, J CLIN MICROBIOL, V43, P3373, DOI 10.1128/JCM.43.7.3373-3379.2005; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210	50	135	139	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15177	10.1371/journal.pone.0015177	http://dx.doi.org/10.1371/journal.pone.0015177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151999	gold, Green Published, Green Submitted			2022-12-27	WOS:000284868000030
J	Povarova, OI; Kuznetsova, IM; Turoverov, KK				Povarova, Olga I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.			Differences in the Pathways of Proteins Unfolding Induced by Urea and Guanidine Hydrochloride: Molten Globule State and Aggregates	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; ALPHA-LACTALBUMIN; ACTIN; INTERMEDIATE; FLUORESCENCE; STABILITY; BINDING	It was shown that at low concentrations guanidine hydrochloride (GdnHCl) can cause aggregation of proteins in partially folded state and that fluorescent dye 1-anilinonaphthalene-8-sulfonic acid (ANS) binds with these aggregates rather than with hydrophobic clusters on the surface of protein in molten globule state. That is why the increase in ANS fluorescence intensity is often recorded in the pathway of protein denaturation by GdnHCl, but not by urea. So what was previously believed to be the molten globule state in the pathway of protein denaturation by GdnHCl, in reality, for some proteins represents the aggregates of partially folded molecules.	[Povarova, Olga I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Povarova, OI (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	kkt@mail.cytspb.rssi.ru	Kuznetsova, Irina M./R-9844-2017; Povarova, Olga I/F-9060-2017; Turoverov, Konstantin/S-2079-2016	Kuznetsova, Irina M./0000-0002-3336-4834; Povarova, Olga/0000-0003-1568-7493; Turoverov, Konstantin/0000-0002-6977-1896	Russian Academy of Sciences	Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Program "Molecular and Cell Biology'' of the Russian Academy of Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANUFRIEVA EV, 1994, VYSOKOMOL SOEDIN, V36, P449; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Kuznetsova IM, 2002, BIOCHEMISTRY-US, V41, P13127, DOI 10.1021/bi026412x; Mason PE, 2004, J AM CHEM SOC, V126, P11462, DOI 10.1021/ja040034x; McDuff FO, 2004, BIOCHEM CELL BIOL, V82, P305, DOI 10.1139/o03-072; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; MULQUEEN PM, 1982, ARCH BIOCHEM BIOPHYS, V215, P28, DOI 10.1016/0003-9861(82)90275-2; Pace C N, 1986, Methods Enzymol, V131, P266; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Peters CD, 1997, BIOCHEM CELL BIOL, V75, P55, DOI 10.1139/bcb-75-1-55; Povarova OI, 2007, CELL BIOL INT, V31, P405, DOI 10.1016/j.cellbi.2007.01.025; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; REES MK, 1967, J BIOL CHEM, V242, P4449; RODIONOVA NA, 1989, MOL BIOL+, V23, P528; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Toldo LIG, 1997, COMPUT APPL BIOSCI, V13, P475; Turoverov K K, 1998, Tsitologiia, V40, P806; Turoverov KK, 2002, BIOCHEMISTRY-US, V41, P1014, DOI 10.1021/bi015548c; TUROVEROV KK, 1976, FEBS LETT, V62, P4, DOI 10.1016/0014-5793(76)80003-8	24	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15035	10.1371/journal.pone.0015035	http://dx.doi.org/10.1371/journal.pone.0015035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152408	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100052
J	Liu, ZQ; Han, J; Jia, LT; Maillet, JC; Bai, GA; Xu, L; Jia, ZP; Zheng, QH; Zhang, WD; Monette, R; Merali, Z; Zhu, Z; Wang, W; Ren, W; Zhang, X				Liu, Zhiqiang; Han, Jing; Jia, Lintao; Maillet, Jean-Christian; Bai, Guang; Xu, Lin; Jia, Zhengping; Zheng, Qiaohua; Zhang, Wandong; Monette, Robert; Merali, Zul; Zhu, Zhou; Wang, Wei; Ren, Wei; Zhang, Xia			Synaptic Neurotransmission Depression in Ventral Tegmental Dopamine Neurons and Cannabinoid-Associated Addictive Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTOR ENDOCYTOSIS; IN-VIVO; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; FEAR EXTINCTION; PLASTICITY; COCAINE; NMDA; AREA	Drug addiction is an association of compulsive drug use with long-term associative learning/memory. Multiple forms of learning/memory are primarily subserved by activity-or experience-dependent synaptic long-term potentiation (LTP) and long-term depression (LTD). Recent studies suggest LTP expression in locally activated glutamate synapses onto dopamine neurons (local Glu-DA synapses) of the midbrain ventral tegmental area (VTA) following a single or chronic exposure to many drugs of abuse, whereas a single exposure to cannabinoid did not significantly affect synaptic plasticity at these synapses. It is unknown whether chronic exposure of cannabis (marijuana or cannabinoids), the most commonly used illicit drug worldwide, induce LTP or LTD at these synapses. More importantly, whether such alterations in VTA synaptic plasticity causatively contribute to drug addictive behavior has not previously been addressed. Here we show in rats that chronic cannabinoid exposure activates VTA cannabinoid CB1 receptors to induce transient neurotransmission depression at VTA local Glu-DA synapses through activation of NMDA receptors and subsequent endocytosis of AMPA receptor GluR2 subunits. A GluR2-derived peptide blocks cannabinoid-induced VTA synaptic depression and conditioned place preference, i.e., learning to associate drug exposure with environmental cues. These data not only provide the first evidence, to our knowledge, that NMDA receptor-dependent synaptic depression at VTA dopamine circuitry requires GluR2 endocytosis, but also suggest an essential contribution of such synaptic depression to cannabinoid-associated addictive learning, in addition to pointing to novel pharmacological strategies for the treatment of cannabis addiction.	[Liu, Zhiqiang; Han, Jing; Ren, Wei; Zhang, Xia] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Liu, Zhiqiang; Han, Jing; Jia, Lintao; Maillet, Jean-Christian; Zheng, Qiaohua; Merali, Zul; Zhang, Xia] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada; [Liu, Zhiqiang; Han, Jing; Jia, Lintao; Maillet, Jean-Christian; Zheng, Qiaohua; Merali, Zul; Zhang, Xia] Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; [Liu, Zhiqiang; Han, Jing; Jia, Lintao; Maillet, Jean-Christian; Zheng, Qiaohua; Merali, Zul; Zhang, Xia] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Bai, Guang] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Program Neurosci, Baltimore, MD 21201 USA; [Xu, Lin] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Peoples R China; [Jia, Zhengping] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Zhang, Wandong; Monette, Robert] Natl Res Council Canada, Inst Biol Sci, Neurobiol Program, Ottawa, ON K1A 0R6, Canada; [Zhu, Zhou; Wang, Wei] Huazhong Univ Sci & Technol, Dept Neurol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Shaanxi Normal University; University of Ottawa; University of Ottawa; University of Ottawa; University System of Maryland; University of Maryland Baltimore; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Research Council Canada; Huazhong University of Science & Technology	Liu, ZQ (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China.	Xia.Zhang@rohcg.on.ca	Jia, zhengping/AAZ-4190-2021	Xu, Lin/0000-0002-2710-3507; Zhang, Wandong/0000-0001-6412-8124	Canadian Institutes of Health Research [MOP-62951]; National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA; Chinese Education Ministry	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA(NARSAD); Chinese Education Ministry(Ministry of Education, China)	This research was supported by a grant (MOP-62951) from Canadian Institutes of Health Research awarded to XZ who was a recipient of Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA, and Cheung Kong Scholar (Chang Jiang Scholar) from the Chinese Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Anwyl R, 2006, PROG NEUROBIOL, V78, P17, DOI 10.1016/j.pneurobio.2005.12.001; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bedingfield JS, 1995, BRIT J PHARMACOL, V116, P3323, DOI 10.1111/j.1476-5381.1995.tb15142.x; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Bonci A, 1999, J NEUROSCI, V19, P3723; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Cui SS, 2001, J NEUROSCI, V21, P9867, DOI 10.1523/JNEUROSCI.21-24-09867.2001; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; De Vries TJ, 2001, NAT MED, V7, P1151, DOI 10.1038/nm1001-1151; Elkashef A, 2008, SUBST ABUS, V29, P17, DOI 10.1080/08897070802218166; FARB CR, 1995, J COMP NEUROL, V362, P86, DOI 10.1002/cne.903620106; Fattore L, 1999, BEHAV BRAIN RES, V104, P141, DOI 10.1016/S0166-4328(99)00059-5; Good CH, 2010, J NEUROSCI, V30, P7900, DOI 10.1523/JNEUROSCI.1507-10.2010; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; Harris GC, 2004, NEUROSCIENCE, V129, P841, DOI 10.1016/j.neuroscience.2004.09.018; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hill MN, 2004, EUR J NEUROSCI, V20, P859, DOI 10.1111/j.1460-9568.2004.03522.x; Hill MN, 2004, EUR J PHARMACOL, V499, P291, DOI 10.1016/j.ejphar.2004.06.069; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Leonoudakis D, 2008, J NEUROSCI, V28, P2119, DOI 10.1523/JNEUROSCI.5159-07.2008; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lovinger David M., 2008, V184, P435; Lu J, 2003, NEUROSCIENCE, V121, P123, DOI 10.1016/S0306-4522(03)00421-4; Lupica CR, 2004, BRIT J PHARMACOL, V143, P227, DOI 10.1038/sj.bjp.0705931; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mao SC, 2009, MOL PHARMACOL, V76, P369, DOI 10.1124/mol.108.053728; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Mato S, 2005, J NEUROSCI, V25, P11619, DOI 10.1523/JNEUROSCI.2294-05.2005; McDonald AJ, 1996, NEUROSCI LETT, V208, P175, DOI 10.1016/0304-3940(96)12585-4; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nugent FS, 2008, NEUROPSYCHOPHARMACOL, V33, P1704, DOI 10.1038/sj.npp.1301561; Radley JJ, 2007, BRAIN RES, V1134, P87, DOI 10.1016/j.brainres.2006.11.045; Ro S, 2005, BIOTECHNIQUES, V38, P625, DOI 10.2144/05384RN01; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Vlachou S, 2003, BEHAV BRAIN RES, V141, P215, DOI 10.1016/S0166-4328(02)00370-4; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104	57	21	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15634	10.1371/journal.pone.0015634	http://dx.doi.org/10.1371/journal.pone.0015634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187978	Green Submitted, gold, Green Published			2022-12-27	WOS:000285575200052
J	Yang, CH; Chuang, LY; Shih, TM; Chang, HW				Yang, Cheng-Hong; Chuang, Li-Yeh; Shih, Tsung-Mu; Chang, Hsueh-Wei			hSAGEing: An Improved SAGE-Based Software for Identification of Human Tissue-Specific or Common Tumor Markers and Suppressors	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; SERIAL ANALYSIS; BREAST-CANCER; OVARIAN-CANCER; OVEREXPRESSION; SURVIVAL; TOOL; TRANSCRIPTS; CARCINOMA; CLUSTERIN	Background: SAGE (serial analysis of gene expression) is a powerful method of analyzing gene expression for the entire transcriptome. There are currently many well-developed SAGE tools. However, the cross-comparison of different tissues is seldom addressed, thus limiting the identification of common-and tissue-specific tumor markers. Methodology/Principal Findings: To improve the SAGE mining methods, we propose a novel function for cross-tissue comparison of SAGE data by combining the mathematical set theory and logic with a unique "multi-pool method" that analyzes multiple pools of pair-wise case controls individually. When all the settings are in "inclusion", the common SAGE tag sequences are mined. When one tissue type is in "inclusion" and the other types of tissues are not in "inclusion", the selected tissue-specific SAGE tag sequences are generated. They are displayed in tags-per-million (TPM) and fold values, as well as visually displayed in four kinds of scales in a color gradient pattern. In the fold visualization display, the top scores of the SAGE tag sequences are provided, along with cluster plots. A user-defined matrix file is designed for cross-tissue comparison by selecting libraries from publically available databases or user-defined libraries. Conclusions/Significance: The hSAGEing tool provides a combination of friendly cross-tissue analysis and an interface for comparing SAGE libraries for the first time. Some up-or down-regulated genes with tissue-specific or common tumor markers and suppressors are identified computationally. The tool is useful and convenient for in silico cancer transcriptomic studies and is freely available at http://bio.kuas.edu.tw/hSAGEing	[Yang, Cheng-Hong; Shih, Tsung-Mu] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Yang, Cheng-Hong] Toko Univ, Dept Network Syst, Chiayi, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; Kaohsiung Medical University; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Yang, CH (corresponding author), Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan.	chuang@isu.edu.tw; changhw@kmu.edu.tw	Chang, Hsueh-Wei/C-9654-2009; Yang, Cheng-Hong/K-2438-2019; Yang, Cheng-Hong/M-7984-2013; Chuang, Li-Yeh/E-5005-2011	Chang, Hsueh-Wei/0000-0003-0068-2366; Yang, Cheng-Hong/0000-0002-2741-0072; 	National Science Council in Taiwan [NSC97-2311-B-037-003-MY3, NSC97-2622-E-151-008-CC2, NSC96-2221-E-214-050-MY3, NSC96-2311-B037-002, NSC96-2622-E214-004-CC3, DOH99-TD-C-111-002, KMU-EM-98-1.4, KMU-EM-99-1.4]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work is partly supported by the National Science Council in Taiwan under grant NSC97-2311-B-037-003-MY3, NSC97-2622-E-151-008-CC2, NSC96-2221-E-214-050-MY3, NSC96-2311-B037-002, NSC96-2622-E214-004-CC3, the funds DOH99-TD-C-111-002, KMU-EM-98-1.4 and KMU-EM-99-1.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldinger I, 2005, PANCREATOLOGY, V5, P370, DOI 10.1159/000086537; Bala P, 2005, GENE, V364, P123, DOI 10.1016/j.gene.2005.05.044; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Buckhaults P, 2003, CANCER RES, V63, P4144; Divina P, 2004, NUCLEIC ACIDS RES, V32, pD482, DOI 10.1093/nar/gkh058; Emerson JW, 2009, CANCER INFORM, V7, P29; Felix RS, 2009, CANCER LETT, V278, P41, DOI 10.1016/j.canlet.2008.12.022; Galante PAF, 2007, BIOINFORMATICS, V23, P903, DOI 10.1093/bioinformatics/btm023; Kim YC, 2006, FEBS LETT, V580, P6721, DOI 10.1016/j.febslet.2006.11.013; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Lee S, 2005, RNA, V11, P939, DOI 10.1261/rna.7239605; Leyritz J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-378; Liang P, 2002, P NATL ACAD SCI USA, V99, P11547, DOI 10.1073/pnas.192436299; Lonergan KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009162; Luoh SW, 2004, ONCOGENE, V23, P1354, DOI 10.1038/sj.onc.1207251; Murray D, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-50; Nakayama K, 2006, P NATL ACAD SCI USA, V103, P18739, DOI 10.1073/pnas.0604083103; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; Prochasson P, 1999, EXP CELL RES, V248, P243, DOI 10.1006/excr.1999.4402; Robertson N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r6; STOLL RR, 1979, SET THEORY LOGIC; Tsukishiro S, 2005, GYNECOL ONCOL, V96, P516, DOI 10.1016/j.ygyno.2004.10.036; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wali A, 2005, LUNG CANCER, V48, P19, DOI 10.1016/j.lungcan.2004.10.011; Wang SM, 2007, TRENDS GENET, V23, P42, DOI 10.1016/j.tig.2006.11.001; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Xie D, 2005, CANCER-AM CANCER SOC, V103, P277, DOI 10.1002/cncr.20765; Yang CH, 2009, BIOINFORMATION, V3, P291, DOI 10.6026/97320630003291; Yang GFF, 2009, INT J GYNECOL CANCER, V19, P1342, DOI 10.1111/IGC.0b013e3181a83ed9; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; Ye SQ, 2002, CELL RES, V12, P105, DOI 10.1038/sj.cr.7290116; Ye SQ, 2002, J BIOMED SCI, V9, P384, DOI 10.1159/000064547	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14369	10.1371/journal.pone.0014369	http://dx.doi.org/10.1371/journal.pone.0014369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179408	gold, Green Published, Green Submitted			2022-12-27	WOS:000285572900006
J	Braun, A; Dofiles, L; Rousselle, S; Guerrero, L; Gunther, J; Yednock, T; Stricker-Krongrad, A; Messersmith, E				Braun, Anne; Dofiles, Lilibeth; Rousselle, Serge; Guerrero, Luis; Gunther, Jane; Yednock, Ted; Stricker-Krongrad, Alain; Messersmith, Elizabeth			Effects of an Alpha-4 Integrin Inhibitor on Restenosis in a New Porcine Model Combining Endothelial Denudation and Stent Placement	PLOS ONE			English	Article							DRUG-ELUTING STENTS; NEOINTIMAL HYPERPLASIA; BALLOON-INJURY; BARE-METAL; CORONARY-ARTERIES; HYPERSENSITIVITY; IMPLANTATION; TRANILAST; GROWTH	Restenosis remains the main complication of balloon angioplasty and/or stent implantation. Preclinical testing of new pharmacologic agents preventing restenosis largely rely on porcine models, where restenosis is assessed after endothelial abrasion of the arterial wall or stent implantation. We combined endothelial cell denudation and implantation of stents to develop a new clinically relevant porcine model of restenosis, and used this model to determine the effects of an alpha 4 integrin inhibitor, ELN 457946, on restenosis. Balloon-angioplasty endothelial cell denudation and subsequent implantation of bare metal stents in the left anterior descending coronary, iliac, and left common carotid arteries was performed in domestic pigs, treated with vehicle or ELN 457946, once weekly via subcutaneous injections, for four weeks. After 1 month, histopathology and morphometric analyses of the arteries showed complete healing and robust, consistent restenotic response in stented arteries. Treatment with ELN 457946 resulted in a reduction in the neointimal response, with decreases in area percent stenosis between 12% in coronary arteries and 30% in peripheral vessels. This is the first description of a successful pig model combining endothelial cell denudation and bare metal stent implantation. This new double injury model may prove particularly useful to assess pharmacological effects of drug candidates on restenosis, in coronary and/or peripheral arteries. Furthermore, the ELN 457946 alpha 4 integrin inhibitor, administered subcutaneously, reduced inflammation and restenosis in stented coronary and peripheral arteries in pigs, therefore representing a promising systemic therapeutic approach in reducing restenosis in patients undergoing angioplasty and/or stent implantation.	[Braun, Anne; Guerrero, Luis; Stricker-Krongrad, Alain] Preclin Serv Massachusetts, Charles River Labs, Shrewsbury, MA USA; [Dofiles, Lilibeth; Gunther, Jane; Yednock, Ted; Messersmith, Elizabeth] Elan Pharmaceut Inc, San Francisco, CA USA; [Rousselle, Serge] Alizee Pathol LLC, Thurmont, MD USA		Braun, A (corresponding author), Preclin Serv Massachusetts, Charles River Labs, Shrewsbury, MA USA.	bostonegles@yahoo.com			Elan Pharmaceuticals	Elan Pharmaceuticals	This work was funded by Elan Pharmaceuticals. Elan Pharmaceuticals had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Barringhaus KG, 2004, J VASC RES, V41, P252, DOI 10.1159/000078646; Brito L, 2007, INT J NANOMED, V2, P143; Burke SE, 1999, J CARDIOVASC PHARM, V33, P829, DOI 10.1097/00005344-199906000-00001; Busnelli M, 2009, ATHEROSCLEROSIS, V207, P384, DOI 10.1016/j.atherosclerosis.2009.05.022; Charles R, 2000, CIRC RES, V87, P282, DOI 10.1161/01.RES.87.4.282; Chen YD, 2006, CHINESE MED J-PEKING, V119, P360, DOI 10.1097/00029330-200603010-00002; Danenberg HD, 2003, CIRCULATION, V108, P2798, DOI 10.1161/01.CIR.0000097002.69209.CD; Danenberg HD, 2003, J CARDIOVASC PHARM, V42, P671, DOI 10.1097/00005344-200311000-00014; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; Fitzgerald PJ, 2001, CIRCULATION, V103, P1828; GRINSTEAD WC, 1994, CORONARY ARTERY DIS, V5, P425, DOI 10.1097/00019501-199405000-00009; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huo YQ, 2000, CIRC RES, V87, P153, DOI 10.1161/01.RES.87.2.153; Ishiwata S, 2000, J AM COLL CARDIOL, V35, P1331, DOI 10.1016/S0735-1097(00)00528-3; KLING D, 1995, CIRC RES, V77, P1121, DOI 10.1161/01.RES.77.6.1121; Labinaz M, 2000, CAN J CARDIOL, V16, P187; Lee CW, 2008, CATHETER CARDIO INTE, V71, P594, DOI 10.1002/ccd.21399; Levitzki A, 2005, CARDIOVASC RES, V65, P581, DOI 10.1016/j.cardiores.2004.08.008; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nakazawa G, 2007, AM J CARDIOL, V100, p36M, DOI 10.1016/j.amjcard.2007.08.020; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Perkins LEL, 2010, VET PATHOL, V47, P58, DOI 10.1177/0300985809352978; Rodriguez AE, 2009, EXPERT OPIN EMERG DR, V14, P561, DOI 10.1517/14728210903203808; Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974; Schwartz RS, 2004, J AM COLL CARDIOL, V44, P1373, DOI 10.1016/j.jacc.2004.04.060; Schwartz RS, 2002, CIRCULATION, V106, P1867, DOI 10.1161/01.CIR.0000033485.20594.6F; SCHWARTZ RS, 1994, ARTERIOSCLER THROMB, V14, P395, DOI 10.1161/01.ATV.14.3.395; Steinberg DH, 2009, AM J CARDIOL, V103, P491, DOI 10.1016/j.amjcard.2008.09.107; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Touchard AG, 2006, TOXICOL PATHOL, V34, P11, DOI 10.1080/01926230500499407; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Virmani R, 2003, HEART, V89, P133, DOI 10.1136/heart.89.2.133; Virmani R, 1999, CURR OPIN LIPIDOL, V10, P499, DOI 10.1097/00041433-199912000-00004; Ward MR, 2000, ATHEROSCLEROSIS, V151, P407, DOI 10.1016/S0021-9150(99)00407-4; Ward MR, 2002, ARTERIOSCL THROM VAS, V22, P940, DOI 10.1161/01.ATV.0000019405.84384.9C; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; WELT FGP, 1996, ARTERIOSCLER THROMB, V20, P2553	37	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14314	10.1371/journal.pone.0014314	http://dx.doi.org/10.1371/journal.pone.0014314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179441	gold, Green Published, Green Submitted			2022-12-27	WOS:000285246900019
J	Panneton, WM; Kumar, VB; Gan, Q; Burke, WJ; Galvin, JE				Panneton, W. Michael; Kumar, V. B.; Gan, Qi; Burke, William J.; Galvin, James E.			The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NIGRA PARS COMPACTA; INDUCED ROTATIONAL BEHAVIOR; TOXIC DOPAMINE METABOLITE; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; TYROSINE-HYDROXYLASE; GENE-EXPRESSION; 6-OHDA LESIONS; BASAL GANGLIA	Background: The etiology of Parkinson disease (PD) has yet to be fully elucidated. We examined the consequences of injections of 3,4-dihydroxyphenylacetaldehyde (DOPAL), a toxic metabolite of dopamine, into the substantia nigra of rats on motor behavior and neuronal survival. Methods/Principal Findings: A total of 800 nl/rat of DOPAL (1 mu g/200 nl) was injected stereotaxically into the substantia nigra over three sites while control animals received similar injections of phosphate buffered saline. Rotational behavior of these rats was analyzed, optical density of striatal tyrosine hydroxylase was calculated, and unbiased stereological counts of the substantia nigra were made. The rats showed significant rotational asymmetry ipsilateral to the lesion, supporting disruption of dopaminergic nigrostriatal projections. Such disruption was verified since the density of striatal tyrosine hydroxylase decreased significantly (p<0.001) on the side ipsilateral to the DOPAL injections when compared to the non-injected side. Stereological counts of neurons stained for Nissl in pars compacta of the substantia nigra significantly decreased (p<0.001) from control values, while counts of those in pars reticulata were unchanged after DOPAL injections. Counts of neurons immunostained for tyrosine hydroxylase also showed a significant (p=0.032) loss of dopaminergic neurons. In spite of significant loss of dopaminergic neurons, DOPAL injections did not induce significant glial reaction in the substantia nigra. Conclusions: The present study provides the first in vivo quantification of substantia nigra pars compacta neuronal loss after injection of the endogenous toxin DOPAL. The results demonstrate that injections of DOPAL selectively kills SN DA neurons, suggests loss of striatal DA terminals, spares non-dopaminergic neurons of the pars reticulata, and triggers a behavioral phenotype (rotational asymmetry) consistent with other PD animal models. This study supports the "catecholaldehyde hypothesis'' as an important link for the etiology of sporadic PD.	[Panneton, W. Michael; Gan, Qi] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Kumar, V. B.] St Louis Univ, Sch Med, Dept Geriatr, St Louis, MO USA; [Burke, William J.] St Louis Univ, Sch Med, Dept Neurol, St Louis, MO USA; [Galvin, James E.] NYU, Dept Neurol, Ctr Excellence Brain Aging, Langone Med Ctr, New York, NY 10016 USA; [Galvin, James E.] NYU, Dept Psychiat, Ctr Excellence Brain Aging, Langone Med Ctr, New York, NY 10016 USA	Saint Louis University; Saint Louis University; Saint Louis University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Panneton, WM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	pannetwm@slu.edu	Kumar, Vijaya/GSN-0719-2022; Galvin, James/AAM-7492-2021		Saint Louis University School of Medicine	Saint Louis University School of Medicine	This work was supported by Saint Louis University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; Blandini F, 2001, FUNCT NEUROL, V16, P99; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Blandini F, 2001, NEUROL SCI, V22, P49, DOI 10.1007/s100720170041; Blandini Fabio, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS124, DOI 10.1016/j.parkreldis.2008.04.015; BLASCHKO H, 1952, PHARMACOL REV, V4, P415; Burke WJ, 2008, ACTA NEUROPATHOL, V115, P193, DOI 10.1007/s00401-007-0303-9; Burke WJ, 1997, BRAIN RES, V760, P290, DOI 10.1016/S0006-8993(97)00447-2; BURKE WJ, 1988, BIOCHEM PHARMACOL, V37, P1391, DOI 10.1016/0006-2952(88)90799-X; Burke WJ, 1998, BRAIN RES, V787, P328, DOI 10.1016/S0006-8993(97)01488-1; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Burke WJ, 1999, ANAL BIOCHEM, V273, P111, DOI 10.1006/abio.1999.4196; CAHILL AL, 1981, J NEUROCHEM, V37, P1109, DOI 10.1111/j.1471-4159.1981.tb04660.x; CARMAN LS, 1991, BRAIN RES, V553, P275, DOI 10.1016/0006-8993(91)90835-J; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen JJ, 2006, AM J HEALTH-SYST PH, V63, P915, DOI 10.2146/ajhp050395; Emborg ME, 2004, J NEUROSCI METH, V139, P121, DOI 10.1016/j.jneumeth.2004.08.004; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Fahn S, 1997, CNS DRUGS, V8, P376, DOI 10.2165/00023210-199708050-00004; Fleming Sheila M, 2005, NeuroRx, V2, P495, DOI 10.1602/neurorx.2.3.495; Galter D, 2003, NEUROBIOL DIS, V14, P637, DOI 10.1016/j.nbd.2003.09.001; Galvin JE, 2006, ACTA NEUROPATHOL, V112, P115, DOI 10.1007/s00401-006-0096-2; GLICK SD, 1986, PHYSIOL BEHAV, V38, P67, DOI 10.1016/0031-9384(86)90133-2; Goldstein D, 2009, WORLD C PD REL UNPUB; Gonzalez D, 2006, ACTA MED OKAYAMA, V60, P319; Henderson JM, 2005, BEHAV BRAIN RES, V162, P222, DOI 10.1016/j.bbr.2005.03.017; Henderson JM, 2005, BEHAV BRAIN RES, V160, P267, DOI 10.1016/j.bbr.2004.12.008; Henderson JM, 2003, BEHAV BRAIN RES, V139, P105, DOI 10.1016/S0166-4328(02)00087-6; Konitsiotis S, 1998, BEHAV BRAIN RES, V92, P77, DOI 10.1016/S0166-4328(97)00127-7; Konitsiotis S, 2006, BEHAV BRAIN RES, V170, P337, DOI 10.1016/j.bbr.2006.02.030; Kristal BS, 2001, FREE RADICAL BIO MED, V30, P924, DOI 10.1016/S0891-5849(01)00484-1; Lamensdorf I, 2000, BRAIN RES, V868, P191, DOI 10.1016/S0006-8993(00)02309-X; Lamensdorf I, 2000, J NEUROSCI RES, V60, P552, DOI 10.1002/(SICI)1097-4547(20000515)60:4<552::AID-JNR14>3.0.CO;2-U; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Leshan RL, 2010, J NEUROSCI, V30, P5713, DOI 10.1523/JNEUROSCI.1001-10.2010; Li SW, 2001, MOL BRAIN RES, V93, P1, DOI 10.1016/S0169-328X(01)00120-6; Li SW, 1998, BIOORG CHEM, V26, P45, DOI 10.1006/bioo.1998.1087; Mandel S, 2005, ANN NY ACAD SCI, V1053, P356, DOI 10.1196/annals.1344.031; MATTAMMAL MB, 1993, J CHROMATOGR-BIOMED, V614, P205, DOI 10.1016/0378-4347(93)80310-Z; McCormack AL, 2006, NEUROSCIENCE, V141, P929, DOI 10.1016/j.neuroscience.2006.03.069; McPherson RJ, 2000, SYNAPSE, V36, P194, DOI 10.1002/(SICI)1098-2396(20000601)36:3<194::AID-SYN4>3.3.CO;2-4; MOKRY J, 1995, PHYSIOL RES, V44, P143; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Pioli EY, 2008, NEUROSCIENCE, V153, P1213, DOI 10.1016/j.neuroscience.2008.01.084; Pioli EY, 2004, BRAIN RES, V1022, P251, DOI 10.1016/j.brainres.2004.07.014; Plaitakis A, 2000, J NEUROL, V247, P25, DOI 10.1007/PL00007757; Rees JN, 2009, CHEM RES TOXICOL, V22, P1256, DOI 10.1021/tx9000557; Reichmann H, 2000, J NEUROL, V247, P63; Rodrigues RWP, 2001, INT J NEUROSCI, V109, P91, DOI 10.3109/00207450108986528; SAKAI K, 1994, BRAIN RES, V633, P144, DOI 10.1016/0006-8993(94)91533-4; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Thiel CM, 2001, NEUROPSYCHOBIOLOGY, V43, P192, DOI 10.1159/000054889; THOMAS J, 1994, EXP NEUROL, V126, P159, DOI 10.1006/exnr.1994.1054; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Weber M, 2004, NEUROSCI LETT, V358, P17, DOI 10.1016/j.neulet.2003.12.053; Werner CJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-8; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Willis G L, 1993, Int J Neurosci, V71, P135, DOI 10.3109/00207459309000599; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004	72	84	88	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15251	10.1371/journal.pone.0015251	http://dx.doi.org/10.1371/journal.pone.0015251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179455	Green Submitted, Green Published, gold			2022-12-27	WOS:000285246900038
J	Takikita, S; Schreiner, C; Baum, R; Xie, T; Ralston, E; Plotz, PH; Raben, N				Takikita, Shoichi; Schreiner, Cynthia; Baum, Rebecca; Xie, Tao; Ralston, Evelyn; Plotz, Paul H.; Raben, Nina			Fiber Type Conversion by PGC-1 alpha Activates Lysosomal and Autophagosomal Biogenesis in Both Unaffected and Pompe Skeletal Muscle	PLOS ONE			English	Article							ACID ALPHA-GLUCOSIDASE; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ENZYME REPLACEMENT THERAPY; ALGLUCOSIDASE ALPHA; GLYCOGEN AUTOPHAGY; PGC-1 COACTIVATORS; SIGNALING PATHWAYS; NATURAL COURSE; CELL-DEATH; DISEASE	PGC-1 alpha is a transcriptional co-activator that plays a central role in the regulation of energy metabolism. Our interest in this protein was driven by its ability to promote muscle remodeling. Conversion from fast glycolytic to slow oxidative fibers seemed a promising therapeutic approach in Pompe disease, a severe myopathy caused by deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA) which is responsible for the degradation of glycogen. The recently approved enzyme replacement therapy (ERT) has only a partial effect in skeletal muscle. In our Pompe mouse model (KO), the poor muscle response is seen in fast but not in slow muscle and is associated with massive accumulation of autophagic debris and ineffective autophagy. In an attempt to turn the therapy-resistant fibers into fibers amenable to therapy, we made transgenic KO mice expressing PGC-1 alpha in muscle (tgKO). The successful switch from fast to slow fibers prevented the formation of autophagic buildup in the converted fibers, but PGC-1 alpha failed to improve the clearance of glycogen by ERT. This outcome is likely explained by an unexpected dramatic increase in muscle glycogen load to levels much closer to those observed in patients, in particular infants, with the disease. We have also found a remarkable rise in the number of lysosomes and autophagosomes in the tgKO compared to the KO. These data point to the role of PGC-1 alpha in muscle glucose metabolism and its possible role as a master regulator for organelle biogenesis - not only for mitochondria but also for lysosomes and autophagosomes. These findings may have implications for therapy of lysosomal diseases and other disorders with altered autophagy.	[Takikita, Shoichi; Schreiner, Cynthia; Baum, Rebecca; Xie, Tao; Plotz, Paul H.; Raben, Nina] NIAMSD, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA; [Ralston, Evelyn] NIAMSD, Light Imaging Sect, Off Sci & Technol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Takikita, S (corresponding author), NIAMSD, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA.	rabenn@mail.nih.gov			National Institute of Arthritis and Musculoskeleta and Skin Diseases of the National Institutes of Health; NIH; Genzyme Corporation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041099, ZICAR041186, ZIAAR041132] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeleta and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Corporation(Sanofi-AventisGenzyme Corporation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. Dr. Takikita was supported in part by a Cooperative Research and Development Agreement (CRADA) between the NIH and Genzyme Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Douillard-Guilloux G, 2008, HUM MOL GENET, V17, P3876, DOI 10.1093/hmg/ddn290; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fukuda T, 2007, CURR NEUROL NEUROSCI, V7, P71, DOI 10.1007/s11910-007-0024-4; Fukuda T, 2006, MOL THER, V14, P831, DOI 10.1016/j.ymthe.2006.08.009; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hawes ML, 2007, MOL GENET METAB, V91, P343, DOI 10.1016/j.ymgme.2007.04.018; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hickson-Bick DLM, 2008, J MOL CELL CARDIOL, V44, P411, DOI 10.1016/j.yjmcc.2007.10.013; Hirschhorn R., 2000, METABOLIC MOL BASES, P3389; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Kondomerkos DJ, 2005, HISTOL HISTOPATHOL, V20, P689, DOI 10.14670/HH-20.689; Kotoulas OB, 2004, MICROSC RES TECHNIQ, V64, P10, DOI 10.1002/jemt.20046; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben N, 2010, AUTOPHAGY IN PRESS, V6; Raben N, 2010, MOL GENET M IN PRESS, V6; Raben N, 2007, AUTOPHAGY, V3, P546, DOI 10.4161/auto.4591; Raben N, 2009, METHOD ENZYMOL, V453, P417, DOI 10.1016/S0076-6879(08)04021-4; Raben N, 2009, AUTOPHAGY, V5, P111, DOI 10.4161/auto.5.1.7293; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; SCHIAFFINO S, 1972, J CELL BIOL, V52, P41, DOI 10.1083/jcb.52.1.41; Schiaffino S, 2008, AUTOPHAGY, V4; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Strothotte S, 2010, J NEUROL, V257, P91, DOI 10.1007/s00415-009-5275-3; TAMAKI H, 1994, J HISTOCHEM CYTOCHEM, V42, P1285, DOI 10.1177/42.9.8064136; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Winkel LPF, 2005, J NEUROL, V252, P875, DOI 10.1007/s00415-005-0922-9; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Zhou J, 2009, INT J BIOCHEM CELL B, V41, P2334, DOI 10.1016/j.biocel.2009.06.007; Zhu Y, 2005, BIOCH J	58	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15239	10.1371/journal.pone.0015239	http://dx.doi.org/10.1371/journal.pone.0015239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179212	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900035
J	Ruiz, S; Brennand, K; Panopoulos, AD; Herrerias, A; Gage, FH; Izpisua-Belmonte, JC				Ruiz, Sergio; Brennand, Kristen; Panopoulos, Athanasia D.; Herrerias, Aida; Gage, Fred H.; Carlos Izpisua-Belmonte, Juan			High-Efficient Generation of Induced Pluripotent Stem Cells from Human Astrocytes	PLOS ONE			English	Article							INDUCTION; MOUSE; FIBROBLASTS; LINKING	The reprogramming of human somatic cells to induced pluripotent stem (hiPS) cells enables the possibility of generating patient-specific autologous cells for regenerative medicine. A number of human somatic cell types have been reported to generate hiPS cells, including fibroblasts, keratinocytes and peripheral blood cells, with variable reprogramming efficiencies and kinetics. Here, we show that human astrocytes can also be reprogrammed into hiPS (ASThiPS) cells, with similar efficiencies to keratinocytes, which are currently reported to have one of the highest somatic reprogramming efficiencies. ASThiPS lines were indistinguishable from human embryonic stem (ES) cells based on the expression of pluripotent markers and the ability to differentiate into the three embryonic germ layers in vitro by embryoid body generation and in vivo by teratoma formation after injection into immunodeficient mice. Our data demonstrates that a human differentiated neural cell type can be reprogrammed to pluripotency and is consistent with the universality of the somatic reprogramming procedure.	[Ruiz, Sergio; Panopoulos, Athanasia D.; Carlos Izpisua-Belmonte, Juan] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Brennand, Kristen; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Herrerias, Aida; Carlos Izpisua-Belmonte, Juan] Ctr Regenerat Med Barcelona, Barcelona, Spain	Salk Institute; Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Ruiz, S (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Brennand, Kristen J/U-5470-2019; Brennand, Kristen J/J-8704-2012; Ruiz, Sergio/G-1561-2016	Brennand, Kristen J/0000-0003-0993-5956; Ruiz, Sergio/0000-0002-0177-6965; Panopoulos, Athanasia/0000-0002-9610-2604	Lookout Fund; G. Harold and Leila Y. Mathers Charitable Foundation; CIRM [RL1-00649, RC1-00115-1]; Ministerio de Ciencia e Innovacion (MICINN); Sanofi-Aventis; Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER); Fundacion Cellex	Lookout Fund; G. Harold and Leila Y. Mathers Charitable Foundation; CIRM(California Institute for Regenerative Medicine); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Sanofi-Aventis(Sanofi-Aventis); Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER); Fundacion Cellex(Foundation CELLEX)	Work in this manuscript was supported by the Lookout Fund, the G. Harold and Leila Y. Mathers Charitable Foundation, CIRM RL1-00649 and RC1-00115-1 (F. H. G.) and Ministerio de Ciencia e Innovacion (MICINN), Sanofi-Aventis, Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER), Fundacion Cellex and the G. Harold and Leila Y. Mathers Charitable Foundation (J.C.I.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; CHO HJ, 2010, BLOOD           0503; DENOULET P, 1986, GENE, V50, P289, DOI 10.1016/0378-1119(86)90333-1; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Lagarkova MA, 2010, CELL CYCLE, V9, P937, DOI 10.4161/cc.9.5.10869; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu H, 2010, HEPATOLOGY, V51, P1810, DOI 10.1002/hep.23626; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; PAPANDRIKOPOULOU A, 1989, NATURE, V340, P650, DOI 10.1038/340650a0; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PATEL M, 2010, STEM CELL REV   0325; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	34	55	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15526	10.1371/journal.pone.0015526	http://dx.doi.org/10.1371/journal.pone.0015526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21170306	gold, Green Published			2022-12-27	WOS:000285135800028
J	Faux, MC; Coates, JL; Kershaw, NJ; Layton, MJ; Burgess, AW				Faux, Maree C.; Coates, Janine L.; Kershaw, Nadia J.; Layton, Meredith J.; Burgess, Antony W.			Independent Interactions of Phosphorylated beta-Catenin with E-Cadherin at Cell-Cell Contacts and APC at Cell Protrusions	PLOS ONE			English	Article							ADENOMATOUS-POLYPOSIS-COLI; WNT SIGNALING PATHWAY; TRCP-UBIQUITIN LIGASE; F-BOX PROTEIN; TYROSINE PHOSPHORYLATION; MICROTUBULE STABILITY; MOLECULAR SWITCH; EPITHELIAL-CELLS; ADHESION; CANCER	Background: The APC tumour suppressor functions in several cellular processes including the regulation of beta-catenin in Wnt signalling and in cell adhesion and migration. Findings: In this study, we establish that in epithelial cells N-terminally phosphorylated beta-catenin specifically localises to several subcellular sites including cell-cell contacts and the ends of cell protrusions. N-terminally phosphorylated beta-catenin associates with E-cadherin at adherens junctions and with APC in cell protrusions. We isolated APC-rich protrusions from stimulated cells and detected beta-catenin, GSK3 beta and CK1 alpha, but not axin. The APC/phospho-beta-catenin complex in cell protrusions appears to be distinct from the APC/axin/beta-catenin destruction complex. GSK3b phosphorylates the APC-associated population of beta-catenin, but not the cell junction population. beta-catenin associated with APC is rapidly phosphorylated and dephosphorylated. HGF and wound-induced cell migration promote the localised accumulation of APC and phosphorylated beta-catenin at the leading edge of migrating cells. APC siRNA and analysis of colon cancer cell lines show that functional APC is required for localised phospho-beta-catenin accumulation in cell protrusions. Conclusions: We conclude that N-terminal phosphorylation of beta-catenin does not necessarily lead to its degradation but instead marks distinct functions, such as cell migration and/or adhesion processes. Localised regulation of APC-phospho-beta-catenin complexes may contribute to the tumour suppressor activity of APC.	[Faux, Maree C.; Coates, Janine L.; Burgess, Antony W.] Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; [Kershaw, Nadia J.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Layton, Meredith J.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Ludwig Institute for Cancer Research; Walter & Eliza Hall Institute; Monash University	Faux, MC (corresponding author), Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia.	Maree.faux@ludwig.edu.au	Kershaw, Nadia/G-5770-2014	Kershaw, Nadia/0000-0002-3554-2622	National Health and Medical Research Council of Australia [487922]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	MCF and AWB are supported by the National Health and Medical Research Council of Australia Program Grant 487922. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COTTRELL S, 1992, LANCET, V340, P626, DOI 10.1016/0140-6736(92)92169-G; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Faux MC, 2008, ONCOGENE, V27, P5808, DOI 10.1038/onc.2008.205; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Fodde R, 2003, NAT CELL BIOL, V5, P190, DOI 10.1038/ncb0303-190; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; HADJIHANNAS MV, EMBO REP, V11, P317; HARRIS ES, MOL BIOL CELL; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Maher MT, PLOS ONE, V5; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; OLSEN JV, SCI SIGNAL, V3, pRA3; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Polakis P, 2000, GENE DEV, V14, P1837; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sadot E, 2002, J CELL SCI, V115, P2771; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Sharma M, 2006, J BIOL CHEM, V281, P17140, DOI 10.1074/jbc.M513027200; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Votin V, 2005, J CELL SCI, V118, P5699, DOI 10.1242/jcs.02679; Wang ZH, 2003, CANCER RES, V63, P5234; WHITEHEAD RH, 1992, IMMUNOL CELL BIOL, V70, P227, DOI 10.1038/icb.1992.30; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhang HH, 2009, INT J CANCER, V125, P297, DOI 10.1002/ijc.24289; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	68	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14127	10.1371/journal.pone.0014127	http://dx.doi.org/10.1371/journal.pone.0014127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152425	gold, Green Published			2022-12-27	WOS:000284755100008
J	Kim, PTW; Hoffman, BG; Plesner, A; Helgason, CD; Verchere, CB; Chung, SW; Warnock, GL; Mui, ALF; Ong, CJ				Kim, Peter T. W.; Hoffman, Brad G.; Plesner, Annette; Helgason, Cheryl D.; Verchere, C. Bruce; Chung, Stephen W.; Warnock, Garth L.; Mui, Alice L. F.; Ong, Christopher J.			Differentiation of Mouse Embryonic Stem Cells into Endoderm without Embryoid Body Formation	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; RETINOIC ACID; DEFINITIVE ENDODERM; EFFICIENT DIFFERENTIATION; PARIETAL ENDODERM; LIVER DEVELOPMENT; INSULIN-RELEASE; EXPRESSION; PANCREAS; GENES	Pluripotent embryonic stem cells hold a great promise as an unlimited source of tissue for treatment of chronic diseases such as Type 1 diabetes. Herein, we describe a protocol using all-trans-retinoic acid, basic fibroblast growth factor and dibutyryl cAMP (DBcAMP) in the absence of embryoid body formation, for differentiation of murine embryonic stem cells into definitive endoderm that may serve as pancreatic precursors. The produced cells were analyzed by quantitative PCR, immunohistochemistry and static insulin release assay for markers of trilaminar embryo, and pancreas. Differentiated cells displayed increased Sox17 and Foxa2 expression consistent with definitive endoderm production. There was minimal production of Sox7, an extraembryonic endoderm marker, and Oct4, a marker of pluripotency. There was minimal mesoderm or neuroectoderm formation based on expression levels of the markers brachyury and Sox1, respectively. Various assays revealed that the cell clusters generated by this protocol express markers of the pancreatic lineage including insulin I, insulin II, C-peptide, PDX-1, carboxypeptidase E, pan-cytokeratin, amylase, glucagon, PAX6, Ngn3 and Nkx6.1. This protocol using all-trans-retinoic acid, DBcAMP, in the absence of embryoid bodies, generated cells that have features of definitive endoderm that may serve as pancreatic endocrine precursors.	[Kim, Peter T. W.; Hoffman, Brad G.; Helgason, Cheryl D.; Chung, Stephen W.; Warnock, Garth L.; Mui, Alice L. F.; Ong, Christopher J.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Plesner, Annette; Verchere, C. Bruce] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1W5, Canada	University of British Columbia; University of British Columbia	Kim, PTW (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada.	chris.ong@ubc.ca		Hoffman, Brad/0000-0002-5420-4493; Plesner, Annette/0000-0002-2188-7056	UBC Dept. of Surgery; Vancouver Coastal Health Research Institute	UBC Dept. of Surgery; Vancouver Coastal Health Research Institute	This work was funded by Concept Award funding from UBC Dept. of Surgery and Vancouver Coastal Health Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANG SL, 1993, DEVELOPMENT, V119, P1301; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Blumentrath J, 2001, CELL BIOCHEM FUNCT, V19, P159, DOI 10.1002/cbf.907; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Darlington GJ, 1999, CURR OPIN CELL BIOL, V11, P678, DOI 10.1016/S0955-0674(99)00035-6; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; Deutsch G, 2001, DEVELOPMENT, V128, P871; DEVASKAR SU, 1993, REGUL PEPTIDES, V48, P55, DOI 10.1016/0167-0115(93)90335-6; Futaki S, 2004, MOL CELL BIOL, V24, P10492, DOI 10.1128/MCB.24.23.10492-10503.2004; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; Harris Thomas M, 2002, Funct Integr Genomics, V2, P105, DOI 10.1007/s10142-002-0062-6; Hart AH, 2002, DEVELOPMENT, V129, P3597; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Hill CS, 2001, CURR OPIN GENET DEV, V11, P533, DOI 10.1016/S0959-437X(00)00229-X; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kato S, 1999, CELL MOL BIOL, V45, P631; KROON E, 2008, NAT BIOTECHNOL; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajagopal J, 2003, SCIENCE, V299, P363; Rossant J, 2004, SEMIN CELL DEV BIOL, V15, P573, DOI 10.1016/j.semcdb.2004.04.003; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SASAKI H, 1993, DEVELOPMENT, V118, P47; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Thompson JR, 2002, MOL CELL ENDOCRINOL, V195, P119, DOI 10.1016/S0303-7207(02)00180-6; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; YAN MH, 1994, NATURE, V372, P798; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	43	18	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14146	10.1371/journal.pone.0014146	http://dx.doi.org/10.1371/journal.pone.0014146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152387	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100026
J	Pemble, CW; Mehta, PK; Mehra, S; Li, ZM; Nourse, A; Lee, RE; White, SW				Pemble, Charles W.; Mehta, Perdeep K.; Mehra, Smriti; Li, Zhenmei; Nourse, Amanda; Lee, Richard E.; White, Stephen W.			Crystal Structure of the 6-Hydroxymethyl-7,8-Dihydropterin Pyrophosphokinase center dot Dihydropteroate Synthase Bifunctional Enzyme from Francisella tularensis	PLOS ONE			English	Article							SIZE-DISTRIBUTION ANALYSIS; ESCHERICHIA-COLI; ARGININE RESIDUE-82; TERNARY COMPLEX; CRYSTALLOGRAPHY; MECHANISM; SEQUENCE; TARGET; ROLES; ULTRACENTRIFUGATION	The 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) and dihydropteroate synthase (DHPS) enzymes catalyze sequential metabolic reactions in the folate biosynthetic pathway of bacteria and lower eukaryotes. Both enzymes represent validated targets for the development of novel anti-microbial therapies. We report herein that the genes which encode (HPPK)-H-Ft and (DHPS)-D-Ft from the biowarfare agent Francisella tularensis are fused into a single polypeptide. The potential of simultaneously targeting both modules with pterin binding inhibitors prompted us to characterize the molecular details of the multifunctional complex. Our high resolution crystallographic analyses reveal the structural organization between (HPPK)-H-Ft and (DHPS)-D-Ft which are tethered together by a short linker. Additional structural analyses of substrate complexes reveal that the active sites of each module are virtually indistinguishable from those of the monofunctional enzymes. The fused bifunctional enzyme therefore represents an excellent vehicle for finding inhibitors that engage the pterin binding pockets of both modules that have entirely different architectures. To demonstrate that this approach has the potential of producing novel two-hit inhibitors of the folate pathway, we identify and structurally characterize a fragment-like molecule that simultaneously engages both active sites. Our study provides a molecular framework to study the enzyme mechanisms of HPPK and DHPS, and to design novel and much needed therapeutic compounds to treat infectious diseases.	[Pemble, Charles W.; Mehra, Smriti; Li, Zhenmei; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Mehta, Perdeep K.] St Jude Childrens Res Hosp, Dept Informat Sci, Memphis, TN 38105 USA; [Nourse, Amanda] St Jude Childrens Res Hosp, Hartwell Ctr, Memphis, TN 38105 USA; [White, Stephen W.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Pemble, CW (corresponding author), Duke Univ, Duke Med Sch Crystallog, Durham, NC 27706 USA.	richard.lee@stjude.org; stephen.white@stjude.org	Lee, Richard/AAX-3996-2021; Lee, Richard/J-4997-2013; White, Stephen W/N-8164-2018	Lee, Richard/0000-0002-2397-0443; Lee, Richard/0000-0002-2397-0443; Mehta, Perdeep/0000-0003-4081-8352; Nourse, Amanda/0000-0003-4595-5321	National Institutes of Health [AI070721]; Cancer Center [CA21765]; American Lebanese Syrian Associated Charities (ALSAC); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this research was provided by National Institutes of Health grant AI070721, Cancer Center core grant CA21765, and the American Lebanese Syrian Associated Charities (ALSAC) (http://www.stjude.org/stjude/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SER-CAT supporting institutions may be found at www.ser.anl.gov/new/index.html. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.	Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babaoglu K, 2004, STRUCTURE, V12, P1705, DOI 10.1016/j.str.2004.07.011; Baca AM, 2000, J MOL BIOL, V302, P1193, DOI 10.1006/jmbi.2000.4094; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BALBO A, 2007, CURR PROTOC IMMUNOL, pCH18; Bermingham A, 2000, J BIOL CHEM, V275, P17962, DOI 10.1074/jbc.M000331200; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Blaszczyk J, 2004, BIOCHEMISTRY-US, V43, P1469, DOI 10.1021/bi036053l; Blaszczyk J, 2003, BIOCHEMISTRY-US, V42, P1573, DOI 10.1021/bi0267994; Blaszczyk J, 2000, STRUCTURE, V8, P1049, DOI 10.1016/S0969-2126(00)00502-5; Blaszczyk J, 2007, ACTA CRYSTALLOGR D, V63, P1169, DOI 10.1107/S0907444907047452; BROWN GM, 1971, ADV ENZYMOL RAMB, V35, P35; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burman WJ, 2003, AM J MED, V115, P358, DOI 10.1016/S0002-9343(03)00372-3; Cheok MH, 2009, J PEDIAT HEMATOL ONC, V31, P224, DOI 10.1097/MPH.0b013e318196a2a6; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DOMAGK G., 1935, Deutsche Medizinische Wochenschrift, V61, P250, DOI 10.1055/s-0028-1129486; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GLECKMAN R, 1979, AM J HOSP PHARM, V36, P893, DOI 10.1093/ajhp/36.7.893; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hampele IC, 1997, J MOL BIOL, V268, P21, DOI 10.1006/jmbi.1997.0944; Hennig M, 1999, J MOL BIOL, V287, P211, DOI 10.1006/jmbi.1999.2623; Hevener KE, 2010, J MED CHEM, V53, P166, DOI 10.1021/jm900861d; Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lau Sheung-Mei, 2004, Journal of Microbiology Immunology and Infection, V37, P185; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lawrence MC, 2005, J MOL BIOL, V348, P655, DOI 10.1016/j.jmb.2005.03.021; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Li GY, 2006, BIOCHEMISTRY-US, V45, P12573, DOI 10.1021/bi061057m; Li Y, 2002, BIOCHEMISTRY-US, V41, P8777, DOI 10.1021/bi025968h; Li Y, 2003, BIOCHEMISTRY-US, V42, P1581, DOI 10.1021/bi026800z; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Matherly LH, 2001, PROG NUCLEIC ACID RE, V67, P131, DOI 10.1016/S0079-6603(01)67027-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mouillon JM, 2002, BIOCHEM J, V363, P313, DOI 10.1042/0264-6021:3630313; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi GB, 2000, BBA-PROTEIN STRUCT M, V1478, P289, DOI 10.1016/S0167-4838(00)00043-1; Skold O, 2000, DRUG RESIST UPDATE, V3, P155, DOI 10.1054/drup.2000.0146; Stammers DK, 1999, FEBS LETT, V456, P49, DOI 10.1016/S0014-5793(99)00860-1; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Xiao B, 1999, STRUCTURE, V7, P489, DOI 10.1016/S0969-2126(99)80065-3; Xiao B, 2001, J BIOL CHEM, V276, P40274, DOI 10.1074/jbc.M103837200	54	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14165	10.1371/journal.pone.0014165	http://dx.doi.org/10.1371/journal.pone.0014165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152407	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100042
J	Foster, JM; Davis, PJ; Raverdy, S; Sibley, MH; Raleigh, EA; Kumar, S; Carlow, CKS				Foster, Jeremy M.; Davis, Paul J.; Raverdy, Sylvine; Sibley, Marion H.; Raleigh, Elisabeth A.; Kumar, Sanjay; Carlow, Clotilde K. S.			Evolution of Bacterial Phosphoglycerate Mutases: Non-Homologous Isofunctional Enzymes Undergoing Gene Losses, Gains and Lateral Transfers	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; ANALOGOUS ENZYMES; GENOME SEQUENCES; ARCHAEAL; SUPERFAMILY; PROTEIN; SPECIFICITY; INSIGHTS; EXCHANGE; REFLECT	Background: The glycolytic phosphoglyceratemutases exist as non-homologous isofunctional enzymes (NISE) having independent evolutionary origins and no similarity in primary sequence, 3D structure, or catalytic mechanism. Cofactor-dependent PGM (dPGM) requires 2,3-bisphosphoglycerate for activity; cofactor-independent PGM (iPGM) does not. The PGM profile of any given bacterium is unpredictable and some organisms such as Escherichia coli encode both forms. Methods/Principal Findings: To examine the distribution of PGM NISE throughout the Bacteria, and gain insight into the evolutionary processes that shape their phyletic profiles, we searched bacterial genome sequences for the presence of dPGM and iPGM. Both forms exhibited patchy distributions throughout the bacterial domain. Species within the same genus, or even strains of the same species, frequently differ in their PGM repertoire. The distribution is further complicated by the common occurrence of dPGM paralogs, while iPGM paralogs are rare. Larger genomes are more likely to accommodate PGM paralogs or both NISE forms. Lateral gene transfers have shaped the PGM profiles with intradomain and interdomain transfers apparent. Archaeal-type iPGM was identified in many bacteria, often as the sole PGM. To address the function of PGM NISE in an organism encoding both forms, we analyzed recombinant enzymes from E. coli. Both NISE were active mutases, but the specific activity of dPGM greatly exceeded that of iPGM, which showed highest activity in the presence of manganese. We created PGM null mutants in E. coli and discovered the Delta dPGM mutant grew slowly due to a delay in exiting stationary phase. Overexpression of dPGM or iPGM overcame this defect. Conclusions/Significance: Our biochemical and genetic analyses in E. coli firmly establish dPGM and iPGM as NISE. Metabolic redundancy is indicated since only larger genomes encode both forms. Non-orthologous gene displacement can fully account for the non-uniform PGM distribution we report across the bacterial domain.	[Foster, Jeremy M.; Davis, Paul J.; Raverdy, Sylvine; Sibley, Marion H.; Raleigh, Elisabeth A.; Kumar, Sanjay; Carlow, Clotilde K. S.] New England Biolabs Inc, Div Parasitol, Ipswich, MA USA	New England Biolabs	Foster, JM (corresponding author), New England Biolabs Inc, Div Parasitol, Ipswich, MA USA.	foster@neb.com	Kumar, Sanjay/AAO-2593-2021	Raleigh, Elisabeth A./0000-0003-0745-9925	New England Biolabs; US National Institutes of Health/National Institute for Allergy and Infectious Diseases [2R44 A1061865-02]	New England Biolabs; US National Institutes of Health/National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by New England Biolabs and by US National Institutes of Health/National Institute for Allergy and Infectious Diseases (SBIR Grant Number 2R44 A1061865-02). The authors are employees of New England Biolabs; this funder is therefore considered by PLoS ONE to have played a role in study design, data collection and analysis; however, the authors confirm that the funder did not play a direct role in the study.	Almonacid DE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000700; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 1998, TRENDS GENET, V14, P442, DOI 10.1016/S0168-9525(98)01553-4; Bond CS, 2001, J BIOL CHEM, V276, P3247, DOI 10.1074/jbc.M007318200; Bond CS, 2002, J MOL BIOL, V316, P1071, DOI 10.1006/jmbi.2002.5418; Brinkman FSL, 2002, GENOME RES, V12, P1159, DOI 10.1101/gr.341802; CARRERAS J, 1982, COMP BIOCHEM PHYS B, V71, P591, DOI 10.1016/0305-0491(82)90467-9; CARRERAS J, 1980, BIOCHEM BIOPH RES CO, V96, P1267, DOI 10.1016/0006-291X(80)90088-1; Chander M, 1999, J STRUCT BIOL, V126, P156, DOI 10.1006/jsbi.1999.4112; Chander M, 1998, CAN J MICROBIOL, V44, P759, DOI 10.1139/cjm-44-8-759; Chevalier N, 2000, EUR J BIOCHEM, V267, P1464, DOI 10.1046/j.1432-1327.2000.01145.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Djikeng A, 2007, PARASITOL RES, V100, P887, DOI 10.1007/s00436-006-0332-7; Dolezal P, 2004, GENE, V329, P81, DOI 10.1016/j.gene.2003.12.022; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Foster JM, 2009, PARASITOL RES, V104, P1047, DOI 10.1007/s00436-008-1287-7; FOTHERGILLGILMORE LA, 1989, ADV ENZYMOL RAMB, V62, P227; Fraser HI, 1999, FEBS LETT, V455, P344, DOI 10.1016/S0014-5793(99)00910-2; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Galperin M Y, 1998, In Silico Biol, V1, P55; Galperin MY, 1999, CURR OPIN BIOTECH, V10, P571, DOI 10.1016/S0958-1669(99)00035-X; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Galperin MY, 2001, PROTEINS, V45, P318, DOI 10.1002/prot.1152; Galperin MY, 1999, GENETICA, V106, P159, DOI 10.1023/A:1003705601428; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Graham DE, 2002, FEBS LETT, V517, P190, DOI 10.1016/S0014-5793(02)02619-4; Guerra DG, 2004, EUR J BIOCHEM, V271, P1798, DOI 10.1111/j.1432-1033.2004.04097.x; Hannaert Veronique, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated; Huisman G.W., 1996, ESCHERICHIA COLI SAL, P1672; Jedrzejas MJ, 2001, CHEM REV, V101, P607, DOI 10.1021/cr000253a; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; Johnsen U, 2007, EXTREMOPHILES, V11, P647, DOI 10.1007/s00792-007-0094-x; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Koonin EV, 1996, CURR OPIN GENET DEV, V6, P757, DOI 10.1016/S0959-437X(96)80032-3; Koonin EV, 1997, MOL MICROBIOL, V25, P619, DOI 10.1046/j.1365-2958.1997.4821861.x; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Koonin EV, 2003, SEQUENCE EVOLUTION F; KUHN NJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P342, DOI 10.1006/abbi.1993.1521; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kyrpides NC, 1999, TRENDS GENET, V15, P298, DOI 10.1016/S0168-9525(99)01811-9; LEYVAVAZQUEZ MA, 1994, J BACTERIOL, V176, P3903, DOI 10.1128/JB.176.13.3903-3910.1994; LIAPOUNOVA NA, 2006, EUKARYOT CELL; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Morett E, 2003, NAT BIOTECHNOL, V21, P790, DOI 10.1038/nbt834; MORRIS VL, 1995, J BACTERIOL, V177, P1727, DOI 10.1128/jb.177.7.1727-1733.1995; NAIRN J, 1994, BIOCHEM J, V297, P603, DOI 10.1042/bj2970603; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Oda Y, 2008, P NATL ACAD SCI USA, V105, P18543, DOI 10.1073/pnas.0809160105; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P470, DOI 10.1016/j.pt.2007.08.002; Otto TD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-544; Pearson CL, 2000, J BACTERIOL, V182, P4121, DOI 10.1128/JB.182.14.4121-4123.2000; Raverdy S, 2007, MOL BIOCHEM PARASIT, V156, P210, DOI 10.1016/j.molbiopara.2007.08.002; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rigden DJ, 2003, FEBS LETT, V536, P77, DOI 10.1016/S0014-5793(03)00014-0; RODICIO R, 1987, MOL GEN GENET, V206, P133, DOI 10.1007/BF00326548; Ronimus Ron S., 2003, Archaea, V1, P199, DOI 10.1155/2003/162593; Uhrinova S, 2001, J MOL BIOL, V306, P275, DOI 10.1006/jmbi.2000.4390; van der Oost J, 2002, FEMS MICROBIOL LETT, V212, P111, DOI 10.1016/S0378-1097(02)00720-6; van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059; Watkins HA, 2006, J BACTERIOL, V188, P3589, DOI 10.1128/JB.188.10.3589-3599.2006; Wojciechowski CL, 2002, J BIOL CHEM, V277, P50476, DOI 10.1074/jbc.M209326200; Zhang YH, 2004, J BIOL CHEM, V279, P37185, DOI 10.1074/jbc.M405877200	71	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13576	10.1371/journal.pone.0013576	http://dx.doi.org/10.1371/journal.pone.0013576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21187861	Green Submitted, gold, Green Published			2022-12-27	WOS:000283487400003
J	Hellman, U; Malm, L; Ma, LP; Larsson, G; Morner, S; Fu, M; Engstrom-Laurent, A; Waldenstrom, A				Hellman, Urban; Malm, Linus; Ma, Li-Ping; Larsson, Goran; Morner, Stellan; Fu, Michael; Engstrom-Laurent, Anna; Waldenstrom, Anders			Growth Factor PDGF-BB Stimulates Cultured Cardiomyocytes to Synthesize the Extracellular Matrix Component Hyaluronan	PLOS ONE			English	Article							FALSE DISCOVERY RATE; CELL-LINE; EXPRESSION; SYNTHASES; ANGIOGENESIS; FIBROBLASTS; DEGRADATION; FRAGMENTS; RECEPTOR	Background: Hyaluronan (HA) is a glycosaminoglycan located in the interstitial space which is essential for both structural and cell regulatory functions in connective tissue. We have previously shown that HA synthesis is up-regulated in a rat model of experimental cardiac hypertrophy and that cardiac tissue utilizes two different HA synthases in the hypertrophic process. Cardiomyocytes and fibroblasts are two major cell types in heart tissue. The fibroblasts are known to produce HA, but it has been unclear if cardiomyocytes share the same feature, and whether or not the different HA synthases are activated in the different cell types. Methodology/Principal Findings: This study shows, for the first time that cardiomyocytes can produce HA. Cardiomyocytes (HL-1) and fibroblasts (NIH 3T3) were cultivated in absence or presence of the growth factors FGF2, PDGF-BB and TGFB2. HA concentration was quantified by ELISA, and the size of HA was estimated using dynamic light scattering. Cardiomyocytes synthesized HA but only when stimulated by PDGF-BB, whereas fibroblasts synthesized HA without addition of growth factors as well as when stimulated by any of the three growth factors. When fibroblasts were stimulated by the growth factors, reverse dose dependence was observed, where the highest dose induced the least amount of HA. With the exception of TGFB2, a trend of reverse dose dependence of HA size was also observed. Conclusions/Significance: Co-cultivation of cardiomyocytes and fibroblasts (80%/20%) increased HA concentration far more that can be explained by HA synthesis by the two cell types separately, revealing a crosstalk between cardiomyocytes and fibroblasts that induces HA synthesis. We conclude that dynamic changes of the myocardium, such as in cardiac hypertrophy, do not depend on the cardiomyocyte alone, but are achieved when both cardiomyocytes and fibroblasts are present.	[Hellman, Urban; Morner, Stellan; Engstrom-Laurent, Anna; Waldenstrom, Anders] Umea Univ, Dept Publ Hlth & Clin Med Med, Umea, Sweden; [Hellman, Urban] Umea Univ, Umea Univ Hosp, Dept Med Biosci Med & Clin Genet, Ctr Heart, Umea, Sweden; [Malm, Linus; Larsson, Goran] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Ma, Li-Ping] Second Mil Med Univ, Dept Cardiol, Changhai Hosp, Shanghai, Peoples R China; [Ma, Li-Ping; Fu, Michael] Gothenburg Univ, Inst Med, Sahlgrenska Acad, Wallenberg Lab,Dept Mol & Clin Med, Gothenburg, Sweden	Umea University; Umea University; Umea University; Naval Medical University; University of Gothenburg	Hellman, U (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med Med, Umea, Sweden.	urban.hellman@medbio.umu.se	Hellman, Urban/L-7820-2019	Hellman, Urban/0000-0002-3822-0725; Waldenstrom, Anders/0000-0002-5304-0802	Swedish Heart Lung Foundation; Swedish Research Council; Heart Foundation of Northern Sweden; Northern County Councils Cooperation Committee	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart Foundation of Northern Sweden; Northern County Councils Cooperation Committee	This research received financial support from the Swedish Heart Lung Foundation, the Swedish Research Council, the Heart Foundation of Northern Sweden and the Northern County Councils Cooperation Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Craig EA, 2010, EXP CELL RES; David-Raoudi M, 2008, WOUND REPAIR REGEN, V16, P274, DOI 10.1111/j.1524-475X.2007.00342.x; EngstromLaurent A, 1997, J INTERN MED, V242, P57, DOI 10.1046/j.1365-2796.1997.00174.x; FEINBERG RN, 1983, SCIENCE, V220, P1177, DOI 10.1126/science.6857242; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Hellman U, 2010, GENOMICS; Hellman U, 2008, CELL TISSUE RES, V332, P49, DOI 10.1007/s00441-007-0562-8; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; KNUDSON W, 1989, CIBA F SYMP, V143, P150; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Miller JC, 1993, STAT ANAL CHEM, P62; Olutoye OO, 1997, J PEDIATR SURG, V32, P1037, DOI 10.1016/S0022-3468(97)90394-8; Paiva P, 2005, GYNECOL ONCOL, V98, P193, DOI 10.1016/j.ygyno.2005.02.031; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Takano S, 2007, J BIOCHEM, V141, P345, DOI 10.1093/jb/mvm039; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; WALDENSTROM A, 1991, J CLIN INVEST, V88, P1622, DOI 10.1172/JCI115475; WEISSMANN B, 1954, J BIOL CHEM, V208, P417; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340	34	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14393	10.1371/journal.pone.0014393	http://dx.doi.org/10.1371/journal.pone.0014393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200430	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900008
J	Ghosh, S; Heffernan, J				Ghosh, Suma; Heffernan, Jane			Influenza Pandemic Waves under Various Mitigation Strategies with 2009 H1N1 as a Case Study	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; OSELTAMIVIR; TRANSMISSION; VACCINATION; DYNAMICS; STRAIN; VIRUS; MODEL	A significant feature of influenza pandemics is multiple waves of morbidity and mortality over a few months or years. The size of these successive waves depends on intervention strategies including antivirals and vaccination, as well as the effects of immunity gained from previous infection. However, the global vaccine manufacturing capacity is limited. Also, antiviral stockpiles are costly and thus, are limited to very few countries. The combined effect of antivirals and vaccination in successive waves of a pandemic has not been quantified. The effect of acquired immunity from vaccination and previous infection has also not been characterized. In times of a pandemic threat countries must consider the effects of a limited vaccine, limited antiviral use and the effects of prior immunity so as to adopt a pandemic strategy that will best aid the population. We developed a mathematical model describing the first and second waves of an influenza pandemic including drug therapy, vaccination and acquired immunity. The first wave model includes the use of antiviral drugs under different treatment profiles. In the second wave model the effects of antivirals, vaccination and immunity gained from the first wave are considered. The models are used to characterize the severity of infection in a population under different drug therapy and vaccination strategies, as well as school closure, so that public health policies regarding future influenza pandemics are better informed.	[Ghosh, Suma; Heffernan, Jane] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Ghosh, Suma; Heffernan, Jane] York Univ, Ctr Dis Modelling, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	Ghosh, S (corresponding author), York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada.	suma.ghosh1@gmail.com; jmheffer@yorku.ca			Natural Sciences and Engineering Research Council of Canada, Mathematics of Information Technology and Complex Systems; Ontario Early Researcher Award	Natural Sciences and Engineering Research Council of Canada, Mathematics of Information Technology and Complex Systems(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	SG and JH are grateful to Natural Sciences and Engineering Research Council of Canada, Mathematics of Information Technology and Complex Systems, and JH is also grateful to Ontario Early Researcher Award for the support to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ME, 2008, B MATH BIOL, V70, P382, DOI 10.1007/s11538-007-9257-2; ANDERSON R M, 1991; Andreasen V, 2003, J MATH BIOL, V46, P504, DOI 10.1007/s00285-002-0186-2; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Boelle PY, 2009, EURO SURVEILL, V14; Boni MF, 2004, THEOR POPUL BIOL, V65, P179, DOI 10.1016/j.tpb.2003.10.002; Democratis J, 2006, J ANTIMICROB CHEMOTH, V58, P911, DOI 10.1093/jac/dkl376; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Duvvuri VRSK, 2010, INFLUENZA OTHER RESP, V4, P249, DOI 10.1111/j.1750-2659.2010.00161.x; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Heffernan JM, 2008, THEOR POPUL BIOL, V73, P134, DOI 10.1016/j.tpb.2007.10.003; Heffernan JM, 2009, P ROY SOC B-BIOL SCI, V276, P2071, DOI 10.1098/rspb.2009.0057; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Linde A, 2001, ANTIVIR RES, V51, P81, DOI 10.1016/S0166-3542(01)00129-2; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Moghadas SM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-73; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Simonsen L, 2005, THREAT PANDEMIC INFL, P89, DOI DOI 10.2105/AJPH.2007.119933; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x	43	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14307	10.1371/journal.pone.0014307	http://dx.doi.org/10.1371/journal.pone.0014307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187938	gold, Green Submitted, Green Published			2022-12-27	WOS:000285575200004
J	Liu, C; Guan, J; Kang, YX; Xiu, HM; Chen, Y; Deng, B; Liu, KS				Liu, Chao; Guan, Jing; Kang, Yunxiao; Xiu, Heming; Chen, Ying; Deng, Bao; Liu, Kunshen			Inhibition of Dehydration-Induced Water Intake by Glucocorticoids Is Associated with Activation of Hypothalamic Natriuretic Peptide Receptor-A in Rat	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; BRAIN; DEXAMETHASONE; PREDNISONE; EXPRESSION; LOCALIZATION; HYPERTENSION; POLYPEPTIDE; METABOLISM; INCREASES	Atrial natriuretic peptide (ANP) provides a potent defense mechanism against volume overload in mammals. Its primary receptor, natriuretic peptide receptor-A (NPR-A), is localized mostly in the kidney, but also is found in hypothalamic areas involved in body fluid volume regulation. Acute glucocorticoid administration produces potent diuresis and natriuresis, possibly by acting in the renal natriuretic peptide system. However, chronic glucocorticoid administration attenuates renal water and sodium excretion. The precise mechanism underlying this paradoxical phenomenon is unclear. We assume that chronic glucocorticoid administration may activate natriuretic peptide system in hypothalamus, and cause volume depletion by inhibiting dehydration-induced water intake. Volume depletion, in turn, compromises renal water excretion. To test this postulation, we determined the effect of dexamethasone on dehydration-induced water intake and assessed the expression of NPR-A in the hypothalamus. The rats were deprived of water for 24 hours to have dehydrated status. Prior to free access to water, the water-deprived rats were pretreated with dexamethasone or vehicle. Urinary volume and water intake were monitored. We found that dexamethasone pretreatment not only produced potent diuresis, but dramatically inhibited the dehydration-induced water intake. Western blotting analysis showed the expression of NPR-A in the hypothalamus was dramatically upregulated by dexamethasone. Consequently, cyclic guanosine monophosphate (the second messenger for the ANP) content in the hypothalamus was remarkably increased. The inhibitory effect of dexamethasone on water intake presented in a time-and dose-dependent manner, which emerged at least after 18-hour dexamethasone pretreatment. This effect was glucocorticoid receptor (GR) mediated and was abolished by GR antagonist RU486. These results indicated a possible physiologic role for glucocorticoids in the hypothalamic control of water intake and revealed that the glucocorticoids can act centrally, as well as peripherally, to assist in the normalization of extracellular fluid volume.	[Liu, Chao; Chen, Ying; Deng, Bao; Liu, Kunshen] Hebei Med Univ, Ctr Heart, Hosp 1, Shijiazhuang, Peoples R China; [Guan, Jing] Hebei Gen Hosp, Stomatol Div, Shijiazhuang, Peoples R China; [Kang, Yunxiao] Hebei Med Univ, Dept Neurobiol, Shijiazhuang, Peoples R China; [Xiu, Heming] Hebei Med Univ, Cent Lab, Hosp 1, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Liu, C (corresponding author), Hebei Med Univ, Ctr Heart, Hosp 1, Shijiazhuang, Peoples R China.	ksliud@sohu.com	Liu, Chao/A-7533-2008; Liu, Kunshen/A-7699-2008	Liu, Chao/0000-0002-5323-6733; chen, ying/0000-0001-8490-5672	Nature Cardiovascular Drug Institute	Nature Cardiovascular Drug Institute	Nature Cardiovascular Drug Institute sponsored the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JA, 1999, EUR J PHARMACOL, V370, P271, DOI 10.1016/S0014-2999(99)00121-1; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; ANTUNESRODRIGUES J, 1985, P NATL ACAD SCI USA, V82, P8720, DOI 10.1073/pnas.82.24.8720; ANTUNESRODRIGUES J, 1986, ENDOCRINOLOGY, V118, P1726, DOI 10.1210/endo-118-4-1726; CHROUSOS GP, 1988, KIDNEY INT, V34, pS18; DANANBERG J, 1992, AM J PHYSIOL, V263, pH1377, DOI 10.1152/ajpheart.1992.263.5.H1377; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; De Wardener HE, 2001, PHYSIOL REV, V81, P1599, DOI 10.1152/physrev.2001.81.4.1599; GARCIA R, 1985, BIOCHEM BIOPH RES CO, V131, P806, DOI 10.1016/0006-291X(85)91311-7; GARDNER DG, 1986, BIOCHEM BIOPH RES CO, V139, P1047, DOI 10.1016/S0006-291X(86)80283-2; GARDNER DG, 1988, J CLIN INVEST, V82, P1275, DOI 10.1172/JCI113726; GEIGER H, 1991, NEUROENDOCRINOLOGY, V53, P63, DOI 10.1159/000125698; Goy MF, 2001, BIOCHEM J, V358, P379, DOI 10.1042/0264-6021:3580379; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Jahng JW, 2008, EUR J PHARMACOL, V581, P64, DOI 10.1016/j.ejphar.2007.11.029; KATSUURA G, 1986, EUR J PHARMACOL, V121, P285, DOI 10.1016/0014-2999(86)90502-9; LACZI F, 1991, NEUROPEPTIDES, V19, P183, DOI 10.1016/0143-4179(91)90117-2; LAUE L, 1988, J STEROID BIOCHEM, V29, P591, DOI 10.1016/0022-4731(88)90156-2; LIU C, 2010, POTENT DIURETIC EFFE; Liu C, 2007, CAN J CARDIOL, V23, P865, DOI 10.1016/S0828-282X(07)70840-1; Liu C, 2006, J CARDIOVASC PHARM, V48, P173, DOI 10.1097/01.fjc.0000245242.57088.5b; MANTYH CR, 1987, BRAIN RES, V412, P329, DOI 10.1016/0006-8993(87)91140-1; MICKERSON JN, 1959, BMJ-BRIT MED J, V1, P876, DOI 10.1136/bmj.1.5126.876; Oliveira MHA, 1997, BRAZ J MED BIOL RES, V30, P465, DOI 10.1590/S0100-879X1997000400006; Paxinos G., 1997, RAT BRAININ STEREOTA, V3; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P10043, DOI 10.1073/pnas.87.24.10043; Ryan MC, 1997, PEPTIDES, V18, P495, DOI 10.1016/S0196-9781(96)00329-4; SIMPSON CW, 1974, PHARMACOL BIOCHEM BE, V2, P19, DOI 10.1016/0091-3057(74)90130-0; TARJAN E, 1988, REGUL PEPTIDES, V23, P63, DOI 10.1016/0167-0115(88)90422-3; Thunhorst RL, 2007, AM J PHYSIOL-REG I, V293, pR1444, DOI 10.1152/ajpregu.00294.2007; Turner SW, 1996, HYPERTENSION, V27, P184, DOI 10.1161/01.HYP.27.2.184; Wallerath T, 1999, P NATL ACAD SCI USA, V96, P13357, DOI 10.1073/pnas.96.23.13357; WALLS EK, 1977, PHYSIOL BEHAV, V19, P171, DOI 10.1016/0031-9384(77)90177-9; Whitworth JA, 2000, HYPERTENSION, V36, P912, DOI 10.1161/01.HYP.36.5.912; Woodard GE, 2003, NEUROSCI RES, V47, P421, DOI 10.1016/j.neures.2003.08.002; Zhang HM, 2008, INT HEART J, V49, P587, DOI 10.1536/ihj.49.587	37	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15607	10.1371/journal.pone.0015607	http://dx.doi.org/10.1371/journal.pone.0015607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187974	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200049
J	Yao, JQ; Hennessey, T; Flynt, A; Lai, E; Beal, MF; Lin, MT				Yao, Jiaqi; Hennessey, Tom; Flynt, Alex; Lai, Eric; Beal, M. Flint; Lin, Michael T.			MicroRNA-Related Cofilin Abnormality in Alzheimer's Disease	PLOS ONE			English	Article							ACTIN DYNAMICS; HIRANO BODIES; EXPRESSION; BETA; ADF/COFILIN; PROTEIN; NEURODEGENERATION	Rod-like structures composed of actin and the actin-binding protein cofilin are found in Alzheimer's disease (AD) patients. However, the mechanisms underlying formation of these structures and their pathological consequences are still largely unknown. We found that microRNAs 103 and 107 repress translation of cofilin, and that reduced levels of miR-103 or miR-107 are associated with elevated cofilin protein levels and formation of rod-like structures in a transgenic mouse model of AD. These results suggest that microRNAs may play an important role in cytoskeletal pathology in AD.	[Yao, Jiaqi; Hennessey, Tom; Beal, M. Flint; Lin, Michael T.] Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Flynt, Alex; Lai, Eric] Mem Sloan Kettering Canc Ctr, Dept Dev Biol, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Yao, JQ (corresponding author), Weill Cornell Med Coll, Dept Neurol, New York, NY USA.	mtl2002@med.cornell.edu	Lai, Eric C/A-3412-2008		American Health Assistance Foundation [A2009606]; National Institutes of Health [R01 AG20729, R01 GM083300]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020729] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the American Health Assistance Foundation (A2009606 to JY) and the National Institutes of Health (R01 AG20729 to MTL and R01 GM083300 to ECL). The authors thank the donors of Alzheimer's Disease Research (ADR), a program of the American Health Assistance Foundation, for support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Guo H., 2010, NATURE, V466, P835; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; HIRANO A, 1994, NEUROPATH APPL NEURO, V20, P3, DOI 10.1111/j.1365-2990.1994.tb00951.x; Hsu WC, 2008, J NEURAL TRANSM, V115, P1537, DOI 10.1007/s00702-008-0117-5; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; MACIVER SK, 1995, NEUROREPORT, V6, P1985, DOI 10.1097/00001756-199510010-00008; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773	26	55	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15546	10.1371/journal.pone.0015546	http://dx.doi.org/10.1371/journal.pone.0015546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179570	gold, Green Published, Green Submitted			2022-12-27	WOS:000285381200027
J	Bernal, AB; Vickers, MH; Hampton, MB; Poynton, RA; Sloboda, DM				Bernal, Angelica B.; Vickers, Mark H.; Hampton, Mark B.; Poynton, Rebecca A.; Sloboda, Deborah M.			Maternal Undernutrition Significantly Impacts Ovarian Follicle Number and Increases Ovarian Oxidative Stress in Adult Rat Offspring	PLOS ONE			English	Article							CATCH-UP GROWTH; HIGH-FAT DIET; DEVELOPMENTAL ORIGINS; DIFFERENTIATION FACTOR-9; REPRODUCTIVE FUNCTION; PEROXIREDOXIN-III; IN-UTERO; LEPTIN; PUBERTY; ONSET	Background: We have shown recently that maternal undernutrition (UN) advanced female pubertal onset in a manner that is dependent upon the timing of UN. The long-term consequence of this accelerated puberty on ovarian function is unknown. Recent findings suggest that oxidative stress may be one mechanism whereby early life events impact on later physiological functioning. Therefore, using an established rodent model of maternal UN at critical windows of development, we examined maternal UN-induced changes in offspring ovarian function and determined whether these changes were underpinned by ovarian oxidative stress. Methodology/Principal Findings: Our study is the first to show that maternal UN significantly reduced primordial and secondary follicle number in offspring in a manner that was dependent upon the timing of maternal UN. Specifically, a reduction in these early stage follicles was observed in offspring born to mothers undernourished throughout both pregnancy and lactation. Additionally, antral follicle number was reduced in offspring born to all mothers that were UN regardless of whether the period of UN was restricted to pregnancy or lactation or both. These reductions were associated with decreased mRNA levels of genes critical for follicle maturation and ovulation. Increased ovarian protein carbonyls were observed in offspring born to mothers UN during pregnancy and/or lactation and this was associated with peroxiredoxin 3 hyperoxidation and reduced mRNA levels; suggesting compromised antioxidant defence. This was not observed in offspring of mothers UN during lactation alone. Conclusions: We propose that maternal UN, particularly at a time-point that includes pregnancy, results in reduced offspring ovarian follicle numbers and mRNA levels of regulatory genes and may be mediated by increased ovarian oxidative stress coupled with a decreased ability to repair the resultant oxidative damage. Together these data are suggestive of maternal UN potentially contributing to premature ovarian ageing in offspring.	[Bernal, Angelica B.; Vickers, Mark H.; Sloboda, Deborah M.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Bernal, Angelica B.; Vickers, Mark H.; Sloboda, Deborah M.] Natl Res Ctr Growth & Dev, Auckland, New Zealand; [Hampton, Mark B.; Poynton, Rebecca A.] Univ Otago, Dept Pathol, Free Rad Res Grp, Christchurch, New Zealand	University of Auckland; University of Auckland; University of Otago	Bernal, AB (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	d.sloboda@auckland.ac.nz	Dalton-O'Reilly, Jessica/AAM-8569-2021; Hampton, Mark B/A-8490-2008	Hampton, Mark B/0000-0002-7349-3729; Vickers, Mark/0000-0003-4876-9356	National Research Centre for Growth and Development	National Research Centre for Growth and Development	The current study was funded by the National Research Centre for Growth and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Ahima RS, 1997, J CLIN INVEST, V99, P391, DOI 10.1172/JCI119172; Barkan D, 1999, ENDOCRINOLOGY, V140, P1731, DOI 10.1210/en.140.4.1731; Barkan D, 2004, FASEB J, V18, P133, DOI 10.1096/fj.04-2271fje; BILLIG H, 1993, ENDOCRINOLOGY, V133, P2204, DOI 10.1210/en.133.5.2204; Bluher Susann, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P458, DOI 10.1097/MED.0b013e3282f1cfdc; Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Cheung CC, 1997, ENDOCRINOLOGY, V138, P855, DOI 10.1210/en.138.2.855; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Connor KL, 2010, J DEV ORIG HLTH DIS, V1, P245, DOI 10.1017/S2040174410000346; Couillard C, 2005, J CLIN ENDOCR METAB, V90, P6454, DOI 10.1210/jc.2004-2438; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Faria TD, 2010, NUTRITION, V26, P1000, DOI 10.1016/j.nut.2009.09.026; Faria TD, 2004, J NUTR BIOCHEM, V15, P123, DOI 10.1016/j.jnutbio.2003.08.011; FARIA TD, 2010, NUTRITION IN PRESS; Gardner DS, 2009, PHILOS T R SOC B, V364, P3419, DOI 10.1098/rstb.2009.0121; Gluckman PD, 2005, BIOL NEONATE, V87, P127, DOI 10.1159/000082311; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Hilakivi-Clarke L, 1999, NUTRITION, V15, P392, DOI 10.1016/S0899-9007(99)00029-5; HIRSHFIELD AN, 1978, BIOL REPROD, V19, P597, DOI 10.1095/biolreprod19.3.597; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Jozwik M, 1999, MOL HUM REPROD, V5, P409, DOI 10.1093/molehr/5.5.409; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Keisler D.H., 2016, J ANIM SCI, V74, P1, DOI [10.2527/1996.74suppl_31x, DOI 10.2527/1996.74SUPPL_31X]; Kiess W, 1998, EUR J ENDOCRINOL, V138, P26, DOI 10.1530/eje.0.1380026; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Leonhardt M, 2003, BIOL REPROD, V68, P390, DOI 10.1095/biolreprod.102.003269; Loui A, 2010, J TRACE ELEM MED BIO, V24, P111, DOI 10.1016/j.jtemb.2009.11.004; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002; Nilsson EE, 2002, BIOL REPROD, V67, P1018, DOI 10.1095/biolreprod.101.002527; Orisaka M, 2006, MOL ENDOCRINOL, V20, P2456, DOI 10.1210/me.2005-0357; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 2005, MECH AGEING DEV, V126, P852, DOI 10.1016/j.mad.2005.03.005; PASZKOWSKI T, 1995, CLIN CHIM ACTA, V236, P173, DOI 10.1016/0009-8981(95)98130-9; Picton HM, 2001, THERIOGENOLOGY, V55, P1193, DOI 10.1016/S0093-691X(01)00478-2; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rae MT, 2002, ANIM REPROD SCI, V72, P63, DOI 10.1016/S0378-4320(02)00068-4; Ricci AG, 2006, REPRODUCTION, V132, P771, DOI 10.1530/rep.1.01164; Roman EA, 2005, MOL CELL ENDOCRINOL, V242, P33, DOI 10.1016/j.mce.2005.07.007; Rosenfeld CS, 2001, REPRODUCTION, V122, P215, DOI 10.1530/rep.0.1220215; Simmons RA, 2006, FREE RADICAL BIO MED, V40, P917, DOI 10.1016/j.freeradbiomed.2005.12.018; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; Spicer LJ, 2001, DOMEST ANIM ENDOCRIN, V21, P251, DOI 10.1016/S0739-7240(01)00120-5; Spicer LJ, 2000, ENDOCRINE, V12, P53, DOI 10.1385/ENDO:12:1:53; Suzuki T, 1999, FERTIL STERIL, V72, P720, DOI 10.1016/S0015-0282(99)00332-5; TARIN JJ, 1995, HUM REPROD, V10, P1563, DOI 10.1093/HUMREP/10.6.1563; Tarin JJ, 1996, MOL HUM REPROD, V2, P717, DOI 10.1093/molehr/2.10.717; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; TARRYADKINS JL, 2010, FASEB J; Theys N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006110; Tilly J L, 1996, Rev Reprod, V1, P162, DOI 10.1530/revreprod/1.3.162; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x; Vitt UA, 2000, ENDOCRINOLOGY, V141, P3814, DOI 10.1210/en.141.10.3814; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273	66	106	108	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15558	10.1371/journal.pone.0015558	http://dx.doi.org/10.1371/journal.pone.0015558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179452	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900046
J	Dillon, PF; Root-Bernstein, R; Robinson, NE; Abraham, WM; Berney, C				Dillon, Patrick F.; Root-Bernstein, Robert; Robinson, N. Edward; Abraham, William M.; Berney, Catherine			Receptor-Mediated Enhancement of Beta Adrenergic Drug Activity by Ascorbate In Vitro and In Vivo	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; LATE BRONCHIAL RESPONSES; AIRWAY HYPERRESPONSIVENESS; ACID; DESENSITIZATION; BINDING; KINASE; INTERNALIZATION; NOREPINEPHRINE; STIMULATION	Rationale: Previous in vitro research demonstrated that ascorbate enhances potency and duration of activity of agonists binding to alpha 1 adrenergic and histamine receptors. Objectives: Extending this work to beta 2 adrenergic systems in vitro and in vivo. Methods: Ultraviolet spectroscopy was used to study ascorbate binding to adrenergic receptor preparations and peptides. Force transduction studies on acetylcholine-contracted trachealis preparations from pigs and guinea pigs measured the effect of ascorbate on relaxation due to submaximal doses of beta adrenergic agonists. The effect of inhaled albuterol with and without ascorbate was tested on horses with heaves and sheep with carbachol-induced bronchoconstriction. Measurements: Binding constants for ascorbate binding to beta adrenergic receptor were derived from concentration-dependent spectral shifts. Dose- dependence curves were obtained for the relaxation of pre-contracted trachealis preparations due to beta agonists in the presence and absence of varied ascorbate. Tachyphylaxis and fade were also measured. Dose response curves were determined for the effect of albuterol plus-and-minus ascorbate on airway resistance in horses and sheep. Main Results: Ascorbate binds to the beta 2 adrenergic receptor at physiological concentrations. The receptor recycles dehydroascorbate. Physiological and supra-physiological concentrations of ascorbate enhance submaximal epinephrine and isoproterenol relaxation of trachealis, producing a 3-10-fold increase in sensitivity, preventing tachyphylaxis, and reversing fade. In vivo, ascorbate improves albuterol's effect on heaves and produces a 10-fold enhancement of albuterol activity in "asthmatic'' sheep. Conclusions: Ascorbate enhances beta-adrenergic activity via a novel receptor-mediated mechanism; increases potency and duration of beta adrenergic agonists effective in asthma and COPD; prevents tachyphylaxis; and reverses fade. These novel effects are probably caused by a novel mechanism involving phosphorylation of aminergic receptors and have clinical and drug-development applications.	[Dillon, Patrick F.; Root-Bernstein, Robert] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Robinson, N. Edward; Berney, Catherine] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Abraham, William M.] Mt Sinai Med Ctr, Dept Res, Miami Beach, FL 33140 USA	Michigan State University; Michigan State University; Mount Sinai Medical Center	Dillon, PF (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	rootbern@msu.edu			Acorn Technologies, Inc.	Acorn Technologies, Inc.	The research was partially funded by Acorn Technologies, Inc. and partially by Maurine Bernstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders have no financial interests in the research.	Abraham WM, 1999, AM J RESP CRIT CARE, V159, P1205, DOI 10.1164/ajrccm.159.4.9806002; Abraham WM, 2000, AM J RESP CRIT CARE, V162, P603, DOI 10.1164/ajrccm.162.2.9911061; ABRAHAM WM, 1994, J CLIN INVEST, V93, P776, DOI 10.1172/JCI117032; Altman P.I., 1961, BLOOD OTHER BODY FLU; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Clark RB, 2002, METHOD ENZYMOL, V343, P506; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; DERKSEN FJ, 1980, AM J VET RES, V41, P1756; Derksen FJ, 1999, AM J VET RES, V60, P689; Derksen FJ, 1996, EQUINE VET J, V28, P306, DOI 10.1111/j.2042-3306.1996.tb03094.x; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Dillon PF, 2006, AM J PHYSIOL-CELL PH, V291, pC977, DOI 10.1152/ajpcell.00613.2005; Dillon PF, 2000, BIOPHYS J, V79, P370, DOI 10.1016/S0006-3495(00)76298-9; Dillon PF, 2004, AM J PHYSIOL-HEART C, V286, pH2353, DOI 10.1152/ajpheart.00968.2003; ERJEFALT I, 1991, AM REV RESPIR DIS, V144, P788, DOI 10.1164/ajrccm/144.4.788; Greiff L, 1998, THORAX, V53, P1010, DOI 10.1136/thx.53.12.1010; Grossmann M, 2001, HYPERTENSION, V37, P949, DOI 10.1161/01.HYP.37.3.949; HOUSTON JB, 1976, RES COMMUN CHEM PATH, V14, P643; KIMURA K, 1994, J NEUROCHEM, V63, P2093; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; LANZARA R, 2005, INT J PHARMACEUT, V1, P122; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Lin R, 2008, PULM PHARMACOL THER, V21, P115, DOI 10.1016/j.pupt.2007.06.003; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; Lundblad LKA, 2007, AM J RESP CRIT CARE, V175, P768, DOI 10.1164/rccm.200610-1410OC; Mak S, 2001, CIRCULATION, V103, P826, DOI 10.1161/01.CIR.103.6.826; MAXWELL LC, 1983, MICROVASC RES, V26, P81, DOI 10.1016/0026-2862(83)90057-2; May JM, 2001, BBA-GEN SUBJECTS, V1528, P159, DOI 10.1016/S0304-4165(01)00188-X; McDonald JH., 2008, HDB BIOL STAT; Monahan KD, 2004, AM J PHYSIOL-HEART C, V286, pH2113, DOI 10.1152/ajpheart.01054.2003; Moore RH, 2007, AM J RESP CELL MOL, V36, P254, DOI 10.1165/rcmb.2006-0158OC; PARRA L, 1995, EUR J PHARMACOL, V277, P99, DOI 10.1016/0014-2999(95)00067-U; Penn RB, 2008, N-S ARCH PHARMACOL, V378, P149, DOI 10.1007/s00210-008-0263-1; Ren JH, 2005, AUTON NEUROSCI-BASIC, V117, P67, DOI 10.1016/j.autneu.2004.10.007; Robinson NE, 1999, VET J, V157, P160, DOI 10.1053/tvjl.1998.0281; Robinson NE, 1996, BRIT VET J, V152, P283, DOI 10.1016/S0007-1935(96)80101-1; Root-Bernstein R, 2002, DRUG DEVELOP RES, V57, P58, DOI 10.1002/ddr.10110; Root-Bernstein R, 2008, DRUG DEVELOP RES, V69, P242, DOI 10.1002/ddr.20250; RootBernstein RS, 1997, J THEOR BIOL, V188, P447, DOI 10.1006/jtbi.1997.0476; ROTH NS, 1991, P NATL ACAD SCI USA, V88, P6201, DOI 10.1073/pnas.88.14.6201; Rubenstein LA, 1998, J MOL STRUC-THEOCHEM, V430, P57, DOI 10.1016/S0166-1280(98)90217-2; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRASSER RH, 1986, P NATL ACAD SCI USA, V83, P6362, DOI 10.1073/pnas.83.17.6362; SVEDMYR N, 1990, AM REV RESPIR DIS, V141, pS31; van der Vliet A, 1999, AM J PHYSIOL-LUNG C, V276, pL289, DOI 10.1152/ajplung.1999.276.2.L289; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Venegas JG, 2005, RESP PHYSIOL NEUROBI, V148, P57, DOI 10.1016/j.resp.2005.05.023; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15130	10.1371/journal.pone.0015130	http://dx.doi.org/10.1371/journal.pone.0015130			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179213	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900029
J	Yan, J; Cai, ZH				Yan, Jun; Cai, Zhonghua			Molecular Evolution and Functional Divergence of the Cytochrome P450 3 (CYP3) Family in Actinopterygii (Ray-Finned Fish)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; WHOLE-GENOME DUPLICATION; PHYLOGENETIC ANALYSIS; RATES	Background: The cytochrome P450 (CYP) superfamily is a multifunctional hemethiolate enzyme that is widely distributed from Bacteria to Eukarya. The CYP3 family contains mainly the four subfamilies CYP3A, CYP3B, CYP3C and CYP3D in vertebrates; however, only the Actinopterygii (ray-finned fish) have all four subfamilies and detailed understanding of the evolutionary relationship of Actinopterygii CYP3 family members would be valuable. Methods and Findings: Phylogenetic relationships were constructed to trace the evolutionary history of the Actinopterygii CYP3 family genes. Selection analysis, relative rate tests and functional divergence analysis were combined to interpret the relationship of the site-specific evolution and functional divergence in the Actinopterygii CYP3 family. The results showed that the four CYP3 subfamilies in Actinopterygii might be formed by gene duplication. The first gene duplication event was responsible for divergence of the CYP3B/C clusters from ancient CYP3 before the origin of the Actinopterygii, which corresponded to the fish-specific whole genome duplication (WGD). Tandem repeat duplication in each of the homologue clusters produced stable CYP3B, CYP3C, CYP3A and CYP3D subfamilies. Acceleration of asymmetric evolutionary rates and purifying selection together were the main force for the production of new subfamilies and functional divergence in the new subset after gene duplication, whereas positive selection was detected only in the retained CYP3A subfamily. Furthermore, nearly half of the functional divergence sites appear to be related to substrate recognition, which suggests that site-specific evolution is closely related with functional divergence in the Actinopterygii CYP3 family. Conclusions: The split of fish-specific CYP3 subfamilies was related to the fish-specific WGD, and site-specific acceleration of asymmetric evolutionary rates and purifying selection was the main force for the origin of the new subfamilies and functional divergence in the new subset after gene duplication. Site-specific evolution in substrate recognition was related to functional divergence in the Actinopterygii CYP3 family.	[Yan, Jun; Cai, Zhonghua] Tsinghua Univ, Dept Biol Sci, Beijing 100084, Peoples R China; [Yan, Jun; Cai, Zhonghua] Tsinghua Univ, Dept Biotechnol, Beijing 100084, Peoples R China; [Yan, Jun; Cai, Zhonghua] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Yan, J (corresponding author), Tsinghua Univ, Dept Biol Sci, Beijing 100084, Peoples R China.	caizh@sz.tsinghua.edu.cn			International Cooperative Projects of Shenzhen [ZYA200903260036A]; Shenzhen and Longgang Agricultural Bureau; Shenzhen committee of Science, Industry, Trade and Information Technology of China	International Cooperative Projects of Shenzhen; Shenzhen and Longgang Agricultural Bureau; Shenzhen committee of Science, Industry, Trade and Information Technology of China	This study was supported by grants from the International Cooperative Projects of Shenzhen (ZYA200903260036A), agricultural integrated project from Shenzhen and Longgang Agricultural Bureau, and scientific platform project from Shenzhen committee of Science, Industry, Trade and Information Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Corley-Smith GE, 2006, BIOCHEM BIOPH RES CO, V340, P1039, DOI 10.1016/j.bbrc.2005.12.110; Daly AK, 2006, CLIN PHARMACOKINET, V45, P13, DOI 10.2165/00003088-200645010-00002; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Goldstone JV, 2008, CELL BIOL TOXICOL, V24, P483, DOI 10.1007/s10565-008-9107-5; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; McArthur AG, 2003, J MOL EVOL, V57, P200, DOI 10.1007/s00239-003-2466-x; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Nelson David R, 2006, Methods Mol Biol, V320, P1; Nelson David R., 2009, Human Genomics, V4, P59; NELSON DR, 1987, MOL BIOL EVOL, V4, P572; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; Qiu H, 2008, PHARMACOGENET GENOM, V18, P53, DOI 10.1097/FPC.0b013e3282f313f8; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shen RF, 1998, J BIOMED SCI, V5, P153, DOI 10.1007/BF02253465; Siroka Z, 2004, ACTA VET BRNO, V73, P123, DOI 10.2754/avb200473010123; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torimoto N, 2007, DRUG METAB DISPOS, V35, P484, DOI 10.1124/dmd.106.011304; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; YOSHIDA Y, 2000, BIOCH BIOPH RES COMM, V273	43	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14276	10.1371/journal.pone.0014276	http://dx.doi.org/10.1371/journal.pone.0014276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170327	Green Published, Green Submitted, gold			2022-12-27	WOS:000285181400007
J	Tsui, DWY; Lam, YMD; Lee, WS; Leung, TY; Lau, TK; Lau, ET; Tang, MHY; Akolekar, R; Nicolaides, KH; Chiu, RWK; Lo, YMD; Chim, SSC				Tsui, Dana W. Y.; Lam, Y. M. Doris; Lee, Wing S.; Leung, Tak Y.; Lau, Tze K.; Lau, Elizabeth T.; Tang, Mary H. Y.; Akolekar, Ranjit; Nicolaides, Kypros H.; Chiu, Rossa W. K.; Lo, Y. M. Dennis; Chim, Stephen S. C.			Systematic Identification of Placental Epigenetic Signatures for the Noninvasive Prenatal Detection of Edwards Syndrome	PLOS ONE			English	Article							DIFFERENTIAL DNA METHYLATION; MATERNAL PLASMA; FETAL DNA; ALLELIC RATIO; DIGITAL PCR; DIAGNOSIS; ORIGIN; SITES; GENE; EPIGENOMICS	Background: Noninvasive prenatal diagnosis of fetal aneuploidy by maternal plasma analysis is challenging owing to the low fractional and absolute concentrations of fetal DNA in maternal plasma. Previously, we demonstrated for the first time that fetal DNA in maternal plasma could be specifically targeted by epigenetic (DNA methylation) signatures in the placenta. By comparing one such methylated fetal epigenetic marker located on chromosome 21 with another fetal genetic marker located on a reference chromosome in maternal plasma, we could infer the relative dosage of fetal chromosome 21 and noninvasively detect fetal trisomy 21. Here we apply this epigenetic-genetic (EGG) chromosome dosage approach to detect Edwards syndrome (trisomy 18) in the fetus noninvasively. Principal Findings: We have systematically identified methylated fetal epigenetic markers on chromosome 18 by methylated DNA immunoprecipitation (MeDIP) and tiling array analysis with confirmation using quantitative DNA methylation assays. Methylated DNA sequences from an intergenic region between the VAPA and APCDD1 genes (the VAPA-APCDD1 DNA) were detected in pre-delivery, but not post-delivery, maternal plasma samples. The concentrations correlated positively with those of an established fetal genetic marker, ZFY, in pre-delivery maternal plasma. The ratios of methylated VAPA-APCDD1(chr18) to ZFY(chrY) were higher in maternal plasma samples of 9 male trisomy 18 fetuses than those of 27 male euploid fetuses (Mann-Whitney test, P=0.029). We defined the cutoff value for detecting trisomy 18 fetuses as mean+1.96 SD of the EGG ratios of the euploid cases. Eight of 9 trisomy 18 and 1 of 27 euploid cases showed EGG ratios higher than the cutoff value, giving a sensitivity of 88.9% and a specificity of 96.3%. Conclusions: Our data have shown that the methylated VAPA-APCDD1 DNA in maternal plasma is predominantly derived from the fetus. We have demonstrated that this novel fetal epigenetic marker in maternal plasma is useful for the noninvasive detection of fetal trisomy 18.	[Tsui, Dana W. Y.; Lam, Y. M. Doris; Lee, Wing S.; Lau, Tze K.; Chiu, Rossa W. K.; Lo, Y. M. Dennis; Chim, Stephen S. C.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Hong Kong, Hong Kong, Peoples R China; [Tsui, Dana W. Y.; Lam, Y. M. Doris; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Lee, Wing S.; Leung, Tak Y.; Lau, Tze K.; Chim, Stephen S. C.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Lau, Elizabeth T.; Tang, Mary H. Y.] Tsan Yuk Hosp, Prenatal Diagnost & Counselling Dept, Hong Kong, Hong Kong, Peoples R China; [Akolekar, Ranjit; Nicolaides, Kypros H.] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Tsui, DWY (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Hong Kong, Hong Kong, Peoples R China.	sschim@cuhk.edu.hk	Chim, Stephen SC/O-6271-2016; Tang, Mary Hoi Yin/A-7638-2013; Lo, Yuk Ming Dennis/D-4468-2011	Chim, Stephen SC/0000-0002-2152-7050; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Lau, Tze Kin/0000-0002-0242-1410; Nicolaides, Kypros/0000-0003-1266-0711	University Grants Committee of the Government of the Hong Kong, Special Administration Region, China [AoE/M-04/06]; Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK462909]; Li Ka Shing Foundation	University Grants Committee of the Government of the Hong Kong, Special Administration Region, China; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Li Ka Shing Foundation	This study was supported by the University Grants Committee of the Government of the Hong Kong, Special Administration Region, China, under the Areas of Excellence Scheme (AoE/M-04/06) and by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. CUHK462909). Y.M.D. Lo is supported by the Chair Professorship scheme of the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; CHAN KC, 2006, CLIN CHEM; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Diamandis EP, 2010, CLIN CHEM, V56, P1216, DOI 10.1373/clinchem.2010.148007; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lui YNYN, 2002, CLIN CHEM, V48, P421; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Old RW, 2007, REPROD BIOMED ONLINE, V15, P227, DOI 10.1016/S1472-6483(10)60713-4; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Ragoussis J, 2006, PLOS GENET, V2, P920, DOI 10.1371/journal.pgen.0020100; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tsui DWY, 2007, PRENATAL DIAG, V27, P1212, DOI 10.1002/pd.1897; Tsui NBY, 2010, CLIN CHEM, V56, P73, DOI 10.1373/clinchem.2009.132662; Tsui NBY, 2009, PRENATAL DIAG, V29, P1031, DOI 10.1002/pd.2340; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni012; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	38	23	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15069	10.1371/journal.pone.0015069	http://dx.doi.org/10.1371/journal.pone.0015069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152411	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100058
J	Xu, G; Wu, JY; Zhou, LL; Chen, BH; Sun, ZS; Zhao, FQ; Tao, ZH				Xu, Gang; Wu, Jinyu; Zhou, LingLin; Chen, Binghua; Sun, Zhongsheng; Zhao, Fangqing; Tao, Zhihua			Characterization of the Small RNA Transcriptomes of Androgen Dependent and Independent Prostate Cancer Cell Line by Deep Sequencing	PLOS ONE			English	Article							MOUSE MODEL; EXPRESSION; MECHANISMS; METASTASIS; MICRORNAS; MIR-29; FAMILY; GROWTH; ZEB1	Given the important roles of miRNA in post-transcriptional regulation and its implications for cancer, characterization of miRNA facilitates us to uncover molecular mechanisms underlying the progression of androgen-independent prostate cancer (PCa). The emergence of next-generation sequencing technologies has dramatically changed the speed of all aspects of sequencing in a rapid and cost-effective fashion, which can permit an unbiased, quantitive and in-depth investigation of small RNA transcriptome. In this study, we used high-throughput Illumina sequencing to comprehensively represent the full complement of individual small RNA and to characterize miRNA expression profiles in both the androgen dependent and independent Pca cell line. At least 83 miRNAs are significantly differentially expressed, of which 41 are up-regulated and 42 are down-regulated, indicating these miRNAs may be involved in the transition of LNCaP to an androgen-independent phenotype. In addition, we have identified 43 novel miRNAs from the androgen dependent and independent PCa library and 3 of them are specific to the androgen-independent PCa. Function annotation of target genes indicated that most of these differentially expressed miRNAs tend to target genes involved in signal transduction and cell communication, epically the MAPK signaling pathway. The small RNA transcriptomes obtained in this study provide considerable insights into a better understanding of the expression and function of small RNAs in the development of androgen-independent prostate cancer.	[Xu, Gang; Chen, Binghua; Tao, Zhihua] Wenzhou Med Coll, Ctr Clin Lab Diag, Affiliated Hosp 1, Wenzhou, Peoples R China; [Wu, Jinyu; Zhou, LingLin; Sun, Zhongsheng; Zhao, Fangqing] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China; [Sun, Zhongsheng] Chinese Acad Sci, Inst Psychol, Behav Genet Ctr, Beijing 100101, Peoples R China; [Zhao, Fangqing] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences	Xu, G (corresponding author), Wenzhou Med Coll, Ctr Clin Lab Diag, Affiliated Hosp 1, Wenzhou, Peoples R China.	sunzs@psych.ac.cn; fuz3@psu.edu; wwwtzh@wz.zj.cn	Zhao, Fangqing/P-6309-2019	Zhao, Fangqing/0000-0002-6216-1235	Zhejiang Provincial Natural Science Foundation of China [Y2100902]; Wenzhou Science and Technology Project [Y20100011]; Zhejiang Provincial Science and Technology Platform of Analysis and Testing Technology Projects [2009F82G2090045]; National High Technology Research and Development Program of China [2006AA02A304]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Wenzhou Science and Technology Project; Zhejiang Provincial Science and Technology Platform of Analysis and Testing Technology Projects; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the Zhejiang Provincial Natural Science Foundation of China (No. Y2100902), Wenzhou Science and Technology Project (Y20100011), Zhejiang Provincial Science and Technology Platform of Analysis and Testing Technology Projects (2009F82G2090045) and National High Technology Research and Development Program of China (2006AA02A304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; COPPOLA V, 2009, ENDOCR RELAT CANC; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Drake JM, 2009, MOL BIOL CELL, V20, P2207, DOI 10.1091/mbc.E08-10-1076; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gioeli D, 1999, CANCER RES, V59, P279; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu S, 1999, ENDOCRINOLOGY, V140, P5054, DOI 10.1210/en.140.11.5054; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Schroder FH, 2008, EUR UROL, V53, P1129, DOI 10.1016/j.eururo.2008.01.049; Shi XF, 2004, ACTA CRYSTALLOGR E, V60, pO1255, DOI 10.1107/S1600536804015107; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Tang Y, 2006, CLIN CANCER RES, V12, P169, DOI 10.1158/1078-0432.CCR-05-1388; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; White RWD, 2009, UROL ONCOL-SEMIN ORI, V27, P307, DOI 10.1016/j.urolonc.2009.01.004; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	33	64	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15519	10.1371/journal.pone.0015519	http://dx.doi.org/10.1371/journal.pone.0015519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152091	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100090
J	Zimmermann, M; Atmanene, C; Xu, QY; Fouillen, L; Van Dorsselaer, A; Bonnet, D; Marsol, C; Hibert, M; Sanglier-Cianferani, S; Pigault, C; McNamara, LK; Watterson, DM; Haiech, J; Kilhoffer, MC				Zimmermann, Michael; Atmanene, Cedric; Xu, Qingyan; Fouillen, Laetitia; Van Dorsselaer, Alain; Bonnet, Dominique; Marsol, Claire; Hibert, Marcel; Sanglier-Cianferani, Sarah; Pigault, Claire; McNamara, Laurie K.; Watterson, D. Martin; Haiech, Jacques; Kilhoffer, Marie-Claude			Homodimerization of the Death-Associated Protein Kinase Catalytic Domain: Development of a New Small Molecule Fluorescent Reporter	PLOS ONE			English	Article							TUMOR SUPPRESSION; CELL-DEATH; ZIP KINASE; CALMODULIN; APOPTOSIS; POLARIZATION	Background: Death-Associated Protein Kinase (DAPK) is a member of the Ca(2+)/calmodulin regulated serine/threonine protein kinases. Its biological function has been associated with induced cell death, and in vivo use of selective small molecule inhibitors of DAPK catalytic activity has demonstrated that it is a potential therapeutic target for treatment of brain injuries and neurodegenerative diseases. Methodology/Principal Findings: In the in vitro study presented here, we describe the homodimerization of DAPK catalytic domain and the crucial role played by its basic loop structure that is part of the molecular fingerprint of death protein kinases. Nanoelectrospray ionization mass spectrometry of DAPK catalytic domain and a basic loop mutant DAPK protein performed under a variety of conditions was used to detect the monomer-dimer interchange. A chemical biological approach was used to find a fluorescent probe that allowed us to follow the oligomerization state of the protein in solution. Conclusions/Significance: The use of this combined biophysical and chemical biology approach facilitated the elucidation of a monomer-dimer equilibrium in which the basic loop plays a key role, as well as an apparent allosteric conformational change reported by the fluorescent probe that is independent of the basic loop structure.	[Zimmermann, Michael; Xu, Qingyan; Bonnet, Dominique; Marsol, Claire; Hibert, Marcel; Pigault, Claire; Haiech, Jacques; Kilhoffer, Marie-Claude] Univ Strasbourg, Fac Pharm, Ctr Natl Rech Sci, Lab Innovat Therapeut,Unite Mixte Rech 7200, Illkirch Graffenstaden, France; [Atmanene, Cedric; Fouillen, Laetitia; Van Dorsselaer, Alain; Sanglier-Cianferani, Sarah] Univ Strasbourg, Ctr Natl Rech Sci, Unite Mixte Rech 7178,Lab Spectrometrie Masse Bio, Inst Pluridisciplinaire Hubert Curien,Dept Sci An, Strasbourg, France; [Xu, Qingyan] Xiamen Univ, Sch Sci, Xiamen, Fujian Province, Peoples R China; [McNamara, Laurie K.; Watterson, D. Martin] Northwestern Univ, Chicago, IL 60611 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Xiamen University; Northwestern University	Zimmermann, M (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	haiech@pharma.u-strasbg.fr	FOUILLEN, Laetitia/AAV-9710-2020; haiech, jacques J/F-2890-2010; Bonnet, Dominique/N-7275-2014	FOUILLEN, Laetitia/0000-0002-1204-9296; Bonnet, Dominique/0000-0002-8252-9199; Cianferani, Sarah/0000-0003-4013-4129; Zimmermann, Michael/0000-0002-5797-3589; haiech, jacques/0000-0003-2908-8053; Watterson, Daniel/0000-0001-7605-5866	Agence Nationale de Recherche (ANR); Centre National de la Recherche Scientifique (CNRS); University of Strasbourg; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031311] Funding Source: NIH RePORTER	Agence Nationale de Recherche (ANR)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by Agence Nationale de Recherche (ANR) programme caphe and by financial support from Centre National de la Recherche Scientifique (CNRS) and University of Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANG CD, 1978, INT J PEPT PROT RES, V11, P246; Dagher R, 2006, BBA-MOL CELL RES, V1763, P1250, DOI 10.1016/j.bbamcr.2006.09.027; de Diego I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000552; de la Torre JG, 2000, BIOPHYS J, V78, p401A; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; HIBERT M, 2006, Patent No. 2006003330; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; KILHOFFER MC, 1992, BIOCHEMISTRY-US, V31, P8098, DOI 10.1021/bi00149a046; Laue TM, 1992, COMPUTER AIDED INTER, P90; McNamara LK, 2009, ACTA CRYSTALLOGR D, V65, P241, DOI 10.1107/S0907444908043679; RINK H, 1987, TETRAHEDRON LETT, V28, P3787, DOI 10.1016/S0040-4039(00)96384-6; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher AM, 2004, BIOCHEMISTRY-US, V43, P8116, DOI 10.1021/bi049589v; Shani G, 2004, MOL CELL BIOL, V24, P8611, DOI 10.1128/MCB.24.19.8611-8626.2004; Shohat G, 2002, BBA-PROTEINS PROTEOM, V1600, P45, DOI 10.1016/S1570-9639(02)00443-0; Tereshko V, 2001, NAT STRUCT BIOL, V8, P899, DOI 10.1038/nsb1001-899; Velentza AV, 2003, BIOORG MED CHEM LETT, V13, P3465, DOI 10.1016/S0960-894X(03)00733-9; Velentza AV, 2001, J BIOL CHEM, V276, P38956, DOI 10.1074/jbc.M104273200	19	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14120	10.1371/journal.pone.0014120	http://dx.doi.org/10.1371/journal.pone.0014120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152427	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100006
J	Fiorentini, A; Rosi, MC; Grossi, C; Luccarini, I; Casamenti, F				Fiorentini, Anna; Rosi, Maria Cristina; Grossi, Cristina; Luccarini, Ilaria; Casamenti, Fiorella			Lithium Improves Hippocampal Neurogenesis, Neuropathology and Cognitive Functions in APP Mutant Mice	PLOS ONE			English	Article							ADULT NEUROGENESIS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; DENTATE GYRUS; NEWBORN NEURONS; BETA-CATENIN; MOUSE MODEL; DISRUPTION; STRATEGIES; REGULATORS	Background: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive deterioration of cognitive functions, extracellular beta-amyloid (Ab) plaques and intracellular neurofibrillary tangles within neocortex and hippocampus. Adult hippocampal neurogenesis plays an important role in learning and memory processes and its abnormal regulation might account for cognitive impairments associated with AD. Methodology/Principal Findings: The double transgenic (Tg) CRND8 mice (overexpressing the Swedish and Indiana mutations in the human amyloid precursor protein), aged 2 and 6 months, were used to examine in vivo the effects of 5 weeks lithium treatment. BrdU labelling showed a decreased neurogenesis in the subgranular zone of Tg mice compared to non-Tg mice. The decrease of hippocampal neurogenesis was accompanied by behavioural deficits and worsened with age and pathology severity. The differentiation into neurons and maturation of the proliferating cells were also markedly impaired in the Tg mice. Lithium treatment to 2-month-old Tg mice significantly stimulated the proliferation and neuron fate specification of newborn cells and fully counteracted the transgene-induced impairments of cognitive functions. The drug, by the inhibition of GSK-3 beta and subsequent activation of Wnt/ss-catenin signalling promoted hippocampal neurogenesis. Finally, the data show that the lithium's ability to stimulate neurogenesis and cognitive functions was lost in the aged Tg mice, thus indicating that the lithium-induced facilitation of neurogenesis and cognitive functions declines as brain Ab deposition and pathology increases. Conclusions: Lithium, when given on time, stimulates neurogenesis and counteracts AD-like pathology.	[Fiorentini, Anna; Rosi, Maria Cristina; Grossi, Cristina; Luccarini, Ilaria; Casamenti, Fiorella] Univ Florence, Dept Pharmacol, Florence, Italy	University of Florence	Fiorentini, A (corresponding author), Univ Florence, Dept Pharmacol, Florence, Italy.	fiorella.casamenti@unifi.it			Ministero dell'Istruzione, dell'Universita' e della Ricerca [PRIN2008R25HBW_01]; Universita' degli Studi di Firenze, Italy	Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Universita' degli Studi di Firenze, Italy	This work was supported by grants from Ministero dell'Istruzione, dell'Universita' e della Ricerca (PRIN2008R25HBW_01) and Universita' degli Studi di Firenze, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLUCCI A, 2006, NEUROBIOL DIS, V165, P1643; Bellucci A, 2007, NEUROBIOL DIS, V27, P328, DOI 10.1016/j.nbd.2007.06.008; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chuang TT, 2010, BBA-MOL BASIS DIS, V1802, P872, DOI 10.1016/j.bbadis.2009.12.008; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Grossi C, 2009, J ALZHEIMERS DIS, V17, P423, DOI 10.3233/JAD-2009-1063; Hampel H, 2009, J CLIN PSYCHIAT, V70, P922, DOI 10.4088/JCP.08m04606; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jagasia R, 2006, TRENDS MOL MED, V12, P400, DOI 10.1016/j.molmed.2006.07.006; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lovestone S, 1997, LANCET, V350, P232, DOI 10.1016/S0140-6736(05)62221-0; NAKATSU SL, 1974, NATURE, V248, P334, DOI 10.1038/248334a0; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Rowe MK, 2007, NEUROSCI BIOBEHAV R, V31, P920, DOI 10.1016/j.neubiorev.2007.03.002; Schaeffer EL, 2009, PROG NEURO-PSYCHOPH, V33, P1087, DOI 10.1016/j.pnpbp.2009.06.024; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Tariot PN, 2009, J CLIN PSYCHIAT, V70, P919, DOI 10.4088/JCP.09com05331; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; YAMAMOTO T, 1986, NEUROPATH APPL NEURO, V12, P3, DOI 10.1111/j.1365-2990.1986.tb00677.x; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	47	129	129	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14382	10.1371/journal.pone.0014382	http://dx.doi.org/10.1371/journal.pone.0014382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187954	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200008
J	Giri, PK; Tang, XH; Thangamani, S; Shenoy, RT; Ding, JL; Swaminathan, K; Sivaraman, J				Giri, Pankaj Kumar; Tang, Xuhua; Thangamani, Saravanan; Shenoy, Rajesh T.; Ding, Jeak Ling; Swaminathan, Kunchithapadam; Sivaraman, J.			Modifying the Substrate Specificity of Carcinoscorpius rotundicauda Serine Protease Inhibitor Domain 1 to Target Thrombin	PLOS ONE			English	Article							INNATE IMMUNITY; PROTEINASE-INHIBITORS; COMPLEX; SERPIN; DISCOVERY; SOFTWARE; HIRUDIN; DRUG	Protease inhibitors play a decisive role in maintaining homeostasis and eliciting antimicrobial activities. Invertebrates like the horseshoe crab have developed unique modalities with serine protease inhibitors to detect and respond to microbial and host proteases. Two isoforms of an immunomodulatory two-domain Kazal-like serine protease inhibitor, CrSPI-1 and CrSPI-2, have been recently identified in the hepatopancreas of the horseshoe crab, Carcinoscorpius rotundicauda. Full length and domain 2 of CrSPI-1 display powerful inhibitory activities against subtilisin. However, the structure and function of CrSPI-1 domain-1 (D1) remain unknown. Here, we report the crystal structure of CrSPI-1-D1 refined up to 2.0 angstrom resolution. Despite the close structural homology of CrSPI-1-D1 to rhodniin-D1 (a known thrombin inhibitor), the CrSPI-1-D1 does not inhibit thrombin. This prompted us to modify the selectivity of CrSPI-1-D1 specifically towards thrombin. We illustrate the use of structural information of CrSPI-1-D1 to modify this domain into a potent thrombin inhibitor with IC50 of 26.3 nM. In addition, these studies demonstrate that, besides the rigid conformation of the reactive site loop of the inhibitor, the sequence is the most important determinant of the specificity of the inhibitor. This study will lead to the significant application to modify a multi-domain inhibitor protein to target several proteases.	[Giri, Pankaj Kumar; Tang, Xuhua; Thangamani, Saravanan; Shenoy, Rajesh T.; Ding, Jeak Ling; Swaminathan, Kunchithapadam; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Giri, PK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsdjl@nus.edu.sg; dbsks@nus.edu.sg; dbsjayar@nus.edu.sg	Ding, Jeak/H-8057-2012; Shenoy, Rajesh/ABD-3976-2020; Thangamani, Saravanan/E-7371-2010; Sivaraman, J/H-8028-2012	Shenoy, Rajesh/0000-0002-5035-8321; Thangamani, Saravanan/0000-0002-4269-5993; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council of Singapore (BMRC); A*STAR Singapore [R154000362305]	Biomedical Research Council of Singapore (BMRC)(Agency for Science Technology & Research (A*STAR)); A*STAR Singapore(Agency for Science Technology & Research (A*STAR))	Biomedical Research Council of Singapore (BMRC) and A*STAR Singapore (R154000362305) provided financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PB, 2001, TRENDS IMMUNOL, V22, P47, DOI 10.1016/S1471-4906(00)01803-2; Barrette-Ng IH, 2003, J BIOL CHEM, V278, P31391, DOI 10.1074/jbc.M304562200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; De Simone G, 1999, BIOPOLYMERS, V51, P19, DOI 10.1002/(SICI)1097-0282(1999)51:1<19::AID-BIP4>3.0.CO;2-G; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; DING JL, 1993, BIOCHIM BIOPHYS ACTA, V1202, P149, DOI 10.1016/0167-4838(93)90076-4; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gurm HS, 2005, AM HEART J, V149, pS43, DOI 10.1016/j.ahj.2004.10.022; Hemmi H, 2005, BIOCHEMISTRY-US, V44, P9626, DOI 10.1021/bi0472806; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; IKEO K, 1995, J MOL EVOL, V40, P331, DOI 10.1007/BF00163238; Jiang N, 2009, J INNATE IMMUN, V1, P465, DOI 10.1159/000209224; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Leblond J, 2006, THROMB HAEMOSTASIS, V95, P243, DOI 10.1160/TH05-08-0561; Markwardt F, 2002, PATHOPHYSIOL HAEMO T, V32, P15, DOI 10.1159/000069104; MARKWARDT F, 1994, THROMB RES, V74, P1, DOI 10.1016/0049-3848(94)90032-9; Maynes JT, 2005, ACTA CRYSTALLOGR D, V61, P580, DOI 10.1107/S0907444905004889; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; OCHMAN H, 1988, GENETICS, V120, P621; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfau R, 2003, CURR OPIN DRUG DISC, V6, P437; Richer MJ, 2004, P NATL ACAD SCI USA, V101, P10560, DOI 10.1073/pnas.0401406101; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Salzet M, 2001, TRENDS IMMUNOL, V22, P285, DOI 10.1016/S1471-4906(01)01895-6; Steinmetzer T, 2001, EXPERT OPIN INV DRUG, V10, P845, DOI 10.1517/13543784.10.5.845; Stubbs MT, 1997, J BIOL CHEM, V272, P19931, DOI 10.1074/jbc.272.32.19931; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vacca JP, 2000, CURR OPIN CHEM BIOL, V4, P394, DOI 10.1016/S1367-5931(00)00112-5; VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x; Weitz JI, 2002, THROMB RES, V106, pV275, DOI 10.1016/S0049-3848(02)00093-2	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15258	10.1371/journal.pone.0015258	http://dx.doi.org/10.1371/journal.pone.0015258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188150	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200027
J	Wascher, CAF; Fraser, ON; Kotrschal, K				Wascher, Claudia A. F.; Fraser, Orlaith N.; Kotrschal, Kurt			Heart Rate during Conflicts Predicts Post-Conflict Stress-Related Behavior in Greylag Geese	PLOS ONE			English	Article							PASSIVE SOCIAL SUPPORT; DISPLACEMENT ACTIVITIES; ANSER-ANSER; RECONCILIATION; RESPONSES; CONSOLATION; VASOTOCIN; STARLINGS; FAMILIES; EMOTION	Background: Social stressors are known to be among the most potent stressors in group-living animals. This is not only manifested in individual physiology (heart rate, glucocorticoids), but also in how individuals behave directly after a conflict. Certain 'stress-related behaviors' such as autopreening, body shaking, scratching and vigilance have been suggested to indicate an individual's emotional state. Such behaviors may also alleviate stress, but the behavioral context and physiological basis of those behaviors is still poorly understood. Methodology/Principal Findings: We recorded beat-to-beat heart rates (HR) of 22 greylag geese in response to agonistic encounters using fully implanted sensor-transmitter packages. Additionally, for 143 major events we analyzed the behavior shown by our focal animals in the first two minutes after an interaction. Our results show that the HR during encounters and characteristics of the interaction predicted the frequency and duration of behaviors shown after a conflict. Conclusions/Significance: To our knowledge this is the first study to quantify the physiological and behavioral responses to single agonistic encounters and to link this to post conflict behavior. Our results demonstrate that 'stress-related behaviors' are flexibly modulated by the characteristics of the preceding aggressive interaction and reflect the individual's emotional strain, which is linked to autonomic arousal. We found no support for the stress-alleviating hypothesis, but we propose that stress-related behaviors may play a role in communication with other group members, particularly with pair-partners.	[Wascher, Claudia A. F.; Kotrschal, Kurt] Univ Vienna, Konrad Lorenz Forsch Stelle, Vienna, Austria; [Wascher, Claudia A. F.; Kotrschal, Kurt] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Wascher, Claudia A. F.; Fraser, Orlaith N.] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Wascher, CAF (corresponding author), Univ Vienna, Konrad Lorenz Forsch Stelle, Vienna, Austria.	claudia.wascher@klf.ac.at	Wascher, Claudia/L-4005-2015	Wascher, Claudia/0000-0003-4360-363X	Fonds zur Forderung der wissenschaftlichen Forschung [15766-B03, 21489-B17]; Austrian Science Fund (FWF) [P 21489] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by "Fonds zur Forderung der wissenschaftlichen Forschung'' projects 15766-B03 and 21489-B17 to K. Kotrschal (www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F, 2010, BIOL LETTERS, V6, P27, DOI 10.1098/rsbl.2009.0513; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butovskaya ML, 2008, BEHAVIOUR, V145, P1557, DOI 10.1163/156853908786131342; Castles DL, 1998, ETHOLOGY, V104, P126; Castles DL, 1999, ANIM BEHAV, V58, P1207, DOI 10.1006/anbe.1999.1250; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Hemetsberger J, 2010, INTERACT STUD, V11, P380, DOI 10.1075/is.11.3.03hem; Johnstone RA, 2001, P NATL ACAD SCI USA, V98, P9177, DOI 10.1073/pnas.161058798; Kalueff AV, 2004, BRAIN RES PROTOC, V13, P151, DOI 10.1016/j.brainresprot.2004.04.002; Kotrschal K, 2010, ANIMAL BEHAV EVOLUTI, P121; Kutsukake N, 2001, Anim Cogn, V4, P259, DOI 10.1007/s10071-001-0119-2; Kutsukake N, 2006, ETHOLOGY, V112, P581, DOI 10.1111/j.1439-0310.2006.01200.x; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Major P, 1998, PHYSIOL BEHAV, V63, P381, DOI 10.1016/S0031-9384(97)00454-X; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Nephew BC, 2003, HORM BEHAV, V44, P222, DOI 10.1016/j.yhbeh.2003.06.002; Nephew BC, 2003, GEN COMP ENDOCR, V133, P173, DOI 10.1016/S0016-6480(03)00165-5; Nephew BC, 2005, HORM BEHAV, V47, P280, DOI 10.1016/j.yhbeh.2004.11.007; Parr LA, 2005, CURR OPIN NEUROBIOL, V15, P716, DOI 10.1016/j.conb.2005.10.017; Peake Tom M., 2006, P13; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prinzinger R, 2002, J ORNITHOL, V143, P456, DOI 10.1046/j.1439-0361.2002.02039.x; Riters LV, 1997, ANN NY ACAD SCI, V807, P478, DOI 10.1111/j.1749-6632.1997.tb51943.x; Scheiber IBR, 2005, BEHAVIOUR, V142, P1535, DOI 10.1163/156853905774831873; Scheiber IBR, 2005, ANN NY ACAD SCI, V1046, P154, DOI 10.1196/annals.1343.012; Scheiber IBR, 2009, ANIM BEHAV, V77, P1211, DOI 10.1016/j.anbehav.2009.01.026; Scheiber IBR, 2009, HORM BEHAV, V55, P133, DOI 10.1016/j.yhbeh.2008.09.006; Schino G, 1996, ANXIETY, V2, P186; Spoor JR, 2004, GROUP PROCESS INTERG, V7, P398, DOI 10.1177/1368430204046145; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; WASCHER AFC, J COMP PSYC IN PRESS; Wascher CAF, 2008, P ROY SOC B-BIOL SCI, V275, P1653, DOI 10.1098/rspb.2008.0146; Wascher CAF, 2008, J COMP PSYCHOL, V122, P100, DOI 10.1037/0735-7036.122.1.100; Wascher CAF, 2009, ANIM BEHAV, V77, P955, DOI 10.1016/j.anbehav.2009.01.013; Weiss BM, 2004, ETHOLOGY, V110, P429, DOI 10.1111/j.1439-0310.2004.00979.x; [No title captured]	45	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15751	10.1371/journal.pone.0015751	http://dx.doi.org/10.1371/journal.pone.0015751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187927	Green Published, gold			2022-12-27	WOS:000285575200068
J	Wicklund, L; Leao, RN; Stromberg, AM; Mousavi, M; Hovatta, O; Nordberg, A; Marutle, A				Wicklund, Linn; Leao, Richardson N.; Stromberg, Anne-Marie; Mousavi, Malahat; Hovatta, Outi; Nordberg, Agneta; Marutle, Amelia			beta-Amyloid 1-42 Oligomers Impair Function of Human Embryonic Stem Cell-Derived Forebrain Cholinergic Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; SUBVENTRICULAR ZONE; NICOTINIC RECEPTORS; SIGNALING PATHWAY; PROGENITOR CELLS; PRECURSOR CELLS; MOUSE-BRAIN; LINES	Cognitive impairment in Alzheimer's disease (AD) patients is associated with a decline in the levels of growth factors, impairment of axonal transport and marked degeneration of basal forebrain cholinergic neurons (BFCNs). Neurogenesis persists in the adult human brain, and the stimulation of regenerative processes in the CNS is an attractive prospect for neuroreplacement therapy in neurodegenerative diseases such as AD. Currently, it is still not clear how the pathophysiological environment in the AD brain affects stem cell biology. Previous studies investigating the effects of the beta-amyloid (A beta) peptide on neurogenesis have been inconclusive, since both neurogenic and neurotoxic effects on progenitor cell populations have been reported. In this study, we treated pluripotent human embryonic stem (hES) cells with nerve growth factor (NGF) as well as with fibrillar and oligomeric A beta(1-40) and A beta(1-42) (nM-mu M concentrations) and thereafter studied the differentiation in vitro during 28-35 days. The process applied real time quantitative PCR, immunocytochemistry as well as functional studies of intracellular calcium signaling. Treatment with NGF promoted the differentiation into functionally mature BFCNs. In comparison to untreated cells, oligomeric Ab(1-40) increased the number of functional neurons, whereas oligomeric A beta(1-42) suppressed the number of functional neurons. Interestingly, oligomeric Ab exposure did not influence the number of hES cell-derived neurons compared with untreated cells, while in contrast fibrillar A beta(1-40) and A beta(1-42) induced gliogenesis. These findings indicate that A beta(1-42) oligomers may impair the function of stem cell-derived neurons. We propose that it may be possible for future AD therapies to promote the maturation of functional stem cell-derived neurons by altering the brain microenvironment with trophic support and by targeting different aggregation forms of A beta.	[Wicklund, Linn; Mousavi, Malahat; Nordberg, Agneta; Marutle, Amelia] Karolinska Inst, Div Alzheimer Neurobiol, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Leao, Richardson N.] Karolinska Inst, Neuronal Oscillat Lab, Dept Neurosci, Stockholm, Sweden; [Stromberg, Anne-Marie; Hovatta, Outi] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Nordberg, Agneta] Karolinska Univ Hosp Huddinge, Dept Geriatr Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Wicklund, L (corresponding author), Karolinska Inst, Div Alzheimer Neurobiol, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	amelia.marutle@ki.se	Leao, Richardson/AAX-4985-2020; nordberg, agneta/ABD-2479-2021	Leao, Richardson/0000-0001-8496-1965; Nordberg, Agneta/0000-0001-7345-5151	Swedish Research Council [05871, K2010-54X-15080-07-5]; Stockholm County Council-Karolinska Institute; Karolinska Institutet Strategic Neuroscience Program; Swedish Brain Foundation; Swedish Brain Power; Magnus Bergvalls Foundation; KI Foundations; Johnson Johnson; European Union; Foundation for Old Servants; Gun and Bertil Stohnes Foundation; Dementia Association; Alzheimer Foundation in Sweden; Lars Hierta Memorial Foundation; Olle Engkvist Byggmastare Foundation; International Human Frontier Science Program Organization	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council-Karolinska Institute(Karolinska Institutet); Karolinska Institutet Strategic Neuroscience Program; Swedish Brain Foundation; Swedish Brain Power; Magnus Bergvalls Foundation; KI Foundations; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); European Union(European Commission); Foundation for Old Servants; Gun and Bertil Stohnes Foundation; Dementia Association; Alzheimer Foundation in Sweden; Lars Hierta Memorial Foundation; Olle Engkvist Byggmastare Foundation; International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by the Swedish Research Council (project 05871 and K2010-54X-15080-07-5), Stockholm County Council-Karolinska Institute (ALF grants), the Karolinska Institutet Strategic Neuroscience Program, Swedish Brain Foundation, Swedish Brain Power, Magnus Bergvalls Foundation, KI Foundations, an academic grant from Johnson & Johnson administered through the Karolinska Institutet, the ESTOOLS consortium under the Sixth Research Framework Program of the European Union, the Foundation for Old Servants, Gun and Bertil Stohnes Foundation, The Dementia Association, Alzheimer Foundation in Sweden, The Lars Hierta Memorial Foundation and Olle Engkvist Byggmastare Foundation. RNL is supported by a long-term fellowship from the International Human Frontier Science Program Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bruno MA, 2009, J NEUROPATH EXP NEUR, V68, P857, DOI 10.1097/NEN.0b013e3181aed9e6; Calafiore M, 2006, NEUROBIOL AGING, V27, P606, DOI 10.1016/j.neurobiolaging.2005.03.019; Capsoni S, 2006, CELL MOL NEUROBIOL, V26, P619, DOI 10.1007/s10571-006-9112-2; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen Y, 2009, CELL DEATH DIFFER, V16, P386, DOI 10.1038/cdd.2008.94; Cuello AC, 2010, J MOL NEUROSCI, V40, P230, DOI 10.1007/s12031-009-9238-z; Eglen R. M., 2006, Autonomic & Autacoid Pharmacology, V26, P219, DOI 10.1111/j.1474-8673.2006.00368.x; ERIKSDOTTER JM, 1998, DEMENT GERIATR COGN, V9, P246, DOI DOI 10.1159/000017069; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; Heese K, 2006, NEUROSIGNALS, V15, P1, DOI 10.1159/000094383; Heo C, 2007, J NEUROCHEM, V102, P493, DOI 10.1111/j.1471-4159.2007.04499.x; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Madziar B, 2008, J NEUROCHEM, V107, P1284, DOI 10.1111/j.1471-4159.2008.05681.x; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Muotri AR, 2005, P NATL ACAD SCI USA, V102, P18644, DOI 10.1073/pnas.0509315102; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Nilbratt M, 2010, J CELL MOL MED, V14, P1476, DOI 10.1111/j.1582-4934.2009.00916.x; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Paraoanu LE, 2007, LIFE SCI, V80, P2375, DOI 10.1016/j.lfs.2007.03.008; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Strom S, 2010, IN VITRO CELL DEV-AN, V46, P337, DOI 10.1007/s11626-010-9308-0; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Waldau B, 2008, CELL MOL LIFE SCI, V65, P2372, DOI 10.1007/s00018-008-8053-y; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yu WF, 2005, EXP NEUROL, V192, P215, DOI 10.1016/j.expneurol.2004.12.015	42	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15600	10.1371/journal.pone.0015600	http://dx.doi.org/10.1371/journal.pone.0015600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179413	Green Published, Green Submitted, gold			2022-12-27	WOS:000285572900023
J	Bjork, BC; Fujiwara, Y; Davis, SW; Qiu, HY; Saunders, TL; Sandy, P; Orkin, S; Camper, SA; Beier, DR				Bjork, Bryan C.; Fujiwara, Yuko; Davis, Shannon W.; Qiu, Haiyan; Saunders, Thomas L.; Sandy, Peter; Orkin, Stuart; Camper, Sally A.; Beier, David R.			A Transient Transgenic RNAi Strategy for Rapid Characterization of Gene Function during Embryonic Development	PLOS ONE			English	Article							BEAUTY TRANSPOSON SYSTEM; SLEEPING-BEAUTY; MAMMALIAN-CELLS; LENTIVIRAL VECTORS; STEM-CELLS; MICE; INTERFERENCE; EXPRESSION; MUTATIONS; MOUSE	RNA interference (RNAi) is a powerful strategy for studying the phenotypic consequences of reduced gene expression levels in model systems. To develop a method for the rapid characterization of the developmental consequences of gene dysregulation, we tested the use of RNAi for "transient transgenic" knockdown of mRNA in mouse embryos. These methods included lentiviral infection as well as transposition using the Sleeping Beauty (SB) and PiggyBac (PB) transposable element systems. This approach can be useful for phenotypic validation of putative mutant loci, as we demonstrate by confirming that knockdown of Prdm16 phenocopies the ENU-induced cleft palate (CP) mutant, csp1. This strategy is attractive as an alternative to gene targeting in embryonic stem cells, as it is simple and yields phenotypic information in a matter of weeks. Of the three methodologies tested, the PB transposon system produced high numbers of transgenic embryos with the expected phenotype, demonstrating its utility as a screening method.	[Bjork, Bryan C.; Qiu, Haiyan; Beier, David R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Fujiwara, Yuko; Orkin, Stuart] Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Div Hematol & Oncol, Boston, MA 02115 USA; [Davis, Shannon W.; Saunders, Thomas L.; Camper, Sally A.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Davis, Shannon W.; Saunders, Thomas L.; Camper, Sally A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Sandy, Peter] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT)	Bjork, BC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA.	beier@receptor.med.harvard.edu		Saunders, Thom/0000-0003-2015-101X; Camper, Sally/0000-0001-8556-3379	University of Michigan Cancer Center (National Institutes of Health (NIH)) [CA46592]; University of Michigan Multipurpose Arthritis Center (NIH) [AR20557]; University of Michigan Center for Organogenesis; University of Michigan Gut Peptide Research Center (NIH) [DK34933]; University of Michigan Nathan Shock Center for the Biology of Aging (NIH) [P30AG013283]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000815]; NIH [R01HD34283, R37HD30428];  [F32HD045066];  [K12DE014528];  [RO1HD36404];  [R01MH081187]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036404, R01HD034283] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD045066, R37HD030428] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K12DE014528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	University of Michigan Cancer Center (National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Multipurpose Arthritis Center (NIH)(University of Michigan SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Center for Organogenesis(University of Michigan System); University of Michigan Gut Peptide Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Nathan Shock Center for the Biology of Aging (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Core support was provided by the University of Michigan Cancer Center (National Institutes of Health (NIH) grant CA46592), the University of Michigan Multipurpose Arthritis Center (NIH grant AR20557), the University of Michigan Center for Organogenesis, the University of Michigan Gut Peptide Research Center (NIH grant DK34933), the University of Michigan Nathan Shock Center for the Biology of Aging (NIH grant P30AG013283), and the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000815). SW Davis and SA Camper were supported by NIH grants R01HD34283 and R37HD30428. BC Bjork was supported by F32HD045066 and K12DE014528. BC Bjork, H Qiu, and DR Beier were supported by RO1HD36404 and R01MH081187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2006, HUM MOL GENET, V15, pR75, DOI 10.1093/hmg/ddl061; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Geurts AM, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-30; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heggestad AD, 2004, BIOCHEM BIOPH RES CO, V316, P643, DOI 10.1016/j.bbrc.2004.02.090; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Ikeda R, 2007, MOL CELL BIOL, V27, P1665, DOI 10.1128/MCB.01500-06; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Kirilov M, 2007, TRANSGENIC RES, V16, P783, DOI 10.1007/s11248-007-9119-6; Makinen PI, 2006, J GENE MED, V8, P433, DOI 10.1002/jgm.860; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miskey C, 2005, CELL MOL LIFE SCI, V62, P629, DOI 10.1007/s00018-004-4232-7; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Nagy A., 2003, MANIPULATING MOUSE E; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Park CW, 2005, GENES CELLS, V10, P763, DOI 10.1111/j.1365-2443.2005.00875.x; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sager JJ, 2010, BRAIN STRUCT FUNCT, V214, P285, DOI 10.1007/s00429-009-0237-1; Sandy P, 2005, BIOTECHNIQUES, V39, P215, DOI 10.2144/05392RV01; Singer O, 2006, NAT PROTOC, V1, P286, DOI 10.1038/nprot.2006.44; Wang N, 2007, J BIOMED SCI, V14, P767, DOI 10.1007/s11373-007-9189-8; Wilber A, 2006, MOL THER, V13, P625, DOI 10.1016/j.ymthe.2005.10.014; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yu Q, 2004, DEVELOPMENT, V131, P6211, DOI 10.1242/dev.01543; Yusa K, 2004, MOL CELL BIOL, V24, P4004, DOI 10.1128/MCB.24.9.4004-4018.2004; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219	42	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14375	10.1371/journal.pone.0014375	http://dx.doi.org/10.1371/journal.pone.0014375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179568	Green Published, Green Submitted, gold			2022-12-27	WOS:000285381200016
J	Reiner, JE; Kishore, RB; Levin, BC; Albanetti, T; Boire, N; Knipe, A; Helmerson, K; Deckman, KH				Reiner, Joseph E.; Kishore, Rani B.; Levin, Barbara C.; Albanetti, Thomas; Boire, Nicholas; Knipe, Ashley; Helmerson, Kristian; Deckman, Koren Holland			Detection of Heteroplasmic Mitochondrial DNA in Single Mitochondria	PLOS ONE			English	Article							STANDARD REFERENCE MATERIAL; MTDNA GENOME; CHROMOSOME; DISEASE; MANIPULATION; ORGANIZATION; ORGANELLES; MUTATIONS; SEQUENCE	Background: Mitochondrial DNA (mtDNA) genome mutations can lead to energy and respiratory-related disorders like myoclonic epilepsy with ragged red fiber disease (MERRF), mitochondrial myopathy, encephalopathy, lactic acidosis and stroke (MELAS) syndrome, and Leber's hereditary optic neuropathy (LHON). It is not well understood what effect the distribution of mutated mtDNA throughout the mitochondrial matrix has on the development of mitochondrial-based disorders. Insight into this complex sub-cellular heterogeneity may further our understanding of the development of mitochondria-related diseases. Methodology: This work describes a method for isolating individual mitochondria from single cells and performing molecular analysis on that single mitochondrion's DNA. An optical tweezer extracts a single mitochondrion from a lysed human HL-60 cell. Then a micron-sized femtopipette tip captures the mitochondrion for subsequent analysis. Multiple rounds of conventional DNA amplification and standard sequencing methods enable the detection of a heteroplasmic mixture in the mtDNA from a single mitochondrion. Significance: Molecular analysis of mtDNA from the individually extracted mitochondrion demonstrates that a heteroplasmy is present in single mitochondria at various ratios consistent with the 50/50 heteroplasmy ratio found in single cells that contain multiple mitochondria.	[Reiner, Joseph E.; Kishore, Rani B.; Helmerson, Kristian] NIST, Phys Measurement Lab, Gaithersburg, MD 20899 USA; [Levin, Barbara C.] NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA; [Albanetti, Thomas; Boire, Nicholas; Knipe, Ashley; Deckman, Koren Holland] Gettysburg Coll, Dept Chem, Gettysburg, PA 17325 USA	National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; Gettysburg College	Reiner, JE (corresponding author), NIST, Phys Measurement Lab, Gaithersburg, MD 20899 USA.	joseph.reiner@nist.gov	Helmerson, Kristian/E-3683-2013; Reiner, Joseph/B-7893-2013	Helmerson, Kristian/0000-0002-6387-0949; Reiner, Joseph/0000-0002-1056-8703				Agarwal A, 2007, ANAL CHEM, V79, P3589, DOI 10.1021/ac062049e; Agarwal R, 2005, OPT EXPRESS, V13, P8906, DOI 10.1364/OPEX.13.008906; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; BERNS MW, 1989, P NATL ACAD SCI USA, V86, P4539, DOI 10.1073/pnas.86.12.4539; Butler JM, 1998, TRENDS BIOTECHNOL, V16, P158, DOI 10.1016/S0167-7799(98)01173-1; Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen Y, 2007, ELECTROPHORESIS, V28, P2406, DOI 10.1002/elps.200600628; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Dahl HHM, 2001, AM J MED GENET, V106, P1, DOI 10.1002/ajmg.1427; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dufresne ER, 2001, REV SCI INSTRUM, V72, P1810, DOI 10.1063/1.1344176; Fuller KM, 2003, CURR OPIN BIOTECH, V14, P35, DOI 10.1016/S0958-1669(02)00008-3; Gertz EM, 2005, BLAST SCORING PARAME; Greaves LC, 2006, IUBMB LIFE, V58, P143, DOI 10.1080/15216540600686888; Jeffries GDM, 2007, NANO LETT, V7, P415, DOI 10.1021/nl0626784; Kuroiwa T, 1996, PROTOPLASMA, V194, P275, DOI 10.1007/BF01882033; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Levin BC, 2003, MITOCHONDRION, V2, P387, DOI 10.1016/S1567-7249(03)00010-2; Levin BC, 1999, GENOMICS, V55, P135, DOI 10.1006/geno.1998.5513; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Nambiar R, 2002, OPT LETT, V27, P836, DOI 10.1364/OL.27.000836; Niu H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000774; Pauzauskie PJ, 2006, NAT MATER, V5, P97, DOI 10.1038/nmat1563; Poe BG, 2010, ANAL BIOANAL CHEM, V397, P3397, DOI 10.1007/s00216-010-3751-3; Resnick A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316378; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Shelby JP, 2005, PHOTOCHEM PHOTOBIOL, V81, P994, DOI 10.1562/2005-02-02-RA-431R1.1; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Tang H, 2007, OPT EXPRESS, V15, P12708, DOI 10.1364/OE.15.012708; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VOROBJEV IA, 1993, BIOPHYS J, V64, P533, DOI 10.1016/S0006-3495(93)81398-5; Wang HW, 2004, J OPT A-PURE APPL OP, V6, P89, DOI 10.1088/1464-4258/6/1/016; Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113	38	20	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14359	10.1371/journal.pone.0014359	http://dx.doi.org/10.1371/journal.pone.0014359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179558	gold, Green Published			2022-12-27	WOS:000285381200009
J	Yi, Y; Ma, Y; Gao, F; Mao, XH; Peng, H; Feng, YJ; Fan, Z; Wang, GH; Guo, G; Yan, JH; Zeng, H; Zou, QM; Gao, GF				Yi, Yong; Ma, Ying; Gao, Feng; Mao, Xuhu; Peng, Hao; Feng, Youjun; Fan, Zheng; Wang, Guihua; Guo, Gang; Yan, Jinghua; Zeng, Hao; Zou, Quanming; Gao, George F.			Crystal Structure of EHEC Intimin: Insights into the Complementarity between EPEC and EHEC	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; TIR; RECEPTOR; O157-H7; CRYSTALLIZATION; RECOGNITION; ATTACHMENT; EVOLUTION; INFECTION; ADHESION	Enterohaemorrhagic E. coli (EHEC) O157:H7 is a primary food-borne bacterial pathogen capable of causing life-threatening human infections which poses a serious challenge to public health worldwide. Intimin, the bacterial outer-membrane protein, plays a key role in the initiating process of EHEC infection. This activity is dependent upon translocation of the intimin receptor (Tir), the intimin binding partner of the bacteria-encoded host cell surface protein. Intimin has attracted considerable attention due to its potential function as an antibacterial drug target. Here, we report the crystal structure of the Tir-binding domain of intimin (Int188) from E. coli O157: H7 at 2.8 angstrom resolution, together with a mutant (IntN916Y) at 2.6 angstrom. We also built the structural model of EHEC intimin-Tir complex and analyzed the key binding residues. It suggested that the binding pattern of intimin and Tir between EHEC and Enteropathogenic E. coli (EPEC) adopt a similar mode and they can complement with each other. Detailed structural comparison indicates that there are four major points of structural variations between EHEC and EPEC intimins: one in Domain I (Ig-like domain), the other three located in Domain II (C-type lectin-like domain). These variations result in different binding affinities. These findings provide structural insight into the binding pattern of intimin to Tir and the molecular mechanism of EHEC O157: H7.	[Yi, Yong; Ma, Ying; Mao, Xuhu; Guo, Gang; Zeng, Hao; Zou, Quanming] Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Clin Immunol, Chongqing, Peoples R China; [Ma, Ying; Peng, Hao; Feng, Youjun; Fan, Zheng; Wang, Guihua; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Yi, Yong] 306th Hosp PLA, Beijing, Peoples R China; [Feng, Youjun; Wang, Guihua] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Yi, Yong; Peng, Hao; Feng, Youjun; Fan, Zheng; Wang, Guihua; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China; [Gao, Feng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Army Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences	Yi, Y (corresponding author), Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Clin Immunol, Chongqing, Peoples R China.	qmzou@mail.tmmu.com.cn; gaof@im.ac.cn	Feng, Youjun/I-4134-2012; Gao, George Fu/ABD-5229-2021		National Natural Science Foundation of China (NSFC) [30670167, 30770514]; China-Japan Joint Laboratory of Molecular Immunology and Molecular Microbiology; Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology)	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China-Japan Joint Laboratory of Molecular Immunology and Molecular Microbiology; Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from National Natural Science Foundation of China (NSFC) (30670167 and 30770514). The China-Japan Joint Laboratory of Molecular Immunology and Molecular Microbiology is, in part, supported by Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology). GFG is a leading principal investigator of the NSFC Innovative Research Group (81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Bobie J, 1998, J CLIN MICROBIOL, V36, P662, DOI 10.1128/JCM.36.3.662-668.1998; Babol-Pokora Katarzyna, 2009, Arch Med Sadowej Kryminol, V59, P118; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batchelor M, 2000, EMBO J, V19, P2452, DOI 10.1093/emboj/19.11.2452; Bell C, 2002, INT J FOOD MICROBIOL, V78, P197, DOI 10.1016/S0168-1605(02)00188-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celli J, 2000, CELL MICROBIOL, V2, P1, DOI 10.1046/j.1462-5822.2000.00033.x; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; HENDERSON S, AUST N Z J PSYCHIAT, V44, P1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Kenny B, 1999, MOL MICROBIOL, V31, P1229, DOI 10.1046/j.1365-2958.1999.01265.x; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; La Ragione RM, 2005, J MED MICROBIOL, V54, P485, DOI 10.1099/jmm.0.45897-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu H, 2002, MOL MICROBIOL, V45, P1557, DOI 10.1046/j.1365-2958.2002.03137.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Oswald E, 2000, INFECT IMMUN, V68, P64, DOI [10.1128/IAI.68.1.64-71.2000, 10.1128/IAI.68.11.6402-6410.2000]; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Soderstrom A., 2005, EURO SURVEILL, V10; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Wang HX, 2004, ELECTROCHEM SOLID ST, V7, pA302, DOI 10.1149/1.1789831; Watanabe Y, 1999, EMERG INFECT DIS, V5, P424, DOI 10.3201/eid0503.990313; Welinder-Olsson C, 2005, SCAND J INFECT DIS, V37, P405, DOI 10.1080/00365540510038523; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; Zhou MH, 2004, ACTA CRYSTALLOGR D, V60, P1473, DOI 10.1107/S0907444904013587; 2009, CRYSTALCLEAR CRYSTAL	34	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15285	10.1371/journal.pone.0015285	http://dx.doi.org/10.1371/journal.pone.0015285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179574	Green Published, Green Submitted, gold			2022-12-27	WOS:000285381200023
J	Dauvillee, D; Delhaye, S; Gruyer, S; Slomianny, C; Moretz, SE; d'Hulst, C; Long, CA; Ball, SG; Tomavo, S				Dauvillee, David; Delhaye, Stephane; Gruyer, Sebastien; Slomianny, Christian; Moretz, Samuel E.; d'Hulst, Christophe; Long, Carole A.; Ball, Steven G.; Tomavo, Stanislas			Engineering the Chloroplast Targeted Malarial Vaccine Antigens in Chlamydomonas Starch Granules	PLOS ONE			English	Article							BLOOD-STAGE VACCINE; PLASMODIUM-FALCIPARUM; IN-VITRO; BIOSYNTHESIS; PARASITE; INVASION; AMYLOSE	Background: Malaria, an Anopheles-borne parasitic disease, remains a major global health problem causing illness and death that disproportionately affects developing countries. Despite the incidence of malaria, which remains one of the most severe infections of human populations, there is no licensed vaccine against this life-threatening disease. In this context, we decided to explore the expression of Plasmodium vaccine antigens fused to the granule bound starch synthase (GBSS), the major protein associated to the starch matrix in all starch-accumulating plants and algae such as Chlamydomonas reinhardtii. Methods and Findings: We describe the development of genetically engineered starch granules containing plasmodial vaccine candidate antigens produced in the unicellular green algae Chlamydomonas reinhardtii. We show that the C-terminal domains of proteins from the rodent Plasmodium species, Plasmodium berghei Apical Major Antigen AMA1, or Major Surface Protein MSP1 fused to the algal granule bound starch synthase (GBSS) are efficiently expressed and bound to the polysaccharide matrix. Mice were either immunized intraperitoneally with the engineered starch particles and Freund adjuvant, or fed with the engineered particles co-delivered with the mucosal adjuvant, and challenged intraperitoneally with a lethal inoculum of P. Berghei. Both experimental strategies led to a significantly reduced parasitemia with an extension of life span including complete cure for intraperitoneal delivery as assessed by negative blood thin smears. In the case of the starch bound P. falciparum GBSS-MSP1 fusion protein, the immune sera or purified immunoglobulin G of mice immunized with the corresponding starch strongly inhibited in vitro the intra-erythrocytic asexual development of the most human deadly plasmodial species. Conclusion: This novel system paves the way for the production of clinically relevant plasmodial antigens as algal starch-based particles designated herein as amylosomes, demonstrating that efficient production of edible vaccines can be genetically produced in Chlamydomonas.	[Dauvillee, David; Delhaye, Stephane; Gruyer, Sebastien; d'Hulst, Christophe; Ball, Steven G.; Tomavo, Stanislas] Univ Sci & Technol Lille, CNRS, UGSF, UMR 8576, Villeneuve Dascq, France; [Delhaye, Stephane; Tomavo, Stanislas] Univ Lille Nord France, Inst Pasteur Lille, INSERM, Ctr Infect & Immun Lille,CNRS,UMR 8204,U1019, Lille, France; [Slomianny, Christian] Univ Sci & Technol Lille, INSERM, U1003, Lab Physiol Cellulaire, Villeneuve Dascq, France; [Moretz, Samuel E.; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dauvillee, D (corresponding author), Univ Sci & Technol Lille, CNRS, UGSF, UMR 8576, Villeneuve Dascq, France.	Stan.Tomavo@pasteur-lille.fr	D'HULST, Christophe/B-2072-2012; D'Hulst, Christophe/AAX-2809-2020; Dauvillée, David/A-2174-2009; Slomianny, Christian/L-8285-2018	D'HULST, Christophe/0000-0002-5556-9099; D'Hulst, Christophe/0000-0002-5556-9099; Dauvillée, David/0000-0002-0751-9193; delhaye, stephane/0000-0001-9438-6730; Ball, Steven/0000-0003-1629-1650	Centre National de la Recherche Scientifique (CNRS); Institut Medicale de la Recherche Scientifique (INSERM); Institut Pasteur de Lille (IPL); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Medicale de la Recherche Scientifique (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur de Lille (IPL); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the Centre National de la Recherche Scientifique (CNRS), Institut Medicale de la Recherche Scientifique (INSERM) and the Institut Pasteur de Lille (IPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SG, 1998, TRENDS PLANT SCI, V3, P462, DOI 10.1016/S1360-1385(98)01342-9; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Bock R, 2010, TRENDS BIOTECHNOL, V28, P246, DOI 10.1016/j.tibtech.2010.01.006; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; DELRUE B, 1992, J BACTERIOL, V174, P3612, DOI 10.1128/JB.174.11.3612-3620.1992; Dzierszinski F, 2002, ANTIMICROB AGENTS CH, V46, P3197, DOI 10.1128/AAC.46.10.3197-3207.2002; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Gonzalez A, 2009, AM J TROP MED HYG, V81, P595, DOI 10.4269/ajtmh.2009.08-0637; Good MF, 2001, NAT REV IMMUNOL, V1, P117, DOI 10.1038/35100540; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; KINDLE K, 1990, GENETICS, V87, P1228; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Ral JP, 2006, PLANT PHYSIOL, V142, P305, DOI 10.1104/pp.106.081885; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Schroda M, 2002, PLANT J, V31, P445, DOI 10.1046/j.1365-313X.2002.01371.x; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093; van de Wal M, 1998, J BIOL CHEM, V273, P22232, DOI 10.1074/jbc.273.35.22232; VandenKoornhuyse N, 1996, J BIOL CHEM, V271, P16281, DOI 10.1074/jbc.271.27.16281; Warzecha H, 2003, J VIROL, V77, P8702, DOI 10.1128/JVI.77.16.8702-8711.2003; Wattebled F, 2002, EUR J BIOCHEM, V269, P3810, DOI 10.1046/j.1432-1033.2002.03072.x; World Health Organization, 2008, WORLD MAL REP	34	58	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15424	10.1371/journal.pone.0015424	http://dx.doi.org/10.1371/journal.pone.0015424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179538	Green Published, Green Submitted, gold			2022-12-27	WOS:000285340000025
J	Shegarfi, H; Naper, C; Rolstad, B; Inngjerdingen, M				Shegarfi, Hamid; Naper, Christian; Rolstad, Bent; Inngjerdingen, Marit			Listeria monocytogenes Infection Affects a Subset of Ly49-Expressing NK Cells in the Rat	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ENCODED TARGET LIGANDS; NECROSIS-FACTOR-ALPHA; MONOCLONAL-ANTIBODY; INTERFERON-GAMMA; IMMUNE-RESPONSES; 2 COMPLEMENTARY; LY49 RECEPTORS; GENE-COMPLEX; MICE	NK cells are protective against certain bacterial and viral infections, and their production of IFN-gamma is important for the early innate immune defence against L. monocytogenes. We have previously shown that depletion of NK cells in rats leads to increased bacterial burden upon L. monocytogenes infection, and that a subset of NK cells encompassing the majority of Ly49 receptors (Ly49s3(+) NK cells) contributed to this effect. In this study, we have further investigated how the Ly49s3(+) NK cell subset is affected by L. monocytogenes infection. We observed an increased percentage of Ly49s3(+) NK cells in the spleen and a reduction in the bone marrow within the first 48 hrs of L. monocytogenes infection. Concomitantly, we observed increased expression levels of the inflammatory chemokine receptors CCR5 and CXCR3 by Ly49s3(+) bone marrow NK cells, as compared to Ly49s3(-) NK cells, suggesting involvement of Ly49s3(+) NK cells in the early phase of infection. However, NK cell production of IFN-gamma was independent of Ly49 receptor expression. Furthermore, we observed increased expression levels of MHC class I molecules on both macrophages and NK cells during the first 48 hrs of infection, paralleled by a reduction in the surface expression of Ly49s3 on NK cells. In conclusion, L. monocytogenes infection modulates the tissue distribution of Ly49s3(+) NK cells, and induces increased MHC class I expression and hence reduced surface expression of Ly49 receptors on NK cells. These changes indicate that L. monocytogenes infection may have multiple effects on NK cells in vivo, and suggests the involvement of Ly49-expressing NK cells in the immune responses towards L. monocytogenes.	[Shegarfi, Hamid; Rolstad, Bent] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Naper, Christian; Inngjerdingen, Marit] Univ Oslo, Rikshosp, Inst Immunol, N-0027 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway	Shegarfi, H (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway.	marit.inngjerdingen@rr-research.no		Naper, Christian/0000-0002-2435-3615; Shegarfi, Hamid/0000-0002-5782-9026	Research Council of Norway; Norwegian Cancer Society	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from The Research Council of Norway (www.forskningsradet.no) and The Norwegian Cancer Society (www.kreftforeningen.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANCROFT GJ, 1991, IMMUNOL REV, V124, P5, DOI 10.1111/j.1600-065X.1991.tb00613.x; Bernardini G, 2008, BLOOD, V111, P3626, DOI 10.1182/blood-2007-08-106203; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Bubonja M, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/54202; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; CHANG RJ, 1986, J IMMUNOL, V137, P2853; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Flesch IEA, 1998, INT IMMUNOL, V10, P757, DOI 10.1093/intimm/10.6.757; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; HUMANN J, 2010, J IMMUNOL; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kase A, 1998, J IMMUNOL, V161, P6133; KING DP, 1983, J IMMUNOL, V131, P315; Kveberg L, 2006, IMMUNOGENETICS, V58, P905, DOI 10.1007/s00251-006-0154-x; Kveberg L, 2006, J IMMUNOL, V176, P4133, DOI 10.4049/jimmunol.176.7.4133; Kveberg L, 2010, J LEUKOCYTE BIOL, V88, P87, DOI 10.1189/jlb.0110039; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lapaque N, 2009, J IMMUNOL, V182, P4339, DOI 10.4049/jimmunol.0803329; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; MCKNIGHT AJ, 1992, IMMUNOLOGY, V75, P286; Naper C, 2005, J IMMUNOL, V174, P2702, DOI 10.4049/jimmunol.174.5.2702; Naper C, 2002, J IMMUNOL, V169, P22, DOI 10.4049/jimmunol.169.1.22; Naper C, 2002, EUR J IMMUNOL, V32, P2031, DOI 10.1002/1521-4141(200207)32:7<2031::AID-IMMU2031>3.0.CO;2-H; Nylenna O, 2005, EUR J IMMUNOL, V35, P261, DOI 10.1002/eji.200425429; OlssonAlheim MY, 1997, J IMMUNOL, V159, P3189; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; RUITENBERG EJ, 1976, BRIT J EXP PATHOL, V57, P310; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Shegarfi H, 2009, SCAND J IMMUNOL, V70, P238, DOI 10.1111/j.1365-3083.2009.02292.x; TAUB DD, 1995, J IMMUNOL, V155, P3877; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Westgaard IH, 2004, J LEUKOCYTE BIOL, V76, P1200, DOI 10.1189/jlb.0903428; Zeng XY, 2003, INFECT IMMUN, V71, P1306, DOI 10.1128/IAI.71.3.1306-1315.2003; Zhong MX, 2004, INFECT IMMUN, V72, P1057, DOI 10.1128/IAI.72.2.1057-1064.2004	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15579	10.1371/journal.pone.0015579	http://dx.doi.org/10.1371/journal.pone.0015579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179539	gold, Green Published, Green Submitted			2022-12-27	WOS:000285340000028
J	Daunizeau, J; den Ouden, HEM; Pessiglione, M; Kiebel, SJ; Stephan, KE; Friston, KJ				Daunizeau, Jean; den Ouden, Hanneke E. M.; Pessiglione, Matthias; Kiebel, Stefan J.; Stephan, Klaas E.; Friston, Karl J.			Observing the Observer (I): Meta-Bayesian Models of Learning and Decision-Making	PLOS ONE			English	Article							UNCERTAINTY; INFORMATION; MOTION	In this paper, we present a generic approach that can be used to infer how subjects make optimal decisions under uncertainty. This approach induces a distinction between a subject's perceptual model, which underlies the representation of a hidden "state of affairs" and a response model, which predicts the ensuing behavioural (or neurophysiological) responses to those inputs. We start with the premise that subjects continuously update a probabilistic representation of the causes of their sensory inputs to optimise their behaviour. In addition, subjects have preferences or goals that guide decisions about actions given the above uncertain representation of these hidden causes or state of affairs. From a Bayesian decision theoretic perspective, uncertain representations are so-called "posterior" beliefs, which are influenced by subjective "prior" beliefs. Preferences and goals are encoded through a "loss" (or "utility") function, which measures the cost incurred by making any admissible decision for any given (hidden) state of affair. By assuming that subjects make optimal decisions on the basis of updated (posterior) beliefs and utility (loss) functions, one can evaluate the likelihood of observed behaviour. Critically, this enables one to "observe the observer", i.e. identify (context-or subject-dependent) prior beliefs and utility-functions using psychophysical or neurophysiological measures. In this paper, we describe the main theoretical components of this meta-Bayesian approach (i.e. a Bayesian treatment of Bayesian decision theoretic predictions). In a companion paper ('Observing the observer (II): deciding when to decide'), we describe a concrete implementation of it and demonstrate its utility by applying it to simulated and real reaction time data from an associative learning task.	[Daunizeau, Jean; Stephan, Klaas E.; Friston, Karl J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Pessiglione, Matthias] Hop La Pitie Salpetriere, Brain & Spine Inst, Paris, France; [Daunizeau, Jean; Stephan, Klaas E.] Univ Zurich, Lab Social & Neural Syst Res, Inst Empir Res Econ, Zurich, Switzerland; [Kiebel, Stefan J.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [den Ouden, Hanneke E. M.] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Zurich; Max Planck Society; Radboud University Nijmegen	Daunizeau, J (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	j.daunizeau@fil.ion.ucl.ac.uk	Ouden, Hanneke den/D-3019-2009; Pessiglione, Mathias/E-2141-2017; Daunizeau, Jean/F-9225-2010; Friston, Karl/D-9230-2011; Kiebel, Stefan J/B-1551-2009; Daunizeau, Jean/AAB-3996-2019	Ouden, Hanneke den/0000-0001-7039-5130; Pessiglione, Mathias/0000-0002-6992-3677; Daunizeau, Jean/0000-0001-9142-1270; Friston, Karl/0000-0001-7984-8909; Kiebel, Stefan J/0000-0002-5052-1117; Stephan, Klaas Enno/0000-0002-8594-9092	Wellcome Trust; SystemsX.ch; NCCR "Neural Plasticity"; University of Zurich	Wellcome Trust(Wellcome Trust); SystemsX.ch; NCCR "Neural Plasticity"; University of Zurich	This work was funded by the Wellcome Trust (HDO, KJF), SystemsX.ch (JD, KES) and NCCR "Neural Plasticity" (KES). The authors also gratefully acknowledge support by the University Research Priority Program "Foundations of Human Social Behaviour" at the University of Zurich (JD, KES). Relevant URLs are given below: SystemsX.ch: http://www.systemsx.ch/projects/systemsxch-projects/research-technology-and-development-projects-rtd/neurochoice/; NCCR: "Neural Plasticity": http://www.nccr-neuro.ethz.ch/; University Research Priority Program "Foundations of Human Social Behaviour" at the University of Zurich: http://www.socialbehavior.uzh.ch/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeel P., 2004, ICML, V1; BEAL M, 2003, THESIS UCL UK; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Brodersen KH, 2008, NEURAL NETWORKS, V21, P1247, DOI 10.1016/j.neunet.2008.08.007; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; DAUNIZEAU J, OPTIMIZING EXP UNPUB; Daunizeau J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015555; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; Dayan P, 2003, IETE J RES, V49, P171, DOI 10.1080/03772063.2003.11416335; Dayan P, 2009, PHARMACOPSYCHIATRY, V42, pS56, DOI 10.1055/s-0028-1124107; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; Dayan P, 2009, NEURAL NETWORKS, V22, P213, DOI 10.1016/j.neunet.2009.03.004; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; Friston KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006421; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; HADAMARD J, 1902, PRINCETON U B, P49; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HELMHOLTZ H, 1925, PHYSL OPTICS, V3; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kersten D, 1996, NATURE, V379, P31, DOI 10.1038/379031a0; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kiebel Stefan J, 2009, Front Neuroinform, V3, P20, DOI 10.3389/neuro.11.020.2009; Kirk D. E, 2004, OPTIMAL CONTROL THEO; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; KNILL DC, 1998, VISION RES, V38, P780; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, PLOS BIOL, V2, P1652, DOI 10.1371/journal.pbio.0020330; KRISHNAMURTHY D, 2009, EFFICIENT ALGO UNPUB; Lee TS, 2003, J PHYSIOL-PARIS, V97, P121, DOI 10.1016/j.jphysparis.2003.09.015; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; MACH E, 1980, CONTRIBUTIONS ANAL S; Mamassian P, 2003, NEUROREPORT, V14, P971, DOI 10.1097/01.wnr.0000069061.85441.f2; Mamassian P, 2002, NEU INF PRO, P13; McClelland JL, 2010, TRENDS COGN SCI, V14, P348, DOI 10.1016/j.tics.2010.06.002; Ng A.Y., 2000, MACHINE LEARNING, V1, P2; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; RAMACHANDRAN D, 2007, P C IJCAI 07; Rao RPN, 1999, VISION RES, V39, P1963, DOI 10.1016/S0042-6989(98)00279-X; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; ROBERT C, 1992, ECONOMICA; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Shoham Y., 2009, MULTIAGENT SYSTEMS A; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Swartz RJ, 2006, J AM STAT ASSOC, V101, P1, DOI 10.1198/016214505000000998; Tenenbaum JB, 2007, INDUCTIVE REASONING: EXPERIMENTAL, DEVELOPMENTAL, AND COMPUTATIONAL APPROACHES, P167; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; TODOROV E, 2006, ADV NEURAL INFORM PR, V19, P1369; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Trommershauser J, 2003, SPATIAL VISION, V16, P255, DOI 10.1163/156856803322467527; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; van Ee R, 2003, J OPT SOC AM A, V20, P1398, DOI 10.1364/JOSAA.20.001398; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WOLPERT D, 2001, 2001 AAAI SPRING S G; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yoshida W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000254; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8	68	91	91	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15554	10.1371/journal.pone.0015554	http://dx.doi.org/10.1371/journal.pone.0015554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	694JH	21179480	Green Submitted, Green Published, gold			2022-12-27	WOS:000285292500025
J	Nazir, A; Sammi, SR; Singh, P; Tripathi, RK				Nazir, Aamir; Sammi, Shreesh Raj; Singh, Pankaj; Tripathi, Raj Kamal			Trans-Cellular Introduction of HIV-1 Protein Nef Induces Pathogenic Response in Caenorhabditis elegans	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DOWN-REGULATION; MHC-I; COMPLEX; ACTIVATION; BINDING; FAMILY; CD4; LIPODYSTROPHY; TRANSCRIPTION	Background: Caenorhabditis elegans has emerged as a very powerful model for studying the host pathogen interactions. Despite the absence of a naturally occurring viral infection for C. elegans, the model is now being exploited experimentally to study the basic aspects of virus-host interplay. The data generated from recent studies suggests that the virus that infects mammalian cells does infect, replicate and accumulate in C. elegans. Methodology/Principal Findings: We took advantage of the easy-to-achieve protein introduction in C. elegans and employing the methodology, we administered HIV-1 protein Nef into live worms. Nef is known to be an important protein for exacerbating HIV-1 pathogenesis in host by enhancing viral replication. The deletion of nef from the viral genome has been reported to inhibit its replication in the host, thereby leading to delayed pathogenesis. Our studies, employing Nef introduction into C. elegans, led to creation of an in-vivo model that allowed us to study, whether or not, the protein induces effect in the whole organism. We observed a marked lipodystrophy, effect on neuromuscular function, impaired fertility and reduced longevity in the worms exposed to Nef. The observed effects resemble to those observed in Nef transgenic mice and most interestingly the effects also relate to some of the pathogenic aspects exhibited by human AIDS patients. Conclusions/Significance: Our studies underline the importance of this in vivo model for studying the interactions of Nef with host proteins, which could further be used for identifying possible inhibitors of such interactions.	[Nazir, Aamir; Sammi, Shreesh Raj] Cent Drug Res Inst, Div Toxicol, Lab Funct Genom & Mol Toxicol, CSIR, Lucknow 226001, Uttar Pradesh, India; [Singh, Pankaj; Tripathi, Raj Kamal] Cent Drug Res Inst, Div Toxicol, Lab Immunotoxicol, CSIR, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Nazir, A (corresponding author), Cent Drug Res Inst, Div Toxicol, Lab Funct Genom & Mol Toxicol, CSIR, Lucknow 226001, Uttar Pradesh, India.	anazir@cdri.res.in; rk_tripathi@cdri.res.in	Sammi, Shreesh Raj/AAA-1591-2019	Nazir, Aamir/0000-0002-2503-1335; Raj Sammi, Shreesh/0000-0003-4163-8628	Council of Scientific and Industrial Research Network Project [NWP 0034]; Department of Science and Technology [0050/2009]	Council of Scientific and Industrial Research Network Project(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	The study was supported by funds from Council of Scientific and Industrial Research Network Project (NWP 0034) and Department of Science and Technology (0050/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOPAIN K, 2006, J VIROL, V6, P3050; Arora VK, 2000, J VIROL, V74, P11081, DOI 10.1128/JVI.74.23.11081-11087.2000; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200; Balasubramanyam A, 2007, AM J PHYSIOL-ENDOC M, V292, pE40, DOI 10.1152/ajpendo.00163.2006; Baumeister R, 2002, TRENDS BIOTECHNOL, V20, P147, DOI 10.1016/S0167-7799(01)01925-4; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Betzi S, 2007, P NATL ACAD SCI USA, V104, P19256, DOI 10.1073/pnas.0707130104; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; BRENNER S, 1974, GENETICS, V77, P71; Brey CW, 2009, INT J BIOL SCI, V5, P622; Carr A, 2003, AIDS, V17, pS141, DOI 10.1097/00002030-200304001-00017; Coleman SH, 2005, J VIROL, V79, P2066, DOI 10.1128/JVI.79.4.2066-2078.2005; Delom F, 2007, BIOCHEM BIOPH RES CO, V352, P587, DOI 10.1016/j.bbrc.2006.11.046; Dhawan R, 1999, J TOXICOL ENV HEAL A, V58, P451, DOI 10.1080/009841099157179; Duerr Janet S, 2006, WormBook, P1; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Gorry PR, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-66; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Hanna Z, 1998, J VIROL, V72, P121, DOI 10.1128/JVI.72.1.121-132.1998; Hanna Z, 2006, VIROLOGY, V346, P40, DOI 10.1016/j.virol.2005.10.010; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Valdes-Ferrer SI, 2009, AIDS RES HUM RETROV, V25, P749, DOI 10.1089/aid.2008.0257; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KIRCHHOFF F, 2002, IMMUNITY, V16, P493; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Liu WH, 2006, P NATL ACAD SCI USA, V103, P4174, DOI 10.1073/pnas.0506442103; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; NEILL EO, 2006, J VIROL, V80, P1311; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Pulkkinen K, 2004, J VIROL, V78, P12773, DOI 10.1128/JVI.78.23.12773-12780.2004; Raney A, 2005, J VIROL, V79, P12732, DOI 10.1128/JVI.79.20.12732-12741.2005; Rauch S, 2008, J VIROL, V82, P2918, DOI 10.1128/JVI.02185-07; Renkema GH, 1999, CURR BIOL, V9, P1407, DOI 10.1016/S0960-9822(00)80086-X; Ruan QL, 2009, J TOXICOL ENV HEAL A, V72, P746, DOI 10.1080/15287390902841532; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shaham S, 2006, P NATL ACAD SCI USA, V103, P3955, DOI 10.1073/pnas.0600779103; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Stiernagle T., 1999, C ELEGANS PRACTICAL, P51; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Zhang J, 2009, EXP CELL RES, V315, P2568, DOI 10.1016/j.yexcr.2009.04.025; Zheng YH, 2001, CURR BIOL, V11, P875, DOI 10.1016/S0960-9822(01)00237-8	53	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15312	10.1371/journal.pone.0015312	http://dx.doi.org/10.1371/journal.pone.0015312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179446	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900043
J	Spin, JM; Quertermous, T; Tsao, PS				Spin, Joshua M.; Quertermous, Thomas; Tsao, Philip S.			Chromatin Remodeling Pathways in Smooth Muscle Cell Differentiation, and Evidence for an Integral Role for p300	PLOS ONE			English	Article							CREB-BINDING PROTEIN; HISTONE ACETYLTRANSFERASE ACTIVITY; SERUM RESPONSE FACTOR; GENE-EXPRESSION; IN-VITRO; ALPHA-ACTIN; LYSINE 9; TRANSCRIPTION; ACETYLATION; METHYLATION	Background: Phenotypic alteration of vascular smooth muscle cells (SMC) in response to injury or inflammation is an essential component of vascular disease. Evidence suggests that this process is dependent on epigenetic regulatory processes. P300, a histone acetyltransferase (HAT), activates crucial muscle-specific promoters in terminal (non-SMC) myocyte differentiation, and may be essential to SMC modulation as well. Results: We performed a subanalysis examining transcriptional time-course microarray data obtained using the A404 model of SMC differentiation. Numerous chromatin remodeling genes (up to 62% of such genes on our array platform) showed significant regulation during differentiation. Members of several chromatin-remodeling families demonstrated involvement, including factors instrumental in histone modification, chromatin assembly-disassembly and DNA silencing, suggesting complex, multi-level systemic epigenetic regulation. Further, trichostatin A, a histone deacetylase inhibitor, accelerated expression of SMC differentiation markers in this model. Ontology analysis indicated a high degree of p300 involvement in SMC differentiation, with 60.7% of the known p300 interactome showing significant expression changes. Knockdown of p300 expression accelerated SMC differentiation in A404 cells and human SMCs, while inhibition of p300 HAT activity blunted SMC differentiation. The results suggest a central but complex role for p300 in SMC phenotypic modulation. Conclusions: Our results support the hypothesis that chromatin remodeling is important for SMC phenotypic switching, and detail wide-ranging involvement of several epigenetic modification families. Additionally, the transcriptional coactivator p300 may be partially degraded during SMC differentiation, leaving an activated subpopulation with increased HAT activity and SMC differentiation-gene specificity.	[Spin, Joshua M.; Quertermous, Thomas; Tsao, Philip S.] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Stanford University	Spin, JM (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	jspin@cvmed.stanford.edu		Spin, Joshua/0000-0002-4256-9161; Quertermous, Thomas/0000-0002-7645-9067	NIH [5K08 HL080567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL080567] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by NIH grant 5K08 HL080567. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dietze EC, 2003, BIOCHEM BIOPH RES CO, V302, P841, DOI 10.1016/S0006-291X(03)00266-3; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Goodman RH, 2000, GENE DEV, V14, P1553; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Marmorstein R, 2001, NAT REV MOL CELL BIO, V2, P422, DOI 10.1038/35073047; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Minucci S, 1997, P NATL ACAD SCI USA, V94, P11295, DOI 10.1073/pnas.94.21.11295; Okamoto H, 2006, J ATHEROSCLER THROMB, V13, P183, DOI 10.5551/jat.13.183; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Partanen M, 1999, INT J DEV BIOL, V43, P487; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Qiu P, 2006, BIOCHEM BIOPH RES CO, V348, P351, DOI 10.1016/j.bbrc.2006.07.009; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Richon VM, 2004, METHOD ENZYMOL, V376, P199; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sagar V, 2004, BIOORGAN MED CHEM, V12, P3383, DOI 10.1016/j.bmc.2004.03.070; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Spin JM, 2004, PHYSIOL GENOMICS, V19, P292, DOI 10.1152/physiolgenomics.00148.2004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wada H, 2000, J BIOL CHEM, V275, P25330, DOI 10.1074/jbc.M000828200; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang SX, 2005, J BIOL CHEM, V280, P6204, DOI 10.1074/jbc.M409506200; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zheng YJ, 2005, J AM CHEM SOC, V127, P17182, DOI 10.1021/ja0558544; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188	61	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14301	10.1371/journal.pone.0014301	http://dx.doi.org/10.1371/journal.pone.0014301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179216	gold, Green Submitted, Green Published			2022-12-27	WOS:000285246900013
J	Jain, V; Liegler, T; Vittinghoff, E; Hartogensis, W; Bacchetti, P; Poole, L; Loeb, L; Pilcher, CD; Grant, RM; Deeks, SG; Hecht, FM				Jain, Vivek; Liegler, Teri; Vittinghoff, Eric; Hartogensis, Wendy; Bacchetti, Peter; Poole, Lauren; Loeb, Lisa; Pilcher, Christopher D.; Grant, Robert M.; Deeks, Steven G.; Hecht, Frederick M.			Transmitted Drug Resistance in Persons with Acute/Early HIV-1 in San Francisco, 2002-2009	PLOS ONE			English	Article							EXPERIENCED HIV-1-INFECTED PATIENTS; PLACEBO-CONTROLLED TRIAL; PERFORMANCE-CHARACTERISTICS; TMC125 ETRAVIRINE; GENOTYPING KIT; DOUBLE-BLIND; INFECTION; TRANSMISSION; EFFICACY; SAFETY	Background: Transmitted HIV-1 drug resistance (TDR) is an ongoing public health problem, representing 10-20% of new HIV infections in many geographic areas. TDR usually arises from two main sources: individuals on antiretroviral therapy (ART) who are failing to achieve virologic suppression, and individuals who acquired TDR and transmit it while still ART-naive. TDR rates can be impacted when novel antiretroviral medications are introduced that allow for greater virologic suppression of source patients. Although several new HIV medications were introduced starting in late 2007, including raltegravir, maraviroc, and etravirine, it is not known whether the prevalence of TDR was subsequently affected in 2008-2009. Methodology/Principal Findings: We performed population sequence genotyping on individuals who were diagnosed with acute or early HIV (<6 months duration) and who enrolled in the Options Project, a prospective cohort, between 2002 and 2009. We used logistic regression to compare the odds of acquiring drug-resistant HIV before versus after the arrival of new ART (2005-2007 vs. 2008-2009). From 2003-2007, TDR rose from 7% to 24%. Prevalence of TDR was then 15% in 2008 and in 2009. While the odds of acquiring TDR were lower in 2008-2009 compared to 2005-2007, this was not statistically significant (odds ratio 0.65, 95% CI 0.31-1.38; p = 0.27). Conclusions: Our study suggests that transmitted drug resistance rose from 2003-2007, but this upward trend did not continue in 2008 and 2009. Nevertheless, the TDR prevalence in 2008-2009 remained substantial, emphasizing that improved management strategies for drug-resistant HIV are needed if TDR is to be further reduced. Continued surveillance for TDR will be important in understanding the full impact of new antiretroviral medications.	[Jain, Vivek; Liegler, Teri; Hartogensis, Wendy; Poole, Lauren; Loeb, Lisa; Pilcher, Christopher D.; Deeks, Steven G.; Hecht, Frederick M.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Vittinghoff, Eric; Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Grant, Robert M.] Univ Calif San Francisco, Gladstone Inst Virol, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Jain, V (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA.	rhecht@php.ucsf.edu		Grant, Robert/0000-0002-0851-7085; Hecht, Frederick/0000-0002-5782-1171; Loeb Stanga, Lisa/0000-0001-7471-5381	National Institutes of Health, National Institute of Allergy and Infectious Diseases [T32 AI060530, PO1 AI071713, K24AI069994]; University of California San Francisco Center for AIDS Research [P30 AI027763]; University of California San Francisco Clinical and Translational Science Institute [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, T32AI060530, P01AI071713, K24AI069994] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of California San Francisco Center for AIDS Research(University of California System); University of California San Francisco Clinical and Translational Science Institute(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health, National Institute of Allergy and Infectious Diseases (T32 AI060530, PO1 AI071713 to FMH, and K24AI069994 to SGD). This work was also supported in part by the University of California San Francisco Center for AIDS Research (P30 AI027763) and the University of California San Francisco Clinical and Translational Science Institute (UL1 RR024131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour JD, 2004, J INFECT DIS, V190, P251, DOI 10.1086/422036; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Haubrich R, 2007, AIDS, V21, pF11, DOI 10.1097/QAD.0b013e3280b07b47; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Hicks C, 2009, CLIN INFECT DIS, V48, P931, DOI 10.1086/597290; Hurt CB, 2009, ANTIVIR THER, V14, P673; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Kuritzkes DR, 2003, J CLIN MICROBIOL, V41, P1594, DOI 10.1128/JCM.41.4.1594-1599.2003; Lazzarin A, 2007, LANCET, V370, P39, DOI 10.1016/S0140-6736(07)61048-4; MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289; Madruga JV, 2007, LANCET, V370, P29, DOI 10.1016/S0140-6736(07)61047-2; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Scherrer AU, 2010, JAIDS-J ACQ IMM DEF, V53, P464, DOI 10.1097/QAI.0b013e3181bca4ec; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	27	54	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15510	10.1371/journal.pone.0015510	http://dx.doi.org/10.1371/journal.pone.0015510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170322	gold, Green Published, Green Submitted			2022-12-27	WOS:000285181400024
J	Chu-Shore, J; Westover, MB; Bianchi, MT				Chu-Shore, Jesse; Westover, M. Brandon; Bianchi, Matt T.			Power Law versus Exponential State Transition Dynamics: Application to Sleep-Wake Architecture	PLOS ONE			English	Article							PHYSIOLOGY; PATTERNS; DISEASE; CYCLE	Background: Despite the common experience that interrupted sleep has a negative impact on waking function, the features of human sleep-wake architecture that best distinguish sleep continuity versus fragmentation remain elusive. In this regard, there is growing interest in characterizing sleep architecture using models of the temporal dynamics of sleep-wake stage transitions. In humans and other mammals, the state transitions defining sleep and wake bout durations have been described with exponential and power law models, respectively. However, sleep-wake stage distributions are often complex, and distinguishing between exponential and power law processes is not always straightforward. Although mono-exponential distributions are distinct from power law distributions, multi-exponential distributions may in fact resemble power laws by appearing linear on a log-log plot. Methodology/Principal Findings: To characterize the parameters that may allow these distributions to mimic one another, we systematically fitted multi-exponential-generated distributions with a power law model, and power law-generated distributions with multi-exponential models. We used the Kolmogorov-Smirnov method to investigate goodness of fit for the "incorrect" model over a range of parameters. The "zone of mimicry" of parameters that increased the risk of mistakenly accepting power law fitting resembled empiric time constants obtained in human sleep and wake bout distributions. Conclusions/Significance: Recognizing this uncertainty in model distinction impacts interpretation of transition dynamics (self-organizing versus probabilistic), and the generation of predictive models for clinical classification of normal and pathological sleep architecture.	[Chu-Shore, Jesse] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Westover, M. Brandon] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bianchi, Matt T.] Massachusetts Gen Hosp, Dept Neurol, Sleep Div, Boston, MA 02114 USA; [Bianchi, Matt T.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Chu-Shore, J (corresponding author), Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA.	thebianchi@gmail.com		Shore, Jesse/0000-0003-3812-0262	Neurology Department, Massachusetts General Hospital; Harvard/MIT Health Sciences and Technology - Beth Israel Deaconess Medical Center; Pfizer, Inc; Merck Co.	Neurology Department, Massachusetts General Hospital; Harvard/MIT Health Sciences and Technology - Beth Israel Deaconess Medical Center; Pfizer, Inc(Pfizer); Merck Co.(Merck & Company)	Dr. Bianchi receives funding from the Neurology Department, Massachusetts General Hospital, and the Clinical Investigator Training Program: Harvard/MIT Health Sciences and Technology - Beth Israel Deaconess Medical Center, in collaboration with Pfizer, Inc. and Merck & Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Bernstein S, 1929, ACTA MATH-DJURSHOLM, V52, P1; Bianchi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011356; Blumberg MS, 2007, EUR J NEUROSCI, V25, P512, DOI 10.1111/j.1460-9568.2006.05292.x; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Buzsaki G., 2006, RHYTHMS BRAIN, P448; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Fuller PM, 2006, J BIOL RHYTHM, V21, P482, DOI 10.1177/0748730406294627; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; HAVLIN S, 1995, CHAOS SOLITON FRACT, V6, P171, DOI 10.1016/0960-0779(95)80025-C; Hu K, 2009, P NATL ACAD SCI USA, V106, P2490, DOI 10.1073/pnas.0806087106; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; KEMP B, 1986, SLEEP, V9, P405, DOI 10.1093/sleep/9.3.405; Kim JU, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.076401; Kishi A, 2008, AM J PHYSIOL-REG I, V294, pR1980, DOI 10.1152/ajpregu.00925.2007; Klerman EB, 2004, SLEEP, V27, P793, DOI 10.1093/sleep/27.4.793; LIPSITZ LA, 2004, SCI AGING KNOWLEDGE, pPE16; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Peng Chung-Kang, 1994, Integrative Physiological and Behavioral Science, V29, P283, DOI 10.1007/BF02691332; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Swihart BJ, 2008, J CLIN SLEEP MED, V4, P349; YANG MCK, 1973, BIOMETRICS, V29, P667, DOI 10.2307/2529133	27	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14204	10.1371/journal.pone.0014204	http://dx.doi.org/10.1371/journal.pone.0014204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151998	Green Published, gold, Green Submitted			2022-12-27	WOS:000284868000018
J	Zemanick, ET; Wagner, BD; Sagel, SD; Stevens, MJ; Accurso, FJ; Harris, JK				Zemanick, Edith T.; Wagner, Brandie D.; Sagel, Scott D.; Stevens, Mark J.; Accurso, Frank J.; Harris, J. Kirk			Reliability of Quantitative Real-Time PCR for Bacterial Detection in Cystic Fibrosis Airway Specimens	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PERIODONTAL PATHOGENS; PULMONARY INFECTIONS; DIAGNOSTIC-ACCURACY; ANAEROBIC CULTURE; LUNG INFECTIONS; SPUTUM; CHILDREN; DIVERSITY; SAMPLES	The cystic fibrosis (CF) airway microbiome is complex; polymicrobial infections are common, and the presence of fastidious bacteria including anaerobes make culture-based diagnosis challenging. Quantitative real-time PCR (qPCR) offers a culture-independent method for bacterial quantification that may improve diagnosis of CF airway infections; however, the reliability of qPCR applied to CF airway specimens is unknown. We sought to determine the reliability of nine specific bacterial qPCR assays (total bacteria, three typical CF pathogens, and five anaerobes) applied to CF airway specimens. Airway and salivary specimens from clinically stable pediatric CF subjects were collected. Quantitative PCR assay repeatability was determined using triplicate reactions. Split-sample measurements were performed to measure variability introduced by DNA extraction. Results from qPCR were compared to standard microbial culture for Pseudomonas aeruginosa, Staphylococcus aureus, and Haemophilus influenzae, common pathogens in CF. We obtained 84 sputa, 47 oropharyngeal and 27 salivary specimens from 16 pediatric subjects with CF. Quantitative PCR detected bacterial DNA in over 97% of specimens. All qPCR assays were highly reproducible at quantities >10(2) rRNA gene copies/reaction with coefficient of variation less than 20% for over 99% of samples. There was also excellent agreement between samples processed in duplicate. Anaerobic bacteria were highly prevalent and were detected in mean quantities similar to that of typical CF pathogens. Compared to a composite gold standard, qPCR and culture had variable sensitivities for detection of P. aeruginosa, S. aureus and H. influenzae from CF airway samples. By reliably quantifying fastidious airway bacteria, qPCR may improve our understanding of polymicrobial CF lung infections, progression of lung disease and ultimately improve antimicrobial treatments.	[Zemanick, Edith T.; Sagel, Scott D.; Stevens, Mark J.; Accurso, Frank J.; Harris, J. Kirk] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Wagner, Brandie D.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Zemanick, ET (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO USA.	zemanick.edith@tchden.org	Zemanick, Edith/D-5260-2017; Zemanick, Edith T/ABF-9455-2020	Zemanick, Edith/0000-0002-7507-9337; Zemanick, Edith T/0000-0002-7507-9337; Wagner, brandie/0000-0002-2745-0103; Harris, Jonathan/0000-0002-2378-4202	Cystic Fibrosis Foundation [ZEMANI07DO, ZEMANI08A0]; Colorado Clinical and Translational Science Award (CTSA) [1UL1RR014780]; National Center for Research Resources, National Institutes of Health (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014780, UL1RR025780] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Colorado Clinical and Translational Science Award (CTSA); National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Cystic Fibrosis Foundation grants, numbers ZEMANI07DO and ZEMANI08A0 (http://www.cff.org), and Colorado Clinical and Translational Science Award (CTSA) grant number 1UL1RR014780, Clinical Translational Research Centers Program, National Center for Research Resources, National Institutes of Health (NIH) (http://www.ctsaweb.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beringer P M, 2000, Curr Opin Pulm Med, V6, P545, DOI 10.1097/00063198-200011000-00015; Biagi E, 2009, EUR J CLIN MICROBIOL, V28, P281, DOI 10.1007/s10096-008-0617-0; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bossuyt PM, 2003, CLIN CHEM LAB MED, V41, P68, DOI 10.1515/CCLM.2003.012; Boutaga K, 2005, FEMS IMMUNOL MED MIC, V45, P191, DOI 10.1016/j.femsim.2005.03.011; Boutaga K, 2007, J PERIODONTOL, V78, P79, DOI 10.1902/jop.2007.060078; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Goldstein EJC, 2008, ANAEROBE, V14, P68, DOI 10.1016/j.anaerobe.2008.01.001; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HAMMERSCHLAG MR, 1980, J CLIN MICROBIOL, V11, P552, DOI 10.1128/JCM.11.6.552-557.1980; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Kahl B, 1998, J INFECT DIS, V177, P1023, DOI 10.1086/515238; Lambiase A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-4; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Muldrew KL, 2009, CURR OPIN PEDIATR, V21, P102, DOI 10.1097/MOP.0b013e328320d87e; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nadkarni MA, 2004, J CLIN MICROBIOL, V42, P5238, DOI 10.1128/JCM.42.11.5238-5244.2004; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rosenfeld M, 1999, PEDIATR PULM, V28, P321, DOI 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V; Rosey AL, 2007, J MICROBIOL METH, V68, P88, DOI 10.1016/j.mimet.2006.06.010; Rubin BK, 2009, RESP CARE, V54, P726, DOI 10.4187/002013209790983269; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Saiman Lisa, 2004, Paediatr Respir Rev, V5 Suppl A, pS367, DOI 10.1016/S1526-0542(04)90065-6; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van Belkum A, 2000, FEMS IMMUNOL MED MIC, V27, P51, DOI 10.1111/j.1574-695X.2000.tb01411.x; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Worlitzsch D, 2009, CLIN MICROBIOL INFEC, V15, P454, DOI 10.1111/j.1469-0691.2008.02659.x; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07; Zemanick ET, 2010, PEDIATR PULM, V45, P569, DOI 10.1002/ppul.21221	39	53	54	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15101	10.1371/journal.pone.0015101	http://dx.doi.org/10.1371/journal.pone.0015101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152087	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100072
J	Anne, J				Anne, Joel			C-Terminal Moiety of Tudor Contains Its In Vivo Activity in Drosophila	PLOS ONE			English	Article							POLE PLASM; GERM PLASM; METHYLTRANSFERASE CAPSULEEN; ARGININE RESIDUES; SM PROTEINS; MELANOGASTER; DOMAIN; LOCALIZATION; GENE; METHYLATION	Background: In early Drosophila embryos, the germ plasm is localized to the posterior pole region and is partitioned into the germline progenitors, known as pole cells. Germ plasm, or pole plasm, contains the polar granules which form during oogenesis and are required for germline development. Components of these granules are also present in the perinuclear region of the nurse cells, the nuage. One such component is Tudor (Tud) which is a large protein containing multiple Tudor domains. It was previously reported that specific Tudor domains are required for germ cell formation and Tud localization. Methodology/Principal Findings: In order to better understand the function of Tud the distribution and functional activity of fragments of Tud were analyzed. These fragments were fused to GFP and the fusion proteins were synthesized during oogenesis. Non-overlapping fragments of Tud were found to be able to localize to both the nuage and pole plasm. By introducing these fragments into a tud mutant background and testing their ability to rescue the tud phenotype, I determined that the C-terminal moiety contains the functional activity of Tud. Dividing this fragment into two parts reduces its localization in pole plasm and abolishes its activity. Conclusions/Significance: I conclude that the C-terminal moiety of Tud contains all the information necessary for its localization in the nuage and pole plasm and its pole cell-forming activity. The present results challenge published data and may help refining the functional features of Tud.	[Anne, Joel] Deutsch Krebsforschungszentrum, Dept Dev Genet, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Anne, J (corresponding author), Univ Bern, Inst Biol Cellulaire, Bern, Switzerland.	joel.anne@izb.unibe.ch			DKFZ	DKFZ(Helmholtz Association)	This work was funded by the DKFZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikura R, 2001, MECH DEVELOP, V107, P97, DOI 10.1016/S0925-4773(01)00455-5; Amikura R, 2005, MECH DEVELOP, V122, P1087, DOI 10.1016/j.mod.2005.06.003; Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; BARDSLEY A, 1993, DEVELOPMENT, V119, P207; BEAMS HW, 1974, INT REV CYTOL, V39, P413, DOI 10.1016/S0074-7696(08)60944-4; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Callebaut I, 1997, BIOCHEM J, V321, P125, DOI 10.1042/bj3210125; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; EDDY EM, 1975, INT REV CYTOL, V43, P229; GOLUMBESKI GS, 1991, GENE DEV, V5, P2060, DOI 10.1101/gad.5.11.2060; HAY B, 1988, DEVELOPMENT, V103, P625; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kirino Y, 2010, RNA, V16, P70, DOI 10.1261/rna.1869710; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; MAHOWALD AP, 1962, J EXP ZOOL, V151, P201, DOI 10.1002/jez.1401510302; Mahowald AP, 2001, INT REV CYTOL, V203, P187; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Nishida KM, 2009, EMBO J, V28, P3820, DOI 10.1038/emboj.2009.365; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; RONGO C, 1995, DEVELOPMENT, V121, P2737; Sano H, 2002, MECH DEVELOP, V112, P129, DOI 10.1016/S0925-4773(01)00654-2; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Talbot K, 1998, HUM MOL GENET, V7, P2149, DOI 10.1093/hmg/7.13.2149; Thomson T, 2004, GENESIS, V40, P164, DOI 10.1002/gene.20079; Vanzo NF, 2002, DEVELOPMENT, V129, P3705	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14378	10.1371/journal.pone.0014378	http://dx.doi.org/10.1371/journal.pone.0014378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179416	gold, Green Published, Green Submitted			2022-12-27	WOS:000285572900010
J	Marim, FM; Silveira, TN; Lima, DS; Zamboni, DS				Marim, Fernanda M.; Silveira, Tatiana N.; Lima, Djalma S., Jr.; Zamboni, Dario S.			A Method for Generation of Bone Marrow-Derived Macrophages from Cryopreserved Mouse Bone Marrow Cells	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; HUMAN MONOCYTES; RECOGNITION	The broad use of transgenic and gene-targeted mice has established bone marrow-derived macrophages (BMDM) as important mammalian host cells for investigation of the macrophages biology. Over the last decade, extensive research has been done to determine how to freeze and store viable hematopoietic human cells; however, there is no information regarding generation of BMDM from frozen murine bone marrow (BM) cells. Here, we establish a highly efficient protocol to freeze murine BM cells and further generate BMDM. Cryopreserved murine BM cells maintain their potential for BMDM differentiation for more than 6 years. We compared BMDM obtained from fresh and frozen BM cells and found that both are similarly able to trigger the expression of CD80 and CD86 in response to LPS or infection with the intracellular bacteria Legionella pneumophila. Additionally, BMDM obtained from fresh or frozen BM cells equally restrict or support the intracellular multiplication of pathogens such as L. pneumophila and the protozoan parasite Leishmania (L.) amazonensis. Although further investigation are required to support the use of the method for generation of dendritic cells, preliminary experiments indicate that bone marrow-derived dendritic cells can also be generated from cryopreserved BM cells. Overall, the method described and validated herein represents a technical advance as it allows ready and easy generation of BMDM from a stock of frozen BM cells.	[Marim, Fernanda M.; Silveira, Tatiana N.; Lima, Djalma S., Jr.; Zamboni, Dario S.] Univ Sao Paulo FMRP USP, Sch Med Ribeirao Preto, Dept Cell Biol, Ribeirao Preto, Brazil	Universidade de Sao Paulo	Marim, FM (corresponding author), Univ Sao Paulo FMRP USP, Sch Med Ribeirao Preto, Dept Cell Biol, Ribeirao Preto, Brazil.	dszamboni@fmrp.usp.br	Lima-Junior, Djalma/H-4833-2013; Silveira, Tatiana/A-8924-2013; Zamboni, Dario S/D-3024-2012	Lima-Junior, Djalma/0000-0002-2092-8047; Silveira, Tatiana/0000-0001-5883-8621; Zamboni, Dario S/0000-0002-7856-7512	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV/CNPq); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/52867-4]; TNS; DSLJ; FAPESP [06/55084-0, 09/05054-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); TNS; DSLJ; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV/CNPq) and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant 06/52867-4). FMM is recipient of a master fellowship from CNPq; TNS and DSLJ are supported by doctoral fellowships from FAPESP (06/55084-0 and 09/05054-6 respectively). DSZ is a Research Fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint B, 1999, BONE MARROW TRANSPL, V23, P613, DOI 10.1038/sj.bmt.1701623; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Berz D, 2007, AM J HEMATOL, V82, P463, DOI 10.1002/ajh.20707; Carregaro V, 2008, J LEUKOCYTE BIOL, V84, P104, DOI 10.1189/jlb.1107797; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; Donnenberg AD, 2002, CYTOTHERAPY, V4, P157, DOI 10.1080/146532402317381866; ENGLEN MD, 1995, J IMMUNOL METHODS, V184, P281, DOI 10.1016/0022-1759(95)00136-X; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Hiebl B, 2008, CLIN HEMORHEOL MICRO, V39, P221, DOI 10.3233/CH-2008-1086; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Kram D, 2008, J IMMUNOL METHODS, V333, P79, DOI 10.1016/j.jim.2008.01.004; LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Morrissette Naomi, 1999, Trends in Cell Biology, V9, P199, DOI 10.1016/S0962-8924(99)01540-8; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003	20	208	209	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15263	10.1371/journal.pone.0015263	http://dx.doi.org/10.1371/journal.pone.0015263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179419	Green Published, gold, Green Submitted			2022-12-27	WOS:000285572900016
J	Gleicher, N; Weghofer, A; Lee, IH; Barad, DH				Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.			FMR1 Genotype with Autoimmunity-Associated Polycystic Ovary-Like Phenotype and Decreased Pregnancy Chance	PLOS ONE			English	Article							TRIPLE CGG REPEATS; REPRODUCTIVE FAILURE; RISK-FACTOR; GENE; PREMUTATION; AUTOANTIBODIES; RECEPTOR; HORMONE; RESERVE; FSH	The FMR1 gene partially appears to control ovarian reserve, with a specific ovarian sub-genotype statistically associated with a polycystic ovary (PCO) like phenotype. Some forms of PCO have been associated with autoimmunity. We, therefore, investigated in multiple regression analyses associations of ovary-specific FMR1 genotypes with autoimmunity and pregnancy chances (with in vitro fertilization, IVF) in 339 consecutive infertile women (455 IVF cycles), 75 with PCO-like phenotype, adjusted for age, race/ethnicity, medication dosage and number of oocytes retrieved. Patients included 183 (54.0%) with normal (norm) and 156 (46%) with heterozygous (het) FMR1 genotypes; 133 (39.2%) demonstrated laboratory evidence of autoimmunity: 51.1% of het-norm/low, 38.3% of norm and 24.2% het-norm/high genotype and sub-genotypes demonstrated autoimmunity (p = 0.003). Prevalence of autoimmunity increased further in PCO-like phenotype patients with het-norm/low genotype (83.3%), remained unchanged with norm (34.0%) and decreased in het-norm/high women (10.0%; P<0.0001). Pregnancy rates were significantly higher with norm (38.6%) than het-norm/low (22.2%, p = 0.001). FMR1 sub-genotype het-norm/low is strongly associated with autoimmunity and decreased pregnancy chances in IVF, reaffirming the importance of the distal long arm of the X chromosome (FMR1 maps at Xq27.3) for autoimmunity, ovarian function and, likely, pregnancy chance with IVF.	[Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.] CHR, New York, NY USA; [Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.] Fdn Reprod Med, New York, NY USA; [Gleicher, Norbert] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Weghofer, Andrea] Univ Vienna, Sch Med, Dept Obstet & Gynecol, Vienna, Austria; [Barad, David H.] Albert Einstein Coll Med, Dept Epidemiol & Social Med, New York, NY USA; [Barad, David H.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, New York, NY USA	Yale University; University of Vienna; Yeshiva University; Yeshiva University	Gleicher, N (corresponding author), CHR, New York, NY USA.	ngleicher@thechr.com; dbarad@thechr.com	Barad, David/AAF-4332-2021		Foundation for Reproductive Medicine; Center for Human Reproduction	Foundation for Reproductive Medicine; Center for Human Reproduction	This work was supported by the Foundation for Reproductive Medicine and by intramural funds from the Center for Human Reproduction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ASRM PRACT COMM, 1999, ANT ANT DO NOT AFF 4; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P781, DOI 10.1210/jc.2005-2153; BANNATYNE P, 1990, INT J GYNECOL PATHOL, V9, P191, DOI 10.1097/00004347-199007000-00001; Barad DH, 2007, OBSTET GYNECOL, V109, P1404, DOI 10.1097/01.AOG.0000264065.37661.a0; Barad DH, 2009, FERTIL STERIL, V91, P1553, DOI 10.1016/j.fertnstert.2008.09.069; BARAD DH, 2010, RBMONLINE IN PRESS; Barad DH, 2009, FERTIL STERIL, V92, pS105; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Bodega B, 2006, HUM REPROD, V21, P952, DOI 10.1093/humrep/dei432; Bretherick KL, 2005, HUM GENET, V117, P376, DOI 10.1007/s00439-005-1326-8; Coulam CB, 2000, FERTIL STERIL, V74, P631; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Fenichel P, 1999, LANCET, V353, P2210, DOI 10.1016/S0140-6736(99)00256-1; FRISCHMUTH KH, 2010, FERTIL STERIL, V93, P2291; Geva E, 1997, FERTIL STERIL, V67, P599, DOI 10.1016/S0015-0282(97)81351-9; GLEICHER N, 1993, AUTOIMMUNITY, V16, P115, DOI 10.3109/08916939308993318; Gleicher N, 1999, RHEUMATOLOGY, V38, P485, DOI 10.1093/rheumatology/38.6.485; Gleicher N, 2007, AUTOIMMUN REV, V7, P42, DOI 10.1016/j.autrev.2007.06.001; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P485, DOI 10.1016/j.rbmo.2009.12.017; Gleicher N, 2009, REPROD BIOMED ONLINE, V19, P385, DOI 10.1016/S1472-6483(10)60173-3; Gleicher N, 2009, HUM REPROD, V24, P2395, DOI 10.1093/humrep/dep256; Gleicher N, 2009, ACTA OBSTET GYN SCAN, V88, P1024, DOI 10.1080/00016340903171058; Gleicher N, 2009, MENOPAUSE, V16, P760, DOI 10.1097/gme.0b013e318193c48b; Gleicher N, 2009, FERTIL STERIL, V91, P1707, DOI 10.1016/j.fertnstert.2008.01.099; Gleicher N, 2009, FERTIL STERIL, V91, P1700, DOI 10.1016/j.fertnstert.2008.01.098; Hill JA, 2000, FERTIL STERIL, V74, P439, DOI 10.1016/S0015-0282(00)00705-6; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Hornstein MD, 2000, FERTIL STERIL, V74, P635, DOI 10.1016/S0015-0282(00)01529-6; Hundscheid RDL, 2001, HUM REPROD, V16, P457, DOI 10.1093/humrep/16.3.457; KIM YJ, 2010, ARCH GYNECOL OBSTET; KUIVASAARIPIRIN.P, 2010, GYNECOL ENDOCRINOL; La Marca A, 2009, J CLIN ENDOCR METAB, V94, P3816, DOI 10.1210/jc.2009-0817; Larizza D, 2009, J AUTOIMMUN, V33, P25, DOI 10.1016/j.jaut.2009.03.002; LONDSDALE RN, 1991, HISTOPATHOLOGY, V19, P77; Marozzi A, 2000, HUM GENET, V107, P304, DOI 10.1007/s004390000364; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; OTT J, 2010, FERTIL STER IN PRESS; Persani L, 2009, J AUTOIMMUN, V33, P35, DOI 10.1016/j.jaut.2009.03.004; Pessach IM, 2009, J AUTOIMMUN, V33, P17, DOI 10.1016/j.jaut.2009.03.003; Segars JH, 2010, J CLIN ENDOCR METAB, V95, P2058, DOI 10.1210/jc.2010-0518; Singer T, 2009, FERTIL STERIL, V91, P2616, DOI 10.1016/j.fertnstert.2008.03.034; Singh RR, 1998, J CLIN INVEST, V102, P1841, DOI 10.1172/JCI3872; Sutmuller M, 1999, CLIN EXP IMMUNOL, V115, P275, DOI 10.1046/j.1365-2249.1999.00798.x; Urman B, 2004, REPROD BIOMED ONLINE, V8, P419, DOI 10.1016/S1472-6483(10)60926-1; VANGELDEREN CJ, 1993, J REPROD MED, V38, P381; Wall JR, 2010, ENDOKRYNOL POL, V61, P222; Welt CK, 2004, J CLIN ENDOCR METAB, V89, P4569, DOI 10.1210/jc.2004-0347; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004; ENTREZ GENE; 2004, HUM REPROD, V19, P41	54	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15303	10.1371/journal.pone.0015303	http://dx.doi.org/10.1371/journal.pone.0015303			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179569	Green Published, gold, Green Submitted			2022-12-27	WOS:000285381200025
J	Seong, KH; Akimaru, H; Dai, P; Nomura, T; Okada, M; Ishii, S				Seong, Ki-Hyeon; Akimaru, Hiroshi; Dai, Ping; Nomura, Teruaki; Okada, Masahiro; Ishii, Shunsuke			Inhibition of the Nuclear Import of Cubitus Interruptus by Roadkill in the Presence of Strong Hedgehog Signal	PLOS ONE			English	Article							PROTEIN-KINASE-A; KINESIN-RELATED PROTEIN; REQUIRES PHOSPHORYLATION; GENE-EXPRESSION; DROSOPHILA; TRANSCRIPTION; TRANSDUCTION; SUPPRESSOR; PATHWAY; DEGRADATION	Hedgehog (Hh) signalling plays an important role in various developmental processes by activating the Cubitus interruptus (Ci)/Glioblastoma (Gli) family of transcription factors. In the process of proper pattern formation, Ci activity is regulated by multiple mechanisms, including processing, trafficking, and degradation. However, it remains elusive how Ci distinctly recognizes the strong and moderate Hh signals. Roadkill (Rdx) induces Ci degradation in the anterior region of the Drosophila wing disc. Here, we report that Rdx inhibited Ci activity by two different mechanisms. In the region abutting the anterior/posterior boundary, which receives strong Hh signal, Rdx inhibited the nuclear import of Ci by releasing importin alpha 3 from Ci. In this region, Rdx negatively regulated the expression of transcription factor Knot/Collier. In farther anterior regions receiving moderate levels of Hh signal, Rdx induced Ci degradation, as reported previously. Thus, two different mechanisms by which Rdx negatively regulates Ci may play an important role in the fine-tuning of Hh responses.	[Seong, Ki-Hyeon; Akimaru, Hiroshi; Dai, Ping; Nomura, Teruaki; Okada, Masahiro; Ishii, Shunsuke] RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki, Japan	RIKEN	Seong, KH (corresponding author), RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki, Japan.	sishii@rtc.riken.jp	Ishii, Shunsuke/A-5271-2016	Ishii, Shunsuke/0000-0002-6530-2478; Seong, Ki-Hyeon/0000-0002-0606-8896	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23370079] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Dai P, 2003, DEV CELL, V4, P917, DOI 10.1016/S1534-5807(03)00158-8; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Dussillol-Godar F, 2006, DEV BIOL, V291, P53, DOI 10.1016/j.ydbio.2005.12.004; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Methot N, 2000, DEVELOPMENT, V127, P4001; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Pignoni F, 1997, DEVELOPMENT, V124, P271; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Sisson BE, 2006, DEV BIOL, V294, P258, DOI 10.1016/j.ydbio.2006.02.050; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Smelkinson MG, 2007, DEV CELL, V13, P481, DOI 10.1016/j.devcel.2007.09.006; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang GL, 2000, GENE DEV, V14, P2893, DOI 10.1101/gad.843900; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; XU T, 1993, DEVELOPMENT, V117, P1223; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	63	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15365	10.1371/journal.pone.0015365	http://dx.doi.org/10.1371/journal.pone.0015365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179535	Green Published, Green Submitted, gold			2022-12-27	WOS:000285340000024
J	Tamada, K; Tomonaga, S; Hatanaka, F; Nakai, N; Takao, K; Miyakawa, T; Nakatani, J; Takumi, T				Tamada, Kota; Tomonaga, Shozo; Hatanaka, Fumiyuki; Nakai, Nobuhiro; Takao, Keizo; Miyakawa, Tsuyoshi; Nakatani, Jin; Takumi, Toru			Decreased Exploratory Activity in a Mouse Model of 15q Duplication Syndrome; Implications for Disturbance of Serotonin Signaling	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; TRANSPORTER KNOCKOUT MICE; 5-HT TRANSPORTER; AUTISTIC DISORDER; CELL-CYCLE; RECEPTOR; BEHAVIOR; DOPAMINE; ANXIETY; BRAIN	Autism spectrum disorders (ASDs) have garnered significant attention as an important grouping of developmental brain disorders. Recent genomic studies have revealed that inherited or de novo copy number variations (CNVs) are significantly involved in the pathophysiology of ASDs. In a previous report from our laboratory, we generated mice with CNVs as a model of ASDs, with a duplicated mouse chromosome 7C that is orthologous to human chromosome 15q11-13. Behavioral analyses revealed paternally duplicated (patDp/+) mice displayed abnormal behaviors resembling the symptoms of ASDs. In the present study, we extended these findings by performing various behavioral tests with C57BL/6J patDp/+ mice, and comprehensively measuring brain monoamine levels with ex vivo high performance liquid chromatography. Compared with wild-type controls, patDp/+ mice exhibited decreased locomotor and exploratory activities in the open field test, Y-maze test, and fear-conditioning test. Furthermore, their decreased activity levels overcame increased appetite induced by 24 hours of food deprivation in the novelty suppressed feeding test. Serotonin levels in several brain regions of adult patDp/+ mice were lower than those of wild-type control, with no concurrent changes in brain levels of dopamine or norepinephrine. Moreover, analysis of monoamines in postnatal developmental stages demonstrated reduced brain levels of serotonin in young patDp/+ mice. These findings suggest that a disrupted brain serotonergic system, especially during postnatal development, may generate the phenotypes of patDp/+ mice.	[Tamada, Kota; Tomonaga, Shozo; Hatanaka, Fumiyuki; Nakai, Nobuhiro; Nakatani, Jin; Takumi, Toru] Osaka Biosci Inst, Suita, Osaka 565, Japan; [Tamada, Kota; Nakai, Nobuhiro] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Tamada, Kota; Hatanaka, Fumiyuki; Nakai, Nobuhiro; Takumi, Toru] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Kyoto, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med, Aichi, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Patterns, Okazaki, Aichi 444, Japan; [Miyakawa, Tsuyoshi; Takumi, Toru] Japan Sci & Technol Agcy, Saitama, Japan	Kyoto University; Hiroshima University; Kyoto University; Fujita Health University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Tamada, K (corresponding author), Osaka Biosci Inst, Suita, Osaka 565, Japan.	takumi@hiroshima-u.ac.jp	Takao, Keizo/B-9527-2008; Tomonaga, Shozo/S-3307-2018; Miyakawa, Tsuyoshi/A-7741-2008	Takao, Keizo/0000-0002-4734-3583; Tomonaga, Shozo/0000-0003-0888-1407; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Nakai, Nobuhiro/0000-0002-7171-230X	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Integrative Brain Research (IBR-shien); Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Foundation for Growth Science; Sankyo Foundation of Life Science; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation; Uehara Memorial Foundation; Novartis Foundation (Japan) for the promotion of Science; Nippon Boehringer Ingelheim Co., Ltd; Grants-in-Aid for Scientific Research [22780240] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Integrative Brain Research (IBR-shien); Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Foundation for Growth Science; Sankyo Foundation of Life Science; Mitsubishi Pharma Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Novartis Foundation (Japan) for the promotion of Science(Novartis); Nippon Boehringer Ingelheim Co., Ltd(Boehringer Ingelheim); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	S.T. and J.N. were supported by a Japan Society for the Promotion of Science fellowship. This work was supported in part by a grant from the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Integrative Brain Research (IBR-shien), Core Research for Evolutional Science and Technology of Japan Science and Technology Agency, and by research grants from the Foundation for Growth Science, the Sankyo Foundation of Life Science, the Mitsubishi Pharma Research Foundation, the Takeda Science Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Naito Foundation, the Uehara Memorial Foundation, the Novartis Foundation (Japan) for the promotion of Science, and Nippon Boehringer Ingelheim Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Caston J, 1998, BRAIN RES, V808, P232, DOI 10.1016/S0006-8993(98)00847-6; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Chugani DC, 1999, ANN NEUROL, V45, P287, DOI 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Cook EH, 1997, AM J HUM GENET, V60, P928; Crandall JE, 2007, J NEUROSCI, V27, P3813, DOI 10.1523/JNEUROSCI.5124-06.2007; Croonenberghs J, 2000, NEUROPSYCHOPHARMACOL, V22, P275, DOI 10.1016/S0893-133X(99)00131-1; Depienne C, 2009, BIOL PSYCHIAT, V66, P349, DOI 10.1016/j.biopsych.2009.01.025; Devlin B, 2005, MOL PSYCHIATR, V10, P1110, DOI 10.1038/sj.mp.4001724; Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x; Frederick AL, 2009, DEV NEUROSCI-BASEL, V31, P7, DOI 10.1159/000207490; Glickman G, 2010, NEUROSCI BIOBEHAV R, V34, P755, DOI 10.1016/j.neubiorev.2009.11.017; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; Hollander E, 2005, NEUROPSYCHOPHARMACOL, V30, P582, DOI 10.1038/sj.npp.1300627; Holmes A, 2002, PSYCHOPHARMACOLOGY, V161, P160, DOI 10.1007/s00213-002-1024-3; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Holmes A, 2001, NEUROSCI BIOBEHAV R, V25, P261, DOI 10.1016/S0149-7634(01)00012-4; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; Kalueff AV, 2007, BRAIN RES, V1169, P87, DOI 10.1016/j.brainres.2007.07.009; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Liu RJ, 2000, BRAIN RES, V873, P34, DOI 10.1016/S0006-8993(00)02468-9; Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00029; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Nakajima R, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-7; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Nakatani Y, 2008, EUR J NEUROSCI, V27, P2466, DOI 10.1111/j.1460-9568.2008.06201.x; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Ohtani N, 2003, J NEUROSCI, V23, P2840; Okado N, 2001, BRAIN DEV-JPN, V23, pS11, DOI 10.1016/S0387-7604(01)00371-0; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Pierce K, 2001, BIOL PSYCHIAT, V49, P655, DOI 10.1016/S0006-3223(00)01008-8; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sharp T, 2007, TRENDS PHARMACOL SCI, V28, P629, DOI 10.1016/j.tips.2007.10.009; Sotty F, 2009, NEUROPHARMACOLOGY, V57, P18, DOI 10.1016/j.neuropharm.2009.03.016; Stanwood GD, 2007, J NEUROSCI, V27, P152, DOI 10.1523/JNEUROSCI.4591-06.2007; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; TAKAO K, 2006, J VIS EXP; Takumi T, 2010, BRAIN DEV-JPN, V32, P753, DOI 10.1016/j.braindev.2010.05.001; TODD RD, 1992, BIOL PSYCHIAT, V31, P794, DOI 10.1016/0006-3223(92)90311-M; Tsujimura A, 2008, FRONT BEHAV NEUROSCI, V2, DOI 10.3389/neuro.08.004.2008; UMEDA T, PLOS ONE IN PRESS; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012; Zhang L, 2005, CEREB CORTEX, V15, P74, DOI 10.1093/cercor/bhh110; Zhao S, 2006, NEUROSCIENCE, V140, P321, DOI 10.1016/j.neuroscience.2006.01.049	56	83	87	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15126	10.1371/journal.pone.0015126	http://dx.doi.org/10.1371/journal.pone.0015126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179543	Green Published, Green Submitted, gold			2022-12-27	WOS:000285340000017
J	Bornmann, L; Mutz, R; Daniel, HD				Bornmann, Lutz; Mutz, Ruediger; Daniel, Hans-Dieter			A Reliability-Generalization Study of Journal Peer Reviews: A Multilevel Meta-Analysis of Inter-Rater Reliability and Its Determinants	PLOS ONE			English	Review							DECISION-MAKING; SCIENTIFIC ABSTRACTS; REFEREE AGREEMENT; EFFECTS MODELS; STANDS TODAY; MANUSCRIPT; ASSESSMENTS; RATINGS; BIAS; SUBMISSIONS	Background: This paper presents the first meta-analysis for the inter-rater reliability (IRR) of journal peer reviews. IRR is defined as the extent to which two or more independent reviews of the same scientific document agree. Methodology/Principal Findings: Altogether, 70 reliability coefficients (Cohen's Kappa, intra-class correlation [ICC], and Pearson product-moment correlation [r]) from 48 studies were taken into account in the meta- analysis. The studies were based on a total of 19,443 manuscripts; on average, each study had a sample size of 311 manuscripts (minimum: 28, maximum: 1983). The results of the meta- analysis confirmed the findings of the narrative literature reviews published to date: The level of IRR (mean ICC/r(2) = .34, mean Cohen's Kappa = .17) was low. To explain the study-to-study variation of the IRR coefficients, meta- regression analyses were calculated using seven covariates. Two covariates that emerged in the meta-regression analyses as statistically significant to gain an approximate homogeneity of the intra-class correlations indicated that, firstly, the more manuscripts that a study is based on, the smaller the reported IRR coefficients are. Secondly, if the information of the rating system for reviewers was reported in a study, then this was associated with a smaller IRR coefficient than if the information was not conveyed. Conclusions/Significance: Studies that report a high level of IRR are to be considered less credible than those with a low level of IRR. According to our meta- analysis the IRR of peer assessments is quite limited and needs improvement (e. g., reader system).	[Bornmann, Lutz] Max Planck Gesell, Munich, Germany; [Mutz, Ruediger; Daniel, Hans-Dieter] ETH, Zurich, Switzerland; [Daniel, Hans-Dieter] Univ Zurich, Evaluat Off, Zurich, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Bornmann, L (corresponding author), Max Planck Gesell, Munich, Germany.	bornmann@gv.mpg.de	White, Howard D/A-7034-2009; Mutz, Rüdiger/AAA-9629-2021; Mutz, Ruediger/A-2226-2009; Daniel, Hans-Dieter/A-2419-2013; Bornmann, Lutz/A-3926-2008	Mutz, Rüdiger/0000-0003-3345-6090; Bornmann, Lutz/0000-0003-0810-7091				BAILAR JC, 1991, BEHAV BRAIN SCI, V14, P137, DOI 10.1017/S0140525X00065705; BAKANIC V, 1987, AM SOCIOL REV, V52, P631, DOI 10.2307/2095599; Baker WL, 2009, INT J CLIN PRACT, V63, P1426, DOI 10.1111/j.1742-1241.2009.02168.x; Bateman IJ, 2003, LAND ECON, V79, P235, DOI 10.2307/3146869; Beretvas SN, 2003, EDUC PSYCHOL MEAS, V63, P75, DOI 10.1177/0013164402239318; BEYER JM, 1995, ACAD MANAGE J, V38, P1219, DOI 10.2307/256856; BHANDARI M, 2004, CLIN ORTHOP RELAT R, V423, P217; Blackburn JL, 2006, PSYCHOL SCI, V17, P378, DOI 10.1111/j.1467-9280.2006.01715.x; BOHANNON RW, 1986, PHYS THER, V66, P1431, DOI 10.1093/ptj/66.9.1431a; Borenstein M., 2009, INTRO METAANALYSIS; Bornmann L, 2008, ANGEW CHEM INT EDIT, V47, P7173, DOI 10.1002/anie.200800513; Bornmann L, 2007, J INFORMETR, V1, P226, DOI 10.1016/j.joi.2007.03.001; *BRIT AC, 2007, PEER REV CHALL HUM S; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P229, DOI 10.1001/jama.280.3.229; Campanario JM, 1998, SCI COMMUN, V19, P277, DOI 10.1177/1075547098019004002; Campanario JM, 1998, SCI COMMUN, V19, P181, DOI 10.1177/1075547098019003002; Cho MK, 1998, JAMA-J AM MED ASSOC, V280, P243, DOI 10.1001/jama.280.3.243; CICCHETTI DV, 1976, YALE J BIOL MED, V49, P373; CICCHETTI DV, 1980, AM PSYCHOL, V35, P300, DOI 10.1037/0003-066X.35.3.300; CICCHETTI DV, 1991, BEHAV BRAIN SCI, V14, P119, DOI 10.1017/S0140525X00065675; CICCHETTI DV, 1978, BIOMETRICS, V34, P728; CICCHETTI DV, 1979, P AM STAT ASSOC, V22, P596; Cohen IT, 2006, ANESTH ANALG, V102, P1501, DOI 10.1213/01.ane.0000200314.73035.4d; COHEN IT, 2005, J ED PERIOPERATIVE M, V7; Cole S, 2000, ASIST MON SER, P109; CONN HO, 1974, CLIN RES, V22, P128; Daniel H.D., 1993, GUARDIANS SCI FAIRNE, DOI [10.1002/3527602208, DOI 10.1002/3527602208]; DANIEL HD, 1993, ANGEW CHEM INT EDIT, V32, P234, DOI 10.1002/anie.199302341; DERSIMONIAN R, 1983, HARVARD EDUC REV, V53, P1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; EBEL RL, 1951, PSYCHOMETRIKA, V16, P407; Eckes T, 2004, DIAGNOSTICA, V50, P65, DOI 10.1026/0012-1924.50.2.65; Egger M, 2002, INT J EPIDEMIOL, V31, P1, DOI 10.1093/ije/31.1.1; Falagas ME, 2006, MAYO CLIN PROC, V81, P705, DOI 10.4065/81.5.705; Field AP, 2001, PSYCHOL METHODS, V6, P161, DOI 10.1037//1082-989X.6.2.161; FISKE DW, 1990, AM PSYCHOL, V45, P591, DOI 10.1037/0003-066X.45.5.591; Glass G.V., 1976, ED RES, V5, P3, DOI [10.2307/1174772, DOI 10.3102/0013189X005010003, 10.2307/1174772ISSN0536-1036]; GLIDEWELL JC, 1988, AM J COMMUN PSYCHOL, V16, P759, DOI 10.1007/BF00930891; Godlee F, 2002, JAMA-J AM MED ASSOC, V287, P2762, DOI 10.1001/jama.287.21.2762; GOLDMAN RL, 1994, EVAL HEALTH PROF, V17, P3, DOI 10.1177/016327879401700101; Goldstein H, 2000, J ROY STAT SOC C-APP, V49, P399, DOI 10.1111/1467-9876.00200; Good CD, 1999, S AFR MED J, V89, P397; GOTTFREDSON SD, 1978, AM PSYCHOL, V33, P920, DOI 10.1037/0003-066x.33.10.920; Gupta P, 2006, INDIAN PEDIATR, V43, P479; HARGENS LL, 1990, SOC SCI RES, V19, P1, DOI 10.1016/0049-089X(90)90012-8; Hedges L.V., 1994, HDB RES SYNTHESIS; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hemlin S, 2006, SCI TECHNOL HUM VAL, V31, P173, DOI 10.1177/0162243905283639; HENDRICK C, 1976, PERSONALITY SOCIAL P, V2, P207; HENDRICK C, 1977, PERSONALITY SOCIAL P, V3, P1; Herzog HA, 2005, ANTHROZOOS, V18, P175, DOI 10.2752/089279305785594180; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Howard L, 1998, BRIT J PSYCHIAT, V173, P110, DOI 10.1192/bjp.173.2.110; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Hunter J. E., 2004, METHODS METAANALYSIS; Hunter J.E., 1990, METHODS META ANAL CO; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; Jayasinghe UW, 2006, SCIENTOMETRICS, V69, P591, DOI 10.1007/s11192-006-0171-4; JUSTICE AC, 1994, JAMA-J AM MED ASSOC, V272, P117, DOI 10.1001/jama.272.2.117; Kemp S, 2005, J ECON PSYCHOL, V26, P779, DOI 10.1016/j.joep.2005.05.004; Kemper KJ, 1996, ARCH PEDIAT ADOL MED, V150, P380, DOI 10.1001/archpedi.1996.02170290046007; Kirk SA, 1997, SOC WORK RES, V21, P121, DOI 10.1093/swr/21.2.121; LaFollette MarcelC., 1992, STEALING PRINT FRAUD, DOI 10.1525/9780520917804; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langfeldt L, 2001, SOC STUD SCI, V31, P820, DOI 10.1177/030631201031006002; LeBreton JM, 2008, ORGAN RES METHODS, V11, P815, DOI 10.1177/1094428106296642; LEMPERT RO, 1985, LAW SOC REV, V19, P529; LIENERT GA, 1987, SCHULNOTEN EVALUATIO; LINDEN W, 1992, CAN J BEHAV SCI, V24, P433, DOI 10.1037/h0078757; LINDSEY D, 1988, SCIENTOMETRICS, V14, P75, DOI 10.1007/BF02020243; LITTLE RC, 2007, SAS MIXED MODELS; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Marsh HW, 2007, AUST PSYCHOL, V42, P33, DOI 10.1080/00050060600823275; Marsh HW, 2009, REV EDUC RES, V79, P1290, DOI 10.3102/0034654309334143; MARSH HW, 1981, J EDUC PSYCHOL, V73, P872, DOI 10.1037/0022-0663.73.6.872; Marusic A, 2002, CROAT MED J, V43, P286; MCREYNOLDS P, 1971, AM PSYCHOL, V26, P400, DOI 10.1037/h0037937; Montgomery AA, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-8; MORROW JR, 1992, RES Q EXERCISE SPORT, V63, P200, DOI 10.1080/02701367.1992.10607582; MUNLEY PH, 1988, J COUNS PSYCHOL, V35, P198, DOI 10.1037/0022-0167.35.2.198; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Neff BD, 2006, BIOSCIENCE, V56, P333, DOI 10.1641/0006-3568(2006)56[333:IPRAGO]2.0.CO;2; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P91, DOI 10.1016/0895-4356(91)90205-N; Petty RE, 1999, PERS SOC PSYCHOL B, V25, P188, DOI 10.1177/0146167299025002005; PLUG C, 1993, S AFR J PSYCHOL, V23, P43, DOI 10.1177/008124639302300108; Rothwell PM, 2000, BRAIN, V123, P1964, DOI 10.1093/brain/123.9.1964; RUBIN HR, 1993, J GEN INTERN MED, V8, P255, DOI 10.1007/BF02600092; RUBIN HR, 1992, CLIN RES, V40, pA589; SCARR S, 1978, AM PSYCHOL, V33, P935, DOI 10.1037/h0078544; SCOTT JR, 2005, 5 INT C PEER REV BIO; SCOTT WA, 1974, AM PSYCHOL, V29, P698, DOI 10.1037/h0037631; Shadish W. R., 2001, EXPT QUASIEXPERIMENT, V2nd; SIEGELMAN SS, 1991, RADIOLOGY, V178, P637, DOI 10.1148/radiology.178.3.1994394; Smith R, 2006, J ROY SOC MED, V99, P178, DOI 10.1258/jrsm.99.4.178; Snodgrass R, 2006, SIGMOD REC, V35, P8; STRAYHORN J, 1993, AM J PSYCHIAT, V150, P947; Thompson B, 2000, EDUC PSYCHOL MEAS, V60, P174, DOI 10.1177/00131640021970448; Timmer Antje, 2003, BMC Med Res Methodol, V3, P2, DOI 10.1186/1471-2288-3-2; Vacha-Haase T, 1998, EDUC PSYCHOL MEAS, V58, P6, DOI 10.1177/0013164498058001002; Van den Noortgate W, 2003, EDUC PSYCHOL MEAS, V63, P765, DOI 10.1177/0013164402251027; van der Steen LPE, 2003, PLAST RECONSTR SURG, V111, P2215, DOI 10.1097/01.PRS.0000061092.88629.82; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Weller A, 2002, EDITORIAL PEER REV I; White HD, 2005, ISSI 2005: PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE OF THE INTERNATIONAL SOCIETY FOR SCIENTOMETRICS AND INFORMETRICS, VOLS 1 AND 2, P442; WHITEHURST GJ, 1983, DEV REV, V3, P73, DOI 10.1016/0273-2297(83)90009-6; Wood M, 2004, J INF SCI, V30, P2, DOI 10.1177/0165551504041673; YADOLLAHIE M, 2004, SAUDI MED J SS44, V25; Ziman J. M., 2000, REAL SCI WHAT IT IS	110	105	106	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14331	10.1371/journal.pone.0014331	http://dx.doi.org/10.1371/journal.pone.0014331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	694JH	21179459	Green Published, Green Submitted, gold			2022-12-27	WOS:000285292500009
J	Schneider, MR; Dahlhoff, M; Horst, D; Hirschi, B; Trulzsch, K; Muller-Hocker, J; Vogelmann, R; Allgauer, M; Gerhard, M; Steininger, S; Wolf, E; Kolligs, FT				Schneider, Marlon R.; Dahlhoff, Maik; Horst, David; Hirschi, Benjamin; Truelzsch, Konrad; Mueller-Hoecker, Josef; Vogelmann, Roger; Allgaeuer, Michael; Gerhard, Markus; Steininger, Sylvia; Wolf, Eckhard; Kolligs, Frank T.			A Key Role for E-cadherin in Intestinal Homeostasis and Paneth Cell Maturation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; IN-VIVO; CROHNS-DISEASE; N-CADHERIN; STEM-CELLS; GASTROINTESTINAL-TRACT; JUNCTIONAL COMPLEX; SIGNALING PATHWAY; GENE-EXPRESSION; FGF RECEPTOR	Background: E-cadherin is a major component of adherens junctions. Impaired expression of E-cadherin in the small intestine and colon has been linked to a disturbed intestinal homeostasis and barrier function. Down-regulation of E-cadherin is associated with the pathogenesis of infections with enteropathogenic bacteria and Crohn's disease. Methods and Findings: To genetically clarify the function of E-cadherin in intestinal homeostasis and maintenance of the epithelial defense line, the Cdh1 gene was conditionally inactivated in the mouse intestinal epithelium. Inactivation of the Cdh1 gene in the small intestine and colon resulted in bloody diarrhea associated with enhanced apoptosis and cell shedding, causing life-threatening disease within 6 days. Loss of E-cadherin led cells migrate faster along the crypt-villus axis and perturbed cellular differentiation. Maturation and positioning of goblet cells and Paneth cells, the main cell lineage of the intestinal innate immune system, was severely disturbed. The expression of anti-bacterial cryptidins was reduced and mice showed a deficiency in clearing enteropathogenic bacteria from the intestinal lumen. Conclusion: These results highlight the central function of E-cadherin in the maintenance of two components of the intestinal epithelial defense: E-cadherin is required for the proper function of the intestinal epithelial lining by providing mechanical integrity and is a prerequisite for the proper maturation of Paneth and goblet cells.	[Schneider, Marlon R.; Dahlhoff, Maik; Wolf, Eckhard] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Munich, Germany; [Schneider, Marlon R.; Dahlhoff, Maik; Wolf, Eckhard] Univ Munich, Lab Funct Genome Anal LAFUGA, Gene Ctr, Munich, Germany; [Horst, David; Mueller-Hoecker, Josef] Univ Munich, Inst Pathol, D-8000 Munich, Germany; [Hirschi, Benjamin; Kolligs, Frank T.] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany; [Truelzsch, Konrad] Univ Munich, Inst Microbiol, Max Von Pettenkofer Inst, Munich, Germany; [Vogelmann, Roger; Allgaeuer, Michael; Gerhard, Markus; Steininger, Sylvia] Tech Univ Munich, Dept Med 2, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; Technical University of Munich	Schneider, MR (corresponding author), Univ Munich, Inst Mol Anim Breeding & Biotechnol, Munich, Germany.	fkolligs@med.uni-muenchen.de	Gerhard, Markus/P-8996-2019; Dahlhoff, Maik/AGH-1182-2022; Gerhard, Markus/N-3387-2014	Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Wolf, Eckhard/0000-0002-0430-9510; Allgaeuer, Michael/0000-0003-4518-7887; Schneider, Marlon/0000-0002-9570-3491; Hirschi, Benjamin/0000-0002-1046-8307; Dahlhoff, Maik/0000-0001-9189-7631; Trulzsch, Konrad/0000-0002-1937-5043	Else Kroner-Fresenius-Stiftung [P50/08//A43/08]; University of Munich [865438-6]	Else Kroner-Fresenius-Stiftung; University of Munich	This work was supported by a grant from the Else Kroner-Fresenius-Stiftung (http://www.ekfs.de) to FTK and MRS (P50/08//A43/08) and a grant from the University of Munich (www.uni-muenchen.de) to FTK (865438-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, GASTROENTEROLOGY, V133, P1755, DOI 10.1053/j.gastro.2007.10.029; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; Chambers FG, 1997, INFECT IMMUN, V65, P3561, DOI 10.1128/IAI.65.9.3561-3570.1997; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jankowski JAZ, 1998, LAB INVEST, V78, P1155; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; KEIGHLEY MRB, 1982, GASTROENTEROLOGY, V83, P1271; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Laukoetter MG, 2008, WORLD J GASTROENTERO, V14, P401, DOI 10.3748/wjg.14.401; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Loessner H, 2007, CELL MICROBIOL, V9, P1529, DOI 10.1111/j.1462-5822.2007.00890.x; Meddings J, 2008, GUT, V57, P438, DOI 10.1136/gut.2007.143172; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Oellerich MF, 2007, INFECT IMMUN, V75, P3802, DOI 10.1128/IAI.00419-07; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Smits R, 2000, GASTROENTEROLOGY, V119, P1045, DOI 10.1053/gast.2000.18162; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Young P, 2003, EMBO J, V22, P5723, DOI 10.1093/emboj/cdg560; Zbar AP, 2004, J GASTROENTEROL, V39, P413, DOI 10.1007/s00535-004-1335-8	54	129	131	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14325	10.1371/journal.pone.0014325	http://dx.doi.org/10.1371/journal.pone.0014325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179475	gold, Green Published, Green Submitted			2022-12-27	WOS:000285292500007
J	Cadet, JL; Brannock, C; Krasnova, IN; Ladenheim, B; Mccoy, MT; Chou, J; Lehrmann, E; Wood, WH; Becker, KG; Wang, Y				Cadet, Jean Lud; Brannock, Christie; Krasnova, Irina N.; Ladenheim, Bruce; McCoy, Michael T.; Chou, Jenny; Lehrmann, Elin; Wood, William H.; Becker, Kevin G.; Wang, Yun			Methamphetamine-Induced Dopamine- Independent Alterations in Striatal Gene Expression in the 6-Hydroxydopamine Hemiparkinsonian Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; FENFLURAMINE-INDUCED ACTIVATION; DA UPTAKE SITES; NEUROMEDIN-U; GROWTH-FACTOR; STRIATOPALLIDAL NEURONS; PARKINSONS-DISEASE; GLUTAMATE RELEASE; SUBSTANTIA-NIGRA	Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle are used extensively as a model of Parkinson's disease. The present experiments sought to identify genes that were affected in the dopamine (DA)-denervated striatum after 6-hydroxydopamine-induced destruction of the nigrostriatal dopaminergic pathway in the rat. We also examined whether a single injection of methamphetamine (METH) (2.5 mg/kg) known to cause changes in gene expression in the normally DA-innervated striatum could still influence striatal gene expression in the absence of DA. Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle resulted in METH-induced rotational behaviors ipsilateral to the lesioned side and total striatal DA depletion on the lesioned side. This injection also caused decrease in striatal serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels. DA depletion was associated with increases in 5-HIAA/5-HT ratios that were potentiated by the METH injection. Microarray analyses revealed changes (+/- 1.7-fold, p<0.025) in the expression of 67 genes on the lesioned side in comparison to the intact side of the saline-treated hemiparkinsonian animals. These include follistatin, neuromedin U, and tachykinin 2 which were up-regulated. METH administration caused increases in the expression of c-fos, Egr1, and Nor-1 on the intact side. On the DA-depleted side, METH administration also increased the expression of 61 genes including Pdgf-d and Cox-2. There were METH-induced changes in 16 genes that were common in the DA-innervated and DA-depleted sides. These include c-fos and Nor-1 which show greater changes on the normal DA side. Thus, the present study documents, for the first time, that METH mediated DA-independent changes in the levels of transcripts of several genes in the DA-denervated striatum. Our results also implicate 5-HT as a potential player in these METH-induced alterations in gene expression because the METH injection also caused significant increases in 5-HIAA/5-HT ratios on the DA-depleted side.	[Cadet, Jean Lud; Brannock, Christie; Krasnova, Irina N.; Ladenheim, Bruce; McCoy, Michael T.; Chou, Jenny; Wang, Yun] NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA; [Lehrmann, Elin; Wood, William H.; Becker, Kevin G.] NIDA, Gene Express & Genom Unit, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Cadet, JL (corresponding author), NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA.	jcadet@intra.nida.nih.gov		Lehrmann, Elin/0000-0002-9869-9475; Becker, Kevin/0000-0002-6794-6656	National Institute on Drug Abuse and National Institute of Aging, National Institutes of Health (NIH)/Department of Health and Human Services (DHHS); NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000174, ZIADA000461, ZIADA000429, ZIADA000552, ZIADA000576] Funding Source: NIH RePORTER	National Institute on Drug Abuse and National Institute of Aging, National Institutes of Health (NIH)/Department of Health and Human Services (DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was supported by Intramural Research Programs of National Institute on Drug Abuse and National Institute of Aging, National Institutes of Health (NIH)/Department of Health and Human Services (DHHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEKAWA T, 1994, BRAIN RES, V643, P276, DOI 10.1016/0006-8993(94)90033-7; Adams DH, 2005, MOL BRAIN RES, V133, P131, DOI 10.1016/j.molbrainres.2004.10.005; Adams DH, 2001, NEUROSCIENCE, V102, P843, DOI 10.1016/S0306-4522(00)00530-3; ALTAR CA, 1987, J NEUROCHEM, V48, P390, DOI 10.1111/j.1471-4159.1987.tb04106.x; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; ANGULO JA, 1991, MOL BRAIN RES, V11, P161, DOI 10.1016/0169-328X(91)90117-G; ANGULO JA, 1986, EUR J PHARMACOL, V130, P341, DOI 10.1016/0014-2999(86)90290-6; Azdad K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006908; BEAN AJ, 1989, J NEUROSCI, V9, P4430; Beauvais G, 2010, BRAIN RES, V1318, P1, DOI 10.1016/j.brainres.2009.12.083; BERGER K, 1991, BRAIN RES BULL, V26, P301, DOI 10.1016/0361-9230(91)90242-C; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Bernard DJ, 2001, RECENT PROG HORM RES, V56, P417, DOI 10.1210/rp.56.1.417; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bilezikjian LM, 2001, CLIN EXP PHARMACOL P, V28, P244, DOI 10.1046/j.1440-1681.2001.03422.x; Bilezikjian LM, 2006, REPRODUCTION, V132, P207, DOI 10.1530/rep.1.01073; Bottner M, 2006, J NEUROENDOCRINOL, V18, P97, DOI 10.1111/j.1365-2826.2005.01384.x; Budhiraja S, 2009, FUND CLIN PHARMACOL, V23, P149, DOI 10.1111/j.1472-8206.2009.00667.x; BURGUNDER JM, 1989, NEUROSCIENCE, V32, P323, DOI 10.1016/0306-4522(89)90081-X; Bustamante D, 2002, J NEUROCHEM, V83, P645, DOI 10.1046/j.1471-4159.2002.01171.x; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; CADET JL, 1992, BRAIN RES, V595, P316, DOI 10.1016/0006-8993(92)91066-N; CADET JL, 1992, MOL BRAIN RES, V12, P59, DOI 10.1016/0169-328X(92)90068-M; Cadet JL, 2001, SYNAPSE, V41, P40, DOI 10.1002/syn.1058; CAMERON VA, 1994, ENDOCRINOLOGY, V134, P799, DOI 10.1210/en.134.2.799; CAMPBELL K, 1992, P NATL ACAD SCI USA, V89, P10489, DOI 10.1073/pnas.89.21.10489; Cardoso F, 2009, NEUROL CLIN, V27, P719, DOI 10.1016/j.ncl.2009.04.001; CASTEL MN, 1994, EUR J NEUROSCI, V6, P646, DOI 10.1111/j.1460-9568.1994.tb00310.x; Centonze D, 2005, NEUROSCIENCE, V133, P831, DOI 10.1016/j.neuroscience.2005.03.006; Chritin M, 1996, EUR J NEUROSCI, V8, P2511, DOI 10.1111/j.1460-9568.1996.tb01545.x; CHRITIN M, 1993, MOL BRAIN RES, V19, P318, DOI 10.1016/0169-328X(93)90132-9; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; CONLON JM, 1988, J NEUROCHEM, V51, P988, DOI 10.1111/j.1471-4159.1988.tb01837.x; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DOMIN J, 1987, PEPTIDES, V8, P779, DOI 10.1016/0196-9781(87)90058-1; El Atifi-Borel M, 2009, NEUROBIOL DIS, V34, P340, DOI 10.1016/j.nbd.2009.02.002; Enge M, 2003, NEUROCHEM RES, V28, P271, DOI 10.1023/A:1022421001288; Fahn S, 2008, MOVEMENT DISORD, V23, pS497, DOI 10.1002/mds.22028; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Funa K, 1996, NEUROSCIENCE, V74, P825, DOI 10.1016/0306-4522(96)00152-2; Garcia-Arencibia M, 2008, NEUROSCI LETT, V438, P10, DOI 10.1016/j.neulet.2008.04.041; Gardier AM, 2000, J NEUROCHEM, V74, P1363, DOI 10.1046/j.1471-4159.2000.0741363.x; Gartlon J, 2004, PSYCHOPHARMACOLOGY, V177, P1, DOI 10.1007/s00213-004-1918-3; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1991, J NEUROSCI, V11, P1016; GRAHAM WC, 1990, BRAIN RES, V514, P93, DOI 10.1016/0006-8993(90)90439-I; Hanson GR, 1999, MOL BRAIN RES, V66, P111, DOI 10.1016/S0169-328X(99)00033-9; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Herrera-Marschitz M, 2010, PROG NEUROBIOL, V90, P176, DOI 10.1016/j.pneurobio.2009.01.005; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Ishida Y, 1998, BRAIN RES, V809, P107, DOI 10.1016/S0006-8993(98)00874-9; Jayanthi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006092; KARSTAEDT PJ, 1994, EXP NEUROL, V126, P25, DOI 10.1006/exnr.1994.1039; Kita T, 2000, NEUROPHARMACOLOGY, V39, P399, DOI 10.1016/S0028-3908(99)00175-6; Konradi C, 2004, NEUROBIOL DIS, V17, P219, DOI 10.1016/j.nbd.2004.07.005; Konradi C, 1996, J NEUROSCI, V16, P4231; Krasnova IN, 2008, GENES BRAIN BEHAV, V7, P193, DOI 10.1111/j.1601-183X.2007.00338.x; Krasnova IN, 2007, NEUROTOX RES, V11, P107, DOI 10.1007/BF03033390; Krasnova IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008790; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; LI SJ, 1990, MOL BRAIN RES, V8, P219, DOI 10.1016/0169-328X(90)90020-E; MALENDOWICZ LK, 1994, NEUROPEPTIDES, V26, P47, DOI 10.1016/0143-4179(94)90092-2; Meshul CK, 1999, NEUROSCIENCE, V88, P1, DOI 10.1016/S0306-4522(98)00189-4; Meurers BH, 2009, J NEUROSCI, V29, P6828, DOI 10.1523/JNEUROSCI.5310-08.2009; MINAMINO N, 1988, BIOCHEM BIOPH RES CO, V156, P355, DOI 10.1016/S0006-291X(88)80848-9; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; MORRIS BJ, 1989, J MOL NEUROSCI, V1, P9, DOI 10.1007/BF02896851; Mukerji SS, 2007, J CEREBR BLOOD F MET, V27, P1161, DOI 10.1038/sj.jcbfm.9600423; NASH JF, 1992, BRAIN RES, V581, P237, DOI 10.1016/0006-8993(92)90713-J; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; PAUL ML, 1992, J NEUROSCI, V12, P3729, DOI 10.1523/jneurosci.12-10-03729.1992; PAUL ML, 1995, NEUROSCIENCE, V66, P347, DOI 10.1016/0306-4522(94)00582-P; Paulsen RE, 1995, J MOL NEUROSCI, V6, P249, DOI 10.1007/BF02736784; Peier A, 2009, ENDOCRINOLOGY, V150, P3101, DOI 10.1210/en.2008-1772; Rouillard C, 1996, MOL BRAIN RES, V37, P105, DOI 10.1016/0169-328X(95)00284-Y; Shan LX, 2000, J BIOL CHEM, V275, P39482, DOI 10.1074/jbc.C000522200; Shimada A, 1996, ANN NY ACAD SCI, V801, P361, DOI 10.1111/j.1749-6632.1996.tb17456.x; Simola N, 2009, NEUROSCIENCE, V158, P1625, DOI 10.1016/j.neuroscience.2008.11.009; Sjoborg M, 1998, EXP BRAIN RES, V119, P245, DOI 10.1007/s002210050338; STEPHANS SE, 1994, SYNAPSE, V17, P203, DOI 10.1002/syn.890170310; Thomas DM, 2005, FASEB J, V19, P515, DOI 10.1096/fj.05-4873fje; Thomas DM, 2005, J PHARMACOL EXP THER, V313, P870, DOI 10.1124/jpet.104.080242; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Touchon JC, 2005, EXP NEUROL, V193, P131, DOI 10.1016/j.expneurol.2004.11.023; Tretter YP, 1996, NEUROREPORT, V7, P1819, DOI 10.1097/00001756-199607290-00026; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; WANG JQ, 1995, J PHARMACOL EXP THER, V273, P909; Wang JQ, 1996, BRAIN RES BULL, V39, P349, DOI 10.1016/0361-9230(96)00002-0; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Yang H, 2006, LIFE SCI, V78, P1940, DOI 10.1016/j.lfs.2005.08.001; ZETTERSTROM T, 1983, J NEUROCHEM, V41, P1769, DOI 10.1111/j.1471-4159.1983.tb00893.x; ZETTERSTROM T, 1986, BRAIN RES, V376, P1, DOI 10.1016/0006-8993(86)90893-0; ZHANG WQ, 1988, BRAIN RES, V461, P335, DOI 10.1016/0006-8993(88)90264-8	99	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15643	10.1371/journal.pone.0015643	http://dx.doi.org/10.1371/journal.pone.0015643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179447	Green Submitted, gold, Green Published			2022-12-27	WOS:000285246900049
J	Iyegbe, CO; Abiola, OO; Towlson, C; Powell, JF; Whatley, SA				Iyegbe, Conrad O.; Abiola, Oduola O.; Towlson, Chris; Powell, John F.; Whatley, Steven A.			Evidence for Varied Aetiologies Regulating the Transmission of Prion Disease: Implications for Understanding the Heritable Basis of Prion Incubation Times	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; QUANTITATIVE-TRAIT-LOCI; CREUTZFELDT-JAKOB-DISEASE; GENETIC DISSECTION; MONOZYGOTIC TWINS; COMPLEX TRAITS; GENOME-WIDE; MICE; SCRAPIE; METAANALYSIS	Background: Transmissible Spongiform Encephalopathies (TSEs) are a group of progressive fatal neurodegenerative disorders, triggered by abnormal folding of the endogenous prion protein molecule. The encoding gene is a major biological factor influencing the length of the asymptomatic period after infection. It remains unclear the extent to which the variation between quantitative trait loci (QTLs) reported in mouse models is due to methodological differences between approaches or genuine differences between traits. With this in mind, our approach to identifying genetic factors has sought to extend the linkage mapping approach traditionally applied, to a series of additional traits, while minimising methodological variability between them. Our approach allows estimations of heritability to be derived, as well as predictions to be made about possible existence of genetic overlap between the various traits. Methodology/Principal Findings: Our data indicate a surprising degree of heritability (up to 60%). Correlations between traits are also identified. A series of QTLs on chromosomes 1, 2, 3, 4, 6, 11 and 18 accompany our heritability estimates. However, only a locus on chromosome 11 has a general effect across all 4 models explored. Conclusions/Significance: We have achieved some success in detecting novel and pre-existing QTLs associated with incubation time. However, aside from the general effects described, the model-specific nature of the broader host genetic architecture has also been brought into clearer focus. This suggests that genetic overlap can only partially account for the general heritability of incubation time when factors, such as the nature of the TSE agent and the route of administration are considered. This point is highly relevant to vCJD (a potential threat to public health) where the route of primary importance is oral, while the QTLs being sought derive exclusively from studies of the ic route. Our results highlight the limitations of a single-model approach to QTL-mapping of TSEs.	[Iyegbe, Conrad O.] Kings Coll London, Inst Psychiat, Psychosis Ctr, London WC2R 2LS, England; [Iyegbe, Conrad O.; Towlson, Chris; Powell, John F.; Whatley, Steven A.] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Iyegbe, CO (corresponding author), Kings Coll London, Inst Psychiat, Psychosis Ctr, London WC2R 2LS, England.	c.iyegbe@iop.kcl.ac.uk	Powell, John F/G-4412-2011	Powell, John F/0000-0001-6124-439X	Medical Research Council, United Kingdom [G9627297]	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was carried out with the support of grant number G9627297 of the Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ano Y, 2009, PROTEIN PEPTIDE LETT, V16, P247, DOI 10.2174/092986609787601642; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Falconer DS, 1996, QUANTITATIVE GENETIC; Field A, 2013, DISCOVERING STAT USI; FRASER H, 1992, J GEN VIROL, V73, P1891, DOI 10.1099/0022-1317-73-8-1891; Gillies M, 2009, VOX SANG, V97, P211, DOI 10.1111/j.1423-0410.2009.01222.x; Hamasaki S, 1998, LANCET, V352, P1358, DOI 10.1016/S0140-6736(05)60749-0; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; KINGSBURY DT, 1983, J IMMUNOL, V131, P491; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANTOS PL, 1992, NEUROSCI LETT, V147, P67, DOI 10.1016/0304-3940(92)90776-4; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; LLOYD SE, 2009, NEUROGENETICS   1001; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Moreno CR, 2003, GENETICS, V165, P2085; MOULD DL, 1967, J COMP PATHOL, V77, P387, DOI 10.1016/0021-9975(67)90023-0; O'Shea M, 2008, GENETICS, V180, P559, DOI 10.1534/genetics.108.090894; OUTRAM GW, 1973, J COMP PATHOL, V83, P19, DOI 10.1016/0021-9975(73)90023-6; Owen MJ, 2010, ARCH GEN PSYCHIAT, V67, P667, DOI 10.1001/archgenpsychiatry.2010.69; PLOMIN R, 1993, BEHAV GENET, V23, P197, DOI 10.1007/BF01067425; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; RODRIGUEZ LA, 1994, ALCOHOL CLIN EXP RES, V18, P1416, DOI 10.1111/j.1530-0277.1994.tb01444.x; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; ROSENTHAL R, 1991, PSYCHOSOM MED, V53, P247, DOI 10.1097/00006842-199105000-00001; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Webb T, 2009, NEUROPATH APPL NEURO, V35, P427, DOI 10.1111/j.1365-2990.2009.01012.x; Webb TEF, 2009, AM J MED GENET B, V150B, P496, DOI 10.1002/ajmg.b.30844; 2007, EUROSURVEILL, V12	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14186	10.1371/journal.pone.0014186	http://dx.doi.org/10.1371/journal.pone.0014186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152031	Green Published, gold, Green Submitted			2022-12-27	WOS:000284868000009
J	Stamatakis, EA; Adapa, RM; Absalom, AR; Menon, DK				Stamatakis, Emmanuel A.; Adapa, Ram M.; Absalom, Anthony R.; Menon, David K.			Changes in Resting Neural Connectivity during Propofol Sedation	PLOS ONE			English	Article							ANTERIOR THALAMIC NUCLEI; DEFAULT-MODE NETWORK; CEREBRAL-BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; GENERAL-ANESTHESIA; HUMAN BRAIN; CONSCIOUSNESS; SLEEP; TASK; SEVOFLURANE	Background: The default mode network consists of a set of functionally connected brain regions (posterior cingulate, medial prefrontal cortex and bilateral parietal cortex) maximally active in functional imaging studies under "no task" conditions. It has been argued that the posterior cingulate is important in consciousness/awareness, but previous investigations of resting interactions between the posterior cingulate cortex and other brain regions during sedation and anesthesia have produced inconsistent results. Methodology/Principal Findings: We examined the connectivity of the posterior cingulate at different levels of consciousness. "No task" fMRI (BOLD) data were collected from healthy volunteers while awake and at low and moderate levels of sedation, induced by the anesthetic agent propofol. Our data show that connectivity of the posterior cingulate changes during sedation to include areas that are not traditionally considered to be part of the default mode network, such as the motor/somatosensory cortices, the anterior thalamic nuclei, and the reticular activating system. Conclusions/Significance: This neuroanatomical signature resembles that of non-REM sleep, and may be evidence for a system that reduces its discriminable states and switches into more stereotypic patterns of firing under sedation.	[Stamatakis, Emmanuel A.; Adapa, Ram M.; Absalom, Anthony R.; Menon, David K.] Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, England	University of Cambridge	Stamatakis, EA (corresponding author), Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, England.	eas46@cam.ac.uk	Absalom, Anthony/GPG-1582-2022; Adapa, Ram/D-7925-2012	Adapa, Ram/0000-0002-9845-8532; Absalom, Anthony/0000-0001-7563-9157; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Queens' College Cambridge; Wellcome Trust; Raymond and Beverly Sackler Studentship; BOC; National Institute for Health Research; Medical Research Council [G0001237, G0600986, G9439390] Funding Source: researchfish; MRC [G0001237, G0600986, G9439390] Funding Source: UKRI	Queens' College Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission); Raymond and Beverly Sackler Studentship; BOC; National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	EAS is funded by the Stephen Erskine Fellowship, Queens' College Cambridge. RMA is supported by a Wellcome Trust Clinical Research Training Fellowship, and the Raymond and Beverly Sackler Studentship. ARA and DKM are funded by the BOC Professorship of the Royal College of Anaesthetists. DKM is funded by the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalom AR, 2009, BRIT J ANAESTH, V103, P26, DOI 10.1093/bja/aep143; Absalom AR, 2009, CRIT CARE, V13, DOI 10.1186/cc7776; AGGLETON JP, 1993, NEUROPSYCHOLOGIA, V31, P1001, DOI 10.1016/0028-3932(93)90029-Y; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Baars BJ, 2002, TRENDS COGN SCI, V6, P47, DOI 10.1016/S1364-6613(00)01819-2; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; Dehaene S, 2005, PLOS BIOL, V3, P910, DOI 10.1371/journal.pbio.0030141; Fiset P, 1999, J NEUROSCI, V19, P5506; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Haenggi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7723; Harding A, 2000, BRAIN, V123, P141, DOI 10.1093/brain/123.1.141; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; He BJ, 2009, TRENDS COGN SCI, V13, P302, DOI 10.1016/j.tics.2009.04.004; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Huotari AM, 2004, BRIT J ANAESTH, V92, P18, DOI 10.1093/bja/aeh022; Johnston AJ, 2003, BRIT J ANAESTH, V91, P781, DOI 10.1093/bja/aeg256; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kiviniemi VJ, 2005, MAGN RESON IMAGING, V23, P531, DOI 10.1016/j.mri.2005.02.009; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Leslie K, 2009, ANESTHESIOLOGY, V111, P547, DOI 10.1097/ALN.0b013e3181adf768; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maquet P, 2000, J SLEEP RES, V9, P207; MARSH B, 1991, BRIT J ANAESTH, V67, P41, DOI 10.1093/bja/67.1.41; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Ogawa K, 2003, ANESTHESIOLOGY, V98, P1101, DOI 10.1097/00000542-200305000-00012; Olson D, 2007, NEUROCRIT CARE, V7, P227, DOI 10.1007/s12028-007-0069-x; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Paus T, 2000, PROG BRAIN RES, V126, P65; Peltier SJ, 2005, NEUROREPORT, V16, P285, DOI 10.1097/00001756-200502280-00017; Qiu ML, 2008, MAGN RESON MED, V60, P987, DOI 10.1002/mrm.21759; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schlunzen L, 2004, ACTA ANAESTH SCAND, V48, P1268, DOI 10.1111/j.1399-6576.2004.00505.x; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1990, J NEUROSCI, V10, P2541; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Talairach J., 1988, COPLANAR STEREOTAXIC; Tononi G, 2005, PROG BRAIN RES, V150, P109, DOI 10.1016/S0079-6123(05)50009-8; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vahle-Hinz C, 2007, EXP BRAIN RES, V176, P159, DOI 10.1007/s00221-006-0604-6; Veselis RA, 2005, ANESTHESIOLOGY, V102, P26, DOI 10.1097/00000542-200501000-00008; Veselis RA, 2009, ANESTHESIOLOGY, V110, P295, DOI 10.1097/ALN.0b013e3181942ef0; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Ying SW, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-2; 2006, ANESTHESIOL, V104, P847	74	122	124	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14224	10.1371/journal.pone.0014224	http://dx.doi.org/10.1371/journal.pone.0014224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	688QY	21151992	gold, Green Published, Green Submitted			2022-12-27	WOS:000284868000022
J	Kim, EJ; Kim, ES; Covey, E; Kim, JJ				Kim, Eun Joo; Kim, Earnest S.; Covey, Ellen; Kim, Jeansok J.			Social Transmission of Fear in Rats: The Role of 22-kHz Ultrasonic Distress Vocalization	PLOS ONE			English	Article							C-FOS EXPRESSION; 22 KHZ CALLS; LABORATORY RATS; AMYGDALA; MODULATION; RESPONSES; INACTIVATION; STIMULATION; PLAYBACK; NUCLEUS	Background: Social alarm calls alert animals to potential danger and thereby promote group survival. Adult laboratory rats in distress emit 22-kHz ultrasonic vocalization (USV) calls, but the question of whether these USV calls directly elicit defensive behavior in conspecifics is unresolved. Methodology/Principal Findings: The present study investigated, in pair-housed male rats, whether and how the conditioned fear-induced 22-kHz USVs emitted by the 'sender' animal affect the behavior of its partner, the 'receiver' animal, when both are placed together in a novel chamber. The sender rats' conditioned fear responses evoked significant freezing (an overt evidence of fear) in receiver rats that had previously experienced an aversive event but not in naive receiver rats. Permanent lesions and reversible inactivations of the medial geniculate nucleus (MGN) of the thalamus effectively blocked the receivers' freeezing response to the senders' conditioned fear responses, and this occurred in absence of lesions/inactivations impeding the receiver animals' ability to freeze and emit 22-kHz USVs to the aversive event per se. Conclusions/Significance: These results-that prior experience of fear and intact auditory system are required for receiver rats to respond to their conspecifics' conditioned fear responses-indicate that the 22-kHz USV is the main factor for social transmission of fear and that learning plays a crucial role in the development of social signaling of danger by USVs.	[Kim, Eun Joo; Kim, Earnest S.; Covey, Ellen; Kim, Jeansok J.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Covey, Ellen; Kim, Jeansok J.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kim, EJ (corresponding author), Univ Washington, Dept Psychol, Seattle, WA 98195 USA.	jeansokk@u.washington.edu		Kim, Jeansok/0000-0001-7964-106X	National Institute of Mental Health [R01 MH64457]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064457] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institute of Mental Health R01 MH64457 (http://www.nimh.nih.gov/index.shtml) to JJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2007, BEHAV BRAIN RES, V182, P327, DOI 10.1016/j.bbr.2007.03.009; ANDERSON JW, 1954, SCIENCE, V119, P808, DOI 10.1126/science.119.3101.808; Beckett SRG, 1997, BRAIN RES BULL, V42, P421, DOI 10.1016/S0361-9230(96)00332-2; BLANCHARD RJ, 1991, PHYSIOL BEHAV, V50, P967, DOI 10.1016/0031-9384(91)90423-L; BLANCHARD RJ, 1989, J COMP PSYCHOL, V103, P70, DOI 10.1037/0735-7036.103.1.70; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; Boatman JA, 2006, EUR J NEUROSCI, V24, P894, DOI 10.1111/j.1460-9568.2006.04965.x; Borta A, 2006, BEHAV BRAIN RES, V166, P271, DOI 10.1016/j.bbr.2005.08.009; Bredy TW, 2009, LEARN MEMORY, V16, P12, DOI 10.1101/lm.1226009; BRUCHEY AK, 2010, BEHAV BRAIN RES; BRUDZYNSKI SM, 1995, PHYSIOL BEHAV, V57, P1039, DOI 10.1016/0031-9384(95)00003-2; BRUDZYNSKI SM, 1991, J PSYCHIATR NEUROSCI, V16, P221; Choi JS, 2003, J NEUROSCI, V23, P8713; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; CRUIKSHANK SJ, 1992, BEHAV NEUROSCI, V106, P471, DOI 10.1037/0735-7044.106.3.471; Endres T, 2007, BEHAV BRAIN RES, V185, P69, DOI 10.1016/j.bbr.2007.07.012; EVANS C, 1995, LANGUAGE ANIMAL COMM; FANSELOW MS, 1985, BEHAV NEUROSCI, V99, P589, DOI 10.1037/0735-7044.99.3.589; Goldstein LE, 1996, J NEUROSCI, V16, P4787; Gould J.L., 1982, ETHOLOGY MECH EVOLUT; Graham Lauren K., 2009, Psychol. Neurosci., V2, P219, DOI 10.3922/j.psns.2009.2.015; Holldobler B., 1990, pi; Howland JG, 2002, J NEUROSCI, V22, P1137, DOI 10.1523/JNEUROSCI.22-03-01137.2002; Kim JJ, 2005, J NEUROSCI, V25, P1532, DOI 10.1523/JNEUROSCI.4623-04.2005; KIM JJ, 1991, BEHAV NEUROSCI, V105, P126, DOI 10.1037/0735-7044.105.1.126; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Lee HJ, 2001, J NEUROSCI, V21, P4116, DOI 10.1523/JNEUROSCI.21-11-04116.2001; Lindquist DH, 2004, J NEUROSCI, V24, P3610, DOI 10.1523/JNEUROSCI.4839-03.2004; Litvin Y, 2007, BEHAV BRAIN RES, V182, P166, DOI 10.1016/j.bbr.2006.11.038; Masuda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006794; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Rescorla R., 1972, CLASSICAL CONDITION; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Sadananda M, 2008, NEUROSCI LETT, V435, P17, DOI 10.1016/j.neulet.2008.02.002; SALES GD, 1991, BEHAV PROCESS, V24, P83, DOI 10.1016/0376-6357(91)90001-G; SEYFARTH RM, 1992, SCI AM, V267, P122, DOI 10.1038/scientificamerican1292-122; SHERMAN PW, 1979, NAT HIST, V88, P50; Song EY, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00024; VANDERPOEL AM, 1991, BEHAVIOUR, V119, P127, DOI 10.1163/156853991X00409; WEINBERGER NM, 2010, HEAR RES; Wohr M, 2008, ANIM BEHAV, V76, P749, DOI 10.1016/j.anbehav.2008.04.017	43	131	135	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15077	10.1371/journal.pone.0015077	http://dx.doi.org/10.1371/journal.pone.0015077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152023	Green Submitted, Green Published, gold			2022-12-27	WOS:000284821300016
J	Dong, S; Corre, B; Nika, K; Pellegrini, S; Michel, F				Dong, Shen; Corre, Beatrice; Nika, Konstantina; Pellegrini, Sandra; Michel, Frederique			T Cell Receptor Signal Initiation Induced by Low-Grade Stimulation Requires the Cooperation of LAT in Human T Cells	PLOS ONE			English	Article							SRC-FAMILY KINASES; LIPID RAFTS; TYROSINE PHOSPHORYLATION; IMMUNOLOGICAL SYNAPSE; CROSS-LINKING; LCK ACTIVITY; ACTIVATION; CD45; FYN; LYMPHOCYTES	Background: One of the earliest activation events following stimulation of the T cell receptor (TCR) is the phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs) within the CD3-associated complex by the Src family kinase Lck. There is accumulating evidence that a large pool of Lck is constitutively active in T cells but how the TCR is connected to Lck and to the downstream signaling cascade remains elusive. Methodology/Principal Findings: We have analyzed the phosphorylation state of Lck and Fyn and TCR signaling in human naive CD4(+) T cells and in the transformed T cell line, Hut-78. The latter has been shown to be similar to primary T cells in TCR-inducible phosphorylations and can be highly knocked down by RNA interference. In both T cell types, basal phosphorylation of Lck and Fyn on their activatory tyrosine was observed, although this was much less pronounced in Hut-78 cells. TCR stimulation led to the co-precipitation of Lck with the transmembrane adaptor protein LAT (linker for activation of T cells), Erk-mediated phosphorylation of Lck and no detectable dephosphorylation of Lck inhibitory tyrosine. Strikingly, upon LAT knockdown in Hut-78 cells, we found that LAT promoted TCR-induced phosphorylation of Lck and Fyn activatory tyrosines, TCR zeta chain phosphorylation and Zap-70 activation. Notably, LAT regulated these events at low strength of TCR engagement. Conclusions/Significance: Our results indicate for the first time that LAT promotes TCR signal initiation and suggest that this adaptor may contribute to maintain active Lck in proximity of their substrates.	[Dong, Shen; Corre, Beatrice; Pellegrini, Sandra; Michel, Frederique] Inst Pasteur, Dept Immunol, Unit Cytokine Signaling, F-75724 Paris, France; [Dong, Shen; Corre, Beatrice; Pellegrini, Sandra; Michel, Frederique] CNRS, URA 1961, Paris, France; [Nika, Konstantina] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Oxford	Dong, S (corresponding author), Inst Pasteur, Dept Immunol, Unit Cytokine Signaling, F-75724 Paris, France.	frederique.michel@pasteur.fr	Pellegrini, Sandra -/G-5546-2015; Pellegrini, Sandra/Y-6351-2019; Dong, Shen/ABC-2875-2020	Pellegrini, Sandra -/0000-0001-5837-7589; Pellegrini, Sandra/0000-0001-5837-7589; dong, Shen/0000-0001-8839-7046; Michel, Frederique/0000-0002-3524-2232; Nika, Konstantina/0000-0002-9620-0263	Institut Pasteur; Association pour la Recherche sur le Cancer (ARC); Centre National de la Recherche Scientifique (CNRS); Ministere de l'Education Nationale de la Recherche et de Technologie (M.E.N.R.T)	Institut Pasteur(European Commission); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale de la Recherche et de Technologie (M.E.N.R.T)	This work was supported by grants from the Institut Pasteur, Association pour la Recherche sur le Cancer (ARC) and Centre National de la Recherche Scientifique (CNRS). S. Dong is a PhD student financed by Ministere de l'Education Nationale de la Recherche et de Technologie (M.E.N.R.T) and ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; BIFFEN M, 1994, EMBO J, V13, P1920, DOI 10.1002/j.1460-2075.1994.tb06461.x; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; Davidson D, 2007, MOL CELL BIOL, V27, P1960, DOI 10.1128/MCB.01983-06; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Edmonds SD, 2002, J IMMUNOL, V169, P5036, DOI 10.4049/jimmunol.169.9.5036; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Falahati R, 2007, J IMMUNOL, V178, P2056, DOI 10.4049/jimmunol.178.4.2056; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; Filipp D, 2008, J BIOL CHEM, V283, P26409, DOI 10.1074/jbc.M710372200; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; GAZDAR AF, 1980, BLOOD, V55, P409; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Jang IK, 2010, P NATL ACAD SCI USA, V107, P10620, DOI 10.1073/pnas.0905039107; Jiang YX, 2007, LEUKEMIA RES, V31, P541, DOI 10.1016/j.leukres.2006.07.010; Kabouridis PS, 2003, BIOCHEM J, V371, P907, DOI 10.1042/BJ20021578; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kumar L, 2005, P NATL ACAD SCI USA, V102, P19063, DOI 10.1073/pnas.0509176102; Lapinski PE, 2009, IMMUNOL REV, V232, P240, DOI 10.1111/j.1600-065X.2009.00829.x; LIU H, 1970, P NATL ACAD SCI USA, V107, P10166; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; Nika K, 2007, J BIOL CHEM, V282, P36000, DOI 10.1074/jbc.M702779200; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VEILLETTE A, 1989, MOL CELL BIOL, V9, P4441, DOI 10.1128/MCB.9.10.4441; WATTS JD, 1993, J BIOL CHEM, V268, P23275; WEIL R, 1994, J BIOL CHEM, V269, P22830; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006	56	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15114	10.1371/journal.pone.0015114	http://dx.doi.org/10.1371/journal.pone.0015114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152094	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100077
J	Schroder, A; Eichner, J; Supper, J; Eichner, J; Wanke, D; Henneges, C; Zell, A				Schroeder, Adrian; Eichner, Johannes; Supper, Jochen; Eichner, Jonas; Wanke, Dierk; Henneges, Carsten; Zell, Andreas			Predicting DNA-Binding Specificities of Eukaryotic Transcription Factors	PLOS ONE			English	Article							ACID SUBSTITUTION MATRICES; OPEN-ACCESS DATABASE; SACCHAROMYCES-CEREVISIAE; SECONDARY STRUCTURE; SEQUENCE-ANALYSIS; PROFILES; ANNOTATION; RECOGNITION; SIMILARITY; PROTEINS	Today, annotated amino acid sequences of more and more transcription factors (TFs) are readily available. Quantitative information about their DNA-binding specificities, however, are hard to obtain. Position frequency matrices (PFMs), the most widely used models to represent binding specificities, are experimentally characterized only for a small fraction of all TFs. Even for some of the most intensively studied eukaryotic organisms (i.e., human, rat and mouse), roughly one-sixth of all proteins with annotated DNA-binding domain have been characterized experimentally. Here, we present a new method based on support vector regression for predicting quantitative DNA-binding specificities of TFs in different eukaryotic species. This approach estimates a quantitative measure for the PFM similarity of two proteins, based on various features derived from their protein sequences. The method is trained and tested on a dataset containing 1 239 TFs with known DNA-binding specificity, and used to predict specific DNA target motifs for 645 TFs with high accuracy.	[Schroeder, Adrian; Eichner, Johannes; Supper, Jochen; Eichner, Jonas; Henneges, Carsten; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tubingen ZBIT, Tubingen, Germany; [Wanke, Dierk] Univ Tubingen, Ctr Plant Mol Biol ZMBP, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Schroder, A (corresponding author), Univ Tubingen, Ctr Bioinformat Tubingen ZBIT, Tubingen, Germany.	adrian.schroeder@uni-tuebingen.de	Wanke, Dierk/AAA-8529-2019		National Genome Research Network (NGFN II) of the Federal Ministry of Education and Research in Germany [0313323, 0313080 L]	National Genome Research Network (NGFN II) of the Federal Ministry of Education and Research in Germany	This work was funded by the National Genome Research Network (NGFN II) of the Federal Ministry of Education and Research in Germany under contract numbers 0313323 and 0313080 L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Alamanova D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-225; Alleyne TM, 2009, BIOINFORMATICS, V25, P1012, DOI 10.1093/bioinformatics/btn645; Andrade MA, 1999, BIOINFORMATICS, V15, P391, DOI 10.1093/bioinformatics/15.5.391; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; BALDI P, 1994, P NATL ACAD SCI USA, V91, P1059, DOI 10.1073/pnas.91.3.1059; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Bock C, 2007, PLOS COMPUT BIOL, V3, P1055, DOI 10.1371/journal.pcbi.0030110; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Boutet Emmanuel, 2007, V406, P89; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Engelhardt BE, 2005, PLOS COMPUT BIOL, V1, P432, DOI 10.1371/journal.pcbi.0010045; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; Gerlt JA, 2000, GENOME BIOL, V1; HARRISON CJ, 1994, SCIENCE, V263, P224, DOI 10.1126/science.8284672; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Jensen LJ, 2003, BIOINFORMATICS, V19, P635, DOI 10.1093/bioinformatics/btg036; Juncker AS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-206; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kretschmann E, 2001, BIOINFORMATICS, V17, P920, DOI 10.1093/bioinformatics/17.10.920; Leontovich AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-31; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Li H, 2008, BIOINFORMATICS, V24, P1874, DOI 10.1093/bioinformatics/btn332; Liao L, 2003, J COMPUT BIOL, V10, P857, DOI 10.1089/106652703322756113; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; LUTHY R, 1991, PROTEINS, V10, P229, DOI 10.1002/prot.340100307; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Mahony S, 2005, BIOINFORMATICS, V21, pI283, DOI 10.1093/bioinformatics/bti1025; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MEHTA PK, 1995, PROTEIN SCI, V4, P2517, DOI 10.1002/pro.5560041208; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; MIYAZAWA S, 1993, PROTEIN ENG, V6, P267, DOI 10.1093/protein/6.3.267; Moll A, 2005, J COMPUT AID MOL DES, V19, P791, DOI 10.1007/s10822-005-9027-x; Mungall C. J., 2002, GENOME BIOL, V3; Narlikar L, 2006, BIOINFORMATICS, V22, pE384, DOI 10.1093/bioinformatics/btl251; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; NIEFIND K, 1991, J MOL BIOL, V219, P481, DOI 10.1016/0022-2836(91)90188-C; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Piipari M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-348; Prakash A, 2005, NAT BIOTECHNOL, V23, P1249, DOI 10.1038/nbt1140; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Saigo H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-246; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sarai A, 2005, ANNU REV BIOPH BIOM, V34, P379, DOI 10.1146/annurev.biophys.34.040204.144537; SHENTAL N, 2003, LEARNING DISTANCE FU, P11; Stegmaier Philip, 2004, Genome Inform, V15, P276; Supper J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-334; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Van Loo P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r66; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; Waterhouse A.M., 2009, BIOINFORMATICS; Wei L, 1997, Pac Symp Biocomput, P465; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wingender E, 1997, MOL BIOL+, V31, P483; Wrzodek C, 2010, BIOSYSTEMS, V99, P79, DOI 10.1016/j.biosystems.2009.09.005; Zhou D., 2004, ADV NEURAL INFORM PR, V16; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	79	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e13876	10.1371/journal.pone.0013876	http://dx.doi.org/10.1371/journal.pone.0013876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152420	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100002
J	Bordner, AJ				Bordner, Andrew J.			Towards Universal Structure-Based Prediction of Class II MHC Epitopes for Diverse Allotypes	PLOS ONE			English	Article							HYDROGEN-BOND INTERACTIONS; NONBONDED INTERACTIONS; ENERGY PARAMETERS; PEPTIDE-BINDING; GEOMETRICAL PARAMETERS; PROTEIN HLA-DR1; T-CELLS; HLA-DR; SUSCEPTIBILITY; COMPLEX	The binding of peptide fragments of antigens to class II MHC proteins is a crucial step in initiating a helper T cell immune response. The discovery of these peptide epitopes is important for understanding the normal immune response and its misregulation in autoimmunity and allergies and also for vaccine design. In spite of their biomedical importance, the high diversity of class II MHC proteins combined with the large number of possible peptide sequences make comprehensive experimental determination of epitopes for all MHC allotypes infeasible. Computational methods can address this need by predicting epitopes for a particular MHC allotype. We present a structure-based method for predicting class II epitopes that combines molecular mechanics docking of a fully flexible peptide into the MHC binding cleft followed by binding affinity prediction using a machine learning classifier trained on interaction energy components calculated from the docking solution. Although the primary advantage of structure-based prediction methods over the commonly employed sequence-based methods is their applicability to essentially any MHC allotype, this has not yet been convincingly demonstrated. In order to test the transferability of the prediction method to different MHC proteins, we trained the scoring method on binding data for DRB1*0101 and used it to make predictions for multiple MHC allotypes with distinct peptide binding specificities including representatives from the other human class II MHC loci, HLA-DP and HLA-DQ, as well as for two murine allotypes. The results showed that the prediction method was able to achieve significant discrimination between epitope and non-epitope peptides for all MHC allotypes examined, based on AUC values in the range 0.632-0.821. We also discuss how accounting for peptide binding in multiple registers to class II MHC largely explains the systematically worse performance of prediction methods for class II MHC compared with those for class I MHC based on quantitative prediction performance estimates for peptide binding to class II MHC in a fixed register.				bordner.andrew@mayo.edu			Mayo Clinic	Mayo Clinic	This work was funded by the Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Anderton SM, 2002, NAT IMMUNOL, V3, P175, DOI 10.1038/ni756; BAISCH JM, 1990, NEW ENGL J MED, V322, P1836, DOI 10.1056/NEJM199006283222602; Betancourt MR, 1999, PROTEIN SCI, V8, P361; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Bordner AJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-41; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cui J, 2006, IMMUNOGENETICS, V58, P607, DOI 10.1007/s00251-006-0117-2; Davies MN, 2003, MOL MED, V9, P220, DOI 10.2119/2003-00032.Sansom; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Fairchild PJ, 1996, INT IMMUNOL, V8, P1035, DOI 10.1093/intimm/8.7.1035; Fernandez-Recio J, 2002, PROTEIN SCI, V11, P280, DOI 10.1110/ps.19202; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Haselden BM, 1999, J EXP MED, V189, P1885, DOI 10.1084/jem.189.12.1885; Hattotuwagama CK, 2006, J CHEM INF MODEL, V46, P1491, DOI 10.1021/ci050380d; Larche M, 2006, CURR OPIN IMMUNOL, V18, P745, DOI 10.1016/j.coi.2006.09.013; Lata Sneh, 2007, V409, P201, DOI 10.1007/978-1-60327-118-9_14; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu Wen, 2007, V409, P283, DOI 10.1007/978-1-60327-118-9_20; Marcotte GV, 1998, J ALLERGY CLIN IMMUN, V101, P506, DOI 10.1016/S0091-6749(98)70358-6; MATSUKI K, 1992, LANCET, V339, P1052, DOI 10.1016/0140-6736(92)90571-J; Maverakis E, 2003, P NATL ACAD SCI USA, V100, P5342, DOI 10.1073/pnas.0936151100; McFarland BJ, 1999, BIOCHEMISTRY-US, V38, P16663, DOI 10.1021/bi991393l; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; MOMANY FA, 1975, J PHYS CHEM-US, V79, P2361, DOI 10.1021/j100589a006; Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Murugan Naveen, 2005, Immunome Res, V1, P6, DOI 10.1186/1745-7580-1-6; NEMETHY G, 1983, J PHYS CHEM-US, V87, P1883, DOI 10.1021/j100234a011; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Oldfield WLG, 2002, LANCET, V360, P47, DOI 10.1016/S0140-6736(02)09332-7; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Salomon J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-501; Schafroth HD, 2004, PROTEINS, V54, P534, DOI 10.1002/prot.10608; Seamons A, 2003, J EXP MED, V197, P1391, DOI 10.1084/jem.20022226; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Simon A, 2002, MOL IMMUNOL, V38, P681, DOI 10.1016/S0161-5890(01)00103-1; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Tong JC, 2006, BIOINFORMATICS, V22, P1232, DOI 10.1093/bioinformatics/btl071; Tong Joo Chuan, 2006, Immunome Res, V2, P1, DOI 10.1186/1745-7580-2-1; von Garnier C, 2000, EUR J IMMUNOL, V30, P1638, DOI 10.1002/1521-4141(200006)30:6<1638::AID-IMMU1638>3.0.CO;2-R; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wilson N, 2001, IMMUNITY, V14, P513, DOI 10.1016/S1074-7613(01)00140-6; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; Zhang C, 2004, PROTEIN SCI, V13, P400, DOI 10.1110/ps.03348304; Zhang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009272	57	21	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14383	10.1371/journal.pone.0014383	http://dx.doi.org/10.1371/journal.pone.0014383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187956	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200009
J	Holm, L; Haslund, ML; Robach, P; van Hall, G; Calbet, JAL; Saltin, B; Lundby, C				Holm, Lars; Haslund, Mads Lyhne; Robach, Paul; van Hall, Gerrit; Calbet, Jose A. L.; Saltin, Bengt; Lundby, Carsten			Skeletal Muscle Myofibrillar and Sarcoplasmic Protein Synthesis Rates Are Affected Differently by Altitude-Induced Hypoxia in Native Lowlanders	PLOS ONE			English	Article							DOWN-REGULATION; ADAPTATIONS; EXERCISE; DEMAND; ACCLIMATIZATION; INTERLEUKIN-6; MITOCHONDRIAL; MECHANISMS; EXPRESSION; TURNOVER	As a consequence to hypobaric hypoxic exposure skeletal muscle atrophy is often reported. The underlying mechanism has been suggested to involve a decrease in protein synthesis in order to conserve O-2. With the aim to challenge this hypothesis, we applied a primed, constant infusion of 1-C-13-leucine in nine healthy male subjects at sea level and subsequently at high-altitude (4559 m) after 7-9 days of acclimatization. Physical activity levels and food and energy intake were controlled prior to the two experimental conditions with the aim to standardize these confounding factors. Blood samples and expired breath samples were collected hourly during the 4 hour trial and vastus lateralis muscle biopsies obtained at 1 and 4 hours after tracer priming in the overnight fasted state. Myofibrillar protein synthesis rate was doubled; 0.041 +/- 0.018 at sea-level to 0.080 +/- 0.018%.hr(-1) (p<0.05) when acclimatized to high altitude. The sarcoplasmic protein synthesis rate was in contrast unaffected by altitude exposure; 0.052 +/- 0.019 at sea-level to 0.059 +/- 0.010%.hr(-1) (p>0.05). Trends to increments in whole body protein kinetics were seen: Degradation rate elevated from 2.51 +/- 0.21 at sea level to 2.73 +/- 0.13 mu mol.kg-(1).min(-1) (p = 0.05) at high altitude and synthesis rate similar; 2.24 +/- 0.20 at sea level and 2.43 +/- 0.13 mu mol.kg(-1).min(-1) (p>0.05) at altitude. We conclude that whole body amino acid flux is increased due to an elevated protein turnover rate. Resting skeletal muscle myocontractile protein synthesis rate was concomitantly elevated by high-altitude induced hypoxia, whereas the sarcoplasmic protein synthesis rate was unaffected by hypoxia. These changed responses may lead to divergent adaptation over the course of prolonged exposure.	[Holm, Lars] Univ Copenhagen, Dept Orthopaed Surg M, Copenhagen, Denmark; [Holm, Lars] Univ Copenhagen, Inst Sports Med, Bispebjerg Hosp, Copenhagen, Denmark; [Holm, Lars] Univ Copenhagen, Ctr Healthy Ageing, Fac Hlth Sci, Copenhagen, Denmark; [Haslund, Mads Lyhne; van Hall, Gerrit; Saltin, Bengt; Lundby, Carsten] Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark; [Robach, Paul] Ecole Natl Ski & Alpinisme, Chamonix Mt Blanc, France; [van Hall, Gerrit] Univ Copenhagen, Rigshosp, Metab Mass Spectrometry Facil, DK-2100 Copenhagen, Denmark; [van Hall, Gerrit] Univ Copenhagen, Dept Biomed Sci, Fac Hlth Sci, Copenhagen, Denmark; [Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Canary Islands, Spain	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Universidad de Las Palmas de Gran Canaria	Holm, L (corresponding author), Univ Copenhagen, Dept Orthopaed Surg M, Copenhagen, Denmark.	L.Holm.isotope@gmail.com	Holm, Lars/AAI-1320-2020; Calbet, Jose A L/H-6693-2015; Holm, Lars/G-8181-2017	Calbet, Jose A L/0000-0002-9215-6234; antunez, Ariel/0000-0002-2548-7885; Holm, Lars/0000-0002-4392-9616; van Hall, Gerrit/0000-0002-2519-8127	Novo Nordisk Fonden	Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was financially supported by the Novo Nordisk Fonden (www.novonordiskfonden.dk) to CL while working at the Copenhagen Muscle Research Center, Rigshospitalet, Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; Desplanches D, 1996, J APPL PHYSIOL, V81, P1946, DOI 10.1152/jappl.1996.81.5.1946; Green H, 2000, J APPL PHYSIOL, V88, P634, DOI 10.1152/jappl.2000.88.2.634; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Guillet C, 2004, EXP GERONTOL, V39, P745, DOI 10.1016/j.exger.2004.02.011; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Heerlein K, 2005, AM J RESP CELL MOL, V32, P44, DOI 10.1165/rcmb.2004-0202OC; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; HOPPELER H, 1990, INT J SPORTS MED, V11, pS3, DOI 10.1055/s-2007-1024846; HOPPELER H, 1990, EXPERIENTIA, V46, P1185, DOI 10.1007/BF01936933; HOWALD H, 1990, INT J SPORTS MED, V11, pS10, DOI 10.1055/s-2007-1024847; Imoberdorf R, 2006, MED SCI SPORT EXER, V38, P1082, DOI 10.1249/01.mss.0000222836.66391.35; KAYSER B, 1992, J APPL PHYSIOL, V73, P2425, DOI 10.1152/jappl.1992.73.6.2425; Klausen T, 1997, EUR J APPL PHYSIOL, V76, P480, DOI 10.1007/s004210050278; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; KRAGGERUD SM, 1995, ANTICANCER RES, V15, P683; Larsen JJ, 1997, J PHYSIOL-LONDON, V504, P241, DOI 10.1111/j.1469-7793.1997.241bf.x; Ljungqvist OH, 1997, AM J PHYSIOL-ENDOC M, V273, pE564, DOI 10.1152/ajpendo.1997.273.3.E564; Lundby C, 2004, J EXP BIOL, V207, P3865, DOI 10.1242/jeb.01225; Lundby C, 2008, J PHYSIOL-LONDON, V586, P123, DOI 10.1113/jphysiol.2007.146035; Lundby C, 2009, CELL MOL LIFE SCI, V66, P3615, DOI 10.1007/s00018-009-0146-8; MACDOUGALL JD, 1991, ACTA PHYSIOL SCAND, V142, P421, DOI 10.1111/j.1748-1716.1991.tb09176.x; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Mizuno M, 2008, HIGH ALT MED BIOL, V9, P311, DOI 10.1089/ham.2008.1009; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; PREEDY VR, 1989, BIOCHEM J, V257, P519, DOI 10.1042/bj2570519; PREEDY VR, 1985, BIOCHEM J, V228, P179, DOI 10.1042/bj2280179; Rennie M J, 1983, Prog Clin Biol Res, V136, P317; Robach P, 2007, BLOOD, V109, P4724, DOI 10.1182/blood-2006-08-040006; Toffolo G, 2003, AM J PHYSIOL-ENDOC M, V285, pE1142, DOI 10.1152/ajpendo.00106.2003; Van Hall G, 2002, AM J PHYSIOL-ENDOC M, V283, pE1203, DOI 10.1152/ajpendo.00134.2001; van Hall G, 1999, P NUTR SOC, V58, P979, DOI 10.1017/S0029665199001299; Vigano A, 2008, PROTEOMICS, V8, P4668, DOI 10.1002/pmic.200800232	34	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15606	10.1371/journal.pone.0015606	http://dx.doi.org/10.1371/journal.pone.0015606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187972	Green Published, gold			2022-12-27	WOS:000285575200048
J	Thangaraj, K; Naidu, BP; Crivellaro, F; Tamang, R; Upadhyay, S; Sharma, VK; Reddy, AG; Walimbe, SR; Chaubey, G; Kivisild, T; Singh, L				Thangaraj, Kumarasamy; Naidu, B. Prathap; Crivellaro, Federica; Tamang, Rakesh; Upadhyay, Shashank; Sharma, Varun Kumar; Reddy, Alla G.; Walimbe, S. R.; Chaubey, Gyaneshwer; Kivisild, Toomas; Singh, Lalji			The Influence of Natural Barriers in Shaping the Genetic Structure of Maharashtra Populations	PLOS ONE			English	Article							Y-CHROMOSOME; INDIAN POPULATION; MTDNA VARIATION; CASTE; SETTLEMENT; ORIGIN; SOUTH; ASIA; HISTORIES	Background: The geographical position of Maharashtra state makes it rather essential to study the dispersal of modern humans in South Asia. Several hypotheses have been proposed to explain the cultural, linguistic and geographical affinity of the populations living in Maharashtra state with other South Asian populations. The genetic origin of populations living in this state is poorly understood and hitherto been described at low molecular resolution level. Methodology/Principal Findings: To address this issue, we have analyzed the mitochondrial DNA (mtDNA) of 185 individuals and NRY (non-recombining region of Y chromosome) of 98 individuals belonging to two major tribal populations of Maharashtra, and compared their molecular variations with that of 54 South Asian contemporary populations of adjacent states. Inter and intra population comparisons reveal that the maternal gene pool of Maharashtra state populations is composed of mainly South Asian haplogroups with traces of east and west Eurasian haplogroups, while the paternal haplogroups comprise the South Asian as well as signature of near eastern specific haplogroup J2a. Conclusions/Significance: Our analysis suggests that Indian populations, including Maharashtra state, are largely derived from Paleolithic ancient settlers; however, a more recent (similar to 10 Ky older) detectable paternal gene flow from west Asia is well reflected in the present study. These findings reveal movement of populations to Maharashtra through the western coast rather than mainland where Western Ghats-Vindhya Mountains and Narmada-Tapti rivers might have acted as a natural barrier. Comparing the Maharastrian populations with other South Asian populations reveals that they have a closer affinity with the South Indian than with the Central Indian populations.	[Thangaraj, Kumarasamy; Naidu, B. Prathap; Tamang, Rakesh; Upadhyay, Shashank; Sharma, Varun Kumar; Reddy, Alla G.; Chaubey, Gyaneshwer; Singh, Lalji] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Crivellaro, Federica; Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England; [Walimbe, S. R.] Deccan Coll Postgrad & Res Inst, Dept Archaeol, Pune, Maharashtra, India; [Chaubey, Gyaneshwer; Kivisild, Toomas] Univ Tartu, Dept Evolutionary Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Chaubey, Gyaneshwer; Kivisild, Toomas] Estonian Bioctr, Tartu, Estonia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Cambridge; University of Tartu; Estonian Biocentre	Thangaraj, K (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	thangs@ccmb.res.in; lalji@ccmb.res.in	Chaubey, Gyaneshwer/H-2753-2012; Chaubey, Gyaneshwer/AAC-6409-2019; Sharma, Varun Kumar/AAQ-5947-2020; Kivisild, Toomas/P-5889-2017	Chaubey, Gyaneshwer/0000-0003-2899-3852; Chaubey, Gyaneshwer/0000-0003-2899-3852; Kivisild, Toomas/0000-0002-6297-7808; Crivellaro, Federica/0000-0003-1656-8605; Upadhyay, Shashank/0000-0002-0560-196X; Thangaraj, Kumarasamy/0000-0002-0075-0106; Sharma, Varun Kumar/0000-0001-8575-6939	Council of Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR); UK-India Education and Research Initiative (UKIERI) [RG47772]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); UK-India Education and Research Initiative (UKIERI)	The work was funded by the Council of Scientific and Industrial Research (CSIR), Indian Council of Medical Research (ICMR) and UK-India Education and Research Initiative (UKIERI) grant RG47772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ayub Qasim, 2009, Briefings in Functional Genomics & Proteomics, V8, P395, DOI 10.1093/bfgp/elp015; Baig MM, 2004, ANN HUM GENET, V68, P453, DOI 10.1046/j.1529-8817.2004.00108.x; Barnabas S, 2006, ANN HUM GENET, V70, P42, DOI 10.1111/j.1529-8817.2005.00207.x; CHAUBEY G, MOL BIOL EVOL; CHAUBEY G, 2010, DEMOGRAPHIC HISTORY; Chaubey G, 2008, INT J HUM GENET, V8, P41, DOI 10.1080/09723757.2008.11886018; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; CHAUHAN P, 2010, EVOLUTION HISTORY PO, P64; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foote R.B., 1876, MEM GEOL SURV INDIA, V12, P1; Forster P, 1996, AM J HUM GENET, V59, P935; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Korisettar R, 2007, VERTEBR PALEOBIOL PA, P69, DOI 10.1007/1-4020-5562-5_4; Kumar S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-230; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Rajkumar R, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-23; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; SINGH KS, 1997, PEOPLE INDIA OXFORD, P1266; Thangaraj K, 1999, ELECTROPHORESIS, V20, P1743, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1743::AID-ELPS1743>3.0.CO;2-V; Thangaraj K, 2005, HUM GENET, V116, P507, DOI 10.1007/s00439-005-1271-6; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thangaraj K, 2002, J ANDROL, V23, P815; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; Trivedi R, 2008, INT J HUM GENET, V8, P97, DOI 10.1080/09723757.2008.11886023; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	39	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15283	10.1371/journal.pone.0015283	http://dx.doi.org/10.1371/journal.pone.0015283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187967	gold, Green Submitted, Green Published			2022-12-27	WOS:000285575200030
J	Bur, IM; Zouaoui, S; Fontanaud, P; Coutry, N; Molino, F; Martin, AO; Mollard, P; Bonnefont, X				Bur, Isabelle M.; Zouaoui, Sonia; Fontanaud, Pierre; Coutry, Nathalie; Molino, Francois; Martin, Agnes O.; Mollard, Patrice; Bonnefont, Xavier			The Comparison between Circadian Oscillators in Mouse Liver and Pituitary Gland Reveals Different Integration of Feeding and Light Schedules	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; PERIPHERAL-TISSUES; COUPLED OSCILLATORS; ELECTRICAL-ACTIVITY; ADRENAL-GLAND; BODY TIME; CLOCK; RHYTHMS; PHASE	The mammalian circadian system is composed of multiple peripheral clocks that are synchronized by a central pacemaker in the suprachiasmatic nuclei of the hypothalamus. This system keeps track of the external world rhythms through entrainment by various time cues, such as the light-dark cycle and the feeding schedule. Alterations of photoperiod and meal time modulate the phase coupling between central and peripheral oscillators. In this study, we used real-time quantitative PCR to assess circadian clock gene expression in the liver and pituitary gland from mice raised under various photoperiods, or under a temporal restricted feeding protocol. Our results revealed unexpected differences between both organs. Whereas the liver oscillator always tracked meal time, the pituitary circadian clockwork showed an intermediate response, in between entrainment by the light regimen and the feeding-fasting rhythm. The same composite response was also observed in the pituitary gland from adrenalectomized mice under daytime restricted feeding, suggesting that circulating glucocorticoids do not inhibit full entrainment of the pituitary clockwork by meal time. Altogether our results reveal further aspects in the complexity of phase entrainment in the circadian system, and suggest that the pituitary may host oscillators able to integrate multiple time cues.	[Bur, Isabelle M.; Zouaoui, Sonia; Fontanaud, Pierre; Coutry, Nathalie; Molino, Francois; Martin, Agnes O.; Mollard, Patrice; Bonnefont, Xavier] Inst Genom Fonct, CNRS, UMR 5203, Montpellier, France; [Bur, Isabelle M.; Zouaoui, Sonia; Fontanaud, Pierre; Coutry, Nathalie; Molino, Francois; Martin, Agnes O.; Mollard, Patrice; Bonnefont, Xavier] INSERM, U661, Montpellier, France; [Bur, Isabelle M.; Zouaoui, Sonia; Fontanaud, Pierre; Coutry, Nathalie; Molino, Francois; Martin, Agnes O.; Mollard, Patrice; Bonnefont, Xavier] Univ Montpellier, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Bur, IM (corresponding author), Inst Neurosci Cellulaires & Integrat, Strasbourg, France.	Xavier.Bonnefont@igf.cnrs.fr	BONNEFONT, Xavier/AAH-3882-2019; COUTRY, Nathalie/O-9352-2017	BONNEFONT, Xavier/0000-0003-4778-4060; COUTRY, Nathalie/0000-0001-5830-4013; Martin, Agnes/0000-0001-6680-7139; ZOUAOUI, Sonia/0000-0003-0467-3280	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); European Community [MERG-CT-2004-004899]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Community(European Commission)	This work was supported by Centre National de la Recherche Scientifique (CNRS) and Institut National de la Sante et de la Recherche Medicale (INSERM), and a Marie Curie Reintegration Grant from the European Community to XB (MERG-CT-2004-004899). IMB was a fellow of the French Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bonnefont X, 2003, FEBS LETT, V548, P49, DOI 10.1016/S0014-5793(03)00727-0; Bonnefont X, 2010, J NEUROENDOCRINOL, V22, P209, DOI 10.1111/j.1365-2826.2010.01955.x; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Bur IM, 2009, J BIOL CHEM, V284, P9066, DOI 10.1074/jbc.M808360200; Carr AJF, 2003, CURR BIOL, V13, P1543, DOI 10.1016/S0960-9822(03)00619-5; Challet E, 2003, BIOL CHEM, V384, P711, DOI 10.1515/BC.2003.079; DAAN S, 1978, J THEOR BIOL, V70, P297, DOI 10.1016/0022-5193(78)90378-8; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 1999, AM J PHYSIOL-REG I, V277, pR1376, DOI 10.1152/ajpregu.1999.277.5.R1376; Evuarherhe O, 2009, J ENDOCRINOL, V202, P279, DOI 10.1677/JOE-09-0175; Fahrenkrug J, 2008, J NEUROENDOCRINOL, V20, P323, DOI 10.1111/j.1365-2826.2008.01651.x; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hastings M.H., 1999, J NEUROSCI, V11, P1; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hughes M, 2007, COLD SPRING HARB SYM, V72, P381, DOI 10.1101/sqb.2007.72.011; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Jilg A, 2005, EUR J NEUROSCI, V22, P2845, DOI 10.1111/j.1460-9568.2005.04485.x; Kalsbeek A, 2007, ENDOCRINOLOGY, V148, P5635, DOI 10.1210/en.2007-0776; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; SITZMANN BD, 2008, NEUROBIOL AGING; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; SUMOVA A, 1995, P NATL ACAD SCI USA, V92, P7754, DOI 10.1073/pnas.92.17.7754; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P11227, DOI 10.1073/pnas.0401882101; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	49	33	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15316	10.1371/journal.pone.0015316	http://dx.doi.org/10.1371/journal.pone.0015316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179516	Green Published, gold			2022-12-27	WOS:000285340000020
J	Casey, R; Blumenkrantz, D; Millington, K; Montamat-Sicotte, D; Kon, OM; Wickremasinghe, M; Bremang, S; Magtoto, M; Sridhar, S; Connell, D; Lalvani, A				Casey, Rosalyn; Blumenkrantz, Deena; Millington, Kerry; Montamat-Sicotte, Damien; Kon, Onn Min; Wickremasinghe, Melissa; Bremang, Samuel; Magtoto, Murphy; Sridhar, Saranya; Connell, David; Lalvani, Ajit			Enumeration of Functional T-Cell Subsets by Fluorescence-Immunospot Defines Signatures of Pathogen Burden in Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; IFN-GAMMA; POLYFUNCTIONAL CD4(+); INFECTION; RESPONSES; MEMORY; DISEASE; VACCINE; ASSAY	Background: IFN-gamma and IL-2 cytokine-profiles define three functional T-cell subsets which may correlate with pathogen load in chronic intracellular infections. We therefore investigated the feasibility of the immunospot platform to rapidly enumerate T-cell subsets by single-cell IFN-gamma/IL-2 cytokine-profiling and establish whether immunospot-based T-cell signatures distinguish different clinical stages of human tuberculosis infection. Methods: We used fluorophore-labelled anti-IFN-gamma and anti-IL-2 antibodies with digital overlay of spatially-mapped colour-filtered images to enumerate dual and single cytokine-secreting M. tuberculosis antigen-specific T-cells in tuberculosis patients and in latent tuberculosis infection (LTBI). We validated results against established measures of cytokine-secreting T-cells. Results: Fluorescence-immunospot correlated closely with single-cytokine enzyme-linked-immunospot for IFN-gamma-secreting T-cells and IL-2-secreting T-cells and flow-cytometry-based detection of dual IFN-gamma/IL-2-secreting T-cells. The untreated tuberculosis signature was dominated by IFN-gamma-only-secreting T-cells which shifted consistently in longitudinally-followed patients during treatment to a signature dominated by dual IFN-gamma/IL-2-secreting T-cells in treated patients. The LTBI signature differed from active tuberculosis, with higher proportions of IL-2-only and IFN-gamma/IL-2-secreting T-cells and lower proportions of IFN-gamma-only-secreting T-cells. Conclusions: Fluorescence-immunospot is a quantitative, accurate measure of functional T-cell subsets; identification of cytokine-signatures of pathogen burden, distinct clinical stages of M. tuberculosis infection and long-term immune containment suggests application for treatment monitoring and vaccine evaluation.	[Casey, Rosalyn; Blumenkrantz, Deena; Millington, Kerry; Montamat-Sicotte, Damien; Bremang, Samuel; Magtoto, Murphy; Sridhar, Saranya; Connell, David; Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, TB Res Unit, London, England; [Kon, Onn Min; Wickremasinghe, Melissa] St Marys Hosp, Imperial Coll Healthcare NHS Trust, London, England	Imperial College London; Imperial College London	Casey, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, TB Res Unit, London, England.	a.lalvani@imperial.ac.uk		Connell, David/0000-0002-7008-8883; Kon, Onn Min/0000-0003-2647-4688; Lalvani, Ajit/0000-0002-2396-246X; Sridhar, Saranya/0000-0002-4267-3102	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust. AL is a Wellcome Trust Senior Research Fellow in Clinical Science and National Institute of Health Research Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Adetifa IM, 2010, PLOS ONE, V5; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; CACCAMO N, 2010, EUR J IMMUNOL; Chee CBE, 2010, EUR RESPIR J, V36, P355, DOI 10.1183/09031936.00151309; Ciuffreda D, 2008, EUR J IMMUNOL, V38, P2665, DOI 10.1002/eji.200838336; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Doherty TM, 2009, CLIN CHEST MED, V30, P783, DOI 10.1016/j.ccm.2009.08.008; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Gazagne A, 2003, J IMMUNOL METHODS, V283, P91, DOI 10.1016/j.jim.2003.08.013; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hinks TSC, 2009, INFECT IMMUN, V77, P5486, DOI 10.1128/IAI.01436-08; Huaman MC, 2009, VACCINE, V27, P5239, DOI 10.1016/j.vaccine.2009.06.066; Karulin AY, 2000, J IMMUNOL, V164, P1862, DOI 10.4049/jimmunol.164.4.1862; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lalvani A, 2008, EUR RESPIR J, V32, P1428, DOI 10.1183/09031936.00148308; Lalvani A, 2008, J INFECT DIS, V197, P941, DOI 10.1086/529049; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lalvani A, 2010, BRIT MED BULL, V93, P69, DOI 10.1093/bmb/ldp039; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Okamoto Y, 1998, IMMUNOPHARMACOLOGY, V39, P107, DOI 10.1016/S0162-3109(98)00007-1; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Quast S, 2005, CELL IMMUNOL, V237, P28, DOI 10.1016/j.cellimm.2005.09.002; Rebhahn JA, 2008, COMPUT METH PROG BIO, V92, P54, DOI 10.1016/j.cmpb.2008.06.002; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Semmo N, 2007, WORLD J GASTROENTERO, V13, P4831, DOI 10.3748/wjg.v13.i36.4831; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tena-Coki NG, 2010, AM J RESP CRIT CARE, V182, P120, DOI 10.1164/rccm.200912-1862OC; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; Wilkinson KA, 2009, AM J RESP CRIT CARE, V180, P674, DOI 10.1164/rccm.200904-0568OC; 2009, STMARYS HOSP TB SERV	46	64	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15619	10.1371/journal.pone.0015619	http://dx.doi.org/10.1371/journal.pone.0015619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179481	gold, Green Published, Green Submitted			2022-12-27	WOS:000285292500031
J	Mayes, AE; Murray, PG; Gunn, DA; Tomlin, CC; Catt, SD; Wen, YB; Zhou, LP; Wang, HQ; Catt, M; Granger, SP				Mayes, Andrew E.; Murray, Peter G.; Gunn, David A.; Tomlin, Cyrena C.; Catt, Sharon D.; Wen, Yi B.; Zhou, Li P.; Wang, Hong Q.; Catt, Michael; Granger, Stewart P.			Environmental and Lifestyle Factors Associated with Perceived Facial Age in Chinese Women	PLOS ONE			English	Article							EXTRINSIC FACTORS; AGING APPEARANCE; SKIN; HEALTH; DEFINITION; BIOMARKER; RISK; OLD	Perceived facial age has been proposed as a biomarker of ageing with 'looking young for one's age' linked to physical and cognitive functioning and to increased survival for Caucasians. We have investigated the environmental and lifestyle factors associated with perceived facial ageing in Chinese women. Facial photographs were collected from 250 Chinese women, aged 25-70 years in Shanghai, China. Perceived facial age was determined and related to chronological age for each participant. Lifestyle and health information was collected by questionnaire. Bivariate analyses (controlling for chronological age) identified and quantified lifestyle variables associated with perceived facial age. Independent predictors of perceived age were identified by multivariate modelling. Factors which significantly associated with looking younger for one's chronological age included greater years of education (p<0.001), fewer household members (p=0.027), menopausal status (p=0.020), frequency of visiting one's doctor (p=0.013), working indoors (p<0.001), spending less time in the sun (p=0.015), moderate levels of physical activity (p=0.004), higher frequency of teeth cleaning (p<0.001) and more frequent use of facial care products: cleanser (p<0.001); moisturiser (p=0.016) or night cream (p=0.016). Overall, 36.5% of the variation in the difference between perceived and chronological age could be explained by a combination of chronological age and 6 independent lifestyle variables. We have thus identified and quantified a number of factors associated with younger appearance in Chinese women. Presentation of these factors in the context of facial appearance could provide significant motivation for the adoption of a range of healthy behaviours at the level of both individuals and populations.	[Mayes, Andrew E.; Murray, Peter G.; Gunn, David A.; Tomlin, Cyrena C.; Catt, Sharon D.; Catt, Michael; Granger, Stewart P.] Unilever Discover, Sharnbrook, Beds, England; [Wen, Yi B.; Zhou, Li P.; Wang, Hong Q.] Unilever Discover, Shanghai, Peoples R China	Unilever; Unilever	Mayes, AE (corresponding author), Unilever Discover, Colworth Sci Pk, Sharnbrook, Beds, England.	Andrew.Mayes@unilever.com		Catt, Michael/0000-0003-0935-7973; Gunn, David/0000-0001-9866-3221	Unilever; Medical Research Council [G0900686] Funding Source: researchfish; MRC [G0900686] Funding Source: UKRI	Unilever(Unilever); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was fully funded by Unilever (http://www.unilever.com) and all study staff were employed by Unilever Research at the time of the study. Study staff were responsible for the design of the study, data collection and analysis, decision to publish, and preparation of the manuscript on behalf of Unilever.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Christensen K, 2004, EPIDEMIOLOGY, V15, P251, DOI 10.1097/01.ede.0000112211.11416.a6; Christensen Kaare, 2009, BMJ, V339, pb5262; Chung JH, 2003, PHOTODERMATOL PHOTO, V19, P109, DOI 10.1034/j.1600-0781.2003.00027.x; Cosgrove MC, 2007, AM J CLIN NUTR, V86, P1225, DOI 10.1093/ajcn/86.4.1225; Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x; Guinot C, 2002, ARCH DERMATOL, V138, P1454, DOI 10.1001/archderm.138.11.1454; Gunn DA, 2008, BIOGERONTOLOGY, V9, P357, DOI 10.1007/s10522-008-9141-y; Gunn DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008021; Hawkins Stacy S, 2004, Dermatol Ther, V17 Suppl 1, P63, DOI 10.1111/j.1396-0296.2004.04S1008.x; KADUNCE DP, 1991, ANN INTERN MED, V114, P840, DOI 10.7326/0003-4819-114-10-840; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Li CB, 2006, INT PSYCHOGERIATR, V18, P551, DOI 10.1017/S1041610205002966; MacArthur JD, MACARTHUR RES NETWOR; Mayes AE, 2010, J EUR ACAD DERMATOL, V24, P341, DOI 10.1111/j.1468-3083.2009.03418.x; Morita A, 2007, J DERMATOL SCI, V48, P169, DOI 10.1016/j.jdermsci.2007.06.015; Myint PK, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b349; Ng TP, 2009, AM J GERIAT PSYCHIAT, V17, P407, DOI 10.1097/JGP.0b013e31819a808e; Nkengne A, 2008, J EUR ACAD DERMATOL, V22, P982, DOI 10.1111/j.1468-3083.2008.02698.x; Pollack CE, 2007, AM J PREV MED, V33, P250, DOI 10.1016/j.amepre.2007.04.033; Purba MB, 2001, AGE AGEING, V30, P227, DOI 10.1093/ageing/30.3.227; Rexbye H, 2006, AGE AGEING, V35, P110, DOI 10.1093/ageing/afj031; Rexbye H., 2007, INT J AGEING LATER L, V2, P61, DOI [DOI 10.3384/IJAL.1652-8670.072161, 10.3384/ijal.1652-8670.072161]; Samson N., 2010, International Journal of Cosmetic Science, V32, P167, DOI 10.1111/j.1468-2494.2009.00535.x; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Shekar SN, 2005, J INVEST DERMATOL, V125, P1119, DOI 10.1111/j.0022-202X.2005.23961.x; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Verdier-Sevrain S, 2006, EXP DERMATOL, V15, P83, DOI 10.1111/j.1600-0625.2005.00377.x; Wang YN, 2009, J ZHEJIANG UNIV-SC B, V10, P57, DOI 10.1631/jzus.B0820071; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; Wildt L, 1999, LANCET, V354, P224, DOI 10.1016/S0140-6736(99)01436-1; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Zhao P, 1998, ARCH ENVIRON HEALTH, V53, P405, DOI 10.1080/00039899809605728	35	36	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15270	10.1371/journal.pone.0015270	http://dx.doi.org/10.1371/journal.pone.0015270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	693SY	21179450	Green Submitted, Green Published, gold			2022-12-27	WOS:000285246900040
J	Garcia, JR; MacKillop, J; Aller, EL; Merriwether, AM; Wilson, DS; Lum, JK				Garcia, Justin R.; MacKillop, James; Aller, Edward L.; Merriwether, Ann M.; Wilson, David Sloan; Lum, J. Koji			Associations between Dopamine D4 Receptor Gene Variation with Both Infidelity and Sexual Promiscuity	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; EXTRA-PAIR PATERNITY; DRD4; PERSPECTIVE; STRATEGIES; SELECTION; PARTNERS; NUMBER; BIRDS	Background: Human sexual behavior is highly variable both within and between populations. While sex-related characteristics and sexual behavior are central to evolutionary theory (sexual selection), little is known about the genetic bases of individual variation in sexual behavior. The variable number tandem repeats (VNTR) polymorphism in exon III of the human dopamine D4 receptor gene (DRD4) has been correlated with an array of behavioral phenotypes and may be predicatively responsible for variation in motivating some sexual behaviors, particularly promiscuity and infidelity. Methodology/Principal Findings: We administered an anonymous survey on personal history of sexual behavior and intimate relationships to 181 young adults. We also collected buccal wash samples and genotyped the DRD4 VNTR. Here we show that individuals with at least one 7-repeat allele (7R+) report a greater categorical rate of promiscuous sexual behavior (i.e., having ever had a "one-night stand'') and report a more than 50% increase in instances of sexual infidelity. Conclusions/Significance: DRD4 VNTR genotype varies considerably within and among populations and has been subject to relatively recent, local selective pressures. Individual differences in sexual behavior are likely partially mediated by individual genetic variation in genes coding for motivation and reward in the brain. Conceptualizing these findings in terms of r/K selection theory suggests a mechanism for selective pressure for and against the 7R+ genotype that may explain the considerable global allelic variation for this polymorphism.	[Garcia, Justin R.; Aller, Edward L.; Lum, J. Koji] SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY 13902 USA; [Garcia, Justin R.; Aller, Edward L.; Wilson, David Sloan; Lum, J. Koji] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA; [Garcia, Justin R.; Wilson, David Sloan; Lum, J. Koji] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Garcia, Justin R.; Merriwether, Ann M.; Wilson, David Sloan; Lum, J. Koji] SUNY Binghamton, Inst Evolutionary Studies, Binghamton, NY USA; [MacKillop, James] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [MacKillop, James] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA; [Merriwether, Ann M.] SUNY Binghamton, Dept Psychol, Binghamton, NY USA; [Merriwether, Ann M.] SUNY Binghamton, Dept Human Dev, Binghamton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University System of Georgia; University of Georgia; Brown University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Garcia, JR (corresponding author), SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY 13902 USA.	justin.r.garcia@gmail.com	, James/ABI-3641-2020	, James/0000-0002-8695-1071; Lauwereyns, Jan/0000-0003-0551-2550; Garcia, Justin/0000-0002-5198-4578	Binghamton University's Foundation; Binghamton University; National Institutes of Health [K23 AA016936, P30 DA027827]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA016936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA027827] Funding Source: NIH RePORTER	Binghamton University's Foundation; Binghamton University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Harpur College Research Awards from Binghamton University's Foundation to JRG and ELA, Binghamton University startup funds to JKL, and grants from the National Institutes of Health to JM (K23 AA016936; P30 DA027827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KG, 2006, CURR ANTHROPOL, V47, P513, DOI 10.1086/504167; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Baker R.R., 1995, HUMAN SPERM COMPETIT; Ben Zion IZ, 2006, MOL PSYCHIATR, V11, P782, DOI 10.1038/sj.mp.4001832; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Buss DM., 2003, EVOLUTION DESIRE; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Chen CS, 1999, EVOL HUM BEHAV, V20, P309, DOI 10.1016/S1090-5138(99)00015-X; Cherkas LF, 2004, TWIN RES, V7, P649, DOI 10.1375/1369052042663922; Congdon E, 2008, AM J MED GENET B, V147B, P27, DOI 10.1002/ajmg.b.30557; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Eisenberg DTA, 2010, SOC COGN AFFECT NEUR, V5, P194, DOI 10.1093/scan/nsp026; EISENBERG DTA, 2007, EVOLUTIONARY PSYCHOL, V5, P696; Feigelson HS, 2001, CANCER EPIDEM BIOMAR, V10, P1005; Fisher HE, 2002, ARCH SEX BEHAV, V31, P413, DOI 10.1023/A:1019888024255; Fisher HE., 1992, ANATOMY LOVE NATURAL; Garcia JR., 2008, J SOC EVOL CULT PSYC, V2, DOI [10.1037/h0099345, DOI 10.1037/H0099345]; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Guo G, 2007, EUR J HUM GENET, V15, P279, DOI 10.1038/sj.ejhg.5201763; Halpern CT, 2007, ARCH SEX BEHAV, V36, P543, DOI 10.1007/s10508-006-9084-9; Hamarman S, 2004, J CHILD ADOL PSYCHOP, V14, P564, DOI 10.1089/cap.2004.14.564; Hamer D, 2000, MOL PSYCHIATR, V5, P11, DOI 10.1038/sj.mp.4000662; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; JANKOWIAK WR, 1992, ETHNOLOGY, V31, P149, DOI 10.2307/3773618; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kitchen AM, 2006, ANIM BEHAV, V71, P1029, DOI 10.1016/j.anbehav.2005.06.015; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; MAC ARTHUR ROBERT H., 1967; MacKillop J, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-11; McGeary J, 2009, PHARMACOL BIOCHEM BE, V93, P222, DOI 10.1016/j.pbb.2009.03.010; MELIS MR, 1995, NEUROSCI BIOBEHAV R, V19, P19, DOI 10.1016/0149-7634(94)00020-2; NEUMAN MG, 2008, TRUTH CHEATING WHY M; Peterson RL, 2005, BRAIN RES BULL, V67, P391, DOI 10.1016/j.brainresbull.2005.06.015; Ray LA, 2009, ADDICT BIOL, V14, P238, DOI 10.1111/j.1369-1600.2008.00120.x; REICHARD U, 1995, ETHOLOGY, V100, P99; Schmitt DP, 2004, J PERS SOC PSYCHOL, V86, P560, DOI 10.1037/0022-3514.86.4.560; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wilson M, 1993, Violence Vict, V8, P271; Zietsch BP, 2010, BEHAV GENET, V40, P12, DOI 10.1007/s10519-009-9300-1	46	66	67	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14162	10.1371/journal.pone.0014162	http://dx.doi.org/10.1371/journal.pone.0014162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152404	gold, Green Published			2022-12-27	WOS:000284755100039
J	Iwamura, T; Wilson, KA; Venter, O; Possingham, HP				Iwamura, Takuya; Wilson, Kerrie A.; Venter, Oscar; Possingham, Hugh P.			A Climatic Stability Approach to Prioritizing Global Conservation Investments	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; SPECIES DISTRIBUTIONS; FUTURE; SHIFTS; RANGE; UNCERTAINTY; RICHNESS; PATTERNS; IMPACTS	Climate change is impacting species and ecosystems globally. Many existing templates to identify the most important areas to conserve terrestrial biodiversity at the global scale neglect the future impacts of climate change. Unstable climatic conditions are predicted to undermine conservation investments in the future. This paper presents an approach to developing a resource allocation algorithm for conservation investment that incorporates the ecological stability of ecoregions under climate change. We discover that allocating funds in this way changes the optimal schedule of global investments both spatially and temporally. This allocation reduces the biodiversity loss of terrestrial endemic species from protected areas due to climate change by 22% for the period of 2002-2052, when compared to allocations that do not consider climate change. To maximize the resilience of global biodiversity to climate change we recommend that funding be increased in ecoregions located in the tropics and/or mid-elevation habitats, where climatic conditions are predicted to remain relatively stable. Accounting for the ecological stability of ecoregions provides a realistic approach to incorporating climate change into global conservation planning, with potential to save more species from extinction in the long term.	[Iwamura, Takuya; Wilson, Kerrie A.; Venter, Oscar; Possingham, Hugh P.] Univ Queensland, Ctr Ecol, Brisbane, Qld, Australia	University of Queensland	Iwamura, T (corresponding author), Univ Queensland, Ctr Ecol, Brisbane, Qld, Australia.	t.iwamura@uq.edu.au	Venter, Oscar/G-6893-2011; POSSINGHAM, HUGH/R-8310-2019; Wilson, Kerrie/W-4181-2019; Possingham, Hugh/B-1337-2008; Venter, Oscar/ABE-1477-2021; Wilson, Kerrie A/C-8058-2009; Iwamura, Takuya/D-1125-2018	POSSINGHAM, HUGH/0000-0001-7755-996X; Wilson, Kerrie/0000-0002-0092-935X; Possingham, Hugh/0000-0001-7755-996X; Wilson, Kerrie A/0000-0002-0092-935X; Iwamura, Takuya/0000-0002-3740-7758	Commonwealth Department of Sustainability, Environment, Water, Population and Communities; Australian Government; Australian Research Council	Commonwealth Department of Sustainability, Environment, Water, Population and Communities; Australian Government(Australian GovernmentCGIAR); Australian Research Council(Australian Research Council)	This research was partly supported by a Commonwealth Environmental Research Facility grant from the Commonwealth Department of Sustainability, Environment, Water, Population and Communities. T. I. and O.V. were funded by the Australian Government's Endeavour Program. K. A. W. and H. P. P. were funded by fellowships from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; BARTHOLOME E, 2002, GLC 2000 GLOB LAND C; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Brooks T, 2004, NATURE, V431, P1046, DOI 10.1038/4311046a; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; BROWN J, 1997, REORGANIZATION ARID, P9729; Carwardine J, 2008, P NATL ACAD SCI USA, V105, P11446, DOI 10.1073/pnas.0707157105; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Costello C, 2004, RESOUR ENERGY ECON, V26, P157, DOI 10.1016/j.reseneeco.2003.11.005; Cowling R. M., 1999, Diversity and Distributions, V5, P51, DOI 10.1046/j.1472-4642.1999.00038.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Du MY, 2004, GLOBAL PLANET CHANGE, V41, P241, DOI 10.1016/j.gloplacha.2004.01.010; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GOLDEWIJK K, 2009, GLOBAL ECOL IN PRESS; Guilhaumon F, 2008, P NATL ACAD SCI USA, V105, P15458, DOI 10.1073/pnas.0803610105; Halpern BS, 2006, CONSERV BIOL, V20, P56, DOI 10.1111/j.1523-1739.2005.00258.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; HIJMANS RJ, WORLDCLIM INTERPOLAT; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; Lee TM, 2008, P ROY SOC B-BIOL SCI, V275, P1261, DOI 10.1098/rspb.2007.1732; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Midgley GF, 2002, GLOBAL ECOL BIOGEOGR, V11, P445, DOI 10.1046/j.1466-822X.2002.00307.x; Mitchell T., 2003, J CLIMATE; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; MITTERMEIER RA, 1993, BIODIVERS CONSERV, V2, P637, DOI 10.1007/BF00051964; Mulongoy K.J., 2004, PROTECTED AREAS BIOD; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2007, BIOL CONSERV, V140, P40, DOI 10.1016/j.biocon.2007.07.025; Nakicenovic N, 2000, PNNLSA39650; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; *UNEP WCMC, 2009, WORLD DAT PROT AR WD; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Willis SG, 2009, ENVIRON MANAGE, V43, P836, DOI 10.1007/s00267-008-9125-3; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; WWF, 2006, WILDFINDER ONL DAT S; Zimmerer KS, 2004, AMBIO, V33, P520, DOI 10.1639/0044-7447(2004)033[0520:GAMTIT]2.0.CO;2	54	40	40	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15103	10.1371/journal.pone.0015103	http://dx.doi.org/10.1371/journal.pone.0015103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152095	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100073
J	Kruewel, T; Schenone, S; Radi, M; Maga, G; Rohrbeck, A; Botta, M; Borlak, J				Kruewel, Thomas; Schenone, Silvia; Radi, Marco; Maga, Giovanni; Rohrbeck, Astrid; Botta, Maurizio; Borlak, Juergen			Molecular Characterization of c-Abl/c-Src Kinase Inhibitors Targeted against Murine Tumour Progenitor Cells that Express Stem Cell Markers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MYELOGENOUS LEUKEMIA-CELLS; CHRONIC MYELOID-LEUKEMIA; LUNG-CANCER CELLS; TYROSINE KINASE; HEPATOCELLULAR-CARCINOMA; BIOLOGICAL EVALUATION; BREAST-CANCER; DNA-DAMAGE; IN-VITRO	Background: The non-receptor tyrosine kinases c-Abl and c-Src are overexpressed in various solid human tumours. Inhibition of their hyperactivity represents a molecular rationale in the combat of cancerous diseases. Here we examined the effects of a new family of pyrazolo [3,4-d] pyrimidines on a panel of 11 different murine lung tumour progenitor cell lines, that express stem cell markers, as well as on the human lung adenocarcinoma cell line A549, the human hepatoma cell line HepG2 and the human colon cancer cell line CaCo2 to obtain insight into the mode of action of these experimental drugs. Methodology/Principal Findings: Treatment with the dual kinase inhibitors blocked c-Abl and c-Src kinase activity efficiently in the nanomolar range, induced apoptosis, reduced cell viability and caused cell cycle arrest predominantly at G0/G1 phase while western blot analysis confirmed repressed protein expression of c-Abl and c-Src as well as the interacting partners p38 mitogen activated protein kinase, heterogenous ribonucleoprotein K, cyclin dependent kinase 1 and further proteins that are crucial for tumour progression. Importantly, a significant repression of the epidermal growth factor receptor was observed while whole genome gene expression analysis evidenced regulation of many cell cycle regulated genes as well integrin and focal adhesion kinase (FAK) signalling to impact cytoskeleton dynamics, migration, invasion and metastasis. Conclusions/Significance: Our experiments and recently published in vivo engraftment studies with various tumour cell lines revealed the dual kinase inhibitors to be efficient in their antitumour activity.	[Kruewel, Thomas; Rohrbeck, Astrid; Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany; [Schenone, Silvia] Univ Genoa, Dept Pharmaceut Sci, Genoa, Italy; [Radi, Marco; Botta, Maurizio] Univ Siena, Dept Chem & Pharmaceut Technol, I-53100 Siena, Italy; [Maga, Giovanni] Inst Mol Genet IMG CNR, Pavia, Italy; [Kruewel, Thomas; Rohrbeck, Astrid; Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany	Hannover Medical School; University of Genoa; University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Fraunhofer Gesellschaft	Kruewel, T (corresponding author), Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany.	borlak@item.fraunhofer.de	Maga, Giovanni/C-5409-2009; Radi, Marco/P-1457-2017	Maga, Giovanni/0000-0001-8092-1552; Radi, Marco/0000-0002-0874-6697	Ministry of Science and Culture, Lower Saxony, Germany [25A.5-76251-99-3/00]; EU [CM0602]	Ministry of Science and Culture, Lower Saxony, Germany; EU(European Commission)	Funding was provided by the Ministry of Science and Culture, Lower Saxony, Germany; Grant number: 25A.5-76251-99-3/00 to Juergen Borlak and EU COST (European Cooperation in Science and Technology) Action CM0602 "Inhibitors of angiogenesis: design, synthesis and biological exploitation (ANGIOKEM)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph D, 2007, MOL CELL BIOL, V27, P1758, DOI 10.1128/MCB.02014-06; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Bruno O, 2007, J MED CHEM, V50, P3618, DOI 10.1021/jm0704402; Burger JA, 2009, EXPERT OPIN INV DRUG, V18, P481, DOI [10.1517/13543780902804249 , 10.1517/13543780902804249]; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Carraro F, 2006, J MED CHEM, V49, P1549, DOI 10.1021/jm050603r; Carraro F, 2004, J MED CHEM, V47, P1595, DOI 10.1021/jm034257u; Choi D, 2009, WORLD J GASTROENTERO, V15, P2258, DOI 10.3748/wjg.15.2258; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Fabarius A, 2008, HAEMATOL-HEMATOL J, V93, P1145, DOI 10.3324/haematol.12793; Fabbro D, 2002, PHARMACOL THERAPEUT, V93, P79, DOI 10.1016/S0163-7258(02)00179-1; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Giles FJ, 2009, LEUKEMIA, V23, P1698, DOI 10.1038/leu.2009.111; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Haura EB, 2010, J CLIN ONCOL, V28, P1387, DOI 10.1200/JCO.2009.25.4029; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Huynh H, 2010, EXPERT OPIN EMERG DR, V15, P13, DOI 10.1517/14728210903571659; Ischenko I, 2008, ONCOGENE, V27, P7212, DOI 10.1038/onc.2008.326; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jia HY, 2009, LEUKEMIA RES, V33, P1512, DOI 10.1016/j.leukres.2009.03.033; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Johnson FM, 2010, CANCER-AM CANCER SOC, V116, P1582, DOI 10.1002/cncr.24927; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Krystal GW, 2001, DRUG RESIST UPDATE, V4, P16, DOI 10.1054/drup.2000.0176; Lappi-Blanco E, 2006, AM J CLIN PATHOL, V126, P717, DOI 10.1309/PFGXCLNG2N17PJX9; Lindstrom AK, 2009, ANTICANCER RES, V29, P2577; Manetti F, 2007, J MED CHEM, V50, P5579, DOI 10.1021/jm061449r; Martinelli G, 2005, LEUKEMIA, V19, P1872, DOI 10.1038/sj.leu.2403950; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Nautiyal J, 2009, CANCER LETT, V283, P143, DOI 10.1016/j.canlet.2009.03.035; Niehof M, 2005, MOL PHARMACOL, V67, P604, DOI 10.1124/mol.104.008672; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Oetzel C, 2000, CLIN CANCER RES, V6, P1958; Oh JW, 2009, BIOL PHARM BULL, V32, P573, DOI 10.1248/bpb.32.573; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Payton M, 2006, CANCER RES, V66, P4299, DOI 10.1158/0008-5472.CAN-05-2507; Reamon-Buettner SM, 2008, CANCER RES, V68, P7587, DOI 10.1158/0008-5472.CAN-08-0967; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Rohrbeck A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007315; Saad F, 2010, CANCER TREAT REV, V36, P177, DOI 10.1016/j.ctrv.2009.11.005; Saad F, 2009, BJU INT, V103, P434, DOI 10.1111/j.1464-410X.2008.08249.x; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; Schenone S, 2004, EUR J MED CHEM, V39, P153, DOI 10.1016/j.ejmech.2003.11.007; Schenone S, 2008, EUR J MED CHEM, V43, P2665, DOI 10.1016/j.ejmech.2008.01.034; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Skorski T, 2002, ONCOGENE, V21, P8591, DOI 10.1038/sj.onc.1206087; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Thom I, 2009, ANTICANCER RES, V29, P249; Walenkamp AME, 2009, NEOPLASIA, V11, P333, DOI 10.1593/neo.81508; Watson CJ, 2009, J MAMMARY GLAND BIOL, V14, P171, DOI 10.1007/s10911-009-9126-8; Yardley DA, 2009, CLIN BREAST CANCER, V9, P237, DOI 10.3816/CBC.2009.n.040; Yau T, 2009, LIVER INT, V29, P10, DOI 10.1111/j.1478-3231.2008.01916.x; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang Xiaozhu, 2008, Int J Med Sci, V5, P209; Zhu AX, 2008, CANCER-AM CANCER SOC, V112, P250, DOI 10.1002/cncr.23175; Zhu AX, 2009, CANCER J, V15, P263, DOI 10.1097/PPO.0b013e3181af5e35	68	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14143	10.1371/journal.pone.0014143	http://dx.doi.org/10.1371/journal.pone.0014143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152443	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100023
J	Lin, HF; Tsai, PC; Lin, RT; Khor, GT; Sheu, SH; Juo, SHH				Lin, Hsiu-Fen; Tsai, Pei-Chien; Lin, Ruey-Tay; Khor, Gim-Thean; Sheu, Sheng-Hsiung; Juo, Suh-Hang Hank			Sex Differential Genetic Effect of Chromosome 9p21 on Subclinical Atherosclerosis	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; ENVIRONMENTAL CONTRIBUTIONS; ASSOCIATION ANALYSIS; RISK; PLAQUE; HERITABILITY; PHENOTYPES; VARIANTS	Background: Chromosome 9p21 has recently been shown to be a risk region for a broad range of vascular diseases. Since carotid intima-media thickness (IMT) and plaque are independent predictors for vascular diseases, the association between 9p21 and these two phenotypes was investigated. Methodology/Principal Findings: Carotid segment-specific IMT and plaques were obtained in 1083 stroke-and myocardial infarction-free volunteers. We tested the genotypes and haplotypes of key single nucleotide polymorphisms (SNPs) on chromosome 9p21 for the associations with carotid IMT and plaque. Multivariate permutation analyses demonstrated that carriers of the T allele of SNP rs1333040 were significantly associated with thicker common carotid artery (CCA) IMT (p = 0.021) and internal carotid artery (ICA) IMT (p = 0.033). The risk G allele of SNP rs2383207 was associated with ICA IMT (p = 0.007). Carriers of the C allele of SNP rs1333049 were found to be significantly associated with thicker ICA IMT (p = 0.010) and the greater risk for the presence of carotid plaque (OR = 1.57 for heterozygous carriers; OR = 1.75 for homozygous carriers). Haplotype analysis showed a global p value of 0.031 for ICA IMT and 0.115 for the presence of carotid plaque. Comparing with the other haplotypes, the risk TGC haplotype yielded an adjusted p value of 0.011 and 0.017 for thicker ICA IMT and the presence of carotid plaque respectively. Further analyzing the data separated by sex, the results were significant only in men but not in women. Conclusions: Chromosome 9p21 had a significant association with carotid atherosclerosis, especially ICA IMT. Furthermore, such genetic effect was in a gender-specific manner in the Han Chinese population.	[Lin, Hsiu-Fen; Lin, Ruey-Tay; Khor, Gim-Thean] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lin, Hsiu-Fen; Lin, Ruey-Tay] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Tsai, Pei-Chien; Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Sheu, Sheng-Hsiung] Kaohsiung Med Univ Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan; [Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Dept Internal Med, Coll Med, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Lin, HF (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.	hjuo@kmu.edu.tw	Juo, Suh-Hang/C-9545-2009	Lin, Hsiu-Fen/0000-0001-6343-826X; Tsai, Pei-Chien/0000-0002-5044-6727	National Health Research Institutes, Taiwan [NHRI-Ex96-9607PI]; National Science Council, Taiwan [NSC 97-2314-B-037-019, NSC 98-2314-B-037-048]; Kaohsiung Medical University [KMUH98-8I11]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University	This work was supported by the following grants: National Health Research Institutes, Taiwan (NHRI-Ex96-9607PI); National Science Council, Taiwan (NSC 97-2314-B-037-019; NSC 98-2314-B-037-048) and Kaohsiung Medical University intramural grant (KMUH98-8I11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bjorck HM, 2009, J INTERN MED, V265, P373, DOI 10.1111/j.1365-2796.2008.02020.x; Bown MJ, 2008, CIRC-CARDIOVASC GENE, V1, P39, DOI 10.1161/CIRCGENETICS.108.789727; Cunnington MS, 2009, ATHEROSCLEROSIS, V203, P41, DOI 10.1016/j.atherosclerosis.2008.06.025; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Homma S, 2001, STROKE, V32, P830, DOI 10.1161/01.STR.32.4.830; Hunt KJ, 2002, STROKE, V33, P2775, DOI 10.1161/01.STR.0000043827.03966.EF; Juo SHH, 2004, STROKE, V35, P2243, DOI 10.1161/01.STR.0000142132.20442.d8; Kornet L, 1998, ARTERIOSCL THROM VAS, V18, P1877, DOI 10.1161/01.ATV.18.12.1877; Liao YC, 2008, STROKE, V39, P3159, DOI 10.1161/STROKEAHA.108.522789; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Ozaki K, 2009, NAT GENET, V41, P329, DOI 10.1038/ng.326; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samani NJ, 2008, ARTERIOSCL THROM VAS, V28, P1679, DOI 10.1161/ATVBAHA.108.170332; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sayed-Tabatabaei FA, 2005, STROKE, V36, P2351, DOI 10.1161/01.STR.0000185719.66735.dd; Spence JD, 2004, STROKE, V35, pE87, DOI 10.1161/01.STR.0000125715.47831.37; Srivastava RAK, 1997, J BIOL CHEM, V272, P33360, DOI 10.1074/jbc.272.52.33360; Stork S, 2004, CIRCULATION, V110, P344, DOI 10.1161/01.CIR.0000134966.10793.C9; Tzeng JY, 2006, AM J HUM GENET, V78, P231, DOI 10.1086/500025; Yamagishi K, 2009, EUR HEART J, V30, P1222, DOI 10.1093/eurheartj/ehp087; Ye S, 2008, J AM COLL CARDIOL, V52, P378, DOI 10.1016/j.jacc.2007.11.087; Zureik M, 2000, ARTERIOSCL THROM VAS, V20, P1622, DOI 10.1161/01.ATV.20.6.1622	29	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15124	10.1371/journal.pone.0015124	http://dx.doi.org/10.1371/journal.pone.0015124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152093	gold, Green Submitted, Green Published			2022-12-27	WOS:000284755100082
J	dos Santos, RMZ; Amador, A; de Souza, WV; de Albuquerque, MFPM; Dawson, SP; Ruffino-Netto, A; Zarate-Blades, CR; Silva, CL				Zorzenon dos Santos, Rita M.; Amador, Ana; de Souza, Wayner V.; de Albuquerque, Maria Fatima P. M.; Ponce Dawson, Silvina; Ruffino-Netto, Antonio; Zarate-Blades, Carlos R.; Silva, Celio L.			A Dynamic Analysis of Tuberculosis Dissemination to Improve Control and Surveillance	PLOS ONE			English	Article							INFECTIOUS-DISEASES; GIS; EPIDEMIOLOGY; HEALTH; SPACE	Background: Detailed analysis of the dynamic interactions among biological, environmental, social, and economic factors that favour the spread of certain diseases is extremely useful for designing effective control strategies. Diseases like tuberculosis that kills somebody every 15 seconds in the world, require methods that take into account the disease dynamics to design truly efficient control and surveillance strategies. The usual and well established statistical approaches provide insights into the cause-effect relationships that favour disease transmission but they only estimate risk areas, spatial or temporal trends. Here we introduce a novel approach that allows figuring out the dynamical behaviour of the disease spreading. This information can subsequently be used to validate mathematical models of the dissemination process from which the underlying mechanisms that are responsible for this spreading could be inferred. Methodology/Principal Findings: The method presented here is based on the analysis of the spread of tuberculosis in a Brazilian endemic city during five consecutive years. The detailed analysis of the spatio-temporal correlation of the yearly geo-referenced data, using different characteristic times of the disease evolution, allowed us to trace the temporal path of the aetiological agent, to locate the sources of infection, and to characterize the dynamics of disease spreading. Consequently, the method also allowed for the identification of socio-economic factors that influence the process. Conclusions/Significance: The information obtained can contribute to more effective budget allocation, drug distribution and recruitment of human skilled resources, as well as guiding the design of vaccination programs. We propose that this novel strategy can also be applied to the evaluation of other diseases as well as other social processes.	[Zorzenon dos Santos, Rita M.; Amador, Ana] Univ Fed Pernambuco, Dept Fis, BR-50739 Recife, PE, Brazil; [Amador, Ana; Ponce Dawson, Silvina] Univ Buenos Aires, FCEN UBA, Dept Fis, Buenos Aires, DF, Argentina; [de Souza, Wayner V.; de Albuquerque, Maria Fatima P. M.] Fiocruz MS, Ctr Pesquisa Ageu Magalhaes, Recife, PE, Brazil; [de Albuquerque, Maria Fatima P. M.] Univ Fed Pernambuco, Dept Med, BR-50739 Recife, PE, Brazil; [Ruffino-Netto, Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Social Med, Sao Paulo, Brazil; [Zarate-Blades, Carlos R.; Silva, Celio L.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Sao Paulo, Brazil	Universidade Federal de Pernambuco; University of Buenos Aires; Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; Universidade de Sao Paulo; Universidade de Sao Paulo	dos Santos, RMZ (corresponding author), Univ Fed Pernambuco, Dept Fis, Cidade Univ, BR-50739 Recife, PE, Brazil.	rita.zorzenon@gmail.com; clsilva@cpt.fmrp.usp.br	Silva, Celio/C-4639-2012; Souza, Wayner V/H-3798-2013; Zárate-Bladés, Carlos R/C-9663-2015	Silva, Celio/0000-0002-0043-4568; Zárate-Bladés, Carlos R/0000-0002-7728-7869; Ponce Dawson, Silvina/0000-0001-6550-4267; Souza, Wayner/0000-0002-0939-9332; Amador, Ana/0000-0002-1040-2359	Instituto do Milenio REDE-TB; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) [0012-05.03/04, 0203-1.05/08]	Instituto do Milenio REDE-TB; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This study received financial support from the following Brazilian institutions: the Instituto do Milenio REDE-TB, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br), the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://www.fapesp.br), and the Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE, http://www.facepe.br-Pronex-EDT 0012-05.03/04 and Pronex-APQ 0203-1.05/08). Additional support was provided by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, http://www.agencia.gov.ar) of Argentina. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; BAILEY T, 1995, INTERACTIVE SPATIAL, P73; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Cromley EK, 2003, ANNU REV PUBL HEALTH, V24, P7, DOI 10.1146/annurev.publhealth.24.012902.141019; Frieden TR, 2005, CLIN CHEST MED, V26, P197, DOI 10.1016/j.ccm.2005.02.001; Graham AJ, 2004, ACTA TROP, V91, P219, DOI 10.1016/j.actatropica.2004.05.001; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; *IBGE, DEM CENS 2000; Knorr-Held L, 2003, J R STAT SOC C-APPL, V52, P169, DOI 10.1111/1467-9876.00396; Krieger N, 2003, EPIDEMIOLOGY, V14, P384, DOI 10.1097/01.ede.0000071473.69307.8a; Lawson AB, 2006, STAT METHODS SPATIAL; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Rogers DJ, 2003, NAT REV MICROBIOL, V1, P231, DOI 10.1038/nrmicro776; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Ruffino-Netto A, 2001, Rev Panam Salud Publica, V9, P306, DOI 10.1590/S1020-49892001000500004; Souza W V, 2000, Rev Panam Salud Publica, V8, P403, DOI 10.1590/S1020-49892000001100005; Souza WV, 2005, REV SAUDE PUBL, V39, P82, DOI 10.1590/S0034-89102005000100011; STAUFFER D, 1994, INTRO PERCOLATION TH; STYBLO K, 1967, B WORLD HEALTH ORGAN, V37, P819; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; Wang XH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000250; *WHO, 2009, GLOB TUB CONTR SHORT; DATA OBTAINED NATL D	25	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14140	10.1371/journal.pone.0014140	http://dx.doi.org/10.1371/journal.pone.0014140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152440	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100020
J	Kurth, F; Belard, S; Mombo-Ngoma, G; Schuster, K; Adegnika, AA; Bouyou-Akotet, MK; Kremsner, PG; Ramharter, M				Kurth, Florian; Belard, Sabine; Mombo-Ngoma, Ghyslain; Schuster, Katharina; Adegnika, Ayola A.; Bouyou-Akotet, Marielle K.; Kremsner, Peter G.; Ramharter, Michael			Adolescence As Risk Factor for Adverse Pregnancy Outcome in Central Africa - A Cross-Sectional Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT	Background: Sub-Saharan Africa has the highest rates of maternal and neonatal mortality worldwide. Young maternal age at delivery has been proposed as risk factor for adverse pregnancy outcome, yet there is insufficient data from Sub-Saharan Africa. The present study aimed to investigate the influence of maternal adolescence on pregnancy outcomes in the Central African country Gabon. Methodology and Principal Findings: Data on maternal age, parity, birth weight, gestational age, maternal Plasmodium falciparum infection, use of bednets, and intake of intermittent preventive treatment of malaria in pregnancy were collected in a cross-sectional survey in 775 women giving birth in three mother-child health centers in Gabon. Adolescent women (<= 16 years of age) had a significantly increased risk to deliver a baby with low birth weight in univariable analysis (22.8%, 13/57, vs. 9.3%, 67/718, OR: 2.9, 95% CI: 1.5-5.6) and young maternal age showed a statistically significant association with the risk for low birth weight in multivariable regression analysis after correction for established risk factors (OR: 2.7; 95% CI: 1.1-6.5). In further analysis adolescent women were shown to attend significantly less antenatal care visits than adult mothers (3.3 +/- 1.9 versus 4.4 +/- 1.9 mean visits, p<0.01, n = 356) and this difference accounted at least for part of the excess risk for low birth weight in adolescents. Conclusion: Our data demonstrate the importance of adolescent age as risk factor for adverse pregnancy outcome. Antenatal care programs specifically tailored for the needs of adolescents may be necessary to improve the frequency of antenatal care visits and pregnancy outcomes in this risk group in Central Africa.	[Kurth, Florian; Belard, Sabine; Mombo-Ngoma, Ghyslain; Schuster, Katharina; Adegnika, Ayola A.; Kremsner, Peter G.; Ramharter, Michael] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Kurth, Florian] Univ Hosp Carl Gustav Carus, Dept Neonatol & Paediat Intens Care, Dresden, Germany; [Kurth, Florian; Belard, Sabine; Mombo-Ngoma, Ghyslain; Schuster, Katharina; Adegnika, Ayola A.; Kremsner, Peter G.; Ramharter, Michael] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Belard, Sabine; Schuster, Katharina] Univ Freiburg, Dept Paediat & Adolescent Med, Freiburg, Germany; [Mombo-Ngoma, Ghyslain; Bouyou-Akotet, Marielle K.] Univ Sci Sante, Dept Parasitol, Libreville, Gabon; [Adegnika, Ayola A.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Ramharter, Michael] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Eberhard Karls University of Tubingen; University of Freiburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Medical University of Vienna	Kurth, F (corresponding author), Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon.	michael.ramharter@meduniwien.ac.at	ADEGNIKA, Ayola Akim/AAK-7307-2020; Mombo-Ngoma, Ghyslain/I-4305-2019; Bélard, Sabine/J-9557-2019; Kurth, Florian/H-7427-2012; Ramharter, Michael/C-5273-2013	Mombo-Ngoma, Ghyslain/0000-0003-2658-8706; Bélard, Sabine/0000-0002-2008-418X; Kurth, Florian/0000-0002-3807-473X; Ramharter, Michael/0000-0002-9259-1885	independent Karl Landsteiner Gesellschaft, Austria	independent Karl Landsteiner Gesellschaft, Austria	This study was supported by a grant of the independent Karl Landsteiner Gesellschaft, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM I, 2007, LOW BODY MASS INDEX, DOI DOI 10.1093/TROPEJ/FMM110; ADEGNIKA, COMMUNICATION; Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798; CHAIBVA CN, 2009, MIDWIVERY       0224, DOI DOI 10.1016/J.MIDW.2009.01.001; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Elshibly EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-244; Feresu SA, 2004, PAEDIATR PERINAT EP, V18, P154, DOI 10.1111/j.1365-3016.2003.00539.x; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kurth F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-79; Milabyo Kyamusugulwa Patrick, 2006, Sante, V16, P103; Paranjothy S, 2009, ARCH DIS CHILD, V94, P239, DOI 10.1136/adc.2007.115915; Ramharter M, 2005, J INFECT DIS, V191, P1005, DOI 10.1086/427781; Ramharter M, 2004, AIDS, V18, P1847, DOI 10.1097/00002030-200409030-00015; Ramharter M, 2007, WIEN KLIN WOCHENSCHR, V119, P8, DOI 10.1007/s00508-007-0857-5; Ramharter M, 2007, AM J TROP MED HYG, V77, P418, DOI 10.4269/ajtmh.2007.77.418; Scholl T O, 1989, Paediatr Perinat Epidemiol, V3, P357, DOI 10.1111/j.1365-3016.1989.tb00524.x; United Nations, 2002, UN MILL DECL; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; World Health Organization, 2007, MAT MORT 2005 EST DE; World Health Organization, 2005, WORLD HLTH REP 2005	23	60	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14367	10.1371/journal.pone.0014367	http://dx.doi.org/10.1371/journal.pone.0014367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188301	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200006
J	Norgate, M; Southon, A; Greenough, M; Cater, M; Farlow, A; Batterham, P; Bush, AI; Subramaniam, VN; Burke, R; Camakaris, J				Norgate, Melanie; Southon, Adam; Greenough, Mark; Cater, Michael; Farlow, Ashley; Batterham, Philip; Bush, Ashley I.; Subramaniam, V. Nathan; Burke, Richard; Camakaris, James			Syntaxin 5 Is Required for Copper Homeostasis in Drosophila and Mammals	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MTF-1; PLASMA-MEMBRANE; TRANSPORTER; DISEASE; MENKES; MELANOGASTER; TRAFFICKING; EXPRESSION; WILSON; HCTR1	Copper is essential for aerobic life, but many aspects of its cellular uptake and distribution remain to be fully elucidated. A genome-wide screen for copper homeostasis genes in Drosophila melanogaster identified the SNARE gene Syntaxin 5 (Syx5) as playing an important role in copper regulation; flies heterozygous for a null mutation in Syx5 display increased tolerance to high dietary copper. The phenotype is shown here to be due to a decrease in copper accumulation, a mechanism also observed in both Drosophila and human cell lines. Studies in adult Drosophila tissue suggest that very low levels of Syx5 result in neuronal defects and lethality, and increased levels also generate neuronal defects. In contrast, mild suppression generates a phenotype typical of copper-deficiency in viable, fertile flies and is exacerbated by co-suppression of the copper uptake gene Ctr1A. Reduced copper uptake appears to be due to reduced levels at the plasma membrane of the copper uptake transporter, Ctr1. Thus Syx5 plays an essential role in copper homeostasis and is a candidate gene for copper-related disease in humans.	[Norgate, Melanie; Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Southon, Adam; Greenough, Mark; Farlow, Ashley; Batterham, Philip; Camakaris, James] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Greenough, Mark; Cater, Michael; Bush, Ashley I.] Mental Hlth Res Inst Victoria, Parkville, Vic, Australia; [Subramaniam, V. Nathan] Queensland Inst Med Res, Membrane Transport Lab, Brisbane, Qld 4006, Australia	Monash University; University of Melbourne; QIMR Berghofer Medical Research Institute	Norgate, M (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	richard.burke@monash.edu	Greenough, Mark/AAK-1615-2021; Batterham, Philip/G-5914-2012; Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Subramaniam, V. Nathan/A-1901-2010	Batterham, Philip/0000-0001-9840-9119; Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Subramaniam, V. Nathan/0000-0002-4583-7790; Greenough, Mark/0000-0001-6767-0584; Burke, Richard/0000-0003-0086-0767; Farlow, Ashley/0000-0003-3789-6456	International Copper Association [DP0451599]; Australian Research Council; Australian Institute of Nuclear Science and Engineering	International Copper Association; Australian Research Council(Australian Research Council); Australian Institute of Nuclear Science and Engineering	This work was supported by grants from the International Copper Association (grant DP0451599, www.copper.org), the Australian Research Council (www.arc.gov.au), and the Australian Institute of Nuclear Science and Engineering (www.ainse.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; BACH JP, J NEUROLOGICAL SCI, V291, P95; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; BINKS T, J BIOL INORGANIC CHE; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; DANKS DM, 1988, ANNU REV NUTR, V8, P235, DOI 10.1146/annurev.nu.08.070188.001315; DASCHER C, 1994, J BIOL CHEM, V269, P29363; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Klomp AEM, 2003, BIOCHEM J, V370, P881, DOI 10.1042/BJ20021128; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; Maryon EB, 2007, BIOPHYS J, p358A; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; NORGATE M, 2007, 5 INT BIOM S BIOM 20, P683; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Southon A, 2004, BIOCHEM J, V383, P303, DOI 10.1042/BJ20040745; Southon A, 2008, J EXP BIOL, V211, P709, DOI 10.1242/jeb.014159; Stein MP, 2002, TRENDS CELL BIOL, V12, P374, DOI 10.1016/S0962-8924(02)02331-0; Subramaniam VN, 1997, J BIOL CHEM, V272, P25441, DOI 10.1074/jbc.272.41.25441; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Xu H, 2002, DEV BIOL, V251, P294, DOI 10.1006/dbio.2002.0830; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14303	10.1371/journal.pone.0014303	http://dx.doi.org/10.1371/journal.pone.0014303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188142	gold, Green Published			2022-12-27	WOS:000285575200003
J	Barnes, L; Tran, C; Sorg, O; Hotz, R; Grand, D; Carraux, P; Didierjean, L; Stamenkovic, I; Saurat, JH; Kaya, G				Barnes, Laurent; Tran, Christian; Sorg, Olivier; Hotz, Raymonde; Grand, Denise; Carraux, Pierre; Didierjean, Liliane; Stamenkovic, Ivan; Saurat, Jean-Hilaire; Kaya, Guerkan			Synergistic Effect of Hyaluronate Fragments in Retinaldehyde-Induced Skin Hyperplasia Which Is a Cd44-Dependent Phenomenon	PLOS ONE			English	Article							EPIDERMAL CD44 EXPRESSION; SCLEROSUS-ET-ATROPHICUS; GROWTH-FACTOR; MOUSE SKIN; TOPICAL RETINALDEHYDE; RETINOIC ACID; KERATINOCYTES; ADHESION; RECEPTOR; DERMATOPOROSIS	Background: CD44 is a polymorphic proteoglycan and functions as the principal cell-surface receptor for hyaluronate (HA). Heparin-binding epidermal growth factor (HB-EGF) activation of keratinocyte erbB receptors has been proposed to mediate retinoid-induced epidermal hyperplasia. We have recently shown that intermediate size HA fragments (HAFi) reverse skin atrophy by a CD44-dependent mechanism. Methodology and Principal Findings: Treatment of primary mouse keratinocyte cultures with retinaldehyde (RAL) resulted in the most significant increase in keratinocyte proliferation when compared with other retinoids, retinoic acid, retinol or retinoyl palmitate. RAL and HAFi showed a more significant increase in keratinocyte proliferation than RAL or HAFi alone. No proliferation with RAL was observed in CD44(-/-) keratinocytes. HA synthesis inhibitor, 4-methylumbelliferone inhibited the proliferative effect of RAL. HB-EGF, erbB1, and tissue inhibitor of MMP-3 blocking antibodies abrogated the RAL- or RAL- and HAFi-induced keratinocyte proliferation. Topical application of RAL or RAL and HAFi for 3 days caused a significant epidermal hyperplasia in the back skin of wild-type mice but not in CD44(-/-) mice. Topical RAL and HAFi increased epidermal CD44 expression, and the epidermal and dermal HA. RAL induced the expression of active HB-EGF and erbB1. However, treatment with RAL and HAFi showed a more significant increase in pro-HB-EGF when compared to RAL or HAFi treatments alone. We then topically applied RAL and HAFi twice a day to the forearm skin of elderly dermatoporosis patients. After 1 month of treatment, we observed a significant clinical improvement. Conclusions and Significance: Our results indicate that (i) RAL-induced in vitro and in vivo keratinocyte proliferation is a CD44-dependent phenomenon and requires the presence of HA, HB-EGF, erbB1 and MMPs, (ii) RAL and HAFi show a synergy in vitro and in vivo in mouse skin, and (iii) the combination of RAL and HAFi seems to have an important therapeutic effect in dermatoporosis.	[Barnes, Laurent; Tran, Christian; Sorg, Olivier; Hotz, Raymonde; Grand, Denise; Carraux, Pierre; Didierjean, Liliane; Saurat, Jean-Hilaire; Kaya, Guerkan] Univ Geneva, Dept Dermatol, Geneva, Switzerland; [Stamenkovic, Ivan] Univ Lausanne, Inst Pathol, Lausanne, Switzerland	University of Geneva; University of Lausanne	Barnes, L (corresponding author), Univ Geneva, Dept Dermatol, Geneva, Switzerland.	gkaya@hcuge.ch			University of Geneva; Genderm Research Program; Swiss National Science Foundation [310000-122322, 3100-65090-01]; Molecular Oncology National Centre for Competence in Research (NCCR)	University of Geneva; Genderm Research Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Molecular Oncology National Centre for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	This work was supported by the University of Geneva Dermatology Fund, Genderm Research Program and Swiss National Science Foundation grant 310000-122322 to GK and JHS, and Swiss National Science Foundation grant 3100-65090-01 and the Molecular Oncology National Centre for Competence in Research (NCCR) to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Calikoglu E, 2006, PHOTOCHEM PHOTOBIOL, V82, P1342, DOI 10.1562/2006-02-10-RA-801; Didierjean L, 1996, J INVEST DERMATOL, V107, P714, DOI 10.1111/1523-1747.ep12365603; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; HUDSON DL, 1995, J CELL SCI, V108, P1959; Kaya G, 2005, BRIT J DERMATOL, V152, P570, DOI 10.1111/j.1365-2133.2005.06396.x; Kaya G, 2005, J INVEST DERMATOL, V124, P284, DOI 10.1111/j.0022-202X.2004.23579.x; Kaya G, 2000, J INVEST DERMATOL, V115, P1054, DOI 10.1046/j.1523-1747.2000.00194.x; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; Kaya G, 2008, ARCH DERMATOL, V144, P1303, DOI 10.1001/archderm.144.10.1303; Kaya G, 2006, PLOS MED, V3, P2291, DOI 10.1371/journal.pmed.0030493; Kaya G, 2007, DERMATOLOGY, V215, P284, DOI 10.1159/000107621; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; Piepkorn M, 2003, ARCH DERMATOL RES, V295, P93, DOI 10.1007/s00403-003-0391-x; SAURAT JH, 1994, J INVEST DERMATOL, V103, P770, DOI 10.1111/1523-1747.ep12412861; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; Xian WJ, 1997, ONCOGENE, V14, P1435, DOI 10.1038/sj.onc.1200980; Xiao JH, 1999, EMBO J, V18, P1539, DOI 10.1093/emboj/18.6.1539; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	22	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14372	10.1371/journal.pone.0014372	http://dx.doi.org/10.1371/journal.pone.0014372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179550	Green Submitted, Green Published, gold			2022-12-27	WOS:000285381200015
J	Holt, AG; Bissig, D; Mirza, N; Rajah, G; Berkowitz, B				Holt, Avril Genene; Bissig, David; Mirza, Najab; Rajah, Gary; Berkowitz, Bruce			Evidence of Key Tinnitus-Related Brain Regions Documented by a Unique Combination of Manganese-Enhanced MRI and Acoustic Startle Reflex Testing	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; RESONANCE-IMAGING MEMRI; GAZE-EVOKED TINNITUS; INFERIOR COLLICULUS; AUDITORY-CORTEX; ANIMAL-MODEL; RAT-BRAIN; BEHAVIORAL PARADIGM; CALCIUM-CHANNELS; SPIKE DISCHARGES	Animal models continue to improve our understanding of tinnitus pathogenesis and aid in development of new treatments. However, there are no diagnostic biomarkers for tinnitus-related pathophysiology for use in awake, freely moving animals. To address this disparity, two complementary methods were combined to examine reliable tinnitus models (rats repeatedly administered salicylate or exposed to a single noise event): inhibition of acoustic startle and manganese-enhanced MRI. Salicylate-induced tinnitus resulted in wide spread supernormal manganese uptake compared to noise-induced tinnitus. Neither model demonstrated significant differences in the auditory cortex. Only in the dorsal cortex of the inferior colliculus (DCIC) did both models exhibit supernormal uptake. Therefore, abnormal membrane depolarization in the DCIC appears to be important in tinnitus-mediated activity. Our results provide the foundation for future studies correlating the severity and longevity of tinnitus with hearing loss and neuronal activity in specific brain regions and tools for evaluating treatment efficacy across paradigms.	[Holt, Avril Genene; Bissig, David; Mirza, Najab; Rajah, Gary; Berkowitz, Bruce] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Berkowitz, Bruce] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA	Wayne State University; Wayne State University	Holt, AG (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	agholt@med.wayne.edu		Holt, Avril Genene/0000-0001-6225-1700; Bissig, David/0000-0001-9664-5433	National Institutes of Health [DC007733, EY018109, P30]; Kresge Eye Institute; Wayne State University School of Medicine; NATIONAL EYE INSTITUTE [R21EY018109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC007733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kresge Eye Institute; Wayne State University School of Medicine; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	These studies were supported by the National Institutes of Health [DC007733 to AGH, EY018109 to BAB, P30 Grants (Anatomy and Cell Biology, Wayne State University and Kresge Hearing Research Institute, University of Michigan)], University Medical Student Grant to GR, an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute) and Wayne State University School of Medicine MD/PhD program for DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvestad S, 2007, NEUROIMAGE, V38, P57, DOI 10.1016/j.neuroimage.2007.07.027; ANDERSEN RA, 1980, J COMP NEUROL, V191, P479, DOI 10.1002/cne.901910310; Angenstein F, 2007, CEREB CORTEX, V17, P28, DOI 10.1093/cercer/bhj121; Aoki I, 2004, NMR BIOMED, V17, P569, DOI 10.1002/nbm.941; Bahmad Fayez M Jr, 2006, Int Tinnitus J, V12, P140; Bauer CA, 1999, OTOLARYNG HEAD NECK, V121, P457, DOI 10.1016/S0194-5998(99)70237-8; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P4733, DOI 10.1167/iovs.06-1516; Berkowitz BA, 2006, INVEST OPHTH VIS SCI, V47, P2668, DOI 10.1167/iovs.05-1588; Berkowitz BA, 2010, MOL VIS, V16, P1776; Bissig D, 2009, NEUROIMAGE, V44, P627, DOI 10.1016/j.neuroimage.2008.10.013; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; CACACE AT, 1994, HEARING RES, V81, P22, DOI 10.1016/0378-5955(94)90149-X; CACACE AT, 1994, AUDIOLOGY, V33, P291; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; CHEN GD, 1995, HEARING RES, V82, P158, DOI 10.1016/0378-5955(94)00174-O; Chuang KH, 2009, MAGN RESON IMAGING, V27, P594, DOI 10.1016/j.mri.2008.10.006; Chuang KH, 2006, MAGN RESON MED, V55, P604, DOI 10.1002/mrm.20797; Cross DJ, 2007, AM J NEURORADIOL, V28, P1865, DOI 10.3174/ajnr.A0693; Denk DM, 1997, ACTA OTO-LARYNGOL, V117, P825, DOI 10.3109/00016489709114208; DIAMOND IT, 1969, BRAIN RES, V15, P305, DOI 10.1016/0006-8993(69)90160-7; Dieler R, 2002, LARYNGO RHINO OTOL, V81, P196, DOI 10.1055/s-2002-25041; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; DRUGA R, 1984, PHYSIOL BOHEMOSLOV, V33, P31; Druga R, 1997, PHYSIOL RES, V46, P215; EVANS EF, 1973, EXP BRAIN RES, V17, P428; Fa ZQ, 2010, NEUROSCI LETT, V481, P110, DOI 10.1016/j.neulet.2010.06.063; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); FAYELUND H, 1985, ANAT EMBRYOL, V173, P53, DOI 10.1007/BF00707304; Francis HW, 2000, HEARING RES, V149, P91, DOI 10.1016/S0378-5955(00)00165-9; Gadjanski I, 2009, ANN NEUROL, V66, P81, DOI 10.1002/ana.21668; Guitton MJ, 2003, J NEUROSCI, V23, P3944; Heffner HE, 2005, BEHAV NEUROSCI, V119, P734, DOI 10.1037/0735-7044.119.3.734; Heffner HE, 2002, HEARING RES, V170, P83, DOI 10.1016/S0378-5955(02)00343-X; HIRSCH JA, 1988, J PHYSIOL-LONDON, V396, P535, DOI 10.1113/jphysiol.1988.sp016976; HOLT A, 2005, DIFFERENTIAL GENE EX, P329; Itoh K, 2008, NEUROSCIENCE, V154, P732, DOI 10.1016/j.neuroscience.2008.03.080; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; JASTREBOFF PJ, 1986, J ACOUST SOC AM, V80, P1384, DOI 10.1121/1.394391; JASTREBOFF PJ, 1994, AM J OTOL, V15, P19; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kaltenbach JA, 2007, PROG BRAIN RES, V166, P89, DOI 10.1016/S0079-6123(07)66009-9; KAY IS, 1993, EUR ARCH OTO-RHINO-L, V250, P51; KOERBER KC, 1966, EXP NEUROL, V16, P119, DOI 10.1016/0014-4886(66)90091-4; Lee JH, 2005, MAGN RESON MED, V53, P640, DOI 10.1002/mrm.20368; Lew HL, 2007, J REHABIL RES DEV, V44, pVII; Liu YX, 2007, NEUROPHARMACOLOGY, V53, P870, DOI 10.1016/j.neuropharm.2007.08.015; Liu YX, 2005, HEARING RES, V205, P271, DOI 10.1016/j.heares.2005.03.028; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Ma WLD, 2006, HEARING RES, V212, P9, DOI 10.1016/j.heares.2005.10.003; Melcher JR, 2009, HEARING RES, V257, P63, DOI 10.1016/j.heares.2009.08.005; Moody D. B, 2004, TINNITUS THEORY MANA, P80; NORENA AJ, 2010, NEUROSCIENCE; Oertel D, 1991, Curr Opin Neurobiol, V1, P221, DOI 10.1016/0959-4388(91)90082-I; Paul AK, 2009, NEUROIMAGE, V44, P312, DOI 10.1016/j.neuroimage.2008.09.024; PFEIFFER RR, 1966, EXP BRAIN RES, V1, P220; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Salembier L, 2006, ACTA OTO-LARYNGOL, V126, P93, DOI 10.1080/03655230600895242; Snow J. B., 2004, TINNITUS THEORY MANA; Sun N, 2006, NEUROSCIENCE, V138, P77, DOI 10.1016/j.neuroscience.2005.10.034; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; SYKA J, 1988, AUDITORY PATHWAY STR; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Wenzel GI, 2010, EUR ARCH OTO-RHINO-L, V267, P691, DOI 10.1007/s00405-009-1126-1; Winer JA, 1998, J COMP NEUROL, V400, P147; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Yu X, 2008, NEUROIMAGE, V39, P223, DOI 10.1016/j.neuroimage.2007.08.029; Yu X, 2007, P NATL ACAD SCI USA, V104, P12193, DOI 10.1073/pnas.0700960104	74	61	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14260	10.1371/journal.pone.0014260	http://dx.doi.org/10.1371/journal.pone.0014260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179508	Green Published, gold, Green Submitted			2022-12-27	WOS:000285340000001
J	Lee, N; Iyer, SS; Mu, J; Weissman, JD; Ohali, A; Howcroft, TK; Lewis, BA; Singer, DS				Lee, Namhoon; Iyer, Shankar S.; Mu, Jie; Weissman, Jocelyn D.; Ohali, Anat; Howcroft, T. Kevin; Lewis, Brian A.; Singer, Dinah S.			Three Novel Downstream Promoter Elements Regulate MHC Class I Promoter Activity in Mammalian Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; CORE PROMOTER; GENE-EXPRESSION; BASAL PROMOTER; FUNCTIONAL-CHARACTERIZATION; REPRESSES TRANSCRIPTION; DNA-BINDING; TATA-BOX; C-JUN; DROSOPHILA	Background: MHC class I transcription is regulated by two distinct types of regulatory pathways: 1) tissue-specific pathways that establish constitutive levels of expression within a given tissue and 2) dynamically modulated pathways that increase or decrease expression within that tissue in response to hormonal or cytokine mediated stimuli. These sets of pathways target distinct upstream regulatory elements, have distinct basal transcription factor requirements, and utilize discrete sets of transcription start sites within an extended core promoter. Methodology/Principal Findings: We studied regulatory elements within the MHC class I promoter by cellular transfection and in vitro transcription assays in HeLa, HeLa/CIITA, and tsBN462 of various promoter constructs. We have identified three novel MHC class I regulatory elements (GLE, DPE-L1 and DPE-L2), located downstream of the major transcription start sites, that contribute to the regulation of both constitutive and activated MHC class I expression. These elements located at the 3' end of the core promoter preferentially regulate the multiple transcription start sites clustered at the 5' end of the core promoter. Conclusions/Significance: Three novel downstream elements (GLE, DPE-L1, DPE-L2), located between +1 and +32 bp, regulate both constitutive and activated MHC class I gene expression by selectively increasing usage of transcription start sites clustered at the 5' end of the core promoter upstream of +1 bp. Results indicate that the downstream elements preferentially regulate TAF1-dependent, relative to TAF1-independent, transcription.	[Lee, Namhoon; Iyer, Shankar S.; Mu, Jie; Weissman, Jocelyn D.; Ohali, Anat; Singer, Dinah S.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Lee, Namhoon] Johns Hopkins Univ, NIH, Bethesda, MD USA; [Iyer, Shankar S.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Howcroft, T. Kevin] NCI, Div Canc Biol, Bethesda, MD 20892 USA; [Lewis, Brian A.; Singer, Dinah S.] NCI, Metab Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; National Institutes of Health (NIH) - USA; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lee, N (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	Dinah.singer@nih.gov		Lewis, Brian/0000-0002-8321-0665	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC009279, ZIASC010375, ZIABC009285] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anish R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005103; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; DAVID-WATINE B, 1990, IMMUNOL TODAY, V11, P286, DOI 10.1016/0167-5699(90)90114-O; FRELS WI, 1985, SCIENCE, V228, P577, DOI 10.1126/science.3885396; Gill G, 2001, ESSAYS BIOCHEM, V37, P33, DOI 10.1042/bse0370033; GIRDLESTONE J, 1995, IMMUNOBIOLOGY, V193, P229, DOI 10.1016/S0171-2985(11)80548-6; Girdlestone J, 1996, EUR J IMMUNOGENET, V23, P395; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Howcroft TK, 1999, MOL CELL BIOL, V19, P4788; HOWCROFT TK, 1993, EMBO J, V12, P3163, DOI 10.1002/j.1460-2075.1993.tb05985.x; Howcroft TK, 2003, IMMUNOL RES, V27, P1, DOI 10.1385/IR:27:1:1; Howcroft TK, 2003, MOL CELL BIOL, V23, P3377, DOI 10.1128/MCB.23.10.3377-3391.2003; HOWCROFT TK, 1995, IMMUNITY, V3, P127; Ishiguro N, 1997, J BIOL CHEM, V272, P15993, DOI 10.1074/jbc.272.25.15993; IYER V, 1995, MOL CELL BIOL, V15, P7059; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kaufmann J, 1996, GENE DEV, V10, P873, DOI 10.1101/gad.10.7.873; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; LEBOUTEILLER P, 1994, CRIT REV IMMUNOL, V14, P89, DOI 10.1615/CritRevImmunol.v14.i2.10; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Lee MP, 2005, GENOME RES, V15, P1189, DOI 10.1101/gr.3873705; Lewis BA, 2000, P NATL ACAD SCI USA, V97, P7172, DOI 10.1073/pnas.120181197; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; MAGUIRE JE, 1992, MOL CELL BIOL, V12, P3078, DOI 10.1128/MCB.12.7.3078; Martin BK, 1997, IMMUNITY, V6, P591, DOI 10.1016/S1074-7613(00)80347-7; Nagarajan UM, 2000, J IMMUNOL, V164, P3666, DOI 10.4049/jimmunol.164.7.3666; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Raval A, 2003, J IMMUNOL, V170, P922, DOI 10.4049/jimmunol.170.2.922; Raval A, 2001, MOL CELL, V7, P105, DOI 10.1016/S1097-2765(01)00159-9; Reinberg D, 1998, COLD SPRING HARB SYM, V63, P83, DOI 10.1101/sqb.1998.63.83; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; SINGER DS, 1988, CURR TOP MICROBIOL, V137, P148; SINGER DS, 1982, P NATL ACAD SCI-BIOL, V79, P1403, DOI 10.1073/pnas.79.5.1403; Singer DS, 1997, CRIT REV IMMUNOL, V17, P463; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; Weissman JDJ, 2000, J BIOL CHEM, V275, P10160, DOI 10.1074/jbc.275.14.10160; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Wong C, 1999, MOL CELL BIOL, V19, P1821; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103	54	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15278	10.1371/journal.pone.0015278	http://dx.doi.org/10.1371/journal.pone.0015278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179443	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900041
J	Varedi, SM; Ventura, AC; Merajver, SD; Lin, XN				Varedi K, S. Marjan; Ventura, Alejandra C.; Merajver, Sofia D.; Lin, Xiaoxia Nina			Multisite Phosphorylation Provides an Effective and Flexible Mechanism for Switch-Like Protein Degradation	PLOS ONE			English	Article							CDK INHIBITOR SIC1; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; RETINOBLASTOMA PROTEIN; COVALENT MODIFICATION; POLYVALENT LIGAND; KINASE; COMPLEX; ULTRASENSITIVITY	Phosphorylation-triggered degradation is a common strategy for elimination of regulatory proteins in many important cell signaling processes. Interesting examples include cyclin-dependent kinase inhibitors such as p27 in human and Sic1 in yeast, which play crucial roles during the G1/S transition in the cell cycle. In this work, we have modeled and analyzed the dynamics of multisite-phosphorylation-triggered protein degradation systematically. Inspired by experimental observations on the Sic1 protein and a previous intriguing theoretical conjecture, we develop a model to examine in detail the degradation dynamics of a protein featuring multiple phosphorylation sites and a threshold site number for elimination in response to a kinase signal. Our model explains the role of multiple phosphorylation sites, compared to a single site, in the regulation of protein degradation. A single-site protein cannot convert a graded input of kinase increase to much sharper output, whereas multisite phosphorylation is capable of generating a highly switch-like temporal profile of the substrate protein with two characteristics: a temporal threshold and rapid decrease beyond the threshold. We introduce a measure termed temporal response coefficient to quantify the extent to which a response in the time domain is switch-like and further investigate how this property is determined by various factors including the kinase input, the total number of sites, the threshold site number for elimination, the order of phosphorylation, the kinetic parameters, and site preference. Some interesting and experimentally verifiable predictions include that the non-degradable fraction of the substrate protein exhibits a more switch-like temporal profile; a sequential system is more switch-like, while a random system has the advantage of increased robustness; all the parameters, including the total number of sites, the threshold site number for elimination and the kinetic parameters synergistically determine the exact extent to which the degradation profile is switch-like. Our results suggest design principles for protein degradation switches which might be a widespread mechanism for precise regulation of cellular processes such as cell cycle progression.	[Varedi K, S. Marjan; Lin, Xiaoxia Nina] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Ventura, Alejandra C.; Merajver, Sofia D.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Merajver, Sofia D.; Lin, Xiaoxia Nina] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Lin, Xiaoxia Nina] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Varedi, SM (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	ninalin@umich.edu	Ganji, Davood Domiri/Z-3664-2019	Ganji, Davood Domiri/0000-0002-2344-526X	University of Michigan, Center of Computational Medicine and Bioinformatics (CCMB); Department of Defense; Burroughs Wellcome Fund; Breast Cancer Research Foundation; NIH [RO1 CA77612]; NATIONAL CANCER INSTITUTE [R01CA077612] Funding Source: NIH RePORTER	University of Michigan, Center of Computational Medicine and Bioinformatics (CCMB)(University of Michigan System); Department of Defense(United States Department of Defense); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Michigan, Center of Computational Medicine and Bioinformatics (CCMB) 2007 Pilot Grant. ACV was supported by the Department of Defense Breast Cancer Research Program. SDM was funded by the Burroughs Wellcome Fund, the Breast Cancer Research Foundation and the NIH (RO1 CA77612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Bao MZ, 2010, EUKARYOT CELL, V9, P31, DOI 10.1128/EC.00250-09; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Benito J, 1998, EMBO J, V17, P482, DOI 10.1093/emboj/17.2.482; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Borg M, 2007, P NATL ACAD SCI USA, V104, P9650, DOI 10.1073/pnas.0702580104; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; CHOCK PB, 1977, P NATL ACAD SCI USA, V74, P2766, DOI 10.1073/pnas.74.7.2766; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Coccetti P, 2006, BIOCHEM BIOPH RES CO, V346, P786, DOI 10.1016/j.bbrc.2006.05.171; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Cross FR, 2007, GENETICS, V176, P1541, DOI 10.1534/genetics.107.073494; Deshaies RJ, 1997, CURR OPIN GENET DEV, V7, P7, DOI 10.1016/S0959-437X(97)80103-7; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Dueber JE, 2007, NAT BIOTECHNOL, V25, P660, DOI 10.1038/nbt1308; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Krishnamurthy S, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-13; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu XF, 2010, BIOPHYS J, V98, P1396, DOI 10.1016/j.bpj.2009.12.4307; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; NUGROHO TT, 1994, MOL CELL BIOL, V14, P3320, DOI 10.1128/MCB.14.5.3320; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park HJ, 2008, J BIOL CHEM, V283, P23264, DOI 10.1074/jbc.M801720200; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Patwardhan P, 2007, CELL SIGNAL, V19, P2218, DOI 10.1016/j.cellsig.2007.06.006; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Qian H, 2008, BIOCHEMISTRY-US, V47, P2211, DOI 10.1021/bi702125s; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Salazar C, 2003, J MOL BIOL, V327, P31, DOI 10.1016/S0022-2836(03)00085-8; Salazar C, 2007, FEBS J, V274, P1046, DOI 10.1111/j.1742-4658.2007.05653.x; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Sedgwick C, 2006, BIOCHEM J, V399, P151, DOI 10.1042/BJ20060363; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Thron CD, 1997, ONCOGENE, V15, P317, DOI 10.1038/sj.onc.1201190; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang SQ, 2007, LEUKEMIA RES, V31, P839, DOI 10.1016/j.leukres.2006.08.016; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	75	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14029	10.1371/journal.pone.0014029	http://dx.doi.org/10.1371/journal.pone.0014029			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179196	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900001
J	Wong, SSC; Truong, K				Wong, Stanley S. C.; Truong, Kevin			Fluorescent Protein-Based Methods for On-Plate Screening of Gene Insertion	PLOS ONE			English	Article								Background: Unlike the commonly used method of blue-white screening for gene insertion, a fluorescent protein-based screening method offers a gain-of-function screening process without using any co-factors and a gene fusion product with a fluorescent protein reporter that is further useful in cell imaging studies. However, complications related to protein-folding efficiencies of the gene insert in fusion with fluorescent protein reporters prevent effective on-plate bacterial colony selection leading to its limited use. Methodology/Principal Findings: Here, we present three methods to tackle this problem. Our first method promotes the folding of the gene insert by using an N-terminal protein such as calmodulin that is well folded and expressed. Under this method, fluorescence was increased more than 30x over control allowing for enhanced screening. Our second method creates a fluorescent protein that is N-terminal to the gene upon insertion, thereby reducing the dependency of the fluorescent protein reporter on the folding of the gene insert. Our third method eliminates any dependence of the fluorescent protein reporter on the folding of the gene insert by using a stop and start sequence for protein translation. Conclusions/Significance: The three methods together will expand the usefulness of fluorescence on-plate screening and offer a powerful alternative to blue-white screening.	[Wong, Stanley S. C.; Truong, Kevin] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Truong, Kevin] Univ Toronto, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON, Canada	University of Toronto; University of Toronto	Wong, SSC (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	kevin.truong@utoronto.ca		Truong, Kevin/0000-0002-9520-2144	Canadian Institutes of Health Research [81262]; Heart and Stroke Foundation [NA6241]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by grants to KT from the Canadian Institutes of Health Research (# 81262) and Heart and Stroke Foundation (# NA6241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody JR, 2004, ANAL BIOCHEM, V333, P1, DOI 10.1016/j.ab.2004.05.054; CABANTOUS S, 2005, NAT BIOTECHNOL, V23, P6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; DAS A, 1984, NUCLEIC ACIDS RES, V12, P12; Gerth ML, 2004, PROTEIN ENG DES SEL, V17, P595, DOI 10.1093/protein/gzh068; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; ISRAEL DI, 1993, NUCLEIC ACIDS RES, V21, P5; KEESE P, 1996, NUCLEIC ACIDS RES, V24, P2; Kim HK, 1998, BRAIN RES BULL, V47, P35, DOI 10.1016/S0361-9230(98)00020-3; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; PAPINA M, 2002, COMP BIOCH PHYSL B, V131, P8; PEDELACQ JD, 2006, NAT BIOTECHNOL, V24, P11; RIZZO MA, 2004, NAT BIOTECHNOL, V22, P5; SHINE J, 1975, NAT BIOTECHNOL, V254, P5; STEEGE DA, 1977, P NATL ACAD SCI USA, V74, P4163, DOI 10.1073/pnas.74.10.4163; Truong K, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-8; TSIEN RY, 1998, ANNU REV BIOCHEM, V67, P38; WALDO GS, 1999, NAT BIOTECHNOL, V17, P5; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	19	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14274	10.1371/journal.pone.0014274	http://dx.doi.org/10.1371/journal.pone.0014274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170317	Green Published, Green Submitted, gold			2022-12-27	WOS:000285181400006
J	Cheng, MC; Lu, CL; Luu, SU; Tsai, HM; Hsu, SH; Chen, TT; Chen, CH				Cheng, Min-Chih; Lu, Chao-Lin; Luu, Sy-Ueng; Tsai, Ho-Min; Hsu, Shih-Hsin; Chen, Tzu-Ting; Chen, Chia-Hsiang			Genetic and Functional Analysis of the DLG4 Gene Encoding the Post-Synaptic Density Protein 95 in Schizophrenia	PLOS ONE			English	Article							NMDA RECEPTOR SUBUNIT; PREFRONTAL CORTEX; SYNONYMOUS MUTATIONS; PSD-95; EXPRESSION; ASSOCIATION; GLUTAMATE; LINKAGE; THALAMUS; PHENCYCLIDINE	Hypofunction of N-methyl-D-aspartate (NMDA) receptor-mediated signal transduction has been implicated in the pathophysiology of schizophrenia. Post-synaptic density protein 95 (PSD95) plays a critical role in regulating the trafficking and activity of the NMDA receptor and altered expression of the PSD95 has been detected in the post-mortem brain of patients with schizophrenia. The study aimed to examine whether the DLG4 gene that encodes the PSD95 may confer genetic susceptibility to schizophrenia. We re-sequenced the core promoter, all the exons, and 3' untranslated regions (UTR) of the DLG4 gene in 588 Taiwanese schizophrenic patients and conducted an association study with 539 non-psychotic subjects. We did not detect any rare mutations at the protein-coding sequences of the DLG4 gene associated with schizophrenia. Nevertheless, we identified four polymorphic markers at the core promoter and 5' UTR and one single nucleotide polymorphism (SNP) at the 3'UTR of the DLG4 gene in this sample. Genetic analysis showed an association of a haplotype (C-D) derived from 2 polymorphic markers at the core promoter (odds ratio = 1.26, 95% confidence interval = 1.06-1.51, p = 0.01), and a borderline association of the T allele of the rs13331 at 3'UTR with schizophrenia (odds ratio = 1.19, 95% confidence interval = 0.99-1.43, p = 0.06). Further reporter gene assay showed that the C-D-C-C and the T allele of the rs13331 had significant lower activity than their counter parts. Our data indicate that the expression of the DLG4 gene is subject to regulation by the polymorphic markers at the core promoter region, 5' and 3'UTR of the gene, and is associated with the susceptibility of schizophrenia.	[Cheng, Min-Chih; Chen, Tzu-Ting] Yuli Vet Hosp, Yuli Mental Hlth Res Ctr, Dept Psychiat, Yuli Township, Peoples R China; [Lu, Chao-Lin] Hualien Armed Forces Gen Hosp, Dept Psychiat, Xincheng Township, Peoples R China; [Luu, Sy-Ueng] Taoyuan Armed Forces Gen Hosp, Dept Psychiat, Longtan Township, Peoples R China; [Tsai, Ho-Min; Hsu, Shih-Hsin; Chen, Chia-Hsiang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Mental Hlth & Addict Med, Longtan Township, Peoples R China; [Chen, Chia-Hsiang] Tzu Chi Univ, Inst Med Sci, Yuli Township, Peoples R China; [Chen, Chia-Hsiang] Chang Gung Mem Hosp, Dept Psychiat, Linkou, Taiwan; [Chen, Chia-Hsiang] Chang Gung Univ, Sch Med, Gueishan Township, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Cheng, MC (corresponding author), Yuli Vet Hosp, Yuli Mental Hlth Res Ctr, Dept Psychiat, Yuli Township, Peoples R China.	cchen@nhri.org.tw	Chen, Chia-Hsiang/E-3939-2010; Cheng, Min-Chih/B-1363-2013	Cheng, Min-Chih/0000-0002-2962-0911	National Science Council; National Health Research Institutes, China	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, China(National Health Research Institutes - Taiwan)	This study was supported by grants from the National Science Council and National Health Research Institutes, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beneyto M, 2008, NEUROPSYCHOPHARMACOL, V33, P2175, DOI 10.1038/sj.npp.1301604; Clinton SM, 2006, J NEUROCHEM, V98, P1114, DOI 10.1111/j.1471-4159.2006.03954.x; Clinton SM, 2004, NEUROPSYCHOPHARMACOL, V29, P1353, DOI 10.1038/sj.npp.1300451; Clinton SM, 2003, AM J PSYCHIAT, V160, P1100, DOI 10.1176/appi.ajp.160.6.1100; Cousins SL, 2009, NEUROSCIENCE, V158, P89, DOI 10.1016/j.neuroscience.2007.12.051; Cousins SL, 2008, J NEUROCHEM, V104, P903, DOI 10.1111/j.1471-4159.2007.05067.x; Coyle JT, 2002, CNS NEUROL DISORD-DR, V1, P183, DOI 10.2174/1568007024606212; Coyle JT, 2004, PSYCHOPHARMACOLOGY, V174, P32, DOI 10.1007/s00213-003-1709-2; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Funk AJ, 2009, NEUROREPORT, V20, P1019, DOI 10.1097/WNR.0b013e32832d30d9; Han K, 2008, PROG NEUROBIOL, V84, P263, DOI 10.1016/j.pneurobio.2007.10.011; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Kajimoto Y, 2003, NEUROPSYCHOPHARMACOL, V28, P1831, DOI 10.1038/sj.npp.1300212; Kawashima R, 2006, NEUROSCI LETT, V400, P168, DOI 10.1016/j.neulet.2006.02.036; Klei L, 2005, HUM GENET, V117, P349, DOI 10.1007/s00439-005-1320-1; Kristiansen LV, 2006, MOL PSYCHIATR, V11, P737, DOI 10.1038/sj.mp.4001844; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; Lane HY, 2008, BIOL PSYCHIAT, V63, P9, DOI 10.1016/j.biopsych.2007.04.038; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mueller HT, 2004, MOL BRAIN RES, V121, P60, DOI 10.1016/j.molbrainres.2003.11.004; Ohnuma T, 2000, NEUROREPORT, V11, P3133, DOI 10.1097/00001756-200009280-00019; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sauna ZE, 2007, PHARMACOGENOMICS, V8, P527, DOI 10.2217/14622416.8.6.527; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shim SS, 2007, EUR ARCH PSY CLIN N, V258, P16, DOI 10.1007/s00406-007-0757-8; Stahl SM, 2007, CNS SPECTRUMS, V12, P265, DOI 10.1017/S1092852900021015; Stathakis DG, 1999, J NEUROCHEM, V73, P2250, DOI 10.1046/j.1471-4159.1999.0732250.x; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Stephenson FA, 2006, BIOCHEM SOC T, V34, P877, DOI 10.1042/BST0340877; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Toyooka K, 2002, J NEUROCHEM, V83, P797, DOI 10.1046/j.1471-4159.2002.01181.x; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tsai SJ, 2007, J NEURAL TRANSM, V114, P423, DOI 10.1007/s00702-006-0587-2; Zhang JP, 2007, J BIOL CHEM, V282, P15778, DOI 10.1074/jbc.M611485200; Zhang JP, 2009, J NEUROSCI, V29, P2948, DOI 10.1523/JNEUROSCI.4424-08.2009	43	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15107	10.1371/journal.pone.0015107	http://dx.doi.org/10.1371/journal.pone.0015107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151988	gold, Green Published, Green Submitted			2022-12-27	WOS:000284868000024
J	Fiori, LM; Wanner, B; Jomphe, V; Croteau, J; Vitaro, F; Tremblay, RE; Bureau, A; Turecki, G				Fiori, Laura M.; Wanner, Brigitte; Jomphe, Valerie; Croteau, Jordie; Vitaro, Frank; Tremblay, Richard E.; Bureau, Alexandre; Turecki, Gustavo			Association of Polyaminergic Loci With Anxiety, Mood Disorders, and Attempted Suicide	PLOS ONE			English	Article							DIAGNOSTIC INTERVIEW SCHEDULE; SPERMINE SYNTHASE; MAJOR DEPRESSION; SAT-1-1415T/C POLYMORPHISM; LINKAGE DISEQUILIBRIUM; MENTAL-DISORDERS; CHILDHOOD ABUSE; GENE-EXPRESSION; YOUNG-ADULTS; RISK-FACTORS	Background: The polyamine system has been implicated in a number of psychiatric conditions, which display both alterations in polyamine levels and altered expression of genes related to polyamine metabolism. Studies have identified associations between genetic variants in spermidine/spermine N1-acetyltransferase (SAT1) and both anxiety and suicide, and several polymorphisms appear to play important roles in determining gene expression. Methodology/Principal Findings: We genotyped 63 polymorphisms, spread across four polyaminergic genes (SAT1, spermine synthase (SMS), spermine oxidase (SMOX), and ornithine aminotransferase like-1 (OATL1)), in 1255 French-Canadian individuals who have been followed longitudinally for 22 years. We assessed univariate associations with anxiety, mood disorders, and attempted suicide, as assessed during early adulthood. We also investigated the involvement of gene-environment interactions in terms of childhood abuse, and assessed internalizing and externalizing symptoms as endophenotypes mediating these interactions. Overall, each gene was associated with at least one main outcome: anxiety (SAT1, SMS), mood disorders (SAT1, SMOX), and suicide attempts (SAT1, OATL1). Several SAT1 polymorphisms displayed disease-specific risk alleles, and polymorphisms in this gene were involved in gene-gene interactions with SMS to confer risk for anxiety disorders, as well as gene-environment interactions between childhood physical abuse and mood disorders. Externalizing behaviors demonstrated significant mediation with regards to the association between OATL1 and attempted suicide, however there was no evidence that externalizing or internalizing behaviors were appropriate endophenotypes to explain the associations with mood or anxiety disorders. Finally, childhood sexual abuse did not demonstrate mediating influences on any of our outcomes. Conclusions/Significance: These results demonstrate that genetic variants in polyaminergic genes are associated with psychiatric conditions, each of which involves a set of separate and distinct risk alleles. As several of these polymorphisms are associated with gene expression, these findings may provide mechanisms to explain the alterations in polyamine metabolism which have been observed in psychiatric disorders.	[Fiori, Laura M.; Turecki, Gustavo] McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Wanner, Brigitte; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Jomphe, Valerie; Croteau, Jordie; Bureau, Alexandre] Univ Laval, Ctr Rech Univ Laval Robert Giffard, Quebec City, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin 2, Ireland	McGill University; Universite de Montreal; Laval University; University College Dublin	Fiori, LM (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.	gustavo.turecki@mcgill.ca	Turecki, Gustavo/K-5100-2015; Tremblay, Richard E./O-1360-2014	Bureau, Alexandre/0000-0001-8220-9999; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institute of Health Research [MOPs 79253, 53321]; Natural Sciences and Engineering Research Council of Canada; Fonds de la recherche en sante du Quebec	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institute of Health Research (www.cihr-irsc.gc.ca) MOPs 79253 and 53321. LMF received a scholarship from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) and AB and GT received scientist awards from the Fonds de la recherche en sante du Quebec (www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Becerra-Solano LE, 2009, AM J MED GENET A, V149A, P328, DOI 10.1002/ajmg.a.32641; BECK RW, 1974, PSYCHOL REP, V34, P445, DOI 10.2466/pr0.1974.34.2.445; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermudo-Soriano CR, 2009, PROG NEURO-PSYCHOPH, V33, P345, DOI 10.1016/j.pnpbp.2008.12.015; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Breton JJ, 1998, J AM ACAD CHILD PSY, V37, P1167, DOI 10.1097/00004583-199811000-00016; BREZO J, 2009, MOL PSYCHIAT; Brezo J, 2008, ARCH PEDIAT ADOL MED, V162, P1015, DOI 10.1001/archpedi.162.11.1015; Brezo J, 2008, BRIT J PSYCHIAT, V193, P134, DOI 10.1192/bjp.bp.107.037994; Brezo J, 2008, PSYCHIAT CLIN N AM, V31, P179, DOI 10.1016/j.psc.2008.01.008; Brezo J, 2007, PSYCHOL MED, V37, P1563, DOI 10.1017/S003329170700058X; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Chen GG, 2010, NEUROPSYCHOPHARMACOL, V35, P1477, DOI 10.1038/npp.2010.17; de Alencastro G, 2008, J MED GENET, V45, P539, DOI 10.1136/jmg.2007.056713; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De La Vega Francisco M, 2006, Pac Symp Biocomput, P487, DOI 10.1142/9789812701626_0045; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fergusson DM, 2000, PSYCHOL MED, V30, P23, DOI 10.1017/S003329179900135X; Fiori LM, 2008, J PSYCHIATR NEUROSCI, V33, P102; Fiori LM, 2010, INT J NEUROPSYCHOPH, V13, P725, DOI 10.1017/S1461145709991167; Fiori LM, 2010, AM J MED GENET B, V153B, P825, DOI 10.1002/ajmg.b.31040; FIORI LM, 2009, MOL PSYCHIA IN PRESS; Fisher SA, 2001, GENET EPIDEMIOL, V21, pS18, DOI 10.1002/gepi.2001.21.s1.s18; Flori LM, 2009, BIOL PSYCHIAT, V66, P460, DOI 10.1016/j.biopsych.2009.04.002; Fu Q, 2002, PSYCHOL MED, V32, P11, DOI 10.1017/S0033291701004846; Gaiteri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009970; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gilad GM, 2003, CELL MOL NEUROBIOL, V23, P637, DOI 10.1023/A:1025036532672; Guipponi M, 2009, AM J MED GENET B, V150B, P799, DOI 10.1002/ajmg.b.30901; HEYER E, 1995, AM J HUM GENET, V56, P970; Holmbeck GN, 2002, J PEDIATR PSYCHOL, V27, P87, DOI 10.1093/jpepsy/27.1.87; Kesler SR, 2009, NEUROGENETICS, V10, P299, DOI 10.1007/s10048-009-0184-2; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kim CD, 2005, AM J PSYCHIAT, V162, P1017, DOI 10.1176/appi.ajp.162.5.1017; Kim CD, 2003, PSYCHOL MED, V33, P1299, DOI 10.1017/S0033291703008146; Klempan TA, 2009, MOL PSYCHIATR, V14, P175, DOI 10.1038/sj.mp.4002110; Klempan TA, 2009, AM J MED GENET B, V150B, P934, DOI 10.1002/ajmg.b.30920; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; McGirr A, 2007, J CLIN PSYCHIAT, V68, P721, DOI 10.4088/JCP.v68n0509; McGirr A, 2008, SCHIZOPHR RES, V98, P217, DOI 10.1016/j.schres.2007.09.009; McGirr A, 2009, AM J PSYCHIAT, V166, P1124, DOI 10.1176/appi.ajp.2009.08111744; McGuffin P, 2001, Crisis, V22, P61, DOI 10.1027//0227-5910.22.2.61; Mosing MA, 2009, DEPRESS ANXIETY, V26, P1004, DOI 10.1002/da.20611; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Reis DJ, 2000, TRENDS PHARMACOL SCI, V21, P187, DOI 10.1016/S0165-6147(00)01460-7; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; ROBINS LN, 1982, PSYCHOL MED, V12, P855, DOI 10.1017/S0033291700049151; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seiler N, 2005, J CELL MOL MED, V9, P623, DOI 10.1111/j.1582-4934.2005.tb00493.x; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; SIMARD LR, 1994, HUM MOL GENET, V3, P459, DOI 10.1093/hmg/3.3.459; Statham DJ, 1998, PSYCHOL MED, V28, P839, DOI 10.1017/S0033291798006916; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; TREMBLAY RE, 1991, J ABNORM CHILD PSYCH, V19, P285, DOI 10.1007/BF00911232; Turecki G, 2005, J PSYCHIATR NEUROSCI, V30, P398; Turecki G, 2003, AM J MED GENET B, V118B, P36, DOI 10.1002/ajmg.b.10006; Vaquero-Lorenzo C, 2009, AM J MED GENET B, V150B, P515, DOI 10.1002/ajmg.b.30850; Weissman MM, 2005, ARCH GEN PSYCHIAT, V62, P29, DOI 10.1001/archpsyc.62.1.29	65	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15146	10.1371/journal.pone.0015146	http://dx.doi.org/10.1371/journal.pone.0015146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	687DK	21152090	gold, Green Published			2022-12-27	WOS:000284755100084
J	Nagai, K; Yamamoto, K; Fujiwara, H; An, J; Ochi, T; Suemori, K; Yasumi, T; Tauchi, H; Koh, K; Sato, M; Morimoto, A; Heike, T; Ishii, E; Yasukawa, M				Nagai, Kozo; Yamamoto, Ken; Fujiwara, Hiroshi; An, Jun; Ochi, Toshiki; Suemori, Koichiro; Yasumi, Takahiro; Tauchi, Hisamichi; Koh, Katsuyoshi; Sato, Maho; Morimoto, Akira; Heike, Toshio; Ishii, Eiichi; Yasukawa, Masaki			Subtypes of Familial Hemophagocytic Lymphohistiocytosis in Japan Based on Genetic and Functional Analyses of Cytotoxic T Lymphocytes	PLOS ONE			English	Article							MUTATIONS; PERFORIN; MUNC13-4; IDENTIFICATION; EXOCYTOSIS; EXPRESSION; GUIDELINES; DEFECTS; LINKAGE; FUSION	Background: Familial hemophagocytic lymphohistiocytosis (FHL) is a rare disease of infancy or early childhood. To clarify the incidence and subtypes of FHL in Japan, we performed genetic and functional analyses of cytotoxic T lymphocytes (CTLs) in Japanese patients with FHL. Design and Methods: Among the Japanese children with hemophagocytic lymphohistiocytosis (HLH) registered at our laboratory, those with more than one of the following findings were eligible for study entry under a diagnosis of FHL: positive for known genetic mutations, a family history of HLH, and impaired CTL-mediated cytotoxicity. Mutations of the newly identified causative gene for FHL5, STXBP2, and the cytotoxicity and degranulation activity of CTLs in FHL patients, were analyzed. Results: Among 31 FHL patients who satisfied the above criteria, PRF1 mutation was detected in 17 (FHL2) and UNC13D mutation was in 10 (FHL3). In 2 other patients, 3 novel mutations of STXBP2 gene were confirmed (FHL5). Finally, the remaining 2 were classified as having FHL with unknown genetic mutations. In all FHL patients, CTL-mediated cytotoxicity was low or deficient, and degranulation activity was also low or absent except FHL2 patients. In 2 patients with unknown genetic mutations, the cytotoxicity and degranulation activity of CTLs appeared to be deficient in one patient and moderately impaired in the other. Conclusions: FHL can be diagnosed and classified on the basis of CTL-mediated cytotoxicity, degranulation activity, and genetic analysis. Based on the data obtained from functional analysis of CTLs, other unknown gene(s) responsible for FHL remain to be identified.	[Nagai, Kozo; Fujiwara, Hiroshi; An, Jun; Ochi, Toshiki; Suemori, Koichiro; Yasukawa, Masaki] Ehime Univ, Dept Bioregulatory Med, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Nagai, Kozo; Ishii, Eiichi] Ehime Univ, Dept Pediat, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Yamamoto, Ken] Kyushu Univ, Dept Mol Genet, Med Inst Bioregulat, Fukuoka 812, Japan; [Fujiwara, Hiroshi; Yasukawa, Masaki] Ehime Univ, Proteomed Res Ctr, Matsuyama, Ehime 790, Japan; [Yasumi, Takahiro; Heike, Toshio] Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto, Japan; [Koh, Katsuyoshi] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Sato, Maho] Osaka Med Ctr, Dept Pediat, Osaka, Japan; [Sato, Maho] Res Inst Maternal & Child Hlth, Osaka, Japan; [Morimoto, Akira] Jichi Med Univ, Dept Pediat, Sch Med, Shimotsuke, Tochigi, Japan	Ehime University; Ehime University; Kyushu University; Ehime University; Kyoto University; University of Tokyo; Osaka Medical Center for Cancer & Cardiovascular Diseases; Jichi Medical University	Nagai, K (corresponding author), Ehime Univ, Dept Bioregulatory Med, Grad Sch Med, Matsuyama, Ehime 790, Japan.	ishiei@m.ehime-u.ac.jp; yasukawa@m.ehime-u.ac.jp		Yasumi, Takahiro/0000-0003-3257-5071	Ministry of Health and Labor; Ministry of Education, Culture, Sports, Science and Technology, Japan; Medical Institute of Bioregulation, Kyushu University; Grants-in-Aid for Scientific Research [22591159] Funding Source: KAKEN	Ministry of Health and Labor; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Medical Institute of Bioregulation, Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research, a Grant-in-Aid for Cancer Research from the Ministry of Health and Labor, and grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the patients and their family members who participated in this study. We also wish to thank all members of the Japan FHL study group. This work was performed as part of the Cooperative Research project program of the Medical Institute of Bioregulation, Kyushu University.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Arico M, 2001, BRIT J HAEMATOL, V114, P761, DOI 10.1046/j.1365-2141.2001.02936.x; Bryceson YT, 2007, BLOOD, V110, P1906, DOI 10.1182/blood-2007-02-074468; Caballes RL, 1997, PATHOLOGY, V29, P92, DOI 10.1080/00313029700169644; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; Dufourcq-Lagelouse R, 1999, AM J HUM GENET, V64, P172, DOI 10.1086/302194; Ericson KG, 2001, AM J HUM GENET, V68, P590, DOI 10.1086/318796; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Filipovich AH, 1997, J PEDIATR-US, V130, P337; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; HENTER JI, 1991, SEMIN ONCOL, V18, P29; Hong WJ, 2005, TRENDS CELL BIOL, V15, P644, DOI 10.1016/j.tcb.2005.10.003; Ishii E, 2005, BLOOD, V105, P3442, DOI 10.1182/blood-2004-08-3296; Ishii E, 2007, INT J HEMATOL, V86, P58, DOI 10.1532/IJH97.07012; JANKA GE, 1983, EUR J PEDIATR, V140, P221, DOI 10.1007/BF00443367; LOY TS, 1991, SEMIN ONCOL, V18, P34; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; Ohadi M, 1999, AM J HUM GENET, V64, P165, DOI 10.1086/302187; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suga N, 2002, BRIT J HAEMATOL, V116, P346, DOI 10.1046/j.1365-2141.2002.03266.x; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Ueda I, 2006, PEDIATR BLOOD CANCER, V46, P482, DOI 10.1002/pbc.20511; Ueda I, 2003, BRIT J HAEMATOL, V121, P503, DOI 10.1046/j.1365-2141.2003.04298.x; Valdez AC, 1999, J CELL SCI, V112, P845; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Yamamoto K, 2005, J HUM GENET, V50, P600, DOI 10.1007/s10038-005-0293-1; Yamamoto K, 2004, J MED GENET, V41, P763, DOI 10.1136/jmg.2004.021121; Yanai F, 2003, J IMMUNOL, V170, P2205, DOI 10.4049/jimmunol.170.4.2205; Yasukawa M, 2000, BLOOD, V95, P2352, DOI 10.1182/blood.V95.7.2352.007k40_2352_2355; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	35	30	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14173	10.1371/journal.pone.0014173	http://dx.doi.org/10.1371/journal.pone.0014173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152410	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100049
J	Salani, B; Passalacqua, M; Maffioli, S; Briatore, L; Hamoudane, M; Contini, P; Cordera, R; Maggi, D				Salani, Barbara; Passalacqua, Mario; Maffioli, Sara; Briatore, Lucia; Hamoudane, Meriem; Contini, Paola; Cordera, Renzo; Maggi, Davide			IGF-IR Internalizes with Caveolin-1 and PTRF/Cavin in Hacat Cells	PLOS ONE			English	Article							GROWTH-FACTOR-I; TRANSCRIPT RELEASE FACTOR; RECEPTOR INTERNALIZATION; SIGNAL-TRANSDUCTION; POLYMERASE-I; LIPID RAFTS; INSULIN; PTRF; ENDOCYTOSIS; PHOSPHORYLATION	Background: Insulin-like growth factor-I receptor (IGF-IR) is a tyrosine kinase receptor (RTK) associated with caveolae, invaginations of the plasma membrane that regulate vesicular transport, endocytosis and intracellular signaling. IGF-IR internalization represents a key mechanism of down-modulation of receptors number on plasma membrane. IGF-IR interacts directly with Caveolin-1 (Cav-1), the most relevant protein of caveolae. Recently it has been demonstrated that the Polymerase I and Transcript Release Factor I (PTRF/Cavin) is required for caveolae biogenesis and function. The role of Cav-1 and PTRF/Cavin in IGF-IR internalization is still to be clarified. Methodology/Principal Findings: We have investigated the interaction of IGF-IR with Cav-1 and PTRF/Cavin in the presence of IGF1in human Hacat cells. We show that IGF-IR internalization triggers Cav-1 and PTRF/Cavin translocation from plasma membrane to cytosol and increases IGF-IR interaction with these proteins. In fact, Cav-1 and PTRF/Cavin co-immunoprecipitate with IGF-IR during receptor internalization. We found a different time course of co-immunoprecipitation between IGF-IR and Cav-1 compared to IGF-IR and PTRF/Cavin. Cav-1 and PTRF/Cavin silencing by siRNA differently affect surface IGF-IR levels following IGF1 treatment: Cav-1 and PTRF/Cavin silencing significantly affect IGF-IR rate of internalization, while PTRF/Cavin silencing also decreases IGF-IR plasma membrane recovery. Since Cav-1 phosphorylation could have a role in IGF-IR internalization, the mutant Cav-1Y14F lacking Tyr14 was transfected. Cav-1Y14F transfected cells showed a reduced internalization of IGF-IR compared with cells expressing wild type Cav-1. Receptor internalization was not impaired by Clathrin silencing. These findings support a critical role of caveolae in IGF-IR intracellular traveling. Conclusions/Significance: These data indicate that Caveolae play a role in IGF-IR internalization. Based on these findings, Cav-1 and PTRF/Cavin could represent two relevant and distinct targets to modulate IGF-IR function.	[Salani, Barbara; Maffioli, Sara; Briatore, Lucia; Hamoudane, Meriem; Cordera, Renzo; Maggi, Davide] Univ Genoa, Dept Endocrinol & Med DiSEM, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Dept Expt Med DIMES, Ctr Excellence Biomed Res, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Italian Inst Biostruct & Biosyst INBB, Genoa, Italy; [Contini, Paola] Univ Genoa, Dept Internal Med & Med Specialties DIMI, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa	Salani, B (corresponding author), Univ Genoa, Dept Endocrinol & Med DiSEM, Genoa, Italy.	davide.maggi@unige.it	maggi, davide/AAL-4687-2020; contini, paola/AAB-7625-2019; Cordera, Renzo/I-7229-2017; Passalacqua, Mario/W-1973-2019	Cordera, Renzo/0000-0002-5280-9691; Passalacqua, Mario/0000-0003-2779-6259; MAGGI, DAVIDE CARLO/0000-0003-3928-1295	Ministero dell'Universita e della Ricerca (MIUR); Fondi Italiani per la Ricerca di Base (FIRB); Fondazione CARIGE; University of Genova	Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondi Italiani per la Ricerca di Base (FIRB); Fondazione CARIGE(Fondazione Carige); University of Genova	This work was supported by grants from Ministero dell'Universita e della Ricerca (MIUR), Fondi Italiani per la Ricerca di Base (FIRB), Fondazione CARIGE and University of Genova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Biedi C, 2003, ENDOCRINOLOGY, V144, P5497, DOI 10.1210/en.2003-0417; Chadda R, 2008, CELL, V132, P23, DOI 10.1016/j.cell.2007.12.021; Czarny M, 2000, FEBS LETT, V467, P326, DOI 10.1016/S0014-5793(00)01174-1; DAVALOS A, MOL CELL PROTEOMICS, V9, P2109; de Laurentiis Angela, 2007, Open Biochem J, V1, P12, DOI 10.2174/1874091X00701010012; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; HSU D, 1994, ENDOCRINOLOGY, V134, P744, DOI 10.1210/en.134.2.744; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Maggi D, 2002, BIOCHEM BIOPH RES CO, V295, P1085, DOI 10.1016/S0006-291X(02)00809-4; Maggi D, 1999, DIABETOLOGIA, V42, P435, DOI 10.1007/s001250051176; Matthews LC, 2005, ENDOCRINOLOGY, V146, P5463, DOI 10.1210/en.2005-0236; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; ORLICHENKO L, 2005, J BIOL CHEM; Panetta D, 2004, BIOCHEM BIOPH RES CO, V316, P240, DOI 10.1016/j.bbrc.2004.02.037; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Podar K, 2003, J BIOL CHEM, V278, P5794, DOI 10.1074/jbc.M208636200; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Razani B, 2001, J CLIN INVEST, V108, P1553, DOI 10.1172/JCI14611; Repetto S, 2005, BIOCHEM BIOPH RES CO, V337, P849, DOI 10.1016/j.bbrc.2005.09.125; SALANI B, 2007, ENDOCRINOLOGY; Salani B, 2008, ENDOCRINOLOGY, V149, P461, DOI 10.1210/en.2007-0312; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; ZAPF A, 1994, ENDOCRINOLOGY, V134, P2445, DOI 10.1210/en.134.6.2445	38	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14157	10.1371/journal.pone.0014157	http://dx.doi.org/10.1371/journal.pone.0014157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152401	Green Submitted, gold, Green Published			2022-12-27	WOS:000284755100035
J	Sissoko, D; Ezzedine, K; Giry, C; Moendandze, A; Lernout, T; D'Ortenzio, E; Pettinelli, F; Malvy, D				Sissoko, Daouda; Ezzedine, Khaled; Giry, Claude; Moendandze, Amrat; Lernout, Tinne; D'Ortenzio, Eric; Pettinelli, Francois; Malvy, Denis			Seroepidemiology of Dengue Virus in Mayotte, Indian Ocean, 2006	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SOUTHERN VIETNAM; REUNION ISLAND; RISK-FACTORS; EPIDEMIC; SEROPREVALENCE; INFECTION; OUTBREAK; COMOROS; ARBOVIRUSES	Background: Although Dengue virus (DENV) circulation had been documented in neighbouring South-western Indian Ocean Islands, its presence in Mayotte is poorly characterised. To address this issue, we aimed to assess the seroprevalence of dengue IgG antibodies (DENV-IgG Ab) among the population and to investigate potential associations with individual and household characteristics. Methods/Principal Findings: In November-December 2006 we conducted a cross-sectional serologic survey in Mayotte among 1,154 inhabitants aged >= 2 years by using a multistage cluster random sampling method. The overall prevalence of DENV-specific IgG antibodies (ELISA) was 22.73% (95% CI, 18.16-27.31). The age-specific seroprevalence increased with age (chi(2) for trend = 11.86, P<0.0006), and was linked with previous known outbreaks in this region. In multivariate analysis, older age, being born in the Comoros and living in a household with a low socioeconomic index were positively associated with DENV IgG antibody positivity. Conclusions: These findings document substantial prior exposure of the population of Mayotte to DENV and highlight the risk of severe illness due to the possibility of sequential DENV infections. Further investigations characterizing current DENV circulation patterns and associated serotypes are needed.	[Sissoko, Daouda; Malvy, Denis] Univ Victor Segalen Bordeaux 2, Ctr Rene Labusquiere, Bordeaux, France; [Ezzedine, Khaled] Ctr Hosp Univ, Serv Dermatol, Hop St Andre, Bordeaux, France; [Giry, Claude; Pettinelli, Francois] Ctr Hosp Mayotte, Biol Lab, Mamoudzou, Mayotte, France; [Moendandze, Amrat] Direct Sante & PMI, Conseil Gen Mayotte, Mamoudzou, Mayotte, France; [Lernout, Tinne] Cellule Inst Veille Sanitaire Reg Ocean Indien, Mayotte, France; [D'Ortenzio, Eric] Cellule Inst Veille Sanitaire Reg Ocean Indien, La Reunion, France; [Malvy, Denis] Ctr Hosp Univ, Serv Med Interne & Malad Trop, Hop St Andre, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institute of Public Health Surveillance; Institute of Public Health Surveillance; CHU Bordeaux	Sissoko, D (corresponding author), Univ Victor Segalen Bordeaux 2, Ctr Rene Labusquiere, Bordeaux, France.	khaled.ezzedine@chu-bordeaux.fr	MALVY, Denis/T-7930-2019; Ezzedine, Khaled/A-3072-2009; Ezzedine, Khaled/F-2716-2017; Sissoko, Daouda/L-9193-2013	Ezzedine, Khaled/0000-0002-5468-4589; Sissoko, Daouda/0000-0002-8890-7170; D'Ortenzio, Eric/0000-0002-4527-6209	French Ministry of Health (Regional Bureau of Hospitalization, Local Bureau of Welfare and Social Affairs); French Institute of Public Health Surveillance	French Ministry of Health (Regional Bureau of Hospitalization, Local Bureau of Welfare and Social Affairs); French Institute of Public Health Surveillance	This study was funded by the French Ministry of Health (Regional Bureau of Hospitalization, Local Bureau of Welfare and Social Affairs) and the French Institute of Public Health Surveillance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204; Bartley LM, 2002, EPIDEMIOL INFECT, V128, P213, DOI 10.1017/S0950268801006495; BOISIER P, 1994, ANN SOC BELG MED TR, V74, P217; Catteau C, 2005, Med Trop (Mars), V65, P515; da Rosa APAT, 2000, EMERG INFECT DIS, V6, P298; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000; GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280, DOI 10.4269/ajtmh.1986.35.1280; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; KLES V, 1994, B SOC PATHOL EXOT, V87, P71; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; McBride WJH, 1998, AM J TROP MED HYG, V59, P457, DOI 10.4269/ajtmh.1998.59.457; MCCARTHY DD, 1946, E AFR MED J, P293; Messer WB, 2003, EMERG INFECT DIS, V9, P800; METSELAAR D, 1980, B WORLD HEALTH ORGAN, V58, P937; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521; Reiskind MH, 2001, TROP MED INT HEALTH, V6, P212, DOI 10.1046/j.1365-3156.2001.00703.x; Renault P, 2007, AM J TROP MED HYG, V77, P727; SALMON CT, 1983, PUBLIC OPIN QUART, V47, P270, DOI 10.1086/268785; Sang RC, 2008, AM J TROP MED HYG, V78, P77; Sissoko D, 2003, Med Trop (Mars), V63, P553; Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x; Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x; Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201; Yamashiro T, 2004, AM J TROP MED HYG, V71, P138, DOI 10.4269/ajtmh.2004.71.138; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529; Zeller HG, 1998, B SOC PATHOL EXOT, V91, P56	33	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14141	10.1371/journal.pone.0014141	http://dx.doi.org/10.1371/journal.pone.0014141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152441	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100021
J	Svensson, L; McDowall, A; Giles, KM; Stanley, P; Feske, S; Hogg, N				Svensson, Lena; McDowall, Alison; Giles, Katherine M.; Stanley, Paula; Feske, Stefan; Hogg, Nancy			Calpain 2 Controls Turnover of LFA-1 Adhesions on Migrating T Lymphocytes	PLOS ONE			English	Article							CELL-ADHESION; PLASMA-MEMBRANE; TRPC CHANNELS; CA2+ ENTRY; CALCIUM; ACTIVATION; INHIBITOR; PROTEASE; MOBILITY; INVOLVEMENT	The immune cells named T lymphocytes circulate around the body fulfilling their role in immunosurveillance by monitoring the tissues for injury or infection. To migrate from the blood into the tissues, they make use of the integrin LFA-1 which is exclusively expressed by immune cells. These highly motile cells attach and migrate on substrates expressing the LFA-1 ligand ICAM-1. The molecular events signaling LFA-1 activation and adhesion are now reasonably well identified, but the process of detaching LFA-1 adhesions is less understood. The cysteine protease calpain is involved in turnover of integrinmediated adhesions in less motile cell types. In this study we have explored the involvement of calpain in turnover of LFA-1mediated adhesions of T lymphocytes. Using live cell imaging and immunohistochemistry, we demonstrate that turnover of adhesions depends on the Ca(2+)-dependent enzyme, calpain 2. Inhibition of calpain activity by means of siRNA silencing or pharmacological inhibition results in inefficient disassembly of LFA-1 adhesions causing T lymphocyte elongation and shedding of LFA-1 clusters behind the migrating T lymphocytes. We show that calpain 2 is distributed throughout the T lymphocyte, but is most active at the trailing edge as detected by expression of its fluorescent substrate CMAC, t-BOC-Leu-Met. Extracellular Ca(2+) entry is essential for the activity of calpain 2 that is constantly maintained as the T lymphocytes migrate. Use of T cells from a patient with mutation in ORAI1 revealed that the major calcium-release-activated-calcium channel is not the ion channel delivering the Ca(2+). We propose a model whereby Ca(2+) influx, potentially through stretch activated channels, is sufficient to activate calpain 2 at the trailing edge of a migrating T cell and this activity is essential for the turnover of LFA-1 adhesions.	[Svensson, Lena; McDowall, Alison; Giles, Katherine M.; Stanley, Paula; Hogg, Nancy] Canc Res UK London Res Inst, Leukocyte Adhes Lab, London, England; [Feske, Stefan] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA	Cancer Research UK; New York University; NYU Langone Medical Center	Svensson, L (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat, Acad Dept Rheumatol, London WC2R 2LS, England.	nancy.hogg@cancer.org.uk	Pawson, Mark C/A-6085-2010; Feske, stefan/ABB-3554-2021; Markides, Constantinos/E-1816-2015	Feske, stefan/0000-0001-5431-8178; McDowall, Alison/0000-0003-2018-1462	Cancer Research UK; Marie Curie individual fellowship	Cancer Research UK(Cancer Research UK); Marie Curie individual fellowship(European Commission)	work was supported by Cancer Research UK and a Marie Curie individual fellowship to LS. These organisations had no role in the design of the study, data collection and analysis, decision to publish or in the preparation of the manuscript.	Bleijs DA, 2001, J BIOL CHEM, V276, P10338, DOI 10.1074/jbc.M008967200; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Butler JT, 2009, J NEUROSCI RES, V87, P626, DOI 10.1002/jnr.21882; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedrich P, 2004, BIOCHEM BIOPH RES CO, V323, P1131, DOI 10.1016/j.bbrc.2004.08.194; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; HARA J, 1988, J CLIN INVEST, V81, P989, DOI 10.1172/JCI113453; Hood JL, 2006, BIOESSAYS, V28, P850, DOI 10.1002/bies.20440; KASAI Y, 1986, J BIOCHEM-TOKYO, V100, P183, DOI 10.1093/oxfordjournals.jbchem.a121691; Kim K, 2009, J BIOL CHEM, V284, P22149, DOI 10.1074/jbc.M109.000752; KUO WN, 1994, MOL CELL BIOCHEM, V136, P157, DOI 10.1007/BF00926076; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Rock MT, 2000, EXP CELL RES, V261, P260, DOI 10.1006/excr.2000.5048; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Tompa P, 1996, J BIOL CHEM, V271, P33161, DOI 10.1074/jbc.271.52.33161; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; WenzelSeifert K, 1996, BIOCHEM J, V314, P679, DOI 10.1042/bj3140679; Wernimont SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010513; Winslow MM, 2005, SCIENCE, V307, P56, DOI 10.1126/science.1108163; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198	52	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15090	10.1371/journal.pone.0015090	http://dx.doi.org/10.1371/journal.pone.0015090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152086	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100067
J	Kohler, K; Xiong, SQ; Brzostek, J; Mehrabi, M; Eissmann, P; Harrison, A; Cordoba, SP; Oddos, S; Miloserdov, V; Gould, K; Burroughs, NJ; van der Merwe, PA; Davis, DM				Koehler, Karsten; Xiong, Shiqiu; Brzostek, Joanna; Mehrabi, Maryam; Eissmann, Philipp; Harrison, Alice; Cordoba, Shaun-Paul; Oddos, Stephane; Miloserdov, Vladimir; Gould, Keith; Burroughs, Nigel J.; van der Merwe, Philip Anton; Davis, Daniel M.			Matched Sizes of Activating and Inhibitory Receptor/Ligand Pairs Are Required for Optimal Signal Integration by Human Natural Killer Cells	PLOS ONE			English	Article							MHC CLASS-I; IMMUNOLOGICAL SYNAPSE; IMMUNE SYNAPSES; HLA-C; NK CELLS; T-CELLS; CRYSTAL-STRUCTURE; TARGET-CELLS; B-CELLS; LIGAND	It has been suggested that receptor-ligand complexes segregate or co-localise within immune synapses according to their size, and this is important for receptor signaling. Here, we set out to test the importance of receptor-ligand complex dimensions for immune surveillance of target cells by human Natural Killer (NK) cells. NK cell activation is regulated by integrating signals from activating receptors, such as NKG2D, and inhibitory receptors, such as KIR2DL1. Elongating the NKG2D ligand MICA reduced its ability to trigger NK cell activation. Conversely, elongation of KIR2DL1 ligand HLA-C reduced its ability to inhibit NK cells. Whereas normal-sized HLA-C was most effective at inhibiting activation by normal-length MICA, only elongated HLA-C could inhibit activation by elongated MICA. Moreover, HLA-C and MICA that were matched in size co-localised, whereas HLA-C and MICA that were different in size were segregated. These results demonstrate that receptor-ligand dimensions are important in NK cell recognition, and suggest that optimal integration of activating and inhibitory receptor signals requires the receptor-ligand complexes to have similar dimensions.	[Koehler, Karsten; Mehrabi, Maryam; Eissmann, Philipp; Oddos, Stephane; Davis, Daniel M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England; [Xiong, Shiqiu; Harrison, Alice; Cordoba, Shaun-Paul; van der Merwe, Philip Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Brzostek, Joanna; Gould, Keith] Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst, London, England; [Miloserdov, Vladimir; Burroughs, Nigel J.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England	Imperial College London; University of Oxford; Imperial College London; University of Warwick	Kohler, K (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	anton.vandermerwe@path.ox.ac.uk; d.davis@imperial.ac.uk	van der Merwe, P. Anton/F-8539-2011	Brzostek, Joanna/0000-0002-5621-2649; Mehrabi, Maryam/0000-0001-8809-2146; Gould, Keith/0000-0003-0913-5422; Davis, Daniel/0000-0002-9182-291X	Biotechnology and Biological Sciences Research Council [BB/D011663/1]; MRC [G0500563]; Wolfson Royal Society; Medical Research Council [G19/31, G0500563] Funding Source: researchfish; BBSRC [BB/D011663/1] Funding Source: UKRI; MRC [G19/31] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wolfson Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This work was funded by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk; BB/D011663/1) and the MRC (www.mrc.ac.uk; G0500563). DMD is supported by a Wolfson Royal Society Research Merit Award (royalsociety.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Barclay A. N, 1997, LEUKOCYTE ANTIGEN FA; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Brzostek J, 2010, EUR J IMMUNOL, V40, P2050, DOI 10.1002/eji.201040335; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Burshtyn DN, 2000, CURR BIOL, V10, P777, DOI 10.1016/S0960-9822(00)00568-6; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Choudhuri K, 2009, J BIOL CHEM, V284, P26096, DOI 10.1074/jbc.M109.039966; Chuang SS, 2000, IMMUNOLOGY, V100, P378, DOI 10.1046/j.1365-2567.2000.00031.x; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Culley FJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000159; Davis DM, 2009, NAT REV IMMUNOL, V9, P543, DOI 10.1038/nri2602; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Faure M, 2003, J IMMUNOL, V170, P6107, DOI 10.4049/jimmunol.170.12.6107; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hidano S, 2008, INT IMMUNOL, V20, P345, DOI 10.1093/intimm/dxm150; HOGLUND P, 1991, J EXP MED, V174, P327, DOI 10.1084/jem.174.2.327; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Mandelboim O, 1997, P NATL ACAD SCI USA, V94, P4604, DOI 10.1073/pnas.94.9.4604; McCann FE, 2003, J IMMUNOL, V170, P2862, DOI 10.4049/jimmunol.170.6.2862; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sharma D, 2009, J IMMUNOL, V183, P4569, DOI 10.4049/jimmunol.0901734; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SHIMIZU Y, 1988, P NATL ACAD SCI USA, V85, P227, DOI 10.1073/pnas.85.1.227; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Standeven LJ, 2004, J IMMUNOL, V173, P5617, DOI 10.4049/jimmunol.173.9.5617; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vyas YM, 2001, J IMMUNOL, V167, P4358, DOI 10.4049/jimmunol.167.8.4358; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145	61	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e15374	10.1371/journal.pone.0015374	http://dx.doi.org/10.1371/journal.pone.0015374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21179506	Green Submitted, Green Published, gold			2022-12-27	WOS:000283839100020
J	Carrolo, M; Frias, MJ; Pinto, FR; Melo-Cristino, J; Ramirez, M				Carrolo, Margarida; Frias, Maria Joao; Pinto, Francisco Rodrigues; Melo-Cristino, Jose; Ramirez, Mario			Prophage Spontaneous Activation Promotes DNA Release Enhancing Biofilm Formation in Streptococcus pneumoniae	PLOS ONE			English	Article							EXTRACELLULAR DNA; BACTERIAL BIOFILMS; ENTEROCOCCUS-FAECALIS; PSEUDOALTEROMONAS-TUNICATA; MIDDLE-EAR; CELL-DEATH; BACTERIOPHAGE; AUTOLYSIN; PHAGES; CONTRIBUTES	Streptococcus pneumoniae (pneumococcus) is able to form biofilms in vivo and previous studies propose that pneumococcal biofilms play a relevant role both in colonization and infection. Additionally, pneumococci recovered from human infections are characterized by a high prevalence of lysogenic bacteriophages (phages) residing quiescently in their host chromosome. We investigated a possible link between lysogeny and biofilm formation. Considering that extracellular DNA (eDNA) is a key factor in the biofilm matrix, we reasoned that prophage spontaneous activation with the consequent bacterial host lysis could provide a source of eDNA, enhancing pneumococcal biofilm development. Monitoring biofilm growth of lysogenic and non-lysogenic pneumococcal strains indicated that phage-infected bacteria are more proficient at forming biofilms, that is their biofilms are characterized by a higher biomass and cell viability. The presence of phage particles throughout the lysogenic strains biofilm development implicated prophage spontaneous induction in this effect. Analysis of lysogens deficient for phage lysin and the bacterial major autolysin revealed that the absence of either lytic activity impaired biofilm development and the addition of DNA restored the ability of mutant strains to form robust biofilms. These findings establish that limited phage-mediated host lysis of a fraction of the bacterial population, due to spontaneous phage induction, constitutes an important source of eDNA for the S. pneumoniae biofilm matrix and that this localized release of eDNA favors biofilm formation by the remaining bacterial population.	[Carrolo, Margarida; Frias, Maria Joao; Melo-Cristino, Jose; Ramirez, Mario] Univ Lisbon, Inst Microbiol, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal; [Pinto, Francisco Rodrigues] Univ Lisbon, Ctr Quim & Bioquim, Fac Ciencias, Campo Grande, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Carrolo, M (corresponding author), Univ Lisbon, Inst Microbiol, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal.	ramirez@fm.ul.pt	Carrolo, Margarida/AAM-2938-2020; Ramirez, Mario/B-4993-2008; Carrolo, Margarida/C-4781-2009; Pinto, Francisco/A-7443-2008; Melo-Cristino, Jose A G/H-3726-2013	Ramirez, Mario/0000-0002-4084-6233; Pinto, Francisco/0000-0002-4217-0054; Melo-Cristino, Jose A G/0000-0001-8643-1722; Frias, Maria Joao/0000-0002-8060-1206; Carrolo, Margarida/0000-0002-6866-9515	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/35854/2007, SFRH/BD/38543/2007, PTDC/SAU-ESA/64888/2006, PIC/IC/83065/2007]; Fundacao Calouste Gulbenkian; GlaxoSmithKline	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian(European Commission); GlaxoSmithKline(GlaxoSmithKline)	M. C. and M.J.F. are supported by research grants from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/35854/2007 and SFRH/BD/38543/2007 respectively). This work was partly supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/SAU-ESA/64888/2006 and PIC/IC/83065/2007), Fundacao Calouste Gulbenkian and an unrestricted grant from GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Ausubel F., 1999, CURRENT PROTOCOLS MO; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Bossi L, 2003, J BACTERIOL, V185, P6467, DOI 10.1128/JB.185.21.6467-6471.2003; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Desiere F, 2001, VIROLOGY, V288, P325, DOI 10.1006/viro.2001.1085; Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Frias MJ, 2009, J BACTERIOL, V191, P5428, DOI 10.1128/JB.00477-09; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Little JW, 2005, PHAGES THEIR ROLES B, V1st, P37; Livny J, 2004, MOL MICROBIOL, V51, P1691, DOI 10.1111/j.1365-2958.2003.03934.x; Lizcano A, 2010, MICROB PATHOGENESIS, V48, P124, DOI 10.1016/j.micpath.2010.01.002; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; LWOFF A, 1953, BACTERIOL REV, V17, P269, DOI 10.1128/MMBR.17.4.269-337.1953; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mai-Prochnow A, 2004, APPL ENVIRON MICROB, V70, P3232, DOI 10.1128/AEM.70.6.3232-3238.2004; Mai-Prochnow A, 2006, APPL ENVIRON MICROB, V72, P5414, DOI 10.1128/AEM.00546-06; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Moscoso M, 2004, MOL MICROBIOL, V54, P783, DOI 10.1111/j.1365-2958.2004.04305.x; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Moscoso M, 2009, INT MICROBIOL, V12, P77, DOI 10.2436/20.1501.01.84; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Ramirez M, 1999, J BACTERIOL, V181, P3618, DOI 10.1128/JB.181.12.3618-3625.1999; Reid SD, 2009, J INFECT DIS, V199, P786, DOI 10.1086/597042; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Severina E, 1999, J CLIN MICROBIOL, V37, P3308, DOI 10.1128/JCM.37.10.3308-3315.1999; Spoering AL, 2006, CURR OPIN MICROBIOL, V9, P133, DOI 10.1016/j.mib.2006.02.004; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Tapiainen T, 2010, APMIS, V118, P255, DOI 10.1111/j.1600-0463.2010.02587.x; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; TOMASZ A, 1988, J BACTERIOL, V170, P5931, DOI 10.1128/jb.170.12.5931-5934.1988; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Williamson SJ, 2008, ISME J, V2, P1112, DOI 10.1038/ismej.2008.73	50	104	109	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15678	10.1371/journal.pone.0015678	http://dx.doi.org/10.1371/journal.pone.0015678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187931	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200062
J	Hayasaka, N; Larue, SI; Green, CB				Hayasaka, Naoto; Larue, Silvia I.; Green, Carla B.			Differential Contribution of Rod and Cone Circadian Clocks in Driving Retinal Melatonin Rhythms in Xenopus	PLOS ONE			English	Article							PERIPHERAL-TISSUES; LAEVIS; GENE; PHOTORECEPTORS; EXPRESSION	Background: Although an endogenous circadian clock located in the retinal photoreceptor layer governs various physiological events including melatonin rhythms in Xenopus laevis, it remains unknown which of the photoreceptors, rod and/or cone, is responsible for the circadian regulation of melatonin release. Methodology/Principal Findings: We selectively disrupted circadian clock function in either the rod or cone photoreceptor cells by generating transgenic Xenopus tadpoles expressing a dominant-negative CLOCK (XCL Delta Q) under the control of a rod or cone-specific promoter. Eyecup culture and continuous melatonin measurement revealed that circadian rhythms of melatonin release were abolished in a majority of the rod-specific XCL Delta Q transgenic tadpoles, although the percentage of arrhythmia was lower than that of transgenic tadpole eyes expressing XCL Delta Q in both rods and cones. In contrast, whereas a higher percentage of arrhythmia was observed in the eyes of the cone-specific XCL Delta Q transgenic tadpoles compare to wildtype counterparts, the rate was significantly lower than in rod-specific transgenics. The levels of the transgene expression were comparable between these two different types of transgenics. In addition, the average overall melatonin levels were not changed in the arrhythmic eyes, suggesting that CLOCK does not affect absolute levels of melatonin, only its temporal expression pattern. Conclusions/Significance: These results suggest that although the Xenopus retina is made up of approximately equal numbers of rods and cones, the circadian clocks in the rod cells play a dominant role in driving circadian melatonin rhythmicity in the Xenopus retina, although some contribution of the clock in cone cells cannot be excluded.	[Hayasaka, Naoto; Larue, Silvia I.; Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Virginia	Hayasaka, N (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA.	hayasaka@med.kindai.ac.jp	Hayasaka, Naoto/C-9370-2011; Wilson, Matthew H/K-3193-2013		NIMH [MH61461]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061461] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from NIMH (MH61461) to CBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lopez C, 2004, BRAIN RES, V1024, P137, DOI 10.1016/j.brainres.2004.07.057; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BESHARSE JC, 1988, EXP EYE RES, V47, P609, DOI 10.1016/0014-4835(88)90098-X; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; CAHILL GM, 1990, J NEUROCHEM, V54, P716, DOI 10.1111/j.1471-4159.1990.tb01932.x; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; GREEN CB, 1995, VISUAL NEUROSCI, V12, P663, DOI 10.1017/S0952523800008956; Gustincich S, 2004, P NATL ACAD SCI USA, V101, P5069, DOI 10.1073/pnas.0400913101; Hayasaka N, 2005, METHOD ENZYMOL, V393, P205, DOI 10.1016/S0076-6879(05)93006-1; Hayasaka N, 2002, J NEUROSCI, V22, P1600, DOI 10.1523/JNEUROSCI.22-05-01600.2002; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Krizaj D, 1998, J COMP NEUROL, V398, P529; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee HS, 2003, NAT NEUROSCI, V6, P111, DOI 10.1038/nn1006; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ribelayga C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011020; ROLLAG MD, 1976, ENDOCRINOLOGY, V98, P482, DOI 10.1210/endo-98-2-482; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Steenhard BM, 2000, J NEUROSCI, V20, P8572; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Witkovsky P, 2003, J NEUROSCI, V23, P7670; Witkovsky P, 2000, MICROSC RES TECHNIQ, V50, P338, DOI 10.1002/1097-0029(20000901)50:5<338::AID-JEMT3>3.0.CO;2-I; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405; Zhu HS, 2000, MOL BRAIN RES, V75, P303, DOI 10.1016/S0169-328X(99)00309-5; Zhu HS, 2001, MOL VIS, V7, P210; Zhuang MH, 2000, MOL BRAIN RES, V82, P52, DOI 10.1016/S0169-328X(00)00177-7	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15599	10.1371/journal.pone.0015599	http://dx.doi.org/10.1371/journal.pone.0015599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187976	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200046
J	Sherwood, R; Pearson, J				Sherwood, Rachel; Pearson, Joel			Closing the Mind's Eye: Incoming Luminance Signals Disrupt Visual Imagery	PLOS ONE			English	Article							MENTAL-IMAGERY; WORKING-MEMORY; RETINOTOPIC ORGANIZATION; TERM-MEMORY; PERCEPTION; ATTENTION; VISION; BRAIN; PERFORMANCE; APPEARANCE	Mental imagery has been associated with many cognitive functions, both high and low-level. Despite recent scientific advances, the contextual and environmental conditions that most affect the mechanisms of visual imagery remain unclear. It has been previously shown that the greater the level of background luminance the weaker the effect of imagery on subsequent perception. However, in these experiments it was unclear whether the luminance was affecting imagery generation or storage of a memory trace. Here, we report that background luminance can attenuate both mental imagery generation and imagery storage during an unrelated cognitive task. However, imagery generation was more sensitive to the degree of luminance. In addition, we show that these findings were not due to differential dark adaptation. These results suggest that afferent visual signals can interfere with both the formation and priming-memory effects associated with visual imagery. It follows that background luminance may be a valuable tool for investigating imagery and its role in various cognitive and sensory processes.	[Sherwood, Rachel; Pearson, Joel] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Sherwood, R (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	Joel@pearsonlab.org		Pearson, Joel/0000-0003-3704-5037	The University of New South Wales; National Health and Medical Research Council (Australia) [457146]	The University of New South Wales; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by The University of New South Wales and a National Health and Medical Research Council (Australia) CJ Martin Fellowship 457146 to J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERBACH E, 1961, AT&T TECH J, V40, P309, DOI 10.1002/j.1538-7305.1961.tb03987.x; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley AD, 2000, J EXP PSYCHOL GEN, V129, P126, DOI 10.1037//0096-3445.129.1.126; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Dean GM, 2008, EXP PSYCHOL, V55, P283, DOI 10.1027/1618-3169.55.4.283; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Ganis G., 2006, CASE MENTAL IMAGERY; Hecht S, 1937, J GEN PHYSIOL, V20, P831, DOI 10.1085/jgp.20.6.831; HEUER F, 1986, CAN J PSYCHOL, V40, P161, DOI 10.1037/h0080090; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Klein I, 2004, COGNITIVE BRAIN RES, V22, P26, DOI 10.1016/j.cogbrainres.2004.07.006; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; Pearson J, 2008, CURR BIOL, V18, P982, DOI 10.1016/j.cub.2008.05.048; Pelli D. G., 1997, SPATIAL VISION, V10; Perky CW, 1910, AM J PSYCHOL, V21, P422, DOI 10.2307/1413350; Pylyshyn Z, 2003, TRENDS COGN SCI, V7, P113, DOI 10.1016/S1364-6613(03)00003-2; PYLYSHYN ZW, 1973, PSYCHOL BULL, V80, P1, DOI 10.1037/h0034650; REISBERG D, 1987, CAN J PSYCHOL, V41, P521, DOI 10.1037/h0084167; Sack AT, 2005, SCIENCE, V308, P702, DOI 10.1126/science.1107784; Sacks O., 2003, NEW YORKER, V79, P48; Serruya G, 2009, J CLIN PSYCHOL, V65, P791, DOI 10.1002/jclp.20616; Slotnick SD, 2008, CURR BIOL, V18, pR603, DOI 10.1016/j.cub.2008.06.002; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Smyth MM, 1998, APPL COGNITIVE PSYCH, V12, P145, DOI 10.1002/(SICI)1099-0720(199804)12:2<145::AID-ACP505>3.0.CO;2-Z; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Tanaka Y, 1998, P NATL ACAD SCI USA, V95, P12729, DOI 10.1073/pnas.95.21.12729; Tartaglia EM, 2009, CURR BIOL, V19, P2081, DOI 10.1016/j.cub.2009.10.060; Wais PE, 2010, J NEUROSCI, V30, P8541, DOI 10.1523/JNEUROSCI.1478-10.2010; WOOLFOLK RL, 1985, COGNITIVE THER RES, V9, P335, DOI 10.1007/BF01183852	38	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15217	10.1371/journal.pone.0015217	http://dx.doi.org/10.1371/journal.pone.0015217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698EM	21187952	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200023
J	van der Velden, WJFM; Herbers, AHE; Feuth, T; Schaap, NPM; Donnelly, JP; Blijlevens, NMA				van der Velden, Walter J. F. M.; Herbers, Alexandra H. E.; Feuth, Ton; Schaap, Nicolaas P. M.; Donnelly, J. Peter; Blijlevens, Nicole M. A.			Intestinal Damage Determines the Inflammatory Response and Early Complications in Patients Receiving Conditioning for a Stem Cell Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; MUCOSAL BARRIER INJURY; C-REACTIVE PROTEIN; MYELOABLATIVE THERAPY; VIRIDANS STREPTOCOCCI; CONSENSUS CONFERENCE; NEUTROPENIC PATIENTS; CANCER; BACTEREMIA	Background: Stem cell transplantation (SCT) is still complicated by the occurrence of fever and inflammatory complications attributed to neutropenia and subsequent infectious complications. The role of mucosal barrier injury (MBI) of the intestinal tract therein has received little attention. Methods: We performed a retrospective analysis in 163 SCT recipients of which data had been collected prospectively on intestinal damage (citrulline), inflammation (C-reactive protein), and neutrophil count. Six different conditioning regimens were studied; 5 myeloablative (MA) and 1 non-myeloablative (NMA). Linear mixed model multivariate and AUC analyses were used to define the role of intestinal damage in post-SCT inflammation. We also studied the relationship between the degree of intestinal damage and the occurrence of early post-SCT complications. Results: In the 5 MA regimen there was a striking pattern of inflammatory response that coincided with the occurrence of severe intestinal damage. This contrasted with a modest inflammatory response seen in the NMA regimen in which intestinal damage was limited. With linear mixed model analysis the degree of intestinal damage was shown the most important determinant of the inflammatory response, and both neutropenia and bacteremia had only a minor impact. AUC analysis revealed a strong correlation between citrulline and CRP (Pearson correlation r = 0.96). Intestinal damage was associated with the occurrence of bacteremia and acute lung injury, and influenced the kinetics of acute graft-versus-host disease. Conclusion: The degree of intestinal damage after myeloablative conditioning appeared to be the most important determined the inflammatory response following SCT, and was associated with inflammatory complications. Studies should explore ways to ameliorate cytotoxic therapy-induced intestinal damage in order to reduce complications associated with myeloablative conditioning therapy.	[van der Velden, Walter J. F. M.; Herbers, Alexandra H. E.; Schaap, Nicolaas P. M.; Donnelly, J. Peter; Blijlevens, Nicole M. A.] Radboud Univ Nijmegen, Dept Hematol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Feuth, Ton] Radboud Univ Nijmegen, Dept Epidemiol Biostat & Hlth Technol Assessment, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van der Velden, WJFM (corresponding author), Radboud Univ Nijmegen, Dept Hematol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	w.vandervelden@hemat.umcn.nl	Donnelly, J Peter/AAC-1041-2019; Schaap, Nicolaas/L-4625-2015; van der Velden, Walter/D-2216-2016; Blijlevens, N.M.A./H-8012-2014	Donnelly, J Peter/0000-0002-8521-335X; Schaap, Nicolaas/0000-0001-7696-4752; 				Abraham E, 2000, CRIT CARE MED, V28, P232, DOI 10.1097/00003246-200001000-00039; Andersen J, 2006, BONE MARROW TRANSPL, V37, P635, DOI 10.1038/sj.bmt.1705295; Bachanova V, 2009, BONE MARROW TRANSPL, V43, P237, DOI 10.1038/bmt.2008.313; Blijlevens NMA, 2005, BONE MARROW TRANSPL, V36, P703, DOI 10.1038/sj.bmt.1705118; Blijlevens NMA, 2005, BONE MARROW TRANSPL, V35, P707, DOI 10.1038/sj.bmt.1704863; Blijlevens NMA, 2004, BONE MARROW TRANSPL, V34, P193, DOI 10.1038/sj.bmt.1704563; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; Chakraverty R, 2006, J EXP MED, V203, P2021, DOI 10.1084/jem.20060376; Choi SW, 2008, BLOOD, V112, P1539, DOI 10.1182/blood-2008-02-138867; Cooke KR, 2000, J IMMUNOL, V165, P6612, DOI 10.4049/jimmunol.165.11.6612; Costa SF, 2006, AM J INFECT CONTROL, V34, P36, DOI 10.1016/j.ajic.2005.10.007; Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; DEPAUW BE, 1994, ANN INTERN MED, V120, P834, DOI 10.7326/0003-4819-120-10-199405150-00004; Diaconescu R, 2004, BLOOD, V104, P1550, DOI 10.1182/blood-2004-03-0804; DONNELLY JP, 1993, SCAND J INFECT DIS, V25, P43, DOI 10.1080/00365549309169668; ELTING LS, 1992, CLIN INFECT DIS, V14, P1201, DOI 10.1093/clinids/14.6.1201; Fassas ABT, 2005, LEUKEMIA LYMPHOMA, V46, P1159, DOI 10.1080/10428190500086121; Gorak E, 2005, BIOL BLOOD MARROW TR, V11, P542, DOI 10.1016/j.bbmt.2005.04.009; GUIOT HFL, 1990, INFECTION, V18, P131, DOI 10.1007/BF01642100; Herbers AH, 2010, ANN ONCOL, V21, P1706, DOI 10.1093/annonc/mdp596; Herbers AHE, 2008, BONE MARROW TRANSPL, V42, P345, DOI 10.1038/bmt.2008.170; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Johansson JE, 1997, BONE MARROW TRANSPL, V19, P921, DOI 10.1038/sj.bmt.1700765; Kim SY, 2008, AM J HEMATOL, V83, P784, DOI 10.1002/ajh.21227; Logan RM, 2007, CANCER TREAT REV, V33, P448, DOI 10.1016/j.ctrv.2007.03.001; Marron A, 2000, CLIN INFECT DIS, V31, P1126, DOI 10.1086/317460; Ong ZY, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-22; PIZZO PA, 1990, J INFECT DIS, V161, P397, DOI 10.1093/infdis/161.3.397; POUTSIAKA DD, 2010, BONE MARROW IN PRESS; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Ruescher TJ, 1998, CANCER-AM CANCER SOC, V82, P2275, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q; Schots R, 2003, LEUKEMIA, V17, P1150, DOI 10.1038/sj.leu.2402946; Schots R, 2002, BONE MARROW TRANSPL, V30, P441, DOI 10.1038/sj.bmt.1703672; Takatsuka H, 2000, BONE MARROW TRANSPL, V26, P419, DOI 10.1038/sj.bmt.1702517; Tsuji E, 2003, INT J CANCER, V107, P303, DOI 10.1002/ijc.11196; Turner BE, 2008, TRANSPLANTATION, V86, P968, DOI 10.1097/TP.0b013e3181874787; van der Velden WJFM, 2009, BONE MARROW TRANSPL, V43, P55, DOI 10.1038/bmt.2008.270	38	72	75	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15156	10.1371/journal.pone.0015156	http://dx.doi.org/10.1371/journal.pone.0015156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188146	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200017
J	Eldh, M; Ekstrom, K; Valadi, H; Sjostrand, M; Olsson, B; Jernas, M; Lotvall, J				Eldh, Maria; Ekstrom, Karin; Valadi, Hadi; Sjostrand, Margareta; Olsson, Bob; Jernas, Margareta; Lotvall, Jan			Exosomes Communicate Protective Messages during Oxidative Stress; Possible Role of Exosomal Shuttle RNA	PLOS ONE			English	Article							PC12 CELL TOLERANCE; COMPLEX CLASS-II; HYDROGEN-PEROXIDE; TRANSFERRIN RECEPTOR; PROTEIN OXIDATION; BIOGENESIS; APOPTOSIS; VESICLES; EXTERNALIZATION; ACCUMULATION	Background: Exosomes are small extracellular nanovesicles of endocytic origin that mediate different signals between cells, by surface interactions and by shuttling functional RNA from one cell to another. Exosomes are released by many cells including mast cells, dendritic cells, macrophages, epithelial cells and tumour cells. Exosomes differ compared to their donor cells, not only in size, but also in their RNA, protein and lipid composition. Methodology/Principal Findings: In this study, we show that exosomes, released by mouse mast cells exposed to oxidative stress, differ in their mRNA content. Also, we show that these exosomes can influence the response of other cells to oxidative stress by providing recipient cells with a resistance against oxidative stress, observed as an attenuated loss of cell viability. Furthermore, Affymetrix microarray analysis revealed that the exosomal mRNA content not only differs between exosomes and donor cells, but also between exosomes derived from cells grown under different conditions; oxidative stress and normal conditions. Finally, we also show that exposure to UV-light affects the biological functions associated with exosomes released under oxidative stress. Conclusions/Significance: These results argue that the exosomal shuttle of RNA is involved in cell-to-cell communication, by influencing the response of recipient cells to an external stress stimulus.	[Eldh, Maria; Ekstrom, Karin; Sjostrand, Margareta; Lotvall, Jan] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Krefting Res Ctr, Gothenburg, Sweden; [Valadi, Hadi] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Eldh, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Krefting Res Ctr, Gothenburg, Sweden.	jan.lotvall@gu.se	Eldh, Maria/AFO-1744-2022; Valadi, Hadi/ABH-9766-2020; Ekström, Karin/M-7501-2013	Valadi, Hadi/0000-0003-3482-2451; Ekström, Karin/0000-0001-7808-4572; Olsson, Bob/0000-0002-6368-6172; Eldh, Maria/0000-0003-2173-1796; Lotvall, Jan/0000-0001-9195-9249	Swedish Research Council; Herman Krefting Foundation against Asthma Allergy; VBG GROUP CENTRE for Asthma and Allergy Research at University of Gothenburg	Swedish Research Council(Swedish Research CouncilEuropean Commission); Herman Krefting Foundation against Asthma Allergy; VBG GROUP CENTRE for Asthma and Allergy Research at University of Gothenburg	This study was funded by the Swedish Research Council, Herman Krefting Foundation against Asthma Allergy, and the VBG GROUP CENTRE for Asthma and Allergy Research at University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615; Alonso-Fernandez A, 2009, THORAX, V64, P581, DOI 10.1136/thx.2008.100537; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen ZH, 2005, NEUROSCI LETT, V383, P256, DOI 10.1016/j.neulet.2005.04.022; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Fatokun AA, 2006, BONE, V39, P542, DOI 10.1016/j.bone.2006.02.062; GREENBERG JR, 1979, NUCLEIC ACIDS RES, V6, P715, DOI 10.1093/nar/6.2.715; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nadeem A, 2003, J ALLERGY CLIN IMMUN, V111, P72, DOI 10.1067/mai.2003.17; Omata Y, 2008, FREE RADICAL BIO MED, V45, P1437, DOI 10.1016/j.freeradbiomed.2008.08.018; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Palomba L, 1999, BIOCHEM PHARMACOL, V58, P1743, DOI 10.1016/S0006-2952(99)00271-3; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; PONTA H, 1979, MOL GEN GENET, V175, P13, DOI 10.1007/BF00267850; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; SETLOW JK, 1964, BIOCHIM BIOPHYS ACTA, V87, P664, DOI 10.1016/0926-6550(64)90284-1; SPITZ DR, 1987, J CELL PHYSIOL, V131, P364, DOI 10.1002/jcp.1041310308; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; SZYPOWSKA A, 2010, ANTIOXID REDOX SIGNA; Takeda M, 1999, NEPHRON, V81, P234, DOI 10.1159/000045282; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; TIAN T, 2010, J CELL BIOCH; Tsukagoshi H, 2000, RESP MED, V94, P584, DOI 10.1053/rmed.2000.0785; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225; Wigginton KR, 2010, ENVIRON SCI TECHNOL, V44, P5437, DOI 10.1021/es100435a; Wijeratne SSK, 2005, J AGR FOOD CHEM, V53, P8768, DOI 10.1021/jf0512003; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wurtmann EJ, 2009, CRIT REV BIOCHEM MOL, V44, P34, DOI [10.1080/10409230802594043, 10.1080/10409230802594043 ]; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	51	318	339	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15353	10.1371/journal.pone.0015353	http://dx.doi.org/10.1371/journal.pone.0015353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179422	Green Published, Green Submitted, gold			2022-12-27	WOS:000285572900019
J	Er, F; Ederer, S; Nia, AM; Caglayan, E; Dahlem, KM; Semmo, N; Gassanov, N				Er, Fikret; Ederer, Stefan; Nia, Amir M.; Caglayan, Evren; Dahlem, Kristina M.; Semmo, Nasser; Gassanov, Natig			Accuracy of Doppler-Echocardiographic Mean Pulmonary Artery Pressure for Diagnosis of Pulmonary Hypertension	PLOS ONE			English	Article							INFERIOR VENA-CAVA; RIGHT HEART; AMERICAN-SOCIETY; EUROPEAN-ASSOCIATION; STANDARDS COMMITTEE; TASK-FORCE; GUIDELINES; RECOMMENDATIONS; QUANTIFICATION; CATHETERIZATION	Background: The validity of Doppler echocardiographic (DE) measurement of systolic pulmonary artery pressure (sPAP) has been questioned. Recent studies suggest that mean pulmonary artery pressure (mPAP) might reflect more accurately the invasive pressures. Methodology/Principal Findings: 241 patients were prospectively studied to evaluate the diagnostic accuracy of mPAP for the diagnosis of PH. Right heart catheterization (RHC) and DE were performed in 164 patients mainly for preoperative evaluation of heart valve dysfunction. The correlation between DE and RHC was better when mPAP (r = 0.93) and not sPAP (r = 0.81) was assessed. Bland-Altman analysis revealed a smaller variation of mPAP than sPAP. The following ROC analysis identified that a mPAP >= 25.5 mmHg is useful for the diagnosis of PH. This value was validated in an independent cohort of patients (n = 50) with the suspicion of chronic-thromboembolic pulmonary hypertension. The calculated diagnostic accuracy was 98%, based on excellent sensitivity of 98% and specificity of 100%. The corresponding positive and negative predictive values were 100%, respectively 88%. Conclusion: mPAP has been found to be highly accurate for the initial diagnosis of PH. A cut-off value of 25.5 mmHg might be helpful to avoid unnecessary RHC and select patients in whom RHC might be beneficial.	[Er, Fikret; Ederer, Stefan; Nia, Amir M.; Caglayan, Evren; Dahlem, Kristina M.; Gassanov, Natig] Univ Cologne, Dept Internal Med 3, Cologne, Germany; [Semmo, Nasser] Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany	University of Cologne; University of Freiburg	Er, F (corresponding author), Univ Cologne, Dept Internal Med 3, Cologne, Germany.	Fikret.Er@uk-koeln.de	Caglayan, Evren/ABB-8674-2020					Abbas AE, 2003, AM J CARDIOL, V92, P1373, DOI 10.1016/j.amjcard.2003.08.037; Aduen JF, 2009, J AM SOC ECHOCARDIOG, V22, P814, DOI 10.1016/j.echo.2009.04.007; ADUEN JF, 2010, CHEST; Arcasoy SM, 2003, AM J RESP CRIT CARE, V167, P735, DOI 10.1164/rccm.200210-1130OC; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Arora H, 2008, TEX HEART I J, V35, P38; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; BERGER M, 1985, J AM COLL CARDIOL, V6, P359, DOI 10.1016/S0735-1097(85)80172-8; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Brennan JM, 2007, J AM SOC ECHOCARDIOG, V20, P857, DOI 10.1016/j.echo.2007.01.005; Chemla D, 2004, CHEST, V126, P1313, DOI 10.1378/chest.126.4.1313; Chemla D, 2009, CHEST, V135, P760, DOI 10.1378/chest.08-0904; CURRIE PJ, 1985, J AM COLL CARDIOL, V6, P750, DOI 10.1016/S0735-1097(85)80477-0; D'Cruz IA, 1998, ECHOCARDIOGR-J CARD, V15, P759, DOI 10.1111/j.1540-8175.1998.tb00677.x; Fisher MR, 2007, EUR RESPIR J, V30, P914, DOI 10.1183/09031936.00033007; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Lai WW, 2008, INT J CARDIOVAS IMAG, V24, P691, DOI 10.1007/s10554-008-9314-4; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lindqvist P, 2008, EUR J ECHOCARDIOGR, V9, P225, DOI 10.1016/j.euje.2007.04.002; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; MORENO FL, 1984, AM J CARDIOL, V53, P579, DOI 10.1016/0002-9149(84)90034-1; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Swanson KL, 2008, MED SCI MONITOR, V14, pCR177; Syyed R, 2008, CHEST, V133, P633, DOI 10.1378/chest.07-1367; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709	31	17	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15670	10.1371/journal.pone.0015670	http://dx.doi.org/10.1371/journal.pone.0015670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179417	Green Published, gold, Green Submitted			2022-12-27	WOS:000285572900025
J	Tone, SO; Dayanandan, B; Fournier, AE; Mandato, CA				Tone, Stephan Ong; Dayanandan, Bama; Fournier, Alyson E.; Mandato, Craig A.			GSK3 Regulates Mitotic Chromosomal Alignment through CRMP4	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; RESPONSE MEDIATOR PROTEINS; AXON OUTGROWTH INHIBITION; BI-ORIENTATION; MICROTUBULE DYNAMICS; SPINDLE ATTACHMENTS; CELL-DIVISION; GROWTH CONES; AURORA-A; PHOSPHORYLATION	Background: Glycogen Synthase Kinase 3 (GSK3) has been implicated in regulating chromosomal alignment and mitotic progression but the physiological substrates mediating these GSK3-dependent effects have not been identified. Collapsin Response Mediator Protein 4 (CRMP4) is a cytosolic phosphoprotein known to regulate cytoskeletal dynamics and is a known physiological substrate of GSK3. In this study, we investigate the role of CRMP4 during mitosis. Methodology and Principal Findings: Here we demonstrate that during mitosis CRMP4 phosphorylation is regulated in a GSK3-dependent manner. We show that CRMP4 localizes to spindle microtubules during mitosis and loss of CRMP4 disrupts chromosomal alignment and mitotic progression. The effect of CRMP4 on chromosomal alignment is dependent on phosphorylation by GSK3 identifying CRMP4 as a critical GSK3 substrate during mitotic progression. We also provide mechanistic data demonstrating that CRMP4 regulates spindle microtubules consistent with its known role in the regulation of the microtubule cytoskeleton. Conclusion and Significance: Our findings identify CRMP4 as a key physiological substrate of GSK3 in regulating chromosomal alignment and mitotic progression through its effect on spindle microtubules.	[Tone, Stephan Ong; Fournier, Alyson E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Dayanandan, Bama; Mandato, Craig A.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University; McGill University	Tone, SO (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	alyson.fournier@mcgill.ca; craig.mandato@mcgill.ca			Canadian Institutes of Health Research (CIHR) [MOPS68970, MOP64332]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR). C.A.M. is supported by a CIHR grant MOPS68970 and A.E.F. is supported by a CIHR grant MOP64332. S.O.T. is supported by a fellowship from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Alabed YZ, 2007, J NEUROSCI, V27, P1702, DOI 10.1523/JNEUROSCI.5055-06.2007; Alabed YZ, 2010, J NEUROSCI, V30, P5635, DOI 10.1523/JNEUROSCI.6154-09.2010; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; Byk T, 1996, J NEUROSCI, V16, P688; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P30, DOI 10.1016/j.mrgentox.2007.10.016; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fumoto K, 2008, ONCOGENE, V27, P4478, DOI 10.1038/onc.2008.92; Gaetano C, 1997, J BIOL CHEM, V272, P12195, DOI 10.1074/jbc.272.18.12195; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Goold RG, 1999, J CELL SCI, V112, P3373; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Inatome R, 2000, J BIOL CHEM, V275, P27291; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; MINTURN JE, 1995, J COMP NEUROL, V355, P369, DOI 10.1002/cne.903550304; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; PAN S, 2009, LUNG CANC; PIZARRO JG, 2008, J CELL MOL MED; Quach TT, 2004, MOL CELL NEUROSCI, V25, P433, DOI 10.1016/j.mcn.2003.11.006; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.0.CO;2-0; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wang JZ, 1998, FEBS LETT, V436, P28, DOI 10.1016/S0014-5793(98)01090-4; Wang LH, 1996, J NEUROSCI, V16, P6197; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; YOSHIMURA T, 2005, RAS REGULATES NEURON, P7; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	53	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14345	10.1371/journal.pone.0014345	http://dx.doi.org/10.1371/journal.pone.0014345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179545	Green Published, Green Submitted, gold			2022-12-27	WOS:000285340000014
J	Gazave, E; Lapebie, P; Renard, E; Vacelet, J; Rocher, C; Ereskovsky, AV; Lavrov, DV; Borchiellini, C				Gazave, Eve; Lapebie, Pascal; Renard, Emmanuelle; Vacelet, Jean; Rocher, Caroline; Ereskovsky, Alexander V.; Lavrov, Dennis V.; Borchiellini, Carole			Molecular Phylogeny Restores the Supra-Generic Subdivision of Homoscleromorph Sponges (Porifera, Homoscleromorpha)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SECONDARY STRUCTURE; CALCAREOUS SPONGES; DEMOSPONGIAE; MITOCHONDRIAL; PROTEIN; MODEL; DNA; EVOLUTIONARY; SUBSTITUTION	Background: Homoscleromorpha is the fourth major sponge lineage, recently recognized to be distinct from the Demospongiae. It contains <100 described species of exclusively marine sponges that have been traditionally subdivided into 7 genera based on morphological characters. Because some of the morphological features of the homoscleromorphs are shared with eumetazoans and are absent in other sponges, the phylogenetic position of the group has been investigated in several recent studies. However, the phylogenetic relationships within the group remain unexplored by modern methods. Methodology/Principal Findings: Here we describe the first molecular phylogeny of Homoscleromorpha based on nuclear ( 18S and 28S rDNA) and complete mitochondrial DNA sequence data that focuses on inter-generic relationships. Our results revealed two robust clades within this group, one containing the spiculate species ( genera Plakina, Plakortis, Plakinastrella and Corticium) and the other containing aspiculate species ( genera Oscarella and Pseudocorticium), thus rejecting a close relationship between Pseudocorticium and Corticium. Among the spiculate species, we found affinities between the Plakortis and Plakinastrella genera, and between the Plakina and Corticium. The validity of these clades is furthermore supported by specific morphological characters, notably the type of spicules. Furthermore, the monophyly of the Corticium genus is supported while the monophyly of Plakina is not. Conclusions/Significance: As the result of our study we propose to restore the pre-1995 subdivision of Homoscleromorpha into two families: Plakinidae Schulze, 1880 for spiculate species and Oscarellidae Lendenfeld, 1887 for aspiculate species that had been rejected after the description of the genus Pseudocorticium. We also note that the two families of homoscleromorphs exhibit evolutionary stable, but have drastically distinct mitochondrial genome organizations that differ in gene content and gene order.	[Gazave, Eve; Lapebie, Pascal; Renard, Emmanuelle; Vacelet, Jean; Rocher, Caroline; Ereskovsky, Alexander V.; Borchiellini, Carole] Aix Marseille Univ, Ctr Oceanol Marseille, Marine Endoume Stn, CNRS,DIMAR,UMR 6540, Marseilles, France; [Ereskovsky, Alexander V.] St Petersburg State Univ, Dept Embryol, Fac Biol & Soils, St Petersburg, Russia; [Lavrov, Dennis V.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Saint Petersburg State University; Iowa State University	Gazave, E (corresponding author), Aix Marseille Univ, Ctr Oceanol Marseille, Marine Endoume Stn, CNRS,DIMAR,UMR 6540, Marseilles, France.	carole.borchiellini@univmed.fr	Gazave, Eve/F-2665-2010; Lavrov, Dennis/V-3699-2019; Ereskovsky, Alexander/B-3136-2013; Ereskovsky, Alexander/W-1504-2019	Lavrov, Dennis/0000-0002-2745-1704; Ereskovsky, Alexander/0000-0003-1079-7204; Lapebie, Pascal/0000-0003-4073-0633; Gazave, Eve/0000-0002-4647-6640	Centre National de Recherche Scientifique, Universite de la Mediterranee; National Science foundation [DEB-0828783]; Iowa State University; Russian Foundation of Basic Research [N 09-04-00337]; European Marie Curie Mobility program [MIF1-CT-2006-040065]	Centre National de Recherche Scientifique, Universite de la Mediterranee; National Science foundation(National Science Foundation (NSF)); Iowa State University; Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); European Marie Curie Mobility program(European Commission)	This work was supported by the Centre National de Recherche Scientifique, Universite de la Mediterranee, a DEB-0828783 grant from the National Science foundation, a foreign travel grant from Iowa State University, the program Russian Foundation of Basic Research N 09-04-00337 and European Marie Curie Mobility program (fellowship of A. Ereskovsky, MIF1-CT-2006-040065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; [Anonymous], 2002, SYSTEMA PORIFERA GUI; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Borchiellini C, 2001, J EVOLUTION BIOL, V14, P171, DOI 10.1046/j.1420-9101.2001.00244.x; Boury-Esnault N, 2003, INVERTEBR BIOL, V122, P187, DOI 10.1111/j.1744-7410.2003.tb00084.x; BOURYESNAULT N, 1995, OPHELIA, V43, P25, DOI 10.1080/00785326.1995.10430575; Bowerbank J.S., 1864, MONOGRAPH BRIT SPONG, V1; Burger G, 2007, NAT PROTOC, V2, P603, DOI 10.1038/nprot.2007.59; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CAVA AMS, 1992, MAR BIOL, V113, P299; DENDY A, 1905, REPORT SPONGES COLLE; DIAZ MC, 1994, P 4 INT POR C U AMST, P93; DIXON MT, 1993, MOL BIOL EVOL, V10, P256; Dohrmann M, 2008, SYST BIOL, V57, P388, DOI 10.1080/10635150802161088; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ereskovsky AV, 2009, BIOESSAYS, V31, P89, DOI 10.1002/bies.080058; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1571, DOI 10.1017/S0025315407058201; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gazave E, 2008, DEV GENES EVOL, V218, P479, DOI 10.1007/s00427-008-0242-z; Gazave E, 2010, MOL PHYLOGENET EVOL, V57, P35, DOI 10.1016/j.ympev.2010.05.028; Grothe F., 1989, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V106, P155; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall B.G., 2004, PHYLOGENETIC TREES M; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Hudelot C, 2003, MOL PHYLOGENET EVOL, V28, P241, DOI 10.1016/S1055-7903(03)00061-7; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kornprobst JM, 2005, SUBSTANCES NATURELLE, V2, P246; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lapebie P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005823; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; LENDENFELD RV, 1886, P ZOOL SOC LOND, P558; Levi C., 1956, Archives de Zoologie Experimentale et Generale, V93, P1; Levi C., 1973, TRAITE ZOOLOGIE P GR, V3, P577; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Maldonado M, 1999, NATURE, V401, P785, DOI 10.1038/44560; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Morell V, 1996, SCIENCE, V273, P569, DOI 10.1126/science.273.5275.569; Muricy G, 1998, ZOOL J LINN SOC-LOND, V124, P169, DOI 10.1111/j.1096-3642.1998.tb00572.x; Muricy G, 1996, MAR ECOL PROG SER, V138, P181, DOI 10.3354/meps138181; Muricy G., 2002, SYSTEMA PORIFERA GUI, P71, DOI [10.1007/978-1-4615-0747-5_6, DOI 10.1007/978-1-4615-0747-5_6]; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Pearson W R, 1994, Methods Mol Biol, V25, P365; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reid R. E. H., 1970, Symp. zool. Soc. Lond., VNo. 25, P63; Sanderson Michael J., 1994, American Journal of Botany, V81, P183; Schmidt O., 1862, SPONGIEN ADRIATISCHE; Schmidt O., 1870, GRUNDZUGE SPONGIEN F; Schulze F.E., 1880, Z WISSENSCHAFTLICHE, V34, P407; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sollas WJ, 1885, ANN MAG NAT HIST, V16, DOI [10.1080/00222938509459901, DOI 10.1080/00222938509459901]; SPERLING EA, 2007, PORIFERAN PARAPHYLY, P355; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tillier ERM, 1998, GENETICS, V148, P1993; Topsent E., 1897, REV SUISSE ZOOL, V4, P421, DOI DOI 10.5962/BHL.PART.35507; Uriz MJ, 2006, CAN J ZOOL, V84, P322, DOI 10.1139/Z06-032; Uriz MJ, 2003, MICROSC RES TECHNIQ, V62, P279, DOI 10.1002/jemt.10395; VANSOEST RWM, 1984, BIJDR DIERKD, V54, P211, DOI 10.1163/26660644-05402007; VANSOEST RWM, 2008, WORLD PORIFERA DATAB; Vosmaer G.C.J., 1884, MITTEILUNGEN ZOOLOGI, V5, P483; Wang XJ, 2007, MOL BIOL EVOL, V24, P363, DOI 10.1093/molbev/msl167; Wang XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002723; WHEELER WC, 1988, MOL BIOL EVOL, V5, P90; WIEDENMAYER F, 1994, ABH, V116, P1; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	90	72	74	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14290	10.1371/journal.pone.0014290	http://dx.doi.org/10.1371/journal.pone.0014290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179486	Green Published, Green Submitted, gold			2022-12-27	WOS:000285292500001
J	Ravache, M; Weber, C; Merienne, K; Trottier, Y				Ravache, Myriam; Weber, Chantal; Merienne, Karine; Trottier, Yvon			Transcriptional Activation of REST by Sp1 in Huntington's Disease Models	PLOS ONE			English	Article							RESTRICTIVE SILENCER FACTOR; GENE-EXPRESSION CHANGES; NF-KAPPA-B; TRANSGENIC MICE; MOUSE MODEL; NEURONAL DIFFERENTIATION; BINDING-SITE; TARGET GENES; IN-VIVO; POLYGLUTAMINE	In Huntington's disease (HD), mutant huntingtin (mHtt) disrupts the normal transcriptional program of disease neurons by altering the function of several gene expression regulators such as Sp1. REST (Repressor Element-1 Silencing Transcription Factor), a key regulator of neuronal differentiation, is also aberrantly activated in HD by a mechanism that remains unclear. Here, we show that the level of REST mRNA is increased in HD mice and in NG108 cells differentiated into neuronal-like cells and expressing a toxic mHtt fragment. Using luciferase reporter gene assay, we delimited the REST promoter regions essential for mHtt-mediated REST upregulation and found that they contain Sp factor binding sites. We provide evidence that Sp1 and Sp3 bind REST promoter and interplay to fine-tune REST transcription. In undifferentiated NG108 cells, Sp1 and Sp3 have antagonistic effect, Sp1 acting as an activator and Sp3 as a repressor. Upon neuronal differentiation, we show that the amount and ratio of Sp1/Sp3 proteins decline, as does REST expression, and that the transcriptional role of Sp3 shifts toward a weak activator. Therefore, our results provide new molecular information to the transcriptional regulation of REST during neuronal differentiation. Importantly, specific knockdown of Sp1 abolishes REST upregulation in NG108 neuronal-like cells expressing mHtt. Our data together with earlier reports suggest that mHtt triggers a pathogenic cascade involving Sp1 activation, which leads to REST upregulation and repression of neuronal genes.	[Ravache, Myriam; Weber, Chantal; Merienne, Karine; Trottier, Yvon] Univ Strasbourg, CNRS, INSERM, IGBMC,U964,UMR 1704, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ravache, M (corresponding author), Univ Rennes 1, INSERM, UMR 991, Rennes, France.	Yvon.TROTTIER@igbmc.fr	Trottier, Yvon/H-8852-2016	Trottier, Yvon/0000-0001-7230-4810; Merienne, Karine/0000-0003-2549-2315	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg (UdS); Federation pour la Recherche sur le Cerveau (FRC); Association Huntington France (AHF); Association pour la recherche sur le cancer (ARC)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg (UdS); Federation pour la Recherche sur le Cerveau (FRC); Association Huntington France (AHF); Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by funds from the Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg (UdS); Federation pour la Recherche sur le Cerveau (FRC). M.R. was supported by a fellowship from Association Huntington France (AHF) and from Association pour la recherche sur le cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleymane G, 2006, HUM MOL GENET, V15, P691, DOI 10.1093/hmg/ddi483; Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; Alpy F, 2003, ONCOGENE, V22, P3770, DOI 10.1038/sj.onc.1206500; Augood SJ, 1996, NEUROSCIENCE, V72, P1023, DOI 10.1016/0306-4522(95)00595-1; Augood SJ, 1997, ANN NEUROL, V42, P215, DOI 10.1002/ana.410420213; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Calderone A, 2003, J NEUROSCI, V23, P2112; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chan EYW, 2002, HUM MOL GENET, V11, P1939, DOI 10.1093/hmg/11.17.1939; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Feng ZH, 1999, MOL BRAIN RES, V69, P144, DOI 10.1016/S0169-328X(99)00099-6; Ferrante RJ, 2004, J NEUROSCI, V24, P10335, DOI 10.1523/JNEUROSCI.2599-04.2004; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Koenigsberger C, 2000, P NATL ACAD SCI USA, V97, P2291, DOI 10.1073/pnas.050578797; Kojima T, 2001, MOL BRAIN RES, V90, P174, DOI 10.1016/S0169-328X(01)00107-3; Lardenois A, 2006, NUCLEIC ACIDS RES, V34, pW578, DOI 10.1093/nar/gkl193; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Lietz M, 2003, EUR J BIOCHEM, V270, P2, DOI 10.1046/j.1432-1033.2003.03360.x; Lorincz MT, 2004, MOL CELL NEUROSCI, V26, P135, DOI 10.1016/j.mcn.2004.01.016; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Merienne K, 2003, J BIOL CHEM, V278, P16957, DOI 10.1074/jbc.M212049200; Merienne K, 2007, NEUROBIOL DIS, V25, P571, DOI 10.1016/j.nbd.2006.11.002; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Napolitano M, 2008, NEUROSCI LETT, V434, P241, DOI 10.1016/j.neulet.2007.09.056; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; Ryu H, 2003, J NEUROSCI, V23, P3597; Sadri-Vakili G, 2006, NAT CLIN PRACT NEURO, V2, P330, DOI 10.1038/ncpneuro0199; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Smith R, 2006, HUM MOL GENET, V15, P3119, DOI 10.1093/hmg/ddl252; Spencer EM, 2006, NEUROBIOL DIS, V24, P41, DOI 10.1016/j.nbd.2006.04.020; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Thomas EA, 2006, J NEUROSCI RES, V84, P1151, DOI 10.1002/jnr.21046; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Yefimova MG, 2010, NEUROBIOL DIS, V40, P311, DOI 10.1016/j.nbd.2010.06.005; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	61	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14311	10.1371/journal.pone.0014311	http://dx.doi.org/10.1371/journal.pone.0014311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179468	Green Submitted, gold, Green Published			2022-12-27	WOS:000285292500003
J	Iwasaki, W; Yamamoto, Y; Takagi, T				Iwasaki, Wataru; Yamamoto, Yasunori; Takagi, Toshihisa			TogoDoc Server/Client System: Smart Recommendation and Efficient Management of Life Science Literature	PLOS ONE			English	Article								In this paper, we describe a server/client literature management system specialized for the life science domain, the TogoDoc system (Togo, pronounced Toe-Go, is a romanization of a Japanese word for integration). The server and the client program cooperate closely over the Internet to provide life scientists with an effective literature recommendation service and efficient literature management. The content-based and personalized literature recommendation helps researchers to isolate interesting papers from the "tsunami'' of literature, in which, on average, more than one biomedical paper is added to MEDLINE every minute. Because researchers these days need to cover updates of much wider topics to generate hypotheses using massive datasets obtained from public databases or omics experiments, the importance of having an effective literature recommendation service is rising. The automatic recommendation is based on the content of personal literature libraries of electronic PDF papers. The client program automatically analyzes these files, which are sometimes deeply buried in storage disks of researchers' personal computers. Just saving PDF papers to the designated folders makes the client program automatically analyze and retrieve metadata, rename file names, synchronize the data to the server, and receive the recommendation lists of newly published papers, thus accomplishing effortless literature management. In addition, the tag suggestion and associative search functions are provided for easy classification of and access to past papers (researchers who read many papers sometimes only vaguely remember or completely forget what they read in the past). The TogoDoc system is available for both Windows and Mac OS X and is free. The TogoDoc Client software is available at http://tdc.cb.k.u-tokyo.ac.jp/, and the TogoDoc server is available at https://docman.dbcls.jp/pubmed_recom.	[Iwasaki, Wataru; Takagi, Toshihisa] Univ Tokyo, Dept Computat Biol, Kashiwa, Chiba, Japan; [Yamamoto, Yasunori; Takagi, Toshihisa] Database Ctr Life Sci, Tokyo, Japan; [Takagi, Toshihisa] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Iwasaki, W (corresponding author), Univ Tokyo, Dept Computat Biol, Kashiwa, Chiba, Japan.	iwasaki@k.u-tokyo.ac.jp; yy@dbcls.jp	Iwasaki, Wataru/O-4917-2014	Iwasaki, Wataru/0000-0002-9169-9245	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Integrated Database Project and KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Systems Genomics'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MEDLINE CITATION COU; apache, AP HTTP SERV PROJ; Bell G, 2009, SCIENCE, V323, P1297, DOI 10.1126/science.1170411; *CITEULIKE, CITEULIKE EV LIB; *DOI, DIG OBJ ID DOI SYST; *ECL, ECL RCP; HOFFER TB, 2005, 06302 NSF; Hull D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000204; JOHNSON D, 2006, RSS ATOM ACTION WEB; *JPEDAL, JPEDAL JAV PDF VIEW; Lin J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-423; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Mcsherry D, 2005, ARTIF INTELL REV, V24, P179, DOI 10.1007/s10462-005-4612-x; *MEND, MEND AC REF MAN SOFT; MINLIE H, 2010, COLING 2010, V463; *MYSQL, MYSQL WORLDS MOST PO; *NCBI, NCBI E UT; Perl, PERL PROGR LANG; Powledge TM, 2000, CURR BIOL, V10, pR254, DOI 10.1016/S0960-9822(00)00423-1; *RSS, RSS 0 91 SPEC NETSC; Rubin DL, 2008, BRIEF BIOINFORM, V9, P75, DOI 10.1093/bib/bbm059; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schutze H., 2008, INTRO INFORM RETRIEV, V39; SEWELL W, 1964, B MED LIBR ASSOC, V52, P164; Tuchler T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-406; Yoneya T, 2007, GENOME INFORM SER, V18, P267; TOKYO CABINET MODERN; BIBUTILS BIBLIO CONV; ATOM SYNDICATION FOR; INDRI LANGUAGE MODEL; APPL JSON MEDIA TYPE; PAPERS	32	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15305	10.1371/journal.pone.0015305	http://dx.doi.org/10.1371/journal.pone.0015305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179453	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900042
J	Pukelsheim, K; Stoeger, T; Kutschke, D; Ganguly, K; Wjst, M				Pukelsheim, Katrin; Stoeger, Tobias; Kutschke, David; Ganguly, Koustav; Wjst, Matthias			Cytokine Profiles in Asthma Families Depend on Age and Phenotype	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; COLONY-STIMULATING FACTOR; SERUM INTERFERON-GAMMA; T-CELLS; PROINFLAMMATORY CYTOKINES; LUNG-FUNCTION; INTERLEUKIN-8; INFLAMMATION; SEVERITY; CHILDREN	Background: Circulating cytokine patterns may be relevant for the diagnosis of asthma, for the discrimination of certain phenotypes, and prognostic factors for exacerbation of disease. Methodology/Principal Findings: In this study we investigated serum samples from 944 individuals of 218 asthma-affected families by a multiplex, microsphere based system detecting at high sensitivity eleven asthma associated mediators: eotaxin (CCL11), granulocyte macrophage stimulating factor (GM-CSF), interferon gamma (IFN gamma), interleukin-4 (IL-4), IL-5, IL-8, IL-10, IL-12 (p40), IL-13, IL-17 and tumor necrosis factor alpha (TNF alpha). Single cytokine levels were largely similar between asthmatic and healthy individuals when analysing asthma as single disease entity. Regulatory differences between parental and pediatric asthma were reflected by six of the eleven mediators analyzed (eotaxin, IL-4, IL-5, IL-10, IL-12, TNF alpha). IL-12 (p40) and IL-5 were the best predictor for extrinsic asthma in children with an increased odds ratio of 2.85 and 1.96 per log pg/ml increase (IL-12 (p40): 1.2-6.8, p = 0.019, and IL-5: 1.2-2.5, p = 0.025). Frequent asthma attacks in children are associated with elevated IL-5 serum levels (p = 0.013). Cytokine patterns seem to be individually balanced in both, healthy and diseased adults and children, with various cytokines correlating among each other (IL-17 and IFN gamma (r(s) = 0.67), IL-4 and IL-5 (r(s) = 0.55), IFN gamma and GM-CSF (r(s) = 0.54)). Conclusion/Significance: Our data support mainly an age-but also an asthma phenotype-dependent systemic immune regulation.	[Pukelsheim, Katrin; Stoeger, Tobias; Kutschke, David; Ganguly, Koustav; Wjst, Matthias] Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Munich, Germany; [Ganguly, Koustav] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pukelsheim, K (corresponding author), Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Munich, Germany.	m@wjst.de	Stöger, Tobias/M-9861-2014	Stöger, Tobias/0000-0002-2790-0389	BMBF [07ALE087]; Deutsche Forschungsgemeinschaft [DFG WI621/5-1, DFG FR1526/1]; National Genome Network [01GS0122]; HMGU (Helmholtz Center Munich, former GSF) [fA1/4r, FE 75051]; EU	BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Genome Network; HMGU (Helmholtz Center Munich, former GSF)(Helmholtz Association); EU(European Commission)	The asthma family study was funded by BMBF 07ALE087, Deutsche Forschungsgemeinschaft DFG WI621/5-1, DFG FR1526/1 and National Genome Network 01GS0122. K. P. and M. W. are funded by HMGU (Helmholtz Center Munich, former GSF (Gesellschaft fA1/4r Strahlenforschung) research center) FE 75051 and the EU Grant Europrevall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmuller Janine, 2005, BMC Pulm Med, V5, P1, DOI 10.1186/1471-2466-5-1; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; CORRIGAN CJ, 1990, AM REV RESPIR DIS, V141, P970, DOI 10.1164/ajrccm/141.4_Pt_1.; Dente FL, 2006, ANN ALLERG ASTHMA IM, V97, P312, DOI 10.1016/S1081-1206(10)60795-8; Friebe A, 2008, ARCH PATHOL LAB MED, V132, P1802, DOI 10.1043/1543-2165-132.11.1802; Halonen M, 2009, J IMMUNOL, V182, P3285, DOI 10.4049/jimmunol.0711996; Hollander C, 2007, RESP MED, V101, P1947, DOI 10.1016/j.rmed.2007.04.010; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; John M, 1998, AM J RESP CRIT CARE, V157, P256, DOI 10.1164/ajrccm.157.1.9703079; Krogulska A, 2009, J INVEST ALLERG CLIN, V19, P43; Kumar Rakesh K., 2006, Inflammation & Allergy Drug Targets, V5, P253, DOI 10.2174/187152806779010909; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Litonjua AA, 2003, ANN ALLERG ASTHMA IM, V90, P422, DOI 10.1016/S1081-1206(10)61827-3; Meyts I, 2006, J IMMUNOL, V177, P6460, DOI 10.4049/jimmunol.177.9.6460; Nakajima H, 2007, INT ARCH ALLERGY IMM, V142, P265, DOI 10.1159/000097357; Nakamura H, 1999, AM J RESP CRIT CARE, V160, P1952, DOI 10.1164/ajrccm.160.6.9811089; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Perez-Machado MA, 2004, ALLERGY, V59, P346, DOI 10.1046/j.1398-9995.2003.00328.x; Prokesova L, 2006, PEDIAT ALLERG IMM-UK, V17, P175, DOI 10.1111/j.1399-3038.2006.00395.x; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SAHA SK, 2009, GRANULOCYTE MACROPHA; SAITO H, 1988, INT ARCH ALLER A IMM, V87, P286, DOI 10.1159/000234687; Shute JK, 1997, AM J RESP CRIT CARE, V155, P1877, DOI 10.1164/ajrccm.155.6.9196089; Silvestri M, 2006, CLIN EXP ALLERGY, V36, P1373, DOI 10.1111/j.1365-2222.2006.02502.x; Tateno H, 2004, RESP MED, V98, P782, DOI 10.1016/j.rmed.2004.01.005; ten Hacken NHT, 1998, EUR RESPIR J, V11, P312, DOI 10.1183/09031936.98.11020312; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Wjst M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-60; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Yamashita N, 2002, CELL IMMUNOL, V219, P92, DOI 10.1016/S0008-8749(02)00565-8	36	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14299	10.1371/journal.pone.0014299	http://dx.doi.org/10.1371/journal.pone.0014299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179211	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000285246900012
J	Ebihara, A; Nitta, JH; Ito, M				Ebihara, Atsushi; Nitta, Joel H.; Ito, Motomi			Molecular Species Identification with Rich Floristic Sampling: DNA Barcoding the Pteridophyte Flora of Japan	PLOS ONE			English	Article							CHLOROPLAST DNA; FERN; HYMENOPHYLLACEAE; GAMETOPHYTES; POPULATION; PHYLOGENY; COMPLEX; GENUS; RBCL; SPOROPHYTES	Background: DNA barcoding is expected to be an effective identification tool for organisms with heteromorphic generations such as pteridophytes, which possess a morphologically simple gametophyte generation. Although a reference data set including complete coverage of the target local flora/fauna is necessary for accurate identification, DNA barcode studies including such rich taxonomic sampling on a countrywide scale are lacking. Methodology/Principal Findings: The Japanese pteridophyte flora (733 taxa including subspecies and varieties) was used to test the utility of two plastid DNA barcode regions (rbcL and trnH-psbA) with the intention of developing an identification system for native gametophytes. DNA sequences were obtained from each of 689 (94.0%) taxa for rbcL and 617 (84.2%) taxa for trnH-psbA. Mean interspecific divergence values across all taxon pairs (K2P genetic distances) did not reveal a significant difference in rate between trnH-psbA and rbcL, but mean K2P distances of each genus showed significant heterogeneity according to systematic position. The minimum fail rate of taxon discrimination in an identification test using BLAST (12.52%) was obtained when rbcL and trnH-psbA were combined, and became lower in datasets excluding infraspecific taxa or apogamous taxa, or including sexual diploids only. Conclusions/Significance: This study demonstrates the overall effectiveness of DNA barcodes for species identification in the Japanese pteridophyte flora. Although this flora is characterized by a high occurrence of apogamous taxa that pose a serious challenge to identification using DNA barcodes, such taxa are limited to a small number of genera, and only minimally detract from the overall success rate. In the case that a query sequence is matched to a known apogamous genus, routine species identification may not be possible. Otherwise, DNA barcoding is a practical tool for identification of most Japanese pteridophytes, and is especially anticipated to be helpful for identification of non-hybridizing gametophytes.	[Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan; [Nitta, Joel H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ito, Motomi] Univ Tokyo, Grad Sch Arts & Sci, Dept Syst Sci, Meguro Ku, Tokyo, Japan	National Museum of Nature and Science; University of California System; University of California Berkeley; University of Tokyo	Ebihara, A (corresponding author), Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan.	ebihara@kahaku.go.jp	Nitta, Joel/J-5467-2019	Nitta, Joel/0000-0003-4719-7472				Andrew RL, 2003, AUST SYST BOT, V16, P69, DOI 10.1071/SB01043; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Ebihara A, 2003, SYST BOT, V28, P228; Ebihara A, 2007, BOT J LINN SOC, V155, P1, DOI 10.1111/j.1095-8339.2007.00684.x; Ebihara A, 2009, MOL ECOL, V18, P4904, DOI 10.1111/j.1365-294X.2009.04406.x; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; FARRAR DR, 1967, SCIENCE, V155, P1266, DOI 10.1126/science.155.3767.1266; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; GASTONY GJ, 1992, AM J BOT, V79, P716, DOI 10.2307/2444887; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Grant V., 1981, PLANT SPECIATION; Guo QF, 2003, ECOGRAPHY, V26, P129, DOI 10.1034/j.1600-0587.2003.03379.x; Haufler CH, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P303, DOI 10.1017/CBO9780511541827.013; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Holman JE, 2000, AUST J BOT, V48, P569, DOI 10.1071/BT98032; Horandl E, 2004, INT J PLANT SCI, V165, P615, DOI 10.1086/386557; Ishikawa Hiroshi, 2003, APG Acta Phytotaxonomica et Geobotanica, V54, P59; IWATSUKI K, 1995, FLORA JAPAN, V1; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li FW, 2009, PLANT SYST EVOL, V281, P77, DOI 10.1007/s00606-009-0188-2; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; MOMOSE S, 1967, GAMETOPHYTES JAPANES; NAKAIKE T, 1992, NEW FLORA JAPAN PTER; NAKAIKE T, 2004, J NIPPON FERNIST S2, V3; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nitta JH, 2008, TAXON, V57, P725, DOI 10.1002/tax.573006; Nitta JH, 2009, BRITTONIA, V61, P392, DOI 10.1007/s12228-009-9097-5; Park CH, 2003, J PLANT RES, V116, P93, DOI 10.1007/s10265-003-0081-y; Pryer KM, 2001, AM J BOT, V88, P1118, DOI 10.2307/2657095; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Robertson A, 2004, MOL ECOL, V13, P123, DOI 10.1046/j.1365-294X.2003.02025.x; RUMSEY FJ, 1996, PTERIDOLOGY PERSPECT, P563; SATO T, 1981, CAN J BOT, V59, P604, DOI 10.1139/b81-085; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schneider H, 2006, MOL ECOL NOTES, V6, P989, DOI 10.1111/j.1471-8286.2006.01424.x; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Sheffield E, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P49, DOI 10.1017/CBO9780511541827.003; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; STEIN DB, 1990, ANN MO BOT GARD, V77, P334, DOI 10.2307/2399548; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAKAMIYA M, 1996, INDEX CHROMOSOMES JA; Tate JA, 2003, SYST BOT, V28, P723; Vogel JC, 1998, BOT ACTA, V111, P247, DOI 10.1111/j.1438-8677.1998.tb00704.x; Watkins JE, 2009, AM FERN J, V99, P162, DOI 10.1640/0002-8444-99.3.162; Yatabe Y, 2001, AM J BOT, V88, P1517, DOI 10.2307/3558459	58	105	118	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15136	10.1371/journal.pone.0015136	http://dx.doi.org/10.1371/journal.pone.0015136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170336	Green Published, Green Submitted, gold			2022-12-27	WOS:000285084100020
J	Hamilton, DW; Oates, CJ; Hasanzadeh, A; Mittler, S				Hamilton, Douglas W.; Oates, Christine J.; Hasanzadeh, Abdollah; Mittler, Silvia			Migration of Periodontal Ligament Fibroblasts on Nanometric Topographical Patterns: Influence of Filopodia and Focal Adhesions on Contact Guidance	PLOS ONE			English	Article							EPITHELIAL-CELLS; IN-VITRO; CYTOSKELETAL ORGANIZATION; OSTEOBLAST ADHESION; SURFACE-TOPOGRAPHY; NANOTOPOGRAPHY; PHOSPHORYLATION; MECHANISMS; IMPLANTS; TISSUE	Considered to be the "holy grail'' of dentistry, regeneration of the periodontal ligament in humans remains a major clinical problem. Removal of bacterial biofilms is commonly achieved using EDTA gels or lasers. One side effect of these treatment regimens is the etching of nanotopographies on the surface of the tooth. However, the response of periodontal ligament fibroblasts to such features has received very little attention. Using laser interference lithography, we fabricated precisely defined topographies with continuous or discontinuous nanogrooves to assess the adhesion, spreading and migration of PDL fibroblasts. PDL fibroblasts adhered to and spread on all tested surfaces, with initial spreading and focal adhesion formation slower on discontinuous nanogrooves. Cells had a significantly smaller planar area on both continuous and discontinuous nanogrooves in comparison with cells on non-patterned controls. At 24 h post seeding, cells on both types of nanogrooves were highly elongated parallel to the groove long axis. Time-lapse video microscopy revealed that PDL fibroblast movement was guided on both types of grooves, but migration velocity was not significantly different from cells cultured on non-patterned controls. Analysis of filopodia formation using time-lapse video microscopy and labeling of vinculin and F-actin revealed that on nanogrooves, filopodia were highly aligned at both ends of the cell, but with increasing time filopodia and membrane protrusions developed at the side of the cell perpendicular to the cell long axis. We conclude that periodontal ligament fibroblasts are sensitive to nanotopographical depths of 85-100 mu m, which could be utilized in regeneration of the periodontal ligament.	[Hamilton, Douglas W.; Oates, Christine J.; Mittler, Silvia] Univ Western Ontario, Schulich Sch Med & Dent, Grad Program Biomed Engn, London, ON, Canada; [Hamilton, Douglas W.] Univ Western Ontario, Schulich Sch Med & Dent, Div Oral Biol, London, ON, Canada; [Hasanzadeh, Abdollah; Mittler, Silvia] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Hamilton, DW (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Grad Program Biomed Engn, London, ON, Canada.	dhamil2@uwo.ca	Mittler, Silvia/B-5639-2015; Hamilton, Douglas W/L-8932-2015	Mittler, Silvia/0000-0001-8998-1877; Hamilton, Douglas W/0000-0002-9798-5197	Canadian Foundation [18742]; Natural Sciences and Engineering Research Council of Canada [R4091A06]	Canadian Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors thank Dr Wankei Wan for financial support of CJO. This work was funded by the Canadian Foundation for Innovation Leaders Opportunity Fund (18742) and the Natural Sciences and Engineering Research Council of Canada Discovery Grants Program R4091A06 (D. W. Hamilton). www.nserc-crsng.gc.ca. www.innovation.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar Jasim M, 2005, Dent Clin North Am, V49, P517, DOI 10.1016/j.cden.2005.03.003; Babay N, 2000, Indian J Dent Res, V11, P53; Babay N, 2001, J Contemp Dent Pract, V2, P13; Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9; Blomlof J, 1996, J CLIN PERIODONTOL, V23, P50, DOI 10.1111/j.1600-051X.1996.tb00504.x; Blomlof J, 1996, J CLIN PERIODONTOL, V23, P12, DOI 10.1111/j.1600-051X.1996.tb00498.x; BRECKENRIDGE LJ, 1995, J NEUROSCI RES, V42, P266, DOI 10.1002/jnr.490420215; Bruckmann C, 2005, BIOMATERIALS, V26, P339, DOI 10.1016/j.biomaterials.2004.02.031; Chehroudi B, 1997, J BIOMED MATER RES, V34, P279; CHOU LS, 1995, J CELL SCI, V108, P1563; Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415; Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534; Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028; Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001; Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004; Dalby MJ, 2003, J BIOMED MATER RES A, V67A, P1025, DOI 10.1002/jbm.a.10139; Davies JE, 1998, INT J PROSTHODONT, V11, P391; Drisko C L, 1991, Curr Opin Dent, V1, P74; Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918; Gamal Ahmed Y, 2003, J Int Acad Periodontol, V5, P11; Gonzales Silverio-Ruiz K, 2007, CYTOKINE, V39, P130, DOI 10.1016/j.cyto.2007.06.009; Hamilton DW, 2006, CALCIFIED TISSUE INT, V78, P314, DOI 10.1007/s00223-005-0238-x; Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041; Hamilton DW, 2007, BIOMATERIALS, V28, P2281, DOI 10.1016/j.biomaterials.2007.01.026; Hamilton DW, 2005, EXP CELL RES, V309, P429, DOI 10.1016/j.yexcr.2005.06.015; Hamilton DW, 2005, CELL BIOL INT, V29, P605, DOI 10.1016/j.cellbi.2005.03.013; Hamilton DW, 2005, CELL BIOL INT, V29, P408, DOI 10.1016/j.cellbi.2004.12.008; Kalkwarf K L, 1991, Curr Opin Dent, V1, P87; Karring T, 2000, J Int Acad Periodontol, V2, P101; Kassab M, 2003, COMPEND CONTIN ED DE, V24, P44; Kassab M, 2003, COMPEND CONTIN ED DE, V24, P36; Kassab M, 2003, COMPEND CONTIN ED DE, V24, P40; Kassab Moawia, 2003, Compend Contin Educ Dent, V24, P31; Kokubu E, 2009, J BIOMED MATER RES A, V91A, P663, DOI 10.1002/jbm.a.32273; Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030; Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012; Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075; OAKLEY C, 1995, CELL MOTIL CYTOSKEL, V31, P45, DOI 10.1002/cm.970310106; OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8; Owen GR, 2005, BIOMATERIALS, V26, P7447, DOI 10.1016/j.biomaterials.2005.05.055; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Schwartz Z, 1997, PERIODONTOL 2000, V14, P158, DOI 10.1111/j.1600-0757.1997.tb00196.x; Schwarz F, 2003, LASER SURG MED, V33, P140, DOI 10.1002/lsm.10201; Sculean A, 2004, INT J PERIODONT REST, V24, P327; Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H	49	51	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15129	10.1371/journal.pone.0015129	http://dx.doi.org/10.1371/journal.pone.0015129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152020	Green Submitted, Green Published, gold			2022-12-27	WOS:000284821300018
J	Ralainirina, N; Brons, NHC; Ammerlaan, W; Hoffmann, C; Hentges, F; Zimmer, J				Ralainirina, Natacha; Brons, Nicolaas H. C.; Ammerlaan, Wim; Hoffmann, Celine; Hentges, Francois; Zimmer, Jacques			Mouse Natural Killer (NK) Cells Express the Nerve Growth Factor Receptor TrkA, which Is Dynamically Regulated	PLOS ONE			English	Article							CD107A; ASTHMA	Background: Nerve growth factor (NGF) is a neurotrophin crucial for the development and survival of neurons. It also acts on cells of the immune system which express the NGF receptors TrkA and p75(NTR) and can be produced by them. However, mouse NK cells have not yet been studied in this context. Methodology/Principal Findings: We used cell culture, flow cytometry, confocal microscopy and ELISA assays to investigate the expression of NGF receptors by NK cells and their secretion of NGF. We show that resting NK cells express TrkA and that the expression is different on NK cell subpopulations defined by the relative presence of CD27 and CD11b. Expression of TrkA is dramatically increased in IL-2-activated NK cells. The p75 NTR is expressed only on a very low percentage of NK cells. Functionally, NGF moderately inhibits NK cell degranulation, but does not influence proliferation or cytokine production. NK cells do not produce NGF. Conclusions/Significance: We demonstrate for the first time that mouse NK cells express the NGF receptor TrkA and that this expression is dynamically regulated.	[Ralainirina, Natacha; Hentges, Francois; Zimmer, Jacques] CRP Sante, Lab Immunogenet & Allergol, Luxembourg, Luxembourg; [Brons, Nicolaas H. C.; Ammerlaan, Wim] CRP Sante, Core Facil Flow Cytometry, Luxembourg, Luxembourg; [Hoffmann, Celine] CRP Sante, Plant Mol Biol Lab, Luxembourg, Luxembourg	Luxembourg Institute of Health; Luxembourg Institute of Health; Luxembourg Institute of Health	Ralainirina, N (corresponding author), CRP Sante, Lab Immunogenet & Allergol, Luxembourg, Luxembourg.	jacques.zimmer@crp-sante.lu	Hoffmann, Céline/F-3741-2016	Hoffmann, Céline/0000-0002-7564-2329; Zimmer, Jacques/0000-0002-7118-6944	Luxembourgish National Research Fund (FNR)	Luxembourgish National Research Fund (FNR)(Luxembourg National Research Fund)	The work of Natacha Ralainirina was supported by an AFR Grant from the Luxembourgish National Research Fund (FNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arredondo LR, 2001, EUR J IMMUNOL, V31, P625; Bracci-Laudiero L, 2003, J NEUROIMMUNOL, V136, P130, DOI 10.1016/S0165-5728(03)00007-9; Caroleo MC, 2001, J NEUROIMMUNOL, V113, P193, DOI 10.1016/S0165-5728(00)00441-0; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Frossard N, 2004, EUR J PHARMACOL, V500, P453, DOI 10.1016/j.ejphar.2004.07.044; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lambiase A, 1997, J ALLERGY CLIN IMMUN, V100, P408, DOI 10.1016/S0091-6749(97)70256-2; Lambiase A, 2004, CURR OPIN ALLERGY CL, V4, P425, DOI 10.1097/00130832-200410000-00015; Nassenstein C, 2006, EUR J PHARMACOL, V533, P195, DOI 10.1016/j.ejphar.2005.12.061; Nassenstein C, 2006, EXP TOXICOL PATHOL, V57, P55, DOI 10.1016/j.etp.2006.02.008; Orr MT, 2010, NAT IMMUNOL, V11, P321, DOI 10.1038/ni.1849; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Rogers ML, 2010, J NEUROIMMUNOL, V226, P93, DOI 10.1016/j.jneuroim.2010.05.040; SAMAH B, 2008, CLIN EXP IMMUNOL, V131, P80; Samah B, 2009, J NEUROVIROL, V15, P71, DOI 10.1080/13550280802482575; Vega JA, 2003, J ANAT, V203, P1, DOI 10.1046/j.1469-7580.2003.00203.x; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Yokoyama WM, 2010, BIOL BLOOD MARROW TR, V16, pS97, DOI 10.1016/j.bbmt.2009.10.009	21	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15053	10.1371/journal.pone.0015053	http://dx.doi.org/10.1371/journal.pone.0015053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152021	Green Published, gold, Green Submitted			2022-12-27	WOS:000284821300014
J	Blanco, G; Lemus, JA				Blanco, Guillermo; Lemus, Jesus A.			Livestock Drugs and Disease: The Fatal Combination behind Breeding Failure in Endangered Bearded Vultures	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; INFECTIOUS BURSAL DISEASE; WEST-NILE-VIRUS; AVIAN INFLUENZA; GYPAETUS-BARBATUS; WILD BIRDS; RT-PCR; REAL; CONSERVATION; DIVERSITY	There is increasing concern about the impact of veterinary drugs and livestock pathogens as factors damaging wildlife health, especially of threatened avian scavengers feeding upon medicated livestock carcasses. We conducted a comprehensive study of failed eggs and dead nestlings in bearded vultures (Gypaetus barbatus) to attempt to elucidate the proximate causes of breeding failure behind the recent decline in productivity in the Spanish Pyrenees. We found high concentrations of multiple veterinary drugs, primarily fluoroquinolones, in most failed eggs and nestlings, associated with multiple internal organ damage and livestock pathogens causing disease, especially septicaemia by swine pathogens and infectious bursal disease. The combined impact of drugs and disease as stochastic factors may result in potentially devastating effects exacerbating an already high risk of extinction and should be considered in current conservation programs for bearded vultures and other scavenger species, especially in regards to dangerous veterinary drugs and highly pathogenic poultry viruses.	[Blanco, Guillermo; Lemus, Jesus A.] CSIC, Dept Ecol Evolut, Museo Ciencias Nat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Museu de Ciencies Naturals de Barcelona	Blanco, G (corresponding author), CSIC, Dept Ecol Evolut, Museo Ciencias Nat, Madrid, Spain.	gblanco@mncn.csic.es	Blanco, Guillermo/L-3170-2014	Blanco, Guillermo/0000-0001-5742-4929	Spanish Ministerio de Educacion y Ciencia [CGL2007-61395/BOS]	Spanish Ministerio de Educacion y Ciencia(Spanish Government)	The study was funded by the project CGL2007-61395/BOS of Spanish Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernanke J, 2009, REV ENVIRON CONTAM T, V198, P1, DOI 10.1007/978-0-387-09647-6_1; Blanco G, 2003, ENVIRON TOXICOL CHEM, V22, P2711, DOI 10.1897/02-519; Blanco G, 2009, ANIM CONSERV, V12, P571, DOI 10.1111/j.1469-1795.2009.00283.x; Blanco G., 2007, ENV RES TRENDS, P153; BLANCO G, 2009, VULTURES FEEDING S S, P402; Blanco G, 2007, ENVIRON MICROBIOL, V9, P1738, DOI 10.1111/j.1462-2920.2007.01291.x; Blanco G, 2006, J APPL ECOL, V43, P990, DOI 10.1111/j.1365-2664.2006.01200.x; Cardoso M, 2005, VIRUS GENES, V30, P371, DOI 10.1007/s11262-005-6781-8; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Carrete M, 2009, ECOL APPL, V19, P840, DOI 10.1890/07-2134.1; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Chen BY, 1996, AVIAN PATHOL, V25, P269, DOI 10.1080/03079459608419141; Childs J.E., 2007, WILDLIFE EMERGING ZO; Cho KO, 1999, VET PATHOL, V36, P314, DOI 10.1354/vp.36-4-314; Davidson I, 2008, VIRUS GENES, V36, P1, DOI 10.1007/s11262-007-0165-1; Elliott JE, 1996, J WILDLIFE DIS, V32, P486, DOI 10.7589/0090-3558-32.3.486; Farkas T, 2007, ZOONOSES PUBLIC HLTH, V54, P38, DOI 10.1111/j.1863-2378.2007.01005.x; Gangoso L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006333; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gibbs E. P. J., 2002, DOMESTIC ANIMAL WILD; Godoy JA, 2004, MOL ECOL, V13, P371, DOI 10.1046/j.1365-294X.2003.02075.x; Gottdenker NL, 2005, BIOL CONSERV, V126, P429, DOI 10.1016/j.biocon.2005.06.025; Greiner Ellis C., 1994, P1007; Hamoud MM, 2007, J VET DIAGN INVEST, V19, P35, DOI 10.1177/104063870701900106; Hernandez-Divers SM, 2008, AVIAN DIS, V52, P558, DOI 10.1637/8298-032808-Reg.1; HILL E F, 1982, Environmental Toxicology and Chemistry, V1, P27, DOI 10.1897/1552-8618(1982)1[27:APOBFM]2.0.CO;2; HILL EF, 1988, J WILDLIFE DIS, V24, P51, DOI 10.7589/0090-3558-24.1.51; Himsworth CG, 2009, AVIAN DIS, V53, P129, DOI 10.1637/8387-063008-Case.1; HIRALDO F, 1979, MONOGRAFIAS ICONA, V22; Hsu CM, 2006, AVIAN DIS, V50, P348, DOI 10.1637/7485-121105R.1; Islam A, 2006, J VIROL METHODS, V132, P127, DOI 10.1016/j.jviromet.2005.10.009; Jeon WJ, 2008, VIRUS RES, V137, P153, DOI 10.1016/j.virusres.2008.06.013; Kiss I, 2006, ACTA VET HUNG, V54, P525, DOI 10.1556/AVet.54.2006.4.10; Kuscu B, 2008, J VET SCI, V9, P15, DOI 10.4142/jvs.2008.9.1.15; Lemus JA, 2009, ENVIRON POLLUT, V157, P2421, DOI 10.1016/j.envpol.2009.03.013; Lemus J. A., 2009, VULTURES SUPPLEMENTA, P374; Lemus JA, 2009, P ROY SOC B-BIOL SCI, V276, P2307, DOI 10.1098/rspb.2009.0071; Lemus JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001444; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217; Margalida A, 2003, IBIS, V145, P244, DOI 10.1046/j.1474-919X.2003.00148.x; Margalida A, 2010, J APPL ECOL, V47, P931, DOI 10.1111/j.1365-2664.2010.01835.x; Mekkes DR, 2005, AVIAN PATHOL, V34, P348, DOI 10.1080/03079450500179954; Muller H, 2003, VET MICROBIOL, V97, P153, DOI 10.1016/j.vetmic.2003.08.005; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Potti J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001276; Prescott J. F., 2000, ANTIMICROBIAL THERAP; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Schettler E, 2003, J WILDLIFE DIS, V39, P57, DOI 10.7589/0090-3558-39.1.57; Schrenzel M, 2007, J VET DIAGN INVEST, V19, P479, DOI 10.1177/104063870701900504; Selgrade MK, 2007, TOXICOL SCI, V100, P328, DOI 10.1093/toxsci/kfm244; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; SOINE C, 1993, AVIAN DIS, V37, P467, DOI 10.2307/1591674; SYLVESTER SA, 2006, INDIAN J POULTRY SCI, V3, P283; Tadese T, 2003, J VET DIAGN INVEST, V15, P141, DOI 10.1177/104063870301500208; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Wray C., 2000, SALMONELLA DOMESTIC; Zhang Y, 2006, ARCH VIROL, V151, P1525, DOI 10.1007/s00705-006-0731-1	61	5	5	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14163	10.1371/journal.pone.0014163	http://dx.doi.org/10.1371/journal.pone.0014163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152405	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100040
J	Brinkhof, MWG; Spycher, BD; Yiannoutsos, C; Weigel, R; Wood, R; Messou, E; Boulle, A; Egger, M; Sterne, JAC				Brinkhof, Martin W. G.; Spycher, Ben D.; Yiannoutsos, Constantin; Weigel, Ralf; Wood, Robin; Messou, Eugene; Boulle, Andrew; Egger, Matthias; Sterne, Jonathan A. C.		Int Epidemiological Database Evalu	Adjusting Mortality for Loss to Follow-Up: Analysis of Five ART Programmes in Sub-Saharan Africa	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; RAPID SCALE-UP; ANTIRETROVIRAL THERAPY; SURVIVAL CURVES; COHORT PROFILE; RISK-FACTORS; LOW-INCOME; OUTCOMES; AIDS; CARE	Background: Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because many patients are lost to follow-up. Outcomes in these patients are generally unknown but studies tracing patients have shown mortality to be high. We adjusted programme-level mortality in the first year of antiretroviral treatment (ART) for excess mortality in patients lost to follow-up. Methods and Findings: Treatment-naive patients starting combination ART in five programmes in Cote d'Ivoire, Kenya, Malawi and South Africa were eligible. Patients whose last visit was at least nine months before the closure of the database were considered lost to follow-up. We filled missing survival times in these patients by multiple imputation, using estimates of mortality from studies that traced patients lost to follow-up. Data were analyzed using Weibull models, adjusting for age, sex, ART regimen, CD4 cell count, clinical stage and treatment programme. A total of 15,915 HIV-infected patients (median CD4 cell count 110 cells/mu L, median age 35 years, 68% female) were included; 1,001 (6.3%) were known to have died and 1,285 (14.3%) were lost to follow-up in the first year of ART. Crude estimates of mortality at one year ranged from 5.7% (95% CI 4.9-6.5%) to 10.9% (9.6-12.4%) across the five programmes. Estimated mortality hazard ratios comparing patients lost to follow-up with those remaining in care ranged from 6 to 23. Adjusted estimates based on these hazard ratios ranged from 10.2% (8.9-11.6%) to 16.9% (15.0-19.1%), with relative increases in mortality ranging from 27% to 73% across programmes. Conclusions: Naive survival analysis ignoring excess mortality in patients lost to follow-up may greatly underestimate overall mortality, and bias ART programme evaluations. Adjusted mortality estimates can be obtained based on excess mortality rates in patients lost to follow-up.	[Brinkhof, Martin W. G.; Spycher, Ben D.; Egger, Matthias] Univ Bern, Div Int & Environm Hlth, ISPM, Bern, Switzerland; [Yiannoutsos, Constantin] Indiana Univ, Div Biostat, Indianapolis, IN 46204 USA; [Weigel, Ralf] Kamuzu Cent Hosp, Lighthouse Trust, Lilongwe, Malawi; [Weigel, Ralf] Minist Hlth, Lilongwe, Malawi; [Wood, Robin] Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Messou, Eugene] Programme PAC CI, Abidjan, Cote Ivoire; [Boulle, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Sterne, Jonathan A. C.] Univ Bristol, Dept Social Med, Bristol, Avon, England	University of Bern; Indiana University System; Indiana University-Purdue University Indianapolis; University of Cape Town; University of Cape Town; University of Bristol	Brinkhof, MWG (corresponding author), Univ Bern, Div Int & Environm Hlth, ISPM, Bern, Switzerland.	egger@ispm.unibe.ch	Weigel, Ralf/ABD-2310-2020; Wood, Robin/G-8509-2011; Sterne, Jonathan/Z-3106-2019; Boulle, Andrew/C-1413-2008; Spycher, Ben D/B-3308-2008	Weigel, Ralf/0000-0001-9034-2634; Sterne, Jonathan/0000-0001-8496-6053; Boulle, Andrew/0000-0002-7713-8062; Spycher, Ben D/0000-0002-1430-5695; Brinkhof, Martin/0000-0002-9319-665X; Egger, Matthias/0000-0001-7462-5132	Office of AIDS Research (OAR) of the National Institutes of Health (NIH); Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS); National Institute of Allergy and Infectious Diseases (NIAID) [U01-AI069924, U01-AI069911, U01-AI069919]; United Kingdom Medical Research Council (MRC) [G0600599]; NIH [U01-AI069911-04S2]; Medical Research Council [G0600599] Funding Source: researchfish; MRC [G0600599] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, U01AI069919, U01AI069911] Funding Source: NIH RePORTER	Office of AIDS Research (OAR) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Office of AIDS Research (OAR) of the National Institutes of Health (NIH), the Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), and the National Institute of Allergy and Infectious Diseases (NIAID, grants U01-AI069924, U01-AI069911, U01-AI069919). JACS was supported by United Kingdom Medical Research Council (MRC) grant G0600599. CY was supported by NIH grant U01-AI069911-04S2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MW, 2009, BIOMETRICS, V65, P301, DOI 10.1111/j.1541-0420.2008.01043.x; Bartlett JA, 2009, LANCET INFECT DIS, V9, P637, DOI 10.1016/S1473-3099(09)70227-0; Bekker LG, 2006, SAMJ S AFR MED J, V96, P315; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P657; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; BRINKHOF MW, 2008, B WORLD HEALTH ORGAN, V86, P497; Chi BH, 2010, AM J EPIDEMIOL, V171, P924, DOI 10.1093/aje/kwq008; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Frangakis CE, 2001, BIOMETRICS, V57, P333, DOI 10.1111/j.0006-341X.2001.00333.x; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; GENG EH, 2009, J ACQ IMMUN DEF SYND, V53, P405; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; HOCHGESANG M, 2006, AIDS 2006 16 INT AID; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Ndiaye B, 2009, AIDS, V23, P1786, DOI 10.1097/QAD.0b013e32832e3469; Ndiaye B, 2009, ANTIVIR THER, V14, P567; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; PHIRI S, 2004, LIGHTHOUSE CTR COMPR; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	35	66	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14149	10.1371/journal.pone.0014149	http://dx.doi.org/10.1371/journal.pone.0014149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152392	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100028
J	Hoelen, H; Kleizen, B; Schmidt, A; Richardson, J; Charitou, P; Thomas, PJ; Braakman, I				Hoelen, Hanneke; Kleizen, Bertrand; Schmidt, Andre; Richardson, John; Charitou, Paraskevi; Thomas, Philip J.; Braakman, Ineke			The Primary Folding Defect and Rescue of Delta F508 CFTR Emerge during Translation of the Mutant Domain	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; CYSTIC-FIBROSIS; GENE; MUTATION; CHANNEL; DEGRADATION; DISRUPTION; PROTEASOME; PHENOTYPE	In the vast majority of cystic fibrosis (CF) patients, deletion of residue F508 from CFTR is the cause of disease. F508 resides in the first nucleotide binding domain (NBD1) and its absence leads to CFTR misfolding and degradation. We show here that the primary folding defect arises during synthesis, as soon as NBD1 is translated. Introduction of either the I539T or G550E suppressor mutation in NBD1 partially rescues Delta F508 CFTR to the cell surface, but only I539T repaired Delta F508 NBD1. We demonstrated rescue of folding and stability of NBD1 from full-length Delta F508 CFTR expressed in cells to isolated purified domain. The co-translational rescue of Delta F508 NBD1 misfolding in CFTR by I539T advocates this domain as the most important drug target for cystic fibrosis.	[Hoelen, Hanneke; Kleizen, Bertrand; Charitou, Paraskevi; Braakman, Ineke] Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Schmidt, Andre; Richardson, John; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Utrecht University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hoelen, H (corresponding author), Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	i.braakman@uu.nl	Thomas, Philip J/F-7115-2012	Kleizen, Bertrand/0000-0002-4640-1796; Braakman, Ineke/0000-0003-1592-4364	Netherlands Organisation for Scientific Research (NWO); Division of Health Research and Development (ZonMW); Cystic Fibrosis Foundation; National Institutes of Health [DK49835, DE12309]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835, R01DK049835] Funding Source: NIH RePORTER	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Division of Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Netherlands Organisation for Scientific Research (NWO), Division of Health Research and Development (ZonMW) (IB), the Cystic Fibrosis Foundation (IB and PJT) and by National Institutes of Health (PJT; DK49835 and DE12309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Buchner J, 2005, PROTEIN FOLDING HANDBOOK, P1, DOI 10.1002/9783527619498; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Myerson JW, 2010, FASEB J, V24; Ostedgaard LS, 1997, BIOCHEMISTRY-US, V36, P1287, DOI 10.1021/bi962174s; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Sun X, 2008, J CLIN INVEST, V118, P1578, DOI 10.1172/JCI34599; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; THIBODEAU PH, 2010, J BIOL CHEM; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	50	69	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15458	10.1371/journal.pone.0015458	http://dx.doi.org/10.1371/journal.pone.0015458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152102	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100086
J	Lindeman, LC; Reiner, AH; Mathavan, S; Alestrom, P; Collas, P				Lindeman, Leif C.; Reiner, Andrew H.; Mathavan, Sinnakaruppan; Alestroem, Peter; Collas, Philippe			Tiling Histone H3 Lysine 4 and 27 Methylation in Zebrafish Using High-Density Microarrays	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; DIFFERENTIATED CELLS; GENOME; CHROMATIN; PATTERNS; GENES; PLURIPOTENT; MARKS; POLYCOMB	Background: Uncovering epigenetic states by chromatin immunoprecipitation and microarray hybridization (ChIP-chip) has significantly contributed to the understanding of gene regulation at the genome-scale level. Many studies have been carried out in mice and humans; however limited high-resolution information exists to date for non-mammalian vertebrate species. Principal Findings: We report a 2.1-million feature high-resolution Nimblegen tiling microarray for ChIP-chip interrogations of epigenetic states in zebrafish (Danio rerio). The array covers 251 megabases of the genome at 92 base-pair resolution. It includes similar to 15 kb of upstream regulatory sequences encompassing all RefSeq promoters, and over 5 kb in the 59 end of coding regions. We identify with high reproducibility, in a fibroblast cell line, promoters enriched in H3K4me3, H3K27me3 or co-enriched in both modifications. ChIP-qPCR and sequential ChIP experiments validate the ChIP-chip data and support the co-enrichment of trimethylated H3K4 and H3K27 on a subset of genes. H3K4me3- and/or H3K27me3-enriched genes are associated with distinct transcriptional status and are linked to distinct functional categories. Conclusions: We have designed and validated for the scientific community a comprehensive high-resolution tiling microarray for investigations of epigenetic states in zebrafish, a widely used developmental and disease model organism.	[Lindeman, Leif C.; Reiner, Andrew H.; Collas, Philippe] Univ Oslo, Inst Basic Med Sci, Fac Med, Oslo, Norway; [Lindeman, Leif C.; Reiner, Andrew H.; Collas, Philippe] Univ Oslo, Norwegian Ctr Stem Cell Res, Oslo, Norway; [Mathavan, Sinnakaruppan] Genome Inst Singapore, Singapore, Singapore; [Alestroem, Peter] Norwegian Sch Vet Sci, BasAM, Oslo, Norway	University of Oslo; University of Oslo; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Norwegian University of Life Sciences	Lindeman, LC (corresponding author), Univ Oslo, Inst Basic Med Sci, Fac Med, Oslo, Norway.	philippe.collas@medisin.uio.no			Norwegian Research Council of Norway	Norwegian Research Council of Norway(Research Council of Norway)	This work was funded by grants from the Norwegian Research Council of Norway to PA and PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LG, 2007, BIOTECHNIQUES, V43, P791, DOI 10.2144/000112625; Akkers RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008820; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Dahl JA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r13; Delbarre E, 2010, MOL BIOL CELL, V21, P1872, DOI 10.1091/mbc.E09-09-0839; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Sorensen AL, 2010, MOL BIOL CELL, V21, P2066, DOI 10.1091/mbc.E10-01-0018; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	34	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15651	10.1371/journal.pone.0015651	http://dx.doi.org/10.1371/journal.pone.0015651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187971	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200057
J	Zanet, J; Freije, A; Ruiz, M; Coulon, V; Sanz, JR; Chiesa, J; Gandarillas, A				Zanet, Jennifer; Freije, Ana; Ruiz, Maria; Coulon, Vincent; Sanz, J. Ramon; Chiesa, Jean; Gandarillas, Alberto			A Mitosis Block Links Active Cell Cycle with Human Epidermal Differentiation and Results in Endoreplication	PLOS ONE			English	Article							STEM-CELLS; TRANSGENIC MICE; CHROMOSOME SEGREGATION; INVOLUCRIN SYNTHESIS; HUMAN KERATINOCYTES; EXPRESSION; MYC; ENDOREDUPLICATION; MOUSE; SKIN	How human self-renewal tissues co-ordinate proliferation with differentiation is unclear. Human epidermis undergoes continuous cell growth and differentiation and is permanently exposed to mutagenic hazard. Keratinocytes are thought to arrest cell growth and cell cycle prior to terminal differentiation. However, a growing body of evidence does not satisfy this model. For instance, it does not explain how skin maintains tissue structure in hyperproliferative benign lesions. We have developed and applied novel cell cycle techniques to human skin in situ and determined the dynamics of key cell cycle regulators of DNA replication or mitosis, such as cyclins E, A and B, or members of the anaphase promoting complex pathway: cdc14A, Ndc80/Hec1 and Aurora kinase B. The results show that actively cycling keratinocytes initiate terminal differentiation, arrest in mitosis, continue DNA replication in a special G2/M state, and become polyploid by mitotic slippage. They unambiguously demonstrate that cell cycle progression coexists with terminal differentiation, thus explaining how differentiating cells increase in size. Epidermal differentiating cells arrest in mitosis and a genotoxic-induced mitosis block rapidly pushes epidermal basal cells into differentiation and polyploidy. These observations unravel a novel mitosis-differentiation link that provides new insight into skin homeostasis and cancer. It might constitute a self-defence mechanism against oncogenic alterations such as Myc deregulation.	[Freije, Ana; Ruiz, Maria; Sanz, J. Ramon; Gandarillas, Alberto] Univ Cantabria, Cell Cycle Stem Cell Decis & Canc Lab, Res & Training Inst, Fdn Marques Valdecilla IFMAV FMDV,Mol Biol Dept, E-39005 Santander, Spain; [Zanet, Jennifer; Coulon, Vincent; Gandarillas, Alberto] INSERM, Lab Dermatol Mol, UPRES EA3754, Inst Univ Rech Clin,UMI, Montpellier, France; [Gandarillas, Alberto] INSERM, ADR Languedoc Roussillon, Montpellier, France; [Chiesa, Jean] CHU Nimes, Unite Fonct Cytogenet Antenatale & Oncol, Nimes, France; [Sanz, J. Ramon] HUMV, Serv Cirugia Plast, Santander, Spain	Universidad de Cantabria; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Hospital Universitario Marques de Valdecilla (HUMV)	Zanet, J (corresponding author), INSERM, Lab Dermatol Mol, UPRES EA3754, Inst Univ Rech Clin,UMI, Montpellier, France.	gandarillasa@unican.es	Coulon, Vincent/B-2437-2009; Coulon, Vincent/AFF-7934-2022	Coulon, Vincent/0000-0002-3168-8755; Coulon, Vincent/0000-0002-3168-8755; RUIZ SOTO, MARIA/0000-0003-2672-1407	Association pour la Recherce sur le Cancer (ARC; France); La Ligue Nationale contre le Cancer and La Ligue de l'Herault (France); Societe Francaise de Dermatologie (France); Instituto de Salud Carlos III (ISCIII-Programa Regiones Emergentes; Spain); Fondo de Investigaciones Sanitarias (Spain) [ISCIII-FIS: PI080890]; French Council; ISCIII (Spain); Fundacion Marques de Valdecilla - Instituto de Formacion e Investigacion Marques de Valdecilla (FMDV-IFIMAV; Spain)	Association pour la Recherce sur le Cancer (ARC; France); La Ligue Nationale contre le Cancer and La Ligue de l'Herault (France); Societe Francaise de Dermatologie (France); Instituto de Salud Carlos III (ISCIII-Programa Regiones Emergentes; Spain)(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias (Spain)(Instituto de Salud Carlos III); French Council; ISCIII (Spain)(Instituto de Salud Carlos III); Fundacion Marques de Valdecilla - Instituto de Formacion e Investigacion Marques de Valdecilla (FMDV-IFIMAV; Spain)	This work was funded by the Association pour la Recherce sur le Cancer (ARC; France), La Ligue Nationale contre le Cancer and La Ligue de l'Herault (France), Societe Francaise de Dermatologie (France), Instituto de Salud Carlos III (ISCIII-Programa Regiones Emergentes; Spain), and Fondo de Investigaciones Sanitarias (ISCIII-FIS: PI080890; Spain). JZ was the recipient of a fellowship from the French Council, AG and MR received fellowships from ISCIII (Spain), and AF received a fellowship from the Fundacion Marques de Valdecilla - Instituto de Formacion e Investigacion Marques de Valdecilla (FMDV-IFIMAV; Spain). AG also belongs to the INSERM (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalaf M, 1999, ONCOGENE, V18, P1419, DOI 10.1038/sj.onc.1202448; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; BATACSORGO Z, 1993, J EXP MED, V178, P1271, DOI 10.1084/jem.178.4.1271; CHIESA J, 1995, VISUALISATION NUCL A, P185; Dazard JE, 2000, ONCOGENE, V19, P3693, DOI 10.1038/sj.onc.1203695; de Marval PLM, 2001, AM J PATHOL, V159, P369, DOI 10.1016/S0002-9440(10)61703-8; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dick FA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-26; DOVER R, 1987, J INVEST DERMATOL, V89, P349, DOI 10.1111/1523-1747.ep12471751; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Flores I, 2004, ONCOGENE, V23, P5923, DOI 10.1038/sj.onc.1207796; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; Gandarillas A, 2000, ONCOGENE, V19, P3278, DOI 10.1038/sj.onc.1203630; Garcia P, 2000, ONCOGENE, V19, P1820, DOI 10.1038/sj.onc.1203494; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Harvat BL, 1998, J CELL SCI, V111, P1185; Hauser PJ, 1998, ONCOGENE, V17, P3083, DOI 10.1038/sj.onc.1202235; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; IBRAHIM J, 1985, ARCH ORAL BIOL, V30, P627, DOI 10.1016/0003-9969(85)90084-6; ISHIDA R, 1991, CANCER RES, V51, P4909; JACK EM, 1990, HEPATOLOGY, V11, P286, DOI 10.1002/hep.1840110220; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; KARALOVA E M, 1988, Byulleten' Eksperimental'noi Biologii i Meditsiny, V106, P604; KARTASOVA T, 1992, MOL CARCINOGEN, V6, P18, DOI 10.1002/mc.2940060105; Kasili R, 2010, GENETICS, V185, P257, DOI 10.1534/genetics.109.113274; KIRK D, 1980, CELL BIOL INT REP, V4, P83, DOI 10.1016/0309-1651(80)90013-2; Kondorosi E, 2000, CURR OPIN PLANT BIOL, V3, P488, DOI 10.1016/S1369-5266(00)00118-7; Larkins BA, 2001, J EXP BOT, V52, P183, DOI 10.1093/jexbot/52.355.183; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; MacAuley A, 1998, MOL BIOL CELL, V9, P795, DOI 10.1091/mbc.9.4.795; Macias E, 2008, CANCER RES, V68, P162, DOI 10.1158/0008-5472.CAN-07-2461; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mandrioli M, 2010, Q REV BIOL, V85, P159, DOI 10.1086/652341; Mantel C, 2008, CELL CYCLE, V7, P484, DOI 10.4161/cc.7.4.5316; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Mena AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013037; Mills AD, 2000, NAT CELL BIOL, V2, P244, DOI 10.1038/35008670; MULLER R, 1995, TRENDS GENET, V11, P173, DOI 10.1016/S0168-9525(00)89039-3; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; NAKATANI S, 1992, ARCH DERMATOL RES, V284, P349, DOI 10.1007/BF00372038; Paramio JM, 1999, MOL CELL BIOL, V19, P3086; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; PENNEYS NS, 1970, ARCH DERMATOL, V101, P323, DOI 10.1001/archderm.101.3.323; Pierce AM, 1998, P NATL ACAD SCI USA, V95, P8858, DOI 10.1073/pnas.95.15.8858; PINKUS H, 1966, ARCH DERMATOL, V94, P351, DOI 10.1001/archderm.94.3.351; Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035; REGNIER M, 1986, J INVEST DERMATOL, V87, P472, DOI 10.1111/1523-1747.ep12455517; Rheinwald JG., 1989, CELL GROWTH DIVISION, P81; Robles AI, 1996, P NATL ACAD SCI USA, V93, P7634, DOI 10.1073/pnas.93.15.7634; Rodriguez-Puebla ML, 2000, AM J PATHOL, V157, P1039, DOI 10.1016/S0002-9440(10)64616-0; Santos M, 2002, J BIOL CHEM, V277, P35371, DOI 10.1074/jbc.M205143200; SAUER K, 1995, GENE DEV, V9, P1327, DOI 10.1101/gad.9.11.1327; Schellmann S, 2005, INT J DEV BIOL, V49, P579, DOI 10.1387/ijdb.051983ss; Schindler K, 2009, BIOL REPROD, V80, P795, DOI 10.1095/biolreprod.108.074906; SUN TT, 1976, CELL, V9, P511, DOI 10.1016/0092-8674(76)90033-7; TOUNEKTI O, 1993, CANCER RES, V53, P5462; Traas J, 1998, CURR OPIN PLANT BIOL, V1, P498, DOI 10.1016/S1369-5266(98)80042-3; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; VAUGHAN FL, 1976, MOL CELL BIOCHEM, V12, P171, DOI 10.1007/BF01741715; Vinardell JM, 2003, PLANT CELL, V15, P2093, DOI 10.1105/tpc.014373; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; WATT FM, 1981, J CELL BIOL, V90, P738, DOI 10.1083/jcb.90.3.738; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298; Zimmet JM, 1997, MOL CELL BIOL, V17, P7248, DOI 10.1128/MCB.17.12.7248	74	74	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15701	10.1371/journal.pone.0015701	http://dx.doi.org/10.1371/journal.pone.0015701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187932	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200065
J	Basile, LFH; Lozano, MD; Alvarenga, MY; Pereira, JF; Machado, S; Velasques, B; Ribeiro, P; Piedade, R; Anghinah, R; Knyazev, G; Ramos, RT				Basile, Luis F. H.; Lozano, Mirna D.; Alvarenga, Milkes Y.; Pereira, Jose F., Jr.; Machado, Sergio; Velasques, Bruna; Ribeiro, Pedro; Piedade, Roberto; Anghinah, Renato; Knyazev, Gennady; Ramos, Renato T.			Minor and Unsystematic Cortical Topographic Changes of Attention Correlates between Modalities	PLOS ONE			English	Article							FUNCTIONAL MRI; BRAIN; GENERATION; CORTEX; TASKS; RECONSTRUCTIONS; OSCILLATIONS; VARIABILITY; RELIABILITY; POTENTIALS	In this study we analyzed the topography of induced cortical oscillations in 20 healthy individuals performing simple attention tasks. We were interested in qualitatively replicating our recent findings on the localization of attention-induced beta bands during a visual task [1], and verifying whether significant topographic changes would follow the change of attention to the auditory modality. We computed corrected latency averaging of each induced frequency bands, and modeled their generators by current density reconstruction with Lp-norm minimization. We quantified topographic similarity between conditions by an analysis of correlations, whereas the inter-modality significant differences in attention correlates were illustrated in each individual case. We replicated the qualitative result of highly idiosyncratic topography of attention-related activity to individuals, manifested both in the beta bands, and previously studied slow potential distributions [2]. Visual inspection of both scalp potentials and distribution of cortical currents showed minor changes in attention-related bands with respect to modality, as compared to the theta and delta bands, known to be major contributors to the sensory-related potentials. Quantitative results agreed with visual inspection, supporting to the conclusion that attention-related activity does not change much between modalities, and whatever individual changes do occur, they are not systematic in cortical localization across subjects. We discuss our results, combined with results from other studies that present individual data, with respect to the function of cortical association areas.	[Basile, Luis F. H.; Lozano, Mirna D.; Ramos, Renato T.] Univ Metodista Sao Paulo, Fac Saude, Psychophysiol Lab, Sao Paulo, Brazil; [Basile, Luis F. H.; Alvarenga, Milkes Y.; Pereira, Jose F., Jr.] Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, Brazil; [Machado, Sergio; Velasques, Bruna; Ribeiro, Pedro; Piedade, Roberto] Univ Fed Rio de Janeiro, Dept Psychiat, Rio De Janeiro, Brazil; [Ramos, Renato T.] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil; [Anghinah, Renato] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil; [Alvarenga, Milkes Y.] Univ Sao Judas Tadeu, Sao Paulo, Brazil; [Knyazev, Gennady] Russian Acad Med Sci, Inst Physiol, Siberian Branch, Novosibirsk, Russia	Universidade Metodista de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Sao Judas Tadeu; Research Institute for Neurosciences & Medicine; Russian Academy of Medical Sciences; Russian Academy of Sciences	Basile, LFH (corresponding author), Univ Metodista Sao Paulo, Fac Saude, Psychophysiol Lab, Sao Paulo, Brazil.	lbasile@usp.br	Ramos, Renato T/G-1566-2013; Pereira Júnior, José Francisco/D-9804-2013; Knyazev, Gennady G/F-6095-2010; Machado, Sergio/M-9384-2013; Velasques, Bruna/D-3989-2012	Pereira Júnior, José Francisco/0000-0002-1185-8147; Knyazev, Gennady G/0000-0002-8628-4678; Machado, Sergio/0000-0001-8946-8467; 	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [07/50390-9]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grant 07/50390-9 from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbas H, 1992, Adv Neurol, V57, P91; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P91, DOI 10.1016/S0167-8760(00)00135-5; BASILE LFH, 1994, ELECTROEN CLIN NEURO, V90, P157, DOI 10.1016/0013-4694(94)90007-8; Basile LFH, 2004, BRAZ J MED BIOL RES, V37, P97, DOI 10.1590/S0100-879X2004000100014; Basile LFH, 2003, INT J PSYCHOPHYSIOL, V48, P55, DOI 10.1016/S0167-8760(03)00004-7; Basile LFH, 2002, INT J PSYCHOPHYSIOL, V45, P227, DOI 10.1016/S0167-8760(02)00014-4; Basile LFH, 1997, INT J PSYCHOPHYSIOL, V27, P29, DOI 10.1016/S0167-8760(97)00784-8; BASILE LFH, 1998, COCAINA CRACK ABUSO; Basile LFH, 2007, BIOL RES, V40, P451, DOI [10.4067/S0716-97602007000500007, /S0716-97602007000500007]; Basile LFH, 2007, INT J PSYCHOPHYSIOL, V65, P238, DOI 10.1016/j.ijpsycho.2007.05.001; Basile LFH, 2006, INT J PSYCHOPHYSIOL, V61, P149, DOI 10.1016/j.ijpsycho.2005.09.004; Brannen JH, 2001, AM J NEURORADIOL, V22, P1711; Buchner H, 1997, ELECTROEN CLIN NEURO, V102, P267, DOI 10.1016/S0013-4694(96)95698-9; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; Fell J, 2004, J COGNITIVE NEUROSCI, V16, P1595, DOI 10.1162/0898929042568514; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; Gruber WR, 2005, CEREB CORTEX, V15, P371, DOI 10.1093/cercor/bhh139; Hanslmayr S, 2007, CEREB CORTEX, V17, P1, DOI 10.1093/cercor/bhj129; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; Hudson AJ, 2000, CAN J NEUROL SCI, V27, P2, DOI 10.1017/S0317167100051908; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Macko K A, 1985, Res Publ Assoc Res Nerv Ment Dis, V63, P73; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; Mazoyer, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Mechelli A, 2002, NEUROIMAGE, V17, P1459, DOI 10.1006/nimg.2002.1231; Noppeney U, 2004, J ANAT, V205, P433, DOI 10.1111/j.0021-8782.2004.00343.x; Otzenberger H, 2005, NEUROPSYCHOLOGY, V19, P484, DOI 10.1037/0894-4105.19.4.484; Pandya D. N., 1988, COMP PRIMATE BIOL, V4, P39; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Seghier ML, 2007, NEUROIMAGE, V36, P594, DOI 10.1016/j.neuroimage.2007.03.021; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Valencia M, 2006, J NEUROSCI METH, V154, P142, DOI 10.1016/j.jneumeth.2005.12.011; Wei XC, 2004, NEUROIMAGE, V21, P1000, DOI 10.1016/j.neuroimage.2003.10.039; [No title captured]	39	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15022	10.1371/journal.pone.0015022	http://dx.doi.org/10.1371/journal.pone.0015022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698DS	21179421	gold, Green Submitted, Green Published			2022-12-27	WOS:000285572900013
J	Saraiva, LM; da Silva, GSS; Galina, A; da-Silva, WS; Klein, WL; Ferreira, ST; De Felice, FG				Saraiva, Leonardo M.; Seixas da Silva, Gisele S.; Galina, Antonio; da-Silva, Wagner S.; Klein, William L.; Ferreira, Sergio T.; De Felice, Fernanda G.			Amyloid-beta Triggers the Release of Neuronal Hexokinase 1 from Mitochondria	PLOS ONE			English	Article							SOLUBLE-PROTEIN OLIGOMERS; A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TAU-HYPERPHOSPHORYLATION; GLUCOSE-METABOLISM; NEUROTOXICITY; HIPPOCAMPAL; DEPOSITION; MECHANISM	Brain accumulation of the amyloid-beta peptide (A beta) and oxidative stress underlie neuronal dysfunction and memory loss in Alzheimer's disease (AD). Hexokinase (HK), a key glycolytic enzyme, plays important pro-survival roles, reducing mitochondrial reactive oxygen species (ROS) generation and preventing apoptosis in neurons and other cell types. Brain isozyme HKI is mainly associated with mitochondria and HK release from mitochondria causes a significant decrease in enzyme activity and triggers oxidative damage. We here investigated the relationship between A beta-induced oxidative stress and HK activity. We found that A beta triggered HKI detachment from mitochondria decreasing HKI activity in cortical neurons. A beta oligomers further impair energy metabolism by decreasing neuronal ATP levels. A beta-induced HKI cellular redistribution was accompanied by excessive ROS generation and neuronal death. 2-deoxyglucose blocked A beta-induced oxidative stress and neuronal death. Results suggest that A beta-induced cellular redistribution and inactivation of neuronal HKI play important roles in oxidative stress and neurodegeneration in AD.	[Saraiva, Leonardo M.; Seixas da Silva, Gisele S.; Galina, Antonio; da-Silva, Wagner S.; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil; [Klein, William L.; De Felice, Fernanda G.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Universidade Federal do Rio de Janeiro; Northwestern University	Saraiva, LM (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil.	felice@bioqmed.ufrj.br	Galina, Antonio/A-9292-2008; De Felice, Fernanda G/M-1074-2017; da Silva, Gisele S Seixas/J-7628-2017; Ferreira, Sergio/AAZ-1576-2020; da Silva, Wagner S/A-7835-2008	Ferreira, Sergio/0000-0001-7160-9866; da Silva, Wagner S/0000-0002-0001-0386	Human Frontier Science Program (HFSP); John Simon Guggenheim Memorial Foundation; Howard Hughes Medical Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro/Brazil; Instituto Nacional de Neurociencia Translacional/Brazil; American Health Assistance Foundation; Alzheimer's Association; National Institutes of Health-National Institute on Aging [RO1-AG18877, RO1-AG22547]; NATIONAL INSTITUTE ON AGING [R01AG018877, R01AG022547] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP)(Human Frontier Science Program); John Simon Guggenheim Memorial Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro/Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Neurociencia Translacional/Brazil; American Health Assistance Foundation; Alzheimer's Association(Alzheimer's Association); National Institutes of Health-National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Human Frontier Science Program (HFSP) and The John Simon Guggenheim Memorial Foundation (FGF), Howard Hughes Medical Institute (STF), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro/Brazil and Instituto Nacional de Neurociencia Translacional/Brazil (FGF and STF). WLK is supported by grants from the American Health Assistance Foundation, Alzheimer's Association, National Institutes of Health-National Institute on Aging Grants RO1-AG18877 and RO1-AG22547. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andersson CX, 2005, BIOCHEM J, V387, P377, DOI 10.1042/BJ20041387; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Baum L, 1996, MOL CHEM NEUROPATHOL, V29, P253, DOI 10.1007/BF02815006; Bigl M, 2003, J NEURAL TRANSM, V110, P77, DOI 10.1007/s00702-002-0772-x; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang TJ, 2005, MOL CELL NEUROSCI, V28, P42, DOI 10.1016/j.mcn.2004.08.009; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Jolivet Renaud, 2009, Front Neuroenergetics, V1, P4, DOI 10.3389/neuro.14.004.2009; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mark RJ, 1997, J NEUROSCI, V17, P1046; Martins SM, 2006, J BIOL CHEM, V281, P26121, DOI 10.1074/jbc.M605367200; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Moreira PI, 2005, ANN NY ACAD SCI, V1043, P545, DOI 10.1196/annals.1333.062; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015; Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; ROSE IA, 1967, J BIOL CHEM, V242, P1635; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P418, DOI 10.1093/jnen/63.5.418; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; Skaff DA, 2005, J BIOL CHEM, V280, P38403, DOI 10.1074/jbc.M506943200; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang Z, 2008, NEUROSCI LETT, V434, P6, DOI 10.1016/j.neulet.2008.01.057; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147	52	71	75	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15230	10.1371/journal.pone.0015230	http://dx.doi.org/10.1371/journal.pone.0015230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179577	Green Submitted, Green Published, gold			2022-12-27	WOS:000285381200018
J	Anne, J				Anne, Joel			Targeting and Anchoring Tudor in the Pole Plasm of the Drosophila Oocyte	PLOS ONE			English	Article							GERM-CELL FORMATION; VASA PROTEIN; METHYLTRANSFERASE CAPSULEEN; POSTERIOR LOCALIZATION; OSKAR TRANSLATION; COMPONENT; GRANULES; GENE; MELANOGASTER; POLARITY	Background: Germline formation is a highly regulated process in all organisms. In Drosophila embryos germ cells are specified by the pole plasm, a specialized cytoplasmic region containing polar granules. Components of these granules are also present in the perinuclear ring surrounding nurse cells, the nuage. Two such molecules are the Vasa and Tudor proteins. How Tudor localizes and is maintained in the pole plasm is, however, not known. Methodology/Principal Findings: Here, the process of Tudor localization in nuage and pole plasm was analyzed. The initial positioning of Tudor at the posterior pole of stage 9 oocytes was found to occur in the absence of a structurally detectable nuage. However, in mutants for genes encoding components of the nuage, including vasa, aubergine, maelstrom, and krimper, Tudor was detached from the posterior cortex in stage 10 oocytes, suggesting a prior passage in the nuage for its stability in the pole plasm. Further studies indicated that Valois, which was previously shown to bind in vitro to Tudor, mediates the localization of Tudor in the pole plasm by physically interacting with Oskar, the polar granule organizer. An association between Tudor and Vasa mediated by RNA was also detected in ovarian extracts. Conclusions/Significance: The present data challenge the view that the assembly of the polar granules occurs in a stepwise and hierarchical manner and, consequently, a revised model of polar granule assembly is proposed. In this model Oskar recruits two downstream components of the polar granules, Vasa and Tudor, independently from each other: Vasa directly interacts with Oskar while Valois mediates the recruitment of Tudor by interacting with Oskar and Tudor.	[Anne, Joel] Deutsch Krebsforschungszentrum, Dept Dev Genet, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Anne, J (corresponding author), Univ Bern, Inst Biol Cellulaire, Bern, Switzerland.	joel.anne@izb.unibe.ch			Deutsches Krebsforschungszentrum (DKFZ)	Deutsches Krebsforschungszentrum (DKFZ)(Helmholtz Association)	Research was funded by the Deutsches Krebsforschungszentrum (DKFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikura R, 2001, MECH DEVELOP, V107, P97, DOI 10.1016/S0925-4773(01)00455-5; Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; BARDSLEY A, 1993, DEVELOPMENT, V119, P207; BEAMS HW, 1974, INT REV CYTOL, V39, P413, DOI 10.1016/S0074-7696(08)60944-4; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Clegg NJ, 1997, DEVELOPMENT, V124, P4661; EDDY EM, 1975, INT REV CYTOL, V43, P229; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Harris AN, 2001, DEVELOPMENT, V128, P2823; HAY B, 1988, DEVELOPMENT, V103, P625; HAY B, 1990, DEVELOPMENT, V109, P425; Jones JR, 2007, DEVELOPMENT, V134, P233, DOI 10.1242/dev.02729; JONGENS TA, 1992, CELL, V70, P569, DOI 10.1016/0092-8674(92)90427-E; KIM JS, 1993, PROTEIN SCI, V2, P348; Kirino Y, 2010, J BIOL CHEM, V285, P8148, DOI 10.1074/jbc.M109.089821; KOBAYASHI S, 1993, SCIENCE, V260, P1521, DOI 10.1126/science.7684857; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Mahowald AP, 2001, INT REV CYTOL, V203, P187; MAHOWALD AP, 1978, GENET BIOL DROSOPHIL, V2, P141; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; RONGO C, 1995, DEVELOPMENT, V121, P2737; Sano H, 2002, MECH DEVELOP, V112, P129, DOI 10.1016/S0925-4773(01)00654-2; Snee MJ, 2004, J CELL SCI, V117, P2109, DOI 10.1242/jcs.01059; Styhler S, 1998, DEVELOPMENT, V125, P1569; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Tearle R., 1987, DROSOPHILA INFORMATI, V66, P209; Thomson T, 2004, GENESIS, V40, P164, DOI 10.1002/gene.20079; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Wilson JE, 1996, DEVELOPMENT, V122, P1631	36	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14362	10.1371/journal.pone.0014362	http://dx.doi.org/10.1371/journal.pone.0014362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179512	gold, Green Submitted, Green Published			2022-12-27	WOS:000285340000016
J	Gendrin, C; Sarrazin, S; Bonnaffe, D; Jault, JM; Lortat-Jacob, H; Dessen, A				Gendrin, Claire; Sarrazin, Stephane; Bonnaffe, David; Jault, Jean-Michel; Lortat-Jacob, Hugues; Dessen, Andrea			Hijacking of the Pleiotropic Cytokine Interferon-gamma by the Type III Secretion System of Yersinia pestis	PLOS ONE			English	Article							ANTIGEN FUSION PEPTIDE; V-ANTIGEN; PSEUDOMONAS-AERUGINOSA; HEPARAN-SULFATE; HOST MEMBRANES; PORE FORMATION; TIP COMPLEX; IFN-GAMMA; BINDING; PROTEIN	Yersinia pestis, the causative agent of bubonic plague, employs its type III secretion system to inject toxins into target cells, a crucial step in infection establishment. LcrV is an essential component of the T3SS of Yersinia spp, and is able to associate at the tip of the secretion needle and take part in the translocation of anti-host effector proteins into the eukaryotic cell cytoplasm. Upon cell contact, LcrV is also released into the surrounding medium where it has been shown to block the normal inflammatory response, although details of this mechanism have remained elusive. In this work, we reveal a key aspect of the immunomodulatory function of LcrV by showing that it interacts directly and with nanomolar affinity with the inflammatory cytokine IFN gamma. In addition, we generate specific IFN gamma mutants that show decreased interaction capabilities towards LcrV, enabling us to map the interaction region to two basic C-terminal clusters of IFN gamma. Lastly, we show that the LcrV-IFN gamma interaction can be disrupted by a number of inhibitors, some of which display nanomolar affinity. This study thus not only identifies novel potential inhibitors that could be developed for the control of Yersinia-induced infection, but also highlights the diversity of the strategies used by Y. pestis to evade the immune system, with the hijacking of pleiotropic cytokines being a long-range mechanism that potentially plays a key role in the severity of plague.	[Gendrin, Claire; Sarrazin, Stephane; Jault, Jean-Michel; Lortat-Jacob, Hugues; Dessen, Andrea] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct,UMR 5075, Grenoble, France; [Bonnaffe, David] Univ Paris 11, Inst Chim Mol & Mat Orsay, Lab Chim Organ Multifonct, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Universite Paris Saclay	Gendrin, C (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Biol Struct,UMR 5075, Grenoble, France.	andrea.dessen@ibs.fr	jault, jean-michel/G-2086-2012	jault, jean-michel/0000-0003-1743-2777; Dessen, Andrea/0000-0001-6487-4020	Comissariat a l'Energie Atomique (CEA); Mizutani Foundation for Glycoscience; DGA [06.70.151.00.470.75.96]	Comissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission); Mizutani Foundation for Glycoscience; DGA	CG was the recipient of a postdoctoral fellowship from the Comissariat a l'Energie Atomique (CEA) and SS was supported by a grant from the Mizutani Foundation for Glycoscience. This work was supported by DGA grant number 06.70.151.00.470.75.96 (to AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov VM, 2007, J PROTEOME RES, V6, P2222, DOI 10.1021/pr070036r; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Broms JE, 2003, J INFECT DIS, V188, P239, DOI 10.1086/376452; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; BRUBAKER RR, 1991, CONTRIB TO MICROBIOL, V12, P127; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; DIVITA G, 1992, BIOCHEMISTRY-US, V31, P5791, DOI 10.1021/bi00140a015; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999; Fields KA, 1999, INFECT IMMUN, V67, P4801, DOI 10.1128/IAI.67.9.4801-4813.1999; Frank DW, 2002, J INFECT DIS, V186, P64, DOI 10.1086/341069; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Haelewyn J, 1995, BIOCHEM MOL BIOL INT, V37, P1163; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; LORTAT-JACOB H, 1991, J CLIN INVEST, V87, P878, DOI 10.1172/JCI115093; Lortat-Jacob H, 1996, J BIOL CHEM, V271, P16139, DOI 10.1074/jbc.271.27.16139; Lubineau A, 2004, CHEM-EUR J, V10, P4265, DOI 10.1002/chem.200306063; LUNDELL DJ, 1994, PHARMACOL THERAPEUT, V64, P1, DOI 10.1016/0163-7258(94)90031-0; MOTIN VL, 1994, INFECT IMMUN, V62, P4192, DOI 10.1128/IAI.62.10.4192-4201.1994; Motin VL, 1996, INFECT IMMUN, V64, P4313, DOI 10.1128/IAI.64.10.4313-4318.1996; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; NAKAJIMA R, 1995, INFECT IMMUN, V63, P3021, DOI 10.1128/IAI.63.8.3021-3029.1995; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Nanao M, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-21; Nedialkov YA, 1997, INFECT IMMUN, V65, P1196, DOI 10.1128/IAI.65.4.1196-1203.1997; Nilles ML, 1998, J BACTERIOL, V180, P3410, DOI 10.1128/JB.180.13.3410-3420.1998; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Ramamurthi KS, 2002, ANNU REV CELL DEV BI, V18, P107, DOI 10.1146/annurev.cellbio.18.012502.105912; Sadir R, 1998, J BIOL CHEM, V273, P10919, DOI 10.1074/jbc.273.18.10919; Sarrazin S, 2005, J BIOL CHEM, V280, P37558, DOI 10.1074/jbc.M507729200; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; VanHaverbeke C, 2004, BIOCHEM J, V384, P93, DOI 10.1042/BJ20040757; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; Wilson M, 1998, INFECT IMMUN, V66, P2401, DOI 10.1128/IAI.66.6.2401-2409.1998; Yahr TL, 1997, J BACTERIOL, V179, P7165, DOI 10.1128/jb.179.22.7165-7168.1997	54	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15242	10.1371/journal.pone.0015242	http://dx.doi.org/10.1371/journal.pone.0015242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179438	Green Submitted, gold, Green Published			2022-12-27	WOS:000285246900036
J	Crawford, JE; Guelbeogo, WM; Sanou, A; Traore, A; Vernick, KD; Sagnon, N; Lazzaro, BP				Crawford, Jacob E.; Guelbeogo, Wamdaogo M.; Sanou, Antoine; Traore, Alphonse; Vernick, Kenneth D.; Sagnon, N'Fale; Lazzaro, Brian P.			De Novo Transcriptome Sequencing in Anopheles funestus Using Illumina RNA-Seq Technology	PLOS ONE			English	Article							PROTEIN FAMILIES; MALARIA VECTOR; TOOL; DATABASE; GAMBIAE; ANNOTATION; GENERATION; EVOLUTION; ALIGNMENT; REVEALS	Background: Anopheles funestus is one of the primary vectors of human malaria, which causes a million deaths each year in sub-Saharan Africa. Few scientific resources are available to facilitate studies of this mosquito species and relatively little is known about its basic biology and evolution, making development and implementation of novel disease control efforts more difficult. The An. funestus genome has not been sequenced, so in order to facilitate genome-scale experimental biology, we have sequenced the adult female transcriptome of An. funestus from a newly founded colony in Burkina Faso, West Africa, using the Illumina GAIIx next generation sequencing platform. Methodology/Principal Findings: We assembled short Illumina reads de novo using a novel approach involving iterative de novo assemblies and "target-based" contig clustering. We then selected a conservative set of 15,527 contigs through comparisons to four Dipteran transcriptomes as well as multiple functional and conserved protein domain databases. Comparison to the Anopheles gambiae immune system identified 339 contigs as putative immune genes, thus identifying a large portion of the immune system that can form the basis for subsequent studies of this important malaria vector. We identified 5,434 1: 1 orthologues between An. funestus and An. gambiae and found that among these 1: 1 orthologues, the protein sequence of those with putative immune function were significantly more diverged than the transcriptome as a whole. Short read alignments to the contig set revealed almost 367,000 genetic polymorphisms segregating in the An. funestus colony and demonstrated the utility of the assembled transcriptome for use in RNA-seq based measurements of gene expression. Conclusions/Significance: We developed a pipeline that makes de novo transcriptome sequencing possible in virtually any organism at a very reasonable cost ($6,300 in sequencing costs in our case). We anticipate that our approach could be used to develop genomic resources in a diversity of systems for which full genome sequence is currently unavailable. Our An. funestus contig set and analytical results provide a valuable resource for future studies in this non-model, but epidemiologically critical, vector insect.	[Crawford, Jacob E.; Lazzaro, Brian P.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Guelbeogo, Wamdaogo M.; Sanou, Antoine; Traore, Alphonse; Sagnon, N'Fale] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Vernick, Kenneth D.] Inst Pasteur, Dept Parasitol & Mycol, CNRS, Unit Hosts Vectors & Infect Agents URA3012, Paris, France; [Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, St Paul, MN USA	Cornell University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Minnesota System; University of Minnesota Twin Cities	Crawford, JE (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	jc598@cornell.edu		Crawford, Jacob/0000-0002-6745-9145; Sanou, Antoine/0000-0002-3598-8800	National Institutes of Health [AI062995]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant AI062995 from the National Institutes of Health. Additional support to JEC came from The Grace Griswold Endowment at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; *AN GEN CLUST COMM, 2008, GEN AN VECT CAP MAJ; [Anonymous], 1968, ANOPHELINAE AFR S SA; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Cohuet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-227; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costantini C., 1999, Parassitologia (Rome), V41, P595; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; *DR 12 GEN CONS, 2007, SCIENCE, V450, P203; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Grimaldi David, 2005, pi; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Jiang R, 2009, GENETICS, V181, P187, DOI 10.1534/genetics.107.080630; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Obbard DJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-117; R Core Team, 2020, R LANG ENV STAT COMP; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Serazin AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007976; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; *WHO UNICEF, 2009, WORLD MAL REP; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-5; Yassine H, 2010, CELL MICROBIOL, V12, P1, DOI 10.1111/j.1462-5822.2009.01388.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	53	119	125	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14202	10.1371/journal.pone.0014202	http://dx.doi.org/10.1371/journal.pone.0014202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151993	gold, Green Published, Green Submitted			2022-12-27	WOS:000284868000016
J	Makita, K; Fevre, EM; Waiswa, C; Eisler, MC; Welburn, SC				Makita, Kohei; Fevre, Eric M.; Waiswa, Charles; Eisler, Mark C.; Welburn, Susan C.			How Human Brucellosis Incidence in Urban Kampala Can Be Reduced Most Efficiently? A Stochastic Risk Assessment of Informally-Marketed Milk	PLOS ONE			English	Article							BOVINE BRUCELLOSIS; SEROLOGICAL DIAGNOSIS; MACROPHAGES; INFECTION; ABORTUS; UGANDA; AREAS; COWS	Background: In Kampala, Uganda, studies have shown a significant incidence of human brucellosis. A stochastic risk assessment involving two field surveys (cattle farms and milk shops) and a medical record survey was conducted to assess the risk of human brucellosis infection through consumption of informally marketed raw milk potentially infected with Brucella abortus in Kampala and to identify the best control options. Methodology/Principal Findings: In the cattle farm survey, sera of 425 cows in 177 herds in the Kampala economic zone were sampled and tested for brucellosis using a competitive enzyme-linked immunosorbent assay (CELISA). Farmers were interviewed for dairy information. In the milk shop surveys, 135 milk sellers in the urban areas were interviewed and 117 milk samples were collected and tested using an indirect enzyme-linked immunosorbent assay (IELISA). A medical record survey was conducted in Mulago National Referral Hospital for serological test results. A risk model was developed synthesizing data from these three surveys. Possible control options were prepared based on the model and the reduction of risk was simulated for each scenario. Overall, 12.6% (6.8-18.9: 90% CI) of informally marketed milk in urban Kampala was contaminated with B. abortus at purchase and the annual incidence rate was estimated to be 5.8 (90% CI: 5.3-6.2) per 10,000 people. The best control option would be the construction of a milk boiling centre either in Mbarara, the largest source of milk, or in peri-urban Kampala and to ensure that milk traders always sell milk to the boiling centre; 90% success in enforcing these two options would reduce risk by 47.4% (21.6-70.1: 90% CI) and 82.0% (71.0-89.0: 90% CI), respectively. Conclusion/Significance: This study quantifies the risk of human brucellosis infection through informally marketed milk and estimates the incidence rate in Kampala for the first time; risk-based mitigation strategies are outlined to assist in developing policy.	[Makita, Kohei; Eisler, Mark C.; Welburn, Susan C.] Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Ctr Infect Dis,Div Pathway Med, Edinburgh, Midlothian, Scotland; [Fevre, Eric M.] Univ Edinburgh, Sch Biol Sci, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Waiswa, Charles] Makerere Univ, Fac Vet Med, Kampala, Uganda	University of Edinburgh; University of Edinburgh; Makerere University	Makita, K (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Ctr Infect Dis,Div Pathway Med, Edinburgh, Midlothian, Scotland.	kmakita@rakuno.ac.jp	Eisler, Mark/AAK-1119-2020	Eisler, Mark/0000-0001-6843-3345; Fevre, Eric/0000-0001-8931-4986; Welburn, Susan/0000-0002-9903-7086	UK Department for International Development (DFID); Japan International Cooperation Agency (JICA); Wellcome Trust [085308]	UK Department for International Development (DFID); Japan International Cooperation Agency (JICA); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors would like to thank the UK Department for International Development (DFID, http://www.dfid.gov.uk/) Animal Health Programme (KM, EMF, MCE, SCW) for support for this work, although the views expressed are not necessarily those of DFID. KM thanks the Japan International Cooperation Agency (JICA, http://www.jica.go.jp/english/) for research grant support (Overseas Long-term Programme). EMF is funded by the Wellcome Trust (085308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, STAT ABSTR 2005; Arimi SM, 2005, ACTA TROP, V96, P1, DOI 10.1016/j.actatropica.2005.05.012; Bartholomew MJ, 2005, RISK ANAL, V25, P99, DOI 10.1111/j.0272-4332.2005.00570.x; Codex Alimentarius Commission, 1999, PRINC GUID COND MICR; COLLINS CH, 1987, IRISH VET J, V41, P363; Ellis F, 1998, WORLD DEV, V26, P213, DOI 10.1016/S0305-750X(97)10042-0; *EUR FOOD SAF AUTH, 2010, NEW STORY       0512; EYER JM, 1986, AM J PUBLIC HEALTH, V76, P573; *FAO, 1953, MILK PAST PLANN PLAN; Faye B., 2005, PREV VET MED, V67, p267 , DOI DOI 10.1016/J.PREVETMED.2004.11.002; Gall D, 2004, REV SCI TECH OIE, V23, P989; GRACE D, 2008, HLTH CITY HARVESTS G; Guatteo R, 2007, VET RES, V38, P849, DOI 10.1051/vetres:2007038; Heuvelink AE, 2009, INT J FOOD MICROBIOL, V134, P70, DOI 10.1016/j.ijfoodmicro.2008.12.026; Kangethe EK, 2007, E AFR MED J, V84, P96; KAPLAN J, 1982, J CELL BIOL, V94, P12, DOI 10.1083/jcb.94.1.12; Kunda J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-315; Kyebambe Peterson S, 2005, Afr Health Sci, V5, P69; Makita K, 2010, LAND USE POLICY, V27, P888, DOI 10.1016/j.landusepol.2009.12.003; Makita K, 2008, ANN NY ACAD SCI, V1149, P309, DOI 10.1196/annals.1428.015; Mwiine F. N., 2004, THESIS MAKERERE U KA; NAKAVUMA J, 1994, THESIS MAKERERE U KA; Nations United, 2004, REP UG PUBL ADM COUN; Ndyabahinduka D G, 1978, Ann Ist Super Sanita, V14, P229; Nero LA, 2008, ZOONOSES PUBLIC HLTH, V55, P299, DOI 10.1111/j.1863-2378.2008.01130.x; NEWTON FJ, 1974, BRIT VET J, V130, P249, DOI 10.1016/S0007-1935(17)35889-X; Oloffs A, 1988, REV ELEV MED VET PAY, V51, P101; Portanti O, 2006, J VET MED B, V53, P494, DOI 10.1111/j.1439-0450.2006.00971.x; Rivera DY, 2003, REV SCI TECH OIE, V22, P1065, DOI 10.20506/rst.22.3.1454; SCHLESINGER RB, 1992, FUND APPL TOXICOL, V19, P584, DOI 10.1016/0272-0590(92)90097-2; STAAL SJ, 2003, UGANDA DAIRY SUBSECT; Tetley TD, 2002, CHEST, V121, p156S, DOI 10.1378/chest.121.5_suppl.156S; Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; *WHO, 2009, ZOON VET PUBL HLTH; WHO FAO OIE, 2006, BRUC HUM AN; Wilson G., 1942, PASTEURIZATION MILK; ZUNIGA EA, 2005, REV LATINOARM MICROB, V47, P88	38	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14188	10.1371/journal.pone.0014188	http://dx.doi.org/10.1371/journal.pone.0014188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152072	Green Published, Green Submitted, gold			2022-12-27	WOS:000284821300006
J	Lima, BL; Santos, EJC; Fernandes, GR; Merkel, C; Mello, MRB; Gomes, JPA; Soukoyan, M; Kerkis, A; Massironi, SMG; Visintin, JA; Pereira, LV				Lima, Bruno L.; Santos, Enrico J. C.; Fernandes, Gustavo R.; Merkel, Christian; Mello, Marco R. B.; Gomes, Juliana P. A.; Soukoyan, Marina; Kerkis, Alexandre; Massironi, Silvia M. G.; Visintin, Jose A.; Pereira, Lygia V.			A New Mouse Model for Marfan Syndrome Presents Phenotypic Variability Associated with the Genetic Background and Overall Levels of Fbn1 Expression	PLOS ONE			English	Article							PATHOGENESIS; FIBRILLIN-1; MUTATION; MODIFIER; MICE; MICROFIBRILS; FRAGMENTS; SURVIVAL; REVEALS; FAMILY	Marfan syndrome is an autosomal dominant disease of connective tissue caused by mutations in the fibrillin-1 encoding gene FBN1. Patients present cardiovascular, ocular and skeletal manifestations, and although being fully penetrant, MFS is characterized by a wide clinical variability both within and between families. Here we describe a new mouse model of MFS that recapitulates the clinical heterogeneity of the syndrome in humans. Heterozygotes for the mutant Fbn1 allele mg Delta(loxPneo), carrying the same internal deletion of exons 19-24 as the mg Delta mouse model, present defective microfibrillar deposition, emphysema, deterioration of aortic wall and kyphosis. However, the onset of a clinical phenotypes is earlier in the 129/Sv than in C57BL/6 background, indicating the existence of genetic modifiers of MFS between these two mouse strains. In addition, we characterized a wide clinical variability within the 129/Sv congenic heterozygotes, suggesting involvement of epigenetic factors in disease severity. Finally, we show a strong negative correlation between overall levels of Fbn1 expression and the severity of the phenotypes, corroborating the suggested protective role of normal fibrillin-1 in MFS pathogenesis, and supporting the development of therapies based on increasing Fbn1 expression.	[Lima, Bruno L.; Santos, Enrico J. C.; Fernandes, Gustavo R.; Merkel, Christian; Gomes, Juliana P. A.; Soukoyan, Marina; Kerkis, Alexandre; Pereira, Lygia V.] Univ Sao Paulo, Dept Genet & Biol Evolut, Genet Mol Lab, BR-05508 Sao Paulo, Brazil; [Massironi, Silvia M. G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Mello, Marco R. B.; Visintin, Jose A.] Univ Sao Paulo, Fac Vet & Zootecnia, Dept Anim Reprod, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Lima, BL (corresponding author), Univ Sao Paulo, Dept Genet & Biol Evolut, Genet Mol Lab, BR-05508 Sao Paulo, Brazil.	lpereira@usp.br	visintin, jose a/D-8608-2012; Merkel, Christian/K-7057-2012; Pereira, Lygia V/C-1049-2012; Santos, Enrico/B-7398-2017; Gomes, Juliana/K-6153-2016; Fernandes, Gustavo/C-8683-2013; Massironi, Silvia/N-4881-2017	Pereira, Lygia V/0000-0002-0002-725X; Gomes, Juliana/0000-0002-2000-4848; MELLO, MARCO ROBERTO/0000-0002-9790-4764; Fernandes, Gustavo/0000-0003-4667-9947; Massironi, Silvia/0000-0003-4690-1755	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP: www.fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; Booms P, 2000, HUM GENET, V107, P216, DOI 10.1007/s004390000368; Buoni S, 2004, ANN HUM GENET, V68, P633, DOI 10.1046/j.1529-8817.2004.00113.x; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Gayraud B, 2000, J CELL BIOL, V150, P667, DOI 10.1083/jcb.150.3.667; GRAY JR, 1994, J MED GENET, V31, P51, DOI 10.1136/jmg.31.1.51; HOGAN A, 1994, MANIPULATING MOUSE E; Hutchinson S, 2003, HUM MOL GENET, V12, P2269, DOI 10.1093/hmg/ddg241; Judge DP, 2008, ANNU REV MED, V59, P43, DOI 10.1146/annurev.med.59.103106.103801; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KAINULAINEN K, 1991, ANN MED, V23, P395, DOI 10.3109/07853899109148080; KAINULAINEN K, 1991, AM J HUM GENET, V49, P662; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MURAISHI H, NIPPON HOSHASEN GIJU, V66, P260; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; OTSURU S, 2010, EXP HEMATOL; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pu WT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000643; Pyeritz R E, 1979, Birth Defects Orig Artic Ser, V15, P155; PYERITZ RE, 1986, AM FAM PHYSICIAN, V34, P83; PYERITZ RE, 1990, NEW ENGL J MED, V323, P987, DOI 10.1056/NEJM199010043231409; PYERITZ RE, 1981, NEW ENGL J MED, V305, P1011, DOI 10.1056/NEJM198110223051711; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; SILVERMAN DI, 1995, J AM COLL CARDIOL, V26, P1062, DOI 10.1016/0735-1097(95)00258-0; Sukoyan MA, 2002, BRAZ J MED BIOL RES, V35, P535, DOI 10.1590/S0100-879X2002000500004; Sunaga S, 1997, MOL REPROD DEV, V46, P109, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;109::AID-MRD1&gt;3.0.CO;2-U; SWEET A, 1992, BIOCHEM MED METAB B, V47, P97, DOI 10.1016/0885-4505(92)90011-M; Wheeler FC, 2005, MAMM GENOME, V16, P414, DOI 10.1007/s00335-005-2468-7; Whiteman P, 2003, HUM MOL GENET, V12, P727, DOI 10.1093/hmg/ddg081; Yang TX, 2005, AM J PHYSIOL-RENAL, V288, pF1125, DOI 10.1152/ajprenal.00219.2004; ZANGALA T, 2007, J VIS EXP	36	45	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14136	10.1371/journal.pone.0014136	http://dx.doi.org/10.1371/journal.pone.0014136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152435	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100017
J	Milotti, E; Chignola, R				Milotti, Edoardo; Chignola, Roberto			Emergent Properties of Tumor Microenvironment in a Real-Life Model of Multicell Tumor Spheroids	PLOS ONE			English	Article							CELL POPULATIONS; VORONOI DIAGRAMS; GROWTH; DYNAMICS; SIMULATION; OXYGENATION; METABOLISM; CARCINOMA; THERAPY; CULTURE	Multicellular tumor spheroids are an important in vitro model of the pre-vascular phase of solid tumors, for sizes well below the diagnostic limit: therefore a biophysical model of spheroids has the ability to shed light on the internal workings and organization of tumors at a critical phase of their development. To this end, we have developed a computer program that integrates the behavior of individual cells and their interactions with other cells and the surrounding environment. It is based on a quantitative description of metabolism, growth, proliferation and death of single tumor cells, and on equations that model biochemical and mechanical cell-cell and cell-environment interactions. The program reproduces existing experimental data on spheroids, and yields unique views of their microenvironment. Simulations show complex internal flows and motions of nutrients, metabolites and cells, that are otherwise unobservable with current experimental techniques, and give novel clues on tumor development and strong hints for future therapies.	[Milotti, Edoardo] Univ Trieste, Dipartimento Fis, Trieste, Italy; [Milotti, Edoardo; Chignola, Roberto] Ist Nazl Fis Nucl, Sez Trieste, Trieste, Italy; [Chignola, Roberto] Univ Verona, Dipartimento Biotecnol, I-37100 Verona, Italy	University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Verona	Milotti, E (corresponding author), Univ Trieste, Dipartimento Fis, Trieste, Italy.	edoardo.milotti@ts.infn.it	Milotti, Edoardo/AAA-7076-2020	CHIGNOLA, Roberto/0000-0001-6981-6890; Milotti, Edoardo/0000-0001-7348-9765	Italian Institute for Nuclear Physics (INFN)	Italian Institute for Nuclear Physics (INFN)(Istituto Nazionale di Fisica Nucleare (INFN))	This work has been supported by the Italian Institute for Nuclear Physics (INFN) under the names VIRTUS, VBL and VBL-Rad. Relevant information can be found on the INFN website, http://www.infn.it/indexen.php. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER H, 1987, CANCER RES, V47, P3504; Alberts B, 2008, MOL BIOL CELL; Alvarez-Perez J, 2005, MAGN RESON MATER PHY, V18, P293, DOI 10.1007/s10334-005-0013-z; Bjerkvig R., 1992, SPHEROID CULTURE CAN; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; CASCIARI JJ, 1992, CELL PROLIFERAT, V25, P1, DOI 10.1111/j.1365-2184.1992.tb01433.x; Chignola R, 2000, CELL PROLIFERAT, V33, P219, DOI 10.1046/j.1365-2184.2000.00174.x; CHIGNOLA R, 1995, BRIT J CANCER, V72, P607, DOI 10.1038/bjc.1995.381; Chignola R, 2005, PHYS BIOL, V2, P8, DOI 10.1088/1478-3967/2/1/002; Chignola R, 2004, PHYSICA A, V338, P261, DOI 10.1016/j.physa.2004.02.049; Chignola R, 2007, PHYS BIOL, V4, P114, DOI 10.1088/1478-3975/4/2/005; Chignola R, 2006, PHYSICA A, V371, P463, DOI 10.1016/j.physa.2006.03.044; Cornish-Bowden A., 1979, FUNDAMENTALS ENZYME, DOI 10.1016/C2013-0-04130-8; de Berg M., 2008, COMPUTATIONAL GEOMET, V3; Deisboeck TS, 2009, BIOESSAYS, V31, P190, DOI 10.1002/bies.200800084; DORIE MJ, 1982, EXP CELL RES, V141, P201, DOI 10.1016/0014-4827(82)90082-9; DWYER RA, 1991, DISCRETE COMPUT GEOM, V6, P343, DOI 10.1007/BF02574694; Engelberg JA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-110; Flekkoy EG, 2000, PHYS REV E, V62, P2140, DOI 10.1103/PhysRevE.62.2140; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Gottfried E, 2006, CELL CYCLE, V5, P691, DOI 10.4161/cc.5.7.2624; GUIBAS LJ, 1992, ALGORITHMICA, V7, P381, DOI 10.1007/BF01758770; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Khaitan D, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-12; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Milotti E, 2007, PHYSICA A, V379, P133, DOI 10.1016/j.physa.2006.12.034; Milotti E, 2009, COMPUT PHYS COMMUN, V180, P2166, DOI 10.1016/j.cpc.2009.06.021; Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; MUELLERKLIESER W, 1986, BRIT J CANCER, V53, P345, DOI 10.1038/bjc.1986.58; NEDERMAN T, 1984, CANCER RES, V44, P3090; O'Rourke J, 1998, COMPUTATIONAL GEOMET; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Schaller G, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051910; Stein AM, 2007, BIOPHYS J, V92, P356, DOI 10.1529/biophysj.106.093468; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; SUTHERLAND RM, 1986, CANCER RES, V46, P5320; Venkatasubramanian R, 2006, J THEOR BIOL, V242, P440, DOI 10.1016/j.jtbi.2006.03.011; Walenta S, 2000, J HISTOCHEM CYTOCHEM, V48, P509, DOI 10.1177/002215540004800409; Wolfram Research I, 2008, MATH; Yu P, 2003, APPL PHYS LETT, V83, P575, DOI 10.1063/1.1594830; YUHAS JM, 1977, CANCER RES, V37, P3639	44	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e13942	10.1371/journal.pone.0013942	http://dx.doi.org/10.1371/journal.pone.0013942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152429	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100003
J	Olsen, CM; Childs, DS; Stanwood, GD; Winder, DG				Olsen, Christopher M.; Childs, Daniel S.; Stanwood, Gregg D.; Winder, Danny G.			Operant Sensation Seeking Requires Metabotropic Glutamate Receptor 5 (mGluR5)	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; NULL MUTANT MICE; ANTAGONIST MPEP; ALLOSTERIC MODULATORS; ALCOHOL DEPENDENCE; VISUAL-STIMULI; COCAINE; BEHAVIOR; REINFORCEMENT; ANXIETY	Pharmacological and genetic studies have suggested that the metabotropic glutamate receptor 5 (mGluR5) is critically involved in mediating the reinforcing effects of drugs of abuse, but not food. The purpose of this study was to use mGluR5 knockout (KO), heterozygous (Het), and wildtype (WT) mice to determine if mGluR5 modulates operant sensation seeking (OSS), an operant task that uses varied sensory stimuli as a reinforcer. We found that mGluR5 KO mice had significantly reduced OSS responding relative to WT mice, while Het mice displayed a paradoxical increase in OSS responding. Neither KO nor Het mice exhibited altered operant responding for food as a reinforcer. Further, we assessed mGluR5 KO, Het and WT mice across a battery of cocaine locomotor, place preference and anxiety related tests. Although KO mice showed expected differences in some locomotor and anxiety measures, Het mice either exhibited no phenotype or an intermediate one. In total, these data demonstrate a key role for mGluR5 in OSS, indicating an important role for this receptor in reinforcement-based behavior.	[Olsen, Christopher M.; Childs, Daniel S.; Winder, Danny G.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Olsen, Christopher M.; Stanwood, Gregg D.; Winder, Danny G.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37212 USA; [Olsen, Christopher M.; Stanwood, Gregg D.; Winder, Danny G.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37212 USA; [Stanwood, Gregg D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Olsen, CM (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	chris.olsen@vanderbilt.edu	Olsen, Christopher/C-3542-2008; Winder, Danny G./H-4857-2013; Olsen, Christopher/G-9595-2013	Olsen, Christopher/0000-0003-2700-0310; Olsen, Christopher/0000-0003-2700-0310; Stanwood, Gregg/0000-0001-6005-1203; Childs, Daniel/0000-0001-7643-2836	NIH [DA19112, DA026994];  [P30HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA026994, R01DA019112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support was provided by NIH grants DA19112 (DGW) and DA026994 (CMO). Behavioral work was performed at the Vanderbilt Murine Neurobehavioral Laboratory, which is supported in part by P30HD15052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom P, 2004, NEUROPSYCHOPHARMACOL, V29, P921, DOI 10.1038/sj.npp.1300381; BARON A, 1962, J COMP PHYSIOL PSYCH, V55, P1011, DOI 10.1037/h0044286; Bird MK, 2008, INT J NEUROPSYCHOPH, V11, P765, DOI 10.1017/S1461145708008572; Bird MK, 2010, INT J NEUROPSYCHOPH, V13, P133, DOI 10.1017/S1461145709990162; Bisaga A, 2008, EUR NEUROPSYCHOPHARM, V18, P794, DOI 10.1016/j.euroneuro.2008.05.004; Blatter K, 2006, EXP BRAIN RES, V168, P541, DOI 10.1007/s00221-005-0114-y; Bradbury MJ, 2005, J PHARMACOL EXP THER, V313, P395, DOI 10.1124/jpet.104.076406; Brodkin J, 2002, EUR J NEUROSCI, V16, P2241, DOI 10.1046/j.1460-9568.2002.02294.x; Cain ME, 2006, BEHAV PROCESS, V73, P360, DOI 10.1016/j.beproc.2006.08.007; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; Carroll FI, 2008, ANN NY ACAD SCI, V1141, P221, DOI 10.1196/annals.1441.015; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Colby CR, 2003, J NEUROSCI, V23, P2488; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Cunningham CL, 2003, PSYCHOPHARMACOLOGY, V170, P409, DOI 10.1007/s00213-003-1559-y; Gass JT, 2009, NEUROPSYCHOPHARMACOL, V34, P820, DOI 10.1038/npp.2008.140; Grueter BA, 2006, J NEUROSCI, V26, P3210, DOI 10.1523/JNEUROSCI.0170-06.2006; Heilig M, 2006, PHARMACOL THERAPEUT, V111, P855, DOI 10.1016/j.pharmthera.2006.02.001; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P1031, DOI 10.1038/sj.npp.1300164; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Kinney GG, 2003, J PHARMACOL EXP THER, V306, P116, DOI 10.1124/jpet.103.048702; Kumaresan V, 2009, BEHAV BRAIN RES, V202, P238, DOI 10.1016/j.bbr.2009.03.039; LAPIERRE YD, 1982, CURR THER RES CLIN E, V31, P95; Lu YM, 1997, J NEUROSCI, V17, P5196; Marino MJ, 2006, CURR OPIN PHARMACOL, V6, P98, DOI 10.1016/j.coph.2005.09.006; Martin-Fardon R, 2009, J PHARMACOL EXP THER, V329, P1084, DOI 10.1124/jpet.109.151357; Miner LL, 1995, NEUROREPORT, V6, P2314, DOI 10.1097/00001756-199511270-00011; OCONNOR EC, 2010, NEUROPSYCHOPHARMACOL; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Olive MF, 2005, MOL PHARMACOL, V67, P349, DOI 10.1124/mol.104.003319; Olsen CM, 2006, PSYCHOPHARMACOLOGY, V187, P13, DOI 10.1007/s00213-006-0388-1; Olsen CM, 2009, NEUROPSYCHOPHARMACOL, V34, P1685, DOI 10.1038/npp.2008.226; OLSEN CM, J VISUALIZED E UNPUB; Palucha A, 2007, PHARMACOL THERAPEUT, V115, P116, DOI 10.1016/j.pharmthera.2007.04.007; Paterson NE, 2005, PSYCHOPHARMACOLOGY, V179, P255, DOI 10.1007/s00213-004-2070-9; PECKNOLD JC, 1982, J CLIN PSYCHOPHARM, V2, P129; Platt DM, 2008, PSYCHOPHARMACOLOGY, V200, P167, DOI 10.1007/s00213-008-1191-y; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Schramm-Sapyta NL, 2006, NEUROPSYCHOPHARMACOL, V31, P1444, DOI 10.1038/sj.npp.1300918; Schumann G, 2008, ARCH GEN PSYCHIAT, V65, P826, DOI 10.1001/archpsyc.65.7.826; Spooren W, 2004, DRUG NEWS PERSPECT, V17, P251, DOI 10.1358/dnp.2004.17.4.829052; STEWART J, 1960, J COMP PHYSIOL PSYCH, V53, P187, DOI 10.1037/h0047315; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; THOMPSON TI, 1963, SCIENCE, V141, P55, DOI 10.1126/science.141.3575.55; van der Kam EL, 2007, BEHAV PHARMACOL, V18, pS21	46	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15085	10.1371/journal.pone.0015085	http://dx.doi.org/10.1371/journal.pone.0015085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152045	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100066
J	Petersen, B; Lundegaard, C; Petersen, TN				Petersen, Bent; Lundegaard, Claus; Petersen, Thomas Nordahl			NetTurnP - Neural Network Prediction of Beta-turns by Use of Evolutionary Information and Predicted Protein Sequence Features	PLOS ONE			English	Article							SECONDARY STRUCTURE; GAMMA-TURNS; ACCURACY; EPITOPES; PROGRAM; SET	beta-turns are the most common type of non-repetitive structures, and constitute on average 25% of the amino acids in proteins. The formation of beta-turns plays an important role in protein folding, protein stability and molecular recognition processes. In this work we present the neural network method NetTurnP, for prediction of two-class beta-turns and prediction of the individual beta-turn types, by use of evolutionary information and predicted protein sequence features. It has been evaluated against a commonly used dataset BT426, and achieves a Matthews correlation coefficient of 0.50, which is the highest reported performance on a two-class prediction of beta-turn and not-beta-turn. Furthermore NetTurnP shows improved performance on some of the specific beta-turn types. In the present work, neural network methods have been trained to predict beta-turn or not and individual beta-turn types from the primary amino acid sequence. The individual beta-turn types I, I', II, II', VIII, VIa1, VIa2, VIba and IV have been predicted based on classifications by PROMOTIF, and the two-class prediction of beta-turn or not is a superset comprised of all beta-turn types. The performance is evaluated using a golden set of non-homologous sequences known as BT426. Our two-class prediction method achieves a performance of: MCC = 0.50, Q(total) = 82.1%, sensitivity = 75.6%, PPV = 68.8% and AUC = 0.864. We have compared our performance to eleven other prediction methods that obtain Matthews correlation coefficients in the range of 0.17 - 0.47. For the type specific beta-turn predictions, only type I and II can be predicted with reasonable Matthews correlation coefficients, where we obtain performance values of 0.36 and 0.31, respectively. Conclusion: The NetTurnP method has been implemented as a webserver, which is freely available at http://www.cbs.dtu.dk/services/NetTurnP/. NetTurnP is the only available webserver that allows submission of multiple sequences.	[Petersen, Bent; Lundegaard, Claus; Petersen, Thomas Nordahl] Tech Univ Denmark, Ctr Biol Sequence Anal CBS, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Petersen, B (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal CBS, Dept Syst Biol, DK-2800 Lyngby, Denmark.	tnp@cbs.dtu.dk	Lundegaard, Claus/B-3938-2012	Petersen, Bent/0000-0002-2472-8317; Petersen, Thomas Nordahl/0000-0002-2484-5716				Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Armitage P., 2002, STAT METHODS MED RES; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CHOU PY, 1979, BIOPHYSICAL J, V26; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; Ettmayer P, 1999, J MED CHEM, V42, P971, DOI 10.1021/jm9811007; Fuchs PFJ, 2005, PROTEINS, V59, P828, DOI 10.1002/prot.20461; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GARNIER J, 1989, PREDICTION PROTEIN S; Guruprasad K, 2000, J BIOSCIENCES, V25, P143, DOI 10.1007/BF03404909; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Hu XZ, 2008, J COMPUT CHEM, V29, P1867, DOI 10.1002/jcc.20929; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Kaur H, 2004, BIOINFORMATICS, V20, P2751, DOI 10.1093/bioinformatics/bth322; Kaur H, 2003, PROTEIN SCI, V12, P627, DOI 10.1110/ps.0228903; Kaur H, 2002, BIOINFORMATICS, V18, P1508, DOI 10.1093/bioinformatics/18.11.1508; Kim S, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/btg368; KIRSCHNER A, 2008, GENE; Kountouris P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-407; KRCHNAK V, 1989, METHOD ENZYMOL, V178, P586; KRCHNAK V, 1987, ANAL BIOCHEM, V165, P200, DOI 10.1016/0003-2697(87)90220-X; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Liu LR, 2009, PROTEIN J, V28, P175, DOI 10.1007/s10930-009-9181-4; Lund O, 1997, PROTEIN ENG, V10, P1241, DOI 10.1093/protein/10.11.1241; Lund O, 2005, IMMUNOLOGICAL BIOINF; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; MCGREGOR MJ, 1989, PROTEIN ENG, V2, P521, DOI 10.1093/protein/2.7.521; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MILNERWHITE EJ, 1987, TRENDS BIOCHEM SCI, V12, P189; Pellequer J. L., 1991, V203, P176; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Petersen TN, 2000, PROTEINS, V41, P17, DOI 10.1002/1097-0134(20001001)41:1<17::AID-PROT40>3.0.CO;2-F; Pham Tho Hoan, 2003, Genome Inform, V14, P196; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Shepherd AJ, 1999, PROTEIN SCI, V8, P1045, DOI 10.1110/ps.8.5.1045; Swets JA, 1996, SCI PSYCH S; VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Zhang CT, 1997, BIOPOLYMERS, V41, P673, DOI 10.1002/(SICI)1097-0282(199705)41:6<673::AID-BIP7>3.0.CO;2-N; Zhang QD, 2005, BIOINFORMATICS, V21, P2370, DOI 10.1093/bioinformatics/bti358; Zheng C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-430	47	63	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15079	10.1371/journal.pone.0015079	http://dx.doi.org/10.1371/journal.pone.0015079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152409	gold, Green Submitted, Green Published			2022-12-27	WOS:000284755100062
J	Menendez, P; Kourmpetis, YAI; ter Braak, CJF; van Eeuwijk, FA				Menendez, Patricia; Kourmpetis, Yiannis A. I.; ter Braak, Cajo J. F.; van Eeuwijk, Fred A.			Gene Regulatory Networks from Multifactorial Perturbations Using Graphical Lasso: Application to the DREAM4 Challenge	PLOS ONE			English	Article							MODEL; SELECTION; LIKELIHOOD; REGRESSION; INFERENCE	A major challenge in the field of systems biology consists of predicting gene regulatory networks based on different training data. Within the DREAM4 initiative, we took part in the multifactorial sub-challenge that aimed to predict gene regulatory networks of size 100 from training data consisting of steady-state levels obtained after applying multifactorial perturbations to the original in silico network. Due to the static character of the challenge data, we tackled the problem via a sparse Gaussian Markov Random Field, which relates network topology with the covariance inverse generated by the gene measurements. As for the computations, we used the Graphical Lasso algorithm which provided a large range of candidate network topologies. The main task was to select the optimal network topology and for that, different model selection criteria were explored. The selected networks were compared with the golden standards and the results ranked using the scoring metrics applied in the challenge, giving a better insight in our submission and the way to improve it. Our approach provides an easy statistical and computational framework to infer gene regulatory networks that is suitable for large networks, even if the number of the observations (perturbations) is greater than the number of variables (genes).	[Menendez, Patricia; Kourmpetis, Yiannis A. I.] Wageningen Univ, Lab Bioinformat, Wageningen, Netherlands; [Menendez, Patricia; van Eeuwijk, Fred A.] Ctr BioSyst Genet, Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	Menendez, P (corresponding author), Wageningen Univ, Lab Bioinformat, Wageningen, Netherlands.	cajo.terbraak@wur.nl	Menéndez, Patricia/M-7719-2019; Bujan, Pablo Menendez/W-3736-2017; Menéndez, Patricia/D-8905-2013; Braak, Cajo J. F. ter/G-7006-2011	Menéndez, Patricia/0000-0003-0701-6315; Bujan, Pablo Menendez/0000-0001-9372-1007; Menéndez, Patricia/0000-0003-0701-6315; Braak, Cajo J. F. ter/0000-0002-0414-8745	Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This project was cofinanced by the Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Alon U, 2007, INTRO SYSTEMS BIOL D; Banerjee O, 2008, J MACH LEARN RES, V9, P485; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman J, 2007, ANN APPL STAT, V1, P302, DOI 10.1214/07-AOAS131; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; *GENENETWEAVER, GENENETWEAVER TOOL V; Goutte C, 2005, LECT NOTES COMPUT SC, V3408, P345; Kindermann R., 1980, MARKOV RANDOM FIELDS, DOI [10.1090/conm/001, DOI 10.1090/CONM/001]; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Manning C.D., 2000, FDN STAT NATURAL LAN; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Pan W, 2007, J MACH LEARN RES, V8, P1145; PROVOST F, 1998, P 15 INT C MACH LEAR, P445; RAGHAVAN VV, 1989, ACM T INFORM SYST, V7, P205, DOI 10.1145/65943.65945; Rue H, 2002, SCAND J STAT, V29, P31, DOI 10.1111/1467-9469.00058; RUE H., 2005, GAUSSIAN MARKOV RAND; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Stone M., 1978, Mathematische Operationsforschung und Statistik, Series Statistics, V9, P127, DOI 10.1080/02331887808801414; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Whittaker J., 1990, GRAPHICAL MODELS APP; Zou H, 2007, ANN STAT, V35, P2173, DOI 10.1214/009053607000000127; DREAM4 IN SILICO NET	27	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14147	10.1371/journal.pone.0014147	http://dx.doi.org/10.1371/journal.pone.0014147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188141	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200002
J	Mignardot, JB; Olivier, I; Promayon, E; Nougier, V				Mignardot, Jean-Baptiste; Olivier, Isabelle; Promayon, Emmanuel; Nougier, Vincent			Obesity Impact on the Attentional Cost for Controlling Posture	PLOS ONE			English	Article							OLDER-ADULTS; BODY-WEIGHT; REDUCTION PROGRAM; SWAY MOVEMENTS; VOLUNTARY SWAY; REACTION-TIME; DUAL-TASK; DEMANDS; BALANCE; STABILITY	Background: This study investigated the effects of obesity on attentional resources allocated to postural control in seating and unipedal standing. Methods: Ten non obese adults (BMI = 22.4 +/- 1.3, age = 42.4 +/- 15.1) and 10 obese adult patients (BMI = 35.2 +/- 2.8, age = 46.2 +/- 19.6) maintained postural stability on a force platform in two postural tasks (seated and unipedal). The two postural tasks were performed (1) alone and (2) in a dual-task paradigm in combination with an auditory reaction time task (RT). Performing the RT task together with the postural one was supposed to require some attentional resources that allowed estimating the attentional cost of postural control. 4 trials were performed in each condition for a total of 16 trials. Findings: (1) Whereas seated non obese and obese patients exhibited similar centre of foot pressure oscillations (CoP), in the unipedal stance only obese patients strongly increased their CoP sway in comparison to controls. (2) Whatever the postural task, the additional RT task did not affect postural stability. (3) Seated, RT did not differ between the two groups. (4) RT strongly increased between the two postural conditions in the obese patients only, suggesting that body schema and the use of internal models was altered with obesity. Interpretation: Obese patients needed more attentional resources to control postural stability during unipedal stance than non obese participants. This was not the case in a more simple posture such as seating. To reduce the risk of fall as indicated by the critical values of CoP displacement, obese patients must dedicate a strong large part of their attentional resources to postural control, to the detriment of non-postural events. Obese patients were not able to easily perform multitasking as healthy adults do, reflecting weakened psycho-motor abilities.	[Mignardot, Jean-Baptiste; Olivier, Isabelle; Nougier, Vincent] UJF, CNRS, UMR 5525, Lab TIMC IMAG,Team SPM, La Tronche, France; [Mignardot, Jean-Baptiste; Promayon, Emmanuel] UJF, CNRS, UMR 5525, Lab TIMC IMAG,Team GMCAO, La Tronche, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Mignardot, JB (corresponding author), UJF, CNRS, UMR 5525, Lab TIMC IMAG,Team SPM, La Tronche, France.	jean-baptiste.mignardot@imag.fr	Nougier, Vincent M/B-4993-2013; Olivier, Isabelle/M-6054-2014; Nougier, Vincent/AAG-5794-2021; Promayon, Emmanuel/M-6872-2014	Nougier, Vincent M/0000-0002-9917-0004; Promayon, Emmanuel/0000-0001-8934-6793	French ministry of education	French ministry of education	Doctoral grant from the French ministry of education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basdevant A, 2008, JOINT BONE SPINE, V75, P665, DOI 10.1016/j.jbspin.2008.06.007; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Berrigan F, 2006, INT J OBESITY, V30, P1750, DOI 10.1038/sj.ijo.0803342; Bisson E, 2007, CYBERPSYCHOL BEHAV, V10, P16, DOI 10.1089/cpb.2006.9997; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Brown LA, 2002, ARCH PHYS MED REHAB, V83, P1732, DOI 10.1053/apmr.2002.36400; CLARKSON PM, 1978, EUR J APPL PHYSIOL O, V40, P17, DOI 10.1007/BF00420985; Cliff DP, 2011, MED SCI SPORT EXER, V43, P90, DOI 10.1249/MSS.0b013e3181e741e8; Close JCT, 2005, BEST PRACT RES CL RH, V19, P913, DOI 10.1016/j.berh.2005.06.002; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; Gage WH, 2003, EXP BRAIN RES, V150, P385, DOI 10.1007/s00221-003-1468-7; Greve J, 2007, CLINICS, V62, P717, DOI 10.1590/S1807-59322007000600010; Handrigan GA, 2010, J BIOMECH, V43, P383, DOI 10.1016/j.jbiomech.2009.08.041; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.005; *INT OB TASKFORCE, 2005, OB EUR; International Association for the Study of Obesity, AD OV OB EUR UN EU 2; Lajoie Y, 1999, SPINAL CORD, V37, P245, DOI 10.1038/sj.sc.3100810; Lajoie Y, 1996, EXP AGING RES, V22, P185, DOI 10.1080/03610739608254006; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Maffiuletti NA, 2005, J ENDOCRINOL INVEST, V28, P2, DOI 10.1007/BF03345521; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; Mahboobin A, 2007, NEUROSCI LETT, V429, P147, DOI 10.1016/j.neulet.2007.10.004; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Marsh AP, 2000, GAIT POSTURE, V12, P105, DOI 10.1016/S0966-6362(00)00074-6; McGraw B, 2000, ARCH PHYS MED REHAB, V81, P484, DOI 10.1053/mr.2000.3782; Morasso PG, 1999, NEURAL NETWORKS, V12, P1173, DOI 10.1016/S0893-6080(99)00058-1; Morasso PG, 1999, HUM MOVEMENT SCI, V18, P759, DOI 10.1016/S0167-9457(99)00039-1; Olivier I, 2008, EXP BRAIN RES, V185, P341, DOI 10.1007/s00221-008-1271-6; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Personnier P, 2010, NEUROSCI LETT, V476, P146, DOI 10.1016/j.neulet.2010.04.017; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Saimpont A, 2010, ARCH GERONTOL GERIAT, V51, pE41, DOI 10.1016/j.archger.2009.11.010; Sartorio A, 2001, J ENDOCRINOL INVEST, V24, P393, DOI 10.1007/BF03351039; Simoneau M, 1999, J AM GERIATR SOC, V47, P235, DOI 10.1111/j.1532-5415.1999.tb04584.x; Teasdale N, 2007, INT J OBESITY, V31, P153, DOI 10.1038/sj.ijo.0803360; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Tucker MG, 2009, CLIN BIOMECH, V24, P597, DOI 10.1016/j.clinbiomech.2009.06.002; Tucker MG, 2008, HUM MOVEMENT SCI, V27, P728, DOI 10.1016/j.humov.2008.03.002; van Dieen JH, 2010, GAIT POSTURE, V31, P42, DOI 10.1016/j.gaitpost.2009.08.242; Vuillerme N, 2006, EXP BRAIN RES, V169, P232, DOI 10.1007/s00221-005-0142-7; Wang L, 2008, MED SCI MONITOR, V14, pCR129; Williams HG, 2008, OBESITY, V16, P1421, DOI 10.1038/oby.2008.214	44	49	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14387	10.1371/journal.pone.0014387	http://dx.doi.org/10.1371/journal.pone.0014387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698EM	21187914	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200010
J	Shoji, JY; Kikuma, T; Arioka, M; Kitamoto, K				Shoji, Jun-ya; Kikuma, Takashi; Arioka, Manabu; Kitamoto, Katsuhiko			Macroautophagy-Mediated Degradation of Whole Nuclei in the Filamentous Fungus Aspergillus oryzae	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; AUTOPHAGY; DIFFERENTIATION; VISUALIZATION; MITOCHONDRIA; INFECTION; TRANSPORT; SYSTEMS; HYPHAE; YEAST	Filamentous fungi consist of continuum of multinucleate cells called hyphae, and proliferate by means of hyphal tip growth. Accordingly, research interest has been focusing on hyphal tip cells, but little is known about basal cells in colony interior that do not directly contribute to proliferation. Here, we show that autophagy mediates degradation of basal cell components in the filamentous fungus Aspergillus oryzae. In basal cells, enhanced green fluorescent protein (EGFP)-labeled peroxisomes, mitochondria, and even nuclei were taken up into vacuoles in an autophagy-dependent manner. During this process, crescents of autophagosome precursors matured into ring-like autophagosomes to encircle apparently whole nuclei. The ring-like autophagosomes then disappeared, followed by dispersal of the nuclear material throughout the vacuoles, suggesting the autophagy-mediated degradation of whole nuclei. We also demonstrated that colony growth in a nutrient-depleted medium was significantly inhibited in the absence of functional autophagy. This is a first report describing autophagy-mediated degradation of whole nuclei, as well as suggesting a novel strategy of filamentous fungi to degrade components of existing hyphae for use as nutrients to support mycelial growth in order to counteract starvation.				junya@fungalcell.org; akitamo@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford AE, 1998, ADV BOT RES, V28, P119; BITTNER GD, 1991, TRENDS NEUROSCI, V14, P188, DOI 10.1016/0166-2236(91)90104-3; Darrah PR, 2006, EUKARYOT CELL, V5, P1111, DOI 10.1128/EC.00026-06; DOWSON CG, 1989, NEW PHYTOL, V111, P501, DOI 10.1111/j.1469-8137.1989.tb00713.x; Escano CS, 2009, EUKARYOT CELL, V8, P296, DOI 10.1128/EC.00197-08; Farre JC, 2004, TRENDS CELL BIOL, V14, P515, DOI 10.1016/j.tcb.2004.07.014; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Kikuma T, 2006, EUKARYOT CELL, V5, P1328, DOI 10.1128/EC.00024-06; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Liu TB, 2010, AUTOPHAGY, V6, P74, DOI 10.4161/auto.6.1.10438; Lu E, 2001, CELL DEATH DIFFER, V8, P289, DOI 10.1038/sj.cdd.4400807; Lu JP, 2009, CURR GENET, V55, P461, DOI 10.1007/s00294-009-0259-5; Mabashi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1882, DOI 10.1271/bbb.60052; Maheshwari R, 2005, FEMS MICROBIOL LETT, V249, P7, DOI 10.1016/j.femsle.2005.06.031; Maruyama J, 2001, BIOSCI BIOTECH BIOCH, V65, P1504, DOI 10.1271/bbb.65.1504; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Pinan-Lucarre R, 2003, MOL MICROBIOL, V47, P321, DOI 10.1046/j.1365-2958.2003.03208.x; Richie DL, 2007, EUKARYOT CELL, V6, P2437, DOI 10.1128/EC.00224-07; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Shoji JY, 2006, AUTOPHAGY, V2, P226, DOI 10.4161/auto.2695; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; Taylor MV, 2000, CURR BIOL, V10, pR646, DOI 10.1016/S0960-9822(00)00664-3; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479	26	66	69	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15650	10.1371/journal.pone.0015650	http://dx.doi.org/10.1371/journal.pone.0015650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187926	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200056
J	Zhang, ZJ; Chen, DM; Chen, Y; Liu, WB; Wang, L; Zhao, F; Yao, BD				Zhang, Zhijie; Chen, Dongmei; Chen, Yue; Liu, Wenbao; Wang, Lei; Zhao, Fei; Yao, Baodong			Spatio-Temporal Data Comparisons for Global Highly Pathogenic Avian Influenza (HPAI) H5N1 Outbreaks	PLOS ONE			English	Article							VIRUS-INFECTION; SURVEILLANCE; PATTERNS; MIGRATION; THAILAND; SYSTEMS; SPREAD; BIRDS; RISK; ASIA	Highly pathogenic avian influenza subtype H5N1 is a zoonotic disease and control of the disease is one of the highest priority in global health. Disease surveillance systems are valuable data sources for various researches and management projects, but the data quality has not been paid much attention in previous studies. Based on data from two commonly used databases (Office International des Epizooties (OIE) and Food and Agriculture Organization of the United Nations (FAO)) of global HPAI H5N1 outbreaks during the period of 2003-2009, we examined and compared their patterns of temporal, spatial and spatiotemporal distributions for the first time. OIE and FAO data showed similar trends in temporal and spatial distributions if they were considered separately. However, more advanced approaches detected a significant difference in joint spatio-temporal distribution. Because of incompleteness for both OIE and FAO data, an integrated dataset would provide a more complete picture of global HPAI H5N1 outbreaks. We also displayed a mismatching profile of global HPAI H5N1 outbreaks and found that the degree of mismatching was related to the epidemic severity. The ideas and approaches used here to assess spatiotemporal data on the same disease from different sources are useful for other similar studies.	[Zhang, Zhijie; Chen, Dongmei; Liu, Wenbao; Wang, Lei] Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada; [Zhang, Zhijie; Zhao, Fei; Yao, Baodong] Fudan Univ, Dept Epidemiol, Shanghai 200433, Peoples R China; [Chen, Yue] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	Queens University - Canada; Fudan University; University of Ottawa	Zhang, ZJ (corresponding author), Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada.	epistat@gmail.com; chendm@queensu.ca		zhang, zhijie/0000-0002-1276-787X	Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada [PIV-005]	Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada	This research was supported by a grant from the Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada (grant number PIV-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SSU, 2010, EPIDEMIOL INFECT, V138, P843, DOI 10.1017/S0950268810000178; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; BADDELEY AJ, 1993, J R STAT SOC C-APPL, V42, P641; *BIRDLIFE INT, 2006, IILEGAL IMPORTS PROB; Butler D, 2006, NATURE, V439, P6, DOI 10.1038/439006a; BUTLER D, 2006, NATURE GETS MASHED T; Capua I, 2009, POULTRY SCI, V88, P842, DOI 10.3382/ps.2008-00289; Cecchi G, 2008, GEOSPATIAL HEALTH, V3, P7, DOI 10.4081/gh.2008.227; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Farnsworth ML, 2010, PREV VET MED, V95, P175, DOI 10.1016/j.prevetmed.2010.03.012; Farnsworth ML, 2009, VET RES, V40, DOI 10.1051/vetres/2009003; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Hadorn DC, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-52; Henning J, 2009, VET RES, V40, DOI 10.1051/vetres:2008053; Kaiser J, 2006, SCIENCE, V312, P380, DOI 10.1126/science.312.5772.380; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Martin V, 2007, J WILDLIFE DIS, V43, pS71; MERTON AA, 2008, DISTR FREE COMP MULT; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Pittman M, 2007, J WILDLIFE DIS, V43, pS64; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; ROWLINGSON BS, 1993, COMPUT GEOSCI, V19, P627, DOI 10.1016/0098-3004(93)90099-Q; Rushton J, 2005, WORLD POULTRY SCI J, V61, P491, DOI 10.1079/WPS200570; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Stohr K, 2005, NEW ENGL J MED, V352, P405, DOI 10.1056/NEJMe048344; Tiensin T, 2009, J INFECT DIS, V199, P1735, DOI 10.1086/599207; Toma B., 1999, DICT VET EPIDEMIOLOG; Vallat B, 2006, REV SCI TECH OIE, V25, P163, DOI 10.20506/rst.25.1.1645; Zepeda C, 2005, PREV VET MED, V67, P125, DOI 10.1016/j.prevetmed.2004.11.005	32	24	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15314	10.1371/journal.pone.0015314	http://dx.doi.org/10.1371/journal.pone.0015314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187964	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200037
J	Lu, L; Zhou, XH; Wang, J; Zheng, SG; Horwitz, DA				Lu, Ling; Zhou, Xiaohui; Wang, Julie; Zheng, Song Guo; Horwitz, David A.			Characterization of Protective Human CD4(+)CD25(+) FOXP3(+) Regulatory T Cells Generated with IL-2, TGF-beta and Retinoic Acid	PLOS ONE			English	Article							HUMAN PERIPHERAL-BLOOD; VERSUS-HOST-DISEASE; MEDIATED SUPPRESSION; RECEPTOR EXPRESSION; EX-VIVO; CUTTING EDGE; IN-VIVO; CD4(+); STIMULATION; LYMPHOCYTES	Background: Protective CD4+CD25+ regulatory T cells bearing the Forkhead Foxp3 transcription factor can now be divided into three subsets: Endogenous thymus-derived cells, those induced in the periphery, and another subset induced ex-vivo with pharmacological amounts of IL-2 and TGF-beta. Unfortunately, endogenous CD4+CD25+ regulatory T cells are unstable and can be converted to effector cells by pro-inflammatory cytokines. Although protective Foxp3+CD4+ CD25+ cells resistant to proinflammatory cytokines have been generated in mice, in humans this result has been elusive. Our objective, therefore, was to induce human naive CD4+ cells to become stable, functional CD25+ Foxp3+ regulatory cells that were also resistant to the inhibitory effects of proinflammatory cytokines. Methodology/Principal Findings: The addition of the vitamin A metabolite, all-trans retinoic acid (atRA) to human naive CD4+ cells suboptimally activated with IL-2 and TGF-beta enhanced and stabilized FOXP3 expression, and accelerated their maturation to protective regulatory T cells. AtRA, by itself, accelerated conversion of naive to mature cells but did not induce FOXP3 or suppressive activity. The combination of atRA and TGF-beta enabled CD4+ CD45RA+ cells to express a phenotype and trafficking receptors similar to natural Tregs. AtRA/TGF-beta-induced CD4+ regs were anergic and low producers of IL-2. They had potent in vitro suppressive activity and protected immunodeficient mice from a human-anti-mouse GVHD as well as expanded endogenous Tregs. However, treatment of endogenous Tregs with IL-1 beta and IL-6 decreased FOXP3 expression and diminished their protective effects in vivo while atRA-induced iTregs were resistant to these inhibitory effects. Conclusions/Significance: We have developed a methodology that induces human CD4(+) cells to rapidly become stable, fully functional suppressor cells that are also resistant to proinflammatory cytokines. This methodology offers a practical novel strategy to treat human autoimmune diseases and prevent allograft rejection without the use of agents that kill cells or interfere with signaling pathways.	[Lu, Ling; Zhou, Xiaohui; Wang, Julie; Zheng, Song Guo; Horwitz, David A.] Univ So Calif, Keck Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90033 USA; [Lu, Ling] Nanjing Med Univ, Affiliated Hosp 1, Dept Liver Transplantat, Nanjing, Peoples R China; [Zhou, Xiaohui] Tonji Univ Med, Immune Tolerance Ctr, Shanghai E Hosp, Shanghai, Peoples R China	University of Southern California; Nanjing Medical University	Lu, L (corresponding author), Univ So Calif, Keck Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90033 USA.	szheng@usc.edu; dhorwitz@usc.edu	lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022					Aricha R, 2008, J IMMUNOL, V180, P2132, DOI 10.4049/jimmunol.180.4.2132; AUSTRUP F, 1995, EUR J IMMUNOL, V25, P1487, DOI 10.1002/eji.1830250602; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Godebu E, 2008, J IMMUNOL, V181, P1798, DOI 10.4049/jimmunol.181.3.1798; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hippen KL, 2008, BLOOD, V112, P2847, DOI 10.1182/blood-2008-01-132951; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; Horwitz DA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2511; Iellem A, 2003, EUR J IMMUNOL, V33, P1488, DOI 10.1002/eji.200323658; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Lim HW, 2006, J IMMUNOL, V177, P840, DOI 10.4049/jimmunol.177.2.840; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Miyara M, 2009, J ALLERGY CLIN IMMUN, V123, P749, DOI 10.1016/j.jaci.2009.03.001; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Rao PE, 2005, J IMMUNOL, V174, P1446, DOI 10.4049/jimmunol.174.3.1446; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Selvaraj RK, 2007, J IMMUNOL, V179, P1390, DOI 10.4049/jimmunol.179.2.1390-b; Selvaraj RK, 2008, J IMMUNOL, V180, P2830, DOI 10.4049/jimmunol.180.5.2830; Singh RP, 2007, J IMMUNOL, V178, P7649, DOI 10.4049/jimmunol.178.12.7649; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598	54	95	103	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15150	10.1371/journal.pone.0015150	http://dx.doi.org/10.1371/journal.pone.0015150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179414	Green Submitted, gold, Green Published			2022-12-27	WOS:000285572900014
J	Olotu, A; Fegan, G; Williams, TN; Sasi, P; Ogada, E; Bauni, E; Wambua, J; Marsh, K; Borrmann, S; Bejon, P				Olotu, Ally; Fegan, Gregory; Williams, Thomas N.; Sasi, Philip; Ogada, Edna; Bauni, Evasius; Wambua, Juliana; Marsh, Kevin; Borrmann, Steffen; Bejon, Philip			Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CASE DEFINITIONS; SOUTHERN TANZANIA; EFFICACY; VACCINE; TRANSMISSION; FEVER; AREA; MORBIDITY; MORTALITY	Background: Febrile malaria is the most common clinical manifestation of P. falciparum infection, and is often the primary endpoint in clinical trials and epidemiological studies. Subjective and objective fevers are both used to define the endpoint, but have not been carefully compared, and the relative incidence of clinical malaria by active and passive case detection is unknown. Methods: We analyzed data from cohorts under active and passive surveillance, including 19,462 presentations with fever and 5,551 blood tests for asymptomatic parasitaemia. A logistic regression model was used to calculate Malaria Attributable Fractions (MAFs) for various case definitions. Incidences of febrile malaria by active and passive surveillance were compared in a subset of children matched for age and location. Results: Active surveillance identified three times the incidence of clinical malaria as passive surveillance in a subset of children matched for age and location. Objective fever (temperature >= 37.5 degrees C) gave consistently higher MAFs than case definitions based on subjective fever. Conclusion: The endpoints from active and passive surveillance have high specificity, but the incidence of endpoints is lower on passive surveillance. Subjective fever had low specificity and should not be used in primary endpoint. Passive surveillance will reduce the power of clinical trials but may cost-effectively deliver acceptable sensitivity in studies of large populations.	[Olotu, Ally; Fegan, Gregory; Williams, Thomas N.; Ogada, Edna; Bauni, Evasius; Wambua, Juliana; Marsh, Kevin; Borrmann, Steffen; Bejon, Philip] Ctr Geog Med Res, Wellcome Trust Res Programme, Kenya Med Res Inst, Kilifi, Kenya; [Fegan, Gregory; Marsh, Kevin; Bejon, Philip] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Nuffield Dept Med, Oxford, England; [Sasi, Philip] Muhimbili Univ Hlth & Allied Sci, Dept Clin Pharmacol, Dar Es Salaam, Tanzania; [Borrmann, Steffen] Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany	Kenya Medical Research Institute; University of Oxford; Muhimbili University of Health & Allied Sciences; Ruprecht Karls University Heidelberg	Olotu, A (corresponding author), Ctr Geog Med Res, Wellcome Trust Res Programme, Kenya Med Res Inst, Kilifi, Kenya.	Aolotu@kilifi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018; Borrmann, Steffen/G-1838-2013	Fegan, Greg W/0000-0002-2663-2765; Borrmann, Steffen/0000-0001-9189-4393; Ogada, Edna/0000-0003-0181-2505	Biomedical Research Centre in Oxford; German Research Foundation (DFG) [SFB 544, A7]; Wellcome Trust	Biomedical Research Centre in Oxford; German Research Foundation (DFG)(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	Philip Bejon is supported by the Biomedical Research Centre in Oxford. Steffen Borrmann received funding from German Research Foundation (DFG)(Grant number SFB 544, A7) and Kevin Marsh is supported by Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysekera T, 1997, TROP MED INT HEALTH, V2, P1057, DOI 10.1046/j.1365-3156.1997.d01-183.x; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; DALESSANDRO U, 1995, LANCET, V346, P462, DOI 10.1016/S0140-6736(95)91321-1; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Erhart A, 2007, T ROY SOC TROP MED H, V101, P216, DOI 10.1016/j.trstmh.2006.07.003; Franckel A, 2009, J BIOSOC SCI, V41, P1, DOI 10.1017/S0021932008002885; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; McGuinness D, 1998, T ROY SOC TROP MED H, V92, P527, DOI 10.1016/S0035-9203(98)90902-6; Molyneux CS, 2002, J BIOSOC SCI, V34, P109, DOI 10.1017/S0021932002001098; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-23; Moorthy VS, 2009, VACCINE, V27, P624, DOI 10.1016/j.vaccine.2008.11.034; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Nwanyanwu OC, 1997, ANN TROP MED PARASIT, V91, P359, DOI 10.1080/00034989760978; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Oum S, 2005, TROP MED INT HEALTH, V10, P689, DOI 10.1111/j.1365-3156.2005.01445.x; Rogers WO, 2006, J INFECT DIS, V193, P467, DOI 10.1086/499314; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sumba PO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-245; Teng CL, 2008, J TROP PEDIATRICS, V54, P70, DOI 10.1093/tropej/fmm077; Van den Ende J, 2005, TROP MED INT HEALTH, V10, P1207, DOI 10.1111/j.1365-3156.2005.01508.x	32	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15569	10.1371/journal.pone.0015569	http://dx.doi.org/10.1371/journal.pone.0015569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179571	gold, Green Published, Green Submitted			2022-12-27	WOS:000285381200032
J	Stevenson, CG; Beane, WS				Stevenson, Claire G.; Beane, Wendy Scott			A Low Percent Ethanol Method for Immobilizing Planarians	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SCHMIDTEA-MEDITERRANEA; GENE-EXPRESSION; MODEL SYSTEM; STEM-CELLS; REGENERATION; ORGANIZATION; MECHANISM; EVOLUTION; CILIA	Planarians have recently become a popular model system for the study of adult stem cells, regeneration and polarity. The system is attractive for both undergraduate and graduate research labs, since planarian colonies are low cost and easy to maintain. Also in situ hybridization, immunofluorescence and RNA-interference (RNAi) gene knockdown techniques have been developed for planarian studies. However, imaging of live worms (particularly at high magnifications) is difficult because animals are strongly photophobic; they quickly move away from light sources and out of frame. The current methods available to inhibit movement in planarians include RNAi injection and exposure to cold temperatures. The former is labor and time intensive, while the latter precludes the use of many fluorescent reporter dyes. Here, we report a simple, inexpensive and reversible method to immobilize planarians for live imaging. Our data show that a short 1 hour treatment with 3% ethanol (EtOH) is sufficient to inhibit both the fine and gross movements of Schmidtea mediterranea planarians, of the typical size used (4-6 mm), with full recovery of movement within 3-4 hours. Importantly, EtOH treatment did not interfere with regeneration, even after repeated exposure, nor lyse epithelial cells (as assayed by H&E staining). We demonstrate that a short exposure to a low concentration of EtOH is a quick and effective method of immobilizing planarians, one that is easily adaptable to planarians of all sizes and will increase the accessibility of live imaging assays to planarian researchers.	[Stevenson, Claire G.; Beane, Wendy Scott] Tufts Univ, Dept Biol, Tufts Ctr Regenerat & Dev Biol, Medford, MA 02155 USA	Tufts University	Stevenson, CG (corresponding author), Tufts Univ, Dept Biol, Tufts Ctr Regenerat & Dev Biol, Medford, MA 02155 USA.	wendy.beane@tufts.edu		Beane, Wendy/0000-0002-3762-1025	National Institutes of Health (NIH) [F32 GM083542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083542, F32GM083547] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) National Research Service Award grant F32 GM083542 (http://grants.nih.gov/training/nrsa.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; BAGUNA J, 1989, DEVELOPMENT, V107, P77; BEST JB, 1982, TERATOGEN CARCIN MUT, V2, P277, DOI 10.1002/1520-6866(1990)2:3/4<277::AID-TCM1770020309>3.0.CO;2-8; Castle WA, 1928, J EXP ZOOL, V51, P417, DOI 10.1002/jez.1400510402; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Cebria F, 2008, NEUROSCI RES, V61, P375, DOI 10.1016/j.neures.2008.04.005; Cebria F, 2007, DEV GENES EVOL, V217, P733, DOI 10.1007/s00427-007-0188-6; Chakrabarti A, 1998, CELL TISSUE RES, V293, P453, DOI 10.1007/s004410051137; DEITRICH RA, 1989, PHARMACOL REV, V41, P489; DICIAULA LLR, 1995, BIOTECH HISTOCHEM, V70, P119; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Hicks C, 2006, J NEUROBIOL, V66, P977, DOI 10.1002/neu.20290; HORI I, 1980, TISSUE CELL, V12, P513, DOI 10.1016/0040-8166(80)90040-3; Izuhara K, 2009, CURR MED CHEM, V16, P2867, DOI 10.2174/092986709788803196; LENTZ TL, 1967, J ULTRA MOL STRUCT R, V17, P114, DOI 10.1016/S0022-5320(67)80024-8; MACHEMER H, 1979, J PHYSIOL-LONDON, V296, P49, DOI 10.1113/jphysiol.1979.sp012990; MARTIN GG, 1978, ZOOMORPHOLOGIE, V91, P235, DOI 10.1007/BF00999813; McGee C, 1998, COMP BIOCHEM PHYS B, V119, P293, DOI 10.1016/S0305-0491(97)00328-3; Mitchell KAP, 2009, METHOD CELL BIOL, V94, P87, DOI 10.1016/S0091-679X(08)94004-8; MIYAZAWA K, 1987, TOXICON, V25, P975, DOI 10.1016/0041-0101(87)90160-7; Nishimura K, 2007, DEV NEUROBIOL, V67, P1059, DOI 10.1002/dneu.20377; Nogi T, 2005, DEV BIOL, V287, P314, DOI 10.1016/j.ydbio.2005.09.002; Nogi T, 2005, LATERALITY, V10, P193, DOI 10.1080/1357650054200001440; Nogi T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000464; Nori VS, 1997, J COMP PHYSIOL A, V180, P473, DOI 10.1007/s003590050064; Okamoto K, 2005, ZOOL SCI, V22, P535, DOI 10.2108/zsj.22.535; Oviedo NJ, 2007, DEVELOPMENT, V134, P3121, DOI 10.1242/dev.006635; Oviedo Nestor J, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5054; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Rompolas P, 2009, METHOD CELL BIOL, V93, P81, DOI 10.1016/S0091-679X(08)93004-1; Salo E, 2009, INT J DEV BIOL, V53, P1317, DOI 10.1387/ijdb.072414es; She WY, 2010, LARYNGOSCOPE, V120, P1470, DOI 10.1002/lary.20970; Stephens RE, 2008, ACS CHEM BIOL, V3, P84, DOI 10.1021/cb8000217; STEPHENS RE, 1992, J CELL SCI, V101, P837; Stevens NM, 1907, ARCH ENTWICKLUNG ORG, V24, P350, DOI 10.1007/BF02161840; Umesono Y, 2009, DEV GROWTH DIFFER, V51, P185, DOI 10.1111/j.1440-169X.2009.01099.x	41	21	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15310	10.1371/journal.pone.0015310	http://dx.doi.org/10.1371/journal.pone.0015310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179478	gold, Green Published, Green Submitted			2022-12-27	WOS:000285292500021
J	Guetta, D; Langou, K; Grunwald, D; Klein, G; Aubry, L				Guetta, Dorian; Langou, Karine; Grunwald, Didier; Klein, Gerard; Aubry, Laurence			FYVE-Dependent Endosomal Targeting of an Arrestin-Related Protein in Amoeba	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM AMEBAS; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; BETA-ARRESTIN; RECEPTOR TRAFFICKING; LOCALIZATION; ROLES; ENDOCYTOSIS; MEMBRANES; DOMAINS; PATHWAY	Background: Visual and beta-arrestins are scaffolding proteins involved in the regulation of receptor-dependent intracellular signaling and their trafficking. The arrestin superfamilly includes several arrestin domain-containing proteins and the structurally related protein Vps26. In Dictyostelium discoideum, the arrestin-domain containing proteins form a family of six members, namely AdcA to -F. In contrast to canonical arrestins, Dictyostelium Adc proteins show a more complex architecture, as they possess, in addition to the arrestin core, other domains, such as C2, FYVE, LIM, MIT and SAM, which potentially mediate selective interactions with either lipids or proteins. Methodology and Principal Findings: A detailed analysis of AdcA has been performed. AdcA extends on both sides of the arrestin core, in particular by a FYVE domain which mediates selective interactions with PI(3) P, as disclosed by intrinsic fluorescence measurements and lipid overlay assays. Localization studies showed an enrichment of tagged- and endogenous AdcA on the rim of early macropinosomes and phagosomes. This vesicular distribution relies on a functional FYVE domain. Our data also show that the arrestin core binds the ADP-ribosylation factor ArfA, the unique amoebal Arf member, in its GDP-bound conformation. Significance: This work describes one of the 6 arrestin domain-containing proteins of Dictyostelium, a novel and atypical member of the arrestin clan. It provides the basis for a better understanding of arrestin-related protein involvement in trafficking processes and for further studies on the expanding roles of arrestins in eukaryotes.	[Guetta, Dorian; Langou, Karine; Klein, Gerard; Aubry, Laurence] CEA, DSV, Lab Biochim & Biophys Syst Integres, iRTSV, Grenoble, France; [Grunwald, Didier] CEA, DSV, Lab Transduct Signal, iRTSV, Grenoble, France; [Grunwald, Didier] INSERM, LTS, EMI104, Grenoble, France; [Guetta, Dorian; Klein, Gerard; Aubry, Laurence] CNRS, LBBSI, UMR5092, Grenoble, France; [Guetta, Dorian; Grunwald, Didier; Klein, Gerard; Aubry, Laurence] Univ Grenoble 1, Grenoble, France	CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Guetta, D (corresponding author), CEA, DSV, Lab Biochim & Biophys Syst Integres, iRTSV, Grenoble, France.	laubry@cea.fr		guetta, dafne/0000-0002-7349-1109; Aubry, Laurence/0000-0001-7640-1706	Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique; Universite Joseph Fourier Grenoble I	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier Grenoble I	This work was funded by the Commissariat a l'Energie Atomique, the Centre National de la Recherche Scientifique and the Universite Joseph Fourier Grenoble I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADESSI C, 1995, J CELL SCI, V108, P3331; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Aubry L, 2002, J BIOL CHEM, V277, P21947, DOI 10.1074/jbc.M201718200; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; AUBRY L, 1993, J CELL SCI, V105, P861; Aubry L, 1997, DICTYOSTELIUM MODEL, P65; Aubry Laurence, 2006, V346, P171; Aubry L, 2009, CURR GENOMICS, V10, P133, DOI 10.2174/138920209787847014; Bennett N, 2008, EXP CELL RES, V314, P2822, DOI 10.1016/j.yexcr.2008.06.019; BRENOT F, 1992, BIOCHIMIE, V74, P883, DOI 10.1016/0300-9084(92)90072-M; Chen PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008624; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Ellson CD, 2001, CURR BIOL, V11, P1631, DOI 10.1016/S0960-9822(01)00447-X; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gotthardt D, 2006, MOL CELL PROTEOMICS, V5, P2228, DOI 10.1074/mcp.M600113-MCP200; Graf R, 1999, BIOL CELL, V91, P471, DOI 10.1016/S0248-4900(99)80088-4; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Hacker U, 1997, J CELL SCI, V110, P105; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Journet A, 1999, J CELL SCI, V112, P3833; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Mattei S, 2005, DEV BIOL, V279, P99, DOI 10.1016/j.ydbio.2004.12.004; Mercanti V, 2006, J CELL SCI, V119, P4079, DOI 10.1242/jcs.03190; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Popov S, 2009, J VIROL, V83, P7185, DOI 10.1128/JVI.00198-09; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Price HP, 2007, MOL BIOL CELL, V18, P864, DOI 10.1091/mbc.E06-08-0736; Raiborg C, 2001, J CELL SCI, V114, P2255; Rauchenberger R, 1997, CURR BIOL, V7, P215, DOI 10.1016/S0960-9822(97)70093-9; Ravanel K, 2001, EUR J CELL BIOL, V80, P754, DOI 10.1078/0171-9335-00215; Roman G, 2000, GENETICS, V155, P1281; Rupper AC, 2001, J CELL SCI, V114, P1283; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shinoda J, 2007, BIOCHEM BIOPH RES CO, V364, P258, DOI 10.1016/j.bbrc.2007.09.134; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; WEINER OH, 1993, J CELL BIOL, V123, P23, DOI 10.1083/jcb.123.1.23; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; ZHOU KM, 1995, MOL CELL BIOL, V15, P5645	55	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15249	10.1371/journal.pone.0015249	http://dx.doi.org/10.1371/journal.pone.0015249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179207	Green Published, gold			2022-12-27	WOS:000285246900037
J	Kramer, LB; Shim, J; Previtera, ML; Isack, NR; Lee, MC; Firestein, BL; Rongo, C				Kramer, Lawrence B.; Shim, Jaegal; Previtera, Michelle L.; Isack, Nora R.; Lee, Ming-Chih; Firestein, Bonnie L.; Rongo, Christopher			UEV-1 Is an Ubiquitin-Conjugating Enzyme Variant That Regulates Glutamate Receptor Trafficking in C. elegans Neurons	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEIN; VENTRAL NERVE CORD; AMPA RECEPTORS; ENDOPLASMIC-RETICULUM; POLYUBIQUITIN CHAINS; SYNAPTIC PLASTICITY; CRYSTAL-STRUCTURE; ENDOCYTOSIS; COMPLEX; BINDING	The regulation of AMPA-type glutamate receptor (AMPAR) membrane trafficking is a key mechanism by which neurons regulate synaptic strength and plasticity. AMPAR trafficking is modulated through a combination of receptor phosphorylation, ubiquitination, endocytosis, and recycling, yet the factors that mediate these processes are just beginning to be uncovered. Here we identify the ubiquitin-conjugating enzyme variant UEV-1 as a regulator of AMPAR trafficking in vivo. We identified mutations in uev-1 in a genetic screen for mutants with altered trafficking of the AMPAR subunit GLR-1 in C. elegans interneurons. Loss of uev-1 activity results in the accumulation of GLR-1 in elongated accretions in neuron cell bodies and along the ventral cord neurites. Mutants also have a corresponding behavioral defect-a decrease in spontaneous reversals in locomotion-consistent with diminished GLR-1 function. The localization of other synaptic proteins in uev-1-mutant interneurons appears normal, indicating that the GLR-1 trafficking defects are not due to gross deficiencies in synapse formation or overall protein trafficking. We provide evidence that GLR-1 accumulates at RAB-10-containing endosomes in uev-1 mutants, and that receptors arrive at these endosomes independent of clathrin-mediated endocytosis. UEV-1 homologs in other species bind to the ubiquitin-conjugating enzyme Ubc13 to create K63-linked polyubiquitin chains on substrate proteins. We find that whereas UEV-1 can interact with C. elegans UBC-13, global levels of K63-linked ubiquitination throughout nematodes appear to be unaffected in uev-1 mutants, even though UEV-1 is broadly expressed in most tissues. Nevertheless, ubc-13 mutants are similar in phenotype to uev-1 mutants, suggesting that the two proteins do work together to regulate GLR-1 trafficking. Our results suggest that UEV-1 could regulate a small subset of K63-linked ubiquitination events in nematodes, at least one of which is critical in regulating GLR-1 trafficking.	[Kramer, Lawrence B.; Isack, Nora R.; Lee, Ming-Chih; Rongo, Christopher] Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08855 USA; [Shim, Jaegal] Natl Canc Ctr, Canc Expt Resources Branch, Goyang, South Korea; [Previtera, Michelle L.; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Kramer, Lawrence B.; Previtera, Michelle L.] Rutgers State Univ, Grad Program Mol Biosci, Piscataway, NJ USA	Rutgers State University New Brunswick; National Cancer Center - Korea (NCC); Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kramer, LB (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08855 USA.	rongo@waksman.rutgers.edu		Firestein, Bonnie/0000-0002-1679-3565	National Institutes of Health [R01 NS42023]; National Science Foundation [IBN-0548543, DGE-0333196]; IGERT; Louis Bevier Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); IGERT(National Science Foundation (NSF)); Louis Bevier Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The manuscript was funded by a grant from the National Institutes of Health (R01 NS42023) to CGR and a grant from the National Science Foundation (IBN-0548543) to BLF. MLP was supported by the IGERT Program on Biointerfaces, by National Science Foundation grant DGE-0333196, and by a Louis Bevier Dissertation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Boelens J, 2007, IN VIVO, V21, P215; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Chang HCH, 2005, J CELL SCI, V118, P1945, DOI 10.1242/jcs.02320; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cram EJ, 2006, J CELL SCI, V119, P4811, DOI 10.1242/jcs.03274; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Feldman M, 2009, TRENDS CELL BIOL, V19, P357, DOI 10.1016/j.tcb.2009.05.005; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Glodowski DR, 2005, MOL BIOL CELL, V16, P1417, DOI 10.1091/mbc.E04-10-0885; Govindan JA, 2006, CURR BIOL, V16, P1257, DOI 10.1016/j.cub.2006.05.020; Grunwald ME, 2004, P NATL ACAD SCI USA, V101, P3190, DOI 10.1073/pnas.0306156101; Gudgen M, 2004, BIOCHEM BIOPH RES CO, V325, P479, DOI 10.1016/j.bbrc.2004.10.047; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hanley JG, 2006, BIOCHEM SOC T, V34, P931, DOI 10.1042/BST0340931; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hoseki J, J BIOCH, V147, P19; Howard RA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-32; Hu JH, 2007, MOL BIOL CELL, V18, P3277, DOI 10.1091/mbc.E07-03-0239; Jiang JX, 2006, NEUROSIGNALS, V15, P266, DOI 10.1159/000105517; Jones D, 2001, GENOME BIOL, V3; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Lauwers E, 2010, TRENDS CELL BIOL; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Malerod L, 2007, CURR BIOL, V17, pR42, DOI 10.1016/j.cub.2006.12.009; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Ramirez O, 2010, J MICROSC-OXFORD, V239, P173, DOI 10.1111/j.1365-2818.2010.03369.x; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Rumpel S, 2005, POSTSYNAPTIC RECEPTO; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Syed NA, 2006, APOPTOSIS, V11, P2147, DOI 10.1007/s10495-006-0197-3; Tan JM, 2007, HUM MOL GENET; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Thomson TM, 1998, FEBS LETT, V423, P49, DOI 10.1016/S0014-5793(98)00060-X; Trujillo G, 2010, GENETICS, V186, P135, DOI 10.1534/genetics.110.117341; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Umemura T, 2005, J CELL SCI, V118, P3327, DOI 10.1242/jcs.02457; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Villalobo E, 2002, MOL BIOL EVOL, V19, P39, DOI 10.1093/oxfordjournals.molbev.a003980; Wen R, 2008, PLANT CELL; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	100	19	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14291	10.1371/journal.pone.0014291	http://dx.doi.org/10.1371/journal.pone.0014291			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179194	Green Submitted, Green Published, gold			2022-12-27	WOS:000285246900005
J	Thwaites, GE				Thwaites, Guy E.		UKCIRG	The Management of Staphylococcus aureus Bacteremia in the United Kingdom and Vietnam: A Multi-Centre Evaluation	PLOS ONE			English	Article							COMPETING RISK; INFECTION; GUIDELINES; ECHOCARDIOGRAPHY; ENDOCARDITIS; EXPERIENCE; MORTALITY; DIAGNOSIS; SOCIETY; DISEASE	Background: Staphylococcus aureus bacteremia is a common and serious infection worldwide and although treatment guidelines exist, there is little consensus on optimal management. In this study we assessed the variation in management and adherence to treatment guidelines of S. aureus bacteremia. Methodology/Principal Findings: We prospectively recorded baseline clinical characteristics, management, and in-hospital outcome of all adults with S. aureus bacteremia treated consecutively over one year in eight centres in the United Kingdom, three in Vietnam and one in Nepal. 630 adults were treated for S. aureus bacteremia: 549 in the UK (21% methicillin-resistant), 80 in Vietnam (19% methicillin-resistant) and 1 in Nepal. In the UK, 41% had a removable infection focus (50% intravenous catheter-related), compared to 12% in Vietnam. Significantly (p<0.001) higher proportions of UK than Vietnamese patients had an echocardiogram (50% versus 28%), received more than 14 days antibiotic therapy (84% versus 44%), and received >50% of treatment with oral antibiotics alone (25% versus 4%). UK centres varied significantly (p<0.01) in the proportions given oral treatment alone for >50% of treatment (range 12-40%), in those treated for longer than 28 days (range 13-54%), and in those given combination therapy (range 14-94%). 24% died during admission: older age, time in hospital before bacteremia, and an unidentified infection focus were independent predictors of in-hospital death (p<0.001). Conclusions/Significance: The management of S. aureus bacteremia varies widely between the UK and Vietnam and between centres in the UK with little adherence to published guidelines. Controlled trials defining optimal therapy are urgently required.	[Thwaites, Guy E.; UKCIRG] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Thwaites, GE (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	guy.thwaites@btinternet.com	Llewelyn, Martin/Y-1472-2019; Llewelyn, Martin/A-7194-2011; Thwaites, Guy E/R-4993-2019; Gkrania-Klotsas, Effrossyni/AAT-8424-2021	Llewelyn, Martin/0000-0002-6811-1124; Thwaites, Guy E/0000-0002-2858-2087; Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; Farrar, Jeremy/0000-0002-2700-623X; Whitehorn, James/0000-0003-0789-5954; Torok, Mili Estee/0000-0001-9098-8590; Satta, Giovanni/0000-0002-0120-7885; Kirby, Andrew/0000-0002-2440-9316; Hopkins, Susan/0000-0001-5179-5702; Price, James/0000-0003-2541-8545; Scarborough, Matthew/0000-0002-0455-0785	Hospital for Tropical Diseases, London, UK; Wellcome Trust, UK; Department of Health via the NIHR comprehensive Biomedical Research Centre; UK MRC; NIHR Oxford BioMedical Research Centre; UCLH/UCL Comprehensive Biomedical Centre; Department of Health's NIHR Biomedical Research Centres; MRC [G0701652] Funding Source: UKRI; National Institute for Health Research [ACF-2007-27-002, ACF-2008-18-017] Funding Source: researchfish	Hospital for Tropical Diseases, London, UK; Wellcome Trust, UK(Wellcome Trust); Department of Health via the NIHR comprehensive Biomedical Research Centre; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Oxford BioMedical Research Centre(National Institute for Health Research (NIHR)); UCLH/UCL Comprehensive Biomedical Centre; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the Special Trustees of the Hospital for Tropical Diseases, London, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Guy Thwaites and Heiman Wertheim are funded by the Wellcome Trust, UK. Jonathan Edgeworth receives funding from the Department of Health via the NIHR comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. Sarah Walker is funded by the UK MRC and the NIHR Oxford BioMedical Research Centre. Peter Wilson is part funded by the UCLH/UCL Comprehensive Biomedical Centre which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.	Ammerlaan H, 2009, CLIN INFECT DIS; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Dryden M, 2010, CLIN MICROBIOL INFEC, V16, P3, DOI 10.1111/j.1469-0691.2010.03135.x; Elliott TSJ, 2004, J ANTIMICROB CHEMOTH, V54, P971, DOI 10.1093/jac/dkh474; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Fowler VG, 1997, J AM COLL CARDIOL, V30, P1072, DOI 10.1016/S0735-1097(97)00250-7; Gemmell CG, 2006, J ANTIMICROB CHEMOTH, V57, P589, DOI 10.1093/jac/dkl017; [Health Protection Agency Communicable Disease Surveillance Centre DoH], 2009, SUMM POINTS COMM Q A; Hoa NTT, 1998, T ROY SOC TROP MED H, V92, P503, DOI 10.1016/S0035-9203(98)90891-4; Hussain A, 2010, J ANTIMICROB CHEMOTH, V65, P347, DOI 10.1093/jac/dkp456; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Lesens Olivier, 2003, Eur J Intern Med, V14, P227, DOI 10.1016/S0953-6205(03)00063-3; Melzer M, 2003, CLIN INFECT DIS, V37, P1453, DOI 10.1086/379321; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Naber CK, 2009, CLIN INFECT DIS, V48, pS231, DOI 10.1086/598189; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Nickerson EK, 2009, LANCET INFECT DIS, V9, P130, DOI 10.1016/S1473-3099(09)70022-2; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Sullenberger AL, 2005, J HEART VALVE DIS, V14, P23; Tai BC, 2001, STAT MED, V20, P3589, DOI 10.1002/sim.1079; Tran TS, 1998, J HOSP INFECT, V40, P141, DOI 10.1016/S0195-6701(98)90093-7; Turnidge JD, 2009, MED J AUSTRALIA, V191, P368, DOI 10.5694/j.1326-5377.2009.tb02841.x; Wong V, 2010, CLIN MED, V10, P266, DOI 10.7861/clinmedicine.10-3-266; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	26	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14170	10.1371/journal.pone.0014170	http://dx.doi.org/10.1371/journal.pone.0014170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179193	Green Published, Green Accepted, gold			2022-12-27	WOS:000285246900002
J	Dai, RJ; Zhang, Y; Khan, D; Heid, B; Caudell, D; Crasta, O; Ahmed, SA				Dai, Rujuan; Zhang, Yan; Khan, Deena; Heid, Bettina; Caudell, David; Crasta, Oswald; Ahmed, S. Ansar			Identification of a Common Lupus Disease-Associated microRNA Expression Pattern in Three Different Murine Models of Lupus	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; RHEUMATOID-ARTHRITIS; SIGNALING PROTEINS; INTERFERON-GAMMA; CELL-DEVELOPMENT; IMMUNE-SYSTEM; NITRIC-OXIDE; PLASMA-CELLS; AUTOIMMUNITY	Background: Recent reports have shown that microRNAs (miRNAs) regulate vital immunological processes and have emerged as key regulators of immune system development and function. Therefore, it is important to determine miRNA dysregulation and its pathogenic contribution in autoimmune diseases, an aspect not adequately addressed thus far. Methodology/Principal Findings: In this study, we profiled miRNA expressions in splenic lymphocytes from three murine lupus models (MRL-lpr, B6-lpr and NZB/W-F1) with different genetic background by miRNA microarray assays and Real-time RT-PCR. Despite the genetic differences among these three lupus stains, a common set of dysregulated miRNAs (miR-182-96-183 cluster, miR-31, and miR-155) was identified in splenocytes when compared with age-matched control mice. The association of these miRNAs with the disease was highlighted by our observation that this miRNA expression pattern was evident in NZB/W mice only at an age when lupus disease is manifested. Further, we have shown that the miRNA dysregulation in MRL-lpr mice was not simply due to the activation of splenocytes. By Real-time RT-PCR, we confirmed that these miRNAs were upregulated in both purified splenic B and T cells from MRL-lpr mice. miR-127 and miR-379, which were greatly upregulated in splenocytes from lpr mice, were moderately increased in diseased NZB/W mice. In addition, Real-time RT-PCR revealed that miR-146a, miR-101a, and miR-17-92 were also markedly upregulated in splenic T, but not B cells from MRL-lpr mice. Conclusions/Significance: The identification of common lupus disease-associated miRNAs now forms the basis for the further investigation of the pathogenic contribution of these miRNAs in autoimmune lupus, which will advance our knowledge of the role of miRNAs in autoimmunity. Given that miRNAs are conserved, with regard to both evolution and function, our observation of a common lupus disease-associated miRNA expression pattern in murine lupus models is likely to have significant pathogenic, diagnostic, and/or therapeutic implications in human lupus.	[Dai, Rujuan; Khan, Deena; Heid, Bettina; Caudell, David; Ahmed, S. Ansar] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathol, CMMID, Blacksburg, VA 24061 USA; [Zhang, Yan; Crasta, Oswald] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Dai, RJ (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathol, CMMID, Blacksburg, VA 24061 USA.	rdai05@vt.edu; ansrahmd@vt.edu	zhang, yan/AAG-7349-2019	zhang, yan/0000-0003-0906-9410	Lupus Foundation of America [208-11-110B-033-918-1]; Virginia-Maryland Regional College of Veterinary Medicine (VMRCVM) [IRC 17385]; National Institutes of Health [1 RO1 AI051880]; NIAID, NIH [HHSN272200900040C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051880] Funding Source: NIH RePORTER	Lupus Foundation of America; Virginia-Maryland Regional College of Veterinary Medicine (VMRCVM); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Lupus Foundation of America Novel Pilot Project (208-11-110B-033-918-1), Virginia-Maryland Regional College of Veterinary Medicine (VMRCVM) Intramural Research Competition Grant (IRC 17385), and in part by National Institutes of Health (1 RO1 AI051880). YZ and OC were supported by NIAID, NIH award under contract No. HHSN272200900040C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Dai R, 2007, J IMMUNOL, V179, P1776, DOI 10.4049/jimmunol.179.3.1776; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; DAI Y, 2008, RHEUMATOL INT; Dorner T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2780; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Jonsson MV, 2007, CLIN REV ALLERG IMMU, V32, P215, DOI 10.1007/s12016-007-8012-7; Karpuzoglu E, 2006, ENDOCRINOLOGY, V147, P662, DOI 10.1210/en.2005-0829; KELLEY VE, 1985, CLIN IMMUNOL IMMUNOP, V37, P220, DOI 10.1016/0090-1229(85)90153-9; Kono DH, 2006, SPRINGER SEMIN IMMUN, V28, P83, DOI 10.1007/s00281-006-0030-7; Koopman W J, 1988, Scand J Rheumatol Suppl, V75, P284; Kuo CC, 2007, MOL MED, V13, P561, DOI 10.2119/2007-00021.Kuo; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin L, 2004, J EXP MED, V200, P115, DOI 10.1084/jem.20040612; Liu K, 2006, CLIN IMMUNOL, V119, P123, DOI 10.1016/j.clim.2006.01.014; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pan Q, 2010, MOL HUM REPROD, V16, P215, DOI 10.1093/molehr/gap093; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Reilly CM, 2006, EUR J IMMUNOL, V36, P1296, DOI 10.1002/eji.200535245; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Verthelyi DI, 1998, CELL IMMUNOL, V189, P125, DOI 10.1006/cimm.1998.1372; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang Y, 1997, AM J PATHOL, V151, P1791; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	49	122	131	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14302	10.1371/journal.pone.0014302	http://dx.doi.org/10.1371/journal.pone.0014302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170274	gold, Green Published, Green Submitted			2022-12-27	WOS:000285181400015
J	Bonetti, C; Surace, EM				Bonetti, Ciro; Surace, Enrico Maria			Mouse Embryonic Retina Delivers Information Controlling Cortical Neurogenesis	PLOS ONE			English	Article							RAT VISUAL-CORTEX; TOPOGRAPHIC MAPS; SPINDLE BURSTS; WAVES; CELLS; SPECIFICATION; AREAS; MICE	The relative contribution of extrinsic and intrinsic mechanisms to cortical development is an intensely debated issue and an outstanding question in neurobiology. Currently, the emerging view is that interplay between intrinsic genetic mechanisms and extrinsic information shape different stages of cortical development [1]. Yet, whereas the intrinsic program of early neocortical developmental events has been at least in part decoded [2], the exact nature and impact of extrinsic signaling are still elusive and controversial. We found that in the mouse developing visual system, acute pharmacological inhibition of spontaneous retinal activity (retinal waves-RWs) during embryonic stages increase the rate of corticogenesis (cell cycle withdrawal). Furthermore, early perturbation of retinal spontaneous activity leads to changes of cortical layer structure at a later time point. These data suggest that mouse embryonic retina delivers long-distance information capable of modulating cell genesis in the developing visual cortex and that spontaneous activity is the candidate long-distance acting extrinsic cue mediating this process. In addition, these data may support spontaneous activity to be a general signal coordinating neurogenesis in other developing sensory pathways or areas of the central nervous system.	[Bonetti, Ciro; Surace, Enrico Maria] Telethon Inst Genet & Med TIGEM, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Bonetti, C (corresponding author), Telethon Inst Genet & Med TIGEM, Naples, Italy.	surace@tigem.it		Surace, Enrico Maria/0000-0002-2975-942X	Telethon [TIGEM-P21]; National Eye Institute, National Institute of Health (NEI) [R01EY015136-01]; NATIONAL EYE INSTITUTE [R01EY015136] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); National Eye Institute, National Institute of Health (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants from Telethon (TIGEM-P21) and R01EY015136-01 from the National Eye Institute, National Institute of Health (NEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Bansal A, 2000, J NEUROSCI, V20, P7672; BLANKENSHIP AG, NAT REV NEUROSCI, V11, P18; Chalupa LM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-25; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clandinin TR, 2009, CURR OPIN NEUROBIOL, V19, P174, DOI 10.1016/j.conb.2009.04.011; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Hanganu IL, 2007, J NEUROSCI, V27, P5694, DOI 10.1523/JNEUROSCI.5233-06.2007; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Polleux F, 1997, J COMP NEUROL, V385, P95; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Surace EM, 2003, J VIROL, V77, P7957, DOI 10.1128/JVI.77.14.7957-7963.2003; Syed MM, 2004, J NEUROPHYSIOL, V91, P1999, DOI 10.1152/jn.01129.2003; Triplett JW, 2009, CELL, V139, P175, DOI 10.1016/j.cell.2009.08.028; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015	29	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15211	10.1371/journal.pone.0015211	http://dx.doi.org/10.1371/journal.pone.0015211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170332	gold, Green Submitted, Green Published			2022-12-27	WOS:000285084100030
J	Diegelmann, J; Beigel, F; Zitzmann, K; Kaul, A; Goke, B; Auernhammer, CJ; Bartenschlager, R; Diepolder, HM; Brand, S				Diegelmann, Julia; Beigel, Florian; Zitzmann, Kathrin; Kaul, Artur; Goeke, Burkhard; Auernhammer, Christoph J.; Bartenschlager, Ralf; Diepolder, Helmut M.; Brand, Stephan			Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus	PLOS ONE			English	Article							IFN-LAMBDA; GENE-EXPRESSION; III IFN; PROTEIN; ALPHA; INTERLEUKIN-29; HEPATOCYTES; RECOGNITION; FRACTALKINE; PROTECTION	Background: Specific differences in signaling and antiviral properties between the different Lambda-interferons, a novel group of interferons composed of IL-28A, IL-28B and IL-29, are currently unknown. This is the first study comparatively investigating the transcriptome and the antiviral properties of the Lambda-interferons IL-28A and IL-29. Methodology/Principal Findings: Expression studies were performed by microarray analysis, quantitative PCR (qPCR), reporter gene assays and immunoluminometric assays. Signaling was analyzed by Western blot. HCV replication was measured in Huh-7 cells expressing subgenomic HCV replicon. All hepatic cell lines investigated as well as primary hepatocytes expressed both IFN-lambda receptor subunits IL-10R2 and IFN-lambda R1. Both, IL-28A and IL-29 activated STAT1 signaling. As revealed by microarray analysis, similar genes were induced by both cytokines in Huh-7 cells (IL-28A: 117 genes; IL-29: 111 genes), many of them playing a role in antiviral immunity. However, only IL-28A was able to significantly down-regulate gene expression (n = 272 down-regulated genes). Both cytokines significantly decreased HCV replication in Huh-7 cells. In comparison to liver biopsies of patients with non-viral liver disease, liver biopsies of patients with HCV showed significantly increased mRNA expression of IL-28A and IL-29. Moreover, IL-28A serum protein levels were elevated in HCV patients. In a murine model of viral hepatitis, IL-28 expression was significantly increased. Conclusions/Significance: IL-28A and IL-29 are up-regulated in HCV patients and are similarly effective in inducing antiviral genes and inhibiting HCV replication. In contrast to IL-29, IL-28A is a potent gene repressor. Both IFN-lambda s may have therapeutic potential in the treatment of chronic HCV.	[Diegelmann, Julia; Beigel, Florian; Zitzmann, Kathrin; Goeke, Burkhard; Auernhammer, Christoph J.; Diepolder, Helmut M.; Brand, Stephan] Univ Munich, Dept Med 2, Univ Hosp Munich Grosshadern, Munich, Germany; [Kaul, Artur; Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, Heidelberg, Germany	University of Munich; Ruprecht Karls University Heidelberg	Diegelmann, J (corresponding author), Univ Munich, Dept Med 2, Univ Hosp Munich Grosshadern, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Zitzmann, Kathrin/AAF-6898-2020; Bartenschlager, Ralf/L-2582-2015	Bartenschlager, Ralf/0000-0001-5601-9307	Else Kroner-Fresenius-Stiftung [P50/05/EKMS05/62]; Deutsche Forschungsgemeinschaft (DFG) [BR 1912/5-1]; DCCV; Ludwig-Maximilians-University Munich; Ministry for Research and Education [01 KI 1008A]	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DCCV; Ludwig-Maximilians-University Munich; Ministry for Research and Education	S. Brand was supported by grants from the Else Kroner-Fresenius-Stiftung (Else Kroner Fresenius Memorial Stipendium 2005; P50/05/EKMS05/62), the Deutsche Forschungsgemeinschaft (DFG, BR 1912/5-1), by the Ludwig-Demling Grant 2007 from DCCV e. V., and by grants from the Ludwig-Maximilians-University Munich (Excellence Initiative - Investment Fund 2008 and FoFoLe program 2007 and 2008). F. Beigel was supported by grants from the Ludwig-Maximilians-University Munich (FoFoLe program 2008). Ralf Bartenschlager was supported by a grant of the Ministry for Research and Education (01 KI 1008A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 1999, BBA-BIOMEMBRANES, V1461, P405, DOI 10.1016/S0005-2736(99)00171-6; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Auernhammer CJ, 2003, ENDOCRINOLOGY, V144, P1202, DOI 10.1210/en.2002-220933; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berghall H, 2006, MICROBES INFECT, V8, P2138, DOI 10.1016/j.micinf.2006.04.005; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Brand S, 2002, GASTROENTEROLOGY, V122, P166, DOI 10.1053/gast.2002.30329; Brand S, 2007, AM J PHYSIOL-GASTR L, V292, pG1019, DOI 10.1152/ajpgi.00239.2006; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Dambacher J, 2008, CYTOKINE, V41, P209, DOI 10.1016/j.cyto.2007.11.016; Almeida GMD, 2008, ANTIVIR RES, V80, P302, DOI 10.1016/j.antiviral.2008.06.016; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; HENSON D, 1966, AM J PATHOL, V49, P871; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KELLY JM, 1986, EMBO J, V5, P1601, DOI 10.1002/j.1460-2075.1986.tb04402.x; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Liu ZH, 2005, MOL CANCER RES, V3, P21; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Maher SG, 2008, CANCER BIOL THER, V7, P1109, DOI 10.4161/cbt.7.7.6192; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Orange JS, 1997, J VIROL, V71, P9248, DOI 10.1128/JVI.71.12.9248-9258.1997; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Pagliaccetti NE, 2008, J BIOL CHEM, V283, P30079, DOI 10.1074/jbc.M804296200; Ploss A, 2009, EMBO REP, V10, P1220, DOI 10.1038/embor.2009.223; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Thasler WE, 2006, J PHARMACOL EXP THER, V316, P822, DOI 10.1124/jpet.105.094201; THOMAS DL, 2009, NATURE; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhou L, 2009, NEUROSCIENCE, V159, P629, DOI 10.1016/j.neuroscience.2008.12.036; Zhu HZ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-80; Zitzmann K, 2006, BIOCHEM BIOPH RES CO, V344, P1334, DOI 10.1016/j.bbrc.2006.04.043	55	70	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15200	10.1371/journal.pone.0015200	http://dx.doi.org/10.1371/journal.pone.0015200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170333	Green Published, Green Submitted, gold			2022-12-27	WOS:000285084100028
J	Louapre, P; van Alphen, JJM; Pierre, JS				Louapre, Philippe; van Alphen, Jacques J. M.; Pierre, Jean-Sebastien			Humans and Insects Decide in Similar Ways	PLOS ONE			English	Article							LOCUS-COERULEUS NEURONS; DECISION-MAKING; VIGILANCE TASK; INFORMATION; BEHAVIOR; RULES; EXPLOITATION; ACQUISITION; PERFORMANCE; MOTIVATION	Behavioral ecologists assume that animals use a motivational mechanism for decisions such as action selection and time allocation, allowing the maximization of their fitness. They consider both the proximate and ultimate causes of behavior in order to understand this type of decision-making in animals. Experimental psychologists and neuroeconomists also study how agents make decisions but they consider the proximate causes of the behavior. In the case of patch-leaving, motivation-based decision-making remains simple speculation. In contrast to other animals, human beings can assess and evaluate their own motivation by an introspection process. It is then possible to study the declared motivation of humans during decision-making and discuss the mechanism used as well as its evolutionary significance. In this study, we combine both the proximate and ultimate causes of behavior for a better understanding of the human decision-making process. We show for the first time ever that human subjects use a motivational mechanism similar to small insects such as parasitoids [1] and bumblebees [2] to decide when to leave a patch. This result is relevant for behavioral ecologists as it supports the biological realism of this mechanism. Humans seem to use a motivational mechanism of decision making known to be adaptive to a heterogeneously distributed resource. As hypothesized by Hutchinson et al. [3] and Wilke and Todd [4], our results are consistent with the evolutionary shaping of decision making because hominoids were hunters and gatherers on food patches for more than two million years. We discuss the plausibility of a neural basis for the motivation mechanism highlighted here, bridging the gap between behavioral ecology and neuroeconomy. Thus, both the motivational mechanism observed here and the neuroeconomy findings are most likely adaptations that were selected for during ancestral times.	[Louapre, Philippe; van Alphen, Jacques J. M.; Pierre, Jean-Sebastien] Univ Rennes 1, CNRS, EcoBio UMR6553, CAREN IFR90 FR2116, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes	Louapre, P (corresponding author), Univ Rennes 1, CNRS, EcoBio UMR6553, CAREN IFR90 FR2116, Campus Beaulieu, Rennes, France.	philippe.louapre@mail-univscience.com			CNRS [UMR 6553]; University of Rennes 1	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1	The internal funding for the work was UMR 6553 "EcoBio" allocated by CNRS and University of Rennes 1. There were no external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Collett D, 1994, MODELLING SURVIVAL D; Corallo G, 2008, PSYCHOL SCI, V19, P1110, DOI 10.1111/j.1467-9280.2008.02211.x; Cox DR, 1972, BIOMETRICS, V38, P67; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dehaene S, 2003, TRENDS COGN SCI, V7, P145, DOI 10.1016/S1364-6613(03)00055-X; DORMAN C, 1995, HDB BRAIN THEORY NEU, P591; DRIESSEN G, 1995, J ANIM ECOL, V64, P117, DOI 10.2307/5832; Engelbert M, 2010, WIRES COGN SCI, V1, P245, DOI 10.1002/wcs.4; Glimcher PW, 2003, BRADFORD BOOKS, P1; Guay F, 2000, MOTIV EMOTION, V24, P175, DOI 10.1023/A:1005614228250; Hull C., 1943, PRINCIPLES BEHAV; Hutchinson JMC, 2008, ANIM BEHAV, V75, P1331, DOI 10.1016/j.anbehav.2007.09.006; IWASA Y, 1981, AM NAT, V117, P710, DOI 10.1086/283754; Krebs JR., 1997, BEHAV ECOLOGY EVOLUT; KURLAND JA, 1985, AM ANTHROPOL, V87, P73, DOI 10.1525/aa.1985.87.1.02a00070; Lefebvre D, 2007, BEHAV ECOL SOCIOBIOL, V61, P1707, DOI 10.1007/s00265-007-0402-6; MANGEL M, 1986, ECOLOGY, V67, P1127, DOI 10.2307/1938669; MCCLELLAND DC, 1989, PSYCHOL REV, V96, P690, DOI 10.1037/0033-295X.96.4.690; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; MELTON AW, 1952, ENCY ED RES, P668; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Pierre JS, 2011, OIKOS, V120, P77, DOI 10.1111/j.1600-0706.2010.18603.x; Pirolli P, 2005, COGNITIVE SCI, V29, P343, DOI 10.1207/s15516709cog0000_20; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Schultheiss OC, 2008, SOC COGN AFFECT NEUR, V3, P333, DOI 10.1093/scan/nsn030; SIBLY R, 1976, AM NAT, V110, P601, DOI 10.1086/283093; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Tenhumberg B, 2001, MATH COMPUT MODEL, V33, P597, DOI 10.1016/S0895-7177(00)00264-8; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; van Alpen JJM, 2003, TRENDS ECOL EVOL, V18, P81, DOI 10.1016/S0169-5347(02)00035-6; van Baaren J, 2005, ECOL ENTOMOL, V30, P502, DOI 10.1111/j.0307-6946.2005.00718.x; WAAGE JK, 1979, J ANIM ECOL, V48, P353, DOI 10.2307/4166; Wilke A, 2010, PSICOTHEMA, V22, P4; Wilke A, 2009, COGNITIVE SCI, V33, P497, DOI 10.1111/j.1551-6709.2009.01020.x; Wilke A, 2009, EVOL HUM BEHAV, V30, P161, DOI 10.1016/j.evolhumbehav.2008.11.004; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	45	15	15	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14251	10.1371/journal.pone.0014251	http://dx.doi.org/10.1371/journal.pone.0014251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691MJ	21170378	Green Published, Green Submitted, gold			2022-12-27	WOS:000285084100005
J	Oshiumi, H; Ikeda, M; Matsumoto, M; Watanabe, A; Takeuchi, O; Akira, S; Kato, N; Shimotohno, K; Seya, T				Oshiumi, Hiroyuki; Ikeda, Masanori; Matsumoto, Misako; Watanabe, Ayako; Takeuchi, Osamu; Akira, Shizuo; Kato, Nobuyuki; Shimotohno, Kunitada; Seya, Tsukasa			Hepatitis C Virus Core Protein Abrogates the DDX3 Function That Enhances IPS-1-Mediated IFN-Beta Induction	PLOS ONE			English	Article							BOX RNA HELICASE; ANTIVIRAL SIGNALING PROTEIN; TOLL-LIKE RECEPTOR-3; RIG-I; INNATE IMMUNITY; ADAPTER PROTEIN; PATHWAY; REPLICATION; REQUIREMENT; CELLS	The DEAD box helicase DDX3 assembles IPS-1 (also called Cardif, MAVS, or VISA) in non-infected human cells where minimal amounts of the RIG-I-like receptor (RLR) protein are expressed. DDX3 C-terminal regions directly bind the IPS-1 CARD-like domain as well as the N-terminal hepatitis C virus (HCV) core protein. DDX3 physically binds viral RNA to form IPS-1-containing spots, that are visible by confocal microscopy. HCV polyU/UC induced IPS-1-mediated interferon (IFN)-beta promoter activation, which was augmented by co-transfected DDX3. DDX3 spots localized near the lipid droplets (LDs) where HCV particles were generated. Here, we report that HCV core protein interferes with DDX3-enhanced IPS-1 signaling in HEK293 cells and in hepatocyte Oc cells. Unlike the DEAD box helicases RIG-I and MDA5, DDX3 was constitutively expressed and colocalized with IPS-1 around mitochondria. In hepatocytes (O cells) with the HCV replicon, however, DDX3/IPS-1-enhanced IFN-beta-induction was largely abrogated even when DDX3 was co-expressed. DDX3 spots barely merged with IPS-1, and partly assembled in the HCV core protein located near the LD in O cells, though in some O cells IPS-1 was diminished or disseminated apart from mitochondria. Expression of DDX3 in replicon-negative or core-less replicon-positive cells failed to cause complex formation or LD association. HCV core protein and DDX3 partially colocalized only in replicon-expressing cells. Since the HCV core protein has been reported to promote HCV replication through binding to DDX3, the core protein appears to switch DDX3 from an IFN-inducing mode to an HCV-replication mode. The results enable us to conclude that HCV infection is promoted by modulating the dual function of DDX3.	[Oshiumi, Hiroyuki; Matsumoto, Misako; Watanabe, Ayako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan; [Ikeda, Masanori; Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Okayama, Japan; [Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 565, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Narashino, Chiba 275, Japan	Hokkaido University; Okayama University; Osaka University; Chiba Institute of Technology	Oshiumi, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.	seya-tu@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Oshiumi, Hiroyuki/G-1645-2012; Akira, Shizuo/C-3134-2009; IKEDA, Masanori/B-2279-2011; Takeuchi, Osamu/AAG-9359-2019; Seya, Tsukasa/A-4336-2012; Takeuchi, Osamu/D-6007-2011	Takeuchi, Osamu/0000-0002-1260-6232; Oshiumi, Hiroyuki/0000-0003-1567-8722	Founding Research Centers for Emerging and Reemerging Infectious Diseases; MEXT; Sapporo Biocluster "Bio-S"; Knowledge Cluster Initiative of the MEXT; Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Mochida Foundation; Yakult Foundation; NorthTec Foundation; Waxman Foundation	Founding Research Centers for Emerging and Reemerging Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sapporo Biocluster "Bio-S"; Knowledge Cluster Initiative of the MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Mochida Foundation; Yakult Foundation; NorthTec Foundation; Waxman Foundation	This work was supported in part by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT, Sapporo Biocluster "Bio-S", the Knowledge Cluster Initiative of the MEXT, Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research) and the Ministry of Health, Labor, and Welfare of Japan, Mochida Foundation, Yakult Foundation, NorthTec Foundation and Waxman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Chang PC, 2006, ONCOGENE, V25, P1991, DOI 10.1038/sj.onc.1209239; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Heim MH, 1999, J VIROL, V73, P8469, DOI 10.1128/JVI.73.10.8469-8475.1999; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kravchenko VV, 2003, J BIOL CHEM, V278, P26612, DOI 10.1074/jbc.M303001200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Mamiya N, 1999, J BIOL CHEM, V274, P15751, DOI 10.1074/jbc.274.22.15751; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mulhern O, 2010, EUR J IMMUNOL, V40, P933, DOI 10.1002/eji.201040447; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Scott I, 2010, MITOCHONDRION, V10, P316, DOI 10.1016/j.mito.2010.02.005; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Wang HF, 2009, J VIROL, V83, P5815, DOI 10.1128/JVI.00011-09; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	47	59	64	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14258	10.1371/journal.pone.0014258	http://dx.doi.org/10.1371/journal.pone.0014258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170385	Green Published, gold			2022-12-27	WOS:000285084100012
J	Gold, L; Ayers, D; Bertino, J; Bock, C; Bock, A; Brody, EN; Carter, J; Dalby, AB; Eaton, BE; Fitzwater, T; Flather, D; Forbes, A; Foreman, T; Fowler, C; Gawande, B; Goss, M; Gunn, M; Gupta, S; Halladay, D; Heil, J; Heilig, J; Hicke, B; Husar, G; Janjic, J; Jarvis, T; Jennings, S; Katilius, E; Keeney, TR; Kim, N; Koch, TH; Kraemer, S; Kroiss, L; Le, N; Levine, D; Lindsey, W; Lollo, B; Mayfield, W; Mehan, M; Mehler, R; Nelson, SK; Nelson, M; Nieuwlandt, D; Nikrad, M; Ochsner, U; Ostroff, RM; Otis, M; Parker, T; Pietrasiewicz, S; Resnicow, DI; Rohloff, J; Sanders, G; Sattin, S; Schneider, D; Singer, B; Stanton, M; Sterkel, A; Stewart, A; Stratford, S; Vaught, JD; Vrkljan, M; Walker, JJ; Watrobka, M; Waugh, S; Weiss, A; Wilcox, SK; Wolfson, A; Wolk, SK; Zhang, C; Zichi, D				Gold, Larry; Ayers, Deborah; Bertino, Jennifer; Bock, Christopher; Bock, Ashley; Brody, Edward N.; Carter, Jeff; Dalby, Andrew B.; Eaton, Bruce E.; Fitzwater, Tim; Flather, Dylan; Forbes, Ashley; Foreman, Trudi; Fowler, Cate; Gawande, Bharat; Goss, Meredith; Gunn, Magda; Gupta, Shashi; Halladay, Dennis; Heil, Jim; Heilig, Joe; Hicke, Brian; Husar, Gregory; Janjic, Nebojsa; Jarvis, Thale; Jennings, Susan; Katilius, Evaldas; Keeney, Tracy R.; Kim, Nancy; Koch, Tad H.; Kraemer, Stephan; Kroiss, Luke; Le, Ngan; Levine, Daniel; Lindsey, Wes; Lollo, Bridget; Mayfield, Wes; Mehan, Mike; Mehler, Robert; Nelson, Sally K.; Nelson, Michele; Nieuwlandt, Dan; Nikrad, Malti; Ochsner, Urs; Ostroff, Rachel M.; Otis, Matt; Parker, Thomas; Pietrasiewicz, Steve; Resnicow, Daniel I.; Rohloff, John; Sanders, Glenn; Sattin, Sarah; Schneider, Daniel; Singer, Britta; Stanton, Martin; Sterkel, Alana; Stewart, Alex; Stratford, Suzanne; Vaught, Jonathan D.; Vrkljan, Mike; Walker, Jeffrey J.; Watrobka, Mike; Waugh, Sheela; Weiss, Allison; Wilcox, Sheri K.; Wolfson, Alexey; Wolk, Steven K.; Zhang, Chi; Zichi, Dom			Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery	PLOS ONE			English	Article							IN-VITRO SELECTION; SYSTEMATIC EVOLUTION; STATISTICAL-MODEL; KIDNEY-FUNCTION; RNA LIGANDS; PROTEINS; OLIGONUCLEOTIDES; DIAGNOSTICS; PEGAPTANIB; BINDING	Background The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. Methodology/Principal Findings We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 mu L of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (similar to 100 fM-1 mu M), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. Conclusions/Significance We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.	[Gold, Larry; Ayers, Deborah; Bertino, Jennifer; Bock, Christopher; Bock, Ashley; Brody, Edward N.; Carter, Jeff; Dalby, Andrew B.; Fitzwater, Tim; Flather, Dylan; Forbes, Ashley; Foreman, Trudi; Fowler, Cate; Gawande, Bharat; Goss, Meredith; Gunn, Magda; Gupta, Shashi; Halladay, Dennis; Heil, Jim; Heilig, Joe; Hicke, Brian; Husar, Gregory; Janjic, Nebojsa; Jarvis, Thale; Jennings, Susan; Katilius, Evaldas; Keeney, Tracy R.; Kim, Nancy; Kraemer, Stephan; Kroiss, Luke; Le, Ngan; Lindsey, Wes; Lollo, Bridget; Mayfield, Wes; Mehan, Mike; Mehler, Robert; Nelson, Sally K.; Nelson, Michele; Nieuwlandt, Dan; Nikrad, Malti; Ochsner, Urs; Ostroff, Rachel M.; Otis, Matt; Pietrasiewicz, Steve; Resnicow, Daniel I.; Rohloff, John; Sanders, Glenn; Sattin, Sarah; Schneider, Daniel; Singer, Britta; Stanton, Martin; Sterkel, Alana; Stewart, Alex; Stratford, Suzanne; Vaught, Jonathan D.; Vrkljan, Mike; Walker, Jeffrey J.; Watrobka, Mike; Waugh, Sheela; Weiss, Allison; Wilcox, Sheri K.; Wolfson, Alexey; Wolk, Steven K.; Zhang, Chi; Zichi, Dom] SomaLogic, Boulder, CO USA; [Gold, Larry] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO USA; [Levine, Daniel; Parker, Thomas] Cornell Univ, Rogosin Inst, New York, NY USA; [Levine, Daniel; Parker, Thomas] Cornell Univ, Weill Med Coll, New York, NY USA; [Eaton, Bruce E.; Koch, Tad H.] Univ Colorado, Dept Chem & Biochem, Boulder, CO USA	University of Colorado System; University of Colorado Boulder; Cornell University; Cornell University; University of Colorado System; University of Colorado Boulder	Gold, L (corresponding author), SomaLogic, Boulder, CO USA.	lgold@somalogic.com; jwalker@somalogic.com		Flather, Dylan Paul/0000-0003-3268-5385	SomaLogic	SomaLogic	This work was funded by SomaLogic. SomaLogic had no role in the original prospective CKD study. SomaLogic, with input from D.L. and T.P., designed the retrospective CKD study with archived samples, collected and analyzed the data, decided to publish, and prepared the manuscript. The National Institutes of Health (NIH) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	20090004667 US, 2009, ZICHI D; Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Aebersold R, 2009, NAT METHODS, V6, P411, DOI [10.1038/NMETH.F.255, 10.1038/nmeth.f.255]; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Borrebaeck CAK, 2007, EXPERT REV MOL DIAGN, V7, P673, DOI 10.1586/14737159.7.5.673; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Chaudhary K, 2010, CURR DIABETES REP, V10, P37, DOI 10.1007/s11892-009-0080-z; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; DEWEY TM, 1995, J AM CHEM SOC, V117, P8474, DOI 10.1021/ja00137a027; Doggrell SA, 2005, EXPERT OPIN PHARMACO, V6, P1421, DOI 10.1517/14656566.6.8.1421; Eaton BE, 1997, CURR OPIN CHEM BIOL, V1, P10, DOI 10.1016/S1367-5931(97)80103-2; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Giannelli SV, 2007, J AM GERIATR SOC, V55, P816, DOI 10.1111/j.1532-5415.2007.01196.x; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gugliotti LA, 2004, SCIENCE, V304, P850, DOI 10.1126/science.1095678; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liotta L. A., 2010, CLIN PROTEOM, V6, P4, DOI [10.1007/s12014-010-9045-0, DOI 10.1007/S12014-010-9045-0]; Mitchell P, 2010, NAT BIOTECHNOL, V28, P665, DOI 10.1038/nbt0710-665; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nickolas TL, 2008, CURR OPIN NEPHROL HY, V17, P127, DOI 10.1097/MNH.0b013e3282f4e525; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n; PASCUAL M, 1988, KIDNEY INT, V34, P529, DOI 10.1038/ki.1988.214; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Schneider D, 2009, Multiplexed analyses of test samples, Patent No. [US2009/0042206, 20090042206]; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; Service RF, 2008, SCIENCE, V321, P1758, DOI [10.1126/science.321.5897.1758, 10.1126/science.321.5897.1760]; Silberring J, 2010, TRAC-TREND ANAL CHEM, V29, P128, DOI 10.1016/j.trac.2009.11.007; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tarasow TM, 1997, NATURE, V389, P54, DOI 10.1038/37950; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van Riemsdijk-van Overbeeke IC, 2000, CLIN NEPHROL, V53, P115; Vanholder R, 2008, J NEPHROL, V21, P146; Vaught JD, 2004, J AM CHEM SOC, V126, P11231, DOI 10.1021/ja049009h; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Zichi D, 2008, CURR OPIN CHEM BIOL, V12, P78, DOI 10.1016/j.cbpa.2008.01.016	46	865	932	3	208	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15004	10.1371/journal.pone.0015004	http://dx.doi.org/10.1371/journal.pone.0015004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21165148	Green Published, Green Submitted, gold			2022-12-27	WOS:000285041800017
J	Kim, SM; Park, YY; Park, ES; Cho, JY; Izzo, JG; Zhang, D; Kim, SB; Lee, JH; Bhutani, MS; Swisher, SG; Wu, XF; Coombes, KR; Maru, D; Wang, KK; Buttar, NS; Ajani, JA; Lee, JS				Kim, Soo Mi; Park, Yun-Yong; Park, Eun Sung; Cho, Jae Yong; Izzo, Julie G.; Zhang, Di; Kim, Sang-Bae; Lee, Jeffrey H.; Bhutani, Manoop S.; Swisher, Stephen G.; Wu, Xifeng; Coombes, Kevin R.; Maru, Dipen; Wang, Kenneth K.; Buttar, Navtej S.; Ajani, Jaffer A.; Lee, Ju-Seog			Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MATRICELLULAR PROTEIN; EXPRESSION; SPARC; SURVIVAL; CANCER; OSTEOPONTIN; PROGRESSION; MATRIX; GROWTH	Background: Despite many attempts to establish pre-treatment prognostic markers to understand the clinical biology of esophageal adenocarcinoma (EAC), validated clinical biomarkers or parameters remain elusive. We generated and analyzed tumor transcriptome to develop a practical biomarker prognostic signature in EAC. Methodology/Principal Findings: Untreated esophageal endoscopic biopsy specimens were obtained from 64 patients undergoing surgery and chemoradiation. Using DNA microarray technology, genome-wide gene expression profiling was performed on 75 untreated cancer specimens from 64 EAC patients. By applying various statistical and informatical methods to gene expression data, we discovered distinct subgroups of EAC with differences in overall gene expression patterns and identified potential biomarkers significantly associated with prognosis. The candidate marker genes were further explored in formalin-fixed, paraffin-embedded tissues from an independent cohort (52 patients) using quantitative RT-PCR to measure gene expression. We identified two genes whose expression was associated with overall survival in 52 EAC patients and the combined 2-gene expression signature was independently associated with poor outcome (P < 0.024) in the multivariate Cox hazard regression analysis. Conclusions/Significance: Our findings suggest that the molecular gene expression signatures are associated with prognosis of EAC patients and can be assessed prior to any therapy. This signature could provide important improvement for the management of EAC patients.	[Kim, Soo Mi; Park, Yun-Yong; Park, Eun Sung; Cho, Jae Yong; Kim, Sang-Bae; Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Izzo, Julie G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Zhang, Di; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Lee, Jeffrey H.; Bhutani, Manoop S.; Maru, Dipen; Ajani, Jaffer A.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Coombes, Kevin R.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Swisher, Stephen G.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wang, Kenneth K.; Buttar, Navtej S.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Barrett Esophagus Unit, Rochester, MN USA; [Kim, Soo Mi] Chonbuk Natl Univ Med Sch & Hosp, Dept Physiol, Jeonju, South Korea	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Jeonbuk National University; Jeonbuk National University Hospital	Kim, SM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	jlee@mdanderson.org	Lee, Ju-Seog/X-1786-2018	Lee, Ju-Seog/0000-0002-5666-9753; Coombes, Kevin/0000-0002-7630-2123	National Institutes of Health [CA127672, CA129906, CA138671, CA150229]; University of Texas MD Anderson Cancer Center; Chonbuk National University; Dallas Family; Cantu Family; Smith Family; Park Family; Myer Family; Kevin Fund; River Creek Foundation; NATIONAL CANCER INSTITUTE [R01CA150229, R21CA129906, R21CA127672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center; Chonbuk National University; Dallas Family; Cantu Family; Smith Family; Park Family; Myer Family; Kevin Fund; River Creek Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by a grant from National Institutes of Health (CA127672, CA129906, CA138671, and CA150229); Multidisciplinary Research Program grants from University of Texas MD Anderson Cancer Center; Institute for Personalized Cancer Treatment grant from University of Texas MD Anderson Cancer Center; faculty start-up fund from University of Texas MD Anderson Cancer Center; intramural research fund of Chonbuk National University; Dallas, Cantu, Smith, Park, and Myer Families; the Kevin Fund; and the River Creek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; DE MG, 2003, EUR J SURG ONCOL, V29, P506; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eloubeidi MA, 2002, CANCER-AM CANCER SOC, V95, P1434, DOI 10.1002/cncr.10868; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Hotte SJ, 2002, CANCER-AM CANCER SOC, V95, P506, DOI 10.1002/cncr.10709; Izzo JG, 2007, CANCER EPIDEM BIOMAR, V16, P1200, DOI 10.1158/1055-9965.EPI-06-1083; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim SY, 2002, MOL CELLS, V13, P429; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Mariette C, 2003, CANCER-AM CANCER SOC, V97, P1616, DOI 10.1002/cncr.11228; Rempel SA, 2001, J NEURO-ONCOL, V53, P149, DOI 10.1023/A:1012201300188; Rempel SA, 1999, CLIN CANCER RES, V5, P237; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wild CP, 2003, NAT REV CANCER, V3, P676, DOI 10.1038/nrc1166; Yamashita K, 2003, CANCER, V97, P2412, DOI 10.1002/cncr.11368	25	105	108	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15074	10.1371/journal.pone.0015074	http://dx.doi.org/10.1371/journal.pone.0015074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152079	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100061
J	Lindsley, WG; Blachere, FM; Thewlis, RE; Vishnu, A; Davis, KA; Cao, G; Palmer, JE; Clark, KE; Fisher, MA; Khakoo, R; Beezhold, DH				Lindsley, William G.; Blachere, Francoise M.; Thewlis, Robert E.; Vishnu, Abhishek; Davis, Kristina A.; Cao, Gang; Palmer, Jan E.; Clark, Karen E.; Fisher, Melanie A.; Khakoo, Rashida; Beezhold, Donald H.			Measurements of Airborne Influenza Virus in Aerosol Particles from Human Coughs	PLOS ONE			English	Article							TRANSMISSION; INFECTION; DISEASE	Influenza is thought to be communicated from person to person by multiple pathways. However, the relative importance of different routes of influenza transmission is unclear. To better understand the potential for the airborne spread of influenza, we measured the amount and size of aerosol particles containing influenza virus that were produced by coughing. Subjects were recruited from patients presenting at a student health clinic with influenza-like symptoms. Nasopharyngeal swabs were collected from the volunteers and they were asked to cough three times into a spirometer. After each cough, the cough-generated aerosol was collected using a NIOSH two-stage bioaerosol cyclone sampler or an SKC BioSampler. The amount of influenza viral RNA contained in the samplers was analyzed using quantitative real-time reverse-transcription PCR (qPCR) targeting the matrix gene M1. For half of the subjects, viral plaque assays were performed on the nasopharyngeal swabs and cough aerosol samples to determine if viable virus was present. Fifty-eight subjects were tested, of whom 47 were positive for influenza virus by qPCR. Influenza viral RNA was detected in coughs from 38 of these subjects (81%). Thirty-five percent of the influenza RNA was contained in particles >4 mu m in aerodynamic diameter, while 23% was in particles 1 to 4 mu m and 42% in particles <1 mu m. Viable influenza virus was detected in the cough aerosols from 2 of 21 subjects with influenza. These results show that coughing by influenza patients emits aerosol particles containing influenza virus and that much of the viral RNA is contained within particles in the respirable size range. The results support the idea that the airborne route may be a pathway for influenza transmission, especially in the immediate vicinity of an influenza patient. Further research is needed on the viability of airborne influenza viruses and the risk of transmission.	[Lindsley, William G.; Blachere, Francoise M.; Thewlis, Robert E.; Cao, Gang; Beezhold, Donald H.] NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Morgantown, WV USA; [Vishnu, Abhishek] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA; [Davis, Kristina A.; Fisher, Melanie A.; Khakoo, Rashida] W Virginia Univ, Dept Med, Morgantown, WV 26506 USA; [Palmer, Jan E.; Clark, Karen E.] W Virginia Univ, Well WVU Student Hlth, Morgantown, WV 26506 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University; West Virginia University; West Virginia University	Lindsley, WG (corresponding author), NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Morgantown, WV USA.	wlindsley@cdc.gov		Lindsley, William/0000-0003-0720-5829; Beezhold, Donald/0000-0001-5543-5747; Vishnu, Abhishek/0000-0003-3573-4090	National Institute for Occupational Safety and Health (NIOSH; US Centers for Disease Control and Prevention); US Environmental Protection Agency (EPA) [DW7592259701]	National Institute for Occupational Safety and Health (NIOSH; US Centers for Disease Control and Prevention)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); US Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	This work was supported by internal funds from the National Institute for Occupational Safety and Health (NIOSH; part of the US Centers for Disease Control and Prevention) and by an interagency agreement with the US Environmental Protection Agency (EPA; DW7592259701). NIOSH employees were involved in conducting the study, analyzing the results, and preparing the manuscript.	ACGIH, 2001, DOC THRESH LIM VAL B; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; CAO G, 2010, AAAR 29 ANN C OCT 25; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; GOLDSMITH WT, 2001, ANN FALL M BMES OCT; JENNISON MW, 1942, AEROBIOLOGY, P106; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Liverman C. T., 2009, RESP PROTECTION HEAL; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LOUDON RG, 1967, AM REV RESPIR DIS, V95, P435; MILTON DK, 2010, SWINE ORIGIN H1N1 VI; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Raphael D., 2008, HARRISONS PRINCIPLES, P1127; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wein LM, 2009, RISK ANAL, V29, P949, DOI 10.1111/j.1539-6924.2009.01232.x	25	277	284	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15100	10.1371/journal.pone.0015100	http://dx.doi.org/10.1371/journal.pone.0015100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152051	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100071
J	Willems, A; Batlouni, SR; Esnal, A; Swinnen, JV; Saunders, PTK; Sharpe, RM; Franca, LR; De Gendt, K; Verhoeven, G				Willems, Ariane; Batlouni, Sergio R.; Esnal, Arantza; Swinnen, Johannes V.; Saunders, Philippa T. K.; Sharpe, Richard M.; Franca, Luiz R.; De Gendt, Karel; Verhoeven, Guido			Selective Ablation of the Androgen Receptor in Mouse Sertoli Cells Affects Sertoli Cell Maturation, Barrier Formation and Cytoskeletal Development	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; BLOOD-TESTIS BARRIER; TESTICULAR GENE-EXPRESSION; MALE-MICE LACKING; GERM-CELL; IMMUNOGLOBULIN SUPERFAMILY; MUTANT MOUSE; FUNCTIONAL MATURATION; POSTNATAL-DEVELOPMENT; BINDING PROTEINS	The observation that mice with a selective ablation of the androgen receptor (AR) in Sertoli cells (SC) (SCARKO mice) display a complete block in meiosis supports the contention that SC play a pivotal role in the control of germ cell development by androgens. To delineate the physiological and molecular mechanism responsible for this control, we compared tubular development in pubertal SCARKO mice and littermate controls. Particular attention was paid to differences in SC maturation, SC barrier formation and cytoskeletal organization and to the molecular mediators potentially involved. Functional analysis of SC barrier development by hypertonic perfusion and lanthanum permeation techniques and immunohistochemical analysis of junction formation showed that SCARKO mice still attempt to produce a barrier separating basal and adluminal compartment but that barrier formation is delayed and defective. Defective barrier formation was accompanied by disturbances in SC nuclear maturation (immature shape, absence of prominent, tripartite nucleoli) and SC polarization (aberrant positioning of SC nuclei and cytoskeletal elements such as vimentin). Quantitative RT-PCR was used to study the transcript levels of genes potentially related to the described phenomena between day 8 and 35. Differences in the expression of SC genes known to play a role in junction formation could be shown from day 8 for Cldn11, from day 15 for Cldn3 and Espn, from day 20 for Cdh2 and Jam3 and from day 35 for ZO-1. Marked differences were also noted in the transcript levels of several genes that are also related to cell adhesion and cytoskeletal dynamics but that have not yet been studied in SC (Actn3, Ank3, Anxa9, Scin, Emb, Mpzl2). It is concluded that absence of a functional AR in SC impedes the remodeling of testicular tubules expected at the onset of spermatogenesis and interferes with the creation of the specific environment needed for germ cell development.	[Willems, Ariane; Swinnen, Johannes V.; De Gendt, Karel; Verhoeven, Guido] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Louvain, Belgium; [Batlouni, Sergio R.] Sao Paulo State Univ, Aquaculture Ctr CAUNESP, Sao Paulo, Brazil; [Esnal, Arantza; Saunders, Philippa T. K.; Sharpe, Richard M.] MRC, Ctr Reprod Biol, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Franca, Luiz R.] Univ Fed Minas Gerais, Lab Cellular Biol, Dept Morphol, Inst Biol Sci, Belo Horizonte, MG, Brazil	KU Leuven; Universidade Estadual Paulista; Universidade Federal de Minas Gerais	Willems, A (corresponding author), Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Louvain, Belgium.	guido.verhoeven@med.kuleuven.be	Batlouni, Sergio r/D-2324-2017; DE FRANCA, LUIZ/AAA-6923-2021; Batlouni, Sergio r/F-6357-2010; Saunders, Philippa TK/C-7489-2013; Swinnen, Johannes V/AAA-2214-2022; De Gendt, Karel/A-6332-2009; Sharpe, Richard M/D-2725-2013	Batlouni, Sergio r/0000-0003-3579-2530; Batlouni, Sergio r/0000-0003-3579-2530; Saunders, Philippa TK/0000-0001-9051-9380; Swinnen, Johannes V/0000-0002-7720-5077; Sharpe, Richard M/0000-0003-1686-8085	Katholieke Universiteit Leuven [OT/07/068A]; Fund for Scientific Research Flanders (FWO) [G.0458.05N]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [SB-73064]; MRC [MC_U127684422, MC_U127685844, MC_U127685841] Funding Source: UKRI; Medical Research Council [MC_U127684422, MC_U127685844, MC_U127685841] Funding Source: researchfish	Katholieke Universiteit Leuven(KU Leuven); Fund for Scientific Research Flanders (FWO)(FWO); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work described here was supported by a research grant from the Research Fund of the Katholieke Universiteit Leuven (OT/07/068A; www.kuleuven.be), by a grant and a postdoctoral fellowship (to K. De Gendt; G.0458.05N) from the Fund for Scientific Research Flanders (FWO; www.fwo.be) and by a Ph.D. grant (to A. Willems; SB-73064) from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen; www.iwt.be). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Boukari K, 2009, J CLIN ENDOCR METAB, V94, P1818, DOI 10.1210/jc.2008-1909; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; CAVICCHIA JC, 1991, ANAT REC, V230, P361, DOI 10.1002/ar.1092300309; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; Chatterjee G, 2008, BIOCHEM BIOPH RES CO, V372, P412, DOI 10.1016/j.bbrc.2008.05.053; CHEMES HE, 1979, BIOL REPROD, V21, P251, DOI 10.1095/biolreprod21.1.251; Chemes HE, 2008, J CLIN ENDOCR METAB, V93, P4408, DOI 10.1210/jc.2008-0915; Chlystun M, 2004, BBA-MOL CELL RES, V1742, P141, DOI 10.1016/j.bbamcr.2004.08.017; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DEFRANCA LR, 1994, ANAT REC, V240, P225; Denolet E, 2006, MOL ENDOCRINOL, V20, P321, DOI 10.1210/me.2005-0113; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Eacker SM, 2007, MOL ENDOCRINOL, V21, P895, DOI 10.1210/me.2006-0113; Florin A, 2005, ENDOCRINOLOGY, V146, P1532, DOI 10.1210/en.2004-0834; FRITZ IB, 1983, J REPROD FERTIL, V67, P359, DOI 10.1530/jrf.0.0670359; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goebeler V, 2003, FEBS LETT, V546, P359, DOI 10.1016/S0014-5793(03)00634-3; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; GROOTEGOED JA, 1977, MOL CELL ENDOCRINOL, V9, P159, DOI 10.1016/0303-7207(77)90117-4; Guenette RS, 1997, DEV GENET, V21, P268, DOI 10.1002/(SICI)1520-6408(1997)21:4<268::AID-DVG4>3.0.CO;2-5; Guttinger M, 1998, J CELL BIOL, V141, P1061, DOI 10.1083/jcb.141.4.1061; Gye MC, 2003, INT J ANDROL, V26, P271, DOI 10.1046/j.1365-2605.2003.00423.x; Harrison SMW, 1998, DEV BIOL, V195, P174, DOI 10.1006/dbio.1998.8848; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Holsberger DR, 2005, CELL TISSUE RES, V322, P133, DOI 10.1007/s00441-005-1082-z; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; ISMAIL N, 1992, MICROSC RES TECHNIQ, V20, P43, DOI 10.1002/jemt.1070200106; Johnston DS, 2001, ENDOCRINOLOGY, V142, P2405, DOI 10.1210/en.142.6.2405; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; Komljenovic D, 2009, CELL TISSUE RES, V337, P281, DOI 10.1007/s00441-009-0809-7; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; KUROHMARU M, 1992, TISSUE CELL, V24, P895, DOI 10.1016/0040-8166(92)90024-2; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; LYON MF, 1975, NATURE, V258, P620, DOI 10.1038/258620a0; Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Myers M, 2005, J ANAT, V207, P797, DOI 10.1111/j.1469-7580.2005.00493.x; NAGANO T, 1977, LAB INVEST, V36, P8; Nalam RL, 2009, MOL ENDOCRINOL, V23, P1900, DOI 10.1210/me.2009-0184; NEAVES WB, 1973, J CELL BIOL, V59, P559, DOI 10.1083/jcb.59.3.559; O'Shaughnessy PJ, 2007, ENDOCRINOLOGY, V148, P2914, DOI 10.1210/en.2006-1412; Pelletier RM, 1999, BIOL REPROD, V60, P1128, DOI 10.1095/biolreprod60.5.1128; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Plant TM, 2001, ENDOCR REV, V22, P764, DOI 10.1210/er.22.6.764; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P422, DOI 10.1210/me.2003-0188; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; SETCHELL BP, 1988, DEV FUNCTION REPROD, V2, P77; Sharpe Richard M., 1994, P1363; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; SINGH J, 1995, ENDOCRINOLOGY, V136, P5311, DOI 10.1210/en.136.12.5311; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; Sneddon SF, 2005, ENDOCRINOLOGY, V146, P5304, DOI 10.1210/en.2005-0914; Stuart RO, 2003, KIDNEY INT, V64, P1997, DOI 10.1046/j.1523-1755.2003.00383.x; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; Tapanainen JS, 1997, NAT GENET, V15, P205, DOI 10.1038/ng0297-205; Tsai MY, 2006, P NATL ACAD SCI USA, V103, P18975, DOI 10.1073/pnas.0608565103; Verhoeven G., 2008, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V8, P2, DOI 10.2174/187152208783790750; Vogl AW, 1993, SERTOLI CELL, P39; Wang GS, 2009, J ANDROL, V30, P338, DOI 10.2164/jandrol.108.006890; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Willems A, 2010, INT J ANDROL, V33, P507, DOI 10.1111/j.1365-2605.2009.00964.x; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Wong CH, 2005, CURR TOP DEV BIOL, V71, P263, DOI 10.1016/S0070-2153(05)71008-5; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Zhang CX, 2006, P NATL ACAD SCI USA, V103, P17718, DOI 10.1073/pnas.0608556103; Zhou Q, 2005, BIOL REPROD, V72, P1010, DOI 10.1095/biolreprod.104.035915	74	85	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14168	10.1371/journal.pone.0014168	http://dx.doi.org/10.1371/journal.pone.0014168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152390	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100045
J	Xu, R; Zhen, ZL; Liu, J				Xu, Rui; Zhen, Zonglei; Liu, Jia			Mapping Informative Clusters in a Hierarchial Framework of fMRI Multivariate Analysis	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; SURFACE-BASED ANALYSIS; SELECTION; FACES; CLASSIFICATION; IDENTIFICATION; RECOGNITION; PATTERNS; CORTEX; STATES	Pattern recognition methods have become increasingly popular in fMRI data analysis, which are powerful in discriminating between multi-voxel patterns of brain activities associated with different mental states. However, when they are used in functional brain mapping, the location of discriminative voxels varies significantly, raising difficulties in interpreting the locus of the effect. Here we proposed a hierarchical framework of multivariate approach that maps informative clusters rather than voxels to achieve reliable functional brain mapping without compromising the discriminative power. In particular, we first searched for local homogeneous clusters that consisted of voxels with similar response profiles. Then, a multi-voxel classifier was built for each cluster to extract discriminative information from the multi-voxel patterns. Finally, through multivariate ranking, outputs from the classifiers were served as a multi-cluster pattern to identify informative clusters by examining interactions among clusters. Results from both simulated and real fMRI data demonstrated that this hierarchical approach showed better performance in the robustness of functional brain mapping than traditional voxel-based multivariate methods. In addition, the mapped clusters were highly overlapped for two perceptually equivalent object categories, further confirming the validity of our approach. In short, the hierarchical framework of multivariate approach is suitable for both pattern classification and brain mapping in fMRI studies.	[Xu, Rui; Liu, Jia] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China; [Zhen, Zonglei; Liu, Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Normal University	Xu, R (corresponding author), Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China.	zhenzonglei@bnu.edu.cn	Zhen, Zonglei/GPG-1239-2022	Xu, Rui/0000-0001-8526-3392; Liu, Jia/0000-0003-0383-0934	Chinese Academy of Sciences; National Basic Research Program of China [2010CB833903, 2011CB505402]; National Natural Science Foundation of China [30800295]; Fundamental Research Funds for the Central Universities	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is funded by the 100 Talents Program of the Chinese Academy of Sciences, the National Basic Research Program of China (2010CB833903, 2011CB505402), the National Natural Science Foundation of China (30800295), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellec P, 2006, NEUROIMAGE, V29, P1231, DOI 10.1016/j.neuroimage.2005.08.044; BENALI H, 1994, P SOC PHOTO-OPT INS, V2299, P336, DOI 10.1117/12.179264; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Carroll MK, 2009, NEUROIMAGE, V44, P112, DOI 10.1016/j.neuroimage.2008.08.020; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hanson SJ, 2008, NEURAL COMPUT, V20, P486, DOI 10.1162/neco.2007.09-06-340; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kalousis A, 2007, KNOWL INF SYST, V12, P95, DOI 10.1007/s10115-006-0040-8; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kamitani Y, 2010, NEUROIMAGE, V49, P1949, DOI 10.1016/j.neuroimage.2009.06.040; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; Ku SP, 2008, MAGN RESON IMAGING, V26, P1007, DOI 10.1016/j.mri.2008.02.016; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; Martinez-Ramon M, 2006, NEUROIMAGE, V31, P1129, DOI 10.1016/j.neuroimage.2006.01.022; Meyer FG, 2005, MED IMAGE ANAL, V9, P51, DOI 10.1016/j.media.2004.07.002; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Op de Beeck HP, 2010, NEUROIMAGE, V50, P567, DOI 10.1016/j.neuroimage.2009.12.072; Op de Beeck HP, 2010, NEUROIMAGE, V49, P3414, DOI 10.1016/j.neuroimage.2009.11.022; Op de Beeck HP, 2010, NEUROIMAGE, V49, P1943, DOI 10.1016/j.neuroimage.2009.02.047; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Pessoa L, 2007, CEREB CORTEX, V17, P691, DOI 10.1093/cercor/bhk020; Sato JR, 2009, NEUROIMAGE, V46, P105, DOI 10.1016/j.neuroimage.2009.01.032; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; van Gerven M, 2009, NEUROIMAGE, V46, P665, DOI 10.1016/j.neuroimage.2009.02.041; Vapnik V., 2013, NATURE STAT LAERNING; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050; ZEKI S, 1991, J NEUROSCI, V11, P641; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	44	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15065	10.1371/journal.pone.0015065	http://dx.doi.org/10.1371/journal.pone.0015065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152081	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100057
J	Ma, LA; Jensen, JS; Mancuso, M; Hamasuna, R; Jia, QY; McGowin, CL; Martin, DH				Ma, Liang; Jensen, Jorgen S.; Mancuso, Miriam; Hamasuna, Ryoichi; Jia, Qiuyao; McGowin, Chris L.; Martin, David H.			Genetic Variation in the Complete MgPa Operon and Its Repetitive Chromosomal Elements in Clinical Strains of Mycoplasma genitalium	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; FRAGMENT LENGTH POLYMORPHISM; REAL-TIME PCR; NONGONOCOCCAL URETHRITIS; AZITHROMYCIN TREATMENT; PNEUMONIAE; RECOMBINATION; SPECIMENS; SEQUENCES; PROTEIN	Mycoplasma genitalium has been increasingly recognized as an important microbe not only because of its significant association with human genital tract diseases but also because of its utility as a model for studying the minimum set of genes necessary to sustain life. Despite its small genome, 4.7% of the total genome sequence is devoted to making the MgPa adhesin operon and its nine chromosomal repetitive elements (termed MgPars). The MgPa operon, along with 9 MgPars, is believed to play an important role in pathogenesis of M. genitalium infection and has also served as the main target for development of diagnostic tools. However, genetic variation in the complete MgPa operon and MgPars among clinical strains of M. genitalium has not been addressed. In this study we examined the genetic variation in the complete MgPa operon (approximately 8.5 kb) and full or partial MgPar sequences (0.4-2.6 kb) in 15 geographically diverse strains of M. genitalium. Extensive variation was present in four repeat regions of the MgPa operon (with homology to MgPars) among and within strains while the non-repeat regions (without homology to MgPars) showed low-level variation among strains and no variation within strains. MgPars showed significant variation among strains but were highly homogeneous within strains, supporting gene conversion as the likely recombination mechanism. When applying our sequence data to evaluate published MgPa operon-based diagnostic PCR assays and genotyping systems, we found that 11 of 19 primers contain up to 19 variable nucleotides and that the target for one of two typing systems is located in a hypervariable repeat region, suggesting the likelihood of false results with some of these assays. This study not only provides new insights into the role of the MgPa operon in the pathogenesis of M. genitalium infection but has important implications for the development of diagnostic tools.	[Ma, Liang; Mancuso, Miriam; Jia, Qiuyao; McGowin, Chris L.; Martin, David H.] Louisiana State Univ, Infect Dis Sect, Dept Med, Hlth Sci Ctr, New Orleans, LA USA; [Jensen, Jorgen S.] Statens Serum Inst, Mycoplasma Lab, DK-2300 Copenhagen, Denmark; [Hamasuna, Ryoichi] Univ Occupat & Environm Hlth, Dept Urol, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Statens Serum Institut; University of Occupational & Environmental Health - Japan	Ma, LA (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA.	LMa1@lsuhsc.edu	Jensen, Jørgen Skov/H-5159-2019; Jensen, Jørgen/I-2917-2012	Jensen, Jørgen Skov/0000-0002-7464-7435; Ma, Liang/0000-0002-6078-5730	Department of Defense [W81XWH-08-1-0676]; National Institutes of Health [5 U19 AI061972]; Louisiana Vaccine Center; Louisiana State of Regents [149752505J]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI061972] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Vaccine Center; Louisiana State of Regents; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Department of Defense (grant W81XWH-08-1-0676), the Gulf South Sexually Transmitted Infections/Topical Microbicide Cooperative Research Center grant from the National Institutes of Health (grant 5 U19 AI061972), and the Louisiana Vaccine Center and the South Louisiana Institute for Infectious Disease Research sponsored by the Louisiana State of Regents (grant 149752505J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgos R, 2006, J BACTERIOL, V188, P8627, DOI 10.1128/JB.00978-06; CADIEUX N, 1993, J GEN MICROBIOL, V139, P2431, DOI 10.1099/00221287-139-10-2431; DALLO SF, 1991, MICROB PATHOGENESIS, V10, P475, DOI 10.1016/0882-4010(91)90113-O; DEBARBEYRAC B, 1993, CLIN INFECT DIS, V17, pS83, DOI 10.1093/clinids/17.Supplement_1.S83; DEGUCHI T, 1995, EUR J CLIN MICROBIOL, V14, P629, DOI 10.1007/BF01690742; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hamasuna R, 2005, ANTIMICROB AGENTS CH, V49, P4993, DOI 10.1128/AAC.49.12.4993-4998.2005; Hamasuna R, 2007, J CLIN MICROBIOL, V45, P847, DOI 10.1128/JCM.02056-06; Hjorth SV, 2006, J CLIN MICROBIOL, V44, P2078, DOI 10.1128/JCM.00003-06; HU PC, 1987, INFECT IMMUN, V55, P1126, DOI 10.1128/IAI.55.5.1126-1131.1987; Iverson-Cabral SL, 2007, MOL MICROBIOL, V66, P55, DOI 10.1111/j.1365-2958.2007.05898.x; Iverson-Cabral SL, 2006, INFECT IMMUN, V74, P3715, DOI 10.1128/IAI.00239-06; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Jensen JS, 2006, DAN MED BULL, V53, P1; Jensen JS, 2009, CLIN INFECT DIS, V48, P1655, DOI 10.1086/599034; Jensen JS, 1996, J CLIN MICROBIOL, V34, P286, DOI 10.1128/JCM.34.2.286-291.1996; JENSEN JS, 1993, GENITOURIN MED, V69, P265; JENSEN JS, 1991, J CLIN MICROBIOL, V29, P46, DOI 10.1128/JCM.29.1.46-50.1991; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Kokotovic B, 1999, J CLIN MICROBIOL, V37, P3300, DOI 10.1128/JCM.37.10.3300-3307.1999; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ma L, 2004, J CLIN MICROBIOL, V42, P4876, DOI 10.1128/JCM.42.10.4876-4878.2004; Ma L, 2007, MOL MICROBIOL, V66, P220, DOI 10.1111/j.1365-2958.2007.05911.x; Ma L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-130; McGowin CL, 2010, INFECT IMMUN, V78, P726, DOI 10.1128/IAI.00840-09; Mena L, 2002, CLIN INFECT DIS, V35, P1167, DOI 10.1086/343829; MORRISONPLUMMER J, 1987, INFECT IMMUN, V55, P49, DOI 10.1128/IAI.55.1.49-56.1987; Musatovova O, 2006, J CLIN MICROBIOL, V44, P598, DOI 10.1128/JCM.44.2.598-603.2006; Musatovova O, 2009, J CLIN MICROBIOL, V47, P1469, DOI 10.1128/JCM.01602-08; PALMER HM, 1991, FEMS MICROBIOL LETT, V61, P199; PETERSON SN, 1995, P NATL ACAD SCI USA, V92, P11829, DOI 10.1073/pnas.92.25.11829; Svenstrup HF, 2006, CLIN VACCINE IMMUNOL, V13, P913, DOI 10.1128/CVI.00048-06; Totten PA, 2001, J INFECT DIS, V183, P269, DOI 10.1086/317942; TULLY JG, 1981, LANCET, V1, P1288	36	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15660	10.1371/journal.pone.0015660	http://dx.doi.org/10.1371/journal.pone.0015660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187921	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200059
J	Patapati, KK; Glykos, NM				Patapati, Kalliopi K.; Glykos, Nicholas M.			Order through Disorder: Hyper-Mobile C-Terminal Residues Stabilize the Folded State of a Helical Peptide. A Molecular Dynamics Study	PLOS ONE			English	Article							FOLDING SIMULATIONS; ALPHA-LACTALBUMIN; PROTEINS; MECHANICS; MODELS	Conventional wisdom has it that the presence of disordered regions in the three-dimensional structures of polypeptides not only does not contribute significantly to the thermodynamic stability of their folded state, but, on the contrary, that the presence of disorder leads to a decrease of the corresponding proteins' stability. We have performed extensive 3.4 mu s long folding simulations (in explicit solvent and with full electrostatics) of an undecamer peptide of experimentally known helical structure, both with and without its disordered (four residue long) C-terminal tail. Our simulations clearly indicate that the presence of the apparently disordered (in structural terms) C-terminal tail, increases the thermodynamic stability of the peptide's folded (helical) state. These results show that at least for the case of relatively short peptides, the interplay between thermodynamic stability and the apparent structural stability can be rather subtle, with even disordered regions contributing significantly to the stability of the folded state. Our results have clear implications for the understanding of peptide energetics and the design of foldable peptides.	[Patapati, Kalliopi K.; Glykos, Nicholas M.] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece	Democritus University of Thrace	Patapati, KK (corresponding author), Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece.	glykos@mbg.duth.gr	Glykos, Nicholas/H-9179-2019	Glykos, Nicholas/0000-0003-3782-206X				Altis A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2746330; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Araki A, 2007, PROTEINS, V66, P860, DOI 10.1002/prot.21263; De Mori GMS, 2005, MINI-REV MED CHEM, V5, P353, DOI 10.2174/1389557053544038; Demarest SJ, 1999, BIOCHEMISTRY-US, V38, P7380, DOI 10.1021/bi990320z; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gnanakaran S, 2003, CURR OPIN STRUC BIOL, V13, P168, DOI 10.1016/S0959-440X(03)00040-X; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jiang XW, 2010, J COMPUT CHEM, V31, P2502, DOI 10.1002/jcc.21544; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Khandogin J, 2007, P NATL ACAD SCI USA, V104, P16880, DOI 10.1073/pnas.0703832104; Koehl P, 2006, CURR OPIN STRUC BIOL, V16, P142, DOI 10.1016/j.sbi.2006.03.001; Lin ZX, 2010, J AM CHEM SOC, V132, P7276, DOI 10.1021/ja100879k; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matthes D, 2009, BIOPHYS J, V97, P599, DOI 10.1016/j.bpj.2009.04.061; Mitraki A, 2005, METH MOL B, V300, P125; Mittal J, 2010, BIOPHYS J, V99, pL26, DOI 10.1016/j.bpj.2010.05.005; Mohammed OF, 2009, ANGEW CHEM INT EDIT, V48, P5628, DOI 10.1002/anie.200900513; Montalvo G, 2010, J AM CHEM SOC, V132, P5616, DOI 10.1021/ja100459a; Morra G, 2008, CURR PROTEIN PEPT SC, V9, P181, DOI 10.2174/138920308783955234; Morrone JA, 2010, J CHEM THEORY COMPUT, V6, P1798, DOI 10.1021/ct100054k; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Osterhout JJ, 2005, PROTEIN PEPTIDE LETT, V12, P159, DOI 10.2174/0929866053005890; Permyakov EA, 2000, FEBS LETT, V473, P269, DOI 10.1016/S0014-5793(00)01546-5; Thorpe IF, 2008, J PHYS CHEM B, V112, P13079, DOI 10.1021/jp8015968; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003	33	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15290	10.1371/journal.pone.0015290	http://dx.doi.org/10.1371/journal.pone.0015290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187962	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200033
J	Pita-Thomas, W; Fernandez-Martos, C; Yunta, M; Maza, RM; Navarro-Ruiz, R; Lopez-Rodriguez, MJ; Reigada, D; Nieto-Sampedro, M; Nieto-Diaz, M				Pita-Thomas, Wolfgang; Fernandez-Martos, Carmen; Yunta, Monica; Maza, Rodrigo M.; Navarro-Ruiz, Rosa; Javier Lopez-Rodriguez, Marcos; Reigada, David; Nieto-Sampedro, Manuel; Nieto-Diaz, Manuel			Gene Expression of Axon Growth Promoting Factors in the Deer Antler	PLOS ONE			English	Article							DENSITY OLIGONUCLEOTIDE ARRAYS; EPITHELIUM-DERIVED FACTOR; NEURITE OUTGROWTH; NEUROTROPHIC FACTOR; RETINOIC ACID; CELL-ADHESION; SCHWANN-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; FIN REGENERATION; SENSORY NEURONS	The annual regeneration cycle of deer (Cervidae, Artiodactyla) antlers represents a unique model of epimorphic regeneration and rapid growth in adult mammals. Regenerating antlers are innervated by trigeminal sensory axons growing through the velvet, the modified form of skin that envelopes the antler, at elongation velocities that reach one centimetre per day in the common deer (Cervus elaphus). Several axon growth promoters like NT-3, NGF or IGF-1 have been described in the antler. To increase the knowledge on the axon growth environment, we have combined different gene-expression techniques to identify and characterize the expression of promoting molecules not previously described in the antler velvet. Cross-species microarray analyses of deer samples on human arrays allowed us to build up a list of 90 extracellular or membrane molecules involved in axon growth that were potentially being expressed in the antler. Fifteen of these genes were analysed using PCR and sequencing techniques to confirm their expression in the velvet and to compare it with the expression in other antler and skin samples. Expression of 8 axon growth promoters was confirmed in the velvet, 5 of them not previously described in the antler. In conclusion, our work shows that antler velvet provides growing axons with a variety of promoters of axon growth, sharing many of them with deer's normal and pedicle skin.	[Pita-Thomas, Wolfgang; Fernandez-Martos, Carmen; Yunta, Monica; Maza, Rodrigo M.; Navarro-Ruiz, Rosa; Javier Lopez-Rodriguez, Marcos; Reigada, David; Nieto-Diaz, Manuel] Hosp Nacl Paraplejicos SESCAM, Expt Neurol Unit, Toledo, Spain; [Nieto-Sampedro, Manuel] Inst Cajal Neurociencias CSIC, Neural Plast Lab, Madrid, Spain	Hospital Nacional de Paraplejicos; Consejo Superior de Investigaciones Cientificas (CSIC)	Pita-Thomas, W (corresponding author), Hosp Nacl Paraplejicos SESCAM, Expt Neurol Unit, Toledo, Spain.	mnietod@sescam.jccm.es	Nieto-Diaz, Manuel/R-5163-2017; Maza, Rodrigo Martínez/ABH-3989-2020; Fernandez-Martos, Carmen/J-7770-2014; Reigada, David/AAU-5910-2020; Díaz, Manuel Nieto/ABD-7144-2020	Nieto-Diaz, Manuel/0000-0002-7244-794X; Maza, Rodrigo Martínez/0000-0002-7249-9205; Fernandez-Martos, Carmen/0000-0002-6387-4456; Reigada, David/0000-0001-9041-0705; Yunta, Monica/0000-0002-8060-9582	Castilla-La Mancha Medical Council [ICS 06025, FISCAM PI2008/38]; Spanish Medical Research Foundation [PI081941]; Castilla-La Mancha Medical Research Foundation (FISCAM)	Castilla-La Mancha Medical Council; Spanish Medical Research Foundation; Castilla-La Mancha Medical Research Foundation (FISCAM)	This work was supported by the Castilla-La Mancha Medical Council (projects ICS 06025 and FISCAM PI2008/38) and the Spanish Medical Research Foundation (project PI081941). WPT, MLR and RNR are funded by grants of the Castilla-La Mancha Medical Research Foundation (FISCAM); DRP, MYG, CFM, RMM and MND are contracted researchers of the SESCAM (Castilla-La Mancha Health Service); MNS is research professor of the Spanish Science Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, AFF NET DAT; *AFF, AFF GCOS 1 4 SOFTW; Affymetrix, 2002, STAT ALG DESCR DOC; Albers KM, 2007, NEUROSCIENTIST, V13, P371, DOI 10.1177/10738584070130040901; Allen SP, 2002, DEV BIOL, V251, P409, DOI 10.1006/dbio.2002.0816; [Anonymous], OMIM; [Anonymous], NCBI GEO DAT; [Anonymous], PUBMED; *APPL BIOS, 2006, APPL BIOS REAL TIM P; Baird Andrew, 1994, Current Opinion in Neurobiology, V4, P78, DOI 10.1016/0959-4388(94)90035-3; Barling PM, 2005, CELL BIOL INT, V29, P229, DOI 10.1016/j.cellbi.2004.12.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad B, 2005, BIOINFORMATICS COMPU; BOLSTAD B, 2005, AFFYPLM MODEL BASED; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Boscher C, 2008, CELL SIGNAL, V20, P1061, DOI 10.1016/j.cellsig.2008.01.008; Bouzaffour M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005824; Bubenik GA., 1990, HORNS PRONGHORNS ANT; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; CHALAZONITIS A, 1992, DEV BIOL, V152, P121, DOI 10.1016/0012-1606(92)90162-A; CHAPUT M, 1988, NATURE, V332, P454, DOI 10.1038/332454a0; Chismar JD, 2002, BIOTECHNIQUES, V33, P516, DOI 10.2144/02333st01_11836a; Clark DE, 2006, ANAT REC PART A, V288A, P1281, DOI 10.1002/ar.a.20393; Copois V, 2007, J BIOTECHNOL, V127, P549, DOI 10.1016/j.jbiotec.2006.07.032; Crawford SE, 2001, J CELL SCI, V114, P4421; Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155; Dionne MS, 2002, DEV BIOL, V251, P283, DOI 10.1006/dbio.2002.0829; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; FAIK P, 1988, NATURE, V332, P455, DOI 10.1038/332455a0; FENG JQ, 1995, BBA-GENE STRUCT EXPR, V1263, P163, DOI 10.1016/0167-4781(95)00106-Q; Feng JQ, 1997, BBA-GENE STRUCT EXPR, V1350, P47, DOI 10.1016/S0167-4781(96)00178-9; Francavilla C, 2007, J CELL SCI, V120, P4388, DOI 10.1242/jcs.010744; Francis SM, 1998, J EXP ZOOL, V281, P36, DOI 10.1002/(SICI)1097-010X(19980501)281:1&lt;36::AID-JEZ6&gt;3.0.CO;2-D; Fu CY, 2007, J HUAZHONG UNIV SCI, V27, P186, DOI 10.1007/s11596-007-0221-z; Garcia RL, 1997, J MOL ENDOCRINOL, V19, P173, DOI 10.1677/jme.0.0190173; Gaspar-Lopez E, 2008, EUR J WILDLIFE RES, V54, P753, DOI 10.1007/s10344-008-0185-8; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gautier L, DESCRIPTION AFFY; GenBank, GENBANK; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; GOSS RJ, 1970, CLIN ORTHOP RELAT R, P227; Goss RJ., 1969, PRINCIPLES REGENERAT; GRAY C, 1992, NEUROSCIENCE, V50, P953, DOI 10.1016/0306-4522(92)90218-Q; Grothe C, 2001, ANAT EMBRYOL, V204, P171, DOI 10.1007/s004290100205; GURNEY ME, 1986, SCIENCE, V234, P566, DOI 10.1126/science.3764429; Ha YH, 2005, CARBOHYD RES, V340, P411, DOI 10.1016/j.carres.2004.11.011; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Huo Y, 1997, Biomed Sci Instrum, V33, P541; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; ISHIHARA A, 1994, BRAIN RES, V639, P21, DOI 10.1016/0006-8993(94)91759-0; Ji W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh084; Jorgensen JR, 2009, J MOL NEUROSCI, V39, P104, DOI 10.1007/s12031-009-9189-4; Kaneda N, 1996, J BIOCHEM-TOKYO, V119, P1150; Kapanen A, 2002, J BIOMED MATER RES, V59, P78, DOI 10.1002/jbm.1219; Katogi R, 2004, MECH DEVELOP, V121, P861, DOI 10.1016/j.mod.2004.03.015; Kerrison JB, 2005, MOL VIS, V11, P208; Kimpinski K, 1997, J NEUROBIOL, V33, P395, DOI 10.1002/(SICI)1097-4695(199710)33:4<395::AID-NEU5>3.0.CO;2-5; Korpos E, 2005, MATRIX BIOL, V24, P124, DOI 10.1016/j.matbio.2005.01.005; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; Lai AKW, 2007, TISSUE CELL, V39, P35, DOI 10.1016/j.tice.2007.01.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lertsburapa T, 2004, J NEUROSCI RES, V75, P624, DOI 10.1002/jnr.20002; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000148; Li CY, 2000, ANAT RECORD, V260, P62, DOI 10.1002/1097-0185(20000901)260:1<62::AID-AR70>3.0.CO;2-4; Li CY, 2002, ANAT REC, V268, P125, DOI 10.1002/ar.10120; Li CY, 2001, ANAT EMBRYOL, V204, P375, DOI 10.1007/s004290100204; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Lonn P, 2005, NEUROCHEM RES, V30, P753, DOI 10.1007/s11064-005-6868-6; Lord EA, 2007, ANAT REC, V290, P994, DOI 10.1002/ar.20562; Lustig M, 1999, DEV BIOL, V209, P340, DOI 10.1006/dbio.1999.9250; MARTINOU JC, 1990, DEV BRAIN RES, V52, P175, DOI 10.1016/0165-3806(90)90233-O; MASUDANAKAGAWA LM, 1990, P ROY SOC B-BIOL SCI, V241, P201, DOI 10.1098/rspb.1990.0086; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Matsuzawa M, 1999, CELL MOL NEUROBIOL, V19, P209, DOI 10.1023/A:1006925110584; Mey J, 2006, J NEUROBIOL, V66, P757, DOI 10.1002/neu.20238; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; MICHIKAWA M, 1993, J NEUROSCI RES, V35, P530, DOI 10.1002/jnr.490350509; Moody DE, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-27; Nagpal S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh048; Nieto-Diaz M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-89; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Parmigiani G., 2003, ANAL GENE EXPRESSION; Patruno M, 2001, J EXP BIOL, V204, P843; Pearl EJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-66; Pita-Thomas W, 2010, J NEUROSCI RES, V88, P3034, DOI 10.1002/jnr.22459; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Raivich G, 2007, BRAIN RES REV, V53, P287, DOI 10.1016/j.brainresrev.2006.09.005; Reimers M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-166; Sahenk Z, 2008, EXP NEUROL, V212, P552, DOI 10.1016/j.expneurol.2008.04.015; Sanchez-Camacho C, 2005, BRAIN RES REV, V49, P242, DOI 10.1016/j.brainresrev.2004.10.004; SANTAMARIA JA, 1991, J ANAT, V176, P9; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tal TL, 2010, GERONTOLOGY, V56, P231, DOI 10.1159/000259327; Unezaki S, 2009, J NEUROSCI METH, V178, P308, DOI 10.1016/j.jneumeth.2008.12.022; Vacek Z, 1955, CESK MORFOL, V3, P249; *WEIZM I SCI, GENENOTE DAT; Williams SE, 2006, NEURON, V50, P535, DOI 10.1016/j.neuron.2006.03.037; WISLOCKI GB, 1946, J COMP NEUROL, V85, P1, DOI 10.1002/cne.900850102; Xian CJ, 1999, MOL NEUROBIOL, V20, P157, DOI 10.1007/BF02742440; Yabe T, 2002, J NEUROSCI RES, V68, P161, DOI 10.1002/jnr.10210; YOUNG HE, 1989, ANAT REC, V223, P223, DOI 10.1002/ar.1092230215; Yu CQ, 2008, INVEST OPHTH VIS SCI, V49, P3870, DOI 10.1167/iovs.07-1418; PRIMERS3; ZFP91 CNTF; AFFYTOOLS	110	28	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15706	10.1371/journal.pone.0015706	http://dx.doi.org/10.1371/journal.pone.0015706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187928	Green Published, gold, Green Submitted			2022-12-27	WOS:000285575200066
J	Sadikovic, B; Wang, J; El-Hattab, A; Landsverk, M; Douglas, G; Brundage, EK; Craigen, WJ; Schmitt, ES; Wong, LJC				Sadikovic, Bekim; Wang, Jing; El-Hattab, Ayman; Landsverk, Megan; Douglas, Ganka; Brundage, Ellen K.; Craigen, William J.; Schmitt, Eric S.; Wong, Lee-Jun C.			Sequence Homology at the Breakpoint and Clinical Phenotype of Mitochondrial DNA Deletion Syndromes	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; DOUBLE-STRAND BREAKS; MTDNA DELETIONS; SACCHAROMYCES-CEREVISIAE; LAGGING-STRAND; DIRECT REPEATS; CELLS; MYOPATHIES; MUTATIONS; DISEASE	Mitochondrial DNA (mtDNA) deletions are a common cause of mitochondrial disorders. Large mtDNA deletions can lead to a broad spectrum of clinical features with different age of onset, ranging from mild mitochondrial myopathies (MM), progressive external ophthalmoplegia (PEO), and Kearns-Sayre syndrome (KSS), to severe Pearson syndrome. The aim of this study is to investigate the molecular signatures surrounding the deletion breakpoints and their association with the clinical phenotype and age at onset. MtDNA deletions in 67 patients were characterized using array comparative genomic hybridization (aCGH) followed by PCR-sequencing of the deletion junctions. Sequence homology including both perfect and imperfect short repeats flanking the deletion regions were analyzed and correlated with clinical features and patients' age group. In all age groups, there was a significant increase in sequence homology flanking the deletion compared to mtDNA background. The youngest patient group (<6 years old) showed a diffused pattern of deletion distribution in size and locations, with a significantly lower sequence homology flanking the deletion, and the highest percentage of deletion mutant heteroplasmy. The older age groups showed rather discrete pattern of deletions with 44% of all patients over 6 years old carrying the most common 5 kb mtDNA deletion, which was found mostly in muscle specimens (22/41). Only 15% (3/20) of the young patients (<6 years old) carry the 5 kb common deletion, which is usually present in blood rather than muscle. This group of patients predominantly (16 out of 17) exhibit multisystem disorder and/or Pearson syndrome, while older patients had predominantly neuromuscular manifestations including KSS, PEO, and MM. In conclusion, sequence homology at the deletion flanking regions is a consistent feature of mtDNA deletions. Decreased levels of sequence homology and increased levels of deletion mutant heteroplasmy appear to correlate with earlier onset and more severe disease with multisystem involvement.	[Sadikovic, Bekim; Wang, Jing; El-Hattab, Ayman; Landsverk, Megan; Douglas, Ganka; Brundage, Ellen K.; Craigen, William J.; Schmitt, Eric S.; Wong, Lee-Jun C.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Sadikovic, B (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	ljwong@bcm.edu			Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/35854/2007, SFRH/BD/38543/2007, PTDC/SAU-ESA/64888/2006, PIC/IC/83065/2007]; GlaxoSmithkline; Fundacao Calouste Gulbenkian; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); GlaxoSmithkline(GlaxoSmithKline); Fundacao Calouste Gulbenkian(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	M. C. and M.J.F. are supported by research grants from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/35854/2007 and SFRH/BD/38543/2007 respectively). This work was partly supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/SAU-ESA/64888/2006 and PIC/IC/83065/2007), Fundacao Calouste Gulbenkian and an unrestricted grant from GlaxoSmithkline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c; DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493; Hammans SR, 1994, ESSAYS BIOCHEM, V28, P99; Hanekamp T, 1999, CURR GENET, V34, P438, DOI 10.1007/s002940050418; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465; Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Liang F, 1996, P NATL ACAD SCI USA, V93, P8929, DOI 10.1073/pnas.93.17.8929; Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M; Marie A, 2010, NUCLEIC ACIDS RES, V38, P5706, DOI 10.1093/nar/gkq379; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; Nguyen LH, 2000, J BIOL CHEM, V275, P25900, DOI 10.1074/jbc.M002672200; PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3; Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018; Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016; ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; Schroder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Srivastava S, 2007, HUM MOL GENET, V16, P993, DOI 10.1093/hmg/ddm045; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003; Wong LJC, 2001, GENET MED, V3, P399, DOI 10.1097/00125817-200111000-00004; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a	31	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15687	10.1371/journal.pone.0015687	http://dx.doi.org/10.1371/journal.pone.0015687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187929	Green Published, gold			2022-12-27	WOS:000285575200064
J	Taylor, JM; Han, ZY				Taylor, John M.; Han, Ziying			Purinergic Receptor Functionality Is Necessary for Infection of Human Hepatocytes by Hepatitis Delta Virus and Hepatitis B Virus	PLOS ONE			English	Article							P2X(7) RECEPTORS; SURAMIN; ANTAGONIST; ACTIVATION; PHYSIOLOGY; EXPRESSION; KINASES; BINDING; PROTEIN; SYSTEM	Hepatitis B virus (HBV) and hepatitis delta virus (HDV) are major sources of acute and chronic hepatitis. HDV requires the envelope proteins of HBV for the processes of assembly and infection of new cells. Both viruses are able to infect hepatocytes though previous studies have failed to determine the mechanism of entry into such cells. This study began with evidence that suramin, a symmetrical hexasulfated napthylurea, could block HDV entry into primary human hepatocytes (PHH) and was then extrapolated to incorporate findings of others that suramin is one of many compounds that can block activation of purinergic receptors. Thus other inhibitors, pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS) and brilliant blue G (BBG), both structurally unrelated to suramin, were tested and found to inhibit HDV and HBV infections of PHH. BBG, unlike suramin and PPADS, is known to be more specific for just one purinergic receptor, P2X7. These studies provide the first evidence that purinergic receptor functionality is necessary for virus entry. Furthermore, since P2X7 activation is known to be a major component of inflammatory responses, it is proposed that HDV and HBV attachment to susceptible cells, might also contribute to inflammation in the liver, that is, hepatitis.	[Taylor, John M.; Han, Ziying] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Taylor, JM (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	john.taylor@fccc.edu			Public Health Service [CA-06927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JT was supported by Public Health Service grant CA-06927 and by an Appropriation from the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JS, 1999, VIROLOGY, V258, P141, DOI 10.1006/viro.1999.9723; Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; BALZARINI J, 1986, INT J CANCER, V37, P451, DOI 10.1002/ijc.2910370318; Barrera A, 2004, J VIROL, V78, P5233, DOI 10.1128/JVI.78.10.5233-5243.2004; BROWNE LE, TRENDS PHARM SCI, V31, P229; Burnstock G, 2010, ACTA PHYSIOL, V199, P93, DOI 10.1111/j.1748-1716.2010.02114.x; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Carroll WA, 2009, PURINERG SIGNAL, V5, P63, DOI 10.1007/s11302-008-9110-6; Chai N, 2007, J VIROL, V81, P4912, DOI 10.1128/JVI.02865-06; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chiao CW, 2008, J PHARMACOL EXP THER, V326, P864, DOI 10.1124/jpet.107.135350; Croon J J, 1982, Acta Leiden, V48, P5; Donnelly-Roberts DL, 2009, BRIT J PHARMACOL, V157, P1203, DOI 10.1111/j.1476-5381.2009.00233.x; Emmett DS, 2008, HEPATOLOGY, V47, P698, DOI 10.1002/hep.22035; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Fleck SL, 2003, J BIOL CHEM, V278, P47670, DOI 10.1074/jbc.M306603200; Friedle Scott A, 2010, Recent Pat CNS Drug Discov, V5, P35; Glebe D, 2007, WORLD J GASTROENTERO, V13, P22, DOI 10.3748/wjg.v13.i1.22; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1613-1622.2005; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Gudima S, 2007, J VIROL, V81, P3608, DOI 10.1128/JVI.02277-06; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Kawamura H, 2006, J IMMUNOL, V176, P2152, DOI 10.4049/jimmunol.176.4.2152; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x; Lenertz LY, 2010, BIOCHEMISTRY-US, V49, P4611, DOI 10.1021/bi902083n; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Loeb KR, 2000, HEPATOLOGY, V32, P626, DOI 10.1053/jhep.2000.9878; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Michel AD, 2009, BRIT J PHARMACOL, V156, P1312, DOI 10.1111/j.1476-5381.2009.00135.x; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; PETCU DJ, 1988, VIROLOGY, V167, P385, DOI 10.1016/0042-6822(88)90099-2; Qu Y, 2009, PURINERG SIGNAL, V5, P163, DOI 10.1007/s11302-009-9132-8; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; RIZZETTO M, 1977, GUT, V18, P997, DOI 10.1136/gut.18.12.997; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; Seeger C., 2007, FIELDS VIROLOGY, V1, P2977; Shehnaz D, 2000, J PHARMACOL EXP THER, V292, P346; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Taylor J. M., 2007, FIELDS VIROLOGY, P3031; Urban S, 2008, FUTURE VIROL, V3, P253, DOI 10.2217/17460794.3.3.253; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728	49	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15784	10.1371/journal.pone.0015784	http://dx.doi.org/10.1371/journal.pone.0015784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187936	Green Published, Green Submitted, gold			2022-12-27	WOS:000285575200070
J	Pauchet, Y; Wilkinson, P; Chauhan, R; Ffrench-Constant, RH				Pauchet, Yannick; Wilkinson, Paul; Chauhan, Ritika; Ffrench-Constant, Richard H.			Diversity of Beetle Genes Encoding Novel Plant Cell Wall Degrading Enzymes	PLOS ONE			English	Article							MULBERRY LONGICORN BEETLE; CELLULASE GENE; CDNA CLONING; ENZYMATIC-ACTIVITY; APRIONA-GERMARI; EXPRESSION; ORIGIN; RECOGNITION; INHIBITORS; BIOLOGY	Plant cell walls are a heterogeneous mixture of polysaccharides and proteins that require a range of different enzymes to degrade them. Plant cell walls are also the primary source of cellulose, the most abundant and useful biopolymer on the planet. Plant cell wall degrading enzymes (PCWDEs) are therefore important in a wide range of biotechnological processes from the production of biofuels and food to waste processing. However, despite the fact that the last common ancestor of all deuterostomes was inferred to be able to digest, or even synthesize, cellulose using endogenous genes, all model insects whose complete genomes have been sequenced lack genes encoding such enzymes. To establish if the apparent "disappearance" of PCWDEs from insects is simply a sampling problem, we used 454 mediated pyrosequencing to scan the gut transcriptomes of beetles that feed on a variety of plant derived diets. By sequencing the transcriptome of five beetles, and surveying publicly available ESTs, we describe 167 new beetle PCWDEs belonging to eight different enzyme families. This survey proves that these enzymes are not only present in non-model insects but that the multigene families that encode them are apparently undergoing complex birth-death dynamics. This reinforces the observation that insects themselves, and not just their microbial symbionts, are a rich source of PCWDEs. Further it emphasises that the apparent absence of genes encoding PCWDEs from model organisms is indeed simply a sampling artefact. Given the huge diversity of beetles alive today, and the diversity of their lifestyles and diets, we predict that beetle guts will emerge as an important new source of enzymes for use in biotechnology.	[Pauchet, Yannick; Wilkinson, Paul; Chauhan, Ritika; Ffrench-Constant, Richard H.] Univ Exeter, Penryn, England; [Pauchet, Yannick] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany	University of Exeter; Max Planck Society	Pauchet, Y (corresponding author), Univ Exeter, Penryn, England.	ypauchet@ice.mpg.de	Pauchet, Yannick/AAU-9751-2021	Pauchet, Yannick/0000-0002-2918-8946; ffrench-Constant, Richard/0000-0001-5385-9888	Research and Knowledge Transfer office of the University of Exeter	Research and Knowledge Transfer office of the University of Exeter	This work was supported by pump priming funding from the Research and Knowledge Transfer office of the University of Exeter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellincampi D, 2004, BBA-PROTEINS PROTEOM, V1696, P265, DOI 10.1016/j.bbapap.2003.10.011; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Beutel RG, 2009, NATURWISSENSCHAFTEN, V96, P1293, DOI 10.1007/s00114-009-0601-2; Bown DP, 1997, INSECT BIOCHEM MOLEC, V27, P625, DOI 10.1016/S0965-1748(97)00043-X; Calderon-Cortes N, 2010, INSECT MOL BIOL, V19, P323, DOI 10.1111/j.1365-2583.2010.00991.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fujita K, 2006, BIOCHEM BIOPH RES CO, V345, P502, DOI 10.1016/j.bbrc.2006.04.126; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Girard C, 1999, INSECT BIOCHEM MOLEC, V29, P1129, DOI 10.1016/S0965-1748(99)00104-6; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Kristensen JB, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-11; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2004, COMP BIOCHEM PHYS B, V139, P107, DOI 10.1016/j.cbpc.2004.06.015; Lee SJ, 2005, COMP BIOCHEM PHYS B, V140, P551, DOI 10.1016/j.cbpc.2004.12.003; Lo N, 2003, P ROY SOC B-BIOL SCI, V270, pS69, DOI 10.1098/rsbl.2003.0016; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Ohtoko K, 2000, EXTREMOPHILES, V4, P343, DOI 10.1007/s007920070003; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schiott M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-40; Shen ZC, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.21; Shen ZC, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.24; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sugimura M, 2003, EUR J BIOCHEM, V270, P3455, DOI 10.1046/j.1432-1033.2003.03735.x; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	42	107	113	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15635	10.1371/journal.pone.0015635	http://dx.doi.org/10.1371/journal.pone.0015635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179425	Green Published, gold			2022-12-27	WOS:000285572900024
J	Pokrzywa, M; Dacklin, I; Vestling, M; Hultmark, D; Lundgren, E; Cantera, R				Pokrzywa, Malgorzata; Dacklin, Ingrid; Vestling, Monika; Hultmark, Dan; Lundgren, Erik; Cantera, Rafael			Uptake of Aggregating Transthyretin by Fat Body in a Drosophila Model for TTR-Associated Amyloidosis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; BINDING PROTEIN; A-BETA; TOXICITY; POLYNEUROPATHY; NEURODEGENERATION; LOCALIZATION; ACCUMULATION; MELANOGASTER	Background: A functional link has been established between the severe neurodegenerative disorder Familial amyloidotic polyneuropathy and the enhanced propensity of the plasma protein transthyretin (TTR) to form aggregates in patients with single point mutations in the TTR gene. Previous work has led to the establishment of an experimental model based on transgenic expression of normal or mutant forms of human TTR in Drosophila flies. Remarkably, the severity of the phenotype was greater in flies that expressed a single copy than with two copies of the mutated gene. Methodology/Principal Findings: In this study, we analyze the distribution of normal and mutant TTR in transgenic flies, and the ultrastructure of TTR-positive tissues to clarify if aggregates and/or amyloid filaments are formed. We report the formation of intracellular aggregates of 20 nm spherules and amyloid filaments in thoracic adipose tissue and in brain glia, two tissues that do not express the transgene. The formation of aggregates of nanospherules increased with age and was more considerable in flies with two copies of mutated TTR. Treatment of human neuronal cells with protein extracts prepared from TTR flies of different age showed that the extracts from older flies were less toxic than those from younger flies. Conclusions/Significance: These findings suggest that the uptake of TTR from the circulation and its subsequent segregation into cytoplasmic quasi-crystalline arrays of nanospherules is part of a mechanism that neutralizes the toxic effect of TTR.	[Pokrzywa, Malgorzata; Dacklin, Ingrid; Vestling, Monika; Hultmark, Dan; Lundgren, Erik] Umea Univ, Dept Mol Biol, Umea, Sweden; [Pokrzywa, Malgorzata] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Hultmark, Dan] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Cantera, Rafael] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Cantera, Rafael] IIBCE, Montevideo, Uruguay	Umea University; Linkoping University; Tampere University; Stockholm University; Instituto de Investigaciones Biologicas Clemente Estable Uruguay	Pokrzywa, M (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	malgorzata.pokrzywa@liu.se	Hultmark, Dan/C-5058-2013; Pokrzywa, Małgorzata/GQA-6257-2022	Hultmark, Dan/0000-0002-6506-5855; 	Swedish Research Council; Authority for Animal Welfare; Wallenberg Consortium North; patients association FAMY; Stiftelsen Amyl Norrbotten; Agencia Nacional de Investigacian e Innovacian (Uruguay)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Authority for Animal Welfare; Wallenberg Consortium North; patients association FAMY; Stiftelsen Amyl Norrbotten; Agencia Nacional de Investigacian e Innovacian (Uruguay)	This study was supported by grants from the Swedish Research Council, the Authority for Animal Welfare, Wallenberg Consortium North, the patients association FAMY and Stiftelsen Amyl Norrbotten. RC was supported by the SNI program of the Agencia Nacional de Investigacian e Innovacian (Uruguay). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESHIRE SL, 1983, J HISTOCHEM CYTOCHEM, V31, P608, DOI 10.1177/31.5.6341455; Andersson K, 2002, BIOCHEM BIOPH RES CO, V294, P309, DOI 10.1016/S0006-291X(02)00465-5; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Colon W, 1996, CIBA F SYMP, V199, P228; Colon W, 1996, CIBA F SYMP, P199; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GUSTAVSSON A, 1995, LAB INVEST, V73, P703; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hou X, 2007, FEBS J, V274, P1637, DOI 10.1111/j.1742-4658.2007.05712.x; Inoue S, 1998, J STRUCT BIOL, V124, P1, DOI 10.1006/jsbi.1998.4052; Keeley L.L., 1985, P211; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kramer Jamie M, 2003, Genet Mol Res, V2, P43; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Matsubara K, 2005, BIOCHEMISTRY-US, V44, P3280, DOI 10.1021/bi048838c; Miller JM, 2002, INSECT MOL BIOL, V11, P67, DOI 10.1046/j.0962-1075.2001.00310.x; Murai KK, 2007, NEUROSCIENTIST, V13, P657, DOI 10.1177/1073858407304393; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Olofsson A, 2001, J BIOL CHEM, V276, P39592, DOI 10.1074/jbc.M103599200; Paulsson JF, 2006, DIABETOLOGIA, V49, P1237, DOI 10.1007/s00125-006-0206-7; Pokrzywa M, 2007, EUR J NEUROSCI, V26, P913, DOI 10.1111/j.1460-9568.2007.05728.x; RAZ A, 1969, J BIOL CHEM, V244, P3230; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Rezaval C, 2007, EUR J NEUROSCI, V25, P683, DOI 10.1111/j.1460-9568.2007.05317.x; SARAIVA MJM, 1995, HUM MUTAT, V5, P191; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; SERPELL LC, 1995, J MOL BIOL, V254, P113, DOI 10.1006/jmbi.1995.0604; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sousa MM, 2002, AM J PATHOL, V161, P1935, DOI 10.1016/S0002-9440(10)64469-0; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2002, HISTOL HISTOPATHOL, V17, P239, DOI 10.14670/HH-17.239; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wiseman RL, 2005, BIOCHEMISTRY-US, V44, P16612, DOI 10.1021/bi0511484	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14343	10.1371/journal.pone.0014343	http://dx.doi.org/10.1371/journal.pone.0014343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179560	Green Submitted, Green Published, gold			2022-12-27	WOS:000285381200003
J	Calzolari, M; Bonilauri, P; Bellini, R; Albieri, A; Defilippo, F; Maioli, G; Galletti, G; Gelati, A; Barbieri, I; Tamba, M; Lelli, D; Carra, E; Cordioli, P; Angelini, P; Dottori, M				Calzolari, Mattia; Bonilauri, Paolo; Bellini, Romeo; Albieri, Alessandro; Defilippo, Francesco; Maioli, Giulia; Galletti, Giorgio; Gelati, Antoni; Barbieri, Ilaria; Tamba, Marco; Lelli, Davide; Carra, Elena; Cordioli, Paolo; Angelini, Paola; Dottori, Michele			Evidence of Simultaneous Circulation of West Nile and Usutu Viruses in Mosquitoes Sampled in Emilia-Romagna Region (Italy) in 2009	PLOS ONE			English	Article							PCR ASSAY; AUSTRIA; CULEX; FLAVIVIRUSES; SURVEILLANCE; EMERGENCE	Background: In recent years human diseases due to mosquito-borne viruses were increasingly reported in Emilia-Romagna region (Italy), from the chikungunya virus in 2007 to the West Nile virus (WNV) in 2008. An extensive entomological survey was performed in 2009 to establish the presence and distribution of mosquito arboviruses in this region, with particular reference to flaviviruses. Methodology/Principal Findings: From May 6 to October 31, a total of 190,516 mosquitoes were sampled in georeferenced stations, grouped in 1,789 pools according date of collection, location, and species, and analyzed by reverse transcription polymerase chain reaction (RT-PCR) to detect the presence of RNA belong to Flavivirus genus. WNV was detected in 27 mosquito pools, producing sequences similar to those of birds and human strains obtained in 2008 outbreak, pointed out the probable virus overwintering. Isolation of WNV was achieved from one of these pools. Moreover 56 pools of mosquitoes tested positive for Usutu virus (USUV). Most PCR positive pools consisted of Culex pipiens, which also was the most analyzed mosquito species (81.4% of specimens); interestingly, USUV RNA was also found in two Aedes albopictus mosquito pools. Simultaneous circulation of WNV and USUV in the survey area was highlighted by occurrence of 8 mosquito WNV-and USUV-positive pools and by the overlaying of the viruses "hot spots", obtained by kernel density estimation (KDE) analysis. Land use of sampled stations pointed out a higher proportion of WNV-positive Cx. pipiens pool in rural environments respect the provenience of total sampled pool, while the USUV-positive pools were uniformly captured in the different environments. Conclusions/Significance: Obtained data highlighting the possible role of Cx. pipiens mosquito as the main vector for WNV and USUV in Northern Italy, and the possible involvement of Ae. albopictus mosquito in USUV cycle. The described mosquito-based surveillance could constitute the foundation for a public health alert system targeting mosquito borne arboviruses.	[Calzolari, Mattia; Bonilauri, Paolo; Defilippo, Francesco; Maioli, Giulia; Galletti, Giorgio; Barbieri, Ilaria; Tamba, Marco; Lelli, Davide; Carra, Elena; Cordioli, Paolo; Dottori, Michele] Ist Zooprofilatt Sperimentale Lombardia & dellEmi, Brescia, Italy; [Bellini, Romeo; Albieri, Alessandro] Ctr Agr Ambiente G Nicoli CAA, Crevalcore, Italy; [Gelati, Antoni] Azienda USL Modena, Mirandola, Italy; [Angelini, Paola] DG Sanita & Polit Sociali, Reg Emilia Romagna, Bologna, Italy	IZS Lombardia e Emilia	Calzolari, M (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & dellEmi, Brescia, Italy.	mattia.calzolari@izsler.it	Tamba, Marco/J-5495-2016; dottori, michele/AAB-3815-2019; Calzolari, Mattia/AAB-9487-2019; Lelli, Davide DL/K-5178-2016; Maioli, Giulia/AAB-7559-2019; Lelli, Davide/AAB-6996-2019	Tamba, Marco/0000-0002-5878-4595; Calzolari, Mattia/0000-0001-7489-2556; Maioli, Giulia/0000-0002-7076-9005; Lelli, Davide/0000-0002-5775-6058; defilippo, francesco/0000-0002-1898-0997; Dottori, Michele/0000-0002-9975-0367; Galletti, Giorgio/0000-0003-4522-8976; Bonilauri, Paolo/0000-0002-2625-7993	Regione Emilia-Romagna; CAA [COMM07001]	Regione Emilia-Romagna(Regione Emilia Romagna); CAA	The Regione Emilia-Romagna (ermes.regione.emilia-romagna.it) had partially funded this work to IZSLER (www.izsler.it) and CAA (www.caa.it) by the Regional project on insect borne diseases (COMM07001). No other external funding was utilized for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T. R., 2006, International Journal of Risk Assessment & Management, V6, P253, DOI 10.1504/IJRAM.2006.009546; Angelini P, 2010, EUROSURVEILLANCE, V15, P11; [Anonymous], 2003, MOSQUITOES THEIR CON; Autorino GL, 2002, EMERG INFECT DIS, V8, P1372, DOI 10.3201/eid0812.020234; Bailey T, 1995, INTERACTIVE SPATIAL; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005; Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07; Balenghien T, 2008, VECTOR-BORNE ZOONOT, V8, P589, DOI 10.1089/vbz.2007.0266; Bellini R., 2002, 68 ANN M AM MOSQ CON; Biggerstaff B.J., 2006, POOLEDINFRATE VERSIO; Buckley A, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-71; Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Calistri P, 2010, ZOONOSES PUBLIC HLTH, V57, P211, DOI 10.1111/j.1863-2378.2009.01303.x; CALZOLARI M, 2010, VECTOR BORN IN PRESS; Capobianchi MR, 2010, EUROSURVEILLANCE, V15; Cavrini F, 2009, EUROSURVEILLANCE, V14, P17; *CDC, 2003, GUID SURV PREV CONTR; Chisenhall DM, 2008, J AM MOSQUITO CONTR, V24, P311, DOI 10.2987/5671.1; Chvala S, 2007, VET MICROBIOL, V122, P237, DOI 10.1016/j.vetmic.2007.01.029; Gratz NG, 2006, VECTOR-AND RODENT-BORNE DISEASES OF EUROPE AND NORTH AMERICA: THEIR DISTRIBUTION AND PUBLIC HEALTH BURDEN, P1, DOI 10.2277/ 0521854474; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Gu WD, 2008, T ROY SOC TROP MED H, V102, P817, DOI 10.1016/j.trstmh.2008.03.019; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; KRISZTALOVICS K, 2008, EUROSURVEILLANCE, V13, P7; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; LELLI D, 2009, ATT WORKSH NAZ VIR V; Lelli R, 2008, ZOONOSES PUBLIC HLTH, V55, P361, DOI 10.1111/j.1863-2378.2008.01146.x; Malkinson M, 2002, CURR TOP MICROBIOL, V267, P309; Manarolla G, 2010, VET MICROBIOL, V141, P159, DOI 10.1016/j.vetmic.2009.07.036; Pecorari M, 2009, EUROSURVEILLANCE, V14, P15; Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0; Rizzo C, 2009, EUROSURVEILLANCE, V14, P5; Rizzoli A, 2007, VECTOR-BORNE ZOONOT, V7, P411, DOI 10.1089/vbz.2006.0626; Romi Roberto, 2001, Annali dell'Istituto Superiore di Sanita, V37, P241; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Schaffner E., 2001, MOSQUITOES EUROPE; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; STEINMETZ HW, 2010, VET MICROBIOL; Stojanovich CJ, 1997, MOSQUITOES ITALIAN B; Sutherland GL, 2007, J AM MOSQUITO CONTR, V23, P389, DOI 10.2987/5630.1; TAMBA M, 2010, VECTOR BORN IN PRESS; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang YL, 2006, J CLIN VIROL, V36, P177, DOI 10.1016/j.jcv.2006.02.008; Tiawsirisup S, 2004, VECTOR-BORNE ZOONOT, V4, P190, DOI 10.1089/vbz.2004.4.190; Weissenbock H, 2004, ACTA NEUROPATHOL, V108, P453, DOI 10.1007/s00401-004-0916-1; Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Woodall J.P., 1964, P E AFR ACAD, V2, P141	52	103	105	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14324	10.1371/journal.pone.0014324	http://dx.doi.org/10.1371/journal.pone.0014324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179462	Green Submitted, gold, Green Published			2022-12-27	WOS:000285340000004
J	Dudaniec, RY; Storfer, A; Spear, SF; Richardson, JS				Dudaniec, Rachael Y.; Storfer, Andrew; Spear, Stephen F.; Richardson, John S.			New Microsatellite Markers for Examining Genetic Variation in Peripheral and Core Populations of the Coastal Giant Salamander (Dicamptodon tenebrosus)	PLOS ONE			English	Article							LOCI; RAREFACTION	The Coastal Giant Salamander (Dicamptodon tenebrosus) is classified as threatened at the northern periphery of its range in British Columbia (BC), Canada, primarily due to forestry practices and habitat fragmentation. Characterising dispersal behaviour and population connectivity is therefore a priority for this region, while genetic differentiation in core versus peripheral locations remains unstudied in this wide-ranging species. We present seven new polymorphic microsatellite markers for use in population genetic analyses of D. tenebrosus. We examine locus characteristics and genetic variation in 12 streams at the species' northern range limit in BC, and within two regions representing sub-peripheral (North Cascades) and core localities (South Cascades) in Washington State, United States. In BC, the number of alleles per locus ranged from 2-5 and observed heterozygosity ranged from 0.044-0.825. Genetic differentiation was highest between BC and the South Cascades, and intermediate between BC and the North Cascades. Across loci, mean allelic richness was similar across regions, while private allelic richness was highest in the core locality (corrected for sample size). These new microsatellite loci will be a valuable addition to existing markers for detailed landscape and population genetic analyses of D. tenebrosus across its range.	[Dudaniec, Rachael Y.; Richardson, John S.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Storfer, Andrew; Spear, Stephen F.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	University of British Columbia; Washington State University	Dudaniec, RY (corresponding author), Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada.	rachael.dudaniec@gmail.com	Richardson, John S/G-1513-2012; Dudaniec, Rachael Y/F-4001-2011; Dudaniec, Rachael/AAR-7034-2020	Richardson, John S/0000-0001-8135-7447; Dudaniec, Rachael/0000-0002-1854-6808	Forest Investment Account/Forest Science Program, British Columbia [Y102082]; Cooperative Monitoring, Evaluation and Research Committee [IAA-06-047]	Forest Investment Account/Forest Science Program, British Columbia; Cooperative Monitoring, Evaluation and Research Committee	This work was supported by the Forest Investment Account/Forest Science Program, British Columbia (grant number Y102082; http://www.fia-fsp.ca/), and the Cooperative Monitoring, Evaluation and Research Committee under the Washington Department of Natural Resources Forest Practices Management Program (grant number IAA-06-047 to WSU; http://www.dnr.wa.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Curtis JM, 2000, MOL ECOL, V9, P116, DOI 10.1046/j.1365-294x.2000.00764-6.x; Curtis JMR, 2004, BIOL CONSERV, V115, P45, DOI 10.1016/S0006-3207(03)00092-2; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Gautschi B, 2000, MOL ECOL, V9, P2193, DOI 10.1046/j.1365-294X.2000.105321.x; Gautschi B, 2000, MOL ECOL, V9, P2191, DOI 10.1046/j.1365-294X.2000.105320.x; Hamilton MB, 1999, BIOTECHNIQUES, V27, P500, DOI 10.2144/99273st03; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Steele CA, 2008, MOL ECOL RESOUR, V8, P1071, DOI 10.1111/j.1755-0998.2008.02158.x; Steele CA, 2009, MOL ECOL, V18, P1629, DOI 10.1111/j.1365-294X.2009.04135.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963	18	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14333	10.1371/journal.pone.0014333	http://dx.doi.org/10.1371/journal.pone.0014333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179519	gold, Green Published			2022-12-27	WOS:000285340000008
J	Farago, T; Pongracz, P; Miklosi, A; Huber, L; Viranyi, Z; Range, F				Farago, Tamas; Pongracz, Peter; Miklosi, Adam; Huber, Ludwig; Viranyi, Zsofia; Range, Friederike			Dogs' Expectation about Signalers' Body Size by Virtue of Their Growls	PLOS ONE			English	Article							VOCAL-TRACT LENGTH; DOMESTIC DOG; CANIS-FAMILIARIS; HUMAN LISTENERS; BARKS; INFORMATION; COMMUNICATION; DISCRIMINATE; EXPRESSIONS; PERCEPTION	Several studies suggest that dogs, as well as primates, utilize a mental representation of the signaler after hearing its vocalization and can match this representation with other features provided by the visual modality. Recently it was found that a dogs' growl is context specific and contains information about the caller's body size. Whether dogs can use the encoded information is as yet unclear. In this experiment, we tested whether dogs can assess the size of another dog if they hear an agonistic growl paired with simultaneous video projection of two dog pictures. One of them matched the size of the growling dog, while the other one was either 30% larger or smaller. In control groups, noise, cat pictures or projections of geometric shapes (triangles) were used. The results showed that dogs look sooner and longer at the dog picture matching the size of the caller. No such preference was found with any of the control stimuli, suggesting that dogs have a mental representation of the caller when hearing its vocalization.	[Farago, Tamas; Pongracz, Peter; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Huber, Ludwig; Viranyi, Zsofia; Range, Friederike] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Viranyi, Zsofia; Range, Friederike] Clever Dog Lab, Vienna, Austria	Eotvos Lorand University; University of Vienna	Farago, T (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	peter.celeste.pongracz@gmail.com	Pongrácz, Péter/C-9811-2013; Faragó, Tamás/A-5386-2009; Miklosi, Adam/N-5147-2017	Pongrácz, Péter/0000-0001-5126-299X; Faragó, Tamás/0000-0001-5987-2629; Range, Friederike/0000-0003-3127-5536; Huber, Ludwig/0000-0002-0217-136X; Miklosi, Adam/0000-0003-4831-8985	European Union [FP7-ICT-2007, LIREC-215554]; ETOCOM [TAMOP-4.2.2-08/1/KMR-2008-0007]; Hungarian National Science Foundation [OTKA K82020]; AKTION Osterreich-Ungarn Foundation [74ou3]; Royal Canin	European Union(European Commission); ETOCOM; Hungarian National Science Foundation; AKTION Osterreich-Ungarn Foundation; Royal Canin	This work was supported by The European Union (FP7-ICT-2007 LIREC-215554), the ETOCOM Project (TAMOP-4.2.2-08/1/KMR-2008-0007)through the Hungarian National Development Agency in the framework of Social Renewal Operative Programme supported by EU and co-financed by the European Social Fund, The Hungarian National Science Foundation (OTKA K82020), AKTION Osterreich-Ungarn Foundation (No. 74ou3), and Royal Canin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Andrew Richard J., 2002, P365, DOI 10.1017/CBO9780511546372.012; [Anonymous], 2003, ANIMAL SIGNALS; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; Bouissou MF, 1996, BEHAV PROCESS, V38, P37, DOI 10.1016/0376-6357(96)00016-2; Bovet D, 2000, BEHAV BRAIN RES, V109, P143, DOI 10.1016/S0166-4328(00)00146-7; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; COHEN JA, 1976, BEHAV PROCESS, V1, P77, DOI 10.1016/0376-6357(76)90008-5; Coulon M, 2007, J COMP PSYCHOL, V121, P198, DOI 10.1037/0735-7036.121.2.198; COXCR, 1981, INTEGR COMP BIOL, V21, P197, DOI DOI 10.1093/ICB/21.1.197; ENQUIST M, 1990, ANIM BEHAV, V40, P1, DOI 10.1016/S0003-3472(05)80660-8; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Evans TA, 2005, J EXP PSYCHOL ANIM B, V31, P399, DOI 10.1037/0097-7403.31.4.399; Fagot J, 2000, PICTURE PERCEPTION A, P295; Fant G., 1960, ACOUSTIC THEORY SPEE; Farago T, 2010, ANIM BEHAV, V79, P917, DOI 10.1016/j.anbehav.2010.01.005; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fitch WT, 2000, PHONETICA, V57, P205; Fitch WT, 2003, SPR HDB AUD, V16, P65; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Fogle B, 1992, DOGS MIND; FOX M W, 1971, Zeitschrift fuer Tierpsychologie, V28, P185; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; Guihou A, 2008, EUR J DEV PSYCHOL, V5, P68, DOI 10.1080/17405620600760409; Lieberman P., 1988, SPEECH PHYSL SPEECH; Maros K, 2008, APPL ANIM BEHAV SCI, V114, P159, DOI 10.1016/j.applanim.2008.01.022; Martinez L, 2009, ANIM COGN, V12, pS71, DOI 10.1007/s10071-009-0269-1; Molnar C, 2009, BEHAV PROCESS, V82, P198, DOI 10.1016/j.beproc.2009.06.011; Patterson ML, 2002, J EXP CHILD PSYCHOL, V81, P93, DOI 10.1006/jecp.2001.2644; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Pongracz P, 2003, ETHOLOGY, V109, P809, DOI 10.1046/j.0179-1613.2003.00923.x; Pongracz P, 2006, APPL ANIM BEHAV SCI, V100, P228, DOI 10.1016/j.applanim.2005.12.004; Racca A, 2010, ANIM COGN, V13, P525, DOI 10.1007/s10071-009-0303-3; Range F, 2008, ANIM COGN, V11, P339, DOI 10.1007/s10071-007-0123-2; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Riede T, 1999, J EXP BIOL, V202, P2859; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Siniscalchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003349; Smith DRR, 2005, J ACOUST SOC AM, V118, P3177, DOI 10.1121/1.2047107; Soken NH, 1999, CHILD DEV, V70, P1275, DOI 10.1111/1467-8624.00093; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; Taylor AM, 2008, J ACOUST SOC AM, V123, P2903, DOI 10.1121/1.2896962; Yeon SC, 2007, J VET BEHAV, V2, P141, DOI 10.1016/j.jveb.2007.07.006	46	53	53	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15175	10.1371/journal.pone.0015175	http://dx.doi.org/10.1371/journal.pone.0015175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179521	gold, Green Submitted, Green Published			2022-12-27	WOS:000285340000019
J	Kawaguchi, N; Smith, AJ; Waring, CD; Hasan, MK; Miyamoto, S; Matsuoka, R; Ellison, GM				Kawaguchi, Nanako; Smith, Andrew J.; Waring, Cheryl D.; Hasan, Md Kamrul; Miyamoto, Shinka; Matsuoka, Rumiko; Ellison, Georgina M.			c-kit(pos) GATA-4 High Rat Cardiac Stem Cells Foster Adult Cardiomyocyte Survival through IGF-1 Paracrine Signalling	PLOS ONE			English	Article							GROWTH-FACTOR-I; REGENERATE INFARCTED MYOCARDIUM; BONE-MARROW-CELLS; PROGENITOR CELLS; HEART-FAILURE; MURINE HEART; APOPTOSIS; MECHANISMS; THERAPY; MULTIPOTENT	Background: Resident c-kit positive (c-kit(pos)) cardiac stem cells (CSCs) could be considered the most appropriate cell type for myocardial regeneration therapies. However, much is still unknown regarding their biological properties and potential. Methodology/Principal Findings: We produced clones of high and low expressing GATA-4 CSCs from long-term bulk-cultured c-kit(pos) CSCs isolated from adult rat hearts. When c-kit(pos) GATA-4 high expressing clonal CSCs (cCSCs) were co-cultured with adult rat ventricular cardiomyocytes, we observed increased survival and contractility of the cardiomyocytes, compared to cardiomyocytes cultured alone, co-cultured with fibroblasts or c-kit(pos) GATA-4 low expressing cCSCs. When analysed by ELISA, the concentration of IGF-1 was significantly increased in the c-kit(pos) GATA-4 high cCSC/cardiomyocyte co-cultures and there was a significant correlation between IGF-1 concentration and cardiomyocyte survival. We showed the activation of the IGF-1 receptor and its downstream molecular targets in cardiomyocytes co-cultured with c-kit(pos) GATA-4 high cCSCs but not in cardiomyocytes that were cultured alone, co-cultured with fibroblasts or c-kit(pos) GATA-4 low cCSCs. Addition of a blocking antibody specific to the IGF-1 receptor inhibited the survival of cardiomyocytes and prevented the activation of its signalling in cardiomyocytes in the c-kit(pos) GATA-4 high cCSC/cardiomyocyte co-culture system. IGF-1 supplementation or IGF-1 high conditioned medium taken from the co-culture of c-kit(pos) GATA-4 high cCSCs plus cardiomyocytes did extend the survival and contractility of cardiomyocytes cultured alone and cardiomyocytes co-cultured with c-kit(pos) GATA-4 low cCSCs. Conclusion/Significance: c-kit(pos) GATA-4 high cCSCs exert a paracrine survival effect on cardiomyocytes through induction of the IGF-1R and signalling pathway.	[Kawaguchi, Nanako; Hasan, Md Kamrul; Miyamoto, Shinka; Matsuoka, Rumiko] Tokyo Womens Med Univ, IREIIMS, Tokyo, Japan; [Smith, Andrew J.; Waring, Cheryl D.; Ellison, Georgina M.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Stem Cell & Mol Physiol Lab, Liverpool L3 5UX, Merseyside, England; [Miyamoto, Shinka] Tokyo Womens Med Univ, Heart Inst Japan, Dept Cardiovasc Surg, Tokyo, Japan	Tokyo Women's Medical University; Liverpool John Moores University; Tokyo Women's Medical University	Kawaguchi, N (corresponding author), Tokyo Womens Med Univ, IREIIMS, Tokyo, Japan.	g.m.ellison@ljmu.ac.uk	Ellison-Hughes, Georgina M./B-4597-2016	Ellison-Hughes, Georgina M./0000-0002-2733-3361; Smith, Andrew/0000-0001-7283-5611	Ministry of Education, Culture, Sports, Science and Technology, Japan; British Heart Foundation [PG/06/053, PG 08/085]; European Community [PIRG02-GA-2007-224853]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); British Heart Foundation(British Heart Foundation); European Community(European Commission)	This work was supported by the encouraging Development of Strategic Research Centers, Special Co-ordination Funds for Promoting Science and Technology and a Grant-in Aid for Scientific Research (A), Ministry of Education, Culture, Sports, Science and Technology, Japan; grants to G. M. E from the British Heart Foundation (PG/06/053; PG 08/085) and a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme (PIRG02-GA-2007-224853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2002, CARDIOVASC RES, V55, P787, DOI 10.1016/S0008-6363(02)00493-5; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bernecker Oliver Y, 2003, Cardiovasc Toxicol, V3, P183, DOI 10.1385/CT:3:3:183; Braunwald E, 2000, CIRCULATION, V102, P14; BRAUNWALD E, 1991, AM J CARDIOL, V68, pD1; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Ellison Georgina M, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS52, DOI 10.1038/ncpcardio0773; Ellison GM, 2007, J BIOL CHEM, V282, P11397, DOI 10.1074/jbc.M607391200; Fu YC, 2004, CARDIOVASC RES, V62, P558, DOI 10.1016/j.cardiores.2004.01.039; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Janssens S, 2010, ANNU REV MED, V61, P287, DOI 10.1146/annurev.med.051508.215152; KELLEY C, 1993, DEVELOPMENT, V118, P817; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kubal C, 2006, J THORAC CARDIOV SUR, V132, P1112, DOI 10.1016/j.jtcvs.2006.06.028; Lai VK, 2009, J THORAC CARDIOV SUR, V138, P1400, DOI 10.1016/j.jtcvs.2009.07.013; LaVoie HA, 2004, ENDOCRINOLOGY, V145, P3122, DOI 10.1210/en.2003-1719; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miyamoto S, 2010, STEM CELLS DEV, V19, P105, DOI 10.1089/scd.2009.0041; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Moore XL, 2007, ENDOCRINOLOGY, V148, P1582, DOI 10.1210/en.2006-1324; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nadal-Ginard B, 2006, REV ESP CARDIOL, V59, P1175; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; Reffelmann T, 2009, J AM COLL CARDIOL, V53, P305, DOI 10.1016/j.jacc.2008.10.018; Rosenblatt-Velin N, 2005, J CLIN INVEST, V115, P1724, DOI 10.1172/JCI23418; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Torella Daniele, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS46, DOI 10.1038/ncpcardio0772; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Wu S, 2002, J MOL CELL CARDIOL, V34, P1595, DOI 10.1006/jmcc.2002.2110; Yamaoka M, 2000, J MOL CELL CARDIOL, V32, P881, DOI 10.1006/jmcc.2000.1132; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278	49	68	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14297	10.1371/journal.pone.0014297	http://dx.doi.org/10.1371/journal.pone.0014297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179204	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900010
J	Venner, E; Lisewski, AM; Erdin, S; Ward, RM; Amin, SR; Lichtarge, O				Venner, Eric; Lisewski, Andreas Martin; Erdin, Serkan; Ward, R. Matthew; Amin, Shivas R.; Lichtarge, Olivier			Accurate Protein Structure Annotation through Competitive Diffusion of Enzymatic Functions over a Network of Local Evolutionary Similarities	PLOS ONE			English	Article							GENE ONTOLOGY ANNOTATION; FUNCTION PREDICTION; BINDING-SITES; TRACE; SEQUENCE; RECEPTOR; RESIDUES; DOMAIN; RESOURCE; ESTERASE	High-throughput Structural Genomics yields many new protein structures without known molecular function. This study aims to uncover these missing annotations by globally comparing select functional residues across the structural proteome. First, Evolutionary Trace Annotation, or ETA, identifies which proteins have local evolutionary and structural features in common; next, these proteins are linked together into a proteomic network of ETA similarities; then, starting from proteins with known functions, competing functional labels diffuse link-by-link over the entire network. Every node is thus assigned a likelihood z-score for every function, and the most significant one at each node wins and defines its annotation. In high-throughput controls, this competitive diffusion process recovered enzyme activity annotations with 99% and 97% accuracy at half-coverage for the third and fourth Enzyme Commission (EC) levels, respectively. This corresponds to false positive rates 4-fold lower than nearest-neighbor and 5-fold lower than sequence-based annotations. In practice, experimental validation of the predicted carboxylesterase activity in a protein from Staphylococcus aureus illustrated the effectiveness of this approach in the context of an increasingly drug-resistant microbe. This study further links molecular function to a small number of evolutionarily important residues recognizable by Evolutionary Tracing and it points to the specificity and sensitivity of functional annotation by competitive global network diffusion. A web server is at http://mammoth.bcm.tmc.edu/networks.	[Venner, Eric; Lisewski, Andreas Martin; Erdin, Serkan; Ward, R. Matthew; Amin, Shivas R.; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Venner, Eric; Ward, R. Matthew; Lichtarge, Olivier] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Venner, Eric; Erdin, Serkan; Ward, R. Matthew; Lichtarge, Olivier] WM Keck Ctr Interdisciplinary Biosci Training, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Venner, E (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	lichtarge@bcm.edu	Erdin, Serkan/AAE-4288-2019; Erdin, Serkan/B-4988-2008	Erdin, Serkan/0000-0001-6587-2625	National Science Foundation, NSF [CCF-0905536]; National Institutes of Health [NIH-GM079656, NIH-GM066099, T90 DA022885, R90 DA023418, NLM 5T15LM07093]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656, K12GM084897, R01GM066099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022885, R90DA023418] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Science Foundation, NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Science Foundation (http://www.nsf.gov/) NSF CCF-0905536; National Institutes of Health (http://www.nih.gov/) NIH-GM079656, NIH-GM066099, T90 DA022885, R90 DA023418, NLM 5T15LM07093. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; Almonacid DE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000700; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Baameur F, 2010, MOL PHARMACOL, V77, P405, DOI 10.1124/mol.109.058115; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bonde MM, 2010, BIOCHEM PHARMACOL, V80, P86, DOI 10.1016/j.bcp.2010.03.006; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Brenner SE, 2001, NAT REV GENET, V2, P801, DOI 10.1038/35093574; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chiang RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000142; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Engelhardt BE, 2005, PLOS COMPUT BIOL, V1, P432, DOI 10.1371/journal.pcbi.0010045; Erdin S, 2010, J MOL BIOL, V396, P1451, DOI 10.1016/j.jmb.2009.12.037; Ferre F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-194; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Furnham N, 2009, NAT CHEM BIOL, V5, P521, DOI 10.1038/nchembio0809-521; Gherardini Pier Federico, 2008, Briefings in Functional Genomics & Proteomics, V7, P291, DOI 10.1093/bfgp/eln030; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Glazer DS, 2009, STRUCTURE, V17, P919, DOI 10.1016/j.str.2009.05.010; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Gu PL, 2005, J BIOL CHEM, V280, P31818, DOI 10.1074/jbc.M501924200; Hennig S, 2003, NUCLEIC ACIDS RES, V31, P3712, DOI 10.1093/nar/gkg582; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hsiao TL, 2010, NAT CHEM BIOL, V6, P34, DOI [10.1038/NCHEMBIO.266, 10.1038/nchembio.266]; Hu PZ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S64; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; KRISCH K, 1966, BIOCHIM BIOPHYS ACTA, V122, P265, DOI 10.1016/0926-6593(66)90067-1; Kristensen DM, 2006, PROTEIN SCI, V15, P1530, DOI 10.1110/ps.062152706; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2005, J MOL BIOL, V351, P614, DOI 10.1016/j.jmb.2005.05.067; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Levy ED, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-302; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lichtarge O, 1996, P NATL ACAD SCI USA, V93, P7507, DOI 10.1073/pnas.93.15.7507; Lichtarge O, 2010, CURR OPIN STRUC BIOL, V20, P351, DOI 10.1016/j.sbi.2010.04.002; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mihalek I, 2006, PROTEINS, V63, P87, DOI 10.1002/prot.20866; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; MUKHERJEE JJ, 1993, BIOCHEM J, V295, P81, DOI 10.1042/bj2950081; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Nariai N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000337; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Pandit SB, 2010, BIOINFORMATICS, V26, P687, DOI 10.1093/bioinformatics/btq006; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Qi Y, 2008, GENOME RES, V18, P1991, DOI 10.1101/gr.077693.108; Quan XJ, 2004, DEVELOPMENT, V131, P1679, DOI 10.1242/dev.01055; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Redfern OC, 2007, PLOS COMPUT BIOL, V3, P2333, DOI 10.1371/journal.pcbi.0030232; Redfern OC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000485; Rhee JK, 2005, APPL ENVIRON MICROB, V71, P817, DOI 10.1128/AEM.71.2.817-825.2005; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Ross MK, 2006, BIOCHEM PHARMACOL, V71, P657, DOI 10.1016/j.bcp.2005.11.020; Sadowski MI, 2009, CURR OPIN STRUC BIOL, V19, P357, DOI 10.1016/j.sbi.2009.03.008; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; She R, 2009, GENOME RES, V19, P143, DOI 10.1101/gr.082081.108; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shin HJ, 2007, BIOINFORMATICS, V23, P3217, DOI 10.1093/bioinformatics/btm511; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Sowa ME, 2000, P NATL ACAD SCI USA, V97, P1483, DOI 10.1073/pnas.030409597; Sowa ME, 2001, NAT STRUCT BIOL, V8, P234, DOI 10.1038/84974; Tseng YY, 2009, J MOL BIOL, V387, P451, DOI 10.1016/j.jmb.2008.12.072; Tsuda K, 2005, BIOINFORMATICS, V21, P59, DOI 10.1093/bioinformatics/bti1110; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wang K, 2005, BIOINFORMATICS, V21, P2969, DOI 10.1093/bioinformatics/bti471; Ward RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002136; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Watson JD, 2007, J MOL BIOL, V367, P1511, DOI 10.1016/j.jmb.2007.01.063; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Wilkins AD, 2010, PROTEIN SCI, V19, P1296, DOI 10.1002/pro.406; Wu PC, 2006, J AGR FOOD CHEM, V54, P836, DOI 10.1021/jf052691u; Yao H, 2003, J MOL BIOL, V326, P255, DOI 10.1016/S0022-2836(02)01336-0; Zhou DY, 2004, ADV NEUR IN, V16, P321	96	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14286	10.1371/journal.pone.0014286	http://dx.doi.org/10.1371/journal.pone.0014286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179190	Green Submitted, gold, Green Published			2022-12-27	WOS:000285246900004
J	Dai, Y; DeSano, J; Tang, WH; Meng, XJ; Meng, Y; Burstein, E; Lawrence, TS; Xu, LA				Dai, Yao; DeSano, Jeffrey; Tang, Wenhua; Meng, Xiaojie; Meng, Yang; Burstein, Ezra; Lawrence, Theodore S.; Xu, Liang			Natural Proteasome Inhibitor Celastrol Suppresses Androgen-Independent Prostate Cancer Progression by Modulating Apoptotic Proteins and NF-kappaB	PLOS ONE			English	Article							B ACTIVATION; CONSTITUTIVE ACTIVATION; MELANOMA-CELLS; BORTEZOMIB; MCL-1; GROWTH; NOXA; TRITERPENE; INDUCTION; PATHWAY	Background: Celastrol is a natural proteasome inhibitor that exhibits promising anti-tumor effects in human malignancies, especially the androgen-independent prostate cancer (AIPC) with constitutive NF-kappa B activation. Celastrol induces apoptosis by means of proteasome inhibition and suppresses prostate tumor growth. However, the detailed mechanism of action remains elusive. In the current study, we aim to test the hypothesis that celastrol suppresses AIPC progression via inhibiting the constitutive NF-kappa B activity as well as modulating the Bcl-2 family proteins. Methodology/Principal Findings: We examined the efficacy of celastrol both in vitro and in vivo, and evaluated the role of NF-kappa B in celastrol-mediated AIPC regression. We found that celastrol inhibited cell proliferation in all three AIPC cell lines (PC-3, DU145 and CL1), with IC50 in the range of 1-2 mu M. Celastrol also suppressed cell migration and invasion. Celastrol significantly induced apoptosis as evidenced by increased sub-G1 population, caspase activation and PARP cleavage. Moreover, celastrol promoted cleavage of the anti-apoptotic protein Mcl-1 and activated the pro-apoptotic protein Noxa. In addition, celastrol rapidly blocked cytosolic I kappa B alpha degradation and nuclear translocation of RelA. Likewise, celastrol inhibited the expression of multiple NF-kappa B target genes that are involved in proliferation, invasion and anti-apoptosis. Celastrol suppressed AIPC tumor progression by inhibiting proliferation, increasing apoptosis and decreasing angiogenesis, in PC-3 xenograft model in nude mouse. Furthermore, increased cellular I kappa B alpha and inhibited expression of various NF-kappa B target genes were observed in tumor tissues. Conclusions/Significance: Our data suggest that, via targeting the proteasome, celastrol suppresses proliferation, invasion and angiogenesis by inducing the apoptotic machinery and attenuating constitutive NF-kappa B activity in AIPC both in vitro and in vivo. Celastrol as an active ingredient of traditional herbal medicine could thus be developed as a new therapeutic agent for hormone-refractory prostate cancer.	[Dai, Yao; DeSano, Jeffrey; Tang, Wenhua; Meng, Xiaojie; Meng, Yang; Lawrence, Theodore S.; Xu, Liang] Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Sch Med, Ann Arbor, MI 48109 USA; [Tang, Wenhua; Meng, Xiaojie; Xu, Liang] Univ Kansas, Ctr Canc, Dept Mol Biosci, Lawrence, KS 66045 USA; [Burstein, Ezra] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Burstein, Ezra] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Tang, Wenhua; Meng, Xiaojie; Xu, Liang] Univ Kansas, Ctr Canc, Dept Urol, Lawrence, KS 66045 USA; [Tang, Wenhua; Meng, Xiaojie; Xu, Liang] Univ Kansas, Ctr Canc, Dept Radiat Oncol, Lawrence, KS 66045 USA	University of Michigan System; University of Michigan; University of Kansas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Kansas; University of Kansas	Dai, Y (corresponding author), Univ Florida, Hlth Sci Ctr, Dept Radiat Oncol, Gainesville, FL 32611 USA.	xul@ku.edu	Burstein, Ezra/B-7247-2016	Burstein, Ezra/0000-0003-4341-6367	Department of Defense [W81XWH-06-1-0010]; National Institutes of Health (NIH) National Cancer Institute [R01 CA121830(S1), R21 CA128220, R01 CA134655]; NIH through a University of Michigan Cancer Center [5 P30 CA46592]; NATIONAL CANCER INSTITUTE [R21CA128220, R01CA134655, P30CA046592, R01CA121830] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH through a University of Michigan Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by Department of Defense Prostate Cancer Research Program [W81XWH-06-1-0010] and National Institutes of Health (NIH) National Cancer Institute [R01 CA121830(S1), R21 CA128220 and R01 CA134655] to LX, and by NIH through a University of Michigan Cancer Center Support Grant [5 P30 CA46592]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; An WG, 2000, LEUKEMIA, V14, P1276, DOI 10.1038/sj.leu.2401812; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen M, 2009, MOL CANCER RES, V7, P1946, DOI 10.1158/1541-7786.MCR-09-0243; Dai Y, 2009, AM J TRANSL RES, V1, P1; Dai Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-392; Dai Y, 2008, CLIN CANCER RES, V14, P7701, DOI 10.1158/1078-0432.CCR-08-0188; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; Gasparian AV, 2002, J CELL SCI, V115, P141; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; He D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-343; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Karnak D, 2010, CURR DRUG TARGETS, V11, P699, DOI 10.2174/138945010791170888; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; LIAN J, 2010, CELL DEATH IN PRESS; LIAN J, 2010, AUTOPHAGY IN PRESS, V6; Liu AY, 2004, PROSTATE, V60, P98, DOI 10.1002/pros.20031; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Nagase M, 2003, BIOSCI BIOTECH BIOCH, V67, P1883, DOI 10.1271/bbb.67.1883; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Opferman JT, 2006, CELL DEATH DIFFER, V13, P1260, DOI 10.1038/sj.cdd.4401978; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pajonk F, 1999, J NATL CANCER I, V91, P1956, DOI 10.1093/jnci/91.22.1956; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Papandreou CN, 2004, CANCER RES, V64, P5036, DOI 10.1158/0008-5472.CAN-03-2707; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Podar K, 2008, ONCOGENE, V27, P721, DOI 10.1038/sj.onc.1210679; Qin JZ, 2006, CANCER RES, V66, P9636, DOI 10.1158/0008-5472.CAN-06-0747; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; Satou Y, 2004, LEUKEMIA, V18, P1357, DOI 10.1038/sj.leu.2403400; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Sors A, 2006, BLOOD, V107, P2354, DOI 10.1182/blood-2005-06-2536; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Williams S, 2003, MOL CANCER THER, V2, P835; Wu XQ, 2010, BIOORGAN MED CHEM, V18, P3812, DOI 10.1016/j.bmc.2010.04.046; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225; Zhou YX, 2009, CHINESE MED J-PEKING, V122, P1666, DOI 10.3760/cma.j.issn.0366-6999.2009.14.012	45	82	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14153	10.1371/journal.pone.0014153	http://dx.doi.org/10.1371/journal.pone.0014153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170316	Green Published, Green Submitted, gold			2022-12-27	WOS:000285181400002
J	Kim, EY; Shin, HY; Kim, JY; Kim, DG; Choi, YM; Kwon, HK; Rhee, DK; Kim, YS; Choi, S				Kim, Eun-Young; Shin, Hye Young; Kim, Joo-Young; Kim, Dong-Gun; Choi, Yong-Min; Kwon, Hyuk-Kwon; Rhee, Dong-Kwon; Kim, You-Sun; Choi, Sangdun			ATF3 Plays a Key Role in Kdo(2)-Lipid A-Induced TLR4-Dependent Gene Expression via NF-kappa B Activation	PLOS ONE			English	Article							INDUCIBLE NUCLEAR-PROTEIN; TLR-SIGNALING PATHWAYS; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR-3; NEGATIVE REGULATION; ESCHERICHIA-COLI; TRANSDUCTION; MACROPHAGES; ENDOTOXIN; BINDING	Background: Activating transcription factor 3 (ATF3) is a negative regulator of proinflammatory cytokine expression in macrophages, and ATF3 deficient mice are more susceptible to endotoxic shock. This study addresses the role of ATF3 in the Kdo(2)-Lipid A-induced Toll-like receptor 4 (TLR4) signaling pathway in mouse embryonic fibroblasts (MEF). Kdo(2)-Lipid A upregulates ATF3 expression in wild type MEF cells and induces both nuclear factor kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK) activation via the TLR4 signaling pathway, while neither of these pathways is activated in ATF3-/- MEF cells. Interestingly, in contrast to Kdo(2)-Lipid A, the activation of both NF-kappa B and JNK by TNF-alpha was normal in ATF3-/- MEF cells. Methodology/Principal Findings: We found that several genes were dramatically upregulated in ATF3+/+ MEF cells in response to Kdo(2)-Lipid A treatment, while little difference was observed in the ATF3-/- MEF cells. However, we also found that the signal intensities of I kappa B zeta in ATF3-/- MEF cells were substantially higher than those in wild type MEF cells upon microarray analyses, and upregulated I kappa B zeta expression was detected in the cytosol fraction. Conclusions/Significance: Our findings indicate that ATF3 deficiency affects Kdo(2)-Lipid A-induced TLR4 signaling pathways in MEF cells, that it may upregulate I kappa B zeta expression and that the high levels of I kappa B zeta expression in ATF3-/- cells disrupts Kdo(2)-Lipid A-mediated signaling pathways.	[Kim, Eun-Young; Shin, Hye Young; Choi, Yong-Min; Kwon, Hyuk-Kwon; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Kim, Joo-Young; Kim, Dong-Gun; Kim, You-Sun] Ajou Univ, Inst Med Sci, Sch Med, Suwon 441749, South Korea; [Rhee, Dong-Kwon] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea	Ajou University; Ajou University; Sungkyunkwan University (SKKU)	Kim, EY (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	yousunkim@ajou.ac.kr; sangdunchoi@ajou.ac.kr	kwon, hyukkwon/GRS-1775-2022; kwon, hyuk-kwon/AAS-4154-2021	kwon, hyuk-kwon/0000-0002-4723-4061; Kim, Dong-Gun/0000-0002-0780-6301	Ministry of Education, Science, and Technology [2009-0067084, 2010-0015356]; Korea Food AND Drug Administration [10182KFDA992]; National Research Foundation of Korea (NRF) [2010-0028294]; Korea Science and Engineering Foundation [WCU R33-10045]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food AND Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2009-0067084 to YSK and 2010-0015356 to SC). This work was also partly supported by a grant (10182KFDA992) from Korea Food AND Drug Administration, the Priority Research Centers Program through the National Research Foundation of Korea (NRF) (2010-0028294) and a grant (WCU R33-10045) from the Korea Science and Engineering Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; AKIRA S, 2003, BIOCH SOC T, V31; Biswas SK, 2007, J IMMUNOL, V179, P4083, DOI 10.4049/jimmunol.179.6.4083; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Chung JY, 2002, J CELL SCI, V115, P679; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Fu SL, 2006, BIOCHEM BIOPH RES CO, V339, P137, DOI 10.1016/j.bbrc.2005.11.005; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; GODOWSKI P, 1999, J EXP MED, V189, P1437; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hai T, 1999, GENE EXPRESSION, V7, P321; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim SH, 2004, TOXICOL APPL PHARM, V196, P47, DOI 10.1016/j.taap.2003.11.020; Konadu E, 1999, INFECT IMMUN, V67, P6191, DOI 10.1128/IAI.67.11.6191-6193.1999; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Li LM, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-49; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Nakagomi S, 2003, J NEUROSCI, V23, P5187; NILSSON M, 1995, J BIOL CHEM, V270, P12210, DOI 10.1074/jbc.270.20.12210; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Rolph MS, 2006, J IMMUNOL, V177, P7794, DOI 10.4049/jimmunol.177.11.7794; Sasaki H, 2008, BIOPHYS J, V95, P986, DOI 10.1529/biophysj.108.129197; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Wang ZL, 2008, CELL BIOL INT, V32, P484, DOI 10.1016/j.cellbi.2007.10.009; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738	42	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14181	10.1371/journal.pone.0014181	http://dx.doi.org/10.1371/journal.pone.0014181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152039	Green Published, gold, Green Submitted			2022-12-27	WOS:000284868000007
J	Xie, X; Ma, YT; Yang, YN; Li, XM; Liu, F; Huang, D; Fu, ZY; Ma, XA; Chen, BD; Huang, Y				Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Liu, Fen; Huang, Ding; Fu, Zhen-Yan; Ma, Xiang; Chen, Bang-Dang; Huang, Ying			Alcohol Consumption and Ankle-to-Brachial Index: Results from the Cardiovascular Risk Survey	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; CAROTID ATHEROSCLEROSIS; OLDER-ADULTS; ASSOCIATION; MORTALITY; EXPRESSION; DRINKING	Background and Methodology: A low ankle-to-brachial index (ABI) is a strong correlate of cardiovascular disease and subsequent mortality. The relationship between ABI and alcohol consumption remains unclear. Data are from the Cardiovascular Risk Survey (CRS), a multiple-ethnic, community-based, cross-sectional study of 14 618 Chinese people (5 757 Hans, 4 767 Uygurs, and 4 094 Kazakhs) aged 35 years and over at baseline from Oct. 2007 to March 2010. The relationship between alcohol intake and ABI was determined by use of analysis of covariance and multivariable regressions. Principal Findings: In men, alcohol consumption was significantly associated with ABI (P<0.001). After adjusted for the confounding factors, such as age, sex, ethnicity, body mass index, smoking, work stress, diabetes, and fasting blood glucose, the difference remained significant (P<0.001); either the unadjusted or multivariate-adjusted odds ratio (OR) for peripheral artery disease (PAD) was significantly higher in men who consumed >60.0 g/d [OR = 3.857, (95% CI: 2.555-5.824); OR = 2.797, (95% CI: 1.106-3.129); OR = 2.878, (95% CI: 1.215-4.018); respectively] and was significantly lower in men who consumed 20.1-40.0 g/d [OR = 0.330, (95% CI: 0.181-0.599); OR = 0.484, (95% CI: 0.065-0.894); OR = 0.478, (95% CI: 0.243-1.534); respectively] and 40.1-60.0 g/d [OR = 0.306, (95% CI: 0.096-0.969); OR = 0.267, (95% CI: 0.087-0.886); OR = 0.203, (95% CI: 0.113-0.754); respectively] compared with never drinking, respectively (all P<0.01). Neither in unadjusted nor in multivariate-adjusted model was the association between ABI and alcohol consumption significant (all P>0.05) in women. Similarly, PAD was not correlated with alcohol intake in women (all P>0.05). Conclusions/Significance: Our results indicated that in Chinese men, alcohol consumption was associated with peripheral artery disease, and consumption of less than 60 g/d had an inverse association with peripheral atherosclerosis whereas consumption of 60 g/d or more had a positive association.	[Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Huang, Ding; Fu, Zhen-Yan; Ma, Xiang; Huang, Ying] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Liu, Fen; Fu, Zhen-Yan; Ma, Xiang; Chen, Bang-Dang] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Xie, X (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		Great Technology Special Item Foundation of Xinjiang, China [200733146-3]	Great Technology Special Item Foundation of Xinjiang, China	This work was supported financially by grants from the Great Technology Special Item Foundation of Xinjiang, China(200733146-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 2009, VASC MED, V14, P215, DOI 10.1177/1358863X08101999; [Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1; Chalmers J, 1999, J HYPERTENS, V17, P151; Conte MS, 2008, CIRCULATION, V117, P717, DOI 10.1161/CIRCULATIONAHA.107.754598; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Damiani IT, 2004, ARQ NEURO-PSIQUIAT, V62, P1022, DOI 10.1590/S0004-282X2004000600017; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Djousse L, 2002, STROKE, V33, P1357, DOI 10.1161/01.STR.0000014325.54063.1A; Doobay AV, 2005, ARTERIOSCL THROM VAS, V25, P1463, DOI 10.1161/01.ATV.0000168911.78624.b7; DOOBAY AV, 2005, ARTERIOSCLER THROMB, V25, P1; Eagon PK, 2010, WORLD J GASTROENTERO, V16, P1377, DOI 10.3748/wjg.v16.i11.1377; Fabsitz RR, 1999, AM J EPIDEMIOL, V149, P330; Fagrell B, 1999, J INTERN MED, V246, P331, DOI 10.1046/j.1365-2796.1999.00576.x; Greenland P, 2000, CIRCULATION, V101, P723; JEPSON RG, 1995, EUR J EPIDEMIOL, V11, P9, DOI 10.1007/BF01719940; JUONALA M, 2008, ATHEROSCLEROSIS, V204, pE93; Kauhanen J, 1999, ARTERIOSCL THROM VAS, V19, P3001, DOI 10.1161/01.ATV.19.12.3001; Kobayashi K, 2004, ATHEROSCLEROSIS, V173, P13, DOI 10.1016/j.atherosclerosis.2003.10.013; Laurin D, 2007, CIRCULATION, V116, P2269, DOI 10.1161/CIRCULATIONAHA.106.686477; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Migliacci R, 2008, FAM PRACT, V25, P228, DOI 10.1093/fampra/cmn035; Mukamal KJ, 2008, AM J EPIDEMIOL, V167, P34, DOI 10.1093/aje/kwm274; Mukamal KJ, 2003, ARTERIOSCL THROM VAS, V23, P2252, DOI 10.1161/01.ATV.0000101183.58453.39; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Nunez D, 2010, REV ESP CARDIOL, V63, P54, DOI 10.1016/S0300-8932(10)70009-9; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Ohnishi H, 2003, DIABETES CARE, V26, P437, DOI 10.2337/diacare.26.2.437; Olsen TS, 2010, GENDER MED, V7, P284, DOI 10.1016/j.genm.2010.08.001; Sacanella E, 2003, ADDICT BIOL, V8, P371, DOI 10.1080/13556210310001656376; Schminke U, 2005, STROKE, V36, P1746, DOI 10.1161/01.STR.0000173159.65228.68; Smith S C Jr, 2000, Circulation, V101, P111; Traish AM, 2011, ATHEROSCLEROSIS, V214, P244, DOI 10.1016/j.atherosclerosis.2010.08.078; Vliegenthart R, 2002, AM J EPIDEMIOL, V155, P332, DOI 10.1093/aje/155.4.332; Wallerath T, 2003, J AM COLL CARDIOL, V41, P471, DOI 10.1016/S0735-1097(02)02826-7; Wild SH, 2006, DIABETES CARE, V29, P637, DOI 10.2337/diacare.29.03.06.dc05-1637; Xie X, 2009, CLIN APPL THROMB-HEM, V15, P574, DOI 10.1177/1076029608329581; Xie X, 2009, CLIN CHEM LAB MED, V47, P347, DOI 10.1515/CCLM.2009.078; Yang YN, 2010, CLIN APPL THROMB-HEM, V16, P579, DOI 10.1177/1076029610364522; Zheng ZJ, 1997, ATHEROSCLEROSIS, V131, P115, DOI 10.1016/S0021-9150(97)06089-9; Zureik M, 2004, STROKE, V35, P2770, DOI 10.1161/01.STR.0000147968.48379.c3	43	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15181	10.1371/journal.pone.0015181	http://dx.doi.org/10.1371/journal.pone.0015181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152041	gold, Green Published, Green Submitted			2022-12-27	WOS:000284868000031
J	Kama, A; Tannenbaum, E				Kama, Amit; Tannenbaum, Emmanuel			Effect of the SOS Response on the Mean Fitness of Unicellular Populations: A Quasispecies Approach	PLOS ONE			English	Article							LANDSCAPES; MUTATION; GENOMES	The goal of this paper is to develop a mathematical model that analyzes the selective advantage of the SOS response in unicellular organisms. To this end, this paper develops a quasispecies model that incorporates the SOS response. We consider a unicellular, asexually replicating population of organisms, whose genomes consist of a single, double-stranded DNA molecule, i.e. one chromosome. We assume that repair of post-replication mismatched base-pairs occurs with probability lambda, and that the SOS response is triggered when the total number of mismatched base-pairs is at least l(S). We further assume that the per-mismatch SOS elimination rate is characterized by a first-order rate constant kappa(SOS). For a single fitness peak landscape where the master genome can sustain up to l mismatches and remain viable, this model is analytically solvable in the limit of infinite sequence length. The results, which are confirmed by stochastic simulations, indicate that the SOS response does indeed confer a fitness advantage to a population, provided that it is only activated when DNA damage is so extensive that a cell will die if it does not attempt to repair its DNA.	[Kama, Amit; Tannenbaum, Emmanuel] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel	Ben Gurion University	Tannenbaum, E (corresponding author), Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel.	emanuelt@bgu.ac.il			Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by an Alon Fellowship, Israel Science Foundation (http://www.isf.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash R.B., 1990, INFORM THEORY; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Brumer Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061909; Brumer Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061912; Bull JJ, 2005, PLOS COMPUT BIOL, V1, P450, DOI 10.1371/journal.pcbi.0010061; Kessler DA, 1998, PHYS REV LETT, V80, P2012, DOI 10.1103/PhysRevLett.80.2012; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Nilsson M, 2000, PHYS REV LETT, V84, P191, DOI 10.1103/PhysRevLett.84.191; Sasaki A, 2003, J THEOR BIOL, V224, P241, DOI 10.1016/S0022-5193(03)00161-9; Tannenbaum E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061915; Tannenbaum E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138105; Tannenbaum E, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061916; Tannenbaum E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021903; Tannenbaum E, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011902; Tannenbaum E, 2005, PHYS LIFE REV, V2, P290, DOI 10.1016/j.plrev.2005.08.001; Tannenbaum E, 2006, J THEOR BIOL, V241, P791, DOI 10.1016/j.jtbi.2006.01.016; Voet D., 2005, BIOCHEMISTRY-US; Wilke CO, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-44	19	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14113	10.1371/journal.pone.0014113	http://dx.doi.org/10.1371/journal.pone.0014113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152423	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100005
J	Berenguer, M; Martinez, L; Giorgetti-Peraldi, S; Le Marchand-Brustel, Y; Govers, R				Berenguer, Marion; Martinez, Laurene; Giorgetti-Peraldi, Sophie; Le Marchand-Brustel, Yannick; Govers, Roland			A Serum Factor Induces Insulin-Independent Translocation of GLUT4 to the Cell Surface which Is Maintained in Insulin Resistance	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; GLUCOSE-TRANSPORTER GLUT4; TYROSINE KINASE-ACTIVITY; 3T3-L1 ADIPOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; SIGNALING PATHWAYS; MUSCLE-CELLS; TNF-ALPHA; C-LAMBDA	In response to insulin, glucose transporter GLUT4 translocates from intracellular compartments towards the plasma membrane where it enhances cellular glucose uptake. Here, we show that sera from various species contain a factor that dose-dependently induces GLUT4 translocation and glucose uptake in 3T3-L1 adipocytes, human adipocytes, myoblasts and myotubes. Notably, the effect of this factor on GLUT4 is fully maintained in insulin-resistant cells. Our studies demonstrate that the serum-induced increase in cell surface GLUT4 levels is not due to inhibition of its internalization and is not mediated by insulin, PDGF, IGF-1, or HGF. Similarly to insulin, serum also augments cell surface levels of GLUT1 and TfR. Remarkably, the acute effect of serum on GLUT4 is largely additive to that of insulin, while it also sensitizes the cells to insulin. In accordance with these findings, serum does not appear to activate the same repertoire of downstream signaling molecules that are implicated in insulin-induced GLUT4 translocation. We conclude that in addition to insulin, at least one other biological proteinaceous factor exists that contributes to GLUT4 regulation and still functions in insulin resistance. The challenge now is to identify this factor.	[Berenguer, Marion; Martinez, Laurene; Le Marchand-Brustel, Yannick; Govers, Roland] Fac Med Nice, INSERM, U895, Mediterranean Res Ctr Mol Med C3M,Avenir Team 9, F-06034 Nice, France; [Giorgetti-Peraldi, Sophie; Le Marchand-Brustel, Yannick] Fac Med Nice, INSERM, U895, Mediterranean Res Ctr Mol Med C3M,Team 7, F-06034 Nice, France; [Berenguer, Marion; Martinez, Laurene; Giorgetti-Peraldi, Sophie; Le Marchand-Brustel, Yannick; Govers, Roland] Univ Nice Sophia Antipolis, Fac Med Signaling & Pathol IFR50, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Berenguer, M (corresponding author), Fac Med Nice, INSERM, U895, Mediterranean Res Ctr Mol Med C3M,Avenir Team 9, U210, F-06034 Nice, France.	govers@unice.fr	Govers, Roland/O-5782-2016	Govers, Roland/0000-0003-1359-5333; Giorgetti-Peraldi, Sophie/0000-0002-2751-2618	Institut National de la Sante et de la Recherche Medicale (INSERM); University of Nice-Sophia-Antipolis; Conseil Regional Provence-Alpes-Cote d'Azur; Conseil General des Alpes Maritimes; Alfediam-Roche Diagnostics award; INSERM/Region Provence-Alpes-Cote d'Azur/Servier	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Nice-Sophia-Antipolis; Conseil Regional Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'AzurRegion Auvergne-Rhone-Alpes); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Alfediam-Roche Diagnostics award; INSERM/Region Provence-Alpes-Cote d'Azur/Servier(Institut National de la Sante et de la Recherche Medicale (Inserm)ServierRegion Provence-Alpes-Cote d'Azur)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the University of Nice-Sophia-Antipolis, the Conseil Regional Provence-Alpes-Cote d'Azur, the Conseil General des Alpes Maritimes, and an Alfediam-Roche Diagnostics award. RG is a recipient of an INSERM Avenir grant and LM is supported by an INSERM/Region Provence-Alpes-Cote d'Azur/Servier grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2003, BIOCHEM BIOPH RES CO, V307, P127, DOI 10.1016/S0006-291X(03)01124-0; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bertola A, 2007, J BIOL CHEM, V282, P10325, DOI 10.1074/jbc.M611770200; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chen GL, 2003, FEBS LETT, V534, P54, DOI 10.1016/S0014-5793(02)03774-2; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Foran PGP, 1999, J BIOL CHEM, V274, P28087, DOI 10.1074/jbc.274.40.28087; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; FROESCH ER, 1963, J CLIN INVEST, V42, P1816, DOI 10.1172/JCI104866; Funaki M, 2004, MOL CELL BIOL, V24, P7567, DOI 10.1128/MCB.24.17.7567-7577.2004; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Govers Roland, 2008, V440, P129, DOI 10.1007/978-1-59745-178-9_10; Hausdorff SF, 1999, J BIOL CHEM, V274, P24677, DOI 10.1074/jbc.274.35.24677; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Johnson AO, 1998, J BIOL CHEM, V273, P17968, DOI 10.1074/jbc.273.28.17968; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; Kayali AG, 1998, J BIOL CHEM, V273, P13808, DOI 10.1074/jbc.273.22.13808; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Maier VH, 2000, DIABETOLOGIA, V43, P1273, DOI 10.1007/s001250051523; Manchem VP, 2001, DIABETES, V50, P824, DOI 10.2337/diabetes.50.4.824; Martinez L, 2010, BIOCHEM PHARMACOL, V79, P1300, DOI 10.1016/j.bcp.2009.12.013; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NISHIMURA H, 1994, BIOCHEM J, V302, P271, DOI 10.1042/bj3020271; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1427, DOI 10.1210/en.138.4.1427; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Ricort JM, 1996, EUR J BIOCHEM, V239, P17, DOI 10.1111/j.1432-1033.1996.0017u.x; RINDERKNECHT E, 1976, P NATL ACAD SCI USA, V73, P4379, DOI 10.1073/pnas.73.12.4379; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; SATOH S, 1993, J BIOL CHEM, V268, P17820; SEPPLORENZINO L, 1995, J BIOL CHEM, V270, P16580, DOI 10.1074/jbc.270.28.16580; Somwar R, 2001, BIOCHEM J, V359, P639, DOI 10.1042/0264-6021:3590639; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Tsiani E, 1998, DIABETES, V47, P1676, DOI 10.2337/diabetes.47.11.1676; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15560	10.1371/journal.pone.0015560	http://dx.doi.org/10.1371/journal.pone.0015560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187969	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200040
J	Van Hook, MJ; Berson, DM				Van Hook, Matthew J.; Berson, David M.			Hyperpolarization-Activated Current (I-h) in Ganglion-Cell Photoreceptors	PLOS ONE			English	Article							PACEMAKER CHANNELS; CATION CURRENT; MELANOPSIN CELLS; CAMP MODULATION; LIGHT RESPONSE; CALCIUM INFLUX; BIPOLAR CELLS; HCN CHANNELS; NEURONS; ROD	Intrinsically photosensitive retinal ganglion cells (ipRGCs) express the photopigment melanopsin and serve as the primary retinal drivers of non-image-forming visual functions such as circadian photoentrainment, the pupillary light reflex, and suppression of melatonin production in the pineal. Past electrophysiological studies of these cells have focused on their intrinsic photosensitivity and synaptic inputs. Much less is known about their voltage-gated channels and how these might shape their output to non-image-forming visual centers. Here, we show that rat ipRGCs retrolabeled from the suprachiasmatic nucleus (SCN) express a hyperpolarization-activated inwardly-rectifying current (I-h). This current is blocked by the known I-h blockers ZD7288 and extracellular cesium. As in other systems, including other retinal ganglion cells, I-h in ipRGCs is characterized by slow kinetics and a slightly greater permeability for K+ than for Na+. Unlike in other systems, however, I-h in ipRGCs apparently does not actively contribute to resting membrane potential. We also explore non-specific effects of the common I-h blocker ZD7288 on rebound depolarization and evoked spiking and discuss possible functional roles of I-h in non-image-forming vision. This study is the first to characterize I-h in a well-defined population of retinal ganglion cells, namely SCN-projecting ipRGCs.	[Van Hook, Matthew J.; Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Van Hook, MJ (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	matthew_van_hook@brown.edu		Van Hook, Matthew/0000-0003-1615-4314	National Institutes of Health [R01 EY 12793, R01 EY 17137]; Brown University [1 T32 NS 062443-01]; NATIONAL EYE INSTITUTE [R01EY017137, R01EY012793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS062443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants R01 EY 12793 (DMB), R01 EY 17137 (DMB). MJVH was supported by a Jointly Sponsored Institutional Training Grant 1 T32 NS 062443-01 (Brown University Neuroscience Graduate Program). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akopian A, 1996, J NEUROPHYSIOL, V76, P1828, DOI 10.1152/jn.1996.76.3.1828; Arendt D, 2003, INT J DEV BIOL, V47, P563; ATTWELL D, 1980, J PHYSIOL-LONDON, V309, P287, DOI 10.1113/jphysiol.1980.sp013509; BADER CR, 1979, J PHYSIOL-LONDON, V296, P1; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cangiano L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001327; Chen L, 2007, NEUROSCIENCE, V150, P299, DOI 10.1016/j.neuroscience.2007.09.015; Demontis GC, 1999, J PHYSIOL-LONDON, V515, P813, DOI 10.1111/j.1469-7793.1999.813ab.x; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Endo T, 2008, J NEUROPHYSIOL, V99, P2066, DOI 10.1152/jn.00556.2007; ENG DL, 1990, J PHYSIOL-LONDON, V421, P185, DOI 10.1113/jphysiol.1990.sp017940; FAIN GL, 1978, NATURE, V272, P467, DOI 10.1038/272467a0; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hardie RC, 2001, J EXP BIOL, V204, P3403; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hogan QH, 2008, BRAIN RES, V1207, P102, DOI 10.1016/j.brainres.2008.02.066; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Koizumi A, 2004, MOL VIS, V10, P328; Lee SC, 2007, J NEUROPHYSIOL, V97, P3790, DOI 10.1152/jn.01241.2006; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Meuth SG, 2006, J NEUROPHYSIOL, V96, P1517, DOI 10.1152/jn.01212.2005; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mitra P, 2007, VISUAL NEUROSCI, V24, P709, DOI 10.1017/S0952523807070654; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Oi H, 2008, VISUAL NEUROSCI, V25, P95, DOI 10.1017/S095252380808005X; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Perez-Leon JA, 2006, EUR J NEUROSCI, V24, P1117, DOI 10.1111/j.1460-9568.2006.04999.x; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; Sanchez-Alonso JL, 2008, NEUROSCI LETT, V439, P275, DOI 10.1016/j.neulet.2008.05.016; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Tabata T, 1996, J NEUROPHYSIOL, V75, P1932, DOI 10.1152/jn.1996.75.5.1932; van Welie I, 2006, J PHYSIOL-LONDON, V576, P203, DOI 10.1113/jphysiol.2006.113944; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005	72	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15344	10.1371/journal.pone.0015344	http://dx.doi.org/10.1371/journal.pone.0015344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187958	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200038
J	Cvetkovic-Lopes, V; Eggermann, E; Uschakov, A; Grivel, J; Bayer, L; Jones, BE; Serafin, M; Muhlethaler, M				Cvetkovic-Lopes, Vesna; Eggermann, Emmanuel; Uschakov, Aaron; Grivel, Jeremy; Bayer, Laurence; Jones, Barbara E.; Serafin, Mauro; Muehlethaler, Michel			Rat Hypocretin/Orexin Neurons Are Maintained in a Depolarized State by TRPC Channels	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; CATION CHANNEL; CALCIUM INFLUX; SLEEP; OREXIN; ACTIVATION; BRAIN; OREXIN/HYPOCRETIN; HYPOTHALAMUS; INNERVATION	In a previous study we proposed that the depolarized state of the wake-promoting hypocretin/orexin (hcrt/orx) neurons was independent of synaptic inputs as it persisted in tetrodotoxin and low calcium/high magnesium solutions. Here we show first that these cells are hyperpolarized when external sodium is lowered, suggesting that non-selective cation channels (NSCCs) could be involved. As canonical transient receptor channels (TRPCs) are known to form NSCCs, we looked for TRPCs subunits using single-cell RT-PCR and found that TRPC6 mRNA was detectable in a small minority, TRPC1, TRPC3 and TRPC7 in a majority and TRPC4 and 5 in the vast majority (similar to 90%) of hcrt/orx neurons. Using intracellular applications of TRPC antibodies against subunits known to form NSCCs, we then found that only TRPC5 antibodies elicited an outward current, together with hyperpolarization and inhibition of the cells. These effects were blocked by co-application of a TRPC5 antigen peptide. Voltage-clamp ramps in the presence or absence of TRPC5 antibodies indicated the presence of a current with a reversal potential close to -15 mV. Application of the non-selective TRPC channel blocker, flufenamic acid, had a similar effect, which could be occluded in cells pre-loaded with TRPC5 antibodies. Finally, using the same TRPC5 antibodies we found that most hcrt/orx cells show immunostaining for the TRPC5 subunit. These results suggest that hcrt/orx neurons are endowed with a constitutively active non-selective cation current which depends on TRPC channels containing the TRPC5 subunit and which is responsible for the depolarized and active state of these cells.	[Cvetkovic-Lopes, Vesna; Eggermann, Emmanuel; Uschakov, Aaron; Grivel, Jeremy; Bayer, Laurence; Serafin, Mauro; Muehlethaler, Michel] Ctr Med Univ Geneva, Dept Neurosci Fondamentales, Geneva, Switzerland; [Jones, Barbara E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	University of Geneva; McGill University	Cvetkovic-Lopes, V (corresponding author), Ctr Med Univ Geneva, Dept Neurosci Fondamentales, Geneva, Switzerland.	michel.muhlethaler@unige.ch	Jones, Barbara E/A-8033-2017	BAYER, Laurence/0000-0001-5374-3316	Swiss Fonds National [31003A_120726]	Swiss Fonds National	Supported by grant (31003A_120726) from the Swiss Fonds National to M. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Alam MN, 2005, J PHYSIOL-LONDON, V563, P569, DOI 10.1113/jphysiol.2004.076927; Albert AP, 2006, J PHYSIOL-LONDON, V571, P361, DOI 10.1113/jphysiol.2005.102780; Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Beck B, 2008, CELL CALCIUM, V43, P492, DOI 10.1016/j.ceca.2007.08.005; Brown RE, 2001, NEUROPHARMACOLOGY, V40, P457, DOI 10.1016/S0028-3908(00)00178-7; Burlet S, 2002, J NEUROSCI, V22, P2862, DOI 10.1523/JNEUROSCI.22-07-02862.2002; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; de Lecea L, 2005, FEBS J, V272, P5675, DOI 10.1111/j.1742-4658.2005.04981.x; Eggermann E, 2003, J NEUROSCI, V23, P1557; Faber ESL, 2006, NEUROSCIENCE, V137, P781, DOI 10.1016/j.neuroscience.2005.09.027; Facemire CS, 2004, AM J PHYSIOL-RENAL, V286, pF546, DOI 10.1152/ajprenal.00338.2003; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Henny P, 2006, J COMP NEUROL, V499, P645, DOI 10.1002/cne.21131; Horvath TL, 1999, J COMP NEUROL, V415, P145; Jones BE, 2005, HYPOCRETINS: INTEGRATORS OF PHYSIOLOGICAL FUNCTIONS, P289; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Modirrousta M, 2005, EUR J NEUROSCI, V21, P2807, DOI 10.1111/j.1460-9568.2005.04104.x; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Pena F, 2008, MINI-REV MED CHEM, V8, P812, DOI 10.2174/138955708784912166; Peyron C, 1998, J NEUROSCI, V18, P9996; Piccolino M, 1996, TRENDS NEUROSCI, V19, P120, DOI 10.1016/S0166-2236(96)80017-8; Pizzo P, 2001, J NEUROCHEM, V79, P98, DOI 10.1046/j.1471-4159.2001.00539.x; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saleh SN, 2008, J PHYSIOL-LONDON, V586, P2463, DOI 10.1113/jphysiol.2008.152157; Sergeeva OA, 2003, J NEUROCHEM, V85, P1547, DOI 10.1046/j.1471-4159.2003.01806.x; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Suntsova N, 2007, J NEUROSCI, V27, P1616, DOI 10.1523/JNEUROSCI.3498-06.2007; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Wu GS, 2007, J NEUROSCI, V27, P7447, DOI 10.1523/JNEUROSCI.4266-06.2007; Wu XY, 2002, J BIOL CHEM, V277, P13597, DOI 10.1074/jbc.M110881200; Yan HD, 2009, J NEUROSCI, V29, P10038, DOI 10.1523/JNEUROSCI.1042-09.2009; Zeitzer JM, 2006, TRENDS PHARMACOL SCI, V27, P368, DOI 10.1016/j.tips.2006.05.006; Zhou FW, 2008, J NEUROSCI, V28, P473, DOI 10.1523/JNEUROSCI.3978-07.2008	45	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15673	10.1371/journal.pone.0015673	http://dx.doi.org/10.1371/journal.pone.0015673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179559	gold, Green Submitted, Green Published			2022-12-27	WOS:000285381200035
J	Boyles, RS; Lantz, KM; Poertner, S; Georges, SJ; Andres, AJ				Boyles, Randy S.; Lantz, Kathryn M.; Poertner, Steven; Georges, Stephanie J.; Andres, Andrew J.			Presenilin Controls CBP Levels in the Adult Drosophila Central Nervous System	PLOS ONE			English	Article							LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; NOTCH; CREB; TRANSCRIPTION; ACTIVATION; HYPOTHESIS; GROWTH; GENES	Background: Dominant mutations in both human Presenilin (Psn) genes have been correlated with the formation of amyloid plaques and development of familial early-onset Alzheimer's disease (AD). However, a definitive mechanism whereby plaque formation causes the pathology of familial and sporadic forms of AD has remained elusive. Recent discoveries of several substrates for Psn protease activity have sparked alternative hypotheses for the pathophysiology underlying AD. CBP (CREB-binding protein) is a haplo-insufficient transcriptional co-activator with histone acetly-transferase (HAT) activity that has been proposed to be a downstream target of Psn signaling. Individuals with altered CBP have cognitive deficits that have been linked to several neurological disorders. Methodology/Principal Findings: Using a transgenic RNA-interference strategy to selectively silence CBP, Psn, and Notch in adult Drosophila, we provide evidence for the first time that Psn is required for normal CBP levels and for maintaining specific global acetylations at lysine 8 of histone 4 (H4K8ac) in the central nervous system (CNS). In addition, flies conditionally compromised for the adult-expression of CBP display an altered geotaxis behavior that may reflect a neurological defect. Conclusions/Significance: Our data support a model in which Psn regulates CBP levels in the adult fly brain in a manner that is independent of Notch signaling. Although we do not understand the molecular mechanism underlying the association between Psn and CBP, our results underscore the need to learn more about the basic relationship between Psn-regulated substrates and essential functions of the nervous system.	[Boyles, Randy S.; Lantz, Kathryn M.; Poertner, Steven; Georges, Stephanie J.; Andres, Andrew J.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Boyles, RS (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	andrew.andres@unlv.edu			National Institutes of Health: Nevada INBRE [P20RR16464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	National Institutes of Health: Nevada INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	National Institutes of Health: Nevada INBRE: P20RR16464. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NE, 1998, MECH DEVELOP, V74, P3, DOI 10.1016/S0925-4773(98)00054-9; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cheng CS, 2008, GENE DEV, V22, P1110, DOI 10.1101/gad.1677008; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; deCelis JF, 1996, DEVELOPMENT, V122, P359; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; ERLENMEYER L, 1961, SCIENCE, V134, P1068, DOI 10.1126/science.134.3485.1068; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Goodman RH, 2000, GENE DEV, V14, P1553; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; HEITZLER P, 1993, DEVELOPMENT, V117, P1113; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kumar JP, 2004, GENETICS, V168, P877, DOI 10.1534/genetics.104.029850; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Ludlam WH, 2002, MOL CELL BIOL, V22, P3832, DOI 10.1128/MCB.22.11.3832-3841.2002; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Presente A, 2002, GENESIS, V34, P165, DOI 10.1002/gene.10149; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; RUBINSTEIN JH, 1963, AM J DIS CHILD, V105, P588, DOI 10.1001/archpedi.1963.02080040590010; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Vaskova M, 2000, GENETICS, V156, P229; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922; Wulbeck Corinna, 2007, Methods Mol Biol, V362, P495	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14332	10.1371/journal.pone.0014332	http://dx.doi.org/10.1371/journal.pone.0014332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179466	Green Submitted, gold, Green Published			2022-12-27	WOS:000285292500010
J	Brazelle, W; Kreahling, JM; Gemmer, J; Ma, YH; Cress, WD; Haura, E; Altiok, S				Brazelle, William; Kreahling, Jenny M.; Gemmer, Jennifer; Ma, Yihong; Cress, W. Douglas; Haura, Eric; Altiok, Soner			Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							PHASE-I; CHK1; P53; ACTIVATION; AGENTS; LINES; PHOSPHORYLATION; UCN-01; VIVO; RAS	Background: Histone deacetylase inhibitors (HDACis) are promising anticancer drugs; however, the molecular mechanisms leading to HDACi-induced cell death have not been well understood and no clear mechanism of resistance has been elucidated to explain limited efficacy of HDACis in clinical trials. Methods and Findings: Here, we show that protein levels of checkpoint kinase 1 (Chk1), which has a major role in G(2) cell cycle checkpoint regulation, was markedly reduced at the protein and transcriptional levels in lung cancer cells treated with pan-and selective HDACis LBH589, scriptaid, valproic acid, apicidin, and MS-275. In HDACi treated cells Chk1 function was impaired as determined by decreased inhibitory phosphorylation of cdc25c and its downstream target cdc2 and increased expression of cdc25A and phosphorylated histone H3, a marker of mitotic entry. In time course experiments, Chk1 downregulation occurred after HDACi treatment, preceding apoptosis. Ectopic expression of Chk1 overcame HDACi-induced cell death, and pretreating cells with the cdc2 inhibitor purvalanol A blocked entry into mitosis and prevented cell death by HDACis. Finally, pharmacological inhibition of Chk1 showed strong synergistic effect with LBH589 in lung cancer cells. Conclusions: These results define a pathway through which Chk1 inhibition can mediate HDACi-induced mitotic entry and cell death and suggest that Chk1 could be an early pharmacodynamic marker to assess HDACi efficacy in clinical samples.	[Brazelle, William; Kreahling, Jenny M.; Gemmer, Jennifer; Ma, Yihong; Cress, W. Douglas; Haura, Eric; Altiok, Soner] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol & Expt Therapeut Programs, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Brazelle, W (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol & Expt Therapeut Programs, Tampa, FL 33612 USA.	soner.altiok@moffitt.org			Moffitt Cancer Center	Moffitt Cancer Center	work was funded in part by the Moffitt Cancer Center SPORE grant in lung cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell S, 2008, EXPERT OPIN INV DRUG, V17, P1331, DOI [10.1517/13543784.17.9.1331, 10.1517/13543784.17.9.1331 ]; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Dees EC, 2005, CLIN CANCER RES, V11, P664; Deroanne CF, 2002, ONCOGENE, V21, P427, DOI 10.1038/sj.onc.1205108; Edwards A, 2007, MOL CANCER THER, V6, P2515, DOI 10.1158/1535-7163.MCT-06-0761; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Feng JM, 2008, CANCER BIOL THER, V7, P1726, DOI 10.4161/cbt.7.11.6728; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; KASHII T, 1994, J CANCER RES CLIN, V120, P143, DOI 10.1007/BF01202192; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Noh EL, 2009, BIOCHEM BIOPH RES CO, V378, P326, DOI 10.1016/j.bbrc.2008.11.057; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Qiu L, 1999, BRIT J CANCER, V80, P1252, DOI 10.1038/sj.bjc.6690493; Robbins AR, 2005, CELL CYCLE, V4, P717, DOI 10.4161/cc.4.5.1690; Rubio-Viqueira B, 2007, MOL CANCER THER, V6, P515, DOI 10.1158/1535-7163.MCT-06-0388; Sausville EA, 2001, J CLIN ONCOL, V19, P2319, DOI 10.1200/JCO.2001.19.8.2319; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Warrener R, 2003, FASEB J, V17, P1550, DOI 10.1096/fj.02-1003fje; Yu XD, 2002, J NATL CANCER I, V94, P504; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	40	59	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14335	10.1371/journal.pone.0014335	http://dx.doi.org/10.1371/journal.pone.0014335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179472	Green Published, gold, Green Submitted			2022-12-27	WOS:000285292500012
J	Beitelshees, AL; Johnson, JA; Hames, ML; Gong, Y; Cooper-DeHoff, RM; Wu, J; Cresci, S; Ma, CX; Pepine, CJ; Province, MA; Spertus, JA; McLeod, HL				Beitelshees, Amber L.; Johnson, Julie A.; Hames, Megan L.; Gong, Yan; Cooper-DeHoff, Rhonda M.; Wu, Jun; Cresci, Sharon; Ma, Cynthia X.; Pepine, Carl J.; Province, Michael A.; Spertus, John A.; McLeod, Howard L.			Aromatase Gene Polymorphisms Are Associated with Survival among Patients with Cardiovascular Disease in a Sex-Specific Manner	PLOS ONE			English	Article							ACUTE-CORONARY-SYNDROME; ESTROGEN-RELATED GENES; GENDER-DIFFERENCES; BLOOD-PRESSURE; OUTCOMES; EXPRESSION; TESTOSTERONE; EVOLUTION; GENOTYPE; HORMONES	Introduction: CYP19A1 encodes aromatase, the enzyme responsible for the conversion of androgens to estrogens, and may play a role in variation in outcomes among men and women with cardiovascular disease. We sought to examine genetic variation in CYP19A1 for its potential role in sex differences in cardiovascular disease outcomes. Methods: Caucasian individuals from two independent populations were assessed: 1) a prospective cohort of patients with acute coronary syndromes with 3-year mortality follow-up (n = 568) and 2) a nested case-control study from a randomized, controlled trial of hypertension patients with stable coronary disease in which the primary outcome was death, nonfatal myocardial infarction (MI) or nonfatal stroke (n = 619). Six CYP19A1 SNPs were genotyped (-81371 C>T, -45965 G>C, M201T, R264C, 80 A>G, and + 32226 G>A). The sex*genotype interaction term was assessed for the primary outcome and compared by genotype in men and women when a significant interaction term was identified. Results: We identified a significant interaction between -81371 C>T and sex (p = 0.025) in the ACS population. The variant allele was associated with a 78% increase in mortality in men (HR 1.78, 95% confidence interval [CI] 1.08-2.94) and a nonsignificant 42% decrease in mortality among women (HR 0.58, 95% CI 0.22-1.54). We identified a similar association in the hypertensive CAD group, the -81371 C>T*sex interaction term was p<0.0001, with an associated 65% increase in death, MI, or stroke (HR 1.65, 95% CI 1.00-2.73) in men and a 69% decrease (HR 0.31, 95% CI 0.16-0.6) in women. Conclusions: Using two independent populations, this study is the first to document a significant interaction between CYP19A1 genotype and sex on cardiovascular outcomes. These findings could illuminate potential mechanisms of sex differences in cardiovascular disease outcomes.	[Beitelshees, Amber L.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Johnson, Julie A.; Hames, Megan L.; Gong, Yan; Cooper-DeHoff, Rhonda M.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA; [Johnson, Julie A.; Hames, Megan L.; Gong, Yan; Cooper-DeHoff, Rhonda M.] Univ Florida, Coll Pharm, Ctr Pharmacogenom, Gainesville, FL USA; [Wu, Jun; Province, Michael A.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO USA; [Cresci, Sharon] Washington Univ, Sch Med, Div Cardiovasc, St Louis, MO 63110 USA; [Cresci, Sharon] Washington Univ, Cardiovasc Res Ctr, Sch Med, St Louis, MO USA; [Ma, Cynthia X.; McLeod, Howard L.] Washington Univ, Div Oncol, Sch Med, St Louis, MO USA; [Pepine, Carl J.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL USA; [Spertus, John A.] Univ Missouri, Kansas City, MO 64110 USA; [Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA	University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of Florida; University of Missouri System; University of Missouri Kansas City; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute	Beitelshees, AL (corresponding author), Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	abeitels@medicine.umaryland.edu	Spertus, John/ABD-3075-2021; McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232	National Heart, Lung, and Blood Institute [HL091120, HL077113, HL074730]; National Institutes of Health [RR017568]; University of Florida; Abbott Laboratories; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017568] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL091120, P50HL077113, R01HL074730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida(University of Florida); Abbott Laboratories(Abbott Laboratories); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Heart, Lung, and Blood Institute: HL091120, HL077113 and HL074730; RR017568 from the National Institutes of Health, and grants from the University of Florida Opportunity Fund and Abbott Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beitelshees AL, 2007, PHARMACOGENET GENOM, V17, P719, DOI 10.1097/FPC.0b013e32810f2e3c; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Lanfear DE, 2005, JAMA-J AM MED ASSOC, V294, P1526, DOI 10.1001/jama.294.12.1526; Ma CX, 2005, CANCER RES, V65, P11071, DOI 10.1158/0008-5472.CAN-05-1218; Mehilli J, 2000, JAMA-J AM MED ASSOC, V284, P1799, DOI 10.1001/jama.284.14.1799; Pacanowski MA, 2008, CLIN PHARMACOL THER, V84, P715, DOI 10.1038/clpt.2008.139; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Peter I, 2005, J HYPERTENS, V23, P2193, DOI 10.1097/01.hjh.0000188728.66183.92; Peter I, 2008, J CLIN ENDOCR METAB, V93, P2779, DOI 10.1210/jc.2008-0106; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Ramirez-Lorca R, 2007, HYPERTENSION, V50, P884, DOI 10.1161/HYPERTENSIONAHA.107.096263; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Ren J, 2009, OBESITY, V17, P1114, DOI 10.1038/oby.2009.8; Shaw LJ, 2008, J CLIN ENDOCR METAB, V93, P1276, DOI 10.1210/jc.2007-0425; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105	18	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15180	10.1371/journal.pone.0015180	http://dx.doi.org/10.1371/journal.pone.0015180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170323	Green Published, gold			2022-12-27	WOS:000285181400021
J	Sefah, K; Meng, L; Lopez-Colon, D; Jimenez, E; Liu, C; Tan, WH				Sefah, Kwame; Meng, Ling; Lopez-Colon, Dalia; Jimenez, Elizabeth; Liu, Chen; Tan, Weihong			DNA Aptamers as Molecular Probes for Colorectal Cancer Study	PLOS ONE			English	Article							IN-VITRO SELECTION; RNA APTAMERS; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; FLOW-CYTOMETRY; LIVE CELLS; LIGANDS; RECOGNITION; VIRUS; LYMPHOMA	Background: Understanding the molecular features of specific tumors can increase our knowledge about the mechanism(s) underlying disease development and progression. This is particularly significant for colorectal cancer, which is a heterogeneous complex of diseases developed in a sequential manner through a multistep carcinogenic process. As such, it is likely that tumors with similar characteristics might originate in the same manner and have a similar molecular behavior. Therefore, specific mapping of the molecular features can be potentially useful for both tumor classification and the development of appropriate therapeutic regimens. However, this can only be accomplished by developing high-affinity molecular probes with the ability to recognize specific markers associated with different tumors. Aptamers can most easily meet this challenge based on their target diversity, flexible manipulation and ease of development. Methodology and Results: Using a method known as cell-based Systematic Evolution of Ligands by Exponential enrichment (cell-SELEX) and colorectal cancer cultured cell lines DLD-1 and HCT 116, we selected a panel of target-specific aptamers. Binding studies by flow cytometry and confocal microscopy showed that these aptamers have high affinity and selectivity. Our data further show that these aptamers neither recognize normal colon cells (cultured and fresh), nor do they recognize most other cancer cell lines tested. Conclusion/Significance: The selected aptamers can identify specific biomarkers associated with colorectal cancers. We believe that these probes could be further developed for early disease detection, as well as prognostic markers, of colorectal cancers.	[Sefah, Kwame; Meng, Ling; Lopez-Colon, Dalia; Jimenez, Elizabeth; Tan, Weihong] Univ Florida, Dept Chem, Dept Physiol & Funct Genom, Shands Canc Ctr,UF Genet Inst, Gainesville, FL 32611 USA; [Sefah, Kwame; Meng, Ling; Lopez-Colon, Dalia; Jimenez, Elizabeth; Tan, Weihong] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; [Liu, Chen] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Tan, Weihong] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Sefah, K (corresponding author), Univ Florida, Dept Chem, Dept Physiol & Funct Genom, Shands Canc Ctr,UF Genet Inst, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008; Jimenez, Elizabeth/GQB-5576-2022; Meng, Ling/B-4170-2012	Tan, Weihong/0000-0002-8066-1524; Jimenez, Elizabeth/0000-0001-7798-2194; 	NIH [R01 GM079359];  [NIH CA122648]; NATIONAL CANCER INSTITUTE [R21CA122648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079359] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was funded by the following: NIH:R01 GM079359: Development of Molecular Probes for Biomedical Applications; NIH CA122648, Enrichment and Detection of Exfoliated Cancer Cells. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2007, ANN ONCOL, V18, P77, DOI 10.1093/annonc/mdl336; Arber DA, 2000, J MOL DIAGN, V2, P178, DOI 10.1016/S1525-1578(10)60636-8; Bagg A, 1999, AM J CLIN PATHOL, V112, pS76; Bruno JG, 1999, BIOSENS BIOELECTRON, V14, P457, DOI 10.1016/S0956-5663(99)00028-7; Casado E, 2007, CLIN TRANSL ONCOL, V9, P549, DOI 10.1007/s12094-007-0102-8; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Davis KA, 1998, NUCLEIC ACIDS RES, V26, P3915, DOI 10.1093/nar/26.17.3915; Diederichsen ACP, 1998, APMIS, V106, P562, DOI 10.1111/j.1699-0463.1998.tb01385.x; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Faca V, 2007, BIOTECHNIQUES, V43, P279, DOI 10.2144/000112541; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Hamula CLA, 2008, ANAL CHEM, V80, P7812, DOI 10.1021/ac801272s; Hector S, 2009, BBA-REV CANCER, V1795, P117, DOI 10.1016/j.bbcan.2008.12.002; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Hofmann HP, 1997, RNA, V3, P1289; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; KIM HJ, 2008, BMB REPORTS, P685; Kim SY, 2007, CARCINOGENESIS, V28, P1387, DOI 10.1093/carcin/bgm086; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; KUBIK MF, 1994, NUCLEIC ACIDS RES, V22, P2619, DOI 10.1093/nar/22.13.2619; Kumar PKR, 1997, VIROLOGY, V237, P270, DOI 10.1006/viro.1997.8773; Lindblom A, 2001, CURR OPIN ONCOL, V13, P63, DOI 10.1097/00001622-200101000-00013; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Mallikaratchy P, 2006, CHEM COMMUN, P3229, DOI 10.1039/b604778e; Misono TS, 2005, ANAL BIOCHEM, V342, P312, DOI 10.1016/j.ab.2005.04.013; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; PAN WH, 1995, P NATL ACAD SCI USA, V92, P11509, DOI 10.1073/pnas.92.25.11509; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Rajendran M, 2008, ANAL BIOANAL CHEM, V390, P1067, DOI 10.1007/s00216-007-1735-8; Sefah K, 2009, LEUKEMIA, V23, P235, DOI 10.1038/leu.2008.335; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Tang ZW, 2009, CLIN CHEM, V55, P813, DOI 10.1373/clinchem.2008.113514; TUERK C, 1992, P NATL ACAD SCI USA, V89, P6988, DOI 10.1073/pnas.89.15.6988; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Umar A, 2004, DIS MARKERS, V20, P87, DOI 10.1155/2004/303016; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Wallace ST, 1998, RNA, V4, P112; Wang CL, 2003, J BIOTECHNOL, V102, P15, DOI 10.1016/S0168-1656(02)00360-7; Williams KP, 1997, P NATL ACAD SCI USA, V94, P11285, DOI 10.1073/pnas.94.21.11285	48	62	72	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14269	10.1371/journal.pone.0014269	http://dx.doi.org/10.1371/journal.pone.0014269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170319	Green Published, gold, Green Submitted			2022-12-27	WOS:000285181400003
J	Gong, P; Pirooznia, M; Guan, X; Perkins, EJ				Gong, Ping; Pirooznia, Mehdi; Guan, Xin; Perkins, Edward J.			Design, Validation and Annotation of Transcriptome-Wide Oligonucleotide Probes for the Oligochaete Annelid Eisenia fetida	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY ANALYSIS; LARGE GENOMES; EARTHWORM; DISCOVERY; CLONING; BIOMARKERS; RESPONSES; EXPOSURE; CADMIUM	High density oligonucleotide probe arrays have increasingly become an important tool in genomics studies. In organisms with incomplete genome sequence, one strategy for oligo probe design is to reduce the number of unique probes that target every non-redundant transcript through bioinformatic analysis and experimental testing. Here we adopted this strategy in making oligo probes for the earthworm Eisenia fetida, a species for which we have sequenced transcriptome-scale expressed sequence tags (ESTs). Our objectives were to identify unique transcripts as targets, to select an optimal and non-redundant oligo probe for each of these target ESTs, and to annotate the selected target sequences. We developed a streamlined and easy-to-follow approach to the design, validation and annotation of species-specific array probes. Four 244K-formatted oligo arrays were designed using eArray and were hybridized to a pooled E. fetida cRNA sample. We identified 63,541 probes with unsaturated signal intensities consistently above the background level. Target transcripts of these probes were annotated using several sequence alignment algorithms. Significant hits were obtained for 37,439 (59%) probed targets. We validated and made publicly available 63.5K oligo probes so the earthworm research community can use them to pursue ecological, toxicological, and other functional genomics questions. Our approach is efficient, cost-effective and robust because it (1) does not require a major genomics core facility; (2) allows new probes to be easily added and old probes modified or eliminated when new sequence information becomes available, (3) is not bioinformatics-intensive upfront but does provide opportunities for more in-depth annotation of biological functions for target genes; and (4) if desired, EST orthologs to the UniGene clusters of a reference genome can be identified and selected in order to improve the target gene specificity of designed probes. This approach is particularly applicable to organisms with a wealth of EST sequences but unfinished genome.	[Gong, Ping; Guan, Xin] SpecPro Inc, Environm Serv, Vicksburg, MS USA; [Pirooznia, Mehdi] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Perkins, Edward J.] USA, Army Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS USA	Johns Hopkins University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Gong, P (corresponding author), SpecPro Inc, Environm Serv, Vicksburg, MS USA.	Ping.Gong@usace.army.mil	Pirooznia, Mehdi/AAG-1878-2019	Pirooznia, Mehdi/0000-0002-4210-6458	U.S. Army Engineer Research and Development Center (ERDC)	U.S. Army Engineer Research and Development Center (ERDC)(United States Department of DefenseUnited States Army)	This work was supported by the U.S. Army Environmental Quality Technology Basic Research Program of U.S. Army Engineer Research and Development Center (ERDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SpecPro Inc. supported Ping Gong and Xin Guan through a contract granted by ERDC, and through this employment is considered by PLoS ONE to have played a role in the research. Permission to publish this information was granted by the Chief of Engineers.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Borup RHA, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-33; Brulle F, 2006, ENVIRON SCI TECHNOL, V40, P2844, DOI 10.1021/es052299x; Cerda J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-508; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Chou HH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-347; Chu W, 2005, BIOINFORMATICS, V21, P3385, DOI 10.1093/bioinformatics/bti526; Demuynck S, 2007, COMP BIOCHEM PHYS C, V145, P658, DOI 10.1016/j.cbpc.2007.03.001; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Edwards Clive A., 2004, P3; Ferraresso S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-580; Forrest MS, 2005, ENVIRON HEALTH PERSP, V113, P801, DOI 10.1289/ehp.7635; Gershon D, 2005, NATURE, V437, P1195, DOI 10.1038/4371195a; Gnerre S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r88; Gong P, 2007, ENVIRON SCI TECHNOL, V41, P8195, DOI 10.1021/es0716352; Gong P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S15; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jung KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003337; Lee MS, 2005, BIOCHEM BIOPH RES CO, V328, P1196, DOI 10.1016/j.bbrc.2005.01.079; Leparc GG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1001; Li Weizhong, 2009, V533, P289, DOI 10.1007/978-1-60327-136-3_14; Li Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013715; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Magness CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r60; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Myohara M, 2006, DEV DYNAM, V235, P2051, DOI 10.1002/dvdy.20849; Noh SJ, 2006, DNA RES, V13, P229, DOI 10.1093/dnares/dsl011; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Owen J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-266; Pariset L, 2009, NEW BIOTECHNOL, V25, P272, DOI 10.1016/j.nbt.2009.03.013; Pirooznia M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S7; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Reinecke Andriaan J., 2004, P299; Ricketts HJ, 2004, ECOTOX ENVIRON SAFE, V57, P4, DOI 10.1016/j.ecoenv.2003.08.008; Ruan YJ, 2004, TRENDS BIOTECHNOL, V22, P23, DOI 10.1016/j.tibtech.2003.11.002; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Shaffer C, 2007, NAT BIOTECHNOL, V25, P149, DOI 10.1038/nbt0207-149; Spurgeon DJ, 2005, ENVIRON POLLUT, V136, P443, DOI 10.1016/j.envpol.2005.01.013; Sturzenbaum SR, 2009, P ROY SOC B-BIOL SCI, V276, P789, DOI 10.1098/rspb.2008.1510; Sugimoto M, 2001, BIOSCI BIOTECH BIOCH, V65, P1575, DOI 10.1271/bbb.65.1575; Sundquist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000484; Svendsen C, 2008, ENVIRON SCI TECHNOL, V42, P4208, DOI 10.1021/es702745d; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wallace JC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-28; Yu CG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-52; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	54	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14266	10.1371/journal.pone.0014266	http://dx.doi.org/10.1371/journal.pone.0014266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170345	gold, Green Published			2022-12-27	WOS:000285084100016
J	Fu, Y; Springer, NM; Ying, K; Yeh, CT; Iniguez, AL; Richmond, T; Wu, W; Barbazuk, B; Nettleton, D; Jeddeloh, J; Schnable, PS				Fu, Yan; Springer, Nathan M.; Ying, Kai; Yeh, Cheng-Ting; Iniguez, A. Leonardo; Richmond, Todd; Wu, Wei; Barbazuk, Brad; Nettleton, Dan; Jeddeloh, Jeff; Schnable, Patrick S.			High-Resolution Genotyping via Whole Genome Hybridizations to Microarrays Containing Long Oligonucleotide Probes	PLOS ONE			English	Article							SINGLE-FEATURE POLYMORPHISM; GENETIC-MAP; DISCOVERY; IDENTIFICATION; TRANSCRIPTOME; DIVERSITY; MARKERS; ARRAYS; MAIZE	To date, microarray-based genotyping of large, complex plant genomes has been complicated by the need to perform genome complexity reduction to obtain sufficiently strong hybridization signals. Genome complexity reduction techniques are, however, tedious and can introduce unwanted variables into genotyping assays. Here, we report a microarray-based genotyping technology for complex genomes (such as the 2.3 GB maize genome) that does not require genome complexity reduction prior to hybridization. Approximately 200,000 long oligonucleotide probes were identified as being polymorphic between the inbred parents of a mapping population and used to genotype two recombinant inbred lines. While multiple hybridization replicates provided similar to 97% accuracy, even a single replicate provided similar to 95% accuracy. Genotyping accuracy was further increased to >99% by utilizing information from adjacent probes. This microarray-based method provides a simple, high-density genotyping approach for large, complex genomes.	[Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Ying, Kai] Iowa State Univ, Interdept Genet Grad Program, Ames, IA USA; [Ying, Kai; Schnable, Patrick S.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA; [Yeh, Cheng-Ting; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA USA; [Iniguez, A. Leonardo; Richmond, Todd; Jeddeloh, Jeff] Roche NimbleGen Inc, Madison, WI USA; [Barbazuk, Brad] Univ Florida, Dept Biol, Gainesville, FL USA; [Barbazuk, Brad] Univ Florida, Genet Inst, Gainesville, FL USA; [Nettleton, Dan] Iowa State Univ, Dept Stat, Ames, IA USA	University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Iowa State University; Iowa State University; Roche Holding; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Iowa State University		schnable@iastate.edu	Springer, Nathan/F-2680-2013	Springer, Nathan/0000-0002-7301-4759; Yeh, Cheng-Ting/0000-0002-1392-2018; Nettleton, Dan/0000-0002-6045-1036; Schnable, Patrick/0000-0001-9169-5204	Hatch Act funds	Hatch Act funds(United States Department of Agriculture (USDA))	This project was supported in part by Hatch Act funds to Iowa, Minnesota and Florida. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Roche NimbleGen, Inc. (http://www.nimblegen.com/) provided support for this study through the donation of reagents and team-member time. Roles of Roche NimbleGen authors in the work are as follows: A. Leonardo Iniguez participated in experimental design and experimental execution; Todd Richmond participated in experimental and array design; Jeffrey A. Jeddeloh participated in experimental design array design, data interpretation and manuscript preparation.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bernardo AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-251; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Edwards JD, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-13; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Flibotte S, 2009, GENETICS, V181, P33, DOI 10.1534/genetics.108.096487; Fu Y, 2006, GENETICS, V174, P1671, DOI 10.1534/genetics.106.060376; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hsia AP, 2005, THEOR APPL GENET, V111, P218, DOI 10.1007/s00122-005-1997-5; Kidgell C, 2005, CHROMOSOME RES, V13, P225, DOI 10.1007/s10577-005-1503-6; Kumar R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000284; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Salathia N, 2007, PLANT J, V51, P727, DOI 10.1111/j.1365-313X.2007.03194.x; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194	29	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14178	10.1371/journal.pone.0014178	http://dx.doi.org/10.1371/journal.pone.0014178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152036	Green Submitted, gold, Green Published			2022-12-27	WOS:000284868000004
J	Wertheimer, AM; Uhrlaub, JL; Hirsch, A; Medigeshi, G; Sprague, J; Legasse, A; Wilk, J; Wiley, CA; Didier, P; Tesh, RB; Murray, KO; Axthelm, MK; Wong, SW; Nikolich-Zugich, J				Wertheimer, Anne M.; Uhrlaub, Jennifer L.; Hirsch, Alec; Medigeshi, Guruprasad; Sprague, Jerald; Legasse, Alfred; Wilk, Jennifer; Wiley, Clayton A.; Didier, Peter; Tesh, Robert B.; Murray, Kristy O.; Axthelm, Michael K.; Wong, Scott W.; Nikolich-Zugich, Janko			Immune Response to the West Nile Virus in Aged Non-Human Primates	PLOS ONE			English	Article							T-CELLS; INFECTION; EPIDEMIC; ENCEPHALITIS; MONKEYS	Background: Risk of encephalitis from West Nile virus (WNV) infection increases dramatically with age. Understanding the basis of this susceptibility requires development of suitable animal models. Here, we investigated the immune response to WNV in old non-human primates. Methodology/Principal Findings: We investigated clinical, immunological and virological correlates of WNV infection in aging non-human primates. Aged (17-30yrs) and adult (6-9yrs) Rhesus macaques (RM) were challenged with WNV in the presence or the absence of the mosquito salivary gland extract (SGE) to approximate natural infection. None of the 26 animals exhibited clinical signs of the disease. Quantitative PCR suggested discrete and short-lived viremia, but infectious virus was never isolated. There was markedly increased, age-independent, proliferation of CD3(-) non-B cells, followed by B-cell proliferation, which correlated to the loss of detectable WNV genomes. Moreover, animals primed with mosquito salivary gland extract exhibited reduced circulating WNV RNA. While we found the expected age-associated reduction in T cell proliferation, adaptive immunity did not correlate with infection outcome. That was further confirmed in a cohort of thymectomized and/or CD8 T-cell depleted Cynomolgus macaques (CM; N = 15), who also failed to develop WNV disease. Conclusions/significance: Results are consistent with strong and age-independent innate resistance of macaques against WNV challenge. This animal model is therefore not suitable for vaccine and therapeutic testing against WNV. However, understanding the basis of their innate resistance against WNV in macaques could provide helpful clues to improve anti-WNV protection of older adults.	[Wertheimer, Anne M.; Uhrlaub, Jennifer L.; Nikolich-Zugich, Janko] Univ Arizona, Arizona Ctr Aging, Tucson, AZ 85721 USA; [Uhrlaub, Jennifer L.; Nikolich-Zugich, Janko] Univ Arizona, Dept Immunobiol, Tucson, AZ USA; [Hirsch, Alec; Medigeshi, Guruprasad; Sprague, Jerald; Wong, Scott W.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Legasse, Alfred; Wilk, Jennifer; Axthelm, Michael K.; Wong, Scott W.; Nikolich-Zugich, Janko] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Wiley, Clayton A.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Didier, Peter] Tulane Natl Primate Res Ctr, Covington, LA USA; [Tesh, Robert B.] Univ Texas Med Branch, Galveston, TX USA; [Murray, Kristy O.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX USA	University of Arizona; University of Arizona; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tulane University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Wertheimer, AM (corresponding author), Univ Arizona, Arizona Ctr Aging, Tucson, AZ 85721 USA.	nikolich@email.arizona.edu	Wertheimer, Anne/E-5132-2019; Wertheimer, Anne/ABF-7802-2021; Medigeshi, Guruprasad/V-1566-2019	Wertheimer, Anne/0000-0002-6627-4974; Nikolich-Zugich, Janko/0000-0001-5830-5323; Medigeshi, Guruprasad/0000-0001-5333-9743; Uhrlaub, Jennifer/0000-0002-7745-0179	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services [N01 50027 HHSN266200500027C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050027] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, under Contract N01 50027 HHSN266200500027C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222; Briese T, 2000, LANCET, V355, P1614, DOI 10.1016/S0140-6736(00)02220-0; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Cicin-Sain L, 2007, P NATL ACAD SCI USA, V104, P19960, DOI 10.1073/pnas.0705905104; CICINSAIN L, J IMMUNOL, V184, P6739; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Hein WR, 2003, NAT REV IMMUNOL, V3, P79, DOI 10.1038/nri977; Li F, 2002, EUR J IMMUNOL, V32, P1650, DOI 10.1002/1521-4141(200206)32:6<1650::AID-IMMU1650>3.0.CO;2-Q; Malan AK, 2003, AM J CLIN PATHOL, V119, P508, DOI 10.1309/WJJ7UE42DFHTTF1X; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Murray KO, 2008, VECTOR-BORNE ZOONOT, V8, P167, DOI 10.1089/vbz.2007.0109; O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004; Petersen LR, 2002, NEW ENGL J MED, V347, P1225, DOI 10.1056/NEJMo020128; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; POGODINA VV, 1983, ARCH VIROL, V75, P71, DOI 10.1007/BF01314128; Ratterree MS, 2004, J INFECT DIS, V189, P669, DOI 10.1086/381461; Ratterree MS, 2003, EMERG INFECT DIS, V9, P1388, DOI 10.3201/eid0911.030226; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Throsby M, 2007, EXPERT REV VACCINES, V6, P183, DOI 10.1586/14760584.6.2.183; Wolf RF, 2006, VIROLOGY, V355, P44, DOI 10.1016/j.virol.2006.06.033	27	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15514	10.1371/journal.pone.0015514	http://dx.doi.org/10.1371/journal.pone.0015514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151986	Green Published, Green Accepted, gold			2022-12-27	WOS:000284868000034
J	Ribeiro, TL; Copelli, M; Caixeta, F; Belchior, H; Chialvo, DR; Nicolelis, MAL; Ribeiro, S				Ribeiro, Tiago L.; Copelli, Mauro; Caixeta, Fabio; Belchior, Hindiael; Chialvo, Dante R.; Nicolelis, Miguel A. L.; Ribeiro, Sidarta			Spike Avalanches Exhibit Universal Dynamics across the Sleep-Wake Cycle	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; NEURONAL AVALANCHES; PROPOFOL ANALOGS; GABA(A) RECEPTOR; VISUAL-CORTEX; IN-VIVO; RAT; BRAIN; NETWORKS; RANGE	Background: Scale-invariant neuronal avalanches have been observed in cell cultures and slices as well as anesthetized and awake brains, suggesting that the brain operates near criticality, i.e. within a narrow margin between avalanche propagation and extinction. In theory, criticality provides many desirable features for the behaving brain, optimizing computational capabilities, information transmission, sensitivity to sensory stimuli and size of memory repertoires. However, a thorough characterization of neuronal avalanches in freely-behaving (FB) animals is still missing, thus raising doubts about their relevance for brain function. Methodology/Principal Findings: To address this issue, we employed chronically implanted multielectrode arrays (MEA) to record avalanches of action potentials (spikes) from the cerebral cortex and hippocampus of 14 rats, as they spontaneously traversed the wake-sleep cycle, explored novel objects or were subjected to anesthesia (AN). We then modeled spike avalanches to evaluate the impact of sparse MEA sampling on their statistics. We found that the size distribution of spike avalanches are well fit by lognormal distributions in FB animals, and by truncated power laws in the AN group. FB data surrogation markedly decreases the tail of the distribution, i.e. spike shuffling destroys the largest avalanches. The FB data are also characterized by multiple key features compatible with criticality in the temporal domain, such as 1/f spectra and long-term correlations as measured by detrended fluctuation analysis. These signatures are very stable across waking, slow-wave sleep and rapid-eye-movement sleep, but collapse during anesthesia. Likewise, waiting time distributions obey a single scaling function during all natural behavioral states, but not during anesthesia. Results are equivalent for neuronal ensembles recorded from visual and tactile areas of the cerebral cortex, as well as the hippocampus. Conclusions/Significance: Altogether, the data provide a comprehensive link between behavior and brain criticality, revealing a unique scale-invariant regime of spike avalanches across all major behaviors.	[Ribeiro, Tiago L.; Copelli, Mauro] Fed Univ Pernambuco UFPE, Dept Phys, Recife, PE, Brazil; [Copelli, Mauro; Caixeta, Fabio; Nicolelis, Miguel A. L.; Ribeiro, Sidarta] Fed Univ Rio Grande Norte UFRN, Grad Program Neurosci, Natal, RN, Brazil; [Caixeta, Fabio; Belchior, Hindiael; Nicolelis, Miguel A. L.; Ribeiro, Sidarta] Edmond & Lily Safra Int Inst Neurosci Natal ELS I, Natal, RN, Brazil; [Belchior, Hindiael; Ribeiro, Sidarta] Fed Univ Rio Grande Norte UFRN, Dept Physiol, Natal, RN, Brazil; [Chialvo, Dante R.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Ctr Neuroengn, Dept Neurobiol, Durham, NC 27706 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Brain Sci, Durham, NC 27706 USA	Universidade Federal de Pernambuco; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Northwestern University; Duke University; Duke University; Duke University	Ribeiro, TL (corresponding author), Fed Univ Pernambuco UFPE, Dept Phys, Recife, PE, Brazil.	ribeiro@natalneuro.org.br	Caixeta, Fabio V/J-9048-2014; Copelli, Mauro/AAG-8110-2020; Chialvo, Dante R./P-5279-2019; Caixeta, Fabio V/N-9405-2019; Chialvo, Dante R/A-4658-2009; Copelli, Mauro/C-6336-2009; Ribeiro, Sidarta/C-5794-2016	Caixeta, Fabio V/0000-0003-0919-342X; Chialvo, Dante R./0000-0002-1038-3637; Caixeta, Fabio V/0000-0003-0919-342X; Chialvo, Dante R/0000-0002-1038-3637; Copelli, Mauro/0000-0001-7441-2858; Ribeiro, Sidarta/0000-0001-9325-9545	Associacao Alberto Santos Dumont para Apoio a Pesquisa; Financiadora de Estudos e Projetos [01.06.1092.00]; Instituto Nacional de Ciencia e Tecnologia em Interfaces Cerebro Maquina [704134/2009]; Edital Universal [481506/2007-1, 472861/2008-5]; Programa de Apoio a Nucleos de Excelencia; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco [APQ-1140-1.05/08]; Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Pew Latin-American Program in Biomedical Science; National Institute of Dental and Craniofacial Research (NIDCR) [R01-DE011451]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011451] Funding Source: NIH RePORTER	Associacao Alberto Santos Dumont para Apoio a Pesquisa; Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Instituto Nacional de Ciencia e Tecnologia em Interfaces Cerebro Maquina; Edital Universal; Programa de Apoio a Nucleos de Excelencia; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte(Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (FAPERN)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pew Latin-American Program in Biomedical Science; National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Associacao Alberto Santos Dumont para Apoio a Pesquisa, Financiadora de Estudos e Projetos 01.06.1092.00, Instituto Nacional de Ciencia e Tecnologia em Interfaces Cerebro Maquina, 704134/2009, Edital Universal 481506/2007-1 and 472861/2008-5, Programa de Apoio a Nucleos de Excelencia, Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco APQ-1140-1.05/08, Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, graduate fellowships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and the Pew Latin-American Program in Biomedical Science. The project described was supported by Grant Number R01-DE011451 from the National Institute of Dental and Craniofacial Research (NIDCR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDCR or the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; Assis VRV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011923; Baiesi M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.051103; Bak P., 1997, NATURE WORKS SCI SEL; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bekinschtein TA, 2009, NAT NEUROSCI, V12, P1343, DOI 10.1038/nn.2391; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Christensen K, 2002, P NATL ACAD SCI USA, V99, P2509, DOI 10.1073/pnas.012581099; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Corral A, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.035102; Corral A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016101; Davidsen J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.125502; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Haeseler G, 2003, EUR J ANAESTH, V20, P220, DOI 10.1097/00003643-200303000-00007; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; HARRISON NL, 1985, BRIT J PHARMACOL, V84, P381, DOI 10.1111/j.1476-5381.1985.tb12922.x; HARTMAN BK, 1972, P NATL ACAD SCI USA, V69, P2722, DOI 10.1073/pnas.69.9.2722; Hennig MH, 2009, J NEUROSCI, V29, P1077, DOI 10.1523/JNEUROSCI.4880-08.2009; Horvath TL, 1999, J COMP NEUROL, V415, P145; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jensen H., 1998, SELF ORGANIZED CRITI; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Krasowski MD, 2002, J MED CHEM, V45, P3210, DOI 10.1021/jm010461a; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; LEPPAVUORI A, 1980, BRAIN RES, V193, P95, DOI 10.1016/0006-8993(80)90948-8; Lima B, 2010, CEREB CORTEX, V20, P1556, DOI 10.1093/cercor/bhp218; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Omori F, 1894, J COLL SCI IMP U TOK, V7, P111; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pereira A, 2007, P NATL ACAD SCI USA, V104, P18286, DOI 10.1073/pnas.0708611104; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; PLENZ D, 2009, ARXIV09125369V1; Press W. H., 1992, ART SCI COMPUTING; Priesemann V, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-40; Publio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006970; Ranade SP, 2009, J NEUROPHYSIOL, V102, P3026, DOI 10.1152/jn.00507.2009; Rash JE, 2007, NEUROSCIENCE, V147, P938, DOI 10.1016/j.neuroscience.2007.04.061; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Ribeiro S, 2007, FRONT NEUROSCI-SWITZ, V1, P43, DOI 10.3389/neuro.01.1.1.003.2007; ROTHBLAT LA, 1991, BEHAV BRAIN RES, V42, P25, DOI 10.1016/S0166-4328(05)80036-1; Sanchez R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.068302; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SCHULTZ W, 1986, J NEUROPHYSIOL, V55, P660, DOI 10.1152/jn.1986.55.4.660; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STEZHKA VV, 1995, EXP BRAIN RES, V105, P383; THOMSON AM, 1985, NATURE, V313, P479, DOI 10.1038/313479a0; Trapani G, 1998, J MED CHEM, V41, P1846, DOI 10.1021/jm970681h; Vahle-Hinz C, 2002, BRIT J ANAESTH, V89, P123, DOI 10.1093/bja/aef166; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; WALLACE CS, 1995, MOL BRAIN RES, V32, P211, DOI 10.1016/0169-328X(95)00076-5; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004	74	126	126	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14129	10.1371/journal.pone.0014129	http://dx.doi.org/10.1371/journal.pone.0014129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152422	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100010
J	Tuna, M; Smid, M; Zhu, DK; Martens, JWM; Amos, CI				Tuna, Musaffe; Smid, Marcel; Zhu, Dakai; Martens, John W. M.; Amos, Christopher I.			Association between Acquired Uniparental Disomy and Homozygous Mutations and HER2/ER/PR Status in Breast Cancer	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NUCLEOTIDE POLYMORPHISM ANALYSIS; COPY NUMBER ALTERATIONS; ACUTE MYELOID LEUKEMIAS; COLORECTAL CANCERS; ARRAY ANALYSIS; CARCINOMA; HETEROZYGOSITY; TUMORS; ISODISOMY	Background: Genetic alterations in cellular signaling networks are a hallmark of cancer, however, effective methods to discover them are lacking. A novel form of abnormality called acquired uniparental disomy (aUPD) was recently found to pinpoint the region of mutated genes in various cancers, thereby identifying the region for next-generation sequencing. Methods/Principal Findings: We retrieved large genomic data sets from the Gene Expression Omnibus database to perform genome-wide analysis of aUPD in breast tumor samples and cell lines using approaches that can reliably detect aUPD. aUPD was identified in 52.29% of the tumor samples. The most frequent aUPD regions were located at chromosomes 2q, 3p, 5q, 9p, 9q, 10q, 11q, 13q, 14q and 17q. We evaluated the data for any correlation between the most frequent aUPD regions and HER2/neu, ER, and PR status, and found a statistically significant correlation between the recurrent regions of aUPD and triple negative (TN) breast cancers. aUPD at chromosome 17q (VEZF1, WNT3), 3p (SUMF1, GRM7), 9p (MTAP, NFIB) and 11q (CASP1, CASP4, CASP5) are predictors for TN. The frequency of aUPD was found to be significantly higher in TN breast cancer cases compared to HER2/neu-positive and/or ER or PR-positive cases. Furthermore, using previously published mutation data, we found TP53 homozygously mutated in cell lines having aUPD in that locus. Conclusions/Significance: We conclude that aUPD is a common and non-random molecular feature of breast cancer that is most prominent in triple negative cases. As aUPD regions are different among the main pathological subtypes, specific aUPD regions may aid the sub-classification of breast cancer. In addition, we provide statistical support using TP53 as an example that identifying aUPD regions can be an effective approach in finding aberrant genes. We thus conclude that a genome-wide scale analysis of aUPD regions for homozygous sequence alterations can provide valuable insights into breast tumorigenesis.	[Tuna, Musaffe; Zhu, Dakai; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Smid, Marcel; Martens, John W. M.] Erasmus Med Ctr Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands; [Smid, Marcel; Martens, John W. M.] Canc Genom Ctr, Rotterdam, Netherlands	University of Texas System; UTMD Anderson Cancer Center	Tuna, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	mtuna9@gmail.com		Smid, Marcel/0000-0003-0605-1901	National Institutes of Health [R01CA133996]; NATIONAL CANCER INSTITUTE [R01CA133996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by National Institutes of Health grant R01CA133996. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bush Nancy Jo, 2007, Semin Oncol Nurs, V23, P46, DOI 10.1016/j.soncn.2006.11.008; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; Flotho C, 2007, ONCOGENE, V26, P5816, DOI 10.1038/sj.onc.1210361; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Gowher H, 2008, GENE DEV, V22, P2075, DOI 10.1101/gad.1658408; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Griffiths M, 2005, LEUKEMIA, V19, P2355, DOI 10.1038/sj.leu.2403988; Gusterson B, 2009, NAT REV CANCER, V9, P128, DOI 10.1038/nrc2571; Hagstrom SA, 1999, P NATL ACAD SCI USA, V96, P2952, DOI 10.1073/pnas.96.6.2952; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Ittmann M, 2009, NEOPLASIA, V11, P305, DOI 10.1593/neo.81530; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Karow A, 2007, LEUKEMIA, V21, P1303, DOI 10.1038/sj.leu.2404651; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Kratz CP, 2007, HUM MOL GENET, V16, P374, DOI 10.1093/hmg/ddl458; Kuga D, 2008, NEURO-ONCOLOGY, V10, P995, DOI 10.1215/15228517-2008-064; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lips EH, 2007, J PATHOL, V212, P269, DOI 10.1002/path.2180; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Mohamedali AM, 2009, J CLIN ONCOL, V27, P4002, DOI 10.1200/JCO.2009.22.6985; Mullighan CG, 2008, LANCET, V372, P1448, DOI 10.1016/S0140-6736(08)61342-2; Murthy SK, 2002, MODERN PATHOL, V15, P1241, DOI 10.1097/01.MP.0000032535.62750.D1; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; O'Shea D, 2009, BLOOD, V113, P2298, DOI 10.1182/blood-2008-08-174953; Paulsson K, 2008, P NATL ACAD SCI USA, V105, P6708, DOI 10.1073/pnas.0800408105; Ponzone R, 2006, ANN NY ACAD SCI, V1089, P143, DOI 10.1196/annals.1386.037; Raghavan M, 2005, CANCER RES, V65, P375; Raghavan M, 2008, BLOOD, V112, P814, DOI 10.1182/blood-2008-01-132431; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; SZPURKA H, 2008, LEUKEMIA; Tiu RV, 2009, J CLIN ONCOL, V27, P5219, DOI 10.1200/JCO.2009.21.9840; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Volchenboum SL, 2009, CANCER RES, V69, P4143, DOI 10.1158/0008-5472.CAN-08-3112; Walsh CS, 2008, CLIN CANCER RES, V14, P7645, DOI 10.1158/1078-0432.CCR-08-1291; White VA, 1996, GENE CHROMOSOME CANC, V15, P138, DOI 10.1002/(SICI)1098-2264(199602)15:2<138::AID-GCC10>3.3.CO;2-F; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wouters BJ, 2007, LEUKEMIA, V21, P2382, DOI 10.1038/sj.leu.2404795; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596	66	13	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15094	10.1371/journal.pone.0015094	http://dx.doi.org/10.1371/journal.pone.0015094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152100	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100069
J	Xia, ZQ; Chibnik, LB; Glanz, BI; Liguori, M; Shulman, JM; Tran, D; Khoury, SJ; Chitnis, T; Holyoak, T; Weiner, HL; Guttmann, CRG; De Jager, PL				Xia, Zongqi; Chibnik, Lori B.; Glanz, Bonnie I.; Liguori, Maria; Shulman, Joshua M.; Tran, Dong; Khoury, Samia J.; Chitnis, Tanuja; Holyoak, Todd; Weiner, Howard L.; Guttmann, Charles R. G.; De Jager, Philip L.			A Putative Alzheimer's Disease Risk Allele in PCK1 Influences Brain Atrophy in Multiple Sclerosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CYTOSOLIC PHOSPHOENOLPYRUVATE CARBOXYKINASE; CLINICALLY ISOLATED SYNDROMES; COGNITIVE IMPAIRMENT; DIAGNOSTIC-CRITERIA; IDENTIFIES VARIANTS; MRI; SUSCEPTIBILITY; SEVERITY; GENES	Background: Brain atrophy and cognitive dysfunction are neurodegenerative features of Multiple Sclerosis (MS). We used a candidate gene approach to address whether genetic variants implicated in susceptibility to late onset Alzheimer's Disease (AD) influence brain volume and cognition in MS patients. Methods/Principal Findings: MS subjects were genotyped for five single nucleotide polymorphisms (SNPs) associated with susceptibility to AD: PICALM, CR1, CLU, PCK1, and ZNF224. We assessed brain volume using Brain Parenchymal Fraction (BPF) measurements obtained from Magnetic Resonance Imaging (MRI) data and cognitive function using the Symbol Digit Modalities Test (SDMT). Genotypes were correlated with cross-sectional BPF and SDMT scores using linear regression after adjusting for sex, age at symptom onset, and disease duration. 722 MS patients with a mean (+/- SD) age at enrollment of 41 (+/- 10) years were followed for 44 (+/- 28) months. The AD risk-associated allele of a non-synonymous SNP in the PCK1 locus (rs8192708(G)) is associated with a smaller average brain volume (P = 0.0047) at the baseline MRI, but it does not impact our baseline estimate of cognition. PCK1 is additionally associated with higher baseline T2-hyperintense lesion volume (P = 0.0088). Finally, we provide technical validation of our observation in a subset of 641 subjects that have more than one MRI study, demonstrating the same association between PCK1 and smaller average brain volume (P = 0.0089) at the last MRI visit. Conclusion/Significance: Our study provides suggestive evidence for greater brain atrophy in MS patients bearing the PCK1 allele associated with AD-susceptibility, yielding new insights into potentially shared neurodegenerative process between MS and late onset AD.	[Xia, Zongqi; Chibnik, Lori B.; Shulman, Joshua M.; Tran, Dong; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Xia, Zongqi; Chibnik, Lori B.; Shulman, Joshua M.; Tran, Dong; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Liguori, Maria; Guttmann, Charles R. G.] Brigham & Womens Hosp, Dept Radiol, Ctr Neurol Imaging, Boston, MA 02115 USA; [Xia, Zongqi; Shulman, Joshua M.; Khoury, Samia J.; Chitnis, Tanuja; Weiner, Howard L.; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Holyoak, Todd] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA; [Liguori, Maria] CNR, Inst Neurol Sci, Mangone, Italy	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Kansas; University of Kansas Medical Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR)	Xia, ZQ (corresponding author), Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, 75 Francis St, Boston, MA 02115 USA.	pdejager@rics.bwh.harvard.edu	Guttmann, Charles RG/J-3093-2018; Xia, Zongqi/AAX-3091-2020; Xia, Zongqi/AAB-1565-2022; Liguori, Maria/D-4390-2016	Xia, Zongqi/0000-0003-1500-2589; Xia, Zongqi/0000-0003-1500-2589; khoury, samia/0000-0003-3198-6063; Chibnik, Lori/0000-0001-6293-806X; Guttmann, Charles/0000-0002-7006-9762; Liguori, Maria/0000-0003-4338-0392	National Multiple Sclerosis Society [JF2138A1]; National Institutes of Health (NIH) [AI074549-02]; National MS Society (NMSS); American Academy of Neurology (AAN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG034290] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society (NMSS)(National Multiple Sclerosis Society); American Academy of Neurology (AAN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. De Jager is a Harry Weaver Neuroscience Scholar Award Recipient of the National Multiple Sclerosis Society (JF2138A1). Dr. Xia was supported by the National Institutes of Health (NIH) (AI074549-02) and is a recipient of the Clinician Scientist Development Award from the National MS Society (NMSS) and American Academy of Neurology (AAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Burwick RM, 2006, NEUROLOGY, V66, P1373, DOI 10.1212/01.wnl.0000210531.19498.3f; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Case CL, 2007, BBA-GEN SUBJECTS, V1770, P1576, DOI 10.1016/j.bbagen.2007.07.012; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; COLOMBO G, 1978, BIOCHEMISTRY-US, V17, P5321, DOI 10.1021/bi00618a001; Cooper GF, 1997, DATA MIN KNOWL DISC, V1, P203, DOI 10.1023/A:1009787925236; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Drake AS, 2010, MULT SCLER J, V16, P228, DOI 10.1177/1352458509354552; Dunten P, 2002, J MOL BIOL, V316, P257, DOI 10.1006/jmbi.2001.5364; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Gauthier SA, 2007, NEUROLOGY, V68, P2059, DOI 10.1212/01.wnl.0000264890.97479.b1; Glanz BI, 2007, MULT SCLER J, V13, P1004, DOI 10.1177/1352458507077943; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Hanson RW, 2009, J BIOL CHEM, V284, P27021, DOI 10.1074/jbc.R109.040519; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; HEALY BC, 2010, NEUROLOGY IN PRESS; JOHNSON TA, 2010, BIOCHEMISTRY; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Liu LF, 2005, J NEUROIMAGING, V15, p103S, DOI 10.1177/1051228405282864; Losseff NA, 1996, BRAIN, V119, P2009, DOI 10.1093/brain/119.6.2009; Martola J, 2010, NEURORADIOLOGY, V52, P109, DOI 10.1007/s00234-009-0593-9; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meier DS, 2006, NEUROIMAGE, V32, P531, DOI 10.1016/j.neuroimage.2006.04.181; Okuda DT, 2009, BRAIN, V132, P250, DOI 10.1093/brain/awn301; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi J, 2008, NEUROLOGY, V70, P185, DOI 10.1212/01.wnl.0000264004.62612.44; Shulman JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011244; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Tiehuis AM, 2008, STROKE, V39, P1600, DOI 10.1161/STROKEAHA.107.506089; van der Walt A, 2009, NEUROLOGY, V73, P1018, DOI 10.1212/WNL.0b013e3181b9c85e; Wei XC, 2002, J MAGN RESON IMAGING, V15, P203, DOI 10.1002/jmri.10053; Zipoli V, 2010, MULT SCLER J, V16, P62, DOI 10.1177/1352458509350311; Zivadinov R, 2007, INT REV NEUROBIOL, V79, P521, DOI 10.1016/S0074-7742(07)79023-2	38	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14169	10.1371/journal.pone.0014169	http://dx.doi.org/10.1371/journal.pone.0014169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152065	Green Published, gold			2022-12-27	WOS:000284755100046
J	Yang, F; Waters, KM; Miller, JH; Gritsenko, MA; Zhao, R; Du, XX; Livesay, EA; Purvine, SO; Monroe, ME; Wang, YC; Camp, DG; Smith, RD; Stenoien, DL				Yang, Feng; Waters, Katrina M.; Miller, John H.; Gritsenko, Marina A.; Zhao, Rui; Du, Xiuxia; Livesay, Eric A.; Purvine, Samuel O.; Monroe, Matthew E.; Wang, Yingchun; Camp, David G., II; Smith, Richard D.; Stenoien, David L.			Phosphoproteomics Profiling of Human Skin Fibroblast Cells Reveals Pathways and Proteins Affected by Low Doses of Ionizing Radiation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; DNA-DAMAGE; RADIOADAPTIVE RESPONSE; MASS-SPECTROMETRY; COMPLEX FACT; KAPPA-B; PHOSPHORYLATION; EXPRESSION; ACTIVATION; APOPTOSIS	Background: High doses of ionizing radiation result in biological damage; however, the precise relationships between long-term health effects, including cancer, and low-dose exposures remain poorly understood and are currently extrapolated using high-dose exposure data. Identifying the signaling pathways and individual proteins affected at the post-translational level by radiation should shed valuable insight into the molecular mechanisms that regulate dose-dependent responses to radiation. Principal Findings: We have identified 7117 unique phosphopeptides (2566 phosphoproteins) from control and irradiated (2 and 50 cGy) primary human skin fibroblasts 1 h post-exposure. Semi-quantitative label-free analyses were performed to identify phosphopeptides that are apparently altered by radiation exposure. This screen identified phosphorylation sites on proteins with known roles in radiation responses including TP53BP1 as well as previously unidentified radiation-responsive proteins such as the candidate tumor suppressor SASH1. Bioinformatic analyses suggest that low and high doses of radiation affect both overlapping and unique biological processes and suggest a role for MAP kinase and protein kinase A (PKA) signaling in the radiation response as well as differential regulation of p53 networks at low and high doses of radiation. Conclusions: Our results represent the most comprehensive analysis of the phosphoproteomes of human primary fibroblasts exposed to multiple doses of ionizing radiation published to date and provide a basis for the systems-level identification of biological processes, molecular pathways and individual proteins regulated in a dose dependent manner by ionizing radiation. Further study of these modified proteins and affected networks should help to define the molecular mechanisms that regulate biological responses to radiation at different radiation doses and elucidate the impact of low-dose radiation exposure on human health.	[Yang, Feng; Waters, Katrina M.; Gritsenko, Marina A.; Zhao, Rui; Du, Xiuxia; Livesay, Eric A.; Purvine, Samuel O.; Monroe, Matthew E.; Camp, David G., II; Smith, Richard D.; Stenoien, David L.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Miller, John H.] Washington State Univ Tricities, Richland, WA USA; [Wang, Yingchun] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington State University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Yang, F (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	david.stenoien@pnl.gov	Miller, John J/GZG-5663-2022; Smith, Richard D/J-3664-2012; Monroe, Matthew/L-1157-2019; Purvine, Samuel O/O-3358-2017	Smith, Richard D/0000-0002-2381-2349; Purvine, Samuel O/0000-0002-2257-2400; Waters, Katrina/0000-0003-4696-5396	Department of Energy Low Dose Radiation Research Program National Institutes of Health/National Center for Research Resources Proteomics Center at Pacific Northwest National Laboratory [RR18522]; Battelle [DE-AC05-76RLO 1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	Department of Energy Low Dose Radiation Research Program National Institutes of Health/National Center for Research Resources Proteomics Center at Pacific Northwest National Laboratory; Battelle; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding came from the Department of Energy Low Dose Radiation Research Program National Institutes of Health/National Center for Research Resources Proteomics Center at Pacific Northwest National Laboratory (RR18522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. William Morgan for helpful advice during the preparation of this manuscript. Experiments and data analyses were performed in the Environmental Molecular Sciences Laboratory, a DOE national scientific user facility located at the Pacific Northwest National Laboratory (PNNL) in Richland, Washington. PNNL is a multiprogram national laboratory operated by Battelle for the DOE under Contract DE-AC05-76RLO 1830.	Ahmed KM, 2009, FREE RADICAL BIO MED, V46, P1543, DOI 10.1016/j.freeradbiomed.2009.03.012; Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; Averbeck D, 2009, HEALTH PHYS, V97, P493, DOI 10.1097/HP.0b013e3181b08a20; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; BAGGETTA R, 2010, EUR J IMMUNOL; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Belotserkovskaya R, 2004, BBA-GENE STRUCT EXPR, V1677, P87, DOI 10.1016/j.bbaexp.2003.09.017; Brenner DJ, 2006, RADIAT ENVIRON BIOPH, V44, P253, DOI 10.1007/s00411-006-0029-4; Brooks AL, 2003, HEALTH PHYS, V85, P85, DOI 10.1097/00004032-200307000-00016; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; Collins MO, 2007, PROTEOMICS, V7, P2751, DOI 10.1002/pmic.200700145; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Delom F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Du XX, 2008, J PROTEOME RES, V7, P2195, DOI 10.1021/pr070510t; Duroux M, 2004, PLANT J, V40, P660, DOI 10.1111/j.1365-313X.2004.02242.x; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; FERAMISCO JR, 1980, J BIOL CHEM, V255, P4240; Franco N, 2005, RADIAT RES, V163, P623, DOI 10.1667/RR3391; Ham BM, 2008, J PROTEOME RES, V7, P2215, DOI 10.1021/pr700575m; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Krieghoff-Henning E, 2008, BBA-MOL CELL RES, V1783, P2185, DOI 10.1016/j.bbamcr.2008.07.002; Kumari A, 2009, J CELL BIOCHEM, V108, P508, DOI 10.1002/jcb.22280; Kuo HP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000590; Lindvall JM, 2005, CELL IMMUNOL, V235, P46, DOI 10.1016/j.cellimm.2005.07.001; Markova E, 2007, INT J RADIAT BIOL, V83, P319, DOI 10.1080/09553000601170469; McCarthy J, 2003, J PROTEOME RES, V2, P239, DOI 10.1021/pr025564b; Mitsushima M, 2007, EXP CELL RES, V313, P1830, DOI 10.1016/j.yexcr.2007.03.001; Monroe ME, 2008, COMPUT BIOL CHEM, V32, P215, DOI 10.1016/j.compbiolchem.2008.02.006; Morgan WF, 2009, HEALTH PHYS, V97, P426, DOI 10.1097/HP.0b013e3181ab98c7; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; NHEK S, MOL BIOL CELL; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oda Y, 2001, NAT BIOTECHNOL, V19, P379, DOI 10.1038/86783; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Prathapam T, 2002, NUCLEIC ACIDS RES, V30, P5261, DOI 10.1093/nar/gkf658; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rimkus C, 2006, BRIT J CANCER, V95, P1419, DOI 10.1038/sj.bjc.6603452; Rogers LD, 2009, MOL BIOSYST, V5, P1122, DOI 10.1039/b905580k; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Schwartz JL, 2007, INT J RADIAT BIOL, V83, P153, DOI 10.1080/09553000601146949; Shi SDH, 2001, ANAL CHEM, V73, P19, DOI 10.1021/ac000703z; Valerie K, 2007, MOL CANCER THER, V6, P789, DOI 10.1158/1535-7163.MCT-06-0596; Vrouwe MG, 2007, HUM MOL GENET, V16, P1478, DOI 10.1093/hmg/ddm098; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wang T, 2005, J BIOL CHEM, V280, P12593, DOI 10.1074/jbc.M410982200; Warters RL, 2009, RADIAT RES, V172, P82, DOI 10.1667/RR1677.1; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; WONG JW, METHODS MOL BIOL, V604, P273; Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941; Yang F, 2006, J PROTEOME RES, V5, P1252, DOI 10.1021/pr060028v; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200; Zhao R, 2009, J CHROMATOGR B, V877, P663, DOI 10.1016/j.jchromb.2008.12.068	65	17	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14152	10.1371/journal.pone.0014152	http://dx.doi.org/10.1371/journal.pone.0014152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152398	gold, Green Published			2022-12-27	WOS:000284755100031
J	Ni, T; Tu, K; Wang, Z; Song, S; Wu, H; Xie, B; Scott, KC; Grewal, SI; Gao, YA; Zhu, J				Ni, Ting; Tu, Kang; Wang, Zhong; Song, Shen; Wu, Han; Xie, Bin; Scott, Kristin C.; Grewal, Shiv I.; Gao, Yuan; Zhu, Jun			The Prevalence and Regulation of Antisense Transcripts in Schizosaccharomyces pombe	PLOS ONE			English	Article							BIDIRECTIONAL PROMOTERS; HISTONE H2A.Z; YEAST GENOME; RNA; GENES; MAPS; IDENTIFICATION; LANDSCAPE; ROLES; FATE	A strand-specific transcriptome sequencing strategy, directional ligation sequencing or DeLi-seq, was employed to profile antisense transcriptome of Schizosaccharomyces pombe. Under both normal and heat shock conditions, we found that polyadenylated antisense transcripts are broadly expressed while distinct expression patterns were observed for protein-coding and non-coding loci. Dominant antisense expression is enriched in protein-coding genes involved in meiosis or stress response pathways. Detailed analyses further suggest that antisense transcripts are independently regulated with respect to their sense transcripts, and diverse mechanisms might be potentially involved in the biogenesis and degradation of antisense RNAs. Taken together, antisense transcription may have profound impacts on global gene regulation in S. pombe.	[Ni, Ting; Tu, Kang; Song, Shen; Wu, Han; Scott, Kristin C.; Zhu, Jun] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Ni, Ting; Tu, Kang; Wu, Han; Zhu, Jun] NHLBI, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Wang, Zhong] DOE Joint Genome Inst, Walnut Creek, CA USA; [Xie, Bin; Gao, Yuan] Johns Hopkins Univ, Div Genom Epigenom & Bioinformat, Lieber Inst Brain Dev, Baltimore, MD USA; [Gao, Yuan] Johns Hopkins Univ, Neuroregenerat & Stem Cell Biol Program, Inst Cell Engn, Baltimore, MD USA; [Grewal, Shiv I.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); United States Department of Energy (DOE); Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ni, T (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA.	jun.zhu@nih.gov	Gao, Yuan/E-1706-2011; Wang, Zhong/E-7897-2011; Wu, Han/E-3455-2013; Wang, Zhong/J-3244-2019	Wu, Han/0000-0002-3972-698X; Wang, Zhong/0000-0002-6307-0458	Department of Defense [BC074085P1]; Susan G. Komen for the Cure [KG081324]; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Defense (BC074085P1) and Susan G. Komen for the Cure (KG081324) to J.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslett M, 2006, YEAST, V23, P913, DOI 10.1002/yea.1420; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munroe SH, 2006, CELL MOL LIFE SCI, V63, P2102, DOI 10.1007/s00018-006-6070-2; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Osato N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2003-5-1-r5; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shendure J, 2002, GENOME BIOL, V3; Sun M, 2006, GENOME RES, V16, P922, DOI 10.1101/gr.5210006; VIVANCOS AP, 2010, STRANDSPECIFIC DEEP; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	50	43	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15271	10.1371/journal.pone.0015271	http://dx.doi.org/10.1371/journal.pone.0015271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187966	Green Submitted, Green Published, gold			2022-12-27	WOS:000285575200029
J	Patel, A; Tikoo, S; Kobinger, G				Patel, Ami; Tikoo, Suresh; Kobinger, Gary			A Porcine Adenovirus with Low Human Seroprevalence Is a Promising Alternative Vaccine Vector to Human Adenovirus 5 in an H5N1 Virus Disease Model	PLOS ONE			English	Article							INFLUENZA-VIRUS; PREEXISTING IMMUNITY; PROTECTIVE EFFICACY; ANTIBODY-RESPONSE; RHESUS-MONKEYS; TOXICITY; GENE; BOVINE; PIGS; IMMUNOGENICITY	Human adenovirus 5 (AdHu5) vectors are robust vaccine platforms however the presence of naturally-acquired neutralizing antibodies may reduce vector efficacy and potential for re-administration. This study evaluates immune responses and protection following vaccination with a replication-incompetent porcine adenovirus 3 (PAV3) vector as an alternative vaccine to AdHu5 using an avian influenza H5N1 disease model. Vaccine efficacy was evaluated in BALB/c mice following vaccination with different doses of the PAV3 vector expressing an optimized A/Hanoi/30408/2005 H5N1 hemagglutinin antigen (PAV3-HA) and compared with an AdHu5-HA control. PAV3-HA rapidly generated antibody responses, with significant neutralizing antibody titers on day 21, and stronger cellular immune responses detected on day 8, compared to AdHu5-HA. The PAV3-HA vaccine, administered 8 days before challenge, demonstrated improved survival and lower virus load. Evaluation of long-term vaccine efficacy at 12 months post-vaccination showed better protection with the PAV3-HA than with the AdHu5-HA vaccine. Importantly, as opposed to AdHu5, PAV3 vector was not significantly neutralized by human antibodies pooled from over 10,000 individuals. Overall, PAV3-based vector is capable of mediating swift, strong immune responses and offer a promising alternative to AdHu5.	[Patel, Ami; Kobinger, Gary] Canadian Sci Ctr Human & Anim Hlth, Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Patel, Ami; Kobinger, Gary] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Tikoo, Suresh] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada	Canadian Science Centre for Human & Animal Health; Public Health Agency of Canada; University of Manitoba; University of Saskatchewan	Patel, A (corresponding author), Canadian Sci Ctr Human & Anim Hlth, Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	gary_kobinger@phac-aspc.gc.ca			Public Health Agency of Canada; Canadian Institutes for Health Research [83142, 310641]	Public Health Agency of Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Financial support was provided by the Public Health Agency of Canada; Canadian Institutes for Health Research (grant 83142 and team grant 310641 to G. P. K.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao ZJ, 2008, ANTIVIR RES, V79, P12, DOI 10.1016/j.antiviral.2008.02.001; Bangari DS, 2005, BIOCHEM BIOPH RES CO, V327, P960, DOI 10.1016/j.bbrc.2004.12.099; Bangari DS, 2004, VIRUS RES, V105, P127, DOI 10.1016/j.virusres.2004.05.003; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Committee for Proprietary Medicinal Products, 1997, NOT GUID HARM REQ IN; Fattori E, 2006, GENE THER, V13, P1088, DOI 10.1038/sj.gt.3302754; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Hammond JM, 2005, VET J, V169, P17, DOI 10.1016/j.tvjl.2003.09.007; Hammond JM, 2000, VACCINE, V18, P1040, DOI 10.1016/S0264-410X(99)00347-3; Hammond JM, 2001, VACCINE, V19, P3752, DOI 10.1016/S0264-410X(01)00084-6; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hoelscher MA, 2008, J INFECT DIS, V197, P1185, DOI 10.1086/529522; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042; Kodihalli S, 1999, J VIROL, V73, P2094, DOI 10.1128/JVI.73.3.2094-2098.1999; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Moffatt S, 2000, VIROLOGY, V272, P159, DOI 10.1006/viro.2000.0350; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Raviprakash K, 2008, J VIROL, V82, P6927, DOI 10.1128/JVI.02724-07; Reddy PS, 1999, J GEN VIROL, V80, P563, DOI 10.1099/0022-1317-80-3-563; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Roy S, 2006, J GEN VIROL, V87, P2477, DOI 10.1099/vir.0.81989-0; Schwartz JA, 2007, VIROLOGY, V366, P166, DOI 10.1016/j.virol.2007.04.021; SHARMA A, 2010, GENE THER; Sharma A, 2010, VIRUS RES, V153, P134, DOI 10.1016/j.virusres.2010.07.021; Singh N, 2008, MOL THER, V16, P965, DOI 10.1038/mt.2008.12; Takahashi N, 2003, GENE, V303, P89, DOI 10.1016/S0378-1119(02)01107-1; Varnavski AN, 2005, GENE THER, V12, P427, DOI 10.1038/sj.gt.3302347; Varnavski AN, 2002, J VIROL, V76, P5711, DOI 10.1128/JVI.76.11.5711-5719.2002; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Wang DH, 2006, VIROLOGY, V353, P324, DOI 10.1016/j.virol.2006.05.033; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; WHO, 2010, AV INFL; Zakhartchouk AN, 2005, J GEN VIROL, V86, P211, DOI 10.1099/vir.0.80530-0	38	19	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15301	10.1371/journal.pone.0015301	http://dx.doi.org/10.1371/journal.pone.0015301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179494	gold, Green Published, Green Submitted			2022-12-27	WOS:000285381200024
J	Xu, ZY; Yu, JZ; Cho, JM; Yu, J; Kohel, RJ; Percy, RG				Xu, Zhanyou; Yu, John Z.; Cho, Jaemin; Yu, Jing; Kohel, Russell J.; Percy, Richard G.			Polyploidization Altered Gene Functions in Cotton (Gossypium spp.)	PLOS ONE			English	Article							EST-DERIVED MICROSATELLITES; HIRSUTUM L FIBER; CELL ELONGATION; TRANSCRIPTION FACTORS; TRICHOME DEVELOPMENT; MOLECULAR-CLONING; EXPRESSION; IDENTIFICATION; EVOLUTION; MARKERS	Cotton (Gossypium spp.) is an important crop plant that is widely grown to produce both natural textile fibers and cottonseed oil. Cotton fibers, the economically more important product of the cotton plant, are seed trichomes derived from individual cells of the epidermal layer of the seed coat. It has been known for a long time that large numbers of genes determine the development of cotton fiber, and more recently it has been determined that these genes are distributed across At and Dt subgenomes of tetraploid AD cottons. In the present study, the organization and evolution of the fiber development genes were investigated through the construction of an integrated genetic and physical map of fiber development genes whose functions have been verified and confirmed. A total of 535 cotton fiber development genes, including 103 fiber transcription factors, 259 fiber development genes, and 173 SSR-contained fiber ESTs, were analyzed at the subgenome level. A total of 499 fiber related contigs were selected and assembled. Together these contigs covered about 151 Mb in physical length, or about 6.7% of the tetraploid cotton genome. Among the 499 contigs, 397 were anchored onto individual chromosomes. Results from our studies on the distribution patterns of the fiber development genes and transcription factors between the At and Dt subgenomes showed that more transcription factors were from Dt subgenome than At, whereas more fiber development genes were from At subgenome than Dt. Combining our mapping results with previous reports that more fiber QTLs were mapped in Dt subgenome than At subgenome, the results suggested a new functional hypothesis for tetraploid cotton. After the merging of the two diploid Gossypium genomes, the At subgenome has provided most of the genes for fiber development, because it continues to function similar to its fiber producing diploid A genome ancestor. On the other hand, the Dt subgenome, with its non-fiber producing D genome ancestor, provides more transcription factors that regulate the expression of the fiber genes in the At subgenome. This hypothesis would explain previously published mapping results. At the same time, this integrated map of fiber development genes would provide a framework to clone individual full-length fiber genes, to elucidate the physiological mechanisms of the fiber differentiation, elongation, and maturation, and to systematically study the functional network of these genes that interact during the process of fiber development in the tetraploid cottons.	[Xu, Zhanyou; Yu, John Z.; Cho, Jaemin; Yu, Jing; Kohel, Russell J.; Percy, Richard G.] USDA ARS, Crop Germplasm Res Unit, So Plains Agr Res Ctr, College Stn, TX USA	United States Department of Agriculture (USDA)	Xu, ZY (corresponding author), USDA ARS, Crop Germplasm Res Unit, So Plains Agr Res Ctr, College Stn, TX USA.	john.yu@ars.usda.gov			USDA-ARS [6202-21000-025-00D]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by USDA-ARS project "Cotton Genomics and Genetic Analysis" (Project Number: 6202-21000-025-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An C, 2008, THEOR APPL GENET, V116, P1015, DOI 10.1007/s00122-008-0732-4; Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Beasley JO, 1942, GENETICS, V27, P25; BERLIN J. D., 1986, COTTON PHYSL, V1, P375; Cai WW, 1998, GENOMICS, V54, P387, DOI 10.1006/geno.1998.5620; Cedroni ML, 2003, PLANT MOL BIOL, V51, P313, DOI 10.1023/A:1022051100610; Chee PW, 2004, GENOME, V47, P449, DOI [10.1139/g04-002, 10.1139/G04-002]; Chen ZJ, 2007, NEW PHYTOL, V174, P717, DOI 10.1111/j.1469-8137.2007.02084.x; DONG J, 2001, BACTERIAL ARTIFICIAL; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Feng JX, 2004, ACTA BIOCH BIOPH SIN, V36, P51, DOI 10.1093/abbs/36.1.51; Frelichowski JE, 2006, MOL GENET GENOMICS, V275, P479, DOI 10.1007/s00438-006-0106-z; Fryxell P.A., 1992, RHEEDEA, V2, P108; Gialvalis S., 2001, Journal of Cotton Science, V5, P252; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Guo Ying, 2006, Cotton Science, V18, P67; Han ZG, 2004, MOL GENET GENOMICS, V272, P308, DOI 10.1007/s00438-004-1059-8; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Higginson T, 2003, PLANT J, V35, P177, DOI 10.1046/j.1365-313X.2003.01791.x; HOVAV R, 2008, GENETICS; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; JOHN ME, 1992, P NATL ACAD SCI USA, V89, P5769, DOI 10.1073/pnas.89.13.5769; JOHN ME, 1995, PLANT PHYSIOL, V107, P1477, DOI 10.1104/pp.107.4.1477; JOHNSON HB, 1975, BOT REV, V41, P233, DOI 10.1007/BF02860838; Kim HJ, 2004, PLANTA, V218, P516, DOI 10.1007/s00425-003-1133-1; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kohel RJ, 2001, EUPHYTICA, V121, P163, DOI 10.1023/A:1012263413418; KOHEL RJ, 1987, AGRON J, V79, P31, DOI 10.2134/agronj1987.00021962007900010007x; Lee J, 1984, COTTON, P6; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee JJ, 2006, PLANTA, V223, P418, DOI 10.1007/s00425-005-0098-7; Li CH, 2002, PLANT SCI, V163, P1113, DOI 10.1016/S0168-9452(02)00320-5; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Loguercio LL, 1999, MOL GEN GENET, V261, P660; Lynch M, 2000, GENETICS, V154, P459; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Orford SJ, 1998, BBA-GENE STRUCT EXPR, V1398, P342, DOI 10.1016/S0167-4781(98)00065-7; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Rahman HU, 2006, AUST J AGR RES, V57, P583, DOI 10.1071/AR05135; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Semon M, 2008, P NATL ACAD SCI USA, V105, P8333, DOI 10.1073/pnas.0708705105; Serna L, 2006, TRENDS PLANT SCI, V11, P274, DOI 10.1016/j.tplants.2006.04.008; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Taliercio E, 2006, GENOME, V49, P306, DOI 10.1139/G05-115; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Tomkins JP, 2001, MOL BREEDING, V8, P255, DOI 10.1023/A:1013798716098; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Ulloa M, 2005, J HERED, V96, P132, DOI 10.1093/jhered/esi020; Wang C, 2006, THEOR APPL GENET, V112, P770, DOI 10.1007/s00122-005-0183-0; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Werker E, 2000, ADV BOT RES, V31, P1, DOI 10.1016/S0065-2296(00)31005-9; Wilkins TA, 2005, PHYSIOL PLANTARUM, V124, P295, DOI 10.1111/j.1399-3054.2005.00514.x; Wilkins TA, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P231; Wu AM, 2007, CELL RES, V17, P174, DOI 10.1038/sj.cr.7310119; XU Z, 2008, GENOMICS IN PRESS, V92; Xu ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-108; Xu ZY, 2008, GENOMICS, V92, P173, DOI 10.1016/j.ygeno.2008.05.010; Yamamoto E, 1998, PLANT PHYSIOL, V117, P1525; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; You FM, 2007, BIOINFORMATICS, V23, P240, DOI 10.1093/bioinformatics/btl494; YU J, 2000, CONSTRUCTION COTTON; YU QY, 2009, BMC GENOMICS, V10; Zhao GR, 2001, BIOSCI BIOTECH BIOCH, V65, P2789, DOI 10.1271/bbb.65.2789	82	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14351	10.1371/journal.pone.0014351	http://dx.doi.org/10.1371/journal.pone.0014351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179551	Green Submitted, Green Published, gold			2022-12-27	WOS:000285381200007
J	Kilvaer, TK; Valkov, A; Sorbye, S; Smeland, E; Bremnes, RM; Busund, LT; Donnem, T				Kilvaer, Thomas K.; Valkov, Andrej; Sorbye, Sveinung; Smeland, Eivind; Bremnes, Roy M.; Busund, Lill-Tove; Donnem, Tom			Profiling of VEGFs and VEGFRs as Prognostic Factors in Soft Tissue Sarcoma: VEGFR-3 Is an Independent Predictor of Poor Prognosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; CANCER; EXPRESSION; METASTASIS; MARKER	Background: In non-gastrointestinal stromal tumor soft tissue sarcoma (non-GIST STS) optimal treatment is surgery with wide resection margins. Vascular endothelial growth factors (VEGFs) and receptors (VEGFRs) are known to be key players in the initiation of angiogenesis and lymphangiogenesis. This study investigates the prognostic impact of VEGFs and VEGFRs in non-GIST STS with wide and non-wide resection margins. Methods: Tumor samples from 249 patients with non-GIST STS were obtained and tissue microarrays were constructed for each specimen. Immunohistochemistry was used to evaluate the expressions of VEGF-A, -C and -D and VEGFR-1, -2 and -3. Results: In the univariate analyses, VEGF-A (P = 0.040) in the total material, and VEGF-A (P = 0.018), VEGF-C (P = 0.025) and VEGFR-3 (P = 0.027) in the subgroup with wide resection margins, were significant negative prognostic indicators of disease-specific survival (DSS). In the multivariate analysis, high expression of VEGFR-3 (P = 0.042, HR = 1.907, 95% CI 1.024-3.549) was an independent significant negative prognostic marker for DSS among patients with wide resection margins. Conclusion: VEGFR-3 is a strong and independent negative prognostic marker for non-GIST STSs with wide resection margins.	[Kilvaer, Thomas K.; Valkov, Andrej; Sorbye, Sveinung; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Valkov, Andrej; Sorbye, Sveinung; Busund, Lill-Tove] Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway; [Smeland, Eivind; Bremnes, Roy M.; Donnem, Tom] Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Bremnes, Roy M.; Donnem, Tom] Univ Tromso, Inst Clin Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Kilvaer, TK (corresponding author), Univ Tromso, Inst Med Biol, Tromso, Norway.	tom.donnem@uit.no	Kilvaer, Thomas/AAI-7418-2020; Sorbye, Sveinung Wergeland/AAE-7208-2020	Kilvaer, Thomas/0000-0003-1669-0117; Sorbye, Sveinung Wergeland/0000-0002-8250-3992				Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Chao C, 2001, ANN SURG ONCOL, V8, P260, DOI 10.1007/s10434-001-0260-9; Dickinson IC, 2006, ANZ J SURG, V76, P104, DOI 10.1111/j.1445-2197.2006.03615.x; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; DuBois S, 2007, CANCER-AM CANCER SOC, V109, P813, DOI 10.1002/cncr.22455; Fletcher CDM., 2002, WHO CLASSIFICATION T; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Friedrichs N, 2006, HISTOPATHOLOGY, V49, P87, DOI 10.1111/j.1365-2559.2006.02438.x; Ganjoo K, 2010, CANCER-AM CANCER SOC, V116, P1177, DOI 10.1002/cncr.24859; Graeven U, 1999, J CANCER RES CLIN, V125, P577, DOI 10.1007/s004320050319; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hayes AJ, 2004, BRIT J SURG, V91, P242, DOI 10.1002/bjs.4398; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hoffman AC, 2009, CLIN CANCER RES, V15, P5191, DOI 10.1158/1078-0432.CCR-08-2534; Itakura E, 2008, J SURG ONCOL, V97, P74, DOI 10.1002/jso.20766; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Leong SPL, 2006, CANCER METAST REV, V25, P221, DOI 10.1007/s10555-006-8502-8; McArthur G, 2007, ANN SURG ONCOL, V14, P2876, DOI 10.1245/s10434-007-9480-y; Ribatti D, 2010, EUR J CANCER, V46, P6, DOI 10.1016/j.ejca.2009.10.022; Sleijfer S, 2008, ONCOLOGIST, V13, P1193, DOI 10.1634/theoncologist.2008-0188; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Thway K, 2009, CLIN ONCOL-UK, V21, P695, DOI 10.1016/j.clon.2009.07.016; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Yoon SS, 2004, ANN ONCOL, V15, P1261, DOI 10.1093/annonc/mdh309; Yudoh K, 2001, BRIT J CANCER, V84, P1610, DOI 10.1054/bjoc.2001.1837	28	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15368	10.1371/journal.pone.0015368	http://dx.doi.org/10.1371/journal.pone.0015368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179485	gold, Green Submitted, Green Published			2022-12-27	WOS:000285292500024
J	Dumitrescu, D; Oudiz, RJ; Karpouzas, G; Hovanesyan, A; Jayasinghe, A; Hansen, JE; Rosenkranz, S; Wasserman, K				Dumitrescu, Daniel; Oudiz, Ronald J.; Karpouzas, George; Hovanesyan, Arsen; Jayasinghe, Amali; Hansen, James E.; Rosenkranz, Stephan; Wasserman, Karlman			Developing Pulmonary Vasculopathy in Systemic Sclerosis, Detected with Non-Invasive Cardiopulmonary Exercise Testing	PLOS ONE			English	Article							VENTILATORY EFFICIENCY; ARTERIAL-HYPERTENSION; VENOOCCLUSIVE DISEASE; ANAEROBIC THRESHOLD; HEART-FAILURE; GAS-EXCHANGE; PATHOPHYSIOLOGY; LIMITATION; LUNG	Background: Patients with systemic sclerosis (SSc) may develop exercise intolerance due to musculoskeletal involvement, restrictive lung disease, left ventricular dysfunction, or pulmonary vasculopathy (PV). The latter is particularly important since it may lead to lethal pulmonary arterial hypertension (PAH). We hypothesized that abnormalities during cardiopulmonary exercise testing (CPET) in patients with SSc can identify PV leading to overt PAH. Methods: Thirty SSc patients from the Harbor-UCLA Rheumatology clinic, not clinically suspected of having significant pulmonary vascular disease, were referred for this prospective study. Resting pulmonary function and exercise gas exchange were assessed, including peakVO(2), anaerobic threshold (AT), heart rate-VO2 relationship (O-2-pulse), exercise breathing reserve and parameters of ventilation-perfusion mismatching, as evidenced by elevated ventilatory equivalent for CO2 (VE/VCO2) and reduced end-tidal pCO(2) (PETCO2) at the AT. Results: Gas exchange patterns were abnormal in 16 pts with specific cardiopulmonary disease physiology: Eleven patients had findings consistent with PV, while five had findings consistent with left-ventricular dysfunction (LVD). Although both groups had low peak VO2 and AT, a higher VE/VCO2 at AT and decreasing PETCO2 during early exercise distinguished PV from LVD. Conclusions: Previously undiagnosed exercise impairments due to LVD or PV were common in our SSc patients. Cardiopulmonary exercise testing may help to differentiate and detect these disorders early in patients with SSc.	[Dumitrescu, Daniel; Oudiz, Ronald J.; Karpouzas, George; Hovanesyan, Arsen; Jayasinghe, Amali; Hansen, James E.; Wasserman, Karlman] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Dumitrescu, Daniel; Jayasinghe, Amali; Hansen, James E.; Wasserman, Karlman] Herzzentrum Univ Koeln, Innere Med Klin 3, Div Resp & Crit Care Med & Physiol, Cologne, Germany; [Oudiz, Ronald J.; Hovanesyan, Arsen] Herzzentrum Univ Koeln, Innere Med Klin 3, Div Cardiol, Cologne, Germany; [Karpouzas, George] Herzzentrum Univ Koeln, Innere Med Klin 3, Div Rheumatol, Cologne, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Cologne; University of Cologne; University of Cologne	Dumitrescu, D (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.	daniel.dumitrescu@dd-it.de	Dumitrescu, Daniel/ABG-3576-2020; Karpouzas, George/AAE-3343-2019		Actelion Pharmaceuticals	Actelion Pharmaceuticals	This work was partly supported by an unrestricted grant from Actelion Pharmaceuticals (http://www.actelion.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; [Anonymous], 2008, WMA DECL HELS ETH PR; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Davis JA, 1997, EUR J APPL PHYSIOL O, V76, P157, DOI 10.1007/s004210050228; Deboeck G, 2004, EUR RESPIR J, V23, P747, DOI 10.1183/09031936.04.00111904; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Gitt AK, 2002, CIRCULATION, V106, P3079, DOI 10.1161/01.CIR.0000041428.99427.06; Hansen JE, 2007, CHEST, V132, P977, DOI 10.1378/chest.07-0619; Hansen JE, 2004, CHEST, V126, P816, DOI 10.1378/chest.126.3.816; Hansen JE, 1996, CHEST, V109, P1566, DOI 10.1378/chest.109.6.1566; HUSZCZUK A, 1990, EUR RESPIR J, V3, P465; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Kleber FX, 2000, CIRCULATION, V101, P2803, DOI 10.1161/01.CIR.101.24.2803; Kovacs G, 2009, AM J RESP CRIT CARE, V180, P881, DOI 10.1164/rccm.200904-0563OC; Markowitz DH, 2004, J HEART LUNG TRANSPL, V23, P88, DOI 10.1016/S1053-2498(03)00064-0; MIYAUCHI T, 1993, CIRC RES, V73, P887, DOI 10.1161/01.RES.73.5.887; Montani D, 2008, MEDICINE, V87, P220, DOI 10.1097/MD.0b013e31818193bb; Montani D, 2010, RESP MED, V104, pS23, DOI 10.1016/j.rmed.2010.03.014; Mukerjee D, 2003, ANN RHEUM DIS, V62, P1088, DOI 10.1136/ard.62.11.1088; Nishida M, 2004, J CARDIOVASC PHARM, V44, P187, DOI 10.1097/00005344-200408000-00007; Schwaiblmair M, 1996, CHEST, V110, P1520, DOI 10.1378/chest.110.6.1520; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Tolle JJ, 2008, CIRCULATION, V118, P2183, DOI 10.1161/CIRCULATIONAHA.108.787101; Wasserman K, 2005, PRINCIPLES EXERCISE, P104; Wasserman K, 2007, CHEST, V132, P250, DOI 10.1378/chest.06-2872; Yasunobu Y, 2005, CHEST, V127, P1637, DOI 10.1378/chest.127.5.1637	28	51	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14293	10.1371/journal.pone.0014293	http://dx.doi.org/10.1371/journal.pone.0014293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179195	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900007
J	Ferguson, BS; Nam, H; Hopkins, RG; Morrison, RF				Ferguson, Bradley S.; Nam, Heesun; Hopkins, Robin G.; Morrison, Ron F.			Impact of Reference Gene Selection for Target Gene Normalization on Experimental Outcome Using Real-Time qRT-PCR in Adipocytes	PLOS ONE			English	Article							PPAR-GAMMA; QUANTITATIVE PCR; ADIPOSE CONVERSION; 3T3 ADIPOCYTES; RIBOSOMAL-RNA; BETA-ACTIN; RT-PCR; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION	Background: With the current rise in obesity-related morbidities, real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) has become a widely used method for assessment of genes expressed and regulated by adipocytes. In order to measure accurate changes in relative gene expression and monitor intersample variability, normalization to endogenous control genes that do not change in relative expression is commonly used with qRT-PCR determinations. However, historical evidence has clearly demonstrated that the expression profiles of traditional control genes (e.g., beta-actin, GAPDH, alpha-tubulin) are differentially regulated across multiple tissue types and experimental conditions. Methodology/Principal Findings: Therefore, we validated six commonly used endogenous control genes under diverse experimental conditions of inflammatory stress, oxidative stress, synchronous cell cycle progression and cellular differentiation in 3T3-L1 adipocytes using TaqMan qRT-PCR. Under each study condition, we further evaluated the impact of reference gene selection on experimental outcome using examples of target genes relevant to adipocyte function and differentiation. We demonstrate that multiple reference genes are regulated in a condition-specific manner that is not suitable for use in target gene normalization. Conclusion/Significance: Data are presented demonstrating that inappropriate reference gene selection can have profound influence on study conclusions ranging from divergent statistical outcome to inaccurate data interpretation of significant magnitude. This study validated the use of endogenous controls in 3T3-L1 adipocytes and highlights the impact of inappropriate reference gene selection on data interpretation and study conclusions.	[Ferguson, Bradley S.; Nam, Heesun; Hopkins, Robin G.; Morrison, Ron F.] Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro	Ferguson, BS (corresponding author), Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA.	rfmorris@uncg.edu	Ferguson, Bradley/V-3803-2019	Ferguson, Bradley/0000-0003-0357-6075	National Institutes of Health NIDDK [R15-DK082799, F31-DK847702]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK082799] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Grants R15-DK082799 (RFM) and F31-DK847702 (BSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER M, 1985, J BIOL CHEM, V260, P1978; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2004, AM J RESP CRIT CARE, V169, P1167, DOI 10.1164/ajrccm.169.10.958; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Gorzelniak K, 2001, HORM METAB RES, V33, P625, DOI 10.1055/s-2001-17911; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Taylor DL, 2007, VET IMMUNOL IMMUNOP, V115, P43, DOI 10.1016/j.vetimm.2006.10.007; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TROWBRIDGE IS, 1981, P NATL ACAD SCI-BIOL, V78, P3039, DOI 10.1073/pnas.78.5.3039; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	39	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15208	10.1371/journal.pone.0015208	http://dx.doi.org/10.1371/journal.pone.0015208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179435	Green Published, Green Submitted, gold			2022-12-27	WOS:000285246900033
J	Tesson, B; Hildebrand, M				Tesson, Benoit; Hildebrand, Mark			Extensive and Intimate Association of the Cytoskeleton with Forming Silica in Diatoms: Control over Patterning on the Meso- and Micro-Scale	PLOS ONE			English	Article							VALVE MORPHOGENESIS; CELL-DIVISION; THALASSIOSIRA-PSEUDONANA; WALL MORPHOGENESIS; MICROTUBULE CENTER; ACTIN; BACILLARIOPHYCEAE; BIOSILICA; MORPHOLOGY; BIOMINERALIZATION	Background: The diatom cell wall, called the frustule, is predominantly made out of silica, in many cases with highly ordered nano- and micro-scale features. Frustules are built intracellularly inside a special compartment, the silica deposition vesicle, or SDV. Molecules such as proteins (silaffins and silacidins) and long chain polyamines have been isolated from the silica and shown to be involved in the control of the silica polymerization. However, we are still unable to explain or reproduce in vitro the complexity of structures formed by diatoms. Methods/Principal Finding: In this study, using fluorescence microscopy, scanning electron microscopy, and atomic force microscopy, we were able to compare and correlate microtubules and microfilaments with silica structure formed in diversely structured diatom species. The high degree of correlation between silica structure and actin indicates that actin is a major element in the control of the silica morphogenesis at the meso and microscale. Microtubules appear to be involved in the spatial positioning on the mesoscale and strengthening of the SDV. Conclusions/Significance: These results reveal the importance of top down control over positioning of and within the SDV during diatom wall formation and open a new perspective for the study of the mechanism of frustule patterning as well as for the understanding of the control of membrane dynamics by the cytoskeleton.	[Tesson, Benoit; Hildebrand, Mark] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Tesson, B (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	mhildebrand@ucsd.edu			Air Force Office of Scientific Research Multidisciplinary University Research Initiative [RF00965521]	Air Force Office of Scientific Research Multidisciplinary University Research Initiative(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI)	This work was supported by Air Force Office of Scientific Research Multidisciplinary University Research Initiative Grant RF00965521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANK GS, 1983, J PHYCOL, V19, P39, DOI 10.1111/j.0022-3646.1983.00039.x; COHN SA, 1989, PROTOPLASMA, V149, P130, DOI 10.1007/BF01322985; Davis AK, 2008, METAL IONS LIFE SCI, V4, P255; Del Amo Y, 1999, J PHYCOL, V35, P1162; DRUM RW, 1964, J ULTRA MOL STRUCT R, V10, P217, DOI 10.1016/S0022-5320(64)80006-X; EIKE B, 2009, ANGEW CHEM INT EDIT, V48, P9724; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Higgins MJ, 2003, J PHYCOL, V39, P1181, DOI 10.1111/j.0022-3646.2003.03-027.x; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; Hildebrand M, 2007, J PHYCOL, V43, P730, DOI 10.1111/j.1529-8817.2007.00361.x; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Hildebrand M, 2009, J STRUCT BIOL, V166, P316, DOI 10.1016/j.jsb.2009.02.014; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; Kroger N, 1998, PROTIST, V149, P213, DOI 10.1016/S1434-4610(98)70029-X; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Losic D, 2006, J NANOSCI NANOTECHNO, V6, P982, DOI 10.1166/jnn.2006.174; Losic D, 2007, LANGMUIR, V23, P5014, DOI 10.1021/la062666y; Mann DG, 1984, P 7 INT DIATOM S, P113; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; NORTON TA, 1996, PHYCOLOGIA, V35, P353; Pickett-Heaps JD, 1998, J PHYCOL, V34, P995, DOI 10.1046/j.1529-8817.1998.340995.x; PICKETTHEAPS J, 1983, J PHYCOL, V19, P269, DOI 10.1111/j.0022-3646.1983.00269.x; PICKETTHEAPS J, 1981, EUR J CELL BIOL, V25, P150; PICKETTHEAPS J, 1990, PROGR PHYCOLOGICAL R, P1; PICKETTHEAPS JD, 1988, J PHYCOL, V24, P35; PICKETTHEAPS JD, 1994, PROTOPLASMA, V181, P269, DOI 10.1007/BF01666401; PICKETTHEAPS JD, 1979, BIOL CELLULAIRE, V35, P199; PICKETTHEAPS JD, 1988, PROTOPLASMA, V143, P139, DOI 10.1007/BF01291158; Pollock FM, 2005, CELL MOTIL CYTOSKEL, V60, P71, DOI 10.1002/cm.20044; Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200; Poulsen NC, 1999, CELL MOTIL CYTOSKEL, V44, P23, DOI 10.1002/(SICI)1097-0169(199909)44:1<23::AID-CM2>3.3.CO;2-4; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; ROBINSON DH, 1987, TRENDS BIOCHEM SCI, V12, P151, DOI 10.1016/0968-0004(87)90072-7; Round F. E., 1990, DIATOMS BIOL MORPHOL; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; SCHMID AMM, 1979, PROTOPLASMA, V100, P267, DOI 10.1007/BF01279316; SCHMID AMM, 1983, J PHYCOL, V19, P387, DOI 10.1111/j.0022-3646.1983.00387.x; SCHMID AMM, 1980, NOVA HEDWIGIA, V33, P811; Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2; Sumper M, 2002, SCIENCE, V295, P2430, DOI 10.1126/science.1070026; Tesson B, 2010, J STRUCT BIOL, V169, P62, DOI 10.1016/j.jsb.2009.08.013; Van de Meene AML, 2004, EUR J PHYCOL, V39, P93, DOI 10.1080/09670260310001646522; van de Meene AML, 2002, J PHYCOL, V38, P351, DOI 10.1046/j.1529-8817.2002.01124.x; Walsh CJ, 2007, EUR J CELL BIOL, V86, P85, DOI 10.1016/j.ejcb.2006.10.003; Wenzl S, 2008, ANGEW CHEM INT EDIT, V47, P1729, DOI 10.1002/anie.200704994	49	63	69	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14300	10.1371/journal.pone.0014300	http://dx.doi.org/10.1371/journal.pone.0014300			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21200414	Green Published, Green Submitted, gold			2022-12-27	WOS:000285181400014
J	Bonetti, D; Clerici, M; Manfrini, N; Lucchini, G; Longhese, MP				Bonetti, Diego; Clerici, Michela; Manfrini, Nicola; Lucchini, Giovanna; Longhese, Maria Pia			The MRX Complex Plays Multiple Functions in Resection of Yku- and Rif2-Protected DNA Ends	PLOS ONE			English	Article							DOUBLE-STRAND-BREAK; TELOMERE LENGTH REGULATION; SACCHAROMYCES-CEREVISIAE; DAMAGE RESPONSE; CHECKPOINT ACTIVATION; EXONUCLEASE ACTIVITY; MRE11 COMPLEX; BUDDING YEAST; REPAIR; EXO1	The ends of both double-strand breaks (DSBs) and telomeres undergo tightly regulated 59 to 39 resection. Resection of DNA ends, which is specifically inhibited during the G1 cell cycle phase, requires the MRX complex, Sae2, Sgs1 and Exo1. Moreover, it is negatively regulated by the non-homologous end-joining component Yku and the telomeric protein Rif2. Here, we investigate the nuclease activities that are inhibited at DNA ends by Rif2 and Yku in G1 versus G2 by using an inducible short telomere assay. We show that, in the absence of the protective function of Rif2, resection in G1 depends primarily on MRX nuclease activity and Sae2, whereas Exo1 and Sgs1 bypass the requirement of MRX nuclease activity only if Yku is absent. In contrast, Yku-mediated inhibition is relieved in G2, where resection depends on Mre11 nuclease activity, Exo1 and, to a minor extent, Sgs1. Furthermore, Exo1 compensates for a defective MRX nuclease activity more efficiently in the absence than in the presence of Rif2, suggesting that Rif2 inhibits not only MRX but also Exo1. Notably, the presence of MRX, but not its nuclease activity, is required and sufficient to override Yku-mediated inhibition of Exo1 in G2, whereas it is required but not sufficient in G1. Finally, the integrity of MRX is also necessary to promote Exo1- and Sgs1-dependent resection, possibly by facilitating Exo1 and Sgs1 recruitment to DNA ends. Thus, resection of DNA ends that are protected by Yku and Rif2 involves multiple functions of the MRX complex that do not necessarily require its nuclease activity.	[Bonetti, Diego; Clerici, Michela; Manfrini, Nicola; Lucchini, Giovanna; Longhese, Maria Pia] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy	University of Milano-Bicocca	Bonetti, D (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	mariapia.longhese@unimib.it	Pia, Maria/AAK-2693-2020; Manfrini, Nicola/A-1371-2019; Clerici, Michela/AAK-2807-2020	Longhese, Maria Pia/0000-0003-1726-2034; Bonetti, Diego/0000-0003-4131-8042	Associazione Italiana per la Ricerca sul Cancro [IG5636]; MIUR/Universita di Milano-Bicocca; Fondazione Italiana per la Ricerca sul Cancro	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MIUR/Universita di Milano-Bicocca(Ministry of Education, Universities and Research (MIUR)); Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (grant IG5636) to MPL and Cofinanziamenti 2007 and 2008 MIUR/Universita di Milano-Bicocca to GL and MPL, respectively. DB was supported by a fellowship from Fondazione Italiana per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Bonetti D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000966; Bonetti D, 2009, MOL CELL, V35, P70, DOI 10.1016/j.molcel.2009.05.015; Booth C, 2001, NUCLEIC ACIDS RES, V29, P4414, DOI 10.1093/nar/29.21.4414; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chakhparonian M, 2003, TRENDS GENET, V19, P439, DOI 10.1016/S0168-9525(03)00135-5; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Frank CJ, 2006, MOL CELL, V24, P423, DOI 10.1016/j.molcel.2006.10.020; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hirano Y, 2009, MOL CELL, V33, P312, DOI 10.1016/j.molcel.2008.12.027; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Longhese MP, 2006, MOL MICROBIOL, V60, P1099, DOI 10.1111/j.1365-2958.2006.05186.x; Longhese MP, 2010, EMBO J, V29, P2864, DOI 10.1038/emboj.2010.165; Lydall D, 2009, EMBO J, V28, P2174, DOI 10.1038/emboj.2009.176; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moreau S, 1999, MOL CELL BIOL, V19, P556; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Putnam CD, 2009, DNA REPAIR, V8, P974, DOI 10.1016/j.dnarep.2009.04.021; Rattray AJ, 2001, GENETICS, V158, P109; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Viscardi V, 2007, MOL BIOL CELL, V18, P3047, DOI 10.1091/mbc.E07-03-0285; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; Vodenicharov MD, 2010, EMBO J, V29, P3007, DOI 10.1038/emboj.2010.155; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	56	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14142	10.1371/journal.pone.0014142	http://dx.doi.org/10.1371/journal.pone.0014142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152442	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100022
J	Denkova, E; Wong, G; Dolcos, S; Sung, K; Wang, LH; Coupland, N; Dolcos, F				Denkova, Ekaterina; Wong, Gloria; Dolcos, Sanda; Sung, Keen; Wang, Lihong; Coupland, Nicholas; Dolcos, Florin			The Impact of Anxiety-Inducing Distraction on Cognitive Performance: A Combined Brain Imaging and Personality Investigation	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; WORKING-MEMORY; PREFRONTAL CORTEX; SOCIAL ANXIETY; NEURAL SYSTEMS; INDIVIDUAL-DIFFERENCES; EMOTIONAL REACTIVITY; INCREASED AMYGDALA; SEX-DIFFERENCES; FRONTAL-CORTEX	Background: Previous investigations revealed that the impact of task-irrelevant emotional distraction on ongoing goal-oriented cognitive processing is linked to opposite patterns of activation in emotional and perceptual vs. cognitive control/executive brain regions. However, little is known about the role of individual variations in these responses. The present study investigated the effect of trait anxiety on the neural responses mediating the impact of transient anxiety-inducing task-irrelevant distraction on cognitive performance, and on the neural correlates of coping with such distraction. We investigated whether activity in the brain regions sensitive to emotional distraction would show dissociable patterns of co-variation with measures indexing individual variations in trait anxiety and cognitive performance. Methodology/Principal Findings: Event-related fMRI data, recorded while healthy female participants performed a delayed-response working memory (WM) task with distraction, were investigated in conjunction with behavioural measures that assessed individual variations in both trait anxiety and WM performance. Consistent with increased sensitivity to emotional cues in high anxiety, specific perceptual areas (fusiform gyrus - FG) exhibited increased activity that was positively correlated with trait anxiety and negatively correlated with WM performance, whereas specific executive regions (right lateral prefrontal cortex - PFC) exhibited decreased activity that was negatively correlated with trait anxiety. The study also identified a role of the medial and left lateral PFC in coping with distraction, as opposed to reflecting a detrimental impact of emotional distraction. Conclusions: These findings provide initial evidence concerning the neural mechanisms sensitive to individual variations in trait anxiety and WM performance, which dissociate the detrimental impact of emotion distraction and the engagement of mechanisms to cope with distracting emotions. Our study sheds light on the neural correlates of emotion-cognition interactions in normal behaviour, which has implications for understanding factors that may influence susceptibility to affective disorders, in general, and to anxiety disorders, in particular.	[Denkova, Ekaterina; Sung, Keen; Coupland, Nicholas] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada; [Wong, Gloria] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Dolcos, Sanda; Dolcos, Florin] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA; [Wang, Lihong] Duke Univ, Brain Imaging & Anal Ctr, Durham, NC USA; [Dolcos, Florin] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Alberta; University of Alberta; University of Illinois System; University of Illinois Urbana-Champaign; Duke University; University of Illinois System; University of Illinois Urbana-Champaign	Denkova, E (corresponding author), Univ Alberta, Dept Psychiat, Edmonton, AB, Canada.	fdolcos@uiuc.edu	Wang, Lihong/D-8960-2011; Denkova, Ekaterina/AAY-4298-2020; Dolcos, Florin/GZL-8448-2022	Denkova, Ekaterina/0000-0001-9113-719X; Dolcos, Florin/0000-0003-2230-4139; Dolcos, Sanda/0000-0002-7646-8246	University Hospital Foundation; National Alliance for Research on Schizophrenia and Depression; Canadian Psychiatric Research Foundation; Wyeth-CIHR	University Hospital Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); Canadian Psychiatric Research Foundation; Wyeth-CIHR(Canadian Institutes of Health Research (CIHR))	This research was supported by a Research Grant from the University Hospital Foundation (to FD). FD was supported by a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression and a Research Award from the Canadian Psychiatric Research Foundation. ED was supported by a Wyeth-CIHR Post-Doctoral Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Anticevic A, 2010, COGN AFFECT BEHAV NE, V10, P159, DOI 10.3758/CABN.10.2.159; Banich MT, 2009, NEUROSCI BIOBEHAV R, V33, P613, DOI 10.1016/j.neubiorev.2008.09.010; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Bekker MHJ, 2007, GENDER MED, V4, pS178, DOI 10.1016/S1550-8579(07)80057-X; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bruning JL., 1997, COMPUTATIONAL HDB ST, V4th ed.; Compton RJ, 2000, NEUROPSYCHOLOGY, V14, P254, DOI 10.1037//0894-4105.14.2.254; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Dolcos F, 2008, NEUROPSYCHOLOGIA, V46, P326, DOI 10.1016/j.neuropsychologia.2007.07.010; Dolcos F, 2007, BRAIN RES, V1152, P171, DOI 10.1016/j.brainres.2007.03.059; Dolcos F, 2006, NEUROREPORT, V17, P1591, DOI 10.1097/01.wnr.0000236860.24081.be; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Evans KC, 2008, DEPRESS ANXIETY, V25, P496, DOI 10.1002/da.20347; Ewbank MP, 2009, NEUROIMAGE, V44, P1144, DOI 10.1016/j.neuroimage.2008.09.056; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Eysenck MW, 2005, COGNITION EMOTION, V19, P1214, DOI 10.1080/02699930500260245; EYSENCK MW, 1992, COGNITION EMOTION, V6, P409, DOI 10.1080/02699939208409696; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; Fisher R., 1950, STAT METHODS RES WOR; Gentili C, 2008, BRAIN RES BULL, V77, P286, DOI 10.1016/j.brainresbull.2008.08.003; Goel V, 2003, NEUROIMAGE, V20, P2314, DOI 10.1016/j.neuroimage.2003.07.027; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Heatherton TF, 2004, CURR DIR PSYCHOL SCI, V13, P190, DOI 10.1111/j.0963-7214.2004.00305.x; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Lieberman MD, 2009, PERSPECT PSYCHOL SCI, V4, P299, DOI 10.1111/j.1745-6924.2009.01128.x; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Macmillian N.A., 1991, DETECTION THEORY USE; Mak AKY, 2009, NEUROPSYCHOLOGIA, V47, P2900, DOI 10.1016/j.neuropsychologia.2009.06.017; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morey RA, 2008, PSYCHIAT RES-NEUROIM, V162, P59, DOI 10.1016/j.pscychresns.2007.07.007; Morey RA, 2009, J PSYCHIATR RES, V43, P809, DOI 10.1016/j.jpsychires.2008.10.014; Nitschke JB, 2005, INT REV NEUROBIOL, V67, P1, DOI 10.1016/S0074-7742(05)67001-8; Northoff G, 2004, HUM BRAIN MAPP, V21, P202, DOI 10.1002/hbm.20002; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Pujol J, 2009, PSYCHOL MED, V39, P1177, DOI 10.1017/S003329170800500X; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rytwinski NK, 2009, DEPRESS ANXIETY, V26, P34, DOI 10.1002/da.20503; Shields S.A, 1991, INT REV STUDIES EMOT, P227; Simon-Thomas ER, 2005, J COGNITIVE NEUROSCI, V17, P518, DOI 10.1162/0898929053279504; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stein MB, 2002, ARCH GEN PSYCHIAT, V59, P1027, DOI 10.1001/archpsyc.59.11.1027; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Straube T, 2005, NEUROPSYCHOBIOLOGY, V52, P163, DOI 10.1159/000087987; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; TOTTENHAM N, 2002, SAN FRANC ANN M COGN; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; Venkatraman V, 2009, J NEUROSCI, V29, P13158, DOI 10.1523/JNEUROSCI.2708-09.2009; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	74	61	62	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14150	10.1371/journal.pone.0014150	http://dx.doi.org/10.1371/journal.pone.0014150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	687DK	21152391	Green Published, gold			2022-12-27	WOS:000284755100029
J	Feng, JH; Li, MF; Huang, YZ; Xiao, Y				Feng, Jianhui; Li, Mingfeng; Huang, Yanzhao; Xiao, Yi			Symmetric Key Structural Residues in Symmetric Proteins with Beta-Trefoil Fold	PLOS ONE			English	Article							AMINO-ACID-SEQUENCES; RICIN B-CHAIN; GENE DUPLICATION; STRUCTURE ALIGNMENT; NONLINEAR-ANALYSIS; EVOLUTION; FAMILY; PATTERNS; SCAFFOLD; KUNITZ	To understand how symmetric structures of many proteins are formed from asymmetric sequences, the proteins with two repeated beta-trefoil domains in Plant Cytotoxin B-chain family and all presently known beta-trefoil proteins are analyzed by structure-based multi-sequence alignments. The results show that all these proteins have similar key structural residues that are distributed symmetrically in their structures. These symmetric key structural residues are further analyzed in terms of inter-residues interaction numbers and B-factors. It is found that they can be distinguished from other residues and have significant propensities for structural framework. This indicates that these key structural residues may conduct the formation of symmetric structures although the sequences are asymmetric.	[Feng, Jianhui; Li, Mingfeng; Huang, Yanzhao; Xiao, Yi] Huazhong Univ Sci & Technol, Dept Phys, Biophys & Mol Modeling Grp, Wuhan 430074, Peoples R China; [Li, Mingfeng] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Li, Mingfeng] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA	Huazhong University of Science & Technology; Yale University; Yale University	Feng, JH (corresponding author), Huazhong Univ Sci & Technol, Dept Phys, Biophys & Mol Modeling Grp, Wuhan 430074, Peoples R China.	yxiao@mail.hust.edu.cn			National Natural Science Foundation of China [30870678, 11074084, 30525037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported partly by the National Natural Science Foundation of China (www.nsfc.gov.cn) under Grant No. 30870678, 11074084 and 30525037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Brych SR, 2001, PROTEIN SCI, V10, P2587, DOI 10.1110/ps.ps.34701; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Chen CJ, 2007, BIOPOLYMERS, V85, P28, DOI 10.1002/bip.20600; Chen CJ, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.041926; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Giuliani A, 2002, CHEM REV, V102, P1471, DOI 10.1021/cr0101499; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Huang YZ, 2007, CHAOS SOLITON FRACT, V34, P782, DOI 10.1016/j.chaos.2006.03.080; Huang YZ, 2007, PROTEINS, V68, P267, DOI 10.1002/prot.21330; Ji XF, 2007, COMPUT BIOL CHEM, V31, P61, DOI 10.1016/j.compbiolchem.2007.01.002; KUMAR S, 2004, BRIEF BIOINFORMATICS; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Laskin AA, 2005, COMPUT BIOL CHEM, V29, P229, DOI 10.1016/j.compbiolchem.2005.04.003; Li MF, 2005, CHAOS SOLITON FRACT, V25, P491, DOI 10.1016/j.chaos.2004.11.049; Li MF, 2008, PROTEINS, V72, P1161, DOI 10.1002/prot.22010; Li TP, 2003, PROTEIN ENG, V16, P323, DOI 10.1093/protein/gzg044; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCLACHLAN AD, 1976, J MOL BIOL, V107, P159, DOI 10.1016/S0022-2836(76)80024-1; MCLACHLAN AD, 1979, J MOL BIOL, V133, P557, DOI 10.1016/0022-2836(79)90408-X; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Rackovsky S, 1998, P NATL ACAD SCI USA, V95, P8580, DOI 10.1073/pnas.95.15.8580; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Shih ESC, 2004, PROTEINS, V56, P519, DOI 10.1002/prot.20124; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; STILL VC, 1990, J AM CHEM SOC, V112, P6127; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang XC, 2008, J MOL GRAPH MODEL, V26, P829, DOI 10.1016/j.jmgm.2007.04.014; Xu RZ, 2005, COMPUT BIOL CHEM, V29, P79, DOI 10.1016/j.compbiolchem.2004.12.003; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	39	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14138	10.1371/journal.pone.0014138	http://dx.doi.org/10.1371/journal.pone.0014138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152439	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100019
J	Hernandez, G; Breton, YA; Conover, K; Shizgal, P				Hernandez, Giovanni; Breton, Yannick-Andre; Conover, Kent; Shizgal, Peter			At What Stage of Neural Processing Does Cocaine Act to Boost Pursuit of Rewards?	PLOS ONE			English	Article							BRAIN-STIMULATION REWARD; MEDIAL FOREBRAIN-BUNDLE; INTRACRANIAL SELF-STIMULATION; NUCLEUS-ACCUMBENS DOPAMINE; TRAIN-DURATION THRESHOLDS; DECISION-MAKING; ELECTRICAL-STIMULATION; PARAMETRIC ANALYSIS; MATCHING LAW; RAT	Dopamine-containing neurons have been implicated in reward and decision making. One element of the supporting evidence is that cocaine, like other drugs that increase dopaminergic neurotransmission, powerfully potentiates reward seeking. We analyze this phenomenon from a novel perspective, introducing a new conceptual framework and new methodology for determining the stage(s) of neural processing at which drugs, lesions and physiological manipulations act to influence reward-seeking behavior. Cocaine strongly boosts the proclivity of rats to work for rewarding electrical brain stimulation. We show that the conventional conceptual framework and methods do not distinguish between three conflicting accounts of how the drug produces this effect: increased sensitivity of brain reward circuitry, increased gain, or decreased subjective reward costs. Sensitivity determines the stimulation strength required to produce a reward of a given intensity (a measure analogous to the K-M of an enzyme) whereas gain determines the maximum intensity attainable (a measure analogous to the v(max) of an enzyme-catalyzed reaction). To distinguish sensitivity changes from the other determinants, we measured and modeled reward seeking as a function of both stimulation strength and opportunity cost. The principal effect of cocaine was a two-fourfold increase in willingness to pay for the electrical reward, an effect consistent with increased gain or decreased subjective cost. This finding challenges the long-standing view that cocaine increases the sensitivity of brain reward circuitry. We discuss the implications of the results and the analytic approach for theories of how dopaminergic neurons and other diffuse modulatory brain systems contribute to reward pursuit, and we explore the implications of the conceptual framework for the study of natural rewards, drug reward, and mood.	[Hernandez, Giovanni] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Breton, Yannick-Andre; Conover, Kent; Shizgal, Peter] Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada	University System of Maryland; University of Maryland Baltimore; Concordia University - Canada	Hernandez, G (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	peter.shizgal@concordia.ca	Shizgal, Peter/V-5602-2019; Shizgal, Peter/H-9823-2013	Shizgal, Peter/0000-0003-4265-0792; 	Canadian Institutes of Health Research [MOP-74577]; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	The research was supported by a grant to PS from the Canadian Institutes of Health Research (#MOP-74577) and by a group grant from the "Fonds de la Recherche en Sante du Quebec'' to the "Groupe de Recherche en Neurobiologie Comportementale''/Center for Studies in Behavioural Neurobiology (Barbara Woodside, p.i.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; American Psychiatric Association American Psychiatric Association Task Force on DSM-IV, 2000, DIAGN STAT MAN MENT; Anderson RM, 1996, BRAIN RES, V718, P83, DOI 10.1016/0006-8993(96)00038-8; Aragona BJ, 2008, J NEUROSCI, V28, P8821, DOI 10.1523/JNEUROSCI.2225-08.2008; Arvanitogiannis A, 2008, BEHAV NEUROSCI, V122, P1126, DOI 10.1037/a0012679; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bauco P, 1997, J PHARMACOL EXP THER, V283, P1160; BAUM WM, 1969, J EXP ANAL BEHAV, V12, P861, DOI 10.1901/jeab.1969.12-861; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Breton YA, 2009, BEHAV BRAIN RES, V202, P77, DOI 10.1016/j.bbr.2009.03.019; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cheer JF, 2005, P NATL ACAD SCI USA, V102, P19150, DOI 10.1073/pnas.0509607102; Cheer JF, 2007, NEURON, V54, P237, DOI 10.1016/j.neuron.2007.03.021; CHUHMA N, 2005, CELLSCIENCE REV, V2; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P537, DOI 10.1037/0735-7044.108.3.537; CROW TJ, 1970, LIFE SCI, V9, P375, DOI 10.1016/0024-3205(70)90190-6; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; EDMONDS DE, 1974, J COMP PHYSIOL PSYCH, V87, P876, DOI 10.1037/h0037217; EDMONDS DE, 1977, J COMP PHYSIOL PSYCH, V91, P962, DOI 10.1037/h0077391; Efron B, 1993, INTRO BOOTSTRAP, pxvi; ESPOSITO R, 1977, SCIENCE, V195, P189, DOI 10.1126/science.831268; ESPOSITO RU, 1978, PHARMACOL BIOCHEM BE, V8, P437, DOI 10.1016/0091-3057(78)90082-5; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; FIORILLO C, 2010, ATTENTION TIME, P273; FOURIEZOS G, 1990, BEHAV BRAIN RES, V37, P1, DOI 10.1016/0166-4328(90)90066-N; FRANK RA, 1985, PHARMACOL BIOCHEM BE, V22, P527, DOI 10.1016/0091-3057(85)90269-2; FRANK RA, 1988, PHARMACOL BIOCHEM BE, V29, P755, DOI 10.1016/0091-3057(88)90199-2; FULTON S, 2006, BEHAV BRAIN RES; GALLISTEL CR, 1981, PSYCHOL REV, V88, P228, DOI 10.1037/0033-295X.88.3.228; GALLISTEL CR, 1974, J COMP PHYSIOL PSYCH, V87, P848, DOI 10.1037/h0037220; GALLISTEL CR, 1978, J COMP PHYSIOL PSYCH, V92, P977, DOI 10.1037/h0077513; Glimcher PW, 2003, BRADFORD BOOKS, P205; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; GREEN L, 1991, J EXP ANAL BEHAV, V55, P133, DOI 10.1901/jeab.1991.55-133; GRENHOFF J, 1993, J NEURAL TRANSM-GEN, V93, P11, DOI 10.1007/BF01244934; Hayes DJ, 2009, EUR J PHARMACOL, V604, P74, DOI 10.1016/j.ejphar.2008.12.023; Hayes DJ, 2009, BEHAV BRAIN RES, V197, P323, DOI 10.1016/j.bbr.2008.08.034; HERNANDEZ GA, 2009, WHAT STAGE PROCESSIN; Hernandez G, 2008, J NEUROSCI METH, V175, P79, DOI 10.1016/j.jneumeth.2008.08.005; Hernandez G, 2006, BEHAV NEUROSCI, V120, P888, DOI 10.1037/0735-7044.120.4.888; HERRNSTE.RJ, 1974, J EXP ANAL BEHAV, V21, P159, DOI 10.1901/jeab.1974.21-159; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; HEYMAN G, 1988, BIOL DETERMINANTS RE, V7, P157; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Ishida Y, 2001, EUR J NEUROSCI, V13, P1600, DOI 10.1046/j.0953-816x.2001.01520.x; Iversen L, 2000, MOL PSYCHIATR, V5, P357, DOI 10.1038/sj.mp.4000728; KEESEY RE, 1968, J EXP ANAL BEHAV, V11, P293, DOI 10.1901/jeab.1968.11-293; KILLEEN P, 1972, J EXP ANAL BEHAV, V17, P489, DOI 10.1901/jeab.1972.17-489; KIM K, 2010, OPTICAL ACTIVATION D; KOKKINIDIS L, 1990, PHARMACOL BIOCHEM BE, V36, P463, DOI 10.1016/0091-3057(90)90242-A; LEON M, 1992, BEHAV BRAIN RES, V52, P183, DOI 10.1016/S0166-4328(05)80229-3; LIEBMAN JM, 1974, N-S ARCH PHARMACOL, V284, P167, DOI 10.1007/BF00501121; Lin Y, 2007, NEUROPSYCHOPHARMACOL, V32, P835, DOI 10.1038/sj.npp.1301145; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; MILIARESSIS E, 1986, PHYSIOL BEHAV, V37, P85, DOI 10.1016/0031-9384(86)90388-4; MILLER HL, 1976, J EXP ANAL BEHAV, V26, P335, DOI 10.1901/jeab.1976.26-335; Milstein DM, 2007, J NEUROSCI, V27, P4810, DOI 10.1523/JNEUROSCI.0577-07.2007; Moisan J, 1998, BRAIN RES, V786, P143, DOI 10.1016/S0006-8993(97)01457-1; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; OLDS J, 1956, SCIENCE, V124, P265, DOI 10.1126/science.124.3215.265; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; OLDS J, 1958, J COMP PHYSIOL PSYCH, V51, P675, DOI 10.1037/h0039616; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Petry NM, 1997, BEHAV PROCESS, V39, P39, DOI 10.1016/S0376-6357(96)00043-5; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shizgal P, 2001, INT J OBESITY, V25, pS17, DOI 10.1038/sj.ijo.0801906; Shizgal P, 1996, CURR DIR PSYCHOL SCI, V5, P37, DOI 10.1111/1467-8721.ep10772715; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Shizgal P., 1989, NEUROPHARMACOLOGICAL, P106; SIMMONS JM, 1994, BEHAV NEUROSCI, V108, P151, DOI 10.1037/0735-7044.108.1.151; SOLOMON RB, 2007, ESTIMATION SUBJECTIV; Sonnenschein B, 2003, BEHAV NEUROSCI, V117, P978, DOI 10.1037/0735-7044.117.5.978; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Steffensen SC, 2008, EUR J NEUROSCI, V28, P2028, DOI 10.1111/j.1460-9568.2008.06479.x; Sutton MA, 1999, PSYCHOPHARMACOLOGY, V144, P95, DOI 10.1007/s002130050982; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Trepel C, 2005, COGNITIVE BRAIN RES, V23, P34, DOI 10.1016/j.cogbrainres.2005.01.016; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; VALENSTEIN ES, 1964, J COMP PHYSIOL PSYCH, V57, P52, DOI 10.1037/h0048638; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; WISE RA, 1980, PHARMACOL BIOCHEM BE, V13, P213, DOI 10.1016/S0091-3057(80)80033-5; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; YEOMANS JS, 1988, BRAIN RES, V450, P86, DOI 10.1016/0006-8993(88)91547-8; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	101	43	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15081	10.1371/journal.pone.0015081	http://dx.doi.org/10.1371/journal.pone.0015081			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152097	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000284755100064
J	Mokry, M; Hatzis, P; de Bruijn, E; Koster, J; Versteeg, R; Schuijers, J; van de Wetering, M; Guryev, V; Clevers, H; Cuppen, E				Mokry, Michal; Hatzis, Pantelis; de Bruijn, Ewart; Koster, Jan; Versteeg, Rogier; Schuijers, Jurian; van de Wetering, Marc; Guryev, Victor; Clevers, Hans; Cuppen, Edwin			Efficient Double Fragmentation ChIP-seq Provides Nucleotide Resolution Protein-DNA Binding Profiles	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; GENOME-WIDE ANALYSIS; BETA-CATENIN; SITES	Immunoprecipitated crosslinked protein-DNA fragments typically range in size from several hundred to several thousand base pairs, with a significant part of chromatin being much longer than the optimal length for next-generation sequencing (NGS) procedures. Because these larger fragments may be non-random and represent relevant biology that may otherwise be missed, but also because they represent a significant fraction of the immunoprecipitated material, we designed a double-fragmentation ChIP-seq procedure. After conventional crosslinking and immunoprecipitation, chromatin is de-crosslinked and sheared a second time to concentrate fragments in the optimal size range for NGS. Besides the benefits of increased chromatin yields, the procedure also eliminates a laborious size-selection step. We show that the double-fragmentation ChIP-seq approach allows for the generation of biologically relevant genome-wide protein-DNA binding profiles from sub-nanogram amounts of TCF7L2/TCF4, TBP and H3K4me3 immunoprecipitated material. Although optimized for the AB/SOLiD platform, the same approach may be applied to other platforms.	[Mokry, Michal; Hatzis, Pantelis; de Bruijn, Ewart; Schuijers, Jurian; van de Wetering, Marc; Guryev, Victor; Clevers, Hans; Cuppen, Edwin] Hubrecht Inst, Canc Genom Ctr, Utrecht, Netherlands; [Cuppen, Edwin] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Mokry, M (corresponding author), Hubrecht Inst, Canc Genom Ctr, Utrecht, Netherlands.	e.cuppen@hubrecht.e	Versteeg, Rogier/AAQ-1765-2020; Koster, Jan/C-5934-2008; Mokry, Michal/AAN-3809-2021; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; Mokry, Michal/B-6695-2011	Koster, Jan/0000-0002-0890-7585; Mokry, Michal/0000-0002-5298-4852; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Guryev, Victor/0000-0002-5810-6022; Schuijers, Jurian/0000-0003-2531-3516; Versteeg, Rogier/0000-0001-7172-0388	Cancer Genomics Center (Netherlands Genomics Initiative); Human Frontier Science Program Organization	Cancer Genomics Center (Netherlands Genomics Initiative); Human Frontier Science Program Organization(Human Frontier Science Program)	This work was financially supported by the Cancer Genomics Center (Netherlands Genomics Initiative). P. H. was supported by a Human Frontier Science Program Organization long-term fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Teytelman L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006700; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	24	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15092	10.1371/journal.pone.0015092	http://dx.doi.org/10.1371/journal.pone.0015092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152096	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100068
J	Ralhan, R; He, HCH; So, AKC; Tripathi, SC; Kumar, M; Hasan, MR; Kaur, J; Kashat, L; MacMillan, C; Chauhan, SS; Freeman, JL; Walfish, PG				Ralhan, Ranju; He, Helen C. -H.; So, Anthony K. -C.; Tripathi, Satyendra C.; Kumar, Manish; Hasan, Md. Raghibul; Kaur, Jatinder; Kashat, Lawrence; MacMillan, Christina; Chauhan, Shyam Singh; Freeman, Jeremy L.; Walfish, Paul G.			Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; METASTATIC BREAST-CANCER; MONOCLONAL-ANTIBODY; EPCAM EXPRESSION; ADHESION MOLECULE; COLORECTAL-CANCER; RANDOMIZED-TRIAL; ADJUVANT THERAPY; POOR-PROGNOSIS; ANTIGEN EPCAM	Background: We previously demonstrated that nuclear and cytoplasmic accumulation of the intracellular domain (Ep-ICD) of epithelial cell adhesion molecule (EpCAM) accompanied by a reciprocal reduction of its extracellular domain (EpEx), occurs in aggressive thyroid cancers. This study was designed to determine whether similar accumulation of Ep-ICD is a common event in other epithelial cancers. Methodology and Results: Ten epithelial cancers were immunohistochemically analyzed using Ep-ICD and EpEx domain-specific antibodies. The subcellular localization of EpEx and Ep-ICD in the human colon adenocarcinoma cell line CX-1 was observed using immunofluorescence. Nuclear and cytoplasmic Ep-ICD expression was increased in cancers of the breast (31 of 38 tissues, 82%), prostate (40 of 49 tissues, 82%), head and neck (37 of 57 tissues, 65%) and esophagus (17 of 46 tissues, 37%) compared to their corresponding normal tissues that showed membrane localization of the protein. Importantly, Ep-ICD was not detected in the nuclei of epithelial cells in most normal tissues. High nuclear and cytoplasmic Ep-ICD accumulation also occurred in the other six epithelial cancer types analyzed-lung, colon, liver, bladder, pancreatic, and ovarian. A concomitant reduction in membrane EpEx expression was observed in a subset of all cancer types. Receiver operating characteristic curve analysis revealed nuclear Ep-ICD distinguished breast cancers with 82% sensitivity and 100% specificity and prostate cancers with 82% sensitivity and 78% specificity. Similar findings were observed for cytoplasmic accumulation of Ep-ICD in these cancers. We provide clinical evidence of increased nuclear and cytoplasmic Ep-ICD accumulation and a reduction in membranous EpEx in these cancers. Conclusions: Increased nuclear and cytoplasmic Ep-ICD was observed in all epithelial cancers analyzed and distinguished them from normal tissues with high-sensitivity, specificity, and AUC. Development of a robust high throughput assay for Ep-ICD will facilitate the determination of its diagnostic, prognostic and therapeutic relevance in epithelial cancers.	[Ralhan, Ranju; Freeman, Jeremy L.; Walfish, Paul G.] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg Program, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; He, Helen C. -H.; So, Anthony K. -C.; Kashat, Lawrence; Walfish, Paul G.] Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Freeman, Jeremy L.; Walfish, Paul G.] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Freeman, Jeremy L.; Walfish, Paul G.] Univ Toronto, Sch Med, Toronto, ON M5S 1A1, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5S 1A1, Canada; [Ralhan, Ranju; Tripathi, Satyendra C.; Kumar, Manish; Hasan, Md. Raghibul; Kaur, Jatinder; Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Ralhan, Ranju; Kashat, Lawrence; Walfish, Paul G.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Toronto	Ralhan, R (corresponding author), Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg Program, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada.	rralhan@mtsinai.on.ca; pwalfish@mtsinai.on.ca	Tripathi, Satyendra Chandra/L-9352-2017; Kumar, Manish/L-3404-2019; Bhurji, Jatinder K/B-6767-2013	Tripathi, Satyendra Chandra/0000-0003-3917-9645; Kaur, Jatinder/0000-0003-1650-0707	Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Mount Sinai Hospital Department of Medicine; Alex and Simona Shnaider Laboratory in Molecular Oncology; Temmy Latner Dynacare Family Foundation	Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Mount Sinai Hospital Department of Medicine; Alex and Simona Shnaider Laboratory in Molecular Oncology; Temmy Latner Dynacare Family Foundation	This work was financially supported by the Mount Sinai Foundation of Toronto, Da Vinci Gala Fundraiser, Alex and Simona Shnaider Chair in Thyroid Cancer, Mount Sinai Hospital Department of Medicine Research Fund, Alex and Simona Shnaider Laboratory in Molecular Oncology, and Temmy Latner Dynacare Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Antolovic D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-35; Carpenter G, 2009, CANCER CELL, V15, P165, DOI 10.1016/j.ccr.2009.02.005; Cimino A, 2010, BREAST CANCER RES TR, V123, P701, DOI 10.1007/s10549-009-0671-z; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Du WQ, 2009, J CANCER RES CLIN, V135, P1277, DOI 10.1007/s00432-009-0569-5; El-Sahwi K, 2010, MOL CANCER THER, V9, P57, DOI 10.1158/1535-7163.MCT-09-0675; Fields ALA, 2009, J CLIN ONCOL, V27, P1941, DOI 10.1200/JCO.2008.18.5710; Gires O, 2010, J CLIN ONCOL, V28, pE239, DOI 10.1200/JCO.2009.26.8540; Kimura H, 2007, INT J ONCOL, V30, P171; Kurtz JE, 2010, EXPERT OPIN BIOL TH, V10, P951, DOI 10.1517/14712598.2010.482098; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Raffel A, 2010, EUR J ENDOCRINOL, V162, P391, DOI 10.1530/EJE-08-0916; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; RIETHMULLER G, 1994, LANCET, V343, P1177, DOI 10.1016/S0140-6736(94)92398-1; Riethmuller G, 1998, J CLIN ONCOL, V16, P1788, DOI 10.1200/JCO.1998.16.5.1788; Schmelzer E, 2008, FRONT BIOSCI-LANDMRK, V13, P3096, DOI 10.2741/2911; Schmidt M, 2010, ANN ONCOL, V21, P275, DOI 10.1093/annonc/mdp314; Schmoll HJ, 2009, J CLIN ONCOL, V27, P1926, DOI 10.1200/JCO.2008.20.6284; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Terris B, 2010, J HEPATOL, V52, P280, DOI 10.1016/j.jhep.2009.10.026; Trzpis M, 2008, FRONT BIOSCI-LANDMRK, V13, P5050, DOI 10.2741/3063; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Weismann P, 2009, NEOPLASMA, V56, P230; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924	37	32	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14130	10.1371/journal.pone.0014130	http://dx.doi.org/10.1371/journal.pone.0014130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152431	Green Published, gold, Green Submitted			2022-12-27	WOS:000284755100011
J	Zeng, YF; Liao, WJ; Petit, RJ; Zhang, DY				Zeng, Yan-Fei; Liao, Wan-Jin; Petit, Remy J.; Zhang, Da-Yong			Exploring Species Limits in Two Closely Related Chinese Oaks	PLOS ONE			English	Article							PETRAEA MATT. LIEBL.; QUERCUS-ROBUR L; MULTILOCUS GENOTYPE DATA; INTERSPECIFIC GENE FLOW; EUROPEAN WHITE OAKS; POPULATION-STRUCTURE; HYBRID ZONE; MICROSATELLITE LOCI; PUBESCENS WILLD.; DNA VARIATION	Background: The species status of two closely related Chinese oaks, Quercus liaotungensis and Q. mongolica, has been called into question. The objective of this study was to investigate the species status and to estimate the degree of introgression between the two taxa using different approaches. Methodology/Principal Findings: Using SSR (simple sequence repeat) and AFLP (amplified fragment length polymorphism) markers, we found that interspecific genetic differentiation is significant and higher than the differentiation among populations within taxa. Bayesian clusters, principal coordinate analysis and population genetic distance trees all classified the oaks into two main groups consistent with the morphological differentiation of the two taxa rather than with geographic locations using both types of markers. Nevertheless, a few individuals in Northeast China and many individuals in North China have hybrid ancestry according to Bayesian assignment. One SSR locus and five AFLPs are significant outliers against neutral expectations in the interspecific F(ST) simulation analysis, suggesting a role for divergent selection in differentiating species. Main Conclusions/Significance: All results based on SSRs and AFLPs reached the same conclusion: Q. liaotungensis and Q. mongolica maintain distinct gene pools in most areas of sympatry. They should therefore be considered as discrete taxonomic units. Yet, the degree of introgression varies between the two species in different contact zones, which might be caused by different population history or by local environmental factors.	[Zeng, Yan-Fei] Chinese Acad Forestry, Res Inst Forestry, Key Lab Silviculture, State Forestry Adm, Beijing, Peoples R China; [Zeng, Yan-Fei; Liao, Wan-Jin; Zhang, Da-Yong] Beijing Normal Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Coll Life Sci, Beijing 100875, Peoples R China; [Petit, Remy J.] INRA, UMR Biodivers Genes & Ecosyst, Cestas, France; [Petit, Remy J.] Univ Bordeaux, UMR Biodivers Genes & Ecosyst, Cestas, France	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Beijing Normal University; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Zeng, YF (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Key Lab Silviculture, State Forestry Adm, Beijing, Peoples R China.	zhangdy@bnu.edu.cn	Petit, Remy/AAD-9078-2019; Zhang, Da-Yong/B-3078-2011; Petit, Rémy/A-8842-2008	Zhang, Da-Yong/0000-0003-1056-8735; Petit, Rémy/0000-0002-4809-1453	National Natural Science Foundation of China [30430160]; Beijing Normal University; European Union	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Normal University; European Union(European Commission)	This work was financially supported by the National Natural Science Foundation of China (30430160) and Beijing Normal University. RJP's research is supported by the European Union-sponsored Network of Excellence EVOLTREE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2010, MOL ECOL, V19, P2626, DOI 10.1111/j.1365-294X.2010.04631.x; Aldrich PR, 2002, MOL ECOL NOTES, V2, P472, DOI 10.1046/j.1471-8286.2002.00282.x; Aldridge G, 2009, HEREDITY, V102, P257, DOI 10.1038/hdy.2008.112; [Anonymous], 2005, PHYLIP PHYLOGENY INF; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beljaev E. A., 2004, Botanicheskii Zhurnal (St. Petersburg), V89, P1665; BENSON L, 1967, AM J BOT, V54, P1017, DOI 10.2307/2440726; Bodenes C, 1997, HEREDITY, V78, P433, DOI 10.1038/hdy.1997.67; Bodenes C, 1997, MOL ECOL, V6, P713, DOI 10.1046/j.1365-294X.1997.00240.x; Bruschi P, 2000, ANN BOT-LONDON, V85, P325, DOI 10.1006/anbo.1999.1046; Burgarella C, 2009, HEREDITY, V102, P442, DOI 10.1038/hdy.2009.8; Burger W. C., 1975, Taxon, V24, P45, DOI 10.2307/1218998; Chen HY, 1998, QUERCUS, P213; Coart E, 2002, THEOR APPL GENET, V105, P431, DOI 10.1007/s00122-002-0920-6; Coyne J.A., 2004, SPECIATION; Craft KJ, 2002, AM J BOT, V89, P1792, DOI 10.3732/ajb.89.11.1792; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Curtu AL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-284; Dodd RS, 2004, EVOLUTION, V58, P261, DOI 10.1111/j.0014-3820.2004.tb01643.x; DOW BD, 1995, THEOR APPL GENET, V91, P137, DOI 10.1007/BF00220870; Dow BD, 1996, MOL ECOL, V5, P615, DOI 10.1111/j.1365-294X.1996.tb00357.x; Duminil J, 2006, MOL ECOL, V15, P3505, DOI 10.1111/j.1365-294X.2006.03040.x; Dumolin-Lapegue S, 1999, EVOLUTION, V53, P1406, DOI 10.1111/j.1558-5646.1999.tb05405.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; GARDINER AS, 1970, FORESTRY, V43, P151, DOI 10.1093/forestry/43.2.151; Gonzalez-Rodriguez A, 2004, AM J BOT, V91, P401, DOI 10.3732/ajb.91.3.401; Goodman SN, 1999, ANN INTERN MED, V130, P1005, DOI 10.7326/0003-4819-130-12-199906150-00019; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grant V., 1981, PLANT SPECIATION; Gugerli F, 2008, ANN BOT-LONDON, V102, P855, DOI 10.1093/aob/mcn164; Harrison R.G., 1990, Oxford Surveys in Evolutionary Biology, V7, P69; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; HARRISON RG, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P3; Howard DJ, 1997, EVOLUTION, V51, P747, DOI 10.1111/j.1558-5646.1997.tb03658.x; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Huang CJ., 1999, FLORA CHINA, V4, P314; Ishida TA, 2003, AM J BOT, V90, P769, DOI 10.3732/ajb.90.5.769; Jensen J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009058; JENSEN RJ, 1993, AM J BOT, V80, P1358, DOI 10.2307/2445721; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Kampfer S, 1998, HEREDITAS, V129, P183, DOI 10.1111/j.1601-5223.1998.00183.x; Kremer A, 2002, ANN FOR SCI, V59, P777, DOI 10.1051/forest:2002065; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Penaloza-Ramirez JM, 2010, ANN BOT-LONDON, V105, P389, DOI 10.1093/aob/mcp301; Mariette S, 2002, SILVAE GENET, V51, P72; Mishima K, 2006, MOL ECOL NOTES, V6, P695, DOI 10.1111/j.1471-8286.2006.01313.x; Muir G, 2000, NATURE, V405, P1016, DOI 10.1038/35016640; Muir G, 2005, MOL ECOL, V14, P549, DOI 10.1111/j.1365-294X.2004.02418.x; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; MULLER CH, 1952, EVOLUTION, V6, P147, DOI 10.2307/2405620; NASON JD, 1992, AM J BOT, V79, P101, DOI 10.2307/2445203; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M., 1987, MOL EVOLUTIONARY GEN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; Petit RJ, 2004, NEW PHYTOL, V161, P151, DOI 10.1046/j.1469-8137.2003.00944.x; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 2006, NATURE, V440, P524, DOI 10.1038/nature04402; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; RUSHTON BS, 1993, ANN SCI FOREST, V50, P73, DOI DOI 10.1051/FOREST:19930707; Salvini D, 2009, PLANT BIOLOGY, V11, P758, DOI 10.1111/j.1438-8677.2008.00158.x; Scotti-Saintagne C, 2004, GENETICS, V168, P1615, DOI 10.1534/genetics.104.026849; SILLIMAN FE, 1958, AM J BOT, V45, P730, DOI 10.2307/2439732; Steinkellner H, 1997, PLANT MOL BIOL, V33, P1093, DOI 10.1023/A:1005736722794; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Tomlinson PT, 2000, AM MIDL NAT, V143, P154, DOI 10.1674/0003-0031(2000)143[0154:DWTSCI]2.0.CO;2; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Valbuena-Carabana M, 2005, HEREDITY, V95, P457, DOI 10.1038/sj.hdy.6800752; VANVALEN L, 1976, TAXON, V25, P233, DOI 10.2307/1219444; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WANG HX, 1997, GENETIC DIVERSITY AN, P155; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHITTEMORE AT, 1991, P NATL ACAD SCI USA, V88, P2540, DOI 10.1073/pnas.88.6.2540; Williams JH, 2001, HEREDITY, V87, P680, DOI 10.1046/j.1365-2540.2001.00968.x; Yun R, 1998, ACTA BOT SIN, V40, P1040; Zanetto A., 1994, Forest Genetics, V1, P111; ZENG YF, 2008, SPECIES STATUS PHYLO; Zhang YT, 2000, HIGHER PLANTS CHINA, P177; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	88	45	49	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15529	10.1371/journal.pone.0015529	http://dx.doi.org/10.1371/journal.pone.0015529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152084	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100092
J	Lenkey, N; Karoly, R; Lukacs, P; Vizi, ES; Sunesen, M; Fodor, L; Mike, A				Lenkey, Nora; Karoly, Robert; Lukacs, Peter; Vizi, E. Sylvester; Sunesen, Morten; Fodor, Laszlo; Mike, Arpad			Classification of Drugs Based on Properties of Sodium Channel Inhibition: A Comparative Automated Patch-Clamp Study	PLOS ONE			English	Article							LOCAL-ANESTHETICS; LIDOCAINE BLOCK; NA+ CHANNELS; ANTIDEPRESSANT DRUGS; SKELETAL-MUSCLE; PHARMACOKINETICS; VOLUNTEERS; MODULATORS; BINDING; LIPOPHILICITY	Background: There is only one established drug binding site on sodium channels. However, drug binding of sodium channels shows extreme promiscuity: similar to 25% of investigated drugs have been found to potently inhibit sodium channels. The structural diversity of these molecules suggests that they may not share the binding site, and/or the mode of action. Our goal was to attempt classification of sodium channel inhibitors by measuring multiple properties of inhibition in electrophysiology experiments. We also aimed to investigate if different properties of inhibition correlate with specific chemical properties of the compounds. Methodology/Principal Findings: A comparative electrophysiological study of 35 compounds, including classic sodium channel inhibitors (anticonvulsants, antiarrhythmics and local anesthetics), as well as antidepressants, antipsychotics and neuroprotective agents, was carried out using rNav1.2 expressing HEK-293 cells and the QPatch automatic patch-clamp instrument. In the multi-dimensional space defined by the eight properties of inhibition (resting and inactivated affinity, potency, reversibility, time constants of onset and offset, use-dependence and state-dependence), at least three distinct types of inhibition could be identified; these probably reflect distinct modes of action. The compounds were clustered similarly in the multi-dimensional space defined by relevant chemical properties, including measures of lipophilicity, aromaticity, molecular size, polarity and electric charge. Drugs of the same therapeutic indication typically belonged to the same type. We identified chemical properties, which were important in determining specific properties of inhibition. State-dependence correlated with lipophilicity, the ratio of the neutral form of molecules, and aromaticity: We noticed that the highly state dependent inhibitors had at least two aromatic rings, logP>4.0, and pKa<8.0. Conclusions/Significance: The correlations of inhibition properties both with chemical properties and therapeutic profiles would not have been evident through the sole determination of IC(50); therefore, recording multiple properties of inhibition may allow improved prediction of therapeutic usefulness.	[Lenkey, Nora; Karoly, Robert; Lukacs, Peter; Vizi, E. Sylvester; Mike, Arpad] Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary; [Sunesen, Morten] Soph Biosci AS, Ballerup, Denmark; [Fodor, Laszlo] Gedeon Richter Plc, Pharmacol & Drug Safety Res, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Gedeon Richter Chemistry Works	Lenkey, N (corresponding author), Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary.	mike@koki.hu	Mike, Arpad/AAP-6479-2021; Mike, Arpad/N-8604-2013	Mike, Arpad/0000-0002-9095-8161	Hungarian Research Fund [NK 72959]; Janos Bolyai Research Fellowship	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences)	This work was supported by grants from the Hungarian Research Fund (NK 72959), and A. Mike is a recipient of the Janos Bolyai Research Fellowship. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sophion Bioscience A/S, and Gedeon Richter Plc. provided access to the QPatch instruments for performing the experiments.	Ahern CA, 2008, CIRC RES, V102, P86, DOI 10.1161/CIRCRESAHA.107.160663; Bae JW, 2007, INT J CLIN PHARM TH, V45, P110; Bagli M, 1999, J PHARMACOL EXP THER, V291, P547; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; BOKESCH PM, 1986, J PHARMACOL EXP THER, V237, P773; BROWN CM, 1995, BRIT J PHARMACOL, V115, P1425, DOI 10.1111/j.1476-5381.1995.tb16633.x; Brown ML, 1997, J MED CHEM, V40, P602, DOI 10.1021/jm960692v; Brown ML, 1999, J MED CHEM, V42, P1537, DOI 10.1021/jm980556l; Canal M, 1998, CLIN DRUG INVEST, V15, P455, DOI 10.2165/00044011-199815050-00010; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Clare Jeff J, 2007, SEB Exp Biol Ser, V58, P115; Courtney K.R., 1987, LOCAL ANESTHETICS, P53; COURTNEY KR, 1990, MOL PHARMACOL, V37, P855; COURTNEY KR, 1980, J PHARMACOL EXP THER, V213, P114; COURTNEY KR, 1980, J MOL CELL CARDIOL, V12, P1273, DOI 10.1016/0022-2828(80)90071-1; Dockens RC, 1995, BRIT J CLIN PHARMACO, V40, P598, DOI 10.1111/j.1365-2125.1995.tb05806.x; Dubin AE, 2005, J BIOMOL SCREEN, V10, P168, DOI 10.1177/1087057104272295; EHRING GR, 1988, J PHARMACOL EXP THER, V244, P479; ESTEVEZ F, 1995, ALCOHOL, V12, P541, DOI 10.1016/0741-8329(95)00041-0; Farkas S, 2006, CNS DRUG REV, V12, P218, DOI 10.1111/j.1527-3458.2006.00218.x; FINK M, 1977, PSYCHOPHARMACOLOGY, V54, P249, DOI 10.1007/BF00426572; Hanck DA, 2009, CIRC RES, V105, P492, DOI 10.1161/CIRCRESAHA.109.198572; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HILLE B, 1977, J GEN PHYSIOL, V69, P475, DOI 10.1085/jgp.69.4.475; HOPPU K, 1995, PEDIATR NEUROL, V13, P143, DOI 10.1016/0887-8994(95)00142-3; Huang CJ, 2006, NAT BIOTECHNOL, V24, P439, DOI 10.1038/nbt1194; Ilyin VI, 2006, J PHARMACOL EXP THER, V318, P1083, DOI 10.1124/jpet.106.104737; Jerling M, 2006, CLIN PHARMACOKINET, V45, P469, DOI 10.2165/00003088-200645050-00003; Kasper S, 1993, Eur Neuropsychopharmacol, V3, P13, DOI 10.1016/0924-977X(93)90290-3; Kimbrough JT, 2000, J PHYSIOL-LONDON, V529, P93, DOI 10.1111/j.1469-7793.2000.00093.x; Korsgaard MPG, 2009, COMB CHEM HIGH T SCR, V12, P51, DOI 10.2174/138620709787048037; KUCHARCZYK J, 1991, RADIOLOGY, V179, P221, DOI 10.1148/radiology.179.1.2006281; KUO CC, 1994, MOL PHARMACOL, V46, P716; Kutchinsky J, 2003, ASSAY DRUG DEV TECHN, V1, P685, DOI 10.1089/154065803770381048; LEMBERGER L, 1976, BRIT J CLIN PHARMACO, V3, P215, DOI 10.1111/j.1365-2125.1976.tb00595.x; Lenkey N, 2011, NEUROPHARMACOLOGY, V60, P191, DOI 10.1016/j.neuropharm.2010.08.005; Li HL, 1999, MOL PHARMACOL, V55, P134, DOI 10.1124/mol.55.1.134; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; Liu MY, 2008, CLIN THER, V30, P641, DOI 10.1016/j.clinthera.2008.04.005; Mannhold R, 1999, J MED CHEM, V42, P981, DOI 10.1021/jm981047m; Mathes C, 2009, COMB CHEM HIGH T SCR, V12, P78, DOI 10.2174/138620709787047948; Mike Arpad, 2010, Curr Mol Pharmacol, V3, P129; Pancrazio JJ, 1998, J PHARMACOL EXP THER, V284, P208; Reis M, 2009, THER DRUG MONIT, V31, P42, DOI 10.1097/FTD.0b013e31819114ea; Rojpibulstit M, 2003, CLIN DRUG INVEST, V23, P273, DOI 10.2165/00044011-200323040-00007; SCHWARZ W, 1977, BIOPHYS J, V20, P343, DOI 10.1016/S0006-3495(77)85554-9; Smith JAM, 2006, MOL PHARMACOL, V69, P921, DOI 10.1124/mol.105.019257; Tarnawa Istvan, 2007, Recent Pat CNS Drug Discov, V2, P57, DOI 10.2174/157488907779561754; THUMMEL KE, 2006, GOODMAN GILMANS PHAR, P1888; Trivedi S, 2008, ASSAY DRUG DEV TECHN, V6, P167, DOI 10.1089/adt.2007.090; van de Waterbeemd H, 2001, J COMPUT AID MOL DES, V15, P273, DOI 10.1023/A:1008192010023; Wang GX, 2003, J GEN PHYSIOL, V122, p35A; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Wang YS, 2009, BIOORGAN MED CHEM, V17, P7064, DOI 10.1016/j.bmc.2008.10.031; Waring MJ, 2007, BIOORG MED CHEM LETT, V17, P1759, DOI 10.1016/j.bmcl.2006.12.061; Young JM, 2001, CLIN THER, V23, P532, DOI 10.1016/S0149-2918(01)80059-X; ZAMPONI GW, 1993, BIOPHYS J, V65, P80, DOI 10.1016/S0006-3495(93)81042-7; ZAMPONI GW, 1993, BIOPHYS J, V65, P2335, DOI 10.1016/S0006-3495(93)81292-X; ZAMPONI GW, 1994, BIOPHYS J, V67, P1015, DOI 10.1016/S0006-3495(94)80567-3; Zuliani V, 2009, CURR TOP MED CHEM, V9, P396, DOI 10.2174/156802609788317856	60	36	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15568	10.1371/journal.pone.0015568	http://dx.doi.org/10.1371/journal.pone.0015568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187965	gold, Green Published, Green Submitted			2022-12-27	WOS:000285575200042
J	Wang, W; Zhu, JQ; Yu, HM; Tan, FQ; Yang, WX				Wang, Wei; Zhu, Jun-Quan; Yu, He-Ming; Tan, Fu-Qing; Yang, Wan-Xi			KIFC1-Like Motor Protein Associates with the Cephalopod Manchette and Participates in Sperm Nuclear Morphogenesis in Octopus tankahkeei	PLOS ONE			English	Article							INTRAMANCHETTE TRANSPORT; SEMINIFEROUS EPITHELIUM; CHROMATIN ORGANIZATION; CANDIDATE MOTORS; DELTA-TUBULIN; KINESIN-II; GERM-CELLS; MYOSIN VA; LAMIN-A; SPERMIOGENESIS	Background: Nuclear morphogenesis is one of the most fundamental cellular transformations taking place during spermatogenesis. In rodents, a microtubule-based perinuclear structure, the manchette, and a C-terminal kinesin motor KIFC1 are believed to play crucial roles in this process. Spermatogenesis in Octopus tankahkeei is a good model system to explore whether evolution has created a cephalopod prototype of mammalian manchette-based and KIFC1-dependent sperm nuclear shaping machinery. Methodology/Principal Findings: We detected the presence of a KIFC1-like protein in the testis, muscle, and liver of O. tankahkeei by Western Blot. Then we tracked its dynamic localization in spermatic cells at various stages using Immunofluorescence and Immunogold Electron Microscopy. The KIFC1-like protein was not expressed at early stages of spermatogenesis when no significant morphological changes occur, began to be present in early spermatid, localized around and in the nucleus of intermediate and late spermatids where the nucleus was dramatically elongated and compressed, and concentrated at one end of final spermatid. Furthermore, distribution of the motor protein during nuclear elongation and condensation overlapped with that of the cephalopod counterpart of manchette at a significant level. Conclusions/Significance: The results support the assumption that the protein is actively involved in sperm nuclear morphogenesis in O. tankahkeei possibly through bridging the manchette-like perinuclear microtubules to the nucleus and assisting in the nucleocytoplasmic trafficking of specific cargoes. This study represents the first description of the role of a motor protein in sperm nuclear shaping in cephalopod.	[Wang, Wei; Zhu, Jun-Quan; Yu, He-Ming] Ningbo Univ, Fac Life Sci & Bioengn, Ningbo 315211, Zhejiang, Peoples R China; [Wang, Wei; Yu, He-Ming; Yang, Wan-Xi] Zhejiang Univ, Sperm Lab, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Tan, Fu-Qing] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China	Ningbo University; Zhejiang University; Zhejiang University	Wang, W (corresponding author), Ningbo Univ, Fac Life Sci & Bioengn, Ningbo 315211, Zhejiang, Peoples R China.	wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	Yang, Wan-Xi/0000-0001-9304-195X; Yang, Wan-Xi/0000-0001-5695-0150	Zhejiang Provincial Natural Science Foundation of China [Z307536, Y2100296]; National Natural Science Foundation of China [31072198, 40776079]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the following projects: Zhejiang Provincial Natural Science Foundation of China (Grant No Z307536), National Natural Science Foundation of China (http://www.nsfc.gov.cn) (Grant No. 31072198 and 40776079), and Zhejiang Provincial Natural Science Foundation of China (Grant No Y2100296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cinalli RM, 2008, CELL, V132, P559, DOI 10.1016/j.cell.2008.02.003; Dadoune JP, 2004, INT REV CYTOL, V237, P1, DOI 10.1016/S0074-7696(04)37001-4; Dillon N, 2008, DEV CELL, V15, P182, DOI 10.1016/j.devcel.2008.07.013; Extavour CGM, 2007, INTEGR COMP BIOL, V47, P770, DOI 10.1093/icb/icm027; Fan J, 2004, J CELL SCI, V117, P619, DOI 10.1242/jcs.00892; FAWCETT DW, 1971, DEV BIOL, V26, P220, DOI 10.1016/0012-1606(71)90124-2; FIELDS WG, 1976, CAN J ZOOL, V54, P908, DOI 10.1139/z76-105; Fiserova J, 2010, BIOCHEM SOC T, V38, P829, DOI 10.1042/BST0380829; FRANZEN A, 1977, VERH DTSCH ZOOL GES, P123; Gimenez-Bonafe P, 2004, MOL REPROD DEV, V68, P232, DOI 10.1002/mrd.20068; Gimenez-Bonafe P, 2002, MOL REPROD DEV, V62, P357, DOI 10.1002/mrd.10124; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guttman JA, 2000, J CELL SCI, V113, P2167; Hayasaka S, 2008, ASIAN J ANDROL, V10, P561, DOI 10.1111/j.1745-7262.2008.00392.x; HEALY JM, 1990, HELGOLANDER MEERESUN, V44, P109, DOI 10.1007/BF02365434; HEALY JM, 1989, PHILOS T ROY SOC B, V323, P589, DOI 10.1098/rstb.1989.0038; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; KALLIO M, 1995, ENVIRON MOL MUTAGEN, V25, P106, DOI 10.1002/em.2850250204; Kato A, 2004, DEV BIOL, V269, P196, DOI 10.1016/j.ydbio.2004.01.026; Kierszenbaum Abraham L, 2007, Soc Reprod Fertil Suppl, V65, P33; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, CYTOGENET GENOME RES, V103, P337, DOI 10.1159/000076822; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kikkawa M, 2008, TRENDS CELL BIOL, V18, P128, DOI 10.1016/j.tcb.2008.01.002; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lie PPY, 2010, PHILOS T R SOC B, V365, P1581, DOI 10.1098/rstb.2009.0261; Martinez-Soler F, 2007, TISSUE CELL, V39, P99, DOI 10.1016/j.tice.2007.01.005; MAXWELL WL, 1975, PROC R SOC SER B-BIO, V191, P527, DOI 10.1098/rspb.1975.0142; MAXWELL WL, 1974, PROC R SOC SER B-BIO, V186, P181, DOI 10.1098/rspb.1974.0045; MEISTRICH ML, 1990, AM J ANAT, V188, P74, DOI 10.1002/aja.1001880109; MEISTRICH ML, 1993, MOL BIOL MALE REPROD, P66; Miller MG, 1999, BIOL REPROD, V60, P1047, DOI 10.1095/biolreprod60.4.1047; Mochida K, 1998, DEV BIOL, V200, P46, DOI 10.1006/dbio.1998.8942; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Nath S, 2007, MOL BIOL CELL, V18, P1839, DOI 10.1091/mbc.E06-06-0524; Navolanic PM, 2000, BIOL REPROD, V62, P1360, DOI 10.1095/biolreprod62.5.1360; Oakley BR, 2000, TRENDS CELL BIOL, V10, P537, DOI 10.1016/S0962-8924(00)01857-2; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Ribes E, 2004, MOL REPROD DEV, V68, P223, DOI 10.1002/mrd.20069; Ribes E, 2002, MOL REPROD DEV, V62, P363, DOI 10.1002/mrd.10103; Rivkin E, 1997, MOL REPROD DEV, V48, P77, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;77::AID-MRD10&gt;3.0.CO;2-T; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Saade M, 2007, EXP CELL RES, V313, P614, DOI 10.1016/j.yexcr.2006.11.011; Selmi MG, 1996, TISSUE CELL, V28, P613, DOI 10.1016/S0040-8166(96)80064-4; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Smrzka OW, 2000, CURR BIOL, V10, P413, DOI 10.1016/S0960-9822(00)00418-8; Soley JT, 1997, J ANAT, V190, P563, DOI 10.1046/j.1469-7580.1997.19040563.x; Sperry AO, 1996, MOL BIOL CELL, V7, P289, DOI 10.1091/mbc.7.2.289; Swanson WJ, 2002, ANNU REV ECOL SYST, V33, P161, DOI 10.1146/annurev.ecolsys.33.010802.150439; Tanaka H, 2005, CELL MOL LIFE SCI, V62, P344, DOI 10.1007/s00018-004-4394-y; Toshimori K, 2003, ARCH HISTOL CYTOL, V66, P383, DOI 10.1679/aohc.66.383; Tres LL, 1996, MOL REPROD DEV, V44, P395, DOI 10.1002/(SICI)1098-2795(199607)44:3<395::AID-MRD13>3.0.CO;2-#; Vaid KS, 2007, BIOL REPROD, V77, P1037, DOI 10.1095/biolreprod.107.063735; WANG MY, 2007, PROG VET MED, V28, P77; Wang R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-9; Wang W, 2010, COMP BIOCHEM PHYS B, V156, P174, DOI 10.1016/j.cbpb.2010.03.004; White-Cooper H, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P151, DOI 10.1016/B978-0-12-372568-4.00004-5; White-Cooper H, 2010, PHILOS T R SOC B, V365, P1465, DOI 10.1098/rstb.2009.0323; Wilhelmsen K, 2006, J CELL SCI, V119, P5021, DOI 10.1242/jcs.03295; WOUTERSTYROU D, 1988, BIOCHIM BIOPHYS ACTA, V953, P86, DOI 10.1016/0167-4838(88)90012-X; Yang WX, 2006, BIOL REPROD, V74, P684, DOI 10.1095/biolreprod.105.049312; Yang WX, 2003, BIOL REPROD, V69, P1719, DOI 10.1095/biolreprod.102.014878; YOSHIDA T, 1994, J CELL SCI, V107, P625; YU HM, 2010, J CELL BIOL, V32, P251; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zhang YG, 2004, CELL MOTIL CYTOSKEL, V58, P213, DOI 10.1002/cm.20008; Zhu JQ, 2005, J SHELLFISH RES, V24, P1203; Zhu Jun-Quan, 2006, Journal of Fisheries of China, V30, P161; Zou Y, 2002, BIOL REPROD, V66, P843, DOI 10.1095/biolreprod66.3.843	76	14	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15616	10.1371/journal.pone.0015616	http://dx.doi.org/10.1371/journal.pone.0015616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187923	Green Submitted, gold, Green Published			2022-12-27	WOS:000285575200050
J	Minville-Walz, M; Pierre, AS; Pichon, L; Bellenger, S; Fevre, C; Bellenger, J; Tessier, C; Narce, M; Rialland, M				Minville-Walz, Melaine; Pierre, Anne-Sophie; Pichon, Laurent; Bellenger, Sandrine; Fevre, Cecile; Bellenger, Jerome; Tessier, Christian; Narce, Michel; Rialland, Mickael			Inhibition of Stearoyl-CoA Desaturase 1 Expression Induces CHOP-Dependent Cell Death in Human Cancer Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY-ACID SYNTHASE; UNFOLDED PROTEIN RESPONSE; HUMAN-MELANOMA CELLS; INDUCED APOPTOSIS; PROSTATE-CANCER; BREAST-CANCER; PHOSPHATIDYLCHOLINE SYNTHESIS; TRANSCRIPTION FACTOR; TRIGGERS APOPTOSIS	Background: Cancer cells present a sustained de novo fatty acid synthesis with an increase of saturated and monounsaturated fatty acid (MUFA) production. This change in fatty acid metabolism is associated with overexpression of stearoyl-CoA desaturase 1 (Scd1), which catalyses the transformation of saturated fatty acids into monounsaturated fatty acids (e. g., oleic acid). Several reports demonstrated that inhibition of Scd1 led to the blocking of proliferation and induction of apoptosis in cancer cells. Nevertheless, mechanisms of cell death activation remain to be better understood. Principal Findings: In this study, we demonstrated that Scd1 extinction by siRNA triggered abolition of de novo MUFA synthesis in cancer and non-cancer cells. Scd1 inhibition-activated cell death was only observed in cancer cells with induction of caspase 3 activity and PARP-cleavage. Exogenous supplementation with oleic acid did not reverse the Scd1 ablation-mediated cell death. In addition, Scd1 depletion induced unfolded protein response (UPR) hallmarks such as Xbp1 mRNA splicing, phosphorylation of eIF2 alpha and increase of CHOP expression. However, the chaperone GRP78 expression, another UPR hallmark, was not affected by Scd1 knockdown in these cancer cells indicating a peculiar UPR activation. Finally, we showed that CHOP induction participated to cell death activation by Scd1 extinction. Indeed, overexpression of dominant negative CHOP construct and extinction of CHOP partially restored viability in Scd1-depleted cancer cells. Conclusion: These results suggest that inhibition of de novo MUFA synthesis by Scd1 extinction could be a promising anticancer target by inducing cell death through UPR and CHOP activation.	[Minville-Walz, Melaine; Pierre, Anne-Sophie; Pichon, Laurent; Bellenger, Sandrine; Fevre, Cecile; Bellenger, Jerome; Tessier, Christian; Narce, Michel; Rialland, Mickael] Univ Bourgogne, Ctr Rech, INSERM, Lipides Nutr Canc UMR866, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Minville-Walz, M (corresponding author), Univ Bourgogne, Ctr Rech, INSERM, Lipides Nutr Canc UMR866, Dijon, France.	mickael.rialland@u-bourgogne.fr	BELLENGER, Jerome/AAC-9423-2022	BELLENGER, Jerome/0000-0001-8643-6195; Narce, Michel/0000-0002-9986-6247; Rialland, Mickael/0000-0001-9693-9351; Bellenger, Sandrine/0000-0002-4593-5454	INSERM; Region Bourgogne; Centre National Interprofessionnel de l'Economie Laitiare	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Bourgogne(Region Bourgogne-Franche-Comte); Centre National Interprofessionnel de l'Economie Laitiare	This work was supported by grants from INSERM, Region Bourgogne and the Centre National Interprofessionnel de l'Economie Laitiare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaguel FG, 2009, J NEUROSCI RES, V87, P1207, DOI 10.1002/jnr.21918; Ariyama H, 2010, J BIOL CHEM; Baburina I, 1998, J BIOL CHEM, V273, P2169, DOI 10.1074/jbc.273.4.2169; CHAJES V, 1995, INT J CANCER, V63, P169, DOI 10.1002/ijc.2910630204; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Falvella FS, 2002, CARCINOGENESIS, V23, P1933, DOI 10.1093/carcin/23.11.1933; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Griffitts J, 2009, J LIPID RES, V50, P611, DOI 10.1194/jlr.M800265-JLR200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hardy S, 2000, CANCER RES, V60, P6353; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Jiang CC, 2009, CARCINOGENESIS, V30, P197, DOI 10.1093/carcin/bgn220; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; KANNAN R, 1980, CANCER RES, V40, P4606; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Koltun DO, 2009, BIOORG MED CHEM LETT, V19, P2048, DOI 10.1016/j.bmcl.2009.02.019; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Leger S, 2010, BIOORG MED CHEM LETT, V20, P499, DOI 10.1016/j.bmcl.2009.11.111; LI J, 1994, INT J CANCER, V57, P348, DOI 10.1002/ijc.2910570310; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Moore S, 2005, INT J CANCER, V114, P563, DOI 10.1002/ijc.20773; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Ou LH, 2008, J LIPID RES, V49, P985, DOI 10.1194/jlr.M700465-JLR200; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Qiao DH, 2002, BBA-MOL CELL BIOL L, V1583, P108, DOI 10.1016/S1388-1981(02)00190-7; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Rashid A, 1997, AM J PATHOL, V150, P201; RIBONI L, 1984, NEUROCHEM PATHOL, V2, P171, DOI 10.1007/BF02834351; ROBERT J, 1983, BIOCHIM BIOPHYS ACTA, V752, P383, DOI 10.1016/0005-2760(83)90268-0; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SABINE JR, 1967, CANCER RES, V27, P793; SAKAI K, 1992, CARCINOGENESIS, V13, P579, DOI 10.1093/carcin/13.4.579; Scaglia N, 2005, J BIOL CHEM, V280, P25339, DOI 10.1074/jbc.M501159200; Scaglia N, 2005, BBA-MOL CELL BIOL L, V1687, P141, DOI 10.1016/j.bbalip.2004.11.015; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; SIPERSTEIN MD, 1984, J LIPID RES, V25, P1462; Swinnen JV, 2000, INT J CANCER, V88, P176, DOI 10.1002/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Szachowicz-Petelska B, 2007, MOL CELL BIOCHEM, V294, P237, DOI 10.1007/s11010-006-9264-x; Thomas KC, 2007, J PHARMACOL EXP THER, V321, P830, DOI 10.1124/jpet.107.119412; van der Sanden MHM, 2004, J BIOL CHEM, V279, P52007, DOI 10.1074/jbc.M405577200; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Vinciguerra M, 2009, J HEPATOL, V50, pS55, DOI 10.1016/S0168-8278(09)60139-2; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Wei Y, 2007, MOL CELL BIOCHEM, V303, P105, DOI 10.1007/s11010-007-9461-2; Yam D, 1997, CANCER LETT, V111, P179, DOI 10.1016/S0304-3835(96)04530-2; Yeung BHY, 2008, ONCOGENE, V27, P6782, DOI 10.1038/onc.2008.290; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	63	74	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14363	10.1371/journal.pone.0014363	http://dx.doi.org/10.1371/journal.pone.0014363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179554	gold, Green Published, Green Submitted			2022-12-27	WOS:000285381200011
J	De Groof, G; Gwinner, H; Steiger, S; Kempenaers, B; Van der Linden, A				De Groof, Geert; Gwinner, Helga; Steiger, Silke; Kempenaers, Bart; Van der Linden, Annemie			Neural Correlates of Behavioural Olfactory Sensitivity Changes Seasonally in European Starlings	PLOS ONE			English	Article							STURNUS-VULGARIS; LUTEINIZING-HORMONE; GREEN PLANTS; SONG; TESTOSTERONE; RECEPTOR; PROLIFERATION; CONNECTIONS; ACTIVATION; MECHANISMS	Background: Possibly due to the small size of the olfactory bulb (OB) as compared to rodents, it was generally believed that songbirds lack a well-developed sense of smell. This belief was recently revised by several studies showing that various bird species, including passerines, use olfaction in many respects of life. During courtship and nest building, male European starlings (Sturnus vulgaris) incorporate aromatic herbs that are rich in volatile compounds (e. g., milfoil, Achillea millefolium) into the nests and they use olfactory cues to identify these plants. Interestingly, European starlings show seasonal differences in their ability to respond to odour cues: odour sensitivity peaks during nest-building in the spring, but is almost non-existent during the non-breeding season. Methodology/Principal Findings: This study used repeated in vivo Manganese-enhanced MRI to quantify for the first time possible seasonal changes in the anatomy and activity of the OB in starling brains. We demonstrated that the OB of the starling exhibits a functional seasonal plasticity of certain plant odour specificity and that the OB is only able to detect milfoil odour during the breeding season. Volumetric analysis showed that this seasonal change in activity is not linked to a change in OB volume. By subsequently experimentally elevating testosterone (T) in half of the males during the non-breeding season we showed that the OB volume was increased compared to controls. Conclusions/Significance: By investigating the neural substrate of seasonal olfactory sensitivity changes we show that the starlings' OB loses its ability during the non-breeding season to detect a natural odour of a plant preferred as green nest material by male starlings. We found that testosterone, applied during the non-breeding season, does not restore the discriminatory ability of the OB but has an influence on its size.	[De Groof, Geert; Van der Linden, Annemie] Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium; [Gwinner, Helga; Steiger, Silke; Kempenaers, Bart] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Starnberg, Germany	University of Antwerp; Max Planck Society	De Groof, G (corresponding author), Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium.	Geert.DeGroof@ua.ac.be	Van der Linden, Annemie/L-7855-2017; De Groof, Geert/D-8251-2013	Van der Linden, Annemie/0000-0003-2941-6520; Kempenaers, Bart/0000-0002-7505-5458	University of Antwerp; Inter University Attraction Poles [IUAP-NIMI-P6/38]; Funds for Scientific Research (FWO) - Flanders [G.0420.02]; European Network of Excellence (NoE) European Molecular Imaging Laboratories (EMIL) [LSHC -CT- 2004 - 503569]; NoE Diagnostic Molecular Imaging [LSHB-CT-2005-512146]; Max Planck Gessellschaft; FWO - Flanders	University of Antwerp; Inter University Attraction Poles(Belgian Federal Science Policy Office); Funds for Scientific Research (FWO) - Flanders(FWO); European Network of Excellence (NoE) European Molecular Imaging Laboratories (EMIL); NoE Diagnostic Molecular Imaging; Max Planck Gessellschaft; FWO - Flanders(FWO)	This research was supported by Concerted Research Actions (GOA funding) from the University of Antwerp, Inter University Attraction Poles (IUAP-NIMI-P6/38) to AVDL and grants from the Funds for Scientific Research (FWO) - Flanders (project Nr G.0420.02) to AVdL. This research was partly sponsored by European Network of Excellence (NoE) European Molecular Imaging Laboratories (EMIL) (LSHC -CT- 2004 - 503569), NoE Diagnostic Molecular Imaging (DiMI) (LSHB-CT-2005-512146) and by the Max Planck Gessellschaft. GDG was supported by a Ph. D. fellowship of FWO - Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL GF, 1987, PHYSIOL ZOOL, V60, P191, DOI 10.1086/physzool.60.2.30158643; Ball GF, 2004, ANN NY ACAD SCI, V1016, P586, DOI 10.1196/annals.1298.043; Balthazart J, 2009, BEHAV BRAIN RES, V200, P248, DOI 10.1016/j.bbr.2008.08.036; Chuang KH, 2009, NEUROIMAGE, V44, P363, DOI 10.1016/j.neuroimage.2008.08.046; CLARK L, 1985, OECOLOGIA, V67, P169, DOI 10.1007/BF00384280; CLARK L, 1990, J EXP ZOOL, V255, P22, DOI 10.1002/jez.1402550105; CLARK L, 1993, COMP BIOCHEM PHYS A, V104, P305, DOI 10.1016/0300-9629(93)90322-U; Dawley EM, 2006, BRAIN BEHAV EVOLUT, V68, P26, DOI 10.1159/000092311; DAWSON A, 1983, GEN COMP ENDOCR, V49, P286, DOI 10.1016/0016-6480(83)90146-6; De Groof G, 2009, J NEUROSCI, V29, P13557, DOI 10.1523/JNEUROSCI.1788-09.2009; De Ridder E, 2002, AUK, V119, P487, DOI 10.1642/0004-8038(2002)119[0487:SALTEO]2.0.CO;2; Distler PG, 1997, J COMP NEUROL, V383, P529, DOI 10.1002/(SICI)1096-9861(19970714)383:4&lt;529::AID-CNE9&gt;3.0.CO;2-4; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Gwinner H, 2000, ANIM BEHAV, V59, P301, DOI 10.1006/anbe.1999.1306; Gwinner H, 1997, BEHAVIOUR, V134, P337, DOI 10.1163/156853997X00575; GWINNER H, 1987, BEHAVIOUR, V103, P68, DOI 10.1163/156853987X00279; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; HAGELIN JC, 2006, REPROD BEHAV PHYLOGE, P76; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; Heimovics SA, 2008, PHYSIOL BEHAV, V95, P258, DOI 10.1016/j.physbeh.2008.06.009; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; MEREDITH M, 1991, J STEROID BIOCHEM, V39, P601, DOI 10.1016/0960-0760(91)90258-7; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Pautler RG, 2002, NEUROIMAGE, V16, P441, DOI 10.1006/nimg.2002.1075; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Riters LV, 2000, HORM BEHAV, V38, P250, DOI 10.1006/hbeh.2000.1623; Roelants H, 2002, BIOL REPROD, V66, P305, DOI 10.1095/biolreprod66.2.305; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; TINDEMANS I, 2006, NMR BIOMED; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Van Meir V, 2004, NEUROIMAGE, V21, P914, DOI 10.1016/j.neuroimage.2003.10.007; Van Meir V, 2006, NEUROIMAGE, V31, P981, DOI 10.1016/j.neuroimage.2006.01.005; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Yue EL, 2004, BEHAV NEUROSCI, V118, P184, DOI 10.1037/0735-7044.118.1.184	38	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14337	10.1371/journal.pone.0014337	http://dx.doi.org/10.1371/journal.pone.0014337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179464	Green Published, gold, Green Submitted			2022-12-27	WOS:000285340000010
J	Ochiel, DO; Ochsenbauer, C; Kappes, JC; Ghosh, M; Fahey, JV; Wira, CR				Ochiel, Daniel O.; Ochsenbauer, Christina; Kappes, John C.; Ghosh, Mimi; Fahey, John V.; Wira, Charles R.			Uterine Epithelial Cell Regulation of DC-SIGN Expression Inhibits Transmitted/Founder HIV-1 Trans Infection by Immature Dendritic Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FEMALE REPRODUCTIVE-TRACT; ANTIGEN-PRESENTING CELLS; MENSTRUAL-CYCLE; GENITAL-TRACT; GROWTH-FACTOR; T-CELLS; TGF-BETA; HUMAN ENDOMETRIUM; SPERM TRANSPORT	Background: Sexual transmission accounts for the majority of HIV-1 infections. In over 75% of cases, infection is initiated by a single variant (transmitted/founder virus). However, the determinants of virus selection during transmission are unknown. Host cell-cell interactions in the mucosa may be critical in regulating susceptibility to infection. We hypothesized in this study that specific immune modulators secreted by uterine epithelial cells modulate susceptibility of dendritic cells (DC) to infection with HIV-1. Methodology/Principal Findings: Here we report that uterine epithelial cell secretions (i.e. conditioned medium, CM) decreased DC-SIGN expression on immature dendritic cells via a transforming growth factor beta (TGF-beta) mechanism. Further, CM inhibited dendritic cell-mediated trans infection of HIV-1 expressing envelope proteins of prototypic reference. Similarly, CM inhibited trans infection of HIV-1 constructs expressing envelopes of transmitted/founder viruses, variants that are selected during sexual transmission. In contrast, whereas recombinant TGF-beta 1 inhibited trans infection of prototypic reference HIV-1 by dendritic cells, TGF-beta 1 had a minimal effect on trans infection of transmitted/founder variants irrespective of the reporter system used to measure trans infection. Conclusions/Significance: Our results provide the first direct evidence for uterine epithelial cell regulation of dendritic cell transmission of infection with reference and transmitted/founder HIV-1 variants. These findings have immediate implications for designing strategies to prevent sexual transmission of HIV-1.	[Ochiel, Daniel O.; Ghosh, Mimi; Fahey, John V.; Wira, Charles R.] Dartmouth Med Sch, Dept Physiol, Lebanon, NH USA; [Ochsenbauer, Christina; Kappes, John C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	Dartmouth College; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ochiel, DO (corresponding author), Dartmouth Med Sch, Dept Physiol, Lebanon, NH USA.	Daniel.O.Ochiel@Dartmouth.edu			National Institutes of Health [AI51877, AI13541, U01-AI067854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R55AI013541, R01AI071761, R01AI013541, U01AI067854, R37AI013541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was made possible by National Institutes of Health Grants AI51877 and AI13541 (CRW), and U01-AI067854 (JCK and CO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chevronnay HPG, 2008, ENDOCRINOLOGY, V149, P1015, DOI 10.1210/en.2007-0849; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Coleman KD, 2009, FERTIL STERIL, V92, P1107, DOI 10.1016/j.fertnstert.2008.10.047; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; EDMONDS TG, 2010, VIROLOGY; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gelderblom HC, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-60; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hatch SC, 2009, J VIROL, V83, P3496, DOI 10.1128/JVI.02249-08; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Izquierdo-Useros N, 2009, BLOOD, V113, P2732, DOI 10.1182/blood-2008-05-158642; Jameson B, 2002, J VIROL, V76, P1866, DOI 10.1128/JVI.76.4.1866-1875.2002; Jones J, 2007, BIOTECHNIQUES, V43, P589, DOI 10.2144/000112624; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Jones RL, 2000, MOL HUM REPROD, V6, P1107, DOI 10.1093/molehr/6.12.1107; Kaul R, 2010, J LEUKOCYTE BIOL, V88, P427, DOI 10.1189/jlb.0410230; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kim MR, 2005, MOL HUM REPROD, V11, P801, DOI 10.1093/molehr/gah240; Kunz G, 1997, ADV EXP MED BIOL, V424, P267; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Li GL, 2007, BLOOD, V110, P2872, DOI 10.1182/blood-2006-10-050583; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Magerus-Chatinet A, 2007, VIROLOGY, V362, P67, DOI 10.1016/j.virol.2006.11.035; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Min L, 2010, J IMMUNOL, V184, P4625, DOI 10.4049/jimmunol.0903873; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Musso T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003271; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Ochiel DO, 2010, J LEUKOCYTE BIOL, V88, P435, DOI 10.1189/jlb.1009700; Ochsenbauer C, 2009, CURR OPIN HIV AIDS, V4, P418, DOI 10.1097/COH.0b013e32832f011e; Ochsenbauer-Jambor C, 2006, BIOTECHNIQUES, V40, P91, DOI 10.2144/000112072; Petraglia F, 1998, J CLIN ENDOCR METAB, V83, P1194, DOI 10.1210/jc.83.4.1194; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; RICHARDSON JM, 1995, BIOL REPROD, V53, P488, DOI 10.1095/biolreprod53.3.488; Rieger L, 2004, J SOC GYNECOL INVEST, V11, P488, DOI 10.1016/j.jsgi.2004.05.007; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schaefer TM, 2005, AM J REPROD IMMUNOL, V54, P193, DOI 10.1111/j.1600-0897.2005.00298.x; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; SETTLAGE DS, 1973, FERTIL STERIL, V24, P655; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Strobl H, 1999, MICROBES INFECT, V1, P1283, DOI 10.1016/S1286-4579(99)00256-7; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; UNAIDS, 2008, REP GLOB AIDS EP; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wira C, 2005, JAIDS-J ACQ IMM DEF, V38, pS34, DOI 10.1097/01.qai.0000167040.58181.d5; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yeaman GR, 2004, IMMUNOLOGY, V113, P524, DOI 10.1111/j.1365-2567.2004.01990.x; Yeaman GR, 2003, IMMUNOLOGY, V109, P137, DOI 10.1046/j.1365-2567.2003.01623.x; Yeaman GR, 1998, AIDS RES HUM RETROV, V14, pS57; Zervomanolakis I, 2007, ANN NY ACAD SCI, V1101, P1, DOI 10.1196/annals.1389.032	82	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14306	10.1371/journal.pone.0014306	http://dx.doi.org/10.1371/journal.pone.0014306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179465	Green Submitted, Green Published, gold			2022-12-27	WOS:000285292500002
J	Gao, ZF; Li, J; Yin, J; Shen, MW				Gao, Zaifeng; Li, Jie; Yin, Jun; Shen, Mowei			Dissociated Mechanisms of Extracting Perceptual Information into Visual Working Memory	PLOS ONE			English	Article							SHORT-TERM-MEMORY; OBJECT-FILES; HUMAN BRAIN; SPATIAL-FREQUENCY; POTENTIAL N270; FMRI EVIDENCE; ATTENTION; REPRESENTATIONS; FEATURES; SEARCH	Background: The processing mechanisms of visual working memory (VWM) have been extensively explored in the recent decade. However, how the perceptual information is extracted into VWM remains largely unclear. The current study investigated this issue by testing whether the perceptual information was extracted into VWM via an integrated-object manner so that all the irrelevant information would be extracted (object hypothesis), or via a feature-based manner so that only the target-relevant information would be extracted (feature hypothesis), or via an analogous processing manner as that in visual perception (analogy hypothesis). Methodology/Principal Findings: High-discriminable information which is processed at the parallel stage of visual perception and fine-grained information which is processed via focal attention were selected as the representatives of perceptual information. The analogy hypothesis predicted that whereas high-discriminable information is extracted into VWM automatically, fine-grained information will be extracted only if it is task-relevant. By manipulating the information type of the irrelevant dimension in a change-detection task, we found that the performance was affected and the ERP component N270 was enhanced if a change between the probe and the memorized stimulus consisted of irrelevant high-discriminable information, but not if it consisted of irrelevant fine-grained information. Conclusions/Significance: We conclude that dissociated extraction mechanisms exist in VWM for information resolved via dissociated processes in visual perception (at least for the information tested in the current study), supporting the analogy hypothesis.	[Gao, Zaifeng; Li, Jie; Yin, Jun; Shen, Mowei] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Gao, ZF (corresponding author), Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China.	mwshen@zju.edu.cn	Gao, Zaifeng/B-6398-2011	Gao, Zaifeng/0000-0001-9727-8524; Li, Jie/0000-0002-8633-0566	National Natural Science Foundation of China [30870765, 30570604]; Ministry of Education [07JZD0029, 20060335034]; National Foundation for Fostering Talents of Basic Science [J0630760]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education; National Foundation for Fostering Talents of Basic Science	National Natural Science Foundation of China (No. 30870765; No. 30570604), Key Project of Humanities and Social Sciences, Ministry of Education (No. 07JZD0029), Fund of the Ministry of Education for Doctoral Programs in Universities of China (No. 20060335034) and the National Foundation for Fostering Talents of Basic Science (No. J0630760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Astle DE, 2010, J NEUROSCI, V30, P3567, DOI 10.1523/JNEUROSCI.5701-09.2010; Averbach E, 1961, S INFORMATION THEORY, P196, DOI DOI 10.1007/S00213-010-1823-X; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baumann O, 2008, EXP BRAIN RES, V188, P363, DOI 10.1007/s00221-008-1366-0; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cui LL, 2000, NEUROREPORT, V11, P2415, DOI 10.1097/00001756-200008030-00015; Delvenne JF, 2004, VIS COGN, V11, P1, DOI 10.1080/13506280344000167; Druzgal TJ, 2001, COGNITIVE BRAIN RES, V10, P355, DOI 10.1016/S0926-6410(00)00056-2; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; EGLY R, 1994, PSYCHOL SCI, V5, P380, DOI 10.1111/j.1467-9280.1994.tb00289.x; ENNS JT, 1991, PSYCHOL REV, V98, P335, DOI 10.1037/0033-295X.98.3.335; Ester EF, 2009, J NEUROSCI, V29, P15258, DOI 10.1523/JNEUROSCI.4388-09.2009; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gao T, 2010, VIS COGN, V18, P82, DOI 10.1080/13506280802614966; GAO Z, 2009, THESIS ZHEJIANG U HA; Gao ZF, 2009, J VISION, V9, DOI 10.1167/9.7.17; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hollingworth A, 2008, J EXP PSYCHOL GEN, V137, P163, DOI 10.1037/0096-3445.137.1.163; Hollingworth A, 2009, ATTEN PERCEPT PSYCHO, V71, P936, DOI 10.3758/APP.71.4.936; Huang LQ, 2010, J EXP PSYCHOL GEN, V139, P162, DOI 10.1037/a0018034; Hyun JS, 2009, J EXP PSYCHOL HUMAN, V35, P1140, DOI 10.1037/a0015019; Jiang YV, 2008, PERCEPT PSYCHOPHYS, V70, P1581, DOI 10.3758/PP.70.8.1581; Jiang YV, 2009, CURR ISS MEM, P33; Johnson JS, 2008, J EXP PSYCHOL HUMAN, V34, P41, DOI 10.1037/0096-1523.34.1.41; Johnson JS, 2009, PSYCHOL SCI, V20, P568, DOI 10.1111/j.1467-9280.2009.02329.x; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Katzner S, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.012.2009; Lee D, 2001, PERCEPT PSYCHOPHYS, V63, P253, DOI 10.3758/BF03194466; Lepsien J, 2007, CEREB CORTEX, V17, P2072, DOI 10.1093/cercor/bhl116; Luck S., 2008, VISUAL MEMORY; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luria R, 2010, J COGNITIVE NEUROSCI, V22, P496, DOI 10.1162/jocn.2009.21214; Magnussen S, 1998, J EXP PSYCHOL HUMAN, V24, P707; Mao W, 2008, INT J PSYCHOPHYSIOL, V67, P47, DOI 10.1016/j.ijpsycho.2007.10.003; Mayer JS, 2007, NEUROIMAGE, V36, P441, DOI 10.1016/j.neuroimage.2007.03.007; Mayer Jutta S, 2008, Adv Cogn Psychol, V3, P429, DOI 10.2478/v10053-008-0007-2; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Mitroff SR, 2004, PSYCHOL SCI, V15, P420, DOI 10.1111/j.0956-7976.2004.00695.x; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; Neisser U., 1967, COGNITIVE PSYCHOL; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Olson IR, 2002, PERCEPT PSYCHOPHYS, V64, P1055, DOI 10.3758/BF03194756; Schmidt BK, 2002, PERCEPT PSYCHOPHYS, V64, P754, DOI 10.3758/BF03194742; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Shao N, 2010, MEM COGNITION, V38, P629, DOI 10.3758/MC.38.5.629; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Tian SJ, 2001, CLIN ELECTROENCEPHAL, V32, P82, DOI 10.1177/155005940103200207; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Vogel EK, 2005, J COGNITIVE NEUROSCI, V17, P1907, DOI 10.1162/089892905775008599; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Wang HJ, 2001, NEUROSCI LETT, V298, P155, DOI 10.1016/S0304-3940(00)01757-2; Wang YP, 2004, PSYCHOPHYSIOLOGY, V41, P21, DOI 10.1111/j.1469-8986.2003.00134.x; Wang YP, 2003, EXP BRAIN RES, V148, P451, DOI 10.1007/s00221-002-1319-y; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Wolfe JM, 2010, CURR BIOL, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wolfe JM, 1997, VISION RES, V37, P25, DOI 10.1016/S0042-6989(96)00111-3; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; WOLFE JM, 2007, INTEGRATED MODELS CO, V25, P9479; Wood JN, 2007, J EXP PSYCHOL GEN, V136, P639, DOI 10.1037/0096-3445.136.4.639; Woodman GF, 2008, PSYCHON B REV, V15, P223, DOI 10.3758/PBR.15.1.223; Woodman GF, 2004, PSYCHON B REV, V11, P269, DOI 10.3758/BF03196569; Woodman GF, 2003, PSYCHON B REV, V10, P80, DOI 10.3758/BF03196470; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121; XU Q, 2009, APPL PSYCHOL, V15, P106; Xu YD, 2007, P NATL ACAD SCI USA, V104, P18766, DOI 10.1073/pnas.0705618104; Xu Y, 2007, J NEUROSCI, V27, P11676, DOI 10.1523/JNEUROSCI.3545-07.2007; Xu YD, 2009, TRENDS COGN SCI, V13, P167, DOI 10.1016/j.tics.2009.01.008; Xu YD, 2009, J COGNITIVE NEUROSCI, V21, P511, DOI 10.1162/jocn.2008.21024; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Xu YD, 2002, PERCEPT PSYCHOPHYS, V64, P1260, DOI 10.3758/BF03194770; Yang J, 2002, NEUROSCI LETT, V326, P73, DOI 10.1016/S0304-3940(02)00204-5; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zhang X, 2003, CLIN NEUROPHYSIOL, V114, P2461, DOI 10.1016/S1388-2457(03)00251-7	82	33	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14273	10.1371/journal.pone.0014273	http://dx.doi.org/10.1371/journal.pone.0014273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692UU	21170315	gold, Green Submitted, Green Published			2022-12-27	WOS:000285181400005
J	Maioli, M; Santaniello, S; Montella, A; Bandiera, P; Cantoni, S; Cavallini, C; Bianchi, F; Lionetti, V; Rizzolio, F; Marchesi, I; Bagella, L; Ventura, C				Maioli, Margherita; Santaniello, Sara; Montella, Andrea; Bandiera, Pasquale; Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Lionetti, Vincenzo; Rizzolio, Flavio; Marchesi, Irene; Bagella, Luigi; Ventura, Carlo			Hyaluronan Esters Drive Smad Gene Expression and Signaling Enhancing Cardiogenesis in Mouse Embryonic and Human Mesenchymal Stem Cells	PLOS ONE			English	Article							TGF-BETA; HIGH-THROUGHPUT; MIXED ESTERS; IN-VITRO; HEART; NKX2-5; TRANSCRIPTION; DROSOPHILA; DIFFERENTIATION; MESODERM	Background: Development of molecules chemically modifying the expression of crucial orchestrator(s) of stem cell commitment may have significant biomedical impact. We have recently developed hyaluronan mixed esters of butyric and retinoic acids (HBR), turning cardiovascular stem cell fate into a high-yield process. The HBR mechanism(s) remain still largely undefined. Methodology/Principal Findings: We show that in both mouse embryonic stem (ES) cells and human mesenchymal stem cells from fetal membranes of term placenta (FMhMSCs), HBR differentially affected the patterning of Smad proteins, one of the major conductors of stem cell cardiogenesis. Real-time RT-PCR and Western blot analyses revealed that in both cell types HBR enhanced gene and protein expression of Smad1,3, and 4, while down-regulating Smad7. HBR acted at the transcriptional level, as shown by nuclear run-off experiments in isolated nuclei. Immunofluorescence analysis indicated that HBR increased the fluorescent staining for Smad1,3, and 4, confirming that the transcriptional action of HBR encompassed the upregulation of the encoded Smad proteins. Chromatin immune precipitation and transcriptional analyses showed that HBR increased the transcription of the cardiogenic gene Nkx-2.5 through Smad4 binding to its own consensus Smad site. Treatment of mouse ES cells and FMhMSCs with HBR led to the concomitant overexpression of both Smad4 and alpha-sarcomeric actinin. Smad4 silencing by the aid of lentiviral-mediated Smad4 shRNA confirmed a dominant role of Smad4 in HBR-induced cardiogenesis. Conclusions/Significance: The use of HBR may pave the way to novel combinatorial strategies of molecular and stem cell therapy based on fine tuning of targeted Smad transciption and signaling leading to a high-throughput of cardiogenesis without the needs of gene transfer technologies.	[Maioli, Margherita; Santaniello, Sara; Montella, Andrea; Bandiera, Pasquale; Marchesi, Irene; Bagella, Luigi] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Maioli, Margherita; Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Lionetti, Vincenzo; Ventura, Carlo] Univ Bologna, Natl Inst Biostruct & Biosyst, Bologna, Italy; [Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Ventura, Carlo] Univ Bologna, S Orsola Malpighi Hosp, Lab Mol Biol & Stem Cell Engn, Cardiovasc Dept,Natl Inst Biostruct & Biosyst, Bologna, Italy; [Lionetti, Vincenzo] CNR, Inst Clin Physiol, Scuola Super S Anna, Sector Med, I-56100 Pisa, Italy; [Rizzolio, Flavio; Marchesi, Irene; Bagella, Luigi] Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Philadelphia, PA 19122 USA; [Ventura, Carlo] Biosci Inst, Falciano, San Marino	University of Sassari; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Maioli, M (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	carlo.ventura@unibo.it	Lionetti, Vincenzo/G-9528-2014; Bianchi, Francesca/M-2205-2016; Bandiera, Pasquale/F-4276-2017; Montella, Andrea C/ABA-7073-2021; MARCHESI, Irene/H-8371-2019; Rizzolio, Flavio/K-2690-2018; Ventura, Carlo/AAV-3658-2020; Lionetti, Vincenzo/AAH-9503-2020; Lionetti, Vincenzo/AAN-1994-2020; Cantoni, Silvia/H-3938-2011	Bianchi, Francesca/0000-0001-6732-0533; Bandiera, Pasquale/0000-0002-0589-4539; MARCHESI, Irene/0000-0002-4383-6110; Rizzolio, Flavio/0000-0002-3400-4363; Lionetti, Vincenzo/0000-0002-0640-8651; MAIOLI, Margherita/0000-0003-0187-4968; Cavallini, Claudia/0000-0002-8079-9697; BAGELLA, Luigi/0000-0003-2815-037X; Cantoni, Silvia/0000-0002-3866-3307	Regione Emilia Romagna, Italy; Fondazione Luisa Fanti Melloni, Bologna, Italy; Tavola Valdese, Rome, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Fondazione Banco di Sardegna; Regione Autonoma della Sardegna, Italy	Regione Emilia Romagna, Italy(Regione Emilia Romagna); Fondazione Luisa Fanti Melloni, Bologna, Italy; Tavola Valdese, Rome, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Regione Autonoma della Sardegna, Italy(Regione Sardegna)	This work was supported by Regione Emilia Romagna, Programma di Ricerca Regione - Universita 2007/2009, Area 1b "Medicina rigenerativa", Italy; Fondazione Luisa Fanti Melloni, Bologna, Italy; Tavola Valdese, Rome, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Fondazione Banco di Sardegna, and Regione Autonoma della Sardegna, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BODMER R, 1990, DEVELOPMENT, V110, P661; BODMER R, 1993, DEVELOPMENT, V118, P719; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Chen LG, 2007, DIFFERENTIATION, V75, P682, DOI 10.1111/j.1432-0436.2007.00169.x; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Daniel C, 2007, J CELL BIOCHEM, V102, P1420, DOI 10.1002/jcb.21361; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Guh JY, 2003, KIDNEY INT, V64, P2041, DOI 10.1046/j.1523-1755.2003.00330.x; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; He JG, 2010, CLIN EXP PHARMACOL P, V37, P283, DOI 10.1111/j.1440-1681.2009.05281.x; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Li XF, 2003, ENDOCRINOLOGY, V144, P2514, DOI 10.1210/en.2002-220969; Lien CL, 1999, DEVELOPMENT, V126, P75; Lien CL, 2002, DEV BIOL, V244, P257, DOI 10.1006/dbio.2002.0603; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lionetti V, 2010, J BIOL CHEM, V285, P9949, DOI 10.1074/jbc.M109.087254; Liu T, 2010, BIOCHEM J, V430, P191, DOI 10.1042/BJ20100427; Maioli M, 2007, REGEN MED, V2, P193, DOI 10.2217/17460751.2.2.193; Massague J, 2000, GENE DEV, V14, P627; Monzen K, 2001, J CELL BIOL, V153, P687, DOI 10.1083/jcb.153.4.687; Moustakas A, 2001, J CELL SCI, V114, P4359; Pajak B, 2007, ADV MED SCI-POLAND, V52, P83; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAJASINGH J, 2007, CIRC RES, V101, pE68; Reecy JM, 1999, DEVELOPMENT, V126, P839; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Searcy RD, 1998, DEVELOPMENT, V125, P4461; Shen H, 2003, AM J PHYSIOL-GASTR L, V285, pG539, DOI 10.1152/ajpgi.00436.2002; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Song LY, 2007, CIRC RES, V101, P277, DOI 10.1161/CIRCRESAHA.107.155630; Tanaka M, 1999, DEVELOPMENT, V126, P1439; Ventura C, 2000, CIRC RES, V87, P189, DOI 10.1161/01.RES.87.3.189; Ventura C, 2004, J BIOL CHEM, V279, P23574, DOI 10.1074/jbc.M401869200; Ventura C, 2003, CIRC RES, V92, P623, DOI 10.1161/01.RES.0000065169.23780.0E; Ventura C, 2003, CIRC RES, V92, P617, DOI 10.1161/01.RES.0000065168.31147.5B; Ventura C, 2007, J BIOL CHEM, V282, P14243, DOI 10.1074/jbc.M609350200; Wang H, 2003, INT J EXP PATHOL, V84, P153, DOI 10.1046/j.1365-2613.2003.00347.x; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354; Zhang JT, 2009, J APPL TOXICOL, V29, P364, DOI 10.1002/jat.1404; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zhong H, 2009, INT J HEMATOL, V89, P438, DOI 10.1007/s12185-009-0293-6	45	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15151	10.1371/journal.pone.0015151	http://dx.doi.org/10.1371/journal.pone.0015151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152044	gold, Green Published			2022-12-27	WOS:000284755100085
J	Zhan, YY; Maung, SW; Shao, B; Myat, MM				Zhan, Yaoyao; Maung, Saw W.; Shao, Bing; Myat, Monn Monn			The bHLH Transcription Factor, Hairy, Refines the Terminal Cell Fate in the Drosophila Embryonic Trachea	PLOS ONE			English	Article							FGF RECEPTOR HOMOLOG; BRANCHING MORPHOGENESIS; NOTCH; GENE; EXPRESSION; GROWTH; BREATHLESS; MIGRATION; ENCODES; PROTEIN	Background: The pair-rule gene, hairy, encodes a basic helix-loop-helix transcription factor and is required for patterning of the early Drosophila embryo and for morphogenesis of the embryonic salivary gland. Although hairy was shown to be expressed in the tracheal primordia and in surrounding mesoderm, whether hairy plays a role in tracheal development is not known. Principal Findings: Here, we report that hairy is required for refining the terminal cell fate in the embryonic trachea and that hairy's tracheal function is distinct from its earlier role in embryonic patterning. In hairy mutant embryos where the repressive activity of hairy is lost due to lack of its co-repressor binding site, extra terminal cells are specified in the dorsal branches. We show that hairy functions in the muscle to refine the terminal cell fate to a single cell at the tip of the dorsal branch by limiting the expression domain of branchless (bnl), encoding the FGF ligand, in surrounding muscle cells. Abnormal activation of the Bnl signaling pathway in hairy mutant tracheal cells is exemplified by increased number of dorsal branch cells expressing Bnl receptor, Breathless (Btl) and Pointed, a downstream target of the Bnl/Btl signaling pathway. We also show that hairy genetically interacts with bnl in TC fate restriction and that overexpression of bnl in a subset of the muscle surrounding tracheal cells phenocopied the hairy mutant phenotype. Conclusions/Significance: Our studies demonstrate a novel role for Hairy in restriction of the terminal cell fate by limiting the domain of bnl expression in surrounding muscle cells such that only a single dorsal branch cell becomes specified as a terminal cell. These studies provide the first evidence for Hairy in regulation of the FGF signaling pathway during branching morphogenesis.	[Zhan, Yaoyao; Maung, Saw W.; Shao, Bing; Myat, Monn Monn] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA	Cornell University	Zhan, YY (corresponding author), Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA.	mmm2005@med.cornell.edu			Irma T. Hirschl Trust	Irma T. Hirschl Trust	Funding: Irma T. Hirschl Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Bellusci S, 1997, DEVELOPMENT, V124, P4867; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706; CARROLL SB, 1988, GENE DEV, V2, P883, DOI 10.1101/gad.2.7.883; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697; Guillemin K, 1996, DEVELOPMENT, V122, P1353; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; HOOPER KL, 1989, DEVELOPMENT, V107, P489; Ikeya T, 1999, DEVELOPMENT, V126, P4455; INGHAM PW, 1985, GENETICS, V111, P463; JIMENEZ G, 1996, EMBO J, V16; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kokubo H, 2005, TRENDS CARDIOVAS MED, V15, P190, DOI 10.1016/j.tcm.2005.05.005; LEHMANN R, 1994, SITU HYBRIDIZATION R; Llimargas M, 1999, DEVELOPMENT, V126, P2355; Myat MM, 2002, CELL, V111, P879, DOI 10.1016/S0092-8674(02)01140-6; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397; Ohshiro T, 2002, MECH DEVELOP, V114, P3, DOI 10.1016/S0925-4773(02)00042-4; REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428; REUTER R, 1990, DEVELOPMENT, V110, P1031; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; WAINWRIGHT SM, 1992, MOL CELL BIOL, V12, P2475, DOI 10.1128/MCB.12.6.2475; Wang Q, 2010, DEV CELL, V18, P157, DOI 10.1016/j.devcel.2009.11.004; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14134	10.1371/journal.pone.0014134	http://dx.doi.org/10.1371/journal.pone.0014134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152432	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100015
J	Premo, LS; Kuhn, SL				Premo, L. S.; Kuhn, Steven L.			Modeling Effects of Local Extinctions on Culture Change and Diversity in the Paleolithic	PLOS ONE			English	Article							GENE FLOW; POPULATION; DEMOGRAPHY; TECHNOLOGY; EVOLUTION; CONSEQUENCES; NEANDERTHALS; INNOVATION; EMERGENCE	The persistence of early stone tool technologies has puzzled archaeologists for decades. Cognitively based explanations, which presume either lack of ability to innovate or extreme conformism, do not account for the totality of the empirical patterns. Following recent research, this study explores the effects of demographic factors on rates of culture change and diversification. We investigate whether the appearance of stability in early Paleolithic technologies could result from frequent extinctions of local subpopulations within a persistent metapopulation. A spatially explicit agent-based model was constructed to test the influence of local extinction rate on three general cultural patterns that archaeologists might observe in the material record: total diversity, differentiation among spatially defined groups, and the rate of cumulative change. The model shows that diversity, differentiation, and the rate of cumulative cultural change would be strongly affected by local extinction rates, in some cases mimicking the results of conformist cultural transmission. The results have implications for understanding spatial and temporal patterning in ancient material culture.	[Premo, L. S.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Kuhn, Steven L.] Univ Arizona, Sch Anthropol, Tucson, AZ USA	Max Planck Society; University of Arizona	Premo, LS (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	luke.premo@eva.mpg.de			Max Planck Society; University of Arizona	Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Arizona	LSP was supported by the Max Planck Society. SLK was supported by the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Belovsky G.E., 1987, P35, DOI 10.1017/CBO9780511623400.004; Bocquet-Appel JP, 2009, HUM BIOL, V81, P287, DOI 10.3378/027.081.0310; Boeda E., 1991, TECHNIQUES CULTURE, V17, P37; Boyd R, 2005, ORIGIN EVOLUTION CUL; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Chamberlain A, 2009, HUM BIOL, V81, P275, DOI 10.3378/027.081.0309; Delagnes A., 2005, TRANSITIONS TRANSITI, P85; DENNELL RW, 2010, QUATERNARY IN PRESS, DOI DOI 10.1016/J.QUASCIREV.2009.11.027; Diamond J.M., 1984, P191; Eren MI, 2008, J HUM EVOL, V55, P952, DOI 10.1016/j.jhevol.2008.07.009; Foley R, 2003, EVOL ANTHROPOL, V12, P109, DOI 10.1002/evan.10108; Foley R, 2009, PHILOS T R SOC B, V364, P3267, DOI 10.1098/rstb.2009.0136; Gamble C, 1999, PALAEOLITHIC SOC EUR; Gittleman JL, 1998, BIODIVERSITY DYNAMICS, P51; Gowlett JAJ., 1996, MODELLING EARLY HUMA, P191; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J., 2010, INNOVATION CULTURAL, P99, DOI DOI 10.1038/nature00823; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; Hoffecker JF, 2005, EVOL ANTHROPOL, V14, P186, DOI 10.1002/evan.20066; Hublin JJ, 2009, CR PALEVOL, V8, P503, DOI 10.1016/j.crpv.2009.04.001; Kandler A, 2009, THEOR POPUL BIOL, V76, P59, DOI 10.1016/j.tpb.2009.04.004; Klein R., 2002, DAWN HUMAN CULTURE; Klein R.G., 1999, HUMAN CAREER; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Kuhn SL, 2001, BIOSOCIAL S, V13, P99; Kuhn SL, 2006, CURR ANTHROPOL, V47, P953, DOI 10.1086/507197; Lycett SJ, 2010, QUATERN INT, V211, P55, DOI 10.1016/j.quaint.2008.12.001; MCCAULEY DE, 1991, TRENDS ECOL EVOL, V6, P5, DOI 10.1016/0169-5347(91)90139-O; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; McNabb J, 2004, CURR ANTHROPOL, V45, P653, DOI 10.1086/423973; Meignen L, 2009, LITHIC MAT PALEOLITH, P15, DOI DOI 10.1002/9781444311976.CH2; Mellars Paul A., 1996, NEANDERTHAL LEGACY A; Mithen S., 1996, PREHISTORY MIND; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 2000, MOL EVOLUTION PHYLOG; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; O'Brien M.J., 2010, INNOVATION CULTURAL, P3; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Richerson PJ, 2009, HUM BIOL, V81, P211, DOI 10.3378/027.081.0306; Riede F, 2009, HUM BIOL, V81, P309, DOI 10.3378/027.081.0311; Roebroeks W, 2006, J QUATERNARY SCI, V21, P425, DOI 10.1002/jqs.1044; Sharon G, 2009, CURR ANTHROPOL, V50, P335, DOI 10.1086/598849; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Shennan S, 2000, CURR ANTHROPOL, V41, P811, DOI 10.1086/317403; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; Stiner MC, 2002, J ARCHAEOL RES, V10, P1, DOI 10.1023/A:1014588307174; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; Whallon R, 2006, J ANTHROPOL ARCHAEOL, V25, P259, DOI 10.1016/j.jaa.2005.11.004; Whitlock MC, 1997, GENETICS, V146, P427; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Wilensky U., 1999, NETLOGO; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1943, GENETICS, V28, P114; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891; Wynn T, 2004, J HUM EVOL, V46, P467, DOI 10.1016/j.jhevol.2004.01.005	63	85	87	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15582	10.1371/journal.pone.0015582	http://dx.doi.org/10.1371/journal.pone.0015582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698DS	21179418	Green Published, Green Submitted, gold			2022-12-27	WOS:000285572900022
J	Chung, FT; Lin, HC; Kuo, CH; Yu, CT; Chou, CL; Lee, KY; Kuo, HP; Lin, SM				Chung, Fu-Tsai; Lin, Horng-Chyuan; Kuo, Chih-Hsi; Yu, Chih-Teng; Chou, Chun-Liang; Lee, Kang-Yun; Kuo, Han-Pin; Lin, Shu-Min			Extravascular Lung Water Correlates Multiorgan Dysfunction Syndrome and Mortality in Sepsis	PLOS ONE			English	Article							TRANSPULMONARY THERMODILUTION; ORGAN FAILURE; MICROALBUMINURIA; SCORE; CLASSIFICATION; SEVERITY; OUTCOMES	Background: This study was designated to investigate whether increased extravascular lung water index (EVLWI) may correlate multiple organ dysfunction syndrome (MODS) and mortality in sepsis. Methods: We designed a prospective cohort study in an intensive care unit of a tertiary care hospital. Sixty-seven patients with severe sepsis were included. Data were used to determine an association between EVLWI and the development of MODS and mortality. These connections were determined by the multiple logistic regression, plotting the receiver operating characteristic (ROC) curve and by Spearman test. Results: EVLWI levels were higher in MODS patients on day 1 (median (IQR), 18(12.8-23.9) ml/kg, n = 38, p<0.0001) than in those without (median (IQR), 12.4 (7.9-16.3) ml/kg, n = 29) and day 3 (median (IQR), 17.8 (11.2-22.8) ml/kg, n = 29, p = 0.004) than in those without (median (IQR), 12.4 (8.0-16.3) ml/kg, n = 29). EVLWI was used as an independent predictor of the development of MODS (odds ratio, 1.6; p = 0.005; 95% confidence interval, 1.2 similar to 2.2) during ICU stay. The area under the ROC curve showed that EVLWI levels could predict MODS (0.866) and mortality (0.881) during ICU stay. Meanwhile, the higher of SOFA score, the more EVLWI was found on day 1 (r = 0.7041, p<0.0001) and day 3 (r = 0.7732, p<0.0001). Conclusions: Increased EVLWI levels correlates development of MODS and mortality during the patients' ICU stay. Further more, the potential of novel treatment in severe sepsis with lung injury may develop.	[Chung, Fu-Tsai; Lin, Horng-Chyuan; Kuo, Chih-Hsi; Yu, Chih-Teng; Chou, Chun-Liang; Lee, Kang-Yun; Kuo, Han-Pin; Lin, Shu-Min] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Dept Thorac Med, Taipei, Taiwan; [Chung, Fu-Tsai] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Chung, FT (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Dept Thorac Med, Taipei, Taiwan.	smlin100@gmail.com	Lin, Shu-Min/B-9207-2011					Abid O, 2001, CHEST, V120, P1984, DOI 10.1378/chest.120.6.1984; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; ASTIZ ME, 1995, CRIT CARE MED, V23, P265, DOI 10.1097/00003246-199502000-00011; BOGNAR Z, 2010, BURN IN PRESS, DOI DOI 10.1016/J.BURNS.2010.04.006; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Chen YC, 2009, SHOCK, V31, P139, DOI 10.1097/SHK.0b013e31817d419e; Chung FT, 2008, RESP MED, V102, P956, DOI 10.1016/j.rmed.2008.02.016; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Gullo A, 1996, Acta Anaesthesiol Scand Suppl, V109, P70; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Katzenelson R, 2004, CRIT CARE MED, V32, P1550, DOI 10.1097/01.CCM.0000130995.18334.8B; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krau Stephen D, 2007, Crit Care Nurs Clin North Am, V19, P87, DOI 10.1016/j.ccell.2006.11.002; Kuzkov VV, 2006, CRIT CARE MED, V34, P1647, DOI 10.1097/01.CCM.0000218817.24208.2E; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Lin SM, 2008, CRIT CARE MED, V36, P683, DOI 10.1097/CCM.0B013E31816537D8; Lydon Avine, 2003, Int Anesthesiol Clin, V41, P65; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin GS, 2005, CRIT CARE, V9, pR74, DOI 10.1186/cc3025; Michard F, 2007, CRIT CARE MED, V35, P1186, DOI 10.1097/01.CCM.0000259539.49339.66; Molnar Z, 2003, INTENS CARE MED, V29, P391, DOI 10.1007/s00134-003-1651-0; Neumann P, 1999, INTENS CARE MED, V25, P216, DOI 10.1007/s001340050819; Sakka SG, 2000, INTENS CARE MED, V26, P180, DOI 10.1007/s001340050043; Sakka SG, 2002, CHEST, V122, P2080, DOI 10.1378/chest.122.6.2080; Spapen HD, 2005, CHEST, V127, P1413, DOI 10.1378/chest.127.4.1413; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Volman TJH, 2005, SHOCK, V23, P291, DOI 10.1097/01.shk.0000155350.95435.28; Zimmerman JE, 1996, CRIT CARE MED, V24, P1633, DOI 10.1097/00003246-199610000-00006	31	28	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15265	10.1371/journal.pone.0015265	http://dx.doi.org/10.1371/journal.pone.0015265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21187890	Green Published, Green Submitted, gold			2022-12-27	WOS:000285381200021
J	Nelson, E; Sander, H; Hawthorne, P; Conte, M; Ennaanay, D; Wolny, S; Manson, S; Polasky, S				Nelson, Erik; Sander, Heather; Hawthorne, Peter; Conte, Marc; Ennaanay, Driss; Wolny, Stacie; Manson, Steven; Polasky, Stephen			Projecting Global Land-Use Change and Its Effect on Ecosystem Service Provision and Biodiversity with Simple Models	PLOS ONE			English	Article							URBAN FUTURES MODEL; COVER CHANGE; AVOIDED DEFORESTATION; ALTERNATIVE FUTURES; PROTECTED AREAS; AGRICULTURE; DYNAMICS; CONSERVATION; 2ND-GENERATION; URBANIZATION	Background: As the global human population grows and its consumption patterns change, additional land will be needed for living space and agricultural production. A critical question facing global society is how to meet growing human demands for living space, food, fuel, and other materials while sustaining ecosystem services and biodiversity [1]. Methodology/Principal Findings: We spatially allocate two scenarios of 2000 to 2015 global areal change in urban land and cropland at the grid cell-level and measure the impact of this change on the provision of ecosystem services and biodiversity. The models and techniques used to spatially allocate land-use/land-cover (LULC) change and evaluate its impact on ecosystems are relatively simple and transparent [2]. The difference in the magnitude and pattern of cropland expansion across the two scenarios engenders different tradeoffs among crop production, provision of species habitat, and other important ecosystem services such as biomass carbon storage. For example, in one scenario, 5.2 grams of carbon stored in biomass is released for every additional calorie of crop produced across the globe; under the other scenario this tradeoff rate is 13.7. By comparing scenarios and their impacts we can begin to identify the global pattern of cropland and irrigation development that is significant enough to meet future food needs but has less of an impact on ecosystem service and habitat provision. Conclusions/Significance: Urban area and croplands will expand in the future to meet human needs for living space, livelihoods, and food. In order to jointly provide desired levels of urban land, food production, and ecosystem service and species habitat provision the global society will have to become much more strategic in its allocation of intensively managed land uses. Here we illustrate a method for quickly and transparently evaluating the performance of potential global futures.	[Nelson, Erik; Conte, Marc; Ennaanay, Driss; Wolny, Stacie] Stanford Univ, Woods Inst Environm, Nat Capital Project, Stanford, CA 94305 USA; [Sander, Heather; Polasky, Stephen] Univ Minnesota, Conservat Biol Grad Program, St Paul, MN 55108 USA; [Hawthorne, Peter] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Manson, Steven] Univ Minnesota, Dept Geog, St Paul, MN 55108 USA; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	Stanford University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Nelson, E (corresponding author), Stanford Univ, Woods Inst Environm, Nat Capital Project, Stanford, CA 94305 USA.	enelson2@bowdoin.edu	Polasky, Stephen/AAC-5341-2019; Nelson, Erik J./J-4192-2019; Steven, Manson M/B-9061-2008	Nelson, Erik J./0000-0002-7291-5192; Steven, Manson M/0000-0001-7697-5339; Hawthorne, Peter/0000-0003-1125-5239	P and H Bing foundation; V and R Sant foundation; MacArthur foundation; Winslow foundation; Institute on the Environment at the University of Minnesota; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041023] Funding Source: NIH RePORTER	P and H Bing foundation; V and R Sant foundation; MacArthur foundation; Winslow foundation; Institute on the Environment at the University of Minnesota(University of Minnesota System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful for support from P and H Bing, V and R Sant, the MacArthur and Winslow foundations, and the Institute on the Environment at the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2005, ECOL SOC, V10; Alcamo J, 2003, HYDROLOG SCI J, V48, P317, DOI 10.1623/hysj.48.3.317.45290; Alcamo J, 2003, HYDROLOG SCI J, V48, P339, DOI 10.1623/hysj.48.3.339.45278; Alcamo J., 2005, ECOSYSTEMS HUMAN WEL, P145; Alcamo J, 1998, GLOBAL CHANGE SCENAR; Alcamo J, 2005, MILLENNIUM ECOSYSTEM, V2, P297; ALKEMADE R, 2006, INTEGRATED MODELLING, P171; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2008, INT MODEL POLICY ANA; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Bachelet D, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001508; Baker JP, 2004, ECOL APPL, V14, P313, DOI 10.1890/02-5011; BOUWMAN AF, 1993, GLOBAL BIOGEOCHEM CY, V7, P557, DOI 10.1029/93GB01186; BOUWMAN AF, 2006, INTEGRATED MODELLING, P77; Budyko M.I., 1974, CLIMATE LIFE; BUDYKO MI, 1961, IZV AK NAUK SSR G, V6, P6; Byerlee D, 2009, ANNU REV RESOUR ECON, V1, P15, DOI 10.1146/annurev.resource.050708.144239; Carpenter S, 2005, ECOSYSTEMS HUMAN WEL, V2; CHATFIELD C, 1953, FOOD COMPOSITION TAB; Clarke KC, 1997, ENVIRON PLANN B, V24, P247, DOI 10.1068/b240247; *CTR INT EARTH SCI, 2005, GRID POP WORLD VERS; DeFries R., 2004, GeoJournal, V61, P345, DOI 10.1007/s10708-004-5051-y; Donohue RJ, 2007, HYDROL EARTH SYST SC, V11, P983, DOI 10.5194/hess-11-983-2007; Ebeling J, 2008, PHILOS T R SOC B, V363, P1917, DOI 10.1098/rstb.2007.0029; EICKHOUT B, 2006, INTEGRATED MODELING, P61; *EROS, 1996, GTOPO30; FAO (Food and Agriculture Organization of the United Nations), 2009, STAT WORLDS FOR 2009; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Fry J.A., 2009, COMPLETION NATL LAND; GOLDSTEIN JH, 2010, INTEGRATING ECOSYSTE; Guzy MR, 2008, ECOL SOC, V13; Hall CAS, 1995, J BIOGEOGR, V22, P753, DOI 10.2307/2845977; Hamon W.R., 1961, J HYDRAULICS DIVISIO, V87, P107, DOI DOI 10.1061/JYCEAJ.0000599; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hulse D, 2009, LANDSCAPE ECOL, V24, P1067, DOI 10.1007/s10980-008-9255-2; *IMAGE TEAM, 2001, IMAGE 2 2 IMPL SRES; Irwin EG, 2001, AGR ECOSYST ENVIRON, V85, P7, DOI 10.1016/S0167-8809(01)00200-6; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; JOHNSTON RA, 2004, TRANSPORT RES REC, V1831, P202; *JOINT RES CTR EUR, 2003, GLOB LAND COV 2000 D; Kahn ME, 2009, ANNU REV RESOUR ECON, V1, P333, DOI 10.1146/annurev.resource.050708.144249; Kamusoko C, 2009, APPL GEOGR, V29, P435, DOI 10.1016/j.apgeog.2008.10.002; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Keys E, 2005, GLOBAL ENVIRON CHANG, V15, P320, DOI 10.1016/j.gloenvcha.2005.04.004; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lambin EF, 2006; Lambin EF, 2000, AGR ECOSYST ENVIRON, V82, P321, DOI 10.1016/S0167-8809(00)00235-8; Landis J, 1998, ENVIRON PLANN B, V25, P795, DOI 10.1068/b250795; Landis J, 1998, ENVIRON PLANN B, V25, P657, DOI 10.1068/b250657; LANDIS JD, 1994, ENVIRON PLANN B, V21, P399, DOI 10.1068/b210399; Leff B, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002108; Luedeling E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006166; Manders, 2009, ENV FOOD CRISIS ENV; MANSON SM, 2006, ECOSYSTEMS HUMAN WEL, V2, P74; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; Mcdonald RI, 2009, LANDSCAPE URBAN PLAN, V93, P63, DOI 10.1016/j.landurbplan.2009.06.002; MENDELSOHN R, 1994, AM ECON REV, V84, P753; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; MILLY PCD, 1994, WATER RESOUR RES, V30, P2143, DOI 10.1029/94WR00586; MONFREDA C, 2010, FRONT ECOL ENV UNPUB; Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650; Nagendra H, 2008, AMBIO, V37, P330, DOI 10.1579/06-R-184.1; Naidoo R, 2007, BIOL CONSERV, V140, P40, DOI 10.1016/j.biocon.2007.07.025; Nelson E, 2008, P NATL ACAD SCI USA, V105, P9471, DOI 10.1073/pnas.0706178105; Nelson Erik J, 2010, F1000 Biol Rep, V2, P53, DOI 10.3410/B2-53; Nelson G.C., 2009, CLIMATE CHANGE IMPAC, DOI [DOI 10.2499/0896295354, 10.2499/0896295354]; Nelson GC, 2002, AGR ECON-BLACKWELL, V27, P201, DOI 10.1111/j.1574-0862.2002.tb00117.x; *NETH ENV ASS AG, 2006, INT MOD GLOB ENV CHA; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PARTON WJ, 1988, BIOGEOCHEMISTRY, V5, P109, DOI 10.1007/BF02180320; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Pirard R, 2009, ECOL ECON, V68, P2179, DOI 10.1016/j.ecolecon.2009.01.009; PLANTINGA AJ, 2008, 200811 HARV PROJ INT; Pontius RG, 2001, AGR ECOSYST ENVIRON, V85, P191, DOI 10.1016/S0167-8809(01)00183-9; Potter NJ, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003697; Ramankutty N, 2002, AMBIO, V31, P251, DOI 10.1639/0044-7447(2002)031[0251:POTLCI]2.0.CO;2; Reid W., 2006, MILLENNIUM ECOSYSTEM; RIEBSAME WE, 1994, BIOSCIENCE, V44, P350, DOI 10.2307/1312385; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rodriguez JP, 2006, ECOL SOC, V11; Rosegrant M. W., 2002, World water and food to 2025: dealing with scarcity; Rosegrant M. W., 2001, Global food projections to 2020: emerging trends and alternative futures; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Sala O.E., 2005, ECOSYSTEMS HUMAN WEL, P375; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Santhi C, 2006, ENVIRON MODELL SOFTW, V21, P1141, DOI 10.1016/j.envsoft.2005.05.013; Schlenker W, 2005, AM ECON REV, V95, P395, DOI 10.1257/0002828053828455; Seifert P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008352; SEITZINGER SP, 2010, GLOBAL BIOG IN PRESS; SIEBERT S, 2007, GLOBAL MAP IRRIGATED; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; Stern N, 2007, EC CLIMATE CHANGE ST; Strengers B., 2004, GeoJournal, V61, P381, DOI 10.1007/s10708-004-5054-8; SWETNAM RD, 2010, J ENV MANAG IN PRESS; Tacconi L, 2009, ECOL ECON, V68, P2469, DOI 10.1016/j.ecolecon.2008.12.012; Tallis, 2010, INVEST 1 004 BETA US; Tallis HM, 2006, TRENDS ECOL EVOL, V21, P562, DOI 10.1016/j.tree.2006.07.009; Thurow R., 2009, ENOUGH WHY WORLDS PO; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; *UN, 2009, UN COMM DAT; *UN DEV PROGR, 2008, HUM DEV IND STAT UPD; *UN ENV PROGR WORL, 2007, WORLD DAT PROT AR WD; *UN FAO, 2008, FAOSTAT PROD DAT; *UN FAO I APPL SYS, 2000, GLOB AGR ZON; *UN FAO ORG EC COO, 2009, OECD FAO AGR OUTL 19; *UN FAO ORG EC COO, 2008, OECD FAO AGR OUTL 19; United Nations Environment Programme, 2007, GLOB ENV OUTL ENV DE, V4; VANMINNEN JG, 2006, INTEGRATED MODELLING, P113; Veldkamp A, 2001, AGR ECOSYST ENVIRON, V85, P1, DOI 10.1016/S0167-8809(01)00199-2; Vera-Diaz MD, 2008, ECOL ECON, V65, P420, DOI 10.1016/j.ecolecon.2007.07.015; Verburg P. H., 2004, GeoJournal, V61, P309, DOI 10.1007/s10708-004-4946-y; WIKRAMANAYAKE E, 2002, TERRESTRIAL ECOREGIO; Wolock DM, 1999, J AM WATER RESOUR AS, V35, P1341, DOI 10.1111/j.1752-1688.1999.tb04219.x; *WORLD WILDL FUND, 2006, WILDFINDER ONL DAT S; You LZ, 2009, AGR SYST, V99, P126, DOI 10.1016/j.agsy.2008.11.003; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325	118	142	171	14	191	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14327	10.1371/journal.pone.0014327	http://dx.doi.org/10.1371/journal.pone.0014327			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	694ZI	21179509	gold, Green Submitted, Green Published			2022-12-27	WOS:000285340000006
J	Bauer, WR; Nadler, W				Bauer, Wolfgang R.; Nadler, Walter			Thermodynamics of Competitive Molecular Channel Transport: Application to Artificial Nuclear Pores	PLOS ONE			English	Article							DIFFUSION	In an analytical model channel transport is analyzed as a function of key parameters, determining efficiency and selectivity of particle transport in a competitive molecular environment. These key parameters are the concentration of particles, solvent-channel exchange dynamics, as well as particle-in-channel-and interparticle interaction. These parameters are explicitly related to translocation dynamics and channel occupation probability. Slowing down the exchange dynamics at the channel ends, or elevating the particle concentration reduces the in-channel binding strength necessary to maintain maximum transport. Optimized in-channel interaction may even shift from binding to repulsion. A simple equation gives the interrelation of access dynamics and concentration at this transition point. The model is readily transferred to competitive transport of different species, each of them having their individual in-channel affinity. Combinations of channel affinities are determined which differentially favor selectivity of certain species on the cost of others. Selectivity for a species increases if its in-channel binding enhances the species' translocation probablity when compared to that of the other species. Selectivity increases particularly for a wide binding site, long channels, and fast access dynamics. Recent experiments on competitive transport of in-channel binding and inert molecules through artificial nuclear pores serve as a paradigm for our model. It explains qualitatively and quantitatively how binding molecules are favored for transport at the cost of the transport of inert molecules.	[Bauer, Wolfgang R.] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Nadler, Walter] Forschungszentrum Julich, IAS, JSC, D-52425 Julich, Germany	University of Wurzburg; Helmholtz Association; Research Center Julich	Bauer, WR (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany.	w.bauer@medizin.uni-wuerzburg.de			Research Centre 688 of the German Research Foundation	Research Centre 688 of the German Research Foundation	This work was partially supported by the Collaborative Research Centre 688 of the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astier Y, 2006, J AM CHEM SOC, V128, P1705, DOI 10.1021/ja057123+; Bauer WR, 2006, P NATL ACAD SCI USA, V103, P11446, DOI 10.1073/pnas.0601769103; Bauer WR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3026736; Bauer WR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1940056; Berezhkovskii A. M., 2005, CHEM PHYS, V319; Berezhkovskii AM, 2005, BIOPHYS J, V88, pL17, DOI 10.1529/biophysj.104.057588; Berezhkovskii AM, 2003, J CHEM PHYS, V119, P3943, DOI 10.1063/1.1590957; Berezhkovskii AM, 2002, J CHEM PHYS, V116, P9952, DOI 10.1063/1.1475758; Bezrukov SM, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2766720; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Chou T, 1999, PHYS REV LETT, V82, P3552, DOI 10.1103/PhysRevLett.82.3552; Chou T, 1999, J CHEM PHYS, V110, P606, DOI 10.1063/1.478118; Chou T, 1998, PHYS REV LETT, V80, P85, DOI 10.1103/PhysRevLett.80.85; EISENBERG RS, 1995, J CHEM PHYS, V102, P1767, DOI 10.1063/1.468704; GARDINER CW, 1995, HDB STOCHASTIC METHO; Iqbal SM, 2007, NAT NANOTECHNOL, V2, P243, DOI 10.1038/nnano.2007.78; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Kohli P, 2004, SCIENCE, V305, P984, DOI 10.1126/science.1100024; Kolomeisky AB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.048105; LAUGER P, 1973, BIOCHIM BIOPHYS ACTA, V311, P423, DOI 10.1016/0005-2736(73)90323-4; LEVITT DG, 1986, ANNU REV BIOPHYS BIO, V15, P29; NOBLE RD, 1991, J MEMBRANE SCI, V60, P297, DOI 10.1016/S0376-7388(00)81541-0; Reguera D, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061106; van Kampen N. G., 1981, STOCHASTIC PROCESSES; Zhou HX, 2010, J PHYS CHEM LETT, V1, P1973, DOI 10.1021/jz100683t; Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125; Zilman A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000804; Zilman A, 2009, BIOPHYS J, V96, P1235, DOI 10.1016/j.bpj.2008.09.058	28	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15160	10.1371/journal.pone.0015160	http://dx.doi.org/10.1371/journal.pone.0015160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179205	Green Published, gold, Green Submitted			2022-12-27	WOS:000285246900031
J	Zhang, Z; Wang, YX; Wang, LS; Gao, PJ				Zhang, Zheng; Wang, Yuxiao; Wang, Lushan; Gao, Peiji			The Combined Effects of Amino Acid Substitutions and Indels on the Evolution of Structure within Protein Families	PLOS ONE			English	Article							STRUCTURE ALIGNMENT; SECONDARY-STRUCTURE; MUTATION-RATE; SEQUENCE; NUCLEOTIDE; FOLDS; INSERTIONS; DELETIONS; DATABASE; SCOP	Background: In the process of protein evolution, sequence variations within protein families can cause changes in protein structures and functions. However, structures tend to be more conserved than sequences and functions. This leads to an intriguing question: what is the evolutionary mechanism by which sequence variations produce structural changes? To investigate this question, we focused on the most common types of sequence variations: amino acid substitutions and insertions/deletions (indels). Here their combined effects on protein structure evolution within protein families are studied. Results: Sequence-structure correlation analysis on 75 homologous structure families (from SCOP) that contain 20 or more non-redundant structures shows that in most of these families there is, statistically, a bilinear correlation between the amount of substitutions and indels versus the degree of structure variations. Bilinear regression of percent sequence non-identity (PNI) and standardized number of gaps (SNG) versus RMSD was performed. The coefficients from the regression analysis could be used to estimate the structure changes caused by each unit of substitution (structural substitution sensitivity, SSS) and by each unit of indel (structural indel sensitivity, SIDS). An analysis on 52 families with high bilinear fitting multiple correlation coefficients and statistically significant regression coefficients showed that SSS is mainly constrained by disulfide bonds, which almost have no effects on SIDS. Conclusions: Structural changes in homologous protein families could be rationally explained by a bilinear model combining amino acid substitutions and indels. These results may further improve our understanding of the evolutionary mechanisms of protein structures.	[Zhang, Zheng; Wang, Yuxiao; Wang, Lushan; Gao, Peiji] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Wang, Yuxiao] UT SW, Div Basic Sci, Dallas, TX USA	Shandong University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, Z (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	lswang@sdu.edu.cn; gaopj@sdu.edu.cn		Zhang, Zheng/0000-0001-9971-6006	Independent Innovation Foundation of Shandong University [2009jc006]; Scientific Research Reward Fund for Excellent Young and Middle-Aged Scientists in Shandong Province [BS2009SW021]	Independent Innovation Foundation of Shandong University; Scientific Research Reward Fund for Excellent Young and Middle-Aged Scientists in Shandong Province	This work was supported by Independent Innovation Foundation of Shandong University (No. 2009jc006) and Scientific Research Reward Fund for Excellent Young and Middle-Aged Scientists in Shandong Province (Grants No. BS2009SW021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BENNER SA, 1993, J MOL BIOL, V229, P1065, DOI 10.1006/jmbi.1993.1105; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Chung SY, 1996, STRUCTURE, V4, P1123, DOI 10.1016/S0969-2126(96)00119-0; de la CN, 2007, BMCEVOLBIOL, V7, P191; FLORES TP, 1993, PROTEIN SCI, V2, P1811, DOI 10.1002/pro.5560021104; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Grishin NV, 1997, J MOL EVOL, V45, P359, DOI 10.1007/PL00006241; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jiang H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-444; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; Koehl P, 2002, J MOL BIOL, V323, P551, DOI 10.1016/S0022-2836(02)00971-3; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Levitt M, 1998, P NATL ACAD SCI USA, V95, P5913, DOI 10.1073/pnas.95.11.5913; Martinez L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-306; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nachman MW, 2000, GENETICS, V156, P297; Notredame C, 2002, PHARMACOGENOMICS, V3, P131, DOI 10.1517/14622416.3.1.131; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Panchenko AR, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-10; Panchenko AR, 2005, PROTEINS, V61, P535, DOI 10.1002/prot.20644; PASCARELLA S, 1992, J MOL BIOL, V224, P461, DOI 10.1016/0022-2836(92)91008-D; Punta M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000160; Russell RB, 1997, J MOL BIOL, V269, P423, DOI 10.1006/jmbi.1997.1019; RUSSELL RB, 1994, J MOL BIOL, V244, P332, DOI 10.1006/jmbi.1994.1733; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Wood TC, 1999, J MOL BIOL, V291, P977, DOI 10.1006/jmbi.1999.2972; Zhang Z, 2011, MOL BIOL EVOL, V28, P291, DOI 10.1093/molbev/msq196; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	35	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14316	10.1371/journal.pone.0014316	http://dx.doi.org/10.1371/journal.pone.0014316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179197	Green Submitted, Green Published, gold			2022-12-27	WOS:000285246900021
J	Santoriello, C; Gennaro, E; Anelli, V; Distel, M; Kelly, A; Koster, RW; Hurlstone, A; Mione, M				Santoriello, Cristina; Gennaro, Elisa; Anelli, Viviana; Distel, Martin; Kelly, Amanda; Koester, Reinhard W.; Hurlstone, Adam; Mione, Marina			Kita Driven Expression of Oncogenic HRAS Leads to Early Onset and Highly Penetrant Melanoma in Zebrafish	PLOS ONE			English	Article							MALIGNANT-MELANOMA; GENE-EXPRESSION; CANCER; PROTEIN; MUTATIONS; REGULATOR; PATHWAYS; TUMORS; CELLS; MODEL	Background: Melanoma is the most aggressive and lethal form of skin cancer. Because of the increasing incidence and high lethality of melanoma, animal models for continuously observing melanoma formation and progression as well as for testing pharmacological agents are needed. Methodology and Principal Findings: Using the combinatorial Gal4 - UAS system, we have developed a zebrafish transgenic line that expresses oncogenic HRAS under the kita promoter. Already at 3 days transgenic kita-GFP-RAS larvae show a hyper-pigmentation phenotype as earliest evidence of abnormal melanocyte growth. By 2-4 weeks, masses of transformed melanocytes form in the tail stalk of the majority of kita-GFP-RAS transgenic fish. The adult tumors evident between 1-3 months of age faithfully reproduce the immunological, histological and molecular phenotypes of human melanoma, but on a condensed time-line. Furthermore, they show transplantability, dependence on mitfa expression and do not require additional mutations in tumor suppressors. In contrast to kita expressing melanocyte progenitors that efficiently develop melanoma, mitfa expressing progenitors in a second Gal4-driver line were 4 times less efficient in developing melanoma during the three months observation period. Conclusions and Significance: This indicates that zebrafish kita promoter is a powerful tool for driving oncogene expression in the right cells and at the right level to induce early onset melanoma in the presence of tumor suppressors. Thus our zebrafish model provides a link between kita expressing melanocyte progenitors and melanoma and offers the advantage of a larval phenotype suitable for large scale drug and genetic modifier screens.	[Santoriello, Cristina; Gennaro, Elisa; Anelli, Viviana; Mione, Marina] IFOM Fdn, FIRC Inst Mol Oncol, Milan, Italy; [Distel, Martin; Koester, Reinhard W.] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Kelly, Amanda; Hurlstone, Adam] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	IFOM - FIRC Institute of Molecular Oncology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Manchester	Santoriello, C (corresponding author), IFOM Fdn, FIRC Inst Mol Oncol, Milan, Italy.	marina.mione@ifom-ieo-campus.it	Mione, Maria Caterina/I-3073-2013; Mione, Maria Caterina/ABG-9926-2021; Distel, Martin/AAN-6408-2020	Distel, Martin/0000-0001-5942-0817; ANELLI, Viviana Vittoria/0000-0003-1964-3252; Mione, Maria Caterina/0000-0002-9040-3705; Hurlstone, Adam/0000-0001-5260-9457; Koster, Reinhard/0000-0001-6593-8196	Cariplo Foundation [2007-5500]; AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG-8916]; German Ministry of Education and Research (BMBF) [0311889]; Helmholtz Association; Cancer Research UK [C11876/A4495]; Studienstiftung des deutschen Volkes; BBSRC (Biotechnology and Biological Sciences Research Council, U.K.)	Cariplo Foundation(Fondazione Cariplo); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); Cancer Research UK(Cancer Research UK); Studienstiftung des deutschen Volkes; BBSRC (Biotechnology and Biological Sciences Research Council, U.K.)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Cariplo Foundation (grant no. 2007-5500), AIRC (Associazione Italiana per la Ricerca sul Cancro, grant no. IG-8916) to MM; German Ministry of Education and Research (BMBF 0311889) and Helmholtz Association to RK; Cancer Research UK (C11876/A4495) to AH; Fellowship of the Studienstiftung des deutschen Volkes to MD, AIRC to CS and BBSRC (Biotechnology and Biological Sciences Research Council, U.K. to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anelli V, 2009, ZEBRAFISH, V6, P417, DOI 10.1089/zeb.2009.0612; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Ashida A, 2009, INT J CANCER, V124, P862, DOI 10.1002/ijc.24048; Bauer J, 2007, J INVEST DERMATOL, V127, P179, DOI 10.1038/sj.jid.5700490; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bevona C, 2003, ARCH DERMATOL, V139, P1620, DOI 10.1001/archderm.139.12.1620; Dahm R., 2002, ZEBRAFISH PRACTICAL, pxviii; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; DOVEY M, 2009, ZEBRAFISH; Dovey MC, 2009, METHODS MOL BIOL, V568, P1, DOI 10.1007/978-1-59745-280-9_1; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Gaggioli C, 2007, PIGM CELL RES, V20, P161, DOI 10.1111/j.1600-0749.2007.00378.x; GOWN AM, 1986, AM J PATHOL, V123, P195; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Hawkins TA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-42; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Hultman KA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000544; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Larue L, 2007, PIGM CELL RES, V20, P485, DOI 10.1111/j.1600-0749.2007.00411.x; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lister JA, 1999, DEVELOPMENT, V126, P3757; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Michailidou C, 2009, DIS MODEL MECH, V2, P399, DOI 10.1242/dmm.001149; MIONE M, 2010, DIS MODELS MECH, V3; Nonaka D, 2008, J CUTAN PATHOL, V35, P1014, DOI 10.1111/j.1600-0560.2007.00953.x; Orchard GE, 1998, BRIT J BIOMED SCI, V55, P8; Parichy DM, 2003, CURR BIOL, V13, pR947, DOI 10.1016/j.cub.2003.11.038; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Quigley IK, 2002, MICROSC RES TECHNIQ, V58, P442, DOI 10.1002/jemt.10162; Richardson J, 2008, ZEBRAFISH, V5, P289, DOI 10.1089/zeb.2008.0541; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Singh M, 2008, BRIT J DERMATOL, V158, P15, DOI 10.1111/j.1365-2133.2007.08316.x; Stern HM, 2003, NAT REV CANCER, V3, P533, DOI 10.1038/nrc1126; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Wang ZQ, 2009, AM J HUM GENET, V84, P672, DOI 10.1016/j.ajhg.2009.03.019; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Xu XW, 2003, ARCH PATHOL LAB MED, V127, P1083; Yang WS, 2007, J BIOL CHEM, V282, P3273, DOI 10.1074/jbc.M610793200; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162	46	99	102	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15170	10.1371/journal.pone.0015170	http://dx.doi.org/10.1371/journal.pone.0015170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170325	gold, Green Submitted, Green Published			2022-12-27	WOS:000285181400020
J	Harling, G; Msisha, W; Subramanian, SV				Harling, Guy; Msisha, Wezi; Subramanian, S. V.			No Association between HIV and Intimate Partner Violence among Women in 10 Developing Countries	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; DAR-ES-SALAAM; RISK BEHAVIOR; SEXUAL RISK; SOUTH-AFRICA; PREVENTION; INFECTION; HIV/AIDS; TANZANIA; KENYA	Background: Intimate Partner Violence (IPV) has been reported to be a determinant of women's risk for HIV. We examined the relationship between women's self-reported experiences of IPV in their most recent relationship and their laboratory-confirmed HIV serostatus in ten low-to middle-income countries. Methodology/Principal Findings: Data for the study came from the most recent Demographic and Health Surveys conducted in Dominican Republic, Haiti, India, Kenya, Liberia, Malawi, Mali, Rwanda, Zambia and Zimbabwe. Each survey population was a cross-sectional sample of women aged 15-49 years. Information on IPV was obtained by a face-to-face interview with the mother with an 81.1% response rate; information on HIV serostatus was obtained from blood samples with an 85.3% response rate. Demographic and socioeconomic variables were considered as potentially confounding covariates. Logistic regression models accounting for multi-stage survey design were estimated individually for each country and as a pooled total with country fixed effects (n = 60,114). Country-specific adjusted odds ratios (OR) for physical or sexual IPV compared to neither ranged from 0.45 [95% confidence interval (CI): 0.23-0.90] in Haiti to 1.35 [95% CI: 0.95-1.90] in India; the pooled association was 1.03 [95% CI: 0.94-1.13]. Country-specific adjusted ORs for physical and sexual IPV compared to no sexual IPV ranged from 0.41 [95% CI: 0.12-1.36] in Haiti to 1.41 [95% CI: 0.26-7.77] in Mali; the pooled association was 1.05 [95% CI: 0.90-1.22]. Conclusions: IPV and HIV were not found to be consistently associated amongst ever-married women in national population samples in these lower income countries, suggesting that IPV is not consistently associated with HIV prevalence worldwide. More research is needed to understand the circumstances in which IPV and HIV are and are not associated with one another.	[Harling, Guy; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Msisha, Wezi] World Bank, Europe & Cent Asia Human Dev Sector, Washington, DC 20433 USA	Harvard University; Harvard T.H. Chan School of Public Health; The World Bank	Harling, G (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu		Harling, Guy/0000-0001-6604-491X	National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct funding was available for this study. SVS, however, is partially supported by a Career Development Award from the National Institutes of Health (NHLBI K25 HL081275), and would like to acknowledge that support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2009, AIDS, V23, P1565, DOI 10.1097/QAD.0b013e32832cb10c; Andersson N, 2008, AIDS, V22, pS73, DOI 10.1097/01.aids.0000341778.73038.86; Ariane van der Straten RK, 1998, AIDS BEHAV, V2, P61; BARAHONASTRITTM.A, 2008, MULTIPLE FACES INTER; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Cayemittes M., 2007, ENQUETE MORTALITE MO; Centro de Estudios Sociales y Demograficos (CESDEM) y Macro International Inc, 2008, ENC DEM SAL 2007; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; Decker MR, 2009, SEX TRANSM INFECT, V85, P555, DOI 10.1136/sti.2009.036368; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; [DNdlSedlIdMrdlEc Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS)], 2007, ENQ DEM SANT MAL 200; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Fonck K, 2005, AIDS BEHAV, V9, P335, DOI 10.1007/s10461-005-9007-0; Garcia-Moreno C, 2000, AIDS, V14, pS253; Heise L, 2002, INT J GYNECOL OBSTET, V78, pS5, DOI 10.1016/S0020-7292(02)00038-3; Institut National de la Statistique du Rwanda (INSR) and ORC Macro, 2006, RWAND DEM HLTH SURV; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R., 2010, LANCET; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2010, SCIENCE, V329, P145, DOI 10.1126/science.1193794; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Kenya National Bureau of Statistics; Ministry of Health; National AIDS Control Council; The DHS Program ICF International KDHS, 2003, KEN DEM HLTH SURV 20; Kiarie JN, 2006, AIDS, V20, P1763, DOI 10.1097/01.aids.0000242823.51754.0c; Lary H, 2004, INT FAM PLAN PERSPEC, V30, P200, DOI 10.1363/3020004; Liberia Institute of Statistics and Geo-Information Services (LISGIS) Ministry of Health and Social Welfare National AIDS Control Program Macro International Inc, 2008, LIB DEM HLTH SURV 20; *MACR INC, 2008, HIV PREV EST DEM HLT; [Macro International Inc Central Statistical Office (CSO) [Zimbabwe]], 2007, ZIMB DEM HLTH SURV 2; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Martin SL, 2004, LANCET, V363, P1410, DOI 10.1016/S0140-6736(04)16133-3; Martin SL, 1999, JAMA-J AM MED ASSOC, V282, P1967, DOI 10.1001/jama.282.20.1967; NSO ICF, 2005, MAL DEM HLTH SURV 20; Pronyk PM, 2008, AIDS, V22, P1659, DOI 10.1097/QAD.0b013e328307a040; Rutstein S. O., 2004, DHS WEALTH INDEX; Senn TE, 2008, CLIN PSYCHOL REV, V28, P711, DOI 10.1016/j.cpr.2007.10.002; Silverman JG, 2008, JAMA-J AM MED ASSOC, V300, P703, DOI 10.1001/jama.300.6.703; Silverman JG, 2007, SEX TRANSM INFECT, V83, P211, DOI 10.1136/sti.2006.023366; *UNAIDS, 2008, UNAIDS WHO EP FACT S; World Health Organization UNAIDS, 2004, INF B SER, P1; DEMOGRAPHIC HLTH SUR	41	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14257	10.1371/journal.pone.0014257	http://dx.doi.org/10.1371/journal.pone.0014257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691MJ	21170389	gold, Green Published, Green Submitted			2022-12-27	WOS:000285084100011
J	Chuang, YC; Chang, SC; Wang, WK				Chuang, Yu-Chung; Chang, Shan-Chwen; Wang, Wei-Kung			High and Increasing Oxa-51 DNA Load Predict Mortality in Acinetobacter baumannii Bacteremia: Implication for Pathogenesis and Evaluation of Therapy	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; REAL-TIME PCR; STAPHYLOCOCCUS-AUREUS BACTEREMIA; BLOOD-STREAM INFECTIONS; NOSOCOMIAL BACTEREMIA; PROGNOSTIC-FACTORS; CLINICAL-FEATURES; RISK-FACTORS; DISEASE; EPIDEMIOLOGY	Background: While quantification of viral loads has been successfully employed in clinical medicine and has provided valuable insights and useful markers for several viral diseases, the potential of measuring bacterial DNA load to predict outcome or monitor therapeutic responses remains largely unexplored. We tested this possibility by investigating bacterial loads in Acinetobacter baumannii bacteremia, a rapidly increasing nosocomial infection characterized by high mortality, drug resistance, multiple and complicated risk factors, all of which urged the need of good markers to evaluate therapeutics. Methods and Findings: We established a quantitative real-time PCR assay based on an A. baumannii-specific gene, Oxa-51, and conducted a prospective study to examine A. baumannii loads in 318 sequential blood samples from 51 adults patients (17 survivors, 34 nonsurvivors) with culture-proven A. baumannii bacteremia in the intensive care units. Oxa-51 DNA loads were significantly higher in the nonsurvivors than survivors on day 1, 2 and 3 (P = 0.03, 0.001 and 0.006, respectively). Compared with survivors, nonsurvivors had higher maximum Oxa-51 DNA load and a trend of increase from day 0 to day 3 (P, 0.001), which together with Pitt bacteremia score were independent predictors for mortality by multivariate analysis (P = 0.014 and 0.016, for maximum Oxa-51 DNA and change of Oxa-51 DNA, respectively). Kaplan-Meier analysis revealed significantly different survival curves in patients with different maximum Oxa-51 DNA and change of Oxa-51 DNA from day 0 to day 3. Conclusions: High Oxa-51 DNA load and its initial increase could predict mortality. Moreover, monitoring Oxa-51 DNA load in blood may provide direct parameters for evaluating new regimens against A. baumannii in future clinical studies.	[Chuang, Yu-Chung; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Chuang, Yu-Chung] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Douliou City, Taiwan; [Wang, Wei-Kung] Natl Taiwan Univ, Inst Microbiol, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chuang, YC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.	changsc@ntu.edu.tw; wangwk@hawaii.edu	CHUANG, YU-CHUNG/F-4627-2016	CHUANG, YU-CHUNG/0000-0003-3094-8276; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Science Council, Taiwan [NSC-95-2745-B-002-007]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan (NSC-95-2745-B-002-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo LA, 2005, J CLIN MICROBIOL, V43, P903, DOI 10.1128/JCM.43.2.903-905.2005; Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CH, 2003, INFECTION, V31, P331, DOI 10.1007/s15010-003-3223-1; Chen Hsin-Pai, 2005, Journal of Microbiology Immunology and Infection, V38, P127; Cisneros JM, 1996, CLIN INFECT DIS, V22, P1026, DOI 10.1093/clinids/22.6.1026; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Falagas ME, 2006, CLIN INFECT DIS, V43, P389, DOI 10.1086/505599; Feldman C, 2009, CLIN MICROBIOL INFEC, V15, P850, DOI 10.1111/j.1469-0691.2009.02901.x; Fishbain J, 2010, CLIN INFECT DIS, V51, P79, DOI 10.1086/653120; Garcia-Garmendia JL, 2001, CLIN INFECT DIS, V33, P939, DOI 10.1086/322584; Garcia-Garmendia JL, 1999, CRIT CARE MED, V27, P1794, DOI 10.1097/00003246-199909000-00015; Glerant JC, 1999, RESP MED, V93, P208, DOI 10.1016/S0954-6111(99)90010-0; Gomez J, 1999, EUR J CLIN MICROBIOL, V18, P358, DOI 10.1007/PL00015019; Hackett SJ, 2002, ARCH DIS CHILD, V86, P44, DOI 10.1136/adc.86.1.44; Ho YC, 2009, J CLIN MICROBIOL, V47, P1443, DOI 10.1128/JCM.01197-08; Jones RN, 2007, J CLIN MICROBIOL, V45, P227, DOI 10.1128/JCM.01588-06; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lin YC, 2008, J CLIN MICROBIOL, V46, P612, DOI 10.1128/JCM.01798-07; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Ovstebo R, 2004, J CLIN MICROBIOL, V42, P2980, DOI 10.1128/JCM.42.7.2980-2987.2004; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Poutanen SM, 1997, EUR J CLIN MICROBIOL, V16, P737, DOI 10.1007/BF01709254; SCHONHEYDER HC, 1995, SCAND J INFECT DIS, V27, P19, DOI 10.3109/00365549509018967; Schreckenberger PC, 2000, MANUAL CLIN MICROBIO, P539; SEIFERT H, 1995, MEDICINE, V74, P340, DOI 10.1097/00005792-199511000-00004; SULLIVAN TD, 1982, PEDIATRICS, V69, P699; Tsai Tung-Yuan, 2007, Journal of Microbiology Immunology and Infection, V40, P481; Tseng YC, 2007, DIAGN MICR INFEC DIS, V59, P181, DOI 10.1016/j.diagmicrobio.2007.04.024; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Wang JT, 2007, EMERG INFECT DIS, V13, P494, DOI 10.3201/eid1303.060247; Wang JT, 2004, J HOSP INFECT, V58, P97, DOI 10.1016/j.jhin.2004.06.005	35	35	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14133	10.1371/journal.pone.0014133	http://dx.doi.org/10.1371/journal.pone.0014133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152436	Green Submitted, gold, Green Published			2022-12-27	WOS:000284755100014
J	Diez, RR; Rodrigues-Diez, R; Lavoz, C; Rayego-Mateos, S; Civantos, E; Rodriguez-Vita, J; Mezzano, S; Ortiz, A; Egido, J; Ruiz-Ortega, M				Rodrigues Diez, Raul; Rodrigues-Diez, Raquel; Lavoz, Carolina; Rayego-Mateos, Sandra; Civantos, Esther; Rodriguez-Vita, Juan; Mezzano, Sergio; Ortiz, Alberto; Egido, Jesus; Ruiz-Ortega, Marta			Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-beta-Independent Process	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; TIMP-1 EXPRESSION; GENE-EXPRESSION; SMAD PATHWAY; ANG-II; KEY	We have recently described that in an experimental model of atherosclerosis and in vascular smooth muscle cells (VSMCs) statins increased the activation of the Smad pathway by transforming growth factor-beta (TGF-beta), leading to an increase in TGF-beta-dependent matrix accumulation and plaque stabilization. Angiotensin II (AngII) activates the Smad pathway and contributes to vascular fibrosis, although the in vivo contribution of TGF-beta has not been completely elucidated. Our aim was to further investigate the mechanisms involved in AngII-induced Smad activation in the vasculature, and to clarify the beneficial effects of statins on AngII-induced vascular fibrosis. Infusion of AngII into rats for 3 days activates the Smad pathway and increases fibrotic-related factors, independently of TGF-beta, in rat aorta. Treatment with atorvastatin or simvastatin inhibited AngII-induced Smad activation and related-fibrosis. In cultured rat VSMCs, direct AngII/Smad pathway activation was mediated by p38 MAPK and ROCK activation. Preincubation of VSMCs with statins inhibited AngII-induced Smad activation at all time points studied (from 20 minutes to 24 hours). All these data show that statins inhibited several AngII-activated intracellular signaling systems, including p38-MAPK and ROCK, which regulates the AngII/Smad pathway and related profibrotic factors and matrix proteins, independently of TGF-beta responses. The inhibitory effect of statins on the AngII/Smad pathway could explain, at least in part, their beneficial effects on hypertension-induced vascular damage.	[Rodrigues Diez, Raul; Rodrigues-Diez, Raquel; Lavoz, Carolina; Rayego-Mateos, Sandra; Civantos, Esther; Rodriguez-Vita, Juan; Ruiz-Ortega, Marta] Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain; [Mezzano, Sergio] Univ Austral Chile, Sch Med, Div Nephrol, Valdivia, Chile; [Ortiz, Alberto] Fdn Jimenez Diaz, Dialysis Unit, E-28040 Madrid, Spain; [Egido, Jesus] Univ Autonoma Madrid, Fdn Jimenez Diaz, Renal Res Lab, Madrid, Spain	Autonomous University of Madrid; Universidad Austral de Chile; Autonomous University of Madrid	Diez, RR (corresponding author), Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain.	mruizo@fjd.es	MATEOS, SANDRA RAYEGO/AAI-2123-2019; ortiz, alberto/Y-7582-2018; Rodriguez-Vita, Juan/K-2407-2014; Díez, Raquel Rodrigues/ABE-9703-2020; Rodriguez-Vita, Juan/U-6337-2019; Ortega, Marta Ruiz/AAN-2136-2020; Ruiz-Ortega, Marta/D-3584-2012; ruiz-ortega, marta/D-3584-2012	ortiz, alberto/0000-0002-9805-9523; Rodriguez-Vita, Juan/0000-0001-9547-5508; Díez, Raquel Rodrigues/0000-0002-6348-1505; Rodriguez-Vita, Juan/0000-0001-9547-5508; Ortega, Marta Ruiz/0000-0002-1495-6535; Ruiz-Ortega, Marta/0000-0002-1495-6535; ruiz-ortega, marta/0000-0002-1403-2690; Rodrigues Diez, Raul/0000-0002-2456-6709; Rayego-Mateos, Sandra/0000-0001-6874-2359	Sociedad Espanola de Cardiologia, FIS [PI081564, PS09/00447, 2007/63648]; Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo [SCIII-RETIC RD06/0016]; EU [LSHB-CT-2007-036644]; PCI Iberoamerica [A/9571/07]; FONDECYT, Chile [1080083]; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)	Sociedad Espanola de Cardiologia, FIS(Instituto de Salud Carlos III); Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); EU(European Commission); PCI Iberoamerica; FONDECYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)(Instituto de Salud Carlos III)	This work has been supported by grants from Sociedad Espanola de Cardiologia, FIS (PI081564, PS09/00447), SAF 2007/63648 and Red tematica de Investigacion Renal, REDINREN (ISCIII-RETIC RD06/0016) from the Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo, Fondos Feder, the EU project DIALOK: LSHB-CT-2007-036644, PCI Iberoamerica (A/9571/07) and FONDECYT, Chile (1080083). Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO. RRD and CL-V are fellows of FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akool ES, 2005, J BIOL CHEM, V280, P39403, DOI 10.1074/jbc.M504140200; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; Barrios Vivencio, 2009, Expert Rev Cardiovasc Ther, V7, P1317, DOI 10.1586/erc.09.119; Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; Briones AM, 2009, HYPERTENSION, V54, P142, DOI 10.1161/HYPERTENSIONAHA.109.133710; Burke JP, 2009, BRIT J SURG, V96, P541, DOI 10.1002/bjs.6577; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Castoldi G, 2003, AM J PHYSIOL-HEART C, V284, pH635, DOI 10.1152/ajpheart.00986.2001; Chade AR, 2008, J HYPERTENS, V26, P1651, DOI 10.1097/HJH.0b013e328302833a; Gressner OA, 2009, HEPATOLOGY, V49, P2021, DOI 10.1002/hep.22850; Ikedo H, 2003, INT J MOL MED, V11, P645; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; KIM SK, 1995, J PHARMACOL EXP THER, V273, P509; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lin CX, 2008, AM J PHYSIOL-HEART C, V295, pH1253, DOI 10.1152/ajpheart.00481.2008; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nachtigal P, 2009, J ATHEROSCLER THROMB, V16, P265, DOI 10.5551/jat.E745; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rodrigues-Diez R, 2008, PHARM RES-DORDR, V25, P2447, DOI 10.1007/s11095-008-9636-x; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Rodriguez-Vita J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003959; Ruiz-Ortega M, 2003, CURR HYPERTENS REP, V5, P73, DOI 10.1007/s11906-003-0014-0; Ruiz-Ortega M, 2001, CURR OPIN NEPHROL HY, V10, P321, DOI 10.1097/00041552-200105000-00005; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Ruperez M, 2003, CIRCULATION, V108, P1499, DOI 10.1161/01.CIR.0000089129.51288.BA; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Sanchez-Lopez E, 2009, NEFROLOGIA, V29, P382, DOI 10.3265/Nefrologia.2009.29.5.5429.en.full; Touyz RM, 2000, PHARMACOL REV, V52, P639; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Weisberg AD, 2005, ARTERIOSCL THROM VAS, V25, P365, DOI 10.1161/01.ATV.0000152356.85791.52; Yagi S, 2008, CIRC RES, V102, P68, DOI 10.1161/CIRCRESAHA.107.163493; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Zhang GY, 2009, EXP DERMATOL, V18, P947, DOI 10.1111/j.1600-0625.2009.00880.x	36	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14145	10.1371/journal.pone.0014145	http://dx.doi.org/10.1371/journal.pone.0014145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152444	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100025
J	Prasanna, SJ; Gopalakrishnan, D; Shankar, SR; Vasandan, AB				Prasanna, S. Jyothi; Gopalakrishnan, Divya; Shankar, Shilpa Rani; Vasandan, Anoop Babu			Pro-Inflammatory Cytokines, IFN gamma and TNF alpha, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially	PLOS ONE			English	Article							PROLIFERATION IN-VITRO; NECROSIS-FACTOR-ALPHA; STROMAL CELLS; LIFE-SPAN; IMMUNOGENICITY; FETAL; TRANSPLANTATION; REJECTION; RESPONSES; SUPPRESSION	Background: Wharton's jelly derived stem cells (WJMSCs) are gaining attention as a possible clinical alternative to bone marrow derived mesenchymal stem cells (BMMSCs) owing to better accessibility, higher expansion potential and low immunogenicity. Usage of allogenic mesenchymal stem cells (MSC) could be permissible in vivo only if they retain their immune properties in an inflammatory setting. Thus the focus of this study is to understand and compare the immune properties of BMMSCs and WJMSCs primed with key pro-inflammatory cytokines, Interferon-gamma (IFN gamma) and Tumor Necrosis Factor-alpha (TNF alpha). Methodology/Principal Findings: Initially the effect of priming on MSC mediated suppression of alloantigen and mitogen induced lymphoproliferation was evaluated in vitro. Treatment with IFN gamma or TNF alpha, did not ablate the immune-suppression caused by both the MSCs. Extent of immune-suppression was more with WJMSCs than BMMSCs in both the cases. Surprisingly, priming BMMSCs enhanced suppression of mitogen driven lymphoproliferation only; whereas IFN gamma primed WJMSCs were better suppressors of MLRs. Further, kinetic analysis of cytokine profiles in co-cultures of primed/unprimed MSCs and Phytohematoagglutinin (PHA) activated lymphocytes was evaluated. Results indicated a decrease in levels of pro-inflammatory cytokines. Interestingly, a change in kinetics and thresholds of Interleukin-2 (IL-2) secretion was observed only with BMMSCs. Analysis of activation markers on PHA-stimulated lymphocytes indicated different expression patterns in co-cultures of primed/unprimed WJMSCs and BMMSCs. Strikingly, co-culture with WJMSCs resulted in an early activation of a negative co-stimulatory molecule, CTLA4, which was not evident with BMMSCs. A screen for immune suppressive factors in primed/unprimed WJMSCs and BMMSCs indicated inherent differences in IFN gamma inducible Indoleamine 2, 3-dioxygenase (IDO) activity, Hepatocyte growth factor (HGF) and Prostaglandin E-2 (PGE2) levels which could possibly influence the mechanism of immune-modulation. Conclusion/Significance: This study demonstrates that inflammation affects the immune properties of MSCs distinctly. Importantly different tissue derived MSCs could utilize unique mechanisms of immune-modulation.	[Prasanna, S. Jyothi; Gopalakrishnan, Divya; Shankar, Shilpa Rani; Vasandan, Anoop Babu] Manipal Univ, Manipal Inst Regenerat Med, Constituent Inst, Bangalore, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Prasanna, SJ (corresponding author), Manipal Univ, Manipal Inst Regenerat Med, Constituent Inst, Bangalore, Karnataka, India.	jyothi.prasanna@manipal.edu			Department of Biotechnology, India [BT/PR7091/MED/14/941/2006]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by grant BT/PR7091/MED/14/941/2006 obtained from Department of Biotechnology, India (dbtindia.nic.in). The funders have no role in the study design, data analysis and collection, decision to publish or preparation of the manuscript.	Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; CARTER A, 1990, BRIT J HAEMATOL, V74, P424, DOI 10.1111/j.1365-2141.1990.tb06330.x; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chan WK, 2008, EXP HEMATOL, V36, P1545, DOI 10.1016/j.exphem.2008.06.008; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; Clarkson MR, 2005, TRANSPLANTATION, V80, P555, DOI 10.1097/01.tp.0000168432.60022.99; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Fang LB, 2006, TRANSPLANTATION, V82, P1370, DOI 10.1097/01.tp.0000232450.62408.f9; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gotherstrom C, 2004, AM J OBSTET GYNECOL, V190, P239, DOI 10.1016/j.ajog.2003.07.022; Gotherstrom C, 2003, BONE MARROW TRANSPL, V32, P265, DOI 10.1038/sj.bmt.1704111; Gotherstrom C, 2005, HAEMATOLOGICA, V90, P1017; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; JOHANNISSON A, 1995, CYTOMETRY, V19, P343, DOI 10.1002/cyto.990190409; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Kadam SS, 2009, IN VITRO CELL DEV-AN, V45, P23, DOI 10.1007/s11626-008-9155-4; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Krampera M, 2007, STEM CELLS DEV, V16, P797, DOI 10.1089/scd.2007.0024; Krampera M, 2006, CURR OPIN PHARMACOL, V6, P435, DOI 10.1016/j.coph.2006.02.008; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Magatti M, 2008, STEM CELLS, V26, P182, DOI 10.1634/stemcells.2007-0491; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; ROTH MD, 1994, J EXP MED, V179, P857, DOI 10.1084/jem.179.3.857; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Sundin M, 2007, HAEMATOLOGICA, V92, P1208, DOI 10.3324/haematol.11446; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Xuan Min, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P433; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; YOO KH, 2009, CELL IMMUNOL; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190	63	399	423	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9016	10.1371/journal.pone.0009016	http://dx.doi.org/10.1371/journal.pone.0009016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	21152066	Green Submitted, gold, Green Published			2022-12-27	WOS:000274207200013
J	Li, MZ; Xia, YL; Gu, YR; Zhang, K; Lang, QL; Chen, L; Guan, JQ; Luo, ZG; Chen, HS; Li, Y; Li, QH; Li, XA; Jiang, AA; Shuai, SR; Wang, JY; Zhu, Q; Zhou, XC; Gao, XL; Li, XW				Li, Mingzhou; Xia, Youlin; Gu, Yiren; Zhang, Kai; Lang, Qiulei; Chen, Lei; Guan, Jiuqiang; Luo, Zonggang; Chen, Haosi; Li, Yang; Li, Qinghai; Li, Xiang; Jiang, An-an; Shuai, Surong; Wang, Jinyong; Zhu, Qi; Zhou, Xiaochuan; Gao, Xiaolian; Li, Xuewei			MicroRNAome of Porcine Pre- and Postnatal Development	PLOS ONE			English	Article							RAPID EVOLUTION; SWINE GENOME; EXPRESSION; TRANSCRIPTOME; DISCOVERY; PATHWAYS; MIR-122; TARGETS; CLONING; MIRNAS	The domestic pig is of enormous agricultural significance and valuable models for many human diseases. Information concerning the pig microRNAome (miRNAome) has been long overdue and elucidation of this information will permit an atlas of microRNA (miRNA) regulation functions and networks to be constructed. Here we performed a comprehensive search for porcine miRNAs on ten small RNA sequencing libraries prepared from a mixture of tissues obtained during the entire pig lifetime, from the fetal period through adulthood. The sequencing results were analyzed using mammalian miRNAs, the precursor hairpins (pre-miRNAs) and the first release of the high-coverage porcine genome assembly (Sscrofa9, April 2009) and the available expressed sequence tag (EST) sequences. Our results extend the repertoire of pig miRNAome to 867 pre-miRNAs (623 with genomic coordinates) encoding for 1,004 miRNAs, of which 777 are unique. We preformed real-time quantitative PCR (q-PCR) experiments for selected 30 miRNAs in 47 tissue-specific samples and found agreement between the sequencing and q-PCR data. This broad survey provides detailed information about multiple variants of mature sequences, precursors, chromosomal organization, development-specific expression, and conservation patterns. Our data mining produced a broad view of the pig miRNAome, consisting of miRNAs and isomiRs and a wealth of information of pig miRNA characteristics. These results are prelude to the advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies.	[Li, Mingzhou; Gu, Yiren; Zhang, Kai; Guan, Jiuqiang; Luo, Zonggang; Li, Yang; Li, Qinghai; Li, Xiang; Jiang, An-an; Shuai, Surong; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Xia, Youlin; Chen, Haosi; Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Lang, Qiulei] Zhejiang Univ, Dept Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Lang, Qiulei; Zhou, Xiaochuan] LC Sci, Houston, TX USA; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Gao, Xiaolian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Sichuan Agricultural University; University of Houston System; University of Houston; Zhejiang University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China.	xgao@uh.edu; xuewei.li@sicau.edu.cn		Li, Mingzhou/0000-0001-8681-7684; Su, Erzheng/0000-0002-3868-567X	National Special Foundation for Transgenic Species of China [2009ZX08009-155B, 2008ZX08006-003]; National Natural Science Foundation of China [30901024, 30771534]; Department Public Benefit Research Foundation of China [NYHYZX07-034]; NIH [R41 DA029063]	National Special Foundation for Transgenic Species of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department Public Benefit Research Foundation of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Special Foundation for Transgenic Species of China (2009ZX08009-155B and 2008ZX08006-003), the National Natural Science Foundation of China (30901024 and 30771534), the Department Public Benefit Research Foundation of China (NYHYZX07-034) to X. L. and M.L., and the NIH (R41 DA029063) to X.Z. and X.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bashir A, 2005, GENOME RES, V15, P998, DOI 10.1101/gr.3493405; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Green RD, 2007, INT J BIOL SCI, V3, P185; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Jiang ZH, 2007, INT J BIOL SCI, V3, P129; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Rocha D, 2006, DRUG DISCOV TODAY, V11, P475, DOI 10.1016/j.drudis.2006.04.009; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharbati-Tehrani S, 2008, BIOCHEM BIOPH RES CO, V375, P484, DOI 10.1016/j.bbrc.2008.08.048; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	51	103	111	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11541	10.1371/journal.pone.0011541	http://dx.doi.org/10.1371/journal.pone.0011541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	21179198	Green Published, Green Submitted, gold			2022-12-27	WOS:000279781600020
J	Tanaka, Y; Taneichi, M; Kasai, M; Kakiuchi, T; Uchida, T				Tanaka, Yuriko; Taneichi, Maiko; Kasai, Michiyuki; Kakiuchi, Terutaka; Uchida, Tetsuya			Liposome-Coupled Antigens Are Internalized by Antigen-Presenting Cells via Pinocytosis and Cross-Presented to CD8(+) T Cells	PLOS ONE			English	Article							IN-VIVO; VACCINE; RECOGNITION; DIPHTHERIA; TRANSPORT; IMMUNITY; TETANUS; BOOSTER; CYTOSOL; WORLD	We have previously demonstrated that antigens chemically coupled to the surface of liposomes consisting of unsaturated fatty acids were cross-presented by antigen-presenting cells (APCs) to CD8(+) T cells, and that this process resulted in the induction of antigen-specific cytotoxic T lymphocytes. In the present study, the mechanism by which the liposome-coupled antigens were cross-presented to CD8(+) T cells by APCs was investigated. Confocal laser scanning microscopic analysis demonstrated that antigens coupled to the surface of unsaturated-fatty-acid-based liposomes received processing at both MHC class I and class II compartments, while most of the antigens coupled to the surface of saturated-fatty-acid-based liposomes received processing at the class II compartment. In addition, flow cytometric analysis demonstrated that antigens coupled to the surface of unsaturated-fatty-acid-liposomes were taken up by APCs even in a 4 degrees C environment; this was not true of saturated-fatty-acid-liposomes. When two kinds of inhibitors, dimethylamiloride (DMA) and cytochalasin B, which inhibit pinocytosis and phagocytosis by APCs, respectively, were added to the culture of APCs prior to the antigen pulse, DMA but not cytochalasin B significantly reduced uptake of liposome-coupled antigens. Further analysis of intracellular trafficking of liposomal antigens using confocal laser scanning microscopy revealed that a portion of liposome-coupled antigens taken up by APCs were delivered to the lysosome compartment. In agreement with the reduction of antigen uptake by APCs, antigen presentation by APCs was significantly inhibited by DMA, and resulted in the reduction of IFN-gamma production by antigen-specific CD8(+) T cells. These results suggest that antigens coupled to the surface of liposomes consisting of unsaturated fatty acids might be pinocytosed by APCs, loaded onto the class I MHC processing pathway, and presented to CD8(+) T cells. Thus, these liposome-coupled antigens are expected to be applicable for the development of vaccines that induce cellular immunity.	[Tanaka, Yuriko; Kakiuchi, Terutaka] Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan; [Taneichi, Maiko; Kasai, Michiyuki; Uchida, Tetsuya] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan	Toho University; National Institute of Infectious Diseases (NIID)	Tanaka, Y (corresponding author), Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan.	taneichi@nih.go.jp			Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science [21790963]; Toho University Graduate School of Medicine [08-02]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Toho University Graduate School of Medicine(Toho University)	This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (to TU), grants-in-aid for young scientists from the Japan Society for the Promotion of Science (21790963 to YT) and the research promotion grant from Toho University Graduate School of Medicine (No. 08-02 to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerbeck H, 1996, VACCINE, V14, P1265, DOI 10.1016/S0264-410X(96)00092-8; BANKOWSKI MK, 1995, SCIENCE, V267, P243; BEVAN MJ, 1987, NATURE, V325, P192, DOI 10.1038/325192b0; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Chen M, 1999, GASTROENTEROLOGY, V116, P135, DOI 10.1016/S0016-5085(99)70237-4; Chen WS, 2004, EUR J IMMUNOL, V34, P194, DOI 10.1002/eji.200324257; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Gurnani K, 2004, J IMMUNOL, V173, P566, DOI 10.4049/jimmunol.173.1.566; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; Kasturi SP, 2008, NAT IMMUNOL, V9, P461, DOI 10.1038/ni0508-461; MARK A, 1995, VACCINE, V13, P669, DOI 10.1016/0264-410X(94)00017-H; Matsui M, 2010, BIOCHEM BIOPH RES CO, V391, P1494, DOI 10.1016/j.bbrc.2009.12.100; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Naito S, 1996, INT ARCH ALLERGY IMM, V109, P223, DOI 10.1159/000237241; Nakano Y, 1999, INT ARCH ALLERGY IMM, V120, P199, DOI 10.1159/000024268; Nelson D, 2000, J IMMUNOL, V165, P6123, DOI 10.4049/jimmunol.165.11.6123; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Nothdurft HD, 1996, J INFECTION, V32, P119, DOI 10.1016/S0163-4453(96)91281-5; Ohno S, 2009, VACCINE, V27, P3912, DOI 10.1016/j.vaccine.2009.04.001; Rock KL, 2006, IMMUNITY, V25, P523, DOI 10.1016/j.immuni.2006.09.003; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Taneichi M, 2006, J IMMUNOL, V177, P2324, DOI 10.4049/jimmunol.177.4.2324; UCHIDA T, 1985, J IMMUNOL, V134, P772; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Yerly D, 2008, J VIROL, V82, P3147, DOI 10.1128/JVI.02252-07	31	51	51	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15225	10.1371/journal.pone.0015225	http://dx.doi.org/10.1371/journal.pone.0015225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179411	Green Submitted, Green Published, gold			2022-12-27	WOS:000285572900015
J	Padayatty, SJ; Sun, AY; Chen, Q; Espey, MG; Drisko, J; Levine, M				Padayatty, Sebastian J.; Sun, Andrew Y.; Chen, Qi; Espey, Michael Graham; Drisko, Jeanne; Levine, Mark			Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; RECOMMENDED DIETARY ALLOWANCE; ACUTE OXALATE NEPHROPATHY; ACID-INDUCED HEMOLYSIS; TERMINAL HUMAN CANCER; ASCORBIC-ACID; EXPERIMENTAL POLIOMYELITIS; SUPPLEMENTAL ASCORBATE; SUPPORTIVE TREATMENT; HYDROGEN-PEROXIDE	Background: Anecdotal information and case reports suggest that intravenously administered vitamin C is used by Complementary and Alternate Medicine (CAM) practitioners. The scale of such use in the U. S. and associated side effects are unknown. Methods and Findings: We surveyed attendees at annual CAM Conferences in 2006 and 2008, and determined sales of intravenous vitamin C by major U. S. manufacturers/distributors. We also queried practitioners for side effects, compiled published cases, and analyzed FDA's Adverse Events Database. Of 199 survey respondents (out of 550), 172 practitioners administered IV vitamin C to 11,233 patients in 2006 and 8876 patients in 2008. Average dose was 28 grams every 4 days, with 22 total treatments per patient. Estimated yearly doses used (as 25g/50ml vials) were 318,539 in 2006 and 354,647 in 2008. Manufacturers' yearly sales were 750,000 and 855,000 vials, respectively. Common reasons for treatment included infection, cancer, and fatigue. Of 9,328 patients for whom data is available, 101 had side effects, mostly minor, including lethargy/fatigue in 59 patients, change in mental status in 21 patients and vein irritation/phlebitis in 6 patients. Publications documented serious adverse events, including 2 deaths in patients known to be at risk for IV vitamin C. Due to confounding causes, the FDA Adverse Events Database was uninformative. Total numbers of patients treated in the US with high dose vitamin C cannot be accurately estimated from this study. Conclusions: High dose IV vitamin C is in unexpectedly wide use by CAM practitioners. Other than the known complications of IV vitamin C in those with renal impairment or glucose 6 phosphate dehydrogenase deficiency, high dose intravenous vitamin C appears to be remarkably safe. Physicians should inquire about IV vitamin C use in patients with cancer, chronic, untreatable, or intractable conditions and be observant of unexpected harm, drug interactions, or benefit.	[Padayatty, Sebastian J.; Sun, Andrew Y.; Espey, Michael Graham; Levine, Mark] NIDDK, Mol & Clin Nutr Sect, NIH, Bethesda, MD 20892 USA; [Chen, Qi; Drisko, Jeanne] Univ Kansas, Med Ctr, Program Integrat Med, Kansas City, KS 66103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Kansas; University of Kansas Medical Center	Padayatty, SJ (corresponding author), NIDDK, Mol & Clin Nutr Sect, NIH, Bethesda, MD 20892 USA.	MarkL@intra.niddk.nih.gov	Padayatty, Sebastian J/A-8581-2012; Ganapathy, Suthakar/C-1266-2013; Chen, Qi/D-8278-2015	Padayatty, Sebastian J/0000-0001-8758-3170; Ganapathy, Suthakar/0000-0003-3828-5382; Chen, Qi/0000-0002-7173-8411; Sun, Andrew/0000-0002-7925-6580	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2009, J ALTERN COMPLEM MED, V15, P247, DOI 10.1089/acm.2008.0410; Barnes Patricia M, 2004, Adv Data, P1; Bromley J, 2005, ANN PHARMACOTHER, V39, P1566, DOI 10.1345/aph.1E634; CALLEJA H B, 1960, Ohio State Med J, V56, P821; CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; CAMERON E, 1972, LANCET, V1, P542; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; CAMPBELL GD, 1975, ANN INTERN MED, V82, P810, DOI 10.7326/0003-4819-82-6-810_1; Canavese C, 2005, AM J KIDNEY DIS, V45, P540, DOI 10.1053/j.ajkd.2004.10.025; CATHCART RF, 1981, MED HYPOTHESES, V7, P1359, DOI 10.1016/0306-9877(81)90126-2; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; DL VP, 2004, JPEN J PARENTER ENTE, V28, P435; Gaby Alan R, 2002, Altern Med Rev, V7, P389; Gonzalez Michael J, 2005, Integr Cancer Ther, V4, P32, DOI 10.1177/1534735404273861; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; IWAMOTO N, 1994, AM J HEMATOL, V47, P337, DOI 10.1002/ajh.2830470426; IWAMOTO N, 1994, LANCET, V343, P357, DOI 10.1016/S0140-6736(94)91195-9; Jungeblut CW, 1937, J EXP MED, V66, P459, DOI 10.1084/jem.66.4.459; Jungeblut CW, 1939, J EXP MED, V70, P315, DOI 10.1084/jem.70.3.315; Jungeblut CW, 1935, J EXP MED, V62, P517, DOI 10.1084/jem.62.4.517; KLENNER F R, 1949, South Med Surg, V111, P209; KLENNER F R, 1951, South Med Surg, V113, P101; KLENNER FR, 1971, J APPL NUTR, V23, P61; LAWTON JM, 1985, ARCH INTERN MED, V145, P950, DOI 10.1001/archinte.145.5.950; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Levine M, 1999, JAMA-J AM MED ASSOC, V281, P1415, DOI 10.1001/jama.281.15.1415; Levine M, 2009, FREE RADICAL BIO MED, V47, P27, DOI 10.1016/j.freeradbiomed.2009.04.001; Levy T E, 2002, VITAMIN C INFECT DIS; MCALLISTER CJ, 1984, JAMA-J AM MED ASSOC, V252, P1684, DOI 10.1001/jama.1984.03350130016019; McCORMICK W J, 1954, Arch Pediatr, V71, P313; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Padayatty SJ, 2006, NEW ENGL J MED, V355, P1065; Padayatty SJ, 2000, J AM COLL NUTR, V19, P423, DOI 10.1080/07315724.2000.10718941; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; PATTERSON JW, 1951, AM J PHYSIOL, V165, P61, DOI 10.1152/ajplegacy.1951.165.1.61; PATTERSON JW, 1950, J BIOL CHEM, V183, P81; Pauling L., 1976, VITAMIN C COMMON COL; REES DC, 1993, BRIT MED J, V306, P841, DOI 10.1136/bmj.306.6881.841; Riordan HD, 1990, J ORTHOMOL MED, V5, P5; RIORDAN NH, 1995, MED HYPOTHESES, V44, P207, DOI 10.1016/0306-9877(95)90137-X; Riordan NH, 2000, J ORTHOMOL MED, V15, P201; Sabin AB, 1939, J EXP MED, V69, P507, DOI 10.1084/jem.69.4.507; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; WITTES RE, 1985, NEW ENGL J MED, V312, P178, DOI 10.1056/NEJM198501173120310; WONG K, 1994, AUST NZ J MED, V24, P410, DOI 10.1111/j.1445-5994.1994.tb01477.x; 2008, NUTR BUSINESS J	51	231	241	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11414	10.1371/journal.pone.0011414	http://dx.doi.org/10.1371/journal.pone.0011414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628650	Green Published, gold, Green Submitted			2022-12-27	WOS:000279589300002
J	Sato, Y; Poynter, G; Huss, D; Filla, MB; Czirok, A; Rongish, BJ; Little, CD; Fraser, SE; Lansford, R				Sato, Yuki; Poynter, Greg; Huss, David; Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.; Fraser, Scott E.; Lansford, Rusty			Dynamic Analysis of Vascular Morphogenesis Using Transgenic Quail Embryos	PLOS ONE			English	Article							BLOOD-VESSEL FORMATION; LENTIVIRAL VECTORS; CHICK EMBRYO; CELL-MIGRATION; VASCULOGENESIS; MECHANISMS; EXPRESSION; EFFICIENT; EMBRYOGENESIS; ANGIOGENESIS	Background: One of the least understood and most central questions confronting biologists is how initially simple clusters or sheet-like cell collectives can assemble into highly complex three-dimensional functional tissues and organs. Due to the limits of oxygen diffusion, blood vessels are an essential and ubiquitous presence in all amniote tissues and organs. Vasculogenesis, the de novo self-assembly of endothelial cell (EC) precursors into endothelial tubes, is the first step in blood vessel formation [1]. Static imaging and in vitro models are wholly inadequate to capture many aspects of vascular pattern formation in vivo, because vasculogenesis involves dynamic changes of the endothelial cells and of the forming blood vessels, in an embryo that is changing size and shape. Methodology/Principal Findings: We have generated Tie1 transgenic quail lines Tg(tie1:H2B-eYFP) that express H2B-eYFP in all of their endothelial cells which permit investigations into early embryonic vascular morphogenesis with unprecedented clarity and insight. By combining the power of molecular genetics with the elegance of dynamic imaging, we follow the precise patterning of endothelial cells in space and time. We show that during vasculogenesis within the vascular plexus, ECs move independently to form the rudiments of blood vessels, all while collectively moving with gastrulating tissues that flow toward the embryo midline. The aortae are a composite of somatic derived ECs forming its dorsal regions and the splanchnic derived ECs forming its ventral region. The ECs in the dorsal regions of the forming aortae exhibit variable mediolateral motions as they move rostrally; those in more ventral regions show significant lateral-to-medial movement as they course rostrally. Conclusions/Significance: The present results offer a powerful approach to the major challenge of studying the relative role(s) of the mechanical, molecular, and cellular mechanisms of vascular development. In past studies, the advantages of the molecular genetic tools available in mouse were counterbalanced by the limited experimental accessibility needed for imaging and perturbation studies. Avian embryos provide the needed accessibility, but few genetic resources. The creation of transgenic quail with labeled endothelia builds upon the important roles that avian embryos have played in previous studies of vascular development.	[Sato, Yuki; Poynter, Greg; Huss, David; Fraser, Scott E.; Lansford, Rusty] CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA; [Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	California Institute of Technology; University of Kansas; University of Kansas Medical Center	Sato, Y (corresponding author), CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA.	rusty@caltech.edu	Fraser, Scott/Y-3406-2019; Czirok, Andras/E-4253-2014; Rongish, Brenda/G-7637-2016; Lansford, Rusty/C-6956-2014; Rochel, Natacha/A-5718-2016; Sato, Yoshinori/J-2497-2015	Fraser, Scott/0000-0002-5377-0223; Czirok, Andras/0000-0002-2694-5163; Rongish, Brenda/0000-0002-1559-2876; Lansford, Rusty/0000-0002-2159-3699; Ueno, Takamasa/0000-0003-4852-4236; Poussin-Courmontagne, Pierre/0000-0003-4813-6882; POTIER, Noelle/0000-0002-6381-4365; Rochel, Natacha/0000-0002-3573-5889; Takata, Hiroshi/0000-0003-1457-6919; Nakagata, Naomi/0000-0002-5737-9993; Sato, Yoshinori/0000-0001-8250-6598	National Institutes of Health (NIH) National Center for Research Resources [R21HD047347-01]; NIH National Heart, Lung, and Blood Institute [(R01) HL085694, HL068855, HL87136]; NIH Center of Excellence in Genomic Science [P50 HG004071]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047347] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085694, R01HL087136, R01HL068855] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Center of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grants by the National Institutes of Health (NIH) National Center for Research Resources (R21HD047347-01), NIH National Heart, Lung, and Blood Institute (R01) HL085694 (BJR), HL068855 (CDL), HL87136 (AC), and NIH Center of Excellence in Genomic Science (P50 HG004071) supported the work. Y.S. was a postdoctoral fellow for research abroad of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Blomer U, 1997, J VIROL, V71, P6641; Cleaver O, 1998, DEVELOPMENT, V125, P3905; COFFIN JD, 1991, ANAT REC, V231, P383; Czirok A, 2002, J MICROSC-OXFORD, V206, P209, DOI 10.1046/j.1365-2818.2002.01032.x; DE PALMA M, 2003, HUM GENE THER, V14, P1193; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DERUITER MC, 1993, ANAT RECORD, V235, P261, DOI 10.1002/ar.1092350210; DRAKE CJ, 1992, DEV DYNAM, V193, P83, DOI 10.1002/aja.1001930111; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Eichmann A, 2005, INT J DEV BIOL, V49, P259, DOI 10.1387/ijdb.041941ae; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GONZALEZCRUSSI F, 1971, AM J ANAT, V130, P441, DOI 10.1002/aja.1001300406; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Huss D, 2008, LAB ANIMAL, V37, P513, DOI 10.1038/laban1108-513; Iljin K, 2002, FASEB J, V16, P1764, DOI 10.1096/fj.01-1043com; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; PARDANAUD L, 1987, CELL DIFFER DEV, V22, P47, DOI 10.1016/0045-6039(87)90412-X; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Perryn ED, 2008, DEV BIOL, V313, P545, DOI 10.1016/j.ydbio.2007.10.036; Pinter E, 1997, AM J PATHOL, V150, P1523; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; POYNTER G, 2009, COLD SPRING HARBOR P; Pudliszewski M, 2005, INT J DEV BIOL, V49, P355, DOI 10.1387/ijdb.041956mp; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; ROMANOFF A, 1960, HEMATOPOIETIC VASCUL, P571; Rupp PA, 2004, DEVELOPMENT, V131, P2887, DOI 10.1242/dev.01160; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Sedmera D, 2006, ANAT REC PART A, V288A, P933, DOI 10.1002/ar.a.20383; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Trinkaus J.P., 1969, CELLS ORGANS FORCES, Vfirst; Zamir EA, 2005, ANN BIOMED ENG, V33, P854, DOI 10.1007/s10439-005-3037-7; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	50	104	105	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12674	10.1371/journal.pone.0012674	http://dx.doi.org/10.1371/journal.pone.0012674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	21152046	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000281815700006
J	Zhang, Y; Zhu, SL; Yan, DM; Liu, GY; Bai, RY; Wang, DY; Chen, L; Zhu, H; An, HQ; Kew, O; Xu, WB				Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Kew, Olen; Xu, Wenbo			Natural Type 3/Type 2 Intertypic Vaccine-Related Poliovirus Recombinants with the First Crossover Sites within the VP1 Capsid Coding Region	PLOS ONE			English	Article							POLIOMYELITIS; GENOMES; VIRUS; CHILD; CIRCULATION; SEROTYPE-2; SEQUENCES; OUTBREAK; MUTATION; STRAINS	Background: Ten uncommon natural type 3/type 2 intertypic poliovirus recombinants were isolated from stool specimens from nine acute flaccid paralysis case patients and one healthy vaccinee in China from 2001 to 2008. Principal Findings: Complete genomic sequences revealed their vaccine-related genomic features and showed that their first crossover sites were randomly distributed in the 39 end of the VP1 coding region. The length of donor Sabin 2 sequences ranged from 55 to 136 nucleotides, which is the longest donor sequence reported in the literature for this type of poliovirus recombination. The recombination resulted in the introduction of Sabin 2 neutralizing antigenic site 3a (NAg3a) into a Sabin 3 genomic background in the VP1 coding region, which may have been altered by some of the type 3-specific antigenic properties, but had not acquired any type 2-specific characterizations. NAg3a of the Sabin 3 strain seems atypical; other wild-type poliovirus isolates that have circulated in recent years have sequences of NAg3a more like the Sabin 2 strain. Conclusions: 10 natural type 3/type 2 intertypic VP1 capsid-recombinant polioviruses, in which the first crossover sites were found to be in the VP1 coding region, were isolated and characterized. In spite of the complete replacement of NAg3a by type 2-specific amino acids, the serotypes of the recombinants were not altered, and they were totally neutralized by polyclonal type 3 antisera but not at all by type 2 antisera. It is possible that recent type 3 wild poliovirus isolates may be a recombinant having NAg3a sequences derived from another strain during between 1967 and 1980, and the type 3/type 2 recombination events in the 39 end of the VP1 coding region may result in a higher fitness.	[Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Bai, Ruyin] Taishan Med Univ, Taishan City, Peoples R China; [Kew, Olen] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong First Medical University & Shandong Academy of Medical Sciences; Centers for Disease Control & Prevention - USA	Zhang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	National Key Technology R&D Program of China [2008BAI56B00]; National Key Science and Technology Projects of China [2008ZX10004-008]; World Health Organization [I8/181/978]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); National Key Science and Technology Projects of China; World Health Organization(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Key Technology R&D Program of China (Project No. 2008BAI56B00), National Key Science and Technology Projects of China (Project No. 2008ZX10004-008), and a grant I8/181/978 from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; BALANANT J, 1991, VIROLOGY, V184, P645, DOI 10.1016/0042-6822(91)90434-D; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Dedepsidis E, 2008, FEMS IMMUNOL MED MIC, V52, P343, DOI 10.1111/j.1574-695X.2008.00381.x; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-28; Friedrich F, 1996, ACTA VIROL, V40, P27; FURIONE M, 1993, VIROLOGY, V196, P199; HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Karakasiliotis L, 2004, MOL CELL PROBE, V18, P103, DOI 10.1016/j.mcp.2003.09.009; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KOHARA M, 1988, J VIROL, V62, P2828, DOI 10.1128/JVI.62.8.2828-2835.1988; KOHARA M, 1985, J VIROL, V53, P786, DOI 10.1128/JVI.53.3.786-792.1985; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; LIPSKAYA GY, 1991, J MED VIROL, V35, P290, DOI 10.1002/jmv.1890350415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin J, 2002, J VIROL, V76, P10921, DOI 10.1128/JVI.76.21.10921-10928.2002; Martinez CV, 2004, J INFECT DIS, V190, P409, DOI 10.1086/421703; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; MINOR PD, 1989, J GEN VIROL, V70, P1117, DOI 10.1099/0022-1317-70-5-1117; MINOR PD, 1992, J GEN VIROL, V73, P3065, DOI 10.1099/0022-1317-73-12-3065; MINOR PD, 1993, DEV BIOL STAND, V78, P17; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shahmahmoodi S, 2008, VIRUS RES, V137, P168, DOI 10.1016/j.virusres.2008.07.006; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2010, VIRUS RES, V150, P56, DOI 10.1016/j.virusres.2010.02.014; TOYODA H, 1984, J MOL BIOL, V174, P561, DOI 10.1016/0022-2836(84)90084-6; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; World Health Organization, 2004, POL LAB MAN, V4th; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2010, ARCH VIROL, V155, P197, DOI 10.1007/s00705-009-0564-9	43	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15300	10.1371/journal.pone.0015300	http://dx.doi.org/10.1371/journal.pone.0015300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	20463924	Green Published, gold, Green Submitted			2022-12-27	WOS:000285576900026
J	Zhang, Y; Schulte, W; Pink, D; Phipps, K; Zijlstra, A; Lewis, JD; Waisman, DM				Zhang, Yi; Schulte, Wendy; Pink, Desmond; Phipps, Kyle; Zijlstra, Andries; Lewis, John D.; Waisman, David Morton			Sensitivity of Cancer Cells to Truncated Diphtheria Toxin	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; FACTOR FUSION PROTEIN; GROWTH-FACTOR; DENILEUKIN DIFTITOX; CYNOMOLGUS MONKEYS; MOUSE MODEL; IN-VIVO; EXPRESSION; CYTOTOXICITY	Background: Diphtheria toxin (DT) has been utilized as a prospective anti-cancer agent for the targeted delivery of cytotoxic therapy to otherwise untreatable neoplasia. DT is an extremely potent toxin for which the entry of a single molecule into a cell can be lethal. DT has been targeted to cancer cells by deleting the cell receptor-binding domain and combining the remaining catalytic portion with targeting proteins that selectively bind to the surface of cancer cells. It has been assumed that "receptorless'' DT cannot bind to and kill cells. In the present study, we report that "receptorless'' recombinant DT385 is in fact cytotoxic to a variety of cancer cell lines. Methods: In vitro cytotoxicity of DT385 was measured by cell proliferation, cell staining and apoptosis assays. For in vivo studies, the chick chorioallantoic membrane (CAM) system was used to evaluate the effect of DT385 on angiogenesis. The CAM and mouse model system was used to evaluate the effect of DT385 on HEp3 and Lewis lung carcinoma (LLC) tumor growth, respectively. Results: Of 18 human cancer cell lines tested, 15 were affected by DT385 with IC(50) ranging from 0.12-2.8 mu M. Furthermore, high concentrations of DT385 failed to affect growth arrested cells. The cellular toxicity of DT385 was due to the inhibition of protein synthesis and induction of apoptosis. In vivo, DT385 diminished angiogenesis and decreased tumor growth in the CAM system, and inhibited the subcutaneous growth of LLC tumors in mice. Conclusion: DT385 possesses anti-angiogenic and anti-tumor activity and may have potential as a therapeutic agent.	[Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Schulte, Wendy; Pink, Desmond; Zijlstra, Andries; Lewis, John D.] Innovascreen Inc, Halifax, NS, Canada; [Zijlstra, Andries] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Lewis, John D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Dalhousie University; Dalhousie University; Vanderbilt University; Western University (University of Western Ontario)	Zhang, Y (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	david.waisman@dal.ca	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation [018176]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Nova Scotia Health Research Foundation (NSHRF). YZ is supported by a studentship from the Cancer Research Training Program, Dalhousie University. JDL is supported by grant #018176 from the NCIC/Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley RG, 2003, CANCER RES, V63, P5866; BENITEZKING G, 1989, J CELL SCI, V93, P53; Black JH, 2003, LEUKEMIA, V17, P155, DOI 10.1038/sj.leu.2402744; CHADWICK DE, 1993, LEUKEMIA LYMPHOMA, V11, P249, DOI 10.3109/10428199309087002; Chan CH, 1996, BLOOD, V88, P1445, DOI 10.1182/blood.V88.4.1445.bloodjournal8841445; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Cohen KA, 2004, LEUKEMIA LYMPHOMA, V45, P1647, DOI 10.1080/10428190410001663572; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Duvic M, 2008, FUTURE ONCOL, V4, P457, DOI 10.2217/14796694.4.4.457; Falnes PO, 1998, EMBO J, V17, P615, DOI 10.1093/emboj/17.2.615; Feuring-Buske M, 2000, EXP HEMATOL, V28, P1390, DOI 10.1016/S0301-472X(00)00542-7; FITZGERALD D, 1989, J NATL CANCER I, V81, P1455, DOI 10.1093/jnci/81.19.1455; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GILL DM, 1973, J BIOL CHEM, V248, P654; Gonzalez-Moreno O, 2005, INT J CANCER, V114, P870, DOI 10.1002/ijc.20789; Hall PD, 1999, LEUKEMIA, V13, P629, DOI 10.1038/sj.leu.2401357; Hogge DE, 2006, CLIN CANCER RES, V12, P1284, DOI 10.1158/1078-0432.CCR-05-2070; HONJO T, 1971, J BIOL CHEM, V246, P4251; Hotchkiss CE, 1999, TOXICOL APPL PHARM, V158, P152, DOI 10.1006/taap.1999.8691; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; KIND C, 1975, ANAT EMBRYOL, V147, P127, DOI 10.1007/BF00306727; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kwon M, 2001, BIOCHEMISTRY-US, V40, P13246, DOI 10.1021/bi0113420; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; MADSHUS IH, 1992, CURR TOP MICROBIOL, V175, P1; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; MOYNIHAN MR, 1981, INFECT IMMUN, V32, P575, DOI 10.1128/IAI.32.2.575-582.1981; MURPHY JR, 1986, P NATL ACAD SCI USA, V83, P8258, DOI 10.1073/pnas.83.21.8258; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Ramage JG, 2003, LEUKEMIA RES, V27, P79, DOI 10.1016/S0145-2126(02)00077-2; Ramakrishnan S, 1996, CANCER RES, V56, P1324; Turturro F, 2007, EXPERT REV ANTICANC, V7, P11, DOI 10.1586/14737140.7.1.11; Urieto JO, 2004, PROTEIN EXPRES PURIF, V33, P123, DOI 10.1016/j.pep.2003.09.003; Wild R, 2004, BREAST CANCER RES TR, V85, P161, DOI 10.1023/B:BREA.0000025407.02896.ec; WILLIAMS DP, 1990, J BIOL CHEM, V265, P20673; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	40	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10498	10.1371/journal.pone.0010498	http://dx.doi.org/10.1371/journal.pone.0010498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463924	Green Submitted, Green Published, gold			2022-12-27	WOS:000277379400031
